PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Moreno, M; Silvestri, E; De Matteis, R; de Lange, P; Lombardi, A; Glinni, D; Senese, R; Cioffi, F; Salzano, AM; Scaloni, A; Lanni, A; Goglia, F				Moreno, Maria; Silvestri, Elena; De Matteis, Rita; de lange, Pieter; Lombardi, Assunta; Glinni, Daniela; Senese, Rosalba; Cioffi, Federica; Salzano, Anna Maria; Scaloni, Andrea; Lanni, Antonia; Goglia, Fernando			3,5-Diiodo-L-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations	FASEB JOURNAL			English	Article						thyroid hormone; metabolism; proteomics	AKT/PROTEIN KINASE-B; PROTEIN-KINASE; ACID-METABOLISM; GLYCOGEN-SYNTHESIS; GLUCOSE-TRANSPORT; WEIGHT-LOSS; AMINO-ACID; OBESITY; CELLS; RED	The worldwide prevalence of obesity-associated pathologies, including type 2 diabetes, requires thorough investigation of mechanisms and interventions. Recent studies have highlighted thyroid hormone analogs and derivatives as potential agents able to counteract such pathologies. In this study, in rats receiving a high-fat diet (HFD), we analyzed the effects of a 4-wk daily administration of a naturally occurring iodothyronine, 3,5-diiodo-L-thyronine (T2), on the gastrocnemius muscle metabolic/structural phenotype and insulin signaling. The HFD-induced increases in muscle levels of fatty acid translocase (3-fold; P<0.05) and TGs (2-fold, P<0.05) were prevented by T2 (each; P<0.05 vs. HFD). T2 increased insulin-stimulated Akt phosphorylation levels (similar to 2.5-fold; P<0.05 vs. HFD). T2 induced these effects while sparing muscle mass and without cardiac hypertrophy. T2 increased the muscle contents of fast/glycolytic fibers (2-fold; P<0.05 vs. HFD) and sarcolemmal glucose transporter 4 (3-fold; P<0.05 vs. HFD). Adipocyte differentiation-related protein was predominantly present within the slow/oxidative fibers in HFD-T2. In T2-treated rats (vs. HFD), glycolytic enzymes and associated components were up-regulated (proteomic analysis, significance limit: 2-fold; P<0.05), as was phosphofructokinase activity (by 1.3-fold; P<0.05), supporting the metabolic shift toward a more glycolytic phenotype. These results highlight T2 as a potential therapeutic approach to the treatment of diet-induced metabolic dysfunctions.-Moreno, M., Silvestri, E., De Matteis, R., de Lange, P., Lombardi, A., Glinni, D., Senese, R., Cioffi, F., Salzano, A. M., Scaloni, A., Lanni, A., Goglia, F. 3,5-Diiodo-L-thyronine prevents high-fat diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB J. 25, 3312-3324 (2011). www.fasebj.org	[Moreno, Maria; Silvestri, Elena; Glinni, Daniela; Goglia, Fernando] Univ Sannio, Dipartimento Sci Biol Geol & Ambiente, I-82100 Benevento, Italy; [De Matteis, Rita] Univ Urbino Carlo Bo, Dipartimento Sci Biomol, Urbino, Italy; [de lange, Pieter; Senese, Rosalba; Cioffi, Federica; Lanni, Antonia] Univ Naples 2, Dipartimento Sci Vita, Caserta, Italy; [Lombardi, Assunta] Univ Naples Federico II, Sez Fisiol & Igiene, Dipartimento Sci Biol, Naples, Italy; [Salzano, Anna Maria; Scaloni, Andrea] CNR, Inst Sistema Produz Anim Ambiente Mediterraneo 2, Lab Prote & Spettrometria Massa, Naples, Italy	University of Sannio; University of Urbino; Universita della Campania Vanvitelli; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR)	Goglia, F (corresponding author), Univ Sannio, Dipartimento Sci Biol Geol & Ambiente, Via Portarsa 11, I-82100 Benevento, Italy.	goglia@unisannio.it	Salzano, Anna Maria/C-7139-2012; cioffi, federica/AAB-8161-2019; de Lange, Pieter/GXA-3052-2022; De+Matteis, Rita/AAG-6904-2019	Salzano, Anna Maria/0000-0001-7192-8760; cioffi, federica/0000-0002-1530-8556; SENESE, Rosalba/0000-0003-1571-0980; MORENO, Maria/0000-0002-6218-5501; Scaloni, Andrea/0000-0001-9362-8515; DE MATTEIS, Rita/0000-0003-4665-4547; Silvestri, Elena/0000-0002-0592-9033; GOGLIA, Fernando/0000-0003-0468-9645	Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR) Cofinanziamento (COFIN) [20089SRS2X]; MIUR Fondo Investimento Ricerca di Base (FIRB) Medical Research in Italy (MERIT) [RBNE08YFN3_003]; Regione Campania; Regione Campania Rete di Spettrometria di Massa	Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR) Cofinanziamento (COFIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); MIUR Fondo Investimento Ricerca di Base (FIRB) Medical Research in Italy (MERIT); Regione Campania(Regione Campania); Regione Campania Rete di Spettrometria di Massa	This work was partially supported by the following grants: Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR) Cofinanziamento (COFIN) 2008 Protocol 20089SRS2X, MIUR Fondo Investimento Ricerca di Base (FIRB) Medical Research in Italy (MERIT) RBNE08YFN3_003, Regione Campania 2008, and Regione Campania Rete di Spettrometria di Massa.	Albright A, 2000, MED SCI SPORT EXER, V32, P1345; Behan WMH, 2002, J CLIN PATHOL, V55, P375, DOI 10.1136/jcp.55.5.375; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Chabowski A, 2006, AM J PHYSIOL-ENDOC M, V291, pE675, DOI 10.1152/ajpendo.00096.2006; de Lange P, 2008, ENDOCRINOLOGY, V149, P6462, DOI 10.1210/en.2008-0202; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Dimitriadis G, 1997, EUR J CLIN INVEST, V27, P475, DOI 10.1046/j.1365-2362.1997.1380688.x; DIMITRIADIS GD, 1989, BIOCHEM J, V257, P369, DOI 10.1042/bj2570369; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Lanni A, 2005, FASEB J, V19, DOI 10.1096/fj.05.3977fje; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; Miyabara EH, 2005, CELL TISSUE RES, V321, P233, DOI 10.1007/s00441-005-1119-3; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; OPIE LH, 1967, BIOCHEM J, V103, P391, DOI 10.1042/bj1030391; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Phillips SA, 2005, OBES RES, V13, P1321, DOI 10.1038/oby.2005.160; Pimenta AS, 2008, J CELL PHYSIOL, V217, P478, DOI 10.1002/jcp.21520; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; RANDLE PJ, 1963, LANCET, V1, P785; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmitz KH, 2007, AM J CLIN NUTR, V86, P566, DOI 10.1093/ajcn/86.3.566; Scippa GS, 2010, ELECTROPHORESIS, V31, P497, DOI 10.1002/elps.200900459; Silvestri E, 2007, J PROTEOME RES, V6, P3187, DOI 10.1021/pr0701299; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Talamo F, 2003, PROTEOMICS, V3, P440, DOI 10.1002/pmic.200390059; Tanner CJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE1191, DOI 10.1152/ajpendo.00416.2001; Tremblay F, 2001, DIABETES, V50, P1901, DOI 10.2337/diabetes.50.8.1901; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; van Loon LJC, 2006, PFLUG ARCH EUR J PHY, V451, P606, DOI 10.1007/s00424-005-1509-0; Watt MJ, 2009, CLIN EXP PHARMACOL P, V36, P5, DOI 10.1111/j.1440-1681.2008.05075.x; WEINSTEIN SP, 1994, DIABETES, V43, P1185, DOI 10.2337/diabetes.43.10.1185; WEINSTEIN SP, 1991, ENDOCRINOLOGY, V129, P455, DOI 10.1210/endo-129-1-455	45	65	67	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3312	3324		10.1096/fj.11-181982	http://dx.doi.org/10.1096/fj.11-181982			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21670063				2022-12-25	WOS:000295356400004
J	Holloway, C; Cochlin, L; Codreanu, I; Bloch, E; Fatemian, M; Szmigielski, C; Atherton, H; Heather, L; Francis, J; Neubauer, S; Robbins, P; Montgomery, H; Clarke, K				Holloway, Cameron; Cochlin, Lowri; Codreanu, Ion; Bloch, Edward; Fatemian, Marzieh; Szmigielski, Cezary; Atherton, Helen; Heather, Lisa; Francis, Jane; Neubauer, Stefan; Robbins, Peter; Montgomery, Hugh; Clarke, Kieran			Normobaric hypoxia impairs human cardiac energetics	FASEB JOURNAL			English	Article						cardiac energy metabolism; cardiac diastolic function; hypoxic chamber	MAGNETIC-RESONANCE-SPECTROSCOPY; HIGH-ALTITUDE; HEART; TOLERANCE; MAMMALS; HIF-1	Hypoxia causes left ventricular dysfunction in the human heart, but the biochemical mechanism is poorly understood. Here, we tested whether short-term normobaric hypoxia leads to changes in cardiac energetics and early cardiac dysfunction. Healthy male volunteers (n = 12, age 24 +/- 2 yr) were exposed to normobaric hypoxia in a purpose-built hypoxic chamber. The partial pressure of oxygen during end-tidal expiration (P(ET)O(2)) was kept between 50 and 60 mmHg, and peripheral oxygen saturation (SaO(2)) was kept above 80%. Cardiac morphology and function were assessed using magnetic resonance imaging and echocardiography, both before and after 20 h of hypoxic exposure, and high-energy phosphate metabolism [measured as the phosphocreatine (PCr)/ATP ratio] was measured using (31)P magnetic resonance spectroscopy. During hypoxia, PETO(2) and SaO(2) averaged 55 +/- 1 mmHg and 83.6 +/- 0.4%, respectively. Hypoxia caused a 15% reduction in cardiac PCr/ATP (from 2.0 +/- 0.1 to 1.7 +/- 0.1, P<0.01) and reduced diastolic function (measured as E/E ', rising from 6.1 +/- 0.4 to 7.5 +/- 0.7, P<0.01). Normobaric hypoxia causes a rapid decrease in high-energy phosphate metabolism in the human cardiac left ventricle, which may lead to a decline in diastolic function. These findings are important in understanding the response of normal individuals to environmental hypoxia, and to situations in which disease reduces cardiac oxygen delivery.-Holloway, C., Cochlin, L., Codreanu, I., Bloch, E., Fatemian, M., Szmigielski, C., Atherton, H., Heather, L., Francis, J., Neubauer, S., Robbins, P., Montgomery, H., Clarke, K. Normobaric hypoxia impairs human cardiac energetics. FASEB J. 25, 3130-3135 (2011). www.fasebj.org	[Holloway, Cameron; Cochlin, Lowri; Codreanu, Ion; Bloch, Edward; Fatemian, Marzieh; Atherton, Helen; Heather, Lisa; Robbins, Peter; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Holloway, Cameron; Cochlin, Lowri; Codreanu, Ion; Szmigielski, Cezary; Francis, Jane; Neubauer, Stefan] Univ Oxford, Univ Oxford Ctr Clin Magnet Resonance Res, Oxford OX1 3PT, England; [Montgomery, Hugh] UCL, Inst Sport Exercise & Hlth, London, England; [Montgomery, Hugh] UCL, Univ Coll London Inst Human Hlth & Performance, London, England	University of Oxford; University of Oxford; University of London; University College London; University of London; University College London	Holloway, C (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	cameron.holloway@dpag.ox.ac.uk	Codreanu, Ion/AAS-4378-2020; Montgomery, Hugh/L-1229-2019; Robbins, Peter/C-7846-2016; Montgomery, Hugh/C-2592-2008	Codreanu, Ion/0000-0002-2644-5572; Szmigielski, Cezary/0000-0002-0837-6323; Bloch, Edward/0000-0002-0799-3258; Heather, Lisa/0000-0002-7246-1338; Robbins, Peter/0000-0002-4975-0609; Montgomery, Hugh/0000-0001-8797-5019; Neubauer, Stefan/0000-0001-9017-5645	British Heart Foundation (BHF); BHF Centre of Research Excellence, Oxford, UK; British Heart Foundation [PS/02/002/14893, RG/07/004/22659] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); BHF Centre of Research Excellence, Oxford, UK; British Heart Foundation(British Heart Foundation)	The authors thank Emma Carter for plasma metabolite analysis and Dr Robert Olszewski for assistance with the echocardiography. The authors are also very thankful to Federico Formenti and David O'Connor for their assistance with running the hypoxic chamber. The British Heart Foundation (BHF) supported this work. S.N. acknowledges support from the BHF Centre of Research Excellence, Oxford, UK.	Allemann Y, 2004, AM J PHYSIOL-HEART C, V286, pH856, DOI 10.1152/ajpheart.00518.2003; Andrews MT, 2004, BIOCHEM SOC T, V32, P1021, DOI 10.1042/BST0321021; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; BALASUBRAMANIAN V, 1978, CIRCULATION, V57, P1180, DOI 10.1161/01.CIR.57.6.1180; BOTTOMLEY PA, 1992, MAGNET RESON MED, V24, P384, DOI 10.1002/mrm.1910240220; Boussuges A, 2000, AM J RESP CRIT CARE, V161, P264, DOI 10.1164/ajrccm.161.1.9902096; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P1215, DOI 10.1073/pnas.93.3.1215; HOLLOWAY CJ, AM J CLIN NUTR, V93, P748; HOLLOWAY CJ, FASEB J, V25, P792; HOWARD LSGE, 1995, J APPL PHYSIOL, V78, P1088, DOI 10.1152/jappl.1995.78.3.1088; Hudsmith LE, 2008, NAT CLIN PRACT CARD, V5, pS49, DOI 10.1038/ncpcardio1158; Hudsmith LE, 2006, J MAGN RESON IMAGING, V24, P312, DOI 10.1002/jmri.20638; Jung WI, 2000, CIRCULATION, V101, pE121, DOI 10.1161/01.CIR.101.12.e121; Kelly DP, 2008, NAT GENET, V40, P132, DOI 10.1038/ng0208-132; Kjaergaard J, 2006, EUR J APPL PHYSIOL, V98, P411, DOI 10.1007/s00421-006-0299-1; KOLLER EA, 1991, EUR J APPL PHYSIOL O, V62, P228, DOI 10.1007/BF00643747; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Robson MD, 2005, MAGNET RESON MED, V53, P267, DOI 10.1002/mrm.20344; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shen WQ, 1999, CIRCULATION, V100, P2113, DOI 10.1161/01.CIR.100.20.2113; Tyler DJ, 2009, NMR BIOMED, V22, P405, DOI 10.1002/nbm.1350	29	27	29	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					3130	3135		10.1096/fj.11-183426	http://dx.doi.org/10.1096/fj.11-183426			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21646398				2022-12-25	WOS:000294435200026
J	Townsend, D; Yasuda, S; McNally, E; Metzger, JM				Townsend, DeWayne; Yasuda, Soichiro; McNally, Elizabeth; Metzger, Joseph M.			Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex	FASEB JOURNAL			English	Article						muscular dystrophy; hemodynamics; cellular compliance; cardiac fibrosis	GIRDLE MUSCULAR-DYSTROPHY; NITRIC-OXIDE SYNTHASE; GAMMA-SARCOGLYCAN; BETA-SARCOGLYCAN; SMOOTH-MUSCLE; SKELETAL-MUSCLE; PROTEIN; DEFICIENCY; MUTATIONS; DISRUPTION	Duchenne muscular dystrophy (DMD) and limb girdle muscular dystrophy (LGMD) 2C-F result from the loss of dystrophin and the sarcoglycans, respectively. Dystrophin, a cytoskeletal protein, is closely associated with the membrane-bound sarcoglycan complex. Despite this tight biochemical association, the function of dystrophin and the sarcoglycan subunits may differ. The loss of dystrophin in skeletal muscle results in muscle that is highly susceptible to contraction-induced damage, but the skeletal muscle of mice lacking gamma- or delta-sarcoglycan are less susceptible. Using mouse models of DMD, LGMD-2C, and LGMD-2F, we demonstrate that isolated cardiac myocytes from mice lacking either gamma- or delta-sarcoglycan have normal compliance. In contrast, dystrophin-deficient myocytes display poor passive compliance and are susceptible to terminal contracture following mild passive extensions. Mice deficient in dystrophin and, less so, delta-sarcoglycan have reduced survival during in vivo dobutamine stress testing compared to controls. Catheter-based hemodynamic studies show deficits in both baseline and dobutamine-stimulated cardiac function in all of the dystrophic mice compared to control mice, with dystrophin-deficient mice having the poorest function. In contrast, histopathology showed increased fibrosis in the sarcoglycan-deficient hearts, but not in hearts lacking dystrophin. In summary, this study provides important insights into the unique mechanisms of disease underlying these different models of inherited dystrophic cardiomyopathy and supports a model where dystrophin, but not the sarcoglycans, protects the cardiac myocyte against mechanical damage.-Townsend, D., Yasuda, S., McNally, E., Metzger, J. M. Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex. FASEB J. 25, 3106-3114 (2011). www.fasebj.org	[Townsend, DeWayne; Yasuda, Soichiro; Metzger, Joseph M.] Univ Minnesota, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [McNally, Elizabeth] Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Chicago	Townsend, D (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, 6-125 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	town0045@umn.edu	McNally, Elizabeth/W-4909-2019	McNally, Elizabeth/0000-0002-1221-719X	Muscular Dystrophy Association [68419]; U.S. National Institutes of Health [HL61322, HL102066, HL086790]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086790, K08HL102066, R01HL061322] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the Muscular Dystrophy Association (68419 to D. T.) and the U.S. National Institutes of Health (HL61322 to E. M., HL102066 to D. T., and HL086790 to J.M.).	Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Barton ER, 2010, J BIOL CHEM, V285, P17263, DOI 10.1074/jbc.M109.063990; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Bies RD, 1997, J MOL CELL CARDIOL, V29, P3175, DOI 10.1006/jmcc.1997.0568; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; Bosser G, 2004, AM J CARDIOL, V93, P724, DOI 10.1016/j.amjcard.2003.12.005; BRUTSAERT DL, 1989, PHYSIOL REV, V69, P1228, DOI 10.1152/physrev.1989.69.4.1228; Bushby KMD, 1999, HUM MOL GENET, V8, P1875, DOI 10.1093/hmg/8.10.1875; Chen JW, 2007, BBA-MOL BASIS DIS, V1772, P570, DOI 10.1016/j.bbadis.2007.01.014; Cohn RD, 2001, J CLIN INVEST, V107, pR1, DOI 10.1172/JCI11642; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; Duchenne, 1867, Br Med J, V2, P541; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2000, MOL CELL, V5, P141, DOI 10.1016/S1097-2765(00)80410-4; Durbeej M, 2003, P NATL ACAD SCI USA, V100, P8910, DOI 10.1073/pnas.1537554100; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Griffin MA, 2005, J CELL SCI, V118, P1405, DOI 10.1242/jcs.01717; Hack AA, 2000, J CELL SCI, V113, P2535; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hack AA, 1999, P NATL ACAD SCI USA, V96, P10723, DOI 10.1073/pnas.96.19.10723; Hainsey TA, 2003, NEUROMUSCULAR DISORD, V13, P294, DOI 10.1016/S0960-8966(02)00286-9; Heydemann A, 2005, NEUROMUSCULAR DISORD, V15, P601, DOI 10.1016/j.nmd.2005.05.004; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Iwata Y, 2005, MOL CELL BIOCHEM, V268, P59, DOI 10.1007/s11010-005-2998-z; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Li DJ, 2009, HUM MOL GENET, V18, P1209, DOI 10.1093/hmg/ddp015; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Markham LW, 2006, J AM SOC ECHOCARDIOG, V19, P865, DOI 10.1016/j.echo.2006.02.003; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; Norwood F, 2007, EUR J NEUROL, V14, P1305, DOI 10.1111/j.1468-1331.2007.01979.x; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; Pratali L, 2001, AM J CARDIOL, V88, P1374, DOI 10.1016/S0002-9149(01)02116-6; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; Ross J, 1883, Br Med J, V1, P200; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Sen S, 2011, EUR J CELL BIOL, V90, P249, DOI 10.1016/j.ejcb.2010.06.005; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; Townsend D, 2008, MOL THER, V16, P832, DOI 10.1038/mt.2008.52; Townsend D, 2007, MOL THER, V15, P1086, DOI 10.1038/sj.mt.6300144; Trabelsi M, 2008, EUR J HUM GENET, V16, P793, DOI 10.1038/ejhg.2008.9; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; van der Kooi AJ, 1998, HEART, V79, P73, DOI 10.1136/hrt.79.1.73; Vatta M, 2004, J AM COLL CARDIOL, V43, P811, DOI 10.1016/j.jacc.2003.09.052; WALTON JN, 1954, BRAIN, V77, P169, DOI 10.1093/brain/77.2.169; Wheeler MT, 2004, AM J PATHOL, V164, P1063, DOI 10.1016/S0002-9440(10)63193-8; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Yasuda S, 2005, NATURE, V436, P1025, DOI 10.1038/nature03844	57	32	34	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3106	3114		10.1096/fj.10-178913	http://dx.doi.org/10.1096/fj.10-178913			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21665956	Green Published			2022-12-25	WOS:000294435200024
J	Childers, BM; Cao, XH; Weber, GG; Demeler, B; Hart, PJ; Klose, KE				Childers, Brandon M.; Cao, Xiaohang; Weber, Gregor G.; Demeler, Borries; Hart, P. John; Klose, Karl E.			N-terminal Residues of the Vibrio cholerae Virulence Regulatory Protein ToxT Involved in Dimerization and Modulation by Fatty Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; MOLECULAR-WEIGHT; IDENTIFICATION; COLONIZATION; MECHANISMS; INHIBITOR; MOTILITY; VECTORS; CASCADE	The regulatory protein ToxT is an AraC family protein that is responsible for activating transcription of the genes encoding cholera toxin and toxin coregulated pilus, which are required for virulence by the human pathogen Vibrio cholerae. The N terminus of ToxT contains dimerization and regulatory elements, whereas the C terminus contains the DNA binding domain. Bile and long chain fatty acids negatively regulate ToxT activity. Utilizing a comprehensive alanine substitution mutant library of ToxT, 19 N-terminal residues were found to be critical for dimerization and transcriptional activation. One of these mutant proteins (F151A) was confirmed to be monomeric via centrifugation and exhibited a weakened ability to bind to the tcpA promoter in a gel mobility shift assay. Moreover, a V. cholerae toxTF151A mutant failed to colonize the infant mouse intestine, emphasizing the importance of ToxT N-terminal dimerization to cholera pathogenesis. Six N-terminal alanine substitutions allowed ToxT transcriptional activity in the presence of inhibitory concentrations of bile, palmitoleic acid, and the small molecule inhibitor virstatin. Two of these mutations (N106A and L114A) enhance N-terminal dimerization in a bacterial two-hybrid system reconstituted in V. cholerae, which is otherwise disrupted by bile, palmitoleic acid, and virstatin. We demonstrate that V. cholerae toxTN106A and toxTL114A strains colonize the infant mouse intestine at significantly higher levels than the wild type strain. Our results demonstrate that ToxT N-terminal dimerization is required for transcriptional activation and cholera pathogenesis and that fatty acids modulate ToxT activity via modulation of dimerization.	[Childers, Brandon M.; Weber, Gregor G.; Klose, Karl E.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Childers, Brandon M.; Weber, Gregor G.; Klose, Karl E.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Cao, Xiaohang; Demeler, Borries; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Klose, KE (corresponding author), Univ Texas San Antonio, Dept Biol, 1 UTSA Circle, San Antonio, TX 78249 USA.	Karl.Klose@utsa.edu		Demeler, Borries/0000-0002-2414-9518	National Institutes of Health [AI51333, RR-022200, P30 CA054174]; Robert Welch Foundation [AQ-1399]; National Science Foundation [TG-MCB070039]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051333, R56AI051333] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI51333 (to K.E.K.). This work was also supported by Robert Welch Foundation Grant AQ-1399 (to P.J.H.).; We thank John Mekalanos for the V. cholerae transposon library and Haruo Watanabe for the toxT::Cm V. cholerae strain SY1002. Supercomputer analysis was performed on Lonestar at the Texas Advanced Computing Center using National Science Foundation Allocation Grant TG-MCB070039 (to B. D.). The Ultra-Scan development was supported by National Institutes of Health Grant RR-022200 (to B. D.). Analytical ultracentrifugation experiments were performed by Virgil Schirf at the Center for Analytical Ultracentrifugation of Macromolecular Assemblies, supported by National Institutes of Health Grant P30 CA054174 to Cancer Therapy and Research Center in San Antonio.	Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; Brookes E, 2006, PROG COLL POL SCI S, V131, P33, DOI 10.1007/2882_004; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P405, DOI 10.1007/s00249-009-0413-5; Brookes EH, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P361; Cameron DE, 2008, P NATL ACAD SCI USA, V105, P8736, DOI 10.1073/pnas.0803281105; Champion GA, 1997, MOL MICROBIOL, V23, P323, DOI 10.1046/j.1365-2958.1997.2191585.x; Chatterjee A, 2007, INFECT IMMUN, V75, P1946, DOI 10.1128/IAI.01435-06; Chatterjee S, 2010, FEMS MICROBIOL LETT, V306, P54, DOI 10.1111/j.1574-6968.2010.01931.x; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Childers BM, 2007, J MOL BIOL, V367, P1413, DOI 10.1016/j.jmb.2007.01.061; Demeler B, 1997, BIOPHYS J, V72, P397, DOI 10.1016/S0006-3495(97)78680-6; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B., 2011, COMPREHENSIVE DATA A; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; DiRita VJ, 1996, P NATL ACAD SCI USA, V93, P7991, DOI 10.1073/pnas.93.15.7991; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hava DL, 2001, J MICROBIOL METH, V46, P217, DOI 10.1016/S0167-7012(01)00276-7; HOLMGREN J, 1977, J INFECT DIS, V136, pS105, DOI 10.1093/infdis/136.Supplement.S105; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hsiao A, 2009, INFECT IMMUN, V77, P1383, DOI 10.1128/IAI.01156-08; Hung DT, 2005, SCIENCE, V310, P670, DOI 10.1126/science.1116739; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu JR, 2007, BIOTECHNIQUES, V43, P487, DOI 10.2144/000112574; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; MILLER JH, 1992, SHORT COURSE BACTERI, P71; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Prouty MG, 2005, MOL MICROBIOL, V58, P1143, DOI 10.1111/j.1365-2958.2005.04897.x; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508, DOI 10.1128/JB.181.5.1508-1514.1999; Shakhnovich EA, 2007, MOL MICROBIOL, V66, P1331, DOI 10.1111/j.1365-2958.2007.05984.x; Shakhnovich EA, 2007, P NATL ACAD SCI USA, V104, P2372, DOI 10.1073/pnas.0611643104; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; SVENNERHOLM AM, 1978, CURR MICROBIOL, V1, P19, DOI 10.1007/BF02601701; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; Withey JH, 2006, MOL MICROBIOL, V59, P1779, DOI 10.1111/j.1365-2958.2006.05053.x; Withey JH, 2005, J BACTERIOL, V187, P7890, DOI 10.1128/JB.187.23.7890-7900.2005; Yamamoto S, 2009, GENE, V438, P57, DOI 10.1016/j.gene.2009.02.015; Yu RR, 2002, MOL MICROBIOL, V43, P119, DOI 10.1046/j.1365-2958.2002.02721.x	44	40	43	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28644	28655		10.1074/jbc.M111.258780	http://dx.doi.org/10.1074/jbc.M111.258780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673111	Green Published, hybrid			2022-12-25	WOS:000293557800078
J	Picciocchi, A; Debeurme, F; Beaumel, S; Dagher, MC; Grunwald, D; Jesaitis, AJ; Stasia, MJ				Picciocchi, Antoine; Debeurme, Franck; Beaumel, Sylvain; Dagher, Marie-Claire; Grunwald, Didier; Jesaitis, Algirdas J.; Stasia, Marie-Jose			Role of Putative Second Transmembrane Region of Nox2 Protein in the Structural Stability and Electron Transfer of the Phagocytic NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SITE-DIRECTED MUTAGENESIS; FLAVOCYTOCHROME B(558); DIAPHORASE ACTIVITY; GP91(PHOX) SUBUNIT; BINDING-SITE; CYTOCHROME-B; FAMILY; ACTIVATION; DOMAINS	Flavocytochrome b(558) (cytb) of phagocytes is a heterodimeric integral membrane protein composed of two subunits, p22(phox) and gp91(phox). The latter subunit, also known as Nox2, has a cytosolic C-terminal "dehydrogenase domain" containing FAD/NADPH-binding sites. The N-terminal half of Nox2 contains six predicted transmembrane alpha-helices coordinating two hemes. We studied the role of the second transmembrane alpha-helix, which contains a "hot spot" for mutations found in rare X+ and X- chronic granulomatous disease. By site-directed mutagenesis and transfection in X-CGD PLB-985 cells, we examined the functional and structural impact of seven missense mutations affecting five residues. P56L and C59F mutations drastically influence the level of Nox2 expression indicating that these residues are important for the structural stability of Nox2. A53D, R54G, R54M, and R54S mutations do not affect spectral properties of oxidized/reduced cytb, oxidase complex assembly, FAD binding, nor iodonitrotetrazolium (INT) reductase (diaphorase) activity but inhibit superoxide production. This suggests that Ala-53 and Arg-54 are essential in control of electron transfer from FAD. Surprisingly, the A57E mutation partially inhibits FAD binding, diaphorase activity, and oxidase assembly and affects the affinity of immunopurified A57E cytochrome b(558) for p67(phox). By competition experiments, we demonstrated that the second transmembrane helix impacts on the function of the first intracytosolic B-loop in the control of diaphorase activity of Nox2. Finally, by comparing INT reductase activity of immunopurified mutated and wild type cytb under aerobiosis versus anaerobiosis, we showed that INT reduction reflects the electron transfer from NADPH to FAD only in the absence of superoxide production.	[Stasia, Marie-Jose] CHU Grenoble, Chron Granulomatous Dis Diag & Res Ctr, F-38043 Grenoble 9, France; [Picciocchi, Antoine; Debeurme, Franck; Beaumel, Sylvain; Dagher, Marie-Claire; Stasia, Marie-Jose] Univ Grenoble 1, CNRS, Chron Granulomatous Dis Diag & Res Ctr, UMR 5525,Therex TIMC Imag, F-38041 Grenoble, France; [Jesaitis, Algirdas J.] Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA; [Grunwald, Didier] CEA, Inst Rech Sci & Technol Vivant, F-38054 Grenoble 9, France	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Montana State University System; Montana State University Bozeman; CEA	Stasia, MJ (corresponding author), CHU Grenoble, Chron Granulomatous Dis Diag & Res Ctr, BP 217, F-38043 Grenoble 9, France.	mjstasia@chu-grenoble.fr	STASIA, Marie José/M-7165-2014; beaumel, sylvain/M-7397-2014; DAGHER, Marie-Claire/M-6145-2014	DAGHER, Marie-Claire/0000-0001-6878-3169; Jesaitis, Algirdas/0000-0001-9001-5617; STASIA, Marie jose/0000-0003-4466-4880	National Institutes of Health from the Immunodeficiency Network [N01-AI-30070]; Primary Immunodeficiency Disease Consortium; CGD Research Trust, UK [J4G/09/09]; Joseph Fourier University Medical School; Delegation for Clinical Research and Innovations, Grenoble, France; National Institutes of Health from USPHS [3R01AI026711-21S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026711, N01AI030070] Funding Source: NIH RePORTER	National Institutes of Health from the Immunodeficiency Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Primary Immunodeficiency Disease Consortium; CGD Research Trust, UK; Joseph Fourier University Medical School; Delegation for Clinical Research and Innovations, Grenoble, France; National Institutes of Health from USPHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant N01-AI-30070 from the Immunodeficiency Network and the Primary Immunodeficiency Disease Consortium and by CGD Research Trust Grant Award reference J4G/09/09, UK. This work was also supported by grants from Joseph Fourier University Medical School and the Delegation for Clinical Research and Innovations, Grenoble, France.; Supported by National Institutes of Health Grant 3R01AI026711-21S1 from USPHS.	ALIVERTI A, 1993, BIOCHEMISTRY-US, V32, P6374, DOI 10.1021/bi00076a010; Baniulis D, 2005, BBA-PROTEINS PROTEOM, V1752, P186, DOI 10.1016/j.bbapap.2005.07.018; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 1999, J BIOL CHEM, V274, P10451, DOI 10.1074/jbc.274.15.10451; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURRITT JB, 1995, J BIOL CHEM, V270, P16974, DOI 10.1074/jbc.270.28.16974; CALCATERRA NB, 1995, BIOCHEMISTRY-US, V34, P12842, DOI 10.1021/bi00039a045; COHENTANUGI L, 1991, EUR J BIOCHEM, V202, P649, DOI 10.1111/j.1432-1033.1991.tb16419.x; CROSS AR, 1994, J BIOL CHEM, V269, P21448; CROSS AR, 1995, J BIOL CHEM, V270, P8194, DOI 10.1074/jbc.270.14.8194; CSANYI G, 2011, FREE RADIC IN PRESS; Dang PMC, 1999, BIOCHEMISTRY-US, V38, P5746, DOI 10.1021/bi982750f; Debeurme F, 2010, J BIOL CHEM, V285, P33197, DOI 10.1074/jbc.M110.151555; Henderson LM, 1998, J BIOL CHEM, V273, P33216, DOI 10.1074/jbc.273.50.33216; Jackson HM, 2010, J BIOL CHEM, V285, P10281, DOI 10.1074/jbc.M109.084939; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Li XJ, 2005, J BIOL CHEM, V280, P14962, DOI 10.1074/jbc.M500226200; Lord CI, 2008, J IMMUNOL METHODS, V329, P201, DOI 10.1016/j.jim.2007.10.008; Paclet MH, 2004, BIOCHEM J, V382, P981, DOI 10.1042/BJ20040954; Poinas A, 2002, EUR J BIOCHEM, V269, P1243, DOI 10.1046/j.1432-1033.2002.02764.x; Roos D, 2010, BLOOD CELL MOL DIS, V45, P246, DOI 10.1016/j.bcmd.2010.07.012; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROTROSEN D, 1990, J BIOL CHEM, V265, P8745; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; Stasia MJ, 2002, BBA-MOL BASIS DIS, V1586, P316, DOI 10.1016/S0925-4439(01)00110-7; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Wallach TM, 1997, BIOCHEM J, V321, P583, DOI 10.1042/bj3210583; Yoshida LS, 1998, J BIOL CHEM, V273, P27879, DOI 10.1074/jbc.273.43.27879; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	38	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28357	28369		10.1074/jbc.M111.220418	http://dx.doi.org/10.1074/jbc.M111.220418			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659519	hybrid, Green Published			2022-12-25	WOS:000293557800052
J	Gianni, S; Haq, SR; Montemiglio, LC; Jurgens, MC; Engstrom, A; Chi, CN; Brunori, M; Jemth, P				Gianni, Stefano; Haq, S. Raza; Montemiglio, Linda C.; Jurgens, Maike C.; Engstrom, Ake; Chi, Celestine N.; Brunori, Maurizio; Jemth, Per			Sequence-specific Long Range Networks in PSD-95/Discs Large/ZO-1 (PDZ) Domains Tune Their Binding Selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND INTERACTIONS; TRANSITION-STATES; PROTEIN FAMILIES; PLAUSIBLE MODEL; MECHANISM; DYNAMICS; ALLOSTERY; PATHWAYS; MUTATIONS; CATALYSIS	Protein-protein interactions mediated by modular protein domains are critical for cell scaffolding, differentiation, signaling, and ultimately, evolution. Given the vast number of ligands competing for binding to a limited number of domain families, it is often puzzling how specificity can be achieved. Selectivity may be modulated by intradomain allostery, whereby a remote residue is energetically connected to the functional binding site via side chain or backbone interactions. Whereas several energetic pathways, which could mediate intradomain allostery, have been predicted in modular protein domains, there is a paucity of experimental data to validate their existence and roles. Here, we have identified such functional energetic networks in one of the most common protein-protein interaction modules, the PDZ domain. We used double mutant cycles involving site-directed mutagenesis of both the PDZ domain and the peptide ligand, in conjunction with kinetics to capture the fine energetic details of the networks involved in peptide recognition. We performed the analysis on two homologous PDZ-ligand complexes and found that the energetically coupled residues differ for these two complexes. This result demonstrates that amino acid sequence rather than topology dictates the allosteric pathways. Furthermore, our data support a mechanism whereby the whole domain and not only the binding pocket is optimized for a specific ligand. Such cross-talk between binding sites and remote residues may be used to fine tune target selectivity.	[Haq, S. Raza; Jurgens, Maike C.; Engstrom, Ake; Chi, Celestine N.; Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Gianni, Stefano; Montemiglio, Linda C.; Brunori, Maurizio] Sapienza Univ Roma, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gianni, Stefano; Montemiglio, Linda C.; Brunori, Maurizio] Sapienza Univ Roma, Ist Biol & Patol Mol, Consiglio Nazl Ric, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy	Uppsala University; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Chi, CN (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr Box 582, SE-75123 Uppsala, Sweden.	Celestine.Chi@imbim.uu.se; Per.Jemth@imbim.uu.se	gianni, stefano/C-8536-2009	Gianni, Stefano/0000-0003-1653-1925; Brunori, Maurizio/0000-0002-7795-1635	Swedish Research Council [2009-5659]; Human Frontiers Science Program; Italian Ministero dell'Istruzione dell'Universita e della Ricerca [FIRB RBRN07BMCT_007]; Higher Education Commission of Pakistan	Swedish Research Council(Swedish Research CouncilEuropean Commission); Human Frontiers Science Program(Human Frontier Science Program); Italian Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by the Swedish Research Council Grant 2009-5659 (to P. J.), the Human Frontiers Science Program (to P. J.), and the Italian Ministero dell'Istruzione dell'Universita e della Ricerca FIRB RBRN07BMCT_007 (to M. B.).; Supported in part by a fellowship from the Higher Education Commission of Pakistan.	AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Calosci N, 2008, P NATL ACAD SCI USA, V105, P19241, DOI 10.1073/pnas.0804774105; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chi CN, 2008, P NATL ACAD SCI USA, V105, P4679, DOI 10.1073/pnas.0711732105; Chi CN, 2009, BIOCHEMISTRY-US, V48, P7089, DOI 10.1021/bi900559k; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhulesia A, 2008, J AM CHEM SOC, V130, P8931, DOI 10.1021/ja0752080; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Fuentes EJ, 2006, J MOL BIOL, V364, P337, DOI 10.1016/j.jmb.2006.08.076; Gianni S, 2005, J BIOL CHEM, V280, P34805, DOI 10.1074/jbc.M506017200; Gianni S, 2005, PROTEIN ENG DES SEL, V18, P389, DOI 10.1093/protein/gzi047; Gianni S, 2007, P NATL ACAD SCI USA, V104, P128, DOI 10.1073/pnas.0602770104; Gianni S, 2006, STRUCTURE, V14, P1801, DOI 10.1016/j.str.2006.10.010; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; GREEN SM, 1993, BIOCHEMISTRY-US, V32, P10131, DOI 10.1021/bi00089a032; Harris BZ, 2001, J CELL SCI, V114, P3219; Ho BK, 2010, PROTEIN SCI, V19, P398, DOI 10.1002/pro.318; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; Jemth P, 2007, BIOCHEMISTRY-US, V46, P8701, DOI 10.1021/bi7008618; Kaneko T, 2011, TRENDS BIOCHEM SCI, V36, P183, DOI 10.1016/j.tibs.2010.12.001; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; Kozlov G, 2002, J MOL BIOL, V320, P813, DOI 10.1016/S0022-2836(02)00544-2; Liu ZX, 2009, PROTEINS, V77, P823, DOI 10.1002/prot.22498; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Velthuis AJWT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016047	44	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27167	27175		10.1074/jbc.M111.239541	http://dx.doi.org/10.1074/jbc.M111.239541			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21653701	Green Published, hybrid			2022-12-25	WOS:000293268700012
J	Torres, AM; Dnyanmote, AV; Bush, KT; Wu, W; Nigam, SK				Torres, Adriana M.; Dnyanmote, Ankur V.; Bush, Kevin T.; Wu, Wei; Nigam, Sanjay K.			Deletion of Multispecific Organic Anion Transporter Oat1/Slc22a6 Protects against Mercury-induced Kidney Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INORGANIC MERCURY; PROXIMAL TUBULE; RENAL-FAILURE; OAT1; TOXICITY; METHYLMERCURY; CELLS; RAT; NEPHROTOXICITY; ELIMINATION	The primary site of mercury-induced injury is the kidney due to uptake of the reactive Hg2+-conjugated organic anions in the proximal tubule. Here, we investigated the in vivo role of Oat1 (organic anion transporter 1; originally NKT (Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J., Beier, D. R., and Nigam, S. K. (1997) J. Biol. Chem. 272, 6471-6478)) in handling of known nephrotoxic doses of HgCl2. Oat1 (Slc22a6) is a multispecific organic anion drug transporter that is expressed on the basolateral aspects of renal proximal tubule cells and that mediates the initial steps of elimination of a broad range of endogenous metabolites and commonly prescribed pharmaceuticals. Mercury-induced nephrotoxicity was observed in a wild-type model. We then used the Oat1 knock-out to determine in vivo whether the renal injury effects of mercury are mediated by Oat1. Most of the renal injury (both histologically and biochemically as measured by blood urea nitrogen and creatinine) was abolished following HgCl2 treatment of Oat1 knock-outs. Thus, acute kidney injury by HgCl2 was found to be mediated mainly by Oat1. Our findings raise the possibility that pharmacological modulation of the expression and/or function of Oat1 might be an effective therapeutic strategy for reducing renal injury by mercury. This is one of the most striking phenotypes so far identified in the Oat1 knock-out. (Eraly, S. A., Vallon, V., Vaughn, D. A., Gangoiti, J. A., Richter, K., Nagle, M., Monte, J. C., Rieg, T., Truong, D. M., Long, J. M., Barshop, B. A., Kaler, G., and Nigam, S. K. (2006) J. Biol. Chem. 281, 5072-5083).	[Dnyanmote, Ankur V.; Wu, Wei; Nigam, Sanjay K.] Univ Calif San Diego, Div Nephrol & Hypertens, Dept Med, La Jolla, CA 92093 USA; [Torres, Adriana M.] Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Bush, Kevin T.; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, Div Nephrol & Hypertens, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Torres, Adriana/0000-0002-8133-0137	National Institutes of Health [DK079784, GM88824]; Fund for Scientific and Technological Research (FONCYT) [PICT 00966]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 01665]; Society of Toxicology and Colgate-Palmolive; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088824] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Scientific and Technological Research (FONCYT)(FONCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Society of Toxicology and Colgate-Palmolive; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079784 and GM88824 (to S. K. N.). This work was also supported by Fund for Scientific and Technological Research (FONCYT) Grant PICT 00966 and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 01665 (to A. M. T.) and the Society of Toxicology and Colgate-Palmolive (to A. V. D.).	Aslamkhan AG, 2003, MOL PHARMACOL, V63, P590, DOI 10.1124/mol.63.3.590; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Brady WJ, 2004, EMERG MED CLIN N AM, V22, P865, DOI 10.1016/j.emc.2004.05.010; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Bridges CC, 2010, J TOXICOL ENV HEAL B, V13, P385, DOI 10.1080/10937401003673750; Burckhardt BC, 2003, REV PHYSIOL BIOCH P, V146, P95, DOI 10.1007/s10254-002-0003-8; CLARKSON TW, 1993, ENVIRON HEALTH PERSP, V100, P31, DOI 10.2307/3431518; Di Giusto G, 2008, PHARMACOLOGY, V81, P127, DOI 10.1159/000110555; Giusto G, 2010, ARCH TOXICOL, V84, P741, DOI 10.1007/s00204-010-0541-9; Di Giusto G, 2009, ARCH TOXICOL, V83, P887, DOI 10.1007/s00204-009-0445-8; Drasch G, 2001, SCI TOTAL ENVIRON, V267, P151, DOI 10.1016/S0048-9697(00)00806-8; Endou H, 1998, TOXICOL LETT, V103, P29, DOI 10.1016/S0378-4274(98)00275-6; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Green BT, 2000, SOUTHERN MED J, V93, P721; Koh AS, 2002, MOL PHARMACOL, V62, P921, DOI 10.1124/mol.62.4.921; Lee R, 2009, ENVIRON HEALTH PERSP, V117, P871, DOI 10.1289/ehp.0800337; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Lungkaphin A, 2004, AM J PHYSIOL-RENAL, V286, pF68, DOI 10.1152/ajprenal.00075.2003; Magos L, 2006, ANN CLIN BIOCHEM, V43, P257, DOI 10.1258/000456306777695654; Nagle MA, 2011, J BIOL CHEM, V286, P243, DOI 10.1074/jbc.M110.139949; Nava M, 2000, AM J PHYSIOL-RENAL, V279, pF910, DOI 10.1152/ajprenal.2000.279.5.F910; Nigam SK, 2007, NAT CLIN PRACT NEPHR, V3, P443, DOI 10.1038/ncpneph0558; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Stacchiotti A, 2006, TOXICOL LETT, V166, P168, DOI 10.1016/j.toxlet.2006.06.644; Steckling N, 2011, SCI TOTAL ENVIRON, V409, P994, DOI 10.1016/j.scitotenv.2010.11.029; Tanaka-Kagawa T, 1998, J PHARMACOL EXP THER, V285, P335; Torres AM, 2005, BBA-MOL BASIS DIS, V1740, P29, DOI 10.1016/j.bbadis.205.03.002; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; VanWert AL, 2008, MOL PHARMACOL, V74, P122, DOI 10.1124/mol.107.042853; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Villar SR, 2005, KIDNEY INT, V68, P2704, DOI 10.1111/j.1523-1755.2005.00741.x; Wikoff WR, 2011, J PROTEOME RES, V10, P2842, DOI 10.1021/pr200093w; Wu W, 2011, MOL PHARMACOL, V79, P795, DOI 10.1124/mol.110.070607; Wu W, 2009, PHYSIOL GENOMICS, V38, P116, DOI 10.1152/physiolgenomics.90309.2008; Zalups RK, 2005, KIDNEY INT, V68, P1684, DOI 10.1111/j.1523-1755.2005.00585.x; Zalups RK, 2004, J AM SOC NEPHROL, V15, P2023, DOI 10.1097/01.ASN.0000135115.63412.A9; Zalups RK, 2002, TOXICOL APPL PHARM, V182, P234, DOI 10.1006/taap.2002.9448; Zalups RK, 2000, PHARMACOL REV, V52, P113; Zalups RK, 1998, J TOXICOL ENV HEAL A, V53, P615, DOI 10.1080/009841098159079	40	61	65	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26391	26395		10.1074/jbc.M111.249292	http://dx.doi.org/10.1074/jbc.M111.249292			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652719	hybrid, Green Published			2022-12-25	WOS:000293078200016
J	Lee, JY; Passalacqua, KD; Hanna, PC; Sherman, DH				Lee, Jung Yeop; Passalacqua, Karla D.; Hanna, Philip C.; Sherman, David H.			Regulation of Petrobactin and Bacillibactin Biosynthesis in Bacillus anthracis under Iron and Oxygen Variation	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE ACTIVITY; FERRIC UPTAKE REGULATION; ESCHERICHIA-COLI; SIDEROPHORE BIOSYNTHESIS; STERNE 34F(2); SODB GENES; RESISTANCE; HEME; FUR; EXPRESSION	Background: Bacillus anthracis produces two catecholate siderophores, petrobactin and bacillibactin, under iron-limited conditions. Here, we investigate how variable iron and oxygen concentrations influence the biosynthetic output of both siderophores in B. anthracis. In addition, we describe the differential levels of transcription of select genes within the B. anthracis siderophore biosynthetic operons that are responsible for synthesis of petrobactin and bacillibactin, during variable growth conditions. Methodology/Principal Findings: Accumulation of bacillibactin in B. anthracis Sterne (34F(2)) and in a mutant lacking the major superoxide dismutase (Delta sodA1) was almost completely repressed by the addition of 20 mu M of iron. In contrast, petrobactin synthesis in both strains continued up to 20 mM of iron. Accumulation of petrobactin and bacillibactin showed a slight increase with addition of low levels of paraquat-induced oxidative stress in wild type B. anthracis Sterne. Cultures grown with high aeration resulted in greater accumulation of petrobactin relative to low aeration cultures, and delayed the repressive effect of added iron. Conversely, iron-depleted cultures grown with low aeration resulted in increased levels of bacillibactin. No difference was found in overall superoxide dismutase (SOD) activity or transcriptional levels of the sodA1 and sodA2 genes between iron-depleted and iron-replete conditions at high or low aeration, suggesting that SOD regulation and iron metabolism are separate in B. anthracis. The highest transcription of the gene asbB, part of the petrobactin biosynthetic operon, occurred under iron-limitation with high aeration, but transcription was readily detectable even under iron-replete conditions and in low aeration. The gene dhbC, a member of the bacillibactin biosynthetic operon, was only transcribed under conditions of iron-depletion, regardless of growth aeration. Conclusion: These data suggest that bacillibactin regulation is highly sensitive to iron-concentration. In contrast, although regulation of petrobactin is less dependent on iron, it is likely subject to additional levels of regulation that may contribute to virulence of B. anthracis.	[Lee, Jung Yeop; Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lee, Jung Yeop; Sherman, David H.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Lee, Jung Yeop; Sherman, David H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Passalacqua, Karla D.; Hanna, Philip C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lee, JY (corresponding author), Evolva Inc, Palo Alto, CA USA.	davidhs@umich.edu; jylee309@gmail.com	Passalacqua, Karla/AAU-8156-2021	Passalacqua, Karla/0000-0002-2672-3261	Great Lakes Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research [U54AI57153]; Hans W. Vahlteich Professorship; University of Michigan; HHS [N266200400059C-N01-AI-40059]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	Great Lakes Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research; Hans W. Vahlteich Professorship; University of Michigan(University of Michigan System); HHS(United States Department of Health & Human Services); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Great Lakes Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (Grant U54AI57153), and the Hans W. Vahlteich Professorship (D. H. S.). K. D. P. was supported by the University of Michigan F. G. Novy Fellowship, and HHS contract N266200400059C-N01-AI-40059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; ATKIN CL, 1970, J BACTERIOL, V103, P722, DOI 10.1128/JB.103.3.722-733.1970; Bergman NH, 2006, J BACTERIOL, V188, P6092, DOI 10.1128/JB.00723-06; BEYER W, 1991, PROG NUCLEIC ACID RE, V40, P221; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; BROWN SM, 1995, J BACTERIOL, V177, P6536, DOI 10.1128/jb.177.22.6536-6544.1995; BUDDE AD, 1989, MYCOPATHOLOGIA, V108, P125; Bullen JJ, 2006, J MED MICROBIOL, V55, P251, DOI 10.1099/jmm.0.46386-0; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Cendrowski S, 2004, MOL MICROBIOL, V51, P407, DOI 10.1046/j.1365-2958.2003.03861.x; Dao KHT, 1999, ECOL APPL, V9, P441, DOI 10.1890/1051-0761(1999)009[0441:PPBPAE]2.0.CO;2; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; DRECHSEL H, 1995, J IND MICROBIOL, V14, P105, DOI 10.1007/BF01569891; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; HASSETT DJ, 1993, J BACTERIOL, V175, P7658, DOI 10.1128/JB.175.23.7658-7665.1993; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Koppisch AT, 2005, BIOMETALS, V18, P577, DOI 10.1007/s10534-005-1782-6; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Lee JY, 2007, J BACTERIOL, V189, P1698, DOI 10.1128/JB.01526-06; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; NIEDERHOFFER EC, 1990, J BACTERIOL, V172, P1930, DOI 10.1128/jb.172.4.1930-1938.1990; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Passalacqua KD, 2007, J BACTERIOL, V189, P3996, DOI 10.1128/JB.00185-07; Passalacqua KD, 2006, J BACTERIOL, V188, P3837, DOI 10.1128/JB.00239-06; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pfleger BF, 2007, BIOCHEMISTRY-US, V46, P4147, DOI 10.1021/bi6023995; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Stauff DL, 2009, MOL MICROBIOL, V72, P763, DOI 10.1111/j.1365-2958.2009.06684.x; STERNE MAX, 1939, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V13, P313; TARDAT B, 1993, MOL MICROBIOL, V9, P53, DOI 10.1111/j.1365-2958.1993.tb01668.x; TARDAT B, 1991, MOL MICROBIOL, V5, P455, DOI 10.1111/j.1365-2958.1991.tb02129.x; Tarlovsky Y, 2010, J BACTERIOL, V192, P3503, DOI 10.1128/JB.00054-10; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; VANHEYNINGEN WE, 1948, NATURE, V162, P114, DOI 10.1038/162114b0; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Wiebe MG, 2002, BIOCHEM SOC T, V30, P696, DOI 10.1042/bst0300696	40	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20777	10.1371/journal.pone.0020777	http://dx.doi.org/10.1371/journal.pone.0020777			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673962	Green Submitted, Green Published, gold			2022-12-25	WOS:000291356400028
J	Xie, XF; Molina, J; Hernandez, R; Reynolds, A; Boyko, AR; Bustamante, CD; Purugganan, MD				Xie, Xianfa; Molina, Jeanmaire; Hernandez, Ryan; Reynolds, Andy; Boyko, Adam R.; Bustamante, Carlos D.; Purugganan, Michael D.			Levels and Patterns of Nucleotide Variation in Domestication QTL Regions on Rice Chromosome 3 Suggest Lineage-Specific Selection	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADVANCED BACKCROSS POPULATION; ARTIFICIAL SELECTION; ORYZA-RUFIPOGON; LINKAGE DISEQUILIBRIUM; NATURAL-SELECTION; YIELD COMPONENTS; CULTIVATED RICE; MAIZE; WILD	Oryza sativa or Asian cultivated rice is one of the major cereal grass species domesticated for human food use during the Neolithic. Domestication of this species from the wild grass Oryza rufipogon was accompanied by changes in several traits, including seed shattering, percent seed set, tillering, grain weight, and flowering time. Quantitative trait locus (QTL) mapping has identified three genomic regions in chromosome 3 that appear to be associated with these traits. We would like to study whether these regions show signatures of selection and whether the same genetic basis underlies the domestication of different rice varieties. Fragments of 88 genes spanning these three genomic regions were sequenced from multiple accessions of two major varietal groups in O. sativa-indica and tropical japonica-as well as the ancestral wild rice species O. rufipogon. In tropical japonica, the levels of nucleotide variation in these three QTL regions are significantly lower compared to genome-wide levels, and coalescent simulations based on a complex demographic model of rice domestication indicate that these patterns are consistent with selection. In contrast, there is no significant reduction in nucleotide diversity in the homologous regions in indica rice. These results suggest that there are differences in the genetic and selective basis for domestication between these two Asian rice varietal groups.	[Xie, Xianfa; Molina, Jeanmaire; Purugganan, Michael D.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Hernandez, Ryan] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Reynolds, Andy] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Boyko, Adam R.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	New York University; University of Chicago; Cornell University; Stanford University	Xie, XF (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	Xianfa.Xie@gmail.com		Bustamante, Carlos D./0000-0002-4187-7920	National Science Foundation [MCB-0701382]	National Science Foundation(National Science Foundation (NSF))	Funding: This work was funded by a grant from the National Science Foundation Plant Genome Research Program (MCB-0701382, www.nsf.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke JM, 2007, CURR OPIN GENET DEV, V17, P525, DOI 10.1016/j.gde.2007.09.003; Cai HW, 2002, THEOR APPL GENET, V104, P1217, DOI 10.1007/s00122-001-0819-7; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Camus-Kulandaivelu L, 2008, GENETICS, V180, P1107, DOI 10.1534/genetics.108.088849; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Darwin C., 1859, ORIGIN SPECIES MEANS; DOEBLEY J, 1990, P NATL ACAD SCI USA, V87, P9888, DOI 10.1073/pnas.87.24.9888; DOEBLEY J, 1993, GENETICS, V134, P559; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doust AN, 2005, GENETICS, V169, P1659, DOI 10.1534/genetics.104.035543; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Kohn MH, 2000, P NATL ACAD SCI USA, V97, P7911, DOI 10.1073/pnas.97.14.7911; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MATSUO T, 1997, BIOL RICE PLANT; Monna L, 2006, DNA RES, V13, P43, DOI 10.1093/dnares/dsi030; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Oka H. I., 1988, Origin of cultivated rice.; OKA HI, 1982, EUPHYTICA, V31, P41, DOI 10.1007/BF00028305; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Onishi K, 2007, GENOME, V50, P757, DOI 10.1139/G07-051; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Paterson AH, 2002, NEW PHYTOL, V154, P591, DOI 10.1046/j.1469-8137.2002.00420.x; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Poncet V, 1998, HEREDITY, V81, P648, DOI 10.1046/j.1365-2540.1998.00445.x; Pritchard JK, 2000, GENETICS, V155, P945; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Rozen S, 2000, BIOINFORMATICS METHO; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Saisho D, 2007, GENETICS, V177, P1765, DOI 10.1534/genetics.107.079491; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Shimamoto K, 2002, ANNU REV PLANT BIOL, V53, P399, DOI 10.1146/annurev.arplant.53.092401.134447; Shin JH, 2006, J STAT SOFTWARE, P16; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wakeley J., 2008, COALESCENT THEORY IN; WANG ZY, 1992, THEOR APPL GENET, V83, P565, DOI 10.1007/BF00226900; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242	59	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20670	10.1371/journal.pone.0020670	http://dx.doi.org/10.1371/journal.pone.0020670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674010	Green Submitted, Green Published, gold			2022-12-25	WOS:000291356400016
J	Tang, XL; Li, M; Tucker, L; Ramratnam, B				Tang, Xiaoli; Li, Ming; Tucker, Lynne; Ramratnam, Bharat			Glycogen Synthase Kinase 3 Beta (GSK3 beta) Phosphorylates the RNAase III Enzyme Drosha at S300 and S302	PLOS ONE			English	Article							MICRORNAS; REGULATOR; SURVIVAL; GSK-3	The canonical microRNA (miRNA) pathway commences with the enzymatic cleavage of the primary gene transcript (primiRNA) by the RNAase III enzyme Drosha in the nucleus into shorter pre-miRNA species that are subsequently exported to the cytoplasm for further processing into shorter, mature miRNA molecules. Using a series of reporter constructs, we have previously demonstrated that phosphorylation of Drosha at Ser 300 and 302 was required for its nuclear localization. Here, we identify GSK3 beta as the culprit kinase. We demonstrate that Drosha is unable to selectively localize to the nucleus in cells deficient in GSK3 beta. These findings expand the substrate base of GSK3 beta to include a central component of the miRNA biogenesis pathway.	[Tang, Xiaoli; Li, Ming; Tucker, Lynne; Ramratnam, Bharat] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Tang, XL (corresponding author), Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA.	BRamratnam@Lifespan.org	Xie, Huangming/B-2260-2012		National Institutes of Health (NIH) [P20RR025179, R01AI058697, T32DA013911]; Lifespan/Brown/Tufts CFAR [NIH P30AI042853]; Alcohol Research Center on HIV, Brown University [P01 AA019072]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, R01AI058697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P01AA019072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lifespan/Brown/Tufts CFAR; Alcohol Research Center on HIV, Brown University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) (P20RR025179 and R01AI058697). The authors thank the Lifespan/Brown/Tufts CFAR (NIH P30AI042853) and the Alcohol Research Center on HIV, Brown University (P01 AA019072), for assay support. XT was supported by a training grant from NIH (T32DA013911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dugo L, 2007, SHOCK, V27, P113, DOI 10.1097/01.shk.0000238059.23837.68; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; McNeill H, 2010, NAT REV MOL CELL BIO, V11, P404, DOI 10.1038/nrm2902; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002	32	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20391	10.1371/journal.pone.0020391	http://dx.doi.org/10.1371/journal.pone.0020391			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674040	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500013
J	Neff, CP; Kurisu, T; Ndolo, T; Fox, K; Akkina, R				Neff, C. Preston; Kurisu, Theresa; Ndolo, Thomas; Fox, Kami; Akkina, Ramesh			A Topical Microbicide Gel Formulation of CCR5 Antagonist Maraviroc Prevents HIV-1 Vaginal Transmission in Humanized RAG-hu Mice	PLOS ONE			English	Article							T-CELL DEPLETION; MOUSE MODEL; REVERSE-TRANSCRIPTASE; IMMUNE-RESPONSES; SCID MICE; BLT MICE; INFECTION; CHALLENGES; INHIBITOR; THERAPY	For prevention of HIV infection many currently licensed anti-HIV drugs and new ones in the pipeline show potential as topically applied microbicides. While macaque models have been the gold standard for in vivo microbicide testing, they are expensive and sufficient numbers are not available. Therefore, a small animal model that facilitates rapid evaluation of potential candidates for their preliminary efficacy is urgently needed in the microbicide field. We previously demonstrated that RAG-hu humanized mouse model permits HIV-1 mucosal transmission via both vaginal and rectal routes and that oral pre-exposure chemo-prophylactic strategies could be tested in this system. Here in these proof-of-concept studies, we extended this system for topical microbicide testing using HIV-1 as the challenge virus. Maraviroc, a clinically approved CCR5 inhibitor drug for HIV treatment, was formulated as a microbicide gel at 5 mM concentration in 2.2% hydroxyl ethyl cellulose. Female RAG-hu mice were challenged vaginally with HIV-1 an hour after intravaginal application of the maraviroc gel. Our results showed that maraviroc gel treated mice were fully protected against vaginal HIV-1 challenge in contrast to placebo gel treated mice which all became infected. These findings highlight the utility of the humanized mouse models for microbicide testing and, together with the recent data from macaque studies, suggest that maraviroc is a promising candidate for future microbicide clinical trials in the field.	[Neff, C. Preston; Kurisu, Theresa; Ndolo, Thomas; Fox, Kami; Akkina, Ramesh] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Neff, CP (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	akkina@colostate.edu			National Institutes of Health [AI057066, AI073255]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057066, R01AI073255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Studies described here were supported by National Institutes of Health RO1 grants AI057066 and AI073255 to RA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2007, CLIN VACCINE IMMUNOL, V14, P391, DOI 10.1128/CVI.00403-06; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Choudhary SK, 2009, J VIROL, V83, P8254, DOI 10.1128/JVI.00580-09; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; D'Cruz OJ, 2007, AM J REPROD IMMUNOL, V57, P353, DOI 10.1111/j.1600-0897.2007.00478.x; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Di Fabio S, 2003, AIDS, V17, P1597, DOI 10.1097/00002030-200307250-00003; Di Fabio S, 2001, AIDS, V15, P2231, DOI 10.1097/00002030-200111230-00003; Friend DR, 2010, PHARM DEV TECHNOL, V15, P562, DOI 10.3109/10837450903369879; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Khanna KV, 2002, J CLIN INVEST, V109, P205; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; MacArthur RD, 2008, CLIN INFECT DIS, V47, P236, DOI 10.1086/589289; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Neff CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015257; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Van Duyne R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-76; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Veazey RS, 2008, CURR OPIN HIV AIDS, V3, P567, DOI 10.1097/COH.0b013e32830891bb; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Zhang LG, 2007, BLOOD, V109, P2978, DOI 10.1182/blood-2006-07-033159	32	66	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20209	10.1371/journal.pone.0020209	http://dx.doi.org/10.1371/journal.pone.0020209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673796	Green Submitted, gold, Green Published			2022-12-25	WOS:000291309900005
J	Cao, YA; Kusy, S; Luong, R; Wong, RJ; Stevenson, DK; Contag, CH				Cao, Yu-An; Kusy, Sophie; Luong, Richard; Wong, Ronald J.; Stevenson, David K.; Contag, Christopher H.			Heme Oxygenase-1 Deletion Affects Stress Erythropoiesis	PLOS ONE			English	Article							ENDOTHELIAL-CELL ACTIVATION; IN-VIVO; ERYTHROID-DIFFERENTIATION; CARBON-MONOXIDE; EXPRESSION; PROGENITORS; FIBRONECTIN; DEFICIENCY; INTEGRINS; ANEMIA	Background: Homeostatic erythropoiesis leads to the formation of mature red blood cells under non-stress conditions, and the production of new erythrocytes occurs as the need arises. In response to environmental stimuli, such as bone marrow transplantation, myelosuppression, or anemia, erythroid progenitors proliferate rapidly in a process referred to as stress erythropoiesis. We have previously demonstrated that heme oxygenase-1 (HO-1) deficiency leads to disrupted stress hematopoiesis. Here, we describe the specific effects of HO-1 deficiency on stress erythropoiesis. Methodology/Principal Findings: We used a transplant model to induce stress conditions. In irradiated recipients that received hmox(+/-) or hmox(+/+) bone marrow cells, we evaluated (i) the erythrocyte parameters in the peripheral blood; (ii) the staining intensity of CD71-, Ter119-, and CD49d-specific surface markers during erythroblast differentiation; (iii) the patterns of histological iron staining; and (iv) the number of Mac-1(+)-cells expressing TNF-alpha. In the spleens of mice that received hmox(+/-) cells, we show (i) decreases in the proerythroblast, basophilic, and polychromatophilic erythroblast populations; (ii) increases in the insoluble iron levels and decreases in the soluble iron levels; (iii) increased numbers of Mac-1+-cells expressing TNF-a; and (iv) decreased levels of CD49d expression in the basophilic and polychromatophilic erythroblast populations. Conclusions/Significance: As reflected by effects on secreted and cell surface proteins, HO-1 deletion likely affects stress erythropoiesis through the retention of erythroblasts in the erythroblastic islands of the spleen. Thus, HO-1 may serve as a therapeutic target for controlling erythropoiesis, and the dysregulation of HO-1 may be a predisposing condition for hematologic diseases.	[Cao, Yu-An; Kusy, Sophie; Wong, Ronald J.; Stevenson, David K.; Contag, Christopher H.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Luong, Richard] Stanford Univ, Dept Comparat Med, Sch Med, Stanford, CA USA	Stanford University; Stanford University	Cao, YA (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA.	ccontag@stanford.edu		Contag, Christopher/0000-0002-1011-8278	National Institutes of Health [NIH/NIDD071716]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH/NIDD071716). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; AKAHANE K, 1987, INT J CELL CLONING, V5, P16, DOI 10.1002/stem.5530050103; ALLEN TD, 1982, DIFFERENTIATION, V21, P86, DOI 10.1111/j.1432-0436.1982.tb01201.x; Arroyo AG, 1999, IMMUNITY, V11, P555, DOI 10.1016/S1074-7613(00)80131-4; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Broudy VC, 1996, BLOOD, V88, P75; Cao YA, 2008, BLOOD, V112, P4494, DOI 10.1182/blood-2007-12-127621; Delforge M, 2005, LEUKEMIA, V19, P57, DOI 10.1038/sj.leu.2403551; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Flores-Figueroa E, 2002, LEUKEMIA RES, V26, P677, DOI 10.1016/S0145-2126(01)00193-X; Gambero S, 2007, EUR J HAEMATOL, V78, P144, DOI 10.1111/j.1600-0609.2006.00788.x; Hamamura K, 1996, BLOOD, V87, P2513, DOI 10.1182/blood.V87.6.2513.bloodjournal8762513; HARA H, 1976, AM J HEMATOL, V1, P453, DOI 10.1002/ajh.2830010410; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Lee G, 2006, BLOOD, V108, P2064, DOI 10.1182/blood-2006-03-006759; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; McDaid J, 2005, FASEB J, V19, P458, DOI 10.1096/fj.04-2217fje; McGrath KE, 2008, BLOOD, V111, P2409, DOI 10.1182/blood-2007-08-107581; MOLDAWER LL, 1989, FASEB J, V3, P1637, DOI 10.1096/fasebj.3.5.2784116; Obinata M, 1999, CELL STRUCT FUNCT, V24, P171, DOI 10.1247/csf.24.171; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Palis J, 1998, BLOOD REV, V12, P106, DOI 10.1016/S0268-960X(98)90022-4; PAPAYANNOPOULOU T, 1992, BLOOD, V79, P1686; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; ROSEMBLATT M, 1991, J CLIN INVEST, V87, P6, DOI 10.1172/JCI115002; SADAHIRA Y, 1995, J EXP MED, V181, P411, DOI 10.1084/jem.181.1.411; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Soares MP, 2007, FRONT BIOSCI, V12, P4932, DOI 10.2741/2439; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TSAI S, 1987, BLOOD, V69, P1587; ULICH TR, 1990, EXP HEMATOL, V18, P311; VUILLETGAUGLER MH, 1990, BLOOD, V75, P865; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165	41	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20634	10.1371/journal.pone.0020634	http://dx.doi.org/10.1371/journal.pone.0020634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655188	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600112
J	Ferreira, L; Sanchez-Juanes, F; Garcia-Fraile, P; Rivas, R; Mateos, PF; Martinez-Molina, E; Gonzalez-Buitrago, JM; Velazquez, E				Ferreira, Laura; Sanchez-Juanes, Fernando; Garcia-Fraile, Paula; Rivas, Raul; Mateos, Pedro F.; Martinez-Molina, Eustoquio; Manuel Gonzalez-Buitrago, Jose; Velazquez, Encarna			MALDI-TOF Mass Spectrometry Is a Fast and Reliable Platform for Identification and Ecological Studies of Species from Family Rhizobiaceae	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; CLOSE PHYLOGENETIC RELATIONSHIP; MULTILOCUS SEQUENCE-ANALYSIS; KUMMEROWIAE SP-NOV.; RIBOSOMAL-RNA GENE; PHASEOLUS-VULGARIS; SINORHIZOBIUM-MELILOTI; RAPID IDENTIFICATION; SP. NOV.; AGROBACTERIUM-TUMEFACIENS	Family Rhizobiaceae includes fast growing bacteria currently arranged into three genera, Rhizobium, Ensifer and Shinella, that contain pathogenic, symbiotic and saprophytic species. The identification of these species is not possible on the basis of physiological or biochemical traits and should be based on sequencing of several genes. Therefore alternative methods are necessary for rapid and reliable identification of members from family Rhizobiaceae. In this work we evaluated the suitability of Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for this purpose. Firstly, we evaluated the capability of this methodology to differentiate among species of family Rhizobiaceae including those closely related and then we extended the database of MALDI Biotyper 2.0 including the type strains of 56 species from genera Rhizobium, Ensifer and Shinella. Secondly, we evaluated the identification potential of this methodology by using several strains isolated from different sources previously identified on the basis of their rrs, recA and atpD gene sequences. The 100% of these strains were correctly identified showing that MALDI-TOF MS is an excellent tool for identification of fast growing rhizobia applicable to large populations of isolates in ecological and taxonomic studies.	[Ferreira, Laura; Sanchez-Juanes, Fernando; Manuel Gonzalez-Buitrago, Jose] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain; [Garcia-Fraile, Paula; Rivas, Raul; Mateos, Pedro F.; Martinez-Molina, Eustoquio; Velazquez, Encarna] Univ Salamanca, Dept Genet & Microbiol, E-37008 Salamanca, Spain; [Manuel Gonzalez-Buitrago, Jose] Univ Salamanca, Dept Bioquim & Biol Mol, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca	Ferreira, L (corresponding author), Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain.	evp@usal.es	Rivas, Raúl/B-1869-2017; Fraile, Paula Garcia/N-8193-2014; Velázquez, Encarna/B-3669-2017; Mateos, Pedro/L-6001-2014; Sánchez-Juanes, Fernando/AAO-2626-2020	Rivas, Raúl/0000-0003-2202-1470; Fraile, Paula Garcia/0000-0002-9576-2184; Velázquez, Encarna/0000-0002-5946-7241; Mateos, Pedro/0000-0003-1628-598X; Gonzalez-Buitrago, Jose Manuel/0000-0003-4674-071X; Sanchez-Juanes, Fernando/0000-0003-1687-5891; Martinez-Molina, Eustoquio/0000-0002-0983-9780	MICINN; PFMG; JCYL; Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, SPAIN) (Ayuda de Infraestructura)	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); PFMG; JCYL(Junta de Castilla y Leon); Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, SPAIN) (Ayuda de Infraestructura)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by MICINN to EV and PFMG and JCYL to EMM and RR and by the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovacion, SPAIN) (Ayuda de Infraestructura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez ER, 2009, ARCH MICROBIOL, V191, P659, DOI 10.1007/s00203-009-0495-6; Amarger N, 1997, INT J SYST BACTERIOL, V47, P996, DOI 10.1099/00207713-47-4-996; An DS, 2006, INT J SYST EVOL MICR, V56, P443, DOI 10.1099/ijs.0.63942-0; Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Berge O, 2009, INT J SYST EVOL MICR, V59, P367, DOI 10.1099/ijs.0.000521-0; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Bouzar H, 2001, INT J SYST EVOL MICR, V51, P1023, DOI 10.1099/00207713-51-3-1023; CASIDA LE, 1982, INT J SYST BACTERIOL, V32, P339, DOI 10.1099/00207713-32-3-339; Chen WX, 1997, INT J SYST BACTERIOL, V47, P870, DOI 10.1099/00207713-47-3-870; CHEN WX, 1988, INT J SYST BACTERIOL, V38, P392, DOI 10.1099/00207713-38-4-392; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; CRABTREE K., 1967, INT J SYST BACTERIOL, V17, P1; del Villar M, 2008, FEMS MICROBIOL LETT, V282, P273, DOI 10.1111/j.1574-6968.2008.01139.x; DELAJUDIE P, 1994, INT J SYST BACTERIOL, V44, P715, DOI 10.1099/00207713-44-4-715; DELAJUDIE P, 1992, INT J SYST BACTERIOL, V42, P93; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Ferreira L, 2011, CLIN MICROBIOL INFEC, V17, P546, DOI 10.1111/j.1469-0691.2010.03257.x; FERREIRA L, 2010, CLIN MICROBIOL INFEC; Ferreira L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014235; Ferreira L, 2010, ENFERM INFEC MICR CL, V28, P492, DOI 10.1016/j.eimc.2009.12.009; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Garcia-Fraile P, 2007, INT J SYST EVOL MICR, V57, P844, DOI 10.1099/ijs.0.64680-0; Garcia-Fraile P, 2010, CAN J MICROBIOL, V56, P657, DOI [10.1139/W10-048, 10.1139/w10-048]; Gaunt MW, 2001, INT J SYST EVOL MICR, V51, P2037, DOI 10.1099/00207713-51-6-2037; Giebel R, 2010, ADV APPL MICROBIOL, V71, P149, DOI 10.1016/S0065-2164(10)71006-6; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Gu CT, 2008, INT J SYST EVOL MICR, V58, P1364, DOI 10.1099/ijs.0.65661-0; Han TX, 2008, INT J SYST EVOL MICR, V58, P1693, DOI 10.1099/ijs.0.65568-0; Ramirez-Bahena MH, 2008, INT J SYST EVOL MICR, V58, P2484, DOI 10.1099/ijs.0.65621-0; Hilderrand EM, 1940, J AGRIC RES, V61, P0685; HIRSCH P, 1985, SYST APPL MICROBIOL, V6, P281, DOI 10.1016/S0723-2020(85)80032-1; Hou BC, 2009, INT J SYST EVOL MICR, V59, P3051, DOI 10.1099/ijs.0.009647-0; Hunter WJ, 2007, CURR MICROBIOL, V55, P455, DOI 10.1007/s00284-007-9020-9; Iglesias O, 2007, FEMS MICROBIOL LETT, V277, P210, DOI 10.1111/j.1574-6968.2007.00968.x; Jordan D.C., 1984, BERGEYS MANUAL SYSTE; Judicial Commission of the International Committee on Systematics of Prokaryotes, 2008, Int J Syst Evol Microbiol, V58, P1973, DOI 10.1099/ijs.0.2008/005991-0; Kaur J, 2011, INT J SYST EVOL MICR, V61, P1218, DOI 10.1099/ijs.0.017491-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuykendall L. D., 2005, BERGEYS MANUAL SYSTE, V2, P324; Kwon SW, 2005, INT J SYST EVOL MICR, V55, P263, DOI 10.1099/ijs.0.63097-0; Laguerre G, 2001, MICROBIOL-SGM, V147, P981, DOI 10.1099/00221287-147-4-981; Lin DX, 2008, INT J SYST EVOL MICR, V58, P1409, DOI 10.1099/ijs.0.65723-0; Lin DX, 2009, INT J SYST EVOL MICR, V59, P1919, DOI 10.1099/ijs.0.006387-0; LINDSTROM K, 1989, INT J SYST BACTERIOL, V39, P365, DOI 10.1099/00207713-39-3-365; Lu YL, 2009, INT J SYST EVOL MICR, V59, P3006, DOI 10.1099/ijs.0.007237-0; Zurdo-Pineiro JL, 2009, APPL ENVIRON MICROB, V75, P2354, DOI 10.1128/AEM.02811-08; Martens M, 2008, INT J SYST EVOL MICR, V58, P200, DOI 10.1099/ijs.0.65392-0; MARTINEZROMERO E, 1991, INT J SYST BACTERIOL, V41, P417, DOI 10.1099/00207713-41-3-417; Matsui T, 2009, INT J SYST EVOL MICR, V59, P536, DOI 10.1099/ijs.0.65510-0; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Merabet C, 2010, INT J SYST EVOL MICR, V60, P664, DOI 10.1099/ijs.0.012088-0; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Nick G, 1999, INT J SYST BACTERIOL, V49, P1359, DOI 10.1099/00207713-49-4-1359; OPHEL K, 1990, INT J SYST BACTERIOL, V40, P236, DOI 10.1099/00207713-40-3-236; Peng GX, 2008, INT J SYST EVOL MICR, V58, P2158, DOI 10.1099/ijs.0.65632-0; Peng GX, 2002, INT J SYST EVOL MICR, V52, P457, DOI 10.1099/00207713-52-2-457; Quan ZX, 2005, INT J SYST EVOL MICR, V55, P2543, DOI 10.1099/ijs.0.63667-0; Ramirez-Bahena MH, 2009, CAN J MICROBIOL, V55, P1207, DOI [10.1139/W09-074, 10.1139/w09-074]; Ren DW, 2011, INT J SYST EVOL MICR, V61, P580, DOI 10.1099/ijs.0.023143-0; Rivas R, 2007, LETT APPL MICROBIOL, V44, P181, DOI 10.1111/j.1472-765X.2006.02050.x; Rome S, 1996, INT J SYST BACTERIOL, V46, P972, DOI 10.1099/00207713-46-4-972; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAWADA H, 1993, INT J SYST BACTERIOL, V43, P694, DOI 10.1099/00207713-43-4-694; SCHOLLA MH, 1984, INT J SYST BACTERIOL, V34, P484, DOI 10.1099/00207713-34-4-484; SEGOVIA L, 1993, INT J SYST BACTERIOL, V43, P374, DOI 10.1099/00207713-43-2-374; Seibold E, 2010, J CLIN MICROBIOL, V48, P1061, DOI 10.1128/JCM.01953-09; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Snoeck C, 2003, APPL ENVIRON MICROB, V69, P2006, DOI 10.1128/AEM.69.4.2006-2014.2003; Squartini A, 2002, INT J SYST EVOL MICR, V52, P1267, DOI 10.1099/00207713-52-4-1267; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan ZY, 2001, INT J SYST EVOL MICR, V51, P909, DOI 10.1099/00207713-51-3-909; Tanigawa K, 2010, APPL ENVIRON MICROB, V76, P4055, DOI 10.1128/AEM.02698-09; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian CF, 2008, INT J SYST EVOL MICR, V58, P2871, DOI 10.1099/ijs.0.2008/000703-0; Toledo I, 2003, SYST APPL MICROBIOL, V26, P54, DOI 10.1078/072320203322337317; Valverde A, 2006, INT J SYST EVOL MICR, V56, P2631, DOI 10.1099/ijs.0.64402-0; van Berkum P, 1998, INT J SYST BACTERIOL, V48, P13, DOI 10.1099/00207713-48-1-13; van Veen SQ, 2010, J CLIN MICROBIOL, V48, P900, DOI 10.1128/JCM.02071-09; VANRHIJN PJS, 1993, J BACTERIOL, V175, P438, DOI 10.1128/JB.175.2.438-447.1993; Vaz-Moreira I, 2010, INT J SYST EVOL MICR, V60, P144, DOI 10.1099/ijs.0.009498-0; Velazquez E, 2005, MOL PLANT MICROBE IN, V18, P1325, DOI 10.1094/MPMI-18-1325; Velazquez E, 2001, EUR J PLANT PATHOL, V107, P931, DOI 10.1023/A:1013140709873; Velazquez E, 2010, SYST APPL MICROBIOL, V33, P247, DOI 10.1016/j.syapm.2010.04.004; VINCENT J. M., 1970, A manual for the practical study of the root-nodule bacteria.; Wang ET, 1998, INT J SYST BACTERIOL, V48, P687, DOI 10.1099/00207713-48-3-687; Wang ET, 2002, INT J SYST EVOL MICR, V52, P1687, DOI 10.1099/ijs.0.01954-0; Wei GH, 2003, INT J SYST EVOL MICR, V53, P1575, DOI 10.1099/ijs.0.02031-0; Wei GH, 2002, INT J SYST EVOL MICR, V52, P2231, DOI [10.1099/ijs.0.02030-0, 10.1099/00207713-52-6-2231]; Young JM, 2004, INT J SYST EVOL MICR, V54, P149, DOI 10.1099/ijs.0.02870-0; Young JM, 2003, INT J SYST EVOL MICR, V53, P2107, DOI 10.1099/ijs.0.02665-0; Young JM, 2001, INT J SYST EVOL MICR, V51, P89, DOI 10.1099/00207713-51-1-89; Zhang GX, 2011, INT J SYST EVOL MICR, V61, P816, DOI 10.1099/ijs.0.022228-0; Zhang RJ, 2011, INT J SYST EVOL MICR, V61, P512, DOI 10.1099/ijs.0.020156-0	95	72	73	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20223	10.1371/journal.pone.0020223	http://dx.doi.org/10.1371/journal.pone.0020223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655291	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600031
J	Qi, XP; Ma, JM; Du, ZF; Ying, RB; Fei, J; Jin, HY; Han, JS; Wang, JQ; Chen, XL; Chen, CY; Liu, WT; Lu, JJ; Zhang, JG; Zhang, XN				Qi, Xiao-Ping; Ma, Ju-Ming; Du, Zhen-Fang; Ying, Rong-Biao; Fei, Jun; Jin, Hang-Yang; Han, Jian-Shan; Wang, Jin-Quan; Chen, Xiao-Ling; Chen, Chun-Yue; Liu, Wen-Ting; Lu, Jia-Jun; Zhang, Jian-Guo; Zhang, Xian-Ning			RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family	PLOS ONE			English	Article							CODON 918 MUTATION; MEN 2A; PROTOONCOGENE MUTATIONS; GENETIC MODIFIERS; 2B; ALLELE; PHEOCHROMOCYTOMA; POLYMORPHISMS; DISEASE; GUIDELINES	Background: Whole exome sequencing provides a labor-saving and direct means of genetic diagnosis of hereditary disorders in which the pathogenic gene harbors a large cohort of exons. We set out to demonstrate a suitable example of genetic diagnosis of MEN 2A/FMTC (multiple endocrine neoplasia type 2/familial medullary thyroid carcinoma) using this approach. Methodology/Principal Findings: We sequenced the whole exome of six individuals from a large Chinese MEN2A/FMTC pedigree to identify the variants of the RET (REarranged during Transfection) protooncogene and followed this by validation. Then prophylactic or surgical thyroidectomy with modified or level VI lymph node dissection and adrenalectomy were performed for the carriers. The cases were closely followed up. Massively parallel sequencing revealed four missense mutations of RET. We unexpectedly discovered that the proband's daughter with MEN 2A-related MTC presented a novel p. C634Y/V292M/R67H/R982C compound mutation, due to the involvement of p. C634Y in the proband with MEN 2A and p. V292M/R67H/R982C in the proband's husband with FMTC. In the maternal origin, p. C634Y caused bilateral MTC in all 5 cases and bilateral pheochromocytoma in 2 of the 5; the earliest onset age was 28 years. In the paternal origin, one of the six p. V292M/R67H/R982C carriers presented bilateral MTC (70 years old), one only had bilateral C-cell hyperplasia (44 years), two had bilateral multi-nodules (46 and 48 years) and two showed no abnormality (22 and 19 years). Conclusions/Significance: The results confirmed the successful clinical utility of whole exome sequencing, and our data suggested that the p. C634Y/V292M/R67H/R982C mutation of RET exhibited a more aggressive clinical phenotype than p. C634Y or p. V292M/R67H/R982C, while p. V292M/R67H/R982C presented a relatively milder pathogenicity of MTC and likely predisposed to FMTC.	[Qi, Xiao-Ping; Ma, Ju-Ming; Fei, Jun; Jin, Hang-Yang; Han, Jian-Shan; Wang, Jin-Quan] 117th PLA Hosp, Dept Urol Surg, Hangzhou, Zhejiang, Peoples R China; [Qi, Xiao-Ping; Ma, Ju-Ming; Fei, Jun; Jin, Hang-Yang; Han, Jian-Shan; Wang, Jin-Quan] 117th PLA Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Du, Zhen-Fang; Chen, Xiao-Ling; Chen, Chun-Yue; Liu, Wen-Ting; Lu, Jia-Jun; Zhang, Xian-Ning] Zhejiang Univ, Sch Med, Zhejiang Univ Adinovoctr Genet & Genom Med, Natl Educ Base Basic Med Sci,Dept Biochem & Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Ying, Rong-Biao] Tumor Hosp Taizhou, Dept Surg Oncol, Wenling, Zhejiang, Peoples R China; [Zhang, Jian-Guo] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Zhejiang University; Beijing Genomics Institute (BGI)	Zhang, XN (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Univ Adinovoctr Genet & Genom Med, Natl Educ Base Basic Med Sci,Dept Biochem & Genet, Hangzhou 310003, Zhejiang, Peoples R China.	qxplmd@vip.sina.com; zhangxianning@zju.edu.cn			Key Scientific Research Project of Nanjing Military Command, China [09Z038]	Key Scientific Research Project of Nanjing Military Command, China	This study was supported by the Key Scientific Research Project of Nanjing Military Command, China (09Z038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch DK, 2000, EXP CLIN ENDOCR DIAB, V108, P128, DOI 10.1055/s-2000-5806; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonnefond A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013630; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Castellone MD, 2010, CLIN ENDOCRINOL, V73, P529, DOI 10.1111/j.1365-2265.2009.03757.x; Cebrian A, 2005, J CLIN ENDOCR METAB, V90, P6268, DOI 10.1210/jc.2004-2449; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Cranston AN, 2006, CANCER RES, V66, P10179, DOI 10.1158/0008-5472.CAN-06-0884; DELELLIS RA, WHO CLASSIFICATION T, P321; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; Dvorakova S, 2005, J ENDOCRINOL INVEST, V28, P905, DOI 10.1007/BF03345322; Elisei R, 2004, J CLIN ENDOCR METAB, V89, P3579, DOI 10.1210/jc.2003-031898; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Erlic Z, 2010, J CLIN ENDOCR METAB, V95, P308, DOI 10.1210/jc.2009-1728; Frank-Raue K, 2011, HUM MUTAT, V32, P51, DOI 10.1002/humu.21385; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gimm O, 1997, J CLIN ENDOCR METAB, V82, P3902, DOI 10.1210/jc.82.11.3902; Hedges D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008232; Iwashita T, 2000, BIOCHEM BIOPH RES CO, V268, P804, DOI 10.1006/bbrc.2000.2227; Kasprzak L, 2001, J MED GENET, V38, P784, DOI 10.1136/jmg.38.11.784; Kloos RT, 2009, THYROID, V19, P565, DOI 10.1089/thy.2008.0403; Koch CA, 2001, ONCOGENE, V20, P7809, DOI 10.1038/sj.onc.1204991; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Lesueur F, 2006, CANCER RES, V66, P1177, DOI 10.1158/0008-5472.CAN-05-2995; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Menko FH, 2002, J CLIN ENDOCR METAB, V87, P393, DOI 10.1210/jc.87.1.393; Miyauchi A, 1999, JPN J CANCER RES, V90, P1; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nunes AB, 2002, J CLIN ENDOCR METAB, V87, P5658, DOI 10.1210/JC.2002-020345; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; Poturnajova M, 2005, J MOL MED, V83, P287, DOI 10.1007/s00109-004-0604-6; Punales MK, 2003, J CLIN ENDOCR METAB, V88, P2644, DOI 10.1210/jc.2002-021422; Robledo M, 2003, CANCER RES, V63, P1814; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Sasaki A, 2003, HUM GENET, V114, P22, DOI 10.1007/s00439-003-1036-z; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tessitore A, 1999, J CLIN ENDOCR METAB, V84, P3522, DOI 10.1210/jc.84.10.3522; Toledo RA, 2010, J CLIN ENDOCR METAB, V95, P1318, DOI 10.1210/jc.2009-1355; Zhou YL, 2007, CLIN ENDOCRINOL, V67, P570, DOI 10.1111/j.1365-2265.2007.02927.x	42	39	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20353	10.1371/journal.pone.0020353	http://dx.doi.org/10.1371/journal.pone.0020353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655256	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600050
J	Shimizu, S; Brown, M; Sengupta, R; Penfold, ME; Meucci, O				Shimizu, Saori; Brown, Michael; Sengupta, Rajarshi; Penfold, Mark E.; Meucci, Olimpia			CXCR7 Protein Expression in Human Adult Brain and Differentiated Neurons	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR7; N-GLYCOSYLATION; OPIOID RECEPTORS; NERVOUS-SYSTEM; MIGRATION; CXCL12; SURVIVAL; CELLS; RDC1; TRAFFICKING	Background: CXCR7 and CXCR4 are receptors for the chemokine CXCL12, which is involved in essential functions of the immune and nervous systems. Although CXCR7 transcripts are widely expressed throughout the central nervous system, little is known about its protein distribution and function in the adult brain. To evaluate its potential involvement in CXCL12/CXCR4 signaling in differentiated neurons, we studied CXCR7 protein expression in human brain and cultured neurons. Methodology/Principal Findings: Immunohistochemistry and RT-PCR analyses of cortex and hippocampus from control and HIV-positive subjects provided the first evidence of CXCR7 protein expression in human adult neurons, under normal and pathological conditions. Furthermore, confocal microscopy and binding assays in cultured neurons show that CXCR7 protein is mainly located into cytoplasm, while little to no protein expression is found on neuronal plasma membrane. Interestingly, specific CXCR7 ligands that inhibit CXCL12 binding to CXCR7 do not alter CXCR4-activated survival signaling (pERK/pAkt) in rat cortical neurons. Neuronal CXCR7 co-localizes to some extent with the endoplasmic reticulum marker ERp29, but not with early/late endosome markers. Additionally, large areas of overlap are detected in the intracellular pattern of CXCR7 and CXCR4 expression. Conclusions/Significance: Overall, these results implicate CXCR4 as the main CXCL12 signaling receptor on the surface of differentiated neurons and suggest that CXCR7 may interact with CXCR4 at the intracellular level, possibly affecting CXCR4 trafficking and/or coupling to other proteins.	[Shimizu, Saori; Brown, Michael; Sengupta, Rajarshi; Meucci, Olimpia] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Meucci, Olimpia] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA; [Penfold, Mark E.] ChemoCentryx, Mountain View, CA USA	Drexel University; Drexel University	Shimizu, S (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA.	olimpia.meucci@drexelmed.edu			National Institutes of Health [DA15014, DA19808]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015014, R01DA019808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by National Institutes of Health Grants DA15014 and DA19808 (to O.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Penfold is employed by ChemoCentryx; he has provided specific reagents for this study (i.e., one of the anti-CXCR7 Ab and the CXCR7 ligands) and valuable technical & intellectual support.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Achour L, 2009, BLOOD, V113, P1938, DOI 10.1182/blood-2008-02-141275; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373; BERAHOVICH RD, 2010, IMMUNOL LETT; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Burbassi S, 2008, J NEUROIMMUNE PHARM, V3, P26, DOI 10.1007/s11481-007-9083-1; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cai GQ, 2005, FEBS J, V272, P1625, DOI 10.1111/j.1742-4658.2005.04595.x; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; Couvineau A, 1996, BIOCHEMISTRY-US, V35, P1745, DOI 10.1021/bi952022h; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Hattermann K, 2010, CANCER RES, V70, P3299, DOI 10.1158/0008-5472.CAN-09-3642; Hauser KF, 2006, J NEUROIMMUNE PHARM, V1, P98, DOI 10.1007/s11481-005-9000-4; Holtback U, 1999, P NATL ACAD SCI USA, V96, P7271, DOI 10.1073/pnas.96.13.7271; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Kitabatake Y, 2004, BIOL PHARM BULL, V27, P896, DOI 10.1248/bpb.27.896; Klein RS, 2004, TRENDS IMMUNOL, V25, P306, DOI 10.1016/j.it.2004.04.002; Lackner AA, 2007, ANNU REV MED, V58, P461, DOI 10.1146/annurev.med.58.082405.094316; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Ludwig A, 2000, J IMMUNOL, V165, P1044, DOI 10.4049/jimmunol.165.2.1044; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; LUKER KE, 2010, ONCOGENE; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; MacLeod JC, 2004, J COMP NEUROL, V477, P29, DOI 10.1002/cne.20222; Maksym RB, 2009, EUR J PHARMACOL, V625, P31, DOI 10.1016/j.ejphar.2009.04.071; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Miller RJ, 2008, J NEUROSCI, V28, P11792, DOI 10.1523/JNEUROSCI.3588-08.2008; Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nicolai J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.10; Oh JW, 2001, J IMMUNOL, V166, P2695, DOI 10.4049/jimmunol.166.4.2695; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Shimizu N, 2000, J VIROL, V74, P619, DOI 10.1128/JVI.74.2.619-626.2000; Shimizu S, 2007, NEUROBIOL DIS, V25, P17, DOI 10.1016/j.nbd.2006.08.004; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Tiveron MC, 2010, J NEUROIMMUNOL, V224, P72, DOI 10.1016/j.jneuroim.2010.05.011; Wang YL, 2011, NEURON, V69, P61, DOI 10.1016/j.neuron.2010.12.005; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269	50	53	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20680	10.1371/journal.pone.0020680	http://dx.doi.org/10.1371/journal.pone.0020680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655198	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600121
J	Handel, IG; Bronsvoort, BMD; Forbes, JF; Woolhouse, MEJ				Handel, Ian G.; Bronsvoort, Barend M. de C.; Forbes, John F.; Woolhouse, Mark E. J.			Risk-Targeted Selection of Agricultural Holdings for Post-Epidemic Surveillance: Estimation of Efficiency Gains	PLOS ONE			English	Article							SAMPLE-SIZE CALCULATIONS; SUBSTANTIATE FREEDOM; DISEASE FREEDOM; FOOT; TESTS	Current post-epidemic sero-surveillance uses random selection of animal holdings. A better strategy may be to estimate the benefits gained by sampling each farm and use this to target selection. In this study we estimate the probability of undiscovered infection for sheep farms in Devon after the 2001 foot-and-mouth disease outbreak using the combination of a previously published model of daily infection risk and a simple model of probability of discovery of infection during the outbreak. This allows comparison of the system sensitivity (ability to detect infection in the area) of arbitrary, random sampling compared to risk-targeted selection across a full range of sampling budgets. We show that it is possible to achieve 95% system sensitivity by sampling, on average, 945 farms with random sampling and 184 farms with risk-targeted sampling. We also examine the effect of ordering samples by risk to expedite return to a disease-free status. Risk ordering the sampling process results in detection of positive farms, if present, 15.6 days sooner than with randomly ordered sampling, assuming 50 farms are tested per day.	[Handel, Ian G.; Bronsvoort, Barend M. de C.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Handel, Ian G.; Bronsvoort, Barend M. de C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Forbes, John F.] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Handel, IG (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	ian.handel@ed.ac.uk		Bronsvoort, Mark/0000-0002-3271-8485	DEFRA/Scottish Funding Council Veterinary Training and Research Initiative [VT 0101]	DEFRA/Scottish Funding Council Veterinary Training and Research Initiative(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by DEFRA/Scottish Funding Council Veterinary Training and Research Initiative grant VT 0101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD ME, 2007, P BIOL SCI; Branscum AJ, 2006, STAT MED, V25, P2658, DOI 10.1002/sim.2449; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cameron AR, 1998, PREV VET MED, V34, P19, DOI 10.1016/S0167-5877(97)00073-1; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Cannon RM, 2002, PREV VET MED, V52, P227, DOI 10.1016/S0167-5877(01)00262-8; *DEFRA, 2002, FOOT MOUTH DIS UK 1; Diggle PJ, 2006, STAT METHODS MED RES, V15, P325, DOI 10.1191/0962280206sm454oa; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Greiner M, 2005, PREV VET MED, V70, P223, DOI 10.1016/j.prevetmed.2005.03.007; Humphry RW, 2004, PREV VET MED, V65, P173, DOI 10.1016/j.prevetmed.2004.07.003; Johnson WO, 2004, BIOMETRICS, V60, P165, DOI 10.1111/j.0006-341X.2004.00143.x; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; MARTIN SW, 1992, PREV VET MED, V14, P33, DOI 10.1016/0167-5877(92)90082-Q; OIE, 2010, MAN DIAGN TESTS VACC; *OIE, 2010, TER AN HLTH COD; Paton DJ, 2006, VACCINE, V24, P6503, DOI 10.1016/j.vaccine.2006.06.032; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; R Development Core Team, 2009, R FDN STAT COMP; Schuppers ME, 2010, EPIDEMIOL INFECT, V138, P1242, DOI 10.1017/S0950268809991518; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Williams MS, 2009, PREV VET MED, V89, P34, DOI 10.1016/j.prevetmed.2009.01.005	23	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20064	10.1371/journal.pone.0020064	http://dx.doi.org/10.1371/journal.pone.0020064			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21674022	Green Submitted, Green Published, gold			2022-12-25	WOS:000291006500023
J	Pramanik, KC; Boreddy, SR; Srivastava, SK				Pramanik, Kartick C.; Boreddy, Srinivas Reddy; Srivastava, Sanjay K.			Role of Mitochondrial Electron Transport Chain Complexes in Capsaicin Mediated Oxidative Stress Leading to Apoptosis in Pancreatic Cancer Cells	PLOS ONE			English	Article							BENZYL ISOTHIOCYANATE; CYCLE ARREST; GASTRIC-CANCER; IN-VITRO; INDUCTION; ACTIVATION; GENERATION; PEPPER; DEATH; CHILI	We evaluated the mechanism of capsaicin-mediated ROS generation in pancreatic cancer cells. The generation of ROS was about 4-6 fold more as compared to control and as early as 1 h after capsaicin treatment in BxPC-3 and AsPC-1 cells but not in normal HPDE-6 cells. The generation of ROS was inhibited by catalase and EUK-134. To delineate the mechanism of ROS generation, enzymatic activities of mitochondrial complex-I and complex-III were determined in the pure mitochondria. Our results shows that capsaicin inhibits about 2.5-9% and 5-20% of complex-I activity and 8-75% of complex-III activity in BxPC-3 and AsPC-1 cells respectively, which was attenuable by SOD, catalase and EUK-134. On the other hand, capsaicin treatment failed to inhibit complex-I or complex-III activities in normal HPDE-6 cells. The ATP levels were drastically suppressed by capsaicin treatment in both BxPC-3 and AsPC-1 cells and attenuated by catalase or EUK-134. Oxidation of mitochondria-specific cardiolipin was substantially higher in capsaicin treated cells. BxPC-3 derived rho(o) cells, which lack mitochondrial DNA, were completely resistant to capsaicin mediated ROS generation and apoptosis. Our results reveal that the release of cytochrome c and cleavage of both caspase-9 and caspase-3 due to disruption of mitochondrial membrane potential were significantly blocked by catalase and EUK-134 in BxPC-3 cells. Our results further demonstrate that capsaicin treatment not only inhibit the enzymatic activity and expression of SOD, catalase and glutathione peroxidase but also reduce glutathione level. Over-expression of catalase by transient transfection protected the cells from capsaicin-mediated ROS generation and apoptosis. Furthermore, tumors from mice orally fed with 2.5 mg/kg capsaicin show decreased SOD activity and an increase in GSSG/GSH levels as compared to controls. Taken together, our results suggest the involvement of mitochondrial complex-I and III in capsaicin-mediated ROS generation and decrease in antioxidant levels resulting in severe mitochondrial damage leading to apoptosis in pancreatic cancer cells.	[Pramanik, Kartick C.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Sch Pharm, Amarillo, TX USA; Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Sch Pharm, Amarillo, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Pramanik, KC (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Sch Pharm, Amarillo, TX USA.	sanjay.srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020		National Cancer Institute, National Institutes of Health [R01 CA129038, R01 CA106953]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, National Institutes of Health R01 CA129038; R01 CA106953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V354, P50, DOI 10.1016/j.bbrc.2006.12.179; Bhutani M, 2007, CLIN CANCER RES, V13, P3024, DOI 10.1158/1078-0432.CCR-06-2575; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; BUIATTI E, 1989, INT J CANCER, V44, P611, DOI 10.1002/ijc.2910440409; BUSCH SHB, 1983, TRENDS PHARMACOL SCI, V4, P4; CERINIC MM, 1995, J RHEUMATOL, V22, P1447; CHUNGMAN HJ, 2001, CANCER RES, V61, P8578; CORDELL GA, 1993, ANN PHARMACOTHER, V27, P330, DOI 10.1177/106002809302700316; GOVINDARAJAN VS, 1991, CRIT REV FOOD SCI, V29, P435, DOI 10.1080/10408399109527536; Hail N, 2002, JNCI-J NATL CANCER I, V94, P1281, DOI 10.1093/jnci/94.17.1281; Hail N, 2001, CANCER RES, V61, P6698; Hartel M, 2006, GUT, V55, P519, DOI 10.1136/gut.2005.073205; Hatefi Y, 1978, Methods Enzymol, V53, P21; HOLZER P, 1991, PHARMACOL REV, V43, P143; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Ito K, 2004, CANCER RES, V64, P1071, DOI 10.1158/0008-5472.CAN-03-1670; JEMAL A, 2010, CA CANC J CLIN; Jung MY, 2001, CANCER LETT, V165, P139, DOI 10.1016/S0304-3835(01)00426-8; Kandala PK, 2010, MOL PHARMACOL, V78, P297, DOI 10.1124/mol.110.063750; Kang HJ, 2003, INT J CANCER, V103, P475, DOI 10.1002/ijc.10855; KANG JY, 1995, DIGEST DIS SCI, V40, P576, DOI 10.1007/BF02064373; KELSEN D, 1994, SEMIN ONCOL, V21, P58; Kim CS, 2004, J MED FOOD, V7, P267, DOI 10.1089/jmf.2004.7.267; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; Lee YS, 2004, FREE RADICAL RES, V38, P405, DOI 10.1080/10715760410001665262; Lo YC, 2005, WORLD J GASTROENTERO, V11, P6254, DOI 10.3748/wjg.v11.i40.6254; LOPEZCARRILLO L, 1994, AM J EPIDEMIOL, V139, P263, DOI 10.1093/oxfordjournals.aje.a116993; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; MONSEREENUSORN Y, 1983, RES COMMUN CHEM PATH, V41, P95; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Mozsik G, 2005, WORLD J GASTROENTERO, V11, P5180; Nomura K, 2000, BIOCHEM J, V351, P183, DOI 10.1042/0264-6021:3510183; RAGAN CI, 1987, SUBFRACTIONATION MIT, P79; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sahu RP, 2009, CARCINOGENESIS, V30, P1744, DOI 10.1093/carcin/bgp157; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Sathyanarayana MN, 2006, CRIT REV FOOD SCI, V46, P275, DOI 10.1080/1040-830491379236; SICUTERI F, 1989, CLIN J PAIN, V5, P49, DOI 10.1097/00002508-198903000-00010; Surh YJ, 1998, MUTAT RES-FUND MOL M, V402, P259, DOI 10.1016/S0027-5107(97)00305-9; Surh YJ, 2002, J NATL CANCER I, V94, P1263, DOI 10.1093/jnci/94.17.1263; SUZUKI T, 1994, CONSTITUTION RED PEP, P227; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Thoennissen NH, 2010, ONCOGENE, V29, P285, DOI 10.1038/onc.2009.335; Toogood PL, 2008, CURR OPIN CHEM BIOL, V12, P457, DOI 10.1016/j.cbpa.2008.06.002; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; WATSON CPN, 1988, PAIN, V33, P333, DOI 10.1016/0304-3959(88)90292-8; Wen JJ, 2010, ANTIOXID REDOX SIGN, V12, P27, DOI [10.1089/ars.2008.2418, 10.1089/ARS.2008.2418]; Wharton D C, 1978, Methods Enzymol, V53, P646; Xiao D, 2008, J BIOL CHEM, V283, P30151, DOI 10.1074/jbc.M802529200; Yun TK, 1999, ANN NY ACAD SCI, V889, P157, DOI 10.1111/j.1749-6632.1999.tb08734.x; Zhang R, 2008, APOPTOSIS, V13, P1465, DOI 10.1007/s10495-008-0278-6	53	134	140	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20151	10.1371/journal.pone.0020151	http://dx.doi.org/10.1371/journal.pone.0020151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647434	Green Published, Green Submitted, gold			2022-12-25	WOS:000291006500031
J	Bergamaschi, A; Katzenellenbogen, BS				Bergamaschi, A.; Katzenellenbogen, B. S.			Tamoxifen downregulation of miR-451 increases 14-3-3 zeta and promotes breast cancer cell survival and endocrine resistance	ONCOGENE			English	Article						breast cancer; tamoxifen; endocrine resistance; 14-3-3 zeta; miR-451; tumor suppressor	ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; MICRORNAS; DETERMINANTS; RALOXIFENE; MECHANISM; THERAPY; KINASE; GROWTH; RISK	Many estrogen receptor (ER)-positive breast cancers respond well initially to endocrine therapies, but often develop resistance during treatment with selective ER modulators (SERMs) such as tamoxifen. We have reported that the 14-3-3 family member and conserved protein, 14-3-3 zeta, is upregulated by tamoxifen and that high expression correlated with an early time to disease recurrence. However, the mechanism by which tamoxifen upregulates 14-3-3 zeta and may promote the development of endocrine resistance is not known. Our findings herein reveal that the tamoxifen upregulation of 14-3-3 zeta results from its ability to rapidly downregulate microRNA (miR)-451 that specifically targets 14-3-3 zeta. The levels of 14-3-3 zeta and miR-451 were inversely correlated, with 14-3-3 zeta being elevated and miR-451 being at a greatly reduced level in tamoxifen-resistant breast cancer cells. Of note, downregulation of miR-451 was selectively elicited by tamoxifen but not by other SERMs, such as raloxifene or ICI182,780 (Fulvestrant). Increasing the level of miR-451 by overexpression, which decreased 14-3-3 zeta, suppressed cell proliferation and colony formation, markedly reduced activation of HER2, EGFR and MAPK signaling, increased apoptosis, and, importantly, restored the growth-inhibitory effectiveness of SERMs in endocrine-resistant cells. Opposite effects were elicited by miR-451 knockdown. Thus, we identify tamoxifen downregulation of miR-451, and consequent elevation of the key survival factor 14-3-3 zeta, as a mechanistic basis of tamoxifen-associated development of endocrine resistance. These findings suggest that therapeutic approaches to increase expression of this tumor suppressor-like miR should be considered to downregulate 14-3-3 zeta and enhance the effectiveness of endocrine therapies. Furthermore, the selective ability of the SERM tamoxifen but not raloxifene to regulate miR-451 and 14-3-3 zeta may assist in understanding differences in their activities, as seen in the STAR (Study of Tamoxifen and Raloxifene) breast cancer prevention trial and in other clinical trials. Oncogene (2012) 31, 39-47; doi: 10.1038/onc.2011.223; published online 13 June 2011	[Katzenellenbogen, B. S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Coll Med Urbana Champaign, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Katzenellenbogen, BS (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 524 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	katzenel@uiuc.edu	Bergamaschi, Anna/D-2022-2009	Bergamaschi, Anna/0000-0001-8709-1766	Breast Cancer Research Foundation; NIH [P01AG024387, P50 AT006268]; Department of Defense [W81XWH-09-1-0398]; National Center for Complementary & Integrative Health [P50AT006268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024387] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the Breast Cancer Research Foundation (BSK) and the NIH (P01AG024387 and P50 AT006268, BSK), and a Postdoctoral Fellowship from the Department of Defense (W81XWH-09-1-0398, AB). We thank Dr Nancy Weigel, Baylor College of Medicine, for providing lysine-coated adenovirus.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Allgood VE, 1997, BIOCHEMISTRY-US, V36, P224, DOI 10.1021/bi961125c; Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergamaschi A, 2009, P AM ASS CANC RES AN, V2, P2854; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dunn B K, 2001, Breast J, V7, P144, DOI 10.1046/j.1524-4741.2001.007003144.x; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Herman ME, 1996, J STEROID BIOCHEM, V59, P121, DOI 10.1016/S0960-0760(96)00114-8; JAIYESIMI IA, 1995, J CLIN ONCOL, V13, P513, DOI 10.1200/JCO.1995.13.2.513; Katzenellenbogen BS, 2002, SCIENCE, V295, P2380, DOI 10.1126/science.1070442; Katzenellenbogen JA, 1996, MOL ENDOCRINOL, V10, P119, DOI 10.1210/me.10.2.119; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Lowery AJ, 2008, CLIN CANCER RES, V14, P360, DOI 10.1158/1078-0432.CCR-07-0992; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; McPherson RA, 1999, ONCOGENE, V18, P3862, DOI 10.1038/sj.onc.1202730; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Oksvold MP, 2004, FEBS LETT, V569, P207, DOI 10.1016/j.febslet.2004.05.068; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Yang JS, 2010, P NATL ACAD SCI USA, V107, P15163, DOI 10.1073/pnas.1006432107; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110	42	153	167	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	1					39	47		10.1038/onc.2011.223	http://dx.doi.org/10.1038/onc.2011.223			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21666713	Green Accepted			2022-12-25	WOS:000299176200004
J	Chen, IH; Hu, JH; Jow, GM; Chuang, CC; Lee, TT; Liu, DC; Jeng, CJ				Chen, I-Hsiu; Hu, Jui-Hsiang; Jow, Guey-Mei; Chuang, Chao-Chin; Lee, Ting-Ting; Liu, Dai-Chi; Jeng, Chung-Jiuan			Distal End of Carboxyl Terminus Is Not Essential for the Assembly of Rat Eag1 Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CLOSED STATE; SUBUNIT; DOMAIN; ETHER; EXPRESSION; DROSOPHILA; HERG	The assembly of four pore-forming alpha-subunits into tetramers is a prerequisite for the formation of functional K+ channels. A short carboxyl assembly domain (CAD) in the distal end of the cytoplasmic carboxyl terminus has been implicated in the assembly of Eag alpha-subunits, a subfamily of the ether-a-go-go K+ channel family. The precise role of CAD in the formation of Eag tetrameric channels, however, remains unclear. Moreover, it has not been determined whether other protein regions also contribute to the assembly of Eag subunits. We addressed these questions by studying the biophysical properties of a series of different rat Eag1 (rEag1) truncation mutants. Two truncation mutants without CAD (K848X and W823X) yielded functional phenotypes similar to those for wild-type (WT) rEag1 channels. Furthermore, nonfunctional rEag1 truncation mutants lacking the distal region of the carboxyl terminus displayed substantial dominant-negative effects on the functional expression of WT as well as K848X and W823X channels. Our co-immunoprecipitation studies further revealed that truncation mutants containing no CAD indeed displayed significant association with rEag1-WT subunits. Finally, surface biotinylation and protein glycosylation analyses demonstrated that progressive truncations of the carboxyl terminus resulted in aggravating disruptions of membrane trafficking and glycosylation of rEag1 proteins. Overall, our data suggest that the distal carboxyl terminus, including CAD, is dispensable for the assembly of rEag1 K+ channels but may instead be essential for ensuring proper protein biosynthesis. We propose that the S6 segment and the proximal carboxyl terminus may constitute the principal subunit recognition site for the assembly of rEag1 channels.	[Chen, I-Hsiu; Hu, Jui-Hsiang; Chuang, Chao-Chin; Lee, Ting-Ting; Liu, Dai-Chi; Jeng, Chung-Jiuan] Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 12212, Taiwan; [Jow, Guey-Mei] Fu Jen Catholic Univ, Sch Med, Hsinchuang 24205, Taipei County, Taiwan	National Yang Ming Chiao Tung University; Fu Jen Catholic University	Jeng, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Anat & Cell Biol, Taipei 12212, Taiwan.	cjjeng@ym.edu.tw			National Science Council, Taiwan [NSC97-2320-B-010-020-MY3]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was supported by National Science Council, Taiwan, Research Grant NSC97-2320-B-010-020-MY3 and by Aim for the Top University Plan, Ministry of Education, Taiwan (to C. J. J.).	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Aydar E, 2001, J PHYSIOL-LONDON, V534, P1, DOI 10.1111/j.1469-7793.2001.t01-3-00001.x; Brelidze TI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012523; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Daram P, 1997, EMBO J, V16, P3455, DOI 10.1093/emboj/16.12.3455; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dreyer I, 2004, BIOPHYS J, V87, P858, DOI 10.1529/biophysj.103.037671; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Flagg TP, 1999, J GEN PHYSIOL, V114, P685, DOI 10.1085/jgp.114.5.685; Hille B., 2001, ION CHANNELS EXCITAB, P131; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Koster JC, 1998, BIOPHYS J, V74, P1821, DOI 10.1016/S0006-3495(98)77892-0; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Li XD, 1997, J BIOL CHEM, V272, P705, DOI 10.1074/jbc.272.2.705; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Ribera AB, 1996, J NEUROSCI, V16, P1123; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; SHEN NV, 1993, NEURON, V11, P67; Tang CY, 2000, J GEN PHYSIOL, V115, P319, DOI 10.1085/jgp.115.3.319; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; TU LW, 1995, BIOPHYS J, V68, P147, DOI 10.1016/S0006-3495(95)80169-4; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201	42	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27183	27196		10.1074/jbc.M111.233825	http://dx.doi.org/10.1074/jbc.M111.233825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646358	Green Published, hybrid			2022-12-25	WOS:000293268700014
J	Croasdale, R; Ivins, FJ; Muskett, F; Daviter, T; Scott, DJ; Hardy, T; Smerdon, SJ; Fry, AM; Pfuhl, M				Croasdale, Rebecca; Ivins, Frank J.; Muskett, Fred; Daviter, Tina; Scott, David J.; Hardy, Tara; Smerdon, Steven J.; Fry, Andrew M.; Pfuhl, Mark			An Undecided Coiled Coil THE LEUCINE ZIPPER OF Nek2 KINASE EXHIBITS ATYPICAL CONFORMATIONAL EXCHANGE DYNAMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER DOMAIN; PROTEIN-KINASE; DIPOLAR COUPLINGS; FUNCTIONAL-ROLE; BINDING DOMAIN; NMR; ALPHA; NEK2; STABILITY; PACKING	Leucine zippers are oligomerization domains used in a wide range of proteins. Their structure is based on a highly conserved heptad repeat sequence in which two key positions are occupied by leucines. The leucine zipper of the cell cycle-regulated Nek2 kinase is important for its dimerization and activation. However, the sequence of this leucine zipper is most unusual in that leucines occupy only one of the two hydrophobic positions. The other position, depending on the register of the heptad repeat, is occupied by either acidic or basic residues. Using NMR spectroscopy, we show that this leucine zipper exists in two conformations of almost equal population that exchange with a rate of 17 s(-1). We propose that the two conformations correspond to the two possible registers of the heptad repeat. This hypothesis is supported by a cysteine mutant that locks the protein in one of the two conformations. NMR spectra of this mutant showed the predicted 2-fold reduction of peaks in the N-15 HSQC spectrum and the complete removal of cross peaks in exchange spectra. It is possible that interconversion of these two conformations may be triggered by external signals in a manner similar to that proposed recently for the microtubule binding domain of dynein and the HAMP domain. As a result, the leucine zipper of Nek2 kinase is the first example where the frameshift of coiled-coil heptad repeats has been directly observed experimentally.	[Croasdale, Rebecca; Muskett, Fred; Hardy, Tara; Fry, Andrew M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Ivins, Frank J.; Smerdon, Steven J.] Natl Inst Med Res, Div Mol Struct, MRC, London NW7 1AA, England; [Daviter, Tina] Univ London, ISMB Biophys Ctr, London WC1E 7HX, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England	University of Leicester; MRC National Institute for Medical Research; University of London; University of Nottingham	Fry, AM (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	amf5@le.ac.uk; Pfuhl@kcl.ac.uk		Pfuhl, Mark/0000-0001-9592-6639; Scott, David/0000-0002-6726-2078; Smerdon, Stephen/0000-0001-5688-8465	Hope Foundation for Cancer Research; Cancer Research UK; Association for International Cancer Research; Wellcome Trust; Medical Research Council [MC_U117584228] Funding Source: researchfish; MRC [MC_U117584228] Funding Source: UKRI	Hope Foundation for Cancer Research; Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants (to A. M. F.) from the Hope Foundation for Cancer Research, Cancer Research UK, the Association for International Cancer Research, and The Wellcome Trust.	Adamson J. Gordon, 1993, Current Opinion in Biotechnology, V4, P428, DOI 10.1016/0958-1669(93)90008-K; Alber T, 1992, CURR OPIN GENET DEV, V2, P205, DOI 10.1016/S0959-437X(05)80275-8; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fry AM, 2002, ONCOGENE, V21, P6184, DOI 10.1038/sj.onc.1205711; Fry AM, 1999, J BIOL CHEM, V274, P16304, DOI 10.1074/jbc.274.23.16304; Gibbons IR, 2005, J BIOL CHEM, V280, P23960, DOI 10.1074/jbc.M501636200; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Junius FK, 1996, J BIOL CHEM, V271, P13663, DOI 10.1074/jbc.271.23.13663; JUNIUS FK, 1995, BIOCHEMISTRY-US, V34, P6164, DOI 10.1021/bi00018a020; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Nooren IMA, 1999, NAT STRUCT BIOL, V6, P755; OAS TG, 1990, BIOCHEMISTRY-US, V29, P2891, DOI 10.1021/bi00464a001; OFFER G, 1995, J MOL BIOL, V249, P967, DOI 10.1006/jmbi.1995.0352; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SAUDEK V, 1991, PROTEIN ENG, V4, P519, DOI 10.1093/protein/4.5.519; SAUDEK V, 1990, PROTEIN ENG, V4, P3, DOI 10.1093/protein/4.1.3; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P3178, DOI 10.1021/bi00063a033; Zweckstetter M, 2005, J AM CHEM SOC, V127, P11918, DOI 10.1021/ja0534654; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	39	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27537	27547		10.1074/jbc.M110.196972	http://dx.doi.org/10.1074/jbc.M110.196972			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669869	hybrid, Green Published			2022-12-25	WOS:000293268700048
J	Nayak, B; Kondeti, VK; Xie, P; Lin, S; Viswakarma, N; Raparia, K; Kanwar, YS				Nayak, Baibaswata; Kondeti, Vinay K.; Xie, Ping; Lin, Sun; Viswakarma, Navin; Raparia, Kirtee; Kanwar, Yashpal S.			Transcriptional and Post-translational Modulation of myo-Inositol Oxygenase by High Glucose and Related Pathobiological Stresses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UP-REGULATION; DIABETIC-NEPHROPATHY; ALDOSE REDUCTASE; RESPONSE ELEMENT; MESANGIAL CELLS; INOSITOL; GENE; ACTIVATION; EXPRESSION; ENZYME	Renal-specific oxidoreductase/myo-inositol oxygenase (RSOR/MIOX) catabolizes myo-inositol and is implicated in the pathogenesis of diabetic nephropathy. How high glucose (HG) ambience up-regulates its expression and enzyme activity was investigated. MIOX up-regulation was associated with an increase in enzyme activity, which was reduced to basal levels with phosphatase treatment. Using phosphothreonine, protein kinase A (PKA), and PKC substrate antibodies, analyses of kidney lysates of diabetic animals and LLC-PK1/HK-2 cells subjected to HG ambience indicated MIOX to be a phosphoprotein. Kinase phosphorylated recombinant RSOR/MIOX proteins had increased activity confined to exons 2-5. Mutants with substituted phosphorylation sites had a minimal increase in activity. Treatment of cells with PKC, PKA, and PDK1 kinase activators increased activity, whereas inhibitors reduced it. Inhibitors also reduced the phosphorylation and activity of MIOX induced by HG. Besides HG, exposure of cells to oxidants H2O2 and methylglyoxal up-regulated MIOX expression and its phosphorylation and activity, whereas antioxidants N-acetylcysteine, beta-naphthoflavone, and tertiary butyl hydroquinone reduced MIOX expression. Treatment with HG or oxidants or overexpression of MIOX induced nuclear translocation of redox-sensitive transcription factor Nrf2, which binds to antioxidant response elements of various promoters. Promoter analyses revealed an increase in luciferase activity with HG and oxidants. Analyses of antioxidant response elements and carbohydrate response elements revealed an accentuation of DNA-protein interactions with oxidants and under HG ambience. ChIP-PCR and immunofluorescence studies revealed nuclear translocation of carbohydrate response element-binding protein. These findings suggest that phosphorylation of RSOR/MIOX enhances its activity, which is augmented by HGvia transcriptional/translational events that are also modulated by diabetes-related pathobiological stresses.	[Nayak, Baibaswata; Kondeti, Vinay K.; Xie, Ping; Viswakarma, Navin; Raparia, Kirtee; Kanwar, Yashpal S.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Nayak, Baibaswata; Kondeti, Vinay K.; Xie, Ping; Viswakarma, Navin; Raparia, Kirtee; Kanwar, Yashpal S.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Lin, Sun] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China; [Lin, Sun] Cent S Univ, Xiangya Hosp 2, Renal Inst, Changsha 410011, Hunan, Peoples R China	Northwestern University; Northwestern University; Central South University; Central South University	Kanwar, YS (corresponding author), Northwestern Univ, Dept Pathol, 303 E Chicago Ave, Chicago, IL 60611 USA.	y-kanwar@northwestern.edu	Nayak, Baibaswata/L-6156-2016; kondeti, vinay kumar/C-3171-2012		National Institutes of Health [DK60635]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK60635.	Alam J, 2000, J BIOL CHEM, V275, P27694; ANSARI NH, 1993, BIOCHEM MOL BIOL INT, V30, P37; Arner RJ, 2001, BIOCHEM J, V360, P313, DOI 10.1042/bj3600313; Barski OA, 2005, AM J PHYSIOL-RENAL, V289, pF200, DOI 10.1152/ajprenal.00411.2004; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Brownt PM, 2006, P NATL ACAD SCI USA, V103, P15032, DOI 10.1073/pnas.0605143103; CHARALAMPOUS FC, 1957, J BIOL CHEM, V228, P1; Colodny L, 1998, Altern Med Rev, V3, P432; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; GABBAY KH, 1975, ANNU REV MED, V26, P521, DOI 10.1146/annurev.me.26.020175.002513; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; HANKES LV, 1969, ANN NY ACAD SCI, V165, P564; HOLUB BJ, 1986, ANNU REV NUTR, V6, P563, DOI 10.1146/annurev.nu.06.070186.003023; Hu E, 2000, AM J PHYSIOL-RENAL, V279, pF426, DOI 10.1152/ajprenal.2000.279.3.F426; Huang JS, 2007, AM J PHYSIOL-RENAL, V293, pF1072, DOI 10.1152/ajprenal.00020.2007; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jiang ZQ, 2003, LIFE SCI, V72, P2243, DOI 10.1016/S0024-3205(03)00101-2; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Kaspar JW, 2010, J BIOL CHEM, V285, P21349, DOI 10.1074/jbc.M110.121863; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kawa JM, 2003, EXP BIOL MED, V228, P907, DOI 10.1177/153537020322800806; Lauer ME, 2007, J BIOL CHEM, V282, P843, DOI 10.1074/jbc.M608823200; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Nakamura N, 2000, FREE RADICAL BIO MED, V29, P17, DOI 10.1016/S0891-5849(00)00286-0; Narayanan A, 2009, CURR OPIN STRUC BIOL, V19, P156, DOI 10.1016/j.sbi.2009.02.007; Nayak B, 2005, P NATL ACAD SCI USA, V102, P17952, DOI 10.1073/pnas.0509089102; Nguyen T, 2000, J BIOL CHEM, V275, P15466, DOI 10.1074/jbc.M000361200; Nishinaka T, 2001, FREE RADICAL BIO MED, V31, P205, DOI 10.1016/S0891-5849(01)00571-8; OLGEMOLLER B, 1993, DIABETES, V42, P1119, DOI 10.2337/diabetes.42.8.1119; Ooms LM, 2009, BIOCHEM J, V419, P29, DOI 10.1042/BJ20081673; PALMANO KP, 1977, BIOCHEM J, V167, P229, DOI 10.1042/bj1670229; Pendaries C, 2003, FEBS LETT, V546, P25, DOI 10.1016/S0014-5793(03)00437-X; Phillips Aled O, 2003, Curr Diab Rep, V3, P491, DOI 10.1007/s11892-003-0013-1; Phillips AO, 2002, HISTOL HISTOPATHOL, V17, P247, DOI 10.14670/HH-17.247; Prabhu KS, 2005, J BIOL CHEM, V280, P19895, DOI 10.1074/jbc.M502621200; PRICE RG, 1987, RENAL BASEMENT MEMBR, P237; REDDY AS, 2004, DIABETIC NEPHROPATHY; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Reusch JEB, 2003, J CLIN INVEST, V112, P986, DOI 10.1172/JCI200319902; Sanchez AP, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001057; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; STEVENS MJ, 1993, DIABETOLOGIA, V36, P608, DOI 10.1007/BF00404069; Susztak K, 2006, J AM SOC NEPHROL, V17, P361, DOI 10.1681/ASN.2005101109; Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; WHITING PH, 1979, BIOCHEM J, V179, P549, DOI 10.1042/bj1790549; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Xie P, 2009, J AM SOC NEPHROL, V20, P807, DOI 10.1681/ASN.2008091007; Xing G, 2006, BIOCHEMISTRY-US, V45, P5402, DOI 10.1021/bi0526276; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Yang BM, 2010, J DIABETES COMPLICAT, V24, P404, DOI 10.1016/j.jdiacomp.2009.09.005; Yang QW, 2000, P NATL ACAD SCI USA, V97, P9896, DOI 10.1073/pnas.160266197; Zhang YL, 2006, J AM SOC NEPHROL, V17, P1090, DOI 10.1681/ASN.2005111148	58	31	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27594	27611		10.1074/jbc.M110.217141	http://dx.doi.org/10.1074/jbc.M110.217141			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652700	hybrid, Green Published			2022-12-25	WOS:000293268700053
J	Sekiya, A; Okano-Kosugi, H; Yamazaki, CM; Koide, T				Sekiya, Atsushi; Okano-Kosugi, Hitomi; Yamazaki, Chisato M.; Koide, Takaki			Pigment Epithelium-derived Factor (PEDF) Shares Binding Sites in Collagen with Heparin/Heparan Sulfate Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-ANGIOGENIC ACTIVITY; AMINO-ACID-SEQUENCE; CRYSTAL-STRUCTURE; HEPARIN-BINDING; I COLLAGEN; CROSS-LINKING; TUMOR-GROWTH; CELLS; RECEPTOR; STABILITY	Pigment epithelium-derived factor (PEDF) is a collagen-binding protein that is abundantly distributed in various tissues, including the eye. It exhibits various biological functions, such as anti-angiogenic, neurotrophic, and neuroprotective activities. PEDF also interacts with extracellular matrix components such as collagen, heparan sulfate proteoglycans (HSPGs), and hyaluronan. The collagen-binding property has been elucidated to be important for the anti-angiogenic activity in vivo (Hosomichi, J., Yasui, N., Koide, T., Soma, K., and Morita, I. (2005) Biochem. Biophys. Res. Commun. 335, 756-761). Here, we investigated the collagen recognition mechanism by PEDF. We first narrowed down candidate PEDF-binding sequences by taking advantage of previously reported structural requirements in collagen. Subsequent searches for PEDF-binding sequences employing synthetic collagen-like peptides resulted in the identification of one of the critical binding sites for PEDF, human alpha 1(I)(929-938) (IKGHRGFSGL). Further analysis revealed that the collagen recognition by PEDF is sequence-and conformation-specific, and the high affinity binding motif is KGXRG-FXGL in the triple helix. The PEDF-binding motif significantly overlapped with the heparin/HSPG-binding motif, KGHRG(F/Y). The interaction of PEDF with collagen I was specifically competed with by heparin but not by chondroitin sulfate-C or hyaluronan. The binding sequences for PEDF and heparin/HSPG also overlapped with the covalent cross-linking sites between collagen molecules. These findings imply a functional relationship between PEDF and HSPGs during angiogenesis, and the interaction of these molecules is regulated by collagen modifications.	[Sekiya, Atsushi; Yamazaki, Chisato M.; Koide, Takaki] Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan; [Okano-Kosugi, Hitomi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Niigata 9568603, Japan	Waseda University; Niigata University	Koide, T (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Dept Chem & Biochem, Tokyo 1698555, Japan.	koi@waseda.jp			Japan Society for the Promotion of Science [19390032]; Waseda University [2008B-098]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Waseda University	This work was supported by a Grant-in-aid for Scientific Research (B) 19390032 from the Japan Society for the Promotion of Science and Waseda University Grant for Special Research Projects 2008B-098.	Abe R, 2004, AM J PATHOL, V164, P1225, DOI 10.1016/S0002-9440(10)63210-5; Alberdi E, 1998, BIOCHEMISTRY-US, V37, P10643, DOI 10.1021/bi9802317; Alberdi Elena M, 2003, BMC Biochem, V4, P1, DOI 10.1186/1471-2091-4-1; Baba H, 2005, ARTERIOSCL THROM VAS, V25, P1938, DOI 10.1161/01.ATV.0000175759.78338.1e; Becerra SP, 2008, J BIOL CHEM, V283, P33310, DOI 10.1074/jbc.M801287200; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DOGGETT DL, 1992, MECH AGEING DEV, V65, P239, DOI 10.1016/0047-6374(92)90039-G; Fietzek P P, 1976, Int Rev Connect Tissue Res, V7, P1; FIETZEK PP, 1977, P NATL ACAD SCI USA, V74, P84, DOI 10.1073/pnas.74.1.84; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Garcia M, 2004, CANCER RES, V64, P5632, DOI 10.1158/0008-5472.CAN-04-0230; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Hosomichi J, 2005, BIOCHEM BIOPH RES CO, V335, P756, DOI 10.1016/j.bbrc.2005.07.140; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; Ishikawa T, 2010, EXP CELL RES, V316, P951, DOI 10.1016/j.yexcr.2009.12.013; Jairajpuri MA, 2003, J BIOL CHEM, V278, P15941, DOI 10.1074/jbc.M212319200; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; KODA JE, 1985, J BIOL CHEM, V260, P8157; Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005; Konson A, 2011, J BIOL CHEM, V286, P3540, DOI 10.1074/jbc.M110.151548; Kozaki K, 1998, J BIOL CHEM, V273, P15125, DOI 10.1074/jbc.273.24.15125; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Munoz EM, 2004, ARTERIOSCL THROM VAS, V24, P1549, DOI 10.1161/01.ATV.0000137189.22999.3f; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Notari L, 2010, FEBS J, V277, P2192, DOI 10.1111/j.1742-4658.2010.07641.x; Oh JH, 2010, INT J GYNECOL CANCER, V20, P751, DOI 10.1111/IGC.0b013e3181e02faa; Okano-Kosugi H, 2009, ANAL BIOCHEM, V394, P125, DOI 10.1016/j.ab.2009.07.017; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Robins SP, 2007, BIOCHEM SOC T, V35, P849, DOI 10.1042/BST0350849; SANANTONIO JD, 1994, GLYCOBIOLOGY, V4, P327; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275; TANIWAKI T, 1995, J NEUROCHEM, V64, P2509; Valnickova Z, 2007, J BIOL CHEM, V282, P6661, DOI 10.1074/jbc.M610471200; Wang L, 2003, MOL THER, V8, P72, DOI 10.1016/S1525-0016(03)00128-X; WU JJ, 1984, BIOCHEMISTRY-US, V23, P1850, DOI 10.1021/bi00303a041; Wu YQ, 1996, INVEST OPHTH VIS SCI, V37, P1984; Yang WD, 2005, TISSUE ENG, V11, P76, DOI 10.1089/ten.2005.11.76; Yasui N, 2003, J AM CHEM SOC, V125, P15728, DOI 10.1021/ja038148g; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558	52	46	46	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26364	26374		10.1074/jbc.M111.252684	http://dx.doi.org/10.1074/jbc.M111.252684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652703	Green Published, hybrid			2022-12-25	WOS:000293078200013
J	Tian, RQ; Wang, XH; Hou, J; Jia, WH; Yang, Q; Li, YX; Liu, M; Li, X; Tang, H				Tian, Rui-Qing; Wang, Xing-Hua; Hou, Juan; Jia, Wei-Hua; Yang, Qian; Li, Yi-Xuan; Liu, Min; Li, Xin; Tang, Hua			MicroRNA-372 Is Down-regulated and Targets Cyclin-dependent Kinase 2 (CDK2) and Cyclin A1 in Human Cervical Cancer, Which May Contribute to Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; BREAST-CANCER; SMALL RNAS; EXPRESSION; PROLIFERATION; P27(KIP1); ONCOGENES; GENOMICS; HOMOLOG; MIR-222	MicroRNAs are a class of noncoding RNAs that are similar to 22 nucleotides in length. MicroRNAs have been shown to play important roles in cell differentiation and in cancer. Recently, studies have shown that miR-372 is tumorigenic in human reproductive system cancers. However, we provide evidence that miR-372 acts as a tumor suppressor gene in cervical carcinoma. miR-372 was found down-regulated in cervical carcinoma tissues as compared with adjacent normal cervical tissues. Growth curve and FACS assays indicated that ectopic expression of miR-372 suppressed cell growth and induced arrest in the S/G(2) phases of cell cycle in HeLa cells. We used bioinformatic predictions to determine that CDK2 and cyclin A1 were possible targets of miR-372 and confirmed this prediction using a fluorescent reporter assay. Taken together, these findings indicate that an anti-oncogenic role of miR-372 may be through control of cell growth and cell cycle progression by down-regulating the cell cycle genes CDK2 and cyclin A1.	[Tian, Rui-Qing; Wang, Xing-Hua; Hou, Juan; Yang, Qian; Li, Yi-Xuan; Liu, Min; Li, Xin; Tang, Hua] Tianjin Med Univ, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; [Tian, Rui-Qing; Wang, Xing-Hua; Hou, Juan; Yang, Qian; Li, Yi-Xuan; Liu, Min; Li, Xin; Tang, Hua] Tianjin Med Univ, Basic Med Sch, Tianjin 300070, Peoples R China; [Jia, Wei-Hua] Sun Sat Sen Univ Med Sci, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Tianjin Medical University; Tianjin Medical University	Tang, H (corresponding author), 22 Qi Xiang Tai Rd, Tianjin 300070, Peoples R China.	htang2002@yahoo.com	wang, xinghua/AAE-4659-2022; li, yixuan/P-5376-2016		National Natural Science Foundation of China [30873017, 30900736, 31071191]; Natural Science Foundation of Tianjin [08JCZDJC23300, 09JCZDJC17500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (Grants 30873017, 30900736, and 31071191) and the Natural Science Foundation of Tianjin (Grants 08JCZDJC23300 and 09JCZDJC17500).	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Arellano M, 1997, INT J BIOCHEM CELL B, V29, P559, DOI 10.1016/S1357-2725(96)00178-1; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Cho WJ, 2009, MOL CELLS, V28, P521, DOI 10.1007/s10059-009-0158-0; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li A, 2001, NAT CELL BIOL, V3, pE182, DOI 10.1038/35087119; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; ROSENTHAL ET, 1980, CELL, V20, P487, DOI 10.1016/0092-8674(80)90635-2; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wu W, 2007, INT J CANCER, V120, P953, DOI 10.1002/ijc.22454; Yang R, 1999, MOL CELL BIOL, V19, P2400; Yang R, 1997, CANCER RES, V57, P913; Yang R, 1999, BLOOD, V93, P2067; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	44	85	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25556	25563		10.1074/jbc.M111.221564	http://dx.doi.org/10.1074/jbc.M111.221564			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21646351	Green Published, hybrid			2022-12-25	WOS:000293073000018
J	Mangia, CMF; Kissoon, N; Branchini, OA; Andrade, MC; Kopelman, BI; Carcillo, J				Ferreira Mangia, Cristina Malzoni; Kissoon, Niranjan; Branchini, Otavio Augusto; Andrade, Maria Cristina; Kopelman, Benjamin Israel; Carcillo, Joe			Bacterial Sepsis in Brazilian Children: A Trend Analysis from 1992 to 2006	PLOS ONE			English	Article							GUIDELINES; DISEASE; CARE	Background: The objective of this study was to determine the epidemiology of hospitalized pediatric sepsis in Brazil (19922006) and to compare mortality caused by sepsis to that caused by other major childhood diseases. Methods and Findings: We performed a retrospective descriptive study of hospital admissions using a government database of all hospital affiliated with the Brazilian health system. We studied all hospitalizations in children from 28 days through 19 years with diagnosis of bacterial sepsis defined by the criteria of the International Classification of Diseases (ICD), (Appendix S1). Based on the data studied from 1992 through 2006, the pediatric hospital mortality rate was 1.23% and there were 556,073 pediatric admissions with bacterial sepsis with a mean mortality rate of 19.9%. There was a case reduction of 67% over. 1992-2006 (p<0.001); however, the mortality rate remained unchanged (from 1992-1996, 20.5%; and from 20022006, 19.7%). Sepsis-hospital mortality rate was substantially higher than pneumonia (0.5%), HIV (3.3%), diarrhea (0.3%), undernutrition (2.3%), malaria (0.2%) and measles (0.7%). The human development index (HDI) and mortality rates (MR) by region were: North region 0.76 and 21.7%; Northeast region 0.72 and 27.1%; Central-West 0.81 and 23.5%; South region 0.83 and 12.2% and Southeast region 0.82 and 14.8%, respectively. Conclusions: We concluded that sepsis remains an important health problem in children in Brazil. The institution of universal primary care programs has been associated with substantially reduced sepsis incidence and therefore deaths; however, hospital mortality rates in children with sepsis remain unchanged. Implementation of additional health initiatives to reduce sepsis mortality in hospitalized patients could have great impact on childhood mortality rates in Brazil.	[Ferreira Mangia, Cristina Malzoni; Andrade, Maria Cristina; Kopelman, Benjamin Israel] Univ Fed Sao Paulo, Dept Pediat, Escola Paulista Med, Sao Paulo, Brazil; [Kissoon, Niranjan] Univ British Columbia, Dept Pediat, Div Crit Care, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada; [Branchini, Otavio Augusto] Hosp Emilio Ribas, Sao Paulo, Brazil; [Carcillo, Joe] Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA	Universidade Federal de Sao Paulo (UNIFESP); Child & Family Research Institute; University of British Columbia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mangia, CMF (corresponding author), Univ Fed Sao Paulo, Dept Pediat, Escola Paulista Med, Sao Paulo, Brazil.	nkissoon@cw.bc.ca	Kissoon, Niranjan/AAC-6140-2021	Kissoon, Niranjan/0000-0001-8847-9973				Barbosa Arnaldo Prata, 2004, J. Pediatr. (Rio J.), V80, P437, DOI 10.1590/S0021-75572004000800002; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Buysse CMP, 2008, ARCH PEDIAT ADOL MED, V162, P1036, DOI 10.1001/archpedi.162.11.1036; Carcillo JA, 2003, CRIT CARE CLIN, V19, P413, DOI 10.1016/S0749-0704(03)00013-7; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; Carcillo JA, 1997, CRIT CARE CLIN, V13, P553, DOI 10.1016/S0749-0704(05)70328-6; Carcillo Joseph A., 2002, J. Pediatr. (Rio J.), V78, P449, DOI 10.1590/S0021-75572002000600004; Claeson M, 2003, LANCET, V362, P323, DOI 10.1016/S0140-6736(03)13977-3; Fischer Joachim E, 2005, Pediatr Crit Care Med, V6, pS120, DOI 10.1097/01.PCC.0000161583.34305.A0; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; HAYDEN WR, 1994, J PEDIATR-US, V124, P657, DOI 10.1016/S0022-3476(05)83159-2; Teles JMM, 2008, SHOCK, V30, P47, DOI 10.1097/SHK.0b013e318181a128; *MIN SAUD, PORT SAUD SAMU 192 P; Ministerio da Saude, INF SAUD; Molyneux E, 2001, LANCET, V357, P86, DOI 10.1016/S0140-6736(00)03536-4; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Odetola FO, 2007, PEDIATRICS, V119, P487, DOI 10.1542/peds.2006-2353; Opal Steven M, 2005, Pediatr Crit Care Med, V6, pS55, DOI 10.1097/01.PCC.0000161580.79526.4C; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Ferrer APS, 2010, CLINICS, V65, P35, DOI 10.1590/S1807-59322010000100007; *UNICEF, 2006, CHILD DEV IND; United Nation, 2001, ROAD MAP IMPL UN MIL; United Nations Development Programme, HUM DEV REP; Vincent JL, 2003, INTENS CARE MED, V29, pS74; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; CRIT CARE MED, V27, P639	30	23	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e14817	10.1371/journal.pone.0014817	http://dx.doi.org/10.1371/journal.pone.0014817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674036	Green Accepted, Green Published, gold			2022-12-25	WOS:000291355500001
J	Carrai, M; Steinke, V; Vodicka, P; Pardini, B; Rahner, N; Holinski-Feder, E; Morak, M; Schackert, HK; Gorgens, H; Stemmler, S; Betz, B; Kloor, M; Engel, C; Buttner, R; Naccarati, A; Vodickova, L; Novotny, J; Stein, A; Hemminki, K; Propping, P; Forsti, A; Canzian, F; Barale, R; Campa, D				Carrai, Maura; Steinke, Verena; Vodicka, Pavel; Pardini, Barbara; Rahner, Nils; Holinski-Feder, Elke; Morak, Monika; Schackert, Hans K.; Goergens, Heike; Stemmler, Susanne; Betz, Beate; Kloor, Matthias; Engel, Christoph; Buettner, Reinhard; Naccarati, Alessio; Vodickova, Ludmila; Novotny, Jan; Stein, Angelika; Hemminki, Kari; Propping, Peter; Foersti, Asta; Canzian, Federico; Barale, Roberto; Campa, Daniele			Association Between TAS2R38 Gene Polymorphisms and Colorectal Cancer Risk: A Case-Control Study in Two Independent Populations of Caucasian Origin	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BITTER TASTE RECEPTORS; RAT SMALL-INTESTINE; INDIVIDUAL-DIFFERENCES; ALPHA-GUSTDUCIN; PERCEPTION; GUT; 6-N-PROPYLTHIOURACIL; SUSCEPTIBILITY; ABSORPTION	Molecular sensing in the lingual mucosa and in the gastro-intestinal tract play a role in the detection of ingested harmful drugs and toxins. Therefore, genetic polymorphisms affecting the capability of initiating these responses may be critical for the subsequent efficiency of avoiding and/or eliminating possible threats to the organism. By using a tagging approach in the region of Taste Receptor 2R38 (TAS2R38) gene, we investigated all the common genetic variation of this gene region in relation to colorectal cancer risk with a case-control study in a German population (709 controls and 602 cases) and in a Czech population (623 controls and 601 cases). We found that there were no significant associations between individual SNPs of the TAS2R38 gene and colorectal cancer in the Czech or in the German population, nor in the joint analysis. However, when we analyzed the diplotypes and the phenotypes we found that the non-taster group had an increased risk of colorectal cancer in comparison to the taster group. This association was borderline significant in the Czech population, (OR = 1.28, 95% CI 0.99-1.67; P(value) = 0.058) and statistically significant in the German population (OR = 1.36, 95% CI 1.06-1.75; P(value) = 0.016) and in the joint analysis (OR = 1.34, 95% CI 1.12-1.61; P(value) = 0.001). In conclusion, we found a suggestive association between the human bitter tasting phenotype and the risk of CRC in two different populations of Caucasian origin.	[Carrai, Maura; Barale, Roberto; Campa, Daniele] Univ Pisa, Dept Biol, Pisa, Italy; [Steinke, Verena; Rahner, Nils; Propping, Peter] Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; [Vodicka, Pavel; Pardini, Barbara; Naccarati, Alessio; Vodickova, Ludmila] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic; [Vodicka, Pavel; Vodickova, Ludmila] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Holinski-Feder, Elke; Morak, Monika] Univ Munich, Univ Hosp, Dept Internal Med, Munich, Germany; [Holinski-Feder, Elke; Morak, Monika] Med Genet Zentrum MGZ, Ctr Med Genet, Munich, Germany; [Schackert, Hans K.; Goergens, Heike] Tech Univ Dresden, Dept Surg Res, Dresden, Germany; [Stemmler, Susanne] Humangenet Ruhr Univ Bochum, Bochum, Germany; [Betz, Beate] Univ Dusseldorf, Inst Human Genet, Dusseldorf, Germany; [Kloor, Matthias] Univ Heidelberg, Inst Pathol, Dept Appl Tumour Biol, D-6900 Heidelberg, Germany; [Engel, Christoph] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany; [Buettner, Reinhard] Univ Bonn, Inst Pathol, Bonn, Germany; [Novotny, Jan] Charles Univ Prague, Dept Oncol, Fac Med 1, Prague, Czech Republic; [Stein, Angelika; Hemminki, Kari; Foersti, Asta; Canzian, Federico; Campa, Daniele] Deutsch Krebsforschungszentrum DKFZ, German Canc Res Ctr, Heidelberg, Germany; [Hemminki, Kari; Foersti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	University of Pisa; University of Bonn; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; University of Munich; Technische Universitat Dresden; Ruhr University Bochum; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; Leipzig University; University of Bonn; Charles University Prague; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University	Carrai, M (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	d.campa@dkfz.de	Campa, Daniele/K-1617-2016; Pardini, Barbara/K-9451-2016; Vodicka, Pavel/H-3370-2014; Carrai, Maura/AGZ-4973-2022; Vodickova, Ludmila/H-3083-2014; Pardini, Barbara/ABI-2295-2020; Canzian, Federico/I-2804-2014	Campa, Daniele/0000-0003-3220-9944; Pardini, Barbara/0000-0001-9571-4257; Pardini, Barbara/0000-0001-9571-4257; Engel, Christoph/0000-0002-7247-282X; Carrai, Maura/0000-0001-6663-0353; Canzian, Federico/0000-0002-4261-4583; BARALE, Roberto/0000-0003-4161-2241; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243	Grant Agency of the Czech Republic [CZ:GACR:GA310/07/1430]; European Economic Area/Norway Grants; Czech Republic state budget [A/CZ0046/2/0012]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Economic Area/Norway Grants; Czech Republic state budget	This project was partially supported by the Grant Agency of the Czech Republic: CZ:GACR:GA310/07/1430, by the European Economic Area/Norway Grants and the Czech Republic state budget by means of the Research Support Fund: A/CZ0046/2/0012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basson MD, 2005, DIGEST DIS SCI, V50, P483, DOI 10.1007/s10620-005-2462-7; Behrens M, 2010, RESULTS PROBL CELL D, V52, P87, DOI 10.1007/978-3-642-14426-4_8; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campa D, 2008, MUTAT RES-FUND MOL M, V645, P56, DOI 10.1016/j.mrfmmm.2008.08.001; Campa D, 2008, EUR J CANCER, V44, P854, DOI 10.1016/j.ejca.2008.02.004; Campa D, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-112; Campa D, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-88; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drewnowski A, 2001, DRUG METAB DISPOS, V29, P535; Duffy VB, 2007, CURR OPIN GASTROEN, V23, P171, DOI 10.1097/MOG.0b013e3280147d50; Eaden JA, 2001, J GASTROEN HEPATOL, V16, P573; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2010, INT J CANC; Hlavata I, 2010, ONCOL REP, V24, P1347, DOI 10.3892/or_0000992; Kim U, 2005, HUM MUTAT, V26, P199, DOI 10.1002/humu.20203; Kim UK, 2004, J DENT RES, V83, P448, DOI 10.1177/154405910408300603; Kim UK, 2005, CLIN GENET, V67, P275, DOI 10.1111/j.1399-0004.2004.00361.x; Kim UK, 2006, CHEM SENSES, V31, P599, DOI 10.1093/chemse/bjj065; Kiyohara C, 2000, J Epidemiol, V10, P349; Kokrashvili Z, 2009, AM J CLIN NUTR, V90, p822S, DOI 10.3945/ajcn.2009.27462T; Kokrashvili Z, 2009, ANN NY ACAD SCI, V1170, P91, DOI 10.1111/j.1749-6632.2009.04485.x; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; Mace OJ, 2009, J PHYSIOL-LONDON, V587, P195, DOI 10.1113/jphysiol.2008.159616; Mangold E, 2005, INT J CANCER, V116, P692, DOI 10.1002/ijc.20863; McCullough ML, 2003, CANCER CAUSE CONTROL, V14, P959, DOI 10.1023/B:CACO.0000007983.16045.a1; Michaud DS, 2005, CANCER EPIDEM BIOMAR, V14, P138, DOI 10.1158/1055-9965.EPI-05-0428; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Polakova V, 2009, HUM MUTAT, V30, P661, DOI 10.1002/humu.20931; Reed DR, 2010, HUM MOL GENET, V19, P4278, DOI 10.1093/hmg/ddq324; Rozengurt E, 2006, AM J PHYSIOL-GASTR L, V291, pG171, DOI 10.1152/ajpgi.00073.2006; Sacerdote C, 2007, AM J EPIDEMIOL, V166, P576, DOI 10.1093/aje/kwm113; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Siontis KCM, 2010, EUR J HUM GENET, V18, P832, DOI 10.1038/ejhg.2010.26; Strate LL, 2005, CANCER CAUSE CONTROL, V16, P201, DOI 10.1007/s10552-004-3488-4; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Tepper BJ, 1998, AM J HUM GENET, V63, P1271, DOI 10.1086/302124; Tepper BJ, 1998, ANN NY ACAD SCI, V855, P802, DOI 10.1111/j.1749-6632.1998.tb10662.x; Ueda T, 2001, BIOCHEM BIOPH RES CO, V285, P147, DOI 10.1006/bbrc.2001.5136; WARDWELL L, 2009, INT J FOOD SCI NUTR, P1; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092	46	57	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20464	10.1371/journal.pone.0020464	http://dx.doi.org/10.1371/journal.pone.0020464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674048	Green Published, Green Submitted, gold			2022-12-25	WOS:000291310600010
J	Chatenay-Lapointe, M; Shadel, GS				Chatenay-Lapointe, Marc; Shadel, Gerald S.			Repression of Mitochondrial Translation, Respiration and a Metabolic Cycle-Regulated Gene, SLF1, by the Yeast Pumilio-Family Protein Puf3p	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; MESSENGER-RNA TURNOVER; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL NETWORK; BINDING PROTEINS; EXPRESSION; BIOGENESIS; POLYMERASE; MACHINERY	Synthesis and assembly of the mitochondrial oxidative phosphorylation (OXPHOS) system requires genes located both in the nuclear and mitochondrial genomes, but how gene expression is coordinated between these two compartments is not fully understood. One level of control is through regulated expression mitochondrial ribosomal proteins and other factors required for mitochondrial translation and OXPHOS assembly, which are all products of nuclear genes that are subsequently imported into mitochondria. Interestingly, this cadre of genes in budding yeast has in common a 3'-UTR element that is bound by the Pumilio family protein, Puf3p, and is coordinately regulated under many conditions, including during the yeast metabolic cycle. Multiple functions have been assigned to Puf3p, including promoting mRNA degradation, localizing nucleus-encoded mitochondrial transcripts to the outer mitochondrial membrane, and facilitating mitochondria-cytoskeletal interactions and motility. Here we show that Puf3p has a general repressive effect on mitochondrial OXPHOS abundance, translation, and respiration that does not involve changes in overall mitochondrial biogenesis and largely independent of TORC1-mitochondrial signaling. We also identified the cytoplasmic translation factor Slf1p as yeast metabolic cycle-regulated gene that is repressed by Puf3p at the post-transcriptional level and promotes respiration and extension of yeast chronological life span when over-expressed. Altogether, these results should facilitate future studies on which of the many functions of Puf3p is most relevant for regulating mitochondrial gene expression and the role of nuclear-mitochondrial communication in aging and longevity.	[Chatenay-Lapointe, Marc; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Chatenay-Lapointe, Marc; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Yale University; Yale University	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	gerald.shadel@yale.edu	WONG, WEY LIM/C-1054-2010; Wong, Wey-Lim/S-7445-2017	WONG, WEY LIM/0000-0002-2722-3517; Wong, Wey-Lim/0000-0002-2722-3517	National Institutes of Health (NIH) [HL-059655, T32 GM007499]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant HL-059655 awarded to GSS. MCL was supported by NIH pre-doctoral Genetics training grant T32 GM007499. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig AR, 2001, MOL BIOL CELL, V12, P3428, DOI 10.1091/mbc.12.11.3428; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Cereghino GP, 1996, EMBO J, V15, P363, DOI 10.1002/j.1460-2075.1996.tb00366.x; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Deng YP, 2005, INT J MOL MED, V15, P123; Devaux F, 2010, FEBS LETT, V584, P4273, DOI 10.1016/j.febslet.2010.09.030; Eliyahu E, 2010, MOL CELL BIOL, V30, P284, DOI 10.1128/MCB.00651-09; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; GRIVELL LA, 1995, CRIT REV BIOCHEM MOL, V30, P121, DOI 10.3109/10409239509085141; Hagen I, 2004, MOL MICROBIOL, V52, P1413, DOI 10.1111/j.1365-2958.2004.04064.x; Ho SW, 2006, P NATL ACAD SCI USA, V103, P9940, DOI 10.1073/pnas.0509185103; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; KELLEMS RE, 1975, J CELL BIOL, V65, P1, DOI 10.1083/jcb.65.1.1; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Lai LC, 2006, EUKARYOT CELL, V5, P1468, DOI 10.1128/EC.00107-06; Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lelandais G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000409; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Mehta R, 2010, ADV EXP MED BIOL, V694, P14; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Pan Y, 2009, AGING-US, V1, P131, DOI 10.18632/aging.100016; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Russo A, 2006, BBA-MOL CELL RES, V1763, P833, DOI 10.1016/j.bbamcr.2006.05.010; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Shutt TE, 2010, ENVIRON MOL MUTAGEN, V51, P360, DOI 10.1002/em.20571; Sobel SG, 1999, MOL BIOL CELL, V10, P3849, DOI 10.1091/mbc.10.11.3849; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Zarnack K, 2007, MOL GENET GENOMICS, V278, P347, DOI 10.1007/s00438-007-0271-8	40	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20441	10.1371/journal.pone.0020441	http://dx.doi.org/10.1371/journal.pone.0020441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655263	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600069
J	Guo, G; Gehle, P; Doelken, S; Martin-Ventura, JL; von Kodolitsch, Y; Hetzer, R; Robinson, PN				Guo, Gao; Gehle, Petra; Doelken, Sandra; Martin-Ventura, Jose Luis; von Kodolitsch, Yskert; Hetzer, Roland; Robinson, Peter N.			Induction of Macrophage Chemotaxis by Aortic Extracts from Patients with Marfan Syndrome Is Related to Elastin Binding Protein	PLOS ONE			English	Article							GROWTH-FACTOR MODULES; FACTOR-LIKE DOMAINS; MOUSE MODEL; MATRIX METALLOPROTEINASE-1; HUMAN FIBRILLIN-1; THORACIC AORTA; CELL-ADHESION; IN-VITRO; PATHOGENESIS; MUTATIONS	Marfan syndrome is an autosomal dominantly inherited disorder of connective tissue with prominent skeletal, ocular, and cardiovascular manifestations. Aortic aneurysm and dissection are the major determinants of premature death in untreated patients. In previous work, we showed that extracts of aortic tissues from the mgR mouse model of Marfan syndrome showed increased chemotactic stimulatory activity related to the elastin-binding protein. Aortic samples were collected from 6 patients with Marfan syndrome and 8 with isolated aneurysms of the ascending aorta. Control samples were obtained from 11 organ donors without known vascular or connective tissue diseases. Soluble proteins extracted from the aortic samples of the two patient groups were compared against buffer controls and against the aortic samples from controls with respect to the ability to induce macrophage chemotaxis as measured using a modified Boyden chamber, as well as the reactivity to a monoclonal antibody BA4 against bioactive elastin peptides using ELISA. Samples from Marfan patients displayed a statistically significant increase in chemotactic inductive activity compared to control samples. Additionally, reactivity to BA4 was significantly increased. Similar statistically significant increases were identified for the samples from patients with idiopathic thoracic aortic aneurysm. There was a significant correlation between the chemotactic index and BA4 reactivity, and the increases in chemotactic activity of extracts from Marfan patients could be inhibited by pretreatment with lactose, VGVAPG peptides, or BA4, which indicates the involvement of EBP in mediating the effects. Our results demonstrate that aortic extracts of patients with Marfan syndrome can elicit macrophage chemotaxis, similar to our previous study on aortic extracts of the mgR mouse model of Marfan syndrome (Guo et al., Circulation 2006; 114: 1855-62).	[Guo, Gao; Doelken, Sandra; Robinson, Peter N.] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Gehle, Petra; Hetzer, Roland] German Heart Inst Berlin, DHZB, Berlin, Germany; [Gehle, Petra; Hetzer, Roland; Robinson, Peter N.] DHZB, Marfan Zentrum, Berlin, Germany; [Gehle, Petra; Hetzer, Roland; Robinson, Peter N.] Charite, Berlin, Germany; [Doelken, Sandra; Robinson, Peter N.] Max Planck Inst Mol Genet, Berlin, Germany; [Doelken, Sandra; Robinson, Peter N.] Charite, BCRT, D-13353 Berlin, Germany; [Martin-Ventura, Jose Luis] Univ Autonoma Madrid, Fdn Jimenez Diaz, Inst Invest Sanitaria, Vasc Res Lab, Madrid, Spain; [von Kodolitsch, Yskert] Univ Hosp Hamburg Eppendorf, Dept Cardiol Angiol, Ctr Cardiol & Cardiovasc Surg, Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Autonomous University of Madrid; Fundacion Jimenez Diaz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Guo, G (corresponding author), Charite, Inst Med & Human Genet, D-13353 Berlin, Germany.	peter.robinson@charite.de	MARTIN-VENTURA, JOSE LUIS/Z-2386-2019	Robinson, Peter/0000-0002-0736-9199; MARTIN-VENTURA, JOSE LUIS/0000-0003-2090-8641	European Commission [HEALTH-F2-2008-200647]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This project was supported by a grant from the European Commission (FAD; HEALTH-F2-2008-200647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSAMIT RR, 1981, J IMMUNOL, V126, P2194; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Booms P, 2006, J MOL CELL CARDIOL, V40, P234, DOI 10.1016/j.yjmcc.2005.11.009; Booms P, 2005, HUM GENET, V116, P51, DOI 10.1007/s00439-004-1194-7; Booms P, 2000, HUM GENET, V107, P216, DOI 10.1007/s004390000368; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; Chung AWY, 2007, BRIT J PHARMACOL, V152, P305, DOI 10.1038/sj.bjp.0707391; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Chung AWY, 2008, CIRC RES, V102, pE73, DOI 10.1161/CIRCRESAHA.108.174367; Chung AWY, 2007, CIRC RES, V101, P512, DOI 10.1161/CIRCRESAHA.107.157776; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; D'Arrigo C, 1998, CONNECT TISSUE RES, V37, P29, DOI 10.3109/03008209809028898; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; DILLON TJ, 1992, AM REV RESPIR DIS, V146, P1143, DOI 10.1164/ajrccm/146.5_Pt_1.1143; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Fleischer KJ, 1997, ANN THORAC SURG, V63, P1012, DOI 10.1016/S0003-4975(97)00061-1; Fulop T, 2005, PATHOL BIOL, V53, P416, DOI 10.1016/j.patbio.2004.12.023; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Ikonomidis JS, 2006, CIRCULATION, V114, pI365, DOI 10.1161/CIRCULATIONAHA.105.000810; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jovanovic J, 2007, J BIOL CHEM, V282, P6743, DOI 10.1074/jbc.M607008200; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; LONG MM, 1988, BIOCHIM BIOPHYS ACTA, V968, P300, DOI 10.1016/0167-4889(88)90021-3; MARIKO B, 2010, AM J PHYSL CELL PHYS; Matyas G, 2007, HUM GENET, V122, P23, DOI 10.1007/s00439-007-0371-x; McGettrick AJ, 2000, HUM MOL GENET, V9, P1987, DOI 10.1093/hmg/9.13.1987; McGowan SE, 2008, AM J RESP CELL MOL, V38, P435, DOI 10.1165/rcmb.2007-0281OC; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pfaff M, 1996, FEBS LETT, V384, P247, DOI 10.1016/0014-5793(96)00325-0; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; Robinson PN, 2002, HUM MUTAT, V20, P153, DOI 10.1002/humu.10113; Robinson PN, 2001, CELL MOL LIFE SCI, V58, P1698, DOI 10.1007/PL00000807; SCHLATMANN TJM, 1977, AM J CARDIOL, V39, P13, DOI 10.1016/S0002-9149(77)80004-0; Segura AM, 1998, CIRCULATION, V98, pII331; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Shinohara T, 2003, ARTERIOSCL THROM VAS, V23, P1839, DOI 10.1161/01.ATV.0000085016.02363.80; Suk JY, 2004, J BIOL CHEM, V279, P51258, DOI 10.1074/jbc.M408156200; Varga Z, 1997, EXP GERONTOL, V32, P653, DOI 10.1016/S0531-5565(97)00042-9; Vollbrandt T, 2004, J BIOL CHEM, V279, P32924, DOI 10.1074/jbc.M405239200; von Kodolitsch Y, 2010, VASA, V39, P17, DOI 10.1024/0301-1526/a000002; von Kodolitsch Y, 2007, HEART, V93, P755, DOI 10.1136/hrt.2006.098798; WEI SM, 1993, J IMMUNOL METHODS, V164, P175; Whiteman P, 2001, J BIOL CHEM, V276, P17156, DOI 10.1074/jbc.M006547200; Whiteman P, 1998, J BIOL CHEM, V273, P7807, DOI 10.1074/jbc.273.14.7807; WRENN DS, 1986, BIOCHEMISTRY-US, V25, P5172, DOI 10.1021/bi00366a028; Xiong W, 2008, J VASC SURG, V47, P166, DOI 10.1016/j.jvs.2007.09.016; Yang HHC, 2010, VASC PHARMACOL, V52, P37, DOI 10.1016/j.vph.2009.10.005	61	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20138	10.1371/journal.pone.0020138	http://dx.doi.org/10.1371/journal.pone.0020138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647416	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500034
J	Wu, XM; Hu, CP; Li, XZ; Zou, YQ; Zou, JT; Li, YY; Feng, JT				Wu, Xiu-Ming; Hu, Cheng-Ping; Li, Xiao-Zhao; Zou, Ye-Qiang; Zou, Jun-Tao; Li, Yuan-Yuan; Feng, Jun-Tao			Asthma Pregnancy Alters Postnatal Development of Chromaffin Cells in the Rat Adrenal Medulla	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; NGF; EXPRESSION; DYSFUNCTION; HYPOXIA; NEURONS; ATOPY; MICE	Background: Adrenal neuroendocrine plays an important role in asthma. The activity of the sympathoadrenal system could be altered by early life events. The effects of maternal asthma during pregnancy on the adrenal medulla of offspring remain unknown. Methodology/Principal Findings: This study aims to explore the influence of maternal asthma during pregnancy on the development and function of adrenal medulla in offspring from postnatal day 3 (P3) to postnatal day 60 (P60). Asthmatic pregnant rats (AP), nerve growth factor (NGF)-treated pregnant rats (NP) and NGF antibody-treated pregnant rats (ANP) were sensitized and challenged with ovalbumin (OVA); NP and ANP were treated with NGF and NGF antibody respectively. Offspring rats from the maternal group were divided into four groups: offspring from control pregnant rats (OCP), offspring from AP (OAP), offspring from NP (ONP), and offspring from ANP (OANP). The expressions of phenylethanolamine N-methyltransferase (PNMT) protein in adrenal medulla were analyzed. The concentrations of epinephrine (EPI), corticosterone and NGF in serum were measured. Adrenal medulla chromaffin cells (AMCC) were prone to differentiate into sympathetic nerve cells in OAP and ONP. Both EPI and PNMT were decreased in OAP from P3 to P14, and then reached normal level gradually from P30 to P60, which were lower from birth to adulthood in ONP. Corticosterone concentration increased significantly in OAP and ONP. Conclusion/Significance: Asthma pregnancy may promote AMCC to differentiate into sympathetic neurons in offspring rats and inhibit the synthesis of EPI, resulting in dysfunction of bronchial relaxation.	[Wu, Xiu-Ming; Hu, Cheng-Ping; Li, Xiao-Zhao; Zou, Ye-Qiang; Zou, Jun-Tao; Li, Yuan-Yuan; Feng, Jun-Tao] Cent South Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China	Central South University	Wu, XM (corresponding author), Cent South Univ, Xiangya Hosp, Dept Resp Med, Changsha, Hunan, Peoples R China.	jtfeng1976@hotmail.com			National Natural Science Foundation of China [30800502, 30801505, 81070026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 30800502, No. 30801505 and No. 81070026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MB, 1999, J NEUROENDOCRINOL, V11, P569; ALOE L, 1979, P NATL ACAD SCI USA, V76, P1246, DOI 10.1073/pnas.76.3.1246; Bjerg A, 2007, PEDIATRICS, V120, P741, DOI 10.1542/peds.2006-3742; Buttigieg J, 2008, FASEB J, V22, P1317, DOI 10.1096/fj.07-9194com; Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274; de la Calzada Dolores Garcia, 2009, Pediatr Endocrinol Rev, V6 Suppl 3, P343; de Vries A, 2006, CLIN EXP ALLERGY, V36, P1192, DOI 10.1111/j.1365-2222.2006.02549.x; Evinger MJ, 2007, EXP CELL RES, V313, P772, DOI 10.1016/j.yexcr.2006.11.013; Fan JM, 2009, NEUROSCIENCE, V159, P1363, DOI 10.1016/j.neuroscience.2009.02.009; Feng JT, 2005, MED HYPOTHESES, V65, P1043, DOI 10.1016/j.mehy.2005.06.029; Freund V, 2004, REV MAL RESPIR, V21, P328; Grumolato L, 2003, EUR J NEUROSCI, V17, P71, DOI 10.1046/j.1460-9568.2003.02426.x; Hamada K, 2007, J TOXICOL ENV HEAL A, V70, P688, DOI 10.1080/15287390600974692; HERMAN MAR, 1992, BRAIN RES, V575, P257, DOI 10.1016/0006-8993(92)90088-Q; Hodel A, 2001, J NEUROENDOCRINOL, V13, P217; HOFMANN HD, 1989, J ELECTRON MICR TECH, V12, P397, DOI 10.1002/jemt.1060120412; Hu CP, 2002, AM J PHYSIOL-LUNG C, V283, pL494, DOI 10.1152/ajplung.00414.2001; Huber K, 2009, AUTON NEUROSCI-BASIC, V151, P10, DOI 10.1016/j.autneu.2009.07.020; Isidoro-Garcia M, 2007, ALLERGOL IMMUNOPATH, V35, P254, DOI 10.1157/13112992; JAMES G, 2002, J IMMUNOL, V169, P3963; Joachim RA, 2008, CLIN EXP ALLERGY, V38, P283, DOI 10.1111/j.1365-2222.2007.02899.x; Kvetnansky R, 2006, CELL MOL NEUROBIOL, V26, P735, DOI 10.1007/s10571-006-9063-7; Lau Christopher, 2004, Birth Defects Res C Embryo Today, V72, P300, DOI 10.1002/bdrc.20029; LIN L, 2010, ALLERGY ASTHMA CLIN, V6, P1; Molendi-Coste O, 2009, NEUROENDOCRINOLOGY, V90, P54, DOI 10.1159/000209222; MORIMOTO M, 1994, NEUROREPORT, V5, P954, DOI 10.1097/00001756-199404000-00025; Morrison SF, 2000, AM J PHYSIOL-REG I, V279, pR1763, DOI 10.1152/ajpregu.2000.279.5.R1763; Ronchetti R, 2009, ALLERGY ASTHMA PROC, V30, P55, DOI 10.2500/aap.2009.30.3197; Sleiman PMA, 2010, CURR OPIN PEDIATR, V22, P307, DOI 10.1097/MOP.0b013e328339553d; UNSICKER K, 1978, P NATL ACAD SCI USA, V75, P3498, DOI 10.1073/pnas.75.7.3498; Vaag A, 2006, HORM RES, V65, P137, DOI 10.1159/000091519; Wang Jun, 2006, Zhonghua Jiehe He Huxi Zazhi, V29, P812; Yamaguchi-Shima N, 2007, EUR J PHARMACOL, V564, P94, DOI 10.1016/j.ejphar.2007.02.021; Ziegler CG, 2008, ENDOCRINOLOGY, V149, P320, DOI 10.1210/en.2007-0645; Ziegler MG, 2002, ANN NY ACAD SCI, V971, P76, DOI 10.1111/j.1749-6632.2002.tb04437.x	35	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20337	10.1371/journal.pone.0020337	http://dx.doi.org/10.1371/journal.pone.0020337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647384	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500047
J	Church, TS; Thomas, DM; Tudor-Locke, C; Katzmarzyk, PT; Earnest, CP; Rodarte, RQ; Martin, CK; Blair, SN; Bouchard, C				Church, Timothy S.; Thomas, Diana M.; Tudor-Locke, Catrine; Katzmarzyk, Peter T.; Earnest, Conrad P.; Rodarte, Ruben Q.; Martin, Corby K.; Blair, Steven N.; Bouchard, Claude			Trends over 5 Decades in US Occupation-Related Physical Activity and Their Associations with Obesity	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; ADULTS	Background: The true causes of the obesity epidemic are not well understood and there are few longitudinal population-based data published examining this issue. The objective of this analysis was to examine trends in occupational physical activity during the past 5 decades and explore how these trends relate to concurrent changes in body weight in the U.S. Methodology/Principal Findings: Analysis of energy expenditure for occupations in U.S. private industry since 1960 using data from the U.S. Bureau of Labor Statistics. Mean body weight was derived from the U.S. National Health and Nutrition Examination Surveys (NHANES). In the early 1960's almost half the jobs in private industry in the U.S. required at least moderate intensity physical activity whereas now less than 20% demand this level of energy expenditure. Since 1960 the estimated mean daily energy expenditure due to work related physical activity has dropped by more than 100 calories in both women and men. Energy balance model predicted weights based on change in occupation-related daily energy expenditure since 1960 for each NHANES examination period closely matched the actual change in weight for 40-50 year old men and women. For example from 1960-62 to 2003-06 we estimated that the occupation-related daily energy expenditure decreased by 142 calories in men. Given a baseline weight of 76.9 kg in 1960-02, we estimated that a 142 calories reduction would result in an increase in mean weight to 89.7 kg, which closely matched the mean NHANES weight of 91.8 kg in 2003-06. The results were similar for women. Conclusion: Over the last 50 years in the U.S. we estimate that daily occupation-related energy expenditure has decreased by more than 100 calories, and this reduction in energy expenditure accounts for a significant portion of the increase in mean U.S. body weights for women and men.	[Church, Timothy S.; Tudor-Locke, Catrine; Katzmarzyk, Peter T.; Earnest, Conrad P.; Rodarte, Ruben Q.; Martin, Corby K.; Bouchard, Claude] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Thomas, Diana M.] Montclair State Univ, Dept Math Sci, Montclair, NJ USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Exercise Sci, Columbia, SC 29208 USA; [Blair, Steven N.] Univ S Carolina, Arnold Sch Publ Hlth, Dept Epidemiol Biostat, Columbia, SC 29208 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Montclair State University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Church, TS (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.	tim.church@pbrc.edu	Bouchard, Claude/A-7637-2009; Martin, Corby K./N-1976-2017; Katzmarzyk, Peter T/N-1974-2017; Earnest, Conrad P./M-6849-2017; Bouchard, Claude/AAE-2035-2019	Bouchard, Claude/0000-0002-0048-491X; Martin, Corby K./0000-0002-8125-4015; Katzmarzyk, Peter T/0000-0002-9280-6022; Earnest, Conrad P./0000-0002-6546-1268; 				American College., 2006, ACSMS GUID EX TEST P; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; *CDCP, 2008, US PHYS ACT STAT 199; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; LEE MA, POPULATION B US LABO; McDowell MA., 2008, NATL HLTH STAT REPOR; *NAT CTR HLTH STAT, 2009, PREV OV OB EXTR OB A; OGDEN CL, 2004, MEAN BODY WEIGHT HEI, P1; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; THOMAS DM, 2010, COMPUTATIONAL MODEL; THOMAS DM, 2010, J BIOL DYNAMICS; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; TUDORLOCKE C, 2010, J PHYS ACTIVITY HLTH; U. S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A, P1, DOI DOI 10.1017/CB09781107415324.004; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; Westerterp KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004745	20	739	757	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19657	10.1371/journal.pone.0019657	http://dx.doi.org/10.1371/journal.pone.0019657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647427	Green Submitted, gold, Green Published			2022-12-25	WOS:000291006500006
J	Manns, J; Daubrawa, M; Driessen, S; Paasch, F; Hoffmann, N; Loffler, A; Lauber, K; Dieterle, A; Alers, S; Iftner, T; Schulze-Osthoff, K; Stork, B; Wesselborg, S				Manns, Joachim; Daubrawa, Merle; Driessen, Stefan; Paasch, Florian; Hoffmann, Nadine; Loeffler, Antje; Lauber, Kirsten; Dieterle, Alexandra; Alers, Sebastian; Iftner, Thomas; Schulze-Osthoff, Klaus; Stork, Bjoern; Wesselborg, Sebastian			Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: activation of caspase-9 in the absence of Apaf-1	FASEB JOURNAL			English	Article						UCN-01; apoptosome; mitochondria; Bcl-2	CELL-DEATH; CYTOCHROME-C; PHASE-I; PHOSPHORYLATION; MITOCHONDRIAL; UCN-01; 7-HYDROXYSTAUROSPORINE; PROCASPASE-9; MODULATION; MELANOMA	The protein kinase inhibitor staurosporine is one of the most potent and frequently used proapoptotic stimuli, although its mechanism of action is poorly understood. Here, we show that staurosporine as well as its analog 7-hydroxystaurosporine (UCN-01) not only trigger the classical mitochondrial apoptosis pathway but, moreover, activate an additional novel intrinsic apoptosis pathway. Unlike conventional anticancer drugs, staurosporine and UCN-01 induced apoptosis in a variety of tumor cells overexpressing the apoptosis inhibitors Bcl-2 and Bcl-xL. Furthermore, activation of this novel intrinsic apoptosis pathway by staurosporine did not rely on Apaf-1 and apoptosome formation, an essential requirement for the mitochondrial pathway. Nevertheless, as demonstrated in caspase-9-deficient murine embryonic fibroblasts, human lymphoma cells, and chicken DT40 cells, stauro-sporine-induced apoptosis was essentially mediated by caspase-9. Our results therefore suggest that, in addition to the classical cytochrome c/Apaf-1-dependent pathway of caspase-9 activation, staurosporine can induce caspase-9 activation and apoptosis independently of the apoptosome. Since staurosporine derivatives have proven efficacy in clinical trials, activation of this novel pathway might represent a powerful target to induce apoptosis in multidrug-resistant tumor cells.-Manns, J., Daubrawa, M., Driessen, S., Paasch, F., Hoffmann, N., Loffler, A., Lauber, K., Dieterle, A., Alers, S., Iftner, T., Schulze-Osthoff, K., Stork, B., Wesselborg, S. Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: activation of caspase-9 in the absence of Apaf-1. FASEB J. 25, 3250-3261 (2011). www.fasebj.org	[Manns, Joachim; Daubrawa, Merle; Driessen, Stefan; Paasch, Florian; Hoffmann, Nadine; Loeffler, Antje; Lauber, Kirsten; Dieterle, Alexandra; Alers, Sebastian; Stork, Bjoern; Wesselborg, Sebastian] Univ Tubingen, Dept Internal Med 1, Tubingen, Germany; [Iftner, Thomas] Univ Tubingen, Div Expt Virol, Inst Med Virol & Epidemiol Viral Dis, Tubingen, Germany; [Schulze-Osthoff, Klaus] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Wesselborg, S (corresponding author), Univ Dusseldorf, Inst Mol Med, Univ Str 1, D-40225 Dusseldorf, Germany.	sebastian.wesselborg@uni-tuebingen.de	Schulze-Osthoff, Klaus/N-9025-2013; Manns, J/AAA-4986-2020; Stork, Björn/C-2160-2011; Iftner, Thomas/ABF-9029-2020	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Stork, Björn/0000-0002-4167-7806; Wesselborg, Sebastian/0000-0002-5236-942X; Alers, Sebastian/0000-0002-9813-9451; Alers, Alexandra Maria/0000-0002-7863-3559	Deutsche Forschungsgemeinschaft [We 1801/2-4, GRK 1302, SFB 685, SFB 773]; Interdisciplinary Center of Clinical Research Tubingen (IZKF) [01KS9602, 1866-0-0]; Wilhelm Sander-Stiftung [2004.099.1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center of Clinical Research Tubingen (IZKF); Wilhelm Sander-Stiftung	The authors thank Claus Belka (Ludwig-Maximilians University, Munich, Germany), John Blenis (Harvard Medical School, Boston, MA, USA), Simone Fulda (Universtitatsklinikum Ulm, Ulm, Germany), Marja Jaattela (Danish Cancer Society, Copenhagen, Denmark), Ottmar Janssen (University of Kiel, Kiel, Germany), Maria S. Soengas (University of Michigan, Ann Arbor, MI, USA), Edward A. Sausville (National Cancer Institute, Rockville, MD, USA), Andreas Strasser (Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia), Henning Walczak (Imperial College London, London, UK), and the Drug Synthesis and Chemistry Branch (Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA) for providing valuable cell lines and reagents. This work was supported by grants from the Deutsche Forschungsgemeinschaft We 1801/2-4 (S.W.), GRK 1302 (B. S., K.S.O., S. W.), SFB 685 (K. L., K.S.O., S. W.), SFB 773 (B. S., K.S.O., S. W., T. I.), the Interdisciplinary Center of Clinical Research Tubingen (IZKF; Fo. 01KS9602 to S. W.; Fo. 1866-0-0 to B. S.) and the Wilhelm Sander-Stiftung (2004.099.1; S.W.).	Aleo E, 2006, CANCER RES, V66, P9235, DOI 10.1158/0008-5472.CAN-06-0702; Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dees EC, 2005, CLIN CANCER RES, V11, P664; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Gescher A, 2000, CRIT REV ONCOL HEMAT, V34, P127, DOI 10.1016/S1040-8428(00)00058-5; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Harkin ST, 1998, MOL PHARMACOL, V54, P663; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Katoh I, 2004, J BIOL CHEM, V279, P15515, DOI 10.1074/jbc.M311819200; Kawabe T, 2004, MOL CANCER THER, V3, P513; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Marsden VS, 2004, J CELL BIOL, V165, P775, DOI 10.1083/jcb.200312030; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; McDonnell MA, 2008, J BIOL CHEM, V283, P20149, DOI 10.1074/jbc.M802846200; Milleron RS, 2006, J BIOL CHEM, V281, P16991, DOI 10.1074/jbc.M512754200; Nagasaka A, 2010, CELL DEATH DIFFER, V17, P931, DOI 10.1038/cdd.2009.186; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Rudner J, 2001, J CELL SCI, V114, P4161; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Samraj AK, 2007, MOL BIOL CELL, V18, P84, DOI 10.1091/mbc.E06-04-0263; Sausville EA, 2001, J CLIN ONCOL, V19, P2319, DOI 10.1200/JCO.2001.19.8.2319; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Shao RG, 1997, EXP CELL RES, V234, P388, DOI 10.1006/excr.1997.3650; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Tashker JS, 2002, MOL BIOL CELL, V13, P393, DOI 10.1091/mbc.01-06-0291; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Waibel M, 2007, APOPTOSIS, V12, P623, DOI 10.1007/s10495-006-0006-z; Walensky LD, 2006, CELL DEATH DIFFER, V13, P1339, DOI 10.1038/sj.cdd.4401992; Wilson WH, 2000, CLIN CANCER RES, V6, P415; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zanon M, 2004, CANCER RES, V64, P7386, DOI 10.1158/0008-5472.CAN-04-1640; Zhang XD, 2004, MOL CANCER THER, V3, P187	51	68	71	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3250	3261		10.1096/fj.10-177527	http://dx.doi.org/10.1096/fj.10-177527			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21659556				2022-12-25	WOS:000294435200037
J	Zhou, XD; Hu, XY; He, WX; Tang, XY; Shi, Q; Zhang, ZH; Yan, RQ				Zhou, Xiangdong; Hu, Xiangyou; He, Wanxia; Tang, Xiaoying; Shi, Qi; Zhang, Zhuohua; Yan, Riqiang			Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition	FASEB JOURNAL			English	Article						Alzheimer's disease; reticulon; BACE1	BETA-PEPTIDE GENERATION; ALZHEIMERS-DISEASE; AXONAL REGENERATION; GENETIC DELETION; ALPHA-SECRETASE; GAMMA-SECRETASE; NERVOUS-SYSTEM; A-BETA; BACE1; INHIBITION	Excessive production or accumulation of beta-amyloid (A beta) peptides in human brains leads to increased amyloid deposition and cognitive dysfunction, which are invariable pathological features in patients with Alzheimer's disease (AD). Many cellular factors can regulate the production of A beta. In this study, we show that a family of proteins named Nogo receptor proteins (NgR1 to NgR3) regulates A beta production via interaction with amyloid precursor protein (APP). Further mapping of the interacting domain indicates that a small region adjacent to the BACE1 cleavage site of APP mediates interaction of APP with Nogo receptor proteins. Our results also indicate that increased interaction between Nogo receptor and APP reduces surface expression of APP and favors processing of APP by BACE1. When NgR2 was ablated in AD transgenic mice expressing Swedish APP and PS1 Delta E9, amyloid deposition was clearly reduced (0.66% of total measured area in APP(swe)/PS1 Delta E9/NgR2(-/-) mice vs. 0.76% of total measured area in APP(swe)/PS1 Delta E9 mice). Our results demonstrate that down-regulation of NgR expression is a potential approach for inhibiting amyloid deposition in AD patients.-Zhou, X., Hu, X., He, W., Tang, X., Shi, Q., Zhang, Z., Yan, R. Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition. FASEB J. 25, 3146-3156 (2011). www.fasebj.org	[Zhou, Xiangdong; Hu, Xiangyou; He, Wanxia; Tang, Xiaoying; Shi, Qi; Yan, Riqiang] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; [Zhang, Zhuohua] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Cleveland Clinic Foundation; Central South University	Yan, RQ (corresponding author), Cleveland Clin, Dept Neurosci, Lerner Res Inst, 9500 Euclid Ave,NC30, Cleveland, OH 44195 USA.	yanr@ccf.org		Yan, Riqiang/0000-0001-7195-7617	American Health Assistance Foundation [A2006-060]; National Institute on Aging [AG025493]; NATIONAL INSTITUTE ON AGING [R01AG025493] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Chris Nelson for critical reading of this manuscript. This work was fully supported by the American Health Assistance Foundation to R.Y. (A2006-060) between 2006 and 2009. R.Y. is also supported by the National Institute on Aging (AG025493).	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Cafferty WBJ, 2010, J NEUROSCI, V30, P6825, DOI 10.1523/JNEUROSCI.6239-09.2010; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Fournier AE, 2002, PROG BRAIN RES, V137, P361; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hanell A, 2010, J NEUROTRAUM, V27, P1297, DOI 10.1089/neu.2009.1255; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; He WX, 2007, J BIOL CHEM, V282, P29144, DOI 10.1074/jbc.M704181200; He WX, 2006, J MOL BIOL, V363, P625, DOI 10.1016/j.jmb.2006.07.094; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Li SX, 2005, MOL CELL NEUROSCI, V29, P26, DOI 10.1016/j.mcn.2004.12.008; Li WW, 2004, J BIOL CHEM, V279, P43780, DOI 10.1074/jbc.M401803200; Luo XY, 2010, INT J CLIN EXP PATHO, V3, P618; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Murayama KS, 2006, EUR J NEUROSCI, V24, P1237, DOI 10.1111/j.1460-9568.2006.05005.x; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Prior M, 2010, NEUROSCI BIOBEHAV R, V34, P1201, DOI 10.1016/j.neubiorev.2010.01.017; Qahwash I, 2004, J BIOL CHEM, V279, P39010, DOI 10.1074/jbc.M407101200; Shi Q, 2009, J NEUROSCI, V29, P9163, DOI 10.1523/JNEUROSCI.5741-08.2009; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Strittmatter SM, 2002, J MOL NEUROSCI, V19, P117, DOI 10.1007/s12031-002-0021-7; Tomasselli AG, 2003, J NEUROCHEM, V84, P1006, DOI 10.1046/j.1471-4159.2003.01597.x; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Voineskos AN, 2009, J NEUROSCI, V29, P5045, DOI 10.1523/JNEUROSCI.0477-09.2009; Wang RS, 2006, J BIOL CHEM, V281, P15330, DOI 10.1074/jbc.M512574200; Willi R, 2010, J NEUROSCI, V30, P556, DOI 10.1523/JNEUROSCI.4393-09.2010; Wojcik S, 2007, ACTA NEUROPATHOL, V114, P517, DOI 10.1007/s00401-007-0281-y; Yan R, 2006, CELL MOL LIFE SCI, V63, P877, DOI 10.1007/s00018-005-5338-2; Yan RQ, 2001, J BIOL CHEM, V276, P34019, DOI 10.1074/jbc.M105583200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234	46	29	32	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					3146	3156		10.1096/fj.11-184325	http://dx.doi.org/10.1096/fj.11-184325			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21670066	Green Published			2022-12-25	WOS:000294435200028
J	Stephens, AS; Stephens, SR; Hobbs, C; Hutmacher, DW; Bacic-Welsh, D; Woodruff, MA; Morrison, NA				Stephens, Alexandre S.; Stephens, Sebastien R.; Hobbs, Carl; Hutmacher, Deitmar W.; Bacic-Welsh, Desa; Woodruff, Maria Ann; Morrison, Nigel A.			Myocyte Enhancer Factor 2C, an Osteoblast Transcription Factor Identified by Dimethyl Sulfoxide (DMSO)-enhanced Mineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC MICE; MC3T3-E1 CELLS; DIFFERENTIATION; EXPRESSION; MEF2C; GENE	Rapid mineralization of cultured osteoblasts could be a useful characteristic in stem cell-mediated therapies for fracture and other orthopedic problems. Dimethyl sulfoxide (DMSO) is a small amphipathic solvent molecule capable of stimulating cell differentiation. We report that, in primary human osteoblasts, DMSO dose-dependently enhanced the expression of osteoblast differentiation markers alkaline phosphatase activity and extracellular matrix mineralization. Furthermore, similar DMSO-mediated mineralization enhancement was observed in primary osteoblast-like cells differentiated from mouse mesenchymal cells derived from fat, a promising source of starter cells for cell-based therapy. Using a convenient mouse pre-osteoblast model cell line MC3T3-E1, we further investigated this phenomenon showing that numerous osteoblast-expressed genes were elevated in response to DMSO treatment and correlated with enhanced mineralization. Myocyte enhancer factor 2c (Mef2c) was identified as the transcription factor most induced by DMSO, among the numerous DMSO-induced genes, suggesting a role for Mef2c in osteoblast gene regulation. Immunohistochemistry confirmed expression of Mef2c in osteoblast-like cells in mouse mandible, cortical, and trabecular bone. shRNAi-mediated Mef2c gene silencing resulted in defective osteoblast differentiation, decreased alkaline phosphatase activity, and matrix mineralization and knockdown of osteoblast specific gene expression, including osteocalcin and bone sialoprotein. A flow on knockdown of bone-specific transcription factors, Runx2 and osterix by shRNAi knockdown of Mef2c, suggests that Mef2c lies upstream of these two important factors in the cascade of gene expression in osteoblasts.	[Stephens, Alexandre S.; Stephens, Sebastien R.; Bacic-Welsh, Desa; Morrison, Nigel A.] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia; [Hobbs, Carl] Kings Coll London, London WC2R 2LS, England; [Hutmacher, Deitmar W.; Woodruff, Maria Ann] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	Griffith University; University of London; King's College London; Queensland University of Technology (QUT)	Morrison, NA (corresponding author), Griffith Univ, Sch Med Sci, Gold Coast Campus, Southport, Qld 4215, Australia.	n.morrison@griffith.edu.au	Morrison, Nigel A/F-4082-2012; Woodruff, Maria/J-1247-2012; Stephens, Alexandre S/P-1396-2016	Morrison, Nigel A/0000-0003-4774-3808; Stephens, Alexandre S/0000-0003-2465-8117; Woodruff, Maria/0000-0002-4909-5288; Hutmacher, Dietmar Werner/0000-0001-5678-2134	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia (to N. A. M.) and the Australian Research Council (to D. W. H.).	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; AUBIN JE, 1995, BONE, V17, P77; Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Cheung WMW, 2006, FEBS LETT, V580, P121, DOI 10.1016/j.febslet.2005.11.062; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Hassan MQ, 2007, MOL CELL BIOL, V27, P3337, DOI 10.1128/MCB.01544-06; KARSENTY G, 2003, ANN NY ACAD SCI, V423, P385; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lassaux A, 2005, J VIROL, V79, P6560, DOI 10.1128/JVI.79.10.6560-6564.2005; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sakai K, 2001, MATRIX BIOL, V19, P761, DOI 10.1016/S0945-053X(00)00122-0; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Schuler A, 2008, BLOOD, V111, P4532, DOI 10.1182/blood-2007-10-116343; Woods EJ, 2009, CRYOBIOLOGY, V59, P150, DOI 10.1016/j.cryobiol.2009.06.005; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xu J, 2006, J BIOL CHEM, V281, P9152, DOI 10.1074/jbc.M510217200; Zyuz'kov GN, 2007, B EXP BIOL MED+, V143, P535, DOI 10.1007/s10517-007-0173-0	25	31	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30071	30086		10.1074/jbc.M111.253518	http://dx.doi.org/10.1074/jbc.M111.253518			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21652706	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000294046600065
J	Debelyy, MO; Platta, HW; Saffian, D; Hensel, A; Thoms, S; Meyer, HE; Warscheid, B; Girzalsky, W; Erdmann, R				Debelyy, Mykhaylo O.; Platta, Harald W.; Saffian, Delia; Hensel, Astrid; Thoms, Sven; Meyer, Helmut E.; Warscheid, Bettina; Girzalsky, Wolfgang; Erdmann, Ralf			Ubp15p, a Ubiquitin Hydrolase Associated with the Peroxisomal Export Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL TYPE-1 RECEPTOR; SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; DEUBIQUITINATING ENZYME; AAA-PEROXINS; ENDOPLASMIC-RETICULUM; CONSERVED CYSTEINE; PTS1 RECEPTOR; YEAST; PEX5P	Peroxisomal matrix protein import is facilitated by cycling receptors shuttling between the cytosol and the peroxisomal membrane. One crucial step in this cycle is the ATP-dependent release of the receptors from the peroxisomal membrane. This step is facilitated by the peroxisomal AAA (ATPases associated with various cellular activities) proteins Pex1p and Pex6p with ubiquitination of the receptor being the main signal for its export. Here we report that the AAA complex contains dislocase as well as deubiquitinating activity. Ubp15p, a ubiquitin hydrolase, was identified as a novel constituent of the complex. Ubp15p partially localizes to peroxisomes and is capable of cleaving off ubiquitin moieties from the type I peroxisomal targeting sequence (PTS1) receptor Pex5p. Furthermore, Ubp15p-deficient cells are characterized by a stress-related PTS1 import defect. The results merge into a picture in which removal of ubiquitin from the PTS1 receptor Pex5p is a specific event and might represent a vital step in receptor recycling.	[Erdmann, Ralf] Ruhr Univ Bochum, Inst Physiol Chem, Fak Med, Abt Syst Biochem, D-44780 Bochum, Germany; [Thoms, Sven; Meyer, Helmut E.; Warscheid, Bettina] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Physiol Chem, Fak Med, Abt Syst Biochem, Univ Str 150, D-44780 Bochum, Germany.	Ralf.Erdmann@rub.de	Thoms, Sven/B-5763-2013; Platta, Harald Wolfgang/G-7423-2014; Thoms, Sven/K-4530-2019	Platta, Harald Wolfgang/0000-0001-8968-7280; Thoms, Sven/0000-0003-3018-6363; Debelyy, Mykhaylo/0000-0001-9746-5055; Astrid, Hensel/0000-0002-0793-0249; Warscheid, Bettina/0000-0001-5096-1975	Deutsche Forschungsgemeinschaft [SFB642]; European Molecular Biology Organization	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB642.; Supported by a European Molecular Biology Organization long term fellowship. Present address: Dept. of Biochemistry, Inst. for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Birschmann I, 2005, FEBS J, V272, P47, DOI 10.1111/j.1432-1033.2004.04393.x; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Elgersma Y, 1997, EMBO J, V16, P7326, DOI 10.1093/emboj/16.24.7326; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Grou CP, 2008, J BIOL CHEM, V283, P14190, DOI 10.1074/jbc.M800402200; Grou CP, 2009, J BIOL CHEM, V284, P10504, DOI 10.1074/jbc.M808978200; Grunau S, 2011, BIOCHEM J, V434, P161, DOI 10.1042/BJ20101115; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; IZAWA S, 1995, FEBS LETT, V368, P73, DOI 10.1016/0014-5793(95)00603-7; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu C, 2007, BIOTECHNIQUES, V42, P156, DOI 10.2144/000112389; Ma C, 2009, IUBMB LIFE, V61, P713, DOI 10.1002/iub.196; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Melcher K, 2000, ANAL BIOCHEM, V277, P109, DOI 10.1006/abio.1999.4383; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petriv OI, 2004, J BIOL CHEM, V279, P19996, DOI 10.1074/jbc.M400207200; Platta H, 2004, BIOCHEM J, V384, P37, DOI 10.1042/BJ20040572; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Rottensteiner H, 2003, MOL BIOL CELL, V14, P4316, DOI 10.1091/mbc.E03-03-0153; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schrader M, 2008, HISTOCHEM CELL BIOL, V129, P421, DOI 10.1007/s00418-008-0396-9; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Tamura S, 2006, J BIOL CHEM, V281, P27693, DOI 10.1074/jbc.M605159200; Terlecky SR, 2006, BBA-MOL CELL RES, V1763, P1749, DOI 10.1016/j.bbamcr.2006.08.017; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Vornlocher HP, 1999, J BIOL CHEM, V274, P16802, DOI 10.1074/jbc.274.24.16802; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Williams C, 2008, BIOCHEM BIOPH RES CO, V374, P620, DOI 10.1016/j.bbrc.2008.07.054; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; ZHANG JW, 1993, J CELL BIOL, V123, P1133, DOI 10.1083/jcb.123.5.1133; Zhu QL, 1997, P NATL ACAD SCI USA, V94, P7308, DOI 10.1073/pnas.94.14.7308	79	74	76	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28223	28234		10.1074/jbc.M111.238600	http://dx.doi.org/10.1074/jbc.M111.238600			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21665945	Green Published, hybrid			2022-12-25	WOS:000293557800040
J	Tarsio, M; Zheng, HM; Smardon, AM; Martinez-Munoz, GA; Kane, PM				Tarsio, Maureen; Zheng, Huimei; Smardon, Anne M.; Martinez-Munoz, Gloria A.; Kane, Patricia M.			Consequences of Loss of Vph1 Protein-containing Vacuolar ATPases (V-ATPases) for Overall Cellular pH Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; CYTOSOLIC PH; PROTON PUMPS; GENE ENCODES; YEAST; ACIDIFICATION; MUTANTS; GLUCOSE; LOCALIZATION; DISSOCIATION	In yeast cells, subunit a of the vacuolar proton pump (V-ATPase) is encoded by two organelle-specific isoforms, VPH1 and STV1. V-ATPases containing Vph1 and Stv1 localize predominantly to the vacuole and the Golgi apparatus/endosomes, respectively. Ratiometric measurements of vacuolar pH confirm that loss of STV1 has little effect on vacuolar pH. Loss of VPH1 results in vacuolar alkalinization that is even more rapid and pronounced than in vma mutants, which lack all V-ATPase activity. Cytosolic pH responses to glucose addition in the vph1 Delta mutant are similar to those in vma mutants. The extended cytosolic acidification in these mutants arises from reduced activity of the plasma membrane proton pump, Pma1p. Pma1p is mislocalized in vma mutants but remains at the plasma membrane in both vph1 Delta and stv1 Delta mutants, suggesting multiple mechanisms for limiting Pma1 activity when organelle acidification is compromised. pH measurements in early pre-vacuolar compartments via a pHluorin fusion to the Golgi protein Gef1 demonstrate that pH responses of these compartments parallel cytosolic pH changes. Surprisingly, these compartments remain acidic even in the absence of V-ATPase function, possibly as a result of cytosolic acidification. These results emphasize that loss of a single subunit isoform may have effects far beyond the organelle where it resides.	[Tarsio, Maureen; Zheng, Huimei; Smardon, Anne M.; Martinez-Munoz, Gloria A.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	kanepm@upstate.edu		Zheng, Janet/0000-0001-8838-1263	National Institutes of Health [R01 GM50322]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM50322 (to P. M. K.).	Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Amberg DC., 2005, METHODS YEAST GENETI; Bowman EJ, 1997, J BIOL CHEM, V272, P14776, DOI 10.1074/jbc.272.23.14776; Boysen JH, 2006, MOL BIOL CELL, V17, P1344, DOI 10.1091/mbc.e05-10-0949; Braun NA, 2010, J CELL SCI, V123, P2342, DOI 10.1242/jcs.068403; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; Hayashi M, 2005, MOL CELL BIOL, V25, P9478, DOI 10.1128/MCB.25.21.9478-9490.2005; Hirata R., 2001, RIKEN REV, V41, P90; Huang CJ, 2011, J BIOL CHEM, V286, P10058, DOI 10.1074/jbc.M110.197889; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lopez R, 1999, YEAST, V15, P553, DOI 10.1002/(SICI)1097-0061(199905)15:7<553::AID-YEA397>3.0.CO;2-V; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Miranda KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009531; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Perzov N, 2002, J EXP BIOL, V205, P1209; Perzov N, 2000, J BIOL CHEM, V275, P40088, DOI 10.1074/jbc.M007011200; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Plant PJ, 1999, J BIOL CHEM, V274, P37270, DOI 10.1074/jbc.274.52.37270; Portillo F, 2000, BBA-REV BIOMEMBRANES, V1469, P31, DOI 10.1016/S0304-4157(99)00011-8; Qi J, 2007, J BIOL CHEM, V282, P24743, DOI 10.1074/jbc.M700663200; RAMOS S, 1989, J GEN MICROBIOL, V135, P2413; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005	37	48	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28089	28096		10.1074/jbc.M111.251363	http://dx.doi.org/10.1074/jbc.M111.251363			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669878	Green Published, hybrid			2022-12-25	WOS:000293557800027
J	Cartier, J; Berthelet, J; Marivin, A; Gemble, S; Edmond, V; Plenchette, S; Lagrange, B; Hammann, A; Dupoux, A; Delva, L; Eymin, B; Solary, E; Dubrez, L				Cartier, Jessy; Berthelet, Jean; Marivin, Arthur; Gemble, Simon; Edmond, Valerie; Plenchette, Stephanie; Lagrange, Brice; Hammann, Arlette; Dupoux, Alban; Delva, Laurent; Eymin, Beatrice; Solary, Eric; Dubrez, Laurence			Cellular Inhibitor of Apoptosis Protein-1 (cIAP1) Can Regulate E2F1 Transcription Factor-mediated Control of Cyclin Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; FAMILY-MEMBERS; S-PHASE; C-IAPS; EXPRESSION; CANCER; C-IAP1	The inhibitor of apoptosis protein cIAP1 (cellular inhibitor of apoptosis protein-1) is a potent regulator of the tumor necrosis factor (TNF) receptor family and NF-kappa B signaling pathways in the cytoplasm. However, in some primary cells and tumor cell lines, cIAP1 is expressed in the nucleus, and its nuclear function remains poorly understood. Here, we show that the N-terminal part of cIAP1 directly interacts with the DNA binding domain of the E2F1 transcription factor. cIAP1 dramatically increases the transcriptional activity of E2F1 on synthetic and CCNE promoters. This function is not conserved for cIAP2 and XIAP, which are cytoplasmic proteins. Chromatin immunoprecipitation experiments demonstrate that cIAP1 is recruited on E2F binding sites of the CCNE and CCNA promoters in a cell cycle-and differentiation-dependent manner. cIAP1 silencing inhibits E2F1 DNA binding and E2F1-mediated transcriptional activation of the CCNE gene. In cells that express a nuclear cIAP1 such as HeLa, THP1 cells and primary human mammary epithelial cells, down-regulation of cIAP1 inhibits cyclin E and A expression and cell proliferation. We conclude that one of the functions of cIAP1 when localized in the nucleus is to regulate E2F1 transcriptional activity.	[Cartier, Jessy; Berthelet, Jean; Marivin, Arthur; Gemble, Simon; Plenchette, Stephanie; Lagrange, Brice; Hammann, Arlette; Dupoux, Alban; Delva, Laurent; Solary, Eric; Dubrez, Laurence] Fac Med, INSERM, UMR866, F-21079 Dijon, France; [Cartier, Jessy; Berthelet, Jean; Marivin, Arthur; Edmond, Valerie; Plenchette, Stephanie; Lagrange, Brice; Hammann, Arlette; Dupoux, Alban; Delva, Laurent; Solary, Eric; Dubrez, Laurence] Univ Burgundy, Fac Med, Inst Federatif Rech IFR 100, F-21079 Dijon, France; [Edmond, Valerie; Eymin, Beatrice] Inst Albert Bonniot, INSERM, Equipe Bases Mol Progress Canc Poumon, U823, F-38042 Grenoble, France; [Edmond, Valerie; Eymin, Beatrice] Univ Grenoble 1, F-38041 Grenoble, France; [Solary, Eric] Inst Gustave Roussy, INSERM, UMR1009, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Dubrez, L (corresponding author), Fac Med, INSERM, UMR866, 7 Blvd Jeanne dArc, F-21079 Dijon, France.	ldubrez@u-bourgogne.fr	Eymin, Beatrice/M-1962-2013; Plenchette, Stéphanie/AAA-5155-2021; Laurence, Dubrez/P-9472-2019; Dubrez, Laurence/I-4971-2016; eymin, beatrice/U-4670-2019	Eymin, Beatrice/0000-0002-7311-3810; Plenchette, Stéphanie/0000-0003-4483-9206; Laurence, Dubrez/0000-0002-7030-2181; Dubrez, Laurence/0000-0002-7030-2181; eymin, beatrice/0000-0002-7311-3810; Lagrange, Brice/0000-0002-4131-5995; DUPOUX, Alban/0000-0003-3112-2927; Berthelet, Jean/0000-0003-2562-0575; Solary, Eric/0000-0002-8629-1341; DELVA, Laurent/0000-0002-1086-3964; CARTIER, Jessy/0000-0002-0366-8546	Ligue Nationale Contre le Cancer; Comite de Cote d'Or, Nievre, Saone et Loire and Yonne of the Ligue contre le Cancer; Association pour la Recherche sur le Cancer (ARC); association "Cent pour Sang la Vie"; Association Nationale de la Recherche; National Institute of Cancer; "Ministere de l'Enseignement Superieur et de la Recherche" of France	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Comite de Cote d'Or, Nievre, Saone et Loire and Yonne of the Ligue contre le Cancer; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); association "Cent pour Sang la Vie"; Association Nationale de la Recherche; National Institute of Cancer; "Ministere de l'Enseignement Superieur et de la Recherche" of France	This work was supported by grants from the Ligue Nationale Contre le Cancer (equipe labellisee, ES) and the Comite de Cote d'Or, Nievre, Saone et Loire and Yonne of the Ligue contre le Cancer (to L. D.), the Association pour la Recherche sur le Cancer (ARC, to L. D.), the association "Cent pour Sang la Vie", the Association Nationale de la Recherche and the National Institute of Cancer, and fellowships from the "Ministere de l'Enseignement Superieur et de la Recherche" of France (to J. C., A. D., J. B., A. M., B. L. and S. P.) and ARC (to J. C.).	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Cheng L., 2010, ONCOGENE, V38, P62; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; DeGregori J, 2006, CURR MOL MED, V6, P739; Didelot C, 2008, CELL DEATH DIFFER, V15, P859, DOI 10.1038/sj.cdd.4402320; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Dupoux A, 2009, BLOOD, V113, P175, DOI 10.1182/blood-2008-02-137919; Geng Y, 1996, ONCOGENE, V12, P1173; Gibbs J, 2008, ONCOGENE, V27, P98, DOI 10.1038/sj.onc.1210627; Gordon GJ, 2007, J PATHOL, V211, P439, DOI 10.1002/path.2120; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Imoto I, 2002, CANCER RES, V62, P4860; Imoto I, 2001, CANCER RES, V61, P6629; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Ivanova IA, 2009, ONCOGENE, V28, P52, DOI 10.1038/onc.2008.354; Kempkensteffen C, 2007, INT J CANCER, V120, P1081, DOI 10.1002/ijc.22416; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Paggetti J, 2010, ONCOGENE, V29, P5019, DOI 10.1038/onc.2010.254; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Plenchette S, 2004, BLOOD, V104, P2035, DOI 10.1182/blood-2004-01-0065; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Ponnelle T, 2003, PATHOL RES PRACT, V199, P723, DOI 10.1078/0344-0338-00488; Sahin F, 2010, INT J BIOL SCI, V6, P116; Samuel T, 2005, CANCER RES, V65, P210; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tanimoto T, 2005, CANCER LETT, V224, P141, DOI 10.1016/j.canlet.2004.11.049; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vischioni B, 2006, HUM PATHOL, V37, P78, DOI 10.1016/j.humpath.2005.09.022; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Xu L, 2007, MOL CELL, V28, P914, DOI 10.1016/j.molcel.2007.10.027; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao YG, 2007, J BIOL CHEM, V282, P7777, DOI 10.1074/jbc.M609146200	52	33	36	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26406	26417		10.1074/jbc.M110.191239	http://dx.doi.org/10.1074/jbc.M110.191239			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653699	hybrid, Green Published			2022-12-25	WOS:000293078200018
J	Bharrhan, S; Koul, A; Chopra, K; Rishi, P				Bharrhan, Sushma; Koul, Ashwani; Chopra, Kanwaljit; Rishi, Praveen			Catechin Suppresses an Array of Signalling Molecules and Modulates Alcohol-Induced Endotoxin Mediated Liver Injury in a Rat Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; INDUCED OXIDATIVE STRESS; NITRIC-OXIDE SYNTHASE; FACTOR-ALPHA; TRANSCRIPTION FACTOR; EXTRACT PROTECTS; KUPFFER CELLS; DISEASE; MECHANISMS	Induction of nuclear factor kappa B (NF-kappa B)-mediated gene expression has been implicated in the pathogenesis of alcoholic liver disease through enhanced production of reactive oxygen species and pro-inflammatory mediators. The present study was carried out to investigate the role of catechin as a chain breaking inhibitor against experimental alcoholic liver injury. Rats were administered 35% v/v ethanol orally at a dose of 10 g/Kg/day for two weeks, followed by 14 g/Kg/day for 10 weeks. Catechin (50 mg/Kg) was co-supplemented after 4 weeks of alcohol treatment till the end of the dosing period. Following chronic alcohol exposure, rats developed endotoxemia and severe pathological changes in the liver such as pronounced fatty change, vacuolar degeneration and inflammation. These changes were accompanied by activation of NF-kappa B and induction of inflammatory and cytotoxic mediators leading to increased level of tumor necrosis factor-alpha, enhanced formation of malondialdehyde in the liver followed by drastic alterations in the hepatic antioxidant defense systems. Additionally, nitrite levels and lactate dehydrogenase activities were also significantly elevated on chronic alcohol consumption. Alcohol exposure also increased the number of micronucleated cells indicating that alcohol abuse may again be associated with the nuclear changes. Supplementation with catechin ameliorated the alcohol-induced liver injury by downregulating the endotoxin-mediated activation of initial signalling molecule NF-kappa B and further going downstream the signalling cascade including tumor necrosis factor-alpha, nitric oxide and reactive oxygen species and by enhancing the antioxidant profile. These observations correlated well with the histological findings. Moreover, a remarkable decrease in the percentage of micronucleated cells was observed with catechin supplementation indicating an apparent protection against alcohol-induced toxicity. These findings suggest that catechin may alleviate experimental alcoholic liver disease by suppressing induction of NF-kappa B, a key component of signalling pathway, thus forming a pharmacological basis for designing novel therapeutic agents against alcohol induced endotoxin-mediated liver injury.	[Bharrhan, Sushma; Rishi, Praveen] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Koul, Ashwani] Panjab Univ, Dept Biophys, Chandigarh 160014, India; [Chopra, Kanwaljit] Panjab Univ, Pharmacol Res Lab, Univ Inst Pharmaceut Sci, UGC Ctr Adv Study, Chandigarh 160014, India	Panjab University; Panjab University; Panjab University	Bharrhan, S (corresponding author), Panjab Univ, Dept Microbiol, Basic Med Sci Block, Chandigarh 160014, India.	rishipraveen@yahoo.com	Lin, KuanYu/L-9195-2016	Lin, KuanYu/0000-0002-5291-0909; Rishi, Praveen/0000-0001-5425-8064; Koul, Ashwani/0000-0001-7522-412X	Indian Council of Medical Research (ICMR), New Delhi, India [3/1/2(3)/GAS/2008-NCD-II]	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	This research was supported by the Indian Council of Medical Research (ICMR), New Delhi, India, under extramural research projects (Grant no. 3/1/2(3)/GAS/2008-NCD-II). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 2002, BIOL CHEM, V383, P663, DOI 10.1515/BC.2002.068; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baltaziak Marek, 2004, Folia Morphol (Warsz), V63, P123; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barve A, 2008, ANN HEPATOL, V7, P5, DOI 10.1016/S1665-2681(19)31883-6; BAUCHINGER M, 1975, MUTAT RES, V27, P103, DOI 10.1016/0027-5107(75)90277-8; Beier JI, 2010, BIOL CHEM, V391, P1249, DOI 10.1515/BC.2010.137; BERGMEYER HU, 1971, METHOD ENZYMAT AN, P736; Bharrhan S, 2012, INNATE IMMUN-LONDON, V18, P70, DOI 10.1177/1753425910393369; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Castelli E, 1999, HEPATO-GASTROENTEROL, V46, P1664; Chanana V, 2007, MOL IMMUNOL, V44, P1551, DOI 10.1016/j.molimm.2006.08.022; Chanana V, 2006, FEMS IMMUNOL MED MIC, V47, P278, DOI 10.1111/j.1574-695X.2006.00090.x; Chen T, 2003, CURR MOL MED, V3, P519, DOI 10.2174/1566524033479582; Chen X, 2010, PHARMACOGN MAG, V6, P135, DOI 10.4103/0973-1296.62900; COLMAN JC, 1980, GUT, V21, P965, DOI 10.1136/gut.21.11.965; Diehl AM, 2002, ALCOHOL, V27, P7, DOI 10.1016/S0741-8329(02)00204-5; Frei B, 2003, J NUTR, V133, p3275S, DOI 10.1093/jn/133.10.3275S; Fujimoto M, 2000, ALCOHOL CLIN EXP RES, V24, p48S, DOI 10.1111/j.1530-0277.2000.tb00012.x; Gonzalez-Gallego J, 2007, NUTR HOSP, V22, P287; Gramenzi A, 2006, ALIMENT PHARM THER, V24, P1151, DOI 10.1111/j.1365-2036.2006.03110.x; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GUARNER C, 1993, HEPATOLOGY, V18, P1139; Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464; Hill DB, 1999, CLIN BIOCHEM, V32, P563, DOI 10.1016/S0009-9120(99)00056-9; Hines IN, 2004, AM J PHYSIOL-GASTR L, V287, pG310, DOI 10.1152/ajpgi.00094.2004; HIROSE K, 1993, FASEB J, V7, P361, DOI 10.1096/fasebj.7.2.8440412; Huttner E, 1999, ALCOHOL CLIN EXP RES, V23, P344, DOI 10.1111/j.1530-0277.1999.tb04120.x; Iimuro Y, 1997, HEPATOLOGY, V26, P1530; JOLLOW DJ, 1974, PHARMACOLOGY, V11, P151, DOI 10.1159/000136485; Jovanovic SV, 1998, ANTIOX HEALTH DIS, P137; Kasdallah-Grissa A, 2007, LIFE SCI, V80, P1033, DOI 10.1016/j.lfs.2006.11.044; Kaviarasan S, 2008, TOXICOL MECH METHOD, V18, P645, DOI 10.1080/15376510701884985; KIM SJ, 1995, BIOSCI BIOTECH BIOCH, V59, P822, DOI 10.1271/bbb.59.822; Kobayashi H, 2010, PHYTOMEDICINE, V17, P197, DOI 10.1016/j.phymed.2009.12.006; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Lee JS, 2005, MUTAT RES-FUND MOL M, V579, P214, DOI 10.1016/j.mrfmmm.2005.03.027; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lin YL, 1997, MOL PHARMACOL, V52, P465, DOI 10.1124/mol.52.3.465; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Luck H., 1965, METHOD ENZYMATIC ANA, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4; MACSWEEN RNM, 1986, SEMIN LIVER DIS, V6, P221, DOI 10.1055/s-2008-1040605; Matata BM, 2002, J BIOL CHEM, V277, P2330, DOI 10.1074/jbc.M106393200; McKim SE, 2003, GASTROENTEROLOGY, V125, P1834, DOI 10.1053/j.gastro.2003.08.030; McKim SE, 2002, ARCH BIOCHEM BIOPHYS, V406, P40, DOI 10.1016/S0003-9861(02)00425-3; Mullen KD, 1998, CLIN LIVER DIS, V2, P851; Nanji AA, 2003, AM J PHYSIOL-GASTR L, V284, pG321, DOI 10.1152/ajpgi.00230.2002; Nanji AA, 1999, HEPATOLOGY, V30, P934, DOI 10.1002/hep.510300402; NORDMANN R, 1994, ALCOHOL ALCOHOLISM, V29, P513; Ozaras R, 2003, WORLD J GASTROENTERO, V9, P125, DOI 10.3748/wjg.v9.i1.125; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Rao RK, 2004, AM J PHYSIOL-GASTR L, V286, pG881, DOI 10.1152/ajpgi.00006.2004; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; SALAH N, 1995, ARCH BIOCHEM BIOPHYS, V322, P339, DOI 10.1006/abbi.1995.1473; Schaffert CS, 2009, WORLD J GASTROENTERO, V15, P1209, DOI 10.3748/wjg.15.1209; Song KM, 2000, J EXP MED, V191, P1095, DOI 10.1084/jem.191.7.1095; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Szabo G, 2000, J LAB CLIN MED, V135, P367, DOI 10.1067/mlc.2000.106452; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Tilg H, 2007, NAT CLIN PRACT GASTR, V4, P24, DOI 10.1038/ncpgasthep0683; Tsukamoto H, 2001, FASEB J, V15, P1335, DOI 10.1096/fj.00-0650rev; Uesugi T, 2001, HEPATOLOGY, V34, P1149, DOI 10.1053/jhep.2001.29400; Wang HF, 2000, TRENDS FOOD SCI TECH, V11, P152, DOI 10.1016/S0924-2244(00)00061-3; WANG JF, 1995, ALCOHOL CLIN EXP RES, V19, P387, DOI 10.1111/j.1530-0277.1995.tb01520.x; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; WILLS ED, 1966, BIOCHEM J, V99, P667, DOI 10.1042/bj0990667; WORLD MJ, 1987, ALCOHOL ALCOHOLISM, V22, P331; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Yuan Guang-Jin, 2006, Hepatobiliary Pancreat Dis Int, V5, P262; Yuan GJ, 2006, INT J MOL SCI, V7, P204, DOI 10.3390/i7070204; Zhang Xing-Guo, 2006, Hepatobiliary Pancreat Dis Int, V5, P268; Zhen MC, 2007, J NUTR BIOCHEM, V18, P795, DOI 10.1016/j.jnutbio.2006.12.016; Zhong Z, 2002, AM J PHYSIOL-GASTR L, V283, pG957, DOI 10.1152/ajpgi.00216.2001	78	62	68	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20635	10.1371/journal.pone.0020635	http://dx.doi.org/10.1371/journal.pone.0020635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673994	gold, Green Submitted, Green Published			2022-12-25	WOS:000291355500027
J	Siamakpour-Reihani, S; Caster, J; Nepal, DB; Courtwright, A; Hilliard, E; Usary, J; Ketelsen, D; Darr, D; Shen, XJ; Patterson, C; Klauber-DeMore, N				Siamakpour-Reihani, Sharareh; Caster, Joseph; Nepal, Desh Bandhu; Courtwright, Andrew; Hilliard, Eleanor; Usary, Jerry; Ketelsen, David; Darr, David; Shen, Xiang Jun; Patterson, Cam; Klauber-DeMore, Nancy			The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis-A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus	PLOS ONE			English	Article							ACTIVATED T-CELLS; SIGNALING PATHWAY; NUCLEAR FACTOR; PROTEIN-2 SFRP2; GROWTH; EXPRESSION; CARCINOMA; PROLIFERATION; TRANSCRIPTION; TUMORS	Tacrolimus (FK506) is an immunosuppressive drug that binds to the immunophilin FKBPB12. The FK506-FKBP12 complex associates with calcineurin and inhibits its phosphatase activity, resulting in inhibition of nuclear translocation of nuclear factor of activated T-cells (NFAT). There is increasing data supporting a critical role of NFAT in mediating angiogenic responses stimulated by both vascular endothelial growth factor (VEGF) and a novel angiogenesis factor, secreted frizzled-related protein 2 (SFRP2). Since both VEGF and SFRP2 are expressed in breast carcinomas, we hypothesized that tacrolimus would inhibit breast carcinoma growth. Using IHC (IHC) with antibodies to FKBP12 on breast carcinomas we found that FKBP12 localizes to breast tumor vasculature. Treatment of MMTV-neu transgenic mice with tacrolimus (3 mg/kg i.p. daily) (n = 19) resulted in a 73% reduction in the growth rate for tacrolimus treated mice compared to control (n = 15), p = 0.003; which was associated with an 82% reduction in tumor microvascular density (p<0.001) by IHC. Tacrolimus (1 mu M) inhibited SFRP2 induced endothelial tube formation by 71% (p = 0.005) and inhibited VEGF induced endothelial tube formation by 67% (p = 0.004). To show that NFATc3 is required for SFRP2 stimulated angiogenesis, NFATc3 was silenced with shRNA in endothelial cells. Sham transfected cells responded to SFRP2 stimulation in a tube formation assay with an increase in the number of branch points (p<0.003), however, cells transfected with shRNA to NFATc3 showed no increase in tube formation in response to SFRP2. This demonstrates that NFATc3 is required for SFRP2 induced tube formation, and tacrolimus inhibits angiogenesis in vitro and breast carcinoma growth in vivo. This provides a rationale for examining the therapeutic potential of tacrolimus at inhibiting breast carcinoma growth in humans.	[Siamakpour-Reihani, Sharareh; Usary, Jerry; Ketelsen, David; Darr, David; Shen, Xiang Jun; Patterson, Cam; Klauber-DeMore, Nancy] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Caster, Joseph; Nepal, Desh Bandhu; Courtwright, Andrew; Klauber-DeMore, Nancy] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Hilliard, Eleanor; Patterson, Cam; Klauber-DeMore, Nancy] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Siamakpour-Reihani, S (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	nancy_demore@med.unc.edu		Siamakpour-Reihani, Sharareh/0000-0002-2837-443X; caster, joseph/0000-0001-6880-6770	National Cancer Institute [1R01CA142657-01A1]; NIH National Cancer Institute [P50-CA58223]; NATIONAL CANCER INSTITUTE [P50CA058223, R01CA142657] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Cancer Institute (1R01CA142657-01A1) and NIH National Cancer Institute Breast Cancer Specialized Program of Research Excellence grants P50-CA58223 to NK-D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Bhati R, 2008, AM J PATHOL, V172, P1381, DOI 10.2353/ajpath.2008.070988; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Cao Xiao-Wei, 2005, Hepatobiliary Pancreat Dis Int, V4, P269; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Gehmert S, 2008, BIOCHEM BIOPH RES CO, V371, P752, DOI 10.1016/j.bbrc.2008.04.151; Higgins JPT, 2003, AM J SURG PATHOL, V27, P58, DOI 10.1097/00000478-200301000-00007; Jain AB, 1998, TRANSPLANTATION, V66, P1193, DOI 10.1097/00007890-199811150-00014; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Klauber N, 1997, CANCER RES, V57, P81; Klauber N, 1997, NAT MED, V3, P443, DOI 10.1038/nm0497-443; Klauber-DeMore N, 2001, CLIN CANCER RES, V7, P2434; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lee JL, 2004, BREAST CANCER RES TR, V84, P139, DOI 10.1023/B:BREA.0000018412.83348.ff; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Medyouf H, 2007, NAT MED, V13, P736, DOI 10.1038/nm1588; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Moran TP, 2007, VACCINE, V25, P6604, DOI 10.1016/j.vaccine.2007.06.058; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Rafii S, 2003, NAT MED, V9, P166, DOI 10.1038/nm0203-166; Sakai Manabu, 2004, Journal of Medical Investigation, V51, P63, DOI 10.2152/jmi.51.63; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zaichuk TA, 2004, J EXP MED, V199, P1513, DOI 10.1084/jem.20040474	32	65	67	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20412	10.1371/journal.pone.0020412	http://dx.doi.org/10.1371/journal.pone.0020412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673995	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500016
J	Coutsinos, D; Invernizzi, CF; Moisi, D; Oliveira, M; Martinez-Cajas, JL; Brenner, BG; Wainberg, MA				Coutsinos, Dimitrios; Invernizzi, Cedric F.; Moisi, Daniela; Oliveira, Maureen; Martinez-Cajas, Jorge L.; Brenner, Bluma G.; Wainberg, Mark A.			A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE MUTATIONS; THYMIDINE-ANALOG MUTATIONS; TREATMENT-NAIVE PATIENTS; ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; TENOFOVIR DF; IN-VITRO; REPLICATIVE FITNESS; BASE SUBSTITUTION	Numerous studies have suggested that the K65R reverse transcriptase (RT) mutation develops more readily in subtype C than subtype B HIV-1. We recently showed that this discrepancy lies partly in the subtype C template coding sequence that predisposes RT to pause at the site of K65R mutagenesis. However, the mechanism underlying this observation and the elevated rates of K65R development remained unknown. Here, we report that DNA synthesis performed with subtype C templates consistently produced more K65R-containing transcripts than subtype B templates, regardless of the subtype-origin of the RT enzymes employed. These findings confirm that the mechanism involved is template-specific and RT-independent. In addition, a pattern of DNA synthesis characteristic of site-specific primer/template slippage and dislocation was only observed with the subtype C sequence. Analysis of RNA secondary structure suggested that the latter was unlikely to impact on K65R development between subtypes and that Streisinger strand slippage during DNA synthesis at the homopolymeric nucleotide stretch of the subtype C K65 region might occur, resulting in misalignment of the primer and template. Consequently, slippage would lead to a deletion of the middle adenine of codon K65 and the production of a -1 frameshift mutation, which upon dislocation and realignment of the primer and template, would lead to development of the K65R mutation. These findings provide additional mechanistic evidence for the facilitated development of the K65R mutation in subtype C HIV-1.	[Coutsinos, Dimitrios; Invernizzi, Cedric F.; Moisi, Daniela; Oliveira, Maureen; Martinez-Cajas, Jorge L.; Brenner, Bluma G.; Wainberg, Mark A.] McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada; [Coutsinos, Dimitrios; Brenner, Bluma G.; Wainberg, Mark A.] McGill Univ, Dept Microbiol, Montreal, PQ H3A 2T5, Canada; [Coutsinos, Dimitrios; Brenner, Bluma G.; Wainberg, Mark A.] McGill Univ, Dept Immunol, Montreal, PQ, Canada; [Coutsinos, Dimitrios; Invernizzi, Cedric F.; Brenner, Bluma G.; Wainberg, Mark A.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Martinez-Cajas, Jorge L.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; Queens University - Canada	Coutsinos, D (corresponding author), McGill Univ, AIDS Ctr, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Hosp, Montreal, PQ, Canada.	mark.wainberg@mcgill.ca	Brenner, Bluma/I-8714-2019	Invernizzi, Cedric/0000-0002-9807-5195	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by grants to M.A.W. from the Canadian Institutes of Health Research (CIHR) (http://www.cihr-irsc.gc.ca/e/193.html). D.C. is the recipient of a CIHR M.D./Ph.D. fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript. Work by D.C. was performed in partial fulfillment of the requirements for a Ph.D. degree from the Faculty of Graduate Studies and Research, McGill University, Montreal, Quebec, Canada.	Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; Antinori A, 2007, ANTIVIR THER, V12, P1175; Arien KK, 2007, NAT REV MICROBIOL, V5, P141, DOI 10.1038/nrmicro1594; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; BEBENEK K, 1993, J BIOL CHEM, V268, P10324; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2006, AIDS, V20, pF9, DOI 10.1097/01.aids.0000232228.88511.0b; BUISER RG, 1993, BIOCHIM BIOPHYS ACTA, V1216, P20, DOI 10.1016/0167-4781(93)90033-A; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Coutsinos Dimitrios, 2010, Antiviral Chemistry & Chemotherapy, V20, P117, DOI 10.3851/IMP1443; Coutsinos D, 2009, J VIROL, V83, P2029, DOI 10.1128/JVI.01349-08; Das K, 2009, J BIOL CHEM, V284, P35092, DOI 10.1074/jbc.M109.022525; De Mendoza C, 2007, AIDS RES HUM RETROV, V23, P879, DOI 10.1089/aid.2005.0072; Deshpande A, 2010, AIDS RES HUM RETROV, V26, P343, DOI 10.1089/aid.2009.0217; Deval J, 2004, J BIOL CHEM, V279, P25489, DOI 10.1074/jbc.M313534200; Deval J, 2004, J BIOL CHEM, V279, P509, DOI 10.1074/jbc.M308806200; Doualla-Bell F, 2006, ANTIMICROB AGENTS CH, V50, P4182, DOI 10.1128/AAC.00714-06; Feng JY, 2006, NUCLEOS NUCLEOT NUCL, V25, P89, DOI 10.1080/15257770500379157; Frankel Fernando A., 2007, Antiviral Chemistry & Chemotherapy, V18, P93; Frankel FA, 2007, AIDS, V21, P665, DOI 10.1097/QAD.0b013e3280187505; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gonzales MJ, 2001, J INFECT DIS, V184, P998, DOI 10.1086/323601; GRANT PM, 2010, ANTIMICROB AGENTS CH; GU ZX, 1995, P NATL ACAD SCI USA, V92, P2760, DOI 10.1073/pnas.92.7.2760; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Harrigan PR, 2000, J INFECT DIS, V181, P912, DOI 10.1086/315317; Heeney JL, 2006, SCIENCE, V313, P462, DOI 10.1126/science.1123016; HERMAN BD, 2010, J BIOL CHEM; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; HUBER HE, 1989, J BIOL CHEM, V264, P4669; Invernizzi CF, 2009, J INFECT DIS, V200, P1202, DOI 10.1086/605894; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kagan RM, 2007, ANTIVIR RES, V75, P210, DOI 10.1016/j.antiviral.2007.03.006; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Kozal MJ, 2010, ANTIVIR THER, V15, pA34; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Li JF, 2011, J INFECT DIS, V203, P798, DOI 10.1093/infdis/jiq126; Margot NA, 2006, HIV MED, V7, P442, DOI 10.1111/j.1468-1293.2006.00404.x; Margot NA, 2002, AIDS, V16, P1227, DOI 10.1097/00002030-200206140-00004; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; Mathews David H, 2007, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1102s28; McColl DJ, 2008, ANTIVIR THER, V13, P189; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; OKADA Y, 1968, SCIENCE, V162, P807, DOI 10.1126/science.162.3855.807; Orrell C, 2009, ANTIVIR THER, V14, P523; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; Parikh UM, 2006, J INFECT DIS, V194, P651, DOI 10.1086/505711; Parikh UM, 2006, J VIROL, V80, P4971, DOI 10.1128/JVI.80.10.4971-4977.2006; Pillay V, 2008, AIDS RES HUM RETROV, V24, P1449, DOI 10.1089/aid.2008.0180; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SCHINAZI RF, 1994, ANTIMICROB AGENTS CH, V38, P268, DOI 10.1128/AAC.38.2.268; Sluis-Cremer N, 2007, ANTIMICROB AGENTS CH, V51, P48, DOI 10.1128/AAC.00683-06; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; TALBOTT R, 1993, P NATL ACAD SCI USA, V90, P4226, DOI 10.1073/pnas.90.9.4226; Toni TA, 2010, ANTIMICROB AGENTS CH, V54, P907, DOI 10.1128/AAC.01080-09; Turner D, 2009, J MED VIROL, V81, P1509, DOI 10.1002/jmv.21567; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Wainberg MA, 1999, ANTIVIR THER, V4, P87; Wallis CL, 2010, ANTIVIR THER, V15, pA35; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weber J, 2005, J CLIN MICROBIOL, V43, P1395, DOI 10.1128/JCM.43.3.1395-1400.2005; White KL, 2006, ANTIVIR THER, V11, P155; White KL, 2005, AIDS, V19, P1751, DOI 10.1097/01.aids.0000189851.21441.f1; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P18682; Winters MA, 1997, ANTIMICROB AGENTS CH, V41, P757, DOI 10.1128/AAC.41.4.757; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Xu HT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-14	79	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20208	10.1371/journal.pone.0020208	http://dx.doi.org/10.1371/journal.pone.0020208			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655292	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600029
J	Miyata, S; Koyama, Y; Takemoto, K; Yoshikawa, K; Ishikawa, T; Taniguchi, M; Inoue, K; Aoki, M; Hori, O; Katayama, T; Tohyama, M				Miyata, Shingo; Koyama, Yoshihisa; Takemoto, Kana; Yoshikawa, Keiko; Ishikawa, Toshiko; Taniguchi, Manabu; Inoue, Kiyoshi; Aoki, Miwa; Hori, Osamu; Katayama, Taiichi; Tohyama, Masaya			Plasma Corticosterone Activates SGK1 and Induces Morphological Changes in Oligodendrocytes in Corpus Callosum	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; PITUITARY-ADRENAL AXIS; KINASE GENE FAMILY; PROTEIN-KINASE; MESSENGER-RNA; CELL-VOLUME; DIFFERENTIAL EXPRESSION; RAT HIPPOCAMPUS; CHRONIC STRESS; SERUM	Repeated stressful events are known to be associated with onset of depression. Further, stress activates the hypothalamic-pituitary-adrenocortical (HPA) system by elevating plasma cortisol levels. However, little is known about the related downstream molecular pathway. In this study, by using repeated water-immersion and restraint stress (WIRS) as a stressor for mice, we attempted to elucidate the molecular pathway induced by elevated plasma corticosterone levels. We observed the following effects both, in vivo and in vitro: (1) repeated exposure to WIRS activates the 3-phosphoinositide-dependent protein kinase (PDK1)-serum glucocorticoid regulated kinase (SGK1)-N-myc downstream-regulated gene 1 (NDRG1)-adhesion molecule (i.e., N-cadherin, alpha-catenin, and beta-catenin) stabilization pathway via an increase in plasma corticosterone levels; (2) the activation of this signaling pathway induces morphological changes in oligodendrocytes; and (3) after recovery from chronic stress, the abnormal arborization of oligodendrocytes and depression-like symptoms return to the control levels. Our data strongly suggest that these abnomalities of oligodendrocytes are possibly related to depression-like symptoms.	[Miyata, Shingo; Koyama, Yoshihisa; Takemoto, Kana; Yoshikawa, Keiko; Ishikawa, Toshiko; Taniguchi, Manabu; Aoki, Miwa; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan; [Miyata, Shingo; Tohyama, Masaya] Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Dept Clin Disorder Res, Osaka, Japan; [Inoue, Kiyoshi] Emory Univ, Yerkes Natl Primate Res Ctr, Ctr Behav Neurosci, Atlanta, GA 30322 USA; [Hori, Osamu] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat, Kanazawa, Ishikawa, Japan; [Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan; [Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Osaka, Japan	Osaka University; Emory University; Kanazawa University; Hamamatsu University School of Medicine; Kanazawa University; Osaka University	Miyata, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan.	smiyata@anat2.med.osaka-u.ac.jp			Osaka Medical Research Foundation for Incurable Diseases; Japan Society for the Promotion of Science [20700335]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Osaka Medical Research Foundation for Incurable Diseases; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by the Osaka Medical Research Foundation for Incurable Diseases, Grant-in-Aid for Scientific research (No. 20700335) from Japan Society for the Promotion of Science, and the Global COE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding for this study.	Aguilera G, 2000, REGUL PEPTIDES, V96, P23, DOI 10.1016/S0167-0115(00)00196-8; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; BARTANUSZ V, 1993, ENDOCRINOLOGY, V132, P895, DOI 10.1210/en.132.2.895; Bauer NG, 2009, GLIA, V57, P1691, DOI 10.1002/glia.20885; Berger P, 2004, NEUROBIOL DIS, V17, P290, DOI 10.1016/j.nbd.2004.07.014; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chu JW, 2001, J CLIN ENDOCR METAB, V86, P3568, DOI 10.1210/jc.86.8.3568; Cowling RT, 2000, J LEUKOCYTE BIOL, V67, P240, DOI 10.1002/jlb.67.2.240; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Gold PW, 2002, AM J PSYCHIAT, V159, P1826, DOI 10.1176/appi.ajp.159.11.1826; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Hollister RD, 1997, NEUROSCIENCE, V79, P1111, DOI 10.1016/S0306-4522(97)00014-6; HOLSBOERTRACHSLER E, 1991, PSYCHIAT RES, V38, P163, DOI 10.1016/0165-1781(91)90041-M; Honer WG, 1999, NEUROSCIENCE, V91, P1247, DOI 10.1016/S0306-4522(98)00679-4; Ikenaka K, 2006, NEUROSCIENCE, V141, P1971, DOI 10.1016/j.neuroscience.2006.05.022; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; Iwata SI, 2004, SYNAPSE, V51, P279, DOI 10.1002/syn.10307; Kachhap SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000844; Kawabata K, 2010, J NUTR BIOCHEM, V21, P374, DOI 10.1016/j.jnutbio.2009.01.008; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Koyama Y, 2008, J CHEM NEUROANAT, V36, P209, DOI 10.1016/j.jchemneu.2008.08.006; Lacerda ALT, 2005, J PSYCHIATR RES, V39, P347, DOI 10.1016/j.jpsychires.2004.10.004; Lang F, 2000, P NATL ACAD SCI USA, V97, P8157, DOI 10.1073/pnas.97.14.8157; Lang F, 2001, SCI STKE, V108, P1; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leussis MP, 2008, SYNAPSE, V62, P22, DOI 10.1002/syn.20462; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Mizoguchi K, 2001, PSYCHONEUROENDOCRINO, V26, P443, DOI 10.1016/S0306-4530(01)00004-X; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Nishida Y, 2004, MOL BRAIN RES, V123, P121, DOI 10.1016/j.molbrainres.2004.01.008; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Rodriguez D, 1999, ACTA NEUROPATHOL, V97, P469, DOI 10.1007/s004010051016; SCHATZBERG AF, 1985, J PSYCHIAT RES, V19, P57, DOI 10.1016/0022-3956(85)90068-8; Schoenebeck B, 2005, MOL CELL NEUROSCI, V30, P249, DOI 10.1016/j.mcn.2005.07.017; Song Y, 2010, HUM PATHOL, V41, P214, DOI 10.1016/j.humpath.2009.07.011; Stichel CC, 2005, EUR J NEUROSCI, V21, P301, DOI 10.1111/j.1460-9568.2005.03859.x; Van Gemert NG, 2006, STRESS, V9, P165, DOI 10.1080/10253890600966169; Waldegger S, 1997, P NATL ACAD SCI USA, V94, P4440, DOI 10.1073/pnas.94.9.4440; Warntges S, 2002, PFLUG ARCH EUR J PHY, V443, P617, DOI 10.1007/s00424-001-0737-1; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031	50	82	84	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19859	10.1371/journal.pone.0019859	http://dx.doi.org/10.1371/journal.pone.0019859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655274	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600008
J	Zha, WJ; Peng, XX; Chen, RZ; Du, B; Zhu, LL; He, GC				Zha, Wenjun; Peng, Xinxin; Chen, Rongzhi; Du, Bo; Zhu, Lili; He, Guangcun			Knockdown of Midgut Genes by dsRNA-Transgenic Plant-Mediated RNA Interference in the Hemipteran Insect Nilaparvata lugens	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; BROWN PLANTHOPPER; CONFERS RESISTANCE; SYSTEMIC RNAI; EXPRESSION; MARKER; DNA; IDENTIFICATION; MECHANISMS; AUBERGINE	Background: RNA interference (RNAi) is a powerful technique for functional genomics research in insects. Transgenic plants producing double-stranded RNA (dsRNA) directed against insect genes have been reported for lepidopteran and coleopteran insects, showing potential for field-level control of insect pests, but this has not been reported for other insect orders. Methodology/Principal Findings: The Hemipteran insect brown planthopper (Nilaparvata lugens Stal) is a typical phloem sap feeder specific to rice (Oryza sativa L.). To analyze the potential of exploiting RNAi-mediated effects in this insect, we identified genes (Nlsid-1 and Nlaub) encoding proteins that might be involved in the RNAi pathway in N. lugens. Both genes are expressed ubiquitously in nymphs and adult insects. Three genes (the hexose transporter gene NlHT1, the carboxypeptidase gene Nlcar and the trypsin-like serine protease gene Nltry) that are highly expressed in the N. lugens midgut were isolated and used to develop dsRNA constructs for transforming rice. RNA blot analysis showed that the dsRNAs were transcribed and some of them were processed to siRNAs in the transgenic lines. When nymphs were fed on rice plants expressing dsRNA, levels of transcripts of the targeted genes in the midgut were reduced; however, lethal phenotypic effects after dsRNA feeding were not observed. Conclusions: Our study shows that genes for the RNAi pathway (Nlsid-1 and Nlaub) are present in N. lugens. When insects were fed on rice plant materials expressing dsRNAs, RNA interference was triggered and the target genes transcript levels were suppressed. The gene knockdown technique described here may prove to be a valuable tool for further investigations in N. lugens. The results demonstrate the potential of dsRNA-mediated RNAi for field-level control of planthoppers, but appropriate target genes must be selected when designing the dsRNA-transgenic plants.	[Zha, Wenjun; Peng, Xinxin; Chen, Rongzhi; Du, Bo; Zhu, Lili; He, Guangcun] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Zha, WJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	gche@whu.edu.cn		He, Guangcun/0000-0001-6395-4774; Chen, Rongzhi/0000-0002-0122-4415; PENG, XINXIN/0000-0002-1503-5404	Ministry of Agriculture of China [1104002, 200803003]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by the Fundamental Research Funds for the Central University of China (grant no. 1104002) and the Special Fund for Commonwealth Industry (grant no. 200803003) from the Ministry of Agriculture of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Cha YS, 2008, MOL CELLS, V26, P146; Chakraborti D, 2006, AFR J BIOTECHNOL, V5, P585; CHEN J, 2010, INSECT MOL BIOL; Chen RZ, 2007, PLANT CELL, V19, P847, DOI 10.1105/tpc.106.044123; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Dzitoyeva S, 2001, MOL PSYCHIATR, V6, P665, DOI 10.1038/sj.mp.4000955; Fairbairn DJ, 2007, PLANTA, V226, P1525, DOI 10.1007/s00425-007-0588-x; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fire AZ, 2007, ANGEW CHEM INT EDIT, V46, P6967, DOI 10.1002/anie.200701979; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Kikuta S, 2010, INSECT BIOCHEM MOLEC, V40, P805, DOI 10.1016/j.ibmb.2010.07.008; Lechtenberg B, 2003, PLANT J, V34, P507, DOI 10.1046/j.1365-313X.2003.01746.x; Lee SI, 1999, MOL BREEDING, V5, P1; Liao Z, 2010, ARCH INSECT BIOCHEM, V74, P91, DOI 10.1002/arch.20362; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; LIU S, 2010, INSECT BIOCH MOL BIO; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; May RC, 2005, METHOD ENZYMOL, V392, P308, DOI 10.1016/S0076-6879(04)92018-6; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Mlotshwa S, 2002, PLANT CELL, V14, pS289, DOI 10.1105/tpc.001677; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Price DRG, 2007, INSECT BIOCHEM MOLEC, V37, P1138, DOI 10.1016/j.ibmb.2007.07.001; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; RICHARDSON PT, 1982, J EXPT BOT, V33, P202; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Saha P, 2006, PLANTA, V223, P1329, DOI 10.1007/s00425-005-0182-z; Senthil-Nathan S, 2009, ECOTOX ENVIRON SAFE, V72, P1707, DOI 10.1016/j.ecoenv.2009.04.024; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Silva CP, 2004, ARTHROPOD STRUCT DEV, V33, P139, DOI 10.1016/j.asd.2003.12.002; Specchia V, 2008, GENETICS, V178, P1271, DOI 10.1534/genetics.107.078626; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xu WN, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3001; Yadav BC, 2006, MOL BIOCHEM PARASIT, V148, P219, DOI 10.1016/j.molbiopara.2006.03.013; Yang ZF, 2010, Z NATURFORSCH C, V65, P109; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhou XG, 2008, INSECT BIOCHEM MOLEC, V38, P805, DOI 10.1016/j.ibmb.2008.05.005	65	216	237	2	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20504	10.1371/journal.pone.0020504	http://dx.doi.org/10.1371/journal.pone.0020504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655219	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600083
J	Dabrunz, A; Duester, L; Prasse, C; Seitz, F; Rosenfeldt, R; Schilde, C; Schaumann, GE; Schulz, R				Dabrunz, Andre; Duester, Lars; Prasse, Carsten; Seitz, Frank; Rosenfeldt, Ricki; Schilde, Carsten; Schaumann, Gabriele E.; Schulz, Ralf			Biological Surface Coating and Molting Inhibition as Mechanisms of TiO2 Nanoparticle Toxicity in Daphnia magna	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; ENGINEERED NANOPARTICLES; OXIDE NANOPARTICLES; ONCORHYNCHUS-MYKISS; AQUATIC ENVIRONMENT; GOLD NANOPARTICLES; FULLERENE C-60; RAINBOW-TROUT; ECOTOXICOLOGY; NANOMATERIALS	The production and use of nanoparticles (NP) has steadily increased within the last decade; however, knowledge about risks of NP to human health and ecosystems is still scarce. Common knowledge concerning NP effects on freshwater organisms is largely limited to standard short-term (<= 48 h) toxicity tests, which lack both NP fate characterization and an understanding of the mechanisms underlying toxicity. Employing slightly longer exposure times (72 to 96 h), we found that suspensions of nanosized (similar to 100 nm initial mean diameter) titanium dioxide (nTiO(2)) led to toxicity in Daphnia magna at nominal concentrations of 3.8 (72-h EC50) and 0.73 mg/L (96-h EC50). However, nTiO(2) disappeared quickly from the ISO-medium water phase, resulting in toxicity levels as low as 0.24 mg/L (96-h EC50) based on measured concentrations. Moreover, we showed that nTiO(2) (similar to 100 nm) is significantly more toxic than non-nanosized TiO2 (similar to 200 nm) prepared from the same stock suspension. Most importantly, we hypothesized a mechanistic chain of events for nTiO(2) toxicity in D. magna that involves the coating of the organism surface with nTiO(2) combined with a molting disruption. Neonate D. magna (<= 6 h) exposed to 2 mg/L nTiO(2) exhibited a "biological surface coating" that disappeared within 36 h, during which the first molting was successfully managed by 100% of the exposed organisms. Continued exposure up to 96 h led to a renewed formation of the surface coating and significantly reduced the molting rate to 10%, resulting in 90% mortality. Because coating of aquatic organisms by manmade NP might be ubiquitous in nature, this form of physical NP toxicity might result in widespread negative impacts on environmental health.	[Dabrunz, Andre; Duester, Lars; Prasse, Carsten; Seitz, Frank; Rosenfeldt, Ricki; Schaumann, Gabriele E.; Schulz, Ralf] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Duester, Lars; Prasse, Carsten] Fed Inst Hydrol, Dept Aquat Chem, Koblenz, Germany; [Schilde, Carsten] Tech Univ Carolo Wilhelmina Braunschweig, Inst Particle Technol, Braunschweig, Germany	University of Koblenz & Landau; Braunschweig University of Technology	Dabrunz, A (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	R.Schulz@uni-landau.de	Prasse, Carsten/AAR-9120-2020; Schaumann, Gabriele E/B-4283-2015; Schulz, Ralf/ABI-4526-2020; Duester, Lars/I-3478-2014; Prasse, Carsten/M-7847-2015; Schulz, Ralf/G-3674-2011	Schaumann, Gabriele E/0000-0003-1788-2751; Schulz, Ralf/0000-0002-6348-6971; Duester, Lars/0000-0001-7025-3810; Schulz, Ralf/0000-0002-6348-6971; Prasse, Carsten/0000-0002-1470-141X; Seitz, Frank/0000-0002-3181-0140; Schilde, Carsten/0000-0003-0851-8042	Ministry of Science Rhineland-Palatinate research initiative INTERNANO	Ministry of Science Rhineland-Palatinate research initiative INTERNANO	This research was financially supported by the Ministry of Science Rhineland-Palatinate research initiative INTERNANO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouni ZE, 2009, COLLOID SURFACE B, V68, P83, DOI 10.1016/j.colsurfb.2008.09.014; Aruoja V, 2009, SCI TOTAL ENVIRON, V407, P1461, DOI 10.1016/j.scitotenv.2008.10.053; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i; BUIKEMA AJ, 1973, HYDROBIOLOGIA, V41, P391, DOI 10.1007/BF00016626; DEJONG F, 2008, 601506009 RIVM NAT I; Drobne D, 2009, ENVIRON POLLUT, V157, P1157, DOI 10.1016/j.envpol.2008.10.018; DUESTER L, 2011, J ENV MONIT IN PRESS; European Chemicals Bureau, 2003, TECHN GUID DOC RIS 2; Federici G, 2007, AQUAT TOXICOL, V84, P415, DOI 10.1016/j.aquatox.2007.07.009; Ferry JL, 2009, NAT NANOTECHNOL, V4, P441, DOI [10.1038/NNANO.2009.157, 10.1038/nnano.2009.157]; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Handy RD, 2008, ECOTOXICOLOGY, V17, P315, DOI 10.1007/s10646-008-0206-0; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Hartmann NB, 2010, TOXICOLOGY, V269, P190, DOI 10.1016/j.tox.2009.08.008; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Hussain M, 2010, CHEM ENG J, V157, P45, DOI 10.1016/j.cej.2009.10.043; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Lampert W, 2007, LIMNOECOLOGY, V2ed; Lazorchak JM, 2009, ENVIRON TOXICOL CHEM, V28, P1028, DOI 10.1897/08-296.1; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster E, 2006, CARBON, V44, P1112, DOI 10.1016/j.carbon.2005.11.008; Oberdorster G, 2007, ENVIRON HEALTH PERSP, V115, pA290, DOI 10.1289/ehp.115-a290a; OECD Organization for Economic Cooperation and Development, 2004, GUID TEST CHEM 202 D; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Rand G.M., 1985, HEMISPHERE; Ritz C, 2005, J STAT SOFTWARE, V12; Scheringer M, 2008, NAT NANOTECHNOL, V3, P322, DOI 10.1038/nnano.2008.145; *SCI COMM EM NEWL, 2007, OP SCI ASP EX PROP D; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Smith CJ, 2007, AQUAT TOXICOL, V82, P94, DOI 10.1016/j.aquatox.2007.02.003; SMITH FE, 1963, ECOLOGY, V44, P651, DOI 10.2307/1933011; Stone V, 2010, SCI TOTAL ENVIRON, V408, P1745, DOI 10.1016/j.scitotenv.2009.10.035; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; Zhu XS, 2010, CHEMOSPHERE, V79, P928, DOI 10.1016/j.chemosphere.2010.03.022; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	41	143	149	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20112	10.1371/journal.pone.0020112	http://dx.doi.org/10.1371/journal.pone.0020112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647422	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500030
J	Angus, L; Moleirinho, S; Herron, L; Sinha, A; Zhang, X; Niestrata, M; Dholakia, K; Prystowsky, MB; Harvey, KF; Reynolds, PA; Gunn-Moore, FJ				Angus, L.; Moleirinho, S.; Herron, L.; Sinha, A.; Zhang, X.; Niestrata, M.; Dholakia, K.; Prystowsky, M. B.; Harvey, K. F.; Reynolds, P. A.; Gunn-Moore, F. J.			Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP	ONCOGENE			English	Article						Willin/FRMD6; Expanded; Hippo pathway; ezrin; merlin	ORGAN SIZE CONTROL; CELL CONTACT INHIBITION; TUMOR-SUPPRESSOR; DROSOPHILA; GROWTH; PROLIFERATION; PROTEIN; APOPTOSIS; REGULATOR; UPSTREAM	The Salvador/Warts/Hippo (Hippo) signaling pathway defines a novel signaling cascade regulating cell contact inhibition, organ size control, cell growth, proliferation, apoptosis and cancer development in mammals. The Drosophila melanogaster protein Expanded acts in the Hippo signaling pathway to control organ size. Previously, willin/FRMD6 has been proposed as the human orthologue of Expanded. Willin lacks C-terminal sequences that are present in Expanded and, to date, little is known about the functional role of willin in mammalian cells. When willin is expressed in D. melanogaster epithelial tissues, it has the same subcellular localization as Expanded, but cannot rescue growth defects associated with expanded deficiency. However, we show that ectopic willin expression causes an increase in phosphorylation of the core Hippo signaling pathway components MST1/2, LATS1 and YAP, an effect that can be antagonized by ezrin. In MCF10A cells, loss of willin expression displays epithelial-to-mesenchymal transition features and willin overexpression antagonizes YAP activity via the N-terminal FERM domain of willin. Therefore, in mammalian cells willin influences Hippo signaling activity by activating the core Hippo pathway kinase cassette. Oncogene (2012) 31, 238-250; doi:10.1038/onc.2011.224; published online 13 June 2011	[Angus, L.; Moleirinho, S.; Herron, L.; Gunn-Moore, F. J.] Univ St Andrews, Sch Biol, St Andrews KY16 9TF, Fife, Scotland; [Moleirinho, S.; Niestrata, M.; Reynolds, P. A.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland; [Sinha, A.; Zhang, X.; Harvey, K. F.] Peter MacCallum Canc Ctr, Cell Growth & Proliferat Lab, Melbourne, Vic, Australia; [Sinha, A.; Zhang, X.; Harvey, K. F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Dholakia, K.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9TF, Fife, Scotland; [Prystowsky, M. B.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	University of St Andrews; University of St Andrews; Peter Maccallum Cancer Center; University of Melbourne; University of St Andrews; Yeshiva University; Albert Einstein College of Medicine	Gunn-Moore, FJ (corresponding author), Univ St Andrews, Sch Biol, Med & Biol Sci Bldg, St Andrews KY16 9TF, Fife, Scotland.	fjg1@st-and.ac.uk	Herron, Lissa/C-7780-2013; Harvey, Kieran/AAD-5268-2022	Dholakia, Kishan/0000-0001-6534-9009; Herron, Lissa/0000-0001-9961-4421; Reynolds, Paul/0000-0001-8738-1245; Gunn-Moore, Francis James/0000-0003-3422-3387; Harvey, Kieran/0000-0001-7845-369X	BBSRC; EPSRC; Scottish University Life Science Alliance; International Human Frontier Science Program Organization; National Health and Medical Research Council of Australia; Melbourne International Research Scholarship; Fee Remission Scholarship	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Scottish University Life Science Alliance; International Human Frontier Science Program Organization(Human Frontier Science Program); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Research Scholarship; Fee Remission Scholarship	We thank P Burke for embryo injections and N Chang for technical assistance. We also thank the BBSRC and EPSRC for funding to LA; Scottish University Life Science Alliance for funding to SM. KFH holds Career Development Awards from the International Human Frontier Science Program Organization and the National Health and Medical Research Council of Australia and a Project Grant from the National Health and Medical Research Council of Australia. AS holds Melbourne International Research and Fee Remission Scholarships.	Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; Boedigheimer MJ, 1997, DEV GENET, V20, P103, DOI 10.1002/(SICI)1520-6408(1997)20:2<103::AID-DVG3>3.0.CO;2-B; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Gunn-Moore FJ, 2005, FEBS LETT, V579, P5089, DOI 10.1016/j.febslet.2005.07.097; Haase D, 2007, ONCOGENE, V26, P4464, DOI 10.1038/sj.onc.1210225; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Mao YP, 2011, DEVELOPMENT, V138, P947, DOI 10.1242/dev.057166; Milton CC, 2010, DEVELOPMENT, V137, P735, DOI 10.1242/dev.042309; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	35	75	77	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	2					238	250		10.1038/onc.2011.224	http://dx.doi.org/10.1038/onc.2011.224			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21666719	Green Submitted			2022-12-25	WOS:000299307400009
J	Jousse, C; Parry, L; Lambert-Langlais, S; Maurin, AC; Averous, J; Bruhat, A; Carraro, V; Tost, J; Letteron, P; Chen, P; Jockers, R; Launay, JM; Mallet, J; Fafournoux, P				Jousse, Celine; Parry, Laurent; Lambert-Langlais, Sarah; Maurin, Anne-Catherine; Averous, Julien; Bruhat, Alain; Carraro, Valerie; Tost, Jorg; Letteron, Philippe; Chen, Patty; Jockers, Ralf; Launay, Jean-Marie; Mallet, Jacques; Fafournoux, Pierre			Perinatal undernutrition affects the methylation and expression of the leptin gene in adults: implication for the understanding of metabolic syndrome	FASEB JOURNAL			English	Article						nutritional programming; epigenetic; food intake; maternal imprinting	NUTRITION TRANSITION; ENERGY HOMEOSTASIS; DNA METHYLATION; OBESITY; LIFE; DISEASE; HYPOTHALAMUS; EPIGENETICS; EPIGENOME; PROMOTER	Transient environmental influences, such as perinatal nutritional stress, may induce deleterious metabolic symptoms that last for the entire life of individuals, implying that epigenetic modifications play an important role in this process. We have investigated, in mice, the consequences of maternal undernutrition during gestation and lactation on DNA methylation and expression of the leptin gene, which plays a major regulatory role in coordinating nutritional state with many aspects of mammalian biology. We show that animals born to mothers fed a low-protein-diet (F1-LPD group) have a lower body weight/adiposity and exhibit a higher food intake than animals born to mothers fed a control diet (F1-CD group). These modifications persisted throughout life and were associated with lower levels of leptin mRNA and protein in starved F1-LPD mice, emphasizing that maternal protein-undernutrition affects the balance between food intake and energy expenditure in adults. Moreover, this nutritional stress resulted in the removal of methyls at CpGs located in the promoter of leptin, causing a permanent specific modification in the dynamics of the expression of leptin, which exhibits a stronger induction in the F1-LPD than in F1-CD mice in response to a meal. This study is an example of a molecular rationale linking transient environmental influences to permanent phenotypic consequences.-Jousse, C., Parry, L., Lambert-Langlais, S., Maurin, A. C., Averous, J., Bruhat, A., Carraro, V., Tost, J., Letteron, P., Chen, P., Jockers, R., Launay, J. M., Mallet, J., Fafournoux, P. Perinatal undernutrition affects the methylation and expression of the leptin gene in adults: implication for the understanding of metabolic syndrome. FASEB J. 25, 3271-3278 (2011). www.fasebj.org	[Jousse, Celine; Parry, Laurent; Lambert-Langlais, Sarah; Maurin, Anne-Catherine; Averous, Julien; Bruhat, Alain; Carraro, Valerie; Fafournoux, Pierre] INRA, UMR Unite Nutr Humaine 1019, F-63122 St Genes Champanelle, France; [Jousse, Celine; Fafournoux, Pierre] CNRS, Paris, France; [Tost, Jorg] CEA, Inst Genom, Lab Epigenet, Ctr Natl Genotypage, Evry, France; [Letteron, Philippe] INSERM, U773, Fac Med Xavier Bichat CRB3, Paris, France; [Chen, Patty; Jockers, Ralf] CNRS, INSERM, U1016, UMR 8104,Inst Cochin, Paris, France; [Launay, Jean-Marie] Univ Paris 05, Hop Lariboisiere, AP HP, Serv Biochim & Biol Mol,EA 3621,Fac Pharm, Paris, France; [Mallet, Jacques] Univ Paris 06, Hop La Pitie Salpetriere, CNRS,UMR 7091, Lab Genet Mol Neurotransmiss & Proc Neurodegenera, Paris, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Fafournoux, P (corresponding author), INRA, UMR Nutr Humaine 1019, F-63122 St Genes Champanelle, France.	pierre.fafournoux@clermont.inra.fr	Jockers, Ralf/P-2272-2017; Jockers, Ralf/Q-2100-2019; Tost, Joerg/H-7129-2019	Jockers, Ralf/0000-0002-4354-1750; Jockers, Ralf/0000-0002-4354-1750; Tost, Joerg/0000-0002-2683-0817	Agence Nationale de la Recherche Epidiabesity	Agence Nationale de la Recherche Epidiabesity(French National Research Agency (ANR))	The authors thank Anne Terrisse for animal care and Rolando Meloni and Nicole Faucon for critical reading of the manuscript. Funding for this project has been supplied by Agence Nationale de la Recherche Epidiabesity.	BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Caballero B, 2005, NEW ENGL J MED, V352, P1514, DOI 10.1056/NEJMp048310; Cooney CA, 2002, J NUTR, V132, p2393S; Desai M, 1997, AM J PHYSIOL-GASTR L, V273, pG899, DOI 10.1152/ajpgi.1997.273.4.G899; Doak CM, 2005, INT J OBESITY, V29, P129, DOI 10.1038/sj.ijo.0802824; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Holness MJ, 2000, BIOCHEM J, V349, P657, DOI 10.1042/bj3490657; Igoudjil A, 2007, ANTIVIR THER, V12, P389; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lu XY, 2007, CURR OPIN PHARMACOL, V7, P648, DOI 10.1016/j.coph.2007.10.010; Melzner I, 2002, J BIOL CHEM, V277, P45420, DOI 10.1074/jbc.M208511200; Muhlhausler BS, 2004, J NEUROENDOCRINOL, V16, P502, DOI 10.1111/j.1365-2826.2004.01197.x; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Rees WD, 2000, J NUTR, V130, P1821, DOI 10.1093/jn/130.7.1821; Rutten BPF, 2009, SCHIZOPHRENIA BULL, V35, P1045, DOI 10.1093/schbul/sbp104; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Singhal A, 2002, AM J CLIN NUTR, V75, P993, DOI 10.1093/ajcn/75.6.993; Szyf M, 2009, BBA-GEN SUBJECTS, V1790, P878, DOI 10.1016/j.bbagen.2009.01.009; Thompson MP, 1996, BIOCHEM BIOPH RES CO, V224, P332, DOI 10.1006/bbrc.1996.1029; Thompson SL, 2001, TOXICOL LETT, V120, P143, DOI 10.1016/S0378-4274(01)00292-2; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378	36	113	119	0	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3271	3278		10.1096/fj.11-181792	http://dx.doi.org/10.1096/fj.11-181792			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21670064	Bronze			2022-12-25	WOS:000294435200039
J	Hong, JA; Carroll, KS				Hong, Jiyoung A.; Carroll, Kate S.			Deciphering the Role of Histidine 252 in Mycobacterial Adenosine 5 '-Phosphosulfate (APS) Reductase Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; PSEUDOMONAS-AERUGINOSA; SULFATE REDUCTASE; 3'-PHOSPHOADENOSINE-5'-PHOSPHOSULFATE REDUCTASE; ADENOSINE-5'-PHOSPHOSULFATE REDUCTASE; 5-ADENYLYLSULFATE REDUCTASE; CRYSTAL-STRUCTURE; HIGHER-PLANTS; TUBERCULOSIS; BINDING	Mycobacterium tuberculosis adenosine 5'-phosphosulfate reductase (APR) catalyzes the first committed step in sulfate reduction for the biosynthesis of cysteine and is essential for survival in the latent phase of tuberculosis infection. The reaction catalyzed by APR involves the nucleophilic attack by conserved Cys-249 on adenosine 5'-phosphosulfate, resulting in a covalent S-sulfocysteine intermediate that is reduced in subsequent steps by thioredoxin to yield the sulfite product. Cys-249 resides on a mobile active site lid at the C terminus, within a K(R/T)ECG(L/I)H motif. Owing to its strict conservation among sulfonucleotide reductases and its proximity to the active site cysteine, it has been suggested that His-252 plays a key role in APR catalysis, specifically as a general base to deprotonate Cys-249. Using site-directed mutagenesis, we have changed His-252 to an alanine residue and analyzed the effect of this mutation on the kinetic parameters, pH rate profile, and ionization of Cys-249 of APR. Interestingly, our data demonstrate that His-252 does not perturb the pK(a) of Cys-249 or play a direct role in rate-limiting chemical steps of the reaction. Rather, we show that His-252 enhances substrate affinity via interaction with the alpha-phosphate and the endocyclic ribose oxygen. These findings were further supported by isothermal titration calorimetry to provide a thermodynamic profile of ligand-protein interactions. From an applied standpoint, our study suggests that small-molecules targeting residues in the dynamic C-terminal segment, particularly His-252, may lead to inhibitors with improved binding affinity.	[Carroll, Kate S.] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Hong, Jiyoung A.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Scripps Research Institute; University of Michigan System; University of Michigan	Carroll, KS (corresponding author), Scripps Res Inst, Dept Chem, 130 Scripps Way 2B2, Jupiter, FL 33458 USA.	kcarroll@scripps.edu		Hong, Jiyoung/0000-0002-0430-3290; Carroll, Kate/0000-0002-7624-9617	National Institutes of Health [GM087638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087638 (to K. S. C.).	Berndt C, 2004, J BIOL CHEM, V279, P7850, DOI 10.1074/jbc.M309332200; Bhave Devayani P., 2007, Infectious Disorders - Drug Targets, V7, P140; Bhave DP, 2011, J BIOL CHEM, V286, P1216, DOI 10.1074/jbc.M110.193722; Carroll KS, 2005, PLOS BIOL, V3, P1418, DOI 10.1371/journal.pbio.0030250; Carroll KS, 2005, BIOCHEMISTRY-US, V44, P14647, DOI 10.1021/bi051344a; Chartron J, 2006, J MOL BIOL, V364, P152, DOI 10.1016/j.jmb.2006.08.080; Cosconati S, 2008, J MED CHEM, V51, P6627, DOI 10.1021/jm800571m; Dawson RMC., 1989, DATA BIOCH RES; Gao H, 2007, J AM SOC MASS SPECTR, V18, P167, DOI 10.1016/j.jasms.2006.08.010; Hernick M, 2006, BIOCHEMISTRY-US, V45, P15240, DOI 10.1021/bi061405k; Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v; Hirase Kangetsu, 2003, Weed Biology and Management, V3, P147, DOI 10.1046/j.1445-6664.2003.00098.x; Hong JA, 2009, J MED CHEM, V52, P5485, DOI 10.1021/jm900728u; HUTCHISON A, 1989, J HETEROCYCLIC CHEM, V26, P451, DOI 10.1002/jhet.5570260235; Kim SK, 2005, BBA-BIOENERGETICS, V1710, P103, DOI 10.1016/j.bbabio.2005.09.004; Kim SK, 2004, BIOCHEMISTRY-US, V43, P13478, DOI 10.1021/bi048811t; Kopriva S, 2002, J BIOL CHEM, V277, P21786, DOI 10.1074/jbc.M202152200; Kopriva S, 2001, J BIOL CHEM, V276, P42881, DOI 10.1074/jbc.M107424200; Kopriva S, 2007, J BIOL CHEM, V282, P22930, DOI 10.1074/jbc.M702522200; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Mdluli K, 2006, CURR OPIN PHARMACOL, V6, P459, DOI 10.1016/j.coph.2006.06.004; NODA LH, 1953, J AM CHEM SOC, V75, P913, DOI 10.1021/ja01100a041; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; SAWAI H, 1985, CHEM PHARM BULL, V33, P432; Schnell R, 2010, BIOCHEM BIOPH RES CO, V396, P33, DOI 10.1016/j.bbrc.2010.02.118; Senaratne RH, 2006, MOL MICROBIOL, V59, P1744, DOI 10.1111/j.1365-2958.2006.05075.x; Setya A, 1996, P NATL ACAD SCI USA, V93, P13383, DOI 10.1073/pnas.93.23.13383; Weber M, 2000, EUR J BIOCHEM, V267, P3647, DOI 10.1046/j.1432-1327.2000.01394.x; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Yu ZH, 2008, BIOCHEMISTRY-US, V47, P12777, DOI 10.1021/bi801118f	31	3	4	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28567	28573		10.1074/jbc.M111.238998	http://dx.doi.org/10.1074/jbc.M111.238998			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673113	hybrid, Green Published			2022-12-25	WOS:000293557800071
J	Chen, JX; Myerburg, MM; Passero, CJ; Winarski, KL; Sheng, SH				Chen, Jingxin; Myerburg, Mike M.; Passero, Christopher J.; Winarski, Katie L.; Sheng, Shaohu			External Cu2+ Inhibits Human Epithelial Na+ Channels by Binding at a Subunit Interface of Extracellular Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-INHIBITION; SODIUM-CHANNEL; ALPHA-SUBUNIT; GAMMA-SUBUNIT; ION CHANNELS; HISTIDINE-RESIDUES; PULMONARY TOXICITY; HEAVY-METALS; ENAC; EXPRESSION	Epithelial Na+ channels (ENaCs) play an essential role in the regulation of body fluid homeostasis. Certain transition metals activate or inhibit the activity of ENaCs. In this study, we examined the effect of extracellular Cu2+ on human ENaC expressed in Xenopus oocytes and investigated the structural basis for its effects. External Cu2+ inhibited human alpha beta gamma ENaC with an estimated IC50 of 0.3 mu M. The slow time course and a lack of change in the current-voltage relationship were consistent with an allosteric (non pore-plugging) inhibition of human ENaC by Cu2+. Experiments with mixed human and mouse ENaC subunits suggested that both the alpha and beta subunits were primarily responsible for the inhibitory effect of Cu2+ on human ENaC. Lowering bath solution pH diminished the inhibition by Cu2+. Mutations of two alpha, two beta, and two gamma His residues within extracellular domains significantly reduced the inhibition of human ENaC by Cu2+. We identified a pair of residues as potential Cu2+-binding sites at the subunit interface between thumb subdomain of alpha hENaC and palm subdomain of beta hENaC, suggesting a counterclockwise arrangement of alpha, beta, and gamma ENaC subunits in a trimeric channel complex when viewed from above. We conclude that extracellular Cu2+ is a potent inhibitor of human ENaC and binds to multiple sites within the extracellular domains including a subunit interface.	[Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sheng, SH (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, Sch Med, Dept Med, S929 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	shaohu@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 ES014701, K08 HL087932, P30 DK072506, P30 DK079307]; Dialysis Clinic, Inc.; Cystic Fibrosis Foundation RDP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087932, R01HL112863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, P30DK072506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dialysis Clinic, Inc.; Cystic Fibrosis Foundation RDP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES014701, K08 HL087932, P30 DK072506, and P30 DK079307. This work was also supported by a research grant from Dialysis Clinic, Inc. and the Cystic Fibrosis Foundation RDP to the University of Pittsburgh.	Adamson IYR, 1999, TOXICOL APPL PHARM, V157, P43, DOI 10.1006/taap.1999.8658; Askwith CC, 2001, P NATL ACAD SCI USA, V98, P6459, DOI 10.1073/pnas.111155398; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chalfant ML, 1999, AM J PHYSIOL-CELL PH, V276, pC477, DOI 10.1152/ajpcell.1999.276.2.C477; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Davis IC, 2007, ADV EXP MED BIOL, V618, P127; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Ellingsen DG, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P529, DOI 10.1016/B978-012369413-3/50081-1; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; HEGETSCHWEILER K, 1986, INORG CHEM, V25, P107, DOI 10.1021/ic00221a028; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; KISS T, 1994, PHARMACOL REV, V46, P245; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nevin ST, 2003, J BIOL CHEM, V278, P28985, DOI 10.1074/jbc.M300097200; Nie HG, 2010, AM J PHYSIOL-RENAL, V298, pF323, DOI 10.1152/ajprenal.00307.2009; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; Prieditis H, 2002, EXP LUNG RES, V28, P563, DOI 10.1080/01902140290096782; Restrepo-Angulo I, 2010, J APPL TOXICOL, V30, P497, DOI 10.1002/jat.1556; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; SHENG S, 2007, SELDIN GIEBISCHS KID, P743; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Tisato F, 2010, MED RES REV, V30, P708, DOI 10.1002/med.20174; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF236, DOI 10.1152/ajprenal.00002.2007	47	19	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27436	27446		10.1074/jbc.M111.232058	http://dx.doi.org/10.1074/jbc.M111.232058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659509	Green Published, hybrid			2022-12-25	WOS:000293268700039
J	Kosaka-Suzuki, N; Suzuki, T; Pugacheva, EM; Vostrov, AA; Morse, HC; Loukinov, D; Lobanenkov, V				Kosaka-Suzuki, Natsuki; Suzuki, Teruhiko; Pugacheva, Elena M.; Vostrov, Alexander A.; Morse, Herbert C., III; Loukinov, Dmitri; Lobanenkov, Victor			Transcription Factor BORIS (Brother of the Regulator of Imprinted Sites) Directly Induces Expression of a Cancer-Testis Antigen, TSP50, through Regulated Binding of BORIS to the Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC GENE; CTCF-BINDING; EPIGENETIC REGULATION; ENHANCER-BLOCKING; CONTROL REGION; BREAST-CANCER; LUNG-CANCER; PROTEIN; CHROMATIN; INSULATOR	Cancer-testis antigens (CTAs) are normally expressed in testis but are aberrantly expressed in a variety of cancers with varying frequency. More than 100 proteins have been identified as CTA including testes-specific protease 50 (TSP50) and the testis-specific paralogue of CCCTC-binding factor, BORIS (brother of the regulator of imprinted sites). Because many CTAs are considered as excellent targets for tumor immunotherapy, understanding the regulatory mechanisms governing their expression is important. In this study we demonstrate that BORIS is directly responsible for the transcriptional activation of TSP50. We found two BORIS binding sites in the TSP50 promoter that are highly conserved between mouse and human. Mutations of the binding sites resulted in loss of BORIS binding and the ability of BORIS to activate the promoter. However, although expression of BORIS was essential, it was not sufficient for high expression of TSP50 in cancer cells. Further studies showed that binding of BORIS to the target sites was methylation-independent but was diminished by nucleosomal occupancy consistent with the findings that high expression of TSP50 was associated with increased DNase I sensitivity and high BORIS occupancy of the promoter. These findings indicate that BORIS-induced expression of TSP50 is governed by accessibility and binding of BORIS to the promoter. To our knowledge this is the first report of regulated expression of one CTA by another to be validated in a physiological context.	[Lobanenkov, Victor] NIAID, Mol Pathol Sect, Immunopathol Lab, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lobanenkov, V (corresponding author), NIAID, Mol Pathol Sect, Immunopathol Lab, NIH, Twinbrook 1,Rm 1417,MSC-8152,5640 Fishers Lane, Rockville, MD 20852 USA.	vlobanenkov@niaid.nih.gov	Lobanenkov, Victor/ABD-5710-2021; Pugacheva, Elena M/GNH-1756-2022; Lobanenkov, Victor V./AGQ-8903-2022	Pugacheva, Elena M/0000-0001-9693-9853; Lobanenkov, Victor/0000-0001-6665-3635; Morse, Herbert/0000-0002-9331-3705	National Institutes of Health of the NIAID; Japan Society for the Promotion of Science Research at the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001021, ZIAAI000860, ZIAAI000858, ZIAAI001024] Funding Source: NIH RePORTER	National Institutes of Health of the NIAID; Japan Society for the Promotion of Science Research at the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIAID. This work was also supported by the Japan Society for the Promotion of Science Research Fellowship for Japanese Biomedical and Behavioral Researchers at the National Institutes of Health (to T. S.).	Akers SN, 2010, FUTURE ONCOL, V6, P717, DOI [10.2217/fon.10.36, 10.2217/FON.10.36]; Amelio AL, 2006, J VIROL, V80, P2358, DOI 10.1128/JVI.80.5.2358-2368.2006; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chau CM, 2006, J VIROL, V80, P5723, DOI 10.1128/JVI.00025-06; De la Rosa-Velazquez IA, 2007, CANCER RES, V67, P2577, DOI 10.1158/0008-5472.CAN-06-2024; Dougherty CJ, 2008, BIOCHEM BIOPH RES CO, V370, P109, DOI 10.1016/j.bbrc.2008.03.040; Filippova GN, 2002, CANCER RES, V62, P48; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Han L, 2008, MOL CELL BIOL, V28, P1124, DOI 10.1128/MCB.01361-07; Hong JA, 2005, CANCER RES, V65, P7763, DOI 10.1158/0008-5472.CAN-05-0823; Huang Y, 2008, BIOCHEM BIOPH RES CO, V374, P658, DOI 10.1016/j.bbrc.2008.07.087; Jager E, 2006, P NATL ACAD SCI USA, V103, P14453, DOI 10.1073/pnas.0606512103; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kirkin AF, 2002, CANCER INVEST, V20, P222, DOI 10.1081/CNV-120001150; Klenova EA, 2002, SEMIN CANCER BIOL, V12, P399, DOI 10.1016/S1044-579X(02)00060-3; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Libby RT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000257; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Loukinov D, 2006, J CELL BIOCHEM, V98, P1037, DOI 10.1002/jcb.20953; Lu Qianjin, 2004, Methods Mol Biol, V287, P77; Marchand M, 1999, INT J CANCER, V80, P219, DOI 10.1002/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S; Mkrtichyan M, 2008, GENE THER, V15, P61, DOI 10.1038/sj.gt.3303044; Moon H, 2005, EMBO REP, V6, P165, DOI 10.1038/sj.embor.7400334; Nativio R, 2011, HUM MOL GENET, V20, P1363, DOI 10.1093/hmg/ddr018; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohlsson R, 2010, BIOESSAYS, V32, P37, DOI 10.1002/bies.200900118; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Suzuki T, 2010, MOL CELL BIOL, V30, P2473, DOI 10.1128/MCB.01093-09; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wang M, 2008, DNA CELL BIOL, V27, P307, DOI 10.1089/dna.2007.0692; Woloszynska-Read A, 2011, CLIN CANCER RES, V17, P2170, DOI 10.1158/1078-0432.CCR-10-2315; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Yang YX, 1999, J NEUROCHEM, V73, P2286, DOI 10.1046/j.1471-4159.1999.0732286.x; Yuan LM, 1999, CANCER RES, V59, P3215; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	50	27	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27378	27388		10.1074/jbc.M111.243576	http://dx.doi.org/10.1074/jbc.M111.243576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659515	Green Published, hybrid			2022-12-25	WOS:000293268700033
J	Wellenreuther, M; Sanchez-Guillen, RA; Cordero-Rivera, A; Svensson, EI; Hansson, B				Wellenreuther, Maren; Sanchez-Guillen, Rosa A.; Cordero-Rivera, Adolfo; Svensson, Erik I.; Hansson, Bengt			Environmental and Climatic Determinants of Molecular Diversity and Genetic Population Structure in a Coenagrionid Damselfly	PLOS ONE			English	Article							RANGE EXPANSION; EVOLUTIONARY DYNAMICS; GEOGRAPHICAL RANGES; FEMALE POLYMORPHISM; COLOR POLYMORPHISM; PATTERNS; DIFFERENTIATION; DISPERSAL; DISTANCE; ODONATA	Identifying environmental factors that structure intraspecific genetic diversity is of interest for both habitat preservation and biodiversity conservation. Recent advances in statistical and geographical genetics make it possible to investigate how environmental factors affect geographic organisation and population structure of molecular genetic diversity within species. Here we present a study on a common and wide ranging insect, the blue tailed damselfly Ischnura elegans, which has been the target of many ecological and evolutionary studies. We addressed the following questions: (i) Is the population structure affected by longitudinal or latitudinal gradients?; (ii) Do geographic boundaries limit gene flow?; (iii) Does geographic distance affect connectivity and is there a signature of past bottlenecks?; (iv) Is there evidence of a recent range expansion and (vi) what is the effect of geography and climatic factors on population structure? We found low to moderate genetic sub-structuring between populations (mean F-ST = 0.06, D-est = 0.12), and an effect of longitude, but not latitude, on genetic diversity. No significant effects of geographic boundaries (e.g. water bodies) were found. F-ST-and D-est-values increased with geographic distance; however, there was no evidence for recent bottlenecks. Finally, we did not detect any molecular signatures of range expansions or an effect of geographic suitability, although local precipitation had a strong effect on genetic differentiation. The population structure of this small insect has probably been shaped by ecological factors that are correlated with longitudinal gradients, geographic distances, and local precipitation. The relatively weak global population structure and high degree of genetic variation within populations suggest that I. elegans has high dispersal ability, which is consistent with this species being an effective and early coloniser of new habitats.	[Wellenreuther, Maren; Svensson, Erik I.; Hansson, Bengt] Lund Univ, Dept Biol, Lund, Sweden; [Sanchez-Guillen, Rosa A.; Cordero-Rivera, Adolfo] Univ Vigo, Dept Ecoloxia & Bioloxia Anim, Pontevedra, Spain	Lund University; Universidade de Vigo	Wellenreuther, M (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	maren.wellenreuther@biol.lu.se	Hansson, Bengt/L-8874-2013; Svensson, Erik/E-8324-2010; Wellenreuther, Maren/H-2710-2019; Wellenreuther, Maren/A-5555-2009; Wellenreuther, Maren/AAD-8360-2021; Guillén, Rosa Ana Sánchez/Q-5714-2018; Cordero-Rivera, Adolfo/K-4182-2014	Hansson, Bengt/0000-0001-6694-8169; Svensson, Erik/0000-0001-9006-016X; Wellenreuther, Maren/0000-0002-2764-8291; Guillén, Rosa Ana Sánchez/0000-0001-6024-8321; Cordero-Rivera, Adolfo/0000-0002-5087-3550	Wenner-Gren Foundation; The Tryggers Foundation; Swedish Research Council; Spanish Ministry of Science and Innovation [CGL2008-02799, CGL2008-03197-E]	Wenner-Gren Foundation; The Tryggers Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding was provided by a postdoctoral scholarship from the Wenner-Gren Foundation (http://www.wennergren.org/), The Tryggers Foundation (http://www.carltryggersstiftelse.se/) and the Swedish Research Council (http://www.vr.se) to MW, by Spanish Ministry of Science and Innovation (http://www.micinn.es), grant CGL2008-02799 and CGL2008-03197-E (AC-R), and the Swedish Research Council (BH, EIS). RAS-G is supported by a grant (Formacion de Personal Investigador) from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2008, MOL ECOL, V17, P1597, DOI 10.1111/j.1365-294X.2007.03641.x; Askew R. R., 2004, DRAGONFLIES EUROPE; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Brunner PC, 1998, MOL ECOL, V7, P209, DOI 10.1046/j.1365-294x.1998.00341.x; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Conrad KF, 1999, ECOGRAPHY, V22, P524, DOI 10.1111/j.1600-0587.1999.tb00541.x; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; CORDERO A, 1995, ANIM BEHAV, V49, P437, DOI 10.1006/anbe.1995.0057; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Dunkle S.W., 1990, DAMSELFLIES FLORIDA; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Eckstein RL, 2006, MOL ECOL, V15, P2367, DOI 10.1111/j.1365-294X.2006.02944.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI [10.1111/j.1558-5646.1997.tb02384.x, 10.2307/2410956]; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Genner MJ, 2004, ECOGRAPHY, V27, P601, DOI 10.1111/j.0906-7590.2004.03824.x; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GRIBBIN SD, 1990, FRESHWATER BIOL, V24, P295, DOI 10.1111/j.1365-2427.1990.tb00710.x; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hansson B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002794; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P933, DOI 10.1111/j.1365-2486.2007.01318.x; Hellberg ME, 2001, SCIENCE, V292, P1707, DOI 10.1126/science.1060102; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; HINNEKINT BON, 1987, HYDROBIOLOGIA, V146, P3, DOI 10.1007/BF00007574; Hoelzer GA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000126; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Keller D, 2010, BIOL CONSERV, V143, P2658, DOI 10.1016/j.biocon.2010.07.008; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Kittlein MJ, 2008, P ROY SOC B-BIOL SCI, V275, P2633, DOI 10.1098/rspb.2008.0816; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lammi A, 1999, CONSERV BIOL, V13, P1069, DOI 10.1046/j.1523-1739.1999.98278.x; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Mimura M, 2007, HEREDITY, V99, P224, DOI 10.1038/sj.hdy.6800987; Monetti L, 2002, BIOL J LINN SOC, V76, P225, DOI 10.1111/j.1095-8312.2002.tb02084.x; MOPPER S, 1998, GENETIC VARIATION LO; Palmer MA, 1996, TRENDS ECOL EVOL, V11, P322, DOI 10.1016/0169-5347(96)10038-0; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Rivera AC, 2005, ODONATOLOGICA, V34, P1; Rivera AC, 2007, ANIM BEHAV, V74, P247, DOI 10.1016/j.anbehav.2006.06.023; Rousset F, 1997, GENETICS, V145, P1219; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanchez-Guillen RA, 2005, BIOL J LINN SOC, V85, P471, DOI 10.1111/j.1095-8312.2005.00506.x; SANCHEZGUILLEN R, HEREDITY IN PRESS; SANCHEZGUILLEN RA, ADMIXTURE A IN PRESS; SANCHEZGUILLEN RA, BMC EVOLUTI IN PRESS; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Slatkin M, 1994, GENE FLOW POPULATION; Smallshire D., 2004, BRITAINS DRAGONFLIES; Stettmer C, 1996, EUR J ENTOMOL, V93, P579; Svensson EI, 2005, J EVOLUTION BIOL, V18, P1503, DOI 10.1111/j.1420-9101.2005.00946.x; Svensson EI, 2005, AM NAT, V165, P567, DOI 10.1086/429278; Svensson EI, 2009, EVOL ECOL, V23, P93, DOI 10.1007/s10682-007-9208-2; Watts PC, 2005, ECOL ENTOMOL, V30, P541, DOI 10.1111/j.0307-6946.2005.00721.x; Watts PC, 2004, MOL ECOL, V13, P2931, DOI 10.1111/j.1365-294X.2004.02300.x; Watts PC, 2010, BIOL INVASIONS, V12, P3887, DOI 10.1007/s10530-010-9779-7; WELLENREUTHER M, 2010, MOL ECOLOGY RESOURCE; Wellenreuther M, 2010, EVOLUTION, V64, P242, DOI 10.1111/j.1558-5646.2009.00815.x; Wright S, 1943, GENETICS, V28, P114	79	42	44	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20440	10.1371/journal.pone.0020440	http://dx.doi.org/10.1371/journal.pone.0020440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21655216	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500026
J	Dutt, A; Ramos, AH; Hammerman, PS; Mermel, C; Cho, J; Sharifnia, T; Chande, A; Tanaka, KE; Stransky, N; Greulich, H; Gray, NS; Meyerson, M				Dutt, Amit; Ramos, Alex H.; Hammerman, Peter S.; Mermel, Craig; Cho, Jeonghee; Sharifnia, Tanaz; Chande, Ajit; Tanaka, Kumiko Elisa; Stransky, Nicolas; Greulich, Heidi; Gray, Nathanael S.; Meyerson, Matthew			Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ACTIVATING MUTATIONS; THERAPEUTIC TARGET; MULTIPLE-MYELOMA; OVARIAN-CANCER; RECEPTOR; RESISTANCE; GEFITINIB; GENE; TRASTUZUMAB; CARCINOMAS	Background: Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma. Methodology/Principal Findings: Using SNP array analysis, we found that a region of chromosome segment 8p11-12 containing three genes-WHSC1L1, LETM2, and FGFR1-is amplified in 3% of lung adenocarcinomas and 21% of squamous cell lung carcinomas. Furthermore, we demonstrated that a non-small cell lung carcinoma cell line harboring focal amplification of FGFR1 is dependent on FGFR1 activity for cell growth, as treatment of this cell line either with FGFR1-specific shRNAs or with FGFR small molecule enzymatic inhibitors leads to cell growth inhibition. Conclusions/Significance: These studies show that FGFR1 amplification is common in squamous cell lung cancer, and that FGFR1 may represent a promising therapeutic target in non-small cell lung cancer.	[Dutt, Amit; Ramos, Alex H.; Hammerman, Peter S.; Mermel, Craig; Cho, Jeonghee; Sharifnia, Tanaz; Tanaka, Kumiko Elisa; Greulich, Heidi; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Dutt, Amit; Ramos, Alex H.; Mermel, Craig; Sharifnia, Tanaz; Tanaka, Kumiko Elisa; Stransky, Nicolas; Greulich, Heidi; Meyerson, Matthew] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Greulich, Heidi] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Greulich, Heidi] Harvard Univ, Sch Med, Boston, MA USA; [Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Ramos, Alex H.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Dutt, Amit] Tata Mem Hosp, Adv Ctr Treatment Res & Educ, Kharghar, Navi Mumbai, India	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Tata Memorial Centre (TMC); Tata Memorial Hospital	Dutt, A (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	adutt@actrec.gov.in; matthew_meyerson@dfci.harvard.edu	Dutt, Amit/I-1911-2013; Chande, Ajit/K-5031-2014; Meyerson, Matthew L/E-7123-2012; Mermel, Craig/AAZ-7322-2020	Dutt, Amit/0000-0002-1119-4774; Chande, Ajit/0000-0003-2210-5180; Mermel, Craig/0000-0002-0816-3395; Meyerson, Matthew/0000-0002-9133-8108	Novartis Pharmaceuticals; American Lung Association; Uniting Against Lung Cancer; Sarah Thomas Monopoli Fund; Seaman Foundation; Genentech; Department of Biotechnology, Ministry of Science, Government of India; National Lung Cancer Partnership; Novartis; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); American Lung Association; Uniting Against Lung Cancer; Sarah Thomas Monopoli Fund; Seaman Foundation; Genentech(Roche HoldingGenentech); Department of Biotechnology, Ministry of Science, Government of India; National Lung Cancer Partnership; Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding sources for this work include support from Novartis Pharmaceuticals, the American Lung Association, Uniting Against Lung Cancer, the Sarah Thomas Monopoli Fund, the Seaman Foundation and Genentech to M. M. A. D. is supported by a Ramalingaswami fellowship from the Department of Biotechnology, Ministry of Science, Government of India. P. S. H. is supported by a Young Investigator Award from the National Lung Cancer Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. M. is a consultant to Novartis and receives research support from Novartis, receives research support from Genentech, and is a founding advisor and consultant, and an equity holder in Foundation Medicine. N.G. laboratory receives sponsored research from Novartis. However, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Chen J, 2005, ONCOGENE, V24, P8259, DOI 10.1038/sj.onc.1208989; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Freier K, 2007, ORAL ONCOL, V43, P60, DOI 10.1016/j.oraloncology.2006.01.005; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Ishizuka T, 2002, BIOCHEM BIOPH RES CO, V296, P152, DOI 10.1016/S0006-291X(02)00836-7; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Kataoka Y, 2010, ANN ONCOL, V21, P255, DOI 10.1093/annonc/mdp304; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kim SM, 2006, BIOCHEM BIOPH RES CO, V345, P318, DOI 10.1016/j.bbrc.2006.04.095; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Machida S, 2005, INT J CANCER, V114, P224, DOI 10.1002/ijc.20751; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; McDermott U, 2009, CANCER RES, V69, P3937, DOI 10.1158/0008-5472.CAN-08-4327; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Missiaglia E, 2009, GENE CHROMOSOME CANC, V48, P455, DOI 10.1002/gcc.20655; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Neal JW, 2010, CURR TREAT OPTION ON, V11, P36, DOI 10.1007/s11864-010-0120-6; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Phelps RM, 1996, J CELL BIOCHEM, P32; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Richelda R, 1997, BLOOD, V90, P4062, DOI 10.1182/blood.V90.10.4062; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Sarker D, 2008, CLIN CANCER RES, V14, P2075, DOI 10.1158/1078-0432.CCR-07-1466; Selvaggi G, 2009, ONCOLOGY-NY, V23, P1133; Simon R, 2001, CANCER RES, V61, P4514; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; van Rhijn BWG, 2001, CANCER RES, V61, P1265; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2011, SCI TRANSL MED, V3; Wistuba II, 2007, CURR MOL MED, V7, P3, DOI 10.2174/156652407779940468; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; ZHENG J, 1994, AM J PATHOL, V145, P1444; Zhou WJ, 2010, CHEM BIOL, V17, P285, DOI 10.1016/j.chembiol.2010.02.007	61	295	323	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20351	10.1371/journal.pone.0020351	http://dx.doi.org/10.1371/journal.pone.0020351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666749	Green Published, gold			2022-12-25	WOS:000291607000005
J	Dai, L; Chen, DF; Liu, YL; Zhao, Y; Yang, F; Yang, JS; Yang, WJ				Dai, Li; Chen, Dian-Fu; Liu, Yu-Lei; Zhao, Yang; Yang, Fan; Yang, Jin-Shu; Yang, Wei-Jun			Extracellular Matrix Peptides of Artemia Cyst Shell Participate in Protecting Encysted Embryos from Extreme Environments	PLOS ONE			English	Article							SHOCK/ALPHA-CRYSTALLIN PROTEIN; BRINE SHRIMP; TERTIARY ENVELOPE; BIOMINERALIZATION; ANOSTRACA; FRANCISCANA; MEMBRANES; DIAPAUSE; STRAINS; PCR	Background: Many species of the brine shrimp Artemia are found in various severe environments in many parts of the world where extreme salinity, high UV radiation levels, high pH, anoxia, large temperature fluctuations, and intermittent dry conditions are often recorded. To withstand adverse environments, Artemia undergoes an oviparous developmental pathway to release cysts whereas, under favorable conditions, swimming nauplius larvae are formed directly via an ovoviviparous pathway. In the former case these cysts have an extraordinary ability to keep the embryos protected from the harsh environment for long periods. This is achieved through the protection by a complex out-wrapping cyst shell. However, the formation and function of the cyst shell is complex; the details remain largely unclear. Principal Finding: A shell gland-specific gene (SGEG2) was cloned and identified from a suppression subtractive hybridization library. Western blot analysis showed that SGEG2 presumably requires post-translational proteolysis in order to be processed into two mature peptides (SGEG2a and 2b). The three matrix peptides (SGEG1 reported previously, 2a, and 2b) were found to distribute throughout the cyst shell. The results of gene knockdown by RNAi and subsequent resistance to environmental stresses assays indicated that these matrix peptides are required for cyst shell formation and are involved in protecting the encysted embryos from environmental stress. Conclusions/Significance: This study revealed that extracellular matrix peptides participate in protecting embryos from extreme salinity, UV radiation, large temperature fluctuations and dry environments, thereby facilitating their survival. The cyst shell provides an excellent opportunity to link the ecological setting of an organism to the underlying physiological and biochemical processes enabling its survival. The cyst shell material has also a high potential to become an excellent new biomaterial with a high number of prospective uses due, specifically, to such biological characteristics.	[Dai, Li; Chen, Dian-Fu; Liu, Yu-Lei; Zhao, Yang; Yang, Fan; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Wei-Jun] Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Dai, L (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn		Yang, Wei-Jun/0000-0002-4591-8830; Yang, Jin-Shu/0000-0001-6680-7737	National Natural Sciences Foundation of China [40730212]; National Basic Research Program of China (973 Program) [2010CB833803]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Funding: This work was supported by the National Natural Sciences Foundation of China (40730212) and National Basic Research Program of China (973 Program, 2010CB833803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON E, 1970, J ULTRA MOL STRUCT R, V32, P497, DOI 10.1016/S0022-5320(70)80025-9; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Clegg J.S., 1986, P169; Clegg James S., 2002, P129; Clegg JS, 1999, AM ZOOL, V39, P836; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; CROWE JH, 1998, ISOPOW, V6, P440; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Day RM, 2003, CELL STRESS CHAPERON, V8, P183, DOI 10.1379/1466-1268(2003)008<0183:ASHCPF>2.0.CO;2; Drinkwater L.E., 1991, P93; Gaubin Y, 1996, ADV SPACE RES, V18, P221, DOI 10.1016/0273-1177(96)00043-9; HOFMANN GE, 1990, J EXP ZOOL, V253, P287, DOI 10.1002/jez.1402530308; Kawasaki K, 2009, ANNU REV GENET, V43, P119, DOI 10.1146/annurev-genet-102108-134242; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Lakshminarayanan R, 2002, P NATL ACAD SCI USA, V99, P5155, DOI 10.1073/pnas.072658899; LAVENS P, 1986, MAR ECOL-PROG SER, V31, P179; LEE KW, 1994, PROC ANN MEET MSA, P362; Lenz P.H., 1991, P237; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MORRIS JE, 1967, J ULTRA MOL STRUCT R, V20, P244, DOI 10.1016/S0022-5320(67)90285-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; STAPPEN GV, 2002, ARTEMIA BASIC APPL B, P171; Sugumar V, 2006, MICROSC RES TECHNIQ, V69, P957, DOI 10.1002/jemt.20371; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tajik H, 2008, MOLECULES, V13, P1263, DOI 10.3390/molecules13061263; Tanguay JA, 2004, J BIOSCIENCES, V29, P489, DOI 10.1007/BF02712121; Triantaphyllidis GV, 1998, J BIOGEOGR, V25, P213, DOI 10.1046/j.1365-2699.1998.252190.x; Wang SF, 2007, MICROSC RES TECHNIQ, V70, P663, DOI 10.1002/jemt.20451; Warner AH, 2004, ARCH BIOCHEM BIOPHYS, V424, P189, DOI 10.1016/j.abb.2004.02.022; WILLIAMS WD, 1981, HYDROBIOLOGIA, V81-2, P1, DOI 10.1007/BF00048701; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	33	28	29	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20187	10.1371/journal.pone.0020187	http://dx.doi.org/10.1371/journal.pone.0020187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673998	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400002
J	Dao, TMA; Waget, A; Klopp, P; Serino, M; Vachoux, C; Pechere, L; Drucker, DJ; Champion, S; Barthelemy, S; Barra, Y; Burcelin, R; Seree, E				Dao, Thi-Mai Anh; Waget, Aurelie; Klopp, Pascale; Serino, Matteo; Vachoux, Christelle; Pechere, Laurent; Drucker, Daniel J.; Champion, Serge; Barthelemy, Sylvain; Barra, Yves; Burcelin, Remy; Seree, Eric			Resveratrol Increases Glucose Induced GLP-1 Secretion in Mice: A Mechanism which Contributes to the Glycemic Control	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; MITOCHONDRIAL-FUNCTION; INSULIN-SECRETION; SIRT1; OBESITY; INFLAMMATION; EXPRESSION; ACTIVATOR; DISEASE	Resveratrol (RSV) is a potent anti-diabetic agent when used at high doses. However, the direct targets primarily responsible for the beneficial actions of RSV remain unclear. We used a formulation that increases oral bioavailability to assess the mechanisms involved in the glucoregulatory action of RSV in high-fat diet (HFD)-fed diabetic wild type mice. Administration of RSV for 5 weeks reduced the development of glucose intolerance, and increased portal vein concentrations of both Glucagon-like peptid-1 (GLP-1) and insulin, and intestinal content of active GLP-1. This was associated with increased levels of colonic proglucagon mRNA transcripts. RSV-mediated glucoregulation required a functional GLP-1 receptor (Glp1r) as neither glucose nor insulin levels were modulated in Glp1r-/- mice. Conversely, levels of active GLP-1 and control of glycemia were further improved when the Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin was co-administered with RSV. In addition, RSV treatment modified gut microbiota and decreased the inflammatory status of mice. Our data suggest that RSV exerts its actions in part through modulation of the enteroendocrine axis in vivo.	[Dao, Thi-Mai Anh; Waget, Aurelie; Klopp, Pascale; Serino, Matteo; Vachoux, Christelle; Burcelin, Remy] Fac Med Toulouse, INSERM, U1048, Inst Rech Malad Metab & Cardiovasc,I2MC, F-31073 Toulouse, France; [Dao, Thi-Mai Anh; Waget, Aurelie; Klopp, Pascale; Serino, Matteo; Vachoux, Christelle; Burcelin, Remy] Univ Toulouse, UPS, Inst Malad Metab & Cardiovasc, Hop Rangueil, Toulouse, France; [Dao, Thi-Mai Anh; Champion, Serge; Barra, Yves; Seree, Eric] Inst Natl Rech Agron 1260, Fac Pharm, Marseille, France; [Pechere, Laurent] ENTERONOVA SAS, Toulouse, France; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Barthelemy, Sylvain] YVERY SARL, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Dao, TMA (corresponding author), Fac Med Toulouse, INSERM, U1048, Inst Rech Malad Metab & Cardiovasc,I2MC, U317, F-31073 Toulouse, France.	remy.burcelin@inserm.fr; eric.Seree@univmed.fr	burcelin, remy/M-6013-2014; Serino, Matteo/O-3310-2018; Drucker, Daniel J/A-4092-2010	Serino, Matteo/0000-0003-4644-8532; Klopp, Pascale/0000-0002-3515-6115	Agence Nationale de la Recherche [GLP-1]; Merck Sharp and Dohm	Agence Nationale de la Recherche(French National Research Agency (ANR)); Merck Sharp and Dohm	Funding: Remy Burcelin is the recipient of subsidies from the Agence Nationale de la Recherche (Program Brain GLP-1). This manuscript was partly funded by a grant (IISP program) from Merck Sharp and Dohm to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2008, EXPERT OPIN EMERG DR, V13, P593, DOI 10.1517/14728210802584126 ; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Argmann C, 2006, CELL, V126, P837, DOI 10.1016/j.cell.2006.08.031; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; BRUBAKER PL, 1991, ENDOCRINOLOGY, V128, P3175, DOI 10.1210/endo-128-6-3175; Burcelin R, 2005, BRIT J NUTR, V93, pS147, DOI 10.1079/BJN20041340; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, MOL CELL ENDOCRINOL, V276, P18, DOI 10.1016/j.mce.2007.06.003; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Casper RF, 1999, MOL PHARMACOL, V56, P784; Chan MMY, 2002, BIOCHEM PHARMACOL, V63, P99, DOI 10.1016/S0006-2952(01)00886-3; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Drucker DJ, 2002, GASTROENTEROLOGY, V122, P531, DOI 10.1053/gast.2002.31068; Gao XH, 2001, BIOCHEM PHARMACOL, V62, P1299, DOI 10.1016/S0006-2952(01)00775-4; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gribble FM, 2003, DIABETES, V52, P1147, DOI 10.2337/diabetes.52.5.1147; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Khalil A, 2010, TOXICOL LETT, V196, P161, DOI 10.1016/j.toxlet.2010.04.010; Knauf C, 2008, ENDOCRINOLOGY, V149, P4768, DOI 10.1210/en.2008-0180; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LANGCAKE P, 1977, EXPERIENTIA, V33, P151, DOI 10.1007/BF02124034; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nauck M, 1996, DIABETIC MED, V13, pS39; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vitrac X, 2003, LIFE SCI, V72, P2219, DOI 10.1016/S0024-3205(03)00096-1; Wang WB, 2006, J MED MICROBIOL, V55, P1313, DOI 10.1099/jmm.0.46661-0; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yasuda N, 2002, BIOCHEM BIOPH RES CO, V298, P779, DOI 10.1016/S0006-291X(02)02565-2	44	114	119	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20700	10.1371/journal.pone.0020700	http://dx.doi.org/10.1371/journal.pone.0020700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673955	Green Published, gold			2022-12-25	WOS:000291356400019
J	Lekprasert, P; Mayhew, M; Ohler, U				Lekprasert, Parawee; Mayhew, Michael; Ohler, Uwe			Assessing the Utility of Thermodynamic Features for microRNA Target Prediction under Relaxed Seed and No Conservation Requirements	PLOS ONE			English	Article							BASE-PAIRING PROBABILITIES; SITE ACCESSIBILITY; POSTTRANSCRIPTIONAL REGULATION; PROTEIN; DETERMINANTS; IMPACT; LIN-14	Background: Many computational microRNA target prediction tools are focused on several key features, including complementarity to 5'seed of miRNAs and evolutionary conservation. While these features allow for successful target identification, not all miRNA target sites are conserved and adhere to canonical seed complementarity. Several studies have propagated the use of energy features of mRNA: miRNA duplexes as an alternative feature. However, different independent evaluations reported conflicting results on the reliability of energy-based predictions. Here, we reassess the usefulness of energy features for mammalian target prediction, aiming to relax or eliminate the need for perfect seed matches and conservation requirement. Methodology/Principal Findings: We detect significant differences of energy features at experimentally supported human miRNA target sites and at genome-wide sites of AGO protein interaction. This trend is confirmed on datasets that assay the effect of miRNAs on mRNA and protein expression changes, and a simple linear regression model leads to significant correlation of predicted versus observed expression change. Compared to 6-mer seed matches as baseline, application of our energy-based model leads to similar to 3-5-fold enrichment on highly down-regulated targets, and allows for prediction of strictly imperfect targets with enrichment above baseline. Conclusions/Significance: In conclusion, our results indicate significant promise for energy-based miRNA target prediction that includes a broader range of targets without having to use conservation or impose stringent seed match rules.	[Lekprasert, Parawee; Ohler, Uwe] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Lekprasert, Parawee; Mayhew, Michael] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC USA; [Ohler, Uwe] Duke Univ, Dept Biostat, Durham, NC USA; [Ohler, Uwe] Duke Univ, Dept Bioinformat, Durham, NC USA; [Ohler, Uwe] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Lekprasert, P (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.	uwe.ohler@duke.edu			National Science Foundation [MCB-0822033]; Thai government	National Science Foundation(National Science Foundation (NSF)); Thai government	Funding: This work was supported by the National Science Foundation (MCB-0822033 to U.O.). P. L. is the recipient of a Thai government scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Bernhart SH, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-3; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bompfunewerer AF, 2008, J MATH BIOL, V56, P129, DOI 10.1007/s00285-007-0107-5; Chen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005681; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Ghosh Z, 2009, NUCLEIC ACIDS RES, V37, P1035, DOI 10.1093/nar/gkn1004; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo H., 2010, NATURE, V466, P835; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hofacker I.L., 1994, MONATSH CHEM, V125, P22; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Neplioueva V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011710; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RHEAD B, 2009, NUCL ACIDS RES; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Skalsky RL, 2007, J VIROL, V81, P12836, DOI 10.1128/JVI.01804-07; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	44	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20622	10.1371/journal.pone.0020622	http://dx.doi.org/10.1371/journal.pone.0020622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674004	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400011
J	Perez-Martinez, P; Delgado-Lista, J; Garcia-Rios, A; Mc Monagle, J; Gulseth, HL; Ordovas, JM; Shaw, DI; Karlstrom, B; Kiec-Wilk, B; Blaak, EE; Helal, O; Malczewska-Malec, M; Defoort, C; Riserus, U; Saris, WHM; Lovegrove, JA; Drevon, CA; Roche, HM; Lopez-Miranda, J				Perez-Martinez, Pablo; Delgado-Lista, Javier; Garcia-Rios, Antonio; Mc Monagle, Jolene; Gulseth, Hanne L.; Ordovas, Jose M.; Shaw, Danielle I.; Karlstrom, Brita; Kiec-Wilk, Beata; Blaak, Ellen E.; Helal, Olfa; Malczewska-Malec, Malgorzata; Defoort, Catherine; Riserus, Ulf; Saris, Wim H. M.; Lovegrove, Julie A.; Drevon, Christian A.; Roche, Helen M.; Lopez-Miranda, Jose			Glucokinase Regulatory Protein Genetic Variant Interacts with Omega-3 PUFA to Influence Insulin Resistance and Inflammation in Metabolic Syndrome	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FASTING PLASMA-GLUCOSE; FATTY-ACID-COMPOSITION; CARDIOVASCULAR-DISEASE; TRIGLYCERIDE LEVELS; RISK; LOCI; OMEGA-3-FATTY-ACIDS; POLYMORPHISMS; ASSOCIATION	Glucokinase Regulatory Protein (GCKR) plays a central role regulating both hepatic triglyceride and glucose metabolism. Fatty acids are key metabolic regulators, which interact with genetic factors and influence glucose metabolism and other metabolic traits. Omega-3 polyunsaturated fatty acids (n-3 PUFA) have been of considerable interest, due to their potential to reduce metabolic syndrome (MetS) risk. Objective: To examine whether genetic variability at the GCKR gene locus was associated with the degree of insulin resistance, plasma concentrations of C-reactive protein (CRP) and n-3 PUFA in MetS subjects. Design: Homeostasis model assessment of insulin resistance (HOMA-IR), HOMA-B, plasma concentrations of C-peptide, CRP, fatty acid composition and the GCKR rs1260326-P446L polymorphism, were determined in a cross-sectional analysis of 379 subjects with MetS participating in the LIPGENE dietary cohort. Results: Among subjects with n-3 PUFA levels below the population median, carriers of the common C/C genotype had higher plasma concentrations of fasting insulin (P = 0.019), C-peptide (P = 0.004), HOMA-IR (P = 0.008) and CRP (P = 0.032) as compared with subjects carrying the minor T-allele (Leu446). In contrast, homozygous C/C carriers with n-3 PUFA levels above the median showed lower plasma concentrations of fasting insulin, peptide C, HOMA-IR and CRP, as compared with individuals with the T-allele. Conclusions: We have demonstrated a significant interaction between the GCKR rs1260326-P446L polymorphism and plasma n-3 PUFA levels modulating insulin resistance and inflammatory markers in MetS subjects. Further studies are needed to confirm this gene-diet interaction in the general population and whether targeted dietary recommendations can prevent MetS in genetically susceptible individuals.	[Perez-Martinez, Pablo; Delgado-Lista, Javier; Garcia-Rios, Antonio; Lopez-Miranda, Jose] Univ Cordoba, Reina Sofia Univ Hosp, IMIBIC, Lipid & Atherosclerosis Unit, Cordoba, Spain; [Perez-Martinez, Pablo; Delgado-Lista, Javier; Garcia-Rios, Antonio; Lopez-Miranda, Jose] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Cordoba, Spain; [Mc Monagle, Jolene; Roche, Helen M.] Univ Coll Dublin, Nutrigen Res Grp, UCD Sch Publ Hlth & Populat Sci, UCD Conway Inst, Dublin 2, Ireland; [Gulseth, Hanne L.] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ordovas, Jose M.] CNIC, Dept Epidemiol & Populat Genet, Madrid, Spain; [Shaw, Danielle I.; Lovegrove, Julie A.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Shaw, Danielle I.; Lovegrove, Julie A.] Univ Reading, ICMR, Reading, Berks, England; [Karlstrom, Brita; Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Kiec-Wilk, Beata; Malczewska-Malec, Malgorzata] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Kiec-Wilk, Beata; Malczewska-Malec, Malgorzata] Jagiellonian Univ, Coll Med, Dept Metab Dis, Krakow, Poland; [Blaak, Ellen E.; Saris, Wim H. M.] NUTRIM, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Helal, Olfa; Defoort, Catherine] Univ Mediterranee, INRA, INSERM 476, Marseille, France; [Drevon, Christian A.] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway	Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University College Dublin; University of Oslo; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Reading; University of Reading; Uppsala University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Maastricht University; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Oslo	Perez-Martinez, P (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, IMIBIC, Lipid & Atherosclerosis Unit, Cordoba, Spain.	jlopezmir@uco.es	Roche, Helen M/AAF-4164-2019; Lopez-Miranda, Jose/Y-8306-2019; Shaw, Danielle/HGA-4994-2022; Ordovas, Jose/B-8727-2013; Blaak, Ellen/E-3459-2015	Roche, Helen M/0000-0002-0628-3318; Lopez-Miranda, Jose/0000-0002-8844-0718; Perez Martinez, Pablo/0000-0001-7716-8117; Ordovas, Jose/0000-0002-7581-5680; Delgado Lista, Francisco Javier/0000-0002-2982-2716; Blaak, Ellen/0000-0002-2496-3464	European community [505944]; Spanish Ministry of Science and Innovation [AGL2006-01979/ALI, AGL2009-12270, PI10/01041]; Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia [P06-CTS-01425]; Consejeria de Salud, Junta de Andalucia [07/43, PI 0193/09, PI-0252/2009, PI-0058-2010]; Centro de Excelencia Investigadora en Aceite de Oliva y Salud (CEAS); Aktieselskabet Freia Chocolade Fabrik's Medical Foundation; Throne-Holst Foundation for Nutrition Research; Science Foundation Ireland Principal Investigator Programme [06/IM.1/B105]; ISCIII (Programa Rio-Hortega); NIH [HL54776, DK075030]; U.S. Department of Agriculture Research Service [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075030] Funding Source: NIH RePORTER	European community(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia(Junta de Andalucia); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Centro de Excelencia Investigadora en Aceite de Oliva y Salud (CEAS); Aktieselskabet Freia Chocolade Fabrik's Medical Foundation; Throne-Holst Foundation for Nutrition Research; Science Foundation Ireland Principal Investigator Programme(Science Foundation Ireland); ISCIII (Programa Rio-Hortega)(Instituto de Salud Carlos III); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture Research Service(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported in part by research grants from the European community (LIPGENE European Integrated Project-505944), grants from the Spanish Ministry of Science and Innovation (AGL2006-01979/ALI, AGL2009-12270 to JL-M and PI10/01041 to PP-M), Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia (P06-CTS-01425 to JL-M); Consejeria de Salud, Junta de Andalucia (07/43, PI 0193/09 to JL-M, PI-0252/2009 to JD-L and PI-0058-2010 to PP-M). This study was also supported by Centro de Excelencia Investigadora en Aceite de Oliva y Salud (CEAS), Aktieselskabet Freia Chocolade Fabrik's Medical Foundation, and Throne-Holst Foundation for Nutrition Research. HRM is a recipient by Science Foundation Ireland Principal Investigator Programme (06/IM.1/B105). AG-R is supported by a research contract of ISCIII (Programa Rio-Hortega). JMO is supported by NIH grants HL54776 and DK075030 and by the U.S. Department of Agriculture Research Service (contracts 53-K06-5-10 and 58-1950-9-001).	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ferguson JF, 2010, ATHEROSCLEROSIS, V211, P539, DOI 10.1016/j.atherosclerosis.2010.03.027; Ferguson JF, 2010, AM J CLIN NUTR, V91, P794, DOI 10.3945/ajcn.2009.28255; Jenkins DJA, 2008, J AM COLL NUTR, V27, P367, DOI 10.1080/07315724.2008.10719713; JUMP DB, 1994, J LIPID RES, V35, P1076; Kaushik M, 2009, AM J CLIN NUTR, V90, P613, DOI 10.3945/ajcn.2008.27424; Laaksonen DE, 2002, DIABETIC MED, V19, P456, DOI 10.1046/j.1464-5491.2002.00707.x; Lopez-Miranda J, 2007, J MOL MED, V85, P209, DOI 10.1007/s00109-006-0138-1; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Noel SE, 2010, J NUTR, V140, P1846, DOI 10.3945/jn.110.124297; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Perez-Martinez P, 2008, J NUTR, V138, P1609, DOI 10.1093/jn/138.9.1609; Perez-Martinez P, 2010, ATHEROSCLEROSIS, V209, P533, DOI 10.1016/j.atherosclerosis.2009.09.023; Perez-Martinez P, 2009, AM J CLIN NUTR, V89, P391, DOI 10.3945/ajcn.2008.26363; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Reaven G, 2002, CIRCULATION, V106, P286, DOI 10.1161/01.CIR.0000019884.36724.D9; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Roth U, 2002, BIOCHEM J, V365, P223, DOI 10.1042/BJ20020340; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shaw DI, 2009, BRIT J NUTR, V101, P750, DOI 10.1017/S0007114508039962; Tierney AC, 2010, INT J OBES LOND; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Wang L, 2003, AM J CLIN NUTR, V78, P91	33	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20555	10.1371/journal.pone.0020555	http://dx.doi.org/10.1371/journal.pone.0020555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674002	Green Published, gold			2022-12-25	WOS:000291356400007
J	Simon, A; Britton, R; Gozlan, R; Oosterhout, C; Volckaert, FAM; Hanfling, B				Simon, Andrea; Britton, Robert; Gozlan, Rodolphe; van Oosterhout, Cock; Volckaert, Filip A. M.; Haenfling, Bernd			Invasive Cyprinid Fish in Europe Originate from the Single Introduction of an Admixed Source Population Followed by a Complex Pattern of Spread	PLOS ONE			English	Article							PSEUDORASBORA-PARVA; GENETIC DIVERSITY; EVOLUTIONARY GENETICS; DNA; PHYLOGEOGRAPHY; HISTORY; FRESH; HYBRIDIZATION; SUBSTITUTIONS; DISTANCE	The Asian cyprinid fish, the topmouth gudgeon (Pseudorasbora parva), was introduced into Europe in the 1960s. A highly invasive freshwater fish, it is currently found in at least 32 countries outside its native range. Here we analyse a 700 base pair fragment of the mitochondrial cytochrome b gene to examine different models of colonisation and spread within the invasive range, and to investigate the factors that may have contributed to their invasion success. Haplotype and nucleotide diversity of the introduced populations from continental Europe was higher than that of the native populations, although two recently introduced populations from the British Isles showed low levels of variability. Based on coalescent theory, all introduced and some native populations showed a relative excess of nucleotide diversity compared to haplotype diversity. This suggests that these populations are not in mutation-drift equilibrium, but rather that the relative inflated level of nucleotide diversity is consistent with recent admixture. This study elucidates the colonisation patterns of P. parva in Europe and provides an evolutionary framework of their invasion. It supports the hypothesis that their European colonisation was initiated by their introduction to a single location or small geographic area with subsequent complex pattern of spread including both long distance and stepping-stone dispersal. Furthermore, it was preceded by, or associated with, the admixture of genetically diverse source populations that may have augmented its invasive-potential.	[Simon, Andrea; Haenfling, Bernd] Univ Hull, Dept Biol Sci, Evolutionary Biol Grp, Kingston Upon Hull HU6 7RX, N Humberside, England; [Britton, Robert; Gozlan, Rodolphe] Bournemouth Univ, Sch Conservat Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Volckaert, Filip A. M.] Katholieke Univ Leuven, Cent Lab Anim Divers & Systemat, Leuven, Belgium; [van Oosterhout, Cock] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	University of Hull; Bournemouth University; KU Leuven; University of East Anglia	Simon, A (corresponding author), Univ Hull, Dept Biol Sci, Evolutionary Biol Grp, Kingston Upon Hull HU6 7RX, N Humberside, England.	a.simon@2007.hull.ac.uk	Volckaert, Filip/AAC-7691-2019; Britton, Robert/AAO-6673-2020; Britton, Robert/B-5040-2009	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086; van Oosterhout, Cock/0000-0002-5653-738X; Hanfling, Bernd/0000-0001-7630-9360	Natural Environment Research Council [NE/007094/1]; Ministry of the Flemish Community [VLINA/AMINAL/NATUUR/00/11]; Fisheries Society of the British Isles	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Ministry of the Flemish Community; Fisheries Society of the British Isles	The work was funded by The Natural Environment Research Council (project NE/007094/1), Ministry of the Flemish Community (project VLINA/AMINAL/NATUUR/00/11), and Fisheries Society of the British Isles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BANARESCU P., 1965, REV ROUMAINE BIOL SER ZOOL, V10, P219; Banarescu P.M., 1999, FRESHWATER FISHES EU; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barson NJ, 2009, J EVOLUTION BIOL, V22, P485, DOI 10.1111/j.1420-9101.2008.01675.x; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Benejam Lluis, 2005, Limnetica, V24, P273; BERG LS, 1949, RYBY PRESNYCH VOD SS, P477; Briolay J, 1998, MOL PHYLOGENET EVOL, V9, P100, DOI 10.1006/mpev.1997.0441; Britton JR, 2007, AQUAT CONSERV, V17, P749, DOI 10.1002/aqc.809; Britton JR, 2010, BIOL INVASIONS, V12, P1533, DOI 10.1007/s10530-009-9566-5; Broughton RE, 2000, SYST BIOL, V49, P617, DOI 10.1080/106351500750049734; Brown JE, 2008, MOL ECOL, V17, P2598, DOI 10.1111/j.1365-294X.2008.03777.x; Cesco H, 2001, PARASITE, V8, P75, DOI 10.1051/parasite/2001081075; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Durand JD, 2002, MOL PHYLOGENET EVOL, V25, P218, DOI 10.1016/S1055-7903(02)00343-3; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ficetola GF, 2008, MOL ECOL, V17, P773, DOI 10.1111/j.1365-294X.2007.03622.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Geller JB, 2010, ANNU REV MAR SCI, V2, P367, DOI 10.1146/annurev.marine.010908.163745; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Gozlan RE, 2006, FOLIA ZOOL, V55, P53; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Gozlan RE, 2002, J FISH BIOL, V61, P298, DOI 10.1006/jfbi.2002.2042; Gozlan RE, 2010, FISH FISH, V11, P315, DOI 10.1111/j.1467-2979.2010.00361.x; Gozlan RE, 2009, INT J PARASITOL, V39, P1055, DOI 10.1016/j.ijpara.2009.04.012; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hanfling B, 2007, J FISH BIOL, V71, P115, DOI 10.1111/j.1095-8649.2007.01685.x; Hanfling B, 2006, GENETICS, V173, P1487, DOI 10.1534/genetics.105.054296; Hanfling B, 1998, HEREDITY, V80, P110; Hanfling Bernd, 2002, Trends in Ecology and Evolution, V17, P545, DOI 10.1016/S0169-5347(02)02644-7; Haynes GD, 2009, J FISH BIOL, V75, P295, DOI 10.1111/j.1095-8649.2009.02276.x; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Hua X, 2009, J FISH BIOL, V75, P354, DOI 10.1111/j.1095-8649.2009.02323.x; Hudson RR, 1990, OXFORD SURVEYS EVOLU, V1, P1; Jamandre BW, 2009, J FISH BIOL, V75, P393, DOI 10.1111/j.1095-8649.2009.02332.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Le Roux J, 2009, ANN APPL BIOL, V154, P1, DOI 10.1111/j.1744-7348.2008.00280.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lin CJ, 2010, ZOOL SCR, V39, P23, DOI 10.1111/j.1463-6409.2009.00407.x; Liu HZ, 2010, CHINESE SCI BULL, V55, P1501, DOI 10.1007/s11434-010-3159-7; Liu JY, 2009, BIOCHEM SYST ECOL, V37, P556, DOI 10.1016/j.bse.2009.09.002; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; NEI M, 1989, MOL BIOL EVOL, V6, P290; Poulin J, 2005, DIVERS DISTRIB, V11, P241, DOI 10.1111/j.1366-9516.2005.00136.x; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosecchi E, 2001, FRESHWATER BIOL, V46, P845, DOI 10.1046/j.1365-2427.2001.00715.x; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saillant E, 2005, COPEIA, P20, DOI 10.1643/CG-04-200R1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang KL, 2010, MOL PHYLOGENET EVOL, V57, P189, DOI 10.1016/j.ympev.2010.05.021; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Vidal O, 2010, BIOL INVASIONS, V12, P841, DOI 10.1007/s10530-009-9505-5; Watanabe K, 2000, ICHTHYOL RES, V47, P43, DOI 10.1007/BF02674312; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; Wright S, 1943, GENETICS, V28, P114; Yang L, 2008, MOL PHYLOGENET EVOL, V49, P393, DOI 10.1016/j.ympev.2008.05.032; Zidana H, 2009, MOL ECOL, V18, P4380, DOI 10.1111/j.1365-294X.2009.04362.x	71	45	49	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e18560	10.1371/journal.pone.0018560	http://dx.doi.org/10.1371/journal.pone.0018560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674031	Green Accepted, Green Published, gold			2022-12-25	WOS:000291355500002
J	Pacheco, SE; Houseman, EA; Christensen, BC; Marsit, CJ; Kelsey, KT; Sigman, M; Boekelheide, K				Pacheco, Sara E.; Houseman, E. Andres; Christensen, Brock C.; Marsit, Carmen J.; Kelsey, Karl T.; Sigman, Mark; Boekelheide, Kim			Integrative DNA Methylation and Gene Expression Analyses Identify DNA Packaging and Epigenetic Regulatory Genes Associated with Low Motility Sperm	PLOS ONE			English	Article							MALE GERM-CELLS; SPERMATOZOAL RNA; IMPRINTED GENES; MESSENGER-RNA; INFERTILE MEN; SPERMATOGENESIS; FERTILE; EXPOSURE; PROTEIN; INSIGHTS	Background: In previous studies using candidate gene approaches, low sperm count (oligospermia) has been associated with altered sperm mRNA content and DNA methylation in both imprinted and non-imprinted genes. We performed a genome-wide analysis of sperm DNA methylation and mRNA content to test for associations with sperm function. Methods and Results: Sperm DNA and mRNA were isolated from 21 men with a range of semen parameters presenting to a tertiary male reproductive health clinic. DNA methylation was measured with the Illumina Infinium array at 27,578 CpG loci. Unsupervised clustering of methylation data differentiated the 21 sperm samples by their motility values. Recursively partitioned mixture modeling (RPMM) of methylation data resulted in four distinct methylation profiles that were significantly associated with sperm motility (P = 0.01). Linear models of microarray analysis (LIMMA) was performed based on motility and identified 9,189 CpG loci with significantly altered methylation (Q<0.05) in the low motility samples. In addition, the majority of these disrupted CpG loci (80%) were hypomethylated. Of the aberrantly methylated CpGs, 194 were associated with imprinted genes and were almost equally distributed into hypermethylated (predominantly paternally expressed) and hypomethylated (predominantly maternally expressed) groups. Sperm mRNA was measured with the Human Gene 1.0 ST Affymetrix GeneChip Array. LIMMA analysis identified 20 candidate transcripts as differentially present in low motility sperm, including HDAC1 (NCBI 3065), SIRT3 (NCBI 23410), and DNMT3A (NCBI 1788). There was a trend among altered expression of these epigenetic regulatory genes and RPMM DNA methylation class. Conclusions: Using integrative genome-wide approaches we identified CpG methylation profiles and mRNA alterations associated with low sperm motility.	[Pacheco, Sara E.; Marsit, Carmen J.; Kelsey, Karl T.; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Houseman, E. Andres; Christensen, Brock C.; Kelsey, Karl T.] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Sigman, Mark] Brown Univ, Div Urol, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Pacheco, SE (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kim_Boekelheide@Brown.edu	Sigman, Mark/P-3343-2019; Christensen, Brock/B-8460-2009; Kelsey, Karl T/I-1252-2014	Marsit, Carmen/0000-0003-4566-150X; Houseman, Eugene Andres/0000-0003-0703-1830	National Institutes of Health/The National Institute of Environmental Health Sciences (NIH/NIEHS) [P42ES013660];  [5R01CA121147-5];  [T32ES007272-17]; NATIONAL CANCER INSTITUTE [R01CA121147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007272, P42ES013660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	National Institutes of Health/The National Institute of Environmental Health Sciences (NIH/NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was funded by 5R01CA121147-5 and the Superfund Basic Research Program National Institutes of Health/The National Institute of Environmental Health Sciences (NIH/NIEHS) grant P42ES013660. SP was supported by T32ES007272-17 for "Training in Environmental Pathology". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki VW, 2006, MOL HUM REPROD, V12, P41, DOI 10.1093/molehr/gah258; Avendano C, 2009, HUM REPROD, V24, P270, DOI 10.1093/humrep/den381; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Bonaparte E, 2010, HUM REPROD, V25, P1398, DOI 10.1093/humrep/deq074; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Choi E, 2008, J BIOL CHEM, V283, P35283, DOI 10.1074/jbc.M805590200; Christensen BC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001043; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Dadoune JP, 2004, INT REV CYTOL, V237, P1, DOI 10.1016/S0074-7696(04)37001-4; Doerksen T, 2000, ENDOCRINOLOGY, V141, P3235, DOI 10.1210/en.141.9.3235; du Plessis SS, 2010, ANDROLOGIA, V42, P206, DOI 10.1111/j.1439-0272.2009.00980.x; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; GRIFFIN DK, 1995, HUM MOL GENET, V4, P2227, DOI 10.1093/hmg/4.12.2227; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kempisty B, 2008, REPROD FERT DEVELOP, V20, P513, DOI 10.1071/RD07211; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Lalancette C, 2009, J MOL MED, V87, P735, DOI 10.1007/s00109-009-0485-9; LEUSHUIS E, 2010, FERTIL STERIL, DOI DOI 10.1016/J.FERTN-STERT.2010.03.021; Loukinov DI, 2002, P NATL ACAD SCI USA, V99, P6806, DOI 10.1073/pnas.092123699; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Marques CJ, 2010, FERTIL STERIL, V94, P585, DOI 10.1016/j.fertnstert.2009.02.051; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Maynard ND, 2008, NAT METHODS, V5, P307, DOI [10.1038/NMETH.1194, 10.1038/nmeth.1194]; Miller D, 2006, Gynecol Obstet Fertil, V34, P840, DOI 10.1016/j.gyobfe.2006.07.013; Miller D, 2005, TRENDS MOL MED, V11, P156, DOI 10.1016/j.molmed.2005.02.006; Miller D, 1997, MOL HUM REPROD, V3, P669, DOI 10.1093/molehr/3.8.669; Miller D, 2006, HUM REPROD UPDATE, V12, P757, DOI 10.1093/humupd/dml037; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Ostermeier GC, 2002, LANCET, V360, P772, DOI 10.1016/S0140-6736(02)09899-9; PATHAK S, 2008, FERTIL STERIL, DOI DOI 10.1016/J.FERTN-STERT.2008.07.1709; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Sato A, 2011, FERTIL STERIL, V95, P129, DOI 10.1016/j.fertnstert.2010.06.076; Schumacker PT, 2010, CANCER CELL, V17, P5, DOI 10.1016/j.ccr.2009.12.032; Smyth Gordon K, 2003, Methods Mol Biol, V224, P111; Steger K, 2008, HUM REPROD, V23, P11, DOI 10.1093/humrep/dem363; Steilmann C, 2010, REPRODUCTION, V140, P435, DOI 10.1530/REP-10-0139; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Swan SH, 2006, INT J ANDROL, V29, P62, DOI 10.1111/j.1365-2605.2005.00620.x; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Wang H, 2004, J MOL MED, V82, P317, DOI 10.1007/s00109-004-0526-3; World Health Organization DoRHaR, 2010, WHO LAB MAN EX PROC; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884	53	103	110	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20280	10.1371/journal.pone.0020280	http://dx.doi.org/10.1371/journal.pone.0020280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674046	Green Submitted, Green Published, gold			2022-12-25	WOS:000291310600007
J	Rajasuriar, R; Gouillou, M; Spelman, T; Read, T; Hoy, J; Law, M; Cameron, PU; Petoumenos, K; Lewin, SR				Rajasuriar, Reena; Gouillou, Maelenn; Spelman, Tim; Read, Tim; Hoy, Jennifer; Law, Matthew; Cameron, Paul U.; Petoumenos, Kathy; Lewin, Sharon R.			Clinical Predictors of Immune Reconstitution following Combination Antiretroviral Therapy in Patients from the Australian HIV Observational Database	PLOS ONE			English	Article							CD4 CELL COUNT; REVERSE-TRANSCRIPTASE INHIBITORS; VIRUS-INFECTED PATIENTS; SUSTAINED VIRAL SUPPRESSION; RECENT THYMIC EMIGRANTS; NON-AIDS DISEASES; PROTEASE INHIBITORS; HEPATITIS-C; VIROLOGICAL SUPPRESSION; T-CELLS	Background: A small but significant number of patients do not achieve CD4 T-cell counts > 500cells/mu l despite years of suppressive cART. These patients remain at risk of AIDS and non-AIDS defining illnesses. The aim of this study was to identify clinical factors associated with CD4 T-cell recovery following long-term cART. Methods: Patients with the following inclusion criteria were selected from the Australian HIV Observational Database (AHOD): cART as their first regimen initiated at CD4 T-cell count < 500cells/mu l, HIV RNA < 500copies/mu l after 6 months of cART and sustained for at least 12 months. The Cox proportional hazards model was used to identify determinants associated with time to achieve CD4 T-cell counts > 500cells/mu l and > 200cells/mu l. Results: 501 patients were eligible for inclusion from AHOD (n = 2853). The median (IQR) age and baseline CD4 T-cell counts were 39 (32-47) years and 236 (130-350) cells/mu l, respectively. A major strength of this study is the long follow-up duration, median (IQR) = 6.5(3-10) years. Most patients (80%) achieved CD4 T-cell counts > 500cells/mu l, but in 8%, this took > 5 years. Among the patients who failed to reach a CD4 T-cell count > 500cells/mu l, 16% received cART for > 10 years. In a multivariate analysis, faster time to achieve a CD4 T-cell count > 500cells/mu l was associated with higher baseline CD4 T-cell counts (p < 0.001), younger age (p = 0.019) and treatment initiation with a protease inhibitor (PI)-based regimen (vs. non-nucleoside reverse transcriptase inhibitor, NNRTI; p = 0.043). Factors associated with achieving CD4 T-cell counts > 200cells/mu l included higher baseline CD4 T-cell count (p < 0.001), not having a prior AIDS-defining illness (p = 0.018) and higher baseline HIV RNA (p, 0.001). Conclusion: The time taken to achieve a CD4 T-cell count > 500cells/mu l despite long-term cART is prolonged in a subset of patients in AHOD. Starting cART early with a PI-based regimen (vs. NNRTI-based regimen) is associated with more rapid recovery of a CD4 T-cell count > 500cells/mu l.	[Rajasuriar, Reena; Hoy, Jennifer; Cameron, Paul U.; Lewin, Sharon R.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Rajasuriar, Reena] Univ Malaya, Fac Med, Kuala Lumpur, Federal Territo, Malaysia; [Gouillou, Maelenn; Spelman, Tim] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Hoy, Jennifer; Law, Matthew; Petoumenos, Kathy] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Read, Tim] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Hoy, Jennifer; Cameron, Paul U.; Lewin, Sharon R.] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia	Monash University; Universiti Malaya; Burnet Institute; University of New South Wales Sydney; Kirby Institute; Florey Institute of Neuroscience & Mental Health; Burnet Institute	Rajasuriar, R (corresponding author), Monash Univ, Dept Med, Melbourne, Vic 3004, Australia.	Sharon.Lewin@med.monash.edu.au	Rajasuriar, Reena/B-9569-2010; Lewin, Sharon/Z-3297-2019; Hoy, Jennifer/AAK-7968-2020	Rajasuriar, Reena/0000-0003-3756-0629; Lewin, Sharon Ruth/0000-0002-0330-8241; Hoy, Jennifer/0000-0002-6948-7086; Cameron, Paul Urquhart/0000-0002-1906-6945; Law, Matthew/0000-0002-3540-8837	Foundation for AIDS Research; amfAR; U. S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) [U01-AI069907]; Merck Sharp Dohme; Gilead; Bristol-Myers Squibb; Boehringer Ingelheim; Roche; Pfizer; GlaxoSmithKline; Janssen-Cilag; Australian Government Department of Health and Ageing; Malaysian government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	Foundation for AIDS Research; amfAR; U. S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Merck Sharp Dohme(Merck & Company); Gilead(Gilead Sciences); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Roche(Roche Holding); Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Malaysian government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Australian HIV Observational Database is funded as part of the Asia Pacific HIV Observational Database, a program of The Foundation for AIDS Research, amfAR, and is supported in part by a grant from the U. S. National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) (Grant No. U01-AI069907) and by unconditional grants from Merck Sharp & Dohme; Gilead; Bristol-Myers Squibb; Boehringer Ingelheim; Roche; Pfizer; GlaxoSmithKline; and Janssen-Cilag. The National Centre in HIV Epidemiology and Clinical Research is funded by The Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, The University of New South Wales. RR is a recipient of the King Scholarship from the Malaysian government. SRL is an NHMRC Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; *AUSTR SOC HIV MED, 2010, US GUID US ANT AG HI; Australian HIV Observational Database, 2002, HIV MED, V3, P28; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Benito JM, 2002, AIDS RES HUM RETROV, V18, P1379, DOI 10.1089/088922202320935456; Bosch RJ, 2006, JAIDS-J ACQ IMM DEF, V43, P433, DOI 10.1097/01.qai.0000243097.27029.b7; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Castagna A, 2010, ANTIVIR THER, V15, P165, DOI 10.3851/IMP1513; De Luca A, 2006, ANTIVIR THER, V11, P609; *DEP HLTH HUM SERV, 2009, PAN ANT GUID AD AD G; Diaz M, 2003, AIDS, V17, P1145, DOI 10.1097/00002030-200305230-00005; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Egger S, 2009, JAIDS-J ACQ IMM DEF, V50, P513, DOI 10.1097/QAI.0b013e31819906d3; Falster K, 2009, JAIDS-J ACQ IMM DEF, V50, P307, DOI 10.1097/QAI.0b013e3181945ed4; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Friedl AC, 2001, AIDS, V15, P1793, DOI 10.1097/00002030-200109280-00008; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Giordano TP, 2003, CLIN INFECT DIS, V37, P433, DOI 10.1086/376638; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hansjee N, 2004, JAIDS-J ACQ IMM DEF, V36, P671, DOI 10.1097/00126334-200406010-00003; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007; Kaufmann GR, 2002, AIDS, V16, P359, DOI 10.1097/00002030-200202150-00007; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Khanna N, 2008, CLIN INFECT DIS, V47, P1093, DOI 10.1086/592113; Le Moing V, 2007, HIV MED, V8, P156, DOI 10.1111/j.1468-1293.2007.00446.x; Lederman MM, 2000, AIDS, V14, P2635, DOI 10.1097/00002030-200012010-00002; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; LEWDEN CT, 2010, 17 C RETR OPP INF 16; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Lu W, 2000, BLOOD, V96, P250, DOI 10.1182/blood.V96.1.250.013k28_250_258; MACKALL CL, 1995, NEW ENGL J MED, V332, P143, DOI 10.1056/NEJM199501193320303; Massanella M, 2010, AIDS, V24, P959, DOI 10.1097/QAD.0b013e328337b957; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2006, AIDS, V20, P1141, DOI 10.1097/01.aids.0000226954.95094.39; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nakanjako D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-43; Negredo E, 2010, CLIN INFECT DIS, V50, P1300, DOI 10.1086/651689; Nokta MA, 2002, AIDS, V16, P2119, DOI 10.1097/00002030-200211080-00003; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Potter M, 2010, AIDS, V24, P1857, DOI 10.1097/QAD.0b013e32833adbb5; Reekie J, 2010, CANCER-AM CANCER SOC, V116, P5306, DOI 10.1002/cncr.25311; Reiss P, 2000, AIDS, V14, P1383, DOI 10.1097/00002030-200007070-00011; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Ruiz-Mateos E, 2004, CLIN EXP IMMUNOL, V136, P501, DOI 10.1111/j.1365-2249.2004.02474.x; Sakai K, 2010, MICROBES INFECT, V12, P374, DOI 10.1016/j.micinf.2010.01.013; Sfikakis PP, 2005, EUR J CLIN INVEST, V35, P380, DOI 10.1111/j.1365-2362.2005.01499.x; Sloand EM, 1999, BLOOD, V94, P1021, DOI 10.1182/blood.V94.3.1021.415k29_1021_1027; Smith CJ, 2003, AIDS, V17, P963, DOI 10.1097/00002030-200305020-00004; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Smith KY, 2000, J INFECT DIS, V181, P141, DOI 10.1086/315169; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Sullivan PS, 2006, AIDS, V20, P1171, DOI 10.1097/01.aids.0000226958.87471.48; Tarwater PM, 2001, J ACQ IMMUN DEF SYND, V27, P168, DOI 10.1097/00126334-200106010-00012; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Torti C, 2005, J ANTIMICROB CHEMOTH, V56, P190, DOI 10.1093/jac/dki172; Torti C, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-23; Trotta MP, 2010, CLIN INFECT DIS, V51, P456, DOI 10.1086/655151; van Leeuwen R, 2003, AIDS, V17, P987, DOI 10.1097/00002030-200305020-00007; van Leth F, 2004, HIV MED, V5, P74, DOI 10.1111/j.1468-1293.2004.00188.x; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Yazdanpanah Y, 2004, BMJ-BRIT MED J, V328, P249, DOI 10.1136/bmj.37995.435787.A6; Young J, 2009, ANTIVIR THER, V14, P771, DOI 10.3851/IMP1291; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	77	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20713	10.1371/journal.pone.0020713	http://dx.doi.org/10.1371/journal.pone.0020713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674057	Green Published, gold			2022-12-25	WOS:000291310600026
J	De Mukhopadhyay, K; Bandyopadhyay, A; Chang, TTA; Elkahloun, AG; Cornell, JE; Yang, JH; Goins, BA; Yeh, IT; Sun, LZ				De Mukhopadhyay, Keya; Bandyopadhyay, Abhik; Chang, Ting-Tung A.; Elkahloun, Abdel G.; Cornell, John E.; Yang, Junhua; Goins, Beth A.; Yeh, I-Tien; Sun, Lu-Zhe			Isolation and Characterization of a Metastatic Hybrid Cell Line Generated by ER Negative and ER Positive Breast Cancer Cells in Mouse Bone Marrow	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; STEM-CELLS; PROSPECTIVE IDENTIFICATION; SPONTANEOUS FUSION; IN-VITRO; EXPRESSION; HYPOTHESIS; VARIANT	Background: The origin and the contribution of breast tumor heterogeneity to its progression are not clear. We investigated the effect of a growing orthotopic tumor formed by an aggressive estrogen receptor (ER)-negative breast cancer cell line on the metastatic potential of a less aggressive ER-positive breast cancer cell line for the elucidation of how the presence of heterogeneous cancer cells might affect each other's metastatic behavior. Methods: ER positive ZR-75-1/GFP/puro cells, resistant to puromycin and non-tumorigenic/non-metastatic without exogenous estrogen supplementation, were injected intracardiacally into mice bearing growing orthotopic tumors, formed by ER negative MDA-MB-231/GFP/Neo cells resistant to G418. A variant cell line B6, containing both estrogen-dependent and -independent cells, were isolated from GFP expressing cells in the bone marrow and re-inoculated in nude mice to generate an estrogen-independent cell line B6TC. Results: The presence of ER negative orthotopic tumors resulted in bone metastasis of ZR-75-1 without estrogen supplementation. The newly established B6TC cell line was tumorigenic without estrogen supplementation and resistant to both puromycin and G418 suggesting its origin from the fusion of MDA-MB-231/GFP/Neo and ZR-75-1/GFP/puro in the mouse bone marrow. Compared to parental cells, B6TC cells were more metastatic to lung and bone after intracardiac inoculation. More significantly, B6TC mice also developed brain metastasis, which was not observed in the MDA-MB-231/GFP/Neo cell-inoculated mice. Low expression of ER alpha and CD24, and high expression of EMT-related markers such as Vimentin, CXCR4, and Integrin-beta 1 along with high CD44 and ALDH expression indicated stem cell-like characteristics of B6TC. Gene microarray analysis demonstrated a significantly different gene expression profile of B6TC in comparison to those of parental cell lines. Conclusions: Spontaneous generation of the novel hybrid cell line B6TC, in a metastatic site with stem cell-like properties and propensity to metastasize to brain, suggest that cell fusion can contribute to tumor heterogeneity.	[De Mukhopadhyay, Keya; Bandyopadhyay, Abhik; Yang, Junhua; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Chang, Ting-Tung A.; Goins, Beth A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Radiol, San Antonio, TX 78229 USA; [Elkahloun, Abdel G.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Cornell, John E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Yeh, I-Tien] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	De Mukhopadhyay, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	SUNL@uthscsa.edu	, LuZhe/AAW-4095-2021		National Institutes of Health (NIH) [R01CA079683, R01CA075253, P01CA040035]; Department of Defense Breast Cancer Research [W81XWH-06-1-0616]; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through National Cancer Institute Cancer Center [P30CA054174]; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA075253, P01CA040035, R01CA079683] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through National Cancer Institute Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by National Institutes of Health (NIH) grants R01CA079683, R01CA075253, P01CA040035; Department of Defense Breast Cancer Research Program Concept Award W81XWH-06-1-0616; and the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the National Cancer Institute Cancer Center Support Grant P30CA054174. Additional support was provided by the Intramural Program of the National Human Genome Research Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Bandyopadhyay A, 2005, CANCER BIOL THER, V4, P168; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Bolstad B, 2005, BIOINFORMATICS COMPU; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Friedl P, 2005, LANCET ONCOL, V6, P916, DOI 10.1016/S1470-2045(05)70439-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; He XH, 2005, J EXP THER ONCOL, V5, P101; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Hinton CV, 2010, CLIN EXP METASTAS, V27, P97, DOI 10.1007/s10585-008-9210-2; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kirsch David G, 2005, Clin Breast Cancer, V6, P115, DOI 10.3816/CBC.2005.n.013; Klos KJ, 2004, NEUROLOGIST, V10, P31, DOI 10.1097/01.nrl.0000106922.83090.71; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Magni M, 1996, BLOOD, V87, P1097, DOI 10.1182/blood.V87.3.1097.bloodjournal8731097; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; MILLER FR, 1989, CANCER RES, V49, P4316; MULDER KM, 1989, MOL ENDOCRINOL, V3, P1215, DOI 10.1210/mend-3-8-1215; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Palmieri Diane, 2006, Breast Dis, V26, P139; Palmieri D, 2007, CLIN CANCER RES, V13, P1656, DOI 10.1158/1078-0432.CCR-06-2659; Parris GE, 2006, MED HYPOTHESES, V66, P76, DOI 10.1016/j.mehy.2005.08.009; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Price JE, 1996, BREAST CANCER RES TR, V39, P93, DOI 10.1007/BF01806081; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; SUN LZ, 1994, J BIOL CHEM, V269, P26449; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x	48	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20473	10.1371/journal.pone.0020473	http://dx.doi.org/10.1371/journal.pone.0020473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673810	Green Published, gold, Green Submitted			2022-12-25	WOS:000291309900022
J	Arellano-Anaya, ZE; Savistchenko, J; Mathey, J; Huor, A; Lacroux, C; Andreoletti, O; Vilette, D				Arellano-Anaya, Zaira E.; Savistchenko, Jimmy; Mathey, Jacinthe; Huor, Alvina; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier			A Simple, Versatile and Sensitive Cell-Based Assay for Prions from Various Species	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; INFECTIVITY ASSAY; SCRAPIE PRIONS; STRAIN DISCRIMINATION; SURGICAL-STEEL; SHEEP SCRAPIE; PANEL ASSAY; PROTEIN; PRP; CULTURE	Detection and quantification of prion infectivity is a crucial step for various fundamental and applied aspects of prion research. Identification of cell lines highly sensitive to prion infection led to the development of cell-based titration procedures aiming at replacing animal bioassays, usually performed in mice or hamsters. However, most of these cell lines are only permissive to mouse-adapted prions strains and do not allow titration of prions from other species. In this study, we show that epithelial RK13, a cell line permissive to mouse and bank vole prion strains and to natural prion agents from sheep and cervids, enables a robust and sensitive detection of mouse and ovine-derived prions. Importantly, the cell culture work is strongly reduced as the RK13 cell assay procedure designed here does not require subcultivation of the inoculated cultures. We also show that prions effectively bind to culture plastic vessel and are quantitatively detected by the cell assay. The possibility to easily quantify a wider range of prions, including rodent experimental strains but also natural agents from sheep and cervids, should prompt the spread of cell assays for routine prion titration and lead to valuable information in fundamental and applied studies.	[Arellano-Anaya, Zaira E.; Savistchenko, Jimmy; Mathey, Jacinthe; Huor, Alvina; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier] ENVT, INRA, UMR 1225, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Arellano-Anaya, ZE (corresponding author), ENVT, INRA, UMR 1225, Toulouse, France.	d.vilette@envt.fr		ARELLANO-ANAYA, Zaira E/0000-0001-7847-0342	Mexican CONACYT;  [ANR-08-MIEN-010]	Mexican CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); 	This work was partly supported by a grant from ANR-08-MIEN-010 (France) and Z. Arellano was a recipient of a fellowship from Mexican CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Anaya ZEA, 2011, J BIOL CHEM, V286, P8141, DOI 10.1074/jbc.M110.165233; Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Edgeworth JA, 2010, P NATL ACAD SCI USA, V107, P14402, DOI 10.1073/pnas.1004036107; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Edgeworth JA, 2011, J GEN VIROL, V92, P718, DOI 10.1099/vir.0.027201-0; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Genovesi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001069; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Jackson GS, 2005, J GEN VIROL, V86, P869, DOI 10.1099/vir.0.80484-0; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lawson VA, 2008, INT J BIOCHEM CELL B, V40, P2793, DOI 10.1016/j.biocel.2008.05.024; Lawson VA, 2007, J GEN VIROL, V88, P2905, DOI 10.1099/vir.0.82961-0; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mahal Sukhvir P., 2008, V459, P49, DOI 10.1007/978-1-59745-234-2_4; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Neale MH, 2010, J VIROL, V84, P2444, DOI 10.1128/JVI.01855-09; Paquet S, 2004, J VIROL, V78, P7148, DOI 10.1128/JVI.78.13.7148-7152.2004; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1992, BIOCHEMISTRY-US, V31, P12277, DOI 10.1021/bi00164a001; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; Sowemimo-Coker SO, 2010, TRANSFUSION, V50, P980, DOI 10.1111/j.1537-2995.2009.02525.x; Sun R, 2008, VIRAL IMMUNOL, V21, P293, DOI 10.1089/vim.2008.0039; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; You B, 2010, J VIROL METHODS, V164, P1, DOI 10.1016/j.jviromet.2009.10.010; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	57	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20563	10.1371/journal.pone.0020563	http://dx.doi.org/10.1371/journal.pone.0020563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655184	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600099
J	Bryant, PA; Smyth, GK; Robins-Browne, R; Curtis, N				Bryant, Penelope A.; Smyth, Gordon K.; Robins-Browne, Roy; Curtis, Nigel			Technical Variability Is Greater than Biological Variability in a Microarray Experiment but Both Are Outweighed by Changes Induced by Stimulation	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; HUMAN GENE-EXPRESSION; GENDER-DIFFERENCES; LIPOPOLYSACCHARIDE; DESIGN; RATS; LPS	Introduction: A central issue in the design of microarray-based analysis of global gene expression is that variability resulting from experimental processes may obscure changes resulting from the effect being investigated. This study quantified the variability in gene expression at each level of a typical in vitro stimulation experiment using human peripheral blood mononuclear cells (PBMC). The primary objective was to determine the magnitude of biological and technical variability relative to the effect being investigated, namely gene expression changes resulting from stimulation with lipopolysaccharide (LPS). Methods and Results: Human PBMC were stimulated in vitro with LPS, with replication at 5 levels: 5 subjects each on 2 separate days with technical replication of LPS stimulation, amplification and hybridisation. RNA from samples stimulated with LPS and unstimulated samples were hybridised against common reference RNA on oligonucleotide microarrays. There was a closer correlation in gene expression between replicate hybridisations (0.86-0.93) than between different subjects (0.66-0.78). Deconstruction of the variability at each level of the experimental process showed that technical variability (standard deviation (SD) 0.16) was greater than biological variability (SD 0.06), although both were low (SD<0.1 for all individual components). There was variability in gene expression both at baseline and after stimulation with LPS and proportion of cell subsets in PBMC was likely partly responsible for this. However, gene expression changes after stimulation with LPS were much greater than the variability from any source, either individually or combined. Conclusions: Variability in gene expression was very low and likely to improve further as technical advances are made. The finding that stimulation with LPS has a markedly greater effect on gene expression than the degree of variability provides confidence that microarray-based studies can be used to detect changes in gene expression of biological interest in infectious diseases.	[Bryant, Penelope A.; Curtis, Nigel] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Bryant, Penelope A.; Robins-Browne, Roy; Curtis, Nigel] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bryant, Penelope A.; Curtis, Nigel] Royal Childrens Hosp, Dept Gen Med, Infect Dis Unit, Melbourne, Vic, Australia; [Smyth, Gordon K.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3050, Australia; [Smyth, Gordon K.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia; [Robins-Browne, Roy] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Bryant, PA (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia.	nigel.curtis@rch.org.au	Robinsbrowne, Roy/ABF-8434-2020; Curtis, Nigel/B-3491-2012; Smyth, Gordon/B-5276-2008	Robinsbrowne, Roy/0000-0001-9179-7884; Curtis, Nigel/0000-0003-3446-4594; Smyth, Gordon/0000-0001-9221-2892	National Heart Foundation of Australia; Australian National Health and Medical Research Council [216716]; European Society of Paediatric Infectious Diseases	National Heart Foundation of Australia(National Heart Foundation of Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Society of Paediatric Infectious Diseases	This study was supported by a grant from the National Heart Foundation of Australia (www.heartfoundation.org.au) and the Australian National Health and Medical Research Council (no. 216716, www.nhmrc.gov.au). Dr Bryant was the recipient of a European Society of Paediatric Infectious Diseases Fellowship Award (www.espid.org) and a University of Melbourne Research Scholarship (www.unimelb.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2006, J BIOL CHEM, V281, P8118, DOI 10.1074/jbc.M509361200; Asai K, 2001, SHOCK, V16, P340, DOI 10.1097/00024382-200116050-00003; Ashdown H, 2007, AM J PHYSIOL-REG I, V292, pR1667, DOI 10.1152/ajpregu.00274.2006; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Bryant PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004427; Casciano DA, 2006, NAT BIOTECHNOL, V24, P1103, DOI 10.1038/nbt0906-1103; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; DEFEO P, 1992, AM J PHYSIOL, V263, pE794, DOI 10.1152/ajpendo.1992.263.4.E794; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Hintz KA, 2002, J LEUKOCYTE BIOL, V72, P711; Holloway AJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-511; Jozefowski S, 2006, J LEUKOCYTE BIOL, V80, P870, DOI 10.1189/jlb.0705357; Kerkhoven RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001980; Kim KY, 2009, J BIOSCI BIOENG, V108, P252, DOI 10.1016/j.jbiosc.2009.03.017; Kimura Y, 1999, SURG TODAY, V29, P10, DOI 10.1007/BF02482963; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Moller-Levet CS, 2007, BIOINFORMATICS, V23, P2733, DOI 10.1093/bioinformatics/btm441; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Novak JP, 2002, GENOMICS, V79, P104, DOI 10.1006/geno.2001.6675; Pinheiro J, 2001, MIXED EFFECTS MODELS; Poindexter NJ, 2005, J LEUKOCYTE BIOL, V78, P745, DOI 10.1189/jlb.0205116; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; SCHOBER I, 1984, EXP CELL RES, V152, P348, DOI 10.1016/0014-4827(84)90636-0; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SU SD, 1990, J IMMUNOL, V145, P2994; SUREDA A, 2007, BR J SPORTS MED; Von Aulock S, 2006, J INTERF CYTOK RES, V26, P887, DOI 10.1089/jir.2006.26.887; Wachulec M, 1997, AM J PHYSIOL-REG I, V272, pR1252, DOI 10.1152/ajpregu.1997.272.4.R1252; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yang YH, 2002, J COMPUT GRAPH STAT, V11, P108, DOI 10.1198/106186002317375640; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yang ZY, 2000, EXP CLIN IMMUNOGENET, V17, P1, DOI 10.1159/000019119	35	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19556	10.1371/journal.pone.0019556	http://dx.doi.org/10.1371/journal.pone.0019556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655321	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600006
J	Dufresne, F; Markova, S; Vergilino, R; Ventura, M; Kotlik, P				Dufresne, France; Markova, Silvia; Vergilino, Roland; Ventura, Marc; Kotlik, Petr			Diversity in the Reproductive Modes of European Daphnia pulicaria Deviates from the Geographical Parthenogenesis	PLOS ONE			English	Article							BREEDING SYSTEM DIVERSITY; MACROGEOGRAPHIC PATTERNS; PHYLOGENETIC ANALYSIS; COMPUTER-PROGRAM; PULEX GROUP; POLYPLOIDY; HISTORY; POPULATIONS; ASEXUALITY; CLONALITY	Background: Multiple transitions to obligate parthenogenesis have occurred in the Daphnia pulex complex in North America. These newly formed asexual lineages are differentially distributed being found predominantly at high latitudes. This conforms to the rule of geographical parthenogenesis postulating prevalence of asexuals at high latitudes and altitudes. While the reproductive mode of high-latitude populations is relatively well studied, little is known about the reproduction mode in high altitudes. This study aimed to assess the reproductive mode of Daphnia pulicaria, a species of the D. pulex complex, from high altitude lakes in Europe. Methodology/Principal Findings: Variation at eight microsatellite loci revealed that D. pulicaria from the High Tatra Mountains (HTM) had low genotype richness and showed excess of heterozygotes and significant deviations from Hardy-Weinberg expectations, and was thus congruent with reproduction by obligate parthenogenesis. By contrast, populations from the Pyrenees (Pyr) were generally in Hardy-Weinberg equilibrium and had higher genotypic richness, suggesting that they are cyclic parthenogens. Four lakes from lowland areas (LLaP) had populations with an uncertain or mixed breeding mode. All D. pulicaria had mtDNA ND5 haplotypes of the European D. pulicaria lineage. Pyr were distinct from LLaP and HTM at the ND5 gene. By contrast, HTM shared two haplotypes with LLaP and one with Pyr. Principal Coordinate Analysis of the microsatellite data revealed clear genetic differentiation into three groups. HTM isolates were intermediate to Pyr and LLaP, congruent with a hybrid origin. Conclusion/Significance: Inferred transitions to obligate parthenogenesis have occurred only in HTM, most likely as a result of hybridizations. In contrast to North American populations, these transitions do not appear to involve meiosis suppressor genes and have not been accompanied by polyploidy. The absence of obligate parthenogenesis in Pyr, an environment highly similar to the HTM, may be due to the lack of opportunities for hybridization.	[Dufresne, France; Markova, Silvia; Vergilino, Roland] Univ Quebec Rimouski, Ctr Etud Nord, Dept Biol, Quebec City, PQ, Canada; [Markova, Silvia; Kotlik, Petr] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Dept Vertebrate Evolutionary Biol & Genet, Lab Fish Genet, Libechov, Czech Republic; [Ventura, Marc] Spanish Res Council CEAB CSIC, Ctr Adv Studies Blanes, Biodivers & Biogeodynam Grp, Girona, Catalonia, Spain; [Ventura, Marc] Univ Barcelona, Inst Recerca Aigua, Barcelona, Catalonia, Spain	University of Quebec; Universite du Quebec a Rimouski; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Dufresne, F (corresponding author), Univ Quebec Rimouski, Ctr Etud Nord, Dept Biol, Quebec City, PQ, Canada.	france_dufresne@uqar.qc.ca	Kotlík, Petr/AAP-1342-2021; Ventura, Marc/A-5660-2008; Markova, Silvia/G-3875-2014; Kotlik, Petr/B-4633-2009	Kotlík, Petr/0000-0001-9429-0667; Ventura, Marc/0000-0003-1401-414X; Kotlik, Petr/0000-0001-9429-0667	Natural Sciences and Engineering Research Council of Canada; Academy of Sciences of the Czech Republic [KJB600450901, IRP IAPG AV0Z 50450515]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	The study was supported by grants to FD from Natural Sciences and Engineering Research Council of Canada and by the Academy of Sciences of the Czech Republic postdoctoral grant (KJB600450901) to SM. Additional support to the laboratory of SM and PK was provided by the Academy of Sciences of the Czech Republic (Grant IRP IAPG AV0Z 50450515). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aguilera X, 2007, LIMNOL OCEANOGR, V52, P2079, DOI 10.4319/lo.2007.52.5.2079; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; BEATON MJ, 1988, AM NAT, V132, P837, DOI 10.1086/284892; BELKHIR K, LOGICIEL WINDOWS GEN; Bell G., 1982, MASTERPIECE NATURE E; BIERZYCHUDEK P, 1985, EXPERIENTIA, V41, P1255, DOI 10.1007/BF01952068; Buntjer J.B., 2001, PHYLOGENETIC COMPUTE; Calinski T., 1974, COMMUNICATIONS STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CERNY M, 1993, HEREDITY, V71, P497, DOI 10.1038/hdy.1993.168; Colbourne JK, 2004, MOL ECOL NOTES, V4, P485, DOI 10.1111/j.1471-8286.2004.00721.x; Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1006/bijl.1998.0251; CUELLAR O, 1976, SCIENCE, V193, P150, DOI 10.1126/science.779030; Deffontaine V, 2009, MOL ECOL, V18, P2489, DOI 10.1111/j.1365-294X.2009.04162.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dufresne F, 1998, ECOSCIENCE, V5, P433, DOI 10.1080/11956860.1998.11682481; Dufresne F, 1997, P ROY SOC B-BIOL SCI, V264, P201, DOI 10.1098/rspb.1997.0028; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; GLESENER RR, 1978, AM NAT, V112, P659, DOI 10.1086/283308; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haag CR, 2004, ANN ZOOL FENN, V41, P539; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hebert PDN, 2007, LIMNOL OCEANOGR, V52, P2507, DOI 10.4319/lo.2007.52.6.2507; HEBERT PDN, 1993, HEREDITY, V70, P148, DOI 10.1038/hdy.1993.24; Hebert PDN, 2001, HEREDITY, V87, P153, DOI 10.1046/j.1365-2540.2001.00885.x; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; INNES DJ, 1988, EVOLUTION, V42, P1024, DOI 10.1111/j.1558-5646.1988.tb02521.x; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; Legendre P, 1998, NUMERICAL ECOLOGY; Lehto MP, 2010, J ANIM ECOL, V79, P1241, DOI 10.1111/j.1365-2656.2010.01726.x; Markova S, 2007, MOL PHYLOGENET EVOL, V44, P42, DOI 10.1016/j.ympev.2006.12.025; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; Mila B, 2010, MOL ECOL, V19, P108, DOI 10.1111/j.1365-294X.2009.04441.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Paland S, 2005, EVOLUTION, V59, P800; Palsson S, 2000, MOL ECOL, V9, P1075, DOI 10.1046/j.1365-294x.2000.00969.x; Peck JR, 1998, NATURE, V391, P889, DOI 10.1038/36099; Posada D., 2003, CURRENT PROTOCOLS BI; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schurko AM, 2009, TRENDS ECOL EVOL, V24, P208, DOI 10.1016/j.tree.2008.11.010; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; SWOFFORD DL, 2003, PAUP PHYL AN US PARS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; WARD RD, 1994, HEREDITY, V73, P532, DOI 10.1038/hdy.1994.152; Weider LJ, 1999, EVOLUTION, V53, P777, DOI 10.1111/j.1558-5646.1999.tb05372.x	57	21	23	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20049	10.1371/journal.pone.0020049	http://dx.doi.org/10.1371/journal.pone.0020049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655327	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600015
J	Courtes, S; Vernerey, J; Pujadas, L; Magalon, K; Cremer, H; Soriano, E; Durbec, P; Cayre, M				Courtes, Sandrine; Vernerey, Julien; Pujadas, Lluis; Magalon, Karine; Cremer, Harold; Soriano, Eduardo; Durbec, Pascale; Cayre, Myriam			Reelin Controls Progenitor Cell Migration in the Healthy and Pathological Adult Mouse Brain	PLOS ONE			English	Article							NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; NEURONAL PRECURSORS; CHAIN-MIGRATION; CEREBRAL-CORTEX; DENTATE GYRUS; NEUROGENESIS; EXPRESSION; DIFFERENTIATION; DEMYELINATION	Understanding the signals that control migration of neural progenitor cells in the adult brain may provide new therapeutic opportunities. Reelin is best known for its role in regulating cell migration during brain development, but we now demonstrate a novel function for reelin in the injured adult brain. First, we show that Reelin is upregulated around lesions. Second, experimentally increasing Reelin expression levels in healthy mouse brain leads to a change in the migratory behavior of subventricular zone-derived progenitors, triggering them to leave the rostral migratory stream (RMS) to which they are normally restricted during their migration to the olfactory bulb. Third, we reveal that Reelin increases endogenous progenitor cell dispersal in periventricular structures independently of any chemoattraction but via cell detachment and chemokinetic action, and thereby potentiates spontaneous cell recruitment to demyelination lesions in the corpus callosum. Conversely, animals lacking Reelin signaling exhibit reduced endogenous progenitor recruitment at the lesion site. Altogether, these results demonstrate that beyond its known role during brain development, Reelin is a key player in post-lesional cell migration in the adult brain. Finally our findings provide proof of concept that allowing progenitors to escape from the RMS is a potential therapeutic approach to promote myelin repair.	[Courtes, Sandrine; Vernerey, Julien; Magalon, Karine; Cremer, Harold; Durbec, Pascale; Cayre, Myriam] Univ Mediterranee, Inst Biol Dev Marseille Luminy, CNRS, Marseille, France; [Pujadas, Lluis; Soriano, Eduardo] Inst Res Biomed, Barcelona, Spain; [Pujadas, Lluis; Soriano, Eduardo] Univ Barcelona, Ctr Invest Red Endfermedades Neurodegenerat, Barcelona, Spain; [Pujadas, Lluis; Soriano, Eduardo] Univ Barcelona, Dept Cell Biol, Barcelona, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona	Courtes, S (corresponding author), Univ Mediterranee, Inst Biol Dev Marseille Luminy, CNRS, Marseille, France.	myriam.cayre@ibdml.univmed.fr	Pujadas, Lluís/O-7442-2015; Soriano, Eduardo/AAB-3216-2019; PUJADAS, LLUÍS/AAE-1595-2020; Cayre, Myriam/AAG-4614-2021	Pujadas, Lluís/0000-0003-3890-8279; Soriano, Eduardo/0000-0002-3204-9285; PUJADAS, LLUÍS/0000-0003-3890-8279; vernerey, Julien/0000-0002-5413-4210; Cremer, Harold/0000-0002-8673-5176	"Direction Generale de l'Armement'' (DGA); Association for Research on Cancer (ARC); Federation pour la Recherche sur le Cerveau [FRC 1B1/0887]; MICINN [BFU2008-3980]; Fundacio Obra Social Caixa Catalunya	"Direction Generale de l'Armement'' (DGA)(General Electric); Association for Research on Cancer (ARC); Federation pour la Recherche sur le Cerveau; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacio Obra Social Caixa Catalunya	SC is the recipient of a doctoral fellowship from the "Direction Generale de l'Armement'' (DGA) and of a one year fellowship from the Association for Research on Cancer (ARC). This work was supported by grants from the "Federation pour la Recherche sur le Cerveau'' (FRC 1B1/0887). ES was supported by MICINN (BFU2008-3980) and the "Fundacio Obra Social Caixa Catalunya''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade N, 2007, P NATL ACAD SCI USA, V104, P8508, DOI 10.1073/pnas.0611391104; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cantarella C, 2008, DEV NEUROBIOL, V68, P223, DOI 10.1002/dneu.20588; Cayre M, 2006, MOL CELL NEUROSCI, V31, P748, DOI 10.1016/j.mcn.2006.01.004; Cayre M, 2009, PROG NEUROBIOL, V88, P41, DOI 10.1016/j.pneurobio.2009.02.001; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chazal G, 2000, J NEUROSCI, V20, P1446; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Curtis MA, 2007, SCIENCE, V318, DOI 10.1126/science.1145164; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Decker L, 2002, MOL CELL NEUROSCI, V19, P225, DOI 10.1006/mcne.2001.1072; Durbec P, 2001, MOL CELL NEUROSCI, V17, P561, DOI 10.1006/mcne.2000.0951; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gotts JE, 2005, J NEUROSCI RES, V80, P160, DOI 10.1002/jnr.20434; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kam M, 2009, J CHEM NEUROANAT, V37, P196, DOI 10.1016/j.jchemneu.2008.12.009; Kobold D, 2002, J HEPATOL, V36, P607, DOI 10.1016/S0168-8278(02)00050-8; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Magalon K, 2007, EUR J NEUROSCI, V25, P761, DOI 10.1111/j.1460-9568.2007.05335.x; MASSALINI S, 2009, MOL CELL NEUROSCI; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mun-Bryce S, 1998, J CEREBR BLOOD F MET, V18, P1163, DOI 10.1097/00004647-199811000-00001; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Olson EC, 2006, J NEUROSCI, V26, P1767, DOI 10.1523/JNEUROSCI.3000-05.2006; Ourednik V, 2007, CELL TRANSPLANT, V16, P263, DOI 10.3727/000000007783464696; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Panteri R, 2006, MOL CELL NEUROSCI, V32, P133, DOI 10.1016/j.mcn.2006.03.004; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pulido JS, 2007, GRAEF ARCH CLIN EXP, V245, P889, DOI 10.1007/s00417-006-0458-4; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; SALIN P, 1992, P NATL ACAD SCI USA, V89, P9954, DOI 10.1073/pnas.89.20.9954; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; Simo S, 2007, CEREB CORTEX, V17, P294, DOI 10.1093/cercor/bhj147; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Won SJ, 2006, EXP NEUROL, V198, P250, DOI 10.1016/j.expneurol.2005.12.008; Zhao C, 2006, NEUROBIOL AGING, V27, P1298, DOI 10.1016/j.neurobiolaging.2005.06.008; Zhao ST, 2006, J COMP NEUROL, V495, P1, DOI 10.1002/cne.20846	53	48	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20430	10.1371/journal.pone.0020430	http://dx.doi.org/10.1371/journal.pone.0020430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647369	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052500059
J	Nilsson, L; Karshikoff, A				Nilsson, Lennart; Karshikoff, Andrey			Multiple pH Regime Molecular Dynamics Simulation for pK Calculations	PLOS ONE			English	Article							PROTEIN PK(A) CALCULATIONS; ACTIVE-SITE; CONFORMATIONAL FLEXIBILITY; ELECTROSTATIC INTERACTIONS; IONIZATION PROPERTIES; TITRATION CURVES; LIMITATIONS; PREDICTION; STABILITY; ALGORITHM	Ionisation equilibria in proteins are influenced by conformational flexibility, which can in principle be accounted for by molecular dynamics simulation. One problem in this method is the bias arising from the fixed protonation state during the simulation. Its effect is mostly exhibited when the ionisation behaviour of the titratable groups is extrapolated to pH regions where the predetermined protonation state of the protein may not be statistically relevant, leading to conformational sampling that is not representative of the true state. In this work we consider a simple approach which can essentially reduce this problem. Three molecular dynamics structure sets are generated, each with a different protonation state of the protein molecule expected to be relevant at three pH regions, and pK calculations from the three sets are combined to predict pK over the entire pH range of interest. This multiple pH molecular dynamics approach was tested on the GCN4 leucine zipper, a protein for which a full data set of experimental data is available. The pK values were predicted with a mean deviation from the experimental data of 0.29 pH units, and with a precision of 0.13 pH units, evaluated on the basis of equivalent sites in the dimeric GCN4 leucine zipper.	[Nilsson, Lennart; Karshikoff, Andrey] Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden; [Karshikoff, Andrey] Bulgarian Acad Sci, Inst Mol Biol, BU-1113 Sofia, Bulgaria	Karolinska Institutet; Bulgarian Academy of Sciences	Nilsson, L (corresponding author), Karolinska Inst, Ctr Biosci, Dept Biosci & Nutr, Huddinge, Sweden.	Lennart.Nilsson@ki.se	Karshikoff, Andrey D/C-4387-2016; Nilsson, Lennart/B-7208-2009	Nilsson, Lennart/0000-0002-5067-6397	Swedish Research Council [621-2009-4590]; Bulgarian Science Fund [DRG-02/5]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bulgarian Science Fund(National Science Fund of Bulgaria)	This work was supported by grant (621-2009-4590) from the Swedish Research Council (http://www.vr.se/), and by grant (DRG-02/5) from the Bulgarian Science Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov A, 2010, J PHYS CHEM B, V114, P10634, DOI 10.1021/jp104406x; Alexov E, 2003, PROTEINS, V50, P94, DOI 10.1002/prot.10265; Alexov EG, 1997, BIOPHYS J, V72, P2075, DOI 10.1016/S0006-3495(97)78851-9; Baptista AM, 1997, PROTEINS, V27, P523, DOI 10.1002/(SICI)1097-0134(199704)27:4<523::AID-PROT6>3.0.CO;2-B; Barth P, 2007, P NATL ACAD SCI USA, V104, P4898, DOI 10.1073/pnas.0700188104; BASHFORD D, 1991, J PHYS CHEM-US, V95, P9556, DOI 10.1021/j100176a093; Bjelic S, 2008, PROTEINS, V70, P810, DOI 10.1002/prot.21585; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Foloppe N, 2001, J MOL BIOL, V310, P449, DOI 10.1006/jmbi.2001.4767; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Hajjar E, 2009, J PHYS CHEM A, V113, P11783, DOI 10.1021/jp902930u; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamerlin SCL, 2009, J PHYS CHEM B, V113, P1253, DOI 10.1021/jp8071712; KARSHIKOFF A, 1995, PROTEIN ENG, V8, P243, DOI 10.1093/protein/8.3.243; Karshikoff A., 2007, PROTEIN STRUCTURES M, P71; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Khandogin J, 2006, BIOCHEMISTRY-US, V45, P9363, DOI 10.1021/bi060706r; Kieseritzky G, 2008, PROTEINS, V71, P1335, DOI 10.1002/prot.21820; Koumanov A, 2003, PROTEINS, V51, P289, DOI 10.1002/prot.10354; Koumanov A, 2002, PROTEINS, V46, P85, DOI 10.1002/prot.10034; Koumanov A, 2001, J PHYS CHEM B, V105, P9339, DOI 10.1021/jp010949n; Koumanov A, 2001, EUR BIOPHYS J BIOPHY, V30, P198, DOI 10.1007/s002490100139; Lee MS, 2004, PROTEINS, V56, P738, DOI 10.1002/prot.20128; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matousek WM, 2007, J MOL BIOL, V374, P206, DOI 10.1016/j.jmb.2007.09.007; Mitra R, 2008, CURR COMPUT-AID DRUG, V4, P169, DOI 10.2174/157340908785747393; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 2003, PROTEIN SCI, V12, P313, DOI 10.1110/ps.0229903; RASHIN AA, 1986, BIOCHEMISTRY-US, V25, P3619, DOI 10.1021/bi00360a021; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sandberg L, 1997, BIOPHYS CHEM, V65, P189, DOI 10.1016/S0301-4622(96)02262-4; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; TANFORD C, 1957, J AM CHEM SOC, V79, P5333, DOI 10.1021/ja01577a001; Tarus B, 2006, J AM CHEM SOC, V128, P16159, DOI 10.1021/ja064872y; van Vlijmen HWT, 1998, PROTEINS, V33, P145, DOI 10.1002/(SICI)1097-0134(19981101)33:2<145::AID-PROT1>3.0.CO;2-I; WARSHEL A, 1984, P NATL ACAD SCI-BIOL, V81, P4785, DOI 10.1073/pnas.81.15.4785; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Williams SL, 2010, J CHEM THEORY COMPUT, V6, P560, DOI 10.1021/ct9005294; YANG AS, 1993, PROTEINS, V15, P252, DOI 10.1002/prot.340150304	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20116	10.1371/journal.pone.0020116	http://dx.doi.org/10.1371/journal.pone.0020116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647418	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052500032
J	Knauer, SK; Fetz, V; Rabenstein, J; Friedl, S; Hofmann, B; Sabiani, S; Schroder, E; Kunst, L; Proschak, E; Thines, E; Kindler, T; Schneider, G; Marschalek, R; Stauber, RH; Bier, C				Knauer, Shirley K.; Fetz, Verena; Rabenstein, Jens; Friedl, Sandra; Hofmann, Bettina; Sabiani, Samaneh; Schroeder, Elisabeth; Kunst, Lena; Proschak, Eugen; Thines, Eckhard; Kindler, Thomas; Schneider, Gisbert; Marschalek, Rolf; Stauber, Roland H.; Bier, Carolin			Bioassays to Monitor Taspase1 Function for the Identification of Pharmacogenetic Inhibitors	PLOS ONE			English	Article							NUCLEAR EXPORT; TRANSCRIPTIONAL ACTIVATION; PROTEIN STABILITY; NATURAL-PRODUCTS; SYSTEMS BIOLOGY; MLL; PROTEASES; CLEAVAGE; ROLES; ZETA	Background: Threonine Aspartase 1 (Taspase1) mediates cleavage of the mixed lineage leukemia (MLL) protein and leukemia provoking MLL-fusions. In contrast to other proteases, the understanding of Taspase1's (patho) biological relevance and function is limited, since neither small molecule inhibitors nor cell based functional assays for Taspase1 are currently available. Methodology/Findings: Efficient cell-based assays to probe Taspase1 function in vivo are presented here. These are composed of glutathione S-transferase, autofluorescent protein variants, Taspase1 cleavage sites and rational combinations of nuclear import and export signals. The biosensors localize predominantly to the cytoplasm, whereas expression of biologically active Taspase1 but not of inactive Taspase1 mutants or of the protease Caspase3 triggers their proteolytic cleavage and nuclear accumulation. Compared to in vitro assays using recombinant components the in vivo assay was highly efficient. Employing an optimized nuclear translocation algorithm, the triple-color assay could be adapted to a high-throughput microscopy platform (Z'factor = 0.63). Automated high-content data analysis was used to screen a focused compound library, selected by an in silico pharmacophor screening approach, as well as a collection of fungal extracts. Screening identified two compounds, N-[2-[(4-amino-6-oxo-3H-pyrimidin-2-yl)sulfanyl]ethyl]benzenesulfonamide and 2-benzyltriazole-4,5-dicarboxylic acid, which partially inhibited Taspase1 cleavage in living cells. Additionally, the assay was exploited to probe endogenous Taspase1 in solid tumor cell models and to identify an improved consensus sequence for efficient Taspase1 cleavage. This allowed the in silico identification of novel putative Taspase1 targets. Those include the FERM Domain-Containing Protein 4B, the Tyrosine-Protein Phosphatase Zeta, and DNA Polymerase Zeta. Cleavage site recognition and proteolytic processing of these substrates were verified in the context of the biosensor. Conclusions: The assay not only allows to genetically probe Taspase1 structure function in vivo, but is also applicable for high-content screening to identify Taspase1 inhibitors. Such tools will provide novel insights into Taspase1's function and its potential therapeutic relevance.	[Knauer, Shirley K.; Schroeder, Elisabeth; Kunst, Lena] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Inst Mol Biol, Essen, Germany; [Fetz, Verena; Friedl, Sandra; Stauber, Roland H.; Bier, Carolin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, MSC, Mainz, Germany; [Rabenstein, Jens; Sabiani, Samaneh; Marschalek, Rolf] Goethe Univ Frankfurt, Inst Pharmaceut Biol ZAFES, Frankfurt, Germany; [Hofmann, Bettina; Proschak, Eugen; Schneider, Gisbert] Goethe Univ Frankfurt, Inst Organ Chem & Chem Biol ZAFES, Frankfurt, Germany; [Thines, Eckhard] Inst Biotechnol & Drug Res Kaiserslautern IBWF, Kaiserslautern, Germany; [Kindler, Thomas] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Hematol Oncol, Mainz, Germany	University of Duisburg Essen; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Goethe University Frankfurt; Johannes Gutenberg University of Mainz	Knauer, SK (corresponding author), Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Inst Mol Biol, Essen, Germany.	rstauber@uni-mainz.de; bier@uni-mainz.de	Knauer, Shirley K/E-7931-2012; Marschalek, Rolf/D-3404-2011; Kindler, Thomas/K-5995-2013	Knauer, Shirley K/0000-0003-4321-0924; Marschalek, Rolf/0000-0003-4870-3445; Schneider, Gisbert/0000-0001-6706-1084; Stauber, Roland/0000-0002-1341-4523; Thines, Eckhard/0000-0002-4003-2272	German Cancer Aid [FKZ102362]; Head and Neck Cancer Foundation; Wilhelm-Sander Foundation; Chemical Industry; Stiftung Rheinland-Pfalz fur Innovationen; DFG [KN973/1-1, INST371/5-1FUGG]; Alexander-Karl-Foundation; University Mainz	German Cancer Aid(Deutsche Krebshilfe); Head and Neck Cancer Foundation; Wilhelm-Sander Foundation; Chemical Industry; Stiftung Rheinland-Pfalz fur Innovationen; DFG(German Research Foundation (DFG)); Alexander-Karl-Foundation; University Mainz	Grant support: German Cancer Aid - http://www.krebshilfe.de/(FKZ102362 to R. S. and R. M.), Head and Neck Cancer Foundation - http://www.stiftung-tumorforschung.de/(to C. B.), Wilhelm-Sander Foundation - http://www.sanst.de, Funds of the Chemical Industry - http://fonds.vci.de, Stiftung Rheinland-Pfalz fur Innovationen - http://www.stiftung-innovation.rlp.de, DFG KN973/1-1 and INST371/5-1FUGG, donation from R. Patzke, Alexander-Karl-Foundation - http://www.foerdern-und-stiften.uni-mainz.de/225.php, and the University Mainz Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An NF, 2008, J BIOL CHEM, V283, P24718, DOI 10.1074/jbc.M803497200; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Doucet A, 2008, MOL ASPECTS MED, V29, P339, DOI 10.1016/j.mam.2008.04.003; Engels K, 2007, J PATHOL, V211, P532, DOI 10.1002/path.2134; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Fetz V, 2009, SENSORS-BASEL, V9, P5423, DOI 10.3390/s90705423; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Giuliano KA, 2007, METH MOL B, V356, P189; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Haase D, 2007, ONCOGENE, V26, P4464, DOI 10.1038/sj.onc.1210225; Habtemichael N, 2010, GENE, V469, P9, DOI 10.1016/j.gene.2010.08.007; Habtemichael N, 2010, MOL CELL NEUROSCI, V45, P297, DOI 10.1016/j.mcn.2010.07.003; He JT, 2010, J PROTEOME RES, V9, P2565, DOI 10.1021/pr100012p; Heger P, 2001, TRAFFIC, V2, P544, DOI 10.1034/j.1600-0854.2001.20804.x; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Ikenouchi J, 2010, P NATL ACAD SCI USA, V107, P748, DOI 10.1073/pnas.0908423107; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.25; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-5741com; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Knauer SK, 2005, ANAL CHEM, V77, P4815, DOI 10.1021/ac050413o; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liermann JC, 2009, J NAT PROD, V72, P1905, DOI 10.1021/np9005234; Lin XJ, 2006, CLIN CANCER RES, V12, P563, DOI 10.1158/1078-0432.CCR-05-1380; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Marschalek R, 2010, FEBS J, V277, P1822, DOI 10.1111/j.1742-4658.2010.07608.x; Meyer C, 2006, LEUKEMIA, V20, P777, DOI 10.1038/sj.leu.2404150; Muller S, 2004, EXPERT OPIN THER TAR, V8, P211, DOI 10.1517/14728222.8.3.211; Overall CM, 2006, CANCER METAST REV, V25, P69, DOI 10.1007/s10555-006-7890-0; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Rucker E, 2001, PROTEIN EXPRES PURIF, V21, P220, DOI 10.1006/prep.2000.1373; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schlingemann J, 2005, LAB INVEST, V85, P1024, DOI 10.1038/labinvest.3700293; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Ugalde AP, 2010, METHODS MOL BIOL, V622, P3, DOI 10.1007/978-1-60327-299-5_1; Wittschieben JP, 2010, CANCER RES, V70, P2770, DOI 10.1158/0008-5472.CAN-09-4267; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006	49	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e18253	10.1371/journal.pone.0018253	http://dx.doi.org/10.1371/journal.pone.0018253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647428	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500001
J	Chen, BY; Chen, JK; Zhu, MZ; Zhang, DL; Sun, JS; Pei, JM; Feng, HS; Zhu, XX; Jin, J; Yu, J				Chen, Bao-Ying; Chen, Jian-Kang; Zhu, Miao-Zhang; Zhang, Dong-Liang; Sun, Jie-Shen; Pei, Jian-Ming; Feng, Hua-Song; Zhu, Xiao-Xing; Jin, Jian; Yu, Jun			AC-NP: A Novel Chimeric Peptide with Natriuretic and Vasorelaxing Actions	PLOS ONE			English	Article							VASONATRIN PEPTIDE; ATRIAL	The aim of this study was to evaluate the cardiovascular and renal activities of a newly designed natriuretic peptide (NP). Here, we engineered a novel 28-amino acid chimeric peptide, termed AC-NP that combined the 17-amino acid ring of C type natriuretic peptide (CNP) with the 6-amino acid N-terminus and 5-amino acid C-terminus of atrial natriuretic peptide (ANP). Both in vitro and in vivo experiments were performed to determine the actions of AC-NP. In normal rats, AC-NP proved to be more potentially diuretic, natriuretic and hypotensive compared with other NPs, such as ANP, CNP and vasonatrin peptide (VNP), which is another man-made NP. In relaxation of isolated abdominal aorta from rat, AC-NP was equally effective to ANP, CNP and VNP. Elevated levels of 39,59-guanosine monophosphate (cGMP) in plasma and urine cGMP excretion indicated the participation of cGMP in the functions of AC-NP. Taken together, innovative designed AD-NP might be a new candidate therapeutic peptide against cardiorenal disorders.	[Chen, Bao-Ying; Yu, Jun] Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Peoples R China; [Chen, Bao-Ying; Chen, Jian-Kang; Zhang, Dong-Liang; Sun, Jie-Shen] Fourth Mil Med Univ, Sch Basic Med Sci, Ctr Teaching Expt, Xian 710032, Peoples R China; [Zhu, Miao-Zhang; Pei, Jian-Ming] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China; [Feng, Hua-Song] Gen Hosp Navy Force, Dept Resp Dis, Beijing, Peoples R China; [Zhu, Xiao-Xing] Fourth Mil Med Univ, Dept Pharmacol, Xian 710032, Peoples R China; [Jin, Jian] Jiangnan Univ, Mol Pharmacol Lab, Sch Med & Pharmaceut, Wuxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital; Air Force Military Medical University; Jiangnan University	Chen, BY (corresponding author), Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Peoples R China.	jmpei8@fmmu.edu.cn; jinjian31@126.com; pclamper@163.com			Chinese Natural Science Fund [30870902, 30801385]; New Medicine Research Fund [2009ZX09103-671]; Natural Science Fund of Shaan'xi Province [2010JM4050]	Chinese Natural Science Fund(National Natural Science Foundation of China (NSFC)); New Medicine Research Fund; Natural Science Fund of Shaan'xi Province(Natural Science Foundation of Shaanxi Province)	This work was supported by the Chinese Natural Science Fund (No. 30870902, 30801385), New Medicine Research Fund (No. 2009ZX09103-671), and Natural Science Fund of Shaan'xi Province (No. 2010JM4050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerrigter Guido, 2009, Heart Fail Clin, V5, P501, DOI 10.1016/j.hfc.2009.04.002; Chen BY, 2010, REGUL PEPTIDES, V164, P139, DOI 10.1016/j.regpep.2010.06.007; CLAVELL AL, 1993, AM J PHYSIOL, V264, pR290, DOI 10.1152/ajpregu.1993.264.2.R290; Duda T, 2010, MOL CELL BIOCHEM, V334, P37, DOI 10.1007/s11010-009-0335-7; Foran SE, 2000, P NATL ACAD SCI USA, V97, P7621, DOI 10.1073/pnas.130181897; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Igaki T, 1998, HYPERTENS RES-CLIN E, V21, P7, DOI 10.1291/hypres.21.7; Kilic A, 2010, CARDIOVASC RES, V88, P434, DOI 10.1093/cvr/cvq254; La Villa G, 1998, CLIN SCI, V95, P595; Lisy O, 2008, J AM COLL CARDIOL, V52, P60, DOI 10.1016/j.jacc.2008.02.077; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; WARSHAW DM, 1979, CIRC RES, V45, P250, DOI 10.1161/01.RES.45.2.250; WEI CM, 1993, J CLIN INVEST, V92, P2048, DOI 10.1172/JCI116800; Woodard GE, 2005, REGUL PEPTIDES, V129, P183, DOI 10.1016/j.regpep.2005.02.006; YANDLE TG, 1994, J INTERN MED, V235, P561, DOI 10.1111/j.1365-2796.1994.tb01263.x	15	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20477	10.1371/journal.pone.0020477	http://dx.doi.org/10.1371/journal.pone.0020477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647224	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005800053
J	Luo, BQ; Lam, BS; Lee, SH; Wey, S; Zhou, H; Wang, M; Chen, SY; Adams, GB; Lee, AS				Luo, Biquan; Lam, Ben S.; Lee, Sung Hyung; Wey, Shiuan; Zhou, Hui; Wang, Miao; Chen, Si-Yi; Adams, Gregor B.; Lee, Amy S.			The Endoplasmic Reticulum Chaperone Protein GRP94 Is Required for Maintaining Hematopoietic Stem Cell Interactions with the Adult Bone Marrow Niche	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SELF-RENEWAL; B-CELL; STEM/PROGENITOR CELLS; REGULATOR GRP78/BIP; MASTER CHAPERONE; GP96; QUIESCENCE; LINEAGE; MICE	Hematopoietic stem cell (HSC) homeostasis in the adult bone marrow (BM) is regulated by both intrinsic gene expression products and interactions with extrinsic factors in the HSC niche. GRP94, an endoplasmic reticulum chaperone, has been reported to be essential for the expression of specific integrins and to selectively regulate early T and B lymphopoiesis. In GRP94 deficient BM chimeras, multipotent hematopoietic progenitors persisted and even increased, however, the mechanism is not well understood. Here we employed a conditional knockout (KO) strategy to acutely eliminate GRP94 in the hematopoietic system. We observed an increase in HSCs and granulocyte-monocyte progenitors in the Grp94 KO BM, correlating with an increased number of colony forming units. Cell cycle analysis revealed that a loss of quiescence and an increase in proliferation led to an increase in Grp94 KO HSCs. This expansion of the HSC pool can be attributed to the impaired interaction of HSCs with the niche, evidenced by enhanced HSC mobilization and severely compromised homing and lodging ability of primitive hematopoietic cells. Transplanting wild-type (WT) hematopoietic cells into a GRP94 null microenvironment yielded a normal hematology profile and comparable numbers of HSCs as compared to WT control, suggesting that GRP94 in HSCs, but not niche cells, is required for maintaining HSC homeostasis. Investigating this, we further determined that there was a near complete loss of integrin alpha 4 expression on the cell surface of Grp94 KO HSCs, which showed impaired binding with fibronectin, an extracellular matrix molecule known to play a role in mediating HSC-niche interactions. Furthermore, the Grp94 KO mice displayed altered myeloid and lymphoid differentiation. Collectively, our studies establish GRP94 as a novel cell intrinsic factor required to maintain the interaction of HSCs with their niche, and thus regulate their physiology.	[Luo, Biquan; Wey, Shiuan; Zhou, Hui; Wang, Miao; Lee, Amy S.] Univ So Calif Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Luo, Biquan; Wey, Shiuan; Zhou, Hui; Wang, Miao; Lee, Amy S.] Univ So Calif Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Lam, Ben S.; Adams, Gregor B.] Univ So Calif Keck Sch Med, Dept Cell & Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, USC, Los Angeles, CA USA; [Lee, Sung Hyung; Chen, Si-Yi] Univ So Calif Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Luo, BQ (corresponding author), Univ So Calif Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	National Institutes of Health [CA027607]; American Society of Hematology; National Cancer Institute [P30CA014089]; NATIONAL CANCER INSTITUTE [P30CA014089, R37CA027607, R01CA027607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported from the National Institutes of Health CA027607 (ASL) and the American Society of Hematology (GBA). The USC core facilities described were supported in part by P30CA014089 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baker-LePain JC, 2003, CURR OPIN IMMUNOL, V15, P89, DOI 10.1016/S0952791502000067; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2008, GENE THER, V15, P67, DOI 10.1038/sj.gt.3303066; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Forsberg EC, 2009, HAEMATOL-HEMATOL J, V94, P1477, DOI 10.3324/haematol.2009.013730; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Guo W, 2006, PEDIATR RES, V59, p59R, DOI 10.1203/01.pdr.0000203592.04530.06; Haylock DN, 2007, STEM CELLS, V25, P1062, DOI 10.1634/stemcells.2006-0528; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Jiang Y, 2009, BLOOD, V114, P3773, DOI 10.1182/blood-2009-05-219840; Jockheck-Clark AR, 2010, J IMMUNOL, V185, P6819, DOI 10.4049/jimmunol.1000448; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Mao CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010852; Maynard JC, 2010, DEV BIOL, V339, P295, DOI 10.1016/j.ydbio.2009.12.023; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; PERKINS S, 1988, J CLIN INVEST, V81, P1072, DOI 10.1172/JCI113419; Priestley GV, 2006, BLOOD, V107, P2959, DOI 10.1182/blood-2005-07-2670; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Srivastava PK, 2006, CURR OPIN IMMUNOL, V18, P201, DOI 10.1016/j.coi.2006.01.009; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tzeng YS, 2011, BLOOD, V117, P429, DOI 10.1182/blood-2010-01-266833; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Wagers AJ, 2002, GENE THER, V9, P606, DOI 10.1038/sj.gt.3301717; Wanderling S, 2007, MOL BIOL CELL, V18, P3764, DOI 10.1091/mbc.E07-03-0275; Wang M, 2010, CELL DEATH DIFFER, V17, P488, DOI 10.1038/cdd.2009.144; Wierenga PK, 2006, BONE MARROW TRANSPL, V38, P789, DOI 10.1038/sj.bmt.1705534; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	59	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20364	10.1371/journal.pone.0020364	http://dx.doi.org/10.1371/journal.pone.0020364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647226	Green Submitted, gold, Green Published			2022-12-25	WOS:000291005800045
J	Bruno, RD; Boulanger, CA; Smith, GH				Bruno, R. D.; Boulanger, C. A.; Smith, G. H.			Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor	ONCOGENE			English	Article						lobular progenitor; PI-MEC; Int3; Notch4; mammary development	TUMOR VIRUS; PROGESTERONE-RECEPTOR; CELLS; STEM; DIFFERENTIATION; EXPRESSION; INT-3; GENE	The mouse mammary epithelial cell hierarchy contains both multipotent stem cell as well as lineage-limited duct and lobular progenitor cell functions. The latter-also termed parity-identified mammary epithelial cells (PI-MECs)-are marked by beta-galactosidase (beta Gal) expression following pregnancy and involution in whey acidic protein promoter (WAP)-Cre/Rosa26-flox-stop-flox-lacZ (WC/R26) mice, and are the targets of tumorigenic transformation in mouse mammary tumor virus-erbB2 transgenic mice. In this study, we demonstrate that an epithelial population distinct from PI-MECs is transformed during WAP-Int3 tumorigenesis. As expected, WAP-Int3/WC/R26 triple-transgenic mice failed to undergo secretory alveolar development, failed to lactate and developed mammary tumors. Following pregnancy and involution, beta Gal+ mammary epithelial cells were found in the normal mammary tissue, but the resulting mammary tumors were all beta Gal-. WAP-Int3/WC/R26 mammary glands contained ample estrogen receptor alpha (ER alpha)+ MECs, but only rare (<1%) progesterone receptor (PR)+ and RANKL+ cells. In addition, dissociated MECs from WAP-Int3/WC/R26 glands failed to regenerate a mammary tree upon transplantation into a cleared fat-pad of a nu/nu recipient mouse. However, when mixed with normal MECs, PI-MECs from WAP-Int3/WC/R26 mice contributed progeny to the resulting functional outgrowth. The WAP-Int3/WC/R26-derived PI-MECs displayed all of the properties of fully functional lobular progenitors including giving rise to ER alpha+, PR+, smooth muscle actin+ and RANKL+ epithelial progeny. These results demonstrate that WAP-Int3 has no oncogenic effect upon PI-MECs and that the expansion of functional lobular progenitors is required for secretory alveolar development and lactation. Furthermore, lobular progenitor function is ultimately controlled by signals within its microenvironment. Oncogene (2012) 31, 60-67; doi: 10.1038/onc.2011.215; published online 13 June 2011	[Smith, G. H.] NCI, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Smith, GH (corresponding author), NCI, Mammary Biol & Tumorigenesis Lab, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37,Room 1112B, Bethesda, MD 20892 USA.	smithg@mail.nih.gov		Bruno, Robert/0000-0003-3329-9478	NCI's Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010021] Funding Source: NIH RePORTER	NCI's Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NCI's Center for Cancer Research Intramural Research Program funded this work.	Booth BW, 2011, ONCOGENE, V30, P679, DOI 10.1038/onc.2010.439; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2001, ONCOGENE, V20, P2264, DOI 10.1038/sj.onc.1204312; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Bruno RD, 2011, STEM CELL REV REP, V7, P238, DOI 10.1007/s12015-010-9191-9; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; GALLAHAN D, 1987, J VIROL, V61, P66, DOI 10.1128/JVI.61.1.66-74.1987; Gallahan D, 1996, CANCER RES, V56, P1775; GALLAHAN D, 1987, J VIROL, V61, P218, DOI 10.1128/JVI.61.1.218-220.1987; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; JHAPPAN C, 1992, GENE DEV, V6, P345, DOI 10.1101/gad.6.3.345; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Mukherjee A, 2010, FASEB J, V24, P4408, DOI 10.1096/fj.10-157982; Raafat A, 2009, ONCOGENE, V28, P219, DOI 10.1038/onc.2008.379; Smith GH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1856; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323	23	14	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	1					60	67		10.1038/onc.2011.215	http://dx.doi.org/10.1038/onc.2011.215			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21666720	Green Accepted			2022-12-25	WOS:000299176200006
J	Garcia-Marcos, M; Kietrsunthorn, PS; Wang, HH; Ghosh, P; Farquhar, MG				Garcia-Marcos, Mikel; Kietrsunthorn, Patrick S.; Wang, Honghui; Ghosh, Pradipta; Farquhar, Marilyn G.			G Protein Binding Sites on Calnuc (Nucleobindin 1) and NUCB2 (Nucleobindin 2) Define a New Class of G alpha(i)-regulatory Motifs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; HETEROTRIMERIC G-PROTEINS; G-ALPHA-I; GOLOCO-MOTIF; HIGH-THROUGHPUT; DOMAIN; RGS; ACTIVATION; IDENTIFICATION; STABILIZATION	Heterotrimeric G proteins are molecular switches modulated by families of structurally and functionally related regulators. GIV (G alpha-interacting vesicle-associated protein) is the first nonreceptor guanine nucleotide exchange factor (GEF) that activates G alpha(i) subunits via a defined, evolutionarily conserved motif. Here we found that Calnuc and NUCB2, two highly homologous calcium-binding proteins, share a common motif with GIV for G alpha(i) binding and activation. Bioinformatics searches and structural analysis revealed that Calnuc and NUCB2 possess an evolutionarily conserved motif with sequence and structural similarity to the GEF sequence of GIV. Using in vitro pulldown and competition assays, we demonstrate that this motif binds preferentially to the inactive conformation of G alpha(i1) and G alpha(i3) over other G alpha subunits and, like GIV, docks onto the alpha 3/switch II cleft. Calnuc binding was impaired when Lys-248 in the alpha 3 helix of G alpha(i3) was replaced with M, the corresponding residue in G alpha(o), which does not bind to Calnuc. Moreover, mutation of hydrophobic residues in the conserved motif predicted to dock on the alpha 3/switch II cleft of G alpha(i3) impaired the ability of Calnuc and NUCB2 to bind and activate G alpha(i3) in vitro. We also provide evidence that calcium binding to Calnuc and NUCB2 abolishes their interaction with G alpha(i3) in vitro and in cells, probably by inducing a conformational change that renders the G alpha(i)-binding residues inaccessible. Taken together, our results identify a new type of G alpha(i)-regulatory motif named the GBA motif (for G alpha-binding and -activating motif), which is conserved across different proteins throughout evolution. These findings provide the structural basis for the properties of Calnuc and NUCB2 binding to G alpha subunits and its regulation by calcium ions.	[Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Ghosh, Pradipta] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mfarquhar@ucsd.edu	Wang, Hong-Hui/P-9466-2016	Wang, Hong-Hui/0000-0002-4420-9733; Garcia-Marcos, Mikel/0000-0001-9513-4826	National Institutes of Health [DKI7780, CA100768]; Susan G. Komen Foundation [KG080079]; American Gastroenterology Association; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); American Gastroenterology Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DKI7780 and CA100768 (to M. G. F.).; Supported by Postdoctoral Fellowship KG080079 from the Susan G. Komen Foundation.; Supported by a Career Award for Medical Scientists (CAMS) from the Burroughs Wellcome Fund and a Research Scholar Award from the American Gastroenterology Association.	Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Austin RJ, 2008, J MOL BIOL, V377, P1406, DOI 10.1016/j.jmb.2008.01.032; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cuppen E, 2003, COMP FUNCT GENOM, V4, P479, DOI 10.1002/cfg.318; de Alba E, 2004, BIOCHEMISTRY-US, V43, P10039, DOI 10.1021/bi049310a; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DENKER BM, 1992, J BIOL CHEM, V267, P9998; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Kapoor N, 2010, J BIOL CHEM, V285, P31647, DOI 10.1074/jbc.M110.148429; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Lin P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-15; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Mittal V, 2004, J BIOL CHEM, V279, P46772, DOI 10.1074/jbc.M407409200; MIURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1388, DOI 10.1006/bbrc.1994.1384; Morel-Huaux VM, 2002, EUR J CELL BIOL, V81, P87, DOI 10.1078/0171-9335-00224; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Shu FJ, 2007, CELL SIGNAL, V19, P163, DOI 10.1016/j.cellsig.2006.06.002; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sjogren B, 2010, PROG MOL BIOL TRANSL, V91, P81, DOI 10.1016/S1877-1173(10)91004-1; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Willard FS, 2006, BIOCHEM BIOPH RES CO, V339, P1107, DOI 10.1016/j.bbrc.2005.11.132; Woulfe DS, 1999, J BIOL CHEM, V274, P17718, DOI 10.1074/jbc.274.25.17718	48	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28138	28149		10.1074/jbc.M110.204099	http://dx.doi.org/10.1074/jbc.M110.204099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21653697	Green Published, hybrid			2022-12-25	WOS:000293557800032
J	Ge, Q; Nakagawa, T; Wynn, RM; Chook, YM; Miller, BC; Uyeda, K				Ge, Qiang; Nakagawa, Tsutomu; Wynn, R. Max; Chook, Yuh Min; Miller, Bonnie C.; Uyeda, Kosaku			Importin-alpha Protein Binding to a Nuclear Localization Signal of Carbohydrate Response Element-Binding Protein (ChREBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILLIAMS-BEUREN-SYNDROME; TRANSCRIPTION FACTOR; SUBCELLULAR-LOCALIZATION; STRUCTURAL BASIS; GLUCOSE; RECOGNITION; REGION; GENE; PHOSPHORYLATION; LIPOGENESIS	Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that plays a critical role in the glucose-mediated induction of genes involved in hepatic glycolysis and lipogenesis. Circulating blood glucose levels affect ChREBP activity in hepatocytes largely by post-translational mechanisms that include phosphorylation-dependent subcellular localization. Previously, we showed that ChREBP is retained in the cytosol by phosphorylation-dependent binding to 14-3-3 protein dimers and identified the alpha 2 helix (residues 125-135) phospho-Ser(140) domain as the primary 14-3-3 binding site (Sakiyama, H., Wynn, R. M., Lee, W. R., Fukasawa, M., Mizuguchi, H., Gardner, K. H., Repa, J. J., and Uyeda, K. (2008) J. Biol. Chem. 283, 24899-24908). To enter the nucleus in response to high glucose, ChREBP must bind importin-alpha; this heterodimer then forms a complex with importin-beta to interact with the nuclear pore complex. In this work, we recharacterized the importin-alpha binding nuclear localization signal (NLS) of rat ChREBP, identifying it as an extended classical bipartite NLS encompassing minimally residues 158-190. Replacing Lys(159)/Lys(190) residues of ChREBP with alanine resulted in loss of importin-alpha binding, glucose-stimulated transcriptional activity and nuclear localization. Asecondary 14-3-3 protein binding site also was identified, the alpha 3 helix (residues 170-190) phospho-Ser(196) domain. Importin-alpha and 14-3-3 were found to bind competitively to this secondary site. These results suggest an important mechanism by which importin-alpha and 14-3-3 control movement of ChREBP in and out of the nucleus in response to changes in glucose levels in liver and thus further suggest that the extended NLS of ChREBP is a critical glucose-sensing, glucose-responsive site.	[Ge, Qiang; Nakagawa, Tsutomu; Wynn, R. Max; Uyeda, Kosaku] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chook, Yuh Min] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Miller, Bonnie C.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Uyeda, K (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kosaku.uyeda@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019	Wynn, Richard/0000-0002-1879-2136	National Institutes of Health, NIDDK [R01 DK063948]; Department of Veterans Affairs; Welch Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063948] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs(US Department of Veterans Affairs); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK Grant R01 DK063948 and the Department of Veterans Affairs. This work was also supported by the Welch Foundation.	Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cairo S, 2001, HUM MOL GENET, V10, P617, DOI 10.1093/hmg/10.6.617; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Davies MN, 2010, AM J PHYSIOL-ENDOC M, V299, pE665, DOI 10.1152/ajpendo.00349.2010; de Luis O, 2000, EUR J HUM GENET, V8, P215, DOI 10.1038/sj.ejhg.5200435; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; McLane LM, 2009, IUBMB LIFE, V61, P697, DOI 10.1002/iub.194; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103	24	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28119	28127		10.1074/jbc.M111.237016	http://dx.doi.org/10.1074/jbc.M111.237016			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21665952	Green Published, hybrid			2022-12-25	WOS:000293557800030
J	Fagan, RP; Fairweather, NF				Fagan, Robert P.; Fairweather, Neil F.			Clostridium difficile Has Two Parallel and Essential Sec Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-LAYER PROTEINS; CELL-SURFACE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ATP-BINDING; S-LAYER; TOXIN-B; BACTERIAL; GENES; WALL	Protein translocation across the cytoplasmic membrane is an essential process in all bacteria. The Sec system, comprising at its core an ATPase, SecA, and a membrane channel, SecYEG, is responsible for the majority of this protein transport. Recently, a second parallel Sec system has been described in a number of Gram-positive species. This accessory Sec system is characterized by the presence of a second copy of the energizing ATPase, SecA2; where it has been studied, SecA2 is responsible for the translocation of a subset of Sec substrates. In common with many pathogenic Gram-positive species, Clostridium difficile possesses two copies of SecA. Here, we describe the first characterization of the C. difficile accessory Sec system and the identification of its major substrates. Using inducible antisense RNA expression and dominant-negative alleles of secA1 and secA2, we demonstrate that export of the S-layer proteins (SLPs) and an additional cell wall protein (CwpV) is dependent on SecA2. Accumulation of the cytoplasmic precursor of the SLPs SlpA and other cell wall proteins was observed in cells expressing dominant-negative secA1 or secA2 alleles, concomitant with a decrease in the levels of mature SLPs in the cell wall. Furthermore, expression of either dominant-negative allele or antisense RNA knockdown of SecA1 or SecA2 dramatically impaired growth, indicating that both Sec systems are essential in C. difficile.	[Fagan, Robert P.; Fairweather, Neil F.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Imperial College London	Fagan, RP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, S Kensington Campus, London SW7 2AZ, England.	r.fagan@imperial.ac.uk	Fagan, Robert/H-9925-2013	Fagan, Robert/0000-0002-8704-4828	Medical Research Council [G0800170]; MRC [G0800170] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0800170.	Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Caspers M, 2008, ARCH MICROBIOL, V189, P605, DOI 10.1007/s00203-008-0351-0; Chen Q, 2004, MOL MICROBIOL, V53, P843, DOI 10.1111/j.1365-2958.2004.04116.x; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Coulthurst SJ, 2008, MOL MICROBIOL, V69, P1331, DOI 10.1111/j.1365-2958.2008.06367.x; Dang THT, 2010, ACS CHEM BIOL, V5, P279, DOI 10.1021/cb9002859; de la Riva L, 2011, J BACTERIOL, V193, P3276, DOI 10.1128/JB.00248-11; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Economou A, 2001, Expert Opin Ther Targets, V5, P141, DOI 10.1517/14728222.5.2.141; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Fagan R, 2010, METHODS MOL BIOL, V646, P117, DOI 10.1007/978-1-60327-365-7_8; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; GEISSENDORFER M, 1990, APPL MICROBIOL BIOT, V33, P657, DOI 10.1007/BF00604933; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Janoir C, 2007, J BACTERIOL, V189, P7174, DOI 10.1128/JB.00578-07; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; KAWATA T, 1984, FEMS MICROBIOL LETT, V24, P323, DOI 10.1016/0378-1097(84)90273-8; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kuipers EJ, 2008, LANCET, V371, P1486, DOI 10.1016/S0140-6736(08)60635-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz LL, 2002, MOL MICROBIOL, V45, P1043, DOI 10.1046/j.1365-2958.2002.03072.x; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; Pechine S, 2005, J MED MICROBIOL, V54, P193, DOI 10.1099/jmm.0.45800-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Reynolds CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002024; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sheridan PP, 2003, GEOMICROBIOL J, V20, P1, DOI 10.1080/01490450303891; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wright A, 2008, J MED MICROBIOL, V57, P750, DOI 10.1099/jmm.0.47532-0	48	154	155	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27483	27493		10.1074/jbc.M111.263889	http://dx.doi.org/10.1074/jbc.M111.263889			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659510	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000293268700043
J	Gong, R; Wang, YP; Feng, Y; Zhao, Q; Dimitrov, DS				Gong, Rui; Wang, Yanping; Feng, Yang; Zhao, Qi; Dimitrov, Dimiter S.			Shortened Engineered Human Antibody CH2 Domains INCREASED STABILITY AND BINDING TO THE HUMAN NEONATAL Fc RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-G; PROTEINS; REGION; SCAFFOLDS; LYSOZYME; AFFINITY	The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH2 domains are promising scaffolds for construction of libraries containing diverse binders that could also confer some effector functions. We have shown previously that an isolated human CH2 domain is relatively unstable to thermally induced unfolding, but its stability can be improved by engineering an additional disulfide bond (Gong, R., Vu, B. K., Feng, Y., Prieto, D. A., Dyba, M. A., Walsh, J. D., Prabakaran, P., Veenstra, T. D., Tarasov, S. G., Ishima, R., and Dimitrov, D. S. (2009) J. Biol. Chem. 284, 14203-14210). We have hypothesized that the stability of this engineered antibody domain could be further increased by removing unstructured residues. To test our hypothesis, we removed the seven N-terminal residues that are in a random coil as suggested by our analysis of the isolated CH2 crystal structure and NMR data. The resulting shortened engineered CH2 (m01s) was highly soluble, monomeric, and remarkably stable, with a melting temperature (T-m) of 82.6 degrees C, which is about 10 and 30 degrees C higher than those of the original stabilized CH2 (m01) and CH2, respectively. m01s and m01 were more resistant to protease digestion than CH2. A newly identified anti-CH2 antibody that recognizes a conformational epitope bound to m01s significantly better (> 10-fold higher affinity) than to CH2 and slightly better than to m01. m01s bound to a recombinant soluble human neonatal Fc receptor at pH 6.0 more strongly than CH2. These data suggest that shortening the m01 N terminus significantly increases stability without disrupting its conformation and that our approach for increasing stability and decreasing size by removing unstructured regions may also apply to other proteins.	[Gong, Rui; Wang, Yanping; Feng, Yang; Zhao, Qi; Dimitrov, Dimiter S.] NCI, Prot Interact Grp, CCRNP, CCR,NIH, Frederick, MD 21702 USA; [Wang, Yanping] NCI, SAIC Frederick Inc, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Dimitrov, DS (corresponding author), NCI, Prot Interact Grp, CCRNP, CCR,NIH, Bldg 469,Rm 150B, Frederick, MD 21702 USA.	dimiter.dimitrov@nih.gov		Zhao, Qi/0000-0002-5969-6407	National Institutes of Health; National Institutes of Health NIAID; National Institutes of Health NCI Center for Cancer Research; National Institutes of Health NCI [N01-CO-12400]; NATIONAL CANCER INSTITUTE [ZIABC011155, ZIABC010701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Intramural AIDS Targeted Antiviral Program (IATAP), the National Institutes of Health NIAID Intramural Biodefense Program, and the National Institutes of Health NCI Center for Cancer Research Intramural Research Program. This work was supported, in whole or in part, by federal funds from National Institutes of Health NCI Contract N01-CO-12400.	Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; De Sancho D, 2009, J AM CHEM SOC, V131, P2074, DOI 10.1021/ja808843h; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; ELLERSON JR, 1972, FEBS LETT, V24, P318, DOI 10.1016/0014-5793(72)80381-8; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; FENG Y, 2011, PROTEIN EXP IN PRESS; Gong R, 2009, J BIOL CHEM, V284, P14203, DOI 10.1074/jbc.M900769200; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Kolmar H, 2008, FEBS J, V275, P2667, DOI 10.1111/j.1742-4658.2008.06437.x; Nygren PA, 2004, J IMMUNOL METHODS, V290, P3, DOI 10.1016/j.jim.2004.04.006; Prabakaran P, 2008, ACTA CRYSTALLOGR D, V64, P1062, DOI 10.1107/S0907444908025274; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; YASMEEN D, 1976, J IMMUNOL, V116, P518; Zhu Zhongyu, 2009, V525, P129, DOI 10.1007/978-1-59745-554-1_6	20	44	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27288	27293		10.1074/jbc.M111.254219	http://dx.doi.org/10.1074/jbc.M111.254219			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669873	Green Published, hybrid			2022-12-25	WOS:000293268700024
J	Mohammadi, M; Viger, JF; Kumar, P; Barriault, D; Bolin, JT; Sylvestre, M				Mohammadi, Mahmood; Viger, Jean-Francois; Kumar, Pravindra; Barriault, Diane; Bolin, Jeffrey T.; Sylvestre, Michel			Retuning Rieske-type Oxygenases to Expand Substrate Range	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURKHOLDERIA-XENOVORANS LB400; COMAMONAS-TESTOSTERONI B-356; RING-HYDROXYLATING DIOXYGENASE; BIPHENYL DIOXYGENASE; NAPHTHALENE DIOXYGENASE; DIRECTED EVOLUTION; ACTIVE-SITE; POLYCHLORINATED-BIPHENYLS; RANDOM MUTAGENESIS; CRYSTAL-STRUCTURE	Rieske-type oxygenases are promising biocatalysts for the destruction of persistent pollutants or for the synthesis of fine chemicals. In this work, we explored pathways through which Rieske-type oxygenases evolve to expand their substrate range. BphAE(p4), a variant biphenyl dioxygenase generated from Burkholderia xenovorans LB400 BphAE(LB400) by the double substitution T335A/F336M, and BphAE(RR41), obtained by changing Asn(338), Ile(341), and Leu(409) of BphAEp(4) to Gln(338), Val(341), and Phe(409), metabolize dibenzofuran two and three times faster than BphAE(LB400), respectively. Steady-state kinetic measurements of single-and multiple-substitution mutants of BphAE(LB400) showed that the single T335A and the double N338Q/L409F substitutions contribute significantly to enhanced catalytic activity toward dibenzofuran. Analysis of crystal structures showed that the T335A substitution relieves constraints on a segment lining the catalytic cavity, allowing a significant displacement in response to dibenzofuran binding. The combined N338Q/L409F substitutions alter substrate-induced conformational changes of protein groups involved in subunit assembly and in the chemical steps of the reaction. This suggests a responsive induced fit mechanism that retunes the alignment of protein atoms involved in the chemical steps of the reaction. These enzymes can thus expand their substrate range through mutations that alter the constraints or plasticity of the catalytic cavity to accommodate new substrates or that alter the induced fit mechanism required to achieve proper alignment of reaction-critical atoms or groups.	[Mohammadi, Mahmood; Viger, Jean-Francois; Barriault, Diane; Sylvestre, Michel] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada; [Kumar, Pravindra; Bolin, Jeffrey T.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Kumar, Pravindra; Bolin, Jeffrey T.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Kumar, Pravindra] Indian Inst Technol, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India	University of Quebec; Institut national de la recherche scientifique (INRS); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Sylvestre, M (corresponding author), Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ H7V 1B7, Canada.	Michel.Sylvestre@iaf.inrs.ca	KUMAR, PRAVINDRA/AAF-2859-2020	KUMAR, PRAVINDRA/0000-0003-2128-7736; Sylvestre, Michel/0000-0002-6942-3373	Natural Sciences and Engineering Research Council of Canada [RGPIN/39579-2007]; Indian Department of Science and Technology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Indian Department of Science and Technology(Department of Science & Technology (India))	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN/39579-2007 and an Indian Department of Science and Technology young scientist grant	Bak-Jensen KS, 2004, J BIOL CHEM, V279, P10093, DOI 10.1074/jbc.M312825200; Barriault D, 2004, J BIOL CHEM, V279, P47480, DOI 10.1074/jbc.M406805200; Barriault D, 2002, J BACTERIOL, V184, P3794, DOI 10.1128/JB.184.14.3794-3800.2002; Chang YS, 2008, J MOL MICROB BIOTECH, V15, P152, DOI 10.1159/000121327; Chun HK, 2003, J MOL CATAL B-ENZYM, V21, P113, DOI 10.1016/S1381-1177(02)00085-1; Dietrich M, 2009, J BIOTECHNOL, V139, P115, DOI 10.1016/j.jbiotec.2008.10.002; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; ERICKSON BD, 1992, J BACTERIOL, V174, P2903, DOI 10.1128/JB.174.9.2903-2912.1992; Ferraro DJ, 2006, J BACTERIOL, V188, P6986, DOI 10.1128/JB.00707-06; Furukawa K, 2004, J BACTERIOL, V186, P5189, DOI 10.1128/JB.186.16.5189-5196.2004; Furusawa Y, 2004, J MOL BIOL, V342, P1041, DOI 10.1016/j.jmb.2004.07.062; HADDOCK JD, 1995, J BACTERIOL, V177, P5834, DOI 10.1128/jb.177.20.5834-5839.1995; HADDOCK JD, 1995, J BACTERIOL, V177, P20, DOI 10.1128/jb.177.1.20-26.1995; Huang WC, 2007, J MOL BIOL, V373, P633, DOI 10.1016/j.jmb.2007.08.015; Hurtubise Y, 1996, J BIOL CHEM, V271, P8152, DOI 10.1074/jbc.271.14.8152; HURTUBISE Y, 1995, J BACTERIOL, V177, P6610, DOI 10.1128/jb.177.22.6610-6618.1995; Imbeault NYR, 2000, J BIOL CHEM, V275, P12430, DOI 10.1074/jbc.275.17.12430; Inoue K, 2009, J MOL BIOL, V392, P436, DOI 10.1016/j.jmb.2009.07.029; Jakoncic J, 2007, BIOCHEM BIOPH RES CO, V352, P861, DOI 10.1016/j.bbrc.2006.11.117; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kauppi B, 1998, STRUCTURE, V6, P571, DOI 10.1016/S0969-2126(98)00059-8; Kumar P, 2011, ACTA CRYSTALLOGR F, V67, P59, DOI 10.1107/S1744309110043393; Kumar P, 2011, J MOL BIOL, V405, P531, DOI 10.1016/j.jmb.2010.11.009; L'Abbee JB, 2005, APPL MICROBIOL BIOT, V67, P506, DOI 10.1007/s00253-004-1791-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN JJ, 1992, BIOTECHNIQUES, V12, P718; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mohammadi M, 2005, CHEM BIOL, V12, P835, DOI 10.1016/j.chembiol.2005.05.017; Mondello FJ, 1997, APPL ENVIRON MICROB, V63, P3096, DOI 10.1128/AEM.63.8.3096-3103.1997; Ostrander EL, 2009, BIOCHEMISTRY-US, V48, P951, DOI 10.1021/bi802094k; Parales RE, 2000, J BACTERIOL, V182, P1641, DOI 10.1128/JB.182.6.1641-1649.2000; Parales RE, 1999, J BACTERIOL, V181, P1831, DOI 10.1128/JB.181.6.1831-1837.1999; Sambrook J., 2002, MOL CLONING LAB MANU; Seeger M, 2001, J BACTERIOL, V183, P3548, DOI 10.1128/JB.183.12.3548-3555.2001; Seeger M, 2003, APPL ENVIRON MICROB, V69, P5045, DOI 10.1128/AEM.69.9.5045-5050.2003; Seo J, 2011, APPL MICROBIOL BIOT, V89, P1773, DOI 10.1007/s00253-010-2989-1; Suenaga H, 2001, J BACTERIOL, V183, P5441, DOI 10.1128/JB.183.18.5441-5444.2001; Suenaga H, 2001, J BIOL CHEM, V276, P22500, DOI 10.1074/jbc.M101323200; Suenaga H, 1999, J BIOSCI BIOENG, V87, P430, DOI 10.1016/S1389-1723(99)80090-5; Suenaga H, 2006, APPL MICROBIOL BIOT, V71, P168, DOI 10.1007/s00253-005-0135-2; Sylvestre M, 2004, INT BIODETER BIODEGR, V54, P153, DOI 10.1016/j.ibiod.2004.03.011; Vezina J, 2007, J BACTERIOL, V189, P779, DOI 10.1128/JB.01267-06; Xu D, 2002, BIOCHEMISTRY-US, V41, P13627, DOI 10.1021/bi020446n; Zielinski M, 2006, APPL ENVIRON MICROB, V72, P2191, DOI 10.1128/AEM.72.3.2191-2199.2006; Zielinski M, 2003, J BACTERIOL, V185, P6976, DOI 10.1128/JB.185.23.6976-6980.2003	45	29	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27612	27621		10.1074/jbc.M111.255174	http://dx.doi.org/10.1074/jbc.M111.255174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21653696	Green Published, hybrid			2022-12-25	WOS:000293268700054
J	Xiao, YC; Jackson, JO; Liang, SP; Cummins, TR				Xiao, Yucheng; Jackson, James O., II; Liang, Songping; Cummins, Theodore R.			Common Molecular Determinants of Tarantula Huwentoxin-IV Inhibition of Na+ Channel Voltage Sensors in Domains II and IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SCORPION TOXIN; GATED SODIUM-CHANNELS; GATING MODIFIER; PAIN DISORDERS; ALPHA-SUBUNIT; K+ CHANNEL; PROTX-II; INACTIVATION; ACTIVATION; PHARMACOLOGY	The voltage sensors of domains II and IV of sodium channels are important determinants of activation and inactivation, respectively. Animal toxins that alter electrophysiological excitability of muscles and neurons often modify sodium channel activation by selectively interacting with domain II and inactivation by selectively interacting with domain IV. This suggests that there may be substantial differences between the toxin-binding sites in these two important domains. Here we explore the ability of the tarantula huwentoxin-IV (HWTX-IV) to inhibit the activity of the domain II and IV voltage sensors. HWTX-IV is specific for domain II, and we identify five residues in the S1-S2 (Glu-753) and S3-S4 (Glu-811, Leu-814, Asp-816, and Glu-818) regions of domain II that are crucial for inhibition of activation by HWTX-IV. These data indicate that a single residue in the S3-S4 linker (Glu-818 in hNav1.7) is crucial for allowing HWTX-IV to interact with the other key residues and trap the voltage sensor in the closed configuration. Mutagenesis analysis indicates that the five corresponding residues in domain IV are all critical for endowing HWTX-IV with the ability to inhibit fast inactivation. Our data suggest that the toxin-binding motif in domain II is conserved in domain IV. Increasing our understanding of the molecular determinants of toxin interactions with voltage-gated sodium channels may permit development of enhanced isoform-specific voltage-gating modifiers.	[Xiao, Yucheng; Jackson, James O., II; Liang, Songping] Hunan Normal Univ, Life Sci Coll, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Hunan, Peoples R China; [Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA	Hunan Normal University; Indiana University System; Indiana University Bloomington	Liang, SP (corresponding author), Hunan Normal Univ, Life Sci Coll, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; trcummin@iupui.edu	Xiao, Yucheng/H-3600-2012		National Institutes of Health [NS054642, NS053422]; 973 Research Program of China [2010CB529800]; Hunan Provincial Education Department [07A035]; Program for New Century Excellent Talents in University [NCET-07-0279]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS053422, R21NS054642, R01NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Research Program of China(National Basic Research Program of China); Hunan Provincial Education Department(Hunan Provincial Education Department); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054642 and NS053422 (to T. R. C.). This work was also supported by the 973 Research Program of China under Contract 2010CB529800 (to S. L.); the Scientific Research Fund of Hunan Provincial Education Department (07A035) and the Program for New Century Excellent Talents in University under Contract NCET-07-0279 (to Y. X.).	Bechtold DA, 2005, J NEUROL SCI, V233, P27, DOI 10.1016/j.jns.2005.03.003; Blumenthal KM, 2003, CELL BIOCHEM BIOPHYS, V38, P215, DOI 10.1385/CBB:38:2:215; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Corzo G, 2003, FEBS LETT, V547, P43, DOI 10.1016/S0014-5793(03)00666-5; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cummins TR, 2007, PAIN, V131, P243, DOI 10.1016/j.pain.2007.07.026; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Drenth JPH, 2007, J CLIN INVEST, V117, P3603, DOI 10.1172/JCI33297; Goldin AL, 2003, CURR OPIN NEUROBIOL, V13, P284, DOI 10.1016/S0959-4388(03)00065-5; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; Karbat I, 2004, FASEB J, V18, P683, DOI 10.1096/fj.03-0733com; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Liao Z, 2006, BIOCHEMISTRY-US, V45, P15591, DOI 10.1021/bi061457+; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mantegazza M, 2005, J PHYSIOL-LONDON, V568, P13, DOI 10.1113/jphysiol.2005.093484; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Sheets MF, 2007, J PHYSIOL-LONDON, V582, P317, DOI 10.1113/jphysiol.2007.134262; Struyk AF, 2000, J NEUROSCI, V20, P8610; Wang MC, 2007, BIOCHEM BIOPH RES CO, V357, P579, DOI 10.1016/j.bbrc.2007.02.168; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Zuo XP, 2006, FEBS LETT, V580, P4508, DOI 10.1016/j.febslet.2006.07.024	35	50	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27301	27310		10.1074/jbc.M111.246876	http://dx.doi.org/10.1074/jbc.M111.246876			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659528	hybrid, Green Published			2022-12-25	WOS:000293268700026
J	Lemmon, CA; Ohashi, T; Erickson, HP				Lemmon, Christopher A.; Ohashi, Tomoo; Erickson, Harold P.			Probing the Folded State of Fibronectin Type III Domains in Stretched Fibrils by Measuring Buried Cysteine Accessibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; CELL-ADHESION; MATRIX; PROTEIN; ELASTICITY; MOLECULE; CONFORMATION; EXTENSION	Fibronectin (FN) is an extracellular matrix protein that is assembled into fibrils by cells during tissue morphogenesis and wound healing. FN matrix fibrils are highly elastic, but the mechanism of elasticity has been debated: it may be achieved by mechanical unfolding of FN-III domains or by a conformational change of the molecule without domain unfolding. Here, we investigate the folded state of FN-III domains in FN fibrils by measuring the accessibility of buried cysteines. Four of the 15 FN-III domains (III-2, -3, -9, and -11) appear to unfold in both stretched fibrils and in solution, suggesting that these domains spontaneously open and close even in the absence of tension. Two FN-III domains (III-6 and -12) appear to unfold only in fibrils and not in solution. These results suggest that domain unfolding can at best contribute partially to the 4-fold extensibility of fibronectin fibrils.	[Lemmon, Christopher A.; Ohashi, Tomoo; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University	Lemmon, CA (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, 412 Nanaline Duke Bldg,Box 3709, Durham, NC 27710 USA.	christopher.lemmon@duke.edu	Lemmon, Christopher/GPP-1470-2022	Lemmon, Christopher/0000-0002-9049-6366	National Institutes of Health [CA47056, GM089331]; NATIONAL CANCER INSTITUTE [R01CA047056, R37CA047056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA47056 (to H. P. E.) and GM089331 (to C. A. L.).	Abu-Lail NI, 2006, MATRIX BIOL, V25, P175, DOI 10.1016/j.matbio.2005.10.007; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; CHERNOUSOV MA, 1987, FEBS LETT, V217, P124, DOI 10.1016/0014-5793(87)81255-3; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; ERICKSON HP, 1983, J BIOL CHEM, V258, P4539; Erickson HP, 2002, J MUSCLE RES CELL M, V23, P575, DOI 10.1023/A:1023427026818; Fisher TE, 1999, TRENDS BIOCHEM SCI, V24, P379, DOI 10.1016/S0968-0004(99)01453-X; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NAGAI T, 1991, J CELL BIOL, V114, P1295, DOI 10.1083/jcb.114.6.1295; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ohashi T, 1999, P NATL ACAD SCI USA, V96, P2153, DOI 10.1073/pnas.96.5.2153; Ohashi T, 2002, J CELL SCI, V115, P1221; Ohashi T, 2009, BIOCHEMISTRY-US, V48, P4189, DOI 10.1021/bi900001g; Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Sivakumar P, 2006, J CELL SCI, V119, P1350, DOI 10.1242/jcs.02830; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	36	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26375	26382		10.1074/jbc.M111.240028	http://dx.doi.org/10.1074/jbc.M111.240028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652701	Green Published, hybrid			2022-12-25	WOS:000293078200014
J	de Jong, S; Kas, MJH; Kiernan, J; de Mooij-van Malsen, AG; Oppelaar, H; Janson, E; Vukobradovic, I; Farber, CR; Stanford, WL; Ophoff, RA				de Jong, Simone; Kas, Martien J. H.; Kiernan, Jeffrey; de Mooij-van Malsen, Annetrude G.; Oppelaar, Hugo; Janson, Esther; Vukobradovic, Igor; Farber, Charles R.; Stanford, William L.; Ophoff, Roel A.			Hippocampal Gene Expression Analysis Highlights Ly6a/Sca-1 as Candidate Gene for Previously Mapped Novelty Induced Behaviors in Mice	PLOS ONE			English	Article							CHROMOSOME SUBSTITUTION STRAINS; COEXPRESSION NETWORK ANALYSIS; QUANTITATIVE TRAIT LOCI; STEM-CELL; EXPLORATORY-BEHAVIOR; ILLUMINA MICROARRAY; INBRED STRAINS; MOTOR-ACTIVITY; ANXIETY; MOUSE	In this study, we show that the covariance between behavior and gene expression in the brain can help further unravel the determinants of neurobehavioral traits. Previously, a QTL for novelty induced motor activity levels was identified on murine chromosome 15 using consomic strains. With the goal of narrowing down the linked region and possibly identifying the gene underlying the quantitative trait, gene expression data from this F-2-population was collected and used for expression QTL analysis. While genetic variation in these mice was limited to chromosome 15, eQTL analysis of gene expression showed strong cis-effects as well as trans-effects elsewhere in the genome. Using weighted gene co-expression network analysis, we were able to identify modules of co-expressed genes related to novelty induced motor activity levels. In eQTL analyses, the expression of Ly6a (a.k.a. Sca-1) was found to be cis-regulated by chromosome 15. Ly6a also surfaced in a group of genes resulting from the network analysis that was correlated with behavior. Behavioral analysis of Ly6a knock-out mice revealed reduced novelty induced motor activity levels when compared to wild type controls, confirming functional importance of Ly6a in this behavior, possibly through regulating other genes in a pathway. This study shows that gene expression profiling can be used to narrow down a previously identified behavioral QTL in mice, providing support for Ly6a as a candidate gene for functional involvement in novelty responsiveness.	[de Jong, Simone; Janson, Esther; Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Kas, Martien J. H.; Oppelaar, Hugo] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands; [Kiernan, Jeffrey; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [de Mooij-van Malsen, Annetrude G.] Nijmegen Ctr Neurosci, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, Nijmegen, Netherlands; [Vukobradovic, Igor] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Modeling Human Dis, Toronto, ON M5G 1X5, Canada; [Farber, Charles R.] Univ Virginia, Dept Med, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Farber, Charles R.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Toronto; Radboud University Nijmegen; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Virginia; University of Virginia; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	de Jong, S (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	ROphoff@mednet.ucla.edu	Kas, Martien J./G-8269-2018	Kas, Martien J./0000-0002-4471-8618; de Jong, Simone/0000-0002-8002-7195; Farber, Charles/0000-0002-6748-4711; de Mooij-van Malsen, Johanne Gertrude/0000-0003-0960-6431; Stanford, William/0000-0002-5813-8016	Canadian Institutes of Health Research [FRN62788]; Van Walree Fund; Royal Netherlands Academy of Arts and Sciences; Utrecht University; National Institutes of Health	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Van Walree Fund; Royal Netherlands Academy of Arts and Sciences; Utrecht University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: The study was supported by the Canadian Institutes of Health Research (FRN62788) to WLS, by travel grants to SDJ from the Van Walree Fund, the Royal Netherlands Academy of Arts and Sciences, and Utrecht University's California Research Cooperation Fund, and research funding from the National Institutes of Health to RAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly W, 2006, AMYOTROPH LATERAL SC, V7, P112, DOI 10.1080/14660820500443000; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; de Jong S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-20; de Mooij-van Malsen A, 2008, EUR J PHARMACOL, V585, P436, DOI 10.1016/j.ejphar.2008.01.057; DEMOOIJVANMALSE.AJ, 2009, BIOL PSYCHIAT; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gatti DM, 2009, MAMM GENOME, V20, P437, DOI 10.1007/s00335-009-9199-0; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Henderson ND, 2004, BEHAV GENET, V34, P267, DOI 10.1023/B:BEGE.0000017872.25069.44; Holmes C, 2007, J BONE MINER RES, V22, P1373, DOI 10.1359/JBMR.070604; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kas MJH, 2009, GENES BRAIN BEHAV, V8, P13, DOI 10.1111/j.1601-183X.2008.00435.x; Kas MJH, 2008, BEHAV NEUROSCI, V122, P769, DOI 10.1037/0735-7044.122.4.769; Kobayashi K, 2006, EUR J NEUROSCI, V24, P1867, DOI 10.1111/j.1460-9568.2006.05079.x; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Lynch M., 1998, GENETICS ANAL QUANTI; MATHIS C, 1994, BEHAV GENET, V24, P171, DOI 10.1007/BF01067821; Miller BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014458; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Ormel J, 2008, BRIT J PSYCHIAT, V192, P368, DOI 10.1192/bjp.bp.107.039107; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Turri MG, 1999, MAMM GENOME, V10, P1098, DOI 10.1007/s003359901169; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20716	10.1371/journal.pone.0020716	http://dx.doi.org/10.1371/journal.pone.0020716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673958	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400022
J	Becnel, J; Johnson, O; Luo, JN; Nassel, DR; Nichols, CD				Becnel, Jaime; Johnson, Oralee; Luo, Jiangnan; Nassel, Dick R.; Nichols, Charles D.			The Serotonin 5-HT(7)Dro Receptor Is Expressed in the Brain of Drosophila, and Is Essential for Normal Courtship and Mating	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DORSAL RAPHE NUCLEUS; 5-HT7 RECEPTOR; CENTRAL COMPLEX; SEXUAL-BEHAVIOR; ELLIPSOID BODY; FRUITLESS GENE; KNOCKOUT MICE; REM-SLEEP; MELANOGASTER	The 5-HT7 receptor remains one of the less well characterized serotonin receptors. Although it has been demonstrated to be involved in the regulation of mood, sleep, and circadian rhythms, as well as relaxation of vascular smooth muscles in mammals, the precise mechanisms underlying these functions remain largely unknown. The fruit fly, Drosophila melanogaster, is an attractive model organism to study neuropharmacological, molecular, and behavioral processes that are largely conserved with mammals. Drosophila express a homolog of the mammalian 5-HT7 receptor, as well as homologs for the mammalian 5-HT1A, and 5-HT2, receptors. Each fly receptor couples to the same effector pathway as their mammalian counterpart and have been demonstrated to mediate similar behavioral responses. Here, we report on the expression and function of the 5-HT(7)Dro receptor in Drosophila. In the larval central nervous system, expression is detected postsynaptically in discreet cells and neuronal circuits. In the adult brain there is strong expression in all large-field R neurons that innervate the ellipsoid body, as well as in a small group of cells that cluster with the PDF-positive LNvs neurons that mediate circadian activity. Following both pharmacological and genetic approaches, we have found that 5-HT(7)Dro activity is essential for normal courtship and mating behaviors in the fly, where it appears to mediate levels of interest in both males and females. This is the first reported evidence of direct involvement of a particular serotonin receptor subtype in courtship and mating in the fly.	[Becnel, Jaime; Johnson, Oralee; Nichols, Charles D.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA; [Luo, Jiangnan; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Stockholm University	Becnel, J (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA.	cnich1@lsuhsc.edu	Nichols, Charles D/F-7153-2012	Nichols, Charles D/0000-0002-0615-0646	NIH [R21MH078454, R01MH083689]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083689, R21MH078454] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by NIH grants R21MH078454 and R01MH083689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DA, 2007, J COMP NEUROL, V501, P756, DOI 10.1002/cne.21257; BASTOCK M, 1955, COURTSHIP DROSOPHILA, P85; Belenky MA, 2001, J COMP NEUROL, V432, P371, DOI 10.1002/cne.1109; Bellen HJ, 1999, PLANT CELL, V11, P2271, DOI 10.1105/tpc.11.12.2271; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Billeter JC, 2002, ADV GENET, V47, P87, DOI 10.1016/S0065-2660(02)47003-4; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; BREIER A, 1995, SCHIZOPHR RES, V14, P187, DOI 10.1016/0920-9964(94)00043-8; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Ejima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003246; Fleischmann I, 2001, J NEUROGENET, V15, P117, DOI 10.3109/01677060109066198; FRATTA W, 1977, LIFE SCI, V21, P379, DOI 10.1016/0024-3205(77)90518-5; Gessa G L, 1974, Adv Biochem Psychopharmacol, V11, P217; Giordano E, 2002, GENETICS, V160, P637; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Guscott M, 2005, NEUROPHARMACOLOGY, V48, P492, DOI 10.1016/j.neuropharm.2004.11.015; Guscott MR, 2003, NEUROPHARMACOLOGY, V44, P1031, DOI 10.1016/S0028-3908(03)00117-5; HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838; Hedlund PB, 2003, P NATL ACAD SCI USA, V100, P1375, DOI 10.1073/pnas.0337340100; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; Hing ALY, 1996, J NEUROBIOL, V30, P454; Ilius M, 2007, J NEUROGENET, V21, P321, DOI 10.1080/01677060701693503; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Janssen P, 2004, BRIT J PHARMACOL, V143, P331, DOI 10.1038/sj.bjp.0705922; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Liu T, 2008, J NEUROSCI, V28, P5539, DOI 10.1523/JNEUROSCI.5290-07.2008; Liu T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004574; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Monti JM, 2008, BEHAV BRAIN RES, V191, P184, DOI 10.1016/j.bbr.2008.03.025; Monti JM, 2006, BEHAV BRAIN RES, V167, P245, DOI 10.1016/j.bbr.2005.09.025; Neckameyer WS, 2008, NEUROSCIENCE, V156, P841, DOI 10.1016/j.neuroscience.2008.08.020; Neckameyer WS, 1998, J NEUROGENET, V12, P101, DOI 10.3109/01677069809167259; Neumaier JF, 2001, J CHEM NEUROANAT, V21, P63, DOI 10.1016/S0891-0618(00)00092-2; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; Nichols CD, 2006, PHARMACOL THERAPEUT, V112, P677, DOI 10.1016/j.pharmthera.2006.05.012; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Orgad S, 2000, GENETICS, V155, P1267; PANDEY UB, 2011, PHARM REV; Popov A V, 2001, Ross Fiziol Zh Im I M Sechenova, V87, P779; Renn SCP, 1999, J NEUROBIOL, V41, P189; Rollmann SA, 2008, GENETICS, V179, P1327, DOI 10.1534/genetics.108.088435; Roy B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-20; Sakai T, 2009, GENES BRAIN BEHAV, V8, P546, DOI 10.1111/j.1601-183X.2009.00503.x; Siddiqui A, 2007, PHARMACOL BIOCHEM BE, V87, P386, DOI 10.1016/j.pbb.2007.05.012; Sprouse J, 2005, J BIOL RHYTHM, V20, P122, DOI 10.1177/0748730404273432; Thomas DR, 2004, CNS NEUROL DISORD-DR, V3, P81, DOI 10.2174/1568007043482633; Thomas DR, 1998, BRIT J PHARMACOL, V124, P1300, DOI 10.1038/sj.bjp.0701946; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Wu CL, 2007, NAT NEUROSCI, V10, P1578, DOI 10.1038/nn2005; Yamamoto D, 1999, CELL MOL LIFE SCI, V56, P634, DOI 10.1007/s000180050458; Yamamoto D, 1998, BIOCHEM BIOPH RES CO, V246, P1, DOI 10.1006/bbrc.1998.8259; Yamamoto D, 1996, NEUROSCI RES, V26, P95, DOI 10.1016/S0168-0102(96)01087-5; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525	64	73	75	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20800	10.1371/journal.pone.0020800	http://dx.doi.org/10.1371/journal.pone.0020800			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674056	Green Published, Green Submitted, gold			2022-12-25	WOS:000291310600033
J	Li, R; Ackerman, WE; Summerfield, TL; Yu, LB; Gulati, P; Zhang, J; Huang, K; Romero, R; Kniss, DA				Li, Ruth; Ackerman, William E.; Summerfield, Taryn L.; Yu, Lianbo; Gulati, Parul; Zhang, Jie; Huang, Kun; Romero, Roberto; Kniss, Douglas A.			Inflammatory Gene Regulatory Networks in Amnion Cells Following Cytokine Stimulation: Translational Systems Approach to Modeling Human Parturition	PLOS ONE			English	Article							FACTOR-KAPPA-B; FACTOR-BINDING SITES; NECROSIS-FACTOR-ALPHA; INDEPENDENT COMPONENT ANALYSIS; SINGULAR-VALUE DECOMPOSITION; AP-2 TRANSCRIPTION FACTORS; TOLL-LIKE RECEPTOR-2; OXIDATIVE STRESS; EXPRESSION DATA; PRETERM LABOR	A majority of the studies examining the molecular regulation of human labor have been conducted using single gene approaches. While the technology to produce multi-dimensional datasets is readily available, the means for facile analysis of such data are limited. The objective of this study was to develop a systems approach to infer regulatory mechanisms governing global gene expression in cytokine-challenged cells in vitro, and to apply these methods to predict gene regulatory networks (GRNs) in intrauterine tissues during term parturition. To this end, microarray analysis was applied to human amnion mesenchymal cells (AMCs) stimulated with interleukin-1 beta, and differentially expressed transcripts were subjected to hierarchical clustering, temporal expression profiling, and motif enrichment analysis, from which a GRN was constructed. These methods were then applied to fetal membrane specimens collected in the absence or presence of spontaneous term labor. Analysis of cytokine-responsive genes in AMCs revealed a sterile immune response signature, with promoters enriched in response elements for several inflammation-associated transcription factors. In comparison to the fetal membrane dataset, there were 34 genes commonly upregulated, many of which were part of an acute inflammation gene expression signature. Binding motifs for nuclear factor-kappa B were prominent in the gene interaction and regulatory networks for both datasets; however, we found little evidence to support the utilization of pathogen-associated molecular pattern (PAMP) signaling. The tissue specimens were also enriched for transcripts governed by hypoxia-inducible factor. The approach presented here provides an uncomplicated means to infer global relationships among gene clusters involved in cellular responses to labor-associated signals.	[Li, Ruth; Ackerman, William E.; Summerfield, Taryn L.; Kniss, Douglas A.] Ohio State Univ, Div Maternal Fetal Med, Columbus, OH 43210 USA; [Li, Ruth; Ackerman, William E.; Summerfield, Taryn L.; Kniss, Douglas A.] Ohio State Univ, Lab Perinatal Res, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Kniss, Douglas A.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Yu, Lianbo; Gulati, Parul] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Zhang, Jie; Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Intramural Div, NIH,Dept Hlth & Human Serv, Bethesda, MD USA; [Romero, Roberto] Hutzel Womens Hosp, Detroit, MI USA	Ohio State University; Ohio State University; Ohio State University; Ohio State University; Ohio State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Li, R (corresponding author), Ohio State Univ, Div Maternal Fetal Med, Columbus, OH 43210 USA.	kniss.1@osu.edu	yu, lianbo/B-3472-2010; Huang, Kun/E-3272-2011; Gulati, Parul/K-7375-2013; Ackerman, William/E-2612-2011; Romero, Roberto/A-5268-2019	Gulati, Parul/0000-0001-9341-9844; Romero, Roberto/0000-0002-4448-5121; Ackerman, William/0000-0001-7366-3903	National Institute of Child Health and Human Development [WSU07043, N01-HD-2-3342]; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS; NIH [K08 HD049628]; Ohio State University Perinatal Research and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD049628] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Perinatal Research and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by subcontract WSU07043 under National Institute of Child Health and Human Development Contract N01-HD-2-3342 and Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS. Additional support was provided by NIH K08 HD049628 (WEA) and The Ohio State University Perinatal Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman VE, 2004, BIOL REPROD, V71, P2079, DOI 10.1095/biolreprod.104.030841; Ackerman WE, 2007, PLACENTA, V28, P465, DOI 10.1016/j.placenta.2006.06.009; Ackerman WE, 2005, BIOL REPROD, V73, P527, DOI 10.1095/biolreprod.104.039032; Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; Bollopragada S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.032; BRAR HS, 1988, AM J OBSTET GYNECOL, V158, P952, DOI 10.1016/0002-9378(88)90100-7; Brazma A, 1998, GENOME RES, V8, P1202, DOI 10.1101/gr.8.11.1202; Brown CT, 2008, METHOD CELL BIOL, V87, P337, DOI 10.1016/S0091-679X(08)00218-5; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chabane N, 2009, J CELL BIOCHEM, V106, P453, DOI 10.1002/jcb.22027; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chang LW, 2007, NUCLEIC ACIDS RES, V35, pW238, DOI 10.1093/nar/gkm308; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chua G, 2004, CURR OPIN MICROBIOL, V7, P638, DOI 10.1016/j.mib.2004.10.009; Cindrova-Davies T, 2007, AM J PATHOL, V171, P1168, DOI 10.2353/ajpath.2007.070528; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; Coppe A, 2009, NUCLEIC ACIDS RES, V37, P533, DOI 10.1093/nar/gkn948; Cora D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-110; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Dinarello CA, 2009, NEW ENGL J MED, V360, P2467, DOI 10.1056/NEJMe0811014; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; FLEISCHER A, 1987, AM J OBSTET GYNECOL, V157, P40, DOI 10.1016/S0002-9378(87)80342-3; Frigyesi A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-290; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Gunaratne PH, 2010, METHODS MOL BIOL, V667, P297, DOI 10.1007/978-1-60761-811-9_20; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P822, DOI 10.1016/j.ajog.2006.06.053; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hassan SS, 2006, AM J OBSTET GYNECOL, V195, P778, DOI 10.1016/j.ajog.2006.06.021; Hassan SS, 2009, J MATERN-FETAL NEO M, V22, P1183, DOI 10.3109/14767050903353216; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; He F, 2009, J BIOTECHNOL, V144, P190, DOI 10.1016/j.jbiotec.2009.07.013; HEAPS BR, 2007, PRETERM BIRTH MECH M, P70; Hestand MS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-495; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Hung TH, 2004, AM J PATHOL, V164, P1049, DOI 10.1016/S0002-9440(10)63192-6; Iams JD, 2003, OBSTET GYNECOL, V101, P402, DOI 10.1016/S0029-7844(02)02505-X; Ilievski V, 2007, REPROD SCI, V14, P315, DOI 10.1177/1933719107302959; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; Johnsen O, 1998, NUCLEIC ACIDS RES, V26, P512, DOI 10.1093/nar/26.2.512; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kawai T, 2005, ARTHRITIS RES THER, V7, P12, DOI 10.1186/ar1469; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; KENNARD EA, 1995, AM J REPROD IMMUNOL, V34, P65, DOI 10.1111/j.1600-0897.1995.tb00920.x; KHANJANI S, 2010, J CELL MOL MED; Khatri P, 2006, NUCLEIC ACIDS RES, V34, pW626, DOI 10.1093/nar/gkl213; Kim SY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-330; Kim YM, 2004, AM J OBSTET GYNECOL, V191, P1346, DOI 10.1016/j.ajog.2004.07.009; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kniss DA, 1999, J SOC GYNECOL INVEST, V6, P285, DOI 10.1177/107155769900600602; Kniss DA, 2001, PLACENTA, V22, P80, DOI 10.1053/plac.2000.0591; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Krediet TG, 2007, PEDIATR RES, V62, P474, DOI 10.1203/PDR.0b013e31813c9401; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lang CT, 2009, PLACENTA, V30, P711, DOI 10.1016/j.placenta.2009.05.008; Lappas M, 2007, PLACENTA, V28, P543, DOI 10.1016/j.placenta.2006.05.011; Lappas M, 2009, PLACENTA, V30, pS90, DOI 10.1016/j.placenta.2008.10.005; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lee NH, 2005, PHARMACOGENOMICS, V6, P245, DOI 10.1517/14622416.6.3.245; Lee SI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r76; Lee WP, 2009, BRIEF BIOINFORM, V10, P408, DOI 10.1093/bib/bbp028; Lee YW, 2001, J MOL CELL CARDIOL, V33, P83, DOI 10.1006/jmcc.2000.1278; Li H, 2008, FRONT BIOSCI-LANDMRK, V13, P263, DOI 10.2741/2677; Li H, 2007, BIOINFORMATICS, V23, P473, DOI 10.1093/bioinformatics/btl640; LIGGINS GC, 1988, ONSET LABOR CELLULAR, P1; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2001, PAEDIATR PERINAT EP, V15, P78, DOI 10.1046/j.1365-3016.2001.00010.x; LYE SJ, 2007, PRETERM BIRTH MECH M, P3; MacKay C, 2009, BIOCHEM BIOPH RES CO, V390, P187, DOI 10.1016/j.bbrc.2009.08.151; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Mendelson CR, 2005, J STEROID BIOCHEM, V93, P113, DOI 10.1016/j.jsbmb.2004.12.027; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Mitchell CM, 2008, MOL HUM REPROD, V14, P53, DOI 10.1093/molehr/gam086; MITTAL P, 2010, J PERINAT MED; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Nhan-Chang CL, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.045; Norwitz ER, 1999, NEW ENGL J MED, V341, P660, DOI 10.1056/NEJM199908263410906; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Perera PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3039; Perkins DJ, 1997, PROSTAG OTH LIPID M, V54, P727, DOI 10.1016/S0090-6980(97)00144-5; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Pfisterer P, 2002, J BIOL CHEM, V277, P6637, DOI 10.1074/jbc.M108578200; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Posch S, 2007, J BIOINF COMPUT BIOL, V5, P561, DOI 10.1142/S0219720007002886; R Core Team, 2022, R LANG ENV STAT COMP; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rey G, 2008, MOL HUM REPROD, V14, P555, DOI 10.1093/molehr/gan049; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; Robinson JM, 2009, PLACENTA, V30, pS83, DOI 10.1016/j.placenta.2008.10.017; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; ROMERO R, 1993, J REPROD MED, V38, P543; Romero R, 1996, PROSTAG LEUKOTR ESS, V54, P187, DOI 10.1016/S0952-3278(96)90015-0; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shankar R, 2010, REPROD SCI, V17, P297, DOI 10.1177/1933719109353454; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; Smith C, 2001, J IMMUNOL, V167, P5895, DOI 10.4049/jimmunol.167.10.5895; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Su Gang, 2006, In Silico Biology, V6, P307; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tonon L, 2010, NUCLEIC ACIDS RES, V38, pW286, DOI 10.1093/nar/gkq473; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; VAN NE, 2007, BMC BIOINFORM S6, V8, pS4; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Vora S, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-8; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Weiner CP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.034; Wenke AK, 2010, FEBS J, V277, P894, DOI 10.1111/j.1742-4658.2009.07509.x; Whittle WL, 2001, BIOL REPROD, V64, P1019, DOI 10.1095/biolreprod64.4.1019; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Wognum S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005852; Yan X, 2002, PLACENTA, V23, P288, DOI 10.1053/plac.2002.0789; Yan XF, 2007, BIOINFORMATICS, V23, pI577, DOI 10.1093/bioinformatics/btm227; Yao B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-99; Young SL, 2009, REPROD SCI, V16, P809, DOI 10.1177/1933719109342405; Youssef RE, 2009, REPROD SCI, V16, P843, DOI 10.1177/1933719109336621; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang CZ, 2010, INT J ONCOL, V36, P1503, DOI 10.3892/ijo_00000637; Zhang MQ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S3; Zheng JS, 2003, NUCLEIC ACIDS RES, V31, P1995, DOI 10.1093/nar/gkg287; Zhu Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-383	157	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20560	10.1371/journal.pone.0020560	http://dx.doi.org/10.1371/journal.pone.0020560			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655103	Green Published, Green Submitted, gold			2022-12-25	WOS:000291310600016
J	Lombi, E; de Jonge, MD; Donner, E; Kopittke, PM; Howard, DL; Kirkham, R; Ryan, CG; Paterson, D				Lombi, Enzo; de Jonge, Martin D.; Donner, Erica; Kopittke, Peter M.; Howard, Daryl L.; Kirkham, Robin; Ryan, Chris G.; Paterson, David			Fast X-Ray Fluorescence Microtomography of Hydrated Biological Samples	PLOS ONE			English	Article							TOXICITY; NICKEL; ZINC; ELEMENTS; GROWTH; PLANTS; RICE; IRON; PIXE	Metals and metalloids play a key role in plant and other biological systems as some of them are essential to living organisms and all can be toxic at high concentrations. It is therefore important to understand how they are accumulated, complexed and transported within plants. In situ imaging of metal distribution at physiological relevant concentrations in highly hydrated biological systems is technically challenging. In the case of roots, this is mainly due to the possibility of artifacts arising during sample preparation such as cross sectioning. Synchrotron x-ray fluorescence microtomography has been used to obtain virtual cross sections of elemental distributions. However, traditionally this technique requires long data acquisition times. This has prohibited its application to highly hydrated biological samples which suffer both radiation damage and dehydration during extended analysis. However, recent advances in fast detectors coupled with powerful data acquisition approaches and suitable sample preparation methods can circumvent this problem. We demonstrate the heightened potential of this technique by imaging the distribution of nickel and zinc in hydrated plant roots. Although 3D tomography was still impeded by radiation damage, we successfully collected 2D tomograms of hydrated plant roots exposed to environmentally relevant metal concentrations for short periods of time. To our knowledge, this is the first published example of the possibilities offered by a new generation of fast fluorescence detectors to investigate metal and metalloid distribution in radiation-sensitive, biological samples.	[Lombi, Enzo; Donner, Erica] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA, Australia; [Lombi, Enzo; Donner, Erica; Kopittke, Peter M.] CRC CARE, Salisbury, SA, Australia; [de Jonge, Martin D.; Howard, Daryl L.; Paterson, David] Australian Synchrotron, Xray Fluorescence Microscopy, Clayton, Vic, Australia; [Kopittke, Peter M.] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Kirkham, Robin; Ryan, Chris G.] CSIRO, Clayton, Vic 3168, Australia	University of South Australia; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lombi, E (corresponding author), Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA, Australia.	enzo.lombi@unisa.edu	Kirkham, Robin/C-9786-2010; Donner, Erica/A-4809-2012; Lombi, Enzo/F-3860-2013; de Jonge, Martin D/C-3400-2011; Ryan, Chris G/A-6032-2011; Kopittke, Peter/A-6026-2011; Howard, Daryl/E-9107-2013	Kirkham, Robin/0000-0003-1012-3496; Donner, Erica/0000-0001-6465-2233; Lombi, Enzo/0000-0003-3384-0375; de Jonge, Martin D/0000-0001-7731-6175; Ryan, Chris G/0000-0003-2891-3912; Kopittke, Peter/0000-0003-4948-1880; Howard, Daryl/0000-0001-6071-2382	Australian Synchrotron	Australian Synchrotron	This study was supported by the Australian Synchrotron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccouch S, 1998, J PLANT NUTR, V21, P577, DOI 10.1080/01904169809365425; Beetz T, 2003, J SYNCHROTRON RADIAT, V10, P280, DOI 10.1107/S0909049503003261; Bleuet P, 2010, TRAC-TREND ANAL CHEM, V29, P518, DOI 10.1016/j.trac.2010.02.011; Blute NK, 2004, ENVIRON SCI TECHNOL, V38, P6074, DOI 10.1021/es049448g; Carey AM, 2010, PLANT PHYSIOL, V152, P309, DOI 10.1104/pp.109.146126; Chen CY, 2009, CLEAN-SOIL AIR WATER, V37, P304, DOI 10.1002/clen.200800199; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; de Jonge MD, 2010, CURR OPIN STRUC BIOL, V20, P606, DOI 10.1016/j.sbi.2010.09.002; de Jonge MD, 2010, P NATL ACAD SCI USA, V107, P15676, DOI 10.1073/pnas.1001469107; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kirkham R, 2010, AIP CONF PROC, V1234, P240, DOI 10.1063/1.3463181; KIRZ J, 1995, Q REV BIOPHYS, V28, P33, DOI 10.1017/S0033583500003139; KOPITTKE PM, 2011, ENV TOXICOL IN PRESS; Kupper H, 2000, PLANTA, V212, P75, DOI 10.1007/s004250000366; LOMBI E, 2011, ANAL BIOANA IN PRESS; Lombi E, 2011, ENVIRON EXP BOT, V72, P3, DOI 10.1016/j.envexpbot.2010.04.005; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; McNear DH, 2005, ENVIRON SCI TECHNOL, V39, P2210, DOI 10.1021/es0492034; Mihucz VG, 2010, FOOD CHEM, V121, P290, DOI 10.1016/j.foodchem.2009.11.090; PAHLSSON AMB, 1989, WATER AIR SOIL POLL, V47, P287, DOI 10.1007/BF00279329; Paterson DJ, 2007, AIP CONF PROC, V879, P864; PICCINI DF, 1992, J PLANT NUTR, V15, P2343, DOI 10.1080/01904169209364478; Pilhofer M, 2010, METHOD CELL BIOL, V96, P21, DOI 10.1016/S0091-679X(10)96002-0; POWELL MJ, 1986, NEW PHYTOL, V102, P419, DOI 10.1111/j.1469-8137.1986.tb00819.x; Rout GR, 2009, SUSTAINABLE AGRICULTURE, P873, DOI 10.1051/agro:2002073; RUANO A, 1988, J PLANT NUTR, V11, P577, DOI 10.1080/01904168809363824; Ryan CG, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012013; Ryan CG, 2000, INT J IMAG SYST TECH, V11, P219, DOI 10.1002/ima.1007; RYAN CG, 1993, NUCL INSTRUM METH B, V77, P203, DOI 10.1016/0168-583X(93)95545-G; Seregin I V, 2007, Dokl Biol Sci, V415, P295, DOI 10.1134/S0012496607040138; Shaff JE, 2010, PLANT SOIL, V330, P207, DOI 10.1007/s11104-009-0193-9	32	77	78	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20626	10.1371/journal.pone.0020626	http://dx.doi.org/10.1371/journal.pone.0020626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674049	gold, Green Accepted, Green Published			2022-12-25	WOS:000291310600020
J	Lull, ME; Levesque, S; Surace, MJ; Block, ML				Lull, Melinda E.; Levesque, Shannon; Surace, Michael J.; Block, Michelle L.			Chronic Apocynin Treatment Attenuates Beta Amyloid Plaque Size and Microglial Number in hAPP(751)(SL) Mice	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-INDUCED NEUROTOXICITY; ALZHEIMERS-DISEASE; NADPH OXIDASE; PARKINSONS-DISEASE; OXIDATIVE STRESS; DOPAMINERGIC NEUROTOXICITY; ACTIVATED NEUTROPHILS; TETRAZOLIUM SALT; GENE-EXPRESSION; TRANSGENIC MICE	Background: NADPH oxidase is implicated in neurotoxic microglial activation and the progressive nature of Alzheimer's Disease (AD). Here, we test the ability of two NADPH oxidase inhibitors, apocynin and dextromethorphan (DM), to reduce learning deficits and neuropathology in transgenic mice overexpressing human amyloid precursor protein with the Swedish and London mutations (hAPP(751)(SL)). Methods: Four month old hAPP(751)(SL) mice were treated daily with saline, 15 mg/kg DM, 7.5 mg/kg DM, or 10 mg/kg apocynin by gavage for four months. Results: Only hAPP(751)(SL) mice treated with apocynin showed reduced plaque size and a reduction in the number of cortical microglia, when compared to the saline treated group. Analysis of whole brain homogenates from all treatments tested (saline, DM, and apocynin) demonstrated low levels of TNF alpha, protein nitration, lipid peroxidation, and NADPH oxidase activation, indicating a low level of neuroinflammation and oxidative stress in hAPP(751) SL mice at 8 months of age that was not significantly affected by any drug treatment. Despite in vitro analyses demonstrating that apocynin and DM ameliorate A beta-induced extracellular superoxide production and neurotoxicity, both DM and apocynin failed to significantly affect learning and memory tasks or synaptic density in hAPP(751)(SL) mice. To discern how apocynin was affecting plaque levels (plaque load) and microglial number in vivo, in vitro analysis of microglia was performed, revealing no apocynin effects on beta-amyloid (A beta) phagocytosis, microglial proliferation, or microglial survival. Conclusions: Together, this study suggests that while hAPP(751)(SL) mice show increases in microglial number and plaque load, they fail to exhibit elevated markers of neuroinflammation consistent with AD at 8 months of age, which may be a limitation of this animal model. Despite absence of clear neuroinflammation, apocynin was still able to reduce both plaque size and microglial number, suggesting that apocynin may have additional therapeutic effects independent of anti-inflammatory characteristics.	[Lull, Melinda E.; Levesque, Shannon; Surace, Michael J.; Block, Michelle L.] Virginia Commonwealth Univ Med Campus, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Virginia Commonwealth University	Lull, ME (corresponding author), Virginia Commonwealth Univ Med Campus, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	mblock@vcu.edu		Block, Michelle/0000-0001-8303-7914	Alzheimer's Drug Discovery Foundation; Institute for the Study of Aging and National Institute of Environmental Health Sciences/National Institutes of Health [R00ES01540]	Alzheimer's Drug Discovery Foundation; Institute for the Study of Aging and National Institute of Environmental Health Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Alzheimer's Drug Discovery Foundation and the Institute for the Study of Aging and National Institute of Environmental Health Sciences/National Institutes of Health R00ES01540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Goepfert E, 1998, BIOCHEM PHARMACOL, V56, P141, DOI 10.1016/S0006-2952(98)00024-0; Babior BM, 2000, AM J MED, V109, P33, DOI 10.1016/S0002-9343(00)00481-2; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Block ML, 2006, FASEB J, V20, P251, DOI 10.1096/fj.05-4553com; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S8; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Bradley MA, 2010, FREE RADICAL BIO MED, V48, P1570, DOI 10.1016/j.freeradbiomed.2010.02.016; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Cheepsunthorn P, 2001, GLIA, V35, P53, DOI 10.1002/glia.1070; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Cordle A, 2005, J NEUROSCI, V25, P299, DOI 10.1523/JNEUROSCI.2544-04.2005; Deshusses JMP, 2003, PROTEOMICS, V3, P1418, DOI 10.1002/pmic.200300492; DHEEN ST, 2004, GLIA; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; Franklin K. B., 1997, MOUSE BRAIN STEREOTA; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Gao HM, 2003, FASEB J, V17, P1957, DOI 10.1096/fj.03-0203fje; Gao HM, 2003, TRENDS PHARMACOL SCI, V24, P395, DOI 10.1016/S0165-6147(03)00176-7; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043; Ii M, 1996, BRAIN RES, V720, P93, DOI 10.1016/0006-8993(96)00156-4; Imbimbo BP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00019; JANTARATNOTAI N, 2010, CURR ALZHEIMER RES; LEE CY, J NEURAL TRANSM, V117, P949; Levesque S, 2010, BRAIN, V133, P808, DOI 10.1093/brain/awp333; Li GR, 2005, FASEB J, V19, P489, DOI 10.1096/fj.04-2555com; Liu B, 2003, METH MOLEC MED, V79, P387; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Liu SL, 2009, CARDIOVASC RES, V82, P161, DOI 10.1093/cvr/cvp043; Liu YX, 2003, J PHARMACOL EXP THER, V305, P212, DOI 10.1124/jpet.102.043166; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Pei Z, 2003, J PINEAL RES, V34, P194, DOI 10.1034/j.1600-079X.2003.00026.x; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Qian L, 2006, J PHARMACOL EXP THER, V319, P44, DOI 10.1124/jpet.106.106351; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rosi S, 2006, NEUROSCIENCE, V142, P1303, DOI 10.1016/j.neuroscience.2006.08.017; Rutten BPF, 2005, AM J PATHOL, V167, P161, DOI 10.1016/S0002-9440(10)62963-X; Sasaki A, 1997, ACTA NEUROPATHOL, V94, P316, DOI 10.1007/s004010050713; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Shimohama S, 2000, BIOCHEM BIOPH RES CO, V273, P5, DOI 10.1006/bbrc.2000.2897; Sultana R, 2009, METHODS MOL BIOL, V566, P123, DOI 10.1007/978-1-59745-562-6_9; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; VALTIER D, 1992, BRAIN RES, V588, P115, DOI 10.1016/0006-8993(92)91350-N; Van den Worm E, 2001, EUR J PHARMACOL, V433, P225, DOI 10.1016/S0014-2999(01)01516-3; Wedenig M, 2004, NEUROBIOL AGING, V25, pS233, DOI 10.1016/S0197-4580(04)80780-2; Werner Erica, 2003, Sci STKE, V2003, pPL3, DOI 10.1126/stke.2003.168.pl3; WILKINSON BL, 2010, NEUROBIOL AGING; Wilkinson BL, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-30; Willis M, 2007, BRAIN RES, V1143, P199, DOI 10.1016/j.brainres.2007.01.080; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Wu HM, 2009, NEUROPSYCHOPHARMACOL, V34, P2344, DOI 10.1038/npp.2009.64; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; YANKNER BA, 1989, NEUROBIOL AGING, V10, P470, DOI 10.1016/0197-4580(89)90101-2; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje	65	43	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20153	10.1371/journal.pone.0020153	http://dx.doi.org/10.1371/journal.pone.0020153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655287	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600024
J	Sugita, S; Kamei, Y; Akaike, F; Suganami, T; Kanai, S; Hattori, M; Manabe, Y; Fujii, N; Takai-Igarashi, T; Tadaishi, M; Oka, J; Aburatani, H; Yamada, T; Katagiri, H; Kakehi, S; Tamura, Y; Kubo, H; Nishida, K; Miura, S; Ezaki, O; Ogawa, Y				Sugita, Satoshi; Kamei, Yasutomi; Akaike, Fumiko; Suganami, Takayoshi; Kanai, Sayaka; Hattori, Maki; Manabe, Yasuko; Fujii, Nobuharu; Takai-Igarashi, Takako; Tadaishi, Miki; Oka, Jun-ichiro; Aburatani, Hiroyuki; Yamada, Tetsuya; Katagiri, Hideki; Kakehi, Saori; Tamura, Yoshifumi; Kubo, Hideo; Nishida, Kenichi; Miura, Shinji; Ezaki, Osamu; Ogawa, Yoshihiro			Increased Systemic Glucose Tolerance with Increased Muscle Glucose Uptake in Transgenic Mice Overexpressing RXR gamma in Skeletal Muscle	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; X-RECEPTOR; TRIGLYCERIDE SYNTHESIS; TRANSCRIPTION FACTOR; ENERGY-EXPENDITURE; METABOLIC SYNDROME; OBESE MICE; LIVER; SENSITIVITY; TRANSPORT	Background: Retinoid X receptor (RXR) gamma is a nuclear receptor-type transcription factor expressed mostly in skeletal muscle, and regulated by nutritional conditions. Previously, we established transgenic mice overexpressing RXR gamma in skeletal muscle (RXR gamma mice), which showed lower blood glucose than the control mice. Here we investigated their glucose metabolism. Methodology/Principal Findings: RXR gamma mice were subjected to glucose and insulin tolerance tests, and glucose transporter expression levels, hyperinsulinemic-euglycemic clamp and glucose uptake were analyzed. Microarray and bioinformatics analyses were done. The glucose tolerance test revealed higher glucose disposal in RXR gamma mice than in control mice, but insulin tolerance test revealed no difference in the insulin-induced hypoglycemic response. In the hyperinsulinemic-euglycemic clamp study, the basal glucose disposal rate was higher in RXR gamma mice than in control mice, indicating an insulin-independent increase in glucose uptake. There was no difference in the rate of glucose infusion needed to maintain euglycemia (glucose infusion rate) between the RXR gamma and control mice, which is consistent with the result of the insulin tolerance test. Skeletal muscle from RXR gamma mice showed increased Glut1 expression, with increased glucose uptake, in an insulin-independent manner. Moreover, we performed in vivo luciferase reporter analysis using Glut1 promoter (Glut1-Luc). Combination of RXR gamma and PPAR delta resulted in an increase in Glut1-Luc activity in skeletal muscle in vivo. Microarray data showed that RXR gamma overexpression increased a diverse set of genes, including glucose metabolism genes, whose promoter contained putative PPAR-binding motifs. Conclusions/Significance: Systemic glucose metabolism was increased in transgenic mice overexpressing RXR gamma. The enhanced glucose tolerance in RXR gamma mice may be mediated at least in part by increased Glut1 in skeletal muscle. These results show the importance of skeletal muscle gene regulation in systemic glucose metabolism. Increasing RXR gamma expression may be a novel therapeutic strategy against type 2 diabetes.	[Sugita, Satoshi; Kamei, Yasutomi; Akaike, Fumiko; Suganami, Takayoshi; Kanai, Sayaka; Hattori, Maki; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Tokyo, Japan; [Akaike, Fumiko; Hattori, Maki; Oka, Jun-ichiro] Tokyo Univ Sci, Pharmacol Lab, Fac Pharmaceut Sci, Chiba, Japan; [Manabe, Yasuko; Fujii, Nobuharu] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Tokyo 158, Japan; [Takai-Igarashi, Takako] Tokyo Med & Dent Univ, Dept Bioinformat, Grad Sch Biomed Sci, Tokyo, Japan; [Tadaishi, Miki; Miura, Shinji; Ezaki, Osamu] Natl Inst Hlth & Nutr, Nutr Sci Program, Tokyo 162, Japan; [Tadaishi, Miki] Tokyo Univ Agr, Dept Nutr Sci, Fac Appl Biosci, Tokyo, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Ctr Metab Dis, Dept Metab Dis, Sendai, Miyagi 980, Japan; [Kakehi, Saori; Tamura, Yoshifumi] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo 113, Japan; [Tamura, Yoshifumi] Juntendo Univ, Sportol Ctr, Tokyo, Japan; [Kubo, Hideo; Nishida, Kenichi] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Med Res Inst, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo University of Science; Tokyo Metropolitan University; Tokyo Medical & Dental University (TMDU); National Institute of Health & Nutrition - Japan; Tokyo University of Agriculture; University of Tokyo; Tohoku University; Juntendo University; Juntendo University; Daiichi Sankyo Company Limited; Tokyo Medical & Dental University (TMDU)	Kamei, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Med & Metab, Tokyo, Japan.	kamei.mmm@mri.tmd.ac.jp	Fujii, Nobuharu/J-2724-2014; Tamura, Yoshifumi/AFK-2430-2022; Miura, Shinji/K-6516-2013; SUGANAMI, Takayoshi/A-9475-2016	Fujii, Nobuharu/0000-0002-0974-3033; Miura, Shinji/0000-0001-8806-9763; Ogawa, Yoshihiro/0000-0002-0834-2836; Tamura, Yoshifumi/0000-0002-1685-7821	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan); Japanese Ministry of Health, Labor and Welfare; Institute for Molecular and Cellular Regulation, Gunma University; Grants-in-Aid for Scientific Research [23591293] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Institute for Molecular and Cellular Regulation, Gunma University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for scientific research KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo, Japan), research grants from the Japanese Ministry of Health, Labor and Welfare, and by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University. S. Sugita is a Research Fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Davies PJA, 2001, MOL PHARMACOL, V59, P170, DOI 10.1124/mol.59.2.170; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito A, 2007, J BIOL CHEM, V282, P25445, DOI 10.1074/jbc.M701549200; Kamei Y, 2008, ENDOCRINOLOGY, V149, P2293, DOI 10.1210/en.2007-1461; KASLOW HR, 1985, J BIOL CHEM, V260, P9953; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Lowry O. H., 1972, FLEXIBLE SYSTEM ENZY, P1; Marshall BA, 1999, AM J PHYSIOL-ENDOC M, V276, pE390, DOI 10.1152/ajpendo.1999.276.2.E390; MARSHALL BA, 1993, J BIOL CHEM, V268, P18442; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; REN JM, 1993, J BIOL CHEM, V268, P16113; Salway J.G., 2017, METABOLISM GLANCE; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Shen Q, 2004, J BIOL CHEM, V279, P19721, DOI 10.1074/jbc.M311729200; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Stannard SR, 2004, J PHYSIOL-LONDON, V554, P595, DOI 10.1113/jphysiol.2003.053926; Suzuki R, 2004, J BIOL CHEM, V279, P25039, DOI 10.1074/jbc.M311956200; Szanto A, 2004, CELL DEATH DIFFER, V11, pS126, DOI 10.1038/sj.cdd.4401533; Tanaka S, 2007, METABOLISM, V56, P1719, DOI 10.1016/j.metabol.2007.07.017; Uno K, 2006, SCIENCE, V312, P1656, DOI 10.1126/science.1126010; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	32	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20467	10.1371/journal.pone.0020467	http://dx.doi.org/10.1371/journal.pone.0020467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655215	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600074
J	Volman, V; Perc, M; Bazhenov, M				Volman, Vladislav; Perc, Matjaz; Bazhenov, Maxim			Gap Junctions and Epileptic Seizures - Two Sides of the Same Coin?	PLOS ONE			English	Article							ELECTRICAL SYNAPSES; PYRAMIDAL NEURON; OSCILLATIONS; EXPRESSION; NETWORKS; FREQUENCY; NEOCORTEX; CONNEXIN-43; MECHANISMS; SYNCHRONY	Electrical synapses (gap junctions) play a pivotal role in the synchronization of neuronal ensembles which also makes them likely agonists of pathological brain activity. Although large body of experimental data and theoretical considerations indicate that coupling neurons by electrical synapses promotes synchronous activity (and thus is potentially epileptogenic), some recent evidence questions the hypothesis of gap junctions being among purely epileptogenic factors. In particular, an expression of inter-neuronal gap junctions is often found to be higher after the experimentally induced seizures than before. Here we used a computational modeling approach to address the role of neuronal gap junctions in shaping the stability of a network to perturbations that are often associated with the onset of epileptic seizures. We show that under some circumstances, the addition of gap junctions can increase the dynamical stability of a network and thus suppress the collective electrical activity associated with seizures. This implies that the experimentally observed post-seizure additions of gap junctions could serve to prevent further escalations, suggesting furthermore that they are a consequence of an adaptive response of the neuronal network to the pathological activity. However, if the seizures are strong and persistent, our model predicts the existence of a critical tipping point after which additional gap junctions no longer suppress but strongly facilitate the escalation of epileptic seizures. Our results thus reveal a complex role of electrical coupling in relation to epileptiform events. Which dynamic scenario (seizure suppression or seizure escalation) is ultimately adopted by the network depends critically on the strength and duration of seizures, in turn emphasizing the importance of temporal and causal aspects when linking gap junctions with epilepsy.	[Volman, Vladislav; Bazhenov, Maxim] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Volman, Vladislav] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	Salk Institute; University of California System; University of California San Diego; University of Maribor; University of California System; University of California Riverside	Volman, V (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	volman@salk.edu	Perc, Matjaz/A-5148-2009	Perc, Matjaz/0000-0002-3087-541X	National Institutes of Health (NIH) [R01 NS059740]; NSF; Slovenian Research Agency [Z1-2032]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059740] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by the National Institutes of Health (NIH) grant R01 NS059740 (MB and VV). VV acknowledges support from the NSF-sponsored Center for Theoretical Biological Physics at the University of California San Diego. MP acknowledges support from the Slovenian Research Agency (grant number Z1-2032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amitai Y, 2002, J NEUROSCI, V22, P4142, DOI 10.1523/JNEUROSCI.22-10-04142.2002; Aronica E, 2001, ACTA NEUROPATHOL, V101, P449; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; CONNORS BW, 1983, J NEUROSCI, V3, P773; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Goldberg M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000909; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; HOGE G, 2011, J NEUROPHYS IN PRESS; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Kandel E., 2000, PRINCIPLES NEURAL SC; Kapral R, 1995, CHEM WAVES PATTERNS; KEPLER TB, 1990, SCIENCE, V248, P83, DOI 10.1126/science.2321028; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; KRINSKY V, 1991, WAVES PATTERNS BIOL; Lau T, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016015; Lewis TJ, 2000, NETWORK-COMP NEURAL, V11, P299, DOI 10.1088/0954-898X/11/4/304; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Mylvaganam S, 2010, J NEUROCHEM, V112, P92, DOI 10.1111/j.1471-4159.2009.06431.x; Pinto DJ, 2001, SIAM J APPL MATH, V62, P206, DOI 10.1137/S0036139900346453; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Prescott SA, 2006, J NEUROSCI, V26, P9084, DOI 10.1523/JNEUROSCI.1388-06.2006; Reif F., 1985, FUNDAMENTALS STAT TH; Samoilova M, 2003, J NEUROCHEM, V86, P687, DOI 10.1046/j.1471-4159.2003.01893.x; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Traub RD, 2001, EPILEPSIA, V42, P153, DOI 10.1046/j.1528-1157.2001.26900.x; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Volman V, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043013; Winfree A.T., 2000, GEOMETRY BIOL TIME	39	79	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20572	10.1371/journal.pone.0020572	http://dx.doi.org/10.1371/journal.pone.0020572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655239	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600101
J	Hoerter, JAH; Krishnan, V; Lionberger, TA; Walter, NG				Hoerter, John A. H.; Krishnan, Vishalakshi; Lionberger, Troy A.; Walter, Nils G.			siRNA-Like Double-Stranded RNAs Are Specifically Protected Against Degradation in Human Cell Extract	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; RISC-LOADING COMPLEX; DELTA VIRUS RIBOZYME; CHEMICAL-MODIFICATION; MAMMALIAN-CELLS; IN-VITRO; INTERFERENCE; GENE; THERAPEUTICS; ASYMMETRY	RNA interference (RNAi) is a set of intracellular pathways in eukaryotes that controls both exogenous and endogenous gene expression. The power of RNAi to knock down (silence) any gene of interest by the introduction of synthetic small-interfering (si) RNAs has afforded powerful insight into biological function through reverse genetic approaches and has borne a new field of gene therapeutics. A number of questions are outstanding concerning the potency of siRNAs, necessitating an understanding of how short double-stranded RNAs are processed by the cell. Recent work suggests unmodified siRNAs are protected in the intracellular environment, although the mechanism of protection still remains unclear. We have developed a set of doubly-fluorophore labeled RNAs (more precisely, RNA/DNA chimeras) to probe in real-time the stability of siRNAs and related molecules by fluorescence resonance energy transfer (FRET). We find that these RNA probes are substrates for relevant cellular degradative processes, including the RNase H1 mediated degradation of an DNA/RNA hybrid and Dicer-mediated cleavage of a 24-nucleotide (per strand) double-stranded RNA. In addition, we find that 21- and 24-nucleotide double-stranded RNAs are relatively protected in human cytosolic cell extract, but less so in blood serum, whereas an 18-nucleotide double-stranded RNA is less protected in both fluids. These results suggest that RNAi effector RNAs are specifically protected in the cellular environment and may provide an explanation for recent results showing that unmodified siRNAs in cells persist intact for extended periods of time.	[Hoerter, John A. H.; Krishnan, Vishalakshi; Walter, Nils G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lionberger, Troy A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hoerter, JAH (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	nwalter@umich.edu	Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016	Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275	Camille Dreyfus Teacher-Scholar award; NIH [GM081025]; Eli Lilly; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081025] Funding Source: NIH RePORTER	Camille Dreyfus Teacher-Scholar award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly(Eli Lilly); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Camille Dreyfus Teacher-Scholar award and NIH grant GM081025 to N.G.W., an Eli Lilly Predoctoral Fellowship to J.A.H.H., and an NIH Cellular and Molecular Biology training fellowship to T.A.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Bartlett DW, 2007, BIOTECHNOL BIOENG, V97, P909, DOI 10.1002/bit.21285; Behlke MA, 2008, OLIGONUCLEOTIDES, V18, P305, DOI 10.1089/oli.2008.0164; Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103; Braasch DA, 2003, BIOCHEMISTRY-US, V42, P7967, DOI 10.1021/bi0343774; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Harris DA, 2004, J MOL BIOL, V341, P389, DOI 10.1016/j.jmb.2004.05.074; Hoerter JAH, 2004, BIOCHEMISTRY-US, V43, P14624, DOI 10.1021/bi048533y; Hoerter JAH, 2007, RNA, V13, P1887, DOI 10.1261/rna.602307; Jarve A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm694; Jagannath A, 2009, MOL BIOL CELL, V20, P521, DOI 10.1091/mbc.E08-08-0796; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lee SK, 2009, ADV DRUG DELIVER REV, V61, P650, DOI 10.1016/j.addr.2009.03.016; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Ohrt T, 2006, NUCLEIC ACIDS RES, V34, P1369, DOI 10.1093/nar/gkl001; Ohrt T, 2008, CURR PHARM DESIGN, V14, P3674, DOI 10.2174/138161208786898798; Pellino JL, 2005, RNA, V11, P1719, DOI 10.1261/rna.2102805; Pereira MJB, 2002, BIOCHEMISTRY-US, V41, P730, DOI 10.1021/bi011963t; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pileur F, 2003, NUCLEIC ACIDS RES, V31, P5776, DOI 10.1093/nar/gkg748; Potenza N, 2008, INT J MOL SCI, V9, P299, DOI 10.3390/ijms9030299; Raemdonck K, 2006, BIOCHEMISTRY-US, V45, P10614, DOI 10.1021/bi060351b; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ramirez-Carrozzi V, 2001, METHODS, V25, P31, DOI 10.1006/meth.2001.1213; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; RAWLINGS RA, 2011, J MOL BIOL IN PRESS; Schein CH, 1997, NAT BIOTECHNOL, V15, P529, DOI 10.1038/nbt0697-529; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Uhler SA, 2003, J AM CHEM SOC, V125, P14230, DOI 10.1021/ja036854b; Walter NG, 2000, METHOD ENZYMOL, V317, P409; WALTER NG, 2002, CURR PROTOC NUCL ACI; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Watts JK, 2008, DRUG DISCOV TODAY, V13, P842, DOI 10.1016/j.drudis.2008.05.007; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	45	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20359	10.1371/journal.pone.0020359	http://dx.doi.org/10.1371/journal.pone.0020359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647381	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500051
J	Suzuki, K; Matsuzaki, H; Iwata, K; Kameno, Y; Shimmura, C; Kawai, S; Yoshihara, Y; Wakuda, T; Takebayashi, K; Takagai, S; Matsumoto, K; Tsuchiya, KJ; Iwata, Y; Nakamura, K; Tsujii, M; Sugiyama, T; Mori, N				Suzuki, Katsuaki; Matsuzaki, Hideo; Iwata, Keiko; Kameno, Yosuke; Shimmura, Chie; Kawai, Satomi; Yoshihara, Yujiro; Wakuda, Tomoyasu; Takebayashi, Kiyokazu; Takagai, Shu; Matsumoto, Kaori; Tsuchiya, Kenji J.; Iwata, Yasuhide; Nakamura, Kazuhiko; Tsujii, Masatsugu; Sugiyama, Toshirou; Mori, Norio			Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders	PLOS ONE			English	Article							T-CELLS; INTERFERON-GAMMA; IMMUNE-RESPONSE; CHILDREN; SERUM; INTERLEUKIN-12; INFLAMMATION; ACTIVATION; INNATE; BRAIN	Background: Accumulating evidence suggests that dysregulation of the immune system is involved in the pathophysiology of autism spectrum disorders (ASD). The aim of the study was to explore immunological markers in peripheral plasma samples from non-medicated subjects with high-functioning ASD. Methodology/Principal Findings: A multiplex assay for cytokines and chemokines was applied to plasma samples from male subjects with high-functioning ASD (n = 28) and matched controls (n = 28). Among a total of 48 analytes examined, the plasma concentrations of IL-1 beta, IL-1RA, IL-5, IL-8, IL-12(p70), IL-13, IL-17 and GRO-alpha were significantly higher in subjects with ASD compared with the corresponding values of matched controls after correction for multiple comparisons. Conclusion/Significance: The results suggest that abnormal immune responses as assessed by multiplex analysis of cytokines may serve as one of the biological trait markers for ASD.	[Suzuki, Katsuaki; Matsuzaki, Hideo; Iwata, Keiko; Takebayashi, Kiyokazu; Matsumoto, Kaori; Tsuchiya, Kenji J.; Mori, Norio] Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan; [Kameno, Yosuke; Shimmura, Chie; Wakuda, Tomoyasu; Takagai, Shu; Iwata, Yasuhide; Nakamura, Kazuhiko; Mori, Norio] Hamamatsu Univ Sch Med, Dept Psychiat & Neurol, Hamamatsu, Shizuoka 4313192, Japan; [Kawai, Satomi] Natl Hosp Org Tenryu Hosp, Dept Psychiat, Hamamatsu, Shizuoka, Japan; [Yoshihara, Yujiro] Koujin Hosp, Dept Psychiat, Nagoya, Aichi, Japan; [Tsujii, Masatsugu] Chukyo Univ, Fac Sociol, Toyota, Japan; [Sugiyama, Toshirou] Hamamatsu Univ Sch Med, Dept Child & Adolescent Psychiat, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Chukyo University; Hamamatsu University School of Medicine	Suzuki, K (corresponding author), Hamamatsu Univ Sch Med, Res Ctr Child Mental Dev, Hamamatsu, Shizuoka 4313192, Japan.	k-suzuki@hama-med.ac.jp	Tsuchiya, Kenji J./I-9123-2019; MATSUZAKI, HIDEO/AAE-5246-2020	Tsuchiya, Kenji J./0000-0002-1314-4199; MATSUZAKI, HIDEO/0000-0002-6869-1261; Wakuda, Tomoyasu/0000-0002-1924-8167	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22390221]; Grants-in-Aid for Scientific Research [22390222] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to KS (#22390221). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM PSYCH ASS, 1997, US GUID STRUCT CLIN; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashwood P, 2011, BRAIN BEHAV IMMUN, V25, P40, DOI 10.1016/j.bbi.2010.08.003; Ashwood P, 2006, J LEUKOCYTE BIOL, V80, P1, DOI 10.1189/jlb.1205707; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Corbett BA, 2007, MOL PSYCHIATR, V12, P292, DOI 10.1038/sj.mp.4001943; Croonenberghs J, 2002, NEUROPSYCHOBIOLOGY, V45, P1, DOI 10.1159/000048665; Croonenberghs J, 2002, PSYCHOL MED, V32, P1457, DOI 10.1017/S0033291702006037; Di Nisio M, 2005, CANCER-AM CANCER SOC, V104, P2275, DOI 10.1002/cncr.21485; Emanuele E, 2010, NEUROSCI LETT, V471, P162, DOI 10.1016/j.neulet.2010.01.033; Enstrom Amanda, 2008, Am J Biochem Biotechnol, V4, P114; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Fujita-Shimizu A, 2010, PROG NEURO-PSYCHOPH, V34, P455, DOI 10.1016/j.pnpbp.2009.12.020; Grigorenko EL, 2008, PEDIATRICS, V122, pE438, DOI 10.1542/peds.2007-3604; Gupta S, 1998, J NEUROIMMUNOL, V85, P106, DOI 10.1016/S0165-5728(98)00021-6; Hart JP, 2005, INT J RADIAT ONCOL, V63, P1448, DOI 10.1016/j.ijrobp.2005.05.032; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Li LQ, 2010, J IMMUNOL, V185, P4148, DOI 10.4049/jimmunol.1001536; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Magalhaes ES, 2009, J NEUROIMMUNOL, V216, P108, DOI 10.1016/j.jneuroim.2009.09.015; Molloy CA, 2006, J NEUROIMMUNOL, V172, P198, DOI 10.1016/j.jneuroim.2005.11.007; Nakajima H, 2007, INT ARCH ALLERGY IMM, V142, P265, DOI 10.1159/000097357; Nelson PG, 2006, INT J DEV NEUROSCI, V24, P73, DOI 10.1016/j.ijdevneu.2005.10.003; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Onore C, 2009, J NEUROIMMUNOL, V216, P126, DOI 10.1016/j.jneuroim.2009.09.005; RENZONI E, 1995, J AUTISM DEV DISORD, V25, P327; SCHWARZ E, 2010, MOL PSYCHIAT; SINGH VK, 1991, CLIN IMMUNOL IMMUNOP, V61, P448, DOI 10.1016/S0090-1229(05)80015-7; Singh VK, 1996, J NEUROIMMUNOL, V66, P143, DOI 10.1016/0165-5728(96)00014-8; Sweeten TL, 2004, BIOL PSYCHIAT, V55, P434, DOI 10.1016/j.biopsych.2003.09.001; Sweeten TL, 2003, AM J PSYCHIAT, V160, P1691, DOI 10.1176/appi.ajp.160.9.1691; Theoharides T. C., 2010, BIOCH BIOPHYS ACTA; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wechsler D., 1991, WISC 3 WECHSLER INTE; Zimmerman AW, 2005, PEDIATR NEUROL, V33, P195, DOI 10.1016/j.pediatrneurol.2005.03.014; ZIMMERMAN AW, 2006, NEUROBIOLOGY AUTISM	40	158	160	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20470	10.1371/journal.pone.0020470	http://dx.doi.org/10.1371/journal.pone.0020470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647375	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500062
J	Cao, X; Geradts, J; Dewhirst, MW; Lo, HW				Cao, X.; Geradts, J.; Dewhirst, M. W.; Lo, H-W			Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells	ONCOGENE			English	Article						GLI1; tGLI1; breast cancer; angiogenesis; migration and invasion; VEGF	GROWTH-FACTOR RECEPTOR; SONIC-HEDGEHOG; STEM-CELLS; HUMAN GLIOMA; MAMMALIAN HEPARANASE; DOWN-REGULATION; SELF-RENEWAL; TUMOR-GROWTH; FLOOR PLATE; PATHWAY	The Hedgehog signaling pathway is one of the most dysregulated pathways in human cancers. The glioma-associated oncogene homolog 1 (GLI1) transcription factor is the terminal effector of the Hedgehog pathway, frequently activated in human breast cancer and an emerging target of breast cancer therapy. While somatic mutations in the human GLI1 gene have never been reported in any cell or tumor type, we recently uncovered the existence of a novel alternatively spliced, truncated GLI1 (tGLI1) that has an in-frame deletion of 41 codons spanning the entire exon 3 and part of exon 4 of the GLI1 gene. Using glioblastoma models, we showed that tGLI1 has gained the ability to promote glioblastoma migration and invasion via its gain-of-function transcriptional activity. However, the pathological impact of tGLI1 on breast cancer remains undefined. Here, we report that tGLI1 is frequently expressed in human breast cancer cell lines and primary specimens we have examined to date, but is undetectable in normal breast tissues. We found for the first time that tGLI1, but not GLI1, binds to and enhances the human vascular endothelial growth factor-A (VEGF-A) gene promoter, leading to its upregulation. Consequently, tGLI1-expressing MDA-MB-231 breast cancer cells secret higher levels of VEGF-A and contain a higher propensity, than the isogenic cells with control vector and GLI1, to stimulate in vitro angiogenesis of human vascular endothelial cells. We further showed that tGLI1 has gained the ability to enhance the motility and invasiveness of breast cancer cells in a proliferation-independent manner and that this functional gain is associated with increased expression of migration/invasion-associated genes, CD24, MMP-2 and MMP-9. tGLI1 has also acquired the property to facilitate anchorage-independent growth of breast cancer cells. Collectively, our results define tGLI1 as a gain-of-function GLI1 transcription factor and a novel mediator of the behavior of clinically more aggressive breast cancer. Oncogene (2012) 31, 104-115; doi: 10.1038/onc.2011.219; published online 13 June 2011	[Cao, X.; Lo, H-W] Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Durham, NC 27710 USA; [Geradts, J.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA; [Dewhirst, M. W.] Duke Univ, Sch Med, Dept Radiat Oncol, Durham, NC 27710 USA; [Geradts, J.; Dewhirst, M. W.; Lo, H-W] Duke Canc Inst, Durham, NC USA; [Lo, H-W] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Lo, HW (corresponding author), Duke Univ, Sch Med, Dept Surg, Div Surg Sci, Box 3156,433A MSRB I,103 Res Dr, Durham, NC 27710 USA.	huiwen.lo@duke.edu	Dewhirst, Mark/Q-1302-2019	Dewhirst, Mark/0000-0003-3459-6546; Lo, Hui-Wen/0000-0002-0681-7914	NIH [K01-CA118423]; DOD [W81XWH-07-1-0390]; Pediatric Brain Tumor Foundation; Beez Foundation; Intramural Division of Surgical Sciences Dani P. Bolognesi; NATIONAL CANCER INSTITUTE [K01CA118423] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Pediatric Brain Tumor Foundation; Beez Foundation; Intramural Division of Surgical Sciences Dani P. Bolognesi; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NIH grant K01-CA118423, DOD grant W81XWH-07-1-0390, the Pediatric Brain Tumor Foundation and the Beez Foundation and the Intramural Division of Surgical Sciences Dani P. Bolognesi, PhD Award (to H-WL).	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Aigner S, 1997, BLOOD, V89, P3385, DOI 10.1182/blood.V89.9.3385; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Cao XY, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-26; Charafe-Jauffret E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-202; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dasari VR, 2010, AGING-US, V2, P791, DOI 10.18632/aging.100217; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Kameda C, 2009, ANTICANCER RES, V29, P871; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Kennedy KM, 2010, FUTURE ONCOL, V6, P127, DOI [10.2217/fon.09.145, 10.2217/FON.09.145]; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Kim HJ, 2007, CANCER LETT, V258, P98, DOI 10.1016/j.canlet.2007.08.025; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kristiansen G, 2003, CLIN CANCER RES, V9, P4906; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lee JH, 2009, ONCOL REP, V22, P1149, DOI 10.3892/or_00000548; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Lo HW, 2008, MOL CANCER RES, V6, P843, DOI 10.1158/1541-7786.MCR-07-2105; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Meyer MJ, 2010, CANCER RES, V70, P4624, DOI 10.1158/0008-5472.CAN-09-3619; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Nagase T, 2008, ANGIOGENESIS, V11, P71, DOI 10.1007/s10456-008-9105-5; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Runz S, 2008, BIOCHEM BIOPH RES CO, V365, P35, DOI 10.1016/j.bbrc.2007.10.139; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Schmidt M, 2008, ANTICANCER RES, V28, P1719; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; ten Haaf A, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-298; Timoshenko AV, 2006, BRIT J CANCER, V94, P1154, DOI 10.1038/sj.bjc.6603067; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Yang L, 2010, ONCOGENE, V29, P469, DOI 10.1038/onc.2009.392; Zhu H, 2010, CANCER LETT, V294, P101, DOI 10.1016/j.canlet.2010.01.028; Zhu H, 2010, CURR GENOMICS, V11, P238, DOI 10.2174/138920210791233108	52	91	96	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	1					104	115		10.1038/onc.2011.219	http://dx.doi.org/10.1038/onc.2011.219			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21666711	Green Accepted			2022-12-25	WOS:000299176200010
J	Huebbe, P; Nebel, A; Siegert, S; Moehring, J; Boesch-Saadatmandi, C; Most, E; Pallauf, J; Egert, S; Muller, MJ; Schreiber, S; Nothlings, U; Rimbach, G				Huebbe, Patricia; Nebel, Almut; Siegert, Sabine; Moehring, Jennifer; Boesch-Saadatmandi, Christine; Most, Erika; Pallauf, Josef; Egert, Sarah; Mueller, Manfred James; Schreiber, Stefan; Noethlings, Ute; Rimbach, Gerald			APOE epsilon 4 is associated with higher vitamin D levels in targeted replacement mice and humans	FASEB JOURNAL			English	Article						apolipoprotein E; epsilon 4 allele; global allele distribution; evolutionary advantage	APOLIPOPROTEIN-E GENOTYPE; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; D INSUFFICIENCY; E GENE; ALLELE; RISK; ATHEROSCLEROSIS; PREVENTION; INFLAMMATION	The allele epsilon 4 of apolipoprotein E (APOE), which is a key regulator of lipid metabolism, represents a risk factor for cardiovascular diseases and Alzheimer's disease. Despite its adverse effects, the allele is common and shows a nonrandom global distribution that is thought to be the result of evolutionary adaptation. One hypothesis proposes that the APOE epsilon 4 allele protects against vitamin D deficiency. Here we present, for the first time, experimental and epidemiological evidence that the APOE epsilon 4 allele is indeed associated with higher serum vitamin D [25(OH) D] levels. In APOE4 targeted replacement mice, significantly higher 25(OH) D levels were found compared with those in APOE2 and APOE3 mice (70.9 vs. 41.8 and 27.8 nM, P<0.05). Furthermore, multivariate adjusted models show a positive association of the APOE epsilon 4 allele with 25(OH) D levels in a small collective of human subjects (n = 93; P = 0.072) and a general population sample (n = 699; P = 0.003). The novel link suggests epsilon 4 as a modulator of vitamin D status. Although this result agrees well with evolutionary aspects, it appears contradictory with regard to chronic diseases, especially cardiovascular disease. Large prospective cohort studies are now needed to investigate the potential implications of this finding for chronic disease risks.-Huebbe, P., Nebel, A., Siegert, S., Moehring, J., Boesch-Saadatmandi, C., Most, E., Pallauf, J., Egert, S., Muller, M. J., Schreiber, S., Nothlings, U., Rimbach, G. APOE epsilon 4 is associated with higher vitamin D levels in targeted replacement mice and humans. FASEB J. 25, 3262-3270 (2011). www.fasebj.org	[Nebel, Almut] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Huebbe, Patricia; Moehring, Jennifer; Boesch-Saadatmandi, Christine; Egert, Sarah; Mueller, Manfred James; Rimbach, Gerald] Univ Kiel, Inst Human Nutr & Food Sci, D-24105 Kiel, Germany; [Siegert, Sabine; Noethlings, Ute] Univ Kiel, Epidemiol Sect, Inst Expt Med, D-24105 Kiel, Germany; [Most, Erika; Pallauf, Josef] Univ Giessen, Inst Anim Nutr & Nutr Physiol, Giessen, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Clin Internal Med 1, Kiel, Germany; [Schreiber, Stefan; Noethlings, Ute] Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany	University of Kiel; University of Kiel; University of Kiel; Justus Liebig University Giessen; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Nebel, A (corresponding author), Univ Kiel, Inst Clin Mol Biol, Schittenhelmstr 12, D-24105 Kiel, Germany.	a.nebel@mucosa.de	Nebel, Almut/E-4196-2010; Nöthlings, Ute/B-2713-2010; Rimbach, Gerald/A-7178-2011	Rimbach, Gerald/0000-0001-7888-4684; Bosch, Christine/0000-0001-6705-5709	Deutsche Forschungsgemeinschaft; German Federal Ministry of Research and Education	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Research and Education	This study was supported by the Deutsche Forschungsgemeinschaft Excellence Cluster Inflammation at Interfaces and through grants from the German Federal Ministry of Research and Education. P. H. performed the mouse study (sample collection, PCR analyses, total hepatic bile acid analysis) and analyzed the data of the mouse study. J.M., C.B.-S., and P. H. measured the serum 25(OH) D levels in both murine and human samples. E. M. and J.P. did the calcium analysis in bones. S. E. and M.J.M. recruited and phenotyped the MSX subjects. S.Sc. and U.N. established and maintained the PopGen study population. C.B.-S. genotyped the MSX, and A.N. genotyped the PopGen samples. S. Si. and U.N. analyzed the data. G. R., A.N., and U.N. designed the study and coordinated the project. A.N., P. H., U.N., and G. R. wrote the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Borradale D, 2009, NUTR RES REV, V22, P118, DOI 10.1017/S0954422409990102; Corbo RM, 1999, ANN HUM GENET, V63, P301, DOI 10.1046/j.1469-1809.1999.6340301.x; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DAIGER SP, 1975, P NATL ACAD SCI USA, V72, P2076, DOI 10.1073/pnas.72.6.2076; Davignon J, 1988, Trans Am Clin Climatol Assoc, V99, P100; Dietrich M, 2005, LIPIDS, V40, P329, DOI 10.1007/s11745-006-1390-4; Egert S, 2009, BRIT J NUTR, V102, P1065, DOI 10.1017/S0007114509359127; Engelman CD, 2010, J STEROID BIOCHEM, V122, P186, DOI 10.1016/j.jsbmb.2010.06.013; Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gaedicke S, 2008, FEBS LETT, V582, P3542, DOI 10.1016/j.febslet.2008.09.032; Geleijnse JM, 2011, AM J HYPERTENS, V24, P253, DOI 10.1038/ajh.2010.199; Gerdes LU, 2003, CLIN CHEM LAB MED, V41, P628, DOI 10.1515/CCLM.2003.094; Gerdes LU, 2001, J BONE MINER RES, V16, P1906, DOI 10.1359/jbmr.2001.16.10.1906; HANLON CS, 1995, ATHEROSCLEROSIS, V112, P85, DOI 10.1016/0021-9150(94)05402-5; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2011, CURR DRUG TARGETS, V12, P4; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Jofro-Monseny L, 2007, BIOCHEM BIOPH RES CO, V357, P319, DOI 10.1016/j.bbrc.2007.03.150; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Kuhlmann I, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-8; Lucotte G, 1997, HUM BIOL, V69, P253; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Nebel A, 2005, P NATL ACAD SCI USA, V102, P7906, DOI 10.1073/pnas.0408670102; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Oria RB, 2010, BRAZ J MED BIOL RES, V43, P249, DOI 10.1590/S0100-879X2010007500003; Payami H, 2005, HUM GENET, V118, P322, DOI 10.1007/s00439-005-0057-1; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; Walter A, 2000, J VET MED A, V47, P367, DOI 10.1046/j.1439-0442.2000.00301.x; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Will C, 2008, PERITON DIALYSIS INT, V28, P577; Yuen AWC, 2010, MED HYPOTHESES, V74, P39, DOI 10.1016/j.mehy.2009.08.007; Zerwekh JE, 2008, AM J CLIN NUTR, V87, p1087S, DOI 10.1093/ajcn/87.4.1087S; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	45	62	64	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3262	3270		10.1096/fj.11-180935	http://dx.doi.org/10.1096/fj.11-180935			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21659554				2022-12-25	WOS:000294435200038
J	Rong, MQ; Chen, JJ; Tao, H; Wu, YY; Jiang, P; Lu, M; Su, HB; Chi, YP; Cai, TF; Zhao, LQ; Zeng, XZ; Xiao, YC; Liang, SP				Rong, Mingqiang; Chen, Jinjun; Tao, Huai; Wu, Yuanyuan; Jiang, Peng; Lu, Ming; Su, Haibo; Chi, Yupeng; Cai, Tianfu; Zhao, Liqun; Zeng, Xiongzhi; Xiao, Yucheng; Liang, Songping			Molecular basis of the tarantula toxin jingzhaotoxin-III (beta-TRTX-Cj1 alpha) interacting with voltage sensors in sodium channel subtype Nav1.5	FASEB JOURNAL			English	Article						spider toxin; mutation	BETA-SCORPION TOXIN; DOMAIN-II; PROTX-II; CHILOBRACHYS-JINGZHAO; GATING-MODIFIERS; SCANNING MUTAGENESIS; CALCIUM-CHANNELS; ALPHA-SUBUNIT; NA+ CHANNELS; ACTIVATION	With conserved structural scaffold and divergent electrophysiological functions, animal toxins are considered powerful tools for investigating the basic structure-function relationship of voltage-gated sodium channels. Jingzhaotoxin-III (beta-TRTX-Cj1 alpha) is a unique sodium channel gating modifier from the tarantula Chilobrachys jingzhao, because the toxin can selectively inhibit the activation of cardiac sodium channel but not neuronal subtypes. However, the molecular basis of JZTX-III interaction with sodium channels remains unknown. In this study, we showed that JZTX-III was efficiently expressed by the secretory pathway in yeast. Alanine-scanning analysis indicated that 2 acidic residues (Asp1, Glu3) and an exposed hydrophobic patch, formed by 4 Trp residues (residues 8, 9, 28 and 30), play important roles in the binding of JZTX-III to Nav1.5. JZTX-III docked to the Nav1.5 DIIS3-S4 linker. Mutations S799A, R800A, and L804A could additively reduce toxin sensitivity of Nav1.5. We also demonstrated that the unique Arg800, not emerging in other sodium channel subtypes, is responsible for JZTX-III selectively interacting with Nav1.5. The reverse mutation D816R in Nav1.7 greatly increased the sensitivity of the neuronal subtype to JZTX-III. Conversely, the mutation R800D in Nav1.5 decreased JZTX-III's IC50 by 72-fold. Therefore, our results indicated that JZTX-III is a site 4 toxin, but does not possess the same critical residues on sodium channels as other site 4 toxins. Our data also revealed the underlying mechanism for JZTX-III to be highly specific for the cardiac sodium channel.-Rong, M., Chen, J., Tao, H., Wu, Y., Jiang, P., Lu, M., Su, H., Chi, Y., Cai, T., Zhao, L., Zeng, X., Xiao, Y., Liang, S. Molecular basis of the tarantula toxin jing-zhaotoxin-III (beta-TRTX-Cj1 alpha) interacting with voltage sensors in sodium channel subtype Nav1.5. FASEB J. 25, 3177-3185 (2011). www.fasebj.org	[Rong, Mingqiang; Tao, Huai; Wu, Yuanyuan; Jiang, Peng; Lu, Ming; Su, Haibo; Chi, Yupeng; Cai, Tianfu; Zhao, Liqun; Zeng, Xiongzhi; Xiao, Yucheng; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China; [Chen, Jinjun] Hunan Agr Univ, Coll Biol Sci & Technol, Changsha, Hunan, Peoples R China	Hunan Normal University; Hunan Agricultural University	Liang, SP (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn	Xiao, Yucheng/H-3600-2012	Lu, Ming/0000-0003-3768-7267	National 973 Project of China [2010CB529801, 2009BC526510]; Hunan Provincial Education Department [07A035, 10B049]; Chinese Ministry of Education [208096]; Huo Ying Dong Education Foundation [111023]; Program for New Century Excellent Talents in University [NCET-07-0279]; National Natural Science Foundation of China [30900242, 3100047]; Hunan Education Department of Science and Technology [10C0961]	National 973 Project of China(National Basic Research Program of China); Hunan Provincial Education Department(Hunan Provincial Education Department); Chinese Ministry of Education(Ministry of Education, China); Huo Ying Dong Education Foundation; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Education Department of Science and Technology	This work was supported by grants from the National 973 Project of China (2010CB529801, 2009BC526510), the Science Research Fund of the Hunan Provincial Education Department (07A035, 10B049), the Key Project of Chinese Ministry of Education (208096), the Huo Ying Dong Education Foundation (111023), the Program for New Century Excellent Talents in University (NCET-07-0279), the National Natural Science Foundation of China (30900242), the National Natural Science Foundation of China (grant. 3100047), and the Hunan Education Department of Science and Technology Research Project (10C0961).	Benzinger GR, 1998, J BIOL CHEM, V273, P80, DOI 10.1074/jbc.273.1.80; Campos FV, 2007, J GEN PHYSIOL, V130, P257, DOI 10.1085/jgp.200609719; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Cestele S, 2001, J GEN PHYSIOL, V118, P291, DOI 10.1085/jgp.118.3.291; Cestele S, 2006, J BIOL CHEM, V281, P21332, DOI 10.1074/jbc.M603814200; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Chen J, 2008, CELL MOL LIFE SCI, V65, P2431, DOI 10.1007/s00018-008-8135-x; Chen JJ, 2009, PEPTIDES, V30, P1042, DOI 10.1016/j.peptides.2009.02.018; Clare JJ, 2010, EXPERT OPIN INV DRUG, V19, P45, DOI 10.1517/13543780903435340; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Cohen L, 2006, J BIOL CHEM, V281, P20673, DOI 10.1074/jbc.M603212200; Deng MC, 2009, NEUROPHARMACOLOGY, V57, P77, DOI 10.1016/j.neuropharm.2009.04.009; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Halai R, 2009, J BIOL CHEM, V284, P20275, DOI 10.1074/jbc.M109.015339; Jiang QX, 2004, NATURE, V430, P806, DOI 10.1038/nature02735; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Krafte DS, 2008, CURR OPIN PHARMACOL, V8, P50, DOI 10.1016/j.coph.2007.09.007; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Liao Z, 2007, TOXICON, V50, P135, DOI 10.1016/j.toxicon.2007.03.006; Lopreato GF, 2001, P NATL ACAD SCI USA, V98, P7588, DOI 10.1073/pnas.131171798; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; Priest BT, 2007, TOXICON, V49, P194, DOI 10.1016/j.toxicon.2006.09.014; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Spencer CI, 2009, TOXICON, V53, P78, DOI 10.1016/j.toxicon.2008.10.015; Tedford HW, 2004, J BIOL CHEM, V279, P44133, DOI 10.1074/jbc.M404006200; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; Winterfield JR, 2000, J GEN PHYSIOL, V116, P637, DOI 10.1085/jgp.116.5.637; Xiao YC, 2004, J BIOL CHEM, V279, P26220, DOI 10.1074/jbc.M401387200; Xiao YC, 2005, J BIOL CHEM, V280, P12069, DOI 10.1074/jbc.M411651200; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0	41	29	32	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3177	3185		10.1096/fj.10-178848	http://dx.doi.org/10.1096/fj.10-178848			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21665957				2022-12-25	WOS:000294435200030
J	Mizutani, A; Koinuma, D; Tsutsumi, S; Kamimura, N; Morikawa, M; Suzuki, HI; Imamura, T; Miyazono, K; Aburatani, H				Mizutani, Anna; Koinuma, Daizo; Tsutsumi, Shuichi; Kamimura, Naoko; Morikawa, Masato; Suzuki, Hiroshi I.; Imamura, Takeshi; Miyazono, Kohei; Aburatani, Hiroyuki			Cell Type-specific Target Selection by Combinatorial Binding of Smad2/3 Proteins and Hepatocyte Nuclear Factor 4 alpha in HepG2 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-BINDING; TGF-BETA; GENE-EXPRESSION; CHIP-CHIP; MESODERM INDUCERS; EPITHELIAL-CELLS; ORPHAN RECEPTOR; DOWN-REGULATION; TILING-ARRAYS; HOMEOBOX GENE	Specific regulation of target genes by transforming growth factor-beta (TGF-beta) in a given cellular context is determined in part by transcription factors and cofactors that interact with the Smad complex. In this study, we determined Smad2 and Smad3 (Smad2/3) binding regions in the promoters of known genes in HepG2 hepatoblastoma cells, and we compared them with those in HaCaT epidermal keratinocytes to elucidate the mechanisms of cell type- and context-dependent regulation of transcription induced by TGF-beta. Our results show that 81% of the Smad2/3 binding regions in HepG2 cells were not shared with those found in HaCaT cells. Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is expressed in HepG2 cells but not in HaCaT cells, and the HNF4 alpha-binding motif was identified as an enriched motif in the HepG2-specific Smad2/3 binding regions. Chromatin immunoprecipitation sequencing analysis of HNF4 alpha binding regions under TGF-beta stimulation revealed that 32.5% of the Smad2/3 binding regions overlapped HNF4 alpha bindings. MIXL1 was identified as a new combinatorial target of HNF4 alpha and Smad2/3, and both the HNF4 alpha protein and its binding motif were required for the induction of MIXL1 by TGF-beta in HepG2 cells. These findings generalize the importance of binding of HNF4 alpha on Smad2/3 binding genomic regions for HepG2-specific regulation of transcription by TGF-beta and suggest that certain transcription factors expressed in a cell type-specific manner play important roles in the transcription regulated by the TGF-beta-Smad signaling pathway.	[Mizutani, Anna; Koinuma, Daizo; Morikawa, Masato; Suzuki, Hiroshi I.; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan; [Tsutsumi, Shuichi; Kamimura, Naoko; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Imamura, Takeshi] Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, Tokyo 1358550, Japan	University of Tokyo; University of Tokyo; Japanese Foundation for Cancer Research	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	Morikawa, Masato/D-1932-2011; Koinuma, Daizo/Y-8716-2018	Morikawa, Masato/0000-0002-6191-7176; Koinuma, Daizo/0000-0001-5611-2122; Suzuki, Hiroshi/0000-0003-4682-5086	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20221009, 22112002]; Japan Society for the Promotion of Science; Ishidsu Shun Memorial Scholarship	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ishidsu Shun Memorial Scholarship	This work was supported by KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas, Integrative Research on Cancer Microenvironment Network, 22112002 (to K. M.) Grants-in-Aid for Scientific Research (S) 20221009 (to H. A.) and for Young Scientists (B) 10014456 (to D. K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Genome Network Project from Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. A.), and the Global Center of Excellence Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Japan Society for the Promotion of Science.; Supported by an Ishidsu Shun Memorial Scholarship.	Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; Chou WC, 2003, MOL BIOL CELL, V14, P1279, DOI 10.1091/mbc.E02-07-0375; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; de Boussac H, 2010, J BIOL CHEM, V285, P22798, DOI 10.1074/jbc.M110.105593; Ecochard V, 1998, DEVELOPMENT, V125, P2577; Eeckhoute J, 2009, METHODS MOL BIOL, V556, P155, DOI 10.1007/978-1-60327-192-9_11; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ganjam GK, 2009, J BIOL CHEM, V284, P30783, DOI 10.1074/jbc.M109.045260; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hart AH, 2005, BIOCHEM BIOPH RES CO, V333, P1361, DOI 10.1016/j.bbrc.2005.06.044; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ho JWK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-134; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Ishikawa F, 2008, EXP CELL RES, V314, P2131, DOI 10.1016/j.yexcr.2008.03.013; Izzi L, 2007, EMBO J, V26, P3132, DOI 10.1038/sj.emboj.7601753; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; JIANG GQ, 1995, MOL CELL BIOL, V15, P5131; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Kaneshiro K, 2007, GENOMICS, V89, P178, DOI 10.1016/j.ygeno.2006.09.001; Kardassis D, 2000, J BIOL CHEM, V275, P41405, DOI 10.1074/jbc.M007896200; Kim MS, 2009, NATURE, V461, P1007, DOI 10.1038/nature08456; Koinuma D, 2009, CANCER SCI, V100, P2133, DOI 10.1111/j.1349-7006.2009.01299.x; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155; Lim SM, 2009, STEM CELLS, V27, P363, DOI 10.1634/stemcells.2008-1008; LUCAS SS, 2004, BIOCHEM BIOPH RES CO, V321, P688, DOI DOI 10.1016/J.BBRC.2004.07.025]; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mizutani A, 2010, J BIOCHEM, V148, P733, DOI 10.1093/jb/mvq127; Mosialou I, 2010, J BIOL CHEM, V285, P30719, DOI 10.1074/jbc.M110.131771; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; ROSA FM, 1989, CELL, V57, P965, DOI 10.1016/0092-8674(89)90335-8; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Spath GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935; Taylor DG, 1996, NUCLEIC ACIDS RES, V24, P2930, DOI 10.1093/nar/24.15.2930; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Vize PD, 1996, DEV BIOL, V177, P226, DOI 10.1006/dbio.1996.0158; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1	60	37	39	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29848	29860		10.1074/jbc.M110.217745	http://dx.doi.org/10.1074/jbc.M110.217745			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21646355	hybrid, Green Published			2022-12-25	WOS:000294046600044
J	Deisenroth, C; Itahana, Y; Tollini, L; Jin, AW; Zhang, YP				Deisenroth, Chad; Itahana, Yoko; Tollini, Laura; Jin, Aiwen; Zhang, Yanping			p53-inducible DHRS3 Is an Endoplasmic Reticulum Protein Associated with Lipid Droplet Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE/REDUCTASE; STELLATE CELLS; P53; ADIPOGENESIS; EXPRESSION; RETINOL; ENZYMES; DIFFERENTIATION; GENE	The transcription factor p53 plays a critical role in maintaining homeostasis as it relates to cellular growth, proliferation, and metabolism. In an effort to identify novel p53 target genes, a microarray approach was utilized to identify DHRS3 (also known as retSDR1) as a robust candidate gene. DHRS3 is a highly conserved member of the short chain alcohol dehydrogenase/reductase superfamily with a reported role in lipid and retinoid metabolism. Here, we demonstrate that DHRS3 is an endoplasmic reticulum (ER) protein that is shuttled to the ER via an N-terminal endoplasmic reticulum targeting signal. One important function of the ER is synthesis of neutral lipids that are packaged into lipid droplets whose biogenesis occurs from ER-derived membranes. DHRS3 is enriched at focal points of lipid droplet budding where it also localizes to the phospholipid monolayer of ER-derived lipid droplets. p53 promotes lipid droplet accumulation in a manner consistent with DHRS3 enrichment in the ER. As a p53 target gene, the observations of Dhrs3 location and potential function provide novel insight into an unexpected role for p53 in lipid droplet dynamics with implications in cancer cell metabolism and obesity.	[Deisenroth, Chad; Itahana, Yoko; Tollini, Laura; Jin, Aiwen; Zhang, Yanping] Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA; [Deisenroth, Chad; Itahana, Yoko; Tollini, Laura; Jin, Aiwen; Zhang, Yanping] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Tollini, Laura] Univ N Carolina, Sch Med, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Zhang, Yanping] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhang, YP (corresponding author), Univ N Carolina, Sch Med, Dept Radiat Oncol, Chapel Hill, NC 27599 USA.	ypzhang@med.unc.edu			National Institutes of Health; American Cancer Society [2R01-CA100302, 1R01-CA127770, 1RC2CA148487-01]; NATIONAL CANCER INSTITUTE [R01CA127770, RC2CA148487, R01CA100302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the National Institutes of Health and the American Cancer Society (2R01-CA100302, 1R01-CA127770, and 1RC2CA148487-01, to Y.Z.).	Barba I, 1999, CANCER RES, V59, P1861; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Cerignoli F, 2002, CANCER RES, V62, P1196; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2006, J GASTROEN HEPATOL, V21, pS79, DOI 10.1111/j.1440-1746.2006.04585.x; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Haeseleer F, 1998, J BIOL CHEM, V273, P21790, DOI 10.1074/jbc.273.34.21790; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Ide T, 2009, MOL CELL, V36, P379, DOI 10.1016/j.molcel.2009.09.031; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kam RKT, 2010, INT J DEV BIOL, V54, P1355, DOI 10.1387/ijdb.092984rk; Kamei N, 2009, PEDIATR SURG INT, V25, P931, DOI 10.1007/s00383-009-2448-1; Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844; Kondoh H, 2005, CANCER RES, V65, P177; Korotchkina LG, 2009, CELL CYCLE, V8, P3777, DOI 10.4161/cc.8.22.10121; Lefebvre P, 2005, VITAM HORM, V70, P199, DOI 10.1016/S0083-6729(05)70007-8; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Moise AR, 2004, J BIOL CHEM, V279, P50230, DOI 10.1074/jbc.M409130200; MORIWAKI H, 1988, J LIPID RES, V29, P1523; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Okuno M, 2002, FRONT BIOSCI-LANDMRK, V7, pD204, DOI 10.2741/okuno; Oler G, 2008, CLIN CANCER RES, V14, P4735, DOI 10.1158/1078-0432.CCR-07-4372; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Ramsby ML, 1999, METH MOL B, V112, P53; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Staab CA, 2008, CELL MOL LIFE SCI, V65, P3653, DOI 10.1007/s00018-008-8554-8; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Xue JC, 1996, MOL CELL BIOL, V16, P1567; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	42	43	44	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28343	28356		10.1074/jbc.M111.254227	http://dx.doi.org/10.1074/jbc.M111.254227			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659514	Green Published, hybrid			2022-12-25	WOS:000293557800051
J	Liu, ZT; Lin, XW; Cai, ZP; Zhang, ZQ; Han, CS; Jia, SJ; Meng, AM; Wang, Q				Liu, Zhaoting; Lin, Xiwen; Cai, Zhaoping; Zhang, Zhuqiang; Han, Chunsheng; Jia, Shunji; Meng, Anming; Wang, Qiang			Global Identification of SMAD2 Target Genes Reveals a Role for Multiple Co-regulatory Factors in Zebrafish Early Gastrulas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-EYED-PINHEAD; TGF-BETA; MESODERM INDUCTION; SIGNALS; CATENIN; EMBRYOS; DORSAL; DROSOPHILA; DIFFERENTIATION; NORMALIZATION	Nodal and Smad2/3 signals play pivotal roles in mesendoderm induction and axis determination during late blastulation and early gastrulation in vertebrate embryos. However, Smad2/3 direct target genes during those critical developmental stages have not been systematically identified. Here, through ChIP-chip assay, we show that the promoter/enhancer regions of 679 genes are bound by Smad2 in the zebrafish early gastrulas. Expression analyses confirm that a significant proportion of Smad2 targets are indeed subjected to Nodal/Smad2 regulation at the onset of gastrulation. The co-existence of DNA-binding sites of other transcription factors in the Smad2-bound regions allows the identification of well known Smad2-binding partners, such as FoxH1 and Lef1/beta-catenin, as well as many previously unknown Smad2 partners, including Oct1 and Gata6, during embryogenesis. We demonstrate that Oct1 physically associates with and enhances the transcription and mesendodermal induction activity of Smad2, whereas Gata6 exerts an inhibitory role in Smad2 signaling and mesendodermal induction. Thus, our study systemically uncovers a large number of Smad2 targets in early gastrulas and suggests cooperative roles of Smad2 and other transcription factors in controlling target gene transcription, which will be valuable for studying regulatory cascades during germ layer formation and patterning of vertebrate embryos.	[Liu, Zhaoting; Cai, Zhaoping; Meng, Anming; Wang, Qiang] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Lin, Xiwen; Zhang, Zhuqiang; Han, Chunsheng] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Jia, Shunji; Meng, Anming] Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 10084, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Tsinghua University	Meng, AM (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China.	mengam@mail.tsinghua.edu.cn; qiangwang@ioz.ac.cn	Meng, Anming/A-4785-2012; Zhang, Zhuqiang/P-7329-2019	Zhang, Zhuqiang/0000-0001-6513-2854; Meng, Anming/0000-0001-7228-3431; Wang, Qiang/0000-0002-8735-8771	National Basic Research Program of China [2011CB943904, 2011CB943800]; Chinese Academy of Sciences [XDA01010104]; National Natural Science Foundation of China [90919058, 30830068, 30921004/C061003]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2011CB943904 and 2011CB943800, Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA01010104, and the National Natural Science Foundation of China Grants 90919058, 30830068, and 30921004/C061003.	Agius E, 2000, DEVELOPMENT, V127, P1173; Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bennett JT, 2007, DEV BIOL, V304, P525, DOI 10.1016/j.ydbio.2007.01.012; Birch-Machin I, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r63; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; CONLON FL, 1994, DEVELOPMENT, V120, P1919; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Dick A, 2000, GENE, V246, P69, DOI 10.1016/S0378-1119(00)00056-1; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Fan X, 2007, DEV BIOL, V310, P363, DOI 10.1016/j.ydbio.2007.08.008; Fei T, 2010, CELL RES, V20, P1306, DOI 10.1038/cr.2010.158; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; IANNACCONE PM, 1992, DEV DYNAM, V194, P198, DOI 10.1002/aja.1001940305; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Jia SJ, 2009, DEV BIOL, V333, P273, DOI 10.1016/j.ydbio.2009.06.037; KANE DA, 1993, DEVELOPMENT, V119, P447; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Li M, 2001, CHINESE SCI BULL, V46, P1523, DOI 10.1007/BF02900572; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Liu YH, 2001, INVEST OPHTH VIS SCI, V42, P481; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Marstrand TT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001623; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Seiliez I, 2006, DEV BIOL, V290, P152, DOI 10.1016/j.ydbio.2005.11.021; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silvestri C, 2008, DEV CELL, V14, P411, DOI 10.1016/j.devcel.2008.01.004; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Sun ZH, 2007, PROG BIOCHEM BIOPHYS, V34, P595; Sun ZH, 2006, BIOCHEM BIOPH RES CO, V345, P694, DOI 10.1016/j.bbrc.2006.04.148; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Watanabe M, 2002, DEV DYNAM, V225, P448, DOI 10.1002/dvdy.10176; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhou S, 1998, MOL CELL, V2, P121, DOI 10.1016/S1097-2765(00)80120-3; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	70	43	46	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28520	28532		10.1074/jbc.M111.236307	http://dx.doi.org/10.1074/jbc.M111.236307			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669877	hybrid, Green Published			2022-12-25	WOS:000293557800067
J	da Silva, TC; Hussainzada, N; Khantwal, CM; Polli, JE; Swaan, PW				da Silva, Tatiana Claro; Hussainzada, Naissan; Khantwal, Chandra M.; Polli, James E.; Swaan, Peter W.			Transmembrane Helix 1 Contributes to Substrate Translocation and Protein Stability of Bile Acid Transporter SLC10A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAINS; FAMILY SLC10; RESIDUES; NA+; COTRANSPORTER; CHOLESTEROL; MUTAGENESIS; TRAFFICKING; CHAPERONES; INHIBITOR	The human apical sodium-dependent bile acid transporter (hASBT, SLC10A2) plays a critical role in the enterohepatic circulation of bile acids, as well as in cholesterol homeostasis. ASBT reclaims bile acids from the distal ileum via active sodium co-transport, in a multistep process, orchestrated by key residues in exofacial loop regions, as well as in membrane-spanning helices. Here, we unravel the functional contribution of highly conserved transmembrane helix 1 (TM1) on the hASBT transport cycle. Consecutive cysteine substitution of individual residues along the TM1 helix (Ile(29)-Gly(50)), as well as exofacial Asn(27) and Asn(28), resulted in functional impairment of similar to 70% of mutants, despite appreciable cell surface expression for all but G50C. Cell surface expression of G50C and G50A was rescued upon MG132 treatment as well as cyclosporine A, but not by FK506 or bile acids, suggesting that Gly(50) is involved in hASBT folding. TM1 accessibility to membrane-impermeant MTSET remains confined to the exofacial half of the helix along a single, discrete face. Substrate protection from MTSET labeling was temperature-dependent for L34C, T36C, and L38C, consistent with conformational changes playing a role in solvent accessibility for these mutants. Residue Leu(30) was shown to be critical for both bile acid and sodium affinity, while Asn(27), Leu(38), Thr(39), and Met(46) participate in sodium co-transport. Combined, our data demonstrate that TM1 plays a pivotal role in ASBT function and stability, thereby providing further insight in its dynamic transport mechanism.	[da Silva, Tatiana Claro; Hussainzada, Naissan; Khantwal, Chandra M.; Polli, James E.; Swaan, Peter W.] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Swaan, PW (corresponding author), 20 Penn St, Baltimore, MD 21201 USA.	pswaan@rx.umaryland.edu		Swaan, Peter/0000-0003-1767-1487	National Institutes of Health [NIDDK DK061425, DK067530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067530, R01DK061425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants NIDDK DK061425 (to P. W. S.) and DK067530 (to J. E. P.) from the National Institutes of Health.	Absalom NL, 2009, NEUROCHEM RES, V34, P1805, DOI 10.1007/s11064-009-9971-2; Balakrishnan A, 2006, MOL PHARMACEUT, V3, P223, DOI 10.1021/mp060022d; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; Banerjee A, 2008, BIOCHEM J, V410, P391, DOI 10.1042/BJ20071300; Bergheim I, 2006, J LIPID RES, V47, P42, DOI 10.1194/jlr.M500215-JLR200; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Huff MW, 2002, ARTERIOSCL THROM VAS, V22, P1884, DOI 10.1161/01.ATV.0000035390.87288.26; Hussainzada N, 2008, J BIOL CHEM, V283, P20653, DOI 10.1074/jbc.M802885200; Hussainzada N, 2008, MOL PHARMACOL, V73, P305, DOI 10.1124/mol.107.041640; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; Hussainzada N, 2009, BIOCHEMISTRY-US, V48, P8528, DOI 10.1021/bi900616w; Ivery MTG, 2000, MED RES REV, V20, P452, DOI 10.1002/1098-1128(200011)20:6<452::AID-MED2>3.0.CO;2-6; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Kagedahl M, 1997, PHARM RES-DORDR, V14, P176, DOI 10.1023/A:1012044526054; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Khantwal CM, 2008, BIOCHEMISTRY-US, V47, P3606, DOI 10.1021/bi702498w; Kitayama K, 2006, EUR J PHARMACOL, V539, P89, DOI 10.1016/j.ejphar.2006.04.005; Kosters A, 2008, XENOBIOTICA, V38, P1043, DOI [10.1080/00498250802040584, 10.1080/00498250802040584 ]; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Ray A, 2006, BIOORG MED CHEM LETT, V16, P1473, DOI 10.1016/j.bmcl.2005.12.050; Saeki T, 2009, BIOSCI BIOTECH BIOCH, V73, P1535, DOI 10.1271/bbb.90023; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Sun AQ, 2006, J BIOL CHEM, V281, P16410, DOI 10.1074/jbc.M600034200; Tolle-Sander S, 2004, MOL PHARMACEUT, V1, P40, DOI 10.1021/mp034010t; TUCHSEN E, 1987, BIOCHEMISTRY-US, V26, P1918, DOI 10.1021/bi00381a020; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Zhang EY, 2004, BIOCHEMISTRY-US, V43, P11380, DOI 10.1021/bi049270a; Zhang Qiang, 2011, Int J Biochem Mol Biol, V2, P31	35	13	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27322	27332		10.1074/jbc.M110.217802	http://dx.doi.org/10.1074/jbc.M110.217802			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646357	hybrid, Green Published			2022-12-25	WOS:000293268700028
J	Minano-Molina, AJ; Espana, J; Martin, E; Barneda-Zahonero, B; Fado, R; Sole, M; Trullas, R; Saura, CA; Rodriguez-Alvarez, J				Minano-Molina, Alfredo J.; Espana, Judit; Martin, Elsa; Barneda-Zahonero, Bruna; Fado, Rut; Sole, Montse; Trullas, Ramon; Saura, Carlos A.; Rodriguez-Alvarez, Jose			Soluble Oligomers of Amyloid-beta Peptide Disrupt Membrane Trafficking of alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid Receptor Contributing to Early Synapse Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; AMPA-RECEPTORS; ALZHEIMERS-DISEASE; PKA PHOSPHORYLATION; PERISYNAPTIC SITES; SECRETED OLIGOMERS; MOLECULAR-BASIS; PROTEIN-KINASE; IN-VIVO; PLASTICITY	beta-Amyloid (A beta), a peptide generated from the amyloid precursor protein, is widely believed to underlie the pathophysiology of Alzheimer disease (AD). Emerging evidences suggest that soluble A beta oligomers adversely affect synaptic function, leading to cognitive failure associated with AD. The A beta-induced synaptic dysfunction has been attributed to the synaptic removal of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors (AMPARs). However, the molecular mechanisms underlying the loss of AMPAR induced by A beta at synapses are largely unknown. In this study we have examined the effect of A beta oligomers on phosphorylated GluA1 at serine 845, a residue that plays an essential role in the trafficking of AMPARs toward extrasynaptic sites and the subsequent delivery to synapses during synaptic plasticity events. We found that A beta oligomers reduce basal levels of Ser-845 phosphorylation and surface expression of AMPARs affecting AMPAR subunit composition. A beta-induced GluA1 dephosphorylation and reduced receptor surface levels are mediated by an increase in calcium influx into neurons through ionotropic glutamate receptors and activation of the calcium-dependent phosphatase calcineurin. Moreover, A beta oligomers block the extrasynaptic delivery of AMPARs induced by chemical synaptic potentiation. In addition, reduced levels of total and phosphorylated GluA1 are associated with initial spatial memory deficits in a transgenic mouse model of AD. These findings indicate that A beta oligomers could act as a synaptic depressor affecting the mechanisms involved in the targeting of AMPARs to the synapses during early stages of the disease.	[Minano-Molina, Alfredo J.; Espana, Judit; Martin, Elsa; Barneda-Zahonero, Bruna; Fado, Rut; Sole, Montse; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Minano-Molina, Alfredo J.; Espana, Judit; Martin, Elsa; Barneda-Zahonero, Bruna; Fado, Rut; Sole, Montse; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Minano-Molina, Alfredo J.; Espana, Judit; Martin, Elsa; Fado, Rut; Trullas, Ramon; Saura, Carlos A.; Rodriguez-Alvarez, Jose] CSIC, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08036, Spain; [Trullas, Ramon] CSIC, Inst Invest Biomed Barcelona, Barcelona 08036, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona	Rodriguez-Alvarez, J (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Edifici M,Campus Bellaterra, E-08193 Barcelona, Spain.	jose.rodriguez@uab.es	Saura, Carlos A/D-2727-2011; Rodriguez-Alvarez, Jose/F-8403-2011; Miñano-Molina, Alfredo J/C-9863-2011; Saura, Carlos A/AFM-9239-2022; Andrés, Fadó Fadó/L-8585-2014; Trullas, Ramon/D-2197-2016; Piñol, Montse Solé/D-1133-2011	Saura, Carlos A/0000-0003-3692-5657; Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Miñano-Molina, Alfredo J/0000-0002-7761-5682; Andrés, Fadó Fadó/0000-0002-3293-2342; Trullas, Ramon/0000-0001-7951-9881; Piñol, Montse Solé/0000-0003-4240-6562; Barneda Zahonero, Bruna/0000-0002-6557-5222	Ministerio de Ciencia e Innovacion [SAF2008-01904, SAF2010-20925]; RENEVAS [RD06/0026/1009]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas [CB06/05/0042]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); RENEVAS(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas	This work was supported by the Ministerio de Ciencia e Innovacion (Grants SAF2008-01904 to J. R. A. and SAF2010-20925 to C. A. S.), by RENEVAS (Grant RD06/0026/1009 to J. R. A.), and by the Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (Grant CB06/05/0042 to J. R. A.).	Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cullen WK, 1996, NEUROREPORT, V8, P87, DOI 10.1097/00001756-199612200-00018; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Espana J, 2010, J NEUROSCI, V30, P9402, DOI 10.1523/JNEUROSCI.2154-10.2010; Espana J, 2010, BIOL PSYCHIAT, V67, P513, DOI 10.1016/j.biopsych.2009.06.015; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Estus S, 1997, J NEUROSCI, V17, P7736; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jurgensen S, 2011, J BIOL CHEM, V286, P3270, DOI 10.1074/jbc.M110.177790; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liu SJ, 2010, J ALZHEIMERS DIS, V21, P655, DOI 10.3233/JAD-2010-091654; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Parameshwaran K, 2008, EXP NEUROL, V210, P7, DOI 10.1016/j.expneurol.2007.10.008; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Szegedi V, 2005, BRAIN RES, V1062, P120, DOI 10.1016/j.brainres.2005.09.014; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Zhao WQ, 2010, J BIOL CHEM, V285, P7619, DOI 10.1074/jbc.M109.057182	57	78	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27311	27321		10.1074/jbc.M111.227504	http://dx.doi.org/10.1074/jbc.M111.227504			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21665950	hybrid, Green Published			2022-12-25	WOS:000293268700027
J	Tian, Q; Li, T; Hou, WH; Zheng, JY; Schrum, LW; Bonkovsky, HL				Tian, Qing; Li, Ting; Hou, Weihong; Zheng, Jianyu; Schrum, Laura W.; Bonkovsky, Herbert L.			Lon Peptidase 1 (LONP1)-dependent Breakdown of Mitochondrial 5-Aminolevulinic Acid Synthase Protein by Heme in Human Liver Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; MESSENGER-RNA; DEGRADATION; TRANSCRIPTION; EXPRESSION; REPRESSION; PORPHYRIA; GENE	5-Aminolevulinic acid synthase (ALAS-1) is the first rate controlling enzyme that controls cellular heme biosynthesis. Negative feedback regulation of ALAS-1 by the end product heme is well documented and provides the foundation for heme treatment of acute porphyrias, a group of diseases caused by genetic defects in the heme biosynthesis pathway and exacerbated by controlled up-regulation of ALAS-1. Heme is known to affect ALAS-1 activity by repressing gene transcription, accelerating mRNA degradation, and impeding pre-ALAS-1 mitochondrial translocation. In the current study, we examined the effect of heme on the rate of mature ALAS-1 protein turnover in human cells and tissues and explored the mediator involved in this new regulatory mechanism. We found that heme and other metalloporphyrins such as CoPP and CrPP decreased mitochondrial ALAS-1 protein through proteolysis. This degradative effect cannot be emulated by iron or free protoporphyrin, two major chemical components of the heme ring, and is independent of oxidative stress. Down-regulating the activity of mitochondrial LONP1, an ATP-dependent protease that controls the selective turnover of mitochondrial matrix proteins, with potent inhibitors and specific siRNA diminished the negative effect of heme on mitochondrial ALAS-1. Therefore, our data support the existence of a conserved heme feedback regulatory mechanism that functions on the mature form of ALAS-1 protein through the activity of a mitochondrial proteolytic system.	[Bonkovsky, Herbert L.] Carolinas Med Ctr, Cannon Res Ctr, Liver Digest & Metab Disorders Lab, Charlotte, NC 28203 USA; [Tian, Qing; Li, Ting; Hou, Weihong; Zheng, Jianyu; Schrum, Laura W.; Bonkovsky, Herbert L.] Carolinas Med Ctr, Liver Biliary Pancreat Ctr, Charlotte, NC 28203 USA; [Schrum, Laura W.; Bonkovsky, Herbert L.] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Bonkovsky, Herbert L.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; [Bonkovsky, Herbert L.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA	Carolinas Medical Center; Carolinas Medical Center; University of North Carolina; University of North Carolina Charlotte; University of Connecticut; University of North Carolina; University of North Carolina Chapel Hill	Bonkovsky, HL (corresponding author), Carolinas Med Ctr, Cannon Res Ctr, Liver Digest & Metab Disorders Lab, Ste 201,1000 Blythe Blvd, Charlotte, NC 28203 USA.	herbert.bonkovsky@carolinashealthcare.org	hou, wei/GWM-4800-2022; Bonkovsky, Herbert L./AAH-1892-2021	Bonkovsky, Herbert L./0000-0001-7387-3230	National Institutes of Health [5R01DK38825]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825, U54DK083909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01DK38825 (to H. B. L.).	Anderson KE, 2005, ANN INTERN MED, V142, P439, DOI 10.7326/0003-4819-142-6-200503150-00010; Bayot A, 2008, BIOCHIMIE, V90, P260, DOI 10.1016/j.biochi.2007.10.010; Bonkovsky H.L., 1990, HEPATOLOGY TXB LIVER, V2nd ed., P378; BONKOWSKY HL, 1971, P NATL ACAD SCI USA, V68, P2725, DOI 10.1073/pnas.68.11.2725; Cable EE, 2000, ARCH BIOCHEM BIOPHYS, V384, P280, DOI 10.1006/abbi.2000.2117; Correia MA, 2011, DRUG METAB REV, V43, P1, DOI 10.3109/03602532.2010.515222; DREW PD, 1989, BIOCHEM BIOPH RES CO, V162, P102, DOI 10.1016/0006-291X(89)91968-2; Elder G H, 1982, Semin Liver Dis, V2, P87, DOI 10.1055/s-2008-1040699; Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200; GRANICK S, 1975, J BIOL CHEM, V250, P9215; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; HAMILTON JW, 1991, ARCH BIOCHEM BIOPHYS, V289, P387, DOI 10.1016/0003-9861(91)90428-L; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; HAYASHI N, 1983, BIOCHEM BIOPH RES CO, V115, P700, DOI 10.1016/S0006-291X(83)80201-0; Hou WH, 2009, WORLD J GASTROENTERO, V15, P4499, DOI 10.3748/wjg.15.4499; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kolluri S, 2005, BIOCHEM J, V392, P173, DOI 10.1042/BJ20050354; Langer T, 1996, EXPERIENTIA, V52, P1069, DOI 10.1007/BF01952104; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Meyer UA, 2007, DRUG METAB REV, V39, P639, DOI 10.1080/03602530701498737; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; Podvinec M, 2004, P NATL ACAD SCI USA, V101, P9127, DOI 10.1073/pnas.0401845101; SRIVASTAVA G, 1988, J BIOL CHEM, V263, P5202; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yoshino K, 2007, J BIOCHEM, V142, P453, DOI 10.1093/jb/mvm159; Zheng JY, 2008, MOL CELL BIOCHEM, V319, P153, DOI 10.1007/s11010-008-9888-0	27	90	95	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26424	26430		10.1074/jbc.M110.215772	http://dx.doi.org/10.1074/jbc.M110.215772			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659532	hybrid, Green Published			2022-12-25	WOS:000293078200020
J	Sartore, RC; Campos, PB; Trujillo, CA; Ramalho, BL; Negraes, PD; Paulsen, BS; Meletti, T; Costa, ES; Chicaybam, L; Bonamino, MH; Ulrich, H; Rehen, SK				Sartore, Rafaela C.; Campos, Priscila B.; Trujillo, Cleber A.; Ramalho, Bia L.; Negraes, Priscilla D.; Paulsen, Bruna S.; Meletti, Tamara; Costa, Elaine S.; Chicaybam, Leonardo; Bonamino, Martin H.; Ulrich, Henning; Rehen, Stevens K.			Retinoic Acid-Treated Pluripotent Stem Cells Undergoing Neurogenesis Present Increased Aneuploidy and Micronuclei Formation	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; NEURAL PROGENITOR CELLS; NEURONAL DIFFERENTIATION; ES CELLS; SEGREGATION DEFECTS; SPINDLE CHECKPOINT; GENE-EXPRESSION; NERVOUS-SYSTEM; MOUSE EMBRYOS; HUMAN BRAIN	The existence of loss and gain of chromosomes, known as aneuploidy, has been previously described within the central nervous system. During development, at least one-third of neural progenitor cells (NPCs) are aneuploid. Notably, aneuploid NPCs may survive and functionally integrate into the mature neural circuitry. Given the unanswered significance of this phenomenon, we tested the hypothesis that neural differentiation induced by all-trans retinoic acid (RA) in pluripotent stem cells is accompanied by increased levels of aneuploidy, as previously described for cortical NPCs in vivo. In this work we used embryonal carcinoma (EC) cells, embryonic stem (ES) cells and induced pluripotent stem (iPS) cells undergoing differentiation into NPCs. Ploidy analysis revealed a 2-fold increase in the rate of aneuploidy, with the prevalence of chromosome loss in RA primed stem cells when compared to naive cells. In an attempt to understand the basis of neurogenic aneuploidy, micronuclei formation and survivin expression was assessed in pluripotent stem cells exposed to RA. RA increased micronuclei occurrence by almost 2-fold while decreased survivin expression by 50%, indicating possible mechanisms by which stem cells lose their chromosomes during neural differentiation. DNA fragmentation analysis demonstrated no increase in apoptosis on embryoid bodies treated with RA, indicating that cell death is not the mandatory fate of aneuploid NPCs derived from pluripotent cells. In order to exclude that the increase in aneuploidy was a spurious consequence of RA treatment, not related to neurogenesis, mouse embryonic fibroblasts were treated with RA under the same conditions and no alterations in chromosome gain or loss were observed. These findings indicate a correlation amongst neural differentiation, aneuploidy, micronuclei formation and survivin downregulation in pluripotent stem cells exposed to RA, providing evidence that somatically generated chromosomal variation accompanies neurogenesis in vitro.	[Sartore, Rafaela C.; Campos, Priscila B.; Ramalho, Bia L.; Paulsen, Bruna S.; Meletti, Tamara; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Trujillo, Cleber A.; Negraes, Priscilla D.; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Costa, Elaine S.] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, Brazil; [Chicaybam, Leonardo; Bonamino, Martin H.] Inst Nacl Canc, Div Expt Med, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; National Cancer Institute (Inca)	Sartore, RC (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	srehen@lance-ufrj.org	COSTA, ELAINE SOBRAL/AAE-9574-2021; Ulrich, Henning/AAX-8586-2021; Ulrich, Henning/C-5245-2013; Sartore, Rafaela/AAV-5609-2021; Rehen, Stevens/J-5874-2012; Sobral da Costa, Elaine/O-6523-2014	Ulrich, Henning/0000-0002-2114-3815; Ulrich, Henning/0000-0002-2114-3815; Sartore, Rafaela/0000-0002-1801-8650; Rehen, Stevens/0000-0003-4216-9501; Sobral da Costa, Elaine/0000-0002-5340-5816; Ramalho, Bia/0000-0002-9609-961X; Chicaybam Peixoto, Leonardo/0000-0002-1541-9029	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E26/111.556/2008, E26/103.081/2008]; Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq) [573.975/2008-6, 573476/08-0, MCT/CNPq 01/2005 - Institutos do Milenio]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/61285-9]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ - E26/111.556/2008; E26/103.081/2008); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq - 573.975/2008-6; 573476/08-0; MCT/CNPq 01/2005 - Institutos do Milenio); and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - 2006/61285-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Andollo N, 2005, APOPTOSIS, V10, P417, DOI 10.1007/s10495-005-0815-5; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Burgess A, 2006, J BIOL CHEM, V281, P9987, DOI 10.1074/jbc.M512714200; Campos PB, 2009, J VIS EXP; Capparelli R, 1997, CYTOMETRY, V29, P261, DOI 10.1002/(SICI)1097-0320(19971101)29:3<261::AID-CYTO9>3.0.CO;2-E; *CCS UFFRJ COM BIO, 2003, GUID CAR US MAMM NEU, P209; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Damelin M, 2005, CANCER CELL, V8, P479, DOI 10.1016/j.ccr.2005.11.004; Decordier I, 2008, MUTAT RES-GEN TOX EN, V651, P30, DOI 10.1016/j.mrgentox.2007.10.016; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Gupta RK, 2008, CANCER BIOL THER, V7, P1473, DOI 10.4161/cbt.7.9.6428; Herget T, 1998, J NEUROCHEM, V70, P47; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Kaushal D, 2003, J NEUROSCI, V23, P5599; Kim M, 2009, DEV BIOL, V328, P456, DOI 10.1016/j.ydbio.2009.02.001; Kingsbury MA, 2005, P NATL ACAD SCI USA, V102, P6143, DOI 10.1073/pnas.0408171102; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Makrantoni V, 2009, MOL CELL BIOL, V29, P4552, DOI 10.1128/MCB.01911-08; MARTIN GR, 1974, CELL, V2, P163, DOI 10.1016/0092-8674(74)90090-7; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Norppa H, 2003, MUTAGENESIS, V18, P221, DOI 10.1093/mutage/18.3.221; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Okazawa H, 1996, J CELL BIOL, V132, P955, DOI 10.1083/jcb.132.5.955; PAULSEN BS, 2011, STEM CELLS DEV  0318; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pratt MAC, 2006, APOPTOSIS, V11, P589, DOI 10.1007/s10495-006-4603-7; Rajendran RS, 2007, DEV NEUROBIOL, V67, P1334, DOI 10.1002/dneu.20365; Rebuzzini P, 2008, CYTOTECHNOLOGY, V58, P17, DOI 10.1007/s10616-008-9164-x; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Resende RR, 2008, INT J DEV NEUROSCI, V26, P763, DOI 10.1016/j.ijdevneu.2008.07.008; Resende RR, 2008, CELL CALCIUM, V43, P107, DOI 10.1016/j.ceca.2007.04.007; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V70, P99; Saito T, 2008, BRIT J CANCER, V98, P345, DOI 10.1038/sj.bjc.6604160; Sareen D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007630; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sun SC, 2009, CELL CYCLE, V8, P3365, DOI 10.4161/cc.8.20.9855; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Westra JW, 2008, J COMP NEUROL, V507, P1944, DOI 10.1002/cne.21648; Wilson L, 2004, DEV BIOL, V269, P433, DOI 10.1016/j.ydbio.2004.01.034; Yang AH, 2003, J NEUROSCI, V23, P10454; Yurov YB, 2005, J HISTOCHEM CYTOCHEM, V53, P385, DOI 10.1369/jhc.4A6430.2005; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x	58	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20667	10.1371/journal.pone.0020667	http://dx.doi.org/10.1371/journal.pone.0020667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674001	gold, Green Published			2022-12-25	WOS:000291356400014
J	Kommadath, A; Nie, HS; Groenen, MAM; Pas, MFWT; Veerkamp, RF; Smits, MA				Kommadath, Arun; Nie, Haisheng; Groenen, Martien A. M.; Pas, Marinus F. W. Te; Veerkamp, Roel F.; Smits, Mari A.			Regional Regulation of Transcription in the Bovine Genome	PLOS ONE			English	Article							HUMAN HOUSEKEEPING GENES; COEXPRESSED GENES; DNA-SEQUENCE; SELECTION; CLUSTERS; BIOLOGY; BIOCONDUCTOR; UNIFICATION; EXPRESSION; MAP	Eukaryotic genes are distributed along chromosomes as clusters of highly expressed genes termed RIDGEs (Regions of IncreaseD Gene Expression) and lowly expressed genes termed anti-RIDGEs, interspersed among genes expressed at intermediate levels or not expressed. Previous studies based on this observation suggested a dual mechanism of gene regulation, where, in addition to transcription factors, the chromosomal domain influences the expression level of their embedded genes. The objectives here were to provide evidence for the existence of chromosomal regional regulation of transcription in the bovine genome, to analyse the genomic features of genes located within RIDGEs versus anti-RIDGEs and tissue-specific genes versus housekeeping and to examine the genomic distribution of genes subject to positive selection in bovines. Gene expression analysis of four brain tissues and the anterior pituitary of 28 cows identified 70 RIDGEs and 41 anti-RIDGEs (harbouring 3735 and 1793 bovine genes respectively) across the bovine genome which are significantly higher than expected by chance. Housekeeping genes (defined here as genes expressed in all five tissues) were over-represented within RIDGEs but tissue-specific genes (genes expressed in only one of the five tissues) were not. Housekeeping genes and genes within RIDGEs had, in general, higher expression levels and GC content but shorter gene lengths and intron lengths than tissue-specific genes and genes within anti-RIDGES. Our findings suggest the existence of chromosomal regional regulation of transcription in the bovine genome. The genomic features observed for genes within RIDGEs and housekeeping genes in bovines agree with previous studies in several other species further strengthening the hypothesis of selective pressure to keep the highly and widely expressed genes short and compact for transcriptional efficiency. Further, positively selected genes were found non-randomly distributed on the genome with a preference for RIDGEs and regions of intermediate gene expression compared to anti-RIDGEs.	[Kommadath, Arun; Pas, Marinus F. W. Te; Veerkamp, Roel F.; Smits, Mari A.] Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, Lelystad, Netherlands; [Nie, Haisheng; Groenen, Martien A. M.] Wageningen Univ, Anim Breeding & Genom Ctr, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Kommadath, A (corresponding author), Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, Lelystad, Netherlands.	arun.kommadath@wur.nl	Veerkamp, Roel/ABC-9073-2020; Groenen, Martien/D-8408-2012; veerkamp, roel/D-9313-2012; smits, mari/J-4892-2013; Kommadath, Arun/I-4644-2019	Veerkamp, Roel/0000-0002-5240-6534; Groenen, Martien/0000-0003-0484-4545; smits, mari/0000-0002-3493-291X; Kommadath, Arun/0000-0003-3587-6670	European Commission [FOOD-CT-2006-016250, FOOD-CT-2004-506416]; Dutch Ministry of Agriculture, Nature and Food Quality [KB-04-004-012]; International cattle breeding - CRV BV	European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Ministry of Agriculture, Nature and Food Quality; International cattle breeding - CRV BV	This work was co-financed by the European Commission funded projects SABRE (www.sabre-eu.eu/) (contract No. FOOD-CT-2006-016250) and EADGENE (www.eadgene.info/) (contract No. FOOD-CT-2004-506416), the Dutch Ministry of Agriculture, Nature and Food Quality (www.minlnv.nl) (KB-04-004-012) and the International cattle breeding co-operative - CRV BV (www.crv4all.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Casel Pierrot, 2009, BMC Proc, V3 Suppl 4, pS3, DOI 10.1186/1753-6561-3-S4-S3; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Donthu Ravikiran, 2009, BMC Res Notes, V2, P148, DOI 10.1186/1756-0500-2-148; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Folle GA, 2010, CYTOGENET GENOME RES, V128, P17, DOI 10.1159/000296072; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kommadath A, 2010, ANIMAL, V4, P1297, DOI 10.1017/S1751731110000303; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Liu Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-180; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Mijalski T, 2005, P NATL ACAD SCI USA, V102, P8621, DOI 10.1073/pnas.0407672102; Nie HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011990; Nie HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-28; Singer GAC, 2005, MOL BIOL EVOL, V22, P767, DOI 10.1093/molbev/msi062; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Zody MC, 2006, NATURE, V440, P1045, DOI 10.1038/nature04689	34	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20413	10.1371/journal.pone.0020413	http://dx.doi.org/10.1371/journal.pone.0020413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673989	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500017
J	Lopez-Munguia, A; Hernandez-Romero, Y; Pedraza-Chaverri, J; Miranda-Molina, A; Regla, I; Martinez, A; Castillo, E				Lopez-Munguia, Agustin; Hernandez-Romero, Yanet; Pedraza-Chaverri, Jose; Miranda-Molina, Alfonso; Regla, Ignacio; Martinez, Ana; Castillo, Edmundo			Phenylpropanoid Glycoside Analogues: Enzymatic Synthesis, Antioxidant Activity and Theoretical Study of Their Free Radical Scavenger Mechanism	PLOS ONE			English	Article							LIPASE-CATALYZED SYNTHESIS; PHENOLIC-ACIDS; CANDIDA-ANTARCTICA; DERIVATIVES	Phenylpropanoid glycosides (PPGs) are natural compounds present in several medicinal plants that have high antioxidant power and diverse biological activities. Because of their low content in plants (less than 5% w/w), several chemical synthetic routes to produce PPGs have been developed, but their synthesis is a time consuming process and the achieved yields are often low. In this study, an alternative and efficient two-step biosynthetic route to obtain natural PPG analogues is reported for the first time. Two galactosides were initially synthesized from vanillyl alcohol and homovanillyl alcohol by a transgalactosylation reaction catalyzed by Kluyveromyces lactis beta-galactosidase in saturated lactose solutions with a 30%-35% yield. To synthesize PPGs, the galactoconjugates were esterified with saturated and unsaturated hydroxycinnamic acid derivatives using Candida antarctica Lipase B (CaL-B) as a biocatalyst with 40%-60% yields. The scavenging ability of the phenolic raw materials, intermediates and PPGs was evaluated by the 2,2-diphenyl-1-picrylhydrazyl radical (DPPHN.) method. It was found that the biosynthesized PPGs had higher scavenging abilities when compared to ascorbic acid, the reference compound, while their antioxidant activities were found similar to that of natural PPGs. Moreover, density functional theory (DFT) calculations were used to determine that the PPGs antioxidant mechanism proceeds through a sequential proton loss single electron transfer (SPLET). The enzymatic process reported in this study is an efficient and versatile route to obtain PPGs from different phenylpropanoid acids, sugars and phenolic alcohols.	[Lopez-Munguia, Agustin; Hernandez-Romero, Yanet; Miranda-Molina, Alfonso; Castillo, Edmundo] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico; [Pedraza-Chaverri, Jose] Univ Nacl Autonoma Mexico, Dept Biol, Fac Quim, Mexico City 04510, DF, Mexico; [Martinez, Ana] Univ Nacl Autonoma Mexico, Dept Mat Condensada & Criogenia, Inst Invest Mat, Mexico City 04510, DF, Mexico; [Regla, Ignacio] Univ Nacl Autonoma Mexico, Fac Estudios Super Zaragoza, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Lopez-Munguia, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	martina@iim.unam.mx; edmundo@ibt.unam.mx	, Regla/L-5486-2019; Regla, Ignacio/C-4878-2011	Martinez, Ana/0000-0002-0515-1946; Miranda, Alfonso/0000-0003-0418-6386; Lopez Munguia, Agustin/0000-0003-4204-4936; Castillo, Edmundo/0000-0002-8274-4307; Hernandez-Romero, Yanet/0000-0002-5826-0062	PAPIIT-UNAM (MEXICO) [IN226706-3]	PAPIIT-UNAM (MEXICO)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work has been supported by the grant IN226706-3 PAPIIT-UNAM (MEXICO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligiannis N, 2003, J AGR FOOD CHEM, V51, P7308, DOI 10.1021/jf034528+; BALAN K, 2006, Patent No. 20060280820; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bojarova P, 2009, TRENDS BIOTECHNOL, V27, P199, DOI 10.1016/j.tibtech.2008.12.003; Bridiau N, 2006, BIOTECHNOL PROGR, V22, P326, DOI 10.1021/bp050230n; Cances E, 1997, J CHEM PHYS, V107, P3032, DOI 10.1063/1.474659; Cassani J, 2007, ELECTRON J BIOTECHN, V10, P508, DOI 10.2225/vol10-issue4-fulltext-3; Castillo E, 2003, J BIOTECHNOL, V102, P251, DOI 10.1016/S0168-1656(03)00050-6; Castillo E, 2007, FOOD CHEM, V100, P1202, DOI 10.1016/j.foodchem.2005.11.026; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Delazar A, 2008, J NAT MED-TOKYO, V62, P464, DOI 10.1007/s11418-008-0255-y; Duynstee HI, 1999, EUR J ORG CHEM, V1999, P2623; Ersoz T, 2003, Z NATURFORSCH C, V58, P471; Galano A, 2009, CHEM PHYS, V363, P13, DOI 10.1016/j.chemphys.2009.07.003; Gotor-Fernandez V, 2006, J MOL CATAL B-ENZYM, V40, P111, DOI 10.1016/j.molcatb.2006.02.010; Kawada T, 1999, J ORG CHEM, V64, P9268, DOI 10.1021/jo9906983; Kawada T, 2002, J WOOD SCI, V48, P512, DOI 10.1007/BF00766648; Kawada T, 2000, EUR J ORG CHEM, V2000, P2723, DOI 10.1002/1099-0690(200008)2000:15<2723::AID-EJOC2723>3.0.CO;2-Y; Kawada T, 2006, HOLZFORSCHUNG, V60, P492, DOI 10.1515/HF.2006.081; Kennedy JF, 2006, J CHEM TECHNOL BIOT, V81, P866, DOI 10.1002/jctb.1473; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Kurkin VA, 2003, CHEM NAT COMPD+, V39, P123, DOI 10.1023/A:1024876810579; Laporta O, 2004, AGRO FOOD IND HI TEC, V15, P30; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee GS, 2006, BIOTECHNOL LETT, V28, P581, DOI 10.1007/s10529-006-0019-2; Lee S, 2007, B KOR CHEM SOC, V28, P1787; Li Q, 2005, CARBOHYD RES, V340, P1601, DOI 10.1016/j.carres.2005.04.011; Li ZJ, 1998, ACTA CHIM SINICA, V56, P1128; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; Martinez A, 2010, J PHYS CHEM C, V114, P8184, DOI 10.1021/jp100168q; Martinez A, 2009, J PHYS CHEM B, V113, P12113, DOI 10.1021/jp903958h; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; Molyneux P., 2004, SJST, V26, P211, DOI DOI 10.1287/ISRE.6.2.144; MOON JK, 2010, MOLECULES, V15, P4324; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Nenadis N, 2003, J AM OIL CHEM SOC, V80, P451, DOI 10.1007/s11746-003-0719-8; Otto RT, 2000, J MOL CATAL B-ENZYM, V8, P201, DOI 10.1016/S1381-1177(99)00058-2; Pan J, 2003, PHARMAZIE, V58, P767; Rolland Y., 2004, Patent WO, Patent No. [2004/069218 A1, 2004069218]; Sabally K, 2007, BIOCATAL BIOTRANSFOR, V25, P211, DOI 10.1080/10242420701379916; Shi YM, 1999, SCI CHINA SER C, V42, P420, DOI 10.1007/BF02882062; Shimoji Y, 2002, J AGR FOOD CHEM, V50, P6501, DOI 10.1021/jf020458f; Silva FAM, 2000, J AGR FOOD CHEM, V48, P2122, DOI 10.1021/jf9913110; Stamatis H, 2001, J MOL CATAL B-ENZYM, V11, P323, DOI 10.1016/S1381-1177(00)00016-3; Stevenson DE, 2006, ENZYME MICROB TECH, V39, P1236, DOI 10.1016/j.enzmictec.2006.03.006; STEVENSON DE, 1993, BIOTECHNOL BIOENG, V42, P657, DOI 10.1002/bit.260420514; Tomasi J, 1999, J MOL STRUC-THEOCHEM, V464, P211, DOI 10.1016/S0166-1280(98)00553-3; WILDMAN REC, 2006, HDB NUTRACEUTICALS F, P1; Yamaguchi T, 1998, BIOSCI BIOTECH BIOCH, V62, P1201, DOI 10.1271/bbb.62.1201; Zhang SQ, 1997, CARBOHYD RES, V299, P281, DOI 10.1016/S0008-6215(97)00032-3; Zhang SQ, 1998, CARBOHYD RES, V308, P281, DOI 10.1016/S0008-6215(98)00092-5; Zhou FY, 2006, CARBOHYD RES, V341, P2469, DOI 10.1016/j.carres.2006.08.006	53	39	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20115	10.1371/journal.pone.0020115	http://dx.doi.org/10.1371/journal.pone.0020115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674039	Green Published, gold, Green Submitted			2022-12-25	WOS:000291355500006
J	Vladimirov, N; Traub, RD; Tu, YH				Vladimirov, Nikita; Traub, Roger D.; Tu, Yuhai			Wave Speed in Excitable Random Networks with Spatially Constrained Connections	PLOS ONE			English	Article							OSCILLATIONS; MODEL; DIFFUSION; PATTERNS	Very fast oscillations (VFO) in neocortex are widely observed before epileptic seizures, and there is growing evidence that they are caused by networks of pyramidal neurons connected by gap junctions between their axons. We are motivated by the spatio-temporal waves of activity recorded using electrocorticography (ECoG), and study the speed of activity propagation through a network of neurons axonally coupled by gap junctions. We simulate wave propagation by excitable cellular automata (CA) on random (Erdos-Renyi) networks of special type, with spatially constrained connections. From the cellular automaton model, we derive a mean field theory to predict wave propagation. The governing equation resolved by the Fisher-Kolmogorov PDE fails to describe wave speed. A new (hyperbolic) PDE is suggested, which provides adequate wave speed v(< k >) that saturates with network degree < k >, in agreement with intuitive expectations and CA simulations. We further show that the maximum length of connection is a much better predictor of the wave speed than the mean length. When tested in networks with various degree distributions, wave speeds are found to strongly depend on the ratio of network moments < k(2)>/< k > rather than on mean degree < k >, which is explained by general network theory. The wave speeds are strikingly similar in a diverse set of networks, including regular, Poisson, exponential and power law distributions, supporting our theory for various network topologies. Our results suggest practical predictions for networks of electrically coupled neurons, and our mean field method can be readily applied for a wide class of similar problems, such as spread of epidemics through spatial networks.	[Vladimirov, Nikita; Traub, Roger D.; Tu, Yuhai] IBM TJ Watson Res Ctr, Yorktown Hts, NY USA	International Business Machines (IBM)	Vladimirov, N (corresponding author), IBM TJ Watson Res Ctr, Yorktown Hts, NY USA.	nikita.vladimirov@gmail.com			NIH/NINDS [R01NS062955, R01NS44133, R01GM081747]; Alexander von Humboldt Stiftung; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062955, R01NS044133] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants NIH/NINDS (http://nih.gov) R01NS062955 to NV and RDT, R01NS44133 to RDT, R01GM081747 to YT, and Alexander von Humboldt Stiftung (www.humboldt-foundation.de) to RDT. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are employed by the IBM T.J. Watson Research Center and contributed to all aspects of the study.	ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Berg, 2018, RANDOM WALKS BIOL; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; dos Santos RMZ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168102; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Furtado LS, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011907; GREENBERG JM, 1978, SIAM J APPL MATH, V34, P515, DOI 10.1137/0134040; Hua H, 2009, P NATL ACAD SCI USA, V106, P1318, DOI 10.1073/pnas.0811973106; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Lewis TJ, 2000, NETWORK-COMP NEURAL, V11, P299, DOI 10.1088/0954-898X/11/4/304; Munro E, 2010, J COMPUT NEUROSCI, V28, P539, DOI 10.1007/s10827-010-0235-6; Murray J.D., 2001, MATH BIOL; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Perc M, 2007, CHAOS SOLITON FRACT, V31, P280, DOI 10.1016/j.chaos.2005.10.018; Roopun AK, 2009, EPILEPSY BEHAV, V14, P39, DOI 10.1016/j.yebeh.2008.09.008; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sun XJ, 2008, CHAOS, V18, DOI 10.1063/1.2900402; Traub R.D., 2010, CORTICAL OSCILLATION; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Traub RD, 2008, EUR J NEUROSCI, V28, P1603, DOI 10.1111/j.1460-9568.2008.06477.x; Traub RD, 2010, EPILEPSIA, V51, P1587, DOI 10.1111/j.1528-1167.2009.02420.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WAXMAN BM, 1988, IEEE J SEL AREA COMM, V6, P1617, DOI 10.1109/49.12889; Zegura EW, 1996, IEEE INFOCOM SER, P594, DOI 10.1109/INFCOM.1996.493353	29	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20536	10.1371/journal.pone.0020536	http://dx.doi.org/10.1371/journal.pone.0020536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674028	gold, Green Submitted, Green Published			2022-12-25	WOS:000291355500021
J	Leval, A; Sundstrom, K; Ploner, A; Dahlstrom, LA; Widmark, C; Sparen, P				Leval, Amy; Sundstrom, Karin; Ploner, Alexander; Dahlstrom, Lisen Arnheim; Widmark, Catarina; Sparen, Par			Assessing Perceived Risk and STI Prevention Behavior: A National Population-Based Study with Special Reference to HPV	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HIGH-SCHOOL-STUDENTS; CONDOM USE; CONTRACEPTIVE USE; KNOWLEDGE; ATTITUDES; SWEDEN; VACCINATION; DENMARK; HEALTH	Introduction: To better understand trends in sexually transmitted infection (STI) prevention, specifically low prevalence of condom use with temporary partners, the aim of this study was to examine factors associated with condom use and perceptions of STI risk amongst individuals at risk, with the underlying assumption that STI risk perceptions and STI prevention behaviors are correlated. Methods: A national population-based survey on human papillomavirus (HPV) and sexual habits of young adults aged 18-30 was conducted in Sweden in 2007, with 1712 men and 8855 women participating. Regression analyses stratified by gender were performed to measure condom use with temporary partners and STI risk perception. Results: Men's condom use was not associated with STI risk perception while women's was. Awareness of and disease severity perceptions were not associated with either condom use or risk perception though education level correlated with condom use. Women's young age at sexual debut was associated with a higher risk of non-condom use later in life (OR 1.95 95% CI: 1.46-2.60). Women with immigrant mothers were less likely to report seldom/never use of condoms with temporary partners compared to women with Swedish-born mothers (OR 0.53 95% CI: 0.37-0.77). Correlates to STI risk perception differ substantially between sexes. Number of reported temporary partners was the only factor associated for both men and women with condom use and STI risk perception. Conclusions: Public health interventions advocating condom use with new partners could consider employing tactics besides those which primarily aim to increase knowledge or self-perceived risk if they are to be more effective in STI reduction. Gender-specific prevention strategies could be effective considering the differences found in this study.	[Leval, Amy; Sundstrom, Karin; Ploner, Alexander; Dahlstrom, Lisen Arnheim; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Widmark, Catarina] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Widmark, Catarina] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Nursing, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Leval, A (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	amy.leval@ki.se	Sundström, Karin/V-5714-2017	Sundström, Karin/0000-0002-6865-0224; Ploner, Alexander/0000-0002-5042-8326; Sparen, Par/0000-0002-5184-8971	Sanofi Pasteur MSD, Sweden; Swedish National Research School in Health Care Sciences	Sanofi Pasteur MSD, Sweden; Swedish National Research School in Health Care Sciences	Sanofi Pasteur MSD, Sweden, funded the data collection in this study. The work was also supported by funds from the Swedish National Research School in Health Care Sciences. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	*CDCP, 2010, MAL LAT COND SEX TRA; CHRISTIANSON M, 2006, WHATS BEHIND SEXUAL; Dahlstrom LA, 2010, INT J CANCER, V126, P500, DOI 10.1002/ijc.24712; Damani R, 2009, INT J STD AIDS, V20, P761, DOI 10.1258/ijsa.2009.009238; Edgardh K, 2002, SEX TRANSM INFECT, V78, P352, DOI 10.1136/sti.78.5.352; Gerressu M, 2009, SEX TRANSM INFECT, V85, P283, DOI 10.1136/sti.2008.034645; GLANZ K, 1997, HLTH BEHAV HLTH ED; Godeau E, 2008, ARCH PEDIAT ADOL MED, V162, P66, DOI 10.1001/archpediatrics.2007.8; Haimovich S, 2009, EUR J CONTRACEP REPR, V14, P187, DOI 10.1080/13625180902741436; HAMMARLUND K, 2009, RISKY ENCOUNTERS YOU; HERLITZ C, 2010, J PUBLIC HLTH, V38; Hoglund AT, 2009, INT J STD AIDS, V20, P102, DOI 10.1258/ijsa.2008.008200; Kaliyaperumal K, 2004, AECS ILLUMINATION, V4; KJAER SK, 1992, CANCER CAUSE CONTROL, V3, P339, DOI 10.1007/BF00146887; Larsson M, 2007, EUR J CONTRACEP REPR, V12, P119, DOI 10.1080/13625180701217026; Lazarus JV, 2009, PUBLIC HEALTH, V123, P138, DOI 10.1016/j.puhe.2008.10.014; Lazarus JV, 2006, SCAND J PUBLIC HEALT, V34, P92, DOI 10.1080/14034940510032211; Lindh I, 2009, CONTRACEPTION, V80, P163, DOI 10.1016/j.contraception.2009.01.019; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lynge E, 2009, EUR J CANCER, V45, P2714, DOI 10.1016/j.ejca.2009.07.024; Makenzius M, 2009, EUR J CONTRACEP REPR, V14, P268, DOI 10.1080/13625180903015871; *NAT BOARD HLTH WE, 2009, PUBL HLTH REP 2009; Nohr B, 2008, ACTA OBSTET GYN SCAN, V87, P1048, DOI 10.1080/00016340802326373; Novak Daniel P, 2005, Int J Adolesc Med Health, V17, P379; Parsons M.A., 2010, HLTH PROMOTION NURSI; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Semenza JC, 2010, EUROSURVEILLANCE, V15, P32; Silins I, 2000, CANCER EPIDEM BIOMAR, V9, P953; SUNDSTROM K, 2010, ACCEPTABILITY HPV VA; Svenson GR, 2002, AIDS EDUC PREV, V14, P515, DOI 10.1521/aeap.14.8.515.24111; TONES KGJ, 2004, HLTH PROMOTION PLANN; United Nations General Assembly, 2010, UNGASS COUNTR PROGR; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; Winer RL, 2008, J INFECT DIS, V197, P279, DOI 10.1086/524875; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284; World Health Organization, 2008, ADVOCACY COMMUNICATI; Wulff M, 2004, EUR J CONTRACEP REPR, V9, P69, DOI 10.1080/13625180410001715636; Ylitalo N, 1999, INT J CANCER, V81, P357, DOI 10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.3.CO;2-T	38	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20624	10.1371/journal.pone.0020624	http://dx.doi.org/10.1371/journal.pone.0020624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674050	gold, Green Published, Green Submitted			2022-12-25	WOS:000291310600019
J	Alvarez-Alfageme, F; Maharramov, J; Carrillo, L; Vandenabeele, S; Vercammen, D; Van Breusegem, F; Smagghe, G				Alvarez-Alfageme, Fernando; Maharramov, Jafar; Carrillo, Laura; Vandenabeele, Steven; Vercammen, Dominique; Van Breusegem, Frank; Smagghe, Guy			Potential Use of a Serpin from Arabidopsis for Pest Control	PLOS ONE			English	Article							CYSTEINE PROTEASE INHIBITOR; DIGESTIVE PROTEINASES; CRYSTAL-STRUCTURE; CHYMOTRYPSIN-LIKE; MYZUS-PERSICAE; INSECT; PLANTS; LEPIDOPTERA; ADAPTATION; ENZYME	Although genetically modified (GM) plants expressing toxins from Bacillus thuringiensis (Bt) protect agricultural crops against lepidopteran and coleopteran pests, field-evolved resistance to Bt toxins has been reported for populations of several lepidopteran species. Moreover, some important agricultural pests, like phloem-feeding insects, are not susceptible to Bt crops. Complementary pest control strategies are therefore necessary to assure that the benefits provided by those insectresistant transgenic plants are not compromised and to target those pests that are not susceptible. Experimental GM plants producing plant protease inhibitors have been shown to confer resistance against a wide range of agricultural pests. In this study we assessed the potential of AtSerpin1, a serpin from Arabidopsis thaliana (L). Heynh., for pest control. In vitro assays were conducted with a wide range of pests that rely mainly on either serine or cysteine proteases for digestion and also with three non-target organisms occurring in agricultural crops. AtSerpin1 inhibited proteases from all pest and non-target species assayed. Subsequently, the cotton leafworm Spodoptera littoralis Boisduval and the pea aphid Acyrthosiphon pisum (Harris) were fed on artificial diets containing AtSerpin1, and S. littoralis was also fed on transgenic Arabidopsis plants overproducing AtSerpin1. AtSerpin1 supplied in the artificial diet or by transgenic plants reduced the growth of S. littoralis larvae by 65% and 38%, respectively, relative to controls. Nymphs of A. pisum exposed to diets containing AtSerpin1 suffered high mortality levels (LC50 = 637 mu g ml(-1)). The results indicate that AtSerpin1 is a good candidate for exploitation in pest control.	[Alvarez-Alfageme, Fernando; Maharramov, Jafar; Carrillo, Laura; Smagghe, Guy] Univ Ghent, Dept Crop Protect, Fac Biosci Engn, B-9000 Ghent, Belgium; [Vandenabeele, Steven; Vercammen, Dominique; Van Breusegem, Frank] Univ Ghent, VIB Dept Plant Syst Biol, B-9000 Ghent, Belgium; [Vandenabeele, Steven; Vercammen, Dominique; Van Breusegem, Frank] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Alvarez-Alfageme, F (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	fernando.alvarez@art.admin.ch; guy.smagghe@ugent.be	Van Breusegem, Frank/Y-2999-2019; Smagghe, Guy/AAE-8914-2019; Van Breusegem, Frank/AAJ-2647-2020; Carrillo, Laura/K-8472-2017	Smagghe, Guy/0000-0001-8334-3313; Van Breusegem, Frank/0000-0002-3147-0860; Carrillo, Laura/0000-0003-2215-322X; Alvarez, Fernando/0000-0001-8932-3823	Ghent University; Industrial Research Fund (IOF); Multidisciplinary Research Partnership Ghent Bio-economy, of COST Action [862]; Fund for Scientific Research-Flanders (FWO-Vlaanderen); BELSPO [12TKM106]; Marie Curie Fellowship [MOIF-CT-2004]	Ghent University(Ghent University); Industrial Research Fund (IOF); Multidisciplinary Research Partnership Ghent Bio-economy, of COST Action; Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); BELSPO(Belgian Federal Science Policy Office); Marie Curie Fellowship(European Commission)	The authors acknowledge the support of Ghent University, particularly the Industrial Research Fund (IOF) and the Multidisciplinary Research Partnership Ghent Bio-economy, of COST Action 862 to LC, and of Fund for Scientific Research-Flanders (FWO-Vlaanderen) to DV. SV was recipient of a BELSPO grant (12TKM106) and a Marie Curie Fellowship (MOIF-CT-2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Al-Khunaizi M, 2002, BIOCHEMISTRY-US, V41, P3189, DOI 10.1021/bi015999x; Alvarez-Alfageme F, 2007, TRANSGENIC RES, V16, P1, DOI 10.1007/s11248-006-9022-6; Azzouz H, 2005, J INSECT PHYSIOL, V51, P75, DOI 10.1016/j.jinsphys.2004.11.010; BEWLEY GC, 1968, COMP BIOCHEM PHYSIOL, V25, P1061, DOI 10.1016/0010-406X(68)90591-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brookes G., 2005, AgBioForum, V8, P187; Bruning M, 2007, BIOCHEM J, V401, P325, DOI 10.1042/BJ20060648; Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Carrillo L, 2011, TRANSGENIC RES, V20, P305, DOI 10.1007/s11248-010-9417-2; Carrillo L, 2011, PLANT CELL REP, V30, P101, DOI 10.1007/s00299-010-0948-z; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cowgill SE, 2002, MOL ECOL, V11, P821, DOI 10.1046/j.1365-294X.2002.01482.x; Cristofoletti PT, 2003, J INSECT PHYSIOL, V49, P11, DOI 10.1016/S0022-1910(02)00222-6; Dahl SW, 1996, J BIOL CHEM, V271, P25083, DOI 10.1074/jbc.271.41.25083; De Leo F, 2001, INSECT BIOCHEM MOLEC, V31, P593, DOI 10.1016/S0965-1748(00)00164-8; De Leo F, 1998, PLANT PHYSIOL, V118, P997, DOI 10.1104/pp.118.3.997; Deraison C, 2004, INSECT MOL BIOL, V13, P165, DOI 10.1111/j.0962-1075.2004.00474.x; Dunse KM, 2010, P NATL ACAD SCI USA, V107, P15011, DOI 10.1073/pnas.1009241107; Dutton A, 2005, ENTOMOL EXP APPL, V114, P161, DOI 10.1111/j.1570-7458.2005.00239.x; Ferry N, 2006, TRANSGENIC RES, V15, P13, DOI 10.1007/s11248-005-4803-x; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kehr J, 2006, J EXP BOT, V57, P767, DOI 10.1093/jxb/erj087; Lampl N, 2010, J BIOL CHEM, V285, P13550, DOI 10.1074/jbc.M109.095075; Lara P, 2000, TRANSGENIC RES, V9, P169, DOI 10.1023/A:1008905631440; LEE MJ, 1995, INSECT BIOCHEM MOLEC, V25, P49, DOI 10.1016/0965-1748(94)00042-G; Malone LA, 2000, APIDOLOGIE, V31, P25, DOI 10.1051/apido:2000104; Malone Louise A., 2008, V5, P357, DOI 10.1007/978-1-4020-8373-0_13; Marchetti S, 2000, THEOR APPL GENET, V101, P519, DOI 10.1007/s001220051511; McGowan S, 2006, EMBO J, V25, P3144, DOI 10.1038/sj.emboj.7601201; Mulligan EA, 2010, PEST MANAG SCI, V66, P325, DOI 10.1002/ps.1879; MURDOCK LL, 1987, COMP BIOCHEM PHYS B, V87, P783, DOI 10.1016/0305-0491(87)90388-9; Novillo C, 1997, ARCH INSECT BIOCHEM, V36, P181, DOI 10.1002/(SICI)1520-6327(1997)36:3<181::AID-ARCH3>3.0.CO;2-X; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Ortego F, 1996, ARCH INSECT BIOCHEM, V33, P163, DOI 10.1002/(SICI)1520-6327(1996)33:2&lt;163::AID-ARCH6&gt;3.0.CO;2-Z; Pilcher CD, 1997, J ECON ENTOMOL, V90, P669, DOI 10.1093/jee/90.2.669; Rahbe Y, 2003, INSECT BIOCHEM MOLEC, V33, P299, DOI 10.1016/S0965-1748(02)00244-8; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Rasmussen SK, 1996, PLANT MOL BIOL, V30, P673, DOI 10.1007/BF00049343; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Ribeiro APO, 2006, J APPL ENTOMOL, V130, P84, DOI 10.1111/j.1439-0418.2005.01021.x; Rispe C, 2008, MOL BIOL EVOL, V25, P5, DOI 10.1093/molbev/msm222; Roberts TH, 2008, FUNCT INTEGR GENOMIC, V8, P1, DOI 10.1007/s10142-007-0059-2; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Schluter U, 2010, J EXP BOT, V61, P4169, DOI 10.1093/jxb/erq166; Shahidi-Noghabi S, 2008, PHYTOCHEMISTRY, V69, P2972, DOI 10.1016/j.phytochem.2008.09.012; Toenniessen GH, 2003, CURR OPIN PLANT BIOL, V6, P191, DOI 10.1016/S1369-5266(03)00002-5; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Yoo BC, 2000, J BIOL CHEM, V275, P35122, DOI 10.1074/jbc.M006060200; ZWILLING R, 1972, COMP BIOCHEM PHYSIOL, V43, P419, DOI 10.1016/0305-0491(72)90302-1	57	22	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20278	10.1371/journal.pone.0020278	http://dx.doi.org/10.1371/journal.pone.0020278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655276	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600035
J	Chen, ZS; Xiao, YN; Zhang, JJ; Li, J; Liu, YX; Zhao, YY; Ma, CC; Luo, J; Qiu, YM; Huang, G; Korteweg, C; Gu, J				Chen, Zhengshan; Xiao, Yanna; Zhang, Junjun; Li, Jing; Liu, Yuxuan; Zhao, Yingying; Ma, Changchun; Luo, Jin; Qiu, Yamei; Huang, Guowei; Korteweg, Christine; Gu, Jiang			Transcription Factors E2A, FOXO1 and FOXP1 Regulate Recombination Activating Gene Expression in Cancer Cells	PLOS ONE			English	Article							ALPHA HEAVY-CHAIN; V(D)J RECOMBINATION; IMMUNOGLOBULIN-G; B-CELLS; LYMPHOCYTE DEVELOPMENT; NONLYMPHOID CELLS; RAG-2 PROMOTER; PROTEINS; REARRANGEMENT; CARCINOMAS	It has long been accepted that immunoglobulins (Igs) were produced by B lymphoid cells only. Recently Igs have been found to be expressed in various human cancer cells and promote tumor growth. Recombination activating gene 1 (RAG1) and RAG2, which are essential enzymes for initiating variable-diversity-joining segment recombination, have also been found to be expressed in cancer cells. However, the mechanism of RAG activation in these cancer cells has not been elucidated. Here, we investigated the regulatory mechanism of RAG expression in four human cancer cell lines by analyzing transcription factors that induce RAG activation in B cells. By RT-PCR, Western blot and immunofluorescence, we found that transcription factors E2A, FOXO1 and FOXP1 were expressed and localized to the nuclei of these cancer cells. Overexpression of E2A, FOXO1 or Foxp1 increased RAG expression, while RNA interference of E2A, FOXO1 or FOXP1 decreased RAG expression in the cancer cells. Chromatin immunoprecipitation experiments showed acetylation of RAG enhancer (Erag) and E2A, FOXO1 or FOXP1 were bound to Erag in vivo. These results indicate that in these cancer cells the transcription factors E2A, FOXO1 and FOXP1 regulate RAG expression, which initiates Ig gene rearrangement much in the way similar to B lymphocytes.	[Chen, Zhengshan; Xiao, Yanna; Zhang, Junjun; Li, Jing; Ma, Changchun; Luo, Jin; Qiu, Yamei; Huang, Guowei; Korteweg, Christine; Gu, Jiang] Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China; [Liu, Yuxuan; Zhao, Yingying; Gu, Jiang] Peking Beijing Univ, Dept Pathol, Hlth Sci Ctr, Beijing, Peoples R China	Shantou University; Peking University	Chen, ZS (corresponding author), Shantou Univ, Coll Med, Dept Pathol, Shantou, Peoples R China.	jguemailbox@gmail.com	Chen, Zhengshan/J-7499-2014; Ma, Changchun/AAI-4282-2020; Liu, Yuxuan/F-4226-2018	Gu, Jiang/0000-0002-0706-8329; Liu, Yuxuan/0000-0003-4426-9290	National Natural Science Foundation of China [81001199, 81030033, 30971150, 30950110335]; Guangdong Colleges and Universities [LYM10079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Colleges and Universities	This work was supported by grants (81001199 to ZC, 81030033, 30971150 to JG, 30950110335 to KC) from the National Natural Science Foundation of China, and grant LYM10079 to ZC from the Innovative Talents Program of Guangdong Colleges and Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2010, MOL VIS, V16, P408; Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Banham AH, 2001, CANCER RES, V61, P8820; Chen ZS, 2007, FASEB J, V21, P2931, DOI 10.1096/fj.07-8073com; Chen ZS, 2010, CANCER-AM CANCER SOC, V116, P1953, DOI 10.1002/cncr.24892; Chen ZS, 2009, AM J PATHOL, V174, P1139, DOI 10.2353/ajpath.2009.080879; Choi JK, 1996, EMBO J, V15, P5014, DOI 10.1002/j.1460-2075.1996.tb00881.x; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; de Pooter RF, 2010, IMMUNOL REV, V238, P93, DOI 10.1111/j.1600-065X.2010.00957.x; Deng Yu-qing, 2006, Zhonghua Zhongliu Zazhi, V28, P88; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Fuller K, 1997, MOL IMMUNOL, V34, P939, DOI 10.1016/S0161-5890(97)00000-X; Geng LY, 2007, WORLD J GASTROENTERO, V13, P2305, DOI 10.3748/wjg.v13.i16.2305; Goebel P, 2001, J EXP MED, V194, P645, DOI 10.1084/jem.194.5.645; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Huang J, 2008, INT J BIOCHEM CELL B, V40, P1604, DOI 10.1016/j.biocel.2007.12.004; Huang J, 2009, J HISTOCHEM CYTOCHEM, V57, P339, DOI 10.1369/jhc.2008.951434; Iacobucci I, 2008, BLOOD, V112, P3847, DOI 10.1182/blood-2007-09-112631; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kee BL, 1996, J BIOL CHEM, V271, P2373, DOI 10.1074/jbc.271.5.2373; Kishi H, 2002, BLOOD, V99, P576, DOI 10.1182/blood.V99.2.576; Kuo TC, 2009, CURR OPIN IMMUNOL, V21, P173, DOI 10.1016/j.coi.2009.03.008; Lauring J, 1999, MOL CELL BIOL, V19, P2601; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Qiu XY, 2003, CANCER RES, V63, P6488; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Romanow WJ, 2000, MOL CELL, V5, P343, DOI 10.1016/S1097-2765(00)80429-3; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wei XC, 2005, EUR J IMMUNOL, V35, P612, DOI 10.1002/eji.200425185; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; Zhang SA, 2010, CELL MOL LIFE SCI, V67, P985, DOI 10.1007/s00018-009-0231-z; Zheng H, 2007, MOL IMMUNOL, V44, P2221, DOI 10.1016/j.molimm.2006.11.010; Zheng H, 2007, CELL BIOL INT, V31, P82, DOI 10.1016/j.cellbi.2006.09.009	44	17	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20475	10.1371/journal.pone.0020475	http://dx.doi.org/10.1371/journal.pone.0020475			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655267	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600076
J	Moodley, P; Shah, NS; Tayob, N; Connolly, C; Zetola, N; Gandhi, N; Friedland, G; Sturm, AW				Moodley, Prashini; Shah, N. Sarita; Tayob, Nabihah; Connolly, Cathy; Zetola, Nicola; Gandhi, Neel; Friedland, Gerald; Sturm, A. Willem			Spread of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South Africa	PLOS ONE			English	Article								Background: In 2005 a cluster of 53 HIV-infected patients with extensively drug-resistant tuberculosis (XDR-TB) was detected in the Msinga sub-district, the catchment area for the Church of Scotland Hospital (CoSH) in Tugela Ferry, in KwaZulu-Natal province (KZN), South Africa. KZN is divided into 11 healthcare districts. We sought to determine the distribution of XDR TB cases in the province in relation to population density. Methods: In this cross-sectional study, the KZN tuberculosis laboratory database was analysed. Results of all patients with a sputum culture positive for Mycobacterium tuberculosis from January 2006 to June 2007 were included. Drug-susceptibility test results for isoniazid, rifampicin, ethambutol, streptomycin, kanamycin and ofloxacin were available for all patients as well as the location of the hospital where their clinical diagnosis was made. Findings: In total, 20858 patients attending one of 73 hospitals or their adjacent clinics had cultures positive for M. tuberculosis. Of these, 4170 (20%) were MDR-TB cases. Four hundred and forty three (11%) of the MDR tuberculosis cases displayed the XDR tuberculosis susceptibility profile. Only 1429 (34%) of the MDR-TB patients were seen at the provincial referral hospital for treatment. The proportion of XDR-TB amongst culture-confirmed cases was highest in the Msinga subdistrict (19.6%), followed by the remaining part of the Umzinyati district (5.9%) and the other 10 districts (1.1%). The number of hospitals with at least one XDR-TB case increased from 18 (25%) to 58 (80%) during the study period. Interpretation: XDR-TB is present throughout KZN. More than 65% of all diagnosed MDR-TB cases, including XDR-TB patients, were left untreated and likely remained in the community as a source of infection.	[Moodley, Prashini; Shah, N. Sarita; Gandhi, Neel; Friedland, Gerald; Sturm, A. Willem] KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Moodley, Prashini; Sturm, A. Willem] Univ KwaZulu Natal, Dept Infect Prevent & Control, Durban, South Africa; [Moodley, Prashini; Sturm, A. Willem] KwaZulu Natal Dept Hlth, Durban, South Africa; [Shah, N. Sarita; Gandhi, Neel] Albert Einstein Coll Med, Div Gen Internal Med, Bronx, NY 10467 USA; [Shah, N. Sarita; Gandhi, Neel] Albert Einstein Coll Med, Div Infect Dis, Bronx, NY 10467 USA; [Shah, N. Sarita; Gandhi, Neel] Albert Einstein Coll Med, Div Epidemiol, Bronx, NY 10467 USA; [Shah, N. Sarita; Gandhi, Neel; Friedland, Gerald] Tugela Ferry Care & Res TF CaRes Collaborat, Tugela Ferry, Kwazulu Natal, South Africa; [Tayob, Nabihah; Connolly, Cathy] MRC, Durban, Kwazulu Natal, South Africa; [Zetola, Nicola] Univ Penn, Div Infect Dis, Philadelphia, PA 19104 USA; [Friedland, Gerald] Yale Univ, Sch Med, Yale AIDS Program, New Haven, CT USA	University of Kwazulu Natal; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Pennsylvania; Yale University	Moodley, P (corresponding author), KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa.	moodleyp@ukzn.ac.za		Moodley, Pravi/0000-0002-9946-8783	NIAID NIH HHS [R01 AI097045] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097045] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*DEP HLTH S AFR, 2007, NAT HIV SYPH PREV SU; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; HACEK D, 1992, CLIN MICROBIOLOGY PR, V1; HARRISON D, 2009, REPORT OVERVIEW HLTH; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; *STAT S AFR, 2003, STAT REL P0302; WEYER K, 2003, SURVEY TUBERCULOSIS; WHO, 2009, WHOHTMTB2009411	9	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e17513	10.1371/journal.pone.0017513	http://dx.doi.org/10.1371/journal.pone.0017513			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655324	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600002
J	Nascimbeni, M; Pol, S; Saunier, B				Nascimbeni, Michelina; Pol, Stanislas; Saunier, Bertrand			Distinct CD4(+)CD8(+) Double-Positive T Cells in the Blood and Liver of Patients during Chronic Hepatitis B and C	PLOS ONE			English	Article							PERIPHERAL-BLOOD; IMMUNE-RESPONSES; MEMORY CELLS; IN-VIVO; VIRUS; LYMPHOCYTES; LINEAGE	CD4(+) and CD8(+) T cells, the main effectors of adaptive cellular immune responses, differentiate from immature, non-functional CD4(+) CD8(+) double-positive T (DPT) cells in the thymus. Increased proportions of circulating DPT lymphocytes have been observed during acute viral infections; in chronic viral diseases, the role and repartition of extra-thymic DPT cells remain largely uncharacterized. We performed a phenotypic analysis of DPT cells in blood and liver from patients chronically infected by hepatitis C (HCV) or B (HBV) viruses. The highest percentages of DPT cells, predominantly CD4(high)CD8(low), were observed in patients infected by HCV, while HBV-infected patients mostly displayed CD4(low)CD8(high) and CD4(high)CD8(high) DPT cells. All proportions of DPT cells were higher in liver than in blood with, for each subpopulation referred to above, a correlation between their frequencies in these two compartments. In HCV patients, intra-hepatic DPT cells displayed more heterogeneous activation, differentiation and memory phenotypes than in the blood; most of them expressed CD1a, a marker of T cell development in the thymus. Ex vivo, the inoculation of liver slices with HCV produced in cell culture was accompanied by a disappearance of CD8(high) cells, suggesting a direct effect of the virus on the phenotype of DPT cells in the liver. Our results suggest that, in half of the patients, chronic HCV infection promotes the production of DPT cells, perhaps by their re-induction in the thymus and selection in the liver.	[Nascimbeni, Michelina; Pol, Stanislas; Saunier, Bertrand] Paris Descartes Univ, Fac Med, Paris, France; [Nascimbeni, Michelina; Pol, Stanislas; Saunier, Bertrand] CNRS, Inst Cochin, UMR8104, Paris, France; [Nascimbeni, Michelina; Pol, Stanislas; Saunier, Bertrand] INSERM, U1016, Paris, France; [Pol, Stanislas] Cochin Hosp, AP HP, Hepatol Unit, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Nascimbeni, M (corresponding author), Paris Descartes Univ, Fac Med, Paris, France.	bertrand.saunier@inserm.fr		Saunier, Bertrand/0000-0002-0700-3082	Roche	Roche(Roche Holding)	MN was a recipient of a fellowship from Roche. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010788; Beq S, 2009, BLOOD, V114, P816, DOI 10.1182/blood-2008-11-191288; BLUE ML, 1985, J IMMUNOL, V134, P2281; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; Desfrancois J, 2009, INT J CANCER, V125, P374, DOI 10.1002/ijc.24366; Fernandez CS, 2009, J VIROL, V83, P1617, DOI 10.1128/JVI.02138-08; Fritz EA, 2008, VIRAL IMMUNOL, V21, P355, DOI 10.1089/vim.2008.0023; Ghia P, 2007, BRIT J HAEMATOL, V139, P780, DOI 10.1111/j.1365-2141.2007.06867.x; Howe R, 2009, JAIDS-J ACQ IMM DEF, V50, P444, DOI 10.1097/QAI.0b013e31819aa8c4; Hughes GJ, 2008, AIDS, V22, P57, DOI 10.1097/QAD.0b013e3282f151b9; Jimenez E, 2002, J IMMUNOL, V168, P5005, DOI 10.4049/jimmunol.168.10.5005; Lima M, 2003, AM J PATHOL, V163, P763, DOI 10.1016/S0002-9440(10)63703-0; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Nam KH, 2000, INT IMMUNOL, V12, P1095, DOI 10.1093/intimm/12.7.1095; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; Parel Y, 2007, ARTHRITIS RHEUM-US, V56, P3459, DOI 10.1002/art.22927; Periwal SB, 1999, J VIROL, V73, P7633; Rahemtullah A, 2008, LEUKEMIA LYMPHOMA, V49, P1870, DOI 10.1080/10428190802308728; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Spits H, 1998, IMMUNOL REV, V165, P75, DOI 10.1111/j.1600-065X.1998.tb01231.x; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Triyatni M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001333; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang XL, 2008, BLOOD, V112, P4981, DOI 10.1182/blood-2008-05-160077; Zuckermann FA, 1996, IMMUNOLOGY, V87, P500, DOI 10.1046/j.1365-2567.1996.494570.x	30	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20145	10.1371/journal.pone.0020145	http://dx.doi.org/10.1371/journal.pone.0020145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647449	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500027
J	Jegot, G; Derache, C; Castella, S; Lahouassa, H; Pitois, E; Jourdan, ML; Remold-O'Donnell, E; Kellenberger, C; Gauthier, F; Korkmaz, B				Jegot, Gwenhael; Derache, Chrystelle; Castella, Sandrine; Lahouassa, Hichem; Pitois, Elodie; Jourdan, Marie Lise; Remold-O'Donnell, Eileen; Kellenberger, Christine; Gauthier, Francis; Korkmaz, Brice			A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen	FASEB JOURNAL			English	Article						neutrophil; serine protease; drug design	HUMAN POLYMORPHONUCLEAR NEUTROPHILS; CATHEPSIN-G; ELASTASE INHIBITOR; ALPHA-1-ANTITRYPSIN DEFICIENCY; ALPHA-1-PROTEASE INHIBITOR; SERINE PROTEINASES; CRYSTAL-STRUCTURE; CYSTIC-FIBROSIS; IN-VIVO; SURFACE	The physiological and pathological functions of proteinase 3 (PR3) are not well understood due to its close similarity to human neutrophil elastase (HNE) and the lack of a specific inhibitor. Based on structural analysis of the active sites of PR3 and HNE, we generated mutants derived from the polyvalent inhibitor SerpinB1 (monocyte/neutrophil elastase inhibitor) that specifically inhibit PR3 and that differ from wt-SerpinB1 by only 3 or 4 residues in the reactive center loop. The rate constant of association between the best SerpinB1 mutant and PR3 is 1.4 x 10(7) M(-1) . s(-1), which is similar to 100-fold higher than that observed with wt-SerpinB1 and compares with that of alpha 1-protease inhibitor (alpha 1-PI) toward HNE. SerpinB1(S/DAR) is cleaved by HNE, but due to differences in rate, inhibition of PR3 by SerpinB1(S/DAR) is only minimally affected by the presence of HNE even when the latter is in excess. SerpinB1(S/DAR) inhibits soluble PR3 and also membrane-bound PR3 at the surface of activated neutrophils. Moreover, SerpinB1(S/DAR) clears induced PR3 from the surface of activated neutrophils. Overall, these specific inhibitors of PR3 will be valuable for defining biological functions of the protease and may prove useful as therapeutics for PR3-related inflammatory diseases, such as Wegener's granulomatosis.-Jegot, G., Derache, C., Castella, S., Lahouassa, H., Pitois, E., Jourdan, M. L., Remold-O'Donnell, E., Kellenberger, C., Gauthier, F., Korkmaz, B. A substrate-based approach to convert SerpinB1 into a specific inhibitor of proteinase 3, the Wegener's granulomatosis autoantigen. FASEB J. 25, 3019-3031 (2011). www.fasebj.org	[Korkmaz, Brice] Univ Tours, Fac Med, INSERM, U618, F-37032 Tours, France; [Derache, Chrystelle] CNRS, Ctr Biophys Mol, Orleans, France; [Jourdan, Marie Lise] Ctr Hosp Reg Univ, Tours, France; [Remold-O'Donnell, Eileen] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Kellenberger, Christine] CNRS, UMR, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CHU Tours; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Centre National de la Recherche Scientifique (CNRS)	Korkmaz, B (corresponding author), Univ Tours, Fac Med, INSERM, U618, F-37032 Tours, France.	brice.korkmaz@inserm.fr	kellenberger, christine/AAV-9304-2020	KORKMAZ, BRICE/0000-0002-5159-8706	Region Centre; Fonds Europeen de Developpement Regional	Region Centre(Region Centre-Val de Loire); Fonds Europeen de Developpement Regional	This work was supported by Region Centre and the Fonds Europeen de Developpement Regional (Projet INFINHI). B. K. acknowledges the Fondation Pour La Recherche Medicale (FRM). The authors thank Dr. Dieter Jenne (Max Planck Institute of Neurobiology, Martinsried, Germany) for sending proteinase 3 plasmid, Dr. Michele Brillard-Bourdet for sequence analyses, Dr. Martine Cadene (Centre de Biophysique Moleculaire, Orleans, France) for performing MALDI-TOF mass spectrometry analysis, and Dr. Herve Watier and Dr. Danielle Degenne (Centre Hospitalier Regional Universitaire, Tours, France) for providing WG blood samples. The authors appreciatively acknowledge contributions of Dr. Nicolas Guyot, Marine Sigismeau, and Lise Vanderlynden to early phases of this work.	Askew YS, 2001, J BIOL CHEM, V276, P49320, DOI 10.1074/jbc.M108879200; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; Chughtai B, 2004, J AEROSOL MED, V17, P289, DOI 10.1089/jam.2004.17.289; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; COOLEY J, 2010, EUR RESP J; CSERNOK E, 1990, AM J PATHOL, V137, P1113; Djie MZ, 1997, J BIOL CHEM, V272, P16268, DOI 10.1074/jbc.272.26.16268; Dou DF, 2010, BIOORGAN MED CHEM, V18, P1093, DOI 10.1016/j.bmc.2009.12.057; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Felber LM, 2006, FEBS J, V273, P2505, DOI 10.1111/j.1742-4658.2006.05257.x; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Groutas WC, 1997, BIOCHEM BIOPH RES CO, V233, P697, DOI 10.1006/bbrc.1997.6526; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; HATTAR K, EUR RESP J, V36, P187; HOPKINS PCR, 1995, J BIOL CHEM, V270, P11866, DOI 10.1074/jbc.270.20.11866; HUBBARD RC, 1988, JAMA-J AM MED ASSOC, V260, P1259, DOI 10.1001/jama.260.9.1259; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Inoue Y, 2006, J TRAUMA, V60, P936, DOI 10.1097/01.ta.0000217271.25809.a0; JENNE DE, 1990, NATURE, V346, P520, DOI 10.1038/346520a0; Kallenberg CGM, 2008, J AUTOIMMUN, V30, P29, DOI 10.1016/j.jaut.2007.11.005; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Kalupov T, 2009, J BIOL CHEM, V284, P34084, DOI 10.1074/jbc.M109.042903; Koehl C, 2003, J BIOL CHEM, V278, P12609, DOI 10.1074/jbc.M210074200; Korkmaz B, 2002, J BIOL CHEM, V277, P39074, DOI 10.1074/jbc.M202918200; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Korkmaz B, 2005, AM J RESP CELL MOL, V32, P553, DOI 10.1165/rcmb.2004-0374OC; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Korkmaz B, 2009, J BIOL CHEM, V284, P19896, DOI 10.1074/jbc.M901471200; Kuhl A, 2010, J IMMUNOL, V185, P387, DOI 10.4049/jimmunol.0903887; Kuraki T, 2002, AM J RESP CRIT CARE, V166, P496, DOI 10.1164/rccm.2103118; MCELVANEY NG, 1991, LANCET, V337, P392, DOI 10.1016/0140-6736(91)91167-S; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; PATSTON PA, 1991, BIOCHEMISTRY-US, V30, P8876, DOI 10.1021/bi00100a022; Pendergraft WF, 2004, KIDNEY INT, V65, P75, DOI 10.1111/j.1523-1755.2004.00364.x; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Preston GA, 2002, J AM SOC NEPHROL, V13, P2840, DOI 10.1097/01.ASN.0000034911.03334.C3; Quinn Derek J, 2010, Open Respir Med J, V4, P20, DOI 10.2174/1874306401004020020; Ralston DR, 1997, J CLIN INVEST, V100, P1416, DOI 10.1172/JCI119662; REMOLDODONNELL E, 1989, J EXP MED, V169, P1071, DOI 10.1084/jem.169.3.1071; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Rooney CP, 2001, AM J RESP CELL MOL, V24, P747, DOI 10.1165/ajrcmb.24.6.4147; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Stefansson S, 2004, J BIOL CHEM, V279, P29981, DOI 10.1074/jbc.M401913200; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Sugawara S, 2005, CRIT REV IMMUNOL, V25, P343, DOI 10.1615/CritRevImmunol.v25.i5.10; Van Rossum AP, 2005, KIDNEY INT, V68, P537, DOI 10.1111/j.1523-1755.2005.00431.x; van Rossum AP, 2004, J LEUKOCYTE BIOL, V76, P1162, DOI 10.1189/jlb.0604319; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Voynow JA, 2008, INT J BIOCHEM CELL B, V40, P1238, DOI 10.1016/j.biocel.2008.03.003; WEWERS MD, 1987, NEW ENGL J MED, V316, P1055, DOI 10.1056/NEJM198704233161704; Whisstock J, 1996, PROTEINS, V26, P288, DOI 10.1002/(SICI)1097-0134(199611)26:3<288::AID-PROT5>3.0.CO;2-A	59	11	14	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					3019	3031		10.1096/fj.10-176552	http://dx.doi.org/10.1096/fj.10-176552			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21670065				2022-12-25	WOS:000294435200017
J	Zhao, WA; Loh, W; Droujinine, IA; Teo, WS; Kumar, N; Schafer, S; Cui, CH; Zhang, L; Sarkar, D; Karnik, R; Karp, JM				Zhao, Weian; Loh, Weili; Droujinine, Ilia A.; Teo, Weisuong; Kumar, Namit; Schafer, Sebastian; Cui, Cheryl H.; Zhang, Liang; Sarkar, Debanjan; Karnik, Rohit; Karp, Jeffrey M.			Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions	FASEB JOURNAL			English	Article						mesenchymal stem cell; homing; trafficking; cell therapy	MESENCHYMAL STEM-CELLS; L-SELECTIN; P-SELECTIN; BONE-MARROW; DNA APTAMER; TRAFFICKING; LIGANDS; RNA; ENRICHMENT; EXPRESSION	Nature has evolved effective cell adhesion mechanisms to deliver inflammatory cells to inflamed tissue; however, many culture-expanded therapeutic cells are incapable of targeting diseased tissues following systemic infusion, which represents a great challenge in cell therapy. Our aim was to develop simple approaches to program cell-cell interactions that would otherwise not exist toward cell targeting and understanding the complex biology of cell-cell interactions. We employed a chemistry approach to engineer P-or L-selectin binding nucleic acid aptamers onto mesenchymal stem cells (MSCs) to enable them to engage inflamed endothelial cells and leukocytes, respectively. We show for the first time that engineered cells with a single artificial adhesion ligand can recapitulate 3 critical cell interactions in the inflammatory cell adhesion cascade under dynamic flow conditions. Aptamer-engineered MSCs adhered on respective selectin surfaces under static conditions >10 times more efficiently than controls including scrambled-DNA modified MSCs. Significantly, engineered MSCs can be directly captured from the flow stream by selectin surfaces or selectin-expressing cells under flow conditions (<= 2dyn/cm(2)). The simple chemistry approach and the versatility of aptamers permit the concept of engineered cell-cell interactions to be generically applicable for targeting cells to diseased tissues and elucidating the biology of cell-cell interactions.-Zhao, W., Loh, W., Droujinine, I. A., Teo, W., Kumar, N., Schafer, S., Cui, C. H., Zhang, L., Sarkar, D., Karnik, R., Karp, J. M. Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions. FASEB J. 25, 3045-3056 (2011). www.fasebj.org	[Karp, Jeffrey M.] Harvard Univ, Sch Med, PRB, Cambridge, MA 02139 USA; [Zhao, Weian; Loh, Weili; Droujinine, Ilia A.; Teo, Weisuong; Kumar, Namit; Schafer, Sebastian; Cui, Cheryl H.; Zhang, Liang; Sarkar, Debanjan; Karp, Jeffrey M.] Brigham & Womens Hosp, Ctr Regenerat Therapeut, Cambridge, MA USA; [Zhao, Weian; Loh, Weili; Droujinine, Ilia A.; Teo, Weisuong; Kumar, Namit; Schafer, Sebastian; Cui, Cheryl H.; Zhang, Liang; Sarkar, Debanjan; Karp, Jeffrey M.] Brigham & Womens Hosp, Dept Med, Cambridge, MA USA; [Zhao, Weian; Loh, Weili; Droujinine, Ilia A.; Teo, Weisuong; Kumar, Namit; Schafer, Sebastian; Cui, Cheryl H.; Zhang, Liang; Sarkar, Debanjan; Karp, Jeffrey M.] Harvard Stem Cell Inst, Cambridge, MA USA; [Zhao, Weian; Loh, Weili; Droujinine, Ilia A.; Teo, Weisuong; Kumar, Namit; Schafer, Sebastian; Cui, Cheryl H.; Zhang, Liang; Sarkar, Debanjan; Karp, Jeffrey M.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Karnik, Rohit] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Karp, JM (corresponding author), Harvard Univ, Sch Med, PRB, Rm 313,65 Landsdowne St, Cambridge, MA 02139 USA.	jkarp@rics.bwh.harvard.edu	Sarkar, Debanjan/C-6093-2017	Sarkar, Debanjan/0000-0002-6666-3152; KUMAR, NAMIT/0000-0002-5084-3490; Schafer, Sebastian/0000-0002-6909-8275	National Institute of Health (NIH) [HL-097172, HL-095722, DE-019191]; American Heart Association [0970178N]; International Human Frontier Science Program Organization; NIH National Center for Research Resources [P40RR017447]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097172, R01HL095722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019191] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); International Human Frontier Science Program Organization(Human Frontier Science Program); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Uli von Andrian for helpful discussions. This work was supported by National Institute of Health (NIH) grants HL-097172, HL-095722, and DE-019191 (to J.M.K.) and by American Heart Association grant 0970178N (to J.M.K). W.Z. is supported by an International Human Frontier Science Program Organization postdoctoral fellowship. Primary human MSCs were obtained from the Center for Gene Therapy (Texas A&M, College Station, TX, USA), which received funding through NIH National Center for Research Resources grant P40RR017447.	Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; BARGATZE RF, 1994, J EXP MED, V180, P1785, DOI 10.1084/jem.180.5.1785; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chandra RA, 2006, ANGEW CHEM INT EDIT, V45, P896, DOI 10.1002/ANIE.200502421; De Bank PA, 2007, BIOTECHNOL BIOENG, V97, P1617, DOI 10.1002/bit.21343; Detzer A, 2009, CURR TOP MED CHEM, V9, P1109, DOI 10.2174/156802609789630884; Diacovo TG, 1998, J EXP MED, V187, P197, DOI 10.1084/jem.187.2.197; Dimitroff CJ, 2001, J BIOL CHEM, V276, P47623, DOI 10.1074/jbc.M105997200; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FLEMING T, 2002, CELL CELL INTERACTIO; Gartner ZJ, 2009, P NATL ACAD SCI USA, V106, P4606, DOI 10.1073/pnas.0900717106; Guo KT, 2006, STEM CELLS, V24, P2220, DOI 10.1634/stemcells.2006-0015; Hicke BJ, 1996, J CLIN INVEST, V98, P2688, DOI 10.1172/JCI119092; Hodgkinson CP, 2010, HUM GENE THER, V21, P1513, DOI 10.1089/hum.2010.165; Hsiao SC, 2009, LANGMUIR, V25, P6985, DOI 10.1021/la900150n; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jenison RD, 1998, ANTISENSE NUCLEIC A, V8, P265, DOI 10.1089/oli.1.1998.8.265; JONES DA, 1993, BIOPHYS J, V65, P1560, DOI 10.1016/S0006-3495(93)81195-0; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu JW, 2009, CHEM REV, V109, P1948, DOI 10.1021/cr030183i; Ludwig RJ, 2004, J INVEST DERMATOL, V122, P830, DOI 10.1111/j.0022-202X.2004.22318.x; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Oh Hana, 2008, J Vis Exp, DOI 10.3791/745; Phillips JA, 2009, ANAL CHEM, V81, P1033, DOI 10.1021/ac802092j; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Sarkar D, 2008, BIOCONJUGATE CHEM, V19, P2105, DOI 10.1021/bc800345q; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; SIMON SI, 1993, BLOOD, V82, P1097; SUGAMA Y, 1992, J CELL BIOL, V119, P935, DOI 10.1083/jcb.119.4.935; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Veedu RN, 2009, RNA BIOL, V6, P321, DOI 10.4161/rna.6.3.8807; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3; Wu YR, 2010, P NATL ACAD SCI USA, V107, P5, DOI 10.1073/pnas.0909611107; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Yao LB, 1996, J EXP MED, V184, P81, DOI 10.1084/jem.184.1.81; ZHAO W, 2010, MATER TODAY, V13, P14021; Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282; Zhao WA, 2008, ANGEW CHEM INT EDIT, V47, P6330, DOI 10.1002/anie.200705982; Zhao WA, 2008, J AM CHEM SOC, V130, P3610, DOI 10.1021/ja710241b; Zhao WA, 2007, CHEMBIOCHEM, V8, P727, DOI 10.1002/cbic.200700014	53	32	33	3	36	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3045	3056		10.1096/fj.10-178384	http://dx.doi.org/10.1096/fj.10-178384			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21653192	Green Published			2022-12-25	WOS:000294435200019
J	Green, MF; Scott, JW; Steel, R; Oakhill, JS; Kemp, BE; Means, AR				Green, Michelle F.; Scott, John W.; Steel, Rohan; Oakhill, Jonathan S.; Kemp, Bruce E.; Means, Anthony R.			Ca2+/Calmodulin-dependent Protein Kinase Kinase beta Is Regulated by Multisite Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE-5; MOLECULAR-CLONING; CALMODULIN; CASCADE; ALPHA; BDNF; ACTIVATION; EXPRESSION; MECHANISM; CALCIUM	Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKK beta) is a serine/threonine-directed kinase that is activated following increases in intracellular Ca2+. CaMKK beta activates Ca2+/calmodulin-dependent protein kinase I, Ca2+/calmodulin-dependent protein kinase IV, and the AMP-dependent protein kinase in a number of physiological pathways, including learning and memory formation, neuronal differentiation, and regulation of energy balance. Here, we report the novel regulation of CaMKK beta activity by multisite phosphorylation. We identify three phosphorylation sites in the N terminus of CaMKK beta, which regulate its Ca2+/calmodulin-independent autonomous activity. We then identify the kinases responsible for these phosphorylations as cyclin-dependent kinase 5 (CDK5) and glycogen synthase kinase 3 (GSK3). In addition to regulation of autonomous activity, we find that phosphorylation of CaMKK beta regulates its half-life. We find that cellular levels of CaMKK beta correlate with CDK5 activity and are regulated developmentally in neurons. Finally, we demonstrate that appropriate phosphorylation of CaMKK beta is critical for its role in neurite development. These results reveal a novel regulatory mechanism for CaMKK beta-dependent signaling cascades.	[Green, Michelle F.; Means, Anthony R.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Scott, John W.; Steel, Rohan; Oakhill, Jonathan S.; Kemp, Bruce E.] Univ Melbourne, Prot Chem & Metab Unit, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia	Duke University; St. Vincent's Institute of Medical Research; University of Melbourne	Means, AR (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	means001@mc.duke.edu	Scott, John W/AAA-2676-2021; Kemp, Bruce E/L-2633-2014; Scott, John W/P-1170-2018; Kemp, Bruce/G-9602-2019; Oakhill, Jonathan S/F-5724-2011	Scott, John W/0000-0002-1896-9798; Kemp, Bruce E/0000-0001-6735-5082; Scott, John W/0000-0002-1896-9798; Kemp, Bruce/0000-0001-6735-5082; Oakhill, Jonathan S/0000-0002-9475-1440; Green, Michelle/0000-0002-6055-4342; /0000-0002-0423-6120	National Institutes of Health [DK074701, GM033976]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK074701 and GM033976.	Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Atilla-Gokcumen GE, 2006, CHEMBIOCHEM, V7, P1443, DOI 10.1002/cbic.200600117; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; Davare MA, 2009, J NEUROSCI, V29, P9794, DOI 10.1523/JNEUROSCI.1544-09.2009; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; HARIBABU B, 1995, EMBO J, V14, P3679, DOI 10.1002/j.1460-2075.1995.tb00037.x; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hengst U, 2009, NAT CELL BIOL, V11, P1024, DOI 10.1038/ncb1916; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ichimura T, 2008, FEBS LETT, V582, P661, DOI 10.1016/j.febslet.2008.01.037; Jin X, 2003, J NEUROSCI, V23, P5662; Kitani T, 2001, J BIOCHEM, V130, P515, DOI 10.1093/oxfordjournals.jbchem.a003014; Ko J, 2001, J NEUROSCI, V21, P6758; Kokubo M, 2009, J NEUROSCI, V29, P8901, DOI 10.1523/JNEUROSCI.0040-09.2009; LEE JSC, 1994, J BIOL CHEM, V269, P2158; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Mizuno K, 2007, NEUROSCIENCE, V145, P393, DOI 10.1016/j.neuroscience.2006.11.056; Mizuno K, 2006, MOL CELL BIOL, V26, P9094, DOI 10.1128/MCB.01221-06; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 2000, METHOD ENZYMOL, V325, P200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Ohshima T, 1999, J NEUROSCI, V19, P6017, DOI 10.1523/JNEUROSCI.19-14-06017.1999; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Okuno S, 2001, J BIOCHEM, V130, P503, DOI 10.1093/oxfordjournals.jbchem.a003013; Polleux F, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001925; Samuels BA, 2007, NEURON, V56, P823, DOI 10.1016/j.neuron.2007.09.035; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; SEGAL RA, 1995, J NEUROSCI, V15, P4970; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 1997, BIOCHEMISTRY-US, V36, P12823, DOI 10.1021/bi971348i; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Vinet J, 2003, MOL BRAIN RES, V111, P216, DOI 10.1016/S0169-328X(02)00698-8; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030	53	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28066	28079		10.1074/jbc.M111.251504	http://dx.doi.org/10.1074/jbc.M111.251504			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669867	Green Published, hybrid			2022-12-25	WOS:000293557800025
J	Lombardi, ML; Jaalouk, DE; Shanahan, CM; Burke, B; Roux, KJ; Lammerding, J				Lombardi, Maria L.; Jaalouk, Diana E.; Shanahan, Catherine M.; Burke, Brian; Roux, Kyle J.; Lammerding, Jan			The Interaction between Nesprins and Sun Proteins at the Nuclear Envelope Is Critical for Force Transmission between the Nucleus and Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; MECHANICAL STIFFNESS; ACTIN CYTOSKELETON; MEMBRANE PROTEIN; LAMIN; STRAIN; CONNECTIONS; MECHANOTRANSDUCTION; LAMINOPATHIES; INTEGRITY	Maintaining physical connections between the nucleus and the cytoskeleton is important for many cellular processes that require coordinated movement and positioning of the nucleus. Nucleo-cytoskeletal coupling is also necessary to transmit extra-cellular mechanical stimuli across the cytoskeleton to the nucleus, where they may initiate mechanotransduction events. The LINC (Linker of Nucleoskeleton and Cytoskeleton) complex, formed by the interaction of nesprins and SUN proteins at the nuclear envelope, can bind to nuclear and cytoskeletal elements; however, its functional importance in transmitting intracellular forces has never been directly tested. This question is particularly relevant since recent findings have linked nesprin mutations to muscular dystrophy and dilated cardiomyopathy. Using biophysical assays to assess intracellular force transmission and associated cellular functions, we identified the LINC complex as a critical component for nucleo-cytoskeletal force transmission. Disruption of the LINC complex caused impaired propagation of intracellular forces and disturbed organization of the perinuclear actin and intermediate filament networks. Although mechanically induced activation of mechanosensitive genes was normal (suggesting that nuclear deformation is not required for mechanotransduction signaling) cells exhibited other severe functional defects after LINC complex disruption; nuclear positioning and cell polarization were impaired in migrating cells and in cells plated on micropatterned substrates, and cell migration speed and persistence time were significantly reduced. Taken together, our findings suggest that the LINC complex is critical for nucleo-cytoskeletal force transmission and that LINC complex disruption can result in defects in cellular structure and function that may contribute to the development of muscular dystrophies and cardiomyopathies.	[Lombardi, Maria L.; Jaalouk, Diana E.; Lammerding, Jan] Harvard Univ, Dept Med, Brigham & Womens Hosp, Sch Med, Cambridge, MA 02139 USA; [Shanahan, Catherine M.] Kings Coll London, Div Cardiovasc, London SE5 9NU, England; [Burke, Brian] Inst Med Biol, Singapore 138648, Singapore; [Roux, Kyle J.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	Harvard University; Brigham & Women's Hospital; University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); State University System of Florida; University of Florida	Lammerding, J (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Biomed Engn, 235 Weill Hall, Ithaca, NY 14853 USA.	jan.lammerding@cornell.edu	Roux, Kyle/AAH-2019-2021; Lammerding, Jan/A-9498-2016	Roux, Kyle/0000-0001-7530-5528; Lammerding, Jan/0000-0003-4335-8611; Shanahan, Catherine/0000-0002-8352-8171	National Institutes of Health [R01 NS059348, R01 HL082792]; Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER; British Heart Foundation [RG/09/008/27923] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); British Heart Foundation(British Heart Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS059348 and R01 HL082792 (to J.L.). and the Brigham and Women's Hospital Cardiovascular Leadership Group Award.	Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Brosig M, 2010, INT J BIOCHEM CELL B, V42, P1717, DOI 10.1016/j.biocel.2010.07.001; Caille N, 1998, ANN BIOMED ENG, V26, P409, DOI 10.1114/1.132; Chancellor TJ, 2010, BIOPHYS J, V99, P115, DOI 10.1016/j.bpj.2010.04.011; Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28; Coffinier C, 2010, J BIOL CHEM, V285, P20818, DOI 10.1074/jbc.M110.128835; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; De Keulenaer GW, 2002, CIRC RES, V90, P690, DOI 10.1161/01.RES.0000012922.40318.05; Folker ES, 2011, P NATL ACAD SCI USA, V108, P131, DOI 10.1073/pnas.1000824108; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Heydemann A, 2007, TRENDS CARDIOVAS MED, V17, P55, DOI 10.1016/j.tcm.2006.12.002; Lammerding J, 2003, IEEE ENG MED BIOL, V22, P124, DOI 10.1109/MEMB.2003.1256282; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Morawietz H, 1999, CIRC RES, V84, P678, DOI 10.1161/01.RES.84.6.678; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Puckelwartz MJ, 2010, J MOL CELL CARDIOL, V48, P600, DOI 10.1016/j.yjmcc.2009.11.006; Schneider M, 2011, CELL MOL LIFE SCI, V68, P1593, DOI 10.1007/s00018-010-0535-z; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Verstraeten VLRM, 2008, AGING CELL, V7, P383, DOI 10.1111/j.1474-9726.2008.00382.x; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhen YY, 2002, J CELL SCI, V115, P3207	33	329	335	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26743	26753		10.1074/jbc.M111.233700	http://dx.doi.org/10.1074/jbc.M111.233700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652697	hybrid, Green Published			2022-12-25	WOS:000293078200051
J	Marjaneh, MM; Kirk, EP; Posch, MG; Ozcelik, C; Berger, F; Hetzer, R; Otway, R; Butler, TL; Blue, GM; Griffiths, LR; Fatkin, D; Martinson, JJ; Winlaw, DS; Feneley, MP; Harvey, RP				Marjaneh, Mahdi Moradi; Kirk, Edwin P.; Posch, Maximilian G.; Ozcelik, Cemil; Berger, Felix; Hetzer, Roland; Otway, Robyn; Butler, Tanya L.; Blue, Gillian M.; Griffiths, Lyn R.; Fatkin, Diane; Martinson, Jeremy J.; Winlaw, David S.; Feneley, Michael P.; Harvey, Richard P.			Investigation of Association between PFO Complicated by Cryptogenic Stroke and a Common Variant of the Cardiac Transcription Factor GATA4	PLOS ONE			English	Article							PATENT FORAMEN OVALE; CONGENITAL HEART-DISEASE; ATRIAL SEPTAL-DEFECTS; RISK-FACTOR; MUTATIONS; MIGRAINE; NKX2.5; ECHOCARDIOGRAPHY; LIPOPROTEIN(A); GATA-4/5/6	Patent foramen ovale (PFO) is associated with clinical conditions including cryptogenic stroke, migraine and varicose veins. Data from studies in humans and mouse suggest that PFO and the secundum form of atrial septal defect (ASDII) exist in an anatomical continuum of septal dysmorphogenesis with a common genetic basis. Mutations in multiple members of the evolutionarily conserved cardiac transcription factor network, including GATA4, cause or predispose to ASDII and PFO. Here, we assessed whether the most prevalent variant of the GATA4 gene, S377G, was significantly associated with PFO or ASD. Our analysis of world indigenous populations showed that GATA4 S377G was largely Caucasian-specific, and so subjects were restricted to those of Caucasian descent. To select for patients with larger PFO, we limited our analysis to those with cryptogenic stroke in which PFO was a subsequent finding. In an initial study of Australian subjects, we observed a weak association between GATA4 S377G and PFO/Stroke relative to Caucasian controls in whom ASD and PFO had been excluded (OR = 2.16; p = 0.02). However, in a follow up study of German Caucasians no association was found with either PFO or ASD. Analysis of combined Australian and German data confirmed the lack of a significant association. Thus, the common GATA4 variant S377G is likely to be relatively benign in terms of its participation in CHD and PFO/Stroke.	[Marjaneh, Mahdi Moradi; Otway, Robyn; Fatkin, Diane; Feneley, Michael P.; Harvey, Richard P.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Marjaneh, Mahdi Moradi; Kirk, Edwin P.; Fatkin, Diane; Feneley, Michael P.; Harvey, Richard P.] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Kirk, Edwin P.] Sydney Childrens Hosp, Dept Med Genet, Randwick, NSW, Australia; [Posch, Maximilian G.; Ozcelik, Cemil] Charite, ECRC, D-13353 Berlin, Germany; [Posch, Maximilian G.; Berger, Felix; Hetzer, Roland] Deutsch Herzzentrum Berlin, Berlin, Germany; [Butler, Tanya L.; Blue, Gillian M.; Winlaw, David S.] Childrens Hosp, Heart Ctr Children, Westmead, NSW, Australia; [Butler, Tanya L.; Winlaw, David S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Griffiths, Lyn R.] Griffith Univ, Genom Res Ctr, Gold Coast, Australia; [Fatkin, Diane] St Vincents Hosp, Dept Cardiol, Darlinghurst, NSW 2010, Australia; [Martinson, Jeremy J.] Univ Pittsburgh, Pittsburgh, PA USA	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; University of Sydney; University of Sydney; Griffith University; St Vincents Hospital Sydney; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marjaneh, MM (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.	r.harvey@victorchang.edu.au	Ward, Tanya/J-4882-2015; Winlaw, David/B-9405-2019; Winlaw, David S/F-8365-2016	Ward, Tanya/0000-0003-1576-521X; Winlaw, David/0000-0001-8005-3361; Winlaw, David S/0000-0001-8005-3361; Martinson, Jeremy/0000-0003-4673-7238; Kirk, Edwin/0000-0002-4662-0024; Berger, Felix/0000-0001-7881-1557; Blue, Gillian M/0000-0002-1480-9535; Harvey, Richard/0000-0002-9950-9792	National Institutes of Health, USA (NIHLB) [ID 1RO1HL68885-01]; German Helmholtz Association [VH-VI-152]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068885] Funding Source: NIH RePORTER	National Institutes of Health, USA (NIHLB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Helmholtz Association(Helmholtz Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: The study was supported by a grant from the National Institutes of Health, USA (NIHLB; 2002-2004; ID 1RO1HL68885-01) (http://www.nhlbi.nih.gov/funding/index.htm). The German study was supported by the German Helmholtz Association (VH-VI-152) http://www.helmholtz.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; Arquizan C, 2001, STROKE, V32, P1563, DOI 10.1161/01.STR.32.7.1563; Aslam F, 2006, SOUTH MED J, V99, P1367, DOI 10.1097/01.smj.0000251839.59000.47; Balzer David T., 2004, Curr Treat Options Cardiovasc Med, V6, P417, DOI 10.1007/s11936-004-0025-4; Bang OY, 2003, ANN NEUROL, V54, P227, DOI 10.1002/ana.10644; BELKIN RN, 1986, AM J CARDIOL, V57, P310, DOI 10.1016/0002-9149(86)90909-4; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; BRIDGES ND, 1992, CIRCULATION, V86, P1902, DOI 10.1161/01.CIR.86.6.1902; Butler TL, 2010, GENET TEST MOL BIOMA, V14, P797, DOI 10.1089/gtmb.2010.0028; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Centers for Disease Control and Prevention; National Center for Injury Prevention Control, 2007, WISQARS LEAD CAUS DE; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Chen XN, 1999, GENOME RES, V9, P492; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Dalla Volta Giorgio, 2005, J Headache Pain, V6, P328, DOI 10.1007/s10194-005-0223-9; De Castro S, 2000, STROKE, V31, P2407, DOI 10.1161/01.STR.31.10.2407; Di Tullio Marco R, 2002, Curr Cardiol Rep, V4, P141; DITULLIO M, 1992, ANN INTERN MED, V117, P461, DOI 10.7326/0003-4819-117-6-461; FELDT RH, 1971, MAYO CLIN PROC, V46, P794; Ferrarini Giovanni, 2005, J Headache Pain, V6, P71, DOI 10.1007/s10194-005-0154-5; Garg P, 2010, CIRCULATION, V121, P1406, DOI 10.1161/CIRCULATIONAHA.109.895110; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; HANLEY PC, 1985, J AM COLL CARDIOL, V6, P1370, DOI 10.1016/S0735-1097(85)80228-X; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Kasahara H, 2004, CARDIOVASC RES, V64, P40, DOI 10.1016/j.cardiores.2004.06.004; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; Kirk EP, 2006, CIRC RES, V98, P651, DOI 10.1161/01.RES.0000209965.59312.aa; Lamy C, 2002, STROKE, V33, P706, DOI 10.1161/hs0302.104543; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; Lippi G, 2003, CRIT REV CL LAB SCI, V40, P1, DOI 10.1080/713609328; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Marcovina SM, 1998, AM J CARDIOL, V82, p57U, DOI 10.1016/S0002-9149(98)00954-0; Martinson JJ, 2000, AIDS, V14, P483, DOI 10.1097/00002030-200003310-00003; McElhinney DB, 2003, J AM COLL CARDIOL, V42, P1650, DOI 10.1016/j.jacc.2003.05.004; McMahon CJ, 2002, HEART, V87, P256, DOI 10.1136/heart.87.3.256; McNeil JM, 2001, JAMA-J AM MED ASSOC, V285, P1571; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Morrisey EE, 1997, J BIOL CHEM, V272, P8515, DOI 10.1074/jbc.272.13.8515; Musolino R, 2003, CEREBROVASC DIS, V15, P121, DOI 10.1159/000067139; Negi S, 2004, BIOCHEM J, V379, P151, DOI 10.1042/BJ20030985; Ng MYM, 2005, J MED GENET, V42, P235, DOI 10.1136/jmg.2004.024075; Onorato Eustaquio, 2003, J Interv Cardiol, V16, P43; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Poirier O, 2003, EUR J HUM GENET, V11, P659, DOI 10.1038/sj.ejhg.5201023; Posch MG, 2008, AM J MED GENET A, V146A, P251, DOI 10.1002/ajmg.a.32042; RANOUX D, 1993, STROKE, V24, P31, DOI 10.1161/01.STR.24.1.31; Reamon-Buettner SM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.025395; Reamon-Buettner SM, 2004, AM J PATHOL, V164, P2117, DOI 10.1016/S0002-9440(10)63770-4; SACCO RL, 1989, ANN NEUROL, V25, P382, DOI 10.1002/ana.410250410; Sarkozy A, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.026740; Schluterman MK, 2007, AM J MED GENET A, V143A, P817, DOI 10.1002/ajmg.a.31652; Schneider B, 1996, AM J CARDIOL, V77, P1202, DOI 10.1016/S0002-9149(96)00163-4; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schuchlenz HW, 2000, AM J MED, V109, P456, DOI 10.1016/S0002-9343(00)00530-1; Schwerzmann M, 2001, ANN INTERN MED, V134, P21, DOI 10.7326/0003-4819-134-1-200101020-00009; Schwerzmann M, 2004, NEUROLOGY, V62, P1399, DOI 10.1212/01.WNL.0000120677.64217.A9; Sherin Chikhani, 2008, Open Neurol J, V2, P35, DOI 10.2174/1874205X00802010035; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Wilmshurst PT, 2004, HEART, V90, P1315, DOI 10.1136/hrt.2003.025700; Wright DD, 2010, J VASC SURG, V51, P104, DOI 10.1016/j.jvs.2009.08.008; ZABALGOITIAREYES M, 1990, AM J CARDIOL, V66, P761, DOI 10.1016/0002-9149(90)91146-W	67	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20711	10.1371/journal.pone.0020711	http://dx.doi.org/10.1371/journal.pone.0020711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673957	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000291356400021
J	Pazirandeh, A; Sultana, T; Mirza, M; Rozell, B; Hultenby, K; Wallis, K; Vennstrom, B; Davis, B; Arner, A; Heuchel, R; Lohr, M; Philipson, L; Sollerbrant, K				Pazirandeh, Ahmad; Sultana, Taranum; Mirza, Momina; Rozell, Bjorn; Hultenby, Kjell; Wallis, Karin; Vennstrom, Bjorn; Davis, Ben; Arner, Anders; Heuchel, Rainer; Lohr, Matthias; Philipson, Lennart; Sollerbrant, Kerstin			Multiple Phenotypes in Adult Mice following Inactivation of the Coxsackievirus and Adenovirus Receptor (Car) Gene	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULES; TIGHT JUNCTION; ENDOTHELIAL-CELLS; TISSUE-INJURY; GERM-CELLS; EXPRESSION; PANCREAS; PROTEIN; MOUSE; VIRUS	To determine the normal function of the Coxsackievirus and Adenovirus Receptor (CAR), a protein found in tight junctions and other intercellular complexes, we constructed a mouse line in which the CAR gene could be disrupted at any chosen time point in a broad spectrum of cell types and tissues. All knockouts examined displayed a dilated intestinal tract and atrophy of the exocrine pancreas with appearance of tubular complexes characteristic of acinar-to-ductal metaplasia. The mice also exhibited a complete atrio-ventricular block and abnormal thymopoiesis. These results demonstrate that CAR exerts important functions in the physiology of several organs in vivo.	[Pazirandeh, Ahmad] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; [Sultana, Taranum; Mirza, Momina; Sollerbrant, Kerstin] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Sultana, Taranum; Mirza, Momina; Sollerbrant, Kerstin] Univ Hosp, Stockholm, Sweden; [Rozell, Bjorn; Hultenby, Kjell] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Rozell, Bjorn; Hultenby, Kjell] Univ Hosp, Huddinge, Sweden; [Wallis, Karin; Vennstrom, Bjorn; Philipson, Lennart] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Davis, Ben; Arner, Anders] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Heuchel, Rainer; Lohr, Matthias] Karolinska Inst, Dept Clin Sci Intervent & Technol, Huddinge, Sweden	Ludwig Institute for Cancer Research; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Pazirandeh, A (corresponding author), Ludwig Inst Canc Res, Stockholm Branch, S-10401 Stockholm, Sweden.	kerstin.sollerbrant@ki.se	Löhr, Matthias/A-3692-2012; Heuchel, Rainer/P-7875-2019	Löhr, Matthias/0000-0002-7647-198X; Heuchel, Rainer/0000-0002-2782-585X	Swedish Cancer Society [100344]; Swedish Heart-Lung Foundation; Swedish Research Council; RMT Swedish Association of People with Stomach and Bowel Diseases; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); RMT Swedish Association of People with Stomach and Bowel Diseases; Karolinska Institutet(Karolinska Institutet)	This work was supported by: 1. The Swedish Cancer Society (100344) (www.cancerfonden.se); 2. The Swedish Heart-Lung Foundation; 3. The Swedish Research Council; 4. RMT Swedish Association of People with Stomach and Bowel Diseases; 5. The Karolinska Institutet (core facility for mouse physiology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders M, 2003, CANCER RES, V63, P2088; Andersson AM, 1998, J VIROL, V72, P9585, DOI 10.1128/JVI.72.12.9585-9596.1998; Asher DR, 2005, GENESIS, V42, P77, DOI 10.1002/gene.20127; BOCKMAN DE, 1982, AM J SURG, V144, P243, DOI 10.1016/0002-9610(82)90518-9; Bockman DE, 2003, LAB INVEST, V83, P853, DOI 10.1097/01.LAB.0000074918.31303.5A; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Carson SD, 1999, J VIROL, V73, P7077, DOI 10.1128/JVI.73.8.7077-7079.1999; Caruso L, 2010, J MOL CELL CARDIOL, V48, P1194, DOI 10.1016/j.yjmcc.2010.01.022; Chen JW, 2006, CIRC RES, V98, P923, DOI 10.1161/01.RES.0000218041.41932.e3; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Dorner AA, 2005, J CELL SCI, V118, P3509, DOI 10.1242/jcs.02476; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Excoffon KJDA, 2004, J CELL SCI, V117, P4401, DOI 10.1242/jcs.01300; Farmer C, 2009, EXP CELL RES, V315, P2637, DOI 10.1016/j.yexcr.2009.06.008; Fok PT, 2007, J BIOL CHEM, V282, P7512, DOI 10.1074/jbc.M607230200; Hatcher JP, 2001, BEHAV BRAIN RES, V125, P43, DOI 10.1016/S0166-4328(01)00275-3; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Honda T, 2000, MOL BRAIN RES, V77, P19, DOI 10.1016/S0169-328X(00)00036-X; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; Hutchin ME, 2000, HUM GENE THER, V11, P2365, DOI 10.1089/104303400750038471; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Ito M, 2000, CIRC RES, V86, P275, DOI 10.1161/01.RES.86.3.275; Jimenez RE, 1999, AM J PATHOL, V154, P1223, DOI 10.1016/S0002-9440(10)65374-6; Kallewaard NL, 2009, CELL HOST MICROBE, V6, P91, DOI 10.1016/j.chom.2009.05.018; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Mirza M, 2006, EXP CELL RES, V312, P817, DOI 10.1016/j.yexcr.2005.11.030; Mirza M, 2005, EXP CELL RES, V309, P110, DOI 10.1016/j.yexcr.2005.05.023; Mirza M, 2007, ENDOCRINOLOGY, V148, P5459, DOI 10.1210/en.2007-0359; Miyatsuka T, 2006, GENE DEV, V20, P1435, DOI 10.1101/gad.1412806; Nalbantoglu J, 1999, HUM GENE THER, V10, P1009, DOI 10.1089/10430349950018409; Napolitano LM, 1996, SHOCK, V5, P202, DOI 10.1097/00024382-199603000-00006; Piron J, 2008, MOL THER, V16, P1937, DOI 10.1038/mt.2008.209; POUND AW, 1981, BRIT J EXP PATHOL, V62, P547; Raschperger E, 2006, EXP CELL RES, V312, P1566, DOI 10.1016/j.yexcr.2006.01.025; Rebel VI, 2000, STEM CELLS, V18, P176, DOI 10.1634/stemcells.18-3-176; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; ROSENBERG L, 1983, J SURG RES, V35, P63, DOI 10.1016/0022-4804(83)90127-0; ROSENBERG L, 1984, AM J SURG, V147, P146, DOI 10.1016/0002-9610(84)90049-7; Shaw CA, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-42; Shaw CA, 2006, AM J PATHOL, V169, P2148, DOI 10.2353/ajpath.2006.060570; Sollerbrant K, 2003, J BIOL CHEM, V278, P7439, DOI 10.1074/jbc.M205927200; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Vincent T, 2004, J VIROL, V78, P8047, DOI 10.1128/JVI.78.15.8047-8058.2004; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	51	34	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20203	10.1371/journal.pone.0020203	http://dx.doi.org/10.1371/journal.pone.0020203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674029	Green Published, gold, Green Submitted			2022-12-25	WOS:000291355500007
J	Okamoto, Y; Shirakashi, Y; Ihara, M; Urushitani, M; Oono, M; Kawamoto, Y; Yamashita, H; Shimohama, S; Kato, S; Hirano, A; Tomimoto, H; Ito, H; Takahashi, R				Okamoto, Yoko; Shirakashi, Yoshitomo; Ihara, Masafumi; Urushitani, Makoto; Oono, Miki; Kawamoto, Yasuhiro; Yamashita, Hirofumi; Shimohama, Shun; Kato, Shinsuke; Hirano, Asao; Tomimoto, Hidekazu; Ito, Hidefumi; Takahashi, Ryosuke			Colocalization of 14-3-3 Proteins with SOD1 in Lewy Body-Like Hyaline Inclusions in Familial Amyotrophic Lateral Sclerosis Cases and the Animal Model	PLOS ONE			English	Article							CU/ZN-SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; GENE; 14-3-3-PROTEINS; ACCUMULATION; INVOLVEMENT; INTERACTS; POSTERIOR; MUTATION; DISEASE	Background and Purpose: Cu/Zn superoxide dismutase (SOD1) is a major component of Lewy body-like hyaline inclusion (LBHI) found in the postmortem tissue of SOD1-linked familial amyotrophic lateral sclerosis (FALS) patients. In our recent studies, 14-3-3 proteins have been found in the ubiquitinated inclusions inside the anterior horn cells of spinal cords with sporadic amyotrophic lateral sclerosis (ALS). To further investigate the role of 14-3-3 proteins in ALS, we performed immunohistochemical analysis of 14-3-3 proteins and compared their distributions with those of SOD1 in FALS patients and SOD1-overexpressing mice. Methods: We examined the postmortem brains and the spinal cords of three FALS cases (A4V SOD1 mutant). Transgenic mice expressing the G93A mutant human SOD1 (mutant SOD1-Tg mice), transgenic mice expressing the wild-type human SOD1 (wild-type SOD1-Tg mice), and non-Tg wild-type mice were also subjected to the immunohistochemical analysis. Results: In all the FALS patients, LBHIs were observed in the cytoplasm of the anterior horn cells, and these inclusions were immunopositive intensely for pan 14-3-3, 14-3-3 beta, and 14-3-3 gamma. In the mutant SOD1-Tg mice, a high degree of immunoreactivity for misfolded SOD1 (C4F6) was observed in the cytoplasm, with an even greater degree of immunoreactivity present in the cytoplasmic aggregates of the anterior horn cells in the lumbar spinal cord. Furthermore, we have found increased 14-3-3 beta and 14-3-3 gamma immunoreactivities in the mutant SOD1-Tg mice. Double immunofluorescent staining showed that C4F6 and 14-3-3 proteins were partially co-localized in the spinal cord with FALS and the mutant SOD1-Tg mice. In comparison, the wild-type SOD1-Tg and non-Tg wild-type mice showed no or faint immunoreactivity for C4F6 and 14-3-3 proteins (pan 14-3-3, 14-3-3 beta, and 14-3-3 gamma) in any neuronal compartments. Discussion: These results suggest that 14-3-3 proteins may be associated with the formation of SOD1-containing inclusions, in FALS patients and the mutant SOD1-Tg mice.	[Okamoto, Yoko; Shirakashi, Yoshitomo; Ihara, Masafumi; Oono, Miki; Kawamoto, Yasuhiro; Yamashita, Hirofumi; Ito, Hidefumi; Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto, Japan; [Urushitani, Makoto; Oono, Miki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga, Japan; [Shimohama, Shun] Sapporo Med Univ, Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan; [Kato, Shinsuke] Tottori Univ, Fac Med, Inst Neurol Sci, Dept Neuropathol, Tottori 680, Japan; [Hirano, Asao] Montefiore Med Ctr, Dept Pathol, Div Neuropathol, New York, NY USA; [Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie, Japan	Kyoto University; Shiga University of Medical Science; Sapporo Medical University; Tottori University; Montefiore Medical Center; Mie University	Ihara, M (corresponding author), Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto, Japan.	ihara@kuhp.kyoto-u.ac.jp	Ihara, Masafumi/O-5020-2019; Shirakashi, Yoshitomo/F-2831-2014	Ihara, Masafumi/0000-0002-7102-4048; Urushitani, Makoto/0000-0003-2773-9836; Shirakashi, Yoshitomo/0000-0002-3605-6909	Grants-in-Aid for Scientific Research [23390233, 23300131] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Berg D, 2003, ANN NEUROL, V54, P135, DOI 10.1002/ana.10621; BOSTON PF, 1982, J NEUROCHEM, V38, P1475, DOI 10.1111/j.1471-4159.1982.tb07928.x; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Byrne S, 2010, J NEUROL NEUROSURG P; Casareno RLB, 1998, J BIOL CHEM, V273, P23625, DOI 10.1074/jbc.273.37.23625; CEBALLOSPICOT I, 1991, BRAIN RES, V552, P198, DOI 10.1016/0006-8993(91)90084-9; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HIRANO A, 1967, ARCH NEUROL-CHICAGO, V16, P232, DOI 10.1001/archneur.1967.00470210008002; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kawamoto Y, 2005, ACTA NEUROPATHOL, V110, P203, DOI 10.1007/s00401-005-1039-z; Kawamoto Y, 2004, ACTA NEUROPATHOL, V108, P531, DOI 10.1007/s00401-004-0923-2; Kawamoto Y, 2002, ANN NEUROL, V52, P722, DOI 10.1002/ana.10361; Malaspina A, 2000, J NEUROCHEM, V75, P2511, DOI 10.1046/j.1471-4159.2000.0752511.x; MIZUSAWA H, 1989, ACTA NEUROPATHOL, V79, P37, DOI 10.1007/BF00308955; MURAYAMA S, 1989, ACTA NEUROPATHOL, V78, P143, DOI 10.1007/BF00688202; Nakano I, 1984, NEUROL MED CHIR TOKY, V20, P458; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Santpere G, 2009, NEUROSCIENCE, V161, P663, DOI 10.1016/j.neuroscience.2009.05.001; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Shibata N, 2001, NEUROPATHOLOGY, V21, P82, DOI 10.1046/j.1440-1789.2001.00361.x; Shirakashi Y, 2006, ACTA NEUROPATHOL, V112, P681, DOI 10.1007/s00401-006-0132-2; Umahara T, 2004, ACTA NEUROPATHOL, V108, P279, DOI 10.1007/s00401-004-0885-4; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Yamashita H, 2007, J NEUROCHEM, V102, P1497, DOI 10.1111/j.1471-4159.2007.04534.x	27	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20427	10.1371/journal.pone.0020427	http://dx.doi.org/10.1371/journal.pone.0020427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655264	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600066
J	Patel, KN; Liu, Q; Meeker, S; Undem, BJ; Dong, XZ				Patel, Kush N.; Liu, Qin; Meeker, Sonya; Undem, Bradley J.; Dong, Xinzhong			Pirt, a TRPV1 Modulator, Is Required for Histamine-Dependent and -Independent Itch	PLOS ONE			English	Article							SCRATCHING BEHAVIOR; MAST-CELLS; ATOPIC-DERMATITIS; INTRADERMAL SEROTONIN; RECEPTOR ANTAGONISTS; CAPSAICIN RECEPTOR; NC/NGA MICE; ION-CHANNEL; DRY SKIN; ENDOTHELIN-1	Itch, or pruritus, is an important clinical problem whose molecular basis has yet to be understood. Recent work has begun to identify genes that contribute to detecting itch at the molecular level. Here we show that Pirt, known to play a vital part in sensing pain through modulation of the transient receptor potential vanilloid 1 (TRPV1) channel, is also necessary for proper itch sensation. Pirt(-/-) mice exhibit deficits in cellular and behavioral responses to various itch-inducing compounds, or pruritogens. Pirt contributes to both histaminergic and nonhistaminergic itch and, crucially, is involved in forms of itch that are both TRPV1-dependent and -independent. Our findings demonstrate that the function of Pirt extends beyond nociception via TRPV1 regulation to its role as a critical component in several itch signaling pathways.	[Patel, Kush N.; Liu, Qin; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Meeker, Sonya; Undem, Bradley J.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Dong, Xinzhong] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute	Patel, KN (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	xdong2@jhmi.edu			NIH [NS054791, GM087369]; National Science Foundation; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by grants from the NIH to XD (NS054791 and GM087369). XD is an Early Career Scientist of the Howard Hughes Medical Institute. KNP was supported by a Graduate Research Fellowship from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABILA B, 1994, AFR J MED MED SCI, V32, P139; Akiyama T, 2010, ACTA DERM-VENEREOL, V90, P575, DOI 10.2340/00015555-0962; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Bell JK, 2004, BRIT J PHARMACOL, V142, P374, DOI 10.1038/sj.bjp.0705754; Biro T, 2007, BBA-MOL BASIS DIS, V1772, P1004, DOI 10.1016/j.bbadis.2007.03.002; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Dunford PJ, 2007, J ALLERGY CLIN IMMUN, V119, P176, DOI 10.1016/j.jaci.2006.08.034; EZEAMUZIE CI, 1990, J TROP MED HYG, V93, P423; FERREIRA SH, 1989, J CARDIOVASC PHARM, V13, pS220, DOI 10.1097/00005344-198900135-00065; Gokin AP, 2001, J NEUROSCI, V21, P5358, DOI 10.1523/JNEUROSCI.21-14-05358.2001; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Hashimoto Y, 2005, J PHARMACOL SCI, V98, P90, DOI 10.1254/jphs.SC0040209; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Lin SY, 2011, J NEUROSCI, V31, P1410, DOI 10.1523/JNEUROSCI.4682-10.2011; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Macpherson LJ, 2007, J NEUROSCI, V27, P11412, DOI 10.1523/JNEUROSCI.3600-07.2007; Matsushima H, 2004, EUR J IMMUNOL, V34, P1910, DOI 10.1002/eji.200424912; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; McQueen DS, 2007, BRIT J PHARMACOL, V151, P278, DOI 10.1038/sj.bjp.0707216; Metz M, 2006, AM J PATHOL, V169, P815, DOI 10.2353/ajpath.2006.060037; Miyamoto T, 2002, JPN J PHARMACOL, V88, P285, DOI 10.1254/jjp.88.285; MNYIKA KS, 1991, J TROP MED HYG, V94, P27; Namer B, 2008, PAIN, V137, P41, DOI 10.1016/j.pain.2007.08.008; Nojima H, 2004, NEUROSCI LETT, V361, P79, DOI 10.1016/j.neulet.2003.12.013; Oikonomopoulou K, 2006, BIOL CHEM, V387, P677, DOI 10.1515/BC.2006.086; Patel KN, 2011, ACS CHEM NEUROSCI, V2, P17, DOI 10.1021/cn100085g; Patel KN, 2010, NEURON, V68, P334, DOI 10.1016/j.neuron.2010.10.018; Patil MJ, 2011, J NEUROSCI RES, V89, P945, DOI 10.1002/jnr.22597; PEREIRA U, 2010, EXPT MODELS ITCH, P51; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shimada SG, 2006, EUR J PHARMACOL, V530, P281, DOI 10.1016/j.ejphar.2005.11.012; Slominski A, 2004, BBA-GENE STRUCT EXPR, V1680, P67, DOI 10.1016/j.bbaexp.2004.09.002; Sowunmi A, 2000, ANN TROP MED PARASIT, V94, P209, DOI 10.1080/00034980050006375; Steinhoff M, 2006, J INVEST DERMATOL, V126, P1705, DOI 10.1038/sj.jid.5700231; Sugimoto Y, 1998, EUR J PHARMACOL, V351, P1, DOI 10.1016/S0014-2999(98)00288-X; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Takano N, 2006, BRIT J DERMATOL, V154, P426, DOI 10.1111/j.1365-2133.2005.07070.x; Takano N, 2003, EUR J PHARMACOL, V471, P223, DOI 10.1016/S0014-2999(03)01828-4; Thomsen JS, 2001, ACTA DERM-VENEREOL, V81, P250, DOI 10.1080/00015550152572868; Trentin PG, 2006, EXP BIOL MED, V231, P1146; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Walther Andreas, 2002, Pathophysiology, V8, P161, DOI 10.1016/S0928-4680(02)00006-8; WILSON SR, 2011, NAT NEUROSC IN PRESS; Yamaguchi T, 1999, NEUROSCI RES, V35, P77, DOI 10.1016/S0168-0102(99)00070-X; YAMAZAKI M, 1994, BLOOD, V83, P3509; Yatsuzuka R, 2007, EUR J PHARMACOL, V565, P225, DOI 10.1016/j.ejphar.2007.02.062; Yoshioka T, 2009, J INVEST DERMATOL, V129, P714, DOI 10.1038/jid.2008.245	58	44	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20559	10.1371/journal.pone.0020559	http://dx.doi.org/10.1371/journal.pone.0020559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655234	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600097
J	Huang, PW; Galloway, CA; Yoon, Y				Huang, Pinwei; Galloway, Chad A.; Yoon, Yisang			Control of Mitochondrial Morphology Through Differential Interactions of Mitochondrial Fusion and Fission Proteins	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; DYNAMIN-RELATED PROTEIN; DOMINANT OPTIC ATROPHY; MAMMALIAN-CELLS; GTPASE ACTIVITY; EMBRYONIC-DEVELOPMENT; DOMAIN INTERACTIONS; DRP1; PHOSPHORYLATION; MITOFUSIN-2	Mitochondria in mammals are organized into tubular networks that undergo frequent shape change. Mitochondrial fission and fusion are the main components mediating the mitochondrial shape change. Perturbation of the fission/fusion balance is associated with many disease conditions. However, underlying mechanisms of the fission/fusion balance are not well understood. Mitochondrial fission in mammals requires the dynamin-like protein DLP1/Drp1 that is recruited to the mitochondrial surface, possibly through the membrane-anchored protein Fis1 or Mff. Additional dynamin-related GTPases, mitofusin (Mfn) and OPA1, are associated with the outer and inner mitochondrial membranes, respectively, and mediate fusion of the respective membranes. In this study, we found that two heptad-repeat regions (HR1 and HR2) of Mfn2 interact with each other, and that Mfn2 also interacts with the fission protein DLP1. The association of the two heptad-repeats of Mfn2 is fusion inhibitory whereas a positive role of the Mfn2/DLP1 interaction in mitochondrial fusion is suggested. Our results imply that the differential binding of Mfn2-HR1 to HR2 and DLP1 regulates mitochondrial fusion and that DLP1 may act as a regulatory factor for efficient execution of both fusion and fission of mitochondria.	[Huang, Pinwei; Galloway, Chad A.; Yoon, Yisang] Univ Rochester, Sch Med & Dent, Mitochondrial Res & Innovat Grp, Dept Anesthesiol,Dept Pharmacol & Physiol, Rochester, NY 14627 USA	University of Rochester	Huang, PW (corresponding author), Univ Rochester, Sch Med & Dent, Mitochondrial Res & Innovat Grp, Dept Anesthesiol,Dept Pharmacol & Physiol, Rochester, NY 14627 USA.	yisang_yoon@urmc.rochester.edu	Yoon, Yisang/AAJ-7910-2020	Galloway, Chad/0000-0002-1978-7339; Yoon, Yisang/0000-0002-1618-5439	National Institute of Diabetes and Digestive and Kidney Diseases [DK061991, DK078618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061991, R01DK078618] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases (DK061991 and DK078618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bereiter-Hahn J., 1990, International Review of Cytology, V122, P1, DOI 10.1016/S0074-7696(08)61205-X; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Eura Y, 2006, J CELL SCI, V119, P4913, DOI 10.1242/jcs.03253; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; GUNTHRIE C, 1991, GUIDE YEAST GENETICS; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Honda S, 2005, J CELL SCI, V118, P3153, DOI 10.1242/jcs.02449; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; Hynes TR, 2004, J BIOL CHEM, V279, P30279, DOI 10.1074/jbc.M401432200; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Pfanner N, 2004, SCIENCE, V305, P1723, DOI 10.1126/science.1104244; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; YOON Y, 2010, MITOCHONDRIAL DYNAMI; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	51	71	74	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20655	10.1371/journal.pone.0020655	http://dx.doi.org/10.1371/journal.pone.0020655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647385	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052500070
J	Mazzariol, S; Di Guardo, G; Petrella, A; Marsili, L; Fossi, CM; Leonzio, C; Zizzo, N; Vizzini, S; Gaspari, S; Pavan, G; Podesta, M; Garibaldi, F; Ferrante, M; Copat, C; Traversa, D; Marcer, F; Airoldi, S; Frantzis, A; Quiros, YD; Cozzi, B; Fernandez, A				Mazzariol, Sandro; Di Guardo, Giovanni; Petrella, Antonio; Marsili, Letizia; Fossi, Cristina M.; Leonzio, Claudio; Zizzo, Nicola; Vizzini, Salvatrice; Gaspari, Stefania; Pavan, Gianni; Podesta, Michela; Garibaldi, Fulvio; Ferrante, Margherita; Copat, Chiara; Traversa, Donato; Marcer, Federica; Airoldi, Sabina; Frantzis, Alexandros; De Beraldo Quiros, Yara; Cozzi, Bruno; Fernandez, Antonio			Sometimes Sperm Whales (Physeter macrocephalus) Cannot Find Their Way Back to the High Seas: A Multidisciplinary Study on a Mass Stranding	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; NORTH-SEA; GENETIC DIVERSITY; MARINE MAMMALS; METHYL MERCURY; HEAVY-METALS; HABITAT USE; CETACEANS; ATLANTIC; METHYLMERCURY	Background: Mass strandings of sperm whales (Physeter macrocephalus) remain peculiar and rather unexplained events, which rarely occur in the Mediterranean Sea. Solar cycles and related changes in the geomagnetic field, variations in water temperature and weather conditions, coast geographical features and human activities have been proposed as possible causes. In December 2009, a pod of seven male sperm whales stranded along the Adriatic coast of Southern Italy. This is the sixth instance from 1555 in this basin. Methodology/Principal Findings: Complete necropsies were performed on three whales whose bodies were in good condition, carrying out on sampled tissues histopathology, virology, bacteriology, parasitology, and screening of veins looking for gas emboli. Furthermore, samples for age determination, genetic studies, gastric content evaluation, stable isotopes and toxicology were taken from all the seven specimens. The animals were part of the same group and determined by genetic and photo-identification to be part of the Mediterranean population. Causes of death did not include biological agents, or the "gas and fat embolic syndrome", associated with direct sonar exposure. Environmental pollutant tissue concentrations were relatively high, in particular organochlorinated xenobiotics. Gastric content and morphologic tissue examinations showed a prolonged starvation, which likely caused, at its turn, the mobilization of lipophilic contaminants from the adipose tissue. Chemical compounds subsequently entered the blood circulation and may have impaired immune and nervous functions. Conclusions/Significance: A multi-factorial cause underlying this sperm whales' mass stranding is proposed herein based upon the results of postmortem investigations as well as of the detailed analyses of the geographical and historical background. The seven sperm whales took the same "wrong way" into the Adriatic Sea, a potentially dangerous trap for Mediterranean sperm whales. Seismic surveys should be also regarded as potential co-factors, even if no evidence of direct impact has been detected.	[Mazzariol, Sandro] Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy; [Di Guardo, Giovanni; Traversa, Donato] Univ Teramo, Dept Comparat Biomed Sci, Teramo, Italy; [Petrella, Antonio] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Marsili, Letizia; Fossi, Cristina M.; Leonzio, Claudio] Univ Siena, Dept Environm Sci, I-53100 Siena, Italy; [Zizzo, Nicola] Univ Bari, Dept Vet Publ Hlth, Valenzano, Italy; [Vizzini, Salvatrice] Univ Palermo, Dept Earth & Marine Sci, Palermo, Italy; [Gaspari, Stefania] Univ Florence, Dept Evolutionary Biol, Florence, Italy; [Pavan, Gianni] Univ Pavia, Dept Anim Biol, Interdisciplinary Ctr Bioacoust, I-27100 Pavia, Italy; [Podesta, Michela] Museum Nat Hist Milan, Milan, Italy; [Garibaldi, Fulvio] Univ Genoa, Dept Study Terr & Its Resources, Genoa, Italy; [Ferrante, Margherita; Copat, Chiara] Univ Catania, Dept Anat Diagnost Pathol Forens Med Hyg & Publ H, Catania, Italy; [Marcer, Federica; Cozzi, Bruno] Univ Padua, Dept Expt Vet Sci, Legnaro, Italy; [Airoldi, Sabina] Tethys Res Inst, Milan, Italy; [Frantzis, Alexandros] Pelagos Cetacean Res Inst, Vouliagmeni, Greece; [De Beraldo Quiros, Yara; Fernandez, Antonio] Univ Las Palmas Gran Canaria, Dept Morphol, Las Palmas Gran Canaria, Spain	University of Padua; University of Teramo; IZS Puglia e Basilicata; University of Siena; Universita degli Studi di Bari Aldo Moro; University of Palermo; University of Florence; University of Pavia; University of Genoa; University of Catania; University of Padua; Universidad de Las Palmas de Gran Canaria	Mazzariol, S (corresponding author), Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy.	sandro.mazzariol@unipd.it	Fernandez, Antonio/G-3448-2015; Marsili, Letizia/AAC-3836-2022; Marsili, Letizia/AAB-7138-2019; de Quirós, Yara Bernaldo/A-3628-2015; Copat, Chiara/H-2192-2013; Ferrante, Margherita/B-2781-2011; Pavan, Gianni/M-4619-2015; Cozzi, Bruno/H-9618-2019	Fernandez, Antonio/0000-0001-5281-0521; Marsili, Letizia/0000-0002-2474-4587; de Quirós, Yara Bernaldo/0000-0002-2611-0406; Copat, Chiara/0000-0002-2262-6050; Ferrante, Margherita/0000-0001-7596-2464; Pavan, Gianni/0000-0002-4599-9028; Cozzi, Bruno/0000-0002-7531-7040; Traversa, Donato/0000-0003-3411-1326; Fossi, Maria Cristina/0000-0003-0836-4020; NICOLA, ZIZZO/0000-0002-1434-415X; Mazzariol, Sandro/0000-0002-4756-1871; Frantzis, Alexandros/0000-0001-7117-062X	Italian Ministry of the Environment; University of Padova	Italian Ministry of the Environment; University of Padova	The study was funded by the Italian Ministry of the Environment, and partially funded by the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWSKY CR, 1981, HUM PATHOL, V12, P753, DOI 10.1016/S0046-8177(81)80179-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1986, HDB IDENTIFICATION C; Aznar FJ, 2005, DIS AQUAT ORGAN, V67, P239, DOI 10.3354/dao067239; Azzellino A, 2008, DEEP-SEA RES PT I, V55, P296, DOI 10.1016/j.dsr.2007.11.006; BALLSCHMITER K, 1980, FRESEN Z ANAL CHEM, V302, P20, DOI 10.1007/BF00469758; Bearzi G, 2004, AQUAT CONSERV, V14, P363, DOI 10.1002/aqc.626; Bearzi G, 2011, MAMMAL REV, V41, P276, DOI 10.1111/j.1365-2907.2010.00171.x; Beineke A, 2005, ENVIRON SCI TECHNOL, V39, P3933, DOI 10.1021/es048709j; Beineke A, 2007, VET IMMUNOL IMMUNOP, V117, P254, DOI 10.1016/j.vetimm.2007.03.009; Beineke A, 2010, VET IMMUNOL IMMUNOP, V133, P81, DOI 10.1016/j.vetimm.2009.06.019; Belliere EN, 2010, ARCH VIROL, V155, P1307, DOI 10.1007/s00705-010-0697-x; Berube M, 1996, MOL ECOL, V5, P283; BURG JL, 1989, J CLIN MICROBIOL, V27, P1787, DOI 10.1128/JCM.27.8.1787-1792.1989; Bustamante P, 1998, SCI TOTAL ENVIRON, V220, P71, DOI 10.1016/S0048-9697(98)00250-2; Byczkowski JZ, 2001, RISK ANAL, V21, P869, DOI 10.1111/0272-4332.215158; Capelli R, 2008, SCI TOTAL ENVIRON, V390, P569, DOI 10.1016/j.scitotenv.2007.10.036; Chapman L, 2000, ENVIRON HEALTH PERSP, V108, P29, DOI [10.2307/3454631, 10.2307/3454292]; Cheng JP, 2009, ENVIRON INT, V35, P619, DOI 10.1016/j.envint.2008.12.006; Coccini T, 2007, TOXICOLOGY, V238, P34, DOI 10.1016/j.tox.2007.05.018; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P219, DOI 10.1177/33.3.2579122; Das K, 2003, MAR ENVIRON RES, V56, P349, DOI 10.1016/S0141-1136(02)00308-2; Das Krishna, 2006, BMC Ecology, V6, P2, DOI 10.1186/1472-6785-6-2; de Stephanis R, 2008, MAR ECOL PROG SER, V353, P275, DOI 10.3354/meps07164; Debier C, 2006, AQUAT TOXICOL, V80, P149, DOI 10.1016/j.aquatox.2006.08.002; DEQUIROS YB, 2009, 23 ANN C EUR CET SOC; DISCIARA GN, 2006, STATUS DISTRIBUTION, P48; DROUOT V, 2004, J MAR BIOL ASSOC UK, V87, P195; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; Evans K, 2004, MAR POLLUT BULL, V48, P486, DOI 10.1016/j.marpolbul.2003.08.026; Evans K, 2004, ICES J MAR SCI, V61, P1313, DOI 10.1016/j.icesjms.2004.07.026; Fernandez A, 2005, VET PATHOL, V42, P446, DOI 10.1354/vp.42-4-446; Frantzis A., 2003, Journal of Cetacean Research and Management, V5, P219; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; Frodello JP, 2000, ENVIRON POLLUT, V108, P447, DOI 10.1016/S0269-7491(99)00221-3; Gannier A, 2002, MAR ECOL PROG SER, V243, P281, DOI 10.3354/meps243281; GANNIER A, 2006, J MAR BIOL ASSOC UK, V5468, P1; Goldoni M, 2008, FOOD CHEM TOXICOL, V46, P808, DOI 10.1016/j.fct.2007.09.104; Griest W. H., 1983, HDB POLYCYCLIC AROMA, P95; Havarinasab S, 2007, TOXICOL APPL PHARM, V221, P21, DOI 10.1016/j.taap.2007.02.009; Hoelzel AR, 2002, J EVOLUTION BIOL, V15, P567, DOI 10.1046/j.1420-9101.2002.00419.x; Holsbeek L, 1999, MAR POLLUT BULL, V38, P304, DOI 10.1016/S0025-326X(98)00150-7; Ikemoto T, 2004, ARCH ENVIRON CON TOX, V47, P402, DOI 10.1007/s00244-004-3188-9; Jacobsen JK, 2010, MAR POLLUT BULL, V60, P765, DOI 10.1016/j.marpolbul.2010.03.008; Jauniaux T, 1998, J WILDLIFE DIS, V34, P99, DOI 10.7589/0090-3558-34.1.99; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; KENNEDY S, 1991, VET PATHOL, V28, P1, DOI 10.1177/030098589102800101; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; Lyrholm T, 1998, P ROY SOC B-BIOL SCI, V265, P1679, DOI 10.1098/rspb.1998.0488; Lyrholm T, 1996, MOL BIOL EVOL, V13, P1318, DOI 10.1093/oxfordjournals.molbev.a025578; Marcoux M, 2007, MAR ECOL PROG SER, V333, P309, DOI 10.3354/meps333309; Marsili L, 2001, CHEMOSPHERE, V44, P147, DOI 10.1016/S0045-6535(00)00206-X; Marsili L, 1997, ENVIRON MONIT ASSESS, V45, P129, DOI 10.1023/A:1005786627533; Miller PJO, 2009, DEEP-SEA RES PT I, V56, P1168, DOI 10.1016/j.dsr.2009.02.008; Nigro M, 1996, MAR ECOL PROG SER, V135, P137, DOI 10.3354/meps135137; Pantoja S, 2002, DEEP-SEA RES PT I, V49, P1609, DOI 10.1016/S0967-0637(02)00066-3; Pavan G, 2000, J ACOUST SOC AM, V107, P3487, DOI 10.1121/1.429419; Pierce GJ, 2007, FISH RES, V87, P219, DOI 10.1016/j.fishres.2007.06.001; Praca E, 2008, OCEAN SCI, V4, P49, DOI 10.5194/os-4-49-2008; Psarra S, 2000, PROG OCEANOGR, V46, P187, DOI 10.1016/S0079-6611(00)00018-5; Richard KR, 1996, P NATL ACAD SCI USA, V93, P8792, DOI 10.1073/pnas.93.16.8792; Ruiz-Cooley RI, 2004, MAR ECOL PROG SER, V277, P275, DOI 10.3354/meps277275; Su C, 2010, PARASITOLOGY, V137, P1, DOI 10.1017/S0031182009991065; Sundaram B, 2006, J THEOR BIOL, V238, P764, DOI 10.1016/j.jtbi.2005.06.022; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Vanselow KH, 2005, J SEA RES, V53, P319, DOI 10.1016/j.seares.2004.07.006; Vanselow Klaus Heinrich, 2009, Open Marine Biology Journal, V3, P89; Whitehead H, 1998, SCIENCE, V282, P1708, DOI 10.1126/science.282.5394.1708; Whitehead H, 2004, J ANIM ECOL, V73, P190, DOI 10.1111/j.1365-2656.2004.00798.x; Whitehead H., 2003, SPERM WHALES SOCIAL; Wolfe MF, 1998, ENVIRON TOXICOL CHEM, V17, P146, DOI [10.1897/1551-5028(1998)017&lt;0146:EOMOWA&gt;2.3.CO;2, 10.1002/etc.5620170203]; Woshner VM, 2002, TOXICOL PATHOL, V30, P209, DOI 10.1080/019262302753559542; Wright AJ, 2005, MAR MAMMAL SCI, V21, P145, DOI 10.1111/j.1748-7692.2005.tb01214.x	74	72	76	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19417	10.1371/journal.pone.0019417	http://dx.doi.org/10.1371/journal.pone.0019417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21673789	gold, Green Published, Green Submitted			2022-12-25	WOS:000290720200005
J	Coombs, GS; Schmitt, AA; Canning, CA; Alok, A; Low, ICC; Banerjee, N; Kaur, S; Utomo, V; Jones, CM; Pervaiz, S; Toone, EJ; Virshup, DM				Coombs, G. S.; Schmitt, A. A.; Canning, C. A.; Alok, A.; Low, I. C. C.; Banerjee, N.; Kaur, S.; Utomo, V.; Jones, C. M.; Pervaiz, S.; Toone, E. J.; Virshup, D. M.			Modulation of Wnt/beta-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer	ONCOGENE			English	Article						Wnt/beta-catenin; iron; iron chelator; drug therapy; mouse models of cancer	CONNECTIVITY MAP; BINDING; WNT; EXPRESSION; DISEASE; INHIBITION; ANALOGS; PROTEIN; TUMORS; CELLS	Using a screen for Wnt/beta-catenin inhibitors, a family of 8-hydroxyquinolone derivatives with in vivo anti-cancer properties was identified. Analysis of microarray data for the lead compound N-((8-hydroxy-7-quinolinyl) (4-methylphenyl)methyl)benzamide (HQBA) using the Connectivity Map database suggested that it is an iron chelator that mimics the hypoxic response. HQBA chelates Fe(2+) with a dissociation constant of similar to 10(-19) M, with much weaker binding to Fe(3+) and other transition metals. HQBA inhibited proliferation of multiple cell lines in culture, and blocked the progression of established spontaneous cancers in two distinct genetically engineered mouse models of mammary cancer, MMTV-Wnt1 and MMTV-PyMT mice, without overt toxicity. HQBA may inhibit an iron-dependent factor that regulates cell-type-specific beta-catenin-driven transcription. It inhibits cancer cell proliferation independently of its effect on beta-catenin signaling, as it works equally well in MMTV-PyMT tumors and diverse beta-catenin-independent cell lines. HQBA is a promising specific intracellular Fe(2+) chelator with activity against spontaneous mouse mammary cancers. Oncogene (2012) 31, 213-225; doi:10.1038/onc.2011.228; published online 13 June 2011	[Coombs, G. S.; Alok, A.; Kaur, S.; Utomo, V.; Virshup, D. M.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Canning, C. A.; Jones, C. M.] ASTAR, Inst Med Biol, Singapore, Singapore; [Schmitt, A. A.; Toone, E. J.] Duke Univ, Dept Chem, Durham, NC 27706 USA; [Low, I. C. C.; Pervaiz, S.; Virshup, D. M.] Natl Univ Singapore, Dept Physiol, Singapore 117548, Singapore; [Banerjee, N.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Virshup, D. M.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Virshup, D. M.] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Duke University; National University of Singapore; Utah System of Higher Education; University of Utah; National University of Singapore; Duke University	Virshup, DM (corresponding author), Duke NUS Grad Med Sch Singapore, Program Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	david.virshup@duke-nus.edu.sg	Low, Ivan Cherh Chiet/O-1649-2013; Virshup, David M/C-1449-2009; Pervaiz, Shazib/C-4188-2015	Virshup, David M/0000-0001-6976-850X; Kaur, Simran/0000-0003-1510-928X; Low, Ivan Cherh Chiet/0000-0003-2735-395X; Coombs, Gary/0000-0002-0711-185X	Duke-NUS; Singapore Translational Research (STaR); Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore; NIH [T32-GM007105-37]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105] Funding Source: NIH RePORTER	Duke-NUS; Singapore Translational Research (STaR); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Chuck Perou and Philipp Kaldis for assistance with the MMTV-Wnt1 and MMTV-PyMT mice, and Elizabeth Leibold for helpful discussions. The compound library was provided by the Huntsman Cancer Institute Drug Screening Resource at the University of Utah. This research was supported by the Duke-NUS Signature Research Program and the Singapore Translational Research (STaR) Investigator Award (to DMV) funded by the Agency for Science, Technology and Research, Singapore, and the Ministry of Health, Singapore. CAC and CMJ were funded by A*STAR, Singapore. AAS acknowledges support from the Duke Pharmacological Sciences Training Program, NIH T32-GM007105-37.	BERGERON RJ, 1993, BLOOD, V81, P2166; Bergeron RJ, 1999, J MED CHEM, V42, P95, DOI 10.1021/jm980340j; Brookes MJ, 2008, ONCOGENE, V27, P966, DOI 10.1038/sj.onc.1210711; Canning CA, 2007, DEV BIOL, V305, P276, DOI 10.1016/j.ydbio.2007.02.009; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; DiTusa CA, 2001, BIOCHEMISTRY-US, V40, P5338, DOI 10.1021/bi001731e; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hodges YK, 2004, BIOCHEM BIOPH RES CO, V315, P595, DOI 10.1016/j.bbrc.2004.01.101; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jansson PJ, 2010, J INORG BIOCHEM, V104, P1224, DOI 10.1016/j.jinorgbio.2010.07.012; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lucero OM, 2010, CURR ONCOL REP, V12, P314, DOI 10.1007/s11912-010-0114-3; McCulloch MWB, 2009, J NAT PROD, V72, P1651, DOI 10.1021/np900336f; McCulloch MWB, 2009, BIOORGAN MED CHEM, V17, P2189, DOI 10.1016/j.bmc.2008.10.077; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Pang H, 2004, J BIOL CHEM, V279, P1491, DOI 10.1074/jbc.M310022200; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Tian JQ, 2010, CANCER LETT, V298, P231, DOI 10.1016/j.canlet.2010.07.010; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Zhou HY, 2010, INT J CANCER, V127, P2467, DOI 10.1002/ijc.25255	33	54	62	4	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	2					213	225		10.1038/onc.2011.228	http://dx.doi.org/10.1038/onc.2011.228			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21666721	hybrid, Green Published			2022-12-25	WOS:000299307400007
J	Zaric, J; Joseph, JM; Tercier, S; Sengstag, T; Ponsonnet, L; Delorenzi, M; Ruegg, C				Zaric, J.; Joseph, J-M; Tercier, S.; Sengstag, T.; Ponsonnet, L.; Delorenzi, M.; Rueegg, C.			Identification of MAGI1 as a tumor-suppressor protein induced by cyclooxygenase-2 inhibitors in colorectal cancer cells	ONCOGENE			English	Article						COX-2; Wnt signaling; metastasis; colorectal cancer; tumor suppressor	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTEGRIN-MEDIATED ADHESION; GUANYLATE KINASE; SCAFFOLDING MOLECULE; TISSUE POLARITY; BETA-CATENIN; PDZ DOMAIN; PREVENTION; CELECOXIB; GROWTH	Cyclooxyganase-2 (COX-2), a rate-limiting enzyme in the prostaglandin synthesis pathway, is overexpressed in many cancers and contributes to cancer progression through tumor cell-autonomous and paracrine effects. Regular use of non-steroidal anti-inflammatory drugs or selective COX-2 inhibitors (COXIBs) reduces the risk of cancer development and progression, in particular of the colon. The COXIB celecoxib is approved for adjunct therapy in patients with Familial adenomatous polyposis at high risk for colorectal cancer (CRC) formation. Long-term use of COXIBs, however, is associated with potentially severe cardiovascular complications, which hampers their broader use as preventive anticancer agents. In an effort to better understand the tumor-suppressive mechanisms of COXIBs, we identified MAGUK with Inverted domain structure-1 (MAGI1), a scaffolding protein implicated in the stabilization of adherens junctions, as a gene upregulated by COXIB in CRC cells and acting as tumor suppressor. Overexpression of MAGI1 in CRC cell lines SW480 and HCT116 induced an epithelial-like morphology; stabilized E-cadherin and beta-catenin localization at cell-cell junctions; enhanced actin stress fiber and focal adhesion formation; increased cell adhesion to matrix proteins and suppressed Wnt signaling, anchorage-independent growth, migration and invasion in vitro. Conversely, MAGI1 silencing decreased E-cadherin and beta-catenin localization at cell-cell junctions; disrupted actin stress fiber and focal adhesion formation; and enhanced Wnt signaling, anchorage-independent growth, migration and invasion in vitro. MAGI1 overexpression suppressed SW480 and HCT116 subcutaneous primary tumor growth, attenuated primary tumor growth and spontaneous lung metastasis in an orthotopic model of CRC, and decreased the number and size of metastatic nodules in an experimental model of lung metastasis. Collectively, these results identify MAG1 as a COXIB-induced inhibitor of the Wnt/beta-catenin signaling pathway, with tumor-suppressive and anti-metastatic activity in experimental colon cancer. Oncogene (2012) 31, 48-59; doi: 10.1038/onc.2011.218; published online 13 June 2011	[Zaric, J.; Ponsonnet, L.; Rueegg, C.] Univ Fribourg UNIFR, Dept Med, Fac Sci, CH-1700 Fribourg, Switzerland; [Zaric, J.; Ponsonnet, L.; Rueegg, C.] Univ Lausanne UNIL, Univ Med Ctr CHUV, Multidisciplinary Oncol Ctr CePO, Div Expt Oncol, Lausanne, Switzerland; [Zaric, J.; Delorenzi, M.; Rueegg, C.] Ecole Polytech Fed Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Natl Ctr Competence Res NCCR, Lausanne, Switzerland; [Joseph, J-M; Tercier, S.] Univ Lausanne UNIL, Univ Med Ctr CHUV, Dept Pediat Surg, Lausanne, Switzerland; [Sengstag, T.; Delorenzi, M.] Swiss Inst Bioinformat SIB, Lausanne, Switzerland	University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Lausanne; Swiss Institute of Bioinformatics	Ruegg, C (corresponding author), Univ Fribourg UNIFR, Dept Med, Fac Sci, 1 Rue Albert Gockel, CH-1700 Fribourg, Switzerland.	curzio.ruegg@unifr.ch			Medic Foundation; National Center for Competence in Research (NCCR, Molecular Oncology, a research instrument of the Swiss National Science Foundation); European Union [HEALTH-F2-2008-201662]; Swiss Cancer League [OCS 020020-02-2007]	Medic Foundation; National Center for Competence in Research (NCCR, Molecular Oncology, a research instrument of the Swiss National Science Foundation); European Union(European Commission); Swiss Cancer League	We thank Drs M Aguet, Y Hata, L Naldini, A Follenzi and R Iggo for sharing reagents; F Derouet and D Uldry for invaluable technical assistance; N Rives for proof reading the paper and Pfizer for providing celecoxib. This work was supported by grants from the Medic Foundation, the National Center for Competence in Research (NCCR, Molecular Oncology, a research instrument of the Swiss National Science Foundation), the European Union under the auspices of the FP7 collaborative project TuMIC (contract number HEALTH-F2-2008-201662) and by the Swiss Cancer League (OCS 020020-02-2007).	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Araki Y, 2003, CANCER RES, V63, P728; Bertagnolli MM, 2009, CANCER PREV RES, V2, P310, DOI 10.1158/1940-6207.CAPR-08-0206; Bieler G, 2007, ONCOGENE, V26, P5722, DOI 10.1038/sj.onc.1210354; Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chastre E, 2009, FASEB J, V23, P916, DOI 10.1096/fj.08-106344; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589; Dobrosotskaya IY, 2001, BIOCHEM BIOPH RES CO, V283, P969, DOI 10.1006/bbrc.2001.4880; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Dormond O, 2001, NAT MED, V7, P1041, DOI 10.1038/nm0901-1041; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Futaki N, 1997, INFLAMM RES, V46, P496, DOI 10.1007/s000110050232; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Howe LR, 1999, CANCER RES, V59, P1572; Ide N, 1999, ONCOGENE, V18, P7810, DOI 10.1038/sj.onc.1203153; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Jacoby RF, 2000, CANCER RES, V60, P5040; Jones MK, 1999, NAT MED, V5, P1418; Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002; Koch A, 2004, J PATHOL, V204, P546, DOI 10.1002/path.1662; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Laura RP, 2002, EXP CELL RES, V275, P155, DOI 10.1006/excr.2002.5475; MEADE EA, 1993, J BIOL CHEM, V268, P6610; Mino A, 2000, GENES CELLS, V5, P1009, DOI 10.1046/j.1365-2443.2000.00385.x; Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841; Noda M, 2002, J GASTROENTEROL, V37, P896, DOI 10.1007/s005350200151; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Shao JY, 2003, CANCER RES, V63, P5218; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Stolfi C, 2008, BIOCHEM PHARMACOL, V75, P668, DOI 10.1016/j.bcp.2007.09.020; Swamy MV, 2006, CANCER RES, V66, P7370, DOI 10.1158/0008-5472.CAN-05-4619; Taylor J, 1998, GENETICS, V150, P199; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Vadlamudi R, 1999, ONCOGENE, V18, P305, DOI 10.1038/sj.onc.1202307; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang DZ, 2004, CELL CYCLE, V3, P1512, DOI 10.4161/cc.3.12.1288; Wolff T, 1998, DEVELOPMENT, V125, P1149; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817; Zaric J, 2005, J BIOL CHEM, V280, P1077, DOI 10.1074/jbc.M410006200	51	45	47	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	1					48	59		10.1038/onc.2011.218	http://dx.doi.org/10.1038/onc.2011.218			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21666716	Green Published, Green Submitted			2022-12-25	WOS:000299176200005
J	Marrs, WR; Horne, EA; Ortega-Gutierrez, S; Cisneros, JA; Xu, C; Lin, YH; Muccioli, GG; Lopez-Rodriguez, ML; Stella, N				Marrs, William R.; Horne, Eric A.; Ortega-Gutierrez, Silvia; Antonio Cisneros, Jose; Xu, Cong; Lin, Yi Hsing; Muccioli, Giulio G.; Lopez-Rodriguez, Maria L.; Stella, Nephi			Dual Inhibition of alpha/beta-Hydrolase Domain 6 and Fatty Acid Amide Hydrolase Increases Endocannabinoid Levels in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOACYLGLYCEROL LIPASE; ANANDAMIDE HYDROLYSIS; CANNABINOID RECEPTORS; CORTICAL-NEURONS; BRAIN; BLOCKADE; MODULATION; 2-ARACHIDONOYLGLYCEROL; IDENTIFICATION; EFFICACY	Agonists at cannabinoid receptors, such as the phytocannabinoid Delta(9)-tetrahydrocannabinol, exert a remarkable array of therapeutic effects but are also associated with undesirable psychoactive side effects. Conversely, targeting enzymes that hydrolyze endocannabinoids (eCBs) allows for more precise fine-tuning of cannabinoid receptor signaling, thus providing therapeutic relief with reduced side effects. Here, we report the development and characterization of an inhibitor of eCB hydrolysis, UCM710, which augments both N-arachidonoylethanolamine and 2-arachidonoylglycerol levels in neurons. This compound displays a unique pharmacological profile in that it inhibits fatty acid amide hydrolase and alpha/beta-hydrolase domain 6 but not monoacylglycerol lipase. Thus, UCM710 represents a novel tool to delineate the therapeutic potential of compounds that manipulate a subset of enzymes that control eCB signaling.	[Horne, Eric A.; Xu, Cong; Lin, Yi Hsing; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Marrs, William R.] Univ Washington, Neurobiol & Behav Grad Program, Seattle, WA 98195 USA; [Ortega-Gutierrez, Silvia; Antonio Cisneros, Jose; Lopez-Rodriguez, Maria L.] Univ Complutense, Fac Ciencias Quim, Dept Quim Organ 1, E-28040 Madrid, Spain; [Muccioli, Giulio G.] Catholic Univ Louvain, Bioanal & Pharmacol Bioact Lipids Lab, CHAM7230, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Stella, Nephi] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Complutense University of Madrid; Universite Catholique Louvain; University of Washington; University of Washington Seattle	Stella, N (corresponding author), Univ Washington, Dept Pharmacol, 1959 Pacific Ave N, Seattle, WA 98195 USA.	nstella@uw.edu	Lopez-Rodriguez, Maria L/S-6342-2016; Ortega-Gutierrez, Silvia/I-1935-2017; Ortega-Gutierrez, Silvia/ABC-7653-2021; Cisneros Trigo, Jose Antonio/B-1050-2018	Lopez-Rodriguez, Maria L/0000-0001-8607-1085; Ortega-Gutierrez, Silvia/0000-0002-0257-6754; Cisneros Trigo, Jose Antonio/0000-0003-3679-7878; Muccioli, Giulio/0000-0002-1600-9259	National Institute on Drug Abuse [DA026430]; National Institutes of Health United States Public Health Service from NIGMS [2T32 GM007270]; Spanish Ministerio de Ciencia e Innovacion (MICINN); European Social Fund [SAF2010-22198-C02-01]; Ramon y Cajal Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026430] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health United States Public Health Service from NIGMS; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Social Fund(European Social Fund (ESF)); Ramon y Cajal Program(Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute on Drug Abuse Grant DA026430 (to N. S.) and National Institutes of Health United States Public Health Service National Research Service Award 2T32 GM007270 from NIGMS (to W. R. M.). This work was also supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN), European Social Fund Grant SAF2010-22198-C02-01 (to M. L. L.-R.), and the Ramon y Cajal Program (to S. O.-G.).	Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Cisneros JA, 2007, J MED CHEM, V50, P5012, DOI 10.1021/jm070642y; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Gulyas AI, 2004, EUR J NEUROSCI, V20, P441, DOI 10.1111/j.1460-9568.2004.03428.x; Horne EA, 2008, FUTURE LIPIDOL, V3, P435, DOI 10.2217/17460875.3.4.435; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; King AR, 2009, BRIT J PHARMACOL, V157, P974, DOI 10.1111/j.1476-5381.2009.00276.x; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Lichtman AH, 2005, HANDB EXP PHARMACOL, V168, P691; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marrs W, 2007, CHEM BIOL, V14, P1309, DOI 10.1016/j.chembiol.2007.12.004; Marrs W, 2009, AAPS J, V11, P307, DOI 10.1208/s12248-009-9109-0; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Stella N, 2001, EUR J PHARMACOL, V425, P189, DOI 10.1016/S0014-2999(01)01182-7; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; STELLA N, 1995, J NEUROSCI, V15, P3307; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437	26	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28723	28728		10.1074/jbc.M110.202853	http://dx.doi.org/10.1074/jbc.M110.202853			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21665953	hybrid, Green Published			2022-12-25	WOS:000293837000010
J	Guo, AJY; Choi, RCY; Cheung, AWH; Chen, VP; Xu, SL; Dong, TTX; Chen, JJ; Tsim, KWK				Guo, Ava J. Y.; Choi, Roy C. Y.; Cheung, Anna W. H.; Chen, Vicky P.; Xu, Sherry L.; Dong, Tina T. X.; Chen, Ji J.; Tsim, Karl W. K.			Baicalin, a Flavone, Induces the Differentiation of Cultured Osteoblasts AN ACTION VIA THE Wnt/beta-CATENIN SIGNALING PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-REPLACEMENT THERAPY; BONE LOSS; POSTMENOPAUSAL OSTEOPOROSIS; SCUTELLARIA-BAICALENSIS; HEME OXYGENASE-1; GENE-EXPRESSION; PROTEIN; OSTEOPROTEGERIN; GENISTEIN; CELLS	Flavonoids, a group of natural compounds found in a variety of vegetables and herbal medicines, have been intensively reported on regarding their estrogen-like activities and particularly their ability to affect bone metabolism. Here, different subclasses of flavonoids were screened for their osteogenic properties by measuring alkaline phosphatase activity in cultured rat osteoblasts. The flavone baicalin derived mainly from the roots of Scutellaria baicalensis showed the strongest induction of alkaline phosphatase activity. In cultured osteoblasts, application of baicalin increased significantly the osteoblastic mineralization and the levels of mRNAs encoding the bone differentiation markers, including osteonectin, osteocalcin, and collagen type 1 alpha 1. Interestingly, the osteogenic effect of baicalin was not mediated by its estrogenic activity. In contrast, baicalin promoted osteoblastic differentiation via the activation of the Wnt/beta-catenin signaling pathway; the activation resulted in the phosphorylation of glycogen synthase kinase 3 beta and, subsequently, induced the nuclear accumulation of the beta-catenin, leading to the transcription activation of Wnt-targeted genes for osteogenesis. The baicalin-induced osteogenic effects were fully abolished by DKK-1, a blocker of Wnt/beta-catenin receptor. Moreover, baicalin also enhanced the mRNA expression of osteoprotegerin, which could regulate indirectly the activation of osteoclasts. Taken together, our results suggested that baicalin could act via Wnt/beta-catenin signaling to promote osteoblastic differentiation. The osteogenic flavonoids could be very useful in finding potential drugs, or food supplements, for treating post-menopausal osteoporosis.	[Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Chen, Ji J.] Chinese Acad Sci, State Key Lab Phytochem & Plant Resources W China, Kunming Inst Bot, Kunming 650204, Yunnan, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay Rd, Hong Kong, Hong Kong, Peoples R China.	BOTSIM@UST.HK	CHEN, VICKY/C-9223-2016; chen, JJ/HGB-6029-2022	CHEN, VICKY/0000-0003-3753-7170; 	Research Grants Council of Hong Kong HKUST [6419/06M, 662608, N-HKUST629/07]; Croucher Foundation [CAS-CF07/08.SC03]	Research Grants Council of Hong Kong HKUST(Hong Kong Research Grants Council); Croucher Foundation	This work was supported by Research Grants Council of Hong Kong HKUST 6419/06M, 662608, and N-HKUST629/07 and The Croucher Foundation Grant CAS-CF07/08.SC03 (to K. W. K. T.).	Akao T, 2000, J PHARM PHARMACOL, V52, P1563, DOI 10.1211/0022357001777621; Arjmandi BH, 1998, AM J CLIN NUTR, V68, p1358S, DOI 10.1093/ajcn/68.6.1358S; Arjmandi BH, 1996, J NUTR, V126, P161, DOI 10.1093/jn/126.1.161; Berg AO, 2003, AM J NURS, V103, P83; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi RCY, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen085; Choi RCY, 2010, J ALZHEIMERS DIS, V19, P795, DOI 10.3233/JAD-2010-1293; Chow JM, 2005, BIOCHEM PHARMACOL, V69, P1839, DOI 10.1016/j.bcp.2005.03.017; DIDDLE AW, 1984, SOUTH MED J, V77, P868, DOI 10.1097/00007611-198407000-00020; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Gao YH, 1999, BIOCHEM PHARMACOL, V58, P767, DOI 10.1016/S0006-2952(99)00162-8; Glazier MG, 2001, ARCH INTERN MED, V161, P1161, DOI 10.1001/archinte.161.9.1161; Heino TJ, 2008, J ENDOCRINOL, V197, pR1, DOI 10.1677/JOE-07-0629; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382; Horcajada-Molteni MN, 2000, J BONE MINER RES, V15, P2251, DOI 10.1359/jbmr.2000.15.11.2251; Kim HM, 1999, TOXICOLOGY, V135, P109, DOI 10.1016/S0300-483X(99)00047-5; Lin HY, 2005, J CELL PHYSIOL, V202, P579, DOI 10.1002/jcp.20160; Morabito N, 2002, J BONE MINER RES, V17, P1904, DOI 10.1359/jbmr.2002.17.10.1904; MOSCARINI M, 1994, GYNECOL ENDOCRINOL, V8, P203, DOI 10.3109/09513599409072456; Murkies AL, 1998, J CLIN ENDOCR METAB, V83, P297, DOI 10.1210/jc.83.2.297; Orriss IR, 2006, BONE, V39, P300, DOI 10.1016/j.bone.2006.02.063; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763; RIZZOLI R, 1997, LANCET S1, V49, pS20; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; SEEMAN E, 1992, J BONE MINER RES, V7, P1467; Shang YZ, 2006, BIOL PHARM BULL, V29, P805, DOI 10.1248/bpb.29.805; Shen YC, 2003, EUR J PHARMACOL, V465, P171, DOI 10.1016/S0014-2999(03)01378-5; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Song Yuan-zong, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P339; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Walle T, 2005, J NUTR, V135, P48, DOI 10.1093/jn/135.1.48; Windahl SH, 2002, TRENDS ENDOCRIN MET, V13, P195, DOI 10.1016/S1043-2760(02)00594-5; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wu JB, 2008, EUR J PHARMACOL, V588, P333, DOI 10.1016/j.ejphar.2008.04.030; Yamaguchi M, 1998, BIOCHEM PHARMACOL, V55, P71, DOI 10.1016/S0006-2952(97)00402-4; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zheng YZ, 2010, PLANTA MED, V76, P439, DOI 10.1055/s-0029-1186222; Zhu JTT, 2007, J AGR FOOD CHEM, V55, P2438, DOI 10.1021/jf063299z	40	95	99	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27882	27893		10.1074/jbc.M111.236281	http://dx.doi.org/10.1074/jbc.M111.236281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21652696	hybrid, Green Published			2022-12-25	WOS:000293557800007
J	Jefferson, T; Causevic, M; Keller, UAD; Schilling, O; Isbert, S; Geyer, R; Maier, W; Tschickardt, S; Jumpertz, T; Weggen, S; Bond, JS; Overall, CM; Pietrzik, CU; Becker-Pauly, C				Jefferson, Tamara; Causevic, Mirsada; Keller, Ulrich Auf Dem; Schilling, Oliver; Isbert, Simone; Geyer, Rebecca; Maier, Wladislaw; Tschickardt, Sabrina; Jumpertz, Thorsten; Weggen, Sascha; Bond, Judith S.; Overall, Christopher M.; Pietrzik, Claus U.; Becker-Pauly, Christoph			Metalloprotease Meprin beta Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; ALPHA-SUBUNIT; CLEAVAGE; BINDING; HIPPOCAMPAL; ACTIVATION; EXPRESSION; SECRETASE; DOMAIN; SITE	Identification of physiologically relevant substrates is still the most challenging part in protease research for understanding the biological activity of these enzymes. The zinc-dependent metalloprotease meprin beta is known to be expressed in many tissues with functions in health and disease. Here, we demonstrate unique interactions between meprin beta and the amyloid precursor protein (APP). Although APP is intensively studied as a ubiquitously expressed cell surface protein, which is involved in Alzheimer disease, its precise physiological role and relevance remain elusive. Based on a novel proteomics technique termed terminal amine isotopic labeling of substrates (TAILS), APP was identified as a substrate for meprin beta. Processing of APP by meprin beta was subsequently validated using in vitro and in vivo approaches. N-terminal APP fragments of about 11 and 20 kDa were found in human and mouse brain lysates but not in meprin beta(-/-)mouse brain lysates. Although these APP fragments were in the range of those responsible for caspase-induced neurodegeneration, we did not detect cytotoxicity to primary neurons treated by these fragments. Our data demonstrate that meprin beta is a physiologically relevant enzyme in APP processing.	[Causevic, Mirsada; Isbert, Simone; Maier, Wladislaw; Tschickardt, Sabrina; Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55128 Mainz, Germany; [Keller, Ulrich Auf Dem] ETH Honggerberg, Swiss Fed Inst Technol Zurich, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Schilling, Oliver] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Jumpertz, Thorsten; Weggen, Sascha] Univ Dusseldorf, Dept Neuropathol, D-40225 Dusseldorf, Germany; [Bond, Judith S.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z3, Canada	Johannes Gutenberg University of Mainz; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Freiburg; Heinrich Heine University Dusseldorf; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of British Columbia	Pietrzik, CU (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, D-55128 Mainz, Germany.	pietrzik@uni-mainz.de; beckerpa@uni-mainz.de	Keller, Ulrich auf dem/G-6004-2012; Keller, Ulrich auf dem/X-2710-2019; Causevic, Mirsada/AAM-7423-2020; Schilling, O/AAC-8302-2019; Becker-Pauly, Christoph/B-7569-2011	Keller, Ulrich auf dem/0000-0002-3431-7415; Keller, Ulrich auf dem/0000-0002-3431-7415; Causevic, Mirsada/0000-0002-6099-6415; Schilling, Oliver/0000-0001-7678-7653	Deutsche Forschungsgemeinschaft [DFG BE 4086/1-2, DFG PI 379/5-1, SCHI871/2-1]; Competence Network Degenerative Dementias of the German Federal Ministry of Education [01GI1004D, 01GI1004B]; Johannes Gutenberg-University Mainz, Germany; National Institutes of Health, NIDDK [DK 54625, DK 19691]; European Community [200931]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019691, R56DK019691, R01DK054625, R37DK019691] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Competence Network Degenerative Dementias of the German Federal Ministry of Education; Johannes Gutenberg-University Mainz, Germany; National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); European Community(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Deutsche Forschungsgemeinschaft Grants DFG BE 4086/1-2 (to C. B.-P.), DFG PI 379/5-1 (to C. U. P.), and SCHI871/2-1 (to O.S.), by the Competence Network Degenerative Dementias of the German Federal Ministry of Education Grants 01GI1004D (to C. U. P.) and 01GI1004B (to S. W.), and a start-up grant of the Johannes Gutenberg-University Mainz, Germany (to C. B.-P.). The meprin beta<SUP>-/-</SUP> mice were generated with support from National Institutes of Health Grants DK 54625 and DK 19691 from NIDDK (to J. S. B.). The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7) under Grant 200931 (Project IBDase).	Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; De Strooper B, 2000, J CELL SCI, V113, P1857; DELVAUX A, 1992, FEBS LETT, V297, P124, DOI 10.1016/0014-5793(92)80341-D; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Ho A, 2004, P NATL ACAD SCI USA, V101, P2548, DOI 10.1073/pnas.0308655100; Hoareau C, 2008, NEUROBIOL AGING, V29, P542, DOI 10.1016/j.neurobiolaging.2006.11.012; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Keller UAD, 2010, BIOCHIMIE, V92, P1705, DOI 10.1016/j.biochi.2010.04.027; Keller UAD, 2010, MOL CELL PROTEOMICS, V9, P912, DOI 10.1074/mcp.M000032-MCP201; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kusumoto M, 1996, J NEUROCHEM, V67, P1613; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; Multhaup G, 1996, SCIENCE, V271, P1406, DOI 10.1126/science.271.5254.1406; Multhaup G, 1998, BIOCHEMISTRY-US, V37, P7224, DOI 10.1021/bi980022m; Nday CM, 2010, BRAIN RES, V1352, P265, DOI 10.1016/j.brainres.2010.07.008; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Ohsawa I, 2001, J NEUROCHEM, V76, P1411, DOI 10.1046/j.1471-4159.2001.00144.x; Oneda B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002278; PETERSEN LC, 1993, EUR J BIOCHEM, V214, P271, DOI 10.1111/j.1432-1033.1993.tb17921.x; PORTELIUS E, 1996, NEUROBIOL AGING, V67, P1613; Portelius E, 2009, NEURODEGENER DIS, V6, P87, DOI 10.1159/000203774; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; SAMBROOK J, 1989, NATURE, V342, P224, DOI 10.1038/342224a0; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schutte A, 2007, BIOL CHEM, V388, P523, DOI 10.1515/BC.2007.060; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Sinha S, 2002, MED CLIN N AM, V86, P629, DOI 10.1016/S0025-7125(02)00022-6; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SMALL DH, 1994, J NEUROSCI, V14, P2117; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; White AR, 1999, J NEUROSCI, V19, P9170; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008; Zhang HD, 2009, NEUROBIOL AGING, V30, P1245, DOI 10.1016/j.neurobiolaging.2007.11.013	61	76	79	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27741	27750		10.1074/jbc.M111.252718	http://dx.doi.org/10.1074/jbc.M111.252718			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646356	hybrid, Green Published			2022-12-25	WOS:000293268700066
J	Takematsu, H; Yamamoto, H; Naito-Matsui, Y; Fujinawa, R; Tanaka, K; Okuno, Y; Tanaka, Y; Kyogashima, M; Kannagi, R; Kozutsumi, Y				Takematsu, Hiromu; Yamamoto, Harumi; Naito-Matsui, Yuko; Fujinawa, Reiko; Tanaka, Kouji; Okuno, Yasushi; Tanaka, Yoshimasa; Kyogashima, Mamoru; Kannagi, Reiji; Kozutsumi, Yasunori			Quantitative Transcriptomic Profiling of Branching in a Glycosphingolipid Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI-APPARATUS; GLYCOLIPID SYNTHESIS; MOLECULAR-CLONING; CYTOPLASMIC TAIL; UDP-GLCNAC; RAT-BRAIN; SYNTHASE; CELLS; LACTOSYLCERAMIDE; EXPRESSION	Cellular biosynthesis of macromolecules often involves highly branched enzyme pathways, thus cellular regulation of such pathways could be rather difficult. To understand the regulatory mechanism, a systematic approach could be useful. We genetically analyzed a branched biosynthetic pathway for glycosphingolipid (GSL) GM1 using correlation index-based responsible enzyme gene screening (CIRES), a novel quantitative phenotype-genotype correlation analysis. CIRES utilizes transcriptomic profiles obtained from multiple cells. Among a panel of B cell lines, expression of GM1 was negatively correlated with and suppressed by gene expression of CD77 synthase (CD77Syn), whereas no significant positive correlation was found for enzymes actually biosynthesizing GM1. Unexpectedly, a GM1-suppressive phenotype was also observed in the expression of catalytically inactive CD77Syn, ruling out catalytic consumption of lactosylceramide (LacCer) as the main cause for such negative regulation. Rather, CD77Syn seemed to limit other branching reaction(s) by targeting LacCer synthase (LacCer-Syn), a proximal enzyme in the pathway, because they were closely localized in the Golgi apparatus and formed a complex. Moreover, turnover of LacCerSyn was accelerated upon CD77Syn expression to globally change the GSL species expressed. Collectively, these data suggest that transcriptomic assessment of macromolecule biosynthetic pathways can disclose a global regulatory mechanism(s) even when unexpected.	[Takematsu, Hiromu; Yamamoto, Harumi; Naito-Matsui, Yuko; Kozutsumi, Yasunori] Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto 6068501, Japan; [Okuno, Yasushi] Kyoto Univ, Dept Syst Biosci Drug Discovery, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Tanaka, Yoshimasa] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Yamamoto, Harumi; Fujinawa, Reiko; Kozutsumi, Yasunori] RIKEN, RIKEN Frontier Res Syst, Supra Macromol Syst Res Grp, Wako, Saitama 3510198, Japan; [Tanaka, Kouji; Kyogashima, Mamoru; Kannagi, Reiji] Aichi Canc Ctr, Div Mol Pathol, Aichi 4648681, Japan; [Tanaka, Kouji; Kyogashima, Mamoru] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Oncol, Aichi 4648681, Japan	Kyoto University; Kyoto University; Kyoto University; RIKEN; Aichi Cancer Center; Nagoya City University	Takematsu, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Membrane Biochem & Biophys, Sakyo Ku, Kyoto 6068501, Japan.	htakema@pharm.kyoto-u.ac.jp	Kannagi, Reiji/Q-6459-2018	Kannagi, Reiji/0000-0003-4202-2921; Tanaka, Yoshimasa/0000-0002-5024-0614	Takeda Science Foundation; Mizutani Foundation of Glycoscience; Ministry of Science and Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research [21590063] Funding Source: KAKEN	Takeda Science Foundation(Takeda Science Foundation (TSF)); Mizutani Foundation of Glycoscience; Ministry of Science and Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Takeda Science Foundation, Mizutani Foundation of Glycoscience, and a Grant-in-aid for Scientific Research from the Ministry of Science and Culture, Sports and Technology of Japan.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Allende ML, 2000, GLYCOBIOLOGY, V10, P1025, DOI 10.1093/glycob/10.10.1025; Anastasia L, 2008, BBA-GEN SUBJECTS, V1780, P504, DOI 10.1016/j.bbagen.2007.11.011; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Breton C, 1998, J BIOCHEM, V123, P1000; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; CONNELL TD, 1995, MOL MICROBIOL, V16, P21, DOI 10.1111/j.1365-2958.1995.tb02388.x; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; FISHMAN PH, 1978, BIOCHEMISTRY-US, V17, P711, DOI 10.1021/bi00597a024; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Giraudo CG, 2001, P NATL ACAD SCI USA, V98, P1625, DOI 10.1073/pnas.031458398; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Ichikawa S, 1998, TRENDS CELL BIOL, V8, P198, DOI 10.1016/S0962-8924(98)01249-5; Ishii A, 1998, J BIOL CHEM, V273, P31652, DOI 10.1074/jbc.273.48.31652; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; KANNAGI R, 1983, P NATL ACAD SCI-BIOL, V80, P2844, DOI 10.1073/pnas.80.10.2844; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kumagai T, 2010, GLYCOCONJUGATE J, V27, P685, DOI 10.1007/s10719-010-9313-2; Kumagai T, 2009, BIOCHEM BIOPH RES CO, V379, P456, DOI 10.1016/j.bbrc.2008.12.078; Kyogashima M, 2006, GLYCOBIOLOGY, V16, P719, DOI 10.1093/glycob/cwj122; Lala P, 2000, J BIOL CHEM, V275, P6246, DOI 10.1074/jbc.275.9.6246; Lannert H, 1998, J BIOL CHEM, V273, P2939, DOI 10.1074/jbc.273.5.2939; Levine TP, 2007, J CELL BIOL, V179, P11, DOI 10.1083/jcb.200709055; Li JG, 2001, GLYCOBIOLOGY, V11, P217, DOI 10.1093/glycob/11.3.217; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; NAKAMURA M, 1992, J BIOL CHEM, V267, P23507; Nomura T, 1998, J BIOL CHEM, V273, P13570, DOI 10.1074/jbc.273.22.13570; PREUSS U, 1993, J BIOL CHEM, V268, P26273; Quintero CA, 2008, BIOCHEM J, V412, P19, DOI 10.1042/BJ20071725; ROSEMAN S, 1970, CHEM PHYS LIPIDS, V5, P270, DOI 10.1016/0009-3084(70)90024-1; Roseman S, 2001, J BIOL CHEM, V276, P41527, DOI 10.1074/jbc.R100053200; Schachter H, 2000, GLYCOCONJUGATE J, V17, P465; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHWARTZALBIEZ R, 1990, INT IMMUNOL, V2, P929, DOI 10.1093/intimm/2.10.929; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; Togayachi A, 2001, J BIOL CHEM, V276, P22032, DOI 10.1074/jbc.M011369200; Uemura S, 2009, MOL BIOL CELL, V20, P3088, DOI 10.1091/mbc.E08-12-1219; Uliana AS, 2006, J BIOL CHEM, V281, P32852, DOI 10.1074/jbc.M605805200; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; VARKI A, 2009, ESSENTIALS GLYCOBIOL, pCH3; Weiss M, 2000, FEBS LETT, V486, P2, DOI 10.1016/S0014-5793(00)02155-4; Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x; Wendland B, 1998, CURR OPIN CELL BIOL, V10, P513, DOI 10.1016/S0955-0674(98)80067-7; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yamamoto H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001232; Young WW, 2004, J MEMBRANE BIOL, V198, P1, DOI 10.1007/s00232-004-0656-5	54	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27214	27224		10.1074/jbc.M111.234526	http://dx.doi.org/10.1074/jbc.M111.234526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21665948	hybrid, Green Published			2022-12-25	WOS:000293268700017
J	Jiang, Y; Miao, ZH; Xu, L; Yu, B; Gong, JX; Tong, LJ; Chen, Y; Zhou, ZL; Liu, HC; Wang, Y; Guo, YW; Ding, J				Jiang, Yi; Miao, Ze-Hong; Xu, Lei; Yu, Bing; Gong, Jing-Xu; Tong, Lin-Jiang; Chen, Yi; Zhou, Zhao-Li; Liu, Hong-Chun; Wang, Yi; Guo, Yue-Wei; Ding, Jian			Drug Transporter-independent Liver Cancer Cell Killing by a Marine Steroid Methyl Spongoate via Apoptosis Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; TOPOISOMERASE-II; DOWN-REGULATION; MULTIDRUG-RESISTANCE; MEDIATED APOPTOSIS; PROSTATE-CANCER; BREAST-CANCER; TUMOR-CELLS; SALVICINE; STAT3	Hepatocellular carcinoma (HCC) is inherently resistant to the majority of clinical anticancer drugs. To obtain drugs that can circumvent or evade such inherent drug resistance of HCC, we investigated the effect of the marinely derived steroid methyl spongoate (MESP) on HCC cells. MESP displayed potent cell killing against a panel of six HCC cell lines, independent of their expression of drug transporters. MESP did not change the function of the drug transporters, and its cell killing was not impaired in multidrug-resistant cancer cells overexpressing the transporters. The cell killing of MESP was irrelevant to estrogen or androgen signaling and was not associated with cell cycle progression, inhibition of microtubules, and topoisomerases. In contrast, MESP potently induced apoptosis via activation of a proapoptotic caspase cascade and relief of the suppression of antiapoptotic signal transducers and activators of transcription 3 (STAT3) signaling. MESP inhibited the phosphorylation of STAT3, a critical survival signaling factor that reduced the expression of the antiapoptotic protein x-linked inhibitor of apoptosis protein but enhanced the expression of the proapoptotic protein Bax, thus promoting caspase-dependent apoptosis. These data reveal that MESP may well serve as an important candidate drug lead for HCC therapy.	[Jiang, Yi; Miao, Ze-Hong; Xu, Lei; Yu, Bing; Gong, Jing-Xu; Tong, Lin-Jiang; Chen, Yi; Zhou, Zhao-Li; Liu, Hong-Chun; Wang, Yi; Guo, Yue-Wei; Ding, Jian] Chinese Acad Sci, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Miao, ZH (corresponding author), Chinese Acad Sci, Div Antitumor Pharmacol, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	zhmiao@mail.shcnc.ac.cn; jding@mail.shcnc.ac.cn			National Natural Science Foundation of China [81025020, 81021062, 21072204, 30730108]; National Basic Research Program of China [2010CB934000]; Chinese Academy of Sciences [KSCX1-YW-22, SIMM0907KF-09]; Science and Technology Commission of Shanghai Municipality [09540704100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by National Natural Science Foundation of China Grants 81025020, 81021062, 21072204 and 30730108); National Basic Research Program of China Grant 2010CB934000; Major Program of Knowledge Innovation of the Chinese Academy of Sciences Grant KSCX1-YW-22; Science and Technology Commission of Shanghai Municipality Grant 09540704100; and Chinese Academy of Sciences, Key Project Grant SIMM0907KF-09.	Abraham I, 2010, BIOCHEM PHARMACOL, V80, P1497, DOI 10.1016/j.bcp.2010.08.001; Barthomeuf C, 2008, ANTI-CANCER AGENT ME, V8, P886, DOI 10.2174/187152008786847729; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cai Y, 2007, CANCER BIOL THER, V6, P1794, DOI 10.4161/cbt.6.11.4860; Fletcher S, 2009, BIOCHEM CELL BIOL, V87, P825, DOI [10.1139/O09-044, 10.1139/o09-044]; Gimenez-Bonafe P, 2009, CURR CANCER DRUG TAR, V9, P320, DOI 10.2174/156800909788166600; Gong JX, 2010, SYNLETT, P480, DOI 10.1055/s-0029-1218567; Grutter MG, 2000, CURR OPIN STRUC BIOL, V10, P649, DOI 10.1016/S0959-440X(00)00146-9; He X, 2008, CANCER RES, V68, P8678, DOI 10.1158/0008-5472.CAN-08-0294; Isaacs JT, 2010, EXPERT OPIN INV DRUG, V19, P1235, DOI 10.1517/13543784.2010.514262; Jiang CS, 2010, STEROIDS, V75, P1153, DOI 10.1016/j.steroids.2010.08.002; Kanzaki A, 2002, MOL CANCER THER, V1, P1327; Kusaba M, 2007, J HEPATOL, V47, P546, DOI 10.1016/j.jhep.2007.04.017; LaPensee EW, 2010, ENDOCR-RELAT CANCER, V17, pR91, DOI 10.1677/ERC-09-0253; Lee TKW, 2009, LIVER INT, V29, P955, DOI 10.1111/j.1478-3231.2009.02040.x; Liu Y, 2011, APOPTOSIS, V16, P502, DOI 10.1007/s10495-011-0578-0; Masuda M, 2010, CURR CANCER DRUG TAR, V10, P117, DOI 10.2174/156800910790980197; Meng LH, 2001, BIOCHEM PHARMACOL, V62, P733, DOI 10.1016/S0006-2952(01)00732-8; Miao ZH, 2004, INT J CANCER, V110, P627, DOI 10.1002/ijc.20026; Miao ZH, 2003, CANCER RES, V63, P4527; Miao ZH, 2003, INT J CANCER, V106, P108, DOI 10.1002/ijc.11174; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Msaouel P, 2007, EXPERT OPIN EMERG DR, V12, P285, DOI 10.1517/14728214.12.2.285; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Papatheodoridis GV, 2010, J HEPATOL, V53, P348, DOI 10.1016/j.jhep.2010.02.035; Peng J, 2009, ANTI-CANCER AGENT ME, V9, P481, DOI 10.2174/187152009788451833; Rajendran P, 2011, CLIN CANCER RES, V17, P1425, DOI 10.1158/1078-0432.CCR-10-1123; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Shukla S, 2011, CURR DRUG TARGETS, V12, P621, DOI 10.2174/138945011795378540; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; TANABE K, 1991, CANCER RES, V51, P4903; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Thomas M, 2009, J GASTROENTEROL, V44, P136, DOI 10.1007/s00535-008-2252-z; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Yan XH, 2007, BIOORG MED CHEM LETT, V17, P2661, DOI 10.1016/j.bmcl.2007.01.095; Yin J, 2011, ACTA PHARMACOL SIN, V32, P99, DOI 10.1038/aps.2010.185	39	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26461	26469		10.1074/jbc.M111.232728	http://dx.doi.org/10.1074/jbc.M111.232728			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659517	hybrid, Green Published			2022-12-25	WOS:000293078200024
J	Rojas, DA; Moreira-Ramos, S; Zock-Emmenthal, S; Urbina, F; Contreras-Levicoy, J; Kaufer, NF; Maldonado, E				Rojas, Diego A.; Moreira-Ramos, Sandra; Zock-Emmenthal, Susanne; Urbina, Fabiola; Contreras-Levicoy, Juan; Kaeufer, Norbert F.; Maldonado, Edio			Rrn7 Protein, an RNA Polymerase I Transcription Factor, Is Required for RNA Polymerase II-dependent Transcription Directed by Core Promoters with a HomolD Box Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; BASAL TRANSCRIPTION; INITIATION-FACTOR; DNA-BINDING; FACTOR SL1; MEDIATOR; ELEMENTS; RECRUITMENT; TBP	The region in promoters that specifies the transcription machinery is called the core promoter, displaying core promoter elements (CPE) necessary for establishment of a preinitiation complex and the initiation of transcription. A classical CPE is the TATA box. In fission yeast, Schizosaccharomyces pombe, a new CPE, called HomolD box, was discovered. Collectively, 141 ribosomal protein genes encoding the full set of 79 different ribosomal proteins and more than 60 other housekeeping genes display a HomolD box in the core promoter. Here, we show that transcription directed by the HomolD box requires the RNA polymerase II machinery, including the general transcription factors. Most intriguingly, however, we identify, by DNA affinity purification, Rrn7 as the protein binding to the HomolD box. Rrn7 is an evolutionary conserved member of the RNA polymerase I machinery involved in transcription initiation of core ribosomal DNA promoters. ChIP shows that Rrn7 cross-links to a ribosomal protein gene promoter containing the HomolD box but not to a promoter containing a TATA box. Taken together, our results suggest that Rrn7 is an excellent candidate to be involved in the coordination of ribosomal DNA and ribosomal gene transcription during ribosome synthesis and, therefore, offer a new perspective to study conservation and evolvability of regulatory networks in eukaryotes.	[Rojas, Diego A.; Moreira-Ramos, Sandra; Urbina, Fabiola; Contreras-Levicoy, Juan; Maldonado, Edio] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Biol Celular & Mol, Santiago 7, Chile; [Zock-Emmenthal, Susanne; Kaeufer, Norbert F.] Univ Braunschweig Tech Univ, Inst Genet, D-38106 Braunschweig, Germany	Universidad de Chile	Maldonado, E (corresponding author), Independencia 1027, Santiago 7, Chile.	emaldona@med.uchile.cl	Rojas, Diego/E-4369-2014; Rojas, Diego A./AAT-4173-2021	Rojas, Diego A./0000-0002-5388-1070				Boukhgalter B, 2002, GENE, V291, P187, DOI 10.1016/S0378-1119(02)00597-8; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; Contreras-Levicoy J, 2008, FEBS J, V275, P2873, DOI 10.1111/j.1742-4658.2008.06429.x; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FLORES O, 1989, J BIOL CHEM, V264, P8913; Gross T, 1998, NUCLEIC ACIDS RES, V26, P3319, DOI 10.1093/nar/26.14.3319; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hamada M, 2001, MOL CELL BIOL, V21, P6870, DOI 10.1128/MCB.21.20.6870-6881.2001; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; Nabavi S, 2008, CURR GENET, V54, P175, DOI 10.1007/s00294-008-0210-1; Newo ANS, 2007, NUCLEIC ACIDS RES, V35, P1391, DOI 10.1093/nar/gkl1144; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; Siddiqi I, 2001, MOL CELL BIOL, V21, P2292, DOI 10.1128/MCB.21.7.2292-2297.2001; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Tamayo E, 2004, EUR J BIOCHEM, V271, P2561, DOI 10.1111/j.1432-1033.2004.04187.x; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; Witt I, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P343; WITT I, 1993, EMBO J, V12, P1201, DOI 10.1002/j.1460-2075.1993.tb05761.x; WITT I, 1995, NUCLEIC ACIDS RES, V23, P4296, DOI 10.1093/nar/23.21.4296; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	34	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26480	26486		10.1074/jbc.M111.224337	http://dx.doi.org/10.1074/jbc.M111.224337			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21673110	hybrid, Green Published			2022-12-25	WOS:000293078200026
J	Schneider, UV; Geci, I; Johnk, N; Mikkelsen, ND; Pedersen, EB; Lisby, G				Schneider, Uffe V.; Geci, Imrich; Johnk, Nina; Mikkelsen, Nikolaj D.; Pedersen, Erik B.; Lisby, Gorm			Increasing the Analytical Sensitivity by Oligonucleotides Modified with Para- and Ortho-Twisted Intercalating Nucleic Acids - TINA	PLOS ONE			English	Article							THERMAL-STABILITY; DNA; TRIPLEXES; RESISTANT; ANALOGS; DESIGN; RNA	The sensitivity and specificity of clinical diagnostic assays using DNA hybridization techniques are limited by the dissociation of double-stranded DNA (dsDNA) antiparallel duplex helices. This situation can be improved by addition of DNA stabilizing molecules such as nucleic acid intercalators. Here, we report the synthesis of a novel ortho-Twisted Intercalating Nucleic Acid (TINA) amidite utilizing the phosphoramidite approach, and examine the stabilizing effect of ortho-and para-TINA molecules in antiparallel DNA duplex formation. In a thermal stability assay, ortho-and para-TINA molecules increased the melting point (Tm) of Watson-Crick based antiparallel DNA duplexes. The increase in Tm was greatest when the intercalators were placed at the 5' and 3' termini (preferable) or, if placed internally, for each half or whole helix turn. Terminally positioned TINA molecules improved analytical sensitivity in a DNA hybridization capture assay targeting the Escherichia coli rrs gene. The corresponding sequence from the Pseudomonas aeruginosa rrs gene was used as cross-reactivity control. At 150 mM ionic strength, analytical sensitivity was improved 27-fold by addition of ortho-TINA molecules and 7-fold by addition of para-TINA molecules (versus the unmodified DNA oligonucleotide), with a 4-fold increase retained at 1 M ionic strength. Both intercalators sustained the discrimination of mismatches in the dsDNA (indicated by Delta Tm), unless placed directly adjacent to the mismatch - in which case they partly concealed DTm (most pronounced for para-TINA molecules). We anticipate that the presented rules for placement of TINA molecules will be broadly applicable in hybridization capture assays and target amplification systems.	[Schneider, Uffe V.; Johnk, Nina; Mikkelsen, Nikolaj D.; Lisby, Gorm] QuantiBact Inc, Hvidovre, Denmark; [Geci, Imrich; Pedersen, Erik B.] Univ So Denmark, Nucle Acid Ctr, Odense, Denmark; [Geci, Imrich; Pedersen, Erik B.] Univ So Denmark, Dept Chem, Odense, Denmark	University of Southern Denmark; University of Southern Denmark	Schneider, UV (corresponding author), QuantiBact Inc, Hvidovre, Denmark.	uvs@quantibact.com	Schneider, Uffe Vest/GPT-3115-2022; Lisby, Gorm/GMX-0386-2022; Géci, Imrich/HHS-6507-2022; Pedersen, Erik B./M-4573-2017	Schneider, Uffe Vest/0000-0003-1372-7885; Géci, Imrich/0000-0003-0059-9693; Pedersen, Erik B./0000-0002-7917-2379	QuantiBact Inc.	QuantiBact Inc.	This work was funded by QuantiBact Inc. The authors UVS, NJ, NDM and GL are employed by QuantiBact Inc. The funder therefore had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina I, 1996, P NATL ACAD SCI USA, V93, P3199, DOI 10.1073/pnas.93.8.3199; Benner SA, 1998, PURE APPL CHEM, V70, P263, DOI 10.1351/pac199870020263; Christensen UB, 2004, NUCLEOS NUCLEOT NUCL, V23, P207, DOI 10.1081/NCN-120027829; Christensen UB, 2002, NUCLEIC ACIDS RES, V30, P4918, DOI 10.1093/nar/gkf624; Cogoi S, 2009, J MED CHEM, V52, P564, DOI 10.1021/jm800874t; EGHOLM M, 1992, J AM CHEM SOC, V114, P1895, DOI 10.1021/ja00031a062; Filichev VV, 2005, J AM CHEM SOC, V127, P14849, DOI 10.1021/ja053645d; Filichev Vyacheslav V, 2008, Nucleic Acids Symp Ser (Oxf), P347, DOI 10.1093/nass/nrn175; Filichev VV, 2008, CHEM-EUR J, V14, P9968, DOI 10.1002/chem.200800380; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Geci I, 2006, BIOCONJUGATE CHEM, V17, P950, DOI 10.1021/bc060058o; Hanley BP, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-31; Matray TJ, 1998, J AM CHEM SOC, V120, P6191, DOI 10.1021/ja9803310; Moreau V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp661; Morita K, 2002, BIOORG MED CHEM LETT, V12, P73, DOI 10.1016/S0960-894X(01)00683-7; Narayanan S, 2004, NUCLEIC ACIDS RES, V32, P2901, DOI 10.1093/nar/gkh600; Obika S, 1997, TETRAHEDRON LETT, V38, P8735, DOI 10.1016/S0040-4039(97)10322-7; Osman AMA, 2008, BIOORGAN MED CHEM, V16, P9937, DOI 10.1016/j.bmc.2008.10.037; Paramasivam M, 2008, NUCLEIC ACIDS RES, V36, P3494, DOI 10.1093/nar/gkn242; Schneider UV, 2010, NUCLEIC ACIDS RES, V38, P4394, DOI 10.1093/nar/gkq188; Schneider UV, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-4; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; STIRCHAK EP, 1989, NUCLEIC ACIDS RES, V17, P6129, DOI 10.1093/nar/17.15.6129	23	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20565	10.1371/journal.pone.0020565	http://dx.doi.org/10.1371/journal.pone.0020565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673988	Green Published, gold, Green Submitted			2022-12-25	WOS:000291355500024
J	Western, PS; Ralli, RA; Wakeling, SI; Lo, C; van den Bergen, JA; Miles, DC; Sinclair, AH				Western, Patrick S.; Ralli, Rachael A.; Wakeling, Stephanie I.; Lo, Camden; van den Bergen, Jocelyn A.; Miles, Denise C.; Sinclair, Andrew H.			Mitotic Arrest in Teratoma Susceptible Fetal Male Germ Cells	PLOS ONE			English	Article							TESTICULAR TERATOMAS; SEX DETERMINATION; SUPPRESSES MEIOSIS; MEIOTIC INITIATION; PLURIPOTENT CELLS; MOUSE EMBRYOS; MICE; DIFFERENTIATION; PROTEIN; EXPRESSION	Formation of germ cell derived teratomas occurs in mice of the 129/SvJ strain, but not in C57Bl/6 inbred or CD1 outbred mice. Despite this, there have been few comparative studies aimed at determining the similarities and differences between teratoma susceptible and non-susceptible mouse strains. This study examines the entry of fetal germ cells into the male pathway and mitotic arrest in 129T2/SvJ mice. We find that although the entry of fetal germ cells into mitotic arrest is similar between 129T2/SvJ, C57Bl/6 and CD1 mice, there were significant differences in the size and germ cell content of the testis cords in these strains. In 129T2/SvJ mice germ cell mitotic arrest involves upregulation of p27(KIP1), p15(INK4B), activation of RB, the expression of male germ cell differentiation markers NANOS2, DNMT3L and MILI and repression of the pluripotency network. The germ-line markers DPPA2 and DPPA4 show reciprocal repression and upregulation, respectively, while FGFR3 is substantially enriched in the nucleus of differentiating male germ cells. Further understanding of fetal male germ cell differentiation promises to provide insight into disorders of the testis and germ cell lineage, such as testis tumour formation and infertility.	[Western, Patrick S.; Wakeling, Stephanie I.; Miles, Denise C.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Ralli, Rachael A.] Peter MacCallum Canc Ctr, Canc Therapeut Program, Melbourne, Vic, Australia; [van den Bergen, Jocelyn A.; Sinclair, Andrew H.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Monash University; Peter Maccallum Cancer Center; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Western, PS (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia.	patrick.western@monash.edu	Sinclair, Andrew H/A-3598-2010	Sinclair, Andrew H/0000-0003-2741-7992; Western, Patrick/0000-0002-7587-8227	Australian Research Council Centre of Excellence in Biotechnology and Development; Monash Institute of Medical Research	Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council); Monash Institute of Medical Research	This work was supported by the Australian Research Council Centre of Excellence in Biotechnology and Development funds granted to AS and Monash Institute of Medical Research funds granted to PW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Cook MS, 2011, DEVELOPMENT, V138, P23, DOI 10.1242/dev.057000; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; DiNapoli L, 2006, DEVELOPMENT, V133, P1519, DOI 10.1242/dev.02303; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; John T, 2008, CLIN CANCER RES, V14, P3291, DOI 10.1158/1078-0432.CCR-07-1322; KAUFMAN MH, 2003, ATLAS MOUSE DEV; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Kumar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1136; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Masaki H, 2007, J BIOL CHEM, V282, P33034, DOI 10.1074/jbc.M703245200; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; NOGUCHI T, 1982, J NATL CANCER I, V69, P907; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Shovlin TC, 2007, HUM REPROD, V22, P457, DOI 10.1093/humrep/del379; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Spiller CM, 2010, BIOL REPROD, V82, P433, DOI 10.1095/biolreprod.109.078691; STEVENS LC, 1954, P NATL ACAD SCI USA, V40, P1080, DOI 10.1073/pnas.40.11.1080; STEVENS LC, 1964, P NATL ACAD SCI USA, V52, P654, DOI 10.1073/pnas.52.3.654; STEVENS LC, 1966, J NATL CANCER I, V37, P859; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Western P, 2009, INT J DEV BIOL, V53, P393, DOI 10.1387/ijdb.082671pw; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Western PS, 2010, FASEB J, V24, P3026, DOI 10.1096/fj.09-151555; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	45	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20736	10.1371/journal.pone.0020736	http://dx.doi.org/10.1371/journal.pone.0020736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674058	Green Published, gold, Green Submitted			2022-12-25	WOS:000291310600028
J	Bilgmann, K; Moller, LM; Harcourt, RG; Kemper, CM; Beheregaray, LB				Bilgmann, Kerstin; Moeller, Luciana M.; Harcourt, Robert G.; Kemper, Catherine M.; Beheregaray, Luciano B.			The Use of Carcasses for the Analysis of Cetacean Population Genetic Structure: A Comparative Study in Two Dolphin Species	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MITOCHONDRIAL-DNA; TURSIOPS-TRUNCATUS; BIOPSY SYSTEM; LAGENORHYNCHUS-OBSCURUS; SOUTHEASTERN AUSTRALIA; COMPUTER-PROGRAM; SOUTH-AUSTRALIA; KILLER WHALES; ORCINUS-ORCA	Advances in molecular techniques have enabled the study of genetic diversity and population structure in many different contexts. Studies that assess the genetic structure of cetacean populations often use biopsy samples from free-ranging individuals and tissue samples from stranded animals or individuals that became entangled in fishery or aquaculture equipment. This leads to the question of how representative the location of a stranded or entangled animal is with respect to its natural range, and whether similar results would be obtained when comparing carcass samples with samples from free-ranging individuals in studies of population structure. Here we use tissue samples from carcasses of dolphins that stranded or died as a result of bycatch in South Australia to investigate spatial population structure in two species: coastal bottlenose (Tursiops sp.) and short-beaked common dolphins (Delphinus delphis). We compare these results with those previously obtained from biopsy sampled free-ranging dolphins in the same area to test whether carcass samples yield similar patterns of genetic variability and population structure. Data from dolphin carcasses were gathered using seven microsatellite markers and a fragment of the mitochondrial DNA control region. Analyses based on carcass samples alone failed to detect genetic structure in Tursiops sp., a species previously shown to exhibit restricted dispersal and moderate genetic differentiation across a small spatial scale in this region. However, genetic structure was correctly inferred in D. delphis, a species previously shown to have reduced genetic structure over a similar geographic area. We propose that in the absence of corroborating data, and when population structure is assessed over relatively small spatial scales, the sole use of carcasses may lead to an underestimate of genetic differentiation. This can lead to a failure in identifying management units for conservation. Therefore, this risk should be carefully assessed when planning population genetic studies of cetaceans.	[Bilgmann, Kerstin; Moeller, Luciana M.; Beheregaray, Luciano B.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Bilgmann, Kerstin; Moeller, Luciana M.; Beheregaray, Luciano B.] Macquarie Univ, Dept Biol Sci, Mol Ecol Lab, Sydney, NSW 2109, Australia; [Bilgmann, Kerstin; Moeller, Luciana M.; Harcourt, Robert G.] Macquarie Univ, Grad Sch Environm, Marine Mammal Res Grp, Sydney, NSW 2109, Australia; [Kemper, Catherine M.] S Australian Museum, Adelaide, SA 5000, Australia	Flinders University South Australia; Macquarie University; Macquarie University	Bilgmann, K (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	kerstin.bilgmann@mq.edu.au	Beheregaray, Luciano B/A-8621-2008; Beheregaray, Luciano/AAY-6384-2021	Beheregaray, Luciano B/0000-0003-0944-3003; Beheregaray, Luciano/0000-0003-0944-3003; Bilgmann, Kerstin/0000-0003-0681-2301; Moller, Luciana/0000-0002-7293-5847; Harcourt, Robert/0000-0003-4666-2934	Macquarie University; Graduate School of Environment and the Linnean Society of New South Wales; international Macquarie University	Macquarie University; Graduate School of Environment and the Linnean Society of New South Wales; international Macquarie University	The project was funded by Macquarie University, the Graduate School of Environment and the Linnean Society of New South Wales. K.B. was supported by an international Macquarie University Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; BarrettLennard LG, 1996, MAR MAMMAL SCI, V12, P14, DOI 10.1111/j.1748-7692.1996.tb00302.x; Bilgmann K, 2008, ANIM CONSERV, V11, P518, DOI 10.1111/j.1469-1795.2008.00213.x; Bilgmann K, 2007, MAR ECOL PROG SER, V341, P265, DOI 10.3354/meps341265; Bilgmann K, 2007, MAR MAMMAL SCI, V23, P218, DOI 10.1111/j.1748-7692.2006.00099.x; Cassens I, 2005, MOL ECOL, V14, P107, DOI 10.1111/j.1365-294X.2004.02407.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COCKCROFT VG, 1990, S AFR J MARINE SCI, V9, P1; Dalebout ML, 2005, MOL ECOL, V14, P3353, DOI 10.1111/j.1365-294X.2005.02676.x; Di Guardo G, 2005, J VET MED A, V52, P88, DOI 10.1111/j.1439-0442.2005.00693.x; Domingo Mariano, 2001, P425; Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x; Evans Karen, 2003, P400; Frankham R., 2002, INTRO CONSERVATION G; Geraci JR., 2005, MARINE MAMMALS ASHOR; Gilson A, 1998, CALIF FISH GAME, V84, P159; GIMENEZ J, 2011, VET REC, V168, P101, DOI DOI 10.1136/VR.C5284; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hamer DJ, 2008, BIOL CONSERV, V141, P2865, DOI 10.1016/j.biocon.2008.08.024; Harlin AD, 1999, MAR MAMMAL SCI, V15, P409, DOI 10.1111/j.1748-7692.1999.tb00810.x; Hoelzel AR, 1992, MOL ECOL, V1, P119, DOI 10.1111/j.1365-294X.1992.tb00163.x; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, J HERED, V89, P121, DOI 10.1093/jhered/89.2.121; HOELZEL AR, 1994, ANNU REV ECOL SYST, V25, P377; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kemper C., 2003, MARINE MAMMALS FISHE; Kemper C. M., 2005, Australian Mammalogy, V27, P37; Kemper C. M., 2001, Journal of Cetacean Research and Management, V3, P283; Kingston SE, 2004, J HERED, V95, P1, DOI 10.1093/jhered/esh010; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; Lavery TJ, 2008, SCI TOTAL ENVIRON, V390, P77, DOI 10.1016/j.scitotenv.2007.09.016; Lazaro M, 2004, MAR MAMMAL SCI, V20, P201, DOI 10.1111/j.1748-7692.2004.tb01151.x; Moeller LM, 2008, MOL PHYLOGENET EVOL, V49, P674, DOI 10.1016/j.ympev.2008.08.011; Moller LM, 2001, MAR MAMMAL SCI, V17, P249, DOI 10.1111/j.1748-7692.2001.tb01269.x; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Natoli A, 2005, P ROY SOC B-BIOL SCI, V272, P1217, DOI 10.1098/rspb.2005.3076; Natoli A, 2006, J EVOLUTION BIOL, V19, P943, DOI 10.1111/j.1420-9101.2005.01033.x; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; OPORTO JA, 1990, REUN ESP MAM AQ AM V; Parsons KM, 2002, BIOL CONSERV, V108, P175, DOI 10.1016/S0006-3207(02)00103-9; Parsons KM, 1999, MOL ECOL, V8, P1766, DOI 10.1046/j.1365-294x.1999.00723-8.x; Perrin W.F., 1994, GILLNETS CETACEANS; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Schneider S., 2000, ARLEQUIN VER 2 000 S; Sellas AB, 2005, CONSERV GENET, V6, P715, DOI 10.1007/s10592-005-9031-7; SHAUGHNESSY P, 2003, MARINE MAMMALS FISHE; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Valsecchi E, 2004, ANIM CONSERV, V7, P139, DOI 10.1017/S1367943004001325; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WADE PR, 1995, FISH B-NOAA, V93, P345; Wang JY, 1999, MOL ECOL, V8, P1603, DOI 10.1046/j.1365-294x.1999.00741.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Weller David W., 1997, Aquatic Mammals, V23, P49; WHITEHEAD H, 1990, MAR MAMMAL SCI, V6, P316, DOI 10.1111/j.1748-7692.1990.tb00361.x	68	24	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20103	10.1371/journal.pone.0020103	http://dx.doi.org/10.1371/journal.pone.0020103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655285	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600020
J	Buric, M; Hulak, M; Kouba, A; Petrusek, A; Kozak, P				Buric, Milos; Hulak, Martin; Kouba, Antonin; Petrusek, Adam; Kozak, Pavel			A Successful Crayfish Invader Is Capable of Facultative Parthenogenesis: A Novel Reproductive Mode in Decapod Crustaceans	PLOS ONE			English	Article							MARMORKREBS MARBLED CRAYFISH; POPULATION; CAMBARIDAE; PHILIPPI; ASTACIDA; GERMANY; THREAT; FORM	Biological invasions are impacting biota worldwide, and explaining why some taxa tend to become invasive is of major scientific interest. North American crayfish species, particularly of the family Cambaridae, are prominent invaders in freshwaters, defying the "tens rule" which states that only a minority of species introduced to new regions become established, and only a minority of those become invasive and pests. So far, success of cambarid invaders has largely been attributed to rapid maturation, high reproductive output, aggressiveness, and tolerance to pollution. We provide experimental evidence that females of one cambarid species particularly widespread in Europe, the spiny-cheek crayfish Orconectes limosus, are capable of facultative parthenogenesis. Such reproductive mode has never before been recognized in decapods, the most diverse crustacean order. As shown by analysis of seven microsatellite loci, crayfish females kept physically separated from males produced genetically homogeneous offspring identical with maternal individuals; this suggests they reproduced by apomixis, unlike those females which mated with males and had a diverse offspring. Further research is needed to clarify what environmental conditions are necessary for a switch to parthenogenesis in O. limosus, and what role it plays in natural crayfish populations. However, if such reproductive plasticity is present in other cambarid crayfish species, it may contribute to the overwhelming invasive success of this group.	[Buric, Milos; Hulak, Martin; Kouba, Antonin; Kozak, Pavel] Univ S Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, S Bohemian Res Ctr Aquaculture & Biodivers Hydroc, Vodnany, Czech Republic; [Buric, Milos; Hulak, Martin; Kouba, Antonin; Kozak, Pavel] Univ S Bohemia Ceske Budejovice, Res Inst Fish Culture & Hydrobiol, Vodnany, Czech Republic; [Petrusek, Adam] Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic	University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Charles University Prague	Buric, M (corresponding author), Univ S Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, S Bohemian Res Ctr Aquaculture & Biodivers Hydroc, Vodnany, Czech Republic.	buric@vurh.jcu.cz	Kouba, Antonín/C-9338-2015; Kozák, Pavel/G-5025-2015; Petrusek, Adam/A-3510-2008; Buric, Milos/F-8114-2015	Kouba, Antonín/0000-0001-8118-8612; Kozák, Pavel/0000-0002-6985-1538; Petrusek, Adam/0000-0001-5150-4370; Buric, Milos/0000-0003-2220-5579	Czech Ministry of Education, Youth and Sports [MSM0021620828, MSM6007665809]; CENAKVA [CZ.1.05/2.1.00/01.0024]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA601870701]	Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); CENAKVA; Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic)	The research was funded by the Czech Ministry of Education, Youth and Sports (projects MSM0021620828 and MSM6007665809) (http://www.msmt.cz/), the project CENAKVA No. CZ.1.05/2.1.00/01.0024 (http://www.msmt.cz/areas-of-work/research-and-development-for-innovations-operational?highlightWords = VaVpI) and the Grant Agency of the Academy of Sciences of the Czech Republic (IAA601870701) (http://www.gaav.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBAUGH D W, 1973, Southwestern Naturalist, V18, P97, DOI 10.2307/3669916; ANDREWS EA, 1907, YOUNG CRAYFISHES AST, V35; Aquiloni L, 2009, FRESHWATER BIOL, V54, P1510, DOI 10.1111/j.1365-2427.2009.02169.x; Buric M, 2010, ZOOLOGY, V113, P301, DOI 10.1016/j.zool.2010.06.001; Buric M, 2010, ZOOL STUD, V49, P28; Chapman DD, 2007, BIOL LETTERS, V3, P425, DOI 10.1098/rsbl.2007.0189; Chucholl C, 2010, AQUAT INVASIONS, V5, P405, DOI 10.3391/ai.2010.5.4.10; De Meester Luc, 2004, P122; Engelstadter J, 2008, BIOESSAYS, V30, P1138, DOI 10.1002/bies.20833; Filipova L, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011025; Filipova L, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009024; Galeotti P, 2006, P ROY SOC B-BIOL SCI, V273, P1105, DOI 10.1098/rspb.2005.3345; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; Hamr P, 2001, BIOLOGY OF FRESHWATER CRAYFISH, P585; Holdich DM, 2009, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2009025; Holdich D.M., 2006, P49; Hulak M, 2010, J APPL GENET, V51, P73, DOI 10.1007/BF03195713; Jones JPG, 2009, BIOL INVASIONS, V11, P1475, DOI 10.1007/s10530-008-9334-y; Lampert KP, 2008, SEX DEV, V2, P290, DOI 10.1159/000195678; Martin P, 2007, NATURWISSENSCHAFTEN, V94, P843, DOI 10.1007/s00114-007-0260-0; Martin P, 2010, AQUAT INVASIONS, V5, P397, DOI 10.3391/ai.2010.5.4.09; Martin P, 2010, CONTRIB ZOOL, V79, P107, DOI 10.1163/18759866-07903003; MOGIE M, 1986, BIOL J LINN SOC, V28, P321, DOI 10.1111/j.1095-8312.1986.tb01761.x; Momot Walter T., 1995, Reviews in Fisheries Science, V3, P33; Noro C, 2008, ACTA ZOOL-STOCKHOLM, V89, P59, DOI 10.1111/j.1463-6395.2007.00294.x; RUDOLPH EH, 1995, J CRUSTACEAN BIOL, V15, P720, DOI 10.2307/1548821; RUDOLPH EH, 1995, CRUSTACEANA, V68, P705, DOI 10.1163/156854095X01916; Sagi A, 1996, BIOL BULL, V190, P16, DOI 10.2307/1542672; Scholtz G, 2003, NATURE, V421, P806, DOI 10.1038/421806a; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a; Yue GH, 2008, INT J BIOL SCI, V4, P279; Yue GH, 2010, BIOL INVASIONS, V12, P2697, DOI 10.1007/s10530-009-9675-1	32	46	48	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20281	10.1371/journal.pone.0020281	http://dx.doi.org/10.1371/journal.pone.0020281			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655282	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600036
J	Girdwood, D; Xirodimas, DP; Gordon, C				Girdwood, David; Xirodimas, Dimitris P.; Gordon, Colin			The Essential Functions of NEDD8 Are Mediated via Distinct Surface Regions, and Not by Polyneddylation in Schizosaccharomyces pombe	PLOS ONE			English	Article							UBIQUITIN-BINDING DOMAINS; SACCHAROMYCES-CEREVISIAE; MULTIUBIQUITIN CHAINS; POLYUBIQUITIN CHAIN; CULLIN NEDDYLATION; MODIFIER NEDD8; PROTEIN; LIGASE; ACTIVATION; CUL1	The ubiquitin-like protein NEDD8 is highly conserved in eukaryotes, from man to Schizosaccharomyces pombe. NEDD8 conjugation to cullin proteins is a prerequisite for cullin based E3 ubiquitin ligase activity, and essential for S. pombe viability. Here, we have performed alanine scanning mutagenesis of all conserved surface residues and show that the majority of essential residues were located around the hydrophobic patch and the C-terminus. However, we further identified essential residues not previously reported to be involved in ubiquitin ligase regulation that importantly do not prevent Ned8p conjugation. We also find that mutation of all conserved lysine residues in Ned8p, did not affect yeast viability, suggesting that mono-neddylation is sufficient for yeast viability under most conditions.	[Girdwood, David; Gordon, Colin] Western Gen Hosp, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Xirodimas, Dimitris P.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	University of Edinburgh; University of Dundee	Girdwood, D (corresponding author), Western Gen Hosp, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	davidgirdwood@gmail.com		Xirodimas, Dimitris/0000-0001-9275-1140	Medical Research Council; RUBICON network of excellence; Association for International Cancer Research; Medical Research Council [MC_U127584486] Funding Source: researchfish; MRC [MC_U127584486] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RUBICON network of excellence; Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, http://www.mrc.ac.uk/index.htm; RUBICON network of excellence, http://www.rubicon-net. org/; and the Association for International Cancer Research, http://www.aicr.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Mendoza HM, 2003, J BIOL CHEM, V278, P25637, DOI 10.1074/jbc.M212948200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Osaka F, 2000, EMBO J, V19, P3475, DOI 10.1093/emboj/19.13.3475; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Reverter D, 2005, J MOL BIOL, V345, P141, DOI 10.1016/j.jmb.2004.10.022; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Shen LN, 2005, EMBO J, V24, P1341, DOI 10.1038/sj.emboj.7600628; Siergiejuk E, 2009, EMBO J, V28, P3845, DOI 10.1038/emboj.2009.354; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983; Winget JM, 2010, MOL CELL, V38, P627, DOI 10.1016/j.molcel.2010.05.003; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2003, J BIOL CHEM, V278, P28882, DOI 10.1074/jbc.M302888200; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105	40	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20089	10.1371/journal.pone.0020089	http://dx.doi.org/10.1371/journal.pone.0020089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655279	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600019
J	Miyamoto, K; Yumine, N; Mimura, K; Nagahama, M; Li, JH; McClane, BA; Akimoto, S				Miyamoto, Kazuaki; Yumine, Natsuko; Mimura, Kanako; Nagahama, Masahiro; Li, Jihong; McClane, Bruce A.; Akimoto, Shigeru			Identification of Novel Clostridium perfringens Type E Strains That Carry an Iota Toxin Plasmid with a Functional Enterotoxin Gene	PLOS ONE			English	Article							ENCODING PLASMIDS; CPE LOCUS; DIVERSITY; SPORULATION; PREVALENCE	Clostridium perfringens enterotoxin (CPE) is a major virulence factor for human gastrointestinal diseases, such as food poisoning and antibiotic associated diarrhea. The CPE-encoding gene (cpe) can be chromosomal or plasmid-borne. Recent development of conventional PCR cpe-genotyping assays makes it possible to identify cpe location (chromosomal or plasmid) in type A isolates. Initial studies for developing cpe genotyping assays indicated that all cpe-positive strains isolated from sickened patients were typable by cpe-genotypes, but surveys of C. perfringens environmental strains or strains from feces of healthy people suggested that this assay might not be useful for some cpe-carrying type A isolates. In the current study, a pulsed-field gel electrophoresis Southern blot assay showed that four cpe-genotype untypable isolates carried their cpe gene on a plasmid of similar to 65 kb. Complete sequence analysis of the similar to 65 kb variant cpe-carrying plasmid revealed no intact IS elements and a disrupted cytosine methyltransferase (dcm) gene. More importantly, this plasmid contains a conjugative transfer region, a variant cpe gene and variant iota toxin genes. The toxin genes encoded by this plasmid are expressed based upon the results of RT-PCR assays. The similar to 65 kb plasmid is closely related to the pCPF4969 cpe plasmid of type A isolates. MLST analyses indicated these isolates belong to a unique cluster of C. perfringens. Overall, these isolates carrying a variant functional cpe gene and iota toxin genes represent unique type E strains.	[Miyamoto, Kazuaki; Yumine, Natsuko; Mimura, Kanako; Akimoto, Shigeru] Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama, Japan; [Nagahama, Masahiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Microbiol, Tokushima 770, Japan; [Li, Jihong; McClane, Bruce A.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Wakayama Medical University; Tokushima Bunri University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Miyamoto, K (corresponding author), Wakayama Med Univ, Sch Med, Dept Microbiol, Wakayama, Japan.	kazuaki@wakayama-med.ac.jp			National Institute of Allergy and Infectious Diseases [R37 AI19844-29, R01 AI056177-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056177, R37AI019844] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this study were supported by grants R37 AI19844-29 and R01 AI056177-08 from the National Institute of Allergy and Infectious Diseases. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript, and no additional external funding was received for this study.	Billington SJ, 1998, INFECT IMMUN, V66, P4531; Deguchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005598; Garmory HS, 2000, EPIDEMIOL INFECT, V124, P61, DOI 10.1017/S0950268899003295; Gurjar A, 2010, INFECT IMMUN, V78, P4860, DOI 10.1128/IAI.00715-10; Harry KH, 2009, J BACTERIOL, V191, P2728, DOI 10.1128/JB.01839-08; Heikinheimo A, 2006, EMERG INFECT DIS, V12, P1724, DOI 10.3201/eid1211.060478; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Li JH, 2007, APPL ENVIRON MICROB, V73, P7218, DOI 10.1128/AEM.01075-07; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Li JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010932; Li JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006249; Li JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000056; McClane BA, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P423; Miki Y, 2008, APPL ENVIRON MICROB, V74, P5366, DOI 10.1128/AEM.00783-08; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2004, J CLIN MICROBIOL, V42, P1552, DOI 10.1128/JCM.42.4.1552-1558.2004; Miyamoto K, 2002, INFECT IMMUN, V70, P4261, DOI 10.1128/IAI.70.8.4261-4272.2002; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Mueller-Spitz SR, 2010, APPL ENVIRON MICROB, V76, P5556, DOI 10.1128/AEM.01702-09; Parsons JA, 2007, J BACTERIOL, V189, P7782, DOI 10.1128/JB.00783-07; Sarker MR, 1999, MOL MICROBIOL, V33, P946, DOI 10.1046/j.1365-2958.1999.01534.x; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Zhao YL, 1998, J BACTERIOL, V180, P136, DOI 10.1128/JB.180.1.136-142.1998	25	41	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20376	10.1371/journal.pone.0020376	http://dx.doi.org/10.1371/journal.pone.0020376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655254	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000291097600058
J	Oosthuizen, JL; Gomez, P; Ruan, J; Hackett, TL; Moore, MM; Knight, DA; Tebbutt, SJ				Oosthuizen, Jean L.; Gomez, Pol; Ruan, Jian; Hackett, Tillie L.; Moore, Margo M.; Knight, Darryl A.; Tebbutt, Scott J.			Dual Organism Transcriptomics of Airway Epithelial Cells Interacting with Conidia of Aspergillus fumigatus	PLOS ONE			English	Article							IN-VITRO; PATHOGEN INTERACTIONS; ALVEOLAR MACROPHAGES; FUNCTIONAL GENOMICS; GENE-EXPRESSION; INFECTION; HOST; INNATE; A549; VIRULENCE	Background: Given the complex nature of the responses that can occur in host-pathogen interactions, dual transcriptomics offers a powerful method of elucidating these interactions during infection. The gene expression patterns of Aspergillus fumigatus conidia or host cells have been reported in a number of previous studies, but each focused on only one of the interacting organisms. In the present study, we profiled simultaneously the transcriptional response of both A. fumigatus and human airway epithelial cells (AECs). Methodology: 16HBE14o-transformed bronchial epithelial cells were incubated with A. fumigatus conidia at 37 degrees C for 6 hours, followed by genome-wide transcriptome analysis using human and fungal microarrays. Differentially expressed gene lists were generated from the microarrays, from which biologically relevant themes were identified. Human and fungal candidate genes were selected for validation, using RT-qPCR, in both 16HBE14o- cells and primary AECs co-cultured with conidia. Principal Findings: We report that ontologies related to the innate immune response are activated by co-incubation with A. fumigatus condia, and interleukin-6 (IL-6) was confirmed to be up-regulated in primary AECs via RT-qPCR. Concomitantly, A. fumigatus was found to up-regulate fungal pathways involved in iron acquisition, vacuolar acidification, and formate dehydrogenase activity. Conclusion: To our knowledge, this is the first study to apply a dual organism transcriptomics approach to interactions of A. fumigatus conidia and human airway epithelial cells. The up-regulation of IL-6 by epithelia and simultaneous activation of several pathways by fungal conidia warrants further investigation as we seek to better understand this interaction in both health and disease. The cellular response of the airway epithelium to A. fumigatus is important to understand if we are to improve host-pathogen outcomes.	[Oosthuizen, Jean L.; Gomez, Pol; Ruan, Jian; Hackett, Tillie L.; Knight, Darryl A.; Tebbutt, Scott J.] Providence Hlth Care, Inst HEART LUNG Hlth, UBC James Hogg Res Ctr, Vancouver, BC, Canada; [Hackett, Tillie L.; Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Moore, Margo M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Tebbutt, Scott J.] Univ British Columbia, Dept Med, Div Resp Med, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Simon Fraser University; University of British Columbia	Oosthuizen, JL (corresponding author), Providence Hlth Care, Inst HEART LUNG Hlth, UBC James Hogg Res Ctr, Vancouver, BC, Canada.	scott.tebbutt@hli.ubc.ca		Tebbutt, Scott/0000-0002-7908-1581	National Sanitarium Association (Canada); Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; UBC Faculty of Medicine; Canadian Institute of Health Research/Canadian Lung Association/IMPACT; Michael Smith Foundation	National Sanitarium Association (Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); UBC Faculty of Medicine; Canadian Institute of Health Research/Canadian Lung Association/IMPACT(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research)	This research was supported by funding from the National Sanitarium Association (Canada), the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca/e/193.html), and the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/). JLO was the recipient of a UBC Faculty of Medicine Summer Student Research Program Award. TLH is the recipient of Canadian Institute of Health Research/Canadian Lung Association/IMPACT and Michael Smith Foundation for Health Research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AddrizzoHarris DJ, 1997, CHEST, V111, P612, DOI 10.1378/chest.111.3.612; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Botterel F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-97; Bruns S, 2010, PROTEOMICS, V10, P3097, DOI 10.1002/pmic.201000129; Cenci E, 2001, J INFECT DIS, V184, P610, DOI 10.1086/322793; Cortez KJ, 2006, INFECT IMMUN, V74, P2353, DOI 10.1128/IAI.74.4.2353-2365.2006; DeHart DJ, 1997, J INFECT DIS, V175, P146, DOI 10.1093/infdis/175.1.146; Dubourdeau M, 2006, J IMMUNOL, V177, P3994, DOI 10.4049/jimmunol.177.6.3994; Gomez P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-358; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hissen AHT, 2004, INFECT IMMUN, V72, P1402, DOI 10.1128/IAI.72.3.1402-1408.2004; IbrahimGranet O, 1997, MICROBIOL-SGM, V143, P2247, DOI 10.1099/00221287-143-7-2247; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P293, DOI 10.1094/MPMI-20-3-0293; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kauffman HF, 2003, CURR ALLERGY ASTHM R, V3, P101, DOI 10.1007/s11882-003-0021-x; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee Sang Hoon, 2004, Korean Journal of Internal Medicine, V19, P38; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melin P, 2004, MICROBIOL-SGM, V150, P743, DOI 10.1099/mic.0.26807-0; Motley ST, 2004, CELL MICROBIOL, V6, P849, DOI 10.1111/j.1462-5822.2004.00407.x; Moy P, 2004, MOL PLANT MICROBE IN, V17, P1051, DOI 10.1094/MPMI.2004.17.10.1051; Paris S, 1997, INFECT IMMUN, V65, P1510, DOI 10.1128/IAI.65.4.1510-1514.1997; Prigneau O, 2003, YEAST, V20, P723, DOI 10.1002/yea.998; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2010, MICROBES INFECT, V12, P1035, DOI 10.1016/j.micinf.2010.07.005; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shankar J, 2008, J ALLERGY CLIN IMMUN, V121, pS134, DOI 10.1016/j.jaci.2007.12.536; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Tillie-Leblond I, 2005, ALLERGY, V60, P1004, DOI 10.1111/j.1398-9995.2005.00887.x; Tomee JFC, 1997, J INFECT DIS, V176, P300, DOI 10.1086/517272; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Warris A, 2003, J CLIN MICROBIOL, V41, P4101, DOI 10.1128/JCM.41.9.4101-4106.2003; Wasylnka JA, 2003, J CELL SCI, V116, P1579, DOI 10.1242/jcs.00329; Wasylnka JA, 2002, INFECT IMMUN, V70, P3156, DOI 10.1128/IAI.70.6.3156-3163.2002; Zhang YQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000939; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	45	57	239	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20527	10.1371/journal.pone.0020527	http://dx.doi.org/10.1371/journal.pone.0020527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655222	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600088
J	Rohn, TT; Catlin, LW				Rohn, Troy T.; Catlin, Lindsey W.			Immunolocalization of Influenza A Virus and Markers of Inflammation in the Human Parkinson's Disease Brain	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; NEUROINFLAMMATION; NEUROPROTECTION; MODEL	Although much is known regarding the molecular mechanisms leading to neuronal cell loss in Parkinson's disease (PD), the initiating event has not been identified. Prevailing theories including a chemical insult or infectious agent have been postulated as possible triggers, leading to neuroinflammation. We present immunohistochemical data indicating the presence of influenza A virus within the substantia nigra pars compacta (SNpc) from postmortem PD brain sections. Influenza A virus labeling was identified within neuromelanin granules as well as on tissue macrophages in the SNpc. Further supporting a role for neuroinflammation in PD was the identification of T-lymphocytes that colocalized with an antibody to caspase-cleaved Beclin-1 within the SNpc. The presence of influenza A virus together with macrophages and T-lymphocytes may contribute to the neuroinflammation associated with this disease.	[Rohn, Troy T.; Catlin, Lindsey W.] Boise State Univ, Dept Biol, Boise, ID 83725 USA	Idaho; Boise State University	Rohn, TT (corresponding author), Boise State Univ, Dept Biol, Boise, ID 83725 USA.	trohn@boisestate.edu			KO Dementia Foundation, Boise Idaho; NASA [NNX10AN29A]	KO Dementia Foundation, Boise Idaho; NASA(National Aeronautics & Space Administration (NASA))	This work was funded by KO Dementia Foundation, Boise Idaho and a NASA grant, NNX10AN29A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Baumann Sven, 2002, Current Molecular Medicine (Hilversum), V2, P257, DOI 10.2174/1566524024605671; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Bjorklund A, 2010, PROG BRAIN RES, V184, P113, DOI 10.1016/S0079-6123(10)84006-3; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Goldsmith JR, 1997, ENVIRON RES, V73, P156, DOI 10.1006/enrs.1997.3696; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Kaczmarek M, 2010, COMMUN DIS INTELL, V34, P8; Kokoulina P, 2010, NEURODEGENER DIS, V7, P243, DOI 10.1159/000287952; Kumar A, 2004, ARCH NEUROL-CHICAGO, V61, P1057, DOI 10.1001/archneur.61.7.1057; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Miklossy J, 2006, EXP NEUROL, V197, P275, DOI 10.1016/j.expneurol.2005.10.034; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; RAVENHOLT RT, 1982, LANCET, V2, P860; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Rohn T.T., 2009, INT J PHYSL PATH PHA, V1, P24; Rohn TT, 2008, BRAIN RES, V1228, P189, DOI 10.1016/j.brainres.2008.06.094; ROHN TT, 2010, NEUROBIOL DIS; SCHWARTZ J, 1979, ANN NEUROL, V6, P261, DOI 10.1002/ana.410060314; Schwartz M, 2005, J NEUROL SCI, V233, P163, DOI 10.1016/j.jns.2005.03.014; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Villoslada P, 2008, CLIN IMMUNOL, V128, P294, DOI 10.1016/j.clim.2008.04.003; WETMUR JG, 1979, ARCH NEUROL-CHICAGO, V36, P462, DOI 10.1001/archneur.1979.00500440032004; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yamada T, 1996, Parkinsonism Relat Disord, V2, P113, DOI 10.1016/1353-8020(96)00006-5; Yang QA, 2010, NEUROSCIENTIST, V16, P335, DOI 10.1177/1073858409357118; 2011, ANN INTERN MED, V154, P168	32	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20495	10.1371/journal.pone.0020495	http://dx.doi.org/10.1371/journal.pone.0020495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655265	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600079
J	Yang, JJ; Ii, M; Kamei, N; Alev, C; Kwon, SM; Kawamoto, A; Akimaru, H; Masuda, H; Sawa, Y; Asahara, T				Yang, Junjie; Ii, Masaaki; Kamei, Naosuke; Alev, Cantas; Kwon, Sang-Mo; Kawamoto, Atsuhiko; Akimaru, Hiroshi; Masuda, Haruchika; Sawa, Yoshiki; Asahara, Takayuki			CD34(+) Cells Represent Highly Functional Endothelial Progenitor Cells in Murine Bone Marrow	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CORONARY-ARTERY-DISEASE; NEOVASCULARIZATION CAPACITY; MYOCARDIAL-INFARCTION; ISCHEMIA; VIVO; TRANSPLANTATION; VASCULOGENESIS; ANGIOGENESIS; RECRUITMENT	Background: Endothelial progenitor cells (EPCs) were shown to have angiogenic potential contributing to neovascularization. However, a clear definition of mouse EPCs by cell surface markers still remains elusive. We hypothesized that CD34 could be used for identification and isolation of functional EPCs from mouse bone marrow. Methodology/Principal Findings: CD34(+) cells, c-Kit(+)/Sca-1(+)/Lin(-) (KSL) cells, c-Kit(+)/Lin(-) (KL) cells and Sca-1(+)/Lin(-) (SL) cells were isolated from mouse bone marrow mononuclear cells (BMMNCs) using fluorescent activated cell sorting. EPC colony forming capacity and differentiation capacity into endothelial lineage were examined in the cells. Although CD34(+) cells showed the lowest EPC colony forming activity, CD34(+) cells exhibited under endothelial culture conditions a more adherent phenotype compared with the others, demonstrating the highest mRNA expression levels of endothelial markers vWF, VE-cadherin, and Flk-1. Furthermore, a dramatic increase in immediate recruitment of cells to the myocardium following myocardial infarction and systemic cell injection was observed for CD34(+) cells comparing with others, which could be explained by the highest mRNA expression levels of key homing-related molecules Integrin beta 2 and CXCR4 in CD34(+) cells. Cell retention and incorporation into the vasculature of the ischemic myocardium was also markedly increased in the CD34(+) cell-injected group, giving a possible explanation for significant reduction in fibrosis area, significant increase in neovascularization and the best cardiac functional recovery in this group in comparison with the others. Conclusion: These findings suggest that mouse CD34(+) cells may represent a functional EPC population in bone marrow, which could benefit the investigation of therapeutic EPC biology.	[Yang, Junjie; Kamei, Naosuke; Alev, Cantas; Kawamoto, Atsuhiko; Akimaru, Hiroshi; Asahara, Takayuki] RIKEN Ctr Dev Biol, Grp Vasc Regenerat Res, Inst Biomed Res & Innovation, Kobe, Hyogo, Japan; [Yang, Junjie; Sawa, Yoshiki] Osaka Univ, Div Cardiovasc Surg, Dept Surg, Grad Sch Med, Osaka, Japan; [Ii, Masaaki] Osaka Med Coll, Grp Translat Stem Cell Res, Dept Pharmacol, Osaka, Japan; [Kamei, Naosuke] Hiroshima Univ, Dept Orthoped Surg, Grad Sch Biomed Sci, Hiroshima, Japan; [Alev, Cantas] RIKEN Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan; [Kwon, Sang-Mo] CHA Univ, Dept Biomed Sci, CHA Stem Cell Inst, Seoul, South Korea; [Masuda, Haruchika; Asahara, Takayuki] Tokai Univ, Dept Regenerat Med, Sch Med, Kanagawa 2591100, Japan	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Osaka University; Osaka Medical College; Hiroshima University; RIKEN; Pochon Cha University; Tokai University	Yang, JJ (corresponding author), RIKEN Ctr Dev Biol, Grp Vasc Regenerat Res, Inst Biomed Res & Innovation, Kobe, Hyogo, Japan.	sawasec@surg1.med.osaka-u.ac.jp; asa777@is.icc.u-tokai.ac.jp	Alev, Cantas/W-1493-2018; Yang, Junjie/ABA-4361-2021	Alev, Cantas/0000-0002-4879-8782; Yang, Junjie/0000-0002-6822-6423; Kawamoto, Atsuhiko/0000-0002-2733-8015	Ministry of Health, Labor and Welfare Organization in Japan; Foundation of Biomedical Research and Innovation of Kobe	Ministry of Health, Labor and Welfare Organization in Japan; Foundation of Biomedical Research and Innovation of Kobe	This work was supported by research funding from the Ministry of Health, Labor and Welfare Organization in Japan, and the Foundation of Biomedical Research and Innovation of Kobe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RG, 1986, BLOOD, V67, P842; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; BAUMHUETER S, 1993, SCIENCE, V262, P436, DOI 10.1126/science.7692600; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Carmona G, 2008, BLOOD, V111, P2640, DOI 10.1182/blood-2007-04-086231; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Ciarrocchi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001338; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Eguchi M, 2008, J MOL CELL CARDIOL, V45, P661, DOI 10.1016/j.yjmcc.2008.08.002; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwasaki H, 2006, CIRCULATION, V113, P1311, DOI 10.1161/CIRCULATIONAHA.105.541268; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jin H, 2006, J CLIN INVEST, V116, P652, DOI 10.1172/JCI24751; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kamei N, 2010, STEM CELLS, V28, P365, DOI 10.1002/stem.243; Kawamoto A, 2001, CIRCULATION, V103, P634; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kimura T, 2004, BLOOD, V103, P4478, DOI 10.1182/blood-2003-03-0875; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Kwon SM, 2009, CIRC RES, V104, P969, DOI 10.1161/CIRCRESAHA.108.192856; Lee SP, 2006, CIRCULATION, V114, P150, DOI 10.1161/CIRCULATIONAHA.105.595918; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nonaka-Sarukawa M, 2007, INT J CARDIOL, V119, P344, DOI 10.1016/j.ijcard.2006.07.191; Ott I, 2005, FASEB J, V19, P992, DOI 10.1096/fj.04-3219fje; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Shintani Satoshi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS123, DOI 10.1038/ncpcardio0430; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tanaka R, 2008, PLAST RECONSTR SURG, V121, P1929, DOI 10.1097/PRS.0b013e3181715218; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wood HB, 1997, BLOOD, V90, P2300; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003	47	94	105	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20219	10.1371/journal.pone.0020219	http://dx.doi.org/10.1371/journal.pone.0020219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655289	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600030
J	Zheng, M; Lv, LL; Ni, J; Ni, HF; Li, Q; Ma, KL; Liu, BC				Zheng, Min; Lv, Lin-Li; Ni, Jie; Ni, Hai-Feng; Li, Qing; Ma, Kun-Ling; Liu, Bi-Cheng			Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy	PLOS ONE			English	Article							EXPRESSION; MOLECULES; SEDIMENT; APOPTOSIS; GENES; CELLS	Background: Podocyte injury and subsequent excretion in urine play a crucial role in the pathogenesis and progression of diabetic nephropathy (DN). Quantification of messenger RNA (mRNA) expression in urinary sediment by real-time PCR is emerging as a noninvasive method of screening DN-associated biomarkers. We hypothesized that the urinary mRNA profile of podocyte-associated molecules may provide important clinical insight into the different stages of diabetic nephropathy. Methods: DN patients (N = 51) and healthy controls (N = 13) were enrolled in this study. DN patients were divided into a normoalbuminuria group (UAE<30 mg/g, n = 17), a microalbuminuria group (UAE 30 similar to 300 mg/g, n = 15), and a macroalbuminuria group (UAE>300 mg/g, n = 19), according to their urinary albumin excretion (UAE). Relative mRNA abundance of synaptopodin, podocalyxin, CD2-AP, alpha-actin4, and podocin were quantified, and correlations between target mRNAs and clinical parameters were examined. Results: The urinary mRNA levels of all genes studied were significantly higher in the DN group compared with controls (p<0.05), and mRNA levels increased with DN progression. Urinary mRNA levels of all target genes positively correlated with both UAE and BUN. The expression of podocalyxin, CD2-AP, alpha-actin4, and podocin mRNA correlated with serum creatinine (r = 0.457, p = 0.001; r = 0.329, p = 0.01; r = 0.286, p = 0.021; r = 0.357, p = 0.006, respectively). Furthermore, podocalyxin mRNA was found to negatively correlate with eGFR (r = -0.349, p = 0.01). Conclusion: The urinary mRNA profiles of synaptopodin, podocalyxin, CD2-AP, alpha-actin4, and podocin were found to increase with the progression of DN, which suggested that quantification of podocyte-associated molecules will be useful biomarkers of DN.	[Zheng, Min; Lv, Lin-Li; Ni, Jie; Ni, Hai-Feng; Li, Qing; Ma, Kun-Ling; Liu, Bi-Cheng] Southeast Univ, Sch Med, Inst Nephrol, Zhong Da Hosp, Nanjing, Peoples R China	Southeast University - China	Liu, BC (corresponding author), Southeast Univ, Sch Med, Inst Nephrol, Zhong Da Hosp, Nanjing, Peoples R China.	Liubc64@yahoo.com.cn			China National Natural Scientific Fund [30870953]	China National Natural Scientific Fund(National Natural Science Foundation of China (NSFC))	This study was supported by the China National Natural Scientific Fund (No. 30870953) to Prof. Bi-Cheng Liu as PI. (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US REN DAT SYST USRD; Camici M, 2007, BIOMED PHARMACOTHER, V61, P245, DOI 10.1016/j.biopha.2006.12.009; Chan RWY, 2007, RHEUMATOLOGY, V46, P44, DOI 10.1093/rheumatology/kel192; Chan RWY, 2006, NEPHROL DIAL TRANSPL, V21, P1534, DOI 10.1093/ndt/gfk102; Dagogo-Jack S, 2006, J NATL MED ASSOC, V98, P415; Dai HY, 2011, AM J MED SCI, V341, P207, DOI 10.1097/MAJ.0b013e3182010da9; Ichikawa L, 2005, CURR OPIN NEPHROL HY, V14, P205; Ihalmo P, 2008, DIABETOLOGIA, V51, P86, DOI 10.1007/s00125-007-0854-2; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Mas VR, 2005, TRANSPLANTATION, V80, P1686, DOI 10.1097/01.tp.0000185472.79948.db; Menini S, 2007, DIABETOLOGIA, V50, P2591, DOI 10.1007/s00125-007-0821-y; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Miyauchi M, 2009, INTERNAL MED, V48, P1615, DOI 10.2169/internalmedicine.48.2137; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Reidy K, 2009, AM J KIDNEY DIS, V54, P590, DOI 10.1053/j.ajkd.2009.07.003; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Steffes MW, 2001, KIDNEY INT, V59, P2104, DOI 10.1046/j.1523-1755.2001.0590062104.x; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Teiken JM, 2008, ANAT REC, V291, P114, DOI 10.1002/ar.20625; Wang G, 2008, DIABETOLOGIA, V51, P1062, DOI 10.1007/s00125-008-0988-x; Wang G, 2007, J RHEUMATOL, V34, P2358; Wang G, 2007, NEPHRON CLIN PRACT, V106, P169, DOI 10.1159/000104428; Wang G, 2010, RENAL FAILURE, V32, P372, DOI 10.3109/08860221003611737; White KE, 2004, NEPHROL DIAL TRANSPL, V19, P1437, DOI 10.1093/ndt/gfh129; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009	32	77	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20431	10.1371/journal.pone.0020431	http://dx.doi.org/10.1371/journal.pone.0020431			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655212	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600067
J	Sargeant, D; Deverasetty, S; Luo, Y; Baleta, AV; Zobrist, S; Rathnayake, V; Russo, JC; Vyas, J; Muesing, MA; Schiller, MR				Sargeant, David; Deverasetty, Sandeep; Luo, Yang; Baleta, Angel Villahoz; Zobrist, Stephanie; Rathnayake, Viraj; Russo, Jacqueline C.; Vyas, Jay; Muesing, Mark A.; Schiller, Martin R.			HIVToolbox, an Integrated Web Application for Investigating HIV	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DNA-BINDING; NUCLEAR IMPORT; REVERSE-TRANSCRIPTASE; SEQUENCE ALIGNMENT; MINIMOTIF MINER; CATALYTIC CORE; PROTEIN DATA; DOMAIN; ACETYLATION	Many bioinformatic databases and applications focus on a limited domain of knowledge federating links to information in other databases. This segregated data structure likely limits our ability to investigate and understand complex biological systems. To facilitate research, therefore, we have built HIVToolbox, which integrates much of the knowledge about HIV proteins and allows virologists and structural biologists to access sequence, structure, and functional relationships in an intuitive web application. HIV-1 integrase protein was used as a case study to show the utility of this application. We show how data integration facilitates identification of new questions and hypotheses much more rapid and convenient than current approaches using isolated repositories. Several new hypotheses for integrase were created as an example, and we experimentally confirmed a predicted CK2 phosphorylation site. Weblink: [http://hivtoolbox.bio-toolkit.com]	[Sargeant, David; Deverasetty, Sandeep; Baleta, Angel Villahoz; Zobrist, Stephanie; Rathnayake, Viraj; Russo, Jacqueline C.; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Luo, Yang; Muesing, Mark A.] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Vyas, Jay] Univ Connecticut Hlth Ctr, Dept Mol Microbial & Struct Biol, Farmington, CT USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Connecticut	Sargeant, D (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [GM079689, AI078708, AI078708S, AI065321]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078708, R21AI065321, F32AI007870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health [grant number GM079689, AI078708, AI078708S] to MRS and [grant number AI065321] to MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Armon-Omer A, 2004, J MOL BIOL, V336, P1117, DOI 10.1016/j.jmb.2003.11.057; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; CBN: IUPAC-IUB Commission on Biochemical Nomenclature (CBN), 1970, BIOCHEM J, V120, P449; Cereseto A, 2005, EMBO J, V24, P3070, DOI 10.1038/sj.emboj.7600770; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Dampier W, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-47; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; Davey NE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-14; Dirac AMG, 2001, EUR J BIOCHEM, V268, P743, DOI 10.1046/j.1432-1327.2001.01932.x; Doherty RS, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-18; Dolan J, 2009, J MOL BIOL, V385, P568, DOI 10.1016/j.jmb.2008.10.083; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Evans P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008942; Evans P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-27; FRIBORG J, 1995, J ACQ IMMUN DEF SYND, V8, P10; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Gille C, 2006, PROTEIN SCI, V15, P208, DOI 10.1110/ps.051882006; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Klenchin VA, 2008, NUCLEIC ACIDS RES, V36, P5855, DOI 10.1093/nar/gkn577; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEAVITT AD, 1993, J BIOL CHEM, V268, P2113; LEITNER T, 2005, THEORETICAL BIOL BIO; Levin A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-112; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Lutzke RAP, 1998, J VIROL, V72, P4841, DOI 10.1128/JVI.72.6.4841-4848.1998; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125, DOI 10.1093/nar/22.20.4125; Meehan AM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000522; Meggio F, 2001, MOL CELL BIOCHEM, V227, P145, DOI 10.1023/A:1013177326481; Morgan DH, 2006, BIOINFORMATICS, V22, P2049, DOI 10.1093/bioinformatics/btl285; Nathanson N, 1999, SCIENCE, V284, P1619, DOI 10.1126/science.284.5420.1619; Rajasekaran S, 2009, NUCLEIC ACIDS RES, V37, pD185, DOI 10.1093/nar/gkn865; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; Ren G, 2007, J MOL BIOL, V366, P286, DOI 10.1016/j.jmb.2006.11.029; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Riviere L, 2010, J VIROL, V84, P729, DOI 10.1128/JVI.01952-09; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Swingler S, 1997, J VIROL, V71, P4372, DOI 10.1128/JVI.71.6.4372-4377.1997; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobaly-Tapiero J, 2008, TRAFFIC, V9, P1717, DOI 10.1111/j.1600-0854.2008.00792.x; Topper M, 2007, J VIROL, V81, P3012, DOI 10.1128/JVI.02257-06; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vyas J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp616; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	63	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20122	10.1371/journal.pone.0020122	http://dx.doi.org/10.1371/journal.pone.0020122			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647445	Green Published, gold			2022-12-25	WOS:000291006500026
J	Muller, K; Matuschewski, K; Silvie, O				Mueller, Katja; Matuschewski, Kai; Silvie, Olivier			The Puf-Family RNA-Binding Protein Puf2 Controls Sporozoite Conversion to Liver Stages in the Malaria Parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TRANSCRIPTION FACTOR; SEXUAL DEVELOPMENT; MESSENGER-RNA; DNA-BINDING; PUMILIO; MOSQUITO; IDENTIFICATION; TRANSFORMATION; RECOGNITION	Malaria is a vector-borne infectious disease caused by unicellular, obligate intracellular parasites of the genus Plasmodium. During host switch the malaria parasite employs specialized latent stages that colonize the new host environment. Previous work has established that gametocytes, sexually differentiated stages that are taken up by the mosquito vector, control expression of genes required for mosquito colonization by translational repression. Sexual parasite development is controlled by a DEAD-box RNA helicase of the DDX6 family, termed DOZI. Latency of sporozoites, the transmission stage injected during an infectious blood meal, is controlled by the eIF2alpha kinase IK2, a general inhibitor of protein synthesis. Whether RNA-binding proteins participate in translational regulation in sporozoites remains to be studied. Here, we investigated the roles of two RNA-binding proteins of the Puf-family, Plasmodium Puf1 and Puf2, during sporozoite stage conversion. Our data reveal that, in the rodent malaria parasite P. berghei, Puf2 participates in the regulation of IK2 and inhibits premature sporozoite transformation. Inside mosquito salivary glands puf2(-) sporozoites transform over time to round forms resembling early intra-hepatic stages. As a result, mutant parasites display strong defects in initiating a malaria infection. In contrast, Puf1 is dispensable in vivo throughout the entire Plasmodium life cycle. Our findings support the notion of a central role for Puf2 in parasite latency during switch between the insect and mammalian hosts.	[Mueller, Katja; Matuschewski, Kai; Silvie, Olivier] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany	Max Planck Society	Muller, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany.	olivier.silvie@inserm.fr	Silvie, Olivier/K-7290-2017; Silvie, Olivier/AAF-5437-2021	Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940; Matuschewski, Kai/0000-0001-6147-8591; Muller, Katja/0000-0001-5100-0981	Max Planck Society; European Commission (EviMalaR) [34]; Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation; Marie Curie Intra-European fellowship; EMBO	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Commission (EviMalaR)(European CommissionEuropean Commission Joint Research Centre); Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation; Marie Curie Intra-European fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO))	This work was supported by the Max Planck Society, and in part by grants from the European Commission (EviMalaR, #34), the Joachim Siebeneicher Foundation and the Chica and Heinz Schaller Foundation. OS was a recipient of a Marie Curie Intra-European fellowship and an EMBO Long-Term Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly ASI, 2008, MOL MICROBIOL, V69, P152, DOI 10.1111/j.1365-2958.2008.06271.x; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Coleman BI, 2008, CELL MICROBIOL, V10, P1935, DOI 10.1111/j.1462-5822.2008.01203.x; Cui LW, 2002, NUCLEIC ACIDS RES, V30, P4607, DOI 10.1093/nar/gkf600; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Fan Q, 2004, DNA CELL BIOL, V23, P753, DOI 10.1089/dna.2004.23.753; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Hafalla JC, 2011, IMMUNOL REV, V240, P297, DOI 10.1111/j.1600-065X.2010.00988.x; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hegge S, 2010, FASEB J, V24, P5003, DOI 10.1096/fj.10-164814; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Kaiser K, 2003, J EXP MED, V197, P1045, DOI 10.1084/jem.20022100; Koh YY, 2009, RNA, V15, P1090, DOI 10.1261/rna.1545309; Lamont LB, 2004, DEV CELL, V7, P697, DOI 10.1016/j.devcel.2004.09.013; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Miao J, 2010, J CELL SCI, V123, P1039, DOI 10.1242/jcs.059824; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Putrianti ED, 2009, J INFECT DIS, V199, P899, DOI 10.1086/597121; QUENAULT T, 2010, TRENDS CELL BIOL; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; Silvie O, 2007, INT J PARASITOL, V37, P173, DOI 10.1016/j.ijpara.2006.10.005; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	46	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2011	6	5							e19860	10.1371/journal.pone.0019860	http://dx.doi.org/10.1371/journal.pone.0019860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765PE	21673790	gold, Green Submitted, Green Published			2022-12-25	WOS:000290720200041
J	Raab, M; Smith, X; Matthess, Y; Strebhardt, K; Rudd, CE				Raab, Monika; Smith, Xin; Matthess, Yves; Strebhardt, Klaus; Rudd, Christopher E.			SKAP1 Protein PH Domain Determines RapL Membrane Localization and Rap1 Protein Complex Formation for T Cell Receptor (TCR) Activation of LFA-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTING ADAPTER PROTEIN; TYROSINE KINASE; INTEGRIN ACTIVATION; INTERLEUKIN-2 PRODUCTION; MOLECULAR-CLONING; UP-REGULATION; ADHESION; BINDING; FYN; CD4	Although essential for T cell function, the identity of the T cell receptor (TCR) "inside-out" pathway for the activation of lymphocyte function-associated antigen 1 (LFA-1) is unclear. SKAP1 (SKAP-55) is the upstream regulator needed for TCR-induced RapL-Rap1 complex formation and LFA-1 activation. In this paper, we show that SKAP1 is needed for RapL binding to membranes in a manner dependent on the PHdomain of SKAP1 and the PI3K pathway. ASKAP1 PH domain-inactivating mutation (i.e. R131M) markedly impaired RapL translocation to membranes for Rap1 and LFA-1 binding and the up-regulation of LFA-1-intercellular adhesion molecule 1 (ICAM-1) binding. Further, N-terminal myr-tagged SKAP1 for membrane binding facilitated constitutive RapL membrane and Rap1 binding and effectively substituted for PI3K and TCR ligation in the activation of LFA-1 in T cells.	[Raab, Monika; Rudd, Christopher E.] Univ Cambridge, Dept Pathol, Cell Signaling Sect, Cambridge CB2 1QP, England; [Smith, Xin; Rudd, Christopher E.] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Matthess, Yves; Strebhardt, Klaus] Goethe Univ Frankfurt, Sch Med, Dept Obstet & Gynaecol, D-60590 Frankfurt, Germany	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Goethe University Frankfurt	Raab, M (corresponding author), Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	moniraab@yahoo.com	Strebhardt, Klaus/E-8765-2011; Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; Strebhardt, Klaus/0000-0003-2173-9763				BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Collins TL, 1997, IMMUNOL TODAY, V18, P221; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Duke-Cohan JS, 2006, J BIOL CHEM, V281, P13743, DOI 10.1074/jbc.M508774200; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Geng LP, 1999, J IMMUNOL, V163, P5753; Geng LP, 2001, P NATL ACAD SCI USA, V98, P11527, DOI 10.1073/pnas.191378198; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Huang YP, 2005, J BIOL CHEM, V280, P23576, DOI 10.1074/jbc.M413201200; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Kuhne MR, 2003, J IMMUNOL, V171, P860, DOI 10.4049/jimmunol.171.2.860; Kupfer A, 2006, IMMUNITY, V25, P11, DOI 10.1016/j.immuni.2006.07.005; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee JY, 2007, SCIENCE, V317, P206, DOI 10.1126/science.1146073; Liu J, 1998, P NATL ACAD SCI USA, V95, P8779, DOI 10.1073/pnas.95.15.8779; Marie-Cardine A, 1998, J BIOL CHEM, V273, P25789, DOI 10.1074/jbc.273.40.25789; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; MAZEROLLES F, 1991, EUR J IMMUNOL, V21, P887, DOI 10.1002/eji.1830210405; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 1990, IMMUNOL TODAY, V11, P400, DOI 10.1016/0167-5699(90)90159-7; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Shimizu Y, 1995, J CELL BIOL, V131, P1867, DOI 10.1083/jcb.131.6.1867; Swanson KD, 2008, MOL CELL, V32, P564, DOI 10.1016/j.molcel.2008.09.022; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; Wang HY, 2008, TRENDS CELL BIOL, V18, P486, DOI 10.1016/j.tcb.2008.07.005; Wang H, 2007, MOL CELL BIOL, V27, P6863, DOI 10.1128/MCB.00556-07; Wang HY, 2010, IMMUNOL LETT, V128, P148, DOI 10.1016/j.imlet.2009.10.010; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Wardenburg JB, 1996, J BIOL CHEM, V271, P19641, DOI 10.1074/jbc.271.33.19641; Wu JN, 2006, J IMMUNOL, V176, P6681, DOI 10.4049/jimmunol.176.11.6681	47	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29663	29670		10.1074/jbc.M111.222661	http://dx.doi.org/10.1074/jbc.M111.222661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21669874	hybrid, Green Published			2022-12-25	WOS:000294046600025
J	Madsen, DH; Ingvarsen, S; Jurgensen, HJ; Melander, MC; Kjoller, L; Moyer, A; Honore, C; Madsen, CA; Garred, P; Burgdorf, S; Bugge, TH; Behrendt, N; Engelholm, LH				Madsen, Daniel H.; Ingvarsen, Signe; Jurgensen, Henrik J.; Melander, Maria C.; Kjoller, Lars; Moyer, Amanda; Honore, Christian; Madsen, Charlotte A.; Garred, Peter; Burgdorf, Sven; Bugge, Thomas H.; Behrendt, Niels; Engelholm, Lars H.			The Non-phagocytic Route of Collagen Uptake A DISTINCT DEGRADATION PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; MACROPHAGE MANNOSE RECEPTOR; TUMOR-CELL LINES; UROKINASE RECEPTOR; HUMAN-FIBROBLASTS; MONOCLONAL-ANTIBODIES; ENDOTHELIAL-CELLS; TRANSMEMBRANE GLYCOPROTEIN; BINDING-PROPERTIES; LECTIN RECEPTOR	The degradation of collagens, the most abundant proteins of the extracellular matrix, is involved in numerous physiological and pathological conditions including cancer invasion. An important turnover pathway involves cellular internalization and degradation of large, soluble collagen fragments, generated by initial cleavage of the insoluble collagen fibers. We have previously observed that in primary mouse fibroblasts, this endocytosis of collagen fragments is dependent on the receptor urokinase plasminogen activator receptor-associated protein (uPARAP)/Endo180. Others have identified additional mechanisms of collagen uptake, with different associated receptors, in other cell types. These receptors include beta 1-integrins, being responsible for collagen phagocytosis, and the mannose receptor. We have now utilized a newly developed monoclonal antibody against uPARAP/Endo180, which down-regulates the receptor protein level on treated cells, to examine the role of uPARAP/Endo180 as a mediator of collagen internalization by a wide range of cultured cell types. With the exception of macrophages, all cells that proved capable of efficient collagen internalization were of mesenchymal origin and all of these utilized uPARAP/Endo180 for their collagen uptake process. Macrophages internalized collagen in a process mediated by the mannose receptor, a protein belonging to the same protein family as uPARAP/Endo180. beta 1-Integrins were found not to be involved in the endocytosis of soluble collagen, irrespectively of whether this was mediated by uPARAP/Endo180 or the mannose receptor. This further distinguishes these pathways from the phagocytic uptake of particulate collagen.	[Madsen, Daniel H.; Ingvarsen, Signe; Jurgensen, Henrik J.; Melander, Maria C.; Kjoller, Lars; Madsen, Charlotte A.; Behrendt, Niels; Engelholm, Lars H.] Rigshosp, Finsen Lab BRIC, DK-2200 Copenhagen, Denmark; [Honore, Christian; Garred, Peter] Rigshosp, Dept Clin Immunol, Mol Med Lab, DK-2200 Copenhagen, Denmark; [Ingvarsen, Signe] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Moyer, Amanda; Bugge, Thomas H.] NIDCR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Burgdorf, Sven] Univ Bonn, Life & Med Sci LIMES Inst, D-53115 Bonn, Germany	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Bonn	Engelholm, LH (corresponding author), Copenhagen Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	lhe@finsenlab.dk	Ingvarsen, Signe Ziir/AAT-3296-2020	Ingvarsen, Signe Ziir/0000-0001-7800-6443; Honore, Christian/0000-0003-4846-1319; Garred, Peter/0000-0002-2876-8586; Engelholm, Lars/0000-0002-6616-1232; Behrendt, Niels/0000-0003-1833-3922; Madsen, Daniel Hargboel/0000-0002-3183-6201	National Institutes of Health NIDCR; Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Lundbeck Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); European Community [201279]; "Grosserer Alfred Nielsen og Hustrus" foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R67-2010-6200] Funding Source: researchfish	National Institutes of Health NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); European Community(European Commission); "Grosserer Alfred Nielsen og Hustrus" foundation; Copenhagen University Hospital; University of Copenhagen, Faculty of Science; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden)	This work was supported, in whole or in part, by the National Institutes of Health NIDCR Intramural Research Program (to A. M. and T. H. B.), the Danish Cancer Society, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Lundbeck Foundation, the Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer), European Community's Seventh Framework Programme FP7/2007-2011 Grant 201279 (to N. B.), grants from the Lundbeck Foundation and the "Grosserer Alfred Nielsen og Hustrus" foundation (to L. H. E.), the Copenhagen University Hospital (to D. H. M. and H. J. J.), and the University of Copenhagen, Faculty of Science (to S. I.).	ANCIAN P, 1995, BIOCHEMISTRY-US, V34, P13146, DOI 10.1021/bi00040a028; Arora PD, 2008, AM J PHYSIOL-CELL PH, V295, pC130, DOI 10.1152/ajpcell.00168.2008; Arora PD, 2003, EXP CELL RES, V286, P366, DOI 10.1016/S0014-4827(03)00096-X; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; BERTRAM JS, 1980, CANCER LETT, V11, P63, DOI 10.1016/0304-3835(80)90130-5; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Blair HC, 2002, BIOCHEM J, V364, P329, DOI 10.1042/BJ20020165; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; CLAESSON MH, 1994, SCAND J IMMUNOL, V40, P257, DOI 10.1111/j.1365-3083.1994.tb03459.x; DECLERCK PJ, 1995, J BIOL CHEM, V270, P8397, DOI 10.1074/jbc.270.15.8397; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engelholm LH, 2009, FRONT BIOSCI-LANDMRK, V14, P2103, DOI 10.2741/3365; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Engelholm LH, 2001, LAB INVEST, V81, P1403, DOI 10.1038/labinvest.3780354; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; GRAHAM FL, 1974, COLD SPRING HARB SYM, V39, P637, DOI 10.1101/SQB.1974.039.01.077; Hansen LV, 2004, BIOCHEM J, V380, P845, DOI 10.1042/BJ20031478; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hillig T, 2008, J BIOL CHEM, V283, P15217, DOI 10.1074/jbc.C700214200; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck Kenn, 2006, Birth Defects Research, V78, P11, DOI 10.1002/bdrc.20064; Honardoust HA, 2006, HISTOPATHOLOGY, V49, P634, DOI 10.1111/j.1365-2559.2006.02559.x; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; Howard MJ, 2004, OSTEOARTHR CARTILAGE, V12, P74, DOI 10.1016/j.joca.2003.07.001; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Ingvarsen S, 2008, BIOL CHEM, V389, P943, DOI 10.1515/BC.2008.097; ISACKE CM, 1990, MOL CELL BIOL, V10, P2606, DOI 10.1128/MCB.10.6.2606; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jogi A, 2007, J THROMB HAEMOST, V5, P1936, DOI 10.1111/j.1538-7836.2007.02653.x; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; Lee JW, 2002, J ORTHOP RES, V20, P66, DOI 10.1016/S0736-0266(01)00073-0; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; LUND LR, 1992, FEBS LETT, V298, P177, DOI 10.1016/0014-5793(92)80050-Q; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Martinez-Pomares L, 2001, IMMUNOBIOLOGY, V204, P527, DOI 10.1078/0171-2985-00089; MCALLISTER BS, 1993, ARCH BIOCHEM BIOPHYS, V304, P294, DOI 10.1006/abbi.1993.1352; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1; Pataridis S, 2008, J SEP SCI, V31, P3483, DOI 10.1002/jssc.200800351; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; ROMER J, 1994, INT J CANCER, V57, P553, DOI 10.1002/ijc.2910570419; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; SANFORD KK, 1959, J NATL CANCER I, V23, P1035; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schnack N. B., 2002, INT J CANCER, V98, P656; SCHWARTZ AL, 1986, J BIOL CHEM, V261, P5225; Segal G, 2001, J CELL SCI, V114, P119; Sheikh H, 2000, J CELL SCI, V113, P1021; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; SMEDSROD B, 1990, BIOCHEM J, V271, P345, DOI 10.1042/bj2710345; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Szekanecz Z, 2007, CURR OPIN RHEUMATOL, V19, P289, DOI 10.1097/BOR.0b013e32805e87ae; VONFIGURA K, 1984, EMBO J, V3, P1281, DOI 10.1002/j.1460-2075.1984.tb01963.x; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; Wang JHC, 2007, GENE, V391, P1, DOI 10.1016/j.gene.2007.01.014; WATTS C, 1992, J CELL SCI, V103, P1; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323; Ye QS, 2010, EUR CELLS MATER, V20, P197	81	88	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26996	27010		10.1074/jbc.M110.208033	http://dx.doi.org/10.1074/jbc.M110.208033			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652704	Green Published, hybrid			2022-12-25	WOS:000293078200073
J	Tavares, AFN; Teixeira, M; Romao, CC; Seixas, JD; Nobre, LS; Saraiva, LM				Tavares, Ana Filipa N.; Teixeira, Miguel; Romao, Carlos C.; Seixas, Joao D.; Nobre, Ligia S.; Saraiva, Ligia M.			Reactive Oxygen Species Mediate Bactericidal Killing Elicited by Carbon Monoxide-releasing Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; ANTIMICROBIAL ACTION; DNA-DAMAGE; SUPEROXIDE; RESPIRATION; ACONITASE; PATHWAYS; TARGET	CO-releasing molecules (CO-RMs) were previously shown by us to be more potent bactericides than CO gas. This suggests a mechanism of action for CO-RM, which either potentiates the activity of CO or uses another CO-RM-specific effect. We have also reported that CORM-2 induces the expression of genes related to oxidative stress. In the present study we intend to establish whether the generation of reactive oxygen species by CO-RMs may indeed result in the inhibition of bacterial cellular function. We now report that two CO-RMs (CORM-2 and ALF062) stimulate the production of ROS in Escherichia coli, an effect that is abolished by addition of antioxidants. Furthermore, deletion of genes encoding E. coli systems involved in reactive oxygen species scavenging, namely catalases and superoxide dismutases, potentiates the lethality of CORM-2 due to an increase of intracellular ROS content. CORM-2 also induces the expression of the E. coli DNA repair/SOS system recA, and its inactivation enhances toxicity of CORM-2. Moreover, fluorescence microscopy images reveal that CORM-2 causes DNA lesions to bacterial cells. We also demonstrate that cells treated with CORM-2 contain higher levels of free iron arising from destruction of iron-sulfur proteins. Importantly, we show that CO-RMs generate hydroxyl radicals in a cell-free solution, a process that is abolished by scavenging CO. Altogether, we provide a novel insight into the molecular basis of CO-RMs action by showing that their bactericidal properties are linked to cell damage inflicted by the oxidative stress that they are able to generate.	[Saraiva, Ligia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Estacao Agron Nacl, P-2780157 Oeiras, Portugal; [Romao, Carlos C.; Seixas, Joao D.] Alfama Lda, P-2740122 Porto Salvo, Portugal	National Institute for Agricultural Research Portugal; Universidade Nova de Lisboa	Saraiva, LM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Estacao Agron Nacl, Ave Republ, P-2780157 Oeiras, Portugal.	lst@itqb.unl.pt	Saraiva, Ligia M/H-8537-2012; Teixeira, Miguel/A-9098-2011; Teixeira, Miguel/M-1509-2019; Romão, Carlos C/D-1162-2010	Saraiva, Ligia M/0000-0002-0675-129X; Teixeira, Miguel/0000-0003-4124-6237; Teixeira, Miguel/0000-0003-4124-6237; Romão, Carlos C/0000-0001-5061-3743; Nobre, Ligia/0000-0002-3060-2593	Fundacao para a Ciencia e Tecnologia [PTDC/BIA-PRO/098224/2008]; Fundacao para a Ciencia e Tecnologia Studentships [SFRH/BD/38457/2007];  [SFRH/BPD/69325/2010]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia Studentships; 	This work was supported by Fundacao para a Ciencia e Tecnologia project Grant PTDC/BIA-PRO/098224/2008 and Fundacao para a Ciencia e Tecnologia Studentships SFRH/BD/38457/2007 (to A. F. N. T.) and SFRH/BPD/69325/2010 (to L. S. N.).	Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Becerra MC, 2002, BIOCHEM BIOPH RES CO, V297, P1003, DOI 10.1016/S0006-291X(02)02331-8; Brzoska K, 2006, ACTA BIOCHIM POL, V53, P685; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Chung SW, 2008, J CLIN INVEST, V118, P239, DOI 10.1172/JCI32730; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; GARDNER PR, 1991, J BIOL CHEM, V266, P19328; Haldane JBS, 1927, BIOCHEM J, V21, P1068, DOI 10.1042/bj0211068; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson TR, 2007, DALTON T, P1500, DOI 10.1039/b613629j; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; MEISTER A, 1985, METHOD ENZYMOL, V113, P327; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924; Santos-Silva T, 2011, J AM CHEM SOC, V133, P1192, DOI 10.1021/ja108820s; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Seixas JD, 2010, THESIS U NOVA LISBOA; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yonezawa Y, 1999, J TOXICOL ENV HEAL A, V57, P237, DOI 10.1080/009841099157683; ZHANG J, 1992, J CLIN INVEST, V90, P1193, DOI 10.1172/JCI115980; Zhao HT, 2001, FREE RADICAL BIO MED, V31, P599, DOI 10.1016/S0891-5849(01)00619-0	39	95	97	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26708	26717		10.1074/jbc.M111.255752	http://dx.doi.org/10.1074/jbc.M111.255752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646348	Green Published, hybrid			2022-12-25	WOS:000293078200048
J	Cai, WD; Leung, HC				Cai, Weidong; Leung, Hoi-Chung			Rule-Guided Executive Control of Response Inhibition: Functional Topography of the Inferior Frontal Cortex	PLOS ONE			English	Article							STOP-SIGNAL TASK; VENTROLATERAL PREFRONTAL CORTEX; EVENT-RELATED FMRI; COGNITIVE CONTROL; GO/NO-GO; PSYCHOPHYSIOLOGICAL INTERACTIONS; TARGET DETECTION; NEURAL BASIS; PERFORMANCE; MRI	Background: The human inferior frontal cortex (IFC) is a large heterogeneous structure with distinct cytoarchitectonic subdivisions and fiber connections. It has been found involved in a wide range of executive control processes from target detection, rule retrieval to response control. Since these processes are often being studied separately, the functional organization of executive control processes within the IFC remains unclear. Methodology/Principal Findings: We conducted an fMRI study to examine the activities of the subdivisions of IFC during the presentation of a task cue (rule retrieval) and during the performance of a stop-signal task (requiring response generation and inhibition) in comparison to a not-stop task (requiring response generation but not inhibition). We utilized a mixed event-related and block design to separate brain activity in correspondence to transient control processes from rule-related and sustained control processes. We found differentiation in control processes within the IFC. Our findings reveal that the bilateral ventral-posterior IFC/anterior insula are more active on both successful and unsuccessful stop trials relative to not-stop trials, suggesting their potential role in the early stage of stopping such as triggering the stop process. Direct countermanding seems to be outside of the IFC. In contrast, the dorsal-posterior IFC/inferior frontal junction (IFJ) showed transient activity in correspondence to the infrequent presentation of the stop signal in both tasks and the left anterior IFC showed differential activity in response to the task cues. The IFC subdivisions also exhibited similar but distinct patterns of functional connectivity during response control. Conclusions/Significance: Our findings suggest that executive control processes are distributed across the IFC and that the different subdivisions of IFC may support different control operations through parallel cortico-cortical and cortico-striatal circuits.	[Cai, Weidong; Leung, Hoi-Chung] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Cai, Weidong] Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego	Cai, WD (corresponding author), SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA.	w2cai@ucsd.edu; hoi-chung.leung@stonybrook.edu	Cai, Weidong/H-5497-2011		State University of New York at Stony Brook; NIH [DA023044]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023044] Funding Source: NIH RePORTER	State University of New York at Stony Brook; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the State University of New York at Stony Brook (http://www.stonybrook.edu/) and NIH DA023044 (http://drugabuse.gov/nidahome.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2009, NEUROSCI BIOBEHAV R, V33, P611, DOI 10.1016/j.neubiorev.2008.10.003; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Bussey TJ, 2001, BEHAV NEUROSCI, V115, P971, DOI 10.1037//0735-7044.115.5.971; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Cai WD, 2009, BRAIN RES, V1261, P20, DOI 10.1016/j.brainres.2008.12.073; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Congdon E, 2010, NEUROIMAGE, V53, P653, DOI 10.1016/j.neuroimage.2010.06.062; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coxon JP, 2009, J COGNITIVE NEUROSCI, V21, P1193, DOI 10.1162/jocn.2009.21081; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Donohue SE, 2005, NEUROIMAGE, V26, P1140, DOI 10.1016/j.neuroimage.2005.03.019; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hirose S, 2009, NEUROIMAGE, V47, P442, DOI 10.1016/j.neuroimage.2009.04.094; Huettel SA, 2004, NEUROPSYCHOLOGIA, V42, P379, DOI 10.1016/j.neuropsychologia.2003.07.009; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kim J, 2008, MAGN RESON IMAGING, V26, P583, DOI 10.1016/j.mri.2007.10.011; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Leung HC, 2007, J NEUROSCI, V27, P9893, DOI 10.1523/JNEUROSCI.2837-07.2007; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Logan GD, 1984, PSYCHOL REV, V91, P195; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Rushworth MFS, 2005, J NEUROSCI, V25, P11628, DOI 10.1523/JNEUROSCI.2765-05.2005; Sakagami M, 2001, J NEUROSCI, V21, P4801, DOI 10.1523/JNEUROSCI.21-13-04801.2001; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Simons JS, 2005, NEUROPSYCHOLOGIA, V43, P1774, DOI 10.1016/j.neuropsychologia.2005.02.004; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Ullsperger M, 2010, BRAIN STRUCT FUNCT, V214, P629, DOI 10.1007/s00429-010-0261-1; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Wang M, 2000, EUR J NEUROSCI, V12, P3787, DOI 10.1046/j.1460-9568.2000.00238.x; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	64	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20840	10.1371/journal.pone.0020840	http://dx.doi.org/10.1371/journal.pone.0020840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673969	gold, Green Submitted, Green Published			2022-12-25	WOS:000291356400032
J	Uliczka, F; Pisano, F; Kochut, A; Opitz, W; Herbst, K; Stolz, T; Dersch, P				Uliczka, Frank; Pisano, Fabio; Kochut, Annika; Opitz, Wiebke; Herbst, Katharina; Stolz, Tatjana; Dersch, Petra			Monitoring of Gene Expression in Bacteria during Infections Using an Adaptable Set of Bioluminescent, Fluorescent and Colorigenic Fusion Vectors	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; PROMOTER-PROBE VECTORS; YERSINIA-ENTEROCOLITICA; ESCHERICHIA-COLI; LIVING CELLS; PROTEIN; GFP; CONSTRUCTION; FAMILY; EVOLUTION	A family of versatile promoter-probe plasmids for gene expression analysis was developed based on a modular expression plasmid system (pZ). The vectors contain different replicons with exchangeable antibiotic cassettes to allow compatibility and expression analysis on a low-, midi-and high-copy number basis. Suicide vector variants also permit chromosomal integration of the reporter fusion and stable vector derivatives can be used for in vivo or in situ expression studies under non-selective conditions. Transcriptional and translational fusions to the reporter genes gfp(mut3.1), amCyan, dsRed2, luxCDABE, phoA or lacZ can be constructed, and presence of identical multiple cloning sites in the vector system facilitates the interchange of promoters or reporter genes between the plasmids of the series. The promoter of the constitutively expressed gapA gene of Escherichia coli was included to obtain fluorescent and bioluminescent expression constructs. A combination of the plasmids allows simultaneous detection and gene expression analysis in individual bacteria, e. g. in bacterial communities or during mouse infections. To test our vector system, we analyzed and quantified expression of Yersinia pseudotuberculosis virulence genes under laboratory conditions, in association with cells and during the infection process.	[Uliczka, Frank; Pisano, Fabio; Kochut, Annika; Opitz, Wiebke; Herbst, Katharina; Stolz, Tatjana; Dersch, Petra] Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Lower Saxony, Germany; [Uliczka, Frank; Dersch, Petra] Tech Univ Carolo Wilhelmina Braunschweig, Dept Microbiol, Braunschweig, Lower Saxony, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Braunschweig University of Technology	Uliczka, F (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Infect Biol, Braunschweig, Lower Saxony, Germany.	petra.dersch@helmholtz-hzi.de		Dersch, Petra/0000-0001-8177-3280	BMBF [TP1]; Deutsche Forschungsgemeinschaft [SFB621 TP-B10, SPP1316]; Fonds der Chemischen Industrie; HBRS; "Excellence Initiative" of the German Government	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); HBRS; "Excellence Initiative" of the German Government	This work was supported by a grant from the BMBF (Zoonosis Program FBI-Zoo, TP1), the Deutsche Forschungsgemeinschaft (SFB621 TP-B10 and SPP1316) and the Fonds der Chemischen Industrie. W. Opitz was supported by a fellowship from the HBRS - PhD Program "Infection Biology" at the Medical School Hannover funded by the "Excellence Initiative" of the German Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Goulding A, 2008, PROTEIN ENG DES SEL, V21, P101, DOI 10.1093/protein/gzm075; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Hakkila K, 2002, ANAL BIOCHEM, V301, P235, DOI 10.1006/abio.2001.5517; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Hughes KT, 2007, METHOD ENZYMOL, V421, P140, DOI 10.1016/S0076-6879(06)21013-9; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Jakobs S, 2000, FEBS LETT, V479, P131, DOI 10.1016/S0014-5793(00)01896-2; Karsi A, 2006, FEMS MICROBIOL LETT, V260, P216, DOI 10.1111/j.1574-6968.2006.00310.x; Karunakaran R, 2005, MICROBIOL-SGM, V151, P3249, DOI 10.1099/mic.0.28311-0; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Matthysse AG, 1996, FEMS MICROBIOL LETT, V145, P87, DOI 10.1016/0378-1097(96)00392-8; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; METCALF WW, 1993, GENE, V129, P17, DOI 10.1016/0378-1119(93)90691-U; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Pakhomov AA, 2008, CHEM BIOL, V15, P755, DOI 10.1016/j.chembiol.2008.07.009; Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231; Sambrook J., MOL CLONING LAB MANU; Sample V, 2009, CHEM SOC REV, V38, P2852, DOI 10.1039/b913033k; SILHAVY TJ, 1985, MICROBIOL REV, V49, P398, DOI 10.1128/MMBR.49.4.398-418.1985; SILHAVY TJ, EXPT GENE FUSIONS; SKURNIK M, 1992, J BACTERIOL, V174, P2047, DOI 10.1128/jb.174.6.2047-2051.1992; Strauch E, 2000, J BIOTECHNOL, V79, P63, DOI 10.1016/S0168-1656(00)00216-9; Trcek J, 2010, FEMS MICROBIOL LETT, V307, P201, DOI 10.1111/j.1574-6968.2010.01983.x; Valdivia RH, 1997, TRENDS MICROBIOL, V5, P360, DOI 10.1016/S0966-842X(97)01111-6; Viallet PM, 2003, CURR PROTEIN PEPT SC, V4, P375, DOI 10.2174/1389203033487045; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	38	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20425	10.1371/journal.pone.0020425	http://dx.doi.org/10.1371/journal.pone.0020425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673990	Green Submitted, Green Published, gold			2022-12-25	WOS:000291355500018
J	Das, A; Dey, N; Ghosh, A; Das, T; Chatterjee, IB				Das, Archita; Dey, Neekkan; Ghosh, Arunava; Das, Tanusree; Chatterjee, Indu B.			NAD(P)H: Quinone Oxidoreductase 1 Deficiency Conjoint with Marginal Vitamin C Deficiency Causes Cigarette Smoke Induced Myelodysplastic Syndromes	PLOS ONE			English	Article							INDUCED OXIDATIVE DAMAGE; ASCORBIC-ACID; GENETIC SUSCEPTIBILITY; ACUTE-LEUKEMIA; LUNG-CANCER; BENZENE; RISK; APOPTOSIS; MECHANISM; DNA	Background: The etiology of myelodysplastic syndromes (MDS) is largely unknown. Exposure to cigarette smoke (CS) is reported to be associated with MDS risk. There is inconsistent evidence that deficiency of NAD(P)H-quinone: oxidoreductase 1 (NQO1) increases the risk of MDS. Earlier we had shown that CS induces toxicity only in marginal vitamin C-deficient guinea pigs but not in vitamin C-sufficient ones. We therefore considered that NQO1 deficiency along with marginal vitamin C deficiency might produce MDS in CS-exposed guinea pigs. Methodology and Principal Findings: Here we show that CS exposure for 21 days produces MDS in guinea pigs having deficiency of NQO1 (fed 3 mg dicoumarol/day) conjoint with marginal vitamin C deficiency (fed 0.5 mg vitamin C/day). As evidenced by morphology, histology and cytogenetics, MDS produced in the guinea pigs falls in the category of refractory cytopenia with unilineage dysplasia (RCUD): refractory anemia; refractory thrombocytopenia that is associated with ring sideroblasts, micromegakaryocytes, myeloid hyperplasia and aneuploidy. MDS is accompanied by increased CD34(+) cells and oxidative stress as shown by the formation of protein carbonyls and 8-oxodeoxyguanosine. Apoptosis precedes MDS but disappears later with marked decrease in the p53 protein. MDS produced in the guinea pigs are irreversible. MDS and all the aforesaid pathophysiological events do not occur in vitamin C-sufficient guinea pigs. However, after the onset of MDS vitamin C becomes ineffective. Conclusions and Significance: CS exposure causes MDS in guinea pigs having deficiency of NQO1 conjoint with marginal vitamin C deficiency. The syndromes are not produced in singular deficiency of NQO1 or marginal vitamin C deficiency. Our results suggest that human smokers having NQO1 deficiency combined with marginal vitamin C deficiency are likely to be at high risk for developing MDS and that intake of a moderately large dose of vitamin C would prevent MDS.	[Das, Archita; Dey, Neekkan; Ghosh, Arunava; Chatterjee, Indu B.] Univ Calcutta, Coll Sci, Dept Biotechnol, Kolkata, W Bengal, India; [Das, Archita; Dey, Neekkan; Ghosh, Arunava; Chatterjee, Indu B.] Univ Calcutta, Coll Sci, Dr BC Guha Ctr Genet Engn & Biotechnol, Kolkata, W Bengal, India; [Das, Tanusree] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, A (corresponding author), Univ Calcutta, Coll Sci, Dept Biotechnol, Kolkata, W Bengal, India.	ibc123@rediffmail.com	DAS, ARCHITA/ABD-5437-2020; Ghosh, Arunava/I-5939-2019	Ghosh, Arunava/0000-0001-9550-1366; Dey, Neekkan/0000-0002-4042-7215	Juthika Research Foundation; Calcutta University	Juthika Research Foundation; Calcutta University(University of Calcutta)	This research was supported by Juthika Research Foundation and Phulrenu Guha Research Fellowship of Calcutta University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva C, 2010, LEUKEMIA, V24, P1, DOI 10.1038/leu.2009.157; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; ATTAR EC, 2008, HARRISONS MANUAL ONC, P289; AUL C, 1992, BRIT J HAEMATOL, V82, P358, DOI 10.1111/j.1365-2141.1992.tb06430.x; Bain BJ, 2006, DACIE LEWIS PRACTICA, V4, P60; Banerjee S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-21; Bauer AK, 2003, CANCER RES, V63, P929; Bjork J, 2000, EPIDEMIOLOGY, V11, P285, DOI 10.1097/00001648-200005000-00010; Bjork J, 2009, LEUKEMIA RES, V33, P788, DOI 10.1016/j.leukres.2008.10.009; Blagosklonny MV, 2000, LEUKEMIA, V14, P2017, DOI 10.1038/sj.leu.2401979; Bogdanovic AD, 1997, LEUKEMIA, V11, P656, DOI 10.1038/sj.leu.2400640; Bolton JL, 2000, CHEM RES TOXICOL, V13, P135, DOI 10.1021/tx9902082; CARSON DA, 1995, LANCET, V346, P1009, DOI 10.1016/S0140-6736(95)91693-8; CHATTERJEE I, 1961, NATURE, V192, P163, DOI 10.1038/192163a0; CHATTERJEE IB, 1973, SCIENCE, V182, P1271, DOI 10.1126/science.182.4118.1271; Chatterjee IB, 2005, US Patent, Patent No. [6,929,012, 6929012, 6,929, 012]; Dey N, 2010, J BIOSCIENCES, V35, P217, DOI 10.1007/s12038-010-0026-2; Fontenay M, 2008, HAEMATOL-HEMATOL J, V93, P1288, DOI 10.3324/haematol.13563; Frei B, 2008, P NATL ACAD SCI USA, V105, P11037, DOI 10.1073/pnas.0806433105; Ganmore I, 2009, HUM MOL GENET, V18, pR84, DOI 10.1093/hmg/ddp084; Gava A, 1998, GENET MOL BIOL, V21, P77, DOI 10.1590/S1415-47571998000100013; GOGNA A, 2008, JIACM, V9, P143; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Head K A, 1998, Altern Med Rev, V3, P174; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOSODA S, 1974, J BIOL CHEM, V249, P6416; Hwang ES, 2007, TOXICOLOGY, V229, P1, DOI 10.1016/j.tox.2006.10.013; Iskander K, 2005, CHEM-BIOL INTERACT, V153, P147, DOI 10.1016/j.cbi.2005.03.019; Jankowska AM, 2008, LEUKEMIA, V22, P551, DOI 10.1038/sj.leu.2405055; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Lan Q, 2004, CARCINOGENESIS, V25, P2177, DOI 10.1093/carcin/bgh240; Lee KW, 2003, AM J CLIN NUTR, V78, P1074, DOI 10.1093/ajcn/78.6.1074; Lichtman MA, 2007, LEUKEMIA, V21, P1137, DOI 10.1038/sj.leu.2404698; Long DJ, 2002, CANCER RES, V62, P3030; MA X, 2009, AM J EPIDEMIOLOGY; Nebert DW, 2002, GENET MED, V4, P62, DOI 10.1097/00125817-200203000-00003; Panda K, 1999, FREE RADICAL BIO MED, V27, P1064, DOI 10.1016/S0891-5849(99)00154-9; Panda K, 2000, FREE RADICAL BIO MED, V29, P115, DOI 10.1016/S0891-5849(00)00297-5; Park DJ, 1996, SEMIN HEMATOL, V33, P256; Pasqualetti P, 1997, BRIT J HAEMATOL, V97, P659, DOI 10.1046/j.1365-2141.1997.942910.x; Platzbecker U, 2007, CANCER TREAT REV, V33, pS53, DOI 10.1016/j.ctrv.2007.07.021; Pryor WA, 1998, CHEM RES TOXICOL, V11, P441, DOI 10.1021/tx970159y; Rajnoldi AC, 2005, ANN HEMATOL, V84, P429, DOI 10.1007/s00277-005-1034-4; Reis SC, 2009, NEOPLASMA, V56, P435, DOI 10.4149/neo_2009_05_435; Ross D, 2005, CHEM-BIOL INTERACT, V153, P137, DOI 10.1016/j.cbi.2005.03.018; RUSSELL WO, 1952, CANCER RES, V12, P216; SEO IS, 1993, MAYO CLIN PROC, V68, P47, DOI 10.1016/S0025-6196(12)60018-4; Shetty V, 2000, BLOOD, V96, P1388, DOI 10.1182/blood.V96.4.1388.h8001388_1388_1392; Smith MT, 1996, ENVIRON HEALTH PERSP, V104, P1219, DOI 10.2307/3433166; Smith MT, 2001, BLOOD, V97, P1422, DOI 10.1182/blood.V97.5.1422; Smith MT, 1999, P NATL ACAD SCI USA, V96, P7624, DOI 10.1073/pnas.96.14.7624; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615; Steiner M, 1999, CANCER LETT, V135, P67; Stepanov I, 2006, NICOTINE TOB RES, V8, P309, DOI 10.1080/14622200500490151; Stewart B. W., 2003, WORLD CANC REPORT, P21; Strom SS, 2008, SEMIN HEMATOL, V45, P8, DOI 10.1053/j.seminhematol.2007.10.003; Strom SS, 2005, LEUKEMIA, V19, P1912, DOI 10.1038/sj.leu.2403945; SULLIVAN AB, 1976, J PHYS CHEM-US, V80, P2671, DOI 10.1021/j100565a010; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; VEENBAIGENT MJ, 1975, ANN NY ACAD SCI, V258, P339, DOI 10.1111/j.1749-6632.1975.tb29294.x; WALDO AL, 1955, CANCER, V8, P187, DOI 10.1002/1097-0142(1955)8:1<187::AID-CNCR2820080126>3.0.CO;2-S; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Wright JL, 2002, CHEST, V121, p188S, DOI 10.1378/chest.121.5_suppl.188S; Yin L, 2001, LUNG CANCER-J IASLC, V33, P133, DOI 10.1016/S0169-5002(01)00182-9	68	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20590	10.1371/journal.pone.0020590	http://dx.doi.org/10.1371/journal.pone.0020590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655231	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600105
J	Dmitrieva, NI; Burg, MB				Dmitrieva, Natalia I.; Burg, Maurice B.			Increased Insensible Water Loss Contributes to Aging Related Dehydration	PLOS ONE			English	Article							VASOPRESSIN; AGE; SENESCENCE; DELETION; BARRIER	Dehydration with aging is attributed to decreased urine concentrating ability and thirst. We further investigated by comparing urine concentration and water balance in 3, 18 and 27 month old mice, consuming equal amounts of water. During water restriction, 3 month old mice concentrate their urine sufficiently to maintain water balance (stable weight). 18 month old mice concentrate their urine as well, but still lose weight (negative water balance). 27 month old mice do not concentrate their urine as well and lose even more weight than the 18 month old mice, indicating a larger negative water balance. Negative water balance in older mice is accompanied by increased vasopressin excretion, providing further evidence of dehydration. All 3 groups maintain water balance while consuming only the water in gel food containing 56% water. However, both older groups excrete a smaller volume of urine of higher osmolality, indicating greater extra urinary water loss. Since their feces also contain less water, the excess water lost by the older mice apparently is through other routes, presumably insensible loss through the respiratory tract and skin. The greater insensible water loss occurs at an earlier age (18 months) than decreased urine concentrating ability (27 months). We propose that insensible water loss through skin and respiration increases with age, making a major contribution to aging related dehydration.	[Dmitrieva, Natalia I.; Burg, Maurice B.] NHLBI, Lab Kidney & Electrolyte Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Dmitrieva, NI (corresponding author), NHLBI, Lab Kidney & Electrolyte Metab, NIH, Bldg 10, Bethesda, MD 20892 USA.	dmitrien@nhlbi.nih.gov	Dmitrieva, Natalia/Q-9175-2019; Dmitrieva, Natalia/A-2924-2013	Dmitrieva, Natalia/0000-0001-8074-6950; Dmitrieva, Natalia/0000-0001-8074-6950	National Heart, Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001283, ZIAHL006131] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Program of the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Dmitrieva NI, 2007, CELL CYCLE, V6, P3108, DOI 10.4161/cc.6.24.5084; Dmitrieva NI, 2009, AGING-US, V1, P245, DOI 10.18632/aging.100022; Farahmand S, 2009, SKIN RES TECHNOL, V15, P392, DOI 10.1111/j.1600-0846.2009.00376.x; Frolkis VV, 1999, ARCH GERONTOL GERIAT, V29, P193; GEELEN G, 1992, AM J PHYSIOL, V262, pR826, DOI 10.1152/ajpregu.1992.262.5.R826; GHADIALLY R, 1995, J CLIN INVEST, V95, P2281, DOI 10.1172/JCI117919; GILLOOLY M, 1993, THORAX, V48, P39, DOI 10.1136/thx.48.1.39; Guyton AC, 2000, TXB MED PHYSL, P263; Imhof R. E., 2009, International Journal of Cosmetic Science, V31, P97, DOI 10.1111/j.1468-2494.2008.00476.x; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010; Kenney WL, 2001, MED SCI SPORT EXER, V33, P1524, DOI 10.1097/00005768-200109000-00016; Knepper MA, 2008, NAT MED, V14, P14, DOI 10.1038/nm0108-14; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Machado M., 2010, International Journal of Cosmetic Science, V32, P397, DOI 10.1111/j.1468-2494.2010.00587.x; ONEILL PA, 1992, MED LAB SCI, V49, P291; ROWE JW, 1976, NEPHRON, V17, P270, DOI 10.1159/000180731; Sands JM, 2009, SEMIN NEPHROL, V29, P579, DOI 10.1016/j.semnephrol.2009.07.004; Shirreffs SM, 2003, EUR J CLIN NUTR, V57, pS6, DOI 10.1038/sj.ejcn.1601895; Tian Y, 2004, AM J PHYSIOL-RENAL, V287, pF797, DOI 10.1152/ajprenal.00403.2003; Torres VE, 2009, KIDNEY INT, V76, P925, DOI 10.1038/ki.2009.325; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770	23	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20691	10.1371/journal.pone.0020691	http://dx.doi.org/10.1371/journal.pone.0020691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655199	Green Submitted, gold, Green Published			2022-12-25	WOS:000291097600123
J	Fritsch, C; Coeurdassier, M; Giraudoux, P; Raoul, F; Douay, F; Rieffel, D; de Vaufleury, A; Scheifler, R				Fritsch, Clementine; Coeurdassier, Michael; Giraudoux, Patrick; Raoul, Francis; Douay, Francis; Rieffel, Dominique; de Vaufleury, Annette; Scheifler, Renaud			Spatially Explicit Analysis of Metal Transfer to Biota: Influence of Soil Contamination and Landscape	PLOS ONE			English	Article							ECOLOGICAL RISK-ASSESSMENT; WHITE-TOOTHED SHREW; SMALL MAMMALS; CLETHRIONOMYS-GLAREOLUS; CROCIDURA-RUSSULA; HEAVY-METALS; BODY BURDENS; HOST FACTORS; FOOD-CHAIN; EXPOSURE	Concepts and developments for a new field in ecotoxicology, referred to as "landscape ecotoxicology,'' were proposed in the 1990s; however, to date, few studies have been developed in this emergent field. In fact, there is a strong interest in developing this area, both for renewing the concepts and tools used in ecotoxicology as well as for responding to practical issues, such as risk assessment. The aim of this study was to investigate the spatial heterogeneity of metal bioaccumulation in animals in order to identify the role of spatially explicit factors, such as landscape as well as total and extractable metal concentrations in soils. Over a smelter-impacted area, we studied the accumulation of trace metals (TMs: Cd, Pb and Zn) in invertebrates (the grove snail Cepaea sp and the glass snail Oxychilus draparnaudi) and vertebrates (the bank vole Myodes glareolus and the greater white-toothed shrew Crocidura russula). Total and CaCl2-extractable concentrations of TMs were measured in soils from woody patches where the animals were captured. TM concentrations in animals exhibited a high spatial heterogeneity. They increased with soil pollution and were better explained by total rather than CaCl2-extractable TM concentrations, except in Cepaea sp. TM levels in animals and their variations along the pollution gradient were modulated by the landscape, and this influence was species and metal specific. Median soil metal concentrations (predicted by universal kriging) were calculated in buffers of increasing size and were related to bioaccumulation. The spatial scale at which TM concentrations in animals and soils showed the strongest correlations varied between metals, species and landscapes. The potential underlying mechanisms of landscape influence (community functioning, behaviour, etc.) are discussed. Present results highlight the need for the further development of landscape ecotoxicology and multi-scale approaches, which would enhance our understanding of pollutant transfer and effects in ecosystems.	[Fritsch, Clementine; Coeurdassier, Michael; Giraudoux, Patrick; Raoul, Francis; Rieffel, Dominique; de Vaufleury, Annette; Scheifler, Renaud] Univ Franche Comte, Dept Chronoenvironm, UMR UFC CNRS USC INRA 6249, F-25030 Besancon, France; [Douay, Francis] Univ Lille Nord France, Lille, France; [Douay, Francis] LGCgE, EA 4515, Lille, France	INRAE; Universite de Franche-Comte; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Fritsch, C (corresponding author), Univ Franche Comte, Dept Chronoenvironm, UMR UFC CNRS USC INRA 6249, F-25030 Besancon, France.	clementine.fritsch@univ-fcomte.fr	Giraudoux, Patrick/B-9274-2011; Raoul, Francis/H-7706-2012; Scheifler, Renaud/H-2971-2014	Giraudoux, Patrick/0000-0003-2376-0136; Raoul, Francis/0000-0001-9566-9599; Scheifler, Renaud/0000-0002-9620-0204; FRITSCH, Clementine/0000-0003-2062-5799	ANR (Agence Nationale de la Recherche) [ANR-05-ECCO-004]; ADEME (Agence de l'Environnement et de la Maitrise de l'Energie) [0572C0058]; Conseil Regional de Franche-Comte	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); ADEME (Agence de l'Environnement et de la Maitrise de l'Energie); Conseil Regional de Franche-Comte(Region Bourgogne-Franche-Comte)	The STARTT research programme was financially supported by ANR (Agence Nationale de la Recherche - http://www.agence-nationale-recherche.fr - contract n<SUP>o</SUP>ANR-05-ECCO-004) and ADEME (Agence de l'Environnement et de la Maitrise de l'Energie - http://www.ademe.fr - contract n<SUP>o</SUP>0572C0058). CF was financially supported by a grant from ADEME and the Conseil Regional de Franche-Comte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt KF, 1998, ACTA THERIOL, V43, P379, DOI 10.4098/AT.arch.98-49; *AFNOR, 1996, X31147 NF AFNOR; Ares J, 2003, ENVIRON TOXICOL CHEM, V22, P945, DOI 10.1002/etc.5620220501; Baker S, 2003, ECOTOX ENVIRON SAFE, V56, P6, DOI 10.1016/S0147-6513(03)00046-0; Barnthouse Lawrence W., 2008, P1; BAUR A, 1993, MALACOLOGIA, V35, P89; BERGER B, 1993, ENVIRON MONIT ASSESS, V25, P65, DOI 10.1007/BF00549793; Bleeker EAJ, 2007, ENVIRON POLLUT, V148, P824, DOI 10.1016/j.envpol.2007.01.034; Burel F, 2004, LANDSCAPE URBAN PLAN, V67, P195, DOI 10.1016/S0169-2046(03)00039-2; Burel F., 2003, LANDSCAPE ECOLOGY CO; Burger J, 2003, ECOTOX ENVIRON SAFE, V56, P20, DOI 10.1016/S0147-6513(03)00047-2; Cairns J, 1996, ECOL APPL, V6, P790, DOI 10.2307/2269484; CAMERON RAD, 1977, J ANIM ECOL, V46, P173, DOI 10.2307/3954; Carlsen TM, 2004, ENVIRON TOXICOL CHEM, V23, P798, DOI 10.1897/02-202; Chaline J, 1974, PROIES RAPACES; CHARISSOU I, 1999, SUPPLEMENT SCI REV E, V44, P1; CLIFFORD PA, 1995, ENVIRON TOXICOL CHEM, V14, P895, DOI [10.1897/1552-8618(1995)14[895:AATQSC]2.0.CO;2, 10.1002/etc.5620140523]; Coeurdassier M, 2002, ECOTOX ENVIRON SAFE, V53, P425, DOI 10.1016/S0147-6513(02)00004-0; Dallinger R, 2004, ECOTOXICOLOGY, V13, P757, DOI 10.1007/s10646-003-4474-4; Damek-Poprawa M, 2004, ENVIRON RES, V96, P72, DOI 10.1016/j.envres.2004.02.003; Danson FM, 2003, PARASITOLOGY, V127, pS133, DOI 10.1017/S0031182003003639; de la Pena NM, 2003, LANDSCAPE ECOL, V18, P265, DOI 10.1023/A:1024452930326; de Vaufleury AG, 2000, CHEMOSPHERE, V40, P275, DOI 10.1016/S0045-6535(99)00246-5; Douay F, 2009, SCI TOTAL ENVIRON, V407, P5564, DOI 10.1016/j.scitotenv.2009.06.015; Douay F, 2008, WATER AIR SOIL POLL, V188, P247, DOI 10.1007/s11270-007-9541-7; Ettler V, 2005, CHEMOSPHERE, V58, P1449, DOI 10.1016/j.chemosphere.2004.09.084; Fairbrother A, 2007, ECOTOX ENVIRON SAFE, V68, P145, DOI 10.1016/j.ecoenv.2007.03.015; Fowler D, 1998, WATER AIR SOIL POLL, V105, P459, DOI 10.1023/A:1005043829181; Fowler D., 2003, BIOGEOCHEMICAL INVES, V4, P483, DOI DOI 10.1023/B:WAF0.0000028373.02470.BA; Frangi JP, 1997, SCI TOTAL ENVIRON, V205, P71, DOI 10.1016/S0048-9697(97)00184-8; Fritsch C, 2011, ECOTOXICOLOGY, V20, P739, DOI 10.1007/s10646-011-0619-z; Fritsch C, 2010, CHEMOSPHERE, V81, P141, DOI 10.1016/j.chemosphere.2010.06.075; Fritsch C, 2010, ENVIRON POLLUT, V158, P827, DOI 10.1016/j.envpol.2009.09.027; Gaines KF, 2005, SCI TOTAL ENVIRON, V341, P15, DOI 10.1016/j.scitotenv.2004.09.017; Giraudoux P, 2002, NATO SCI SER I LIFE, V341, P251; Grafen A., 2002, MODERN STAT LIFE SCI; Harmsen J., 2008, ISODIS17402; Harmsen J, 2007, J ENVIRON QUAL, V36, P1420, DOI 10.2134/jeq2006.0492; Hendrickx F, 2004, ENVIRON POLLUT, V127, P335, DOI 10.1016/j.envpol.2003.09.001; Hispard F., 2007, ENVIRON INT, V34, P381; Hobbelen PHF, 2006, ENVIRON POLLUT, V144, P639, DOI 10.1016/j.envpol.2006.01.019; Hope BK, 2001, RISK ANAL, V21, P1001, DOI 10.1111/0272-4332.216169; Hope BK, 2000, RISK ANAL, V20, P573, DOI 10.1111/0272-4332.205053; Hope BK, 2006, ENVIRON INT, V32, P983, DOI 10.1016/j.envint.2006.06.005; Kapusta P, 2003, APPL SOIL ECOL, V23, P187, DOI 10.1016/S0929-1393(03)00064-7; Kapustka Larry, 2008, Integrated Environmental Assessment and Management, V4, P290, DOI 10.1897/IEAM_2007-084.1; Kerney MP., 2006, GUIDE ESCARGOTS LIMA; Kitron U, 2006, GEOSPATIAL HEALTH, V1, P49, DOI 10.4081/gh.2006.280; Kooistra L, 2005, ENVIRON SCI TECHNOL, V39, P2177, DOI 10.1021/es049814w; Kooistra L, 2001, ENVIRON MANAGE, V28, P359, DOI 10.1007/s0026702433; KOZAKIEWICZ M, 1976, Acta Theriologica, V21, P314; Kozakiewicz Michal, 2000, Polish Journal of Ecology, V48, P149; Le Louarn H., 2003, RONGEURS FRANCE FAUN; Lidicker WZ, 2008, BIOL REV, V83, P71, DOI 10.1111/j.1469-185X.2007.00032.x; Loos M, 2009, ENVIRON TOXICOL CHEM, V28, P2378, DOI 10.1897/09-028.1; LUGONMOULIN N, 2003, MUSARAIGNES BIOL ECO; Magiera T, 2007, ENVIRON MONIT ASSESS, V125, P19, DOI 10.1007/s10661-006-9235-4; MAHTFELD K, 2000, IMPACT INTRO GASTROP; Marinussen MPJC, 1996, ECOL MODEL, V87, P83, DOI 10.1016/0304-3800(94)00207-X; MASON CF, 1970, OECOLOGIA, V4, P358, DOI 10.1007/BF00393394; Meers E, 2007, ENVIRON EXP BOT, V60, P385, DOI 10.1016/j.envexpbot.2006.12.010; Migeon A, 2009, WATER AIR SOIL POLL, V204, P89, DOI 10.1007/s11270-009-0029-5; Milton A, 2003, ARCH ENVIRON CON TOX, V44, P405, DOI 10.1007/s00244-002-2014-5; Monteiro MS, 2008, ENVIRON TOXICOL CHEM, V27, P2548, DOI 10.1897/08-154.1; Notten MJM, 2005, ENVIRON POLLUT, V138, P178, DOI 10.1016/j.envpol.2005.01.011; Paillat G, 1996, ACTA OECOL, V17, P553; Peakall D, 2003, ECOTOX ENVIRON SAFE, V56, P110, DOI 10.1016/S0147-6513(03)00055-1; Peijnenburg WJGM, 2003, ECOTOX ENVIRON SAFE, V56, P63, DOI 10.1016/S0147-6513(03)00051-4; POLLARD E, 1970, J APPL ECOL, V7, P549, DOI 10.2307/2401977; Purucker ST, 2007, ECOL MODEL, V204, P180, DOI 10.1016/j.ecolmodel.2006.12.032; R Development Core Team, 2006, R LANG ENV STAT COMP; Rieuwerts J, 1996, APPL GEOCHEM, V11, P17, DOI 10.1016/0883-2927(95)00050-X; Rogival D, 2007, ENVIRON POLLUT, V145, P516, DOI 10.1016/j.envpol.2006.04.019; Sadowska ET, 2008, PHYSIOL BIOCHEM ZOOL, V81, P627, DOI 10.1086/590164; Sanchez-Chardi A, 2007, CHEMOSPHERE, V68, P703, DOI 10.1016/j.chemosphere.2007.01.042; Sanchez-Chardi A, 2007, ENVIRON POLLUT, V145, P7, DOI 10.1016/j.envpol.2006.02.033; Sanchez-Chardi A, 2009, CHEMOSPHERE, V76, P387, DOI 10.1016/j.chemosphere.2009.03.036; Scheifler R, 2006, ENVIRON TOXICOL CHEM, V25, P815, DOI 10.1897/04-675R.1; Schipper AM, 2008, ENVIRON TOXICOL CHEM, V27, P919, DOI 10.1897/07-252.1; Shore R. F., 2001, ECOTOXICOLOGY WILD M; Smith PN, 2007, ENVIRON POLLUT, V150, P41, DOI 10.1016/j.envpol.2007.06.009; Smith R, 2005, SOIL USE MANAGE, V21, P527, DOI 10.1079/SUM2005345; Sterckeman T, 2000, ENVIRON POLLUT, V107, P377, DOI 10.1016/S0269-7491(99)00165-7; Sterckeman T, 2002, WATER AIR SOIL POLL, V135, P173, DOI 10.1023/A:1014758811194; TALMAGE SS, 1991, REV ENVIRON CONTAM T, V119, P47; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; van den Brink N, 2010, ENVIRON POLLUT, V158, P245, DOI 10.1016/j.envpol.2009.07.013; van Gestel CAM, 2008, SCI TOTAL ENVIRON, V406, P385, DOI 10.1016/j.scitotenv.2008.05.050; VERMEULEN F, 2009, SPATIALLY EXPLICIT E; Vermeulen F, 2009, ENVIRON POLLUT, V157, P3098, DOI 10.1016/j.envpol.2009.05.017; Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g; VONPROSCHWITZ T, 1994, J CONCHOL, V35, P183; Vuilleumier S, 2007, ECOL MODEL, V201, P369, DOI 10.1016/j.ecolmodel.2006.10.002; Wallace WG, 1998, MAR ECOL PROG SER, V172, P225, DOI 10.3354/meps172225; Wallace WG, 2003, MAR ECOL PROG SER, V257, P125, DOI 10.3354/meps257125; Wijnhoven S, 2007, ARCH ENVIRON CON TOX, V52, P603, DOI 10.1007/s00244-006-0124-1; Wijnhoven S, 2006, HYDROBIOLOGIA, V565, P135, DOI 10.1007/s10750-005-1910-x; WILLIAMSON P, 1979, J MOLLUS STUD, V45, P52; WILLIAMSON P, 1980, OECOLOGIA, V44, P213, DOI 10.1007/BF00572682; WILLIAMSON P, 1976, OIKOS, V27, P493, DOI 10.2307/3543468; WOLDA H, 1971, OECOLOGIA, V7, P361, DOI 10.1007/BF00345860; Woodbury PB, 2003, ENVIRON TOXICOL CHEM, V22, P977, DOI 10.1002/etc.5620220504	102	36	39	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20682	10.1371/journal.pone.0020682	http://dx.doi.org/10.1371/journal.pone.0020682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655187	Green Published, gold			2022-12-25	WOS:000291097600122
J	van Rijn, S; Swaab, H; Magnee, M; van Engeland, H; Kemner, C				van Rijn, Sophie; Swaab, Hanna; Magnee, Maurice; van Engeland, Herman; Kemner, Chantal			Psychophysiological Markers of Vulnerability to Psychopathology in Men with an Extra X Chromosome (XXY)	PLOS ONE			English	Article							EYE-MOVEMENT DYSFUNCTION; SCHIZOTYPAL PERSONALITY-DISORDER; IMPAIRED PREPULSE INHIBITION; SENSORIMOTOR GATING DEFICITS; SMOOTH-PURSUIT; STARTLE RESPONSE; SCHIZOPHRENIA-PATIENTS; KLINEFELTER-SYNDROME; ACOUSTIC STARTLE; P50 SUPPRESSION	Studying genetically defined syndromes associated with increased risk for psychopathology may help in understanding neurodevelopmental mechanisms related to risk for psychopathology. Klinefelter syndrome (47,XXY) is one of the most common sex chromosomal aneuploidies (1 in 650 male births) and associated with increased vulnerability for psychopathology, including psychotic symptoms. Yet, it remains unknown whether this increased risk is associated with underlying psychophysiological mechanisms that are typically deficient in individuals with psychotic disorders. The present study assessed three "classic" psychophysiological markers of psychosis in Klinefelter syndrome (KS): smooth pursuit eye movements (SPEM), prepulse inhibition (PPI) and P50 suppression. Fourteen adults with KS and 15 non-clinical adults participated in the study. Data on SPEM (reflecting visuo-motor control) as well as PPI and P50 suppression (reflecting sensory gating) were collected. Dysfunctions in SPEM were observed in individuals with KS, with less smooth pursuit as expressed in lower position gain. Also, reduced sensory gating in individuals with KS was suggested by significantly reduced prepulse inhibition of the startle response (PPI) (effect size 1.6). No abnormalities were found in suppression of the P50 (effect size 0.6). We speculate that impairments in these psychophysiological mechanisms may reflect core brain dysfunctions that may also mediate the described increased vulnerability for psychotic symptoms in KS. Although speculative, such deficit specific, rather than disorder specific, psychophysiological dysfunctions in KS might convey vulnerability to other types of psychopathology as well. As KS already can be diagnosed prenatally, the predictive value of childhood impairments in prepulse inhibition and smooth pursuit for development of psychopathology later in life could be assessed. In sum, studying individuals with KS may prove to be an avenue of research leading to new hypotheses and insights into "at risk" pathways to psychopathology.	[van Rijn, Sophie; Swaab, Hanna] Leiden Univ, Leiden, Netherlands; [van Rijn, Sophie; Swaab, Hanna] Univ Med Ctr Leiden, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Magnee, Maurice; van Engeland, Herman; Kemner, Chantal] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Utrecht University; Utrecht University Medical Center	van Rijn, S (corresponding author), Leiden Univ, Leiden, Netherlands.	srijn@fsw.leidenuniv.nl	Swaab, Hanna/AAD-2555-2019	van rijn, sophie/0000-0002-9179-7515; Swaab, Hanna/0000-0003-3697-060X	VENI [016.095.060]; Netherlands Organization for Scientific Research (NWO)	VENI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by a VENI grant (grant number 016.095.060 to SvR) from the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; Aukes MF, 2008, BIOL PSYCHIAT, V64, P128, DOI 10.1016/j.biopsych.2007.12.013; BARNEVELD PS, SCHIZOPHR RES; BISHOP DVM, ARCH DIS CH IN PRESS; Boada R, 2009, DEV DISABIL RES REV, V15, P284, DOI 10.1002/ddrr.83; Bojesen A, 2006, J CLIN ENDOCR METAB, V91, P1254, DOI 10.1210/jc.2005-0697; Boks MPM, 2007, SCHIZOPHR RES, V93, P399, DOI 10.1016/j.schres.2007.03.015; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Bruining H, 2009, PEDIATRICS, V123, pE865, DOI 10.1542/peds.2008-1954; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P1660, DOI 10.1176/appi.ajp.157.10.1660; CADENHEAD KS, 1993, AM J PSYCHIAT, V150, P1862; Cadenhead KS, 2001, BIOL PSYCHIAT, V49, p126S; Calkins ME, 2000, AM J MED GENET, V97, P72, DOI 10.1002/(SICI)1096-8628(200021)97:1<72::AID-AJMG10>3.0.CO;2-L; Calkins ME, 1998, BIOL PSYCHIAT, V43, p126S, DOI 10.1016/S0006-3223(98)90868-X; Calkins ME, 2008, BRAIN COGNITION, V68, P436, DOI 10.1016/j.bandc.2008.09.001; Cannon TD, 2005, CURR OPIN PSYCHIATR, V18, P135, DOI 10.1097/00001504-200503000-00005; Castellanos FX, 1996, BIOL PSYCHIAT, V39, P33, DOI 10.1016/0006-3223(95)00101-8; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; CLEMENTZ BA, 1990, PSYCHOL BULL, V108, P77, DOI 10.1037/0033-2909.108.1.77; Dawson ME, 2000, PSYCHIAT RES, V96, P187, DOI 10.1016/S0165-1781(00)00208-0; de Leeuw AS, 2010, INT CLIN PSYCHOPHARM, V25, P232, DOI 10.1097/YIC.0b013e328338c4f0; DELISI LE, 1994, SCHIZOPHRENIA BULL, V20, P495, DOI 10.1093/schbul/20.3.495; Ettinger U, 2004, J PSYCHIATR RES, V38, P177, DOI 10.1016/S0022-3956(03)00105-5; Ettinger U, 2001, SCHIZOPHR RES, V49, P214; Gooding DC, 2000, PSYCHIAT RES, V93, P41, DOI 10.1016/S0165-1781(00)00113-X; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GRATTON G, 1989, PSYCHOPHYSIOLOGY, V26, P222, DOI 10.1111/j.1469-8986.1989.tb03160.x; Hoenig K, 2005, BIOL PSYCHIAT, V57, P1153, DOI 10.1016/j.biopsych.2005.01.040; Holahan ALV, 2005, SCHIZOPHR RES, V76, P43, DOI 10.1016/j.schres.2004.10.005; Hutton S, 1998, NEUROLOGY, V50, P604, DOI 10.1212/WNL.50.3.604; Jha P, 2007, EUR CHILD ADOLES PSY, V16, P305, DOI 10.1007/s00787-007-0601-8; Karoumi B, 2001, PSYCHIAT RES, V101, P209, DOI 10.1016/S0165-1781(01)00227-X; Kemner C, 2002, J CLIN PSYCHIAT, V63, P214; Kumari V, 2005, PSYCHOPHYSIOLOGY, V42, P588, DOI 10.1111/j.1469-8986.2005.00346.x; Kumari V, 2005, NEUROIMAGE, V26, P1052, DOI 10.1016/j.neuroimage.2005.03.002; KUMARI V, 2005, PROGR SCHIZOPHRENIA; Kumra S, 1998, J AM ACAD CHILD PSY, V37, P292, DOI 10.1097/00004583-199803000-00014; Kumra S, 2001, AM J PSYCHIAT, V158, P1291, DOI 10.1176/appi.ajp.158.8.1291; LEE NR, J INT NEURO IN PRESS, P1; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; NAGAMOTO HT, 1989, BIOL PSYCHIAT, V25, P549, DOI 10.1016/0006-3223(89)90215-1; O'Driscoll GA, 2008, BRAIN COGNITION, V68, P359, DOI 10.1016/j.bandc.2008.08.023; Oranje B, 1999, BIOL PSYCHIAT, V45, P883, DOI 10.1016/S0006-3223(98)00128-0; Oranje B, 2006, PSYCHIAT RES, V143, P147, DOI 10.1016/j.psychres.2005.11.002; PERRY W, 1994, AM J PSYCHIAT, V151, P363; Perry W, 2001, BIOL PSYCHIAT, V50, P418, DOI 10.1016/S0006-3223(01)01184-2; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Ross RG, 2003, J AM ACAD CHILD PSY, V42, P468, DOI 10.1097/01.CHI.0000046818.95464.42; SIEVER LJ, 1984, AM J PSYCHIAT, V141, P1560; Smyrnis N, 2007, EXP BRAIN RES, V179, P397, DOI 10.1007/s00221-006-0797-8; SWAAB H, EXECUTIVE FUNC UNPUB; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; TARTAGLIA N, 2010, PEDIATR ENDOCR REV P, V1, P151; Toal F, 2009, BRIT J PSYCHIAT, V194, P418, DOI 10.1192/bjp.bp.107.049007; van Kampen D, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-27; van Rijn S, 2008, J AUTISM DEV DISORD, V38, P1634, DOI 10.1007/s10803-008-0542-1; Van Rijn S, 2006, BRIT J PSYCHIAT, V189, P459, DOI 10.1192/bjp.bp.105.008961; Vorstman JAS, 2009, NEUROPSYCHOPHARMACOL, V34, P739, DOI 10.1038/npp.2008.132; Wynn JK, 2004, BIOL PSYCHIAT, V55, P518, DOI 10.1016/j.biopsych.2003.10.018	64	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20292	10.1371/journal.pone.0020292	http://dx.doi.org/10.1371/journal.pone.0020292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655260	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600038
J	Wang, Y; Wu, CG; Ji, ZH; Wang, BH; Liang, YC				Wang, Yao; Wu, Chunguo; Ji, Zhaohua; Wang, Binghong; Liang, Yanchun			Non-Parametric Change-Point Method for Differential Gene Expression Detection	PLOS ONE			English	Article							CANCER; PATTERNS; MICROARRAYS; INFERENCE; BIOLOGY	Background: We proposed a non-parametric method, named Non-Parametric Change Point Statistic (NPCPS for short), by using a single equation for detecting differential gene expression (DGE) in microarray data. NPCPS is based on the change point theory to provide effective DGE detecting ability. Methodology: NPCPS used the data distribution of the normal samples as input, and detects DGE in the cancer samples by locating the change point of gene expression profile. An estimate of the change point position generated by NPCPS enables the identification of the samples containing DGE. Monte Carlo simulation and ROC study were applied to examine the detecting accuracy of NPCPS, and the experiment on real microarray data of breast cancer was carried out to compare NPCPS with other methods. Conclusions: Simulation study indicated that NPCPS was more effective for detecting DGE in cancer subset compared with five parametric methods and one non-parametric method. When there were more than 8 cancer samples containing DGE, the type I error of NPCPS was below 0.01. Experiment results showed both good accuracy and reliability of NPCPS. Out of the 30 top genes ranked by using NPCPS, 16 genes were reported as relevant to cancer. Correlations between the detecting result of NPCPS and the compared methods were less than 0.05, while between the other methods the values were from 0.20 to 0.84. This indicates that NPCPS is working on different features and thus provides DGE identification from a distinct perspective comparing with the other mean or median based methods.	[Wang, Yao; Wu, Chunguo; Ji, Zhaohua; Liang, Yanchun] Jilin Univ, Coll Comp Sci & Technol, Natl Educ Minist, Key Lab Symbol Computat & Knowledge Engn, Changchun, Jilin, Peoples R China; [Ji, Zhaohua] Inner Mongolia Xingan Vocat & Tech Coll, Wulanhaote, Peoples R China; [Wu, Chunguo; Wang, Binghong] Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China; [Wu, Chunguo; Wang, Binghong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China	Jilin University; University of Shanghai for Science & Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Liang, YC (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Natl Educ Minist, Key Lab Symbol Computat & Knowledge Engn, Changchun, Jilin, Peoples R China.	ycliang@jlu.edu.cn	Wu, Chunguo/A-6901-2008	Wu, Chunguo/0000-0002-7805-8224	National Natural Science Foundation of China (NSFC) [61073075, 60803052, 10872077, 91024026]; National High-Tech R&D Program of China [2009AA02Z307]; Jilin University [200903173]; Colleges and Universities of Inner Mongolia Autonomous Region of China [NJ10320]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China(National High Technology Research and Development Program of China); Jilin University(Jilin University); Colleges and Universities of Inner Mongolia Autonomous Region of China	This work was supported by funds from National Natural Science Foundation of China (NSFC) (61073075, 60803052, 10872077, and 91024026), http://www.nsfc.gov.cn/Portal0/default106.htm; the National High-Tech R&D Program of China (2009AA02Z307), http://www.863.gov.cn/; Jilin University ("985" project, "211" project, Scientific Frontier and Interdisciplinary Subject Project (200903173)); the Science-Technology Research Project of Colleges and Universities of Inner Mongolia Autonomous Region of China (NJ10320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSEVILLE M, 1993, DETECTION ABRUPT CHA; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gottardo R, 2006, BIOMETRICS, V62, P10, DOI 10.1111/j.1541-0420.2005.00397.x; Hu JH, 2008, BIOINFORMATICS, V24, P2193, DOI 10.1093/bioinformatics/btn372; Lian H, 2008, BIOSTATISTICS, V9, P411, DOI 10.1093/biostatistics/kxm042; Lyons-Weiler J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-110; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Magic Z, 2007, J BUON, V12, pS39; Muggeo VMR, 2011, BIOINFORMATICS, V27, P161, DOI 10.1093/bioinformatics/btq647; Pan Wei, 2003, Functional & Integrative Genomics, V3, P117; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Storey JD, 2003, SAM THRESHOLDING FAL; Tan ZP, 2000, J CHINA U SCI TECHNO, V6, P270; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029; Zhang Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-87	22	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20060	10.1371/journal.pone.0020060	http://dx.doi.org/10.1371/journal.pone.0020060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655325	Green Published, gold			2022-12-25	WOS:000291097600017
J	Gulia-Nuss, M; Robertson, AE; Brown, MR; Strand, MR				Gulia-Nuss, Monika; Robertson, Anne E.; Brown, Mark R.; Strand, Michael R.			Insulin-Like Peptides and the Target of Rapamycin Pathway Coordinately Regulate Blood Digestion and Egg Maturation in the Mosquito Aedes aegypti	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; DROSOPHILA; PROTEIN; METABOLISM; EXPRESSION; MIDGUT; ACTIVATION; ANAUTOGENY; GROWTH; FLIES	Background: Mosquitoes are insects that vector many serious pathogens to humans and other vertebrates. Most mosquitoes must feed on the blood of a vertebrate host to produce eggs. In turn, multiple cycles of blood feeding promote frequent contacts with hosts and make mosquitoes ideal disease vectors. Both hormonal and nutritional factors are involved in regulating egg development in the mosquito, Aedes aegypti. However, the processes that regulate digestion of the blood meal remain unclear. Methodology/Principal Findings: Here we report that insulin peptide 3 (ILP3) directly stimulated late phase trypsin-like gene expression in blood fed females. In vivo knockdown of the mosquito insulin receptor (MIR) by RNA interference (RNAi) delayed but did not fully inhibit trypsin-like gene expression in the midgut, ecdysteroid (ECD) production by ovaries, and vitellogenin (Vg) expression by the fat body. In contrast, in vivo treatment with double-stranded MIR RNA and rapamycin completely blocked egg production. In vitro experiments showed that amino acids did not simulate late phase trypsin-like gene expression in the midgut or ECD production by the ovaries. However, amino acids did enhance ILP3-mediated stimulation of trypsin-like gene expression and ECD production. Conclusions/Significance: Overall, our results indicate that ILPs from the brain synchronize blood meal digestion and amino acid availability with ovarian ECD production to maximize Vg expression by the fat body. The activation of digestion by ILPs may also underlie the growth promoting effects of insulin and TOR signaling in other species.	[Gulia-Nuss, Monika; Robertson, Anne E.; Brown, Mark R.; Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Brown, Mark R.; Strand, Michael R.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Gulia-Nuss, M (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	mrbrown@uga.edu; mrstrand@uga.edu	Gulia-Nuss, Monika/V-6809-2019	Gulia-Nuss, Monika/0000-0001-7095-1037	National Insitututes of Health [AI03108]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033108] Funding Source: NIH RePORTER	National Insitututes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Insitututes of Health (AI03108) (MRB and MRS) provided funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003; Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003; Briegel H, 2003, J VECTOR ECOL, V28, P1; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Graf R, 1998, J INSECT PHYSIOL, V44, P451, DOI 10.1016/S0022-1910(98)00042-0; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Lu SJ, 2006, INSECT BIOCHEM MOLEC, V36, P336, DOI 10.1016/j.ibmb.2006.01.011; Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5; Riehle MA, 2006, PEPTIDES, V27, P2547, DOI 10.1016/j.peptides.2006.07.016; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; ROY SG, 2011, INSECT BIOC IN PRESS; Sieglaff DH, 2005, INSECT BIOCHEM MOLEC, V35, P471, DOI 10.1016/j.ibmb.2005.01.011; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Wen ZM, 2010, MOL CELL ENDOCRINOL, V328, P47, DOI 10.1016/j.mce.2010.07.003; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	33	114	117	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20401	10.1371/journal.pone.0020401	http://dx.doi.org/10.1371/journal.pone.0020401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647424	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500056
J	Davis-Dusenbery, BN; Chan, MC; Reno, KE; Weisman, AS; Layne, MD; Lagna, G; Hata, A				Davis-Dusenbery, Brandi N.; Chan, Mun Chun; Reno, Kelsey E.; Weisman, Alexandra S.; Layne, Matthew D.; Lagna, Giorgio; Hata, Akiko			Down-regulation of Kruppel-like Factor-4 (KLF4) by MicroRNA-143/145 Is Critical for Modulation of Vascular Smooth Muscle Cell Phenotype by Transforming Growth Factor-beta and Bone Morphogenetic Protein 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; EMBRYONIC STEM-CELLS; ZINC-FINGER PROTEIN; GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARDIAC-HYPERTROPHY; SIGNALING PATHWAYS; MYOCARDIN; DIFFERENTIATION; SMAD	In the postnatal vasculature, fully differentiated and quiescent vascular smooth muscle cells (VSMCs) in a "contractile" phenotype are required for the normal regulation of vascular tone. The transforming growth factor-beta (TGF-beta) superfamily of growth factors (TGF-beta s and bone morphogenetic proteins (BMPs)) are potent inducers of contractile phenotype and mediate (i) induction of contractile genes, and (ii) inhibition of VSMC growth and migration. Transcription of contractile genes is positively regulated by a regulatory DNA element called a CArG box. The CArG box is activated by the binding of serum response factor and its coactivators, myocardin (Myocd) or Myocd-related transcription factors (MRTFs). Kruppel-like factor-4 (KLF4) is known to inhibit activation of the CArG box. However, the potential role of KLF4 in the contractile activities of TGF-beta or BMP has not been explored. Here, we demonstrate that TGF-beta and BMP4 rapidly down-regulate KLF4 through induction of microRNA-143 (miR-143) and miR-145, which leads to a reduction of KLF4 transcripts and decreased KLF4 protein expression. Inhibition of miR-145 prevents down-regulation of KLF4 and activation of contractile genes by TGF-beta or BMP4, suggesting that modulation of KLF4 is a prerequisite for induction of contractile genes by TGF-beta and BMP4. Interestingly, both TGF-beta and BMP4 activate transcription of the miR-143/145 gene cluster through the CArG box, however, TGF-beta mediates this effect through induction of Myocd expression, whereas BMP4 utilizes nuclear translocation of MRTF-A. Thus, this study sheds light on both the similarities and the differences of TGF-beta and BMP4 signaling in the regulation of KLF4 and contractile genes.	[Davis-Dusenbery, Brandi N.; Chan, Mun Chun; Weisman, Alexandra S.; Lagna, Giorgio; Hata, Akiko] Tufts Univ, Sch Med, Mol Cardiol Res Inst, Tufts Med Ctr, Boston, MA 02111 USA; [Reno, Kelsey E.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Layne, Matthew D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Tufts Medical Center; Tufts University; Tufts University; Boston University	Hata, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, MC 3118,555 Mission Bay Blvd S,Rm 252T, San Francisco, CA 94158 USA.	akiko.hata@ucsf.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613; Layne, Matthew/0000-0003-0007-4870	National Institutes of Health [HD042149, HL082854, HL078869, HL086572, T32 HL069770]; American Heart Association [0940095N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grants HD042149 and HL082854 (to A. H.), HL078869 (to M. D. L.), HL086572 (to G. L.), Training Grant T32 HL069770 (to B. N. D.-D.), and American Heart Association Grant 0940095N (to A. H.).	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Barst RJ, 2005, J CLIN INVEST, V115, P2691, DOI 10.1172/JCI26593; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Chen CH, 2010, ARTERIOSCL THROM VAS, V30, P835, DOI 10.1161/ATVBAHA.109.197251; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Chivukula RR, 2009, CELL, V137, P606, DOI 10.1016/j.cell.2009.04.059; Choi BJ, 2006, PATHOL RES PRACT, V202, P585, DOI 10.1016/j.prp.2006.05.001; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Ghaleb AM, 2007, CANCER RES, V67, P7147, DOI 10.1158/0008-5472.CAN-07-1302; Han Z, 2004, P NATL ACAD SCI USA, V101, P12567, DOI 10.1073/pnas.0405085101; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hu D, 2011, J BIOL CHEM, V286, P6890, DOI 10.1074/jbc.M110.179952; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Jeon ES, 2008, CIRC RES, V103, P635, DOI 10.1161/CIRCRESAHA.108.180885; Kennard S, 2008, J BIOL CHEM, V283, P1324, DOI 10.1074/jbc.M706651200; Kent OA, 2010, GENE DEV, V24, P2754, DOI 10.1101/gad.1950610; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Kuhn AR, 2010, AM J RESP CELL MOL, V42, P506, DOI 10.1165/rcmb.2009-0123OC; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; LAIHO M, 1987, J BIOL CHEM, V262, P17467; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miano JM, 2004, CIRC RES, V95, P340, DOI 10.1161/01.RES.0000140893.16465.2d; Michael MZ, 2003, MOL CANCER RES, V1, P882; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shats I, 2007, CELL CYCLE, V6, P1141, DOI 10.4161/cc.6.10.4251; Tai SK, 2011, CANCER SCI, V102, P895, DOI 10.1111/j.1349-7006.2011.01859.x; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; YU F, 2011, ONCOGENE	61	198	211	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28097	28110		10.1074/jbc.M111.236950	http://dx.doi.org/10.1074/jbc.M111.236950			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673106	hybrid, Green Published			2022-12-25	WOS:000293557800028
J	Kautzmann, MAI; Kim, DS; Felder-Schmittbuhl, MP; Swaroop, A				Kautzmann, Marie-Audrey I.; Kim, Douglas S.; Felder-Schmittbuhl, Marie-Paule; Swaroop, Anand			Combinatorial Regulation of Photoreceptor Differentiation Factor, Neural Retina Leucine Zipper Gene Nrl, Revealed by in Vivo Promoter Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR NR2E3; TRANSCRIPTION FACTOR NRL; CELL-FATE; PINEAL-GLAND; ROR-BETA; EXPRESSION; DEGENERATION; HOMEODOMAIN; MUTATIONS; COMPLEX	Development and homeostasis require stringent spatiotemporal control of gene expression patterns that are established, to a large extent, by combinatorial action of transcription regulatory proteins. The bZIP transcription factor NRL (neural retina leucine zipper) is critical for rod versus cone photoreceptor cell fate choice during retinal development and acts as a molecular switch to produce rods from postmitotic precursors. Loss of Nrl in mouse leads to a cone-only retina, whereas ectopic expression of Nrl in photoreceptor precursors generates rods. To decipher the transcriptional regulatory mechanisms upstream of Nrl, we identified putative cis-control elements in the Nrl promoter/enhancer region by examining cross-species sequence conservation. Using in vivo transfection of promoter-reporter constructs into the mouse retina, we show that a 0.9-kb sequence upstream of the Nrl transcription initiation site is sufficient to drive reporter gene expression in photoreceptors. We further define a 0.3-kb sequence including a proximal promoter (cluster A1) and an enhancer (cluster B) that can direct rod-specific expression in vivo. Electrophoretic mobility shift assays using mouse retinal nuclear extracts, in combination with specific antibodies, demonstrate the binding of retinoid-related orphan nuclear receptor beta (ROR beta), cone rod homeobox, orthodenticle homolog 2, and cyclic AMP response element-binding protein to predicted consensus elements within clusters A and B. Our studies demonstrate Nrl as a direct transcriptional target of ROR beta and suggest that combinatorial action of multiple regulatory factors modulates the expression of Nrl in developing and mature retina.	[Kautzmann, Marie-Audrey I.; Kim, Douglas S.; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Felder-Schmittbuhl, Marie-Paule] CNRS, UPR 3212, Inst Neurosci Cellulaires & Integrat, Dept Neurobiol Rythmes, F-67084 Strasbourg, France	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Swaroop, A (corresponding author), NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bldg 6-338,6 Ctr Dr,MSC0610, Bethesda, MD 20892 USA.	swaroopa@nei.nih.gov		Swaroop, Anand/0000-0002-1975-1141; Kim, Douglas/0000-0001-9029-314X	NEI, National Institutes of Health; NATIONAL EYE INSTITUTE [ZIAEY000450] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the intramural program of NEI, National Institutes of Health.	Akagi T, 2004, J BIOL CHEM, V279, P28492, DOI 10.1074/jbc.M400871200; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Andre E, 1998, GENE, V216, P277, DOI 10.1016/S0378-1119(98)00348-5; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Brzezinski JA, 2010, DEVELOPMENT, V137, P619, DOI 10.1242/dev.043968; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; DeAngelis MM, 2002, ARCH OPHTHALMOL-CHIC, V120, P369; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Georges AB, 2010, FASEB J, V24, P346, DOI 10.1096/fj.09-142117; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Jia L, 2009, P NATL ACAD SCI USA, V106, P17534, DOI 10.1073/pnas.0902425106; Trujillo MJ, 2001, HUM MUTAT, V17, DOI 10.1002/1098-1004(2001)17:1<80::AID-HUMU27>3.0.CO;2-G; KAROLCHIK D, 2009, CURR PROTOC BIOINFOR, V28; Katoh K, 2010, J NEUROSCI, V30, P6515, DOI 10.1523/JNEUROSCI.0771-10.2010; Khanna H, 2006, J BIOL CHEM, V281, P27327, DOI 10.1074/jbc.M605500200; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Lerner LE, 2001, J BIOL CHEM, V276, P34999, DOI 10.1074/jbc.M103301200; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lu AL, 2009, ENDOCRINOLOGY, V150, P1536, DOI 10.1210/en.2008-1092; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Marquardt T, 2003, PROG RETIN EYE RES, V22, P567, DOI 10.1016/S1350-9462(03)00036-3; Matsuda Takahiko, 2008, V423, P259, DOI 10.1007/978-1-59745-194-9_19; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Mitton KP, 2003, HUM MOL GENET, V12, P365, DOI 10.1093/hmg/ddg035; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Nir I, 2001, EXP EYE RES, V73, P265, DOI 10.1006/exer.2001.1037; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101; Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Parapuram SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013885; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Roger JE, 2010, J BIOL CHEM, V285, P25637, DOI 10.1074/jbc.M110.142810; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Siffroi-Fernandez S, 2008, INVEST OPHTH VIS SCI, V49, P1696, DOI 10.1167/iovs.07-1272; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Tjian R, 1996, PHILOS T R SOC B, V351, P491, DOI 10.1098/rstb.1996.0047; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; WEISS ER, 1995, BIOCHEM BIOPH RES CO, V216, P755, DOI 10.1006/bbrc.1995.2686; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717	66	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28247	28255		10.1074/jbc.M111.257246	http://dx.doi.org/10.1074/jbc.M111.257246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673114	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000293557800042
J	Evron, T; Philipp, M; Lu, JY; Meloni, AR; Burkhalter, M; Chen, W; Caron, MG				Evron, Tama; Philipp, Melanie; Lu, Jiuyi; Meloni, Alison R.; Burkhalter, Martin; Chen, Wei; Caron, Marc G.			Growth Arrest Specific 8 (Gas8) and G Protein-coupled Receptor Kinase 2 (GRK2) Cooperate in the Control of Smoothened Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN REGULATORY COMPLEX; PRIMARY CILIUM; GENE-PRODUCT; ZEBRAFISH; LOCALIZATION; TRANSDUCTION; PATHWAY; BETA-ARRESTIN-2; VERTEBRATES; EXPRESSION	The G protein-coupled receptor (GPCR)-like molecule Smoothened (Smo) undergoes dynamic intracellular trafficking modulated by the microtubule associated kinase GRK2 and recruitment of beta-arrestin. Of this trafficking, especially the translocation of Smo into primary cilia and back to the cytoplasm is essential for the activation of Hedgehog (Hh) signaling in vertebrates. The complete mechanism of this bidirectional transport, however, is not completely understood. Here we demonstrate that Growth Arrest Specific 8 (Gas8), a microtubule associated subunit of the Dynein Regulatory Complex (DRC), interacts with Smo to modulate this process. Gas8 knockdown in ciliated cells reduces Smo signaling activity and ciliary localization whereas overexpression stimulates Smo activity in a GRK2-dependent manner. The C terminus of Gas8 is important for both Gas8 interaction with Smo and facilitating Smo signaling. In zebrafish, knocking down Gas8 results in attenuated Hh transcriptional responses and impaired early muscle development. These effects can be reversed by the co-injection of Gas8 mRNA or by constitutive activation of the downstream Gli transcription factors. Furthermore, Gas8 and GRK2 display a synergistic effect on zebrafish early muscle development and some effects of GRK2 knockdown can be rescued by Gas8 mRNA. Interestingly, Gas8 does not interfere with cilia assembly, as the primary cilia architecture is unchanged upon Gas8 knock down or heterologous expression. This is in contrast to cells stably expressing both GRK2 and Smo, in which cilia are significantly elongated. These results identify Gas8 as a positive regulator of Hh signaling that cooperates with GRK2 to control Smo signaling.	[Evron, Tama; Philipp, Melanie; Meloni, Alison R.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Lu, Jiuyi; Chen, Wei] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Burkhalter, Martin] Univ Ulm, Dept Mol Med, D-89081 Ulm, Germany; [Burkhalter, Martin] Univ Ulm, Max Planck Res Grp Stem Cell Aging, D-89081 Ulm, Germany	Duke University; Duke University; Ulm University; Max Planck Society; Ulm University	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Box 3287,RM 487,Carl Bldg, Durham, NC 27710 USA.	caron002@mc.duke.edu	Philipp, Melanie/B-5198-2016	Philipp, Melanie/0000-0003-2714-965X; Chen, Wei/0000-0002-9934-4000; Burkhalter, Martin/0000-0002-8646-3131	National Institutes of Health [NS19576, MH073853]; Machiah Foundation; Jewish Community Federation of San Francisco; Peninsula County; Marin County; Sonoma County; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH073853, R01MH073853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Machiah Foundation; Jewish Community Federation of San Francisco; Peninsula County; Marin County; Sonoma County; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS19576 and MH073853.; Recipient of a postdoctoral fellowship from The Machiah Foundation, a supporting foundation of the Jewish Community Federation of San Francisco, the Peninsula, Marin, & Sonoma Counties.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bisgrove BW, 2005, DEV BIOL, V287, P274, DOI 10.1016/j.ydbio.2005.08.047; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Colantonio JR, 2009, NATURE, V457, P205, DOI 10.1038/nature07520; Colantonio JR, 2006, TRAFFIC, V7, P538, DOI 10.1111/j.1600-0854.2006.00411.x; Epstein DJ, 1996, DEVELOPMENT, V122, P2885; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hammond KL, 2010, DEVELOPMENT, V137, P1361, DOI 10.1242/dev.045666; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Huang P, 2009, DEVELOPMENT, V136, P3089, DOI 10.1242/dev.041343; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hutchings NR, 2002, J CELL BIOL, V156, P867, DOI 10.1083/jcb.200201036; Kalderon D, 2005, CURR BIOL, V15, pR175, DOI 10.1016/j.cub.2005.02.046; Kim HR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-65; KONG GH, 1994, J BIOL CHEM, V269, P13084; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lunt SC, 2009, DEV DYNAM, V238, P1744, DOI 10.1002/dvdy.21999; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Penela P, 2010, P NATL ACAD SCI USA, V107, P1118, DOI 10.1073/pnas.0905778107; Philipp M, 2008, MOL BIOL CELL, V19, P5478, DOI 10.1091/mbc.E08-05-0448; Pitcher JA, 1998, J BIOL CHEM, V273, P12316, DOI 10.1074/jbc.273.20.12316; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Rupp G, 2003, J CELL BIOL, V162, P47, DOI 10.1083/jcb.200303019; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wilson CW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-102	41	25	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27676	27686		10.1074/jbc.M111.234666	http://dx.doi.org/10.1074/jbc.M111.234666			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659505	hybrid, Green Published			2022-12-25	WOS:000293268700060
J	Lin, KP; Chen, SY; Lai, LC; Huang, YL; Chen, JH; Chen, TF; Sun, Y; Wen, LL; Yip, PK; Chu, YM; Chen, WJ; Chen, YC				Lin, Kun-Pei; Chen, Shih-Yuan; Lai, Liang-Chuan; Huang, Yi-Ling; Chen, Jen-Hau; Chen, Ta-Fu; Sun, Yu; Wen, Li-Li; Yip, Ping-Keung; Chu, Yi-Min; Chen, Wei J.; Chen, Yen-Ching			Genetic Polymorphisms of a Novel Vascular Susceptibility Gene, Ninjurin2 (NINJ2), Are Associated with a Decreased Risk of Alzheimer's Disease	PLOS ONE			English	Article							POSTSTROKE DEMENTIA; ADHESION MOLECULES; PREVALENCE; MECHANISMS; DECLINE; MODEL	Background: Accumulated evidences have shown that vascular risk factors, e. g., hypertension, diabetes mellitus and hyperlipidemia, may be related to the risk of dementia. This study investigated the association between genetic polymorphisms of a vascular susceptibility gene, Ninjurin2 (NINJ2), and the risk of dementia, which has not been explored previously. Methods: A total of 275 Alzheimer's disease (AD) patients and 119 vascular dementia (VaD) patients aged 50 or older were recruited from three teaching hospitals from 2007 to 2010. Healthy controls (n = 423) with the same age of cases were recruited from the health checkup and volunteers worked at the hospital during the same time period. Five common (frequency >5%) haplotype-tagging single nucleotide polymorphisms (htSNPs) in NINJ2 were genotyped to test for the association between sequence variants of NINJ2 and dementia risk, and how vascular risk factors modify this association. Results: Homozygosity of two NINJ2 SNPs was significantly associated with a decreased risk of AD [rs11833579: adjusted odds ratio (AOR) = 0.43; 95% confidence interval (CI) = 0.23-0.80; rs12425791: AOR = 0.33, 95% CI = 0.12-0.96]. Five common haplotypes (cumulative frequency = 97%) were identified. The global test for the association between NINJ2 haplotypes and AD was significant (p = 0.03). Haplotype CAGGA was significantly associated with a decreased risk of AD (AOR = 0.32, 95% CI = 0.11-0.94). No associations were observed for VaD. Conclusion: Inherited polymorphisms of the vascular susceptibility gene NINJ2 were associated with AD risk.	[Lin, Kun-Pei; Chen, Shih-Yuan; Huang, Yi-Ling; Chen, Jen-Hau; Chen, Wei J.; Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Kun-Pei; Chen, Jen-Hau] Natl Taiwan Univ Hosp, Dept Geriatr & Gerontol, Taipei, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10764, Taiwan; [Chen, Ta-Fu] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Sun, Yu] En Chu Kong Hosp, Dept Neurol, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Lab Med, Taipei, Taiwan; [Yip, Ping-Keung] Cardinal Tiens Hosp, Ctr Neurol Med, Taipei, Taiwan; [Chu, Yi-Min] Cardinal Tiens Hosp, Dept Lab Med, Taipei, Taiwan; [Chen, Wei J.; Chen, Yen-Ching] Natl Taiwan Univ, Dept Publ Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; [Chen, Wei J.; Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Lin, KP (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	karenchen@ntu.edu.tw	Chen, Jen-Hau/AFP-2878-2022; Huang, YiLing/ABH-8788-2020; Lai, Liang-Chuan/B-4768-2009; Chen, Yen-Ching/D-1098-2010	Lai, Liang-Chuan/0000-0002-3913-5338; Chen, Wei Jen/0000-0001-5899-5870; Chen, Ta-Fu/0000-0003-1988-6924; Chen, Yen-Ching/0000-0002-8159-7202	NSC [96-2314-B-002-197, 97-2314-B-002-168-MY3]	NSC(Ministry of Science and Technology, Taiwan)	Funding: Grant support: NSC 96-2314-B-002-197 and 97-2314-B-002-168-MY3. The URL of funder's website is http://web1.nsc.gov.tw/mp.aspx?mp=7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Araki T, 2000, J NEUROSCI, V20, P187, DOI 10.1523/JNEUROSCI.20-01-00187.2000; Barba R, 2000, STROKE, V31, P1494, DOI 10.1161/01.STR.31.7.1494; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bertram L, 2009, HUM MOL GENET, V18, pR137, DOI 10.1093/hmg/ddp406; BURGOON MP, 1995, J CELL BIOL, V130, P733, DOI 10.1083/jcb.130.3.733; Chapman J, 1996, NEUROLOGY, V46, P1484, DOI 10.1212/WNL.46.5.1484-a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Chui H, 2000, NEUROL CLIN, V18, P951, DOI 10.1016/S0733-8619(05)70234-6; Claassen JAHR, 2006, J GERONTOL A-BIOL, V61, P267, DOI 10.1093/gerona/61.3.267; de la Torre JC, 2010, NEURODEGENER DIS, V7, P116, DOI 10.1159/000285520; Deschaintre Y, 2009, NEUROLOGY, V73, P674, DOI 10.1212/WNL.0b013e3181b59bf3; Dimou L, 2006, J NEUROSCI, V26, P5591, DOI 10.1523/JNEUROSCI.1103-06.2006; Fillit H, 2008, AM J GERIATR PHARMAC, V6, P100, DOI 10.1016/j.amjopharm.2008.06.004; Fonseca ACRG, 2009, J ALZHEIMERS DIS, V17, P503, DOI 10.3233/JAD-2009-1067; Forti P, 2010, J AM GERIATR SOC, V58, P487, DOI 10.1111/j.1532-5415.2010.02731.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hajjar IM, 2008, AM J ALZHEIMERS DIS, V23, P77, DOI 10.1177/1533317507309803; Henon H, 2001, NEUROLOGY, V57, P1216, DOI 10.1212/WNL.57.7.1216; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hoyert Donna L, 2005, Natl Vital Stat Rep, V53, P1; Iemolo Francesco, 2009, Immun Ageing, V6, P13, DOI 10.1186/1742-4933-6-13; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Liu CK, 1996, J FORMOS MED ASSOC, V95, P762; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Panes J, 1998, GASTROENTEROLOGY, V114, P1066, DOI 10.1016/S0016-5085(98)70328-2; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Roman Gustavo C, 2005, Cerebrovasc Dis, V20 Suppl 2, P91, DOI 10.1159/000089361; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Stozicka Z, 2007, ACTA VIROL, V51, P205; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20573	10.1371/journal.pone.0020573	http://dx.doi.org/10.1371/journal.pone.0020573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674003	Green Submitted, gold, Green Published			2022-12-25	WOS:000291356400008
J	Lurie, G; Wilkens, LR; Thompson, PJ; Shvetsov, YB; Matsuno, RK; Carney, ME; Palmieri, RT; Wu, AH; Pike, MC; Pearce, CL; Menon, U; Gentry-Maharaj, A; Gayther, SA; Ramus, SJ; Whittemore, AS; McGuire, V; Sieh, W; Pharoah, PDP; Song, HL; Gronwald, J; Jakubowska, A; Cybulski, C; Lubinski, J; Schildkraut, JM; Berchuck, A; Kjaer, SK; Hogdall, E; Fasching, PA; Beckmann, MW; Ekici, AB; Hein, A; Chenevix-Trench, G; Webb, PM; Beesley, J; Goodman, MT				Lurie, Galina; Wilkens, Lynne R.; Thompson, Pamela J.; Shvetsov, Yurii B.; Matsuno, Rayna K.; Carney, Michael E.; Palmieri, Rachel T.; Wu, Anna H.; Pike, Malcolm C.; Pearce, Celeste L.; Menon, Usha; Gentry-Maharaj, Aleksandra; Gayther, Simon A.; Ramus, Susan J.; Whittemore, Alice S.; McGuire, Valerie; Sieh, Weiva; Pharoah, Paul D. P.; Song, Honglin; Gronwald, Jacek; Jakubowska, Anna; Cybulski, Cezary; Lubinski, Jan; Schildkraut, Joellen M.; Berchuck, Andrew; Kjaer, Susanne Kruger; Hogdall, Estrid; Fasching, Peter A.; Beckmann, Matthias W.; Ekici, Arif B.; Hein, Alexander; Chenevix-Trench, Georgia; Webb, Penelope M.; Beesley, Jonathan; Goodman, Marc T.		Australian Ovarian Canc Study Grp; Australian Canc Study Grp; Ovarian Canc Assoc Consortium	Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ER-BETA; GENETIC POLYMORPHISMS; DOWN-REGULATION; CARCINOGENESIS; SUSCEPTIBILITY; BREAST; CELLS	The association of ovarian carcinoma risk with the polymorphism rs1271572 in the estrogen receptor beta (ESR2) gene was examined in 4946 women with primary invasive ovarian carcinoma and 6582 controls in a pooled analysis of ten case-control studies within the Ovarian Cancer Association Consortium (OCAC). All participants were non-Hispanic white women. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression adjusted for site and age. Women with the TT genotype were at increased risk of ovarian carcinoma compared to carriers of the G allele (OR = 1.10; 95%; CI: 1.01-1.21; p = 0.04); the OR was 1.09 (CI: 0.99-1.20; p = 0.07) after excluding data from the center (Hawaii) that nominated this SNP for OCAC genotyping A stronger association of rs1271572 TT versus GT/GG with risk was observed among women aged <= 50 years versus older women (OR = 1.35; CI: 1.12-1.62; p = 0.002; p for interaction = 0.02) that remained statistically significant after excluding Hawaii data (OR = 1.34; CI: 1.11-1.61; p = 0.009). No heterogeneity of the association was observed by study, menopausal status, gravidity, parity, use of contraceptive or menopausal hormones, tumor histological type, or stage at diagnosis. This pooled analysis suggests that rs1271572 might influence the risk of ovarian cancer, in particular among younger women.	[Lurie, Galina; Wilkens, Lynne R.; Thompson, Pamela J.; Shvetsov, Yurii B.; Matsuno, Rayna K.; Goodman, Marc T.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Matsuno, Rayna K.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Carney, Michael E.] Univ Hawaii, John A Burns Sch Med, Dept Obstet & Gynecol, Honolulu, HI 96822 USA; [Palmieri, Rachel T.; Schildkraut, Joellen M.; Berchuck, Andrew] Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; [Wu, Anna H.; Pike, Malcolm C.; Pearce, Celeste L.; Gayther, Simon A.; Ramus, Susan J.] Univ So Calif, Dept Prevent Med, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Menon, Usha; Gentry-Maharaj, Aleksandra] UCL, Dept Gynecol Oncol, EGA Inst Womens Hlth, London, England; [Whittemore, Alice S.; McGuire, Valerie; Sieh, Weiva] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Pharoah, Paul D. P.; Song, Honglin] Univ Cambridge, Dept Oncol, Cambridge, England; [Gronwald, Jacek; Jakubowska, Anna; Cybulski, Cezary; Lubinski, Jan] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Kjaer, Susanne Kruger; Hogdall, Estrid] Danish Canc Soc, Inst Canc Epidemiol, Dept Viruses Hormones & Canc, Copenhagen, Denmark; [Kjaer, Susanne Kruger] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Gynecol Clin, DK-2100 Copenhagen, Denmark; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Beckmann, Matthias W.; Hein, Alexander] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Gynecol & Obstet, Nurnberg, Germany; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Nurnberg, Germany; [Chenevix-Trench, Georgia; Webb, Penelope M.; Beesley, Jonathan] Queensland Inst Med Res, Div Genet & Populat Hlth, Brisbane, Qld 4006, Australia; [Australian Ovarian Canc Study Grp; Australian Canc Study Grp] Peter MacCallum Canc Study, Melbourne, Vic, Australia	Cancer Research Center of Hawaii; University of Hawaii System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Hawaii System; Duke University; University of Southern California; Memorial Sloan Kettering Cancer Center; University of London; University College London; Stanford University; University of Cambridge; Pomeranian Medical University; Danish Cancer Society; Rigshospitalet; University of Copenhagen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; University of Erlangen Nuremberg; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center	Lurie, G (corresponding author), Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA.	GLurie@crch.hawaii.edu	Johnatty, Sharon E/R-8890-2016; Jakubowska, Anna/O-8050-2014; Garcia-Closas, Montserrat/AAZ-6930-2021; Ramus, Susan/AAG-8352-2019; Pharoah, Paul/V-6658-2019; Ekici, Arif B/C-3971-2013; Menon, Usha/C-4716-2008; Fasching, Peter A/ABH-9912-2020; Gronwald, Jacek/A-4576-2017; Brinton, Louise A/G-7486-2015; Bowtell, David/H-1007-2016; Shvetsov, Yurii/ABA-3196-2020; Hein, Alexander/F-6999-2010; Chenevix-Trench, Georgia/AAV-2014-2020; Webb, Penelope/D-5736-2013; Van Den Berg, David J/G-8598-2017	Johnatty, Sharon E/0000-0002-7888-1966; Jakubowska, Anna/0000-0002-5650-0501; Garcia-Closas, Montserrat/0000-0003-1033-2650; Ramus, Susan/0000-0003-0005-7798; Pharoah, Paul/0000-0001-8494-732X; Ekici, Arif B/0000-0001-6099-7066; Menon, Usha/0000-0003-3708-1732; Fasching, Peter A/0000-0003-4885-8471; Gronwald, Jacek/0000-0002-3643-2871; Brinton, Louise A/0000-0003-3853-8562; Bowtell, David/0000-0001-9089-7525; Hein, Alexander/0000-0003-2601-3398; Chenevix-Trench, Georgia/0000-0002-1878-2587; Webb, Penelope/0000-0003-0733-5930; Van Den Berg, David J/0000-0002-5404-5218; Lubinski, Jan/0000-0003-2931-3003; Hogdall, Claus/0000-0002-5959-8874; Weber, Rachel/0000-0001-7119-7734; Beesley, Jonathan/0000-0003-1942-325X; Goodman, Marc/0000-0002-4839-3021; Hogdall, Estrid/0000-0003-4689-5658; Kjaer, Susanne/0000-0002-8347-1398	Ovarian Cancer Association Consortium; U.S. National Institutes of Health [R01 CA58598, N01-CN-55424, N01-PC-67001]; USC: Public Health Service [CA14089, CA17054, CA61132, CA63464, N01-PC-67010, R03-CA113148]; California Department of Health Services [050-E8709]; UKO: Cancer Research UK; Eve Appeal; OAK Foundation; Department of Health's NIHR Biomedical Research Centre; STA: the U. S. National Institutes of Health/National Cancer Institute [U01CA71966, R01CA16056, U01CA69417, K07CA143047]; SEA: Cancer Research United Kingdom; POL: U.S. National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics (POL) National Cancer Institute [R01-CA-76016 (NCO)]; NCO: the National Cancer Institute [R01-CA-76016]; MAL: Mermaid 1; Danish Cancer Society; National Cancer Institute [R01-CA-61107]; Australian Ovarian Cancer Study; Australian Cancer Study: US Army Medical Research and Material Command [DAMD17-01-1-0729]; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; USC [00-01389V-20170, 2110200]; U.S. Public Health Service [CA14089, CA17054, CA61132, CA63464, N01-PC-67010, R03-CA113148]; National Health and Medical Research Council of Australia [199600, 400281]; The Francis Crick Institute [10124] Funding Source: researchfish; DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC067001, N01PC067010] Funding Source: NIH RePORTER; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055424] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA063464, ZIACP010126, P30CA016056, R01CA058598, K07CA143047, R01CA063464, R01CA061107, R01CA061132, P01CA017054, U01CA071966, R01CA076016, R03CA113148, P30CA014089, U01CA069417] Funding Source: NIH RePORTER	Ovarian Cancer Association Consortium; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USC: Public Health Service; California Department of Health Services; UKO: Cancer Research UK; Eve Appeal; OAK Foundation; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); STA: the U. S. National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SEA: Cancer Research United Kingdom; POL: U.S. National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics (POL) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCO: the National Cancer Institute; MAL: Mermaid 1; Danish Cancer Society(Danish Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Ovarian Cancer Study; Australian Cancer Study: US Army Medical Research and Material Command; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council Queensland(Cancer Council Queensland); Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); USC; U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); The Francis Crick Institute; DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: The Ovarian Cancer Association Consortium: a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith. HAW: the U. S. National Institutes of Health (R01 CA58598, N01-CN-55424, N01-PC-67001); USC: Public Health Service grants CA14089, CA17054, CA61132, CA63464, N01-PC-67010 and R03-CA113148, and California Department of Health Services sub-contract 050-E8709; UKO: Cancer Research UK, the Eve Appeal, the OAK Foundation and the Department of Health's NIHR Biomedical Research Centre funding scheme; STA: the U. S. National Institutes of Health/National Cancer Institute: U01CA71966, R01CA16056, U01CA69417, and K07CA143047; SEA: Cancer Research United Kingdom; POL: Intramural Funds from the U. S. National Cancer Institute, National Institutes of Health, Division of Cancer Epidemiology and Genetics (POL) National Cancer Institute R01-CA-76016 (NCO); NCO: the National Cancer Institute R01-CA-76016; MAL: Mermaid 1, the Danish Cancer Society and the National Cancer Institute R01-CA-61107; The Australian Ovarian Cancer Study and Australian Cancer Study: US Army Medical Research and Material Command (DAMD17-01-1-0729), Cancer Council Victoria, Cancer Council Queensland, Cancer Council New South Wales, Cancer Council South Australia, Cancer Council Tasmania and Cancer Foundation of Western Australia, USC: the California Cancer Research Program grants 00-01389V-20170 and 2110200, U. S. Public Health Service grants CA14089, CA17054, CA61132, CA63464, N01-PC-67010 and R03-CA113148, and California Department of Health Services sub-contract 050-E8709 the National Health and Medical Research Council of Australia (199600 and 400281). PMW and GCT are funded by fellowships from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; Bardin A, 2004, CANCER RES, V64, P5861, DOI 10.1158/0008-5472.CAN-04-0552; Berchuck A, 2008, ADV EXP MED BIOL, V622, P53, DOI 10.1007/978-0-387-68969-2_5; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Drummond AE, 1999, MOL CELL ENDOCRINOL, V149, P153, DOI 10.1016/S0303-7207(98)00247-0; Drummond AE, 2010, J ENDOCRINOL, V205, P15, DOI 10.1677/JOE-09-0379; Enmark E, 1999, J INTERN MED, V246, P133, DOI 10.1046/j.1365-2796.1999.00545.x; Fixemer T, 2003, PROSTATE, V54, P79, DOI 10.1002/pros.10171; Foley EF, 2000, CANCER RES, V60, P245; HENDERSON BE, 1988, CANCER RES, V48, P246; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; Li AJ, 2003, AM J OBSTET GYNECOL, V189, P22, DOI 10.1067/mob.2003.328; Li LC, 2000, BIOCHEM BIOPH RES CO, V275, P682, DOI 10.1006/bbrc.2000.3363; Lindgren PR, 2004, MOL CELL ENDOCRINOL, V221, P97, DOI 10.1016/j.mce.2004.02.020; Lurie G, 2009, CANCER CAUSE CONTROL, V20, P47, DOI 10.1007/s10552-008-9216-8; Park BW, 2003, BREAST CANCER RES TR, V80, P79, DOI 10.1023/A:1024406223619; Pearce CL, 2009, BRIT J CANCER, V100, P412, DOI 10.1038/sj.bjc.6604820; Pearce CL, 2008, CANCER EPIDEM BIOMAR, V17, P393, DOI 10.1158/1055-9965.EPI-07-2512; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Sun Ying-hao, 2005, Zhonghua Wai Ke Za Zhi, V43, P948; Treeck O, 2007, J ENDOCRINOL, V193, P421, DOI 10.1677/JOE-07-0087; Tung KH, 2004, AM J EPIDEMIOL, V159, P750, DOI 10.1093/aje/kwh103; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109	26	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20703	10.1371/journal.pone.0020703	http://dx.doi.org/10.1371/journal.pone.0020703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673961	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400020
J	Nistor, G; Siegenthaler, MM; Poirier, SN; Rossi, S; Poole, AJ; Charlton, ME; McNeish, JD; Airriess, CN; Keirstead, HS				Nistor, Gabriel; Siegenthaler, Monica M.; Poirier, Stephane N.; Rossi, Sharyn; Poole, Aleksandra J.; Charlton, Maura E.; McNeish, John D.; Airriess, Chris N.; Keirstead, Hans S.			Derivation of High Purity Neuronal Progenitors from Human Embryonic Stem Cells	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; SPINAL-CORD-INJURY; NEURAL INDUCTION; DIFFERENTIATION; PATHWAY; PHENOTYPES; CARCINOMA; PROMOTES; RECOVERY; MODEL	The availability of human neuronal progenitors (hNPs) in high purity would greatly facilitate neuronal drug discovery and developmental studies, as well as cell replacement strategies for neurodegenerative diseases and conditions, such as spinal cord injury, stroke, Parkinson's disease, Alzheimer's disease, and Huntington's disease. Here we describe for the first time a method for producing hNPs in large quantity and high purity from human embryonic stem cells (hESCs) in feeder-free conditions, without the use of exogenous noggin, sonic hedgehog or analogs, rendering the process clinically compliant. The resulting population displays characteristic neuronal-specific markers. When allowed to spontaneously differentiate into neuronal subtypes in vitro, cholinergic, serotonergic, dopaminergic and/or noradrenergic, and medium spiny striatal neurons were observed. When transplanted into the injured spinal cord the hNPs survived, integrated into host tissue, and matured into a variety of neuronal subtypes. Our method of deriving neuronal progenitors from hESCs renders the process amenable to therapeutic and commercial use.	[Nistor, Gabriel; Rossi, Sharyn; Keirstead, Hans S.] Univ Calif Irvine, Dept Anat & Neurobiol, Reeve Irvine Res Ctr, Sue & Bill Gross Stem Cell Res Ctr,Sch Med,CIRM I, Irvine, CA 92717 USA; [Siegenthaler, Monica M.; Poole, Aleksandra J.; Airriess, Chris N.] Calif Stem Cell Inc, Irvine, CA USA; [Poirier, Stephane N.; Charlton, Maura E.; McNeish, John D.] Pfizer Regenerat Med, Cambridge, MA USA	University of California System; University of California Irvine; Pfizer	Nistor, G (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Reeve Irvine Res Ctr, Sue & Bill Gross Stem Cell Res Ctr,Sch Med,CIRM I, Sue & Bill Gross Hall, Irvine, CA 92717 USA.	hansk@uci.edu						ABREUVILLACA Y, 2010, BEHAV BRAIN RES; Asano H, 2009, STEM CELLS, V27, P2744, DOI 10.1002/stem.176; Axell MZ, 2009, J NEUROSCI METH, V184, P275, DOI 10.1016/j.jneumeth.2009.08.015; Bentz K, 2006, CELL PHYSIOL BIOCHEM, V18, P275, DOI 10.1159/000097674; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; De Smaele E, 2008, NEOPLASIA, V10, P89, DOI 10.1593/neo.07891; Dhara SK, 2008, DIFFERENTIATION, V76, P454, DOI 10.1111/j.1432-0436.2007.00256.x; Fan GF, 2005, J BIOL CHEM, V280, P40337, DOI 10.1074/jbc.M506810200; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Keirstead HS, 2001, J NEUROSCI RES, V63, P233, DOI 10.1002/1097-4547(20010201)63:3<233::AID-JNR1016>3.0.CO;2-B; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Lenka N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001349; Lupi O, 2007, INT J DERMATOL, V46, P1113, DOI 10.1111/j.1365-4632.2007.03391.x; Marsh D, 2008, CANCER RES, V68, P3295, DOI 10.1158/0008-5472.CAN-08-0174; Mi HY, 2001, J NEUROSCI, V21, P1538, DOI 10.1523/JNEUROSCI.21-05-01538.2001; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Okano H, 2002, J CELL SCI, V115, P1355; Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Satoh K, 2008, ONCOL REP, V19, P1185; Shin S, 2005, STEM CELLS DEV, V14, P266, DOI 10.1089/scd.2005.14.266; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Tarasenko YI, 2007, J NEUROSCI RES, V85, P47, DOI 10.1002/jnr.21098; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281	30	30	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20692	10.1371/journal.pone.0020692	http://dx.doi.org/10.1371/journal.pone.0020692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673956	Green Published, gold			2022-12-25	WOS:000291356400017
J	Stein, M; van Veen, TAB; Hauer, RNW; de Bakker, JMT; van Rijen, HVM				Stein, Mera; van Veen, Toon A. B.; Hauer, Richard N. W.; de Bakker, Jacques M. T.; van Rijen, Harold V. M.			A 50% Reduction of Excitability but Not of Intercellular Coupling Affects Conduction Velocity Restitution and Activation Delay in the Mouse Heart	PLOS ONE			English	Article							FAILING HUMAN HEART; GAP-JUNCTIONS; IMPULSE PROPAGATION; CARDIAC CONDUCTION; CELL-SIZE; MICE; EXPRESSION; CONNEXIN43; DISEASE; SODIUM	Introduction: Computer simulations suggest that intercellular coupling is more robust than membrane excitability with regard to changes in and safety of conduction. Clinical studies indicate that SCN5A (excitability) and/or Connexin43 (Cx43, intercellular coupling) expression in heart disease is reduced by approximately 50%. In this retrospective study we assessed the effect of reduced membrane excitability or intercellular coupling on conduction in mouse models of reduced excitability or intercellular coupling. Methods and Results: Epicardial activation mapping of LV and RV was performed on Langendorff-perfused mouse hearts having the following: 1) Reduced excitability: Scn5a haploinsufficient mice; and 2) reduced intercellular coupling: Cx43(CreER(T)/fl) mice, uninduced (50% Cx43) or induced (10% Cx43) with Tamoxifen. Wild type (WT) littermates were used as control. Conduction velocity (CV) restitution and activation delay were determined longitudinal and transversal to fiber direction during S(1)S(1) pacing and S(1)S(2) premature stimulation until the effective refractory period. In both animal models, CV restitution and activation delay in LV were not changed compared to WT. In contrast, CV restitution decreased and activation delay increased in RV during conduction longitudinal but not transverse to fiber direction in Scn5a heterozygous animals compared to WT. In contrast, a 50% reduction of intercellular coupling did not affect either CV restitution or activation delay. A decrease of 90% Cx43, however, resulted in decreased CV restitution and increased activation delay in RV, but not LV. Conclusion: Reducing excitability but not intercellular coupling by 50% affects CV restitution and activation delay in RV, indicating a higher safety factor for intercellular coupling than excitability in RV.	[Stein, Mera; van Veen, Toon A. B.; de Bakker, Jacques M. T.; van Rijen, Harold V. M.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, Utrecht, Netherlands; [Stein, Mera; Hauer, Richard N. W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [de Bakker, Jacques M. T.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [de Bakker, Jacques M. T.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University	Stein, M (corresponding author), Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Med Physiol, Utrecht, Netherlands.	h.v.m.vanrijen@umcutrecht.nl		van Rijen, Harold/0000-0001-6740-7428	Netherlands Heart Foundation [2003B128]	Netherlands Heart Foundation(Netherlands Heart Foundation)	This study was supported by the Netherlands Heart Foundation (grant No. 2003B128). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; FRAME LH, 1988, CIRCULATION, V78, P1277, DOI 10.1161/01.CIR.78.5.1277; Jongsma HJ, 2000, CIRC RES, V86, P1193, DOI 10.1161/01.RES.86.12.1193; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Kostin S, 2003, MOL CELL BIOCHEM, V242, P135, DOI 10.1023/A:1021154115673; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; Morley GE, 1999, J CARDIOVASC ELECTR, V10, P1361, DOI 10.1111/j.1540-8167.1999.tb00192.x; PETERS NS, 1993, CIRCULATION, V88, P864, DOI 10.1161/01.CIR.88.3.864; Pinski SL, 2000, J ELECTROCARDIOL, V33, P103, DOI 10.1054/jclc.2000.20332; Potse M, 2002, COMPUT METH PROG BIO, V69, P225, DOI 10.1016/S0169-2607(02)00014-7; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Remme CA, 2006, CIRCULATION, V114, P2584, DOI 10.1161/CIRCULATIONAHA.106.653949; ROBERTS DE, 1979, CIRC RES, V44, P701, DOI 10.1161/01.RES.44.5.701; SAUMAREZ RC, 1995, CIRCULATION, V92, P2565, DOI 10.1161/01.CIR.92.9.2565; Shaw RM, 1997, CIRC RES, V81, P727; Spach MS, 2000, CIRC RES, V86, P302, DOI 10.1161/01.RES.86.3.302; Spach MS, 2001, J ELECTROCARDIOL, V34, P69, DOI 10.1054/jelc.2001.28833; SPACH MS, 1981, CIRC RES, V48, P39, DOI 10.1161/01.RES.48.1.39; STEIN M, 2006, NETHERLANDS HEART J, V14; Stein M, 2008, HEART RHYTHM, V5, P438, DOI 10.1016/j.hrthm.2007.10.033; Stein M, 2009, CARDIOVASC RES, V83, P52, DOI 10.1093/cvr/cvp124; Valdivia CR, 2005, J MOL CELL CARDIOL, V38, P475, DOI 10.1016/j.yjmcc.2004.12.012; van Rijen HVM, 2006, ADV CARDIOL, V42, P150, DOI 10.1159/000092567; van Rijen HVM, 2005, CARDIOVASC RES, V66, P9, DOI 10.1016/j.cardiores.2005.02.003; van Rijen HVM, 2004, CIRCULATION, V109, P1048, DOI 10.1161/01.CIR.0000117402.70689.75; van Veen TAB, 2005, CIRCULATION, V112, P1927, DOI 10.1161/CIRCULATIONAHA.105.539072	26	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20310	10.1371/journal.pone.0020310	http://dx.doi.org/10.1371/journal.pone.0020310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673812	Green Published, Green Submitted, gold			2022-12-25	WOS:000291309900013
J	Chen, CF; Chu, CY; Chen, TH; Lee, SJ; Shen, CN; Hsiao, CD				Chen, Chi-Fang; Chu, Che-Yu; Chen, Te-Hao; Lee, Shyh-Jye; Shen, Chia-Ning; Hsiao, Chung-Der			Establishment of a Transgenic Zebrafish Line for Superficial Skin Ablation and Functional Validation of Apoptosis Modulators In Vivo	PLOS ONE			English	Article							SUICIDE GENE-THERAPY; ESCHERICHIA-COLI NITROREDUCTASE; UVB-INDUCED APOPTOSIS; EXPRESSING BACTERIAL NITROREDUCTASE; HUMAN CANCER-CELLS; SUBCELLULAR-LOCALIZATION; TARGETED DISRUPTION; FLUORESCENT PROTEIN; SIGNAL TRANSDUCER; TRANSCRIPTION 3	Background: Zebrafish skin is composed of enveloping and basal layers which form a first-line defense system against pathogens. Zebrafish epidermis contains ionocytes and mucous cells that aid secretion of acid/ions or mucous through skin. Previous studies demonstrated that fish skin is extremely sensitive to external stimuli. However, little is known about the molecular mechanisms that modulate skin cell apoptosis in zebrafish. Methodology/Principal Findings: This study aimed to create a platform to conduct conditional skin ablation and determine if it is possible to attenuate apoptotic stimuli by overexpressing potential apoptosis modulating genes in the skin of live animals. A transgenic zebrafish line of Tg(krt4:NTR-hKikGR)(cy17) (killer line), which can conditionally trigger apoptosis in superficial skin cells, was first established. When the killer line was incubated with the prodrug metrodinazole, the superficial skin displayed extensive apoptosis as judged by detection of massive TUNEL-and active caspase 3-positive signals. Great reductions in NTR-hKikGR(+) fluorescent signals accompanied epidermal cell apoptosis. This indicated that NTR-hKikGR(+) signal fluorescence can be utilized to evaluate apoptotic events in vivo. After removal of metrodinazole, the skin integrity progressively recovered and NTR-hKikGR(+) fluorescent signals gradually restored. In contrast, either crossing the killer line with testing lines or transiently injecting the killer line with testing vectors that expressed human constitutive active Akt1, mouse constitutive active Stat3, or HPV16 E6 element displayed apoptosis-resistant phenotypes to cytotoxic metrodinazole as judged by the loss of reduction in NTR-hKikGR(+) fluorescent signaling. Conclusion/Significance: The killer/testing line binary system established in the current study demonstrates a nitroreductase/metrodinazole system that can be utilized to conditionally perform skin ablation in a real-time manner, and provides a valuable tool to visualize and quantify the anti-apoptotic potential of interesting target genes in vivo. The current work identifies a potential use for transgenic zebrafish as a high-throughput platform to validate potential apoptosis modulators in vivo.	[Chen, Chi-Fang; Shen, Chia-Ning] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Chen, Chi-Fang; Chu, Che-Yu; Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan; [Chen, Te-Hao] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Lee, Shyh-Jye] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Shen, Chia-Ning] Acad Sinica, Genome Res Ctr, Taipei 115, Taiwan; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Ctr Nanotechnol, Chungli, Taiwan	National Taiwan Ocean University; Chung Yuan Christian University; National Museum of Marine Biology & Aquarium; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Chung Yuan Christian University	Chen, CF (corresponding author), Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan.	cnshen@gate.sinica.edu.tw; cdhsiao@cycu.edu.tw	SHEN, CHIA-NING/C-6878-2011; Lee, Shyh-Jye/C-6092-2008; Hsiao, Chung-Der/W-4535-2019	SHEN, CHIA-NING/0000-0002-0747-217X; Lee, Shyh-Jye/0000-0001-8452-9152; Hsiao, Chung-Der/0000-0002-6398-8672	National Science Council [NSC 96-2321-B-033-002-MY2, NSC 97-2622-B-001-002-CC1]; Mackay Memorial Hospital [MMH-CY-9905]; Academia Sinica [5202402020]	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital; Academia Sinica(Academia Sinica - Taiwan)	This work was supported in part by the National Science Council grant (NSC 96-2321-B-033-002-MY2) and the Mackay Memorial Hospital grant (MMH-CY-9905) to C-DH, the National Science Council grant (NSC 97-2622-B-001-002-CC1) and the Summit Project Grants of Academia Sinica #5202402020 to C-NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED FE, 1993, CANCER RES, V53, P2249; ALHASSAN JM, 1985, MAR BIOL, V88, P117, DOI 10.1007/BF00397158; Allen SM, 2003, CANCER RES, V63, P567; ANDERS K, 1994, DIS AQUAT ORGAN, V19, P215, DOI 10.3354/dao019215; Bilsland AE, 2003, ONCOGENE, V22, P370, DOI 10.1038/sj.onc.1206168; Bridgewater JA, 1997, HUM GENE THER, V8, P709, DOI 10.1089/hum.1997.8.6-709; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Chung-Faye GA, 2000, MOL MED TODAY, V6, P82, DOI 10.1016/S1357-4310(99)01598-1; Cui W, 1999, GENE THER, V6, P764, DOI 10.1038/sj.gt.3300873; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; D'Errico M, 2007, MUTAT RES-FUND MOL M, V614, P37, DOI 10.1016/j.mrfmmm.2006.06.009; Decraene D, 2004, J INVEST DERMATOL, V123, P207, DOI 10.1111/j.0022-202X.2004.22702.x; Eimon PM, 2010, APOPTOSIS, V15, P331, DOI 10.1007/s10495-009-0432-9; Felmer RN, 2004, BIOL RES, V37, P449, DOI 10.4067/S0716-97602004000300009; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; GENTEN F, 2009, ATLAS FISH HISTOLOGY, V215; Giannetti L, 2004, ONCOL REP, V11, P401; Grohmann M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-301; Grossman D, 2001, J CLIN INVEST, V108, P991, DOI 10.1172/JCI200113345; Grove JI, 2003, CANCER RES, V63, P5532; Guerra RR, 2008, J FISH BIOL, V73, P572, DOI 10.1111/j.1095-8649.2008.01950.x; Hakkinen J, 2003, AQUAT TOXICOL, V63, P159, DOI 10.1016/S0166-445X(02)00173-X; Hirata T, 2003, AM J PHYSIOL-REG I, V284, pR1199, DOI 10.1152/ajpregu.00267.2002; Hsiao CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000302; Hsu CC, 2010, MAR BIOTECHNOL, V12, P466, DOI 10.1007/s10126-009-9248-4; Hu B, 2010, ORAL ONCOL, V46, P31, DOI 10.1016/j.oraloncology.2009.09.008; Hu SY, 2010, MAR BIOTECHNOL, V12, P569, DOI 10.1007/s10126-009-9244-8; Ingham PW, 2009, HUM MOL GENET, V18, pR107, DOI 10.1093/hmg/ddp091; Jaberipour M, 2010, BIOCHEM PHARMACOL, V79, P102, DOI 10.1016/j.bcp.2009.07.025; Jackson S, 2000, ONCOGENE, V19, P592, DOI 10.1038/sj.onc.1203339; Jarrom D, 2009, BIOCHEMISTRY-US, V48, P7665, DOI 10.1021/bi900674m; Ju BS, 1999, DEV GENET, V25, P158, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;158::AID-DVG10&gt;3.0.CO;2-6; Kamphuis MB, 2007, PROTEIN PEPTIDE LETT, V14, P113, DOI 10.2174/092986607779816096; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kim DJ, 2009, MOL CARCINOGEN, V48, P873, DOI 10.1002/mc.20527; Kumin A, 2006, AM J PATHOL, V169, P1194, DOI 10.2353/ajpath.2006.060119; Kwak SP, 2007, J NEUROSCI RES, V85, P1183, DOI 10.1002/jnr.21223; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Le Tissier PR, 2005, MOL ENDOCRINOL, V19, P1251, DOI 10.1210/me.2004-0223; Leverrier S, 2007, APOPTOSIS, V12, P549, DOI 10.1007/s10495-006-0004-1; Macary G, 2010, VIRCHOWS ARCH, V456, P325, DOI 10.1007/s00428-009-0840-9; Matsuda M, 2010, J BIOL CHEM, V285, P5848, DOI 10.1074/jbc.M109.063453; Morrison RN, 2008, J FISH DIS, V31, P699, DOI 10.1111/j.1365-2761.2008.00934.x; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Noga EJ, 1996, MAR POLLUT BULL, V32, P219, DOI 10.1016/0025-326X(95)00114-3; Nowak M, 2005, CELL DEATH DIFFER, V12, P52, DOI 10.1038/sj.cdd.4401519; Pai CW, 2010, TRANSGENIC RES, V19, P655, DOI 10.1007/s11248-009-9350-4; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pileri SA, 1997, J PATHOL, V183, P116; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Plumb JA, 2001, ONCOGENE, V20, P7797, DOI 10.1038/sj.onc.1204954; Pretti C, 2009, ECOTOX ENVIRON SAFE, V72, P1170, DOI 10.1016/j.ecoenv.2008.09.010; Race PR, 2007, J MOL BIOL, V368, P481, DOI 10.1016/j.jmb.2007.02.012; REIMCHEN TE, 1988, CAN J ZOOL, V66, P2036, DOI 10.1139/z88-299; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Schafer M, 2010, GENE DEV, V24, P1045, DOI 10.1101/gad.568810; Sertznig P, 2008, AM J CLIN DERMATOL, V9, P15, DOI 10.2165/00128071-200809010-00002; Silva MT, 2008, CURR PHARM DESIGN, V14, P170; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; Spooner RA, 2000, CANCER GENE THER, V7, P1348, DOI 10.1038/sj.cgt.0238; Spooner RA, 2001, INT J CANCER, V93, P123, DOI 10.1002/ijc.1288; Springer CJ, 2000, ADV EXP MED BIOL, V465, P403; Suzuki A, 2003, CANCER RES, V63, P674; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Vogelbein WK, 2001, ENVIRON HEALTH PERSP, V109, P687, DOI 10.2307/3454914; Wang YH, 2006, TOXICOL LETT, V163, P191, DOI 10.1016/j.toxlet.2005.10.024; Wilson WR, 2002, CANCER RES, V62, P1425	71	33	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20654	10.1371/journal.pone.0020654	http://dx.doi.org/10.1371/journal.pone.0020654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655190	Green Submitted, gold, Green Published			2022-12-25	WOS:000291097600117
J	Ma, L; Wen, ZS; Liu, Z; Hu, Z; Ma, J; Chen, XQ; Liu, YQ; Pu, JX; Xiao, WL; Sun, HD; Zhou, GB				Ma, Liang; Wen, Zhe-Sheng; Liu, Zi; Hu, Zheng; Ma, Jun; Chen, Xiao-Qin; Liu, Yong-Qiang; Pu, Jian-Xin; Xiao, Wei-Lie; Sun, Han-Dong; Zhou, Guang-Biao			Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer	PLOS ONE			English	Article							PHOSPHO-AKT; SMOKING; SURVIVAL	Background: Lung cancer is the leading cause of cancer deaths worldwide, with a five-year overall survival rate of only 15%. Cancerous inhibitor of PP2A (CIP2A) is a human oncoprotein inhibiting PP2A in many human malignancies. However, whether CIP2A can be a new drug target for lung cancer is largely unclear. Methodology/Principal Findings: Normal and malignant lung tissues were derived from 60 lung cancer patients from southern China. RT-PCR, Western blotting and immunohistochemistry were used to evaluate the expression of CIP2A. We found that among the 60 patients, CIP2A was undetectable or very low in paratumor normal tissues, but was dramatically elevated in tumor samples in 38 (63.3%) patients. CIP2A overexpression was associated with cigarette smoking. Silencing CIP2A by siRNA inhibited the proliferation and clonogenic activity of lung cancer cells. Intriguingly, we found a natural compound, rabdocoetsin B which is extracted from a Traditional Chinese Medicinal herb Rabdosia coetsa, could induce down-regulation of CIP2A and inactivation of Akt pathway, and inhibit proliferation and induce apoptosis in a variety of lung cancer cells. Conclusions/Significance: Our findings strongly indicate that CIP2A could be an effective target for lung cancer drug development, and the therapeutic potentials of CIP2A-targeting agents warrant further investigation.	[Ma, Liang; Liu, Zi; Liu, Yong-Qiang; Zhou, Guang-Biao] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Mol Carcinogenesis & Targeted Therapy Canc, Beijing, Peoples R China; [Ma, Liang] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Wen, Zhe-Sheng; Ma, Jun; Chen, Xiao-Qin] Sun Yat Sen Univ, Canc Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Zheng] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou, Guangdong, Peoples R China; [Pu, Jian-Xin; Xiao, Wei-Lie; Sun, Han-Dong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources W China, Kunming, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Ma, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Div Mol Carcinogenesis & Targeted Therapy Canc, Beijing, Peoples R China.	hdsun@mail.kib.ac.cn; gbzhou@ioz.ac.cn	Zhou, Guang-Biao/ABG-5795-2021; Zhou, Guangbiao/J-6575-2017	Zhou, Guangbiao/0000-0002-6327-2316; Zhou, Guang-Biao/0000-0001-6778-7133	National Key Program for Basic Research (973) [2010CB529201]; Chinese Academy of Sciences [KSCX1-YW-R-26, KSCX2-YW-R-235]; National Natural Science Foundation of China [81071930, 30871110]; National Major Scientific and Technological Program for Drug Discovery [2009ZX09103-101]; Science and Technology Planning Project of Guangzhou [2009Y-C011-2]	National Key Program for Basic Research (973)(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Scientific and Technological Program for Drug Discovery; Science and Technology Planning Project of Guangzhou	This work was supported in part by the National Key Program for Basic Research (973, 2010CB529201), the Key Project of Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-R-26 and KSCX2-YW-R-235), the National Natural Science Foundation of China (81071930, 30871110), the National Major Scientific and Technological Program for Drug Discovery (2009ZX09103-101), and the Science and Technology Planning Project of Guangzhou (2009Y-C011-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile JR, 2010, CANCER BIOL THER, V10, P700, DOI 10.4161/cbt.10.7.13151; Brognard J, 2001, CANCER RES, V61, P3986; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; CHEN YP, 2011, ACTA BOT SIN, V32, P292; Come C, 2009, CLIN CANCER RES, V15, P5092, DOI 10.1158/1078-0432.CCR-08-3283; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; DONG QZ, 2010, ANN SURG ONCOL, P1; FENG T, 2009, CHIN J BIOTECH, V25, P1218; Garcia M, 2007, GLOBAL CANC FACTS FI; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hoo LS, 2002, ONCOGENE, V21, P5006, DOI 10.1038/sj.onc.1205625; Hu Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006257; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Khanna A, 2009, JNCI-J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Li WJ, 2008, CLIN CANCER RES, V14, P3722, DOI 10.1158/1078-0432.CCR-07-4137; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; PENG B, 2010, AACR 101 ANN M; QU W, 2010, MED ONCOL, P1; REMMELE W, 1987, PATHOLOGE, V8, P138; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Vaarala MH, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-136; Wang J, 2011, INT J LAB HEMATOL, V33, P290, DOI 10.1111/j.1751-553X.2010.01288.x; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Zhao DP, 2010, J MED MICROBIOL, V59, P259, DOI 10.1099/jmm.0.014704-0; ZHOU GB, 2010, AACR 101 ANN M 2010, pLB45	29	63	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20159	10.1371/journal.pone.0020159	http://dx.doi.org/10.1371/journal.pone.0020159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655278	Green Submitted, gold, Green Published			2022-12-25	WOS:000291097600025
J	Menendez-Castro, C; Fahlbusch, F; Cordasic, N; Amann, K; Munzel, K; Plank, C; Wachtveitl, R; Rascher, W; Hilgers, KF; Hartner, A				Menendez-Castro, Carlos; Fahlbusch, Fabian; Cordasic, Nada; Amann, Kerstin; Muenzel, Kathrin; Plank, Christian; Wachtveitl, Rainer; Rascher, Wolfgang; Hilgers, Karl F.; Hartner, Andrea			Early and Late Postnatal Myocardial and Vascular Changes in a Protein Restriction Rat Model of Intrauterine Growth Restriction	PLOS ONE			English	Article							AORTIC-WALL THICKNESS; OSTEOPONTIN EXPRESSION; ADULT HYPERTENSION; CARDIAC FIBROSIS; CELL-GROWTH; HYPOXIA; HEART; LEADS; CARDIOMYOCYTES; RETARDATION	Intrauterine growth restriction (IUGR) is a risk factor for cardiovascular disease in later life. Early structural and functional changes in the cardiovascular system after IUGR may contribute to its pathogenesis. We tested the hypothesis that IUGR leads to primary myocardial and vascular alterations before the onset of hypertension. A rat IUGR model of maternal protein restriction during gestation was used. Dams were fed low protein (LP; casein 8.4%) or isocaloric normal protein diet (NP; casein 17.2%). The offspring was reduced to six males per litter. Immunohistochemical and real-time PCR analyses were performed in myocardial and vascular tissue of neonates and animals at day 70 of life. In the aortas of newborn IUGR rats expression of connective tissue growth factor (CTGF) was induced 3.2-fold. At day 70 of life, the expression of collagen I was increased 5.6-fold in aortas of IUGR rats. In the hearts of neonate IUGR rats, cell proliferation was more prominent compared to controls. At day 70 the expression of osteopontin was induced 7.2-fold. A 3- to 7-fold increase in the expression of the profibrotic cytokines TGF-beta and CTGF as well as of microfibrillar matrix molecules was observed. The myocardial expression and deposition of collagens was more prominent in IUGR animals compared to controls at day 70. In the low-protein diet model, IUGR leads to changes in the expression patterns of profibrotic genes and discrete structural abnormalities of vessels and hearts in adolescence, but, with the exception of CTGF, not as early as at the time of birth. Invasive and non-invasive blood pressure measurements confirmed that IUGR rats were normotensive at the time point investigated and that the changes observed occurred independently of an increased blood pressure. Hence, altered matrix composition of the vascular wall and the myocardium may predispose IUGR animals to cardiovascular disease later in life.	[Menendez-Castro, Carlos; Fahlbusch, Fabian; Muenzel, Kathrin; Plank, Christian; Wachtveitl, Rainer; Rascher, Wolfgang; Hartner, Andrea] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, Erlangen, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany; [Cordasic, Nada; Hilgers, Karl F.] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Menendez-Castro, C (corresponding author), Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, Erlangen, Germany.	carlos.menendez-castro@uk-erlangen.de		Fahlbusch, Fabian/0000-0001-5480-0204	"Frieda und Johannes Marohn-Stiftung'' of the University of Erlangen-Nurnberg; University of Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft, Bonn, Germany [SFB 423, A2, B13, Z2]	"Frieda und Johannes Marohn-Stiftung'' of the University of Erlangen-Nurnberg; University of Erlangen-Nurnberg; Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG))	This study was supported by a grant from the "Frieda und Johannes Marohn-Stiftung'' of the University of Erlangen-Nurnberg to A. H. and K. F. H., an ELAN grant from the University of Erlangen-Nurnberg to C. M.-C. and by a grant from the Deutsche Forschungsgemeinschaft, Bonn, Germany (SFB 423, Project A2 to A. H., B13 to C. P. and Z2 to K. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Behr TM, 2000, CIRCULATION, V102, P1315, DOI 10.1161/01.CIR.102.11.1315; Bouzeghrane F, 2005, AM J PHYSIOL-HEART C, V289, pH982, DOI 10.1152/ajpheart.00151.2005; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Briscoe TA, 2004, AM J OBSTET GYNECOL, V191, P847, DOI 10.1016/j.ajog.2004.01.050; Brodszki J, 2005, CIRCULATION, V111, P2623, DOI 10.1161/CIRCULATIONAHA.104.490326; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; Corstius HB, 2005, PEDIATR RES, V57, P796, DOI 10.1203/01.PDR.0000157726.65492.CD; Crispi F, 2010, CIRCULATION, V121, P2427, DOI 10.1161/CIRCULATIONAHA.110.937995; Crispi F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.056; de las Heras N, 2006, J RENIN-ANGIO-ALDO S, V7, P192, DOI 10.3317/jraas.2006.037; Doherty CB, 2003, PLACENTA, V24, P34, DOI 10.1053/plac.2002.0858; Ergaz Z, 2005, REPROD TOXICOL, V20, P301, DOI 10.1016/j.reprotox.2005.04.007; Fan WH, 2000, EUR J CELL BIOL, V79, P915, DOI 10.1078/0171-9335-00122; FOMOVSKY GM, 2009, J MOL CELL CARDIOL; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Goodfellow J, 1998, CARDIOVASC RES, V40, P600, DOI 10.1016/S0008-6363(98)00197-7; Hartner A, 2001, AM J KIDNEY DIS, V38, P153, DOI 10.1053/ajkd.2001.25209; Hui AY, 2006, LIVER INT, V26, P125, DOI 10.1111/j.1478-3231.2005.01202.x; Jansson N, 2006, J PHYSIOL-LONDON, V576, P935, DOI 10.1113/jphysiol.2003.550004; Konishi A, 2003, J STEROID BIOCHEM, V85, P439, DOI 10.1016/S0960-0760(03)00198-5; LangleyEvans SC, 1997, CLIN SCI, V93, P423, DOI 10.1042/cs0930423; LangleyEvans SC, 1996, CLIN SCI, V91, P607, DOI 10.1042/cs0910607; Lim KJ, 2006, PEDIATR RES, V60, P83, DOI 10.1203/01.pdr.0000220361.08181.c3; Lim K, 2010, ANAT REC, V293, P431, DOI 10.1002/ar.21084; Lopes SMCDS, 2004, DEV DYNAM, V231, P542, DOI 10.1002/dvdy.20162; Martyn CN, 1997, LANCET, V350, P953, DOI 10.1016/S0140-6736(96)10508-0; Martyn CN, 1998, LANCET, V352, P173, DOI 10.1016/S0140-6736(97)10404-4; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Nuesken KD, 2008, ENDOCRINOLOGY, V149, P1056, DOI 10.1210/en.2007-0891; Oemar BS, 1997, CIRCULATION, V95, P831; Plank C, 2006, KIDNEY INT, V70, P1974, DOI 10.1038/sj.ki.5001966; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Renault MA, 2010, CIRC-HEART FAIL, V3, P431, DOI 10.1161/CIRCHEARTFAILURE.109.898114; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Ruiz V, 2003, AM J PHYSIOL-LUNG C, V285, pL1026, DOI 10.1152/ajplung.00183.2003; Rutland CS, 2007, PLACENTA, V28, P734, DOI 10.1016/j.placenta.2006.07.001; Satoh M, 2005, EUR J HEART FAIL, V7, P755, DOI 10.1016/j.ejheart.2004.10.019; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Skilton MR, 2006, CLIN SCI, V111, P281, DOI 10.1042/CS20060036; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Swali A, 2010, J PHYSIOL-LONDON, V588, P3809, DOI 10.1113/jphysiol.2010.194928; Tamura A, 2003, CIRC J, V67, P742; TAPANAINEN PJ, 1994, PEDIATR RES, V36, P152, DOI 10.1203/00006450-199408000-00004; Tintu A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005155; Uno Y, 2000, J VESTIBUL RES-EQUIL, V10, P283; Vehaskari VM, 2005, J AM SOC NEPHROL, V16, P2545, DOI 10.1681/ASN.2005030300; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545; Wang ZH, 2009, AM J PHYSIOL-HEART C, V296, pH1321, DOI 10.1152/ajpheart.00440.2008; WIGGLESWORTH JS, 1964, J PATHOL BACTERIOL, V88, P1, DOI 10.1002/path.1700880102; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Xu Y, 2006, FASEB J, V20, P1251, DOI 10.1096/fj.05-4917fje; ZEMAN FJ, 1967, J NUTR, V93, P167, DOI 10.1093/jn/93.2.167	59	40	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20369	10.1371/journal.pone.0020369	http://dx.doi.org/10.1371/journal.pone.0020369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655297	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600055
J	Stenkova, AM; Isaeva, MP; Shubin, FN; Rasskazov, VA; Rakin, AV				Stenkova, Anna M.; Isaeva, Marina P.; Shubin, Felix N.; Rasskazov, Valeri A.; Rakin, Alexander V.			Trends of the Major Porin Gene (ompF) Evolution: Insight from the Genus Yersinia	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; POSITIVE SELECTION; NEISSERIA-GONORRHOEAE; FORMING PROTEINS; 16S RDNA; RECOMBINATION; ENTEROCOLITICA; BACTERIA; STRAINS	OmpF is one of the major general porins of Enterobacteriaceae that belongs to the first line of bacterial defense and interactions with the biotic as well as abiotic environments. Porins are surface exposed and their structures strongly reflect the history of multiple interactions with the environmental challenges. Unfortunately, little is known on diversity of porin genes of Enterobacteriaceae and the genus Yersinia especially. We analyzed the sequences of the ompF gene from 73 Yersinia strains covering 14 known species. The phylogenetic analysis placed most of the Yersinia strains in the same line assigned by 16S rDNA-gyrB tree. Very high congruence in the tree topologies was observed for Y. enterocolitica, Y. kristensenii, Y. ruckeri, indicating that intragenic recombination in these species had no effect on the ompF gene. A significant level of intra- and interspecies recombination was found for Y. aleksiciae, Y. intermedia and Y. mollaretii. Our analysis shows that the ompF gene of Yersinia has evolved with nonrandom mutational rate under purifying selection. However, several surface loops in the OmpF porin contain positively selected sites, which very likely reflect adaptive diversification Yersinia to their ecological niches. To our knowledge, this is a first investigation of diversity of the porin gene covering the whole genus of the family Enterobacteriaceae. This study demonstrates that recombination and positive selection both contribute to evolution of ompF, but the relative contribution of these evolutionary forces are different among Yersinia species.	[Stenkova, Anna M.; Isaeva, Marina P.; Rasskazov, Valeri A.] Russian Acad Sci, Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia; [Shubin, Felix N.] Russian Acad Med Sci, Siberian Branch, Sci Res Inst Epidemiol & Microbiol, Vladivostok, Russia; [Rakin, Alexander V.] Univ Munich, Max von Pettenkofer Inst Hyg & Clin Microbiol, Munich, Germany	Elyakov Pacific Institute of Bioorganic Chemistry; Russian Academy of Sciences; Russian Academy of Medical Sciences; University of Munich	Stenkova, AM (corresponding author), Russian Acad Sci, Pacific Inst Bioorgan Chem, Far Eastern Branch, Vladivostok 690022, Russia.	stenkova@gmail.com	Rasskazov, Valery/M-8853-2013; Issaeva, Marina/H-6167-2014; Stenkova, Anna/H-5978-2014	Issaeva, Marina/0000-0002-2395-0485; Stenkova, Anna/0000-0002-4889-9006; Shubin, Felix/0000-0003-2668-2989	Presidium of the Russian Academy of Sciences [05-I-P10-018]	Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This study was partly funded by the following grant: The program of Presidium of the Russian Academy of Sciences "Molecular and cell biology" 05-I-P10-018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Baldo L, 2006, MOL BIOL EVOL, V23, P437, DOI 10.1093/molbev/msj049; Baldo L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-48; Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; Bodilis J, 2006, ENVIRON MICROBIOL, V8, P1544, DOI 10.1111/j.1462-2920.2006.01045.x; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; BRZOSTEK K, 1989, RES MICROBIOL, V140, P599, DOI 10.1016/0923-2508(89)90192-7; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chevalier S, 2007, ENVIRON MICROBIOL, V9, P824, DOI 10.1111/j.1462-2920.2006.01191.x; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Demarta A, 2004, FEMS MICROBIOL LETT, V238, P423, DOI 10.1016/j.femsle.2004.08.005; Derrick JP, 1999, INFECT IMMUN, V67, P2406, DOI 10.1128/IAI.67.5.2406-2413.1999; Duperthuy M, 2010, ENVIRON MICROBIOL, V12, P951, DOI 10.1111/j.1462-2920.2009.02138.x; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Guzev KV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1104, DOI 10.1007/s10541-005-0231-z; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; IBRAHIM A, 1993, FEMS MICROBIOL LETT, V114, P173, DOI 10.1016/0378-1097(93)90515-4; Ibrahim A, 1997, FEMS MICROBIOL LETT, V146, P73, DOI 10.1111/j.1574-6968.1997.tb10173.x; Isabel S, 2008, J BACTERIOL, V190, P7548, DOI 10.1128/JB.01067-08; Issaeva MP, 2003, ADV EXP MED BIOL, V529, P257; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kotetishvili M, 2005, J CLIN MICROBIOL, V43, P2674, DOI 10.1128/JCM.43.6.2674-2684.2005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu XQ, 2001, MICROBIOL-SGM, V147, P2981, DOI 10.1099/00221287-147-11-2981; Loftus CG, 2002, DIGEST DIS SCI, V47, P2805, DOI 10.1023/A:1021081911456; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Merhej V, 2008, INT J SYST EVOL MICR, V58, P779, DOI 10.1099/ijs.0.65219-0; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; Neubauer H, 2000, INT J MED MICROBIOL, V290, P61; Nielsen R, 1998, GENETICS, V148, P929; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P872, DOI 10.1046/j.1462-2920.2002.00281.x; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2000, MOL BIOL EVOL, V17, P423, DOI 10.1093/oxfordjournals.molbev.a026322; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SMITH JM, 1992, J MOL EVOL, V34, P126; SMITH NH, 1995, MOL BIOL EVOL, V12, P363; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; Sprague LD, 2005, INT J SYST EVOL MICR, V55, P831, DOI 10.1099/ijs.0.63220-0; Sprague LD, 2008, INT J SYST EVOL MICR, V58, P952, DOI 10.1099/ijs.0.65417-0; SU H, 1990, INFECT IMMUN, V58, P1017, DOI 10.1128/IAI.58.4.1017-1025.1990; SUKER J, 1994, MOL MICROBIOL, V12, P253, DOI 10.1111/j.1365-2958.1994.tb01014.x; Sulakvelidze A, 2000, MICROBES INFECT, V2, P497, DOI 10.1016/S1286-4579(00)00311-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ursing J, 1995, CONTRIB TO MICROBIOL, V13, P112; Urwin R, 2002, MOL BIOL EVOL, V19, P1686, DOI 10.1093/oxfordjournals.molbev.a003991; van Putten JPM, 1998, J EXP MED, V188, P941, DOI 10.1084/jem.188.5.941; Vostrikova OP, 2006, RUSS J BIOORG CHEM+, V32, P333, DOI 10.1134/S1068162006040030; Vostrikova OP, 2003, ADV EXP MED BIOL, V529, P261; WEISS MS, 1992, J MOL BIOL, V227, P493, DOI 10.1016/0022-2836(92)90903-W; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7	61	25	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20546	10.1371/journal.pone.0020546	http://dx.doi.org/10.1371/journal.pone.0020546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655186	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600094
J	Xu, L; Xu, W; Wen, ZK; Xiong, SD				Xu, Lin; Xu, Wei; Wen, Zhenke; Xiong, Sidong			In Situ Prior Proliferation of CD4(+) CCR6(+) Regulatory T Cells Facilitated by TGF-beta Secreting DCs Is Crucial for Their Enrichment and Suppression in Tumor Immunity	PLOS ONE			English	Article							EXPRESSION DEFINES; RECRUITMENT; SUBSETS; NAIVE	Background: CD4(+) CD25(+) regulatory T cells (Tregs), a heterogeneous population, were enrichment in tumor mass and played an important role in modulating anti-tumor immunity. Recently, we reported a Treg subset, CCR6(+) Tregs but not CCR6(-)Tregs, were enriched in tumor mass and closely related to poor prognosis of breast cancer patients. However, the underlying mechanism remains elusive. Here, we carefully evaluate the enrichment of CCR6(+) Tregs in tumor mass during progression of breast cancer and explore its possible mechanism. Methodology/Principal Findings: The frequency of CCR6(+) Tregs in tumor infiltrating lymphocytes (TILs) was analyzed at early stage and at late stage of tumor in a murine breast cancer model by FACS respectively. The expansion of CCR6(+) Tregs and their CCR6(-) counterpart in tumor mass were determined by BrdU incorporation assay. The effect and its possible mechanism of tumor-resident antigen presenting cells (APCs) on the proliferation of CCR6(+) Tregs also were evaluated. The role of local expansion of CCR6(+) Tregs in their enrichment and suppression in vivo also was evaluated in adoptive cell transfer assay. We found that the prior enrichment of CCR6(+) Tregs but not CCR6(-) Tregs in tumor mass during progression of murine breast cancer, which was dependent on the dominant proliferation of CCR6(+) Tregs in situ. Further study demonstrated that tumor-resident DCs triggered the proliferation of CCR6(+) Treg cells in TGF-b dependent manner. Adoptive transfer of CCR6(+) Tregs was found to potently inhibit the function of CD8(+) T cells in vivo, which was dependent on their proliferation and subsequently enrichment in tummor mass. Conclusions/Significance: Our finding suggested that CCR6(+) Tregs, a distinct subset of Tregs, exert its predominant suppressive role in tumor immunity through prior in situ expansion, which might ultimately provide helpful thoughts for the designing of Treg-based immunotherapy for tumor in the future.	[Xu, Lin; Wen, Zhenke; Xiong, Sidong] Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xu, Lin; Wen, Zhenke; Xiong, Sidong] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol, Suzhou, Peoples R China; [Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Med Sci, Suzhou, Peoples R China; [Xu, Lin] Zunyi Med Coll, Dept Immunol, Zunyi, Guizhou Prov, Peoples R China	Fudan University; Fudan University; Soochow University - China; Soochow University - China; Zunyi Medical University	Xu, L (corresponding author), Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	sdxiong@suda.edu.cn			Major State Basic Research Development Program of China [2007CB512401]; NSFC [81072413]; Jiangsu "Pan-Deng" Project [BK2010004]; Jiangsu High Level "Shuang-Chuang" Project; Program for Shanghai Outstanding Medical Academic Leader [LJ06011]	Major State Basic Research Development Program of China(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu "Pan-Deng" Project; Jiangsu High Level "Shuang-Chuang" Project; Program for Shanghai Outstanding Medical Academic Leader	This work was funded by Major State Basic Research Development Program of China (2007CB512401, http://www.973.gov.cn/AreaBook.aspx), China NSFC grant (81072413, http://www.nsfc.gov.cn/Portal0/default124.htm; Grant No. 30901318, http://www.nsfc.gov.cn/Portal0/default124.htm), Jiangsu "Pan-Deng" Project (BK2010004, http://www.jstd.gov.cn/kjgl/gxjs/xgzcgd/20090616/185505964.html), Jiangsu High Level "Shuang-Chuang" Project (http:/www.jstd.gov.cn), and the Program for Shanghai Outstanding Medical Academic Leader (LJ06011, http://www.12333sh.gov.cn/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBARA V, 2006, CANCER RES, V66, P4488; BYRNE JA, 1988, J IMMUNOL, V141, P3249; Camisaschi C, 2010, J IMMUNOL, V184, P6545, DOI 10.4049/jimmunol.0903879; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; CROFT M, 1994, J IMMUNOL, V152, P2675; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Fainaru O, 2010, FASEB J, V24, P1411, DOI 10.1096/fj.09-147025; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Haas J, 2008, BLOOD, V111, P761, DOI 10.1182/blood-2007-08-104877; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Lamprecht B, 2008, BLOOD, V112, P3339, DOI 10.1182/blood-2008-01-134783; Mougiakakos D, 2010, ADV CANCER RES, V107, P57, DOI 10.1016/S0065-230X(10)07003-X; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Rivino L, 2010, J EXP MED, V207, P565, DOI 10.1084/jem.20091021; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Tosello V, 2008, CLIN IMMUNOL, V126, P291, DOI 10.1016/j.clim.2007.11.008; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; XU L, 2009, CANCER BIOL THER, V4, P293; XU L, 2009, CHIN J CANC BIOTHER, V16, P485; XU L, 2008, ACTA ACAD MED ZUNYI, V31, P116; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; XUN RL, 2007, P NATL ACAD SCI USA, V104, P2821; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang XS, 2010, J LEUKOCYTE BIOL, V88, P393, DOI 10.1189/jlb.0909633; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	32	17	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20282	10.1371/journal.pone.0020282	http://dx.doi.org/10.1371/journal.pone.0020282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655250	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600037
J	Chapman, TJ; Lambert, K; Topham, DJ				Chapman, Timothy J.; Lambert, Kris; Topham, David J.			Rapid Reactivation of Extralymphoid CD4 T Cells during Secondary Infection	PLOS ONE			English	Article							RESPIRATORY VIRUS-INFECTIONS; NONLYMPHOID TISSUES; INFLUENZA INFECTION; CUTTING EDGE; LUNG AIRWAYS; RESPONSES; IMMUNITY; ANTIGEN; RECRUITMENT; IL-10	After infection, extralymphoid tissues are enriched with effector and memory T cells of a highly activated phenotype. The capacity for rapid effector cytokine response from extralymphoid tissue-memory T cells suggests these cells may perform a 'sentinel' function in the tissue. While it has been demonstrated that extralymphoid CD4+ T cells can directly respond to secondary infection, little is known about how rapidly this response is initiated, and how early activation of T cells in the tissue may affect the innate response to infection. Here we use a mouse model of secondary heterosubtypic influenza infection to show that CD4(+) T cells in the lung airways are reactivated within 24 hours of secondary challenge. Airway CD4(+) T cells initiate an inflammatory cytokine and chemokine program that both alters the composition of the early innate response and contributes to the reduction of viral titers in the lung. These results show that, unlike a primary infection, extralymphoid tissue-memory CD4(+) T cells respond alongside the innate response during secondary infection, thereby shaping the overall immune profile in the airways. These data provide new insights into the role of extralymphoid CD4(+) T cells during secondary immune responses.	[Chapman, Timothy J.; Lambert, Kris; Topham, David J.] Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Rochester, NY 14627 USA	University of Rochester	Chapman, TJ (corresponding author), Univ Rochester, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	david_topham@urmc.rochester.edu		Chapman, Timothy/0000-0002-2337-2136	National Institutes of Health [R01-AG021970, N01-AI50020, HHSN266200700008C]; NIH/NRSA [2T32AI007169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants R01-AG021970 and N01-AI50020 and HHSN266200700008C. TJC is supported by NIH/NRSA training grant #2T32AI007169. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Cauley LS, 2002, J IMMUNOL, V169, P6655, DOI 10.4049/jimmunol.169.12.6655; Chapman TJ, 2010, J IMMUNOL, V184, P3841, DOI 10.4049/jimmunol.0902281; Chapman TJ, 2005, VIROLOGY, V340, P296, DOI 10.1016/j.virol.2005.06.023; Chiu BC, 2007, AM J PATHOL, V171, P829, DOI 10.2353/ajpath.2007.061122; Deepe GS, 2003, J IMMUNOL, V171, P5353, DOI 10.4049/jimmunol.171.10.5353; Ely KH, 2006, J IMMUNOL, V176, P537, DOI 10.4049/jimmunol.176.1.537; Ely KH, 2003, J IMMUNOL, V170, P1423, DOI 10.4049/jimmunol.170.3.1423; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Guo LY, 2009, P NATL ACAD SCI USA, V106, P13463, DOI 10.1073/pnas.0906988106; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Kohlmeier JE, 2009, ANNU REV IMMUNOL, V27, P61, DOI 10.1146/annurev.immunol.021908.132625; Kradin RL, 2004, EXP MOL PATHOL, V76, P205, DOI 10.1016/j.yexmp.2003.12.010; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; LIANG SH, 1994, J IMMUNOL, V152, P1653; MacLeod MKL, 2008, P NATL ACAD SCI USA, V105, P14521, DOI 10.1073/pnas.0807449105; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; McGill J, 2008, J EXP MED, V205, P1635, DOI 10.1084/jem.20080314; McGill J, 2009, J IMMUNOL, V183, P4177, DOI 10.4049/jimmunol.0901109; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Richter M, 2007, J IMMUNOL, V178, P4506, DOI 10.4049/jimmunol.178.7.4506; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Thomas PG, 2006, P NATL ACAD SCI USA, V103, P2764, DOI 10.1073/pnas.0511185103; Topham DJ, 2001, J IMMUNOL, V167, P6983, DOI 10.4049/jimmunol.167.12.6983; Wakim LM, 2008, J IMMUNOL, V181, P5837, DOI 10.4049/jimmunol.181.9.5837; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Welsh RM, 2007, NAT REV MICROBIOL, V5, P555, DOI 10.1038/nrmicro1709; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; Wissinger EL, 2008, J IMMUNOL, V180, P2957, DOI 10.4049/jimmunol.180.5.2957; Woodland David L, 2005, Proc Am Thorac Soc, V2, P126	37	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20493	10.1371/journal.pone.0020493	http://dx.doi.org/10.1371/journal.pone.0020493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647373	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500065
J	Kausrud, KL; Gregoire, JC; Skarpaas, O; Erbilgin, N; Gilbert, M; Okland, B; Stenseth, NC				Kausrud, Kyrre L.; Gregoire, Jean-Claude; Skarpaas, Olav; Erbilgin, Nadir; Gilbert, Marius; Okland, Bjorn; Stenseth, Nils Chr.			Trees Wanted-Dead or Alive! Host Selection and Population Dynamics in Tree-Killing Bark Beetles	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; IPS-TYPOGRAPHUS COLEOPTERA; REPRODUCTIVE SUCCESS; SPRUCE; CURCULIONIDAE; AGGREGATION; ATTRACTION; PHEROMONE; PATTERNS; ECOLOGY	Bark beetles (Coleoptera: Curculionidae, Scolytinae) feed and breed in dead or severely weakened host trees. When their population densities are high, some species aggregate on healthy host trees so that their defences may be exhausted and the inner bark successfully colonized, killing the tree in the process. Here we investigate under what conditions participating with unrelated conspecifics in risky mass attacks on living trees is an adaptive strategy, and what this can tell us about bark beetle outbreak dynamics. We find that the outcome of individual host selection may deviate from the ideal free distribution in a way that facilitates the emergence of tree-killing (aggressive) behavior, and that any heritability on traits governing aggressiveness seems likely to exist in a state of flux or cycles consistent with variability observed in natural populations. This may have implications for how economically and ecologically important species respond to environmental changes in climate and landscape (forest) structure. The population dynamics emerging from individual behavior are complex, capable of switching between "endemic" and "epidemic" regimes spontaneously or following changes in host availability or resistance. Model predictions are compared to empirical observations, and we identify some factors determining the occurrence and self-limitation of epidemics.	[Kausrud, Kyrre L.; Stenseth, Nils Chr.] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Kausrud, Kyrre L.; Okland, Bjorn] Norwegian Forest & Landscape Inst, As, Norway; [Gregoire, Jean-Claude; Gilbert, Marius] Univ Libre Bruxelles, Brussels, Belgium; [Skarpaas, Olav] Norwegian Inst Nat Res, N-0315 Oslo, Norway; [Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Gilbert, Marius] Fonds Natl Rech Sci, B-1050 Brussels, Belgium	University of Oslo; The Norwegian Forest & Landscape Institute; Universite Libre de Bruxelles; Norwegian Institute Nature Research; University of Alberta; Fonds de la Recherche Scientifique - FNRS	Kausrud, KL (corresponding author), Univ Oslo, Dept Biol, CEES, Oslo, Norway.	n.c.stenseth@bio.uio.no	Stenseth, Nils Chr./G-5212-2016; Erbilgin, Nadir/F-3675-2014; Lundquist, John/B-6433-2012; Grégoire, Jean-Claude/F-4397-2011	Stenseth, Nils Chr./0000-0002-1591-5399; Erbilgin, Nadir/0000-0001-9912-8095; Gilbert, Marius/0000-0003-3708-3359; Gregoire, Jean-Claude/0000-0002-3346-4130; Kausrud, Kyrre/0000-0002-2738-7351; Skarpaas, Olav/0000-0001-9727-1672	Research Council of Norway (RCN) [170801]; Centre for Ecological and Evolutionary Synthesis (CEES); Norwegian Forest and Landscape Institute	Research Council of Norway (RCN)(Research Council of Norway); Centre for Ecological and Evolutionary Synthesis (CEES); Norwegian Forest and Landscape Institute	This work was funded by the Research Council of Norway (RCN) Project no. 170801, the Centre for Ecological and Evolutionary Synthesis (CEES), and the Norwegian Forest and Landscape Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender CJ, 2008, ENVIRON ENTOMOL, V37, P817, DOI 10.1603/0046-225X(2008)37[817:LOGDIA]2.0.CO;2; ANDERBRANT O, 1985, OIKOS, V45, P89, DOI 10.2307/3565226; Aukema BH, 2004, OECOLOGIA, V138, P253, DOI 10.1007/s00442-003-1433-y; Aukema BH, 2008, ECOGRAPHY, V31, P348, DOI 10.1111/j.0906-7590.2007.05453.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; BOURTZIS K, INSECT SYMBIOSIS CRC; BYERS JA, 1984, J CHEM ECOL, V10, P861, DOI 10.1007/BF00987969; Byers JA, 1999, J CHEM ECOL, V25, P985, DOI 10.1023/A:1020869422943; BYERS JA, 1984, ENVIRON ENTOMOL, V13, P1191, DOI 10.1093/ee/13.5.1191; BYERS JA, CHEM ECOLOGY BARK BE, P89; Campbell SA, 2006, ECOL ENTOMOL, V31, P437, DOI 10.1111/j.1365-2311.2006.00809.x; Carroll A. L., 2006, IMPACTS CLIMATE CHAN; CHRISTIANSEN E, SPRUCE BARK BEETLE E, P479; Cressman R, 2006, AM NAT, V168, P384, DOI 10.1086/506970; DEJONG MCM, 1986, ENTOMOL EXP APPL, V41, P121, DOI 10.1007/BF00195567; DEJONG MCM, 1988, OIKOS, V51, P88, DOI 10.2307/3565811; Erbilgin N, 2003, AGR FOREST ENTOMOL, V5, P269, DOI 10.1046/j.1461-9563.2003.00186.x; Erbilgin N, 2007, AGR FOREST ENTOMOL, V9, P135, DOI 10.1111/j.1461-9563.2007.00329.x; Eriksson M, 2008, FOREST ECOL MANAG, V255, P1336, DOI 10.1016/j.foreco.2007.10.043; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Franklin AJ, 2001, J CHEM ECOL, V27, P2425, DOI 10.1023/A:1013619313415; Franklin Anne J., 2000, Agricultural and Forest Entomology, V2, P259, DOI 10.1046/j.1461-9563.2000.00075.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GREGOIRE JC, 1996, PHEROMONE MASS TRAPP; Haugen TO, 2006, P ROY SOC B-BIOL SCI, V273, P2917, DOI 10.1098/rspb.2006.3659; Hedgren PO, 2004, FOREST ECOL MANAG, V203, P241, DOI 10.1016/j.foreco.2004.07.055; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Hulcr J, 2006, J APPL ENTOMOL, V130, P275, DOI 10.1111/j.1439-0418.2006.01069.x; McGregor M., 1985, WO46 USDA FOR SERV G, P16; NELSON WA, 2005, 819 NRC; Nelson WA, 2008, J APPL ECOL, V45, P248, DOI 10.1111/j.1365-2664.2007.01374.x; Okland B, 2006, ECOLOGY, V87, P283, DOI 10.1890/05-0135; Okland B, 2004, AGR FOREST ENTOMOL, V6, P141, DOI 10.1111/j.1461-9555.2004.00214.x; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; Piel F, 2005, AGR FOREST ENTOMOL, V7, P161, DOI 10.1111/j.1461-9555.2005.00262.x; Powell JA, 1996, J THEOR BIOL, V179, P243, DOI 10.1006/jtbi.1996.0064; Pureswaran DS, 2008, NATURWISSENSCHAFTEN, V95, P33, DOI 10.1007/s00114-007-0292-5; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Raffa Kenneth F., 1993, P103; Raffa KF, 2005, RECENT ADV PHYTOCHEM, V39, P79; Raffa KF, 2001, CHEMOECOLOGY, V11, P49, DOI 10.1007/PL00001833; Robins GL, 1997, ECOL ENTOMOL, V22, P329, DOI 10.1046/j.1365-2311.1997.00068.x; Saint-Germain M, 2007, AGR FOREST ENTOMOL, V9, P227, DOI 10.1111/j.1461-9563.2007.00337.x; Salle A, 2007, BIOL J LINN SOC, V90, P239, DOI 10.1111/j.1095-8312.2007.00720.x; Sun Xiao-ling, 2006, Journal of Forestry Research (Harbin), V17, P65, DOI 10.1007/s11676-006-0016-2; Taylor P, 2000, BIOL PHILOS, V15, P197, DOI 10.1023/A:1006684801878; van Baalen M, 1999, AM NAT, V154, P69, DOI 10.1086/303215; Wallin KF, 2004, ECOL MONOGR, V74, P101, DOI 10.1890/02-4004; Wallin KF, 2002, ENVIRON ENTOMOL, V31, P1276, DOI 10.1603/0046-225X-31.6.1276; Wermelinger B, 2004, FOREST ECOL MANAG, V202, P67, DOI 10.1016/j.foreco.2004.07.018; WESLIEN J, 1994, ENTOMOL EXP APPL, V71, P133, DOI 10.1007/BF02382381; Zhang QH, 2004, AGR FOREST ENTOMOL, V6, P1, DOI 10.1111/j.1461-9555.2004.00202.x; ZHANG QH, 1992, J APPL ECOL, V29, P672, DOI 10.2307/2404475	53	24	24	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e18274	10.1371/journal.pone.0018274	http://dx.doi.org/10.1371/journal.pone.0018274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647433	Green Published, gold, Green Accepted			2022-12-25	WOS:000291006500002
J	Tan, JQ; Ma, Z; Gao, XC; Wu, YH; Fang, F				Tan, Jieqing; Ma, Zheng; Gao, Xiaochao; Wu, Yanhong; Fang, Fang			Gender Difference of Unconscious Attentional Bias in High Trait Anxiety Individuals	PLOS ONE			English	Article							THREATENING FACIAL EXPRESSIONS; SELECTIVE ATTENTION; TIME-COURSE; EMOTIONAL INFORMATION; SEX-DIFFERENCES; COGNITIVE BIAS; DEPRESSION; PERCEPTION; VIGILANCE; RESPONSES	By combining binocular suppression technique and a probe detection paradigm, we investigated attentional bias to invisible stimuli and its gender difference in both high trait anxiety (HTA) and low trait anxiety (LTA) individuals. As an attentional cue, happy or fearful face pictures were presented to HTAs and LTAs for 800 ms either consciously or unconsciously (through binocular suppression). Participants were asked to judge the orientation of a gabor patch following the face pictures. Their performance was used to measure attentional effect induced by the cue. We found gender differences of attentional effect only in the unconscious condition with HTAs. Female HTAs exhibited difficulty in disengaging attention from the location where fearful faces were presented, while male HTAs showed attentional avoidance of it. Our results suggested that the failure to find attentional avoidance of threatening stimuli in many previous studies might be attributed to consciously presented stimuli and data analysis regardless of participants' gender. These findings also contributed to our understanding of gender difference in anxiety disorder.	[Tan, Jieqing; Ma, Zheng; Gao, Xiaochao; Wu, Yanhong; Fang, Fang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Wu, Yanhong] Capital Normal Univ, Learning & Cognit Lab, Beijing, Peoples R China; [Ma, Zheng] Peking Univ, Yuanpei Coll, Beijing 100871, Peoples R China	Peking University; Capital Normal University; Peking University	Tan, JQ (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	wuyh@pku.edu.cn			Natural Science Foundation of China [31070982, 30770711, 30470568]; Major State Basic Research Development Program of China (973) [2009CB320901]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973)(National Basic Research Program of China)	Work was funded by Natural Science Foundation of China http://www.nsfc.gov.cn/ (31070982, 30770711, 30470568); Major State Basic Research Development Program of China (973) www.most.gov.cn/ (2009CB320901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; [白露 BAI Lu], 2005, [中国心理卫生杂志, Chinese Mental Health Journal], V19, P719; Beck AT, 1985, ANXIETY DISORDERS PH; Bekker MHJ, 1996, CLIN PSYCHOL REV, V16, P129, DOI 10.1016/0272-7358(96)00012-8; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; Broadbent D, 1988, COGNITION EMOTION, V2, P165, DOI 10.1080/02699938808410922; CASTLE DJ, 1995, AUST NZ J PSYCHIAT, V29, P114, DOI 10.3109/00048679509075899; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Ellenbogen MA, 2002, PSYCHOPHYSIOLOGY, V39, P723, DOI 10.1111/1469-8986.3960723; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Fredrikson M, 1996, BEHAV RES THER, V34, P33, DOI 10.1016/0005-7967(95)00048-3; Gibbs NA, 1996, CLIN PSYCHOL REV, V16, P729, DOI 10.1016/S0272-7358(96)00043-8; Goos LM, 2002, J NONVERBAL BEHAV, V26, P27, DOI 10.1023/A:1014418503754; Jansson B, 2005, PERS INDIV DIFFER, V39, P1373, DOI 10.1016/j.paid.2005.04.013; Jiang Y, 2006, P NATL ACAD SCI USA, V103, P17048, DOI 10.1073/pnas.0605678103; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Koster EHW, 2005, BEHAV RES THER, V43, P1087, DOI 10.1016/j.brat.2004.08.004; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Kowler E., 1995, VIS COGN, V2, P215; MACLEOD C, 1992, BEHAV RES THER, V30, P151, DOI 10.1016/0005-7967(92)90138-7; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MATHEWS A, 1994, ANNU REV PSYCHOL, V45, P25, DOI 10.1146/annurev.psych.45.1.25; Mayer B, 1999, CLIN PSYCHOL REV, V19, P571, DOI 10.1016/S0272-7358(98)00060-9; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; McClure EB, 2004, BIOL PSYCHIAT, V55, P1047, DOI 10.1016/j.biopsych.2004.02.013; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; MOGG K, 1995, BEHAV RES THER, V33, P927, DOI 10.1016/0005-7967(95)00031-R; Mogg K, 2004, COGNITION EMOTION, V18, P689, DOI 10.1080/02699930341000158; MOGG K, 1993, J ABNORM PSYCHOL, V102, P304, DOI 10.1037/0021-843X.102.2.304; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Osorio LC, 2003, PERS INDIV DIFFER, V34, P831, DOI 10.1016/S0191-8869(02)00074-0; Rachman S. J., 1998, ANXIETY; Rossignol M, 2005, NEUROSCI LETT, V377, P115, DOI 10.1016/j.neulet.2004.11.091; Simonds VA, 2003, J AFFECT DISORDERS, V77, P197, DOI 10.1016/S0165-0327(02)00113-1; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Waters AM, 2009, J BEHAV THER EXP PSY, V40, P306, DOI 10.1016/j.jbtep.2008.12.008; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.; Yovel I, 2005, PERS INDIV DIFFER, V38, P785, DOI 10.1016/j.paid.2004.06.003; ZHEN X, 1993, CHINESE J CLIN PSYCH, V17, P60; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	34	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20305	10.1371/journal.pone.0020305	http://dx.doi.org/10.1371/journal.pone.0020305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IJ	21647221	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800042
J	Zhao, B; Mankowski, MK; Snyder, BA; Ptak, RG; LiWang, PJ				Zhao, Bo; Mankowski, Marie K.; Snyder, Beth A.; Ptak, Roger G.; LiWang, Patricia J.			Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FUSION-INHIBITOR; HTLV-III; MONONUCLEAR PHAGOCYTES; VIRAL ENVELOPE; PSC-RANTES; T-CELLS; TYPE-1; INFECTION; GP41	Blocking HIV-1 cell entry has long been a major goal of anti-HIV drug development. Here, we report a successful design of two highly potent chimeric HIV entry inhibitors composed of one CCR5-targeting RANTES (regulated on activation normal T cell expressed and secreted) variant (5P12-RANTES or 5P14-RANTES (Gaertner, H., Cerini, F., Escola, J. M., Kuenzi, G., Melotti, A., Offord, R., Rossitto-Borlat, I., Nedellec, R., Salkowitz, J., Gorochov, G., Mosier, D., and Hartley, O. (2008) Proc. Natl. Acad. Sci. U.S.A. 105, 17706-17711)) linked to a gp41 fusion inhibitor, C37. Chimeric inhibitors 5P12-linker-C37 and 5P14-linker-C37 showed extremely high antiviral potency in single cycle and replication-competent viral assays against R5-tropic viruses, with IC50 values as low as 0.004 nM. This inhibition was somewhat strain-dependent and was up to 100-fold better than the RANTES variant alone or in combination with unlinked C37. The chimeric inhibitors also fully retained the antiviral activity of C37 against X4-tropic viruses, and this inhibition can be further enhanced significantly if the target cell co-expresses CCR5 receptor. On human peripheral blood mononuclear cells, the inhibitors showed very strong inhibition against R5-tropic Ba-L strain and X4-tropic IIIB strain, with IC50 values as low as 0.015 and 0.44 nM, which are 45- and 16-fold better than the parent inhibitors, respectively. A clear delivery mechanism requiring a covalent linkage between the two segments of the chimera was observed and characterized. Furthermore, the two chimeric inhibitors are fully recombinant and are easily produced at low cost. These attributes make them excellent candidates for anti-HIV microbicides. The results of this study also suggest a potent approach for optimizing existing HIV entry inhibitors or designing new inhibitors.	[LiWang, Patricia J.] Univ Calif, Merced, CA 95343 USA; [Zhao, Bo] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Mankowski, Marie K.; Snyder, Beth A.; Ptak, Roger G.] So Res Inst, Dept Infect Dis Res, Frederick, MD 21701 USA	University of California System; University of California Merced; Texas A&M University System; Texas A&M University College Station	LiWang, PJ (corresponding author), Univ Calif, 5200 N Lake Rd, Merced, CA 95343 USA.	pliwang@ucmerced.edu	Zhao, Bo/GVT-7665-2022	Zhao, Bo/0000-0002-2163-6484	National Institutes of Health [AI079777]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079777] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI079777.	Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Champagne K, 2009, J BIOL CHEM, V284, P3619, DOI 10.1074/jbc.M809269200; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; ChengMayer C, 1997, J VIROL, V71, P1657, DOI 10.1128/JVI.71.2.1657-1661.1997; CIMINALE V, 1990, AIDS RES HUM RETROV, V6, P1281, DOI 10.1089/aid.1990.6.1281; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GENDELMAN HE, 1992, J IMMUNOL, V148, P422; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; Hamburger AE, 2005, J BIOL CHEM, V280, P12567, DOI 10.1074/jbc.M412770200; Hartley O, 2005, CURR PROTEIN PEPT SC, V6, P207, DOI 10.2174/1389203054065400; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Hartley O, 2003, J VIROL, V77, P6637, DOI 10.1128/JVI.77.12.6637-6644.2003; Heredia A, 2007, AIDS, V21, P1317, DOI 10.1097/QAD.0b013e32815278ea; Ji CH, 2009, J BIOL CHEM, V284, P5175, DOI 10.1074/jbc.M808745200; Kagiampakis I, 2011, ANTIMICROB AGENTS CH, V55, P264, DOI 10.1128/AAC.00376-10; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Kawamura T, 2004, J VIROL, V78, P7602, DOI 10.1128/JVI.78.14.7602-7609.2004; Kopetzki E, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-56; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Pace P, 2008, CURR OPIN DRUG DISC, V11, P471; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pleskoff O, 1997, SCIENCE, V276, P1874, DOI 10.1126/science.276.5320.1874; POPOVIC M, 1984, LANCET, V2, P1472; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Poveda E, 2005, AIDS REV, V7, P139; Ptak RG, 2008, ANTIMICROB AGENTS CH, V52, P1302, DOI 10.1128/AAC.01324-07; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Root MJ, 2004, CURR PHARM DESIGN, V10, P1805, DOI 10.2174/1381612043384448; Stamatatos L, 2000, AIDS RES HUM RETROV, V16, P981, DOI 10.1089/08892220050058407; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Stoddart CA, 2008, J BIOL CHEM, V283, P34045, DOI 10.1074/jbc.M805536200; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang HGH, 2004, CURR PHARM DESIGN, V10, P1785, DOI 10.2174/1381612043384565; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WESTERVELT P, 1991, P NATL ACAD SCI USA, V88, P3097, DOI 10.1073/pnas.88.8.3097; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777	62	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28370	28381		10.1074/jbc.M111.234799	http://dx.doi.org/10.1074/jbc.M111.234799			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659523	hybrid, Green Published			2022-12-25	WOS:000293557800053
J	Dixon, AS; Pendley, SS; Bruno, BJ; Woessner, DW; Shimpi, AA; Cheatham, TE; Lim, CS				Dixon, Andrew S.; Pendley, Scott S.; Bruno, Benjamin J.; Woessner, David W.; Shimpi, Adrian A.; Cheatham, Thomas E., III; Lim, Carol S.			Disruption of Bcr-Abl Coiled Coil Oligomerization by Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITORS; FREE-ENERGY CALCULATIONS; GCN4 LEUCINE-ZIPPER; CYTOCHEMICAL METHODS; MOLECULAR-MECHANICS; SECONDARY STRUCTURE; PROTEIN SWITCH; SALT BRIDGES; HIV-1 ENTRY	Oligomerization is an important regulatory mechanism for many proteins, including oncoproteins and other pathogenic proteins. The oncoprotein Bcr-Abl relies on oligomerization via its coiled coil domain for its kinase activity, suggesting that a designed coiled coil domain with enhanced binding to Bcr-Abl and reduced self-oligomerization would be therapeutically useful. Key mutations in the coiled coil domain of Bcr-Abl were identified that reduce homo-oligomerization through intermolecular charge-charge repulsion yet increase interaction with the Bcr-Abl coiled coil through additional salt bridges, resulting in an enhanced ability to disrupt the oligomeric state of Bcr-Abl. The mutations were modeled computationally to optimize the design. Assays performed in vitro confirmed the validity and functionality of the optimal mutations, which were found to exhibit reduced homo-oligomerization and increased binding to the Bcr-Abl coiled coil domain. Introduction of the mutant coiled coil into K562 cells resulted in decreased phosphorylation of Bcr-Abl, reduced cell proliferation, and increased caspase-3/7 activity and DNA segmentation. Importantly, the mutant coiled coil domain was more efficacious than the wild type in all experiments performed. The improved inhibition of Bcr-Abl through oligomeric disruption resulting from this modified coiled coil domain represents a viable alternative to small molecule inhibitors for therapeutic intervention.	[Cheatham, Thomas E., III; Lim, Carol S.] Univ Utah, Coll Pharm, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84108 USA; [Woessner, David W.] Univ Utah, Coll Pharm, Dept Pharmacol & Toxicol, Salt Lake City, UT 84108 USA; [Cheatham, Thomas E., III] Univ Utah, Coll Pharm, Dept Med Chem, Salt Lake City, UT 84108 USA; [Shimpi, Adrian A.] Juan Diego Catholic High Sch, Draper, UT 84020 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lim, CS (corresponding author), Univ Utah, Coll Pharm, Dept Pharmaceut & Pharmaceut Chem, 421 Wakara Way,Rm 318, Salt Lake City, UT 84108 USA.	tec3@utah.edu; carol.lim@pharm.utah.edu			National Institutes of Health [CA129528, GM079383]; American Foundation for Pharmaceutical Education; University of Utah; ALSAM Foundation; National Science Foundation [TG-MCA01S027]; NCI Cancer Center, Huntsman Cancer Institute [P30 CA042014]; NATIONAL CANCER INSTITUTE [R01CA129528, P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Pharmaceutical Education; University of Utah; ALSAM Foundation; National Science Foundation(National Science Foundation (NSF)); NCI Cancer Center, Huntsman Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129528 (to C. S. L.) and GM079383 (to T. E. C.). This work was also supported by an American Foundation for Pharmaceutical Education predoctoral fellowship (to A. S. D), Graduate Research Fellowship, University of Utah (to A. S. D.) the ALSAM Foundation (to A. A. S), and National Science Foundation Grant TG-MCA01S027 (to T. E. C.; for computer time).; We acknowledge the use of the DNA/Peptide Core (NCI Cancer Center Support Grant P30 CA042014, Huntsman Cancer Institute) and computer time from the Center for High Performance Computing at the University of Utah. We thank Dr. Debbie Eckert for technical assistance in protein purification and Jonathan Constance, Rian Davis, Mohanad Mossalam, Matthew Weinstock, and Dr. Michael Kay for scientific discussions.	Arlinghaus RB, 2002, ONCOGENE, V21, P8560, DOI 10.1038/sj.onc.1206083; Barrett KL, 2001, J HISTOCHEM CYTOCHEM, V49, P821, DOI 10.1177/002215540104900703; Beissert T, 2003, BLOOD, V102, P2985, DOI 10.1182/blood-2003-03-0811; Beissert T, 2008, INT J CANCER, V122, P2744, DOI 10.1002/ijc.23467; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Case DA, 2006, AMBER; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Dixon AS, 2010, BIOTECHNIQUES, V49, P519, DOI 10.2144/000113452; Dixon AS, 2009, J CONTROL RELEASE, V140, P245, DOI 10.1016/j.jconrel.2009.06.026; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eckert DM, 1999, CELL, V99, P103, DOI 10.1016/S0092-8674(00)80066-5; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guo XYD, 1998, ONCOGENE, V17, P825, DOI 10.1038/sj.onc.1201999; Gurnon DG, 2003, J AM CHEM SOC, V125, P7518, DOI 10.1021/ja0357590; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; HODGES RS, 1981, J BIOL CHEM, V256, P1214; Huang SF, 2009, PROTEIN EXPRES PURIF, V64, P167, DOI 10.1016/j.pep.2008.10.023; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Jamieson Catriona H, 2008, Hematology Am Soc Hematol Educ Program, P436, DOI 10.1182/asheducation-2008.1.436; Janssen JJWM, 2009, CURR STEM CELL RES T, V4, P224, DOI 10.2174/157488809789057428; Jelesarov I, 1996, J MOL BIOL, V263, P344, DOI 10.1006/jmbi.1996.0579; Kakar M, 2007, PHARM RES-DORDR, V24, P2146, DOI 10.1007/s11095-007-9333-1; Kakar M, 2007, J CONTROL RELEASE, V120, P220, DOI 10.1016/j.jconrel.2007.04.017; Kammerer RA, 2001, J BIOL CHEM, V276, P13685, DOI 10.1074/jbc.M010492200; Kantarjian HM, 2010, CANCER-AM CANCER SOC, V116, P1419, DOI 10.1002/cncr.24928; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Martin MG, 2009, LEUKEMIA LYMPHOMA, V50, P14, DOI 10.1080/10428190802517765; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Meli M, 2009, METHODS MOL BIOL, V570, P77, DOI 10.1007/978-1-60327-394-7_4; Mian AA, 2009, LEUKEMIA, V23, P2242, DOI 10.1038/leu.2009.194; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Ryan SJ, 2007, J AM CHEM SOC, V129, P10255, DOI 10.1021/ja073717w; Santos FPS, 2009, LEUKEMIA LYMPHOMA, V50, P16, DOI 10.3109/10428190903383427; Sia SK, 2002, P NATL ACAD SCI USA, V99, P14664, DOI 10.1073/pnas.232566599; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Steinbrecher T, 2010, CURR MED CHEM, V17, P767, DOI 10.2174/092986710790514453; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Taylor CM, 2005, BIOCHEMISTRY-US, V44, P16246, DOI 10.1021/bi051493t; Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1101, DOI 10.1177/002215549904700901; Yan Z, 2006, J STRUCT BIOL, V155, P162, DOI 10.1016/j.jsb.2006.03.024; Zhang XW, 2001, MOL CELL BIOL, V21, P840, DOI 10.1128/MCB.21.3.840-853.2001; Zhao X, 2002, NAT STRUCT BIOL, V9, P117; Zitzewitz JA, 2000, J MOL BIOL, V296, P1105, DOI 10.1006/jmbi.2000.3507	55	24	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27751	27760		10.1074/jbc.M111.264903	http://dx.doi.org/10.1074/jbc.M111.264903			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659527	Green Published, hybrid			2022-12-25	WOS:000293268700067
J	Eliades, A; Papadantonakis, N; Bhupatiraju, A; Burridge, KA; Johnston-Cox, HA; Migliaccio, AR; Crispino, JD; Lucero, HA; Trackman, PC; Ravid, K				Eliades, Alexia; Papadantonakis, Nikolaos; Bhupatiraju, Ajoy; Burridge, Kelley A.; Johnston-Cox, Hillary A.; Migliaccio, Anna Rita; Crispino, John D.; Lucero, Hector A.; Trackman, Philip C.; Ravid, Katya			Control of Megakaryocyte Expansion and Bone Marrow Fibrosis by Lysyl Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; ENDOMITOTIC CELL-CYCLE; MATRIX-FORMING ENZYME; EX-VIVO EXPANSION; GROWTH-FACTOR; PLATELET PRODUCTION; OSTEOBLASTIC CELLS; BREAST-CANCER; CORD BLOOD; IN-VIVO	Lysyl oxidase (LOX), a matrix cross-linking protein, is known to be selectively expressed and to enhance a fibrotic phenotype. A recent study of ours showed that LOX oxidizes the PDGF receptor-beta (PDGFR-beta), leading to amplified downstream signaling. Here, we examined the expression and functions of LOX in megakaryocytes (MKs), the platelet precursors. Cells committed to the MK lineage undergo mitotic proliferation to yield diploid cells, followed by endomitosis and acquisition of polyploidy. Intriguingly, LOX expression is detected in diploid-tetraploid MKs, but scarce in polyploid MKs. PDGFR-BB is an inducer of mitotic proliferation in MKs. LOX inhibition with beta-aminopropionitrile reduces PDGFR-BB binding to cells and downstream signaling, as well as its proliferative effect on the MK lineage. Inhibition of LOX activity has no influence on MK polyploidy. We next rationalized that, in a system with an abundance of low ploidy MKs, LOX could be highly expressed and with functional significance. Thus, we resorted to GATA-1(low) mice, where there is an increase in low ploidy MKs, augmented levels of PDGF-BB, and an extensive matrix of fibers. MKs from these mice display high expression of LOX, compared with control mice. Importantly, treatment of GATA-1(low) mice with beta-aminopropionitrile significantly improves the bone marrow fibrotic phenotype, and MK number in the spleen. Thus, our in vitro and in vivo data support a novel role for LOX in regulating MK expansion by PDGF-BB and suggest LOX as a new potential therapeutic target for myelofibrosis.	[Eliades, Alexia; Papadantonakis, Nikolaos] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Johnston-Cox, Hillary A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Eliades, Alexia; Papadantonakis, Nikolaos; Bhupatiraju, Ajoy; Burridge, Kelley A.; Johnston-Cox, Hillary A.; Lucero, Hector A.; Ravid, Katya] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Eliades, Alexia; Papadantonakis, Nikolaos; Bhupatiraju, Ajoy; Burridge, Kelley A.; Johnston-Cox, Hillary A.] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Boston, MA 02118 USA; [Trackman, Philip C.] Boston Univ, Sch Med, Div Oral Biol, Boston, MA 02118 USA; [Migliaccio, Anna Rita] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Crispino, John D.] Northwestern Univ, Div Hematol & Oncol, Chicago, IL 60611 USA	Boston University; Boston University; Boston University; Boston University; Boston University; Icahn School of Medicine at Mount Sinai; Northwestern University	Ravid, K (corresponding author), Boston Univ, Sch Med, Cardiovasc Inst, W-601,700 Albany St, Boston, MA 02118 USA.	kravid@bu.edu	Trackman, Philip C/AAX-9280-2021; Migliaccio, Anna Rita/GWZ-9323-2022; cheng, yong/I-4270-2012	Trackman, Philip C/0000-0001-5064-614X; Crispino, John/0000-0002-8182-8306; Eliades, Alexia/0000-0001-8459-7163; FRANCO MIGLIACCIO, ANNA RITA/0000-0003-1800-271X; Ravid, Katya/0000-0002-9918-3024	National Institutes of Health NHLBI [HL80442]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health NHLBI Grant HL80442 (to K. R.).	Arnold JT, 1997, BLOOD, V89, P823, DOI 10.1182/blood.V89.3.823; Atsawasuwan P, 2005, BIOCHEM BIOPH RES CO, V327, P1042, DOI 10.1016/j.bbrc.2004.12.119; Balduini CL, 2002, HAEMATOLOGICA, V87, P860; Bourquin JP, 2006, P NATL ACAD SCI USA, V103, P3339, DOI 10.1073/pnas.0511150103; BRIDDELL RA, 1990, BLOOD, V76, P516; BURSTEIN SA, 1992, J CELL PHYSIOL, V153, P305, DOI 10.1002/jcp.1041530210; Centurione L, 2004, BLOOD, V104, P3573, DOI 10.1182/blood-2004-01-0193; Chui CMY, 2003, CYTOKINE, V21, P51, DOI 10.1016/S1043-4666(02)00499-4; Debret R, 2010, J INVEST DERMATOL, V130, P2594, DOI 10.1038/jid.2010.186; Deutsch VR, 2006, BRIT J HAEMATOL, V134, P453, DOI 10.1111/j.1365-2141.2006.06215.x; Eliades A, 2010, J BIOL CHEM, V285, P18909, DOI 10.1074/jbc.M110.102145; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; FORNIERI C, 1987, J CELL BIOL, V105, P1463, DOI 10.1083/jcb.105.3.1463; Gilad GM, 2005, NEUROSCI LETT, V376, P210, DOI 10.1016/j.neulet.2004.11.054; Gilad GM, 2001, NEUROSCI LETT, V310, P45, DOI 10.1016/S0304-3940(01)02089-4; Guo Y, 2007, AM J PHYSIOL-CELL PH, V292, pC2095, DOI 10.1152/ajpcell.00613.2006; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231; Hong HH, 1999, LAB INVEST, V79, P1655; ISHIBASHI T, 1989, BLOOD, V74, P1241; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; KOIKE K, 1990, BLOOD, V75, P2286; Lee JE, 2006, J BIOL CHEM, V281, P37282, DOI 10.1074/jbc.M600977200; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Lucero HA, 2008, J BIOL CHEM, V283, P24103, DOI 10.1074/jbc.M709897200; Mazharian A, 2009, EXP HEMATOL, V37, P1238, DOI 10.1016/j.exphem.2009.07.006; McCrann DJ, 2009, BLOOD, V114, P1243, DOI 10.1182/blood-2008-12-195883; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P6781, DOI 10.1073/pnas.94.13.6781; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; Nguyen HG, 2005, BLOOD, V106, P1559, DOI 10.1182/blood-2005-02-0638; Palamakumbura AH, 2002, ANAL BIOCHEM, V300, P245, DOI 10.1006/abio.2001.5464; Papadantonakis N, 2008, CELL CYCLE, V7, P2352, DOI 10.4161/cc.6325; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Rodriguez C, 2008, CARDIOVASC RES, V79, P7, DOI 10.1093/cvr/cvn102; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Su RJ, 2005, STEM CELLS DEV, V14, P223, DOI 10.1089/scd.2005.14.223; Su RJ, 2001, BONE MARROW TRANSPL, V27, P1075, DOI 10.1038/sj.bmt.1703042; TANG SS, 1983, J BIOL CHEM, V258, P4331; TANG SS, 1989, CONNECT TISSUE RES, V19, P93, DOI 10.3109/03008208909016817; Thompson A, 1996, J BIOL CHEM, V271, P22976, DOI 10.1074/jbc.271.38.22976; TRACKMAN PC, 1992, J BIOL CHEM, V267, P8666; Ulich TR, 1996, BLOOD, V87, P5006, DOI 10.1182/blood.V87.12.5006.bloodjournal87125006; Vannucchi AM, 2002, BLOOD, V100, P1123, DOI 10.1182/blood-2002-06-1913; Vannucchi AM, 2005, BLOOD, V105, P3493, DOI 10.1182/blood-2004-04-1320; Vyas P, 1999, BLOOD, V93, P2867; Williams JL, 1998, BLOOD, V91, P4118, DOI 10.1182/blood.V91.11.4118.411k01_4118_4126; Wu Y, 2007, BLOOD, V110, P851, DOI 10.1182/blood-2006-05-022087; YANG M, 1995, BRIT J HAEMATOL, V91, P285, DOI 10.1111/j.1365-2141.1995.tb05291.x; Ye JY, 2010, HAEMATOL-HEMATOL J, V95, P1745, DOI 10.3324/haematol.2009.020958; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248	57	66	68	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27630	27638		10.1074/jbc.M111.243113	http://dx.doi.org/10.1074/jbc.M111.243113			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21665949	Green Published, hybrid			2022-12-25	WOS:000293268700056
J	Hashimoto, T; Adams, KW; Fan, ZY; McLean, PJ; Hyman, BT				Hashimoto, Tadafumi; Adams, Kenneth W.; Fan, Zhanyun; McLean, Pamela J.; Hyman, Bradley T.			Characterization of Oligomer Formation of Amyloid-beta Peptide Using a Split-luciferase Complementation Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALZHEIMERS-DISEASE; IN-VIVO; PROTOFIBRIL FORMATION; SYNAPTIC PLASTICITY; SECRETED OLIGOMERS; PROTEIN OLIGOMERS; SENILE PLAQUES; A-BETA-40; MEMORY	Amyloid-beta peptide (A beta) is the amyloid component of senile plaques in Alzheimer disease (AD) brains. Recently a soluble oliomeric form of A beta in A beta precursor protein transgenic mouse brains and AD brains was identified as a potential causative molecule for memory impairment, suggesting that soluble A beta oligomers cause neurodegeneration in AD. Further characterization of this species has been hampered, however, because the concentrations are quite small and it is difficult to monitor A beta oligomers specifically. Here we developed a novel method for monitoring A beta oligomers using a split-luciferase complementation assay. In this assay, the Nand C-terminal fragments of Gaussia luciferase (Gluc) are fused separately to A beta. We found that conditioned media from both N- and C-terminal fragments of Gluc-tagged A beta 1-42 doubly transfected HEK293 cells showed strong luminescence. We used gel filtration analyses to analyze the size of oligomers formed by the luciferase complementation assay, and found that it matched closely with oligomers formed by endogenous A beta in Tg2576 neurons. Large oligomers (24-36-mers), 8-mers, trimers, and dimers predominate. In both systems, A beta formed oligomers intracellularly, which then appear to be secreted as oligomers. We then evaluated several factors that might impact oligomer formation. The level of oligomerization of A beta 1-40 was similar to that of A beta 1-42. Homodimers formed more readily than heterodimers. The level of oligomerization of murine A beta 1-42 was similar to that of human A beta 1-42. As expected, the familial AD-linked Arctic mutation (E22G) significantly enhanced oligomer formation. These data suggest that Gluc-tagged A beta enables the analysis of A beta oligomers.	[Hashimoto, Tadafumi; Adams, Kenneth W.; Fan, Zhanyun; McLean, Pamela J.; Hyman, Bradley T.] Massachusetts Gen Hosp, Dept Neurol, Alzheimers Dis Res Unit, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hyman, BT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Alzheimer Dis Res Unit, Bldg 114,16th St, Charlestown, MA 02129 USA.	bhyman@partners.org	Hashimoto, Tadafumi/A-7723-2013	Hashimoto, Tadafumi/0000-0001-5442-4800; McLean, Pamela/0000-0003-4870-5715	National Institutes of Health [AG12406]; JSPS; Ellison Medical Foundation/AFAR [2009A059868]; NATIONAL INSTITUTE ON AGING [R37AG012406, R01AG012406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ellison Medical Foundation/AFAR(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG12406 (to B. T. H.), the JSPS Postdoctoral Fellow for Research Abroad (to T. H.), and the Ellison Medical Foundation/AFAR 2009A059868 (to T. H.).	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dolev I, 2004, P NATL ACAD SCI USA, V101, P13909, DOI 10.1073/pnas.0404458101; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Xia WM, 2009, ARCH NEUROL-CHICAGO, V66, P190, DOI 10.1001/archneurol.2008.565; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200	38	47	48	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27081	27091		10.1074/jbc.M111.257378	http://dx.doi.org/10.1074/jbc.M111.257378			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652708	Green Published, hybrid			2022-12-25	WOS:000293268700003
J	Chattopadhyay, R; de la Vega, P; Paik, SH; Murata, Y; Ferguson, EW; Richie, TL; Ooi, GT				Chattopadhyay, Rana; de la Vega, Patricia; Paik, Sun H.; Murata, Yoko; Ferguson, Earl W.; Richie, Thomas L.; Ooi, Guck T.			Early Transcriptional Responses of HepG2-A16 Liver Cells to Infection by Plasmodium falciparum Sporozoites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; GLYPICAN-3 EXPRESSION; GENE-EXPRESSION; MALARIA; STAGE; PARASITES; INHIBITION; PROTECTION; INVOLVEMENT; RECOGNITION	Invasion of hepatocytes by Plasmodium sporozoites deposited by Anopheles mosquitoes, and their subsequent transformation into infective merozoites is an obligatory step in the initiation of malaria. Interactions between the sporozoites and hepatocytes lead to a distinct, complex and coordinated cellular and systemic host response. Little is known about host liver cell response to sporozoite invasion, or whether it is primarily adaptive for the parasite, for the host, or for both. Our present study used gene expression profiling of human HepG2-A16 liver cells infected with Plasmodium falciparum sporozoites to understand the host early cellular events and factors influencing parasite infectivity and sporozoite development. Our results show that as early as 30 min following wild-type, non-irradiated sporozoite exposure, the expressions of at least 742 genes was selectively altered. These genes regulate diverse biological functions, such as immune processes, cell adhesion and communications, metabolism pathways, cell cycle regulation, and signal transduction. These functions reflect cellular events consistent with initial host cell defense responses, as well as alterations in host cells to sustain sporozoites growth and survival. Irradiated sporozoites gave very similar gene expression pattern changes, but direct comparative analysis between liver gene expression profiles caused by irradiated and non-irradiated sporozoites identified 29 genes, including glypican-3, that were specifically up-regulated only in irradiated sporozoites. Elucidating the role of this subset of genes may help identify the molecular basis for the irradiated sporozoites inability to develop intrahepatically, and their usefulness as an immunogen for developing protective immunity against pre-erythrocytic stage malaria.	[Chattopadhyay, Rana; de la Vega, Patricia; Richie, Thomas L.] US Mil Malaria Vaccine Program, Malaria Program, Silver Spring, MD 20910 USA; [de la Vega, Patricia] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Richie, Thomas L.] USN, Med Res Ctr, Silver Spring, MD 20910 USA; [Paik, Sun H.; Murata, Yoko; Ferguson, Earl W.; Ooi, Guck T.] Sun BioMed Technol Inc, Ridgecrest, CA 93555 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Navy	Chattopadhyay, R (corresponding author), US FDA, Div Vaccines & Related Prod Applicat, Off Vaccines Res & Review, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA.	rana.chattopadhyay@fda.hhs.gov; guckooi@sunbmt.com		Richie, Thomas/0000-0002-2946-5456	Department of Defense [W81XWH-05-C-0030]; CRADA [LP-CRADA-NMRC-05-2107, 6000.RAD1.F.A0309]	Department of Defense(United States Department of Defense); CRADA	This work was supported by Department of Defense Small Business Innovative Research Grant W81XWH-05-C-0030 (to S. H. P., Y. M., E. W. F., and G. T. O.) and the work between Sun BioMedical Technologies and the Malaria Program, Naval Medical Research Center was conducted through a CRADA collaboration Grant LP-CRADA-NMRC-05-2107 and was supported by Grant 6000.RAD1.F.A0309 (to R. C., P. V., and T. L. R.).	Abdul-Al HM, 2008, HUM PATHOL, V39, P209, DOI 10.1016/j.humpath.2007.06.004; Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; BECKETT GJ, 1993, ADV CLIN CHEM, V30, P281, DOI 10.1016/S0065-2423(08)60198-5; BECKETT GJ, 1985, CLIN CHIM ACTA, V146, P11, DOI 10.1016/0009-8981(85)90119-6; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Beutler B, 2001, BIOCHEM SOC T, V29, P853, DOI 10.1042/0300-5127:0290853; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9; Carrolo M, 2003, NAT MED, V9, P1363, DOI 10.1038/nm947; Carvalho RS, 2009, EUR J PHARMACOL, V616, P265, DOI 10.1016/j.ejphar.2009.05.030; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; De-Oliveira ACAX, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-81; Ejigiri I, 2009, CURR OPIN MICROBIOL, V12, P401, DOI 10.1016/j.mib.2009.06.006; Frevert U, 1998, EMBO J, V17, P3816, DOI 10.1093/emboj/17.14.3816; Hippo Y, 2004, CANCER RES, V64, P2418, DOI 10.1158/0008-5472.CAN-03-2191; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOLLINGDALE MR, 1984, J IMMUNOL, V132, P909; HOLLINGDALE MR, 1985, AM J TROP MED HYG, V34, P216, DOI 10.4269/ajtmh.1985.34.216; Hsu HC, 1997, CANCER RES, V57, P5179; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kaiser K, 2004, MOL MICROBIOL, V51, P1221, DOI 10.1046/j.1365-2958.2003.03909.x; Kalmbach Y, 2010, J INFECT DIS, V202, P313, DOI 10.1086/653586; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kappe SHI, 2001, P NATL ACAD SCI USA, V98, P9895, DOI 10.1073/pnas.171185198; Karnasuta C, 1995, AM J TROP MED HYG, V53, P607, DOI 10.4269/ajtmh.1995.53.607; Krucken J, 2005, INFECT IMMUN, V73, P436, DOI 10.1128/IAI.73.1.436-443.2005; Leiriao P, 2005, J INFECT DIS, V191, P1576, DOI 10.1086/429635; Liu BW, 2009, AM J PATHOL, V175, P717, DOI 10.2353/ajpath.2009.081129; Maglione PJ, 2009, EUR J IMMUNOL, V39, P676, DOI 10.1002/eji.200839148; MAZIER D, 1985, SCIENCE, V227, P440, DOI 10.1126/science.3880923; Moreira CK, 2004, INT J PARASITOL, V34, P1431, DOI 10.1016/j.ijpara.2004.10.007; MOSER G, 1978, J PROTOZOOL, V25, P119, DOI 10.1111/j.1550-7408.1978.tb03881.x; Mueller AK, 2007, AM J PATHOL, V171, P107, DOI 10.2353/ajpath.2007.060792; Nakatsura T, 2003, BIOCHEM BIOPH RES CO, V306, P16, DOI 10.1016/S0006-291X(03)00908-2; Ouwe-Missi-Oukem-Boyer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016034; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Rasmussen SB, 2009, APMIS, V117, P323, DOI 10.1111/j.1600-0463.2009.02456.x; Rathore D, 2005, J BIOL CHEM, V280, P20524, DOI 10.1074/jbc.M414254200; Rathore D, 2003, J BIOL CHEM, V278, P40905, DOI 10.1074/jbc.M306250200; Rathore D, 2002, J BIOL CHEM, V277, P7092, DOI 10.1074/jbc.M106862200; Renia Laurent, 2002, Methods Mol Med, V72, P507, DOI 10.1385/1-59259-271-6:507; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sacci John B Jr, 2002, Methods Mol Med, V72, P517, DOI 10.1385/1-59259-271-6:517; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; Siau A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000121; SIGLER CI, 1984, AM J TROP MED HYG, V33, P544, DOI 10.4269/ajtmh.1984.33.544; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Simon R, 2007, CANCER INFORM, V3, P11; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; SMITH JE, 1984, LANCET, V2, P757; Sohail M, 2007, CLIN BIOCHEM, V40, P377, DOI 10.1016/j.clinbiochem.2007.01.005; Takai H, 2009, CANCER BIOL THER, V8, P2329, DOI 10.4161/cbt.8.24.9985; Takai H, 2009, LIVER INT, V29, P1056, DOI 10.1111/j.1478-3231.2008.01968.x; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Torgler R, 2008, J IMMUNOL, V180, P3990, DOI 10.4049/jimmunol.180.6.3990; Wang QA, 2004, MOL BIOCHEM PARASIT, V137, P161, DOI 10.1016/j.molbiopara.2004.06.001; Wang XY, 2006, HUM PATHOL, V37, P1435, DOI 10.1016/j.humpath.2006.05.016; Westenberger SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000653; Williams CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010267; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570	64	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26396	26405		10.1074/jbc.M111.240879	http://dx.doi.org/10.1074/jbc.M111.240879			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652718	Green Published, hybrid			2022-12-25	WOS:000293078200017
J	Ding, L; Ma, WS; Littmann, T; Camp, R; Shen, JZ				Ding, Ling; Ma, Wanshu; Littmann, Timothy; Camp, Riley; Shen, Jianzhong			The P2Y(2) Nucleotide Receptor Mediates Tissue Factor Expression in Human Coronary Artery Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; FACTOR PATHWAY INHIBITOR; GROWTH-FACTOR RECEPTOR; FOCAL TYROSINE KINASE; UP-REGULATION; PROTEIN-KINASE; MESSENGER-RNA; P2 RECEPTORS; TNF-ALPHA	The discovery of the role of P2Y(12) receptor in platelet aggregation leads to a new anti-thrombotic drug Plavix; however, little is known about non-platelet P2Y receptors in thrombosis. This study tested the hypothesis that endothelial P2Y receptor(s) mediates up-regulation of tissue factor (TF), the initiator of coagulation cascade. Stimulation of human coronary artery endothelial cells (HCAEC) by UTP/ATP increased the mRNA level of TF but not of its counterpart-tissue factor pathway inhibitor, which was accompanied by up-regulation of TF protein and cell surface activity. RT-PCR revealed a selective expression of P2Y(2) and P2Y(11) receptors in HCAEC. Consistent with this, TF up-regulation was inhibited by suramin or by siRNA silencing of P2Y(2) receptor, but not by NF-157, a P2Y(11)-selective antagonist, suggesting a role for the P2Y(2) receptor. In addition, P2Y(2) receptor activated ERK1/2, JNK, and p38 MAPK pathways without affecting the positive NF-kappa B and negative AKT regulatory pathways of TF expression. Furthermore, TF up-regulation was abolished or partially suppressed by inhibition of p38 or JNK but not ERK1/2. Interestingly, blockade of the PLC/Ca2+ pathway did not affect P2Y(2) receptor activation of p38, JNK, and TF induction. However, blockade of Src kinase reduced phosphorylation of p38 but not JNK, eliminating TF induction. In contrast, inhibition of Rho kinase reduced phosphorylation of JNK but not p38, decreasing TF expression. These findings demonstrate that P2Y(2) receptor mediates TF expression in HCAEC through new mechanisms involving Src/p38 and Rho/JNK pathways, possibly contributing to a prothrombotic status after vascular injury.	[Ding, Ling; Ma, Wanshu; Littmann, Timothy; Camp, Riley; Shen, Jianzhong] Auburn Univ, Harrison Sch Pharm, Dept Pharmacal Sci, Div Pharmacol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Shen, JZ (corresponding author), Auburn Univ, Sch Pharm, Dept Pharmacal Sci, Div Pharmacol, 4306G Walker Bldg, Auburn, AL 36849 USA.	jzs0019@auburn.edu	Ma, Wanshu/J-2447-2019; Ma, Wanshu/A-5233-2018; Shen, Jianzhong/AAH-8184-2019	Ma, Wanshu/0000-0001-7462-2759; 	Auburn University	Auburn University	This work was supported by the New Faculty Startup Fund from Auburn University (to J.S.).	AMERI A, 1992, BLOOD, V79, P3219; Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BAJAJ MS, 1990, P NATL ACAD SCI USA, V87, P8869, DOI 10.1073/pnas.87.22.8869; BIERHAUS A, 1995, J BIOL CHEM, V270, P26419, DOI 10.1074/jbc.270.44.26419; Blum S, 2001, J BIOL CHEM, V276, P33428, DOI 10.1074/jbc.M105474200; Breitenstein A, 2010, CIRC J, V74, P3, DOI 10.1253/circj.CJ-09-0818; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; BURNSTOCK G, 1986, CIRC RES, V58, P319, DOI 10.1161/01.RES.58.3.319; Camera M, 1999, ARTERIOSCL THROM VAS, V19, P531, DOI 10.1161/01.ATV.19.3.531; CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; Eto M, 2002, CIRCULATION, V105, P1756, DOI 10.1161/01.CIR.0000015465.73933.3B; Fang QH, 2006, AM J RESP CELL MOL, V35, P714, DOI 10.1165/rcmb.2005-0026OC; Gachet C, 2005, SEMIN THROMB HEMOST, V31, P162, DOI 10.1055/s-2005-869521; Hou MY, 2000, ARTERIOSCL THROM VAS, V20, P2064, DOI 10.1161/01.ATV.20.9.2064; Kawano H, 2001, BLOOD, V97, P1697, DOI 10.1182/blood.V97.6.1697; Kishi Y, 2003, J HYPERTENS, V21, P1347, DOI 10.1097/00004872-200307000-00024; Koshiba M, 1997, P NATL ACAD SCI USA, V94, P831, DOI 10.1073/pnas.94.3.831; Kunapuli SP, 2003, CURR OPIN PHARMACOL, V3, P175, DOI 10.1016/S1471-4892(03)00007-9; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Mandal SK, 2006, BLOOD, V107, P4746, DOI 10.1182/blood-2005-11-4674; Mechtcheriakova D, 2001, FASEB J, V15, P230, DOI 10.1096/fj.00-0247com; Moons AHM, 2002, CARDIOVASC RES, V53, P313, DOI 10.1016/S0008-6363(01)00452-7; Napoleone E, 1997, BLOOD, V89, P541, DOI 10.1182/blood.V89.2.541; OLSSON RA, 1990, PHYSIOL REV, V70, P761, DOI 10.1152/physrev.1990.70.3.761; PARRY GCN, 1995, ARTERIOSCL THROM VAS, V15, P612, DOI 10.1161/01.ATV.15.5.612; PEARSON JD, 1979, NATURE, V281, P384, DOI 10.1038/281384a0; SCARPATI EM, 1989, J BIOL CHEM, V264, P20705; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Seye CI, 2002, CIRCULATION, V106, P2720, DOI 10.1161/01.CIR.0000038111.00518.35; Seye CI, 1997, ARTERIOSCL THROM VAS, V17, P3602, DOI 10.1161/01.ATV.17.12.3602; Shen JZ, 2005, CIRC RES, V96, P982, DOI 10.1161/01.RES.0000165800.81876.52; Shen JZ, 2004, MOL PHARMACOL, V66, P1265, DOI 10.1124/mol.104.002642; Shimokawa T, 2000, THROMB RES, V100, P211, DOI 10.1016/S0049-3848(00)00332-7; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Soltoff SP, 1998, J BIOL CHEM, V273, P23110, DOI 10.1074/jbc.273.36.23110; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Steffel J, 2005, CIRCULATION, V111, P1685, DOI 10.1161/01.CIR.0000160358.63804.C9; Steffel J, 2005, CIRCULATION, V112, P341, DOI 10.1161/CIRCULATIONAHA.105.553735; Viswambharan H, 2004, CIRC RES, V94, P918, DOI 10.1161/01.RES.0000124302.20396.B7; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839	45	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27027	27038		10.1074/jbc.M111.235176	http://dx.doi.org/10.1074/jbc.M111.235176			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652710	Green Published, hybrid			2022-12-25	WOS:000293078200076
J	Lin, YC; Chen, CC; Cheng, CJ; Yang, RB				Lin, Yuh-Charn; Chen, Chun-Chuan; Cheng, Chien-Jui; Yang, Ruey-Bing			Domain and Functional Analysis of a Novel Breast Tumor Suppressor Protein, SCUBE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE GLYCOPROTEIN; E-CADHERIN; CANCER; GENE; EXPRESSION; GROWTH; ADHESION; ZEBRAFISH; BINDING; IDENTIFICATION	Signal peptide CUB (complement proteins C1r/C1s, Uegf, and Bmp 1)-EGF domain-containing protein 2 (SCUBE2) is a secreted, membrane-associated multidomain protein composed of five recognizable motifs: an NH2-terminal signal peptide sequence, nine copies of epidermal growth factor (EGF)like repeats, a spacer region, three cysteine-rich repeats, and one CUB domain at the COOH terminus. Our previous clinical study showed that SCUBE2 may act as a novel breast tumor suppressor gene and serve as a useful prognostic marker. However, the specific domain responsible for its tumor suppressor activity and the precise mechanisms of its anti-tumor effect remain unknown. Using a combination of biochemical, molecular, and cell biology techniques, we further dissected the molecular functions and signal pathways mediated by the NH2-terminal EGF-like repeats or COOH-terminal CUB domain of SCUBE2. Independent overexpression of the NH2-terminal EGF-like repeats or COOH-terminal CUB domain resulted in suppression of MCF-7 breast cancer cell proliferation and reduced MCF-7 xenograft tumor growth in nude mice. Molecular and biochemical analyses revealed that the COOH-terminal CUB domain could directly bind to and antagonize bone morphogenetic protein activity in an autocrine manner, whereas the NH2-terminal EGF-like repeats could mediate cell-cell homophilic adhesions in a calcium-dependent fashion, interact with E-cadherin (a master tumor suppressor), and decrease the beta-catenin signaling pathway. Together, our data-demonstrate that SCUBE2 has growth inhibitory effects through a coordinated regulation of two distinct mechanisms: antagonizing bone morphogenetic protein and suppressing the beta-catenin pathway in breast cancer cells.	[Cheng, Chien-Jui] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei 110, Taiwan; [Cheng, Chien-Jui] Taipei Med Univ Hosp, Dept Pathol, Taipei 110, Taiwan; [Lin, Yuh-Charn] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Lin, Yuh-Charn; Chen, Chun-Chuan; Yang, Ruey-Bing] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Yang, Ruey-Bing] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University	Cheng, CJ (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei 110, Taiwan.	cjcheng@tmu.edu.tw; rbyang@ibms.sinica.edu.tw	Lin, Yuh-Charn/P-2520-2018; Yang, Ruey-Bing/O-1494-2018	Yang, Ruey-Bing/0000-0003-3017-3714; Lin, Yuh-Charn/0000-0002-8501-4596	Taiwan National Science Council [NSC 97-2320-B-038-019-MY3, NSC 99-2311-B-001-022-MY3]; Academia Sinica [AS-97-FP-L16]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Taiwan National Science Council Grants NSC 97-2320-B-038-019-MY3 (to C. J. C.) and NSC 99-2311-B-001-022-MY3 (to R. B. Y.) and Academia Sinica Grant AS-97-FP-L16 (to R. B. Y.).	Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cheng CJ, 2009, CANCER RES, V69, P3634, DOI 10.1158/0008-5472.CAN-08-3615; Clement JH, 2005, INT J ONCOL, V27, P401; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Grimmond S, 2000, GENOMICS, V70, P74, DOI 10.1006/geno.2000.6370; Grimmond S, 2001, MECH DEVELOP, V102, P209, DOI 10.1016/S0925-4773(00)00586-4; Hajra KM, 2002, CANCER RES, V62, P1613; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollway GE, 2006, DEV BIOL, V294, P104, DOI 10.1016/j.ydbio.2006.02.032; Ishii J, 2002, J BIOL CHEM, V277, P39696, DOI 10.1074/jbc.M206140200; Kawakami A, 2005, CURR BIOL, V15, P480, DOI 10.1016/j.cub.2005.02.018; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lombaerts M, 2006, BRIT J CANCER, V94, P661, DOI 10.1038/sj.bjc.6602996; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Pouliot F, 2003, CANCER RES, V63, P277; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Tsai MT, 2009, BIOCHEM J, V422, P119, DOI 10.1042/BJ20090341; Tu CF, 2008, J BIOL CHEM, V283, P12478, DOI 10.1074/jbc.M705872200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Wu BT, 2004, J BIOL CHEM, V279, P37485, DOI 10.1074/jbc.M405912200; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200	36	41	44	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27039	27047		10.1074/jbc.M111.244418	http://dx.doi.org/10.1074/jbc.M111.244418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652720	Green Published, hybrid			2022-12-25	WOS:000293078200077
J	Anju, V; Kapros, T; Waterborg, JH				Anju, Verma; Kapros, Tamas; Waterborg, Jakob H.			Identification of a Replication-independent Replacement Histone H3 in the Basidiomycete Ustilago maydis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-56 ACETYLATION; VARIANTS; GENE; CHAPERONE; CHROMATIN; TURNOVER; DYNAMICS; SEQUENCE; ANIMALS; PROTEIN	Ustilago maydis is a haploid basidiomycete with single genes for two distinct histone H3 variants. The solitary U1 gene codes for H3.1, predicted to be a replication-independent replacement histone. The U2 gene is paired with histone H4 and produces a putative replication-coupled H3.2 variant. These predictions were evaluated experimentally. U2 was confirmed to be highly expressed in the S phase and had reduced expression in hydroxyurea, and H3.2 protein was not incorporated into transcribed chromatin of stationary phase cells. Constitutive expression of U1 during growth produced similar to 25% of H3 as H3.1 protein, more highly acetylated than H3.2. The level of H3.1 increased when cell proliferation slowed, a hallmark of replacement histones. Half of new H3.1 incorporated into highly acetylated chromatin was lost with a half-life of 2.5 h, the fastest rate of replacement H3 turnover reported to date. This response reflects the characteristic incorporation of replacement H3 into transcribed chromatin, subject to continued nucleosome displacement and a loss of H3 as in animals and plants. Although the two H3 variants are functionally distinct, neither appears to be essential for vegetative growth. KO gene disruption transformants of the U1 and U2 loci produced viable cell lines. The structural and functional similarities of the Ustilago replication-coupled and replication-independent H3 variants with those in animals, in plants, and in ciliates are remarkable because these distinct histone H3 pairs of variants arose independently in each of these clades and in basidiomycetes.	[Anju, Verma; Kapros, Tamas; Waterborg, Jakob H.] UMKC, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Waterborg, JH (corresponding author), UMKC, Sch Biol Sci, Div Cell Biol & Biophys, 414 BSB,5007 Rockhill Rd, Kansas City, MO 64110 USA.	WaterborgJ@umkc.edu	Waterborg, Jakob H./J-5479-2013	Waterborg, Jakob H./0000-0002-2881-4634	Missouri Life Sciences Research Board [13254]	Missouri Life Sciences Research Board	This work was supported by Missouri Life Sciences Research Board Award 13254 (to J. H. W.).	Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Agez M, 2007, STRUCTURE, V15, P191, DOI 10.1016/j.str.2007.01.002; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010851; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Flor-Parra I, 2006, PLANT CELL, V18, P2369, DOI 10.1105/tpc.106.042754; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Garcia-Muse T, 2003, EUKARYOT CELL, V2, P494, DOI 10.1128/EC.2.3.494-500.2003; Holloman WK, 2008, FUNGAL GENET BIOL, V45, pS31, DOI 10.1016/j.fgb.2008.04.006; Holloman WK, 2007, TRENDS MICROBIOL, V15, P525, DOI 10.1016/j.tim.2007.10.007; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; KAPROS T, 1995, PLANT MOL BIOL, V28, P901, DOI 10.1007/BF00042074; Kojic M, 2008, MOL MICROBIOL, V67, P1156, DOI 10.1111/j.1365-2958.2008.06116.x; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Minard LV, 2011, J BIOL CHEM, V286, P7082, DOI 10.1074/jbc.M110.193813; RIDSDALE JA, 1987, NUCLEIC ACIDS RES, V15, P1081, DOI 10.1093/nar/15.3.1081; RIDSDALE JA, 1988, NUCLEIC ACIDS RES, V16, P5915, DOI 10.1093/nar/16.13.5915; RUIZHERRERA J, 1995, MICROBIOL-UK, V141, P695, DOI 10.1099/13500872-141-3-695; Scherer M, 2006, PLANT CELL, V18, P2388, DOI 10.1105/tpc.106.043521; Steinberg G, 2008, TRENDS CELL BIOL, V18, P61, DOI 10.1016/j.tcb.2007.11.008; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Tang Y, 2011, STRUCTURE, V19, P221, DOI 10.1016/j.str.2010.12.012; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P180, DOI 10.1093/nar/22.2.180; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; URBAN MK, 1983, DEV BIOL, V95, P421, DOI 10.1016/0012-1606(83)90043-X; Waterborg J. H., 2002, PROTEIN PROTOCOLS HD, P113; WATERBORG JH, 1991, PLANT PHYSIOL, V96, P453, DOI 10.1104/pp.96.2.453; WATERBORG JH, 1992, PLANT MOL BIOL, V18, P181, DOI 10.1007/BF00034947; WATERBORG JH, 1990, ELECTROPHORESIS, V11, P638, DOI 10.1002/elps.1150110811; WATERBORG JH, 1993, J BIOL CHEM, V268, P4912; Waterborg JH, 1998, J BIOL CHEM, V273, P27602, DOI 10.1074/jbc.273.42.27602; Waterborg JH, 2000, J BIOL CHEM, V275, P13007, DOI 10.1074/jbc.275.17.13007; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P279, DOI 10.1139/O02-021; Waterborg JH, 2002, BIOCHEM CELL BIOL, V80, P363, DOI 10.1139/O02-080; WATERBORG JH, 1990, J BIOL CHEM, V265, P17157; WATERBORG JH, 1995, PLANT PHYSIOL, V109, P393, DOI 10.1104/pp.109.2.393; Waterborg JH, 1996, J MOL EVOL, V43, P194, DOI 10.1007/BF02338827; WATERBORG JH, 2002, PROTEIN PROTOCOLS HD, P103; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Zweidler A, 1978, Methods Cell Biol, V17, P223, DOI 10.1016/S0091-679X(08)61145-0; Zweidler A., 1980, DEV BIOCHEM, V15, P47	46	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25790	25800		10.1074/jbc.M111.254383	http://dx.doi.org/10.1074/jbc.M111.254383			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21646347	Green Published, hybrid			2022-12-25	WOS:000293073000041
J	Herder, C; Baumert, J; Zierer, A; Roden, M; Meisinger, C; Karakas, M; Chambless, L; Rathmann, W; Peters, A; Koenig, W; Thorand, B				Herder, Christian; Baumert, Jens; Zierer, Astrid; Roden, Michael; Meisinger, Christa; Karakas, Mahir; Chambless, Lloyd; Rathmann, Wolfgang; Peters, Annette; Koenig, Wolfgang; Thorand, Barbara			Immunological and Cardiometabolic Risk Factors in the Prediction of Type 2 Diabetes and Coronary Events: MONICA/KORA Augsburg Case-Cohort Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MIDDLE-AGED MEN; HEART-DISEASE; ENDOTHELIAL DYSFUNCTION; ATHEROSCLEROSIS RISK; SERUM CONCENTRATIONS; EUROPEAN-SOCIETY; BIOMARKERS; POPULATION; MELLITUS	Background: This study compares inflammation-related biomarkers with established cardiometabolic risk factors in the prediction of incident type 2 diabetes and incident coronary events in a prospective case-cohort study within the population-based MONICA/KORA Augsburg cohort. Methods and Findings: Analyses for type 2 diabetes are based on 436 individuals with and 1410 individuals without incident diabetes. Analyses for coronary events are based on 314 individuals with and 1659 individuals without incident coronary events. Mean follow-up times were almost 11 years. Areas under the receiver-operating characteristic curve (AUC), changes in Akaike's information criterion (Delta AIC), integrated discrimination improvement (IDI) and net reclassification index (NRI) were calculated for different models. A basic model consisting of age, sex and survey predicted type 2 diabetes with an AUC of 0.690. Addition of 13 inflammation-related biomarkers (CRP, IL-6, IL-18, MIF, MCP-1/CCL2, IL-8/CXCL8, IP-10/CXCL10, adiponectin, leptin, RANTES/CCL5, TGF-beta 1, sE-selectin, sICAM-1; all measured in nonfasting serum) increased the AUC to 0.801, whereas addition of cardiometabolic risk factors (BMI, systolic blood pressure, ratio total/HDL-cholesterol, smoking, alcohol, physical activity, parental diabetes) increased the AUC to 0.803 (Delta AUC [95% CI] 0.111 [0.092-0.149] and 0.113 [0.093-0.149], respectively, compared to the basic model). The combination of all inflammation-related biomarkers and cardiometabolic risk factors yielded a further increase in AUC to 0.847 (Delta AUC [95% CI] 0.044 [0.028-0.066] compared to the cardiometabolic risk model). Corresponding AUCs for incident coronary events were 0.807, 0.825 (Delta AUC [95% CI] 0.018 [0.013-0.038] compared to the basic model), 0.845 (Delta AUC [95% CI] 0.038 [0.028-0.059] compared to the basic model) and 0.851 (Delta AUC [95% CI] 0.006 [0.003-0.021] compared to the cardiometabolic risk model), respectively. Conclusions: Inclusion of multiple inflammation-related biomarkers into a basic model and into a model including cardiometabolic risk factors significantly improved the prediction of type 2 diabetes and coronary events, although the improvement was less pronounced for the latter endpoint.	[Herder, Christian; Roden, Michael] Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Baumert, Jens; Zierer, Astrid; Meisinger, Christa; Peters, Annette; Thorand, Barbara] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, Dusseldorf, Germany; [Karakas, Mahir; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, Ulm, Germany; [Chambless, Lloyd] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Rathmann, Wolfgang] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; Ulm University; University of North Carolina; University of North Carolina Chapel Hill; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Herder, C (corresponding author), Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany.	wolfgang.koenig@uniklinik-ulm.de	Thorand, Barbara/B-5349-2014; Meisinger, Christine/B-5358-2014; Roden, Michael/AAD-3843-2019; Peters, Annette/A-6117-2011	Thorand, Barbara/0000-0002-8416-6440; Peters, Annette/0000-0001-6645-0985; Koenig, Wolfgang/0000-0002-2064-9603; Meisinger, Christa/0000-0002-9026-6544	German Research Foundation [TH-784/2-1, TH-784/2-2]; University of Ulm; Federal Ministry of Health; Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg (formerly GSF National Research Center for Environment and Health); Helmholtz Zentrum Munchen; Federal Ministry of Education and Research, Berlin	German Research Foundation(German Research Foundation (DFG)); University of Ulm; Federal Ministry of Health; Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg (formerly GSF National Research Center for Environment and Health)(Helmholtz Association); Helmholtz Zentrum Munchen(Helmholtz Association); Federal Ministry of Education and Research, Berlin	Funding: This study was supported by research grants from the German Research Foundation (TH-784/2-1 and TH-784/2-2) and by additional funds provided by the University of Ulm, the Federal Ministry of Health, the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia, and the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg (formerly GSF National Research Center for Environment and Health). The MONICA/KORA Augsburg cohort study was financed by the Helmholtz Zentrum Munchen and supported by grants from the Federal Ministry of Education and Research, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Burnham K. P., 1998, MODEL SELECTION INFE; Chambless LE, 2006, STAT MED, V25, P3474, DOI 10.1002/sim.2299; Chambless LE, 2011, STAT MED, V30, P22, DOI 10.1002/sim.4026; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Efron B., 1993, INTRO BOOTSTRAP, P168; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Hanley AJG, 2005, CIRCULATION, V112, P3713, DOI 10.1161/CIRCULATIONAHA.105.559633; Hense HW, 1998, CVD PREVENTION, V1, P318; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2008, EUR J ENDOCRINOL, V158, pR1, DOI 10.1530/EJE-07-0686; Herder C, 2006, ARTERIOSCL THROM VAS, V26, P2147, DOI 10.1161/01.ATV.0000235691.84430.86; Herder C, 2009, DIABETES CARE, V32, P1921, DOI 10.2337/dc09-0476; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Mihaescu R, 2010, AM J EPIDEMIOL, V172, P353, DOI 10.1093/aje/kwq122; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Petrovsky N, 2003, IMMUNOL CELL BIOL, V81, P137, DOI 10.1046/j.0818-9641.2002.01148.x; Rathmann W, 2010, DIABETIC MED, V27, P1116, DOI 10.1111/j.1464-5491.2010.03065.x; Roden M, 2006, NAT CLIN PRACT ENDOC, V2, P335, DOI 10.1038/ncpendmet0190; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Sattar N, 2007, CIRCULATION, V115, P981, DOI 10.1161/CIRCULATIONAHA.106.643114; Sattar N, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000099; Schaeffler V, 1996, ANN NUTR METAB, V40, P129, DOI 10.1159/000177906; Schulze MB, 2009, DIABETES CARE, V32, P2116, DOI 10.2337/dc09-0197; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Stranges S, 2008, OBESITY, V16, P1370, DOI 10.1038/oby.2008.59; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Thorand B, 2005, DIABETES, V54, P2932, DOI 10.2337/diabetes.54.10.2932; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	46	67	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e19852	10.1371/journal.pone.0019852	http://dx.doi.org/10.1371/journal.pone.0019852			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674000	Green Published, Green Submitted, gold			2022-12-25	WOS:000291356400001
J	Rojsitthisak, P; Jongaroonngamsang, N; Romero, RM; Haworth, IS				Rojsitthisak, Pornchai; Jongaroonngamsang, Nutthapon; Romero, Rebecca M.; Haworth, Ian S.			HPLC-UV, MALDI-TOF-MS and ESI-MS/MS Analysis of the Mechlorethamine DNA Crosslink at a Cytosine-Cytosine Mismatch Pair	PLOS ONE			English	Article							IONIZATION-MASS-SPECTROMETRY; ASSISTED LASER-DESORPTION; NUCLEAR-MAGNETIC-RESONANCE; CENTER-DOT-T; TRINUCLEOTIDE REPEATS; LIQUID-CHROMATOGRAPHY; GENETIC-RECOMBINATION; REPLICATION FIDELITY; HUMAN-DISEASE; INTERSTRAND	Background: Mechlorethamine [ClCH2CH2N(CH3)CH2CH2Cl], a nitrogen mustard alkylating agent, has been proven to form a DNA interstrand crosslink at a cytosine-cytosine (C-C) mismatch pair using gel electrophoresis. However, the atomic connectivity of this unusual crosslink is unknown. Methodology/Principal Findings: HPLC-UV, MALDI-TOF-MS, and ESI-MS/MS were used to determine the atomic connectivity of the DNA C-C crosslink formed by mechlorethamine, MALDI-TOF-MS of the HPLC-purified reaction product of mechlorethamine with the DNA duplex d[CTCACACCGTGGTTC]center dot d[GAACCACCGTGTGAG] (underlined bases are a C-C mismatch pair) indicated formation of an interstrand crosslink at m/z 9222.088 [M-2H+Na](+). Following enzymatic digestion of the crosslinked duplex by snake venom phosphodiesterase and calf intestinal phosphatase, ESI-MS/MS indicated the presence of dC-mech-dC [mech = CH2CH2N(CH3)CH2CH2] at m/z 269.2 [M](2+) (expected m/z 269.6, exact mass 539.27) and its hydrolytic product dC-mech-OH at m/z 329.6 [M](+) (expected m/z 329.2). Fragmentation of dC-mech-dC gave product ions at m/z 294.3 and 236.9 [M](+), which are both due to loss of the 4-amino group of cytosine (as ammonia), in addition to dC and dC+HN(CH3)CH = CH2, respectively. The presence of m/z 269.2 [M](2+) and loss of ammonia exclude crosslink formation at cytosine N-4 or O-2 and indicate crosslinking through cytosine N-3 with formation of two quaternary ammonium ions. Conclusions: Our results provide an important addition to the literature, as the first example of the use of HPLC and MS for analysis of a DNA adduct at the N-3 position of cytosine.	[Rojsitthisak, Pornchai; Jongaroonngamsang, Nutthapon] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Food & Pharmaceut Chem, Bangkok, Thailand; [Romero, Rebecca M.; Haworth, Ian S.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	Chulalongkorn University; University of Southern California	Rojsitthisak, P (corresponding author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Food & Pharmaceut Chem, Bangkok, Thailand.	pornchai.r@chula.ac.th	Rojsitthisak, Pornchai/S-4772-2019	Rojsitthisak, Pornchai/0000-0003-1391-6993				Balcome S, 2004, CHEM RES TOXICOL, V17, P950, DOI 10.1021/tx0499463; Boulard Y, 1997, J MOL BIOL, V268, P331, DOI 10.1006/jmbi.1997.0975; Cao HC, 2006, J AM SOC MASS SPECTR, V17, P1335, DOI 10.1016/j.jasms.2006.05.019; Chao MR, 2007, BIOCHEM J, V402, P483, DOI 10.1042/BJ20061447; Chou SH, 1996, J MOL BIOL, V264, P981, DOI 10.1006/jmbi.1996.0691; CUMMINGS J, 1993, J CHROMATOGR-BIOMED, V618, P251, DOI 10.1016/0378-4347(93)80037-5; Dalhus B, 2009, FEMS MICROBIOL REV, V33, P1044, DOI 10.1111/j.1574-6976.2009.00188.x; Darlow JM, 1998, J MOL BIOL, V275, P3, DOI 10.1006/jmbi.1997.1453; Darlow JM, 1998, J MOL BIOL, V275, P17, DOI 10.1006/jmbi.1997.1452; FIELDS EK, 1968, ADV PHYS ORGANIC CHE, V6, P2; GACY AM, 1995, CELL, V81, P533; GAO XL, 1995, J AM CHEM SOC, V117, P8883, DOI 10.1021/ja00139a035; Gaskell M, 2007, NUCLEIC ACIDS RES, V35, P5014, DOI 10.1093/nar/gkm526; Goggin M, 2007, CHEM RES TOXICOL, V20, P839, DOI 10.1021/tx700020q; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Gupta R, 2005, J INORG BIOCHEM, V99, P552, DOI 10.1016/j.jinorgbio.2004.11.001; Gut IG, 2004, HUM MUTAT, V23, P437, DOI 10.1002/humu.20023; HARTLEY JA, 1993, J CHROMATOGR-BIOMED, V618, P277, DOI 10.1016/0378-4347(93)80038-6; Hecker KH, 2000, J BIOCHEM BIOPH METH, V46, P83, DOI 10.1016/S0165-022X(00)00133-0; HILLENKAMP F, 1990, BIOLOGICAL MASS SPECTROMETRY /, P49; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; Jongaroonngamsang N, 2010, J HEALTH RES, V24, P155; Lee AM, 2006, J MOL BIOL, V360, P343, DOI 10.1016/j.jmb.2006.04.065; Mariappan SVS, 1996, NUCLEIC ACIDS RES, V24, P784, DOI 10.1093/nar/24.4.784; Mariappan SVS, 1998, J MOL BIOL, V283, P111, DOI 10.1006/jmbi.1998.1990; Miketova P, 1997, MOL BIOTECHNOL, V8, P249, DOI 10.1007/BF02760778; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Monsandl T, 2010, AUST J CHEM, V63, P1076, DOI 10.1071/CH09640; Nakayabu M, 1998, NUCLEIC ACIDS RES, V26, P1980, DOI 10.1093/nar/26.8.1980; Noll DM, 2001, J AM CHEM SOC, V123, P3405, DOI 10.1021/ja003340t; NORDHOFF E, 1992, RAPID COMMUN MASS SP, V6, P771, DOI 10.1002/rcm.1290061212; NORDHOFF E, 1994, NUCLEIC ACIDS RES, V22, P2460, DOI 10.1093/nar/22.13.2460; Park S, 2005, J AM CHEM SOC, V127, P14355, DOI 10.1021/ja051979x; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; RINK SM, 1993, J AM CHEM SOC, V115, P2551, DOI 10.1021/ja00060a001; RINK SM, 1995, BIOCHEMISTRY-US, V34, P1439, DOI 10.1021/bi00004a039; Rojsitthisak P, 2001, NUCLEIC ACIDS RES, V29, P4716, DOI 10.1093/nar/29.22.4716; Romero RM, 1999, BIOCHEMISTRY-US, V38, P3641, DOI 10.1021/bi981935j; Romero RM, 2001, ARCH BIOCHEM BIOPHYS, V386, P143, DOI 10.1006/abbi.2000.2198; SARMA MH, 1987, BIOCHEMISTRY-US, V26, P7707, DOI 10.1021/bi00398a026; Singh R, 2006, CARCINOGENESIS, V27, P178, DOI 10.1093/carcin/bgi260; Singh R, 2005, CHEM RES TOXICOL, V18, P249, DOI 10.1021/tx049793j; Tost J, 2006, J MASS SPECTROM, V41, P981, DOI 10.1002/jms.1096; Tretyakova N, 2007, CHEM RES TOXICOL, V20, P284, DOI 10.1021/tx060204e; Tu YP, 1996, RAPID COMMUN MASS SP, V10, P1093, DOI 10.1002/(SICI)1097-0231(19960715)10:9<1093::AID-RCM628>3.0.CO;2-S; Wang YS, 2003, ANAL CHEM, V75, P6306, DOI 10.1021/ac034683n; Wang YS, 2004, J AM SOC MASS SPECTR, V15, P1565, DOI 10.1016/j.jasms.2004.07.012; Weaver SLW, 2007, ASTROPHYS J LETT, V671, pL153, DOI 10.1086/525042; Wilds CJ, 2006, TETRAHEDRON LETT, V47, P9125, DOI 10.1016/j.tetlet.2006.10.074; Wilds CJ, 2004, J AM CHEM SOC, V126, P9257, DOI 10.1021/ja0498540; WU KJ, 1994, ANAL CHEM, V66, P1637, DOI 10.1021/ac00082a007; Yu A, 1997, BIOCHEMISTRY-US, V36, P3687, DOI 10.1021/bi9625410	53	14	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20745	10.1371/journal.pone.0020745	http://dx.doi.org/10.1371/journal.pone.0020745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673963	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400026
J	Amengual, J; Gouranton, E; van Helden, YGJ; Hessel, S; Ribot, J; Kramer, E; Kiec-Wilk, B; Razny, U; Lietz, G; Wyss, A; Dembinska-Kiec, A; Palou, A; Keijer, J; Landrier, JF; Bonet, ML; von Lintig, J				Amengual, Jaume; Gouranton, Erwan; van Helden, Yvonne G. J.; Hessel, Susanne; Ribot, Joan; Kramer, Evelien; Kiec-Wilk, Beata; Razny, Ursula; Lietz, Georg; Wyss, Adrian; Dembinska-Kiec, Aldona; Palou, Andreu; Keijer, Jaap; Landrier, Jean Francois; Luisa Bonet, M.; von Lintig, Johannes			Beta-Carotene Reduces Body Adiposity of Mice via BCMO1	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; ACID-METABOLIZING ENZYME; RETINOIC ACID; DIABETES-MELLITUS; LEPTIN EXPRESSION; SERUM CAROTENOIDS; PPAR-GAMMA; IN-VITRO; IDENTIFICATION; TISSUE	Evidence from cell culture studies indicates that beta-carotene-(BC)-derived apocarotenoid signaling molecules can modulate the activities of nuclear receptors that regulate many aspects of adipocyte physiology. Two BC metabolizing enzymes, the BC-15,15'-oxygenase (Bcmo1) and the BC-9',10'-oxygenase (Bcdo2) are expressed in adipocytes. Bcmo1 catalyzes the conversion of BC into retinaldehyde and Bcdo2 into beta-10'-apocarotenal and beta-ionone. Here we analyzed the impact of BC on body adiposity of mice. To genetically dissect the roles of Bcmo1 and Bcdo2 in this process, we used wild-type and Bcmo1(-/-) mice for this study. In wild-type mice, BC was converted into retinoids. In contrast, Bcmo1(-/-) mice showed increased expression of Bcdo2 in adipocytes and beta-10'-apocarotenol accumulated as the major BC derivative. In wild-type mice, BC significantly reduced body adiposity (by 28%), leptinemia and adipocyte size. Genome wide microarray analysis of inguinal white adipose tissue revealed a generalized decrease of mRNA expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) target genes. Consistently, the expression of this key transcription factor for lipogenesis was significantly reduced both on the mRNA and protein levels. Despite beta-10'-apocarotenoid production, this effect of BC was absent in Bcmo1(-/-) mice, demonstrating that it was dependent on the Bcmo1-mediated production of retinoids. Our study evidences an important role of BC for the control of body adiposity in mice and identifies Bcmo1 as critical molecular player for the regulation of PPAR gamma activity in adipocytes	[Amengual, Jaume; Ribot, Joan; Palou, Andreu; Luisa Bonet, M.] Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Palma de Mallorca, Spain; [Amengual, Jaume; Ribot, Joan; Palou, Andreu; Luisa Bonet, M.] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Palma de Mallorca, Spain; [Amengual, Jaume; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Gouranton, Erwan; Keijer, Jaap; Landrier, Jean Francois] Univ Aix Marseille I & II, INRA, UMR Nutriments Lipid & Prevent Malad Metab 1260, Marseille, France; [van Helden, Yvonne G. J.] Wageningen Univ, Wageningen, Netherlands; [van Helden, Yvonne G. J.] Univ Maastricht, Maastricht, Netherlands; [van Helden, Yvonne G. J.; Kramer, Evelien] RIKILT Inst Food Safety, Wageningen, Netherlands; [Hessel, Susanne; von Lintig, Johannes] Univ Freiburg, Inst Biol 1, D-7800 Freiburg, Germany; [Kiec-Wilk, Beata; Razny, Ursula; Dembinska-Kiec, Aldona] Jagiellonian Univ, Coll Med, Dept Clin Biochem, Krakow, Poland; [Lietz, Georg] Newcastle Univ, Sch AFRD, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wyss, Adrian] DSM Nutr Prod, R&D Human Nutr & Hlth, Kaiseraugst, Switzerland	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Case Western Reserve University; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Wageningen University & Research; Maastricht University; Wageningen University & Research; University of Freiburg; Jagiellonian University; Collegium Medicum Jagiellonian University; Newcastle University - UK; DSM NV	Amengual, J (corresponding author), Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Palma de Mallorca, Spain.	luisabonet@uib.es; johannes.vonlintig@case.edu	Lietz, Georg/A-4084-2012; Landrier, Jean-Francois/AAH-2757-2019; Palou, Andreu/K-9881-2014; Razny, Urszula/U-2550-2019; Bonet, M.Luisa/H-6722-2015; Ribot, Joan/L-2224-2014; Keijer, Jaap/J-8089-2013	Landrier, Jean-Francois/0000-0002-8690-8014; Palou, Andreu/0000-0002-0295-4452; Bonet, M.Luisa/0000-0002-8698-0630; Ribot, Joan/0000-0003-4460-9371; Keijer, Jaap/0000-0002-9720-7491; von Lintig, Johannes/0000-0002-2079-2143; Razny, Urszula/0000-0003-1864-8449	EU [FOOD-CT-2004-506360]; NuGO; Spanish Government (Ministerio de Educacion y Ciencia) [AGL2006-04887/ALI, AGL2009-11277/ALI]; INRA; INSERM (France); Instituto de Salud Carlos III (Spanish Government); VLAG/Nutrim	EU(European Commission); NuGO; Spanish Government (Ministerio de Educacion y Ciencia)(Spanish Government); INRA; INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Instituto de Salud Carlos III (Spanish Government)(Instituto de Salud Carlos III); VLAG/Nutrim	This work was developed as part of The European Nutrigenomics Organisation (Network of Excellence, EU Contract FOOD-CT-2004-506360) Focus Team 9 "Window of Benefit for Carotenoids" coordinated by Georg Lietz, and has been sponsored in part by NuGO. It has also been supported by the Spanish Government (Ministerio de Educacion y Ciencia, grant AGL2006-04887/ALI and AGL2009-11277/ALI to Andreu Palou) and by INRA and INSERM (France). CIBERobn is an initiative of the Instituto de Salud Carlos III (Spanish Government). Jaap Keijer, Andreu Palou and Aldona Dembinska-Kiec are members of Mitofood (Cost Action F0602). Jaume Amengual was a fellow from the Spanish Government. Yvonne van Helden is supported by VLAG/Nutrim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Burrows TL, 2009, OBESITY, V17, P162, DOI 10.1038/oby.2008.495; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Coyne T, 2005, AM J CLIN NUTR, V82, P685, DOI 10.1093/ajcn/82.3.685; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; EROGLU A, ARCH BIOCH IN PRESS; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Felipe F, 2005, BBA-MOL BASIS DIS, V1740, P258, DOI 10.1016/j.bbadis.2004.11.014; Felipe F, 2004, DIABETES, V53, P882, DOI 10.2337/diabetes.53.4.882; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; Ford ES, 1999, AM J EPIDEMIOL, V149, P168, DOI 10.1093/oxfordjournals.aje.a009783; Garcia OP, 2009, NUTR REV, V67, P559, DOI 10.1111/j.1753-4887.2009.00228.x; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; Grimaldi PA, 2007, CELL MOL LIFE SCI, V64, P2459, DOI 10.1007/s00018-007-7278-5; Hessel S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706763200; Hollung K, 2004, J CELL BIOCHEM, V92, P307, DOI 10.1002/jcb.20047; KAMEI Y, 1994, LIFE SCI, V55, pPL307, DOI 10.1016/0024-3205(94)90073-6; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Landrier JF, 2008, FREE RADICAL RES, V42, P523, DOI 10.1080/10715760802098859; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leung WC, 2009, FASEB J, V23, P1041, DOI 10.1096/fj.08-121962; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lindshield BL, 2008, J NUTR, V138, P2367, DOI 10.3945/jn.108.099663; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; Mercader J, 2008, CELL PHYSIOL BIOCHEM, V22, P363, DOI 10.1159/000149815; Mercader J, 2007, CELL PHYSIOL BIOCHEM, V20, P1061, DOI 10.1159/000110717; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Pellis L, 2003, PHYSIOL GENOMICS, V16, P99, DOI 10.1152/physiolgenomics.00111.2003; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Ramakrishna V, 2008, ACTA DIABETOL, V45, P41, DOI 10.1007/s00592-007-0018-3; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; van Helden YGJ, 2010, CELL MOL LIFE SCI, V67, P2039, DOI 10.1007/s00018-010-0341-7; van Schothorst EM, 2007, ANAL BIOCHEM, V363, P315, DOI 10.1016/j.ab.2007.01.016; von Lintig J, 2005, BBA-MOL BASIS DIS, V1740, P122, DOI 10.1016/j.bbadis.2004.11.010; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Ylonen K, 2003, AM J CLIN NUTR, V77, P1434; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	53	105	112	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20644	10.1371/journal.pone.0020644	http://dx.doi.org/10.1371/journal.pone.0020644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673813	Green Published, gold			2022-12-25	WOS:000291309900025
J	Shimada, T; Fujita, N; Yamamoto, K; Ishihama, A				Shimada, Tomohiro; Fujita, Nobuyuki; Yamamoto, Kaneyoshi; Ishihama, Akira			Novel Roles of cAMP Receptor Protein (CRP) in Regulation of Transport and Metabolism of Carbon Sources	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; MAJOR FACILITATOR SUPERFAMILY; CATABOLITE ACTIVATOR PROTEIN; POLYMERASE-ALPHA-SUBUNIT; RNA-POLYMERASE; PHOSPHOTRANSFERASE SYSTEM; TRANSCRIPTION ACTIVATION; MOLECULAR CHARACTERIZATION; SIGNAL-TRANSDUCTION; ABC TRANSPORTERS	CRP (cAMP receptor protein), the global regulator of genes for carbon source utilization in the absence of glucose, is the best-studied prokaryotic transcription factor. A total of 195 target promoters on the Escherichia coli genome have been proposed to be under the control of cAMP-bound CRP. Using the newly developed Genomic SELEX screening system of transcription factor-binding sequences, however, we have identified a total of at least 254 CRP-binding sites. Based on their location on the E. coli genome, we predict a total of at least 183 novel regulation target operons, altogether with the 195 hitherto known targets, reaching to the minimum of 378 promoters as the regulation targets of cAMP-CRP. All the promoters selected from the newly identified targets and examined by using the lacZ reporter assay were found to be under the control of CRP, indicating that the Genomic SELEX screening allowed to identify the CRP targets with high accuracy. Based on the functions of novel target genes, we conclude that CRP plays a key regulatory role in the whole processes from the selective transport of carbon sources, the glycolysis-gluconeogenesis switching to the metabolisms downstream of glycolysis, including tricarboxylic acid (TCA) cycle, pyruvate dehydrogenase (PDH) pathway and aerobic respiration. One unique regulation mode is that a single and the same CRP molecule bound within intergenic regions often regulates both of divergently transcribed operons.	[Shimada, Tomohiro; Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Tokyo, Japan; [Shimada, Tomohiro; Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Micronanotechnol Res Ctr, Tokyo, Japan; [Fujita, Nobuyuki] Natl Inst Technol & Evaluat, Dept Biotechnol, Shibuya Ku, Tokyo, Japan	Hosei University; Hosei University	Shimada, T (corresponding author), Hosei Univ, Dept Frontier Biosci, Tokyo, Japan.	aishiham@hosei.ac.jp	Shimada, Tomohiro/E-7660-2014	Shimada, Tomohiro/0000-0002-8361-0730	Ministry of Education, Culture, Sports, Science and Technology of Japan [21710198, 17076016, 8310133, 21241047]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid 21710198, 17076016, 8310133 and 21241047 from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; BOITEUX A, 1983, BIOCHEM J, V211, P631, DOI 10.1042/bj2110631; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Charbit A, 1996, J BIOL CHEM, V271, P9997, DOI 10.1074/jbc.271.17.9997; COOPER RA, 1967, PROC R SOC SER B-BIO, V168, P263, DOI 10.1098/rspb.1967.0065; DALDAL F, 1983, J MOL BIOL, V168, P285, DOI 10.1016/S0022-2836(83)80019-9; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Donahue JL, 2000, J BACTERIOL, V182, P5624, DOI 10.1128/JB.182.19.5624-5627.2000; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; FELDHEIM DA, 1990, J BACTERIOL, V172, P5459, DOI 10.1128/jb.172.9.5459-5469.1990; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; FRAENKEL DG, 1965, J BACTERIOL, V90, P837, DOI 10.1128/JB.90.4.837-842.1965; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; GEERSE RH, 1989, MOL GEN GENET, V218, P348, DOI 10.1007/BF00331288; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; HARMAN JG, 2001, BIOCHIM BIOPHYS ACTA, V154, P1; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; IIDA A, 1993, J BACTERIOL, V175, P5375, DOI 10.1128/JB.175.17.5375-5383.1993; INGLEDEW WJ, 1984, MICROBIOL REV, V48, P222, DOI 10.1128/MMBR.48.3.222-271.1984; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; ISHIHAMA A, 2009, CELLULAR MOL BIOL; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; Ishii D, 2009, BIOSCI BIOTECH BIOCH, V73, P2528, DOI 10.1271/bbb.90421; KATZ J, 1967, BIOCHEMISTRY-US, V6, P2227, DOI 10.1021/bi00859a046; KIM J, 1992, P NATL ACAD SCI USA, V89, P770; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; KREBS A, 1980, CAN J BIOCHEM CELL B, V58, P309, DOI 10.1139/o80-041; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Lemuth K, 2008, APPL ENVIRON MICROB, V74, P7002, DOI 10.1128/AEM.01327-08; Lin SH, 2003, BIOCHEMISTRY-US, V42, P4809, DOI 10.1021/bi027259+; LINTON KJ, 1988, MOL MICROBIOL, V28, P5; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997; Miller JH, EXPT MOL GENETICS; MORI K, 1985, J BIOL CHEM, V260, P4838; Moussatova A, 2008, BBA-BIOMEMBRANES, V1778, P1757, DOI 10.1016/j.bbamem.2008.06.009; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami K, 1997, P NATL ACAD SCI USA, V94, P1709, DOI 10.1073/pnas.94.5.1709; Murakami K, 1996, EMBO J, V15, P4358, DOI 10.1002/j.1460-2075.1996.tb00809.x; Nanchen A, 2008, J BACTERIOL, V190, P2323, DOI 10.1128/JB.01353-07; Ogasawara H, 2007, J BACTERIOL, V189, P5534, DOI 10.1128/JB.00229-07; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; PARKINSON G, 1996, J MOL BIOL, V304, P847; PASSNER JM, 1997, P NATL ACAD SCI USA, V94, P843; PASTAN I, 1970, SCIENCE, V169, P339, DOI 10.1126/science.169.3943.339; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Pyles EA, 1996, BIOCHEMISTRY-US, V35, P1162, DOI 10.1021/bi952187q; ROWLEY DL, 1991, J BACTERIOL, V173, P968, DOI 10.1128/jb.173.3.968-977.1991; Saier MH, 1998, BIOTECHNOL BIOENG, V58, P170, DOI 10.1002/(SICI)1097-0290(19980420)58:2/3<170::AID-BIT9>3.0.CO;2-I; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shimada T, 2007, MOL MICROBIOL, V66, P744, DOI 10.1111/j.1365-2958.2007.05954.x; Shimada T, 2011, J BACTERIOL, V193, P649, DOI 10.1128/JB.01214-10; Stulke J, 1999, CURR OPIN MICROBIOL, V2, P195, DOI 10.1016/S1369-5274(99)80034-4; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; Teramoto J, 2010, NUCLEIC ACIDS RES, V38, P3605, DOI 10.1093/nar/gkq077; Won HS, 2009, BBA-PROTEINS PROTEOM, V1794, P1299, DOI 10.1016/j.bbapap.2009.04.015; Wu LF, 1995, BIOCHIMIE, V77, P744, DOI 10.1016/0300-9084(96)88192-2; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; ZUBAY G, 1970, P NATL ACAD SCI USA, V66, P104, DOI 10.1073/pnas.66.1.104	72	164	164	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20081	10.1371/journal.pone.0020081	http://dx.doi.org/10.1371/journal.pone.0020081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673794	Green Published, gold, Green Submitted			2022-12-25	WOS:000291309900002
J	Chen, B; Jia, TL; Ma, RH; Zhang, B; Kang, L				Chen, Bing; Jia, Tieliu; Ma, Ronghui; Zhang, Bo; Kang, Le			Evolution of Hsp70 Gene Expression: A Role for Changes in AT-Richness within Promoters	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; TRANSCRIPTION FACTOR; DROSOPHILA; GC; REGION; ZESTE; INDUCTION; PATTERNS; SEQUENCE; DOMAINS	In disparate organisms adaptation to thermal stress has been linked to changes in the expression of genes encoding heat-shock proteins (Hsp). The underlying genetics, however, remain elusive. We show here that two AT-rich sequence elements in the promoter region of the hsp70 gene of the fly Liriomyza sativae that are absent in the congeneric species, Liriomyza huidobrensis, have marked cis-regulatory consequences. We studied the cis-regulatory consequences of these elements (called ATRS1 and ATRS2) by measuring the constitutive and heat-shock-induced luciferase luminescence that they drive in cells transfected with constructs carrying them modified, deleted, or intact, in the hsp70 promoter fused to the luciferase gene. The elements affected expression level markedly and in different ways: Deleting ATRS1 augmented both the constitutive and the heat-shock-induced luminescence, suggesting that this element represses transcription. Interestingly, replacing the element with random sequences of the same length and A+T content delivered the wild-type luminescence pattern, proving that the element's high A+T content is crucial for its effects. Deleting ATRS2 decreased luminescence dramatically and almost abolished heat-shock inducibility and so did replacing the element with random sequences matching the element's length and A+T content, suggesting that ATRS2's effects on transcription and heat-shock inducibility involve a common mechanism requiring at least in part the element's specific primary structure. Finally, constitutive and heat-shock luminescence were reduced strongly when two putative binding sites for the Zeste transcription factor identified within ATRS2 were altered through site-directed mutagenesis, and the heat-shock-induced luminescence increased when Zeste was over-expressed, indicating that Zeste participates in the effects mapped to ATRS2 at least in part. AT-rich sequences are common in promoters and our results suggest that they should play important roles in regulatory evolution since they can affect expression markedly and constrain promoter DNA in at least two different ways.	[Chen, Bing; Jia, Tieliu; Ma, Ronghui; Zhang, Bo; Kang, Le] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Chen, B (corresponding author), Chinese Acad Sci, Inst Zool, Beijing, Peoples R China.	lkang@ioz.ac.cn	ma, rong/GVU-3096-2022; Kang, Le/ABD-1116-2022; Chen, Bing/C-4837-2019	Kang, Le/0000-0003-4262-2329; Chen, Bing/0000-0002-1238-3948	State Key Basic Research and Development Projects [2009CB119204]; National Natural Science Foundation of China [30970343]	State Key Basic Research and Development Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by State Key Basic Research and Development Projects (2009CB119204) and National Natural Science Foundation of China (30970343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN J, 1994, J BIOL CHEM, V269, P4804; Antezana MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002145; BENSON M, 1988, EMBO J, V7, P3907, DOI 10.1002/j.1460-2075.1988.tb03277.x; Bernardi G., 2005, STRUCTURAL EVOLUTION; Bettencourt BR, 2001, MOL BIOL EVOL, V18, P1272, DOI 10.1093/oxfordjournals.molbev.a003912; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen B, 2007, J EVOLUTION BIOL, V20, P2056, DOI 10.1111/j.1420-9101.2007.01348.x; Chen B, 2005, OECOLOGIA, V144, P187, DOI 10.1007/s00442-005-0051-2; Chen B, 2008, CELL STRESS CHAPERON, V13, P11, DOI 10.1007/s12192-007-0002-4; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Dekker J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r116; Delaney SK, 2007, PLANT CELL PHYSIOL, V48, P1426, DOI 10.1093/pcp/pcm111; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Forde B G, 1994, Results Probl Cell Differ, V20, P87; Graze RM, 2009, GENETICS, V183, P547, DOI 10.1534/genetics.109.105957; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Huang LH, 2007, J INSECT PHYSIOL, V53, P1199, DOI 10.1016/j.jinsphys.2007.06.011; Huang LH, 2007, INSECT MOL BIOL, V16, P491, DOI 10.1111/j.1365-2583.2007.00744.x; Kang L, 2009, ANNU REV ENTOMOL, V54, P127, DOI 10.1146/annurev.ento.54.110807.090507; Kube D, 1999, GENES IMMUN, V1, P105, DOI 10.1038/sj.gene.6363641; LANEY JD, 1992, GENE DEV, V6, P1531, DOI 10.1101/gad.6.8.1531; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerman DN, 2005, MOL BIOL EVOL, V22, P776, DOI 10.1093/molbev/msi063; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Mason PB, 1997, J BIOL CHEM, V272, P33227, DOI 10.1074/jbc.272.52.33227; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MCINTOSH AH, 1983, APPL ENTOMOL ZOOL, V18, P262, DOI 10.1303/aez.18.262; McManus CJ, 2010, GENOME RES, V20, P816, DOI 10.1101/gr.102491.109; Michalak P, 2001, P NATL ACAD SCI USA, V98, P13195, DOI 10.1073/pnas.231478298; Michaud S, 1997, CELL MOL LIFE SCI, V53, P104, DOI 10.1007/PL00000572; MIRAULT ME, 1982, EMBO J, V1, P1279, DOI 10.1002/j.1460-2075.1982.tb00025.x; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schmid CD, 2006, NUCLEIC ACIDS RES, V34, pD82, DOI 10.1093/nar/gkj146; SPSS Inc, 1998, SPSS BAS 8 0 WIND US; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tajbakhsh J, 2000, EXP CELL RES, V255, P229, DOI 10.1006/excr.1999.4780; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Walser JC, 2006, PLOS GENET, V2, P1541, DOI 10.1371/journal.pgen.0020165; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; WU CT, 1989, TRENDS GENET, V5, P189, DOI 10.1016/0168-9525(89)90074-7; XIAO H, 1988, SCIENCE, V239, P1139, DOI 10.1126/science.3125608; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhang H, 2009, IN VITRO CELL DEV-AN, V45, P201, DOI 10.1007/s11626-009-9177-6; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101	48	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20308	10.1371/journal.pone.0020308	http://dx.doi.org/10.1371/journal.pone.0020308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655251	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600041
J	Hamid, MMA; Remarque, EJ; van Duivenvoorde, LM; van der Werff, N; Walraven, V; Faber, BW; Kocken, CHM; Thomas, AW				Hamid, Muzamil Mahdi Abdel; Remarque, Edmond J.; van Duivenvoorde, Leonie M.; van der Werff, Nicole; Walraven, Vanessa; Faber, Bart W.; Kocken, Clemens H. M.; Thomas, Alan W.			Vaccination with Plasmodium knowlesi AMA1 Formulated in the Novel Adjuvant Co-Vaccine HT (TM) Protects against Blood-Stage Challenge in Rhesus Macaques	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MALARIA VACCINE; FALCIPARUM MALARIA; MEROZOITE ANTIGEN; CLINICAL-TRIAL; IMMUNOGENICITY; ANTIBODIES; CANDIDATE; IMMUNITY; MONKEYS	Plasmodium falciparum apical membrane antigen 1 (PfAMA1) is a leading blood stage vaccine candidate. Plasmodium knowlesi AMA1 (PkAMA1) was produced and purified using similar methodology as for clinical grade PfAMA1 yielding a pure, conformational intact protein. Combined with the adjuvant CoVaccine HT (TM), PkAMA1 was found to be highly immunogenic in rabbits and the efficacy of the PkAMA1 was subsequently tested in a rhesus macaque blood-stage challenge model. Six rhesus monkeys were vaccinated with PkAMA1 and a control group of 6 were vaccinated with PfAMA1. A total of 50 mu g AMA1 was administered intramuscularly three times at 4 week intervals. One of six rhesus monkeys vaccinated with PkAMA1 was able to control parasitaemia, upon blood stage challenge with P. knowlesi H-strain. Four out of the remaining five showed a delay in parasite onset that correlated with functional antibody titres. In the PfAMA1 vaccinated control group, five out of six animals had to be treated with antimalarials 8 days after challenge; one animal did not become patent during the challenge period. Following a rest period, animals were boosted and challenged again. Four of the six rhesus monkeys vaccinated with PkAMA1 were able to control the parasitaemia, one had a delayed onset of parasitaemia and one animal was not protected, while all control animals required treatment. To confirm that the control of parasitaemia was AMA1-related, animals were allowed to recover, boosted and re-challenged with P. knowlesi Nuri strain. All control animals had to be treated with antimalarials by day 8, while five out of six PkAMA1 vaccinated animals were able to control parasitaemia. This study shows that: i) Yeast-expressed PkAMA1 can protect against blood stage challenge; ii) Functional antibody levels as measured by GIA correlated inversely with the day of onset and iii) GIA IC(50) values correlated with estimated in vivo growth rates.	[Hamid, Muzamil Mahdi Abdel; Remarque, Edmond J.; van Duivenvoorde, Leonie M.; van der Werff, Nicole; Walraven, Vanessa; Faber, Bart W.; Kocken, Clemens H. M.; Thomas, Alan W.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands		Hamid, MMA (corresponding author), Univ Khartoum, Inst Endem Dis, Khartoum, Sudan.	Remarque@bprc.nl	Remarque, Ed/AAE-8643-2020; /AAF-6018-2020; Abdel Hamid, Muzamil Mahdi/E-7234-2019	Abdel Hamid, Muzamil Mahdi/0000-0002-6157-4388; Faber, Bart/0000-0001-6808-1204; Kocken, Clemens/0000-0002-4784-1734	European Malaria Vaccine Initiative (EMVI) [0006/2001]	European Malaria Vaccine Initiative (EMVI)	This work was funded by the European Malaria Vaccine Initiative (EMVI) grant number 0006/2001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Blom AG, 2004, VACCINE, V23, P743, DOI 10.1016/j.vaccine.2004.07.021; Breman JG, 2009, J INFECT DIS, V200, P317, DOI 10.1086/600121; Brice GT, 2007, MICROBES INFECT, V9, P1439, DOI 10.1016/j.micinf.2007.07.009; Butcher GA, 2010, T ROY SOC TROP MED H, V104, P75, DOI 10.1016/j.trstmh.2009.05.017; BUTCHER GA, 1972, IMMUNOLOGY, V23, P503; Butcher GA, 1996, PARASITOL TODAY, V12, P378, DOI 10.1016/0169-4758(96)10062-4; COATNEY GR, 1971, PRIMATE MALARIAS; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; DEANS JA, 1984, MOL BIOCHEM PARASIT, V11, P189, DOI 10.1016/0166-6851(84)90065-3; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Deloron P, 1997, CLIN EXP IMMUNOL, V110, P212; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Dutta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008138; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Guilbride DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010685; HAMID MMA, 2011, MALARIA J, V10, P1; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hilgers Luuk A T, 2006, Vaccine, V24 Suppl 2, pS2; Jiang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006559; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kitua AY, 1996, TROP MED INT HEALTH, V1, P475, DOI 10.1046/j.1365-3156.1996.d01-89.x; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lalitha PV, 2004, INFECT IMMUN, V72, P4464, DOI 10.1128/IAI.72.8.4464-4470.2004; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; OUATTARA A, 2010, AM SOC TROP MED HYG; Pierce MA, 2010, VACCINE, V28, P2236, DOI 10.1016/j.vaccine.2009.12.049; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Sagara I, 2009, VACCINE, V27, P3090, DOI 10.1016/j.vaccine.2009.03.014; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; THERA MA, 2010, AM SOC TROP MED HYG; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Weiss WR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001063; Xu HJ, 2000, J IMMUNOL, V165, P389, DOI 10.4049/jimmunol.165.1.389	44	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20547	10.1371/journal.pone.0020547	http://dx.doi.org/10.1371/journal.pone.0020547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655233	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600095
J	Laverty, C; Li, F; Belikoff, EJ; Scott, MJ				Laverty, Corey; Li, Fang; Belikoff, Esther J.; Scott, Maxwell J.			Abnormal Dosage Compensation of Reporter Genes Driven by the Drosophila Glass Multiple Reporter (GMR) Enhancer-Promoter	PLOS ONE			English	Article							CHROMATIN ENTRY SITE; X-CHROMOSOMAL GENES; DNA-BINDING PROTEIN; MSL COMPLEX; LETHAL COMPLEX; ANALYSIS REVEALS; GAGA FACTOR; EXPRESSION; MELANOGASTER; TARGET	In Drosophila melanogaster the male specific lethal (MSL) complex is required for upregulation of expression of most X-linked genes in males, thereby achieving X chromosome dosage compensation. The MSL complex is highly enriched across most active X-linked genes with a bias towards the 3' end. Previous studies have shown that gene transcription facilitates MSL complex binding but the type of promoter did not appear to be important. We have made the surprising observation that genes driven by the glass multiple reporter (GMR) enhancer-promoter are not dosage compensated at X-linked sites. The GMR promoter is active in all cells in, and posterior to, the morphogenetic furrow of the developing eye disc. Using phiC31 integrase-mediated targeted integration, we measured expression of lacZ reporter genes driven by either the GMR or armadillo (arm) promoters at each of three X-linked sites. At all sites, the arm-lacZ reporter gene was dosage compensated but GMR-lacZ was not. We have investigated why GMR-driven genes are not dosage compensated. Earlier or constitutive expression of GMR-lacZ did not affect the level of compensation. Neither did proximity to a strong MSL binding site. However, replacement of the hsp70 minimal promoter with a minimal promoter from the X-linked 6-Phosphogluconate dehydrogenase gene did restore partial dosage compensation. Similarly, insertion of binding sites for the GAGA and DREF factors upstream of the GMR promoter led to significantly higher lacZ expression in males than females. GAGA and DREF have been implicated to play a role in dosage compensation. We conclude that the gene promoter can affect MSL complex-mediated upregulation and dosage compensation. Further, it appears that the nature of the basal promoter and the presence of binding sites for specific factors influence the ability of a gene promoter to respond to the MSL complex.	[Laverty, Corey; Li, Fang; Belikoff, Esther J.; Scott, Maxwell J.] Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand	Massey University	Laverty, C (corresponding author), EMBL, Heidelberg, Germany.	mjscott3@ncsu.edu	Scott, Maxwell J/J-1935-2015	Scott, Maxwell J/0000-0001-6536-4735	Massey University	Massey University	CL was supported by a doctoral scholarship from Massey University. There was no other funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Alekseyenko AA, 2008, CELL, V134, P599, DOI 10.1016/j.cell.2008.06.033; Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bello B, 1998, DEVELOPMENT, V125, P2193; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cagan R, 2009, CURR TOP DEV BIOL, V89, P115, DOI 10.1016/S0070-2153(09)89005-4; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Fagegaltier D, 2004, PLOS BIOL, V2, P1854, DOI 10.1371/journal.pbio.0020341; Fitzsimons HL, 1999, GENETICA, V105, P215, DOI 10.1023/A:1003801402153; Furuhashi H, 2006, DEVELOPMENT, V133, P4475, DOI 10.1242/dev.02620; Gelbart ME, 2009, NAT STRUCT MOL BIOL, V16, P825, DOI 10.1038/nsmb.1644; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; GERGEN JP, 1987, GENETICS, V117, P477; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; GLASER RL, 1986, EMBO J, V5, P747, DOI 10.1002/j.1460-2075.1986.tb04277.x; Gorchakov AA, 2009, GENE DEV, V23, P2266, DOI 10.1101/gad.1840409; Greenberg AJ, 2004, GENETICS, V166, P279, DOI 10.1534/genetics.166.1.279; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; GUTIERREZ AG, 1989, DEV GENET, V10, P155, DOI 10.1002/dvg.1020100305; Hamada FN, 2005, GENE DEV, V19, P2289, DOI 10.1101/gad.1343705; Hay BA, 1997, P NATL ACAD SCI USA, V94, P5195, DOI 10.1073/pnas.94.10.5195; HAY BA, 1994, DEVELOPMENT, V120, P2121; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; Hendrix DA, 2008, P NATL ACAD SCI USA, V105, P7762, DOI 10.1073/pnas.0802406105; Henry RA, 2001, J BIOL CHEM, V276, P31953, DOI 10.1074/jbc.M103008200; Hilfiker A, 1997, EMBO J, V16, P2054, DOI 10.1093/emboj/16.8.2054; Horn C, 2003, GENETICS, V163, P647; Horn C, 2003, NAT BIOTECHNOL, V21, P64, DOI 10.1038/nbt769; Kageyama Y, 2001, EMBO J, V20, P2236, DOI 10.1093/emboj/20.9.2236; Katsani KR, 1999, EMBO J, V18, P698, DOI 10.1093/emboj/18.3.698; Kelley RL, 2003, GENETICS, V164, P565; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Kind J, 2007, GENE DEV, V21, P2030, DOI 10.1101/gad.430807; Kotlikova IV, 2006, GENETICS, V172, P963, DOI 10.1534/genetics.105.045286; Larschan E, 2011, NATURE, V471, P115, DOI 10.1038/nature09757; Laverty C, 2010, CURR OPIN GENET DEV, V20, P171, DOI 10.1016/j.gde.2010.01.007; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Lerach S, 2005, GENESIS, V43, P213, DOI 10.1002/gene.20172; LUCCHESI JC, 1987, ADV GENET, V24, P371, DOI 10.1016/S0065-2660(08)60013-9; Lucchesi JC, 2009, CURR OPIN GENET DEV, V19, P550, DOI 10.1016/j.gde.2009.10.004; Mazumdar A, 2002, BIOESSAYS, V24, P1012, DOI 10.1002/bies.10184; McAnally AA, 2010, GENOME BIOL EVOL, V2, P44, DOI 10.1093/gbe/evp054; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Moore SA, 2010, J BIOL CHEM, V285, P40879, DOI 10.1074/jbc.M110.134312; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Oh H, 2004, CURR BIOL, V14, P481, DOI 10.1016/j.cub.2004.03.004; Ohler U, 2002, GENOME BIOL, V3, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Park Y, 2003, MOL CELL, V11, P977, DOI 10.1016/S1097-2765(03)00147-3; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; Plautz JD, 1996, GENE, V173, P83, DOI 10.1016/0378-1119(95)00700-8; QIAN S, 1995, GENETICS, V139, P733; ROBERTS DB, 1979, NATURE, V280, P691, DOI 10.1038/280691a0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sass GL, 2003, P NATL ACAD SCI USA, V100, P8287, DOI 10.1073/pnas.1332749100; Schiemann AH, 2010, BIOCHEM BIOPH RES CO, V402, P699, DOI 10.1016/j.bbrc.2010.10.088; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Scott MJ, 2004, INSECT BIOCHEM MOLEC, V34, P185, DOI 10.1016/j.ibmb.2003.11.001; SCOTT MJ, 1991, GENE, V109, P177, DOI 10.1016/0378-1119(91)90607-D; Seto H, 2006, GENES CELLS, V11, P499, DOI 10.1111/j.1365-2443.2006.00956.x; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SIMCOX AA, 1985, MOL CELL BIOL, V5, P3397, DOI 10.1128/MCB.5.12.3397; SIMON JA, 1987, NUCLEIC ACIDS RES, V15, P2971, DOI 10.1093/nar/15.7.2971; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Spierer A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000066; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; Stenberg P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000465; Straub T, 2005, GENE DEV, V19, P2284, DOI 10.1101/gad.1343105; Straub T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000302; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Weake VM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-35; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	80	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20455	10.1371/journal.pone.0020455	http://dx.doi.org/10.1371/journal.pone.0020455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655213	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600073
J	Kalchishkova, N; Furst, CM; Heinegard, D; Blom, AM				Kalchishkova, Nikolina; Furst, Camilla Melin; Heinegard, Dick; Blom, Anna M.			NC4 Domain of Cartilage-specific Collagen IX Inhibits Complement Directly Due to Attenuation of Membrane Attack Formation and Indirectly through Binding and Enhancing Activity of Complement Inhibitors C4B-binding Protein and Factor H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGOMERIC MATRIX PROTEIN; EXTRACELLULAR-MATRIX; RHEUMATOID-ARTHRITIS; ALPHA-CHAIN; STRUCTURAL REQUIREMENTS; MASS-SPECTROMETRY; COFACTOR FUNCTION; 9TH COMPONENT; C1Q; DEFICIENCY	Collagen IX containing the N-terminal noncollagenous domain 4 (NC4) is unique to cartilage and a member of the family of fibril-associated collagens with both collagenous and noncollagenous domains. Collagen IX is located at the surface of fibrils formed by collagen II and a minor proportion of collagen XI, playing roles in tissue stability and integrity. The NC4 domain projects out from the fibril surface and provides sites for interaction with other matrix components such as cartilage oligomeric matrix protein, matrilins, fibromodulin, and osteoadherin. Fragmentation of collagen IX and loss of the NC4 domain are early events in cartilage degradation in joint diseases that precedes major damage of collagen II fibrils. Our results demonstrate that NC4 can function as a novel inhibitor of the complement system able to bind C4, C3, and C9 and to directly inhibit C9 polymerization and assembly of the lytic membrane attack complex. NC4 also binds the complement inhibitors C4b-binding protein and factor H and enhances their cofactor activity in degradation of activated complement components C4b and C3b. NC4 interactions with fibromodulin and osteoadherin inhibited binding to C1q and complement activation by these proteins. Taken together, our results suggest that collagen IX and its interactions with matrix components are important parts of a machinery that protects the cartilage from complement activation and chronic inflammation seen in diseases like rheumatoid arthritis.	[Blom, Anna M.] Lund Univ, Dept Lab Med, Wallenberg Lab, Sect Med Prot Chem, S-20502 Malmo, Sweden; [Heinegard, Dick] Lund Univ, Dept Clin Sci, Rheumatol Sect, S-22184 Lund, Sweden	Lund University; Lund University	Blom, AM (corresponding author), Lund Univ, Dept Lab Med, Wallenberg Lab, Sect Med Prot Chem, Floor 4, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022	Blom, Anna/0000-0002-1348-1734; Melin Furst, Camilla/0000-0001-5487-4270	NIAMS; Swedish Research Council [K2009-68X-14928-06-3, K2011-52X-05668-32-3]; Swedish Foundation for Strategic Research; Greta and Johan Kock, Foundation of Osterlund; Inga-Britt, Foundation of Osterlund; Arne Lundberg, Foundation of Osterlund; King Gustav Vth's 80th Anniversary, Foundation of Osterlund; Knut and Alice Wallenberg Foundation; University Hospital in Malmo/Lund; Anna-Greta Crafoord Foundation	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Greta and Johan Kock, Foundation of Osterlund; Inga-Britt, Foundation of Osterlund; Arne Lundberg, Foundation of Osterlund; King Gustav Vth's 80th Anniversary, Foundation of Osterlund; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); University Hospital in Malmo/Lund; Anna-Greta Crafoord Foundation	This work was supported, in whole or in part, by a National Institutes of Health grant from NIAMS. This work was also supported by Swedish Research Council Grants K2009-68X-14928-06-3 and K2011-52X-05668-32-3, Swedish Foundation for Strategic Research, Foundations of Osterlund, Greta and Johan Kock, Inga-Britt, and Arne Lundberg, King Gustav Vth's 80th Anniversary, Knut and Alice Wallenberg Foundation, and grants from the University Hospital in Malmo/Lund. Conflict of interest: Dr. Heinegard owns stock in AnaMar Medical and has filed a patent application concerning type IX collagen as marker of joint destruction.; Recipient of a postdoctoral stipend from the Anna-Greta Crafoord Foundation.	ANDERSSON M, 1991, EUR J CLIN PHARMACOL, V40, P261, DOI 10.1007/BF00315206; BIESECKER G, 1980, J IMMUNOL, V124, P1291; Blom AM, 2003, J BIOL CHEM, V278, P43437, DOI 10.1074/jbc.M306620200; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Budde B, 2005, MOL CELL BIOL, V25, P10465, DOI 10.1128/MCB.25.23.10465-10478.2005; Carlsen S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1989; Crnkic M, 2003, ARTHRITIS RES THER, V5, pR181, DOI 10.1186/ar760; DAHLBACK B, 1983, BIOCHEM J, V209, P837, DOI 10.1042/bj2090837; Danfelter M, 2007, J BIOL CHEM, V282, P36933, DOI 10.1074/jbc.M702491200; DE FRUTOS PG, 1995, J BIOL CHEM, V270, P26950, DOI 10.1074/jbc.270.45.26950; Eyre DR, 2004, J BIOL CHEM, V279, P2568, DOI 10.1074/jbc.M311653200; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Groeneveld TWL, 2005, J IMMUNOL, V175, P4715, DOI 10.4049/jimmunol.175.7.4715; Happonen KE, 2010, ARTHRITIS RHEUM-US, V62, P3574, DOI 10.1002/art.27720; Happonen KE, 2009, J IMMUNOL, V182, P1518, DOI 10.4049/jimmunol.182.3.1518; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; Kojima T, 2001, ARTHRITIS RHEUM, V44, P120, DOI 10.1002/1529-0131(200101)44:1<120::AID-ANR16>3.0.CO;2-X; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; Nilsson SC, 2009, EUR J IMMUNOL, V39, P310, DOI 10.1002/eji.200838702; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Pflieger D, 2010, MOL CELL PROTEOMICS, V9, P593, DOI 10.1074/mcp.M900350-MCP200; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; PODACK ER, 1982, J BIOL CHEM, V257, P5204; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosenberg K, 1998, J BIOL CHEM, V273, P20397, DOI 10.1074/jbc.273.32.20397; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Thur J, 2001, J BIOL CHEM, V276, P6083, DOI 10.1074/jbc.M009512200; Tillgren V, 2009, J BIOL CHEM, V284, P28543, DOI 10.1074/jbc.M109.047076; VANDERREST M, 1985, J BIOL CHEM, V260, P220; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; WOTTON S F, 1991, Biochemical Society Transactions, V19, p375S; Wotton SF, 1999, RHEUMATOLOGY, V38, P338, DOI 10.1093/rheumatology/38.4.338; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	43	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27915	27926		10.1074/jbc.M111.242834	http://dx.doi.org/10.1074/jbc.M111.242834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659506	Green Published, hybrid			2022-12-25	WOS:000293557800010
J	Ceccarelli, V; Racanicchi, S; Martelli, MP; Nocentini, G; Fettucciari, K; Riccardi, C; Marconi, P; Di Nardo, P; Grignani, F; Binaglia, L; Vecchini, A				Ceccarelli, Veronica; Racanicchi, Serena; Martelli, Maria Paola; Nocentini, Giuseppe; Fettucciari, Katia; Riccardi, Carlo; Marconi, Pierfrancesco; Di Nardo, Paolo; Grignani, Francesco; Binaglia, Luciano; Vecchini, Alba			Eicosapentaenoic Acid Demethylates a Single CpG That Mediates Expression of Tumor Suppressor CCAAT/Enhancer-binding Protein delta in U937 Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; STIMULATING FACTOR-RECEPTOR; MAMMARY EPITHELIAL-CELLS; BREAST-CANCER CELLS; C-JUN; C/EBP-DELTA; GENE-EXPRESSION; MACROPHAGE DIFFERENTIATION; TRANSCRIPTION FACTORS; MYELOID DEVELOPMENT	Polyunsaturated fatty acids (PUFAs) inhibit proliferation and induce differentiation in leukemia cells. To investigate the molecular mechanisms whereby fatty acids affect these processes, U937 leukemia cells were conditioned with stearic, oleic, linolenic, alpha-linolenic, arachidonic, eicosapentaenoic, and docosahexaenoic acids. PUFAs affected proliferation; eicosapentaenoic acid (EPA) was the most potent on cell cycle progression. EPA enhanced the expression of the myeloid lineage-specific transcription factors CCAAT/enhancer-binding proteins (C/EBP beta and C/EBP delta), PU.1, and c-Jun, resulting in increased expression of the monocyte lineage-specific target gene, the macrophage colony-stimulating factor receptor. Indeed, it is known that PU.1 and C/EBPs interact with their consensus sequences on a small DNA fragment of macrophage colony-stimulating factor receptor promoter, which is a determinant for expression. We demonstrated that C/EBP beta and C/EBP delta bind the same response element as a heterodimer. We focused on the enhanced expression of C/EBP delta, which has been reported to be a tumor suppressor gene silenced by promoter hypermethylation in U937 cells. After U937 conditioning with EPA and bisulfite sequencing of the -370/-20 CpG island on the C/EBP delta promoter region, we found a site-specific CpG demethylation that was a determinant for the binding activity of Sp1, an essential factor for C/EBP delta gene basal expression. Our results provide evidence for a new role of PUFAs in the regulation of gene expression. Moreover, we demonstrated for the first time that re-expression of the tumor suppressor C/EBP delta is controlled by the methylation state of a site-specific CpG dinucleotide.	[Ceccarelli, Veronica; Binaglia, Luciano; Vecchini, Alba] Univ Perugia, Dept Expt Med & Biochem Sci, I-06126 Perugia, Italy; [Racanicchi, Serena; Martelli, Maria Paola; Nocentini, Giuseppe; Fettucciari, Katia; Riccardi, Carlo; Marconi, Pierfrancesco; Grignani, Francesco] Univ Perugia, Dept Clin & Expt Med, I-06126 Perugia, Italy; [Di Nardo, Paolo] Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy	University of Perugia; University of Perugia; University of Rome Tor Vergata	Vecchini, A (corresponding author), Univ Perugia, Fac Med, Biochem Sect, Dept Expt Med & Biochem Sci, Via Giochetto 3, I-06122 Perugia, Italy.	vecchini@unipg.it	Fettucciari, Katia/K-7661-2015; Martelli, Maria Paola/ABH-3300-2021; Riccardi, Carlo/N-4610-2014; FETTUCCIARI, Katia/N-8664-2019; Nocentini, Giuseppe/GZB-0146-2022; Nocentini, Giuseppe/B-9412-2013; Grignani, Francesco/AAC-2565-2022; Martelli, Maria Paola/I-5618-2012	Fettucciari, Katia/0000-0001-8074-8243; Martelli, Maria Paola/0000-0001-9139-1729; Riccardi, Carlo/0000-0001-9257-3997; FETTUCCIARI, Katia/0000-0001-8074-8243; Nocentini, Giuseppe/0000-0002-5209-0488; DI NARDO, PAOLO/0000-0003-4460-9494; Ceccarelli, Veronica/0000-0003-0424-6940; Vecchini, Alba/0000-0003-1253-7625; Marconi, Pierfrancesco/0000-0002-4213-3413	Ministero delle Politiche Agricole, Alimentari e Forestali; Associazione Italiana per la Ricerca sul Cancro	Ministero delle Politiche Agricole, Alimentari e Forestali; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The work was supported by grants from the Ministero delle Politiche Agricole, Alimentari e Forestali (to L. B.) and Associazione Italiana per la Ricerca sul Cancro (to F. G.).	Agrawal S, 2007, BLOOD, V109, P3895, DOI 10.1182/blood-2006-08-040147; Anderson BM, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-33; Arapshian A, 2000, ONCOGENE, V19, P4066, DOI 10.1038/sj.onc.1203734; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; BECK SA, 1991, CANCER RES, V51, P6089; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Boultwood J, 2007, BRIT J HAEMATOL, V138, P3, DOI 10.1111/j.1365-2141.2007.06604.x; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Calviello G, 1998, INT J CANCER, V75, P699, DOI 10.1002/(SICI)1097-0215(19980302)75:5&lt;699::AID-IJC7&gt;3.0.CO;2-U; Chim CS, 2002, HEMATOL ONCOL, V20, P167, DOI 10.1002/hon.694; Dai ZY, 2004, ONCOGENE, V23, P3521, DOI 10.1038/sj.onc.1207441; Daskalakis M, 2002, BLOOD, V100, P2957, DOI 10.1182/blood.V100.8.2957; Evans LM, 2009, NUTR CANCER, V61, P746, DOI 10.1080/01635580902825597; Finstad HS, 1998, LEUKEMIA, V12, P921, DOI 10.1038/sj.leu.2401030; FINSTAD HS, 1994, BLOOD, V84, P3799, DOI 10.1182/blood.V84.11.3799.bloodjournal84113799; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; GABOR H, 1986, J NATL CANCER I, V76, P1223; GAYNOR R, 1991, BLOOD, V77, P2618; Gerashchenko BI, 2004, CYTOM PART A, V61A, P134, DOI 10.1002/cyto.a.20065; Gery S, 2005, ONCOGENE, V24, P1589, DOI 10.1038/sj.onc.1208393; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; GUFFY MM, 1984, CANCER RES, V44, P1863; Hamm CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008340; Harris WS, 2009, J NUTR, V139, p804S, DOI 10.3945/jn.108.101329; Hass R, 1997, LEUKEMIA RES, V21, P589, DOI 10.1016/S0145-2126(97)00010-6; Hawcroft G, 2010, NEOPLASIA, V12, P618, DOI 10.1593/neo.10388; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu HM, 2000, J BIOL CHEM, V275, P16373, DOI 10.1074/jbc.M910269199; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Hutt JA, 2000, J BIOL CHEM, V275, P29123, DOI 10.1074/jbc.M004476200; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Jung KC, 2006, LEUKEMIA, V20, P122, DOI 10.1038/sj.leu.2404022; Kersh EN, 2006, J IMMUNOL, V176, P4083, DOI 10.4049/jimmunol.176.7.4083; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Li AC, 1998, J BIOL CHEM, V273, P5389, DOI 10.1074/jbc.273.9.5389; LI JM, 1994, CELL GROWTH DIFFER, V5, P743; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; REDDY MA, 1994, J EXP MED, V180, P2309, DOI 10.1084/jem.180.6.2309; REICH R, 1989, BIOCHEM BIOPH RES CO, V160, P559, DOI 10.1016/0006-291X(89)92469-8; ROBERTS WM, 1992, BLOOD, V79, P586; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Sivko GS, 2004, J CELL BIOCHEM, V93, P844, DOI 10.1002/jcb.20224; Spencer L, 2009, EUR J CANCER, V45, P2077, DOI 10.1016/j.ejca.2009.04.026; SZABO E, 1994, CELL GROWTH DIFFER, V5, P439; Tang D, 2006, BREAST CANCER RES TR, V95, P161, DOI 10.1007/s10549-005-9061-3; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Vecchini A, 2005, BBA-MOL CELL BIOL L, V1737, P138, DOI 10.1016/j.bbalip.2005.10.008; Vecchini A, 2004, J LIPID RES, V45, P308, DOI 10.1194/jlr.M300396-JLR200; Vegesna VA, 2002, LEUKEMIA RES, V26, P451, DOI 10.1016/S0145-2126(01)00150-3; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Wendel M, 2009, ANTI-CANCER AGENT ME, V9, P457, DOI 10.2174/1871520610909040457; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P6462, DOI 10.1073/pnas.94.12.6462; Yang ZY, 2000, J BIOL CHEM, V275, P21272, DOI 10.1074/jbc.M000145200; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	66	60	60	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27092	27102		10.1074/jbc.M111.253609	http://dx.doi.org/10.1074/jbc.M111.253609			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659508	Green Published, hybrid			2022-12-25	WOS:000293268700004
J	Haynes, KA; Silver, PA				Haynes, Karmella A.; Silver, Pamela A.			Synthetic Reversal of Epigenetic Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; CELL FATE; GENE-EXPRESSION; AXIAL SKELETON; POLYCOMB; CHROMATIN; CANCER; OVEREXPRESSION; ACTIVATION; SENESCENCE	Controlling cell fate-determining gene expression is key to stem cell differentiation, tissue regeneration, and cancer therapy. To date, custom-built transcription factors recognize the information encoded in specific DNA sequences. Chromatin proteins undergo covalent modifications and form complexes that encode a second layer of information that determines proximal gene activity. Here, we employ a novel gene-targeting approach that exploits a specific chromatin modification to reactivate silenced loci in human cells. We used the human Polycomb chromatin protein and homologues from other species to construct modular synthetic transcription factors, called Pc-TFs, that recognize the repressive trimethyl-histone H3 lysine 27 (H3K27me3) signal and switch silenced genes to an active state. Pc-TF expression in U2OS osteosarcoma cells leads to increased transcription of the senescence locus CDKN2A (p16) and other loci in a chromodomain- and activation module-dependent manner, a switch to a senescence phenotype, and reduced cell proliferation. These results indicate that silenced developmental regulators can be reactivated by a synthetic transcription factor that interacts with chromatin rather than DNA, resulting in an altered cell state. As such, our work extends the flexibility of transcription factor engineering and is the first example of chromatin-mediated synthetic transcription factor targeting.	[Haynes, Karmella A.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Silver, Pamela A.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Silver, PA (corresponding author), 200 Longwood Ave WAB 536, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu		Haynes, Karmella/0000-0002-5975-577X	National Institutes of Health [GM057476, GM36373, 1F32GM087860]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036373, R37GM036373, F32GM087860, R01GM057476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM057476 and GM36373 (to P. A. S.) and 1F32GM087860 (to K. A. H.).	Akasaka T, 1996, DEVELOPMENT, V122, P1513; ALKEMA MJ, 1995, NATURE, V374, P724, DOI 10.1038/374724a0; Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; DJABALI M, 1992, NAT GENET, V2, P113, DOI 10.1038/ng1092-113; EMAMI KH, 1995, MOL CELL BIOL, V15, P5906; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gravina GL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-305; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Haynes KA, 2009, J CELL BIOL, V187, P589, DOI 10.1083/jcb.200908138; Kawamura A, 2002, BIOCHEM BIOPH RES CO, V294, P456, DOI 10.1016/S0006-291X(02)00497-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Liu PQ, 2001, J BIOL CHEM, V276, P11323, DOI 10.1074/jbc.M011172200; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Noppe G, 2009, CYTOM PART A, V75A, P910, DOI 10.1002/cyto.a.20796; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020	29	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27176	27182		10.1074/jbc.C111.229567	http://dx.doi.org/10.1074/jbc.C111.229567			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669865	Green Published, hybrid			2022-12-25	WOS:000293268700013
J	Treberg, JR; Quinlan, CL; Brand, MD				Treberg, Jason R.; Quinlan, Casey L.; Brand, Martin D.			Evidence for Two Sites of Superoxide Production by Mitochondrial NADH-Ubiquinone Oxidoreductase (Complex I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SPECIES GENERATION; ELECTRON-TRANSPORT CHAIN; RAT-HEART MITOCHONDRIA; NAD(P)H REDOX STATE; MECHANISM; INHIBITION; MEMBRANE; TOPOLOGY	Complex I (NADH-ubiquinone oxidoreductase) can form superoxide during forward electron flow (NADH-oxidizing) or, at sufficiently high protonmotive force, during reverse electron transport from the ubiquinone (Q) pool (NAD(+)-reducing). We designed an assay system to allow titration of the redox state of the superoxide-generating site during reverse electron transport in rat skeletal muscle mitochondria: a protonmotive force generated by ATP hydrolysis, succinate: malonate to alter electron supply and modulate the redox state of the Q pool, and inhibition of complex III to prevent QH(2) oxidation via the Q cycle. Stepwise oxidation of the QH(2)/Q pool by increasing malonate concentration slowed the rates of both reverse electron transport and rotenone-sensitive superoxide production by complex I. However, the superoxide production rate was not uniquely related to the resultant potential of the NADH/NAD(+) redox couple. Thus, there is a superoxide producer during reverse electron transport at complex I that responds to Q pool redox state and is not in equilibrium with the NAD reduction state. In contrast, superoxide production during forward electron transport in the presence of rotenone was uniquely related to NAD redox state. These results support a two-site model of complex I superoxide production; one site in equilibrium with the NAD pool, presumably the flavin of the FMN moiety (site I-F) and the other dependent not only on NAD redox state, but also on protonmotive force and the reduction state of the Q pool, presumably a semiquinone in the Q-binding site (site I-Q).	[Treberg, Jason R.; Quinlan, Casey L.; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Treberg, JR (corresponding author), Univ Manitoba, Biol Sci Bldg, Winnipeg, MB R3T 2N2, Canada.	jtreberg@mun.ca	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Treberg, Jason/0000-0001-5112-7325; Quinlan, Casey/0000-0002-7808-8271	National Institutes of Health [P01 AG025901, PL1 AG032118, R01 AG033542]; Ellison Medical Foundation [AG-SS-2288-09]; NATIONAL INSTITUTE ON AGING [P01AG025901, R01AG033542, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 AG025901, PL1 AG032118, and R01 AG033542. This work was also supported by Ellison Medical Foundation Grant AG-SS-2288-09.	Ambrus A, 2009, J NEUROCHEM, V109, P222, DOI 10.1111/j.1471-4159.2009.05942.x; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; BROWN GC, 1988, BIOCHEM J, V252, P473, DOI 10.1042/bj2520473; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Genova ML, 2001, FEBS LETT, V505, P364, DOI 10.1016/S0014-5793(01)02850-2; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KRISHNAMOORTHY G, 1988, J BIOL CHEM, V263, P17566; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1901, DOI 10.1016/j.bbabio.2010.05.012; Ohnishi ST, 2005, J BIOENERG BIOMEMBR, V37, P1, DOI 10.1007/s10863-005-4117-y; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Quinlan C.L., 2011, HDB BIOL AGING, V7th, P47; RAMSAY RR, 1992, BIOCHEM BIOPH RES CO, V189, P47, DOI 10.1016/0006-291X(92)91523-S; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Treberg JR, 2011, J BIOL CHEM, V286, P17579, DOI 10.1074/jbc.M111.227751; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x; Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7	32	152	154	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27103	27110		10.1074/jbc.M111.252502	http://dx.doi.org/10.1074/jbc.M111.252502			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659507	Green Published, hybrid			2022-12-25	WOS:000293268700005
J	Cebulski, J; Malouin, J; Pinches, N; Cascio, V; Austriaco, N				Cebulski, James; Malouin, Joshua; Pinches, Nathan; Cascio, Vincent; Austriaco, Nicanor			Yeast Bax Inhibitor, Bxi1p, Is an ER-Localized Protein That Links the Unfolded Protein Response and Programmed Cell Death in Saccharomyces cerevisiae	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; DOWN-REGULATION; INDUCED APOPTOSIS; PROSTATE-CANCER; PLANT HOMOLOG; BI-1; SUPPRESSOR; REGULATOR; OVEREXPRESSION	Bax inhibitor-1 (BI-1) is an anti-apoptotic gene whose expression is upregulated in a wide range of human cancers. Studies in both mammalian and plant cells suggest that the BI-1 protein resides in the endoplasmic reticulum and is involved in the unfolded protein response (UPR) that is triggered by ER stress. It is thought to act via a mechanism involving altered calcium dynamics. In this paper, we provide evidence that the Saccharomyces cerevisiae protein encoded by the open reading frame, YNL305C, is a bona fide homolog for BI-1. First, we confirm that yeast cells from two different strain backgrounds lacking YNL305C, which we have renamed BXI1, are more sensitive to heat-shock induced cell death than wildtype controls even though they have indistinguishable growth rates at 30 degrees C. They are also more susceptible both to ethanol-induced and to glucose-induced programmed cell death. Significantly, we show that Bxi1p-GFP colocalizes with the ER localized protein Sec63p-RFP. We have also discovered that Delta bxi1 cells are not only more sensitive to drugs that induce ER stress, but also have a decreased unfolded protein response as measured with a UPRE-lacZ reporter. Finally, we have discovered that deleting BXI1 diminishes the calcium signaling response in response to the accumulation of unfolded proteins in the ER as measured by a calcineurin-dependent CDRE-lacZ reporter. In toto, our data suggests that the Bxi1p, like its metazoan homologs, is an ER-localized protein that links the unfolded protein response and programmed cell death.	[Cebulski, James; Malouin, Joshua; Pinches, Nathan; Cascio, Vincent; Austriaco, Nicanor] Providence Coll, Dept Biol, Providence, RI 02918 USA	Providence College	Cebulski, J (corresponding author), Providence Coll, Dept Biol, Providence, RI 02918 USA.	naustria@providence.edu		Austriaco, Nicanor/0000-0003-1854-8181	NIGMS [R15 GM094712]; NSF [MRI-R2 0959354]; NIH [2 P20 RR016457]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103430, R15GM094712] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors' laboratory is supported by the following grants awarded to N. Austriaco: NIGMS R15 GM094712 (http://www.nigms.nih.gov/), NSF MRI-R2 0959354 (http://www.nsf.gov/), and NIH Grant 2 P20 RR016457 to the Rhode Island INBRE Program (http://www.uri.edu/inbre/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2009, FEBS J, V276, P2285, DOI 10.1111/j.1742-4658.2009.06956.x; Amberg DC., 2005, METHODS YEAST GENETI; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Bolduc N, 2002, FEBS LETT, V532, P111, DOI 10.1016/S0014-5793(02)03650-5; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Cowling RT, 1998, MOL MEMBR BIOL, V15, P177, DOI 10.3109/09687689709044319; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; Granot D, 1997, CELL DEATH DIFFER, V4, P555, DOI 10.1038/sj.cdd.4400280; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; Harima Y, 2004, INT J RADIAT ONCOL, V60, P237, DOI 10.1016/j.ijrobp.2004.02.047; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Kawai M, 1999, FEBS LETT, V464, P143, DOI 10.1016/S0014-5793(99)01695-6; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Kim HR, 2008, J BIOL CHEM, V283, P15946, DOI 10.1074/jbc.M800075200; Kitagaki H, 2007, FEBS LETT, V581, P2935, DOI 10.1016/j.febslet.2007.05.048; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Kotsafti A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-35; Krajewska M, 2011, BRAIN RES, V1370, P227, DOI 10.1016/j.brainres.2010.11.015; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; Li XY, 2010, CELL BIOL INT, V34, P1099, DOI 10.1042/CBI20090400; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; ROBINSON KS, 2011, ONCOGENE        0207, DOI DOI 10.1038/ONC.2010.636; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Schmits R, 2002, INT J CANCER, V98, P73, DOI 10.1002/ijc.10170; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Villalva C, 2002, BRIT J HAEMATOL, V118, P791, DOI 10.1046/j.1365-2141.2002.03671.x; WALTER L, 1995, GENOMICS, V28, P301, DOI 10.1006/geno.1995.1145; WALTER L, 1994, MAMM GENOME, V5, P216, DOI 10.1007/BF00360548; Watanabe N, 2008, PLANT SIGNAL BEHAV, V3, P564, DOI 10.4161/psb.3.8.5709; Welsh JB, 2001, CANCER RES, V61, P5974; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9	49	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20882	10.1371/journal.pone.0020882	http://dx.doi.org/10.1371/journal.pone.0020882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673967	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400036
J	Childs, AJ; Cowan, G; Kinnell, HL; Anderson, RA; Saunders, PTK				Childs, Andrew J.; Cowan, Gillian; Kinnell, Hazel L.; Anderson, Richard A.; Saunders, Philippa T. K.			Retinoic Acid Signalling and the Control of Meiotic Entry in the Human Fetal Gonad	PLOS ONE			English	Article							GERM-CELL DIFFERENTIATION; SOMATIC-CELLS; SUPPRESSES MEIOSIS; HUMAN OVARY; MOUSE; EXPRESSION; MICE; INITIATION; RECEPTORS; ACTIVIN	The development of mammalian fetal germ cells along oogenic or spermatogenic fate trajectories is dictated by signals from the surrounding gonadal environment. Germ cells in the fetal testis enter mitotic arrest, whilst those in the fetal ovary undergo sex-specific entry into meiosis, the initiation of which is thought to be mediated by selective exposure of fetal ovarian germ cells to mesonephros-derived retinoic acid (RA). Aspects of this model are hard to reconcile with the spatiotemporal pattern of germ cell differentiation in the human fetal ovary, however. We have therefore examined the expression of components of the RA synthesis, metabolism and signalling pathways, and their downstream effectors and inhibitors in germ cells around the time of the initiation of meiosis in the human fetal gonad. Expression of the three RA-synthesising enzymes, ALDH1A1, 2 and 3 in the fetal ovary and testis was equal to or greater than that in the mesonephros at 8-9 weeks gestation, indicating an intrinsic capacity within the gonad to synthesise RA. Using immunohistochemistry to detect RA receptors RAR alpha, beta and RXR alpha, we find germ cells to be the predominant target of RA signalling in the fetal human ovary, but also reveal widespread receptor nuclear localization indicative of signalling in the testis, suggesting that human fetal testicular germ cells are not efficiently shielded from RA by the action of the RA-metabolising enzyme CYP26B1. Consistent with this, expression of CYP26B1 was greater in the human fetal ovary than testis, although the sexually-dimorphic expression patterns of the germ cell-intrinsic regulators of meiotic initiation, STRA8 and NANOS2, appear conserved. Finally, we demonstrate that RA induces a two-fold increase in STRA8 expression in cultures of human fetal testis, but is not sufficient to cause widespread meiosis-associated gene expression. Together, these data indicate that while local production of RA within the fetal ovary may be important in regulating the onset of meiosis in the human fetal ovary, mechanisms other than CYP26B1-mediated metabolism of RA may exist to inhibit the entry of germ cells into meiosis in the human fetal testis.	[Childs, Andrew J.; Cowan, Gillian; Kinnell, Hazel L.; Saunders, Philippa T. K.] Univ Edinburgh, Queens Med Res Inst, Med Res Council, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Anderson, Richard A.] Univ Edinburgh, Queens Med Res Inst, Ctr Reprod Biol, Div Reprod & Dev Sci, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Edinburgh; University of Edinburgh	Childs, AJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Med Res Council, Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland.	a.childs@ed.ac.uk	Saunders, Philippa TK/C-7489-2013	Saunders, Philippa TK/0000-0001-9051-9380; Childs, Andrew/0000-0003-3937-4037	Medical Research Council [U.1276.00.002.00005.01, U.1276.00.002.00001.01]; Medical Research Scotland [354FRG]; Medical Research Council [MC_U127685844, G1100357, G1002033, G1100356] Funding Source: researchfish; MRC [MC_U127685844, G1100357, G1100356, G1002033] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Scotland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council (www.mrc.ac.uk) core funding to PTKS (U.1276.00.002.00005.01) and RAA (U.1276.00.002.00001.01). AJC is supported by Medical Research Scotland (www.medicalresearchscotland.com research grant 354FRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Best D, 2008, DEVELOPMENT, V135, P1415, DOI 10.1242/dev.019497; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Bowles J, 2009, DEV DYNAM, V238, P2073, DOI 10.1002/dvdy.22024; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; Childs AJ, 2010, STEM CELLS, V28, P1368, DOI 10.1002/stem.440; Childs AJ, 2010, DEV DYNAM, V239, P1211, DOI 10.1002/dvdy.22252; Coutts SM, 2008, DEV BIOL, V314, P189, DOI 10.1016/j.ydbio.2007.11.026; Cowan G, 2010, REPRODUCTION, V139, P749, DOI 10.1530/REP-09-0532; Cupp AS, 1999, ENDOCRINOLOGY, V140, P2343, DOI 10.1210/en.140.5.2343; da Silva SJM, 2004, DEV BIOL, V266, P334, DOI 10.1016/j.ydbio.2003.10.030; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Guerquin MJ, 2010, DEV BIOL, V346, P320, DOI 10.1016/j.ydbio.2010.08.002; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Le Bouffant R, 2010, HUM REPROD, V25, P2579, DOI 10.1093/humrep/deq195; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007501; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; McLaren A, 1984, Symp Soc Exp Biol, V38, P7; MENDELSOHN C, 1992, DEV BIOL, V152, P50, DOI 10.1016/0012-1606(92)90155-A; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295; Morita Y, 1999, ENDOCRINOLOGY, V140, P2696, DOI 10.1210/en.140.6.2696; Niederreither K, 2002, DEVELOPMENT, V129, P3563; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Polkinghorne J, 1989, REV GUIDANCE RES USE; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; Stoop H, 2005, HUM REPROD, V20, P1466, DOI 10.1093/humrep/deh800; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wendling O, 1999, P NATL ACAD SCI USA, V96, P547, DOI 10.1073/pnas.96.2.547	36	101	108	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20249	10.1371/journal.pone.0020249	http://dx.doi.org/10.1371/journal.pone.0020249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674038	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500010
J	Lytkin, NI; Mcvoy, L; Weitkamp, JH; Aliferis, CF; Statnikov, A				Lytkin, Nikita I.; McVoy, Lauren; Weitkamp, Joern-Hendrik; Aliferis, Constantin F.; Statnikov, Alexander			Expanding the Understanding of Biases in Development of Clinical-Grade Molecular Signatures: A Case Study in Acute Respiratory Viral Infections	PLOS ONE			English	Article							MARKOV BLANKET INDUCTION; FALSE DISCOVERY RATE; FEATURE-SELECTION; CAUSAL DISCOVERY; LOCAL CAUSAL; MICROARRAY; CANCER; PATTERNS; PITFALLS	Background: The promise of modern personalized medicine is to use molecular and clinical information to better diagnose, manage, and treat disease, on an individual patient basis. These functions are predominantly enabled by molecular signatures, which are computational models for predicting phenotypes and other responses of interest from high-throughput assay data. Data-analytics is a central component of molecular signature development and can jeopardize the entire process if conducted incorrectly. While exploratory data analysis may tolerate suboptimal protocols, clinical-grade molecular signatures are subject to vastly stricter requirements. Closing the gap between standards for exploratory versus clinically successful molecular signatures entails a thorough understanding of possible biases in the data analysis phase and developing strategies to avoid them. Methodology and Principal Findings: Using a recently introduced data-analytic protocol as a case study, we provide an in-depth examination of the poorly studied biases of the data-analytic protocols related to signature multiplicity, biomarker redundancy, data preprocessing, and validation of signature reproducibility. The methodology and results presented in this work are aimed at expanding the understanding of these data-analytic biases that affect development of clinically robust molecular signatures. Conclusions and Significance: Several recommendations follow from the current study. First, all molecular signatures of a phenotype should be extracted to the extent possible, in order to provide comprehensive and accurate grounds for understanding disease pathogenesis. Second, redundant genes should generally be removed from final signatures to facilitate reproducibility and decrease manufacturing costs. Third, data preprocessing procedures should be designed so as not to bias biomarker selection. Finally, molecular signatures developed and applied on different phenotypes and populations of patients should be treated with great caution.	[Lytkin, Nikita I.; Aliferis, Constantin F.; Statnikov, Alexander] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [McVoy, Lauren; Aliferis, Constantin F.] NYU, Sch Med, Dept Pathol, New York, NY USA; [Weitkamp, Joern-Hendrik] Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37212 USA; [Weitkamp, Joern-Hendrik] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Aliferis, Constantin F.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Statnikov, Alexander] NYU, Sch Med, Dept Med, New York, NY USA	New York University; New York University; Vanderbilt University; Vanderbilt University; Vanderbilt University; New York University	Lytkin, NI (corresponding author), NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA.	Alexander.Statnikov@med.nyu.edu	Weitkamp, Joern-Hendrik/AAZ-8272-2020	Weitkamp, Joern-Hendrik/0000-0002-6654-4823	Eunice Kennedy Shriver National Institute of Child Health and Human Development [K08HD061607]; National Center for Research Resources, National Institutes of Health [1UL1RR029893]; National Library of Medicine, National Institutes of Health [R56 LM007948-04A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD061607] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R56LM007948] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	JHW was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development grant K08HD061607. CFA and AS were supported in part by the grant 1UL1RR029893 from the National Center for Research Resources, National Institutes of Health. CFA was also supported in part by the grant R56 LM007948-04A1 from the National Library of Medicine, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; Aliferis CF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004922; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Anderson T.W, 2003, INTRO MULTIVARIATE S; Azuaje F, 2005, DATA ANALYSIS AND VISUALIZATION IN GENOMICS AND PROTEOMICS, P1, DOI 10.1002/0470094419; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Gonzalez FJ, 2006, ANNU REV PHARMACOL, V46, P41, DOI 10.1146/annurev.pharmtox.45.120403.100007; Guyon I, 2008, CH CRC DATA MIN KNOW, P63; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Janzing D., 2010, JMLR WORKSHOP C P, V6, P1; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Liu Z, 2004, CLIN IMMUNOL, V112, P225, DOI 10.1016/j.clim.2004.03.017; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Pearl J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Somorjai RL, 2003, BIOINFORMATICS, V19, P1484, DOI 10.1093/bioinformatics/btg182; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI 10.1200/JCO.2008.16.7528; Statnikov A., 2010, J MACHINE LEARNING R, V6, P249; Statnikov A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000958; Statnikov Alexander, 2010, BMC Res Notes, V3, P264, DOI 10.1186/1756-0500-3-264; Statnikov A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000790; Statnikov A, 2010, CELL HOST MICROBE, V7, P100, DOI 10.1016/j.chom.2010.01.003; Tsamardinos I., 2003, P 9 INT WORKSH ART I; Vapnik VN, 1998, STAT LEARNING THEORY; Zaas AK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000715; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	40	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20662	10.1371/journal.pone.0020662	http://dx.doi.org/10.1371/journal.pone.0020662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673802	Green Published, gold, Green Submitted			2022-12-25	WOS:000291309900027
J	Angel, R; Matthies, D; Conrad, R				Angel, Roey; Matthies, Diethart; Conrad, Ralf			Activation of Methanogenesis in Arid Biological Soil Crusts Despite the Presence of Oxygen	PLOS ONE			English	Article							CARBON-ISOTOPE FRACTIONATION; METHANOSARCINA-BARKERI; ANAEROBIC-BACTERIA; ARCHAEAL COMMUNITY; NEGEV DESERT; RICE; DIVERSITY; RESPONSES; SEDIMENT; EXPOSURE	Methanogenesis is traditionally thought to occur only in highly reduced, anoxic environments. Wetland and rice field soils are well known sources for atmospheric methane, while aerated soils are considered sinks. Although methanogens have been detected in low numbers in some aerated, and even in desert soils, it remains unclear whether they are active under natural oxic conditions, such as in biological soil crusts (BSCs) of arid regions. To answer this question we carried out a factorial experiment using microcosms under simulated natural conditions. The BSC on top of an arid soil was incubated under moist conditions in all possible combinations of flooding and drainage, light and dark, air and nitrogen headspace. In the light, oxygen was produced by photosynthesis. Methane production was detected in all microcosms, but rates were much lower when oxygen was present. In addition, the delta C-13 of the methane differed between the oxic/oxygenic and anoxic microcosms. While under anoxic conditions methane was mainly produced from acetate, it was almost entirely produced from H-2/CO2 under oxic/oxygenic conditions. Only two genera of methanogens were identified in the BSC-Methanosarcina and Methanocella; their abundance and activity in transcribing the mcrA gene (coding for methyl-CoM reductase) was higher under anoxic than oxic/oxygenic conditions, respectively. Both methanogens also actively transcribed the oxygen detoxifying gene catalase. Since methanotrophs were not detectable in the BSC, all the methane produced was released into the atmosphere. Our findings point to a formerly unknown participation of desert soils in the global methane cycle.	[Angel, Roey; Conrad, Ralf] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Matthies, Diethart] Univ Marburg, Dept Ecol, Marburg, Germany	Max Planck Society; Philipps University Marburg	Conrad, R (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	conrad@mpi-marburg.mpg.de	Angel, Roey/T-3597-2017	Angel, Roey/0000-0002-2804-9661; Matthies, Diethart/0000-0003-2439-0501	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank Prof. Peter Frenzel of the Max-Planck-Institute for Terrestrial Microbiology in Marburg, Germany for his help in designing the microcosms and Horst Henseling for constructing them; Dr. Osnat Gillor of Ben Gurion University of the Negev, Israel for her assistance in the soil sampling; The Institute for Soil Science and Forest Nutrition (IBW) at the University of Gottingen, Germany for determining the isotopic signature of the soil organic carbon. RA was supported by a fellowship of the Max Planck Society.	Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Angel R, 2009, ENVIRON MICROBIOL, V11, P2598, DOI 10.1111/j.1462-2920.2009.01984.x; Banning N, 2005, ENVIRON MICROBIOL, V7, P947, DOI 10.1111/j.1462-2920.2004.00766.x; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Brioukhanov AL, 2006, MICROBIOL-SGM, V152, P1671, DOI 10.1099/mic.0.28542-0; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2009, LIMNOL OCEANOGR, V54, P457, DOI 10.4319/lo.2009.54.2.0457; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Erkel C, 2006, SCIENCE, V313, P370, DOI 10.1126/science.1127062; FETZER S, 1993, FEMS MICROBIOL ECOL, V12, P107; Garcia-Pichel F, 2002, ENCY ENV MICROBIOLOG; GarciaPichel F, 1996, J PHYCOL, V32, P774, DOI 10.1111/j.0022-3646.1996.00774.x; GELWICKS JT, 1994, APPL ENVIRON MICROB, V60, P467, DOI 10.1128/AEM.60.2.467-472.1994; Goevert D, 2009, APPL ENVIRON MICROB, V75, P2605, DOI 10.1128/AEM.02680-08; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P4552, DOI 10.1128/AEM.63.11.4552-4557.1997; JEFFRIES DL, 1993, NEW PHYTOL, V125, P163, DOI 10.1111/j.1469-8137.1993.tb03874.x; KRZYCKI JA, 1987, APPL ENVIRON MICROB, V53, P2597, DOI 10.1128/AEM.53.10.2597-2599.1987; LANGE OL, 1992, FUNCT ECOL, V6, P519, DOI 10.2307/2390048; LANGE OL, 1994, FUNCT ECOL, V8, P253, DOI 10.2307/2389909; Liu CT, 2008, CURR MICROBIOL, V56, P214, DOI 10.1007/s00284-007-9059-7; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lueders T, 2001, ENVIRON MICROBIOL, V3, P194, DOI 10.1046/j.1462-2920.2001.00179.x; Murase J, 2007, ENVIRON MICROBIOL, V9, P3025, DOI 10.1111/j.1462-2920.2007.01414.x; Nisbet EG, 1999, P ROY SOC B-BIOL SCI, V266, P2375, DOI 10.1098/rspb.1999.0934; Oremland R.S., 1988, BIOL ANAEROBIC MICRO; PETERS V, 1995, APPL ENVIRON MICROB, V61, P1673, DOI 10.1128/AEM.61.4.1673-1676.1995; Ramakrishnan B, 2001, FEMS MICROBIOL ECOL, V37, P175, DOI 10.1111/j.1574-6941.2001.tb00865.x; SAKAI S, 2010, INT J SYST EVOL MICR; SCHONHEIT P, 1981, FEMS MICROBIOL LETT, V12, P347, DOI 10.1016/0378-1097(81)90216-0; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; VERSTRAETE MM, 1991, VEGETATIO, V91, P3, DOI 10.1007/BF00036043; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Wilske B, 2008, BIOGEOSCIENCES, V5, P1411, DOI 10.5194/bg-5-1411-2008; Yuan YL, 2009, ENV MICROBIOL REP, V1, P347, DOI 10.1111/j.1758-2229.2009.00036.x; Zaady E, 2010, SEDIMENTOLOGY, V57, P351, DOI 10.1111/j.1365-3091.2009.01081.x; Zehnder AJB, 1988, BIOL ANAEROBIC MICRO, P1; Zhang WW, 2006, J IND MICROBIOL BIOT, V33, P784, DOI 10.1007/s10295-006-0114-3; Zinder Stephen H., 1993, P128	45	159	168	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20453	10.1371/journal.pone.0020453	http://dx.doi.org/10.1371/journal.pone.0020453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655270	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600072
J	Deleidi, M; Cooper, O; Hargus, G; Levy, A; Isacson, O				Deleidi, Michela; Cooper, Oliver; Hargus, Gunnar; Levy, Adam; Isacson, Ole			Oct4-Induced Reprogramming Is Required for Adult Brain Neural Stem Cell Differentiation into Midbrain Dopaminergic Neurons	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; PARKINSONS-DISEASE; PROGENITOR CELLS; MAMMALIAN BRAIN; IN-VITRO; EPIGENETIC REGULATION; NEUROTROPHIC FACTOR; GENE-EXPRESSION; RAT MODEL; FATE	Neural stem cells (NSCs) lose their competency to generate region-specific neuronal populations at an early stage during embryonic brain development. Here we investigated whether epigenetic modifications can reverse the regional restriction of mouse adult brain subventricular zone (SVZ) NSCs. Using a variety of chemicals that interfere with DNA methylation and histone acetylation, we showed that such epigenetic modifications increased neuronal differentiation but did not enable specific regional patterning, such as midbrain dopaminergic (DA) neuron generation. Only after Oct-4 overexpression did adult NSCs acquire a pluripotent state that allowed differentiation into midbrain DA neurons. DA neurons derived from Oct4-reprogrammed NSCs improved behavioural motor deficits in a rat model of Parkinson's disease (PD) upon intrastriatal transplantation. Here we report for the first time the successful differentiation of SVZ adult NSCs into functional region-specific midbrain DA neurons, by means of Oct-4 induced pluripotency.	[Deleidi, Michela; Cooper, Oliver; Hargus, Gunnar; Levy, Adam; Isacson, Ole] Harvard Univ, McLean Hosp, Sch Med, Ctr Neuroregenerat Res, Belmont, MA 02178 USA; [Deleidi, Michela; Cooper, Oliver; Hargus, Gunnar; Levy, Adam; Isacson, Ole] Harvard Univ, Sch Med, Udall Parkinsons Dis Res Ctr Excellence, Boston, MA USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Deleidi, M (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Ctr Neuroregenerat Res, Belmont, MA 02178 USA.	ole_isacson@hms.harvard.edu		Deleidi, Michela/0000-0003-0357-0124; Cooper, Oliver/0000-0001-6567-7491; /0000-0003-2460-5090; Isacson, Ole/0000-0001-8091-8302	Udall Parkinson's Disease Center of Excellence [P50 NS39793]; Michael Stern Foundation [WX81XWH-05-1-0555]; Orchard Foundation; Poul Hansen Family; Consolidated Anti-Aging Foundation; Harold and Ronna Cooper Family; Deutsche Forschungsgemeinschaft [HA5589/1-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER	Udall Parkinson's Disease Center of Excellence; Michael Stern Foundation; Orchard Foundation; Poul Hansen Family; Consolidated Anti-Aging Foundation; Harold and Ronna Cooper Family; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants to O.I. from the Udall Parkinson's Disease Center of Excellence Grant P50 NS39793, Michael Stern Foundation (WX81XWH-05-1-0555), Orchard Foundation, Poul Hansen Family, the Consolidated Anti-Aging Foundation and the Harold and Ronna Cooper Family, postdoctoral fellowship HA5589/1-1 from the Deutsche Forschungsgemeinschaft (to G. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bithell A, 2008, STEM CELLS, V26, P1565, DOI 10.1634/stemcells.2007-0832; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Cooper O, 2004, J NEUROSCI, V24, P8924, DOI 10.1523/JNEUROSCI.2344-04.2004; Daadi MM, 1999, J NEUROSCI, V19, P4484; de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080; Di Stefano B, 2009, STEM CELLS DEV, V18, P707, DOI 10.1089/scd.2008.0180; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hitoshi S, 2004, GENE DEV, V18, P1806, DOI 10.1101/gad.1208404; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Isacson O, 2003, ANN NEUROL, V53, pS135, DOI 10.1002/ana.10482; Jain M, 2003, EXP NEUROL, V182, P113, DOI 10.1016/S0014-4886(03)00055-4; Jin KL, 2005, P NATL ACAD SCI USA, V102, P18189, DOI 10.1073/pnas.0506375102; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kim JB, 2008, NATURE; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kohyama J, 2008, P NATL ACAD SCI USA, V105, P18012, DOI 10.1073/pnas.0808417105; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lunyak VV, 2008, HUM MOL GENET, V17, pR28, DOI 10.1093/hmg/ddn149; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Papanikolaou T, 2008, STEM CELLS DEV, V17, P157, DOI 10.1089/scd.2007.0090; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192	47	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19926	10.1371/journal.pone.0019926	http://dx.doi.org/10.1371/journal.pone.0019926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655272	Green Published, gold			2022-12-25	WOS:000291097600011
J	Pantazopoulos, H; Dolatshad, H; Davis, FC				Pantazopoulos, Harry; Dolatshad, Hamid; Davis, Fred C.			A Fear-Inducing Odor Alters PER2 and c-Fos Expression in Brain Regions Involved in Fear Memory	PLOS ONE			English	Article							INTRINSIC CIRCADIAN CLOCK; ACCESSORY BASAL NUCLEI; HIPPOCAMPAL-FORMATION; BASOLATERAL AMYGDALA; RHYTHMIC EXPRESSION; GENE-EXPRESSION; RAT; FOOD; PROTEIN; RECONSOLIDATION	Evidence demonstrates that rodents learn to associate a foot shock with time of day, indicating the formation of a fear related time-stamp memory, even in the absence of a functioning SCN. In addition, mice acquire and retain fear memory better during the early day compared to the early night. This type of memory may be regulated by circadian pacemakers outside of the SCN. As a first step in testing the hypothesis that clock genes are involved in the formation of a time-stamp fear memory, we exposed one group of mice to fox feces derived odor (TMT) at ZT 0 and one group at ZT 12 for 4 successive days. A separate group with no exposure to TMT was also included as a control. Animals were sacrificed one day after the last exposure to TMT, and PER2 and c-Fos protein were quantified in the SCN, amygdala, hippocampus, and piriform cortex. Exposure to TMT had a strong effect at ZT 0, decreasing PER2 expression at this time point in most regions except the SCN, and reversing the normal rhythm of PER2 expression in the amygdala and piriform cortex. These changes were accompanied by increased c-Fos expression at ZT0. In contrast, exposure to TMT at ZT 12 abolished the rhythm of PER2 expression in the amygdala. In addition, increased c-Fos expression at ZT 12 was only detected in the central nucleus of the amygdala in the TMT12 group. TMT exposure at either time point did not affect PER2 or c-Fos in the SCN, indicating that under a light-dark cycle, the SCN rhythm is stable in the presence of repeated exposure to a fear-inducing stimulus. Taken together, these results indicate that entrainment to a fear-inducing stimulus leads to changes in PER2 and c-Fos expression that are detected 24 hours following the last exposure to TMT, indicating entrainment of endogenous oscillators in these regions. The observed effects on PER2 expression and c-Fos were stronger during the early day than during the early night, possibly to prepare appropriate systems at ZT 0 to respond to a fear-inducing stimulus.	[Pantazopoulos, Harry; Dolatshad, Hamid; Davis, Fred C.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA; [Pantazopoulos, Harry] McLean Hosp, Lab Translat Neurosci, Belmont, MA 02178 USA; [Pantazopoulos, Harry] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Northeastern University; Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Pantazopoulos, H (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	hantazo@mclean.harvard.edu	Pantazopoulos, Harry/M-1435-2016	Pantazopoulos, Harry/0000-0002-0540-1589; Dolatshad, Hamid/0000-0002-4724-1720; Pantazopoulos, Harry/0000-0002-8905-8377	NIH [R01MH06879601]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by NIH Grant R01MH06879601 to Fred C. Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2009, BIOL PSYCHIAT, V65, P829, DOI 10.1016/j.biopsych.2008.12.019; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bando H, 2007, J NEUROSCI, V27, P4359, DOI 10.1523/JNEUROSCI.4131-06.2007; BELING INGEBORG, 1929, ZEITSCHR VERGLEICH PHYSIOL, V9, P259, DOI 10.1007/BF00340159; Benes FM, 2000, ANN NY ACAD SCI, V911, P293; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Buron G, 2007, BEHAV NEUROSCI, V121, P1063, DOI 10.1037/0735-7044.121.5.1063; Cain SW, 2008, NEUROBIOL LEARN MEM, V89, P591, DOI 10.1016/j.nlm.2007.07.011; Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Cain SW, 2004, BEHAV BRAIN RES, V150, P201, DOI 10.1016/j.bbr.2003.07.001; CAMPEAU S, 1991, BRAIN RES, V565, P349, DOI 10.1016/0006-8993(91)91669-R; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Debiec J, 2006, P NATL ACAD SCI USA, V103, P3428, DOI 10.1073/pnas.0507168103; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Debiec J, 2010, NAT NEUROSCI, V13, P536, DOI 10.1038/nn.2520; Desgranges B, 2008, BRAIN RES, V1236, P166, DOI 10.1016/j.brainres.2008.07.123; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Endres T, 2009, J EXP BIOL, V212, P2324, DOI 10.1242/jeb.028498; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Frigato E, 2009, BIOCHEM BIOPH RES CO, V378, P108, DOI 10.1016/j.bbrc.2008.11.006; Fuller PM, 2008, SCIENCE, V320, P1074, DOI 10.1126/science.1153277; Funk D, 2000, BRAIN RES, V866, P262, DOI 10.1016/S0006-8993(00)02249-6; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Geyfman M, 2009, J INVEST DERMATOL, V129, P1063, DOI 10.1038/jid.2008.384; Gibbs JE, 2009, ENDOCRINOLOGY, V150, P268, DOI 10.1210/en.2008-0638; Gottfried JA, 2010, NAT REV NEUROSCI, V11, P628, DOI 10.1038/nrn2883; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Holahan MR, 2004, BEHAV BRAIN RES, V152, P109, DOI 10.1016/j.bbr.2003.09.031; Howard JD, 2009, NAT NEUROSCI, V12, P932, DOI 10.1038/nn.2324; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; Kajiwara R, 2007, EUR J NEUROSCI, V25, P3648, DOI 10.1111/j.1460-9568.2007.05610.x; King JA, 2005, PSYCHONEUROENDOCRINO, V30, P333, DOI 10.1016/j.psyneuen.2004.09.005; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kudo T, 2011, J NEUROSCI, V31, P2746, DOI 10.1523/JNEUROSCI.5792-10.2011; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leibetseder V, 2009, CHRONOBIOL INT, V26, P621, DOI 10.1080/07420520902924939; Li W, 2010, BRAIN, V133, P2714, DOI 10.1093/brain/awq209; Li ZX, 2007, BIOCHEM BIOPH RES CO, V359, P491, DOI 10.1016/j.bbrc.2007.05.156; Loh DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012546; LUSKIN MB, 1983, J COMP NEUROL, V216, P264, DOI 10.1002/cne.902160305; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Miller JP, 2005, NEUROBIOL AGING, V26, P1107, DOI 10.1016/j.neurobiolaging.2004.08.008; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Nathan SV, 2004, ANN NY ACAD SCI, V1032, P179, DOI 10.1196/annals.1314.015; O'Brien J, 2007, HIPPOCAMPUS, V17, P1149, DOI 10.1002/hipo.20346; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; OTTERSEN OP, 1982, J COMP NEUROL, V205, P30, DOI 10.1002/cne.902050104; Pagani JH, 2009, BRAIN RES, V1286, P133, DOI 10.1016/j.brainres.2009.06.062; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Pitkanen A, 2002, HIPPOCAMPUS, V12, P186, DOI 10.1002/hipo.1099; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Roozendaal B, 1997, EUR J NEUROSCI, V9, P76, DOI 10.1111/j.1460-9568.1997.tb01355.x; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Carneiro BTS, 2009, CHRONOBIOL INT, V26, P1273, DOI 10.3109/07420520903404480; Segall LA, 2006, NEUROSCIENCE, V140, P753, DOI 10.1016/j.neuroscience.2006.03.037; Segall LA, 2009, NEUROSCI LETT, V457, P58, DOI 10.1016/j.neulet.2009.03.083; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SHERMAN H, J CELL MOL MED; Sothern RB, 2009, CLIN TER, V160, pE25; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sumova A, 1998, BRAIN RES, V801, P254, DOI 10.1016/S0006-8993(98)00619-2; SUZUKI N, CEREB CORTEX; Thompson BL, 2004, BEHAV BRAIN RES, V149, P209, DOI 10.1016/S0166-4328(03)00216-X; Verwey M, 2007, NEUROSCIENCE, V147, P277, DOI 10.1016/j.neuroscience.2007.04.044; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wallace KJ, 2000, BEHAV NEUROSCI, V114, P912, DOI 10.1037//0735-7044.114.5.912; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020	83	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20658	10.1371/journal.pone.0020658	http://dx.doi.org/10.1371/journal.pone.0020658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655193	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600118
J	Qi, M; Wang, P; O'Toole, N; Barboza, PS; Ungerfeld, E; Leigh, MB; Selinger, LB; Butler, G; Tsang, A; McAllister, TA; Forster, RJ				Qi, Meng; Wang, Pan; O'Toole, Nicholas; Barboza, Perry S.; Ungerfeld, Emilio; Leigh, Mary Beth; Selinger, L. Brent; Butler, Greg; Tsang, Adrian; McAllister, Tim A.; Forster, Robert J.			Snapshot of the Eukaryotic Gene Expression in Muskoxen Rumen-A Metatranscriptomic Approach	PLOS ONE			English	Article							POLYPLASTRON-MULTIVESICULATUM; SEQUENCE SIMILARITY; DEGRADING ENZYMES; RNA GENES; BACTERIAL; DIVERSITY; INSIGHTS; FERMENTATION; RUMINICOLA; HYDROLASES	Background: Herbivores rely on digestive tract lignocellulolytic microorganisms, including bacteria, fungi and protozoa, to derive energy and carbon from plant cell wall polysaccharides. Culture independent metagenomic studies have been used to reveal the genetic content of the bacterial species within gut microbiomes. However, the nature of the genes encoded by eukaryotic protozoa and fungi within these environments has not been explored using metagenomic or metatranscriptomic approaches. Methodology/Principal Findings: In this study, a metatranscriptomic approach was used to investigate the functional diversity of the eukaryotic microorganisms within the rumen of muskoxen (Ovibos moschatus), with a focus on plant cell wall degrading enzymes. Polyadenylated RNA (mRNA) was sequenced on the Illumina Genome Analyzer II system and 2.8 gigabases of sequences were obtained and 59129 contigs assembled. Plant cell wall degrading enzyme modules including glycoside hydrolases, carbohydrate esterases and polysaccharide lyases were identified from over 2500 contigs. These included a number of glycoside hydrolase family 6 (GH6), GH48 and swollenin modules, which have rarely been described in previous gut metagenomic studies. Conclusions/Significance: The muskoxen rumen metatranscriptome demonstrates a much higher percentage of cellulase enzyme discovery and an 8.7x higher rate of total carbohydrate active enzyme discovery per gigabase of sequence than previous rumen metagenomes. This study provides a snapshot of eukaryotic gene expression in the muskoxen rumen, and identifies a number of candidate genes coding for potentially valuable lignocellulolytic enzymes.	[Qi, Meng; Wang, Pan; Ungerfeld, Emilio; McAllister, Tim A.; Forster, Robert J.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Wang, Pan; Selinger, L. Brent] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [O'Toole, Nicholas; Butler, Greg; Tsang, Adrian] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ, Canada; [Barboza, Perry S.; Leigh, Mary Beth] Univ Alaska, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK 99775 USA	Agriculture & Agri Food Canada; University of Lethbridge; Concordia University - Canada; University of Alaska System; University of Alaska Fairbanks	Qi, M (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	Robert.Forster@agr.gc.ca	Ungerfeld, Emilio/AAB-2460-2019; Forster, Robert J/J-4408-2012; McAllister, Tim A./R-9201-2017	Ungerfeld, Emilio/0000-0002-5422-5462; Forster, Robert J/0000-0002-0562-8628; O'Toole, Nicholas/0000-0001-5245-7393; Selinger, Leonard/0000-0001-8205-8334; McAllister, Tim A./0000-0002-8266-6513	Canadian Triticale Biorefinery Initiative; Alberta Innovates Bio Solutions; Genome Canada; Genome Quebec; Genome Alberta; Cellulosic Biofuel Network of Agriculture and Agri-Food Canada	Canadian Triticale Biorefinery Initiative; Alberta Innovates Bio Solutions; Genome Canada(Genome Canada); Genome Quebec; Genome Alberta; Cellulosic Biofuel Network of Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This work was supported by the Canadian Triticale Biorefinery Initiative (http://www.ctbi.ca/) and Cellulosic Biofuel Network of the Agricultural Bioproducts Innovation Program of Agriculture and Agri-Food Canada, Alberta Innovates Bio Solutions (http://www.albertainnovates.ca), Genome Canada (http:// www.genomecanada.ca/), Genome Quebec (http://www.genomequebec.com/v2009/home/), and Genome Alberta (http://www.genomealberta.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; Barboza PS, 2006, PHYSIOL BIOCHEM ZOOL, V79, P497, DOI 10.1086/501058; Bera-Maillet C, 2005, FEMS MICROBIOL LETT, V244, P149, DOI 10.1016/j.femsle.2005.01.035; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cai SC, 2010, APPL ENVIRON MICROB, V76, P3818, DOI 10.1128/AEM.03124-09; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Crater AR, 2007, COMP BIOCHEM PHYS A, V146, P233, DOI 10.1016/j.cbpa.2006.10.019; Devillard E, 1999, FEMS MICROBIOL LETT, V181, P145, DOI 10.1111/j.1574-6968.1999.tb08837.x; Eddy Sean R, 2009, Genome Inform, V23, P205; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 1997, TRENDS MICROBIOL, V5, P483, DOI 10.1016/S0966-842X(97)01159-1; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gloster TM, 2007, J BIOL CHEM, V282, P19177, DOI 10.1074/jbc.M700224200; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; HUNGATE RE, 1964, ANNU REV MICROBIOL, V18, P131, DOI 10.1146/annurev.mi.18.100164.001023; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Liggenstoffer AS, 2010, ISME J, V4, P1225, DOI 10.1038/ismej.2010.49; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MCALLISTER TA, 1994, J ANIM SCI, V72, P3004, DOI 10.2527/1994.72113004x; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Morrison M, 2010, MICROB ECOL, V59, P212, DOI 10.1007/s00248-009-9562-4; Nagy T, 2007, J MOL BIOL, V373, P612, DOI 10.1016/j.jmb.2007.08.007; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Nicholson MJ, 2005, MICROBIOL-SGM, V151, P121, DOI 10.1099/mic.0.27353-0; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Orpin C., 1997, RUMEN MICROBIAL ECOS, P140, DOI [10.1016/0378-1097(87)90045-0, DOI 10.1007/978-94-009-1453-7-4, DOI 10.1016/0378-1097(87)90045-0]; Orpin C. G., 1988, The rumen microbial ecosystem., P129; ORPIN CG, 1975, J GEN MICROBIOL, V91, P249, DOI 10.1099/00221287-91-2-249; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Qi M, 2005, J BACTERIOL, V187, P3739, DOI 10.1128/JB.187.11.3739-3751.2005; Rezaeian M, 2004, MYCOL RES, V108, P1227, DOI 10.1017/S0953756204000929; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Steenbakkers PJM, 2001, J BACTERIOL, V183, P5325, DOI 10.1128/JB.183.18.5325-5333.2001; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; WANG P, 2011, CAN J MICRO IN PRESS; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Williams A.G., 1997, RUMEN MICROBIAL ECOS, P73, DOI DOI 10.1007/978-94-009-1453-7_3; WILLIAMS AG, 1984, CAN J ANIM SCI, V64, P58, DOI 10.4141/cjas84-156; WILLIAMS AG, 1986, MICROBIOL REV, V50, P25, DOI 10.1128/MMBR.50.1.25-49.1986; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Yaoi K, 2007, J MOL BIOL, V370, P53, DOI 10.1016/j.jmb.2007.04.035; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003	63	95	100	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20521	10.1371/journal.pone.0020521	http://dx.doi.org/10.1371/journal.pone.0020521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655220	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000291097600086
J	Samadi, N; Bekele, RT; Goping, IS; Schang, LM; Brindley, DN				Samadi, Nasser; Bekele, Raie T.; Goping, Ing Swie; Schang, Luis M.; Brindley, David N.			Lysophosphatidate Induces Chemo-Resistance by Releasing Breast Cancer Cells from Taxol-Induced Mitotic Arrest	PLOS ONE			English	Article							LIPID PHOSPHATE PHOSPHATASE-1; SPHINGOSINE 1-PHOSPHATE; MICROTUBULE ALTERATIONS; AUTOTAXIN NPP-2; OVARIAN-CANCER; S-PHASE; ACID; APOPTOSIS; PACLITAXEL; INHIBITOR	Background: Taxol is a microtubule stabilizing agent that arrests cells in mitosis leading to cell death. Taxol is widely used to treat breast cancer, but resistance occurs in 25-69% of patients and it is vital to understand how Taxol resistance develops to improve chemotherapy. The effects of chemotherapeutic agents are overcome by survival signals that cancer cells receive. We focused our studies on autotaxin, which is a secreted protein that increases tumor growth, aggressiveness, angiogenesis and metastasis. We discovered that autotaxin strongly antagonizes the Taxol-induced killing of breast cancer and melanoma cells by converting the abundant extra-cellular lipid, lysophosphatidylcholine, into lysophosphatidate. This lipid stimulates specific G-protein coupled receptors that activate survival signals. Methodology/Principal Findings: In this study we determined the basis of these antagonistic actions of lysophosphatidate towards Taxol-induced G2/M arrest and cell death using cultured breast cancer cells. Lysophosphatidate does not antagonize Taxol action in MCF-7 cells by increasing Taxol metabolism or its expulsion through multi-drug resistance transporters. Lysophosphatidate does not lower the percentage of cells accumulating in G2/M by decreasing exit from S-phase or selective stimulation of cell death in G2/M. Instead, LPA had an unexpected and remarkable action in enabling MCF-7 and MDA-MB-468 cells, which had been arrested in G2/M by Taxol, to normalize spindle structure and divide, thus avoiding cell death. This action involves displacement of Taxol from the tubulin polymer fraction, which based on inhibitor studies, depends on activation of LPA receptors and phosphatidylinositol 3-kinase. Conclusions/Significance: This work demonstrates a previously unknown consequence of lysophosphatidate action that explains why autotaxin and lysophosphatidate protect against Taxol-induced cell death and promote resistance to the action of this important therapeutic agent.	[Samadi, Nasser; Bekele, Raie T.; Goping, Ing Swie; Schang, Luis M.; Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Sch Mol & Syst Med, Edmonton, AB, Canada	University of Alberta	Samadi, N (corresponding author), Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Sch Mol & Syst Med, Edmonton, AB, Canada.	david.brindley@ualberta.ca	Schang, Luis/F-9576-2012	samadi, nasser/0000-0001-7960-6432; Schang, Luis Maria/0000-0002-5789-8590	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by the Canadian Institutes of Health Research. This agency had no role in the study design, data collection and analysis, decision to publish, provided the original author and source are credited.	Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Bergstralh DT, 2006, CANCER TREAT REV, V32, P166, DOI 10.1016/j.ctrv.2006.01.004; Blajeski AL, 2001, EXP CELL RES, V270, P277, DOI 10.1006/excr.2001.5349; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Cheng H, 2009, J CLIN ONCOL, V27; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Federico L, 2008, CURR DRUG TARGETS, V9, P698, DOI 10.2174/138945008785132439; Fujino H, 2001, J CHROMATOGR B, V757, P143, DOI 10.1016/S0378-4347(01)00141-4; Gaetano CG, 2009, MOL CARCINOGEN, V48, P801, DOI 10.1002/mc.20524; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; GOMEZMUNOZ A, 1995, J BIOL CHEM, V270, P26318, DOI 10.1074/jbc.270.44.26318; Guo BQ, 2004, BREAST CANCER RES TR, V85, P31, DOI 10.1023/B:BREA.0000021046.29834.12; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hembruff SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-318; Imai A, 2000, J CLIN ENDOCR METAB, V85, P3370, DOI 10.1210/jc.85.9.3370; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; JI C, 2010, ONCOGENE; Kavallaris M, 2001, CANCER RES, V61, P5803; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Krajewski S, 1999, ENDOCR-RELAT CANCER, V6, P29, DOI 10.1677/erc.0.0060029; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Liang Y, 2001, ONCOGENE, V20, P6570, DOI 10.1038/sj.onc.1204815; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Lin SB, 2009, GASTROENTEROLOGY, V136, P1711, DOI 10.1053/j.gastro.2009.01.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Marchetti P, 2002, CRIT REV ONCOL HEMAT, V44, pS3; Martin A, 1997, ONCOGENE, V14, P1571, DOI 10.1038/sj.onc.1200987; Martinez R, 2009, TOXICOL LETT, V190, P86, DOI 10.1016/j.toxlet.2009.07.010; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Mickley L, 2001, MAMM GENOME, V12, P86, DOI 10.1007/s003350010237; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Montenarh M, 2010, CELL TISSUE RES, V342, P139, DOI 10.1007/s00441-010-1068-3; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Morris KE, 2006, J BIOL CHEM, V281, P9297, DOI 10.1074/jbc.M511710200; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nam SW, 2000, ONCOGENE, V19, P241, DOI 10.1038/sj.onc.1203263; Nam SW, 2001, CANCER RES, V61, P6938; Okudaira S, 2010, BIOCHIMIE, V92, P698, DOI 10.1016/j.biochi.2010.04.015; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Samadi N, 2009, ONCOGENE, V28, P1028, DOI 10.1038/onc.2008.442; SAMADI N, 2010, BIOCHIMIE; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; Singh R, 2001, CARCINOGENESIS, V22, P1863, DOI 10.1093/carcin/22.11.1863; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tanyi JL, 2003, CLIN CANCER RES, V9, P3534; Tanyi JL, 2003, CANCER RES, V63, P1073; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Terry NHA, 2006, NAT PROTOC, V1, P859, DOI 10.1038/nprot.2006.113; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Vidot S, 2010, CELL SIGNAL, V22, P926, DOI 10.1016/j.cellsig.2010.01.017; Yamane K, 2005, CLIN CANCER RES, V11, P2355, DOI 10.1158/1078-0432.CCR-04-1734; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196	60	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20608	10.1371/journal.pone.0020608	http://dx.doi.org/10.1371/journal.pone.0020608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647386	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500069
J	Shaye, DD; Greenwald, I				Shaye, Daniel D.; Greenwald, Iva			OrthoList: A Compendium of C. elegans Genes with Human Orthologs	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SYSTEMATIC ANALYSIS; IDENTIFICATION; SIGNAL; EVOLUTION; PATHWAY; INTERFERENCE; LIN-12/NOTCH; RECEPTORS; NEMATODES	Background: C. elegans is an important model for genetic studies relevant to human biology and disease. We sought to assess the orthology between C. elegans and human genes to understand better the relationship between their genomes and to generate a compelling list of candidates to streamline RNAi-based screens in this model. Results: We performed a meta-analysis of results from four orthology prediction programs and generated a compendium, "OrthoList", containing 7,663 C. elegans protein-coding genes. Various assessments indicate that OrthoList has extensive coverage with low false-positive and false-negative rates. Part of this evaluation examined the conservation of components of the receptor tyrosine kinase, Notch, Wnt, TGF-beta and insulin signaling pathways, and led us to update compendia of conserved C. elegans kinases, nuclear hormone receptors, F-box proteins, and transcription factors. Comparison with two published genome-wide RNAi screens indicated that virtually all of the conserved hits would have been obtained had just the OrthoList set (similar to 38% of the genome) been targeted. We compiled Ortholist by InterPro domains and Gene Ontology annotation, making it easy to identify C. elegans orthologs of human disease genes for potential functional analysis. Conclusions: We anticipate that OrthoList will be of considerable utility to C. elegans researchers for streamlining RNAi screens, by focusing on genes with apparent human orthologs, thus reducing screening effort by similar to 60%. Moreover, we find that OrthoList provides a useful basis for annotating orthology and reveals more C. elegans orthologs of human genes in various functional groups, such as transcription factors, than previously described.	[Shaye, Daniel D.; Greenwald, Iva] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10027 USA; [Greenwald, Iva] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY USA; [Greenwald, Iva] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Shaye, DD (corresponding author), Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10027 USA.	ds451@columbia.edu; isg4@columbia.edu	Shaye, Daniel/AAY-5351-2020	Shaye, Daniel/0000-0002-3962-6903	Howard Hughes Medical Institute; National Institutes of Health [CA09538]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Howard Hughes Medical Institute and also supported by National Institutes of Health grant CA09538 to IG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antebi Adam, 2006, WormBook, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; CESC, 1998, SCIENCE, V282, P2012; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chen N, 2004, DEV CELL, V6, P183, DOI 10.1016/S1534-5807(04)00021-8; Eisenmann David M, 2005, WormBook, P1, DOI 10.1895/wormbook.1.7.1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; GERSTEIN MB, 2010, SCIENCE; GREENWALD I, 2005, WORMBOOK, DOI DOI 10.1895/WORMBOOK; Hardin J, 2008, CURR OPIN GENET DEV, V18, P362, DOI 10.1016/j.gde.2008.06.006; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hu Patrick J, 2007, WormBook, P1; Hueber SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010820; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jarriault S, 2002, GENE DEV, V16, P2713, DOI 10.1101/gad.1022402; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Manning Gerard, 2005, WormBook, P1; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Merrihew GE, 2008, GENOME RES, V18, P1660, DOI 10.1101/gr.077644.108; Myers TR, 2007, P NATL ACAD SCI USA, V104, P20368, DOI 10.1073/pnas.0709989104; Newfeld SJ, 1999, GENETICS, V152, P783; Oosterveen T, 2007, DEV BIOL, V308, P438, DOI 10.1016/j.ydbio.2007.05.043; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Savage-Dunn Cathy, 2005, WormBook, P1; Schwarz Erich M, 2005, WormBook, P1; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Sonnhammer ELL, 1997, GENOMICS, V46, P200, DOI 10.1006/geno.1997.4989; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Sundaram Meera V, 2006, WormBook, P1; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thomas JH, 2006, GENOME RES, V16, P1017, DOI 10.1101/gr.5089806; Thomas James H., 2008, Briefings in Functional Genomics & Proteomics, V7, P211, DOI 10.1093/bfgp/eln022; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Van Auken K, 2002, DEVELOPMENT, V129, P5255; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031	57	270	5536	1	245	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20085	10.1371/journal.pone.0020085	http://dx.doi.org/10.1371/journal.pone.0020085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647448	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500024
J	Chandra, A; Srivastava, RK; Kashyap, MP; Kumar, R; Srivastava, RN; Pant, AB				Chandra, Abhijit; Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap; Kumar, Raj; Srivastava, Rajeshwar Nath; Pant, Aditya Bhushan			The Anti-Inflammatory and Antibacterial Basis of Human Omental Defense: Selective Expression of Cytokines and Antimicrobial Peptides	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE; MESSENGER-RNA; RELEASE; IL-8; ADIPOCYTES; ADIPOKINES; MECHANISM; INFECTION; PATHWAYS	Background: The wound healing properties of the human omentum are well known and have extensively been exploited clinically. However, the underlying mechanisms of these effects are not well understood. We hypothesize that the omentum tissue promotes wound healing via modulation of anti-inflammatory pathways, and because the omentum is rich in adipocytes, the adipocytes may modulate the anti-inflammatory response. Factors released by human omentum may affect healing, inflammation and immune defense. Methodology: Six human omentum tissues (non obese, free from malignancy, and any other systemic disorder) were obtained during diagnostic laparoscopies having a negative outcome. Healthy oral mucosa (obtained from routine oral biopsies) was used as control. Cultured adipocytes derived from human omentum were exposed to lipopolysaccharide (LPS) (1-50 ng/mL) for 12-72 hours to identify the non-cytotoxic doses. Levels of expression (mRNA and protein) were carried out for genes associated with pro-and anti-inflammatory cytokine responses and antibacterial/antimicrobial activity using qRT-PCR, western blotting, and cell-based ELISA assays. Results: The study shows significant higher levels of expression (mRNA and protein) of several specific cytokines, and antibacterial peptides in the omentum tissues when compared to oral sub-mucosal tissues. In the validation studies, primary cultures of adipocytes, derived from human omentum were exposed to LPS (5 and 10 ng/mL) for 24 and 48 h. The altered expressions were more pronounced in cultured adipocytes cells when exposed to LPS as compared to the omentum tissue. Conclusions/Significance: Perhaps, this is the first report that provides evidence of expressional changes in pro-and anti-inflammatory cytokines and antibacterial peptides in the normal human omentum tissue as well as adipocytes cultured from this tissue. The study provides new insights on the molecular and cellular mechanisms of healing and defense by the omentum, and suggests the potential applicability of cultured adipocytes derived from the omentum for future therapeutic applications.	[Chandra, Abhijit] CSM Med Univ, Dept Surg Gastroenterol, Erstwhile KG Med Coll, Lucknow, Uttar Pradesh, India; [Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap; Pant, Aditya Bhushan] Indian Inst Toxicol Res, Lucknow, Uttar Pradesh, India; [Srivastava, Ritesh Kumar; Kashyap, Mahendra Pratap] CSIR, New Delhi, India; [Kumar, Raj] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA; [Srivastava, Rajeshwar Nath] CSM Med Univ, Dept Orthopaed Surg, Erstwhile KG Med Coll, Lucknow, Uttar Pradesh, India	King George's Medical University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; Geisinger Commonwealth School of Medicine; King George's Medical University	Chandra, A (corresponding author), CSM Med Univ, Dept Surg Gastroenterol, Erstwhile KG Med Coll, Lucknow, Uttar Pradesh, India.	abpant@rediffmail.com	Srivastava, Ritesh/V-6029-2019; Kashyap, Mahendra/G-4305-2011	Kashyap, Mahendra/0000-0001-7924-4793	Council of Scientific & Industrtail Research, New Delhi, India [SIP-08]	Council of Scientific & Industrtail Research, New Delhi, India	The financial support by Council of Scientific & Industrtail Research, New Delhi, India, through Supra-Institutional Project SIP-08 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassols J, 2009, J CELL BIOCHEM, V107, P1107, DOI 10.1002/jcb.22208; Bender TO, 2007, INT J ARTIF ORGANS, V30, P199, DOI 10.1177/039139880703000304; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Diesen DL, 2008, J PEDIATR SURG, V43, P2308, DOI 10.1016/j.jpedsurg.2008.08.025; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Fain JN, 2005, BIOCHEM PHARMACOL, V69, P1315, DOI 10.1016/j.bcp.2005.02.009; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Fain JN, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-4; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Kashyap MP, 2010, CHEM RES TOXICOL, V23, P1663, DOI 10.1021/tx100234m; KASHYAP MP, 2010, PLOS ONE, V6; Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259; Kuniyoshi Yukio, 2005, Asian Cardiovasc Thorac Ann, V13, P11; Liebermann-Meffert D, 2000, SURG CLIN N AM, V80, P275, DOI 10.1016/S0039-6109(05)70406-0; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Litbarg NO, 2007, CELL TISSUE RES, V328, P487, DOI 10.1007/s00441-006-0356-4; Maenhaut N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-25; Mattacks CA, 1999, CYTOKINE, V11, P334, DOI 10.1006/cyto.1998.0442; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; MELZIG MF, 1995, PHARMAZIE, V50, P558; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Oudhoff MJ, 2010, BIOL CHEM, V391, P541, DOI 10.1515/BC.2010.057; Paslakis G, 2010, NEPHRON EXP NEPHROL, V115, pE96, DOI 10.1159/000313490; Puma F, 2003, J THORAC CARDIOV SUR, V126, P1998, DOI 10.1016/S0022-5223(03)00709-8; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sewter CP, 1999, J ENDOCRINOL, V163, P33, DOI 10.1677/joe.0.1630033; SHIMOTSUMA M, 1991, CELL TISSUE RES, V264, P599, DOI 10.1007/BF00319049; Sopasakis VR, 2005, INT J OBESITY, V29, P1144, DOI 10.1038/sj.ijo.0803002; Srivastava RK, 2010, TOXICOL IND HEALTH, V26, P575, DOI 10.1177/0748233710374464; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Yoshida K, 1997, ANN THORAC SURG, V63, P858, DOI 10.1016/S0003-4975(96)01122-8; Zhang QX, 1997, J SURG RES, V67, P147, DOI 10.1006/jsre.1996.4983; ZHU S, 2011, MOL CELL BI IN PRESS	33	28	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20446	10.1371/journal.pone.0020446	http://dx.doi.org/10.1371/journal.pone.0020446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647223	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800051
J	Liu, ZH; Ciappio, ED; Crott, JW; Brooks, RS; Nesvet, J; Smith, DE; Choi, SW; Mason, JB				Liu, Zhenhua; Ciappio, Eric D.; Crott, Jimmy W.; Brooks, Ryan S.; Nesvet, Jared; Smith, Donald E.; Choi, Sang-Woon; Mason, Joel B.			Combined inadequacies of multiple B vitamins amplify colonic Wnt signaling and promote intestinal tumorigenesis in BAT-LacZ X Apc1638N mice	FASEB JOURNAL			English	Article						colorectal cancer; folate; methylation	EPIGENETIC INACTIVATION; DIETARY-FOLATE; DNA METHYLATION; CANCER; DEFICIENCY; APC; RISK; GENE; EXPRESSION; MUTATION	The Wnt pathway is a pivotal signaling cascade in colorectal carcinogenesis. The purpose of this work is to determine whether depletion of folate and other metabolically related B vitamins induces in vivo activation of intestinal Wnt signaling and whether this occurs in parallel with increased tumorigenesis. A hybrid mouse was created by crossing a Wnt-reporter animal (BAT-LacZ) with a model of colorectal cancer (Apc1638N). A mild depletion of folate and vitamins B-2, B-6, and B-12 was induced over 16 wk, and the control animals in each instance were pair fed a diet containing the basal requirement of these nutrients. The multiplicity of macroscopic tumors and aberrant crypt foci both increased by similar to 50% in the hybrid mice fed the depletion diet (P<0.05). A 4-fold elevation in Wnt signaling was produced by the depletion diet (P<0.05) and was accompanied by significant changes in the expression of a number of Wnt-related genes in a pattern consistent with its activation. Proliferation and apoptosis of the colonic mucosa both changed in a protrans-formational direction (P<0.05). In summary, mild depletion of multiple B vitamins produces in vivo activation of colonic Wnt signaling, implicating it as a key pathway by which B-vitamin inadequacies enhance intestinal tumorigenesis.-Liu, Z., Ciappio, E. D., Crott, J. W., Brooks, R. S., Nesvet, J., Smith, D. E., Choi, S.-W., Mason, J. B. Combined inadequacies of multiple B vitamins amplify colonic Wnt signaling and promote intestinal tumorigenesis in BAT-LacZ X Apc1638N mice. FASEB J. 25, 3136-3145 (2011). www.fasebj.org	[Liu, Zhenhua] Tufts Univ, USDA Human Nutr Res Ctr Aging, Vitamins & Carcinogenesis Lab, Boston, MA 02111 USA; [Smith, Donald E.] Tufts Univ, Comparat Biol Unit, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Liu, Zhenhua; Crott, Jimmy W.; Choi, Sang-Woon; Mason, Joel B.] Tufts Univ, Tufts Med Ctr, Ctr Canc, Boston, MA 02111 USA; [Ciappio, Eric D.; Mason, Joel B.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Mason, Joel B.] Tufts Univ, Div Clin Nutr & Gastroenterol, Tufts Med Ctr, Boston, MA 02111 USA; [Nesvet, Jared] Univ Rochester, Dept Biochem & Biophys, Rochester, NY USA	Tufts University; United States Department of Agriculture (USDA); Tufts University; Tufts Medical Center; Tufts University; Tufts University; Tufts Medical Center; Tufts University; University of Rochester	Liu, ZH (corresponding author), Tufts Univ, USDA Human Nutr Res Ctr Aging, Vitamins & Carcinogenesis Lab, 711 Washington St, Boston, MA 02111 USA.	zhenhua.liu@tufts.edu			Prevent Cancer Foundation; U.S. National Institutes of Health [R21 ES019102]; USDA Agricultural Research Service [1950-074-01S]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019102] Funding Source: NIH RePORTER	Prevent Cancer Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Prevent Cancer Foundation (to Z.L.), U.S. National Institutes of Health grant R21 ES019102 (to J.B.M.), and the USDA Agricultural Research Service (agreement 1950-074-01S). Any opinions, findings, conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the USDA.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Arnold CN, 2004, CANCER BIOL THER, V3, P960, DOI 10.4161/cbt.3.10.1113; Bailey RL, 2010, AM J CLIN NUTR, V91, P231, DOI 10.3945/ajcn.2009.28427; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; BJERKNES M, 1981, ANAT REC, V199, P565, DOI 10.1002/ar.1091990412; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102; Choi SW, 2004, J NUTR, V134, P750, DOI 10.1093/jn/134.4.750; Choi SW, 2003, J NUTR, V133, P1206, DOI 10.1093/jn/133.4.1206; CLIFFORD AJ, 1989, J NUTR, V119, P1956, DOI 10.1093/jn/119.12.1956; Davies PS, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-57; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; EUSSEN SJ, CANC EPIDEMIOL BIOMA, V19, P2549; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fuchs CS, 2002, CANCER EPIDEM BIOMAR, V11, P227; GIOVANNUCCI E, 2002, J NUTR, V132, P2355; Han SP, 2009, INT J MOL MED, V23, P321, DOI 10.3892/ijmm_00000134; Henderson L., 2004, NATL DIET NUTR SURVE; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Katula KS, 2007, J NUTR BIOCHEM, V18, P541, DOI 10.1016/j.jnutbio.2006.11.002; Kim YI, 2004, ENVIRON MOL MUTAGEN, V44, P10, DOI 10.1002/em.20025; Kim YI, 2000, GASTROENTEROLOGY, V119, P151, DOI 10.1053/gast.2000.8518; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; LASKO D, 1991, ANNU REV GENET, V25, P281, DOI 10.1146/annurev.ge.25.120191.001433; LINDENBAUM J, 1994, AM J CLIN NUTR, V60, P2, DOI 10.1093/ajcn/60.1.2; Liu ZH, 2007, J NUTR, V137, P2701, DOI 10.1093/jn/137.12.2701; Mackey AD, 2003, J NUTR, V133, P1362; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mason JB, 2009, NUTR REV, V67, P206, DOI 10.1111/j.1753-4887.2009.00190.x; NICHOALDS GE, 1974, CLIN CHEM, V20, P624; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Planells E, 2003, EUR J CLIN NUTR, V57, P777, DOI 10.1038/sj.ejcn.1601610; Pretlow TP, 2003, AM J PATHOL, V163, P1757, DOI 10.1016/S0002-9440(10)63535-3; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Song J, 2000, CANCER RES, V60, P5434; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taniguchi H, 2005, ONCOGENE, V24, P7946, DOI 10.1038/sj.onc.1208910; Ulrey CL, 2005, HUM MOL GENET, V14, pR139, DOI 10.1093/hmg/ddi100; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Yang K, 1998, CANCER RES, V58, P5713; Yang WC, 2001, CANCER RES, V61, P565; Yates CA, 2001, BRIT J NUTR, V86, P593, DOI 10.1079/BJN2001420; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333	50	13	14	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3136	3145		10.1096/fj.11-184143	http://dx.doi.org/10.1096/fj.11-184143			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21646397	Green Published			2022-12-25	WOS:000294435200027
J	Binder, M; Eberle, F; Seitz, S; Mucke, N; Huber, CM; Kiani, N; Kaderali, L; Lohmann, V; Dalpke, A; Bartenschlager, R				Binder, Marco; Eberle, Florian; Seitz, Stefan; Muecke, Norbert; Hueber, Christian M.; Kiani, Narsis; Kaderali, Lars; Lohmann, Volker; Dalpke, Alexander; Bartenschlager, Ralf			Molecular Mechanism of Signal Perception and Integration by the Innate Immune Sensor Retinoic Acid-inducible Gene-I (RIG-I)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; DOUBLE-STRANDED-RNA; INTERFERON INDUCTION; 5'-TRIPHOSPHATE RNA; ADAPTER PROTEIN; RECOGNITION; MDA5; ACTIVATION; INFECTION; RESPONSES	RIG-I is a major innate immune sensor for viral infection, triggering an interferon (IFN)-mediated antiviral response upon cytosolic detection of viral RNA. Double-strandedness and 5'-terminal triphosphates were identified as motifs required to elicit optimal immunological signaling. However, very little is known about the response dynamics of the RIG-I pathway, which is crucial for the ability of the cell to react to diverse classes of viral RNA while maintaining self-tolerance. In the present study, we addressed the molecular mechanism of RIG-I signal detection and its translation into pathway activation. By employing highly quantitative methods, we could establish the length of the double-stranded RNA(dsRNA) to be the most critical determinant of response strength. Size exclusion chromatography and direct visualization in scanning force microscopy suggested that this was due to cooperative oligomerization of RIG-I along dsRNA. The initiation efficiency of this oligomerization process critically depended on the presence of high affinity motifs, like a 5'-triphosphate. It is noteworthy that for dsRNA longer than 200 bp, internal initiation could effectively compensate for a lack of terminal triphosphates. In summary, our data demonstrate a very flexible response behavior of the RIG-I pathway, in which sensing and integration of at least two distinct signals, initiation efficiency and double strand length, allow the host cell to mount an antiviral response that is tightly adjusted to the type of the detected signal, such as viral genomes, replication intermediates, or small by-products.	[Binder, Marco; Eberle, Florian; Seitz, Stefan; Hueber, Christian M.; Lohmann, Volker; Dalpke, Alexander; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, D-69120 Heidelberg, Germany; [Muecke, Norbert] German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany; [Kiani, Narsis; Kaderali, Lars] Heidelberg Univ, Viroquant Res Grp Modeling, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Binder, M (corresponding author), Heidelberg Univ, Dept Infect Dis, Neuenheimer Feld 345, D-69120 Heidelberg, Germany.	marco_binder@med.uni-heidelberg.de	Binder, Marco/E-9717-2011; Lohmann, Volker/H-4211-2019; kiani, narsis/J-8545-2013; Kiani, Narsis/Y-1045-2019; Bartenschlager, Ralf/L-2582-2015	Binder, Marco/0000-0002-5805-6109; Lohmann, Volker/0000-0001-8719-7608; Kiani, Narsis/0000-0002-0949-046X; Mucke, Norbert/0000-0002-0683-4386; Kaderali, Lars/0000-0002-2359-2294; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft [FOR1202]; Bundesministerium fur Bildung und Forschung [01KI0786]; Medical Faculty of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Medical Faculty of Heidelberg	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR1202 "Mechanisms of Persistence of Hepatotropic Viruses" (to R. B. and V. L.) and Bundesministerium fur Bildung und Forschung Grant 01KI0786 (to R. B.).; Supported by the Postdoc Fellowship of the Medical Faculty of Heidelberg.	Barchet W, 2008, CURR OPIN IMMUNOL, V20, P389, DOI 10.1016/j.coi.2008.07.007; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2010, MOL THER, V18, P1254, DOI 10.1038/mt.2010.90; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	36	95	97	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27278	27287		10.1074/jbc.M111.256974	http://dx.doi.org/10.1074/jbc.M111.256974			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659521	Green Published, hybrid			2022-12-25	WOS:000293268700023
J	Cao, JY; Qiu, S; Zhang, J; Wang, JJ; Zhang, XM; Luo, JH				Cao, Jing-yuan; Qiu, Shuang; Zhang, Jie; Wang, Jie-jie; Zhang, Xiao-min; Luo, Jian-hong			Transmembrane Region of N-Methyl-D-aspartate Receptor (NMDAR) Subunit Is Required for Receptor Subunit Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM RETENTION; GLUTAMATE-RECEPTOR; LIGAND-BINDING; PHARMACOLOGICAL CHAPERONES; TERMINAL DOMAIN; ION CHANNELS; PROTEIN; KAINATE; SIGNAL; AMPA	N-Methyl-D-aspartate receptors (NMDARs), one of three main classes of ionotropic glutamate receptors, play major roles in synaptic plasticity, synaptogenesis, and excitotoxicity. Unlike non-NMDA receptors, NMDARs are thought to comprise obligatory heterotetrameric complexes mainly composed of GluN1 and GluN2 subunits. When expressed alone in heterogenous cells, such as HEK293 cells, most of the NMDAR subunits can neither leave the endoplasmic reticulum (ER) nor be expressed in the cell membrane because of the ER retention signals. Only when NMDARs are heteromerically assembled can the ER retention signals be masked and NMDARs be expressed in the surface membrane. However, the mechanisms underlying NMDAR assembly remain poorly understood. To identify regions in subunits that mediate this assembly, we made a series of truncated or chimeric cDNA constructs. Using FRET measurement in living cells combined with immunostaining and coimmunoprecipitation analysis, we examined the assembly-determining domains of NMDAR subunits. Our results indicate that the transmembrane region of subunits is necessary for the assembly of NMDAR subunits, both for the homodimer and the heteromer.	[Cao, Jing-yuan; Qiu, Shuang; Zhang, Jie; Wang, Jie-jie; Zhang, Xiao-min; Luo, Jian-hong] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol,Dept Neurobiol, Minist Hlth China,Key Lab Med Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Luo, JH (corresponding author), 388 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn	ZHANG, Jie/S-6936-2019; Luo, jian/HGE-7331-2022	ZHANG, Jie/0000-0002-5492-8088; Wang, Jiejie/0000-0001-7585-0585; Zhang, Xiaomin/0000-0002-1179-979X	National Basic Research Program of China [2010CB912002]; National Natural Science Foundation of China [30730038, 30800308]; Fundamental Research Funds for the Central Universities of China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Program of China Grant 2010CB912002, National Natural Science Foundation of China Grants 30730038 and 30800308, and by the Fundamental Research Funds for the Central Universities of China.	Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Call ME, 2007, NAT REV IMMUNOL, V7, P841, DOI 10.1038/nri2186; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Fleck MW, 2003, J NEUROSCI, V23, P1219; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gee VJ, 2007, BRIT J PHARMACOL, V152, P501, DOI 10.1038/sj.bjp.0707429; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Madry C, 2007, MOL PHARMACOL, V72, P1535, DOI 10.1124/mol.107.040071; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200	38	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27698	27705		10.1074/jbc.M111.235333	http://dx.doi.org/10.1074/jbc.M111.235333			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659529	hybrid, Green Published			2022-12-25	WOS:000293268700062
J	Dong, SY; Wang, Y; Cassidy-Amstutz, C; Lu, G; Bigler, R; Jezyk, MR; Li, CH; Hall, TMT; Wang, ZF				Dong, Shuyun; Wang, Yang; Cassidy-Amstutz, Caleb; Lu, Gang; Bigler, Rebecca; Jezyk, Mark R.; Li, Chunhua; Hall, Traci M. Tanaka; Wang, Zefeng			Specific and Modular Binding Code for Cytosine Recognition in Pumilio/FBF (PUF) RNA-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTERACTIONS; SYSTEM; SMART; VEGF	Pumilio/fem-3 mRNA-binding factor (PUF) proteins possess a recognition code for bases A, U, and G, allowing designed RNA sequence specificity of their modular Pumilio (PUM) repeats. However, recognition side chains in a PUM repeat for cytosine are unknown. Here we report identification of a cytosine-recognition code by screening random amino acid combinations at conserved RNA recognition positions using a yeast three-hybrid system. This C-recognition code is specific and modular as specificity can be transferred to different positions in the RNA recognition sequence. A crystal structure of a modified PUF domain reveals specific contacts between an arginine side chain and the cytosine base. We applied the C-recognition code to design PUF domains that recognize targets with multiple cytosines and to generate engineered splicing factors that modulate alternative splicing. Finally, we identified a divergent yeast PUF protein, Nop9p, that may recognize natural target RNAs with cytosine. This work deepens our understanding of natural PUF protein target recognition and expands the ability to engineer PUF domains to recognize any RNA sequence.	[Dong, Shuyun; Wang, Yang; Bigler, Rebecca; Wang, Zefeng] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Cassidy-Amstutz, Caleb; Lu, Gang; Jezyk, Mark R.; Hall, Traci M. Tanaka] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Cassidy-Amstutz, Caleb] N Carolina State Univ, Program Bioinformat, Raleigh, NC 27695 USA; [Li, Chunhua] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing 100124, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; North Carolina State University; Beijing University of Technology	Wang, ZF (corresponding author), Univ N Carolina, Dept Pharmacol, CB 7365, Chapel Hill, NC 27599 USA.	zefeng@med.unc.edu	Wang, Yang/A-1849-2010; Hall, Traci/F-5849-2019	Wang, Yang/0000-0001-9385-7393; Hall, Traci/0000-0001-6166-3009; Bigler, Rebecca/0000-0002-0075-6188; Wang, Zefeng/0000-0002-6605-3637; Dong, Shuyun/0000-0003-2988-6864	National Institute of Environmental Health Sciences; Beckman Foundation; Kimmel Sidney Scholar; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [R01CA158283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR061640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050165] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Beckman Foundation; Kimmel Sidney Scholar; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by a grant from the Intramural Research Program of the National Institute of Environmental Health Sciences (to T. M. T. H.) and by a grant from the Beckman Foundation and the Kimmel Sidney Scholar award (to Z.W.).; We thank Dr. Marvin Wickens (University of Wisconsin) for providing the plasmids and yeast strains for the Y3H assay. We thank Dr. Rajarshi Chudhury for suggestions and help in protein purification, Dr. Chen Qiu for help with RNA binding assays, and Dr. Lars Pedersen and the staff at the SER-CAT beamline for help with X-ray data collection. Data were collected at SER-CAT 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found on-line. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Chen GX, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000026; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipovska A., 2011, NAT CHEM BIOL, DOI 10.1038; Fox JE, 2008, NAT PROTOC, V3, P637, DOI 10.1038/nprot.2008.33; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hook B, 2005, RNA, V11, P227, DOI 10.1261/rna.7202705; Koh YY, 2011, RNA, V17, P718, DOI 10.1261/rna.2540311; Koh YY, 2009, RNA, V15, P1090, DOI 10.1261/rna.1545309; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lu G, 2011, STRUCTURE, V19, P361, DOI 10.1016/j.str.2010.12.019; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Opperman L, 2005, NAT STRUCT MOL BIOL, V12, P945, DOI 10.1038/nsmb1010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Qiu Y, 2009, BIOCHEM SOC T, V37, P1207, DOI 10.1042/BST0371207; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schweers BA, 2002, GENETICS, V161, P1177; Stumpf CR, 2008, METHOD ENZYMOL, V449, P295, DOI 10.1016/S0076-6879(08)02414-2; Thomson E, 2007, RNA, V13, P2165, DOI 10.1261/rna.747607; Tilsner J, 2009, PLANT J, V57, P758, DOI 10.1111/j.1365-313X.2008.03720.x; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wheeler TM, 2007, CURR OPIN NEUROL, V20, P572, DOI 10.1097/WCO.0b013e3282ef6064; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	34	82	91	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26732	26742		10.1074/jbc.M111.244889	http://dx.doi.org/10.1074/jbc.M111.244889			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653694	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000293078200050
J	Rantamaki, T; Vesa, L; Antila, H; Di Lieto, A; Tammela, P; Schmitt, A; Lesch, KP; Rios, M; Castren, E				Rantamaki, Tomi; Vesa, Liisa; Antila, Hanna; Di Lieto, Antonio; Tammela, Paivi; Schmitt, Angelika; Lesch, Klaus-Peter; Rios, Maribel; Castren, Eero			Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade	PLOS ONE			English	Article							SEROTONIN TRANSPORTER; NEURONAL PLASTICITY; MOOD DISORDERS; MESSENGER-RNA; MOUSE-BRAIN; RAT-BRAIN; ACTIVATION; DEPRESSION; MICE; INSENSITIVITY	Background: Antidepressant drugs (ADs) have been shown to activate BDNF (brain-derived neurotrophic factor) receptor TrkB in the rodent brain but the mechanism underlying this phenomenon remains unclear. ADs act as monoamine reuptake inhibitors and after prolonged treatments regulate brain bdnf mRNA levels indicating that monoamine-BDNF signaling regulate AD-induced TrkB activation in vivo. However, recent findings demonstrate that Trk receptors can be transactivated independently of their neurotrophin ligands. Methodology: In this study we examined the role of BDNF, TrkB kinase activity and monoamine reuptake in the AD-induced TrkB activation in vivo and in vitro by employing several transgenic mouse models, cultured neurons and TrkB-expressing cell lines. Principal Findings: Using a chemical-genetic TrkB(F616A) mutant and TrkB overexpressing mice, we demonstrate that ADs specifically activate both the maturely and immaturely glycosylated forms of TrkB receptors in the brain in a TrkB kinase dependent manner. However, the tricyclic AD imipramine readily induced the phosphorylation of TrkB receptors in conditional bdnf(-/-) knock-out mice (132.4+/-8.5% of control; P = 0.01), indicating that BDNF is not required for the TrkB activation. Moreover, using serotonin transporter (SERT) deficient mice and chemical lesions of monoaminergic neurons we show that neither a functional SERT nor monoamines are required for the TrkB phosphorylation response induced by the serotonin selective reuptake inhibitors fluoxetine or citalopram, or norepinephrine selective reuptake inhibitor reboxetine. However, neither ADs nor monoamine transmitters activated TrkB in cultured neurons or cell lines expressing TrkB receptors, arguing that ADs do not directly bind to TrkB. Conclusions: The present findings suggest that ADs transactivate brain TrkB receptors independently of BDNF and monoamine reuptake blockade and emphasize the need of an intact tissue context for the ability of ADs to induce TrkB activity in brain.	[Rantamaki, Tomi; Vesa, Liisa; Antila, Hanna; Di Lieto, Antonio; Castren, Eero] Univ Helsinki, Ctr Neurosci, Sigrid Juselius Lab, Helsinki, Finland; [Tammela, Paivi] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland; [Schmitt, Angelika; Lesch, Klaus-Peter] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Lab Translat Neurosci, Wurzburg, Germany; [Rios, Maribel] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Sigrid Juselius Foundation; University of Helsinki; University of Helsinki; University of Wurzburg; Tufts University	Rantamaki, T (corresponding author), Univ Helsinki, Ctr Neurosci, Sigrid Juselius Lab, Helsinki, Finland.	tomi.rantamaki@helsinki.fi	Lesch, Klaus-Peter/J-4906-2013; Yan, Shuo/B-8381-2009; Tammela, Päivi/A-4670-2010	Lesch, Klaus-Peter/0000-0001-8348-153X; Tammela, Päivi/0000-0003-4697-8066; Rantamaki, Tomi/0000-0002-0052-1434; Castren, Eero/0000-0002-1402-2791; Antila, Hanna/0000-0001-8317-4564	Sigrid Juselius Foundation; Academy of Finland; Finnish Cultural Foundation; Finnish Graduate School for Neuroscience (FGSN); Deutsche Forschungsgemeinschaft [Le 629/4-2]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Graduate School for Neuroscience (FGSN); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Sigrid Juselius Foundation (EC), Academy of Finland (EC), Finnish Cultural Foundation (TR), the Finnish Graduate School for Neuroscience (FGSN; LV) and the Deutsche Forschungsgemeinschaft (Le 629/4-2; KPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang YZ, 2010, J BIOL CHEM, V285, P8207, DOI 10.1074/jbc.M109.091041; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Koponen E, 2005, CELL MOL NEUROBIOL, V25, P973, DOI 10.1007/s10571-005-8468-z; Koponen E, 2004, MOL BRAIN RES, V130, P81, DOI 10.1016/j.molbrainres.2004.07.010; Koponen E, 2004, MOL CELL NEUROSCI, V26, P166, DOI 10.1016/j.mcn.2004.01.006; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Lobato KR, 2008, PROG NEURO-PSYCHOPH, V32, P994, DOI 10.1016/j.pnpbp.2008.01.012; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; LUCCHELLI A, 1995, BRIT J PHARMACOL, V114, P1017, DOI 10.1111/j.1476-5381.1995.tb13307.x; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Miranda C, 2002, J BIOL CHEM, V277, P6455, DOI 10.1074/jbc.M110016200; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Narita N, 1996, EUR J PHARMACOL, V307, P117, DOI 10.1016/0014-2999(96)00254-3; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; PHILLIS JW, 1982, COMP BIOCHEM PHYS C, V72, P179, DOI 10.1016/0306-4492(82)90082-X; Pires VA, 2009, BEHAV PHARMACOL, V20, P134, DOI 10.1097/FBP.0b013e32832a80bf; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Raabe R, 2008, J BIOPHYS; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rammes G, 2007, MOL NEUROBIOL, V35, P160, DOI 10.1007/s12035-007-0006-1; Rantamaki T, 2006, NEUROPHARMACOLOGY, V50, P421, DOI 10.1016/j.neuropharm.2005.10.001; Rantamaki T, 2008, EXPERT OPIN THER TAR, V12, P705, DOI [10.1517/14728222.12.6.705 , 10.1517/14728220802121472]; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Saarelainen T, 2001, CELL MOL NEUROBIOL, V21, P429, DOI 10.1023/A:1012775808253; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Sebastiao AM, 2009, BRIT J PHARMACOL, V158, P15, DOI 10.1111/j.1476-5381.2009.00157.x; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Vesa J, 2000, J BIOL CHEM, V275, P24414, DOI 10.1074/jbc.M001641200; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wiese S, 2007, P NATL ACAD SCI USA, V104, P17210, DOI 10.1073/pnas.0705267104; Wyneken U, 2006, NEUROPSYCHOPHARMACOL, V31, P2415, DOI 10.1038/sj.npp.1301052	49	89	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20567	10.1371/journal.pone.0020567	http://dx.doi.org/10.1371/journal.pone.0020567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666748	Green Submitted, gold, Green Published			2022-12-25	WOS:000291607000012
J	Mai, V; Young, CM; Ukhanova, M; Wang, XY; Sun, YJ; Casella, G; Theriaque, D; Li, N; Sharma, R; Hudak, M; Neu, J				Mai, Volker; Young, Christopher Michael; Ukhanova, Maria; Wang, Xiaoyu; Sun, Yijun; Casella, George; Theriaque, Douglas; Li, Nan; Sharma, Renu; Hudak, Mark; Neu, Josef			Fecal Microbiota in Premature Infants Prior to Necrotizing Enterocolitis	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; PRETERM INFANTS; METAGENOMICS; COLONIZATION; NEONATE	Intestinal luminal microbiota likely contribute to the etiology of necrotizing enterocolitis (NEC), a common disease in preterm infants. Microbiota development, a cascade of initial colonization events leading to the establishment of a diverse commensal microbiota, can now be studied in preterm infants using powerful molecular tools. Starting with the first stool and continuing until discharge, weekly stool specimens were collected prospectively from infants with gestational ages <= 32 completed weeks or birth weights <= 1250 g. High throughput 16S rRNA sequencing was used to compare the diversity of microbiota and the prevalence of specific bacterial signatures in nine NEC infants and in nine matched controls. After removal of short and low quality reads we retained a total of 110,021 sequences. Microbiota composition differed in the matched samples collected 1 week but not <72 hours prior to NEC diagnosis. We detected a bloom (34% increase) of Proteobacteria and a decrease (32%) in Firmicutes in NEC cases between the 1 week and <72 hour samples. No significant change was identified in the controls. At both time points, molecular signatures were identified that were increased in NEC cases. One of the bacterial signatures detected more frequently in NEC cases (p<0.01) matched closest to gamma-Proteobacteria. Although this sequence grouped to the well-studied Enterobacteriaceae family, it did not match any sequence in Genbank by more than 97%. Our observations suggest that abnormal patterns of microbiota and potentially a novel pathogen contribute to the etiology of NEC.	[Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu; Sun, Yijun] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Mai, Volker; Ukhanova, Maria; Wang, Xiaoyu; Sun, Yijun] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Young, Christopher Michael; Li, Nan; Neu, Josef] Univ Florida, Dept Pediat, Gainesville, FL USA; [Sharma, Renu; Hudak, Mark] Univ Florida, Dept Pediat, Jacksonville, FL USA; [Casella, George] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Casella, George] Univ Florida, Genet Inst, Gainesville, FL USA; [Theriaque, Douglas] Univ Florida, Clin & Translat Sci Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mai, V (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	vmai@ufl.edu	Neu, Josef/AAI-2799-2020; Wang, Xiaoyu/J-4101-2018	Wang, Xiaoyu/0000-0002-4504-7799; Young, Christopher/0000-0002-1677-7178	National Institute of Child Health and Human Development [RO1 HD 059143]; National Institutes of Health (NIH); National Center for Research Resources (NCRR) [1UL 1RR029890]; American Cancer Society [MRSGT CCE-107301]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890] Funding Source: NIH RePORTER; Direct For Biological Sciences [1062362] Funding Source: National Science Foundation	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: This work was supported by the National Institute of Child Health and Human Development, grant number RO1 HD 059143 and the National Institutes of Health (NIH) and National Center for Research Resources (NCRR) CTSA grant 1UL 1RR029890. Dr. Mai was also supported by a grant from the American Cancer Society MRSGT CCE-107301. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Caicedo RA, 2005, PEDIATR RES, V58, P625, DOI 10.1203/01.PDR.0000180533.09295.84; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Coats SR, 2007, CELL MICROBIOL, V9, P1191, DOI 10.1111/j.1462-5822.2006.00859.x; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Deshpande G, 2010, PEDIATRICS, V125, P921, DOI 10.1542/peds.2009-1301; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Mai V, 2006, GUT, V55, P1822, DOI 10.1136/gut.2006.108266; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Mshvildadze M, 2008, NUTR REV, V66, P658, DOI 10.1111/j.1753-4887.2008.00119.x; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Munford RS, 2006, PLOS PATHOG, V2, P467, DOI 10.1371/journal.ppat.0020067; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37	28	422	435	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20647	10.1371/journal.pone.0020647	http://dx.doi.org/10.1371/journal.pone.0020647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674011	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400012
J	Zhang, QF; Zhang, YL; Huang, YF; Xue, XY; Yan, H; Sun, XD; Wang, J; McCutchan, TF; Pan, WQ				Zhang, Qingfeng; Zhang, Yilong; Huang, Yufu; Xue, Xiangyang; Yan, He; Sun, Xiaodong; Wang, Jian; McCutchan, Thomas F.; Pan, Weiqing			From In Vivo to In Vitro: Dynamic Analysis of Plasmodium falciparum var Gene Expression Patterns of Patient Isolates during Adaptation to Culture	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; CHONDROITIN-SULFATE-A; FREQUENT RECOMBINATION EVENTS; SEVERE CHILDHOOD MALARIA; PAPUA-NEW-GUINEA; ANTIGENIC VARIATION; FUNCTIONAL SPECIALIZATION; DIFFERENTIAL EXPRESSION; INFECTED ERYTHROCYTES; TANZANIAN CHILDREN	Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), encoded by the var gene family, plays a crucial role in disease virulence through its involvement in binding to various host cellular receptors during infection. Growing evidence suggests that differential expression of the various var subgroups may be involved in parasite virulence. To further explore this issue, we have collected isolates from symptomatic patients in south China-Myanmar border, and characterized their sequence diversity and transcription profiles over time of var gene family, and cytoadherence properties from the time of their initial collection and extending through a two month period of adaptation to culture. Initially, we established a highly diverse, DBL alpha (4 cysteines) subtype-enriched, but unique local repertoire of var-DBL1 alpha sequences by cDNA cloning and sequencing. Next we observed a rapid transcriptional decline of upsA- and upsB-subtype var genes at ring stage through qRT-PCR assays, and a switching event from initial ICAM-I binding to the CD36-binding activity during the first week of adaptive cultivation in vitro. Moreover, predominant transcription of upsA var genes was observed to be correlated with those isolates that showed a higher parasitemia at the time of collection and the ICAM-1-binding phenotype in culture. Taken together, these data indicate that the initial stage of adaptive process in vitro significantly influences the transcription of virulence-related var subtypes and expression of PfEMP1 variants. Further, the specific upregulation of the upsA var genes is likely linked to the rapid propagation of the parasite during natural infection due to the A-type PfEMP1 variant-mediated growth advantages.	[Zhang, Qingfeng; Zhang, Yilong; Xue, Xiangyang; Yan, He; Pan, Weiqing] Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai 200092, Peoples R China; [Huang, Yufu; McCutchan, Thomas F.; Pan, Weiqing] Second Mil Med Univ, Dept Pathogen Biol, Shanghai, Peoples R China; [Sun, Xiaodong; Wang, Jian] Yunnan Inst Parasit Dis, Puer, Peoples R China	Tongji University; Naval Medical University	Zhang, QF (corresponding author), Tongji Univ, Inst Infect Dis & Vaccine Dev, Sch Med, Shanghai 200092, Peoples R China.	wqpan0912@yahoo.com.cn		ZHANG, Qingfeng/0000-0002-8759-9102	National Basic Research Program (973 Program) in China [2007CB513100]; Shanghai Leading Academic Discipline Project [B901]	National Basic Research Program (973 Program) in China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	Funding: This work is supported by grants from the National Basic Research Program (973 Program) in China (2007CB513100) and Shanghai Leading Academic Discipline Project (No. B901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2010, GENE, V453, P37, DOI 10.1016/j.gene.2010.01.001; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Bull PC, 2008, MOL MICROBIOL, V68, P1519, DOI 10.1111/j.1365-2958.2008.06248.x; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Dahlback M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-78; Duffy MF, 2006, MOL BIOCHEM PARASIT, V148, P117, DOI 10.1016/j.molbiopara.2006.03.006; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Falk N, 2009, J INFECT DIS, V200, P347, DOI 10.1086/600071; FELGER I, 1993, EXP PARASITOL, V77, P372, DOI 10.1006/expr.1993.1094; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kaestli M, 2004, J INFECT DIS, V189, P1942, DOI 10.1086/383250; Kalmbach Y, 2010, J INFECT DIS, V202, P313, DOI 10.1086/653586; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kraemer SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-45; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes S, 2007, MOL MICROBIOL, V63, P1237, DOI 10.1111/j.1365-2958.2007.05587.x; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Su Xin-zhuan, 2002, Methods Mol Med, V72, P131, DOI 10.1385/1-59259-271-6:131; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; TURNER GDH, 1994, AM J PATHOL, V145, P1057; van Noort SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009778; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; Zhang QF, 2007, VACCINE, V25, P2112, DOI 10.1016/j.vaccine.2006.11.015; Zhou Shui-sen, 2008, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V26, P401; ZHOU SS, 2009, ZHONGGUO JI SHENG CH, V27	61	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20591	10.1371/journal.pone.0020591	http://dx.doi.org/10.1371/journal.pone.0020591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674009	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400010
J	Maloney, A; Herskowitz, LJ; Koch, SJ				Maloney, Andy; Herskowitz, Lawrence J.; Koch, Steven J.			Effects of Surface Passivation on Gliding Motility Assays	PLOS ONE			English	Article							SINGLE KINESIN MOLECULES; HAND-OVER-HAND; BETA-CASEIN; OPTICAL TWEEZERS; K-CASEIN; MOTOR; MICROTUBULES; STABILIZATION; TEMPERATURE; ASSOCIATION	In this study, we report differences in the observed gliding speed of microtubules dependent on the choice of bovine casein used as a surface passivator. We observed differences in both speed and support of microtubules in each of the assays. Whole casein, comprised of alpha(s1), alpha(s2), beta, and kappa casein, supported motility and averaged speeds of 96 +/- 67 nm/s. Alpha casein can be purchased as a combination of alpha(s1) and alpha(s2) and supported gliding motility and average speeds of 949 +/- 4 nm/s. Beta casein did not support motility very well and averaged speeds of 870 +/- 30 nm/s. Kappa casein supported motility very poorly and we were unable to obtain an average speed. Finally, we observed that mixing alpha, beta, and kappa casein with the proportions found in bovine whole casein supported motility and averaged speeds of 966 +/- 6 nm/s.	[Maloney, Andy] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; Univ New Mexico, Ctr High Technol Mat, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Maloney, A (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.	amaloney@unm.edu		Koch, Steven/0000-0001-9027-7502; Maloney, Andy/0000-0002-8981-4611	DTRA [HDTRA-1-09-1-0018]; INCBN, NSF [DGE-0549500]	DTRA(United States Department of DefenseDefense Threat Reduction Agency); INCBN, NSF	The experiments were funded by DTRA grant number "HDTRA-1-09-1-0018" and the INCBN from a NSF Grant "DGE-0549500". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BINGHAM EW, 1971, J DAIRY SCI, V54, P1077, DOI 10.3168/jds.S0022-0302(71)85974-X; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Bohm KJ, 1997, CELL MOTIL CYTOSKEL, V37, P226, DOI 10.1002/(SICI)1097-0169(1997)37:3<226::AID-CM4>3.0.CO;2-4; Bohm KJ, 2000, FEBS LETT, V466, P59, DOI 10.1016/S0014-5793(99)01757-3; Bohm KJ, 2000, CELL BIOL INT, V24, P335, DOI 10.1006/cbir.1999.0515; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Castro JS, 2010, COLLOID SURFACE B, V76, P199, DOI 10.1016/j.colsurfb.2009.10.033; Castro JS, 2009, MAT SCI ENG C-BIO S, V29, P1609, DOI 10.1016/j.msec.2008.12.026; FIAT AM, 1989, MOL CELL BIOCHEM, V87, P5, DOI 10.1007/BF00421079; Foss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001476; Fox P. F., 1998, DAIRY CHEM BIOCH, P347; Fox P F, 1998, MILK PROTEINS DAIRY, P146; Gagliano J, 2010, EUR BIOPHYS J BIOPHY, V39, P801, DOI 10.1007/s00249-009-0560-8; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; HERSKOWITZ LJ, THESIS; Hess H, 2001, NANO LETT, V1, P235, DOI 10.1021/nl015521e; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Huang YM, 2005, IEEE T ADV PACKAGING, V28, P564, DOI 10.1109/TADVP.2005.858330; Leclerc E, 1997, PHYS REV LETT, V78, P150, DOI 10.1103/PhysRevLett.78.150; Mahamdeh M, 2009, OPT EXPRESS, V17, P17190, DOI 10.1364/OE.17.017190; MALONEY A, 2010, CORRECTED SPEED EFFE; Moorjani SG, 2003, NANO LETT, V3, P633, DOI 10.1021/nl034001b; O'Connell JE, 2003, J COLLOID INTERF SCI, V258, P33, DOI 10.1016/S0021-9797(02)00066-8; OLMSTED JB, 1975, BIOCHEMISTRY-US, V14, P2996, DOI 10.1021/bi00684a032; Ozeki T, 2009, BIOPHYS J, V96, P3305, DOI 10.1016/j.bpj.2008.12.3960; PAYENS TAJ, 1963, BIOCHIM BIOPHYS ACTA, V71, P517, DOI 10.1016/0006-3002(63)91124-7; Phadungath C., 2005, SONGKLANAKARIN J SCI, V27, P201; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Silverman B.W., 1986, DENSITY ESTIMATION S; THOMPSON MP, 1969, J DAIRY SCI, V52, P1166, DOI 10.3168/jds.S0022-0302(69)86719-6; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; VATER W, 1995, J CELL SCI, V108, P1063; Verma Vivek, 2008, J Biol Eng, V2, P14, DOI 10.1186/1754-1611-2-14; Walstra P, 1999, INT DAIRY J, V9, P189, DOI 10.1016/S0958-6946(99)00059-X; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; ZITTLE CA, 1963, J DAIRY SCI, V46, P1189, DOI 10.3168/jds.S0022-0302(63)89243-7; ZITTLE CA, 1961, J DAIRY SCI, V44, P2101, DOI 10.3168/jds.S0022-0302(61)90026-1	45	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e19522	10.1371/journal.pone.0019522	http://dx.doi.org/10.1371/journal.pone.0019522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674032	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500003
J	Carbone, MA; Chen, YH; Hughes, GA; Weinreb, RN; Zabriskie, NA; Zhang, K; Anholt, RRH				Carbone, Mary Anna; Chen, Yuhong; Hughes, Guy A.; Weinreb, Robert N.; Zabriskie, Norman A.; Zhang, Kang; Anholt, Robert R. H.			Genes of the Unfolded Protein Response Pathway Harbor Risk Alleles for Primary Open Angle Glaucoma	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; ER STRESS; MYOCILIN; ASSOCIATION; MUTATIONS; PATHOGENESIS; OPTINEURIN; MUTANTS; QUALITY; SHESIS	The statistical power of genome-wide association (GWA) studies to detect risk alleles for human diseases is limited by the unfavorable ratio of SNPs to study subjects. This multiple testing problem can be surmounted with very large population sizes when common alleles of large effects give rise to disease status. However, GWA approaches fall short when many rare alleles may give rise to a common disease, or when the number of subjects that can be recruited is limited. Here, we demonstrate that this multiple testing problem can be overcome by a comparative genomics approach in which an initial genome-wide screen in a genetically amenable model organism is used to identify human orthologues that may harbor risk alleles for adult-onset primary open angle glaucoma (POAG). Glaucoma is a major cause of blindness, which affects over 60 million people worldwide. Several genes have been associated with juvenile onset glaucoma, but genetic factors that predispose to adult onset primary open angle glaucoma (POAG) remain largely unknown. Previous genome-wide analysis in a Drosophila ocular hypertension model identified transcripts with altered regulation and showed induction of the unfolded protein response (UPR) upon overexpression of transgenic human glaucoma-associated myocilin (MYOC). We selected 16 orthologous genes with 62 polymorphic markers and identified in two independent human populations two genes of the UPR that harbor POAG risk alleles, BIRC6 and PDIA5. Thus, effectiveness of the UPR in response to accumulation of misfolded or aggregated proteins may contribute to the pathogenesis of POAG and provide targets for early therapeutic intervention.	[Carbone, Mary Anna; Anholt, Robert R. H.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Carbone, Mary Anna; Anholt, Robert R. H.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Chen, Yuhong; Hughes, Guy A.; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA; [Chen, Yuhong] Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai Med Sch, Shanghai 200433, Peoples R China; [Weinreb, Robert N.; Zhang, Kang] Univ Calif San Diego, Hamilton Glaucoma Ctr, San Diego, CA 92103 USA; [Weinreb, Robert N.; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA; [Zabriskie, Norman A.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Zhang, Kang] Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu, Sichuan, Peoples R China; [Zhang, Kang] Sichuan Univ, W China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China; [Anholt, Robert R. H.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of California System; University of California San Diego; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Sichuan University; Sichuan University; University of North Carolina; North Carolina State University	Carbone, MA (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	anholt@ncsu.edu	Zhang, Kang/Y-2740-2019; Anholt, Robert/S-5977-2019	Zhang, Kang/0000-0002-4549-1697; 	National Institutes of Health [EY015873, EY018660, EY019270, EY014428, EY021374]; Research to Prevent Blindness; Chinese National 985 Project; Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R01EY014428, R01EY019270, R01EY015873, R01EY018660, R01EY021374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Chinese National 985 Project; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Institutes of Health (EY015873 to RRHA; EY018660, EY019270, EY014428, EY021374 to KZ), Research to Prevent Blindness, Chinese National 985 Project to Sichuan University and West China Hospital (KZ), and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research ( KZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Borras T, 2003, GENETICS, V163, P637; Borst A, 2009, CURR BIOL, V19, pR36, DOI 10.1016/j.cub.2008.11.001; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Johnson DH, 2000, ARCH OPHTHALMOL-CHIC, V118, P974; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kumar A, 2007, MOL VIS, V13, P667; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Liu Cui-Hua, 2007, Chang Gung Med J, V30, P469; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Mozaffarieh M, 2008, MOL VIS, V14, P224; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Julvez LP, 2010, J GLAUCOMA, V19, P587, DOI 10.1097/IJG.0b013e3181ccb77f; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Salminen A, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-41; Sharts-Hopko NC, 2009, AM J NURS, V109, P40, DOI 10.1097/01.NAJ.0000345434.37734.ee; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Wang L, 2007, MOL VIS, V13, P618; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33	34	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20649	10.1371/journal.pone.0020649	http://dx.doi.org/10.1371/journal.pone.0020649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655191	Green Published, gold			2022-12-25	WOS:000291097600115
J	Carson, WF; Ito, T; Schaller, M; Cavassani, KA; Chensue, SW; Kunkel, SL				Carson, William F.; Ito, Toshihiro; Schaller, Matthew; Cavassani, Karen A.; Chensue, Stephen W.; Kunkel, Steven L.			Dysregulated Cytokine Expression by CD4+T cells from Post-Septic Mice Modulates both Th1 and Th2-Mediated Granulomatous Lung Inflammation	PLOS ONE			English	Article							POLYMICROBIAL SEPSIS; INTERFERON-GAMMA; INDUCED IMMUNOSUPPRESSION; DENDRITIC CELLS; T-LYMPHOCYTES; MOUSE MODEL; IFN-GAMMA; MYCOBACTERIAL; INTERLEUKIN-4; APOPTOSIS	Previous epidemiological studies in humans and experimental studies in animals indicate that survivors of severe sepsis exhibit deficiencies in the activation and effector function of immune cells. In particular, CD4+ T lymphocytes can exhibit reduced proliferative capacity and improper cytokine responses following sepsis. To further investigate the cell-intrinsic defects of CD4+ T cells following sepsis, splenic CD4+ T cells from sham surgery and post-septic mice were transferred into lymphopenic mice. These recipient mice were then subjected to both TH1-(purified protein derivative) and TH2-(Schistosoma mansoni egg antigen) driven models of granulomatous lung inflammation. Post-septic CD4+ T cells mediated smaller TH1 and larger TH2 lung granulomas as compared to mice receiving CD4+ T cells from sham surgery donors. However, cytokine production by lymph node cells in antigen restimulation assays indicated increased pan-specific cytokine expression by post-septic CD4+ T cell recipient mice in both TH1 and TH2 granuloma models. These include increased production of T(H)2 cytokines in TH1 inflammation, and increased production of T(H)1 cytokines in TH2 inflammation. These results suggest that cell-intrinsic defects in CD4+ T cell effector function can have deleterious effects on inflammatory processes post-sepsis, due to a defect in the proper regulation of TH-specific cytokine expression.	[Carson, William F.; Ito, Toshihiro; Schaller, Matthew; Cavassani, Karen A.; Chensue, Stephen W.; Kunkel, Steven L.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Chensue, Stephen W.] Healthcare Syst, Vet Affairs Ann Arbor, Dept Pathol & Lab Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Carson, WF (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	wfcarson@umich.edu	Schaller, Matthew/AAL-7640-2020	Carson, William F/0000-0001-9459-3924	National Institutes of Health (NIH) [HL031237, HL089216, HL31963, HL007517]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031237, P01HL031963, T32HL007517, R01HL089216] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health (NIH) grants HL031237, HL089216, HL31963 and HL007517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala A, 1999, IMMUNOLOGY, V97, P45; AYALA A, 1994, J SURG RES, V56, P579, DOI 10.1006/jsre.1994.1092; Ayala A, 2001, CYTOKINE, V14, P37, DOI 10.1006/cyto.2001.0848; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Benjamim CF, 2005, BLOOD, V105, P3588, DOI 10.1182/blood-2004-08-3251; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; CAVASSANI KA, 2010, BLOOD; Chensue SW, 1996, J IMMUNOL, V157, P4602; CHENSUE SW, 1995, J IMMUNOL, V154, P5969; CHENSUE SW, 1994, AM J PATHOL, V145, P1105; Chiu BC, 2003, AM J RESP CELL MOL, V29, P106, DOI 10.1165/rcmb.2002-0241OC; Co DO, 2004, IMMUNOL LETT, V92, P135, DOI 10.1016/j.imlet.2003.11.023; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Ding YL, 2004, SHOCK, V22, P137, DOI 10.1097/01.shk.0000131194.80038.3f; Duan XB, 2008, J LEUKOCYTE BIOL, V83, P305, DOI 10.1189/jlb.0407228; Ehlers S, 2001, J EXP MED, V194, P1847, DOI 10.1084/jem.194.12.1847; Ferguson NR, 1999, INTENS CARE MED, V25, P106, DOI 10.1007/s001340050795; Flohe SB, 2006, J LEUKOCYTE BIOL, V79, P473, DOI 10.1189/jlb.0705413; Hirata M, 2001, PARASITE IMMUNOL, V23, P271, DOI 10.1046/j.1365-3024.2001.00382.x; Ito T, 2007, EUR J IMMUNOL, V37, P2847, DOI 10.1002/eji.200737603; Joshi AD, 2008, EUR J IMMUNOL, V38, P3436, DOI 10.1002/eji.200838629; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; McDunn JE, 2006, J AM COLL SURGEONS, V203, P365, DOI 10.1016/j.jamcollsurg.2006.05.304; Murphey ED, 2004, SHOCK, V21, P415, DOI 10.1097/00024382-200405000-00004; NAPOLITANO LM, 1995, J TRAUMA, V39, P104, DOI 10.1097/00005373-199507000-00014; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Patenaude J, 2010, CELL MOL LIFE SCI, V67, P1315, DOI 10.1007/s00018-009-0251-8; PERL TM, 1995, JAMA-J AM MED ASSOC, V274, P338, DOI 10.1001/jama.274.4.338; Poehlmann H, 2009, CRIT CARE, V13, DOI 10.1186/cc7969; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Rezende SA, 1997, INFECT IMMUN, V65, P3457, DOI 10.1128/IAI.65.8.3457-3461.1997; Roth G, 2003, BIOCHEM BIOPH RES CO, V308, P840, DOI 10.1016/S0006-291X(03)01482-7; Ruth JH, 2000, CYTOKINE, V12, P432, DOI 10.1006/cyto.1999.0595; Smith PM, 2009, J IMMUNOL, V183, P3317, DOI 10.4049/jimmunol.0901504; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; Tinsley KW, 2003, J IMMUNOL, V171, P909, DOI 10.4049/jimmunol.171.2.909; Wen HT, 2008, J LEUKOCYTE BIOL, V83, P439, DOI 10.1189/jlb.0607357; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Wen HT, 2006, AM J PATHOL, V168, P1940, DOI 10.2353/ajpath.2006.051155; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	46	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20385	10.1371/journal.pone.0020385	http://dx.doi.org/10.1371/journal.pone.0020385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655295	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600062
J	Guo, WX; Crossey, EL; Zhang, L; Zucca, S; George, OL; Valenzuela, CF; Zhao, XY				Guo, Weixiang; Crossey, Erin L.; Zhang, Li; Zucca, Stefano; George, Olivia L.; Valenzuela, C. Fernando; Zhao, Xinyu			Alcohol Exposure Decreases CREB Binding Protein Expression and Histone Acetylation in the Developing Cerebellum	PLOS ONE			English	Article							RUBINSTEIN-TAYBI-SYNDROME; NEUROTROPHIN RECEPTOR EXPRESSION; NEONATAL-RAT CEREBELLUM; CENTRAL-NERVOUS-SYSTEM; BRAIN GROWTH SPURT; ETHANOL EXPOSURE; SPECTRUM DISORDERS; DNA METHYLATION; PURKINJE-CELL; EPIGENETIC REGULATION	Background: Fetal alcohol exposure affects 1 in 100 children making it the leading cause of mental retardation in the US. It has long been known that alcohol affects cerebellum development and function. However, the underlying molecular mechanism is unclear. Methodology/Principal Findings: We demonstrate that CREB binding protein (CBP) is widely expressed in granule and Purkinje neurons of the developing cerebellar cortex of naive rats. We also show that exposure to ethanol during the 3(rd) trimester-equivalent of human pregnancy reduces CBP levels. CBP is a histone acetyltransferase, a component of the epigenetic mechanism controlling neuronal gene expression. We further demonstrate that the acetylation of both histone H3 and H4 is reduced in the cerebellum of ethanol-treated rats. Conclusions/Significance: These findings indicate that ethanol exposure decreases the expression and function of CBP in the developing cerebellum. This effect of ethanol may be responsible for the motor coordination deficits that characterize fetal alcohol spectrum disorders.	[Guo, Weixiang; Crossey, Erin L.; Zhang, Li; Zucca, Stefano; George, Olivia L.; Valenzuela, C. Fernando; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico	Guo, WX (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	fvalenzuela@salud.unm.edu; xzhao@waisman.wisc.edu	Zucca, Stefano/G-2459-2015	Zucca, Stefano/0000-0002-8781-3295	NIH [P20 AA017068, MH078972, MH080434, AA14973, AA15614]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080434, R01MH078972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014973, R01AA015614, P20AA017068, R37AA015614, R56AA014973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grants P20 AA017068 to X.Z. and C.F.V, MH078972 and MH080434 to X.Z, and AA14973 and AA15614 to C.F.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Auger AP, 2002, ENDOCRINOLOGY, V143, P3009, DOI 10.1210/en.143.8.3009; Backman C, 1998, ALCOHOL CLIN EXP RES, V22, P1137, DOI 10.1111/j.1530-0277.1998.tb03713.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Carloni S, 2004, J NEUROCHEM, V89, P197, DOI 10.1111/j.1471-4159.2004.02341.x; Chan HM, 2001, J CELL SCI, V114, P2363; Chedotal A, 2010, TRENDS NEUROSCI, V33, P163, DOI 10.1016/j.tins.2010.01.004; Chu J, 2007, ACTA NEUROPATHOL, V113, P659, DOI 10.1007/s00401-007-0199-4; Connor PD, 2006, NEUROPSYCHOLOGIA, V44, P744, DOI 10.1016/j.neuropsychologia.2005.07.016; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Dohrman DP, 1997, ALCOHOL CLIN EXP RES, V21, P882; Galindo R, 2006, ALCOHOL, V40, P111, DOI 10.1016/j.alcohol.2006.11.001; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Green JT, 2004, CEREBELLUM, V3, P178, DOI 10.1080/14734220410017338; Gruol DL, 2006, J NEUROSCI RES, V83, P1381, DOI 10.1002/jnr.20844; GRUOL DL, 1994, BRAIN RES, V634, P283, DOI 10.1016/0006-8993(94)91931-3; HAMRE KM, 1993, ALCOHOL CLIN EXP RES, V17, P610, DOI 10.1111/j.1530-0277.1993.tb00808.x; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; Hennekam RCM, 2006, EUR J HUM GENET, V14, P981, DOI 10.1038/sj.ejhg.5201594; Holmes MC, 2006, MOL CELL ENDOCRINOL, V248, P9, DOI 10.1016/j.mce.2005.12.002; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Koibuchi N, 2008, CEREBELLUM, V7, P530, DOI 10.1007/s12311-008-0069-1; Kumada T, 2007, J NEUROSCI RES, V85, P465, DOI 10.1002/jnr.21149; Kumar A, 2010, ALCOHOL CLIN EXP RES, V34, P928, DOI 10.1111/j.1530-0277.2010.01166.x; Lefebvre T, 2009, J NEUROCHEM, V110, P976, DOI 10.1111/j.1471-4159.2009.06197.x; Lewis B, 2007, PHARMACOL BIOCHEM BE, V88, P114, DOI 10.1016/j.pbb.2007.07.012; Li Z, 2002, DEV BRAIN RES, V139, P237, DOI 10.1016/S0165-3806(02)00573-4; Light KE, 2002, BRAIN RES, V924, P71, DOI 10.1016/S0006-8993(01)03224-3; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; MacDonald JL, 2009, PROG NEUROBIOL, V88, P170, DOI 10.1016/j.pneurobio.2009.04.002; Moore DB, 2004, J NEUROBIOL, V60, P114, DOI 10.1002/neu.20010; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Morte B, 2004, ENDOCRINOLOGY, V145, P1386, DOI 10.1210/en.2003-1123; Nishihara E, 2003, J NEUROSCI, V23, P213; Nishihara E, 2008, CEREBELLUM, V7, P48, DOI 10.1007/s12311-008-0018-z; Norman AL, 2009, DEV DISABIL RES REV, V15, P209, DOI 10.1002/ddrr.72; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Ramadoss J, 2008, AM J PHYSIOL-REG I, V295, pR596, DOI 10.1152/ajpregu.90321.2008; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; Renthal W, 2009, SEMIN CELL DEV BIOL, V20, P387, DOI 10.1016/j.semcdb.2009.01.005; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Siler-Marsiglio KI, 2005, BRAIN RES, V1052, P202, DOI 10.1016/j.brainres.2005.06.030; Soscia SJ, 2006, CELL MOL LIFE SCI, V63, P2039, DOI 10.1007/s00018-006-6208-2; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; Stanton ME, 1998, ALCOHOL CLIN EXP RES, V22, P270, DOI 10.1111/j.1530-0277.1998.tb03649.x; Stromberg H, 1999, BRAIN RES, V818, P510, DOI 10.1016/S0006-8993(98)01219-0; Tang NF, 2006, J NEUROCHEM, V96, P1480, DOI 10.1111/j.1471-4159.2006.03649.x; Tsirigotis M, 2006, NEUROPATH APPL NEURO, V32, P26, DOI 10.1111/j.1365-2990.2005.00694.x; Tsutsui K, 2008, MOL NEUROBIOL, V37, P116, DOI 10.1007/s12035-008-8024-1; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Valor LM, 2011, J NEUROSCI, V31, P1652, DOI 10.1523/JNEUROSCI.4737-10.2011; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Yalcin A, 2003, J NEUROCHEM, V84, P397, DOI 10.1046/j.1471-4159.2003.01540.x; Yamamoto M, 1999, NEUROTOXICOL TERATOL, V21, P141, DOI 10.1016/S0892-0362(98)00048-8; Zhao XY, 2007, EPIGENETICS-US, V2, P126, DOI 10.4161/epi.2.2.4236	64	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19351	10.1371/journal.pone.0019351	http://dx.doi.org/10.1371/journal.pone.0019351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655322	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600005
J	Yu, CS; Lu, CH				Yu, Chin-Sheng; Lu, Chih-Hao			Identification of Antifreeze Proteins and Their Functional Residues by Support Vector Machine and Genetic Algorithms based on n-Peptide Compositions	PLOS ONE			English	Article							DISULFIDE CONNECTIVITY; BINDING; PREDICTION; FOLD	For the first time, multiple sets of n-peptide compositions from antifreeze protein (AFP) sequences of various cold-adapted fish and insects were analyzed using support vector machine and genetic algorithms. The identification of AFPs is difficult because they exist as evolutionarily divergent types, and because their sequences and structures are present in limited numbers in currently available databases. Our results reveal that it is feasible to identify the shared sequential features among the various structural types of AFPs. Moreover, we were able to identify residues involved in ice binding without requiring knowledge of the three-dimensional structures of these AFPs. This approach should be useful for genomic and proteomic studies involving cold-adapted organisms.	[Yu, Chin-Sheng] Feng Chia Univ, Dept Informat Engn & Comp Sci, Taichung 40724, Taiwan; [Yu, Chin-Sheng] Feng Chia Univ, Masters Program Biomed Informat & Biomed Engn, Taichung 40724, Taiwan; [Lu, Chih-Hao] China Med Univ, Grad Inst Mol Syst Biomed, Taichung, Taiwan	Feng Chia University; Feng Chia University; China Medical University Taiwan	Yu, CS (corresponding author), Feng Chia Univ, Dept Informat Engn & Comp Sci, Taichung 40724, Taiwan.	yucs@fcu.edu.tw			National Science Council, Taiwan; National Science Council; China Medical University, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	This work was supported by grants from the National Science Council, Taiwan to CSY and the National Science Council and China Medical University, Taiwan to CHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen YC, 2005, PROTEINS, V61, P507, DOI 10.1002/prot.20627; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Doxey AC, 2006, NAT BIOTECHNOL, V24, P852, DOI 10.1038/nbt1224; Dubchak I, 1999, PROTEINS, V35, P401, DOI 10.1002/(SICI)1097-0134(19990601)35:4<401::AID-PROT3>3.0.CO;2-K; Fan Y, 2002, PLANT CELL REP, V21, P296, DOI 10.1007/s00299-002-0495-3; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Graether SP, 1999, J BIOL CHEM, V274, P11842, DOI 10.1074/jbc.274.17.11842; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graether SP, 2004, EUR J BIOCHEM, V271, P3285, DOI 10.1111/j.1432-1033.2004.04256.x; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; GRIFFITH M, 1995, BIOTECHNOL ADV, V13, P375, DOI 10.1016/0734-9750(95)02001-J; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Hamada T, 2006, PROTEIN SCI, V15, P1010, DOI 10.1110/ps.051700406; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; Jia ZC, 1996, NATURE, V384, P285, DOI 10.1038/384285a0; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Knight CA, 2000, NATURE, V406, P249, DOI 10.1038/35018671; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leinala EK, 2002, STRUCTURE, V10, P619, DOI 10.1016/S0969-2126(02)00745-1; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Lu CH, 2007, PROTEINS, V67, P262, DOI 10.1002/prot.21309; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; RUBINSKY B, 1992, CRYOBIOLOGY, V29, P69, DOI 10.1016/0011-2240(92)90006-N; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Yu CS, 2003, PROTEINS, V50, P531, DOI 10.1002/prot.10313	38	21	24	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20445	10.1371/journal.pone.0020445	http://dx.doi.org/10.1371/journal.pone.0020445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655262	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600071
J	Mulampaka, SN; Dixit, NM				Mulampaka, Shiva Naresh; Dixit, Narendra M.			Estimating the Threshold Surface Density of Gp120-CCR5 Complexes Necessary for HIV-1 Envelope-Mediated Cell-Cell Fusion	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CCR5; NONHUMAN PRIMATE HOSTS; CD4(+) T-CELLS; LIVING CELLS; GLYCOPROTEIN TRIMERS; MEMBRANE-FUSION; DOWN-REGULATION; 6-HELIX BUNDLE; MULTIPLE CCR5	Reduced expression of CCR5 on target CD4(+) cells lowers their susceptibility to infection by R5-tropic HIV-1, potentially preventing transmission of infection and delaying disease progression. Binding of the HIV-1 envelope (Env) protein gp120 with CCR5 is essential for the entry of R5 viruses into target cells. The threshold surface density of gp120-CCR5 complexes that enables HIV-1 entry remains poorly estimated. We constructed a mathematical model that mimics Env-mediated cell-cell fusion assays, where target CD4(+)CCR5(+) cells are exposed to effector cells expressing Env in the presence of a coreceptor antagonist and the fraction of target cells fused with effector cells is measured. Our model employs a reaction network-based approach to describe protein interactions that precede viral entry coupled with the ternary complex model to quantify the allosteric interactions of the coreceptor antagonist and predicts the fraction of target cells fused. By fitting model predictions to published data of cell-cell fusion in the presence of the CCR5 antagonist vicriviroc, we estimated the threshold surface density of gp120-CCR5 complexes for cell-cell fusion as similar to 20 mu m(-2). Model predictions with this threshold captured data from independent cell-cell fusion assays in the presence of vicriviroc and rapamycin, a drug that modulates CCR5 expression, as well as assays in the presence of maraviroc, another CCR5 antagonist, using sixteen different Env clones derived from transmitted or early founder viruses. Our estimate of the threshold surface density of gp120-CCR5 complexes necessary for HIV-1 entry thus appears robust and may have implications for optimizing treatment with coreceptor antagonists, understanding the non-pathogenic infection of non-human primates, and designing vaccines that suppress the availability of target CD4(+)CCR5(+) cells.	[Mulampaka, Shiva Naresh; Dixit, Narendra M.] Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India; [Dixit, Narendra M.] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Mulampaka, SN (corresponding author), Indian Inst Sci, Dept Chem Engn, Bangalore 560012, Karnataka, India.	narendra@chemeng.iisc.ernet.in			National Institutes of Health [AI065334]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI065334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health grant AI065334. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AM, 2007, J BIOL CHEM, V282, P35163, DOI 10.1074/jbc.M705617200; Beaumier CM, 2009, NAT MED, V15, P879, DOI 10.1038/nm.1970; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2010, IMMUNITY, V32, P737, DOI 10.1016/j.immuni.2010.06.004; Chang MI, 2005, J VIROL, V79, P14748, DOI 10.1128/JVI.79.23.14748-14755.2005; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Dobrowsky TM, 2008, J VIROL, V82, P7022, DOI 10.1128/JVI.00053-08; Dobrowsky TM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000855; Doranz BJ, 1999, J VIROL, V73, P10346, DOI 10.1128/JVI.73.12.10346-10358.1999; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Heredia A, 2003, P NATL ACAD SCI USA, V100, P10411, DOI 10.1073/pnas.1834278100; Heredia A, 2008, P NATL ACAD SCI USA, V105, P20476, DOI 10.1073/pnas.0810843106; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hu QX, 2010, J GEN VIROL, V91, P2965, DOI 10.1099/vir.0.025270-0; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Ketas TJ, 2007, VIROLOGY, V364, P281, DOI 10.1016/j.virol.2007.02.022; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; LAYNE SP, 1990, NATURE, V346, P277, DOI 10.1038/346277a0; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Lineberger JE, 2002, J VIROL, V76, P3522, DOI 10.1128/JVI.76.7.3522-3533.2002; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Magnus C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000713; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Markosyan RM, 2009, J VIROL, V83, P10048, DOI 10.1128/JVI.00316-09; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Napier C, 2005, BIOCHEM PHARMACOL, V71, P163, DOI 10.1016/j.bcp.2005.10.024; Pandrea I, 2008, J VIROL, V82, P5501, DOI 10.1128/JVI.02555-07; Pandrea I, 2007, BLOOD, V109, P1069, DOI 10.1182/blood-2006-05-024364; Pandrea Ivona, 2010, Curr HIV/AIDS Rep, V7, P28, DOI 10.1007/s11904-009-0034-8; Percherancier Y, 2003, J BIOL CHEM, V278, P3153, DOI 10.1074/jbc.M207371200; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Platt EJ, 2007, J MOL BIOL, V374, P64, DOI 10.1016/j.jmb.2007.09.016; Popik W, 2002, J VIROL, V76, P4709, DOI 10.1128/JVI.76.10.4709-4722.2002; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sougrat R, 2007, PLOS PATHOG, V3, P571, DOI 10.1371/journal.ppat.0030063; Steffens CM, 2004, J VIROL, V78, P9573, DOI 10.1128/JVI.78.17.9573-9578.2004; Steffens CM, 2003, J VIROL, V77, P4985, DOI 10.1128/JVI.77.8.4985-4991.2003; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Trister AD, 2008, BIOPHYS J, V95, P40, DOI 10.1529/biophysj.107.118430; Viard M, 2002, J VIROL, V76, P11584, DOI 10.1128/JVI.76.22.11584-11595.2002; Yang XZ, 2006, J VIROL, V80, P4388, DOI 10.1128/JVI.80.9.4388-4395.2006; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Zaitseva M, 2003, BBA-BIOMEMBRANES, V1614, P51, DOI 10.1016/S0005-2736(03)00162-7; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e19941	10.1371/journal.pone.0019941	http://dx.doi.org/10.1371/journal.pone.0019941			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647388	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000291052500019
J	Vincent, O; Roditchev, I; Marmottant, P				Vincent, Olivier; Roditchev, Ivan; Marmottant, Philippe			Spontaneous Firings of Carnivorous Aquatic Utricularia Traps: Temporal Patterns and Mechanical Oscillations	PLOS ONE			English	Article								Aquatic species of Utricularia are carnivorous plants living in environments poor in nutrients. Their trapping mechanism has fascinated generations of scientists and is still debated today. It was reported recently that Utricularia traps can fire spontaneously. We show here that these spontaneous firings follow an unexpected diversity of temporal patterns, from "metronomic" traps which fire at fixed time intervals to "random" patterns, displaying more scattered firing times. Some "bursting" traps even combine both aspects, with groups of fast regular firings separated by a variable amount of time. We propose a physical model to understand these very particular behaviors, showing that a trap of Utricularia accomplishes mechanical oscillations, based on continuous pumping and sudden opening of the trap door ( buckling). We isolate the key parameters governing these oscillations and discuss the effect of their fluctuations.	[Vincent, Olivier; Roditchev, Ivan; Marmottant, Philippe] Univ Grenoble 1, CNRS, UMR 5588, Lab Interdisciplinaire Phys, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Vincent, O (corresponding author), Univ Grenoble 1, CNRS, UMR 5588, Lab Interdisciplinaire Phys, Grenoble, France.	philippe.marmottant@ujf-grenoble.fr	Marmottant, Philippe/D-6808-2012; Vincent, Olivier/AAD-5124-2020	Vincent, Olivier/0000-0002-8876-6072	French Ministry of Higher Education and Research	French Ministry of Higher Education and Research	This work was funded by the French Ministry of Higher Education and Research (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec L, 2011, AQUAT BOT, V94, P44, DOI 10.1016/j.aquabot.2010.09.004; Darwin C., 1875, INSECTIVOROUS PLANTS; Gordon E, 2007, REV BIOL TROP, V55, P795; HEIDEJORGENSEN HS, 1981, PARASITISME CARNIVOI; Joyeux M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021911; Juniper B.E., 1989, CARNIVOROUS PLANTS; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Lloyd F.E., 1942, CARNIVOROUS PLANTS; SASAGO A, 1985, BOT MAG TOKYO, V98, P55, DOI 10.1007/BF02488906; Sirova D, 2009, AQUAT BOT, V90, P129, DOI 10.1016/j.aquabot.2008.07.007; SYDENHAM P, 1975, FUNCTIONAL PLANT BIO, V2, P335; TREAT M, 1876, HARPERS NEW MONTHLY, V52, P382; Vincent O, 2011, P ROY SOC B-BIOL SCI, V278, P2909, DOI 10.1098/rspb.2010.2292	13	27	27	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20205	10.1371/journal.pone.0020205	http://dx.doi.org/10.1371/journal.pone.0020205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647417	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500042
J	Caneparo, L; Pantazis, P; Dempsey, W; Fraser, SE				Caneparo, Luca; Pantazis, Periklis; Dempsey, William; Fraser, Scott E.			Intercellular Bridges in Vertebrate Gastrulation	PLOS ONE			English	Article							ZEBRAFISH GASTRULATION; FLUORESCENT PROTEIN; CELLS; MORPHOGENESIS; MOVEMENTS; DYNAMICS; SEQUENCE; ELEMENT; RED	The developing zebrafish embryo has been the subject of many studies of regional patterning, stereotypical cell movements and changes in cell shape. To better study the morphological features of cells during gastrulation, we generated mosaic embryos expressing membrane attached Dendra2 to highlight cellular boundaries. We find that intercellular bridges join a significant fraction of epiblast cells in the zebrafish embryo, reaching several cell diameters in length and spanning across different regions of the developing embryos. These intercellular bridges are distinct from the cellular protrusions previously reported as extending from hypoblast cells (1-2 cellular diameters in length) or epiblast cells (which were shorter). Most of the intercellular bridges were formed at pre-gastrula stages by the daughters of a dividing cell maintaining a membrane tether as they move apart after mitosis. These intercellular bridges persist during gastrulation and can mediate the transfer of proteins between distant cells. These findings reveal a surprising feature of the cellular landscape in zebrafish embryos and open new possibilities for cell-cell communication during gastrulation, with implications for modeling, cellular mechanics, and morphogenetic signaling.	[Caneparo, Luca] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Caneparo, L (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	caneparo@caltech.edu	Fraser, Scott/Y-3406-2019; Pantazis, Periklis/AAR-1795-2021	Fraser, Scott/0000-0002-5377-0223; Pantazis, Periklis (Laki)/0000-0002-8367-9332	Caltech Biological Imaging Center; iFReC; German Science Foundation (Deutsche Forschungsgemeinschaft); Caltech Rosen Scholar Fellowship for Biological Engineering	Caltech Biological Imaging Center; iFReC; German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Caltech Rosen Scholar Fellowship for Biological Engineering	LC is supported by the Caltech Biological Imaging Center and by iFReC. PP is supported by a German Science Foundation (Deutsche Forschungsgemeinschaft) Postdoctoral Fellowship. WD is supported by a Caltech Rosen Scholar Fellowship for Biological Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Concha ML, 1998, DEVELOPMENT, V125, P983; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; KAGEYAMA T, 1987, J EXP ZOOL, V244, P243, DOI 10.1002/jez.1402440208; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; LIAW CW, 1986, J IMMUNOL, V137, P1037; MILLER J, 1995, DEVELOPMENT, V121, P2501; Plachta N, 2011, NAT CELL BIOL, V13, DOI 10.1038/ncb0311-337; Quesada-Hernandez E, 2010, CURR BIOL, V20, P1966, DOI 10.1016/j.cub.2010.10.009; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; SCHOENWOLF GC, 1992, CURR TOP DEV BIOL, V27, P129, DOI 10.1016/S0070-2153(08)60534-7; Sepich DS, 2005, DEV DYNAM, V234, P279, DOI 10.1002/dvdy.20507; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shih J, 1996, DEVELOPMENT, V122, P1313; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; TRINKAUS JP, 1973, DEV BIOL, V30, P68, DOI 10.1016/0012-1606(73)90049-3; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; WARGA RM, 1990, DEVELOPMENT, V108, P569; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	26	57	61	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20230	10.1371/journal.pone.0020230	http://dx.doi.org/10.1371/journal.pone.0020230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647454	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000291006500043
J	Weibrecht, I; Grundberg, I; Nilsson, M; Soderberg, O				Weibrecht, Irene; Grundberg, Ida; Nilsson, Mats; Soderberg, Ola			Simultaneous Visualization of Both Signaling Cascade Activity and End-Point Gene Expression in Single Cells	PLOS ONE			English	Article							IN-SITU DETECTION; PROXIMITY LIGATION; PADLOCK PROBES; MOLECULES; KINASE	We have developed an approach for simultaneous detection of individual endogenous protein modifications and mRNA molecules in single cells in situ. For this purpose we combined two methods previously developed in our lab: in situ proximity ligation assay for the detection of individual protein interactions and -modifications and in situ detection of single mRNA molecules using padlock probes. As proof-of-principle, we demonstrated the utility of the method for simultaneous detection of phosphorylated PDGFR beta and DUSP6/MKP-3 mRNA molecules in individual human fibroblasts upon PDGF-BB stimulation. Further we applied drugs disrupting the PDGFR beta signaling pathway at various sites to show that this combined method can concurrently monitor the molecular effect of the drugs, i.e. inhibition of downstream signaling from the targeted node in the signaling pathway. Due to its ability to detect different types of molecules in single cells in situ the method presented here can contribute to a deeper understanding of cell-to-cell variations and can be applied to e.g. pinpoint effector sites of drugs in a signaling pathway.	[Weibrecht, Irene; Grundberg, Ida; Nilsson, Mats; Soderberg, Ola] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden	Uppsala University	Weibrecht, I (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Rudbeck Lab, Uppsala, Sweden.	ola.soderberg@igp.uu.se	Söderberg, Ola/O-5130-2017	Söderberg, Ola/0000-0003-2883-1925	Knut and Alice Wallenberg Foundation; The Swedish Foundation for Strategic Research; Swedish Research Council; European Union [259796]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); The Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission)	This work was funded by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/), The Swedish Foundation for Strategic Research (http://www.stratresearch.se/), the Swedish Research Council (http://www.vr.se/), and the European Union Seventh Framework Programme (http://cordis.europa.eu/fp7/home_en.html) under grant agreement no. 259796 (DiaTools). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buchdunger E, 1996, CANCER RES, V56, P100; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Fox T, 1998, PROTEIN SCI, V7, P2249, DOI 10.1002/pro.5560071102; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Jarvius M, 2007, MOL CELL PROTEOMICS, V6, P1500, DOI 10.1074/mcp.M700166-MCP200; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Larsson C, 2010, NAT METHODS, V7, P395, DOI [10.1038/NMETH.1448, 10.1038/nmeth.1448]; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Nilsson M, 1997, NAT GENET, V16, P252, DOI 10.1038/ng0797-252; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Team RDC, 2010, R LANG ENV STAT COMP	15	11	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20148	10.1371/journal.pone.0020148	http://dx.doi.org/10.1371/journal.pone.0020148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647446	Green Submitted, Green Published, gold			2022-12-25	WOS:000291006500029
J	Wijndaele, K; Brage, S; Besson, H; Khaw, KT; Sharp, SJ; Luben, R; Bhaniani, A; Wareham, NJ; Ekelund, U				Wijndaele, Katrien; Brage, Soren; Besson, Herve; Khaw, Kay-Tee; Sharp, Stephen J.; Luben, Robert; Bhaniani, Amit; Wareham, Nicholas J.; Ekelund, Ulf			Television Viewing and Incident Cardiovascular Disease: Prospective Associations and Mediation Analysis in the EPIC Norfolk Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIORS; TIME SPENT; MORTALITY; RISK; OBESITY; EXERCISE; WEIGHT; GAIN	Background: Although television viewing time is detrimentally associated with intermediate cardiovascular risk factors, the relationship with incident total (i.e. combined fatal and non-fatal) cardiovascular disease (CVD), non-fatal CVD and coronary heart disease is largely unknown. This study examined whether television viewing time is associated with these three outcomes, independently of physical activity energy expenditure and other confounding variables. Methodology/Principal Findings: A population-based cohort of 12,608 men and women (aged 61.4 +/- 9.0), free from stroke, myocardial infarction and cancer at baseline in 1998-2000 were followed up until 2007 (6.9 +/- 1.9 years). Participants self-reported education, smoking, alcohol use, antihypertensive, lipid lowering and antidepressant medication, disease history, total energy intake, sleep duration, physical activity and television viewing. BMI, waist circumference, blood pressure, triglycerides, HDL cholesterol and glycated haemoglobin (HbA(1c)) were measured by standardized procedures; a clustered metabolic risk score was constructed. Every one hour/day increase in television viewing was associated with an increased hazard for total (HR = 1.06, 95% CI = 1.03-1.08; 2,620 cases), non-fatal CVD (HR = 1.06, 95% CI = 1.03-1.09; 2,134 cases), and coronary heart disease (HR = 1.08, 95% CI = 1.03-1.13; 940 cases), independent of gender, age, education, smoking, alcohol, medication, diabetes status, CVD family history, sleep duration and physical activity energy expenditure. Energy intake, BMI, waist circumference, blood pressure, triglycerides, HDL cholesterol, HbA(1c) and the clustered metabolic risk score only partially mediated these associations. Conclusions: These results indicate that the most prevalent leisure time (sedentary) behaviour, television viewing, independently contributes to increased CVD risk. Recommendations on reducing television viewing time should be considered.	[Wijndaele, Katrien; Brage, Soren; Besson, Herve; Sharp, Stephen J.; Wareham, Nicholas J.; Ekelund, Ulf] Med Res Council Epidemiol Unit, Cambridge, England; [Wijndaele, Katrien] Res Fdn Flanders, Brussels, Belgium; [Wijndaele, Katrien] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Khaw, Kay-Tee; Luben, Robert; Bhaniani, Amit] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Ghent University; University of Cambridge	Wijndaele, K (corresponding author), Med Res Council Epidemiol Unit, Cambridge, England.	ulf.ekelund@mrc-epid.cam.ac.uk	Luben, Robert N/H-5519-2015; Wijndaele, Katrien/H-5465-2013; Brage, Soren/C-6415-2013; Khaw, Kay-Tee/AAZ-3209-2021; Ekelund, Ulf/AAE-8471-2019	Luben, Robert N/0000-0002-5088-6343; Wijndaele, Katrien/0000-0003-2199-7981; Brage, Soren/0000-0002-1265-7355; Ekelund, Ulf/0000-0003-2115-9267	Cancer Research Campaign; Medical Research Council; Stroke Association; British Heart Foundation; Department of Health; Europe Against Cancer Programme Commission of the European Union; Ministry of Agriculture, Fisheries and Food; MRC [MC_U106179473] Funding Source: UKRI; Medical Research Council [MC_U106179473, MC_U106179471, G0401527, G1000143] Funding Source: researchfish	Cancer Research Campaign(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; British Heart Foundation(British Heart Foundation); Department of Health; Europe Against Cancer Programme Commission of the European Union; Ministry of Agriculture, Fisheries and Food; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	EPIC-Norfolk is funded by Cancer Research Campaign; Medical Research Council; Stroke Association; British Heart Foundation; Department of Health; Europe Against Cancer Programme Commission of the European Union and the Ministry of Agriculture, Fisheries and Food. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2010, INT J EPIDEMIOL, V26, P670, DOI [DOI 10.1093/IJE/DYQ105, 10.1093/ije/26.3.670]; *AUST BUR STAT, 2008, AUST US THEIR TIM 20; Ball K, 2002, INT J OBESITY, V26, P1570, DOI 10.1038/sj.ijo.0802150; Besson H, 2008, MED SCI SPORT EXER, V40, P1909, DOI 10.1249/MSS.0b013e318180bcad; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Bingham SA, 1997, INT J EPIDEMIOL, V26, pS137, DOI 10.1093/ije/26.suppl_1.S137; Blanck HM, 2007, OBESITY, V15, P1578, DOI 10.1038/oby.2007.187; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; CLARK BK, 2010, RELATIONSHIP TELEVIS, DOI DOI 10.1249/MSS.0B013E3182019510; Day N, 1999, BRIT J CANCER, V80, P95; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Office for National Statistics, 2006, TIM US SURV 2005 WE; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Research NM, 2000, NIELS REP TEL; Sinha S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-74; STAMATAKIS E, 2011, EUR HEART J, V27, P1610; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Tendera M, 2006, EUR HEART J, V27, P1521, DOI 10.1093/eurheartj/ehl075; Wareham NJ, 2002, INT J EPIDEMIOL, V31, P168, DOI 10.1093/ije/31.1.168; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e	30	82	82	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20058	10.1371/journal.pone.0020058	http://dx.doi.org/10.1371/journal.pone.0020058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21647437	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500022
J	Benned-Jensen, T; Smethurst, C; Holst, PJ; Page, KR; Sauls, H; Sivertsen, B; Schwartz, TW; Blanchard, A; Jepras, R; Rosenkilde, MM				Benned-Jensen, Tau; Smethurst, Christopher; Holst, Peter J.; Page, Kevin R.; Sauls, Howard; Sivertsen, Bjorn; Schwartz, Thue W.; Blanchard, Andy; Jepras, Robert; Rosenkilde, Mette M.			Ligand Modulation of the Epstein-Barr Virus-induced Seven-transmembrane Receptor EBI2 IDENTIFICATION OF A POTENT AND EFFICACIOUS INVERSE AGONIST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CHEMOKINE; BINDING; HERPESVIRUS; ACTIVATION; EXPRESSION; BILF1; ANTAGONISTS; ONCOGENE; ENCODES	The Epstein-Barr virus-induced receptor 2 (EBI2) is a constitutively active seven-transmembrane receptor, which was recently shown to orchestrate the positioning of B cells in the follicle. To date, no ligands, endogenously or synthetic, have been identified that modulate EBI2 activity. Here we describe an inverse agonist, GSK682753A, which selectively inhibited the constitutive activity of EBI2 with high potency and efficacy. In cAMP-response element-binding protein-based reporter and guanosine 5'-3-O-(thio)-triphosphate (GTP gamma S) binding assays, the potency of this compound was 2.6-53.6 nM, and its inhibitory efficacy was 75%. In addition, we show that EBI2 constitutively activated extracellular signal-regulated kinase (ERK) in a pertussis toxin-insensitive manner. Intriguingly, GSK682753A inhibited ERK phosphorylation, GTP gamma S binding, and cAMP-response element-binding protein activation with similar potency. Overexpression of EBI2 profoundly potentiated antibody-stimulated ex vivo proliferation of murine B cells compared with WT cells, whereas this was equivalently reduced for EBI2-deficient B cells. Inhibition of EBI2 constitutive activity suppressed the proliferation in all cases. Importantly, the suppression was of much higher potency (32-fold) in WT or EBI2-overexpressing B cells compared with EBI2-deficient counterparts. Finally, we screened GSK682753A against an EBI2 mutant library to determine putative molecular binding determinants in EBI2. We identified Phe(111) at position III:08/3.32 as being crucial for GSK682753A inverse agonism because Ala substitution resulted in a > 500-fold decrease in IC50. In conclusion, we present the first ligand targeting EBI2. In turn, this molecule provides a useful tool for further characterization of EBI2 as well as serving as a potent lead compound.	[Schwartz, Thue W.; Rosenkilde, Mette M.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Smethurst, Christopher; Page, Kevin R.; Blanchard, Andy; Jepras, Robert] GlaxoSmithKline, Stevenage SG1 2NY, Herts, England; [Holst, Peter J.] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, DK-2200 Copenhagen N, Denmark; [Sauls, Howard] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA	University of Copenhagen; GlaxoSmithKline; University of Copenhagen; GlaxoSmithKline	Rosenkilde, MM (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	rosenkilde@sund.ku.dk		Holst, Peter Johannes/0000-0002-1279-304X; Sivertsen, Borge/0000-0003-4654-9296; Rosenkilde, Mette Marie/0000-0001-9600-3254; Schwartz, Thue W./0000-0002-0261-6904				Arvanitakis L, 1997, NATURE, V385, P347, DOI 10.1038/385347a0; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Beisser PS, 2005, J VIROL, V79, P441, DOI 10.1128/JVI.79.1.441-449.2005; Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; BIRKENBACH M, 1993, J VIROL, V67, P2209, DOI 10.1128/JVI.67.4.2209-2220.1993; BRITT WJ, 1996, FIELDS VIROLOGY, P771; Buck E, 2005, P NATL ACAD SCI USA, V102, P2719, DOI 10.1073/pnas.0500016102; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Claeysen S, 2003, J BIOL CHEM, V278, P699, DOI 10.1074/jbc.C200588200; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Craig FE, 2007, DIAGN MOL PATHOL, V16, P158, DOI 10.1097/PDM.0b013e31804f54a9; Cussac D, 2009, J PHARMACOL EXP THER, V331, P222, DOI 10.1124/jpet.109.156307; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; Gottschalk S, 2005, ANNU REV MED, V56, P29, DOI 10.1146/annurev.med.56.082103.104727; Han SJ, 2005, J BIOL CHEM, V280, P34849, DOI 10.1074/jbc.M506711200; Holst PJ, 2001, J CLIN INVEST, V108, P1789, DOI 10.1172/JCI13622; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Jensen PC, 2009, METHOD ENZYMOL, V461, P171, DOI 10.1016/S0076-6879(09)05408-1; Joost P, 2002, GENOME BIOL, V3; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Kostenis E, 2002, J RECEPT SIGNAL TR R, V22, P267, DOI 10.1081/RRS-120014601; Lapinsh M, 2002, PROTEIN SCI, V11, P795, DOI 10.1110/ps.2500102; Lyngaa R, 2010, ONCOGENE, V29, P4388, DOI 10.1038/onc.2010.173; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; McCune DF, 2000, MOL PHARMACOL, V57, P659, DOI 10.1124/mol.57.4.659; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Paulsen SJ, 2005, J VIROL, V79, P536, DOI 10.1128/JVI.79.1.536-546.2005; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Rosenkilde MM, 2006, CURR DRUG TARGETS, V7, P103, DOI 10.2174/138945006775270259; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shin N, 2002, MOL PHARMACOL, V62, P38, DOI 10.1124/mol.62.1.38; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Yang TY, 2000, J EXP MED, V191, P445, DOI 10.1084/jem.191.3.445; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	46	33	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29292	29302		10.1074/jbc.M110.196345	http://dx.doi.org/10.1074/jbc.M110.196345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21673108	Green Published, hybrid			2022-12-25	WOS:000293837000064
J	Aggarwal, V; Kulothungan, SR; Balamurali, MM; Saranya, SR; Varadarajan, R; Ainavarapu, RK				Aggarwal, Vasudha; Kulothungan, S. Rajendra; Balamurali, M. M.; Saranya, S. R.; Varadarajan, Raghavan; Ainavarapu, Rama Koti			Ligand-modulated Parallel Mechanical Unfolding Pathways of Maltose-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; KINETIC PARTITIONING MECHANISM; SINGLE-MOLECULE; ESCHERICHIA-COLI; ACTIVE-TRANSPORT; DIHYDROFOLATE-REDUCTASE; DISULFIDE BONDS; STABILITY; CHEMOTAXIS; OLIGOSACCHARIDES	Protein folding and unfolding are complex phenomena, and it is accepted that multidomain proteins generally follow multiple pathways. Maltose-binding protein (MBP) is a large (a two-domain, 370-amino acid residue) bacterial periplasmic protein involved in maltose uptake. Despite the large size, it has been shown to exhibit an apparent two-state equilibrium unfolding in bulk experiments. Single-molecule studies can uncover rare events that are masked by averaging in bulk studies. Here, we use single-molecule force spectroscopy to study the mechanical unfolding pathways of MBP and its precursor protein (preMBP) in the presence and absence of ligands. Our results show that MBP exhibits kinetic partitioning on mechanical stretching and unfolds via two parallel pathways: one of them involves a mechanically stable intermediate (path I) whereas the other is devoid of it (path II). The apoMBP unfolds via path I in 62% of the mechanical unfolding events, and the remaining 38% follow path II. In the case of maltose-bound MBP, the protein unfolds via the intermediate in 79% of the cases, the remaining 21% via path II. Similarly, on binding to maltotriose, a ligand whose binding strength with the polyprotein is similar to that of maltose, the occurrence of the intermediate is comparable (82% via path I) with that of maltose. The precursor protein preMBP also shows a similar behavior upon mechanical unfolding. The percentages of molecules unfolding via path I are 53% in the apo form and 68% and 72% upon binding to maltose and maltotriose, respectively, for preMBP. These observations demonstrate that ligand binding can modulate the mechanical unfolding pathways of proteins by a kinetic partitioning mechanism. This could be a general mechanism in the unfolding of other large two-domain ligand-binding proteins of the bacterial periplasmic space.	[Aggarwal, Vasudha; Ainavarapu, Rama Koti] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Ainavarapu, Rama Koti] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Kulothungan, S. Rajendra; Balamurali, M. M.; Saranya, S. R.; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); Indian Institute of Science (IISC) - Bangalore	Ainavarapu, RK (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.	koti@tifr.res.in	MM, Balamurali/ABG-9767-2020; Ainavarapu, Sri Rama Koti/D-1231-2011; Aggarwal, Vasudha/C-3284-2018	Ainavarapu, Sri Rama Koti/0000-0002-1646-2731; Aggarwal, Vasudha/0000-0001-9856-1292; MM, Balamurali/0000-0001-7948-9950	Tata Institute of Fundamental Research	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	This work was supported by the Tata Institute of Fundamental Research (to S. R. K. A.).	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Ainavarapu SRK, 2008, J AM CHEM SOC, V130, P436, DOI 10.1021/ja077851s; Arad-Haase G, 2010, BIOPHYS J, V99, P238, DOI 10.1016/j.bpj.2010.04.004; BASSFORD PJ, 1990, J BIOENERG BIOMEMBR, V22, P401, DOI 10.1007/BF00763175; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; Bertz M, 2008, J MOL BIOL, V378, P447, DOI 10.1016/j.jmb.2008.02.025; Bertz M, 2009, J MOL BIOL, V393, P1097, DOI 10.1016/j.jmb.2009.08.066; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2006, ANGEW CHEM INT EDIT, V45, P642, DOI 10.1002/anie.200502623; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Duan XQ, 2001, J MOL BIOL, V306, P1115, DOI 10.1006/jmbi.2001.4456; Efron B., 1982, JACKKNIFE BOOTSTRAP; Feller G, 1999, BIOCHEMISTRY-US, V38, P4613, DOI 10.1021/bi982650+; Fernandez JM, 2004, SCIENCE, V303, P1674, DOI 10.1126/science.1092497; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Galera-Prat A, 2010, CURR OPIN STRUC BIOL, V20, P63, DOI 10.1016/j.sbi.2010.01.003; Ganesh C, 1997, BIOCHEMISTRY-US, V36, P5020, DOI 10.1021/bi961967b; Hann E, 2007, BIOPHYS J, V92, pL79, DOI 10.1529/biophysj.106.102475; Jones K, 2003, J AM CHEM SOC, V125, P9606, DOI 10.1021/ja0358807; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455; Krishnan B, 2009, J MOL BIOL, V385, P1243, DOI 10.1016/j.jmb.2008.10.094; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Millet O, 2003, P NATL ACAD SCI USA, V100, P12700, DOI 10.1073/pnas.2134311100; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; SCHWARTZ M, 1976, EUR J BIOCHEM, V71, P167, DOI 10.1111/j.1432-1033.1976.tb11102.x; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Thirumalai D, 1997, THEOR CHEM ACC, V96, P14, DOI 10.1007/s002140050198; Thomson J, 1998, BIOPHYS CHEM, V70, P101, DOI 10.1016/S0301-4622(97)00113-0; Udgaonkar JB, 2008, ANNU REV BIOPHYS, V37, P489, DOI 10.1146/annurev.biophys.37.032807.125920; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wright CF, 2003, NAT STRUCT BIOL, V10, P658, DOI 10.1038/nsb947; Zaidi FN, 1997, NAT STRUCT BIOL, V4, P1016, DOI 10.1038/nsb1297-1016; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P2764, DOI 10.1073/pnas.0400091101	50	37	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28056	28065		10.1074/jbc.M111.249045	http://dx.doi.org/10.1074/jbc.M111.249045			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659518	Green Published, hybrid			2022-12-25	WOS:000293557800024
J	Amemiya-Kudo, M; Oka, J; Takeuchi, Y; Okazaki, H; Yamamoto, T; Yahagi, N; Matsuzaka, K; Okazaki, S; Osuga, J; Yamada, N; Murase, T; Shimano, H				Amemiya-Kudo, Michiyo; Oka, Junko; Takeuchi, Yoshinori; Okazaki, Hiroaki; Yamamoto, Takashi; Yahagi, Naoya; Matsuzaka, Kaori; Okazaki, Sachiko; Osuga, Jun-ichi; Yamada, Nobuhiro; Murase, Toshio; Shimano, Hitoshi			Suppression of the Pancreatic Duodenal Homeodomain Transcription Factor-1 (Pdx-1) Promoter by Sterol Regulatory Element-binding Protein-1c (SREBP-1c)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN GENE-TRANSCRIPTION; NUCLEAR FACTOR 3-BETA; BETA-CELL DYSFUNCTION; TRANSGENIC MICE; DIABETES-MELLITUS; TARGET PROMOTERS; HOMEOBOX FACTOR; X-RECEPTOR; EXPRESSION; ACTIVATION	Overexpression of sterol regulatory element-binding protein-1c (SREBP-1c) in beta cells causes impaired insulin secretion and beta cell dysfunction associated with diminished pancreatic duodenal homeodomain transcription factor-1 (PDX-1) expression in vitro and in vivo. To identify the molecular mechanism responsible for this effect, the mouse Pdx-1 gene promoter (2.7 kb) was analyzed in beta cell and non-beta cell lines. Despite no apparent sterol regulatory element-binding protein-binding sites, the Pdx-1 promoter was suppressed by SREBP-1c in beta cells in a dose-dependent manner. PDX-1 activated its own promoter. The E-box (-104/-99 bp) in the proximal region, occupied by ubiquitously expressed upstream stimulatory factors (USFs), was crucial for the PDX-1-positive autoregulatory loop through direct PDX-1.USF binding. This positive feedback activation was a prerequisite for SREBP-1c suppression of the promoter in non-beta cells. SREBP-1c and PDX-1 directly interact through basic helix-loop-helix and homeobox domains, respectively. This robust SREBP-1c.PDX-1 complex interferes with PDX-1.USF formation and inhibits the recruitment of PDX-1 coactivators. SREBP-1c also inhibits PDX-1 binding to the previously described PDX-1-binding site (-2721/-2646 bp) in the distal enhancer region of the Pdx-1 promoter. Endogenous up-regulation of SREBP-1c in INS-1 cells through the activation of liver X receptor and retinoid X receptor by 9-cis-retinoic acid and 22-hydroxycholesterol inhibited PDX-1 mRNA and protein expression. Conversely, SREBP-1c RNAi restored Pdx-1 mRNA and protein levels. Through these multiple mechanisms, SREBP-1c, when induced in a lipotoxic state, repressed PDX-1 expression contributing to the inhibition of insulin expression and beta cell dysfunction.	[Amemiya-Kudo, Michiyo] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Minato Ku, Tokyo 1058470, Japan; [Takeuchi, Yoshinori; Yamamoto, Takashi; Yahagi, Naoya; Matsuzaka, Kaori; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Okazaki, Hiroaki; Okazaki, Sachiko; Osuga, Jun-ichi] Univ Tokyo, Dept Diabet & Metab Dis, Tokyo 1138655, Japan	Toranomon Hospital; University of Tsukuba; University of Tokyo	Amemiya-Kudo, M (corresponding author), Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	michiyoame-tky@umin.ac.jp	Yahagi, Naoya/D-2360-2014; Shimano, Hitoshi/AAI-5648-2020; Shimano, Hitoshi/V-1761-2019	Yahagi, Naoya/0000-0002-1823-1865; Shimano, Hitoshi/0000-0002-5562-5572	Japan Foundation of Cardiovascular Research; Grants-in-Aid for Scientific Research [21591123] Funding Source: KAKEN	Japan Foundation of Cardiovascular Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Japan Foundation of Cardiovascular Research (to M.A.-K.).	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Amemiya-Kudo M, 2005, J BIOL CHEM, V280, P34577, DOI 10.1074/jbc.M506718200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Ben-Shushan E, 2001, J BIOL CHEM, V276, P17533, DOI 10.1074/jbc.M009088200; Bennett MK, 2004, J BIOL CHEM, V279, P37360, DOI 10.1074/jbc.M404693200; BrethertonWatt D, 1996, BIOCHEM J, V313, P495, DOI 10.1042/bj3130495; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carty MD, 1997, J BIOL CHEM, V272, P11986, DOI 10.1074/jbc.272.18.11986; Francis J, 2005, J BIOL CHEM, V280, P36244, DOI 10.1074/jbc.M505741200; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Ishikawa M, 2008, J LIPID RES, V49, P2524, DOI 10.1194/jlr.M800238-JLR200; Iwasaki Y, 2009, BIOCHEM BIOPH RES CO, V378, P545, DOI 10.1016/j.bbrc.2008.11.105; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Marshak S, 2000, MOL CELL BIOL, V20, P7583, DOI 10.1128/MCB.20.20.7583-7590.2000; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Najima Y, 2005, J BIOL CHEM, V280, P27523, DOI 10.1074/jbc.M414549200; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Peshavaria M, 1997, MOL CELL BIOL, V17, P3987, DOI 10.1128/MCB.17.7.3987; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Qian J, 1999, BIOCHEM J, V341, P315, DOI 10.1042/0264-6021:3410315; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sharma S, 1996, J BIOL CHEM, V271, P2294, DOI 10.1074/jbc.271.4.2294; Shimano H, 2007, DIABETES OBES METAB, V9, P133, DOI 10.1111/j.1463-1326.2007.00779.x; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimano H, 2007, J MOL MED, V85, P437, DOI 10.1007/s00109-007-0158-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Stanojevic V, 2004, ENDOCRINOLOGY, V145, P2918, DOI 10.1210/en.2003-1188; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Takahashi A, 2005, DIABETES, V54, P492, DOI 10.2337/diabetes.54.2.492; Taniguchi H, 2003, GENE THER, V10, P15, DOI 10.1038/sj.gt.3301846; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; Watada H, 1996, BIOCHEM BIOPH RES CO, V229, P746, DOI 10.1006/bbrc.1996.1875; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	49	9	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27902	27914		10.1074/jbc.M110.186221	http://dx.doi.org/10.1074/jbc.M110.186221			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21652712	Green Published, hybrid			2022-12-25	WOS:000293557800009
J	Gandhi, UH; Kaushal, N; Ravindra, KC; Hegde, S; Nelson, SM; Narayan, V; Vunta, H; Paulson, RF; Prabhu, KS				Gandhi, Ujjawal H.; Kaushal, Naveen; Ravindra, Kodihalli C.; Hegde, Shailaja; Nelson, Shakira M.; Narayan, Vivek; Vunta, Hema; Paulson, Robert F.; Prabhu, K. Sandeep			Selenoprotein-dependent Up-regulation of Hematopoietic Prostaglandin D-2 Synthase in Macrophages Is Mediated through the Activation of Peroxisome Proliferator-activated Receptor (PPAR) gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; GLUTATHIONE-PEROXIDASE; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); SELENIUM DEFICIENCY; GENE-EXPRESSION; INFLAMMATION; CELLS; CYCLOOXYGENASE-2; MECHANISMS; PATHWAY	The plasticity of macrophages is evident from their dual role in inflammation and resolution of inflammation that are accompanied by changes in the transcriptome and metabolome. Along these lines, we have previously demonstrated that the micronutrient selenium increases macrophage production of arachidonic acid (AA)-derived anti-inflammatory 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) and decreases the proinflammatory PGE(2). Here, we hypothesized that selenium modulated the metabolism of AA by a differential regulation of various prostaglandin (PG) synthases favoring the production of PGD(2) metabolites, Delta(12)-PGJ(2) and 15d-PGJ(2). A dose-dependent increase in the expression of hematopoietic-PGD(2) synthase (H-PGDS) by selenium and a corresponding increase in Delta(12)-PGJ(2) and 15d-PGJ(2) in RAW264.7 macrophages and primary bone marrow-derived macrophages was observed. Studies with organic non-bioavailable forms of selenium and the genetic manipulation of cellular selenium incorporation machinery indicated that selenoproteins were necessary for H-PGDS expression and 15d-PGJ(2) production. Treatment of selenium-deficient macrophages with rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, up-regulated H-PGDS. Furthermore, electrophoretic mobility shift assays indicated the presence of an active peroxisome proliferator-activated receptor-response element in murine Hpgds promoter suggesting a positive feedback mechanism of H-PGDS expression. Alternatively, the expression of nuclear factor-kappa B-dependent thromboxane synthase and microsomal PGE(2) synthase was down-regulated by selenium. Using a Friend virus infection model of murine leukemia, the onset of leukemia was observed only in selenium-deficient and indomethacin-treated selenium-supplemented mice but not in the selenium-supplemented group or those treated with 15d-PGJ(2). These results suggest the importance of selenium in the shunting of AA metabolism toward the production of PGD(2) metabolites, which may have clinical implications.	[Kaushal, Naveen; Ravindra, Kodihalli C.; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Gandhi, Ujjawal H.] Penn State Univ, Ctr Mol Immunol & Infect Dis, Grad Program Mol Toxicol, University Pk, PA 16802 USA; [Hegde, Shailaja; Nelson, Shakira M.; Vunta, Hema] Penn State Univ, Ctr Mol Immunol & Infect Dis, Grad Program Pathobiol, University Pk, PA 16802 USA; [Narayan, Vivek] Penn State Univ, Ctr Mol Immunol & Infect Dis, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA; Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Prabhu, KS (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	ksprabhu@psu.edu		Narayan, Vivek/0000-0002-3232-7898; Kaushal, Naveen/0000-0001-9979-5664	National Institutes of Health [DK077152, AT004350]; American Institute for Cancer Research; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077152, R01DK080040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077152 and AT004350. This work was also supported by the American Institute for Cancer Research.	Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Brigelius-Flohe R, 2008, CHEM BIODIVERS, V5, P389, DOI 10.1002/cbdv.200890039; Cao YZ, 2000, FREE RADICAL BIO MED, V28, P381, DOI 10.1016/S0891-5849(99)00251-8; Catley MC, 2003, FEBS LETT, V547, P75, DOI 10.1016/S0014-5793(03)00672-0; Chen J, 2003, J NEUROCHEM, V86, P1, DOI 10.1046/j.1471-4159.2003.01854.x; Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Forceville X, 2001, THERAPIE, V56, P653; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Gartner R, 1999, MED KLIN, V94, P54; Gartner R, 2003, BIOFACTORS, V19, P165; Hashimoto K, 2005, J IMMUNOL, V174, P525, DOI 10.4049/jimmunol.174.1.525; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Jackson MI, 2008, CURR OPIN CLIN NUTR, V11, P718, DOI 10.1097/MCO.0b013e3283139674; Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Lee CR, 2003, ANTICANCER RES, V23, P2159; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; MADDIPATI KR, 1987, J BIOL CHEM, V262, P17398; Maxey KM, 2000, PROSTAG OTH LIPID M, V62, P15, DOI 10.1016/S0090-6980(00)00072-1; McKenzie RC, 1998, IMMUNOL TODAY, V19, P342, DOI 10.1016/S0167-5699(98)01294-8; Nakamura Y, 2002, J BIOL CHEM, V277, P2687, DOI 10.1074/jbc.M109641200; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Rouzer CA, 2006, BIOCHEMISTRY-US, V45, P14795, DOI 10.1021/bi061723j; Small-Howard AL, 2005, BIOCHEM SOC T, V33, P1493, DOI 10.1042/BST0331493; SMITH WL, 1983, J BIOL CHEM, V258, P5922; Stachowska E, 2009, J PHYSIOL PHARMACOL, V60, P77; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Subramanian A, 2008, J VIROL, V82, P382, DOI 10.1128/JVI.02487-06; Vunta H, 2008, MOL NUTR FOOD RES, V52, P1316, DOI 10.1002/mnfr.200700346; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Yamaguchi S, 2010, J AM CHEM SOC, V132, P824, DOI 10.1021/ja908878n; Zamamiri-Davis F, 2002, FREE RADICAL BIO MED, V32, P890, DOI 10.1016/S0891-5849(02)00775-X	43	72	76	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27471	27482		10.1074/jbc.M111.260547	http://dx.doi.org/10.1074/jbc.M111.260547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669866	hybrid, Green Published			2022-12-25	WOS:000293268700042
J	Hedl, M; Abraham, C				Hedl, Matija; Abraham, Clara			Distinct Roles for Nod2 Protein and Autocrine Interleukin-1 beta in Muramyl Dipeptide-induced Mitogen-activated Protein Kinase Activation and Cytokine Secretion in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; TUMOR-NECROSIS-FACTOR; IL-1-BETA PRODUCTION; HUMAN MONOCYTES; TNF-ALPHA; LIPOPOLYSACCHARIDE; EXPRESSION; DISEASE; MICE; PEPTIDOGLYCAN	Elucidating factors regulating Crohn's disease-associated nucleotide-binding oligomerization domain 2 (Nod2) responses is critical to understanding the mechanisms of intestinal immune homeostasis. Stimulation of primary monocyte-derived macrophages by muramyl dipeptide (MDP), a component of bacterial peptidoglycan and specific Nod2 ligand, produces cytokines, including IL-1 beta. We found that IL-1 beta blockade profoundly inhibits MDP-induced cytokine production in human monocyte-derived macrophages, demonstrating a key role for IL-1 beta autocrine secretion in Nod2-mediated responses. Importantly, although MAPK activation has previously been attributed directly to Nod2 signaling, we determined that the IL-1 beta autocrine loop is responsible for the majority of MDP-induced MAPK activation. Because the critical effects of IL-1 beta autocrine secretion on MAPK activation are observed as early as 10 min after Nod2 stimulation, we hypothesized that secretion of IL-1 beta from preexisting intracellular pro-IL-1 beta stores is necessary for optimal MDP-mediated cytokine induction. Consistently, we detected IL-1 beta secretion within 10 min of MDP treatment. Moreover, caspase-1 inhibition significantly attenuates MDP-mediated early MAPK activation. Importantly, selective JNK/p38 activation is sufficient to rescue the decreased cytokine secretion during Nod2 stimulation in the absence of autocrine IL-1 beta. Finally, we found that the IL-1 beta autocrine loop significantly enhances responses by a broad range of pattern recognition receptors. Taken together, MDP stimulation activates Nod2 to process and release preexisting pro-IL-1 beta stores in a caspase-1-dependent fashion; this secreted IL-1 beta, in turn, contributes to the majority of MDP-initiated MAPK activation and leads to subsequent cytokine secretion. Our findings clarify mechanisms of IL-1 beta contributions to Nod2 responses and elucidate the dominant role of IL-1 beta in MDP-initiated MAPK and cytokine secretion.	[Abraham, Clara] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA	Yale University	Abraham, C (corresponding author), Yale Univ, Dept Internal Med, Sect Digest Dis, 333 Cedar St,LMP 1080, New Haven, CT 06520 USA.	clara.abraham@yale.edu			National Institutes of Health [R01DK077905, DK-P30-34989, U19-AI082713]; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK077905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK077905, DK-P30-34989, and U19-AI082713 (to C. A.). This work was also supported by the Crohn's and Colitis Foundation of America (to C. A. and M. H.).	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Carter JD, 2003, JCR-J CLIN RHEUMATOL, V9, P276, DOI 10.1097/01.RHU.0000081265.06408.e4; CASSATELLA MA, 1993, J EXP MED, V178, P2207, DOI 10.1084/jem.178.6.2207; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; DONNELLY RP, 1995, J IMMUNOL, V155, P1420; Ferwerda G, 2008, EUR J IMMUNOL, V38, P184, DOI 10.1002/eji.200737103; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; GRANOWITZ EV, 1992, BLOOD, V79, P2364; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hedl M, 2011, GASTROENTEROLOGY, V140, P231, DOI 10.1053/j.gastro.2010.09.009; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Kim YG, 2008, IMMUNITY, V28, P246, DOI 10.1016/j.immuni.2007.12.012; Klotz LO, 1999, EUR J BIOCHEM, V260, P917, DOI 10.1046/j.1432-1327.1999.00255.x; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Marina-Garcia N, 2008, J IMMUNOL, V180, P4050, DOI 10.4049/jimmunol.180.6.4050; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Pan QL, 2007, J LEUKOCYTE BIOL, V82, P177, DOI 10.1189/jlb.1006627; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pauleau AL, 2003, MOL CELL BIOL, V23, P7531, DOI 10.1128/MCB.23.21.7531-7539.2003; Pioli PA, 2006, J IMMUNOL, V176, P6647, DOI 10.4049/jimmunol.176.11.6647; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rosenzweig HL, 2008, J LEUKOCYTE BIOL, V84, P529, DOI 10.1189/jlb.0108015; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Shikama Y, 2011, INNATE IMMUN-LONDON, V17, P3, DOI 10.1177/1753425909347508; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Vidal VF, 2001, EUR J IMMUNOL, V31, P1962, DOI 10.1002/1521-4141(200107)31:7<1962::AID-IMMU1962>3.0.CO;2-V; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Villani AC, 2009, NAT GENET, V41, P71, DOI 10.1038/ng.285; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200	43	51	55	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26440	26449		10.1074/jbc.M111.237495	http://dx.doi.org/10.1074/jbc.M111.237495			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659536	hybrid, Green Published			2022-12-25	WOS:000293078200022
J	Lau, ATY; Lee, SY; Xu, YM; Zheng, D; Cho, YY; Zhu, F; Kim, HG; Li, SQ; Zhang, ZG; Bode, AM; Dong, ZG				Lau, Andy T. Y.; Lee, Sung-Young; Xu, Yan-Ming; Zheng, Duo; Cho, Yong-Yeon; Zhu, Feng; Kim, Hong-Gyum; Li, Sheng-Qing; Zhang, Zhiguo; Bode, Ann M.; Dong, Zigang			Phosphorylation of Histone H2B Serine 32 Is Linked to Cell Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN MODIFICATIONS; STERILE-20 KINASE; CANCER; H3; TRANSCRIPTION; APOPTOSIS; PROTEIN; REQUIREMENT; ACTIVATION; REGULATOR	Various types of post-translational modifications of the histone tails have been revealed, but a few modifications have been found within the histone core sequences. Histone core post-translational modifications have the potential to modulate nucleosome structure and DNA accessibility. Here, we studied the histone H2B core domain and found that phosphorylation of H2B serine 32 occurs in normal cycling and mitogen-stimulated cells. Notably, this phosphorylation is elevated in skin cancer cell lines and tissues compared with normal counterparts. The JB6 Cl41 mouse skin epidermal cell line is a well established model for tumor promoter-induced cell transformation and was used to study the function of H2B during EGF-induced carcinogenesis. Remarkably, cells overexpressing a nonphosphorylatable H2BS32A mutant exhibited suppressed growth and EGF-induced cell transformation, possibly because of decreased activation of activator protein-1, compared with control cells overexpressing wild type H2B. We identified ribosomal S6 kinase 2 (RSK2) as the kinase responsible for H2BS32 phosphorylation. Serum-starved JB6 cells contain very little endogenous H2BS32 phosphorylation, and EGF treatment induced this phosphorylation. The phosphorylation was attenuated in RSK2 knock-out MEFs and RSK2 knockdown JB6 cells. Taken together, our results demonstrate a novel role for H2B phosphorylation in cell transformation and show that H2BS32 phosphorylation is critical for controlling activator protein-1 activity, which is a major driver in cell transformation.	[Lau, Andy T. Y.; Lee, Sung-Young; Xu, Yan-Ming; Zheng, Duo; Cho, Yong-Yeon; Zhu, Feng; Kim, Hong-Gyum; Li, Sheng-Qing; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Zhang, Zhiguo] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	University of Minnesota System; Mayo Clinic	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	yongyeon@catholic.ac.kr; zgdong@hi.umn.edu	Cho, Yong-Yeon/AAD-4263-2020; ZHU, Feng/G-3567-2010; Lau, Andy Tao Yin/AAX-9980-2021; ZHU, Feng/C-1303-2010	Lau, Andy Tao Yin/0000-0002-7146-7789; Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA077646, R37CA081064, CA120388, ES016548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA077646, R37CA081064, R01CA120388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, R37CA081064, CA120388, and ES016548. This work was also supported by the Hormel Foundation.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; BODE AM, 2005, SCI STKE, pRE4; Bode AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259mr2; Bonisch C, 2008, EXPERT REV PROTEOMIC, V5, P105, DOI 10.1586/14789450.5.1.105; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Clark DE, 2005, CANCER RES, V65, P3108; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; Lee SY, 2010, J BIOL CHEM, V285, P29525, DOI 10.1074/jbc.M110.127233; Lenfant F, 1996, EMBO J, V15, P3974, DOI 10.1002/j.1460-2075.1996.tb00771.x; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; MANDERS EMM, 1992, J CELL SCI, V103, P857; Parra MA, 2006, MOL CELL BIOL, V26, P3842, DOI 10.1128/MCB.26.10.3842-3852.2006; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sarma K, 2004, METHOD ENZYMOL, V376, P255; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306	30	26	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26628	26637		10.1074/jbc.M110.215590	http://dx.doi.org/10.1074/jbc.M110.215590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646345	Green Published, hybrid			2022-12-25	WOS:000293078200041
J	von Roretz, C; Macri, AM; Gallouzi, IE				von Roretz, Christopher; Macri, Angelo M.; Gallouzi, Imed-Eddine			Transportin 2 Regulates Apoptosis through the RNA-binding Protein HuR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; MESSENGER-RNA; NUCLEAR IMPORT; HEAT-SHOCK; IN-VIVO; CLEAVAGE; INHIBITION; PATHWAYS; RELEASE; STRESS	In response to severe stress, apoptotic cell death is engaged. Apoptosis is a well orchestrated process that involves the activation and implication of many factors. In this study, we identified a role for the nuclear trafficking factor TRN2(transportin 2) in cell death. TRN2 is normally responsible for the nuclear import of the RNA-binding protein HuR. During apoptosis, however, HuR accumulates in the cytoplasm. This is due to the caspase-mediated cleavage of the cytoplasmic fraction of HuR. One of the cleavage fragments generated by this processing of HuR interacts with TRN2 and thus blocks the re-import of HuR into the nucleus. This concentrates HuR in the cytoplasm, advancing apoptosis. Therefore, increasing or decreasing the levels of TRN2 has an inverse consequential effect on cell death, demonstrating for the first time the role of a nucleocytoplasmic transport factor in apoptosis.	[Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Gallouzi, IE (corresponding author), McGill Univ, Dept Biochem, McIntyre Bldg,Rm 915,3655 Promenade Sir William O, Montreal, PQ H3G 1Y6, Canada.	imed.gallouzi@mcgill.ca			National Cancer Institute of Canada [016247]; Canadian Institutes of Health Research [MOP-89798]; Natural Sciences and Engineering Research Council of Canada; Tier 2 Canada Research Chair	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Tier 2 Canada Research Chair(Canada Research Chairs)	This work was supported in part by National Cancer Institute of Canada Operating Grant 016247 and Canadian Institutes of Health Research Operating Grant MOP-89798 (to I.-E. G.).; Recipient of a Natural Sciences and Engineering Research Council of Canada summer undergraduate student award.; Recipient of a Tier 2 Canada Research Chair.	Abdelmohsen K, 2007, CELL CYCLE, V6, P1288, DOI 10.4161/cc.6.11.4299; Beauchamp P, 2010, CELL DEATH DIFFER, V17, P1588, DOI 10.1038/cdd.2010.34; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Di Marco S, 2001, NUCLEIC ACIDS RES, V29, P863, DOI 10.1093/nar/29.4.863; Fadeel B, 2008, CELL DEATH DIFFER, V15, P443, DOI 10.1038/sj.cdd.4402265; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Johnson CR, 2004, APOPTOSIS, V9, P423, DOI 10.1023/B:APPT.0000031457.90890.13; Katsanou V, 2009, MOL CELL BIOL, V29, P2762, DOI 10.1128/MCB.01393-08; Lian XJ, 2009, J BIOL CHEM, V284, P8868, DOI 10.1074/jbc.M806372200; Mazroui R, 2008, J CELL BIOL, V180, P113, DOI 10.1083/jcb.200709030; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Pan W, 2009, J BIOL CHEM, V284, P6946, DOI 10.1074/jbc.M805801200; Papadaki O, 2009, J IMMUNOL, V182, P6779, DOI 10.4049/jimmunol.0900377; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; van der Giessen K, 2003, J BIOL CHEM, V278, P47119, DOI 10.1074/jbc.M308889200; van der Giessen K, 2007, MOL BIOL CELL, V18, P2619, DOI 10.1091/mbc.E07-02-0167; von Roretz C, 2010, J BIOL CHEM, V285, P16806, DOI 10.1074/jbc.M109.087320	26	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25983	25991		10.1074/jbc.M110.216184	http://dx.doi.org/10.1074/jbc.M110.216184			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21646354	Green Published, hybrid			2022-12-25	WOS:000293073000057
J	Fabricius-Bjerre, S; Jensen, RB; Faerch, K; Larsen, T; Molgaard, C; Michaelsen, KF; Vaag, A; Greisen, G				Fabricius-Bjerre, Signe; Jensen, Rikke Beck; Faerch, Kristine; Larsen, Torben; Molgaard, Christian; Michaelsen, Kim Fleischer; Vaag, Allan; Greisen, Gorm			Impact of Birth Weight and Early Infant Weight Gain on Insulin Resistance and Associated Cardiovascular Risk Factors in Adolescence	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; CATCH-UP GROWTH; GLUCOSE-TOLERANCE; CHILDHOOD GROWTH; METABOLIC RISK; LATER LIFE; FETAL; SENSITIVITY; OBESITY; SECRETION	Background: Low birth weight followed by accelerated weight gain during early childhood has been associated with adverse metabolic and cardiovascular outcomes later in life. The aim of this study was to examine the impact of early infant weight gain on glucose metabolism and cardiovascular risk factors in adolescence and to study if the effect differed between adolescents born small for gestational age (SGA) vs. appropriate for gestational age (AGA). Methodology/Principal Findings: Data from 30 SGA and 57 AGA healthy young Danish adolescents were analysed. They had a mean age of 17.6 years and all were born at term. Data on early infant weight gain from birth to three months as well as from birth to one year were available in the majority of subjects. In adolescence, glucose metabolism was assessed by a simplified intravenous glucose tolerance test and body composition was assessed by dual-energy X-ray absorptiometry. Blood pressures as well as plasma concentrations of triglycerides and cholesterol were measured. Early infant weight gain from birth to three months was positively associated with the fasting insulin concentration, HOMA-IR, basal lipid levels and systolic blood pressure at 17 years. There was a differential effect of postnatal weight gain on HOMA-IR in AGA and SGA participants (P for interaction = 0.03). No significant associations were seen between postnatal weight gain and body composition or parameters of glucose metabolism assessed by the simplified intravenous glucose tolerance test. In subgroup analysis, all associations with early infant weight gain were absent in the AGA group, but the associations with basal insulin and HOMA-IR were still present in the SGA group. Conclusion: This study suggests that accelerated growth during the first three months of life may confer an increased risk of later metabolic disturbances - particularly of glucose metabolism - in individuals born SGA.	[Fabricius-Bjerre, Signe; Greisen, Gorm] Rigshosp, Univ Dept Neonatol, DK-2100 Copenhagen, Denmark; [Jensen, Rikke Beck] Rigshosp, Univ Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Faerch, Kristine; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Larsen, Torben] Holbaek Cent Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark; [Molgaard, Christian; Michaelsen, Kim Fleischer] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Frederiksberg, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Steno Diabetes Center; Holbaek Hospital; University of Copenhagen	Fabricius-Bjerre, S (corresponding author), Rigshosp, Univ Dept Neonatol, DK-2100 Copenhagen, Denmark.	greisen@rh.dk	Mølgaard, Christian/D-2052-2014; Greisen, Gorm/AAA-6463-2022; Jensen, Rikke Beck/AAB-3236-2020	Mølgaard, Christian/0000-0002-5311-9457; Greisen, Gorm/0000-0001-8042-3262; Vaag, Allan Arthur/0000-0002-3690-2191; Jensen, Rikke Beck/0000-0002-4522-672X; Faerch, Kristine/0000-0002-6127-0448; Michaelsen, Kim F/0000-0003-0449-0839	Novo Nordisk; Lundbek Foundation; Danish Health Insurance Foundation; European Union [005272]; Danish Diabetes Association	Novo Nordisk(Novo Nordisk); Lundbek Foundation; Danish Health Insurance Foundation; European Union(European Commission); Danish Diabetes Association	Novo Nordisk, the Lundbek Foundation, the Danish Health Insurance Foundation, an EXGENESIS grant (005272) from the European Union and the Danish Diabetes Association supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14; Andersen E, 1982, Ugeskr Laeger, V144, P1760; Barker DJP, 2009, ANN HUM BIOL, V36, P445, DOI 10.1080/03014460902980295; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; COLLE E, 1976, PEDIATRICS, V57, P363; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Fagerberg B, 2004, J INTERN MED, V256, P254, DOI 10.1111/j.1365-2796.2004.01361.x; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; GALVIN P, 1992, DIABETIC MED, V9, P921, DOI 10.1111/j.1464-5491.1992.tb01732.x; Harder T, 1999, Endocr Regul, V33, P25; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Jimenez-Chillaron Josep C, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P23, DOI 10.1097/MED.0b013e328013da8e; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kensara OA, 2005, AM J CLIN NUTR, V82, P980; Larsen T, 1997, EARLY HUM DEV, V47, P157, DOI 10.1016/S0378-3782(96)01780-X; LARSEN T, 1992, BRIT J OBSTET GYNAEC, V99, P469, DOI 10.1111/j.1471-0528.1992.tb13783.x; LARSEN T, 1990, EARLY HUM DEV, V24, P37, DOI 10.1016/0378-3782(90)90004-3; LAW CM, 1992, J EPIDEMIOL COMMUN H, V46, P184, DOI 10.1136/jech.46.3.184; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Levy-Marchal C, 2004, PEDIATR DIABETES, V5, P147, DOI 10.1111/j.1399-543X.2004.00057.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mericq V, 2005, DIABETOLOGIA, V48, P2609, DOI 10.1007/s00125-005-0036-z; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; Pilgaard K, 2010, DIABETOLOGIA, V53, P2526, DOI 10.1007/s00125-010-1917-3; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Ridgway CL, 2011, DIABETES CARE, V34, P187, DOI 10.2337/dc10-1178; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; Soto N, 2003, J CLIN ENDOCR METAB, V88, P3645, DOI 10.1210/jc.2002-030031; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Toft U, 2007, EUR J CLIN NUTR, V61, P270, DOI 10.1038/sj.ejcn.1602503; Veening MA, 2002, J CLIN ENDOCR METAB, V87, P4657, DOI 10.1210/jc.2001-011940; Vielwerth SE, 2008, DIABETOLOGIA, V51, P1483, DOI 10.1007/s00125-008-1037-5; WARSOF SL, 1977, AM J OBSTET GYNECOL, V128, P881, DOI 10.1016/0002-9378(77)90058-8	46	115	119	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20595	10.1371/journal.pone.0020595	http://dx.doi.org/10.1371/journal.pone.0020595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655104	Green Published, Green Submitted, gold			2022-12-25	WOS:000291310600017
J	Yadav, V; Panilaitis, B; Shi, H; Numuta, K; Lee, K; Kaplan, DL				Yadav, Vikas; Panilaitis, Bruce; Shi, Hai; Numuta, Keiji; Lee, Kyongbum; Kaplan, David L.			N-acetylglucosamine 6-Phosphate Deacetylase (nagA) Is Required for N-acetyl Glucosamine Assimilation in Gluconacetobacter xylinus	PLOS ONE			English	Article							ESCHERICHIA-COLI; N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE; CHITIN OLIGOSACCHARIDES; BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM; MARINE-BACTERIA; CELL-WALL; IDENTIFICATION; BIOSYNTHESIS; MUTANTS	Metabolic pathways for amino sugars (N-acetylglucosamine; GlcNAc and glucosamine; Gln) are essential and remain largely conserved in all three kingdoms of life, i.e., microbes, plants and animals. Upon uptake, in the cytoplasm these amino sugars undergo phosphorylation by phosphokinases and subsequently deacetylation by the enzyme N-acetylglucosamine 6-phosphate deacetylase (nagA) to yield glucosamine-6-phosphate and acetate, the first committed step for both GlcNAc assimilation and amino-sugar-nucleotides biosynthesis. Here we report the cloning of a DNA fragment encoding a partial nagA gene and its implications with regard to amino sugar metabolism in the cellulose producing bacterium Glucoacetobacter xylinus (formally known as Acetobacter xylinum). For this purpose, nagA was disrupted by inserting tetracycline resistant gene (nagA:: tet(r); named as Delta nagA) via homologous recombination. When compared to glucose fed conditions, the UDP-GlcNAc synthesis and bacterial growth (due to lack of GlcNAc utilization) was completely inhibited in nagA mutants. Interestingly, that inhibition occured without compromising cellulose production efficiency and its molecular composition under GlcNAc fed conditions. We conclude that nagA plays an essential role for GlcNAc assimilation by G. xylinus thus is required for the growth and survival for the bacterium in presence of GlcNAc as carbon source. Additionally, G. xylinus appears to possess the same molecular machinery for UDP-GlcNAc biosynthesis from GlcNAc precursors as other related bacterial species.	[Yadav, Vikas; Panilaitis, Bruce; Numuta, Keiji; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Shi, Hai; Lee, Kyongbum; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA	Tufts University; Tufts University	Yadav, V (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Danna farber Canc Inst, Boston, MA 02163 USA.	david.kaplan@tufts.edu	Lee, Kyongbum/D-9230-2013; Shi, Hai/K-6254-2012	Lee, Kyongbum/0000-0002-0699-8057	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSLER BL, 1991, J BIOL CHEM, V266, P24276; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; Camacho F, 1996, J CHEM TECHNOL BIOT, V67, P350, DOI 10.1002/(SICI)1097-4660(199612)67:4<350::AID-JCTB564>3.0.CO;2-9; CARR JG, 1958, NATURE, V182, P265, DOI 10.1038/182265b0; Coggins BE, 2003, NAT STRUCT BIOL, V10, P645, DOI 10.1038/nsb948; Doktycz MJ, 2003, ULTRAMICROSCOPY, V97, P209, DOI 10.1016/S0304-3991(03)00045-7; Eisenbeis S, 2008, J BACTERIOL, V190, P5230, DOI 10.1128/JB.00194-08; Ferreira FM, 2000, ACTA CRYSTALLOGR D, V56, P670, DOI 10.1107/S0907444900003668; Ferreira FM, 2006, J MOL BIOL, V359, P308, DOI 10.1016/j.jmb.2006.03.024; FLORENCE VF, 2004, J BIOL CHEM, V279, P2809; Freese EB, 1970, J BACTERIOL, V101, P1046, DOI 10.1128/JB.101.3.1046-1062.1970; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; HOLTJE, 1985, MOL CYTOLOGY ESCHERI, P77; Iida A, 2009, MICROBIOL-SGM, V155, P3021, DOI 10.1099/mic.0.028613-0; IMADA A, 1977, J GEN MICROBIOL, V100, P329, DOI 10.1099/00221287-100-2-329; Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1; Lee JW, 2001, APPL ENVIRON MICROB, V67, P3970, DOI 10.1128/AEM.67.9.3970-3975.2001; Marshall KC, 1990, ADV MICROB ECOL, P387, DOI DOI 10.1007/978-1-4684-7612-5_10; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; MOBLEY HLT, 1982, J BACTERIOL, V150, P8, DOI 10.1128/JB.150.1.8-15.1982; OGAWA R, 1992, INT J BIOL MACROMOL, V14, P343, DOI 10.1016/S0141-8130(05)80076-5; Park JT, 2001, J BACTERIOL, V183, P3842, DOI 10.1128/JB.183.13.3842-3847.2001; PLUMBRIDGE JA, 1990, J BACTERIOL, V172, P2728, DOI 10.1128/jb.172.5.2728-2735.1990; RAETZ CRH, 1987, ESCHERICHIA COLI SAL, V1, P498; Riemann L, 2002, APPL ENVIRON MICROB, V68, P5554, DOI 10.1128/AEM.68.11.5554-5562.2002; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Shigematsu T, 2005, J BIOSCI BIOENG, V99, P415, DOI 10.1263/jbb.99.415; Shirai A, 1997, CARBOHYD POLYM, V32, P223, DOI 10.1016/S0144-8617(97)00009-X; SHIRAI A, 1994, INT J BIOL MACROMOL, V16, P297, DOI 10.1016/0141-8130(94)90059-0; Span PN, 2001, CLIN CHEM, V47, P944; Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847; WHITE RJ, 1967, BIOCHEM J, V118, P89; WONG HC, 1990, P NATL ACAD SCI USA, V87, P8130, DOI 10.1073/pnas.87.20.8130; YADAV V, 2010, APPL ENV MI IN PRESS	42	20	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e18099	10.1371/journal.pone.0018099	http://dx.doi.org/10.1371/journal.pone.0018099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655093	gold, Green Published, Green Submitted			2022-12-25	WOS:000291310600001
J	Chen, H; Sun, YM; Dong, RQ; Yang, SS; Pan, CY; Xiang, D; Miao, MY; Jiao, BH				Chen, Huan; Sun, Yimin; Dong, Ruiqi; Yang, Shengsheng; Pan, Chuanyong; Xiang, Dao; Miao, Mingyong; Jiao, Binghua			Mir-34a Is Upregulated during Liver Regeneration in Rats and Is Associated with the Suppression of Hepatocyte Proliferation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; GROWTH-FACTOR; DOWN-REGULATION; CELL LINE; ACTIVIN-B; EXPRESSION; MICRORNAS; BETA; HEPATECTOMY; FOLLISTATIN	Background: MicroRNAs are a class of small regulatory RNAs that modulate a variety of biological processes, including cellular differentiation, apoptosis, metabolism and proliferation. This study aims to explore the effect of miR-34a in hepatocyte proliferation and its potential role in liver regeneration termination. Methodology/Principal Finding: MiR-34a was highly induced after partial hepatectomy. Overexpression of miR-34a in BRL3A cells could significantly inhibit cell proliferation and down-regulate the expression of inhibin bB (INHBB) and Met. In BRL3A cells, INHBB was identified as a direct target of miR-34a by luciferase reporter assay. More importantly, INHBB siRNA significantly repressed cell proliferation. A decrease of INHBB and Met was detected in regenerating liver. Conclusion/Significance: MiR-34a expression was upregulated during the late phase of liver regeneration. MiR-34amediated regulation of INHBB and Met may collectively contribute to the suppression of hepatocyte proliferation.	[Chen, Huan; Dong, Ruiqi; Yang, Shengsheng; Pan, Chuanyong; Miao, Mingyong; Jiao, Binghua] Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China; [Sun, Yimin] Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China; [Xiang, Dao] Second Mil Med Univ, Dept Cellular Biol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Chen, H (corresponding author), Second Mil Med Univ, Dept Biochem & Mol Biol, Shanghai, Peoples R China.	miaomy@163.com; jiaobh@uninet.com.cn		Chen, Huan/0000-0001-8648-1631	National Natural Science Foundation of China [30800553]; Science and Technology Commission Foundation of Shanghai [10JC1417400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission Foundation of Shanghai	This work was financially supported by National Natural Science Foundation of China (No. 30800553) and Basic Research Program of Science and Technology Commission Foundation of Shanghai (No. 10JC1417400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Arora V, 2000, DRUG METAB DISPOS, V28, P131; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Endo D, 2006, ENDOCR J, V53, P73, DOI 10.1507/endocrj.53.73; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gold EJ, 2005, J MOL ENDOCRINOL, V34, P505, DOI 10.1677/jme.1.01657; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Higgins GM, 1931, ARCH PATHOL, V12, P186; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Li BH, 2010, INT J GYNECOL CANCER, V20, P597, DOI 10.1111/IGC.0b013e3181d63170; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locker J, 2003, HEPATOLOGY, V38, P314, DOI 10.1053/jhep.2003.50299; Luan SH, 2010, ARCH MED RES, V41, P67, DOI 10.1016/j.arcmed.2010.02.007; Mangnall D, 2003, LIVER INT, V23, P124, DOI 10.1034/j.1600-0676.2003.00812.x; Marquez RT, 2010, AM J PHYSIOL-GASTR L, V298, pG535, DOI 10.1152/ajpgi.00338.2009; Niimi S, 2002, BIOL PHARM BULL, V25, P437, DOI 10.1248/bpb.25.437; Oe S, 2004, HEPATOLOGY, V40, P1098, DOI 10.1002/hep.20426; Russell CE, 1999, MOL CELL ENDOCRINOL, V148, P129, DOI 10.1016/S0303-7207(98)00226-3; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Takamura K, 2005, J SURG RES, V126, P3, DOI 10.1016/j.jss.2005.01.002; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; YUAN B, 2011, FEBS LETT, DOI DOI 10.1016/J.FEBSLET.2011.1002.1031; Zhong Z, 2010, LIVER TRANSPLANT, V16, P181, DOI 10.1002/lt.21966	30	81	89	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20238	10.1371/journal.pone.0020238	http://dx.doi.org/10.1371/journal.pone.0020238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655280	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600032
J	Desvars, A; Jego, S; Chiroleu, F; Bourhy, P; Cardinale, E; Michault, A				Desvars, Amelie; Jego, Sylvaine; Chiroleu, Frederic; Bourhy, Pascale; Cardinale, Eric; Michault, Alain			Seasonality of Human Leptospirosis in Reunion Island (Indian Ocean) and Its Association with Meteorological Data	PLOS ONE			English	Article							RISK-FACTORS; OUTBREAK; EPIDEMIOLOGY; RATS	Background: Leptospirosis is a disease which occurs worldwide but particularly affects tropical areas. Transmission of the disease is dependent on its excretion by reservoir animals and the presence of moist environment which allows the survival of the bacteria. Methods and Findings: A retrospective study was undertaken to describe seasonal patterns of human leptospirosis cases reported by the Centre National de References des Leptospiroses (CNRL, Pasteur Institute, Paris) between 1998 and 2008, to determine if there was an association between the occurrence of diagnosed cases and rainfall, temperature and global solar radiation (GSR). Meteorological data were recorded in the town of Saint-Benoit (Meteo France "Beaufonds-Miria'' station), located on the windward (East) coast. Time-series analysis was used to identify the variables that best described and predicted the occurrence of cases of leptospirosis on the island. Six hundred and thirteen cases were reported during the 11-year study period, and 359 cases (58.56%) were diagnosed between February and May. A significant correlation was identified between the number of cases in a given month and the associated cumulated rainfall as well as the mean monthly temperature recorded 2 months prior to diagnosis (r = 0.28 and r = 0.23 respectively). The predictive model includes the number of cases of leptospirosis recorded 1 month prior to diagnosis (b = 0.193), the cumulated monthly rainfall recorded 2 months prior to diagnosis (b = 0.145), the average monthly temperature recorded 0 month prior to diagnosis (b = 3.836), and the average monthly GSR recorded 0 month prior to diagnosis (b = -1.293). Conclusions: Leptospirosis has a seasonal distribution in Reunion Island. Meteorological data can be used to predict the occurrence of the disease and our statistical model can help to implement seasonal prevention measures.	[Desvars, Amelie; Cardinale, Eric] Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, UMR CMAEE, St Clotilde, Reunion, France; [Desvars, Amelie; Cardinale, Eric] Ctr Reg Rech & Veille Malad Emergentes Ocean Indi, St Clotilde, Reunion, France; [Jego, Sylvaine; Chiroleu, Frederic] CIRAD, UMR Peuplement Vegetaux & Bioagresseurs Milieu Tr, St Pierre, Reunion, France; [Bourhy, Pascale] Ctr Natl Reference Leptospiroses, Inst Pasteur, Unite Postulante Biol Spirochetes, Paris, France; [Desvars, Amelie; Michault, Alain] CHR, GHSR, Lab Bacteriol Parasitol Virol Hyg, St Pierre, Reunion, France	CIRAD; CIRAD; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Reunion	Desvars, A (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Unite Mixte Rech Controle Malad Anim Exot & Emerg, UMR CMAEE, St Clotilde, Reunion, France.	amelie.desvars@cirad.fr		Desvars-Larrive, Amelie/0000-0001-7671-696X; CHIROLEU, Frederic/0000-0002-4874-5357				Agesilas F, 2005, ARCH PEDIATRIE, V12, P1344, DOI 10.1016/j.arcped.2005.04.084; BARCELLOS C, 2001, CAD SAUDE PUBLICA S, V17; Brod CS, 2005, REV SOC BRAS MED TRO, V38, P294, DOI 10.1590/S0037-86822005000400003; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005; Douglin CP, 1997, EMERG INFECT DIS, V3, P78, DOI 10.3201/eid0301.970114; DUVAL G, 1991, REV EPIDEMIOL SANTE, V39, P135; EVERARD COR, 1992, J TROP MED HYG, V95, P13; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Gaynor K, 2007, AM J TROP MED HYG, V76, P882, DOI 10.4269/ajtmh.2007.76.882; Henrmann-Storck C, 2005, W INDIAN MED J, V54, P42; HIRSCHAUER C, 2009, B EPIDEMIOLOGIQUE HE, V48, P508; *INSEE, 2010, TABL EC REUN TER ED; Katz AR, 2001, CLIN INFECT DIS, V33, P1834, DOI 10.1086/324084; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lhomme V, 1996, MED MALADIES INFECT, V26, P94, DOI 10.1016/S0399-077X(96)80161-2; MAILLOUX M, 1983, B SOC PATHOL EXOT, V76, P729; McCurry J, 2009, LANCET, V374, P1489, DOI 10.1016/S0140-6736(09)61888-2; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; Mohan ARM, 2009, ACTA TROP, V112, P260, DOI 10.1016/j.actatropica.2009.08.007; Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Pappachan MJ, 2004, J EPIDEMIOL COMMUN H, V58, P1054, DOI 10.1136/jech.2003.018556; Perrocheau A, 1997, EUR J EPIDEMIOL, V13, P161, DOI 10.1023/A:1007300514760; Picardeau M., 2008, Bulletin Epidemiologique Hebdomadaire, P329; Priya CG, 2007, J POSTGRAD MED, V53, P236; RAUNET M, 1991, PHYS ENV SOILS REUNI; Sanders EJ, 1999, AM J TROP MED HYG, V61, P399, DOI 10.4269/ajtmh.1999.61.399; Sehgal SC, 2002, NATL MED J INDIA, V15, P22; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Shumway R.H., 2006, TIME SERIES ANAL ITS; SMITH CE, 1961, B WORLD HEALTH ORGAN, V24, P35; Storck CH, 2008, EPIDEMIOL INFECT, V136, P1407, DOI 10.1017/S0950268807000052; Tassinari WS, 2008, TROP MED INT HEALTH, V13, P503, DOI 10.1111/j.1365-3156.2008.02028.x; Weekes CC, 1997, VET MICROBIOL, V57, P215, DOI 10.1016/S0378-1135(97)00127-2; *WHO, 1999, WKLY EP REC, V74, P267	36	61	62	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20377	10.1371/journal.pone.0020377	http://dx.doi.org/10.1371/journal.pone.0020377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655257	Green Published, gold			2022-12-25	WOS:000291097600059
J	Sun, HG; Hu, YP; Gu, ZN; Wilson, MD; Chen, YQ; Rudel, LL; Willingham, MC; Edwards, IJ				Sun, Haiguo; Hu, Yunping; Gu, Zhennan; Wilson, Martha D.; Chen, Yong Q.; Rudel, Lawrence L.; Willingham, Mark C.; Edwards, Iris J.			Endogenous Synthesis of n-3 Polyunsaturated Fatty Acids in Fat-1 Mice Is Associated with Increased Mammary Gland and Liver Syndecan-1	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; BREAST-CANCER CELLS; TRANSGENIC MICE; DOCOSAHEXAENOIC ACID; NUDE-MICE; CLINICAL-SIGNIFICANCE; REDUCED EXPRESSION; GROWTH-FACTOR; CORE PROTEIN; MENHADEN OIL	Long chain n-3 PUFA have been shown to have chemopreventive properties against breast cancer through various mechanisms. One pathway, studied in human breast cancer cell lines, involves upregulation of the proteoglycan, syndecan-1 (SDC-1) by n-3 PUFA-enriched LDL. Using Fat-1 mice that are able to convert n-6 to n-3 PUFA, we tested whether SDC-1 level in vivo is elevated in mammary glands due to endogenously synthesized rather than LDL-derived n-3 PUFA. Female Fat-1 and wild type (wt) mice were fed an n-6 PUFA-enriched diet for 7 weeks. Fatty acid analysis of plasma lipoproteins showed that total n-6 PUFA reflected dietary intake similarly in both genotypes (VLDL, 36.2 +/- 2.2 and 40.9 +/- 3.9; LDL, 49.0 +/- 3.3 and 48.1 +/- 2.0; HDL, 54.6 +/- 1.2 and 58.2 +/- 1.3, mean +/- SEM percent of total fatty acids for Fat-1 and wt animals respectively). Lipoprotein percent n-3 PUFA was also similar between groups. However, phospholipids and triglycerides extracted from mammary and liver tissues demonstrated significantly higher n-3 PUFA and a corresponding decrease in the ratio n-6/n-3 PUFA in Fat-1 compared to wt mice. This was accompanied by higher SDC-1 in mammary glands and livers of Fat-1 mice, thus demonstrating that endogenously synthesized n-3 PUFA may upregulate SDC-1 in the presence of high dietary n-6 PUFA.	[Sun, Haiguo; Hu, Yunping; Wilson, Martha D.; Rudel, Lawrence L.; Willingham, Mark C.; Edwards, Iris J.] Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA; [Gu, Zhennan; Chen, Yong Q.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA	Wake Forest University; Wake Forest University	Sun, HG (corresponding author), Wake Forest Sch Med, Dept Pathol, Winston Salem, NC USA.	iedwards@wfubmc.edu	Chen, Yong Q/AAI-9864-2021	Chen, Yong Q/0000-0003-4747-4708	National Institutes of Health [R01CA115958, P01CA106742, R01CA107668, P01-HL-49373]; NATIONAL CANCER INSTITUTE [R01CA115958, P01CA106742, R01CA107668] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL049373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following grants from the National Institutes of Health: R01CA115958 (IJE), P01CA106742 (YQC, IJE), R01CA107668 (YQC) and P01-HL-49373 (LLR). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUELELA SH, 1989, CANCER RES, V49, P1434; ABOUELELA SH, 1988, LIPIDS, V23, P948, DOI 10.1007/BF02536342; Anttonen A, 1999, BRIT J CANCER, V79, P558, DOI 10.1038/sj.bjc.6690088; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; Berquin IM, 2007, J CLIN INVEST, V117, P1866, DOI 10.1172/JCI31494; Bougnoux P, 2009, BRIT J CANCER, V101, P1978, DOI 10.1038/sj.bjc.6605441; BOUGNOUX P, PROG LIPID RES, V49, P76; BRADEN LM, 1986, LIPIDS, V21, P285, DOI 10.1007/BF02536414; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chen YQ, 2006, JAMA-J AM MED ASSOC, V296, P282, DOI 10.1001/jama.296.3.282-a; Davies EJ, 2004, CLIN CANCER RES, V10, P5178, DOI 10.1158/1078-0432.CCR-03-0103; Dhodapkar MV, 1998, BLOOD, V91, P2679, DOI 10.1182/blood.V91.8.2679.2679_2679_2688; Edwards IJ, 2004, CLIN CANCER RES, V10, P8275, DOI 10.1158/1078-0432.CCR-04-1357; Edwards IJ, 2008, J BIOL CHEM, V283, P18441, DOI 10.1074/jbc.M802107200; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Fujiya M, 2001, JPN J CANCER RES, V92, P1074, DOI 10.1111/j.1349-7006.2001.tb01062.x; HU Y, NEOPLASIA, V12, P826; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; HURSTING SD, 1990, PREV MED, V19, P242, DOI 10.1016/0091-7435(90)90025-F; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; INKI P, 1994, BRIT J CANCER, V70, P319, DOI 10.1038/bjc.1994.300; ISHIKAWA T, EXP CELL RES, V316, P951; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; JURKOWSKI JJ, 1985, J NATL CANCER I, V74, P1145; KAIZER L, 1989, NUTR CANCER, V12, P61, DOI 10.1080/01635588909514002; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Kumar-Singh S, 1998, J PATHOL, V186, P300, DOI 10.1002/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; Liu W, 1998, J BIOL CHEM, V273, P22825, DOI 10.1074/jbc.273.35.22825; Liu YE, 2007, FEBS J, V274, P3351, DOI 10.1111/j.1742-4658.2007.05869.x; Loussouarn D, 2008, BRIT J CANCER, V98, P1993, DOI 10.1038/sj.bjc.6604400; Lu Y, 2008, MOL CANCER THER, V7, P3203, DOI 10.1158/1535-7163.MCT-08-0494; Ma DWL, 2006, LIPIDS, V41, P35, DOI 10.1007/s11745-006-5067-9; MacLean CH, 2006, JAMA-J AM MED ASSOC, V295, P403, DOI 10.1001/jama.295.4.403; MALI M, 1994, J BIOL CHEM, V269, P27795; Matsumoto A, 1997, INT J CANCER, V74, P482, DOI 10.1002/(SICI)1097-0215(19971021)74:5<482::AID-IJC2>3.0.CO;2-#; Mikami S, 2001, JPN J CANCER RES, V92, P1062, DOI 10.1111/j.1349-7006.2001.tb01061.x; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nackaerts K, 1997, INT J CANCER, V74, P335, DOI 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.3.CO;2-4; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; NOGUCHI M, 1995, ONCOLOGY, V52, P458; Nowak J, 2007, CARCINOGENESIS, V28, P1991, DOI 10.1093/carcin/bgm166; ORR SK, NEUROCHEM RES, V35, P811; Pulkkinen JO, 1997, ACTA OTO-LARYNGOL, V117, P312, DOI 10.3109/00016489709117794; Reddy B S, 1980, Adv Cancer Res, V32, P237, DOI 10.1016/S0065-230X(08)60363-2; ROSE DP, 1995, JNCI-J NATL CANCER I, V87, P587, DOI 10.1093/jnci/87.8.587; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; ROSE DP, 1993, CANCER RES, V53, P4686; ROSE DP, 1993, JNCI-J NATL CANCER I, V85, P1743, DOI 10.1093/jnci/85.21.1743; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; Sanderson RD, 2005, J CELL BIOCHEM, V96, P897, DOI 10.1002/jcb.20602; SASAKI S, 1993, PREV MED, V22, P187, DOI 10.1006/pmed.1993.1016; SHIKANO M, 1994, BBA-LIPID LIPID MET, V1212, P211, DOI 10.1016/0005-2760(94)90255-0; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Stanley MJ, 1999, AM J CLIN PATHOL, V112, P377; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; Sun HG, 2005, CANCER RES, V65, P4442, DOI 10.1158/0008-5472.CAN-04-4200; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Wang ZH, 2005, BIOCHEMISTRY-US, V44, P12355, DOI 10.1021/bi050620i; Wiksten JP, 2001, INT J CANCER, V95, P1, DOI 10.1002/1097-0215(20010120)95:1<1::AID-IJC1000>3.0.CO;2-5; Xia SH, 2005, CARCINOGENESIS, V26, P779, DOI 10.1093/carcin/bgi019; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Yee LD, 2005, J NUTR, V135, P983, DOI 10.1093/jn/135.5.983	71	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20502	10.1371/journal.pone.0020502	http://dx.doi.org/10.1371/journal.pone.0020502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655218	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600082
J	Ruptier, C; De Gasperis, A; Ansieau, S; Granjon, A; Taniere, P; Lafosse, I; Shi, H; Petitjean, A; Taranchon-Clermont, E; Tribollet, V; Voeltzel, T; Scoazec, JY; Maguer-Satta, V; Puisieux, A; Hainaut, P; Cavard, C; de Fromentel, CC				Ruptier, C.; De Gasperis, A.; Ansieau, S.; Granjon, A.; Taniere, P.; Lafosse, I.; Shi, H.; Petitjean, A.; Taranchon-Clermont, E.; Tribollet, V.; Voeltzel, T.; Scoazec, J-Y; Maguer-Satta, V.; Puisieux, A.; Hainaut, P.; Cavard, C.; de Fromentel, C. Caron			TP63 P2 promoter functional analysis identifies beta-catenin as a key regulator of Delta Np63 expression	ONCOGENE			English	Article						beta-catenin; p53 family; promoter; transcriptional regulation; tumour progression	SQUAMOUS-CELL CARCINOMA; STEM-CELLS; TRANSCRIPTIONAL ACTIVITY; DIFFERENTIAL REGULATION; SIGNALING PATHWAY; UP-REGULATION; P53 FAMILY; P63; CANCER; P73	The Delta Np63 protein, a product of the TP63 gene that lacks the N-terminal domain, has a critical role in the maintenance of self renewal and progenitor capacity in several types of epithelial tissues. Delta Np63 is frequently overexpressed in squamous cell carcinoma (SCC) and in some other epithelial tumours. This overexpression may contribute to tumour progression through dominant-negative effects on the transcriptionally active (TA) isoforms of the p53 family (TAp63, TAp73 and p53), as well as through independent mechanisms. However, the molecular basis of Delta Np63 overexpression is not fully understood. Here, we show that the expression of Delta Np63 is regulated by the Wnt/beta-catenin pathway in human hepatocellular carcinoma (HCC) and SCC cell lines. This regulation operates in particular through TCF/LEF sites present in the P2 promoter of TP63. In addition, we show that Delta Np63 and beta-catenin are frequently coexpressed and accumulated in oesophageal SCC, but not in HCC. These results suggest that activation of the b-catenin pathway may contribute to overexpression of Delta Np63 during tumour progression, in a cell type-specific manner. Oncogene (2011) 30, 4656-4665; doi:10.1038/onc.2011.171; published online 6 June 2011	[de Fromentel, C. Caron] CNRS5286, UMR INSERM U1052, Ctr Rech Cancerol Lyon, F-69008 Lyon, France; [Ruptier, C.; De Gasperis, A.; Ansieau, S.; Granjon, A.; Lafosse, I.; Tribollet, V.; Voeltzel, T.; Scoazec, J-Y; Maguer-Satta, V.; Puisieux, A.; de Fromentel, C. Caron] Univ Lyon, Lyon, France; [Ruptier, C.; De Gasperis, A.; Ansieau, S.; Granjon, A.; Lafosse, I.; Tribollet, V.; Voeltzel, T.; Scoazec, J-Y; Maguer-Satta, V.; Puisieux, A.; de Fromentel, C. Caron] Ctr Rech Cancerol Lyon, INSERM U1052, Lyon, France; [Taniere, P.; Shi, H.; Petitjean, A.; Taranchon-Clermont, E.; Hainaut, P.] Int Agcy Res Canc, F-69372 Lyon, France; [Scoazec, J-Y] Hop Edouard Herriot, Hosp Civils Lyon, Serv Cent Anat & Cytol Pathol, Lyon, France; [Puisieux, A.] Ctr Leon Berard, F-69373 Lyon, France; [Puisieux, A.] Inst Univ France, Paris, France; [Cavard, C.] Univ Paris 05, Inst Cochin, Dept Endocrinol Metab & Canc, CNRS UMR 8104, Paris, France; [Cavard, C.] INSERM U567, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; World Health Organization; International Agency for Research on Cancer (IARC); CHU Lyon; UNICANCER; Centre Leon Berard; Institut Universitaire de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	de Fromentel, CC (corresponding author), CNRS5286, UMR INSERM U1052, Ctr Rech Cancerol Lyon, 151 Cours Albert Thomas, F-69008 Lyon, France.	carondef@lyon.fnclcc.fr	Ansieau, Stephane/I-6195-2016; Maguer-Satta, Veronique/U-8857-2019; de Fromentel, Claude Caron/Y-9715-2019; Hainaut, Pierre/B-6018-2012	Maguer-Satta, Veronique/0000-0002-1556-068X; de Fromentel, Claude Caron/0000-0001-7566-3958; Hainaut, Pierre/0000-0002-1303-1610; PUISIEUX, Alain/0000-0002-9938-3798; ANSIEAU, Stephane/0000-0003-0989-2108	INSERM; Association pour la Recherche contre le Cancer [3117]; French Ligue Nationale Contre le Cancer; French Ministere de l'Enseignement et de la Recherche; International Agency for Research on Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); French Ministere de l'Enseignement et de la Recherche; International Agency for Research on Cancer	We thank Drs W Dinjens (University Medical Center, Rotterdam, The Netherlands) and A Costanzo (University of Rome, Italy) for the generous gift of TE-10 cells and pGL3-P2 plasmid, respectively; Drs J Zucmann-Rossi (INSERM U674, Paris, France) and B Terris (Institut Cochin, Paris, France) for the analysis of Delta Np63 expression in HCC samples; Dr B Abedi for her help for IHC experiments; Dr G Martel-Planche and A Masquelet and Ms A Durand and A Charnay for technical assistance; Drs S Sentis, G Hinkal and S and D Cox for critical reading of the manuscript. This project was supported by INSERM and the Association pour la Recherche contre le Cancer (grant number 3117). CR and HS were funded by the French Ligue Nationale Contre le Cancer, AP by the French Ministere de l'Enseignement et de la Recherche, and ET, PT, and VT by the International Agency for Research on Cancer.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ai D, 2007, MOL CELL BIOL, V27, P5765, DOI 10.1128/MCB.01848-06; Ambler CA, 2009, J PATHOL, V217, P206, DOI 10.1002/path.2468; Auriol E, 2005, NUCLEIC ACIDS RES, V33, P4243, DOI 10.1093/nar/gki729; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Cavard C, 2006, ONCOGENE, V25, P599, DOI 10.1038/sj.onc.1208860; Cavard C, 2008, FUTURE ONCOL, V4, P647, DOI 10.2217/14796694.4.5.647; Chu WK, 2008, J BIOL CHEM, V283, P7328, DOI 10.1074/jbc.M800183200; Chu WK, 2006, BIOCHEM BIOPH RES CO, V342, P1356, DOI 10.1016/j.bbrc.2006.02.111; Drewelus I, 2010, CELL CYCLE, V9, P580, DOI 10.4161/cc.9.3.10593; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kudo Junjo, 2007, World J Surg Oncol, V5, P21, DOI 10.1186/1477-7819-5-21; Lanza M, 2006, CELL CYCLE, V5, P1996, DOI 10.4161/cc.5.17.3188; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Marcel V, 2009, CELL MOL LIFE SCI, V66, P391, DOI 10.1007/s00018-008-8336-3; Moll UM, 2004, MOL CANCER RES, V2, P371; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Ninomiya I, 2000, INT J CANCER, V85, P757, DOI 10.1002/(SICI)1097-0215(20000315)85:6<757::AID-IJC3>3.0.CO;2-O; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Patturajan M, 2002, CANCER CELL, V1, P369, DOI 10.1016/S1535-6108(02)00057-0; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Romano RA, 2006, J INVEST DERMATOL, V126, P1469, DOI 10.1038/sj.jid.5700297; Senoo M, 2002, ONCOGENE, V21, P2455, DOI 10.1038/sj.onc.1205330; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Taniere P, 2001, BRIT J CANCER, V85, P721, DOI 10.1054/bjoc.2001.1990; Waltermann A, 2003, ONCOGENE, V22, P5686, DOI 10.1038/sj.onc.1206859; Wu GJ, 2005, CANCER RES, V65, P758; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Zucchi I, 2008, P NATL ACAD SCI USA, V105, P16940, DOI 10.1073/pnas.0808978105	45	22	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV	2011	30	46					4656	4665		10.1038/onc.2011.171	http://dx.doi.org/10.1038/onc.2011.171			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	851EV	21643019				2022-12-25	WOS:000297252100005
J	Chew, YC; Adhikary, G; Wilson, GM; Reece, EA; Eckert, RL				Chew, Yap Ching; Adhikary, Gautam; Wilson, Gerald M.; Reece, E. Albert; Eckert, Richard L.			Protein Kinase C (PKC) delta Suppresses Keratinocyte Proliferation by Increasing p21(Cip1) Level by a KLF4 Transcription Factor-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INVOLUCRIN PROMOTER; HUMAN EPIDERMAL-KERATINOCYTES; KRUPPEL-LIKE FACTOR; SQUAMOUS-CELL CARCINOMA; CALCIUM-INDUCED DIFFERENTIATION; DISTAL REGULATORY REGION; GREEN TEA POLYPHENOL; GENE-EXPRESSION; TUMOR SUPPRESSION; TRANSGENIC MICE	PKC delta increases keratinocyte differentiation and suppresses keratinocyte proliferation and survival. However, the mechanism of proliferation suppression is not well understood. The present studies show that PKC delta overexpression increases p21(Cip1) mRNA and protein level and promoter activity and that treatment with dominant-negative PKC delta, PKC delta-siRNA, or rottlerin inhibits promoter activation. Analysis of the p21(Cip1) promoter upstream regulatory region reveals three DNA segments that mediate PKC delta-dependent promoter activation. The PKC delta response element most proximal to the transcription start site encodes six GC-rich DNA elements. Mutation of these sites results in a loss of PKC delta-dependent promoter activation. Gel mobility supershift and chromatin immunoprecipitation reveal that these DNA elements bind the Kruppel-like transcription factor KLF4. PKC delta increases KLF4 mRNA and protein level and KLF4 binding to the GC-rich elements in the p21(Cip1) proximal promoter. In addition, KLF4-siRNA inhibits PKC delta-dependent p21(Cip1) promoter activity. PKC delta increases KLF4 expression leading to enhanced KLF4 interaction with the GC-rich elements in the p21(Cip1) promoter to activate transcription.	[Chew, Yap Ching; Adhikary, Gautam; Wilson, Gerald M.; Reece, E. Albert; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Reece, E. Albert; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol & Reprod Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507; Chew, Yap Ching/0000-0002-1686-6541	National Institutes of Health [R01 AR046494]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR046494 (to R. L. E.).	Acs P, 2000, CARCINOGENESIS, V21, P887, DOI 10.1093/carcin/21.5.887; Adhikary G, 2004, INVEST OPHTH VIS SCI, V45, P1080, DOI 10.1167/iovs.03-1180; Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Agarwal C, 1999, J BIOL CHEM, V274, P6190, DOI 10.1074/jbc.274.10.6190; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Aziz MH, 2009, J INVEST DERMATOL, V129, P2011, DOI 10.1038/jid.2008.458; Balasubramanian S, 2004, J BIOL CHEM, V279, P24007, DOI 10.1074/jbc.M314331200; Balasubramanian S, 2002, J BIOL CHEM, V277, P1828, DOI 10.1074/jbc.M110376200; Balasubramanian S, 2007, J BIOL CHEM, V282, P6707, DOI 10.1074/jbc.M606003200; Balasubramanian S, 2006, J BIOL CHEM, V281, P36162, DOI 10.1074/jbc.M605368200; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Bollag WB, 2004, DRUG NEWS PERSPECT, V17, P117, DOI 10.1358/dnp.2004.17.2.829045; Bollag WB, 2009, J INVEST DERMATOL, V129, P2330, DOI 10.1038/jid.2009.165; Cabodi S, 2000, MOL CELL, V6, P1121, DOI 10.1016/S1097-2765(00)00110-6; Cheng F, 2009, MOL BIOL CELL, V20, P319, DOI 10.1091/mbc.E08-07-0681; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Denning MF, 2000, EXP DERMATOL, V9, P192, DOI 10.1034/j.1600-0625.2000.009003192.x; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; DLUGOSZ AA, 1994, J INVEST DERMATOL, V102, P409, DOI 10.1111/1523-1747.ep12372171; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISHER GJ, 1993, J INVEST DERMATOL, V101, P553, DOI 10.1111/1523-1747.ep12365967; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; GHERZI R, 1992, BIOCHEM BIOPH RES CO, V184, P283, DOI 10.1016/0006-291X(92)91190-2; Gorospe M, 1999, GENE EXPRESSION, V7, P377; Hara T, 2005, CANCER RES, V65, P7356, DOI 10.1158/0008-5472.CAN-04-4241; Hauser P, 2004, MOL CANCER RES, V2, P96; Hwang CY, 2009, MOL CELL BIOL, V29, P3379, DOI 10.1128/MCB.01758-08; Jansen AP, 2001, CANCER RES, V61, P808; Jaubert J, 2003, DEVELOPMENT, V130, P2767, DOI 10.1242/dev.00477; Jerome-Morais A, 2009, J INVEST DERMATOL, V129, P2365, DOI 10.1038/jid.2009.74; Jiang D, 2009, J CHROMATOGR A, V1216, P6881, DOI 10.1016/j.chroma.2009.08.044; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kamioka N, 2010, BIOCHEM BIOPH RES CO, V394, P106, DOI 10.1016/j.bbrc.2010.02.125; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; LI WQ, 1995, J BIOL CHEM, V270, P8311, DOI 10.1074/jbc.270.14.8311; MATSUI MS, 1992, J INVEST DERMATOL, V99, P565, DOI 10.1111/1523-1747.ep12667411; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; OSADA S, 1990, J BIOL CHEM, V265, P22434; Papp H, 2004, CELL MOL LIFE SCI, V61, P1095, DOI 10.1007/s00018-004-4014-2; Praskova M, 2002, EXP DERMATOL, V11, P344, DOI 10.1034/j.1600-0625.2002.110408.x; Reddig PJ, 1999, CANCER RES, V59, P5710; Riethoven JJM, 2010, METHODS MOL BIOL, V674, P33, DOI 10.1007/978-1-60761-854-6_3; Rorke EA, 2010, ONCOGENE, V29, P5873, DOI 10.1038/onc.2010.315; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shen S, 2001, DIABETES, V50, P255, DOI 10.2337/diabetes.50.2.255; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Sturniolo MT, 2005, ONCOGENE, V24, P2963, DOI 10.1038/sj.onc.1208392; Szegedi A, 2009, EXP DERMATOL, V18, P122, DOI 10.1111/j.1600-0625.2008.00771.x; Verma AK, 2006, MOL CARCINOGEN, V45, P381, DOI 10.1002/mc.20230; Wheeler DL, 2005, PHOTOCHEM PHOTOBIOL, V81, P9, DOI 10.1562/2004-08-12-RA-271.1; Wheeler DL, 2002, ONCOGENE, V21, P3620, DOI 10.1038/sj.onc.1205451; Wong PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008369; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhu L, 2008, J INVEST DERMATOL, V128, P833, DOI 10.1038/sj.jid.5701103	83	42	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28772	28782		10.1074/jbc.M110.205245	http://dx.doi.org/10.1074/jbc.M110.205245			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21652709	hybrid, Green Published			2022-12-25	WOS:000293837000015
J	Lu, RZ; Niesen, MJM; Hu, WD; Vaidehi, N; Shively, JE				Lu, Rongze; Niesen, Michiel J. M.; Hu, Weidong; Vaidehi, Nagarajan; Shively, John E.			Interaction of Actin with Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1) Receptor in Liposomes Is Ca2+- and Phospholipid-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; DYNAMICS SIMULATIONS; CYTOPLASMIC DOMAIN; CONSTANT-PRESSURE; MEMBRANE; DIMERIZATION; HYDRATION; RESIDUES; SYSTEMS; VIEW	The regulation of binding of G-actin to cytoplasmic domains of cell surface receptors is a common mechanism to control diverse biological processes. To model the regulation of G-actin binding to a cell surface receptor we used the cell-cell adhesion molecule carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1-S) in which G-actin binds to its short cytoplasmic domain (12 amino acids; Chen, C. J., Kirshner, J., Sherman, M. A., Hu, W., Nguyen, T., and Shively, J. E. (2007) J. Biol. Chem. 282, 5749-5760). A liposome model system demonstrates that G-actin binds to the cytosolic domain peptide of CEACAM1-S in the presence of negatively charged palmitoyloleoyl phosphatidylserine (POPS) liposomes and Ca2+. In contrast, no binding of G-actin was observed in palmitoyl-oleoyl phosphatidylcholine (POPC) liposomes or when a key residue in the peptide, Phe-454, is replaced with Ala. Molecular Dynamics simulations on CEACAM1-S in an asymmetric phospholipid bilayer show migration of Ca2+ ions to the lipid leaflet containing POPS and reveal two conformations for Phe-454 explaining the reversible availability of this residue for G-actin binding. NMR transverse relaxation optimized spectroscopic analysis of C-13-labeled Phe-454 CEACAM1-S peptide in liposomes plus actin further confirmed the existence of two peptide conformers and the Ca2+ dependence of actin binding. These findings explain how a receptor with a short cytoplasmic domain can recruit a cytosolic protein in a phospholipid and Ca2+-specific manner. In addition, this model system provides a powerful approach that can be applied to study other membrane protein interactions with their cytosolic targets.	[Niesen, Michiel J. M.; Hu, Weidong; Vaidehi, Nagarajan; Shively, John E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, Duarte, CA 91010 USA; [Lu, Rongze] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope	Shively, JE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Immunol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	jshively@coh.org	Niesen, Michiel/AAF-6824-2020; Niesen, Michiel JM/L-8985-2013; Lu, Rongze/R-2149-2016		National Institutes of Health [CA 84202]; NATIONAL CANCER INSTITUTE [R01CA084202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 84202.	Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bouchard M, 1998, BIOCHEMISTRY-US, V37, P3149, DOI 10.1021/bi971892r; Bouschet T, 2008, TRENDS PHARMACOL SCI, V29, P633, DOI 10.1016/j.tips.2008.09.002; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen CJ, 2007, J BIOL CHEM, V282, P5749, DOI 10.1074/jbc.M610903200; Chen CJ, 2004, J IMMUNOL, V172, P3544, DOI 10.4049/jimmunol.172.6.3544; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fallahi-Sichani M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006604; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Ida M, 2004, J BIOCHEM, V135, P583, DOI 10.1093/jb/mvh071; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Ko KS, 2001, J CELL SCI, V114, P1155; KUMPF RA, 1993, SCIENCE, V261, P1708, DOI 10.1126/science.8378771; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muller MM, 2009, J CELL BIOL, V187, P569, DOI 10.1083/jcb.200904150; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pervushin K, 1998, J AM CHEM SOC, V120, P6394, DOI 10.1021/ja980742g; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Thorp EB, 2004, J VIROL, V78, P2682, DOI 10.1128/JVI.78.6.2682-2692.2004; Tieleman DP, 1998, BIOCHEMISTRY-US, V37, P17554, DOI 10.1021/bi981802y; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t	38	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27528	27536		10.1074/jbc.M111.235762	http://dx.doi.org/10.1074/jbc.M111.235762			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669871	Green Published, hybrid			2022-12-25	WOS:000293268700047
J	Iwai, A; Takegami, T; Shiozaki, T; Miyazaki, T				Iwai, Atsushi; Takegami, Tsutomu; Shiozaki, Takuya; Miyazaki, Tadaaki			Hepatitis C Virus NS3 Protein Can Activate the Notch-Signaling Pathway through Binding to a Transcription Factor, SRCAP	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; P53 TUMOR-SUPPRESSOR; CELL-LINE; NONSTRUCTURAL PROTEIN-3; CORE PROTEIN; SUBCELLULAR-LOCALIZATION; MEDIATED TRANSCRIPTION; SERINE PROTEINASE; INDUCED APOPTOSIS; EXPRESSION	Persistent infections of hepatitis C virus (HCV) are known to be a major risk factor for causing hepatocellular carcinomas. Nonstructural protein 3 (NS3) of HCV has serine protease and RNA helicase domains, and is essential for the viral replication. Further, NS3 is also considered to be involved in the development of HCV-induced hepatocellular carcinomas. In this report, we focus on the function of NS3 protein, and propose a novel possible molecular mechanism which is thought to be related to the tumorigenesis caused by the persistent infection of HCV. We identified SRCAP (Snf2-related CBP activator protein) as a NS3 binding protein using yeast two-hybrid screening, and a co-immunoprecipitation assay demonstrated that NS3 can bind to SRCAP in mammalian cells. The results of a reporter gene assay using Hes-1 promoter which is known to be a target gene activated by Notch, indicate that NS3 and SRCAP cooperatively activate the Hes-1 promoter in Hep3B cells. In addition, we show in this report that also p400, which is known as a protein closely resembling SRCAP, would be targeted by NS3. NS3 exhibited binding activity also to the 1449-1808 region of p400 by a co-immunoprecipitation assay, and further the activation of the Notch-mediated transcription of Hes-1 promoter by NS3 decreased significantly by the combined silencing of SRCAP and p400 mRNA using short hairpin RNA. These results suggest that the HCV NS3 protein is involved in the activation of the Notch-signaling pathway through the targeting to both SRCAP and p400.	[Iwai, Atsushi; Shiozaki, Takuya; Miyazaki, Tadaaki] Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Sapporo, Hokkaido, Japan; [Takegami, Tsutomu] Kanazawa Med Univ, Med Res Inst, Uchinada, Ishikawa 92002, Japan	Hokkaido University; Kanazawa Medical University	Iwai, A (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Dept Bioresources, Sapporo, Hokkaido, Japan.	takegami@kanazawa-med.ac.jp	Iwai, Atsushi/I-6469-2019; Miyazaki, Tadaaki/D-9368-2012	Iwai, Atsushi/0000-0002-1491-4693	High-Tech Research Center of Kanazawa Medical University [H2010-10]	High-Tech Research Center of Kanazawa Medical University	Funding: The present work was supported by a Grant for Project Research from the High-Tech Research Center of Kanazawa Medical University (H2010-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Aizaki H, 1998, HEPATOLOGY, V27, P621, DOI 10.1002/hep.510270242; Aizaki H, 2002, HEPATOLOGY, V36, P1431, DOI 10.1053/jhep.2002.36937; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Borowski P, 1997, J VIROL, V71, P2838, DOI 10.1128/JVI.71.4.2838-2843.1997; Borowski P, 1999, J BIOL CHEM, V274, P30722, DOI 10.1074/jbc.274.43.30722; Cantarini MC, 2006, HEPATOLOGY, V44, P446, DOI 10.1002/hep.21272; Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205; Chen Y, 2007, BASIC CLIN PHARMACOL, V101, P427, DOI 10.1111/j.1742-7843.2007.00142.x; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Eissenberg JC, 2005, MOL CELL BIOL, V25, P6559, DOI 10.1128/MCB.25.15.6559-6569.2005; FAILLA C, 1994, J VIROL, V68, P3753, DOI 10.1128/JVI.68.6.3753-3760.1994; Fuchs M, 2001, CELL, V106, P297, DOI 10.1016/S0092-8674(01)00450-0; Fujita T, 1996, BIOCHEM BIOPH RES CO, V229, P825, DOI 10.1006/bbrc.1996.1887; Gale M, 1999, J VIROL, V73, P6506, DOI 10.1128/JVI.73.8.6506-6516.1999; Gao J, 2008, DIGEST LIVER DIS, V40, P114, DOI 10.1016/j.dld.2007.08.001; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; Ghosh AK, 2000, J BIOL CHEM, V275, P7184, DOI 10.1074/jbc.275.10.7184; Giovannini C, 2006, ANTICANCER RES, V26, P2123; Giovannini C, 2009, J HEPATOL, V50, P969, DOI 10.1016/j.jhep.2008.12.032; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRAKOUI A, 1993, J VIROL, V67, P2832, DOI 10.1128/JVI.67.5.2832-2843.1993; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; Gramantieri L, 2007, LIVER INT, V27, P997, DOI 10.1111/j.1478-3231.2007.01544.x; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Ishido S, 1998, FEBS LETT, V438, P258, DOI 10.1016/S0014-5793(98)01312-X; Iwai A, 2003, MICROBIOL IMMUNOL, V47, P601, DOI 10.1111/j.1348-0421.2003.tb03423.x; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jha S, 2008, MOL CELL BIOL, V28, P2690, DOI 10.1128/MCB.01983-07; Johnston H, 1999, J BIOL CHEM, V274, P16370, DOI 10.1074/jbc.274.23.16370; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kwun HJ, 2001, J GEN VIROL, V82, P2235, DOI 10.1099/0022-1317-82-9-2235; Lang SE, 2003, ONCOGENE, V22, P2836, DOI 10.1038/sj.onc.1206376; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LIN C, 1994, J VIROL, V68, P8147, DOI 10.1128/JVI.68.12.8147-8157.1994; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Majumder M, 2001, J VIROL, V75, P1401, DOI 10.1128/JVI.75.3.1401-1407.2001; Monroy MA, 2001, J BIOL CHEM, V276, P40721, DOI 10.1074/jbc.M103615200; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Park JH, 2006, MOL CELL BIOL, V26, P4006, DOI 10.1128/MCB.02185-05; Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999; Prikhod'ko EA, 2004, VIROLOGY, V329, P53, DOI 10.1016/j.virol.2004.08.012; Qi RZ, 2003, CANCER RES, V63, P8323; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Ray RB, 1996, J VIROL, V70, P4438, DOI 10.1128/JVI.70.7.4438-4443.1996; Ray RB, 1997, J BIOL CHEM, V272, P10983; SAKAMURO D, 1995, J VIROL, V69, P3893, DOI 10.1128/JVI.69.6.3893-3896.1995; SELBY MJ, 1993, J GEN VIROL, V74, P1103, DOI 10.1099/0022-1317-74-6-1103; SHIMOTOHNO K, 1995, J HEPATOL, V22, P87; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tsuchihara K, 1999, VIROLOGY, V258, P100, DOI 10.1006/viro.1999.9694; TSUKIYAMAKOHARA K, 1991, VIRUS GENES, V5, P243, DOI 10.1007/BF00568974; Wang CM, 2009, J BIOL CHEM, V284, P16183, DOI 10.1074/jbc.M109.002105; Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000; Xu HY, 2008, SCAND J GASTROENTERO, V43, P1522, DOI 10.1080/00365520802321188; Xu XQ, 2003, VIROLOGY, V313, P615, DOI 10.1016/S0042-6822(03)00386-6; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09	62	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20718	10.1371/journal.pone.0020718	http://dx.doi.org/10.1371/journal.pone.0020718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673954	Green Published, gold			2022-12-25	WOS:000291356400023
J	Medie, FM; Ben Salah, I; Henrissat, B; Raoult, D; Drancourt, M				Medie, Felix Mba; Ben Salah, Iskandar; Henrissat, Bernard; Raoult, Didier; Drancourt, Michel			Mycobacterium tuberculosis Complex Mycobacteria as Amoeba-Resistant Organisms	PLOS ONE			English	Article							FREE-LIVING AMEBAS; ENVIRONMENTAL MYCOBACTERIA; ACANTHAMOEBA-POLYPHAGA; SP-NOV; INFECTIONS; MASSILIENSE; COCULTURE; OUTBREAK; MARINUM; DICTYOSTELIUM	Background: Most environmental non-tuberculous mycobacteria have been demonstrated to invade amoebal trophozoites and cysts, but such relationships are largely unknown for members of the Mycobacterium tuberculosis complex. An environmental source has been proposed for the animal Mycobacterium bovis and the human Mycobacterium canettii. Methodology/Principal Findings: Using optic and electron microscopy and co-culture methods, we observed that 89 +/- 0.6% of M. canettii, 12.4 +/- 0.3% of M. tuberculosis, 11.7 +/- 2% of M. bovis and 11.2 +/- 0.5% of Mycobacterium avium control organisms were phagocytized by Acanthamoeba polyphaga, a ratio significantly higher for M. canettii (P = 0.03), correlating with the significantly larger size of M. canetti organisms (P = 0.035). The percentage of intraamoebal mycobacteria surviving into cytoplasmic vacuoles was 32 +/- 2% for M. canettii, 26 +/- 1% for M. tuberculosis, 28 +/- 2% for M. bovis and 36 +/- 2% for M. avium (P = 0.57). M. tuberculosis, M. bovis and M. avium mycobacteria were further entrapped within the double wall of <1% amoebal cysts, but no M. canettii organisms were observed in amoebal cysts. The number of intracystic mycobacteria was significantly (P = 10(-6)) higher for M. avium than for the M. tuberculosis complex, and sub-culturing intracystic mycobacteria yielded significantly more (P = 0.02) M. avium organisms (34x10(4) CFU/mL) than M. tuberculosis (42x10(1) CFU/mL) and M. bovis (35x10(1) CFU/mL) in the presence of a washing fluid free of mycobacteria. Mycobacteria survived in the cysts for up to 18 days and cysts protected M. tuberculosis organisms against mycobactericidal 5 mg/mL streptomycin and 2.5% glutaraldehyde. Conclusions/Significance: These data indicate that M. tuberculosis complex organisms are amoeba-resistant organisms, as previously demonstrated for non-tuberculous, environmental mycobacteria. Intercystic survival of tuberculous mycobacteria, except for M. canettii, protect them against biocides and could play a role in their life cycle.	[Medie, Felix Mba; Ben Salah, Iskandar; Raoult, Didier; Drancourt, Michel] Univ Aix Marseille 2, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD 189,IFR 48,Fac Med, Marseille, France; [Medie, Felix Mba; Henrissat, Bernard] Univ Aix Marseille 2, UMR CNRS 6098, AFMB, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Medie, FM (corresponding author), Univ Aix Marseille 2, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS 6236, IRD 189,IFR 48,Fac Med, Marseille, France.	Michel.Drancourt@univmed.fr	Henrissat, Bernard/J-2475-2012; RAOULT, Didier/A-8434-2008	Henrissat, Bernard/0000-0002-3434-8588; RAOULT, Didier/0000-0002-0633-5974; Mba Medie, Felix/0000-0002-8265-4563				Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Ahmed N, 2003, INFECT GENET EVOL, V2, P193, DOI 10.1016/S1567-1348(02)00100-4; Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; Astagneau P, 2001, LANCET, V358, P747, DOI 10.1016/S0140-6736(01)05843-3; Ben Salah I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-99; CANETTI G, 1970, LILLE MED, V15, P280; Chilima BZ, 2006, APPL ENVIRON MICROB, V72, P2343, DOI 10.1128/AEM.72.4.2343-2350.2006; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09; Fabre M, 2010, INFECT GENET EVOL, V10, P1165, DOI 10.1016/j.meegid.2010.07.016; Furuya EY, 2008, CLIN INFECT DIS, V46, P1181, DOI 10.1086/529191; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2003, INFECT CONT HOSP EP, V24, P784, DOI 10.1086/502137; Hagedorn M, 2007, CELL MICROBIOL, V9, P2716, DOI 10.1111/j.1462-5822.2007.00993.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Koeck JL, 2011, CLIN MICROBIOL INFEC, V17, P1013, DOI 10.1111/j.1469-0691.2010.03347.x; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993; Medie FM, 2011, PROTEIN EXPRES PURIF, V75, P172, DOI 10.1016/j.pep.2010.08.015; Medie FM, 2010, MICROBIOL-SGM, V156, P1468, DOI 10.1099/mic.0.037812-0; Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; Steinert M, 1998, APPL ENVIRON MICROB, V64, P2256; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Taylor SJ, 2003, APPL ENVIRON MICROB, V69, P4316, DOI 10.1128/AEM.69.7.4316-4319.2003; Thomas V, 2006, APPL ENVIRON MICROB, V72, P2428, DOI 10.1128/AEM.72.4.2428-2438.2006; Viana-Niero C, 2008, J CLIN MICROBIOL, V46, P850, DOI 10.1128/JCM.02052-07; Vincent V, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P573; Winthrop KL, 2002, NEW ENGL J MED, V346, P1366, DOI 10.1056/NEJMoa012643	32	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20499	10.1371/journal.pone.0020499	http://dx.doi.org/10.1371/journal.pone.0020499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673985	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500020
J	Lim, S; Yoon, JW; Kang, SM; Choi, SH; Cho, BJ; Kim, M; Park, HS; Cho, HJ; Shin, H; Kim, YB; Kim, HS; Jang, HC; Park, KS				Lim, Soo; Yoon, Ji Won; Kang, Seon Mee; Choi, Sung Hee; Cho, Bong Jun; Kim, Min; Park, Ho Seon; Cho, Hyun Ju; Shin, Hayley; Kim, Young-Bum; Kim, Hyo Soo; Jang, Hak Chul; Park, Kyong Soo			EGb761, a Ginkgo Biloba Extract, Is Effective Against Atherosclerosis In Vitro, and in a Rat Model of Type 2 Diabetes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTOR; NEOINTIMAL HYPERPLASIA; MOLECULAR-MECHANISMS; BALLOON ANGIOPLASTY; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; ADIPONECTIN; RESTENOSIS; DISEASE	Background: EGb761, a standardized Ginkgo biloba extract, has antioxidant and antiplatelet aggregation and thus might protect against atherosclerosis. However, molecular and functional properties of EGb761 and its major subcomponents have not been well characterized. We investigated the effect of EGb761 and its major subcomponents (bilobalide, kaemferol, and quercetin) on preventing atherosclerosis in vitro, and in a rat model of type 2 diabetes. Methods and Results: EGb761 (100 and 200 mg/kg) or normal saline (control) were administered to Otsuka Long-Evans Tokushima Fatty rats, an obese insulin-resistant rat model, for 6 weeks (from 3 weeks before to 3 weeks after carotid artery injury). Immunohistochemical staining was performed to investigate cell proliferation and apoptosis in the injured arteries. Cell migration, caspase-3 activity and DNA fragmentation, monocyte adhesion, and ICAM-1/VCAM-1 levels were explored in vitro. Treatment with EGb761 dose-dependently reduced intima-media ratio, proliferation of vascular smooth muscle cells (VSMCs) and induced greater apoptosis than the controls. Proliferation and migration of VSMCs in vitro were also decreased by the treatment of EGb761. Glucose homeostasis and circulating adiponectin levels were improved, and plasma hsCRP concentrations were decreased in the treatment groups. Caspase-3 activity and DNA fragmentation increased while monocyte adhesion and ICAM-1/VCAM-1 levels decreased significantly. Among subcomponents of EGb761, kaemferol and quercetin reduced VSMC migration and increased caspase activity. Conclusions: EGb761 has a protective role in the development of atherosclerosis and is a potential therapeutic agent for preventing atherosclerosis.	[Lim, Soo; Yoon, Ji Won; Kang, Seon Mee; Choi, Sung Hee; Cho, Bong Jun; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea; [Lim, Soo; Yoon, Ji Won; Kang, Seon Mee; Choi, Sung Hee; Kim, Min; Park, Ho Seon; Cho, Hyun Ju; Kim, Hyo Soo; Jang, Hak Chul; Park, Kyong Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp, Seoul 151, South Korea; [Shin, Hayley] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Lim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea.	kspark@snu.ac.kr	Choi, Sung-hee/J-5689-2012; Jang, Hak Chul/D-9637-2012; Lim, Soo/AAU-8107-2020; Park, Kyong Soo/C-2265-2008	Jang, Hak Chul/0000-0002-4188-6536; Lim, Soo/0000-0002-4137-1671; Park, Kyong Soo/0000-0003-3597-342X; Park, Ho Seon/0000-0003-1200-4626; CHOI, SUNG HEE/0000-0003-0740-8116	Korean Society of Lipidology and Atherosclerosis; Korea Science and Engineering Foundation [M10642140004-06N4214-00410]; Ministry of Information and Communication/Institute for Information Technology Advancement [2006-S075-01]	Korean Society of Lipidology and Atherosclerosis; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Information and Communication/Institute for Information Technology Advancement	This work was supported by the Korean Society of Lipidology and Atherosclerosis (2008), the Korea Science and Engineering Foundation grants (M10642140004-06N4214-00410) and the Information Technology R&D program of Ministry of Information and Communication/Institute for Information Technology Advancement (2006-S075-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Boveris AD, 2007, PHYTOTHER RES, V21, P735, DOI 10.1002/ptr.2153; CERMAK J, 1993, BLOOD, V82, P513, DOI 10.1182/blood.V82.2.513.513; Chao JCJ, 2004, WORLD J GASTROENTERO, V10, P37; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Choi SE, 2007, J ETHNOPHARMACOL, V110, P49, DOI 10.1016/j.jep.2006.09.001; CLOWES AW, 1983, LAB INVEST, V49, P327; Defeudis FV, 2002, PHARMACOL RES, V46, P565, DOI 10.1016/S1043-6618(02)00233-5; Ferns GAA, 2000, INT J EXP PATHOL, V81, P63, DOI 10.1046/j.1365-2613.2000.00143.x; Gohil K, 2002, CELL MOL BIOL, V48, P625; Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061; Henke N, 2007, CIRC RES, V101, P268, DOI 10.1161/CIRCRESAHA.107.150474; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Kim KS, 2005, ORAL ONCOL, V41, P383, DOI 10.1016/j.oraloncology.2004.09.013; Kudolo GB, 2005, DIABETES RES CLIN PR, V68, P29, DOI 10.1016/j.diabres.2004.08.007; Kudolo GB, 2001, J CLIN PHARMACOL, V41, P600, DOI 10.1177/00912700122010483; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Lim S, 2006, ARTERIOSCL THROM VAS, V26, P808, DOI 10.1161/01.ATV.0000204634.26163.a7; Lim S, 2008, ATHEROSCLEROSIS, V196, P398, DOI 10.1016/j.atherosclerosis.2006.11.017; Lim S, 2009, ATHEROSCLEROSIS, V206, P411, DOI 10.1016/j.atherosclerosis.2009.02.031; Liu FY, 2008, PHYTOTHER RES, V22, P506, DOI 10.1002/ptr.2353; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Mahadevan S, 2008, J FOOD SCI, V73, pR14, DOI 10.1111/j.1750-3841.2007.00597.x; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moreno PR, 1996, CIRCULATION, V94, P3098, DOI 10.1161/01.CIR.94.12.3098; Moreno PR, 1999, J AM COLL CARDIOL, V34, P1045, DOI 10.1016/S0735-1097(99)00338-1; Mori E, 2002, CIRCULATION, V105, P2905, DOI 10.1161/01.CIR.0000018603.67989.71; Oken BS, 1998, ARCH NEUROL-CHICAGO, V55, P1409, DOI 10.1001/archneur.55.11.1409; Orban Z, 1999, J CLIN ENDOCR METAB, V84, P2126, DOI 10.1210/jc.84.6.2126; Oyama Y, 1996, BRAIN RES, V712, P349, DOI 10.1016/0006-8993(95)01440-3; Pasceri V, 2000, CIRCULATION, V102, P2165; PEPYS MB, 1985, INT REV EXP PATHOL, V27, P83; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Rapin JR, 1997, DRUG DEVELOP RES, V40, P68; Rodriguez M, 2007, ATHEROSCLEROSIS, V192, P438, DOI 10.1016/j.atherosclerosis.2007.02.021; Rogers C, 1996, ARTERIOSCL THROM VAS, V16, P1312, DOI 10.1161/01.ATV.16.10.1312; Schulze MB, 2005, DIABETES, V54, P534, DOI 10.2337/diabetes.54.2.534; SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190; Smith JV, 2003, J ALZHEIMERS DIS, V5, P287, DOI 10.3233/JAD-2003-5404; Smith JV, 2004, APPL MICROBIOL BIOT, V64, P465, DOI 10.1007/s00253-003-1527-9; Smith PF, 1996, J ETHNOPHARMACOL, V50, P131, DOI 10.1016/0378-8741(96)01379-7; Tanaka S, 2004, YAKUGAKU ZASSHI, V124, P605, DOI 10.1248/yakushi.124.605; Valli G, 2002, J AM COLL CARDIOL, V39, P1083, DOI 10.1016/S0735-1097(02)01749-7; Walsh K, 2000, CIRC RES, V87, P184, DOI 10.1161/01.RES.87.3.184; Welt FGP, 2000, ARTERIOSCL THROM VAS, V20, P2553, DOI 10.1161/01.ATV.20.12.2553; Wolbink GJ, 1996, J IMMUNOL, V157, P473; Zhang Q, 2009, ACTA PHARMACOL SIN, V30, P1674, DOI 10.1038/aps.2009.173; Zietz B, 2003, FEBS LETT, V545, P103, DOI 10.1016/S0014-5793(03)00568-4; Zimmermann M, 2002, CELL MOL BIOL, V48, P613	51	33	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20301	10.1371/journal.pone.0020301	http://dx.doi.org/10.1371/journal.pone.0020301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655098	gold, Green Submitted, Green Published			2022-12-25	WOS:000291310600008
J	Bober, M; Morgelin, M; Olin, AI; von Pawel-Rammingen, U; Collin, M				Bober, Marta; Morgelin, Matthias; Olin, Anders I.; von Pawel-Rammingen, Ulrich; Collin, Mattias			The Membrane Bound LRR Lipoprotein Slr, and the Cell Wall-Anchored M1 Protein from Streptococcus pyogenes Both Interact with Type I Collagen	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; GROUP-A-STREPTOCOCCI; LISTERIA-MONOCYTOGENES; SURFACE-PROTEINS; CYSTEINE PROTEINASE; COMPLETE GENOME; BINDING; FAMILY; IDENTIFICATION; PATHOGENS	Streptococcus pyogenes is an important human pathogen and surface structures allow it to adhere to, colonize and invade the human host. Proteins containing leucine rich repeats (LRR) have been indentified in mammals, viruses, archaea and several bacterial species. The LRRs are often involved in protein-protein interaction, are typically 20-30 amino acids long and the defining feature of the LRR motif is an 11-residue sequence LxxLxLxxNxL (x being any amino acid). The streptococcal leucine rich (Slr) protein is a hypothetical lipoprotein that has been shown to be involved in virulence, but at present no ligands for Slr have been identified. We could establish that Slr is a membrane attached horseshoe shaped lipoprotein by homology modeling, signal peptidase II inhibition, electron microscopy (of bacteria and purified protein) and immunoblotting. Based on our previous knowledge of LRR proteins we hypothesized that Slr could mediate binding to collagen. We could show by surface plasmon resonance that recombinant Slr and purified M1 protein bind with high affinity to collagen I. Isogenic slr mutant strain (MB1) and emm1 mutant strain (MC25) had reduced binding to collagen type I as shown by slot blot and surface plasmon resonance. Electron microscopy using gold labeled Slr showed multiple binding sites to collagen I, both to the monomeric and the fibrillar structure, and most binding occurred in the overlap region of the collagen I fibril. In conclusion, we show that Slr is an abundant membrane bound lipoprotein that is co-expressed on the surface with M1, and that both these proteins are involved in recruiting collagen type I to the bacterial surface. This underlines the importance of S. pyogenes interaction with extracellular matrix molecules, especially since both Slr and M1 have been shown to be virulence factors.	[Bober, Marta; Morgelin, Matthias; Olin, Anders I.; Collin, Mattias] Lund Univ, Div Infect Med, Dept Clin Sci, Biomed Ctr, Lund, Sweden; [von Pawel-Rammingen, Ulrich] Umea Univ, Dept Mol Biol, Umea, Sweden	Lund University; Umea University	Bober, M (corresponding author), Lund Univ, Div Infect Med, Dept Clin Sci, Biomed Ctr, Lund, Sweden.	marta.bober@med.lu.se	Collin, Mattias/C-6398-2009	Collin, Mattias/0000-0002-6166-7410	Swedish Research Council [2005-4791, 2010-57X-20240, 7480]; Foundations of Crafoord, Jeansson, Wiberg, Kock, Bergvall, Osterlund, Soderberg; Swedish Society for Medicine; Royal Physiografic Society; King Gustaf V Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Crafoord, Jeansson, Wiberg, Kock, Bergvall, Osterlund, Soderberg; Swedish Society for Medicine; Royal Physiografic Society(Royal Society of London); King Gustaf V Memorial Fund; Medical Faculty at Lund University; Hansa Medical AB	This work was supported by grants from the Swedish Research Council (projects 2005-4791 and 2010-57X-20240 to MC, and 7480 to MM), the Foundations of Crafoord, Jeansson, Wiberg, Kock, Bergvall, Osterlund, Soderberg, the Swedish Society for Medicine, the Royal Physiografic Society, King Gustaf V Memorial Fund, the Medical Faculty at Lund University, and Hansa Medical AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; BASCHONG W, 1985, HISTOCHEMISTRY, V83, P409, DOI 10.1007/BF00509201; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Collin M, 2000, MOL MICROBIOL, V36, P1306, DOI 10.1046/j.1365-2958.2000.01942.x; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dinkla K, 2003, J CLIN INVEST, V111, P1905, DOI 10.1172/JCI200317247; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; ELLEN RP, 1972, INFECT IMMUN, V5, P826, DOI 10.1128/IAI.5.5.826-830.1972; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gase K, 1997, MED MICROBIOL IMMUN, V186, P63, DOI 10.1007/s004300050047; Harlow E., 1988, ANTIBODIES LAB MANUA; Harrington DJ, 2000, INFECT IMMUN, V68, P6048, DOI 10.1128/IAI.68.10.6048-6051.2000; HAUSER AR, 1990, J BACTERIOL, V172, P4536, DOI 10.1128/jb.172.8.4536-4542.1990; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janulczyk R, 1999, MOL MICROBIOL, V34, P596, DOI 10.1046/j.1365-2958.1999.01626.x; Jin MS, 2008, CURR OPIN IMMUNOL, V20, P414, DOI 10.1016/j.coi.2008.06.002; Kedzierski L, 2004, ARCH IMMUNOL THER EX, V52, P104; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOSTRZYNSKA M, 1989, FEMS MICROBIOL LETT, V59, P229; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Le Bourhis L, 2007, MICROBES INFECT, V9, P629, DOI 10.1016/j.micinf.2007.01.014; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Melin M, 2010, INFECT IMMUN, V78, P2089, DOI 10.1128/IAI.00811-09; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Nitsche DP, 2006, J BIOL CHEM, V281, P1670, DOI 10.1074/jbc.M506776200; OKADA N, 1994, J CLIN INVEST, V94, P965, DOI 10.1172/JCI117463; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003; SCHALEN C, 1995, APMIS, V103, P59, DOI 10.1111/j.1699-0463.1995.tb01080.x; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; Sook BR, 2008, BIOCHEMISTRY-US, V47, P2678, DOI 10.1021/bi701604y; SPEZIALE P, 1987, FEMS MICROBIOL LETT, V48, P47, DOI 10.1016/0378-1097(87)90133-9; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; STONE J, 1998, THESIS MO U MISSOURI; Suvorov AN, 1996, J BACTERIOL, V178, P5546, DOI 10.1128/jb.178.18.5546-5549.1996; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Waldemarsson J, 2006, J BACTERIOL, V188, P378, DOI 10.1128/JB.188.2.378-388.2006; Weston BF, 2009, INFECT IMMUN, V77, P2840, DOI 10.1128/IAI.01299-08; Zhu H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-15	52	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20345	10.1371/journal.pone.0020345	http://dx.doi.org/10.1371/journal.pone.0020345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655249	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600047
J	Francius, G; Polyakov, P; Merlin, J; Abe, Y; Ghigo, JM; Merlin, C; Beloin, C; Duval, JFL				Francius, Gregory; Polyakov, Pavel; Merlin, Jenny; Abe, Yumiko; Ghigo, Jean-Marc; Merlin, Christophe; Beloin, Christophe; Duval, Jerome F. L.			Bacterial Surface Appendages Strongly Impact Nanomechanical and Electrokinetic Properties of Escherichia coli Cells Subjected to Osmotic Stress	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; LACTIC-ACID BACTERIA; ELECTROPHORETIC MOBILITY; BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS; MECHANICAL-PROPERTIES; MYXOCOCCUS-XANTHUS; PILUS STRUCTURE; OUTER-MEMBRANE; IV PILUS	The physicochemical properties and dynamics of bacterial envelope, play a major role in bacterial activity. In this study, the morphological, nanomechanical and electrohydrodynamic properties of Escherichia coli K-12 mutant cells were thoroughly investigated as a function of bulk medium ionic strength using atomic force microscopy (AFM) and electrokinetics (electrophoresis). Bacteria were differing according to genetic alterations controlling the production of different surface appendages (short and rigid Ag43 adhesins, longer and more flexible type 1 fimbriae and F pilus). From the analysis of the spatially resolved force curves, it is shown that cells elasticity and turgor pressure are not only depending on bulk salt concentration but also on the presence/absence and nature of surface appendage. In 1 mM KNO3, cells without appendages or cells surrounded by Ag43 exhibit large Young moduli and turgor pressures (similar to 700-900 kPa and similar to 100-300 kPa respectively). Under similar ionic strength condition, a dramatic similar to 50% to similar to 70% decrease of these nanomechanical parameters was evidenced for cells with appendages. Qualitatively, such dependence of nanomechanical behavior on surface organization remains when increasing medium salt content to 100 mM, even though, quantitatively, differences are marked to a much smaller extent. Additionally, for a given surface appendage, the magnitude of the nanomechanical parameters decreases significantly when increasing bulk salt concentration. This effect is ascribed to a bacterial exoosmotic water loss resulting in a combined contraction of bacterial cytoplasm together with an electrostatically-driven shrinkage of the surface appendages. The former process is demonstrated upon AFM analysis, while the latter, inaccessible upon AFM imaging, is inferred from electrophoretic data interpreted according to advanced soft particle electrokinetic theory. Altogether, AFM and electrokinetic results clearly demonstrate the intimate relationship between structure/flexibility and charge of bacterial envelope and propensity of bacterium and surface appendages to contract under hypertonic conditions.	[Francius, Gregory; Polyakov, Pavel; Abe, Yumiko; Merlin, Christophe] Nancy Univ, CNRS, UMR7564, Lab Chim Phys & Microbiol Environm, Villers Les Nancy, France; [Merlin, Jenny; Duval, Jerome F. L.] Nancy Univ, CNRS, UMR7569, Lab Environm & Mineralurgie, Vandoeuvre Les Nancy, France; [Ghigo, Jean-Marc; Beloin, Christophe] Inst Pasteur, Unite Genet Biofilms, Paris, France; [Ghigo, Jean-Marc; Beloin, Christophe] CNRS, URA 2172, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Francius, G (corresponding author), Nancy Univ, CNRS, UMR7564, Lab Chim Phys & Microbiol Environm, Villers Les Nancy, France.	gregory.francius@lcpme.cnrs-nancy.fr; jerome.duval@ensg.inpl-nancy.fr	Merlin, Christophe/ABG-7344-2021; Francius, Gregory/A-4246-2015; GHIGO, Jean-Marc/AAP-4011-2021; Francius, Gregory/P-6058-2019; Jerome, Duval/H-6421-2011; BELOIN, Christophe/F-9284-2012	Merlin, Christophe/0000-0002-9261-5322; Francius, Gregory/0000-0001-8533-9449; GHIGO, Jean-Marc/0000-0001-6528-118X; Francius, Gregory/0000-0001-8533-9449; Jerome, Duval/0000-0002-5458-3761; BELOIN, Christophe/0000-0002-0344-3443	French program [ANR-07-JCJC-0024-01 PHYSCHEMBACT]	French program	This work was financially supported by the French program ANR-07-JCJC-0024-01 PHYSCHEMBACT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAKO K, 1983, MICROBIOL IMMUNOL, V27, P95, DOI 10.1111/j.1348-0421.1983.tb03571.x; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; ASCHER U, 1981, ACM T MATH SOFTWARE, V7, P209, DOI 10.1145/355945.355950; BARTLETT D, 1989, NATURE, V342, P572, DOI 10.1038/342572a0; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Beveridge T J, 1981, Int Rev Cytol, V72, P229, DOI 10.1016/S0074-7696(08)61198-5; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Boulbitch A, 2000, J ELECTRON MICROSC, V49, P459, DOI 10.1093/oxfordjournals.jmicro.a023829; Boulbitch A, 2000, PHYS REV LETT, V85, P5246, DOI 10.1103/PhysRevLett.85.5246; Boulbitch AA, 1998, PHYS REV E, V57, P2123, DOI 10.1103/PhysRevE.57.2123; CAFFREY P, 1989, J BACTERIOL, V171, P3634, DOI 10.1128/jb.171.7.3634-3640.1989; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; CHEMERIS N A, 1979, Mikrobiologiya, V48, P99; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; CROSS SE, 2005, ATOMIC FORCE MICROSC, pS1; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Dionisio F, 2002, GENETICS, V162, P1525; Dufrene YF, 2001, ULTRAMICROSCOPY, V86, P113, DOI 10.1016/S0304-3991(00)00079-6; Dufrene YF, 2008, NAT REV MICROBIOL, V6, P674, DOI 10.1038/nrmicro1948; Dufrene YF, 2008, NAT PROTOC, V3, P1132, DOI 10.1038/nprot.2008.101; Duval J. F. L., 2007, ENV COLLOIDS PARTICL, V10, P315; Duval JFL, 2010, CURR OPIN COLLOID IN, V15, P184, DOI 10.1016/j.cocis.2009.12.002; Duval JFL, 2006, LANGMUIR, V22, P3533, DOI 10.1021/la0528293; Duval JFL, 2005, LANGMUIR, V21, P11268, DOI 10.1021/la051735q; Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004; Fan TH, 2003, LANGMUIR, V19, P10930, DOI 10.1021/la035663j; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Francius G, 2007, J PHYS CHEM C, V111, P8299, DOI 10.1021/jp070435+; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gaboriaud F, 2008, LANGMUIR, V24, P10988, DOI 10.1021/la800258n; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; GALLY D, 1993, J BACTERIOL, V175, P3121, DOI 10.1128/JB.175.10.3121-3130.1993; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Hyono A, 2009, LANGMUIR, V25, P10873, DOI 10.1021/la900087c; JACOBSON A, 1972, J VIROL, V10, P835, DOI 10.1128/JVI.10.4.835-843.1972; Jonas K, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-70; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; KLEMM P, 1987, MOL GEN GENET, V208, P439, DOI 10.1007/BF00328136; Korea CG, 2010, ENVIRON MICROBIOL, V12, P1957, DOI 10.1111/j.1462-2920.2010.02202.x; Langlet J, 2008, BIOPHYS J, V94, P3293, DOI 10.1529/biophysj.107.115477; LAWN AM, 1966, J GEN MICROBIOL, V45, P377, DOI 10.1099/00221287-45-2-377; Ledeboer NA, 2005, J BACTERIOL, V187, P3214, DOI 10.1128/JB.187.9.3214-3226.2005; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Mabbett AN, 2009, INT J MED MICROBIOL, V299, P53, DOI 10.1016/j.ijmm.2008.06.003; MARQUIS RE, 1968, J BACTERIOL, V95, P775, DOI 10.1128/JB.95.3.775-781.1968; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Miyazaki J, 2002, FEMS IMMUNOL MED MIC, V33, P23, DOI 10.1111/j.1574-695X.2002.tb00567.x; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; Mortensen NP, 2009, LANGMUIR, V25, P3728, DOI 10.1021/la803898g; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; OBARA M, 1992, BIOCHEM BIOPH RES CO, V186, P645, DOI 10.1016/0006-291X(92)90795-M; Ohshima H, 1995, ADV COLLOID INTERFAC, V62, P189, DOI 10.1016/0001-8686(95)00279-Y; Ohshima H, 2003, J COLLOID INTERF SCI, V258, P252, DOI 10.1016/S0021-9797(02)00169-8; Ohshima H, 2001, COLLOID POLYM SCI, V279, P88, DOI 10.1007/s003960000399; Ohshima H, 1997, COLLOID POLYM SCI, V275, P480, DOI 10.1007/s003960050107; PARANCHYCH W, 1988, ADV MICROB PHYSIOL, V29, P53, DOI 10.1016/S0065-2911(08)60346-X; Pelling AE, 2005, P NATL ACAD SCI USA, V102, P6484, DOI 10.1073/pnas.0501207102; POLYAKOV P, PLOS ONE IN PRESS; Pouttu R, 2000, ADV EXP MED BIOL, V485, P63; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Roux A, 2005, J BACTERIOL, V187, P1001, DOI 10.1128/JB.187.3.1001-1013.2005; Schaer-Zammaretti P, 2003, ULTRAMICROSCOPY, V97, P199, DOI 10.1016/S0304-3991(03)00044-5; Schar-Zammaretti P, 2002, ABSTR PAP AM CHEM S, V224, pU397; Schmid T, 2008, ANAL BIOANAL CHEM, V391, P1899, DOI 10.1007/s00216-008-2100-2; Shamrock VJ, 2009, FEMS YEAST RES, V9, P391, DOI 10.1111/j.1567-1364.2009.00495.x; Silverman PM, 2010, INTEGR BIOL-UK, V2, P25, DOI 10.1039/b917761b; Silverman PM, 1997, MOL MICROBIOL, V23, P423, DOI 10.1046/j.1365-2958.1997.2411604.x; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; SONOHARA R, 1995, BIOPHYS CHEM, V55, P273, DOI 10.1016/0301-4622(95)00004-H; STUART MAC, 1985, COLLOID SURFACE, V15, P49; STUART MAC, 1984, COLLOID POLYM SCI, V262, P423, DOI 10.1007/BF01410263; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; THWAITES JJ, 1991, ADV MICROB PHYSIOL, V32, P173, DOI 10.1016/S0065-2911(08)60008-9; THWAITES JJ, 1985, P NATL ACAD SCI USA, V82, P2163, DOI 10.1073/pnas.82.7.2163; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; Ubbink J, 2005, MICRON, V36, P293, DOI 10.1016/j.micron.2004.11.005; Ubbink J, 2007, CURR OPIN COLLOID IN, V12, P263, DOI 10.1016/j.cocis.2007.08.004; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004; Vadillo-Rodriguez V, 2008, J BACTERIOL, V190, P4225, DOI 10.1128/JB.00132-08; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; Viota J. L., 2009, J COLLOID INTERF SCI, V332, P215; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; Wang YA, 2009, J MOL BIOL, V385, P22, DOI 10.1016/j.jmb.2008.10.054; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999	103	66	66	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20066	10.1371/journal.pone.0020066	http://dx.doi.org/10.1371/journal.pone.0020066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655293	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600018
J	Hersh, AL; Shapiro, DJ; Newland, JG; Polgreen, PM; Beekmann, SE; Shah, SS				Hersh, Adam L.; Shapiro, Daniel J.; Newland, Jason G.; Polgreen, Philip M.; Beekmann, Susan E.; Shah, Samir S.			Variability in Pediatric Infectious Disease Consultants' Recommendations for Management of Community-Acquired Pneumonia	PLOS ONE			English	Article							GUIDELINES; SOCIETY; SUSCEPTIBILITY; EPIDEMIOLOGY; STEWARDSHIP; RESISTANCE; CHILDREN; AMERICA	Background: Community-acquired pneumonia (CAP) is a common childhood infection. CAP complications, such as parapneumonic empyema (PPE), are increasing and are frequently caused by antibiotic-resistant organisms. No clinical guidelines currently exist for management of pediatric CAP and no published data exist about variations in antibiotic prescribing patterns. Our objectives were to describe variation in CAP clinical management for hospitalized children by pediatric infectious disease consultants and to examine associations between recommended antibiotic regimens and local antibiotic resistance levels. Methods: We surveyed pediatric members of the Emerging Infections Network, which consists of 259 pediatric infectious disease physicians. Participants responded regarding their recommended empiric antibiotic regimens for hospitalized children with CAP with and without PPE and their recommendations for duration of therapy. Participants also provided information about the prevalence of penicillin non-susceptible S. pneumoniae and methicillin-resistant S. aureus (MRSA) in their community. Results: We received 148 responses (57%). For uncomplicated CAP, respondents were divided between recommending beta-lactams alone (55%) versus beta-lactams in combination with another class (40%). For PPE, most recommended a combination of a beta-lactam plus an anti-MRSA agent, however, they were divided between clindamycin (44%) and vancomycin (57%). The relationship between reported antibiotic resistance and empiric regimen was mixed. We found no relationship between aminopenicillin use and prevalence of penicillin non-suscepetible S. pneumoniae or clindamycin use and clindamycin resistance, however, respondents were more likely to recommend an anti-MRSA agent when MRSA prevalence increased. Conclusions: Substantial variability exists in recommendations for CAP management. Development of clinical guidelines via antimicrobial stewardship programs and dissemination of data about local antibiotic resistance patterns represent opportunities to improve care.	[Hersh, Adam L.] Univ Utah, Salt Lake City, UT 84112 USA; [Shapiro, Daniel J.] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Newland, Jason G.] Childrens Mercy Hosp & Clin, Kansas City, MO USA; [Polgreen, Philip M.; Beekmann, Susan E.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Shah, Samir S.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Shah, Samir S.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Shah, Samir S.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Shah, Samir S.] Childrens Hosp Philadelphia, Div Infect Dis, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA	Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; Children's Mercy Hospital; University of Iowa; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Hersh, AL (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	adam.hersh@hsc.utah.edu	Shah, Samir/B-2661-2015	Shah, Samir/0000-0001-7902-7000; Polgreen, Philip/0000-0002-0630-5898	Centers for Disease Control and Prevention (CDC) [U50 CCU112346]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grant/cooperative agreement number U50 CCU112346 from the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLASCHKE AJ, 2010, PEDIAT INFECT DIS J; Byington CL, 2006, PEDIATR INFECT DIS J, V25, P250, DOI 10.1097/01.inf.0000202137.37642.ab; Cardoso MRA, 2008, ARCH DIS CHILD, V93, P221, DOI 10.1136/adc.2006.111625; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Furuno JP, 2006, PHARMACOEPIDEM DR S, V15, P1, DOI 10.1002/pds.1135; GERBER JS, 2010, PEDIATRICS; Grijalva CG, 2010, CLIN INFECT DIS, V50, P805, DOI 10.1086/650573; Herigon JC, 2010, PEDIATRICS, V125, pE1294, DOI 10.1542/peds.2009-2867; Hersh AL, 2009, INFECT CONT HOSP EP, V30, P1211, DOI 10.1086/648088; Kaplan SL, 2005, PEDIATR INFECT DIS J, V24, P457, DOI 10.1097/01.inf.0000164162.00163.9d; Kollef MH, 2008, CLIN INFECT DIS, V47, pS3, DOI 10.1086/590061; Lee GE, 2010, PEDIATRICS, V126, P204, DOI 10.1542/peds.2009-3109; Li STT, 2010, PEDIATRICS, V125, P26, DOI 10.1542/peds.2009-0184; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mermel LA, 2008, CLIN INFECT DIS, V46, P1789, DOI 10.1086/588050; Metlay JP, 2002, J GEN INTERN MED, V17, P87, DOI 10.1046/j.1525-1497.2002.10711.x; Mulholland S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004875.pub3; MUSZYNSKI JA, 2010, PEDIAT INFECT DIS J; Newland JG, 2010, PEDIATR INFECT DIS J, V29, P862, DOI 10.1097/INF.0b013e3181ef2507; Patel SJ, 2010, INFECT CONT HOSP EP, V31, P1298, DOI 10.1086/657334; Pogue JM, 2011, INFECT CONT HOSP EP, V32, P289, DOI 10.1086/658665; Rosen J, 2010, J CLIN MICROBIOL, V48, P3372, DOI 10.1128/JCM.01012-10; Schultz KD, 2004, PEDIATRICS, V113, P1735, DOI 10.1542/peds.113.6.1735; WILLIAMS DJ, 2011, ARCH PEDIAT ADOLESC; Yu VL, 2003, CLIN INFECT DIS, V37, P230, DOI 10.1086/377534	26	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20325	10.1371/journal.pone.0020325	http://dx.doi.org/10.1371/journal.pone.0020325			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655259	gold, Green Published			2022-12-25	WOS:000291097600044
J	Reyal, F; Rouzier, R; Depont-Hazelzet, B; Bollet, MA; Pierga, JY; Alran, S; Salmon, RJ; Fourchotte, V; Vincent-Salomon, A; Sastre-Garau, X; Antoine, M; Uzan, S; Sigal-Zafrani, B; De Rycke, Y				Reyal, Fabien; Rouzier, Roman; Depont-Hazelzet, Berenice; Bollet, Marc A.; Pierga, Jean-Yves; Alran, Severine; Salmon, Remy J.; Fourchotte, Virginie; Vincent-Salomon, Anne; Sastre-Garau, Xavier; Antoine, Martine; Uzan, Serge; Sigal-Zafrani, Brigitte; De Rycke, Yann			The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma	PLOS ONE			English	Article							HORMONE-RECEPTOR; CANCER PATIENTS; METASTASES; PREDICTORS; INVOLVEMENT; PORTRAITS; HER-2; RISK	Introduction: Several authors have underscored a strong relation between the molecular subtypes and the axillary status of breast cancer patients. The aim of our work was to decipher the interaction between this classification and the probability of a positive sentinel node biopsy. Materials and Methods: Our dataset consisted of a total number of 2654 early-stage breast cancer patients. Patients treated at first by conservative breast surgery plus sentinel node biopsies were selected. A multivariate logistic regression model was trained and validated. Interaction covariate between ER and HER2 markers was a forced input of this model. The performance of the multivariate model in the training and the two validation sets was analyzed in terms of discrimination and calibration. Probability of axillary metastasis was detailed for each molecular subtype. Results: The interaction covariate between ER and HER2 status was a stronger predictor (p = 0.0031) of positive sentinel node biopsy than the ER status by itself (p = 0.016). A multivariate model to determine the probability of sentinel node positivity was defined with the following variables; tumour size, lympho-vascular invasion, molecular subtypes and age at diagnosis. This model showed similar results in terms of discrimination (AUC = 0.72/0.73/0.72) and calibration (HL p = 0.28/0.05/0.11) in the training and validation sets. The interaction between molecular subtypes, tumour size and sentinel nodes status was approximated. Discussion: We showed that biologically-driven analyses are able to build new models with higher performance in terms of breast cancer axillary status prediction. The molecular subtype classification strongly interacts with the axillary and distant metastasis process.	[Reyal, Fabien; Depont-Hazelzet, Berenice; Alran, Severine; Salmon, Remy J.; Fourchotte, Virginie] Inst Curie, Dept Surg, Paris, France; [Rouzier, Roman; Uzan, Serge] Hop Tenon, Dept Gynaecol, F-75970 Paris, France; [Rouzier, Roman; Uzan, Serge] Univ Paris 06, AP HP, Paris, France; [Bollet, Marc A.] Inst Curie, Dept Med Oncol, Paris, France; [Pierga, Jean-Yves] Inst Curie, Dept Radiat Oncol, Paris, France; [Vincent-Salomon, Anne; Sastre-Garau, Xavier; Sigal-Zafrani, Brigitte] Inst Curie, Dept Tumour Biol, Paris, France; [Antoine, Martine] Hop Tenon, Dept Pathol, F-75970 Paris, France; [De Rycke, Yann] Inst Curie, Dept Biostat, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.	Fabien.reyal@curie.net	; Rouzier, Roman/G-2953-2018	Sastre-Garau, Xavier/0000-0001-5992-2083; Rouzier, Roman/0000-0002-8167-6808				Bader AA, 2002, BREAST CANCER RES TR, V76, P11, DOI 10.1023/A:1020231300974; Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO;2-Y; Crabb SJ, 2008, CLIN BREAST CANCER, V8, P249, DOI 10.3816/CBC.2008.n.028; Fehm T, 2005, STRAHLENTHER ONKOL, V181, P580, DOI 10.1007/s00066-005-1374-y; Freneaux P, 2002, MODERN PATHOL, V15, P641, DOI 10.1038/modpathol.3880580; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Gonzalez-Vela MC, 1999, PATHOL RES PRACT, V195, P611, DOI 10.1016/S0344-0338(99)80126-5; Guarnieri A, 2001, EUR J SURG, V167, P255, DOI 10.1080/110241501300091381; Kim MJ, 2006, HUM PATHOL, V37, P1217, DOI 10.1016/j.humpath.2006.04.015; Lee JH, 2010, CANCER RES TREAT, V42, P30, DOI 10.4143/crt.2010.42.1.30; Liu H, 2008, HUM PATHOL, V39, P167, DOI 10.1016/j.humpath.2007.06.012; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Olivotto IA, 1998, CANCER-AM CANCER SOC, V83, P948, DOI 10.1002/(SICI)1097-0142(19980901)83:5<948::AID-CNCR21>3.3.CO;2-D; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; RAVDIN PM, 1994, J NATL CANCER I, V86, P1771, DOI 10.1093/jnci/86.23.1771; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rivadeneira DE, 2000, J AM COLL SURGEONS, V191, P1, DOI 10.1016/S1072-7515(00)00310-0; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Van Calster B, 2009, BREAST CANCER RES TR, V113, P181, DOI 10.1007/s10549-008-9914-7; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; VANDIEST PJ, 1991, J CLIN PATHOL, V44, P416, DOI 10.1136/jcp.44.5.416; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yip CH, 2009, WORLD J SURG, V33, P54, DOI 10.1007/s00268-008-9782-7	29	87	88	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20297	10.1371/journal.pone.0020297	http://dx.doi.org/10.1371/journal.pone.0020297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655258	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600039
J	Rooney, PJ; Neal, LM; Knoll, LJ				Rooney, Peggy J.; Neal, Lori M.; Knoll, Laura J.			Involvement of a Toxoplasma gondii Chromatin Remodeling Complex Ortholog in Developmental Regulation	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASES; SWIRM DOMAIN; GENES; PROTEIN; IDENTIFICATION; TRANSCRIPTION; LOCALIZATION; BRADYZOITES; INFECTION; REVEALS	The asexual cycle of the parasite Toxoplasma gondii has two developmental stages: a rapidly replicating form called a tachyzoite and a slow growing cyst form called a bradyzoite. While the importance of ATP-independent histone modifications for gene regulation in T. gondii have been demonstrated, ATP-dependent chromatin remodeling pathways have not been examined. In this study we characterized C9, an insertional mutant showing reduced expression of bradyzoite differentiation marker BAG1, in cultured human fibroblasts. This mutant contains an insertion in the gene encoding TgRSC8, which is homologous to the Saccharomyces cerevisiae proteins Rsc8p (remodel the structure of chromatin complex subunit 8) and Swi3p (switch/sucrose non-fermentable [SWI/SNF]) of ATP-dependent chromatin-remodeling complexes. In the C9 mutant, TgRSC8 is the downstream open reading frame on a dicistronic transcript. Though protein was expressed from the downstream gene of the dicistron, TgRSC8 levels were decreased in C9 from those of wild-type parasites, as determined by western immunoblot and flow cytometry. As TgRSC8 localized to the parasite nucleus, we postulated a role in gene regulation. Transcript levels of several markers were assessed by quantitative PCR to test this hypothesis. The C9 mutant displayed reduced steady state transcript levels of bradyzoite-induced genes BAG1, LDH2, SUSA1, and ENO1, all of which were significantly increased with addition of TgRSC8 to the mutant. Transcript levels of some bradyzoite markers were unaltered in C9, or unable to be increased by complementation with TgRSC8, indicating multiple pathways control bradyzoite-upregulated genes. Together, these data suggest a role for TgRSC8 in control of bradyzoite-upregulated gene expression. Thus chromatin remodeling, by both ATP-independent and dependent mechanisms, is an important mode of gene regulation during stage differentiation in parasites.	[Rooney, Peggy J.; Neal, Lori M.; Knoll, Laura J.] Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Rooney, PJ (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	ljknoll@wisc.edu		Rooney, Peggy/0000-0002-2233-3653; Neal, Lori M./0000-0001-5149-9110	National Institute of Allergy and Infectious Diseases (NIAID) [F32AI065023]; National Institute of General Medical Sciences (NIGMS) [T32GM007215-35]; University of Wisconsin Distinguished Graduate/Food Research Institute; American Heart Association [0840059N]; American Cancer Society [RSG-07-202-01-MBC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI065023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin Distinguished Graduate/Food Research Institute; American Heart Association(American Heart Association); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Research Service Award number F32AI065023 from the National Institute of Allergy and Infectious Diseases (NIAID) to PJR; molecular biosciences training grant T32GM007215-35 from the National Institute of General Medical Sciences (NIGMS) and University of Wisconsin Distinguished Graduate/Food Research Institute fellowship to LMN; American Heart Association 0840059N and American Cancer Society RSG-07-202-01-MBC to LJK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIGMS, the National Institutes of Health, the University of Wisconsin, American Heart Association or the American Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bhatti MM, 2006, EUKARYOT CELL, V5, P62, DOI 10.1128/EC.5.1.62-76.2006; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Craver MPJ, 2010, MOL BIOCHEM PARASIT, V169, P120, DOI 10.1016/j.molbiopara.2009.10.006; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Dalmasso MC, 2006, MOL BIOCHEM PARASIT, V148, P103, DOI 10.1016/j.molbiopara.2006.03.005; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dubey JP, 2008, INT J PARASITOL, V38, P1257, DOI 10.1016/j.ijpara.2008.03.007; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; Ferguson DJP, 2004, INT J PARASITOL, V34, P347, DOI 10.1016/j.ijpara.2003.11.024; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frankel MB, 2007, P NATL ACAD SCI USA, V104, P10181, DOI 10.1073/pnas.0701893104; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Harlow E., 1988, ANTIBODIES LAB MANUA; Knoll LJ, 1998, MOL CELL BIOL, V18, P807, DOI 10.1128/MCB.18.2.807; Mullapudi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r34; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; Nallani KC, 2005, PARASITOL RES, V95, P236, DOI 10.1007/s00436-004-1291-5; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; PARMLEY SF, 1995, MOL BIOCHEM PARASIT, V73, P253, DOI 10.1016/0166-6851(95)00100-F; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollard AM, 2008, INFECT IMMUN, V76, P103, DOI 10.1128/IAI.01170-07; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Saeij JPJ, 2008, INFECT IMMUN, V76, P2402, DOI 10.1128/IAI.01494-07; Saeij JPJ, 2005, INFECT IMMUN, V73, P695, DOI 10.1128/IAI.73.2.695-702.2005; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Schwarz JA, 2005, MOL BIOCHEM PARASIT, V144, P159, DOI 10.1016/j.molbiopara.2005.08.011; Seeber F, 1997, PARASITOL RES, V83, P309, DOI 10.1007/s004360050254; Smith AT, 2005, EUKARYOT CELL, V4, P2057, DOI 10.1128/EC.4.12.2057-2065.2005; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Sullivan WJ, 2006, MOL BIOCHEM PARASIT, V148, P109, DOI 10.1016/j.molbiopara.2006.03.010; Tomavo Stanislas, 2007, P285; Treich I, 1997, MOL CELL BIOL, V17, P1768, DOI 10.1128/MCB.17.4.1768; Treich I, 1998, NUCLEIC ACIDS RES, V26, P3739, DOI 10.1093/nar/26.16.3739; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Weiss LM, 1998, INFECT IMMUN, V66, P3295, DOI 10.1128/IAI.66.7.3295-3302.1998; Yoneyama M, 2007, J MOL BIOL, V369, P222, DOI 10.1016/j.jmb.2007.03.027; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhang YW, 2001, INFECT IMMUN, V69, P501, DOI 10.1128/IAI.69.1.501-507.2001	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19570	10.1371/journal.pone.0019570	http://dx.doi.org/10.1371/journal.pone.0019570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655329	Green Submitted, gold, Green Published			2022-12-25	WOS:000291097600007
J	Gottlieb, A; Frenkel-Morgenstern, M; Safro, M; Horn, D				Gottlieb, Assaf; Frenkel-Morgenstern, Milana; Safro, Mark; Horn, David			Common Peptides Study of Aminoacyl-tRNA Synthetases	PLOS ONE			English	Article							PHENYLALANYL-TRANSFER-RNA; GLUTAMINYL-TRANSFER-RNA; STRUCTURAL BASIS; GENETIC-CODE; ACTIVE-SITE; EVOLUTION; ORIGIN; ACID; ACTIVATION; TREE	Background: Aminoacyl tRNA synthetases (aaRSs) constitute an essential enzyme super-family, providing fidelity of the translation process of mRNA to proteins in living cells. They are common to all kingdoms and are of utmost importance to all organisms. It is thus of great interest to understand the evolutionary relationships among them and underline signature motifs defining their common domains. Results: We utilized the Common Peptides (CPs) framework, based on extracted deterministic motifs from all aaRSs, to study family-specific properties. We identified novel aaRS-class related signatures that may supplement the current classification methods and provide a basis for identifying functional regions specific to each aaRS class. We exploited the space spanned by the CPs in order to identify similarities between aaRS families that are not observed using sequence alignment methods, identifying different inter-aaRS associations across different kingdom of life. We explored the evolutionary history of the aaRS families and evolutionary origins of the mitochondrial aaRSs. Lastly, we showed that prevalent CPs significantly overlap known catalytic and binding sites, suggesting that they have meaningful functional roles, as well as identifying a motif shared between aaRSs and a the Biotin-[acetyl-CoA carboxylase] synthetase (birA) enzyme overlapping binding sites in both families. Conclusions: The study presents the multitude of ways to exploit the CP framework in order to extract meaningful patterns from the aaRS super-family. Specific CPs, discovered in this study, may play important roles in the functionality of these enzymes. We explored the evolutionary patterns in each aaRS family and tracked remote evolutionary links between these families.	[Gottlieb, Assaf] Tel Aviv Univ, Balvatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Frenkel-Morgenstern, Milana] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Madrid, Spain; [Safro, Mark] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Horn, David] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University; Centro Nacional de Investigaciones Oncologicas (CNIO); Weizmann Institute of Science; Tel Aviv University	Gottlieb, A (corresponding author), Tel Aviv Univ, Balvatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	assafgot@tau.ac.il		Frenkel-Morgenstern, Milana/0000-0002-0329-4599; Horn, David/0000-0003-2708-186X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; ARTYMIUK PJ, 1994, NAT STRUCT BIOL, V1, P758, DOI 10.1038/nsb1194-758; Austin J, 2002, J BIOL CHEM, V277, P28394, DOI 10.1074/jbc.M204404200; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; Brindefalk B, 2007, MOL BIOL EVOL, V24, P743, DOI 10.1093/molbev/msl202; BURBAUM JJ, 1991, J BIOL CHEM, V266, P16965; Carter CW, 2002, MOL CELL, V10, P705, DOI 10.1016/S1097-2765(02)00688-3; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O; Delarue M, 1995, J MOL EVOL, V41, P703; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Gottlieb A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-91; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Iwasaki W, 2006, J MOL BIOL, V360, P329, DOI 10.1016/j.jmb.2006.04.068; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Kamtekar S, 2007, P NATL ACAD SCI USA, V104, P2620, DOI 10.1073/pnas.0611504104; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Klipcan L, 2004, J THEOR BIOL, V228, P389, DOI 10.1016/j.jtbi.2004.01.014; Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020; Kobayashi T, 2005, J MOL BIOL, V346, P105, DOI 10.1016/j.jmb.2004.11.034; Kotik-Kogan O, 2005, STRUCTURE, V13, P1799, DOI 10.1016/j.str.2005.08.013; KUNIK V, 2005, P 2005 IEEE COMP SYS; Kunik V, 2007, PLOS COMPUT BIOL, V3, P1623, DOI 10.1371/journal.pcbi.0030167; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Massey Steven E., 2006, In Silico Biology, V6, P259; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Rinehart J, 2004, J BIOL CHEM, V279, P1161, DOI 10.1074/jbc.M310100200; SAFRO M, 1995, PROTEIN SCI, V4, P2429, DOI 10.1002/pro.5560041122; Safro MG, 2009, MOL BIOL+, V43, P211, DOI 10.1134/S0026893309020046; Siatecka M, 1998, EUR J BIOCHEM, V256, P80, DOI 10.1046/j.1432-1327.1998.2560080.x; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Solan Z, 2005, P NATL ACAD SCI USA, V102, P11629, DOI 10.1073/pnas.0409746102; Swairjo MA, 2005, P NATL ACAD SCI USA, V102, P988, DOI 10.1073/pnas.0409024102; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Torres-Larios A, 2002, NAT STRUCT BIOL, V9, P343, DOI 10.1038/nsb789; Trifonov EN, 2002, FEBS LETT, V527, P1, DOI 10.1016/S0014-5793(02)03165-4; Weaver LH, 2001, P NATL ACAD SCI USA, V98, P6045, DOI 10.1073/pnas.111128198; Weingart U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-390; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, GENOME RES, V9, P689; Wolf YI, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-14; NUCL ACIDS RES, V38, pD142	55	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20361	10.1371/journal.pone.0020361	http://dx.doi.org/10.1371/journal.pone.0020361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647378	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052500053
J	Howell, KR; Kutiyanawalla, A; Pillai, A				Howell, Kristy R.; Kutiyanawalla, Ammar; Pillai, Anilkumar			Long-Term Continuous Corticosterone Treatment Decreases VEGF Receptor-2 Expression in Frontal Cortex	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MEDIAL PREFRONTAL CORTEX; NEURONAL CALCIUM SENSOR-1; MEMORY CONSOLIDATION; BASOLATERAL AMYGDALA; CHROMAFFIN CELLS; WORKING-MEMORY; PC12 CELLS; STRESS; PATHWAY	Objective: Stress and increased glucocorticoid levels are associated with many neuropsychiatric disorders including schizophrenia and depression. Recently, the role of vascular endothelial factor receptor-2 (VEGFR2/Flk1) signaling has been implicated in stress-mediated neuroplasticity. However, the mechanism of regulation of VEGF/Flk1 signaling under long-term continuous glucocorticoid exposure has not been elucidated. Material and Methods: We examined the possible effects of long-term continuous glucocorticoid exposure on VEGF/Flk1 signaling in cultured cortical neurons in vitro, mouse frontal cortex in vivo, and in post mortem human prefrontal cortex of both control and schizophrenia subjects. Results: We found that long-term continuous exposure to corticosterone (CORT, a natural glucocorticoid) reduced Flk1 protein levels both in vitro and in vivo. CORT treatment resulted in alterations in signaling molecules downstream to Flk1 such as PTEN, Akt and mTOR. We demonstrated that CORT-induced changes in Flk1 levels are mediated through glucocorticoid receptor (GR) and calcium. A significant reduction in Flk1-GR interaction was observed following CORT exposure. Interestingly, VEGF levels were increased in cortex, but decreased in serum following CORT treatment. Moreover, significant reductions in Flk1 and GR protein levels were found in postmortem prefrontal cortex samples from schizophrenia subjects. Conclusions: The alterations in VEGF/Flk1 signaling following long-term continuous CORT exposure represents a molecular mechanism of the neurobiological effects of chronic stress.	[Howell, Kristy R.; Kutiyanawalla, Ammar; Pillai, Anilkumar] Georgia Hlth Sci Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA; [Howell, Kristy R.; Kutiyanawalla, Ammar; Pillai, Anilkumar] Charlie Norwood Vet Affairs Med Ctr, Med Res Serv, Augusta, GA USA	University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Howell, KR (corresponding author), Georgia Hlth Sci Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA.	apillai@georgiahealth.edu	PILLAI, ANILKUMAR/N-4809-2017	Howell, Kristy/0000-0002-0872-5335	NINDS/NIH; National Multiple Sclerosis Society; Department of Veteran Affairs	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Department of Veteran Affairs(US Department of Veterans Affairs)	The authors would also like to acknowledge the Human Brain and Spinal Fluid Resource Center, VA West Los Angeles Healthcare Center, 11301 Wilshire Blvd. Los Angeles, CA 90073 which is supported by NINDS/NIH, National Multiple Sclerosis Society, and Department of Veteran Affairs.	Ardayfio P, 2006, BEHAV NEUROSCI, V120, P249, DOI 10.1037/0735-7044.120.2.249; Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Barsegyan A, 2010, P NATL ACAD SCI USA, V107, P16655, DOI 10.1073/pnas.1011975107; Bauer DE, 2009, J NEURAL TRANSM, V116, P487, DOI 10.1007/s00702-008-0143-3; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cerqueira JJ, 2005, J NEUROSCI, V25, P7792, DOI 10.1523/JNEUROSCI.1598-05.2005; CHAO HM, 1989, NEUROENDOCRINOLOGY, V50, P365, DOI 10.1159/000125250; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; ELLIOTT EM, 1993, BRAIN RES, V602, P84, DOI 10.1016/0006-8993(93)90245-I; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; KELLERWOOD ME, 1984, ENDOCR REV, V5, P1, DOI 10.1210/edrv-5-1-1; KERR DS, 1992, P NATL ACAD SCI USA, V89, P8527, DOI 10.1073/pnas.89.18.8527; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Leitch MM, 2003, NEUROPSYCHOPHARMACOL, V28, P119, DOI 10.1038/sj.npp.1300016; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Lupien SJ, 1999, REV NEUROSCIENCE, V10, P117; MALLART A, 1991, J NEUROGENET, V7, P75, DOI 10.3109/01677069109066212; McEuen JG, 2008, J NEUROSCI, V28, P8169, DOI 10.1523/JNEUROSCI.0004-08.2008; Mexal S, 2006, BRAIN RES, V1106, P1, DOI 10.1016/j.brainres.2006.05.043; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Pan CY, 2002, J NEUROSCI, V22, P2427, DOI 10.1523/JNEUROSCI.22-07-02427.2002; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pillai A, 2008, J NEUROCHEM, V107, P941, DOI 10.1111/j.1471-4159.2008.05665.x; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Qiu JA, 2003, LIFE SCI, V72, P2533, DOI 10.1016/S0024-3205(03)00168-1; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P307, DOI 10.1093/cercor/5.4.307; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; Scalettar BA, 2002, J CELL SCI, V115, P2399; Seib LM, 2003, NEUROSCI LETT, V337, P29, DOI 10.1016/S0304-3940(02)01287-9; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shibuya M, 2006, ENDOTHELIUM-J ENDOTH, V13, P63, DOI 10.1080/10623320600697955; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; SZE PY, 1994, NEUROENDOCRINOLOGY, V59, P457, DOI 10.1159/000126692; Tsujimoto T, 2002, SCIENCE, V295, P2276, DOI 10.1126/science.1068278; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Weiss JL, 2010, CELL MOL NEUROBIOL, V30, P1283, DOI 10.1007/s10571-010-9588-7; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; Wellman CL, 2001, J NEUROBIOL, V49, P245, DOI 10.1002/neu.1079; YOUNG EA, 1995, J NEUROENDOCRINOL, V7, P37, DOI 10.1111/j.1365-2826.1995.tb00665.x; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637	55	53	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20198	10.1371/journal.pone.0020198	http://dx.doi.org/10.1371/journal.pone.0020198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647420	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052500040
J	Jeong, JK; Tremere, LA; Burrows, K; Majewska, AK; Pinaud, R				Jeong, Jin-Kwon; Tremere, Liisa A.; Burrows, Kaiping; Majewska, Ania K.; Pinaud, Raphael			The Mouse Primary Visual Cortex Is a Site of Production and Sensitivity to Estrogens	PLOS ONE			English	Article							DENDRITIC SPINE DENSITY; LONG-TERM; IN-SITU; SYNAPTIC PLASTICITY; RAPID ENHANCEMENT; NEURONAL-ACTIVITY; BRAIN AROMATASE; GENE-EXPRESSION; MENSTRUAL-CYCLE; STRIATE CORTEX	The classic female estrogen, 17 beta-estradiol (E2), has been repeatedly shown to affect the perceptual processing of visual cues. Although gonadal E2 has often been thought to influence these processes, the possibility that central visual processing may be modulated by brain-generated hormone has not been explored. Here we show that estrogen-associated circuits are highly prevalent in the mouse primary visual cortex (V1). Specifically, we cloned aromatase, a marker for estrogen-producing neurons, and the classic estrogen receptors (ERs) ER alpha and ER beta, as markers for estrogen-responsive neurons, and conducted a detailed expression analysis via in-situ hybridization. We found that both monocular and binocular V1 are highly enriched in aromatase-and ER-positive neurons, indicating that V1 is a site of production and sensitivity to estrogens. Using double-fluorescence in-situ hybridization, we reveal the neurochemical identity of estrogen-producing and -sensitive cells in V1, and demonstrate that they constitute a heterogeneous neuronal population. We further show that visual experience engages a large population of aromatase-positive neurons and, to a lesser extent, ER-expressing neurons, suggesting that E2 levels may be locally regulated by visual input in V1. Interestingly, acute episodes of visual experience do not affect the density or distribution of estrogen-associated circuits. Finally, we show that adult mice dark-reared from birth also exhibit normal distribution of aromatase and ERs throughout V1, suggesting that the implementation and maintenance of estrogen-associated circuits is independent of visual experience. Our findings demonstrate that the adult V1 is a site of production and sensitivity to estrogens, and suggest that locally-produced E2 may shape visual cortical processing.	[Jeong, Jin-Kwon; Tremere, Liisa A.; Burrows, Kaiping; Pinaud, Raphael] Univ Oklahoma Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Tremere, Liisa A.; Pinaud, Raphael] Univ Oklahoma Hlth Sci Ctr, Dept Geriatr Med, Oklahoma City, OK USA; [Tremere, Liisa A.; Pinaud, Raphael] Univ Oklahoma Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK USA; [Majewska, Ania K.] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY USA; [Majewska, Ania K.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Rochester; University of Rochester	Jeong, JK (corresponding author), Univ Oklahoma Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.	raphael-pinaud@ouhsc.edu	Jeong, Jin Kwon/AAU-2951-2020	Majewska, Ania/0000-0002-2167-6849; Jeong, Jin Kwon/0000-0002-5261-4915	NIH/NIDCD [R01-DC-010181]; NIH/NEI [R01-EY-0192277]; Schmitt Foundation; Reynolds Foundation; NATIONAL EYE INSTITUTE [R01EY019277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010181] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Schmitt Foundation; Reynolds Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH/NIDCD (R01-DC-010181) - www.nidcd.nih.gov; NIH/NEI (R01-EY-0192277) - www.nei.nih.gov; Schmitt Foundation (no # available) -http://www.urmc.rochester.edu/smd/nanat/schmitt/history.cfm; Reynolds Foundation (no # available) - http://www.dwreynolds.org/Programs/National/Aging/Aging.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balthazart J, 2006, NEUROSCIENCE, V138, P783, DOI 10.1016/j.neuroscience.2005.06.016; Balthazart J, 2003, EUR J NEUROSCI, V17, P1591, DOI 10.1046/j.1460-9568.2003.02598.x; Balthazart J, 2001, J NEUROENDOCRINOL, V13, P63, DOI 10.1046/j.1365-2826.2001.00598.x; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Barha CK, 2010, NEUROPSYCHOPHARMACOL, V35, P547, DOI 10.1038/npp.2009.161; Bi RF, 2000, P NATL ACAD SCI USA, V97, P3602, DOI 10.1073/pnas.060034497; Chen JR, 2009, CEREB CORTEX, V19, P2719, DOI 10.1093/cercor/bhp048; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; DAVIS M J, 1982, Journal of Auditory Research, V22, P173; FILLIT H, 1986, PSYCHONEUROENDOCRINO, V11, P337, DOI 10.1016/0306-4530(86)90019-3; Foy MR, 2001, NEUROBIOL LEARN MEM, V76, P239, DOI 10.1006/nlme.2001.4018; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; GOULD E, 1990, J NEUROSCI, V10, P1286; Gu Q, 1996, J NEUROSCI, V16, P3620; HERBISON AE, 1995, J NEUROSCI, V15, P2328, DOI 10.1523/JNEUROSCI.15-03-02328.1995; Herbison AE, 1997, BRAIN RES BULL, V44, P321, DOI 10.1016/S0361-9230(97)00210-4; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hultcrantz M, 2006, ACTA OTO-LARYNGOL, V126, P10, DOI 10.1080/00016480510038617; Kaczmarek L, 1997, BRAIN RES REV, V23, P237, DOI 10.1016/S0165-0173(97)00005-2; Kumar A, 2002, J NEUROPHYSIOL, V88, P621, DOI 10.1152/jn.2002.88.2.621; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; Liu F, 2008, NAT NEUROSCI, V11, P334, DOI 10.1038/nn2057; Luine VN, 2008, J NEUROENDOCRINOL, V20, P866, DOI 10.1111/j.1365-2826.2008.01710.x; MAGGI A, 1984, EUR J PHARMACOL, V103, P165, DOI 10.1016/0014-2999(84)90205-X; Maney DL, 2011, FRONT NEUROENDOCRIN, V32, P287, DOI 10.1016/j.yfrne.2010.12.002; Mazzocco MMM, 2006, CHILD NEUROPSYCHOL, V12, P87, DOI 10.1080/09297040500266951; McCullough LD, 2003, J NEUROSCI, V23, P8701; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; Miller TW, 2008, J STEROID BIOCHEM, V112, P95, DOI 10.1016/j.jsbmb.2008.09.001; Milner TA, 2010, BRAIN RES, V1351, P74, DOI 10.1016/j.brainres.2010.06.038; Montoya DAC, 1997, BRAIN RES, V778, P430, DOI 10.1016/S0006-8993(97)01206-7; Morales B, 2002, J NEUROSCI, V22, P8084; Mukai H, 2007, J NEUROCHEM, V100, P950, DOI 10.1111/j.1471-4159.2006.04264.x; Murphy DD, 1998, J NEUROSCI, V18, P2550; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P497, DOI 10.1016/0306-4530(92)90008-U; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Pinaud R, 2003, BRAIN RES BULL, V61, P139, DOI 10.1016/S0361-9230(03)00100-X; Pinaud R, 2002, NEUROSCIENCE, V112, P573, DOI 10.1016/S0306-4522(02)00094-5; PINAUD R, 2006, IMM EARL GEN SENS, pR7; PINAUD R, 2005, PLASTICITY VISUAL SY, P153; Pinaud R, 2008, NAT PROTOC, V3, P1370, DOI 10.1038/nprot.2008.115; Pinaud R, 2010, METHODS MOL BIOL, V611, P115, DOI 10.1007/978-1-60327-345-9_9; RAMOA AS, 1988, EXP BRAIN RES, V73, P285; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Resnick SM, 2001, ANN NY ACAD SCI, V949, P203; Roselli CE, 2009, SEMIN REPROD MED, V27, P207, DOI 10.1055/s-0029-1216274; Ross J, 2000, MENT RETARD DEV D R, V6, P135, DOI 10.1002/1098-2779(2000)6:2<135::AID-MRDD8>3.0.CO;2-K; SCHUMACHER M, 1989, NEUROENDOCRINOLOGY, V50, P315, DOI 10.1159/000125239; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; SILLITO AM, 1977, J PHYSIOL-LONDON, V271, P699, DOI 10.1113/jphysiol.1977.sp012021; Smejkalova T, 2010, J NEUROSCI, V30, P16137, DOI 10.1523/JNEUROSCI.4161-10.2010; Snyder MA, 2010, J NEUROSCI METH, V188, P226, DOI 10.1016/j.jneumeth.2010.02.012; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; TREMERE LA, 2005, PLASTICITY VISUAL SY, P229; Tremere LA, 2011, J NEUROSCI, V31, P3271, DOI 10.1523/JNEUROSCI.4355-10.2011; Tremere LA, 2009, J NEUROSCI, V29, P5949, DOI 10.1523/JNEUROSCI.0774-09.2009; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 2000, NEURON, V27, P427, DOI 10.1016/S0896-6273(00)00053-2; WONG M, 1992, J NEUROSCI, V12, P3217, DOI 10.1523/JNEUROSCI.12-08-03217.1992; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; Woolley CS, 1998, HORM BEHAV, V34, P140, DOI 10.1006/hbeh.1998.1466; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990	70	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20400	10.1371/journal.pone.0020400	http://dx.doi.org/10.1371/journal.pone.0020400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647225	Green Submitted, Green Published, gold			2022-12-25	WOS:000291005800048
J	Chen, CA; Lin, CH; Druhan, LJ; Wang, TY; Chen, YR; Zweier, JL				Chen, Chun-An; Lin, Cho-Hao; Druhan, Lawrence J.; Wang, Tse-Yao; Chen, Yeong-Renn; Zweier, Jay L.			Superoxide Induces Endothelial Nitric-oxide Synthase Protein Thiyl Radical Formation, a Novel Mechanism Regulating eNOS Function and Coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-GLUTATHIONYLATION; REPERFUSION INJURY; ESCHERICHIA-COLI; NO SYNTHASE; ELECTRON-TRANSFER; OXIDATIVE STRESS; HEART-FAILURE; GENERATION; NITRATION; ENZYME	An increase in production of reactive oxygen species resulting in a decrease in nitric oxide bioavailability in the endothelium contributes to many cardiovascular diseases, and these reactive oxygen species can oxidize cellular macromolecules. Protein thiols are critical reducing equivalents that maintain cellular redox state and are primary targets for oxidative modification. We demonstrate endothelial NOS(eNOS) oxidant-induced protein thiyl radical formation from tetrahydrobiopterin-free enzyme or following exposure to exogenous superoxide using immunoblotting, immunostaining, and mass spectrometry. Spin trapping with 5,5-dimethyl-1-pyrroline N-oxide (DMPO) followed by immunoblotting using an anti-DMPO antibody demonstrated the formation of eNOS protein radicals, which were abolished by superoxide dismutase and L-NAME, indicating that protein radical formation was due to superoxide generation from the eNOS heme. With tetrahydrobiopterin-reconstituted eNOS, eNOS protein radical formation was completely inhibited. Using mass spectrometric and mutagenesis analysis, we identified Cys-908 as the residue involved in protein radical formation. Mutagenesis of this key cysteine to alanine abolished eNOS thiyl radical formation and uncoupled eNOS, leading to increased superoxide generation. Protein thiyl radical formation leads to oxidation or modification of cysteine with either disulfide bond formation or S-glutathionylation, which induces eNOS uncoupling. Furthermore, in endothelial cells treated with menadione to trigger cellular superoxide generation, eNOS protein radical formation, as visualized with confocal microscopy, was increased, and these results were confirmed by immunoprecipitation with anti-eNOS antibody, followed by immunoblotting with an anti-DMPO antibody. Thus, eNOS protein radical formation provides the basis for a mechanism of superoxide-directed regulation of eNOS, involving thiol oxidation, defining a unique pathway for the redox regulation of cardiovascular function.	[Zweier, Jay L.] Ohio State Univ, Davis Heart & Lung Res Inst, Coll Med, Columbus, OH 43210 USA; Ohio State Univ, Div Cardiovasc Med, Coll Med, Dept Internal Med, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Zweier, JL (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Coll Med, 473 W 12th Ave, Columbus, OH 43210 USA.	Jay.Zweier@osumc.edu	Druhan, Lawrence/E-2994-2011		National Institutes of Health [HL63744, HL65608, HL38324, HL081734, HL83237, K99HL103846]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083237, R01HL038324, R29HL038324, K99HL103846, P01HL065608, R01HL081734, R01HL063744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63744, HL65608, and HL38324 (to J. L. Z.); HL081734 (to L. J. D.); HL83237 (to Y.-R.C.); and K99HL103846 (to C.-A. C.).	ABUSOUD HM, 1995, BIOCHEMISTRY-US, V34, P11167, DOI 10.1021/bi00035a023; ADACHI T, 2005, DRUG DISCOV TODAY, V2, P39; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; CHEN CA, 2009, CIRCULATION, V120, pS1070; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chen CA, 2008, CIRCULATION, V118, pS274; Chen YR, 2005, J BIOL CHEM, V280, P37339, DOI 10.1074/jbc.M503936200; Cuzzocrea S, 1998, BRIT J PHARMACOL, V123, P525, DOI 10.1038/sj.bjp.0701612; Druhan LJ, 2008, BIOCHEMISTRY-US, V47, P7256, DOI 10.1021/bi702377a; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Forstermann U, 2006, BIOL CHEM, V387, P1521, DOI 10.1515/BC.2006.190; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; GERBER NC, 1995, J BIOL CHEM, V270, P17791, DOI 10.1074/jbc.270.30.17791; GNANAIAH W, 1986, J BIOL CHEM, V261, P2649; Harbrecht BG, 1997, ANN SURG, V225, P76, DOI 10.1097/00000658-199701000-00009; HOFMANN H, 1995, BIOCHEMISTRY-US, V34, P13443, DOI 10.1021/bi00041a023; Hothersall JS, 1997, BIOCHEM J, V322, P477, DOI 10.1042/bj3220477; Huang AN, 2001, AM J PHYSIOL-CELL PH, V281, pC719, DOI 10.1152/ajpcell.2001.281.2.C719; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Parodi O, 2007, J CARDIOVASC MED, V8, P765, DOI 10.2459/JCM.0b013e32801194d4; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; POU S, 1992, J BIOL CHEM, V267, P24173; RodriguezCrespo I, 1996, ARCH BIOCHEM BIOPHYS, V336, P151, DOI 10.1006/abbi.1996.0543; ROSEN GM, 1984, P NATL ACAD SCI-BIOL, V81, P7269, DOI 10.1073/pnas.81.23.7269; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; STUEHR DJ, 1991, P NATL ACAD SCI USA, V88, P7773, DOI 10.1073/pnas.88.17.7773; Tummala M, 2008, DNA CELL BIOL, V27, P25, DOI 10.1089/dna.2007.0655; Turko IV, 2002, PHARMACOL REV, V54, P619, DOI 10.1124/pr.54.4.619; Vanin AF, 2000, BBA-GEN SUBJECTS, V1474, P365, DOI 10.1016/S0304-4165(00)00033-7; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Xia Y, 2000, FREE RADICAL BIO MED, V29, P793, DOI 10.1016/S0891-5849(00)00427-5; Xia Y, 1998, J BIOL CHEM, V273, P25804, DOI 10.1074/jbc.273.40.25804; Zhang H, 2008, METHOD ENZYMOL, V440, P65, DOI 10.1016/S0076-6879(07)00804-X; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025; ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	54	53	54	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29098	29107		10.1074/jbc.M111.240127	http://dx.doi.org/10.1074/jbc.M111.240127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21666221	Green Published, hybrid			2022-12-25	WOS:000293837000046
J	Sivan, G; Aviner, R; Elroy-Stein, O				Sivan, Gilad; Aviner, Ranen; Elroy-Stein, Orna			Mitotic Modulation of Translation Elongation Factor 1 Leads to Hindered tRNA Delivery to Ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA DELTA; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; FACTOR EF-1-DELTA; CDC2 KINASE; PHOSPHORYLATION; COMPLEX; INITIATION; SUBUNIT; FACTOR-1-DELTA	Translation elongation in eukaryotes is mediated by the concerted actions of elongation factor 1A (eEF1A), which delivers aminoacylated tRNA to the ribosome; elongation factor 1B (eEF1B) complex, which catalyzes the exchange of GDP to GTP on eEF1A; and eEF2, which facilitates ribosomal translocation. Here we present evidence in support of a novel mode of translation regulation by hindered tRNA delivery during mitosis. A conserved consensus phosphorylation site for the mitotic cyclin-dependent kinase 1 on the catalytic delta subunit of eEF1B (termed eEF1D) is required for its posttranslational modification during mitosis, resulting in lower affinity to its substrate eEF1A. This modification is correlated with reduced availability of eEF1A.tRNA complexes, as well as reduced delivery of tRNA to and association of eEF1A with elongating ribosomes. This mode of regulation by hindered tRNA delivery, although first discovered in mitosis, may represent a more globally applicable mechanism employed under other physiological conditions that involve down-regulation of protein synthesis at the elongation level.	[Sivan, Gilad; Aviner, Ranen; Elroy-Stein, Orna] Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University	Elroy-Stein, O (corresponding author), Tel Aviv Univ, Dept Cell Res & Immunol, George S Wise Fac Life Sci, IL-69978 Tel Aviv, Israel.	ornaes@tauex.tau.ac.il	Aviner, Ranen/AAE-6533-2019	Aviner, Ranen/0000-0002-2476-6487; Elroy-Stein, Orna/0000-0002-3716-1540	Israel Science Foundation [131/07]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 131/07.	Boulben S, 2003, CELL MOL LIFE SCI, V60, P2178, DOI 10.1007/s00018-003-3201-x; Brown T, 2004, CURR PROTOC MOL BIOL; Datta B, 1999, EXP CELL RES, V250, P223, DOI 10.1006/excr.1999.4508; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Gerlitz G, 2002, EUR J BIOCHEM, V269, P2810, DOI 10.1046/j.1432-1033.2002.02974.x; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Guerrucci MA, 1999, GENE, V233, P83, DOI 10.1016/S0378-1119(99)00153-5; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; Jester BC, 2003, P NATL ACAD SCI USA, V100, P14351, DOI 10.1073/pnas.2036253100; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kim SB, 2007, CELL DEATH DIFFER, V14, P982, DOI 10.1038/sj.cdd.4402083; KINZY TG, 1995, GENETICS, V141, P481; Le Sourd F, 2006, FEBS LETT, V580, P2755, DOI 10.1016/j.febslet.2006.04.038; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; Marash L, 2008, MOL CELL, V30, P447, DOI 10.1016/j.molcel.2008.03.018; MARIN O, 1992, FEBS LETT, V301, P111, DOI 10.1016/0014-5793(92)80221-2; Merrick WC, 2000, COLD SPRING HARBOR M, V39, P89; MINELLA O, 1994, CELL MOL BIOL, V40, P521; Minella O, 1996, EUR J BIOCHEM, V237, P685, DOI 10.1111/j.1432-1033.1996.0685p.x; Monnier A, 2001, ZYGOTE, V9, P229, DOI 10.1017/S0967199401001241; MULNERLORILLON O, 1992, EXP CELL RES, V202, P549, DOI 10.1016/0014-4827(92)90111-K; MULNERLORILLON O, 1994, J BIOL CHEM, V269, P20201; Nagano K, 2009, PROTEOMICS, V9, P2861, DOI 10.1002/pmic.200800667; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Ong LL, 2006, J BIOL CHEM, V281, P33621, DOI 10.1074/jbc.M607555200; Ong LL, 2003, J BIOL CHEM, V278, P32115, DOI 10.1074/jbc.M210917200; Pomerening JR, 2003, MOL GENET GENOMICS, V269, P776, DOI 10.1007/s00438-003-0888-1; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Sanders J, 1996, J CELL SCI, V109, P1113; SANG LJ, 2002, BIOCHEM BIOPH RES CO, V291, P158; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; Sheu GT, 1997, J BIOL CHEM, V272, P33290, DOI 10.1074/jbc.272.52.33290; Sivan G, 2008, CELL CYCLE, V7, P741, DOI 10.4161/cc.7.6.5596; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Xiao H, 1998, BIOCHEM BIOPH RES CO, V244, P384, DOI 10.1006/bbrc.1998.8274	40	36	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27927	27935		10.1074/jbc.M111.255810	http://dx.doi.org/10.1074/jbc.M111.255810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21665947	hybrid, Green Published			2022-12-25	WOS:000293557800011
J	Jeon, J; Oh, H; Lee, G; Ryu, JH; Rhee, J; Kim, JH; Chung, KH; Song, WK; Chun, CH; Chun, JS				Jeon, Jimin; Oh, Hwanhee; Lee, Gyusuk; Ryu, Je-Hwang; Rhee, Jinseol; Kim, Jin-Hong; Chung, Kyung-Hwun; Song, Woo-Keun; Chun, Churl-Hong; Chun, Jang-Soo			Cytokine-like 1 Knock-out Mice (Cytl1(-/-)) Show Normal Cartilage and Bone Development but Exhibit Augmented Osteoarthritic Cartilage Destruction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II COLLAGEN EXPRESSION; ARTICULAR CHONDROCYTES; MECHANISMS; CHONDROGENESIS; APOPTOSIS; MOUSE; CELLS; MODEL	We have shown that cytokine-like 1 (Cytl1) is a novel autocrine regulatory factor that regulates chondrogenesis of mouse mesenchymal cells (Kim, J. S., Ryoo, Z. Y., and Chun, J. S. (2007) J. Biol. Chem. 282, 29359-29367). In this previous work, we found that Cytl1 expression was very low in mesenchymal cells, increased dramatically during chondrogenesis, and decreased during hypertrophic maturation, both in vivo and in vitro. Moreover, exogenous addition or ectopic expression of Cytl1 caused chondrogenic differentiation of mouse limb bud mesenchymal cells. In the current study, we generated a Cytl1 knockout (Cytl1(-/-)) mouse to investigate the in vivo role of Cytl1. Deletion of the Cytl1 gene did not affect chondrogenesis or cartilage development. Cytl1(-/-) mice also showed normal endochondral ossification and long bone development. Additionally, ultrastructural features of articular cartilage, such as matrix organization and chondrocyte morphology, were similar in wild-type and Cytl1(-/-) mice. However, Cytl1(-/-) mice were more sensitive to osteoarthritic (OA) cartilage destruction. Compared with wild-type littermates, Cytl1(-/-) mice showed more severe OA cartilage destruction upon destabilization of the medial meniscus of mouse knee joints. In addition, expression levels of Cytl1 were markedly decreased in OA cartilage of humans and experimental mice. Taken together, our results suggest that, rather than regulating cartilage and bone development, Cytl1 is required for the maintenance of cartilage homeostasis, and loss of Cytl1 function is associated with experimental OA cartilage destruction in mice.	[Chun, Churl-Hong] Wonkwang Univ, Sch Med, Dept Orthoped Surg, Iksan 570711, South Korea; [Jeon, Jimin; Oh, Hwanhee; Lee, Gyusuk; Ryu, Je-Hwang; Rhee, Jinseol; Kim, Jin-Hong; Chung, Kyung-Hwun; Song, Woo-Keun; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Kwangju 500712, South Korea; [Jeon, Jimin; Oh, Hwanhee; Lee, Gyusuk; Ryu, Je-Hwang; Rhee, Jinseol; Kim, Jin-Hong; Chung, Kyung-Hwun; Song, Woo-Keun; Chun, Jang-Soo] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju 500712, South Korea	Wonkwang University; Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Chun, CH (corresponding author), Wonkwang Univ, Sch Med, Dept Orthoped Surg, Iksan 570711, South Korea.	cch@wonkwang.ac.kr; jschun@gist.ac.kr		Jeon, Jimin/0000-0003-1843-4555; Kim, Jin-Hong/0000-0002-6480-1929	Korea Healthcare Technology RD project [A101793]	Korea Healthcare Technology RD project	This work was supported by a grant from the Korea Healthcare Technology R&D project (A101793).	Ficker M, 2004, DEV BIOL, V268, P7, DOI 10.1016/j.ydbio.2003.11.023; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hashimoto M, 2008, MED RES REV, V28, P464, DOI 10.1002/med.20113; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Huh YH, 2007, J BIOL CHEM, V282, P17123, DOI 10.1074/jbc.M700599200; Huh YH, 2009, GENE, V448, P7, DOI 10.1016/j.gene.2009.08.015; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kurotani R, 2008, AM J RESP CRIT CARE, V178, P389, DOI 10.1164/rccm.200707-1104OC; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001; Mason RM, 2001, OSTEOARTHR CARTILAGE, V9, P85, DOI 10.1053/joca.2000.0363; Oh CD, 2003, J BIOL CHEM, V278, P36563, DOI 10.1074/jbc.M304857200; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Scott NJA, 2009, BBA-MOL BASIS DIS, V1792, P1175, DOI 10.1016/j.bbadis.2009.09.009; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153	23	35	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27206	27213		10.1074/jbc.M111.218065	http://dx.doi.org/10.1074/jbc.M111.218065			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652695	Green Published, hybrid			2022-12-25	WOS:000293268700016
J	Barry, AN; Otoikhian, A; Bhatt, S; Shinde, U; Tsivkovskii, R; Blackburn, NJ; Lutsenko, S				Barry, Amanda N.; Otoikhian, Adenike; Bhatt, Sujata; Shinde, Ujwal; Tsivkovskii, Ruslan; Blackburn, Ninian J.; Lutsenko, Svetlana			The Lumenal Loop Met(672)-Pro(707) of Copper-transporting ATPase ATP7A Binds Metals and Facilitates Copper Release from the Intramembrane Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; ALPHA-AMIDATING MONOOXYGENASE; DISEASE PROTEIN; FUNCTIONAL-CHARACTERIZATION; CATALYTIC-ACTIVITY; NMR-SPECTROSCOPY; MENKES; EXPRESSION; COORDINATION; CELLS	The copper-transporting ATPase ATP7A has an essential role in human physiology. ATP7A transfers the copper cofactor to metalloenzymes within the secretory pathway; inactivation of ATP7A results in an untreatable neurodegenerative disorder, Menkes disease. Presently, the mechanism of ATP7A-mediated copper release into the secretory pathway is not understood. We demonstrate that the characteristic His/Met-rich segment Met(672)-Pro(707) ( HM-loop) that connects the first two transmembrane segments of ATP7A is important for copper release. Mutations within this loop do not prevent the ability of ATP7A to form a phosphorylated intermediate during ATP hydrolysis but inhibit subsequent dephosphorylation, a step associated with copper release. The HM-loop inserted into a scaffold protein forms two structurally distinct binding sites and coordinates copper in a mixed His-Met environment with an similar to 2:1 stoichiometry. Binding of either copper or silver, a Cu( I) analog, induces structural changes in the loop. Mutations of 4 Met residues to Ile or two His-His pairs to Ala-Gly decrease affinity for copper. Altogether, the data suggest a two-step process, where copper released from the transport sites binds to the first His-( Met)(2) site, triggering a structural change and binding to a second 2-coordinate His-His or His-Met site. We also show that copper binding within the HM-loop stabilizes Cu( I) and protects it from oxidation, which may further aid the transfer of copper from ATP7A to acceptor proteins. The mechanism of copper entry into the secretory pathway is discussed.	[Otoikhian, Adenike; Blackburn, Ninian J.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Portland, OR 97291 USA; [Barry, Amanda N.; Lutsenko, Svetlana] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA; [Bhatt, Sujata; Shinde, Ujwal; Tsivkovskii, Ruslan] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97291 USA	Oregon Health & Science University; Johns Hopkins University; Oregon Health & Science University	Blackburn, NJ (corresponding author), Oregon Hlth & Sci Univ, Inst Environm Hlth, Portland, OR 97291 USA.	ninian@comcast.net; lutsenko@jhmi.edu		Barry, Amanda/0000-0002-7992-0322	National Institutes of Health [P01GM067166]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK077429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01GM067166 (to S. L. and N. J. B.).	Andruzzi L, 2005, J AM CHEM SOC, V127, P16548, DOI 10.1021/ja0529539; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Bagai I, 2007, J BIOL CHEM, V282, P35695, DOI 10.1074/jbc.M703937200; Barnes N, 2005, J BIOL CHEM, V280, P9640, DOI 10.1074/jbc.M413840200; Blackburn NJ, 2000, J BIOL INORG CHEM, V5, P341, DOI 10.1007/PL00010663; di Patti MC, 2009, J BIOL CHEM, V284, P4545, DOI 10.1074/jbc.M805688200; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen K, 2003, J AM CHEM SOC, V125, P12088, DOI 10.1021/ja036070y; Chong LX, 2009, J AM CHEM SOC, V131, P3549, DOI 10.1021/ja807354z; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; El Meskini R, 2003, J BIOL CHEM, V278, P12278, DOI 10.1074/jbc.M211413200; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; GEORGE GN, 1995, EXAFSPAK; Gonzalez-Guerrero M, 2008, J BIOL CHEM, V283, P29753, DOI 10.1074/jbc.M803248200; Himes RA, 2008, ANGEW CHEM INT EDIT, V47, P9084, DOI 10.1002/anie.200803908; Himes RA, 2007, J AM CHEM SOC, V129, P5352, DOI 10.1021/ja0708013; Ibricevic A, 2010, TOXICOL APPL PHARM, V243, P315, DOI 10.1016/j.taap.2009.11.023; Kaler S G, 1998, Adv Pharmacol, V42, P66; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kuo YM, 1997, HUM MOL GENET, V6, P1043, DOI 10.1093/hmg/6.7.1043; Leonhardt K, 2009, J BIOL CHEM, V284, P7793, DOI 10.1074/jbc.M805145200; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Maio N, 2010, J BIOL CHEM, V285, P20507, DOI 10.1074/jbc.M109.090027; Michaiczyk A, 2008, J HISTOCHEM CYTOCHEM, V56, P389, DOI 10.1369/jhc.7A7300.2008; Petris MJ, 2000, HUM MOL GENET, V9, P2845, DOI 10.1093/hmg/9.19.2845; PICKERING IJ, 1993, J AM CHEM SOC, V115, P9498, DOI 10.1021/ja00074a014; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; SANYAL I, 1993, J AM CHEM SOC, V115, P11259, DOI 10.1021/ja00077a027; Sarret G, 2010, J AM CHEM SOC, V132, P3770, DOI 10.1021/ja9083896; Siluvai GS, 2010, J AM CHEM SOC, V132, P5215, DOI 10.1021/ja910759v; Steveson TC, 2003, ENDOCRINOLOGY, V144, P188, DOI 10.1210/en.2002-220716; Tchaparian EH, 2000, ARCH BIOCHEM BIOPHYS, V379, P71, DOI 10.1006/abbi.2000.1842; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Voskoboinik I, 2001, J BIOL CHEM, V276, P28620, DOI 10.1074/jbc.M103532200; Walker JM, 2004, J BIOL CHEM, V279, P15376, DOI 10.1074/jbc.M400053200	39	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26585	26594		10.1074/jbc.M111.229039	http://dx.doi.org/10.1074/jbc.M111.229039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646353	hybrid, Green Published			2022-12-25	WOS:000293078200037
J	Juarez, O; Shea, ME; Makhatadze, GI; Barquera, B				Juarez, Oscar; Shea, Michael E.; Makhatadze, George I.; Barquera, Blanca			The Role and Specificity of the Catalytic and Regulatory Cation-binding Sites of the Na+-pumping NADH:Quinone Oxidoreductase from Vibrio cholerae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; TRANSLOCATING NADH; UBIQUINONE OXIDOREDUCTASE; PROSTHETIC GROUPS; REDOX PROPERTIES; NQRC SUBUNITS; SODIUM CYCLE; REDUCTASE; MARINE; ALGINOLYTICUS	The Na+-translocating NADH: quinone oxidoreductase is the entry site for electrons into the respiratory chain and the main sodium pump in Vibrio cholerae and many other pathogenic bacteria. In this work, we have employed steady-state and transient kinetics, together with equilibrium binding measurements to define the number of cation-binding sites and characterize their roles in the enzyme. Our results show that sodium and lithium ions stimulate enzyme activity, and that Na+-NQR enables pumping of Li+, as well as Na+ across the membrane. We also confirm that the enzyme is not able to translocate other monovalent cations, such as potassium or rubidium. Although potassium is not used as a substrate, Na+-NQR contains a regulatory site for this ion, which acts as a nonessential activator, increasing the activity and affinity for sodium. Rubidium can bind to the same site as potassium, but instead of being activated, enzyme turnover is inhibited. Activity measurements in the presence of both sodium and lithium indicate that the enzyme contains at least two functional sodium-binding sites. We also show that the binding sites are not exclusively responsible for ion selectivity, and other steps downstream in the mechanism also play a role. Finally, equilibrium-binding measurements with Na-22(+) show that, in both its oxidized and reduced states, Na+-NQR binds three sodium ions, and that the affinity for sodium is the same for both of these states.	[Barquera, Blanca] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Barquera, B (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Rm 2239,110 8 St, Troy, NY 12180 USA.	barqub@rpi.edu		Juarez, Oscar/0000-0002-2915-8413	National Institutes of Health [GM 060036]; National Science Foundation [MCB 1052234]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 060036 and National Science Foundation Grant MCB 1052234.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arakaki LSL, 2007, APPL SPECTROSC, V61, P978, DOI 10.1366/000370207781745928; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barquera B, 2003, J AM CHEM SOC, V125, P265, DOI 10.1021/ja0207201; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; BENOS DJ, 1980, J GEN PHYSIOL, V76, P233, DOI 10.1085/jgp.76.2.233; Bogachev AV, 2007, BIOCHEMISTRY-US, V46, P10186, DOI 10.1021/bi700440w; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6299, DOI 10.1021/bi900525v; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; Bogachev AV, 2006, BIOCHEMISTRY-US, V45, P3421, DOI 10.1021/bi052422x; Casutt MS, 2010, ACTA CRYSTALLOGR F, V66, P1677, DOI [10.1107/S1744309110043125, 10.1107/S17443091100431]; Casutt MS, 2010, J BIOL CHEM, V285, P27088, DOI 10.1074/jbc.M109.071126; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P449, DOI 10.1016/0005-2728(86)90113-1; DIBROV PA, 1986, BIOCHIM BIOPHYS ACTA, V850, P458, DOI 10.1016/0005-2728(86)90114-3; Dimroth P, 1997, BBA-BIOENERGETICS, V1318, P11, DOI 10.1016/S0005-2728(96)00127-2; Duffy EB, 2006, J BACTERIOL, V188, P8343, DOI 10.1128/JB.01383-06; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hayashi M, 2001, BBA-BIOENERGETICS, V1505, P37, DOI 10.1016/S0005-2728(00)00275-9; Hayashi M, 2002, ARCH BIOCHEM BIOPHYS, V401, P173, DOI 10.1016/S0003-9861(02)00007-3; Hayashi M, 2001, FEBS LETT, V488, P5, DOI 10.1016/S0014-5793(00)02404-2; Hayashi M, 1997, BIOCHEM MOL BIOL INT, V41, P41; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kato S, 2000, CAN J MICROBIOL, V46, P325, DOI 10.1139/cjm-46-4-325; Nakayama Y, 2000, FEBS LETT, V474, P165, DOI 10.1016/S0014-5793(00)01595-7; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Noskov SY, 2007, J GEN PHYSIOL, V129, P135, DOI 10.1085/jgp.200609633; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Pajor AM, 2010, BIOCHEMISTRY-US, V49, P8937, DOI 10.1021/bi100600j; PfenningerLi XD, 1996, BIOCHEMISTRY-US, V35, P6233, DOI 10.1021/bi953032l; Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a; Rich PR, 2008, J BIOENERG BIOMEMBR, V40, P407, DOI 10.1007/s10863-008-9173-7; Steuber J, 2001, BBA-BIOENERGETICS, V1505, P45, DOI 10.1016/S0005-2728(00)00276-0; Tao ML, 2006, ACTA CRYSTALLOGR F, V62, P110, DOI 10.1107/S174430910504306X; UNEMOTO T, 1993, J BIOENERG BIOMEMBR, V25, P385, DOI 10.1007/BF00762464; URRY DW, 1989, METHOD ENZYMOL, V171, P286; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020	47	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26383	26390		10.1074/jbc.M111.257873	http://dx.doi.org/10.1074/jbc.M111.257873			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652714	Green Published, hybrid			2022-12-25	WOS:000293078200015
J	Mostowy, S; Sancho-Shimizu, V; Hamon, MA; Simeone, R; Brosch, R; Johansen, T; Cossart, P				Mostowy, Serge; Sancho-Shimizu, Vanessa; Hamon, Melanie Anne; Simeone, Roxane; Brosch, Roland; Johansen, Terje; Cossart, Pascale			p62 and NDP52 Proteins Target Intracytosolic Shigella and Listeria to Different Autophagy Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN; ADAPTER; DEGRADATION; P62/SQSTM1; BACTERIA; ESCAPE; SYSTEM; FAMILY	Autophagy is an important mechanism of innate immune defense. We have recently shown that autophagy components are recruited with septins, a new and increasingly characterized cytoskeleton component, to intracytosolic Shigella that have started to polymerize actin. On the other hand, intracytosolic Listeria avoids autophagy recognition by expressing ActA, a bacterial effector required for actin polymerization. Here, we exploit Shigella and Listeria as intracytosolic tools to characterize different pathways of selective autophagy. We show that the ubiquitin-binding adaptor proteins p62 and NDP52 target Shigella to an autophagy pathway dependent upon septin and actin. In contrast, p62 or NDP52 targets the Listeria ActA mutant to an autophagy pathway independent of septin or actin. TNF-alpha, a host cytokine produced upon bacterial infection, stimulates p62-mediated autophagic activity and restricts the survival of Shigella and the Listeria ActA mutant. These data provide a new molecular framework to understand the emerging complexity of autophagy and its ability to achieve specific clearance of intracytosolic bacteria.	[Mostowy, Serge; Hamon, Melanie Anne; Cossart, Pascale] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Mostowy, Serge; Hamon, Melanie Anne; Cossart, Pascale] INSERM U604, F-75015 Paris, France; [Mostowy, Serge; Hamon, Melanie Anne; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Sancho-Shimizu, Vanessa] Necker Med Sch, INSERM U980, Lab Human Genet Infect Dis, Necker Branch, F-75015 Paris, France; [Sancho-Shimizu, Vanessa] Univ Paris 05, F-75015 Paris, France; [Simeone, Roxane; Brosch, Roland] Inst Pasteur, Unite Postulante Pathogen Mycobacterienne Integre, F-75015 Paris, France; [Johansen, Terje] Univ Tromso, Mol Canc Res Grp, Inst Med Biol, N-9037 Tromso, Norway	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UiT The Arctic University of Tromso	Mostowy, S (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	smostowy@pasteur.fr	Johansen, Terje/AAY-1753-2021; Brosch, Roland/AAZ-3850-2021; Brosch, Roland/ABB-4108-2021; Hamon, Melanie/B-3501-2013; Johansen, Terje/N-2971-2015	Johansen, Terje/0000-0003-1451-9578; Brosch, Roland/0000-0003-2587-3863; Johansen, Terje/0000-0003-1451-9578; Hamon, Melanie/0000-0001-5078-4083; SIMEONE, Roxane/0000-0002-7082-7842; Mostowy, Serge/0000-0002-7286-6503	European Research Council [233348]	European Research Council(European Research Council (ERC)European Commission)	International research scholar from the Howard Hughes Medical Institute and recipient of European Research Council Advanced Grant Award 233348.	Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mostowy S, 2012, BACTERIAL PATHOGENESIS: MOLECULAR AND CELLULAR MECHANISMS, P243; Mostowy S, 2011, AUTOPHAGY, V7, P780, DOI 10.4161/auto.7.7.15593; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Mostowy S, 2009, J BIOL CHEM, V284, P11613, DOI 10.1074/jbc.M900231200; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Pohl C, 2009, NAT CELL BIOL, V11, P65, DOI 10.1038/ncb1813; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yap GS, 2007, AUTOPHAGY, V3, P163, DOI 10.4161/auto.3655; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	38	221	227	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26987	26995		10.1074/jbc.M111.223610	http://dx.doi.org/10.1074/jbc.M111.223610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646350	Green Published, hybrid			2022-12-25	WOS:000293078200072
J	Chen, TC; Chien, SJ; Kuo, HC; Huang, WS; Sheen, JM; Lin, TH; Yen, CK; Sung, ML; Chen, CN				Chen, Te-Chuan; Chien, Shao-Ju; Kuo, Hsing-Chun; Huang, Wen-Shih; Sheen, Jiunn-Ming; Lin, Tseng-Hsi; Yen, Chia-Kuang; Sung, Mao-Lin; Chen, Cheng-Nan			High Glucose-treated Macrophages Augment E-Selectin Expression in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE PATHWAYS; SOLUBLE E-SELECTIN; FACTOR-KAPPA-B; INSULIN-RESISTANCE; ADHESION MOLECULES; SHEAR-STRESS; VASCULAR-DISEASE	E-selectin expression by endothelial cells (ECs) is crucial for leukocyte recruitment during the inflammatory response. Macrophage accumulation and serum E-selectin elevation are features of type 2 diabetes mellitus. However, the interactions between macrophages and ECs in regulating vascular endothelial function are not clearly understood. We investigated the mechanisms underlying the modulation of EC E-selectin expression by high glucose (HG)-treated macrophages. Macrophage-conditioned media (MCM) were prepared from HG-treated macrophages. EC stimulation with HG-MCM induced increases the expression and secretion of E-selectin. By using specific inhibitors and small interfering RNAs, we demonstrate that the activation of the JNK and p38 MAPK pathways are critical for HG-MCM-induced E-selectin expression. Transcription factor ELISA and chromatin immunoprecipitation assays further showed that HG-MCM increases the NF-kappa B- and AP-1 DNA-binding activities in ECs. The inhibition of NF-kappa B and AP-1 activation by specific siRNAs blocks the HG-MCM-induced E-selectin promoter activity and expression. Protein arrays and blocking assays using neutralizing antibodies demonstrated that macrophage inflammatory protein 1 alpha and 1 beta in HG-MCM are major mediators for the induction of EC E-selectin expression. These data support the hypothesis that E-selectin up-regulation stimulated by macrophages may play an active role in atherogenesis in the HG condition and suggest a new mechanism by which arterial disease is accelerated in diabetes.	[Yen, Chia-Kuang; Sung, Mao-Lin] St Martin de Porres Hosp, Dept Cardiol, Chiayi 600, Taiwan; [Chen, Te-Chuan] Chang Gung Mem Hosp, Div Nephrol, Kaohsiung 833, Taiwan; [Chien, Shao-Ju] Chang Gung Mem Hosp, Div Pediat Cardiol, Kaohsiung 833, Taiwan; [Sheen, Jiunn-Ming] Chang Gung Mem Hosp, Dept Pediat, Kaohsiung 833, Taiwan; Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan; [Kuo, Hsing-Chun] Chron Dis & Hlth Promot Res Ctr, Dept Nursing, CGIT, Chiayi 613, Taiwan; [Huang, Wen-Shih] Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Chiayi 613, Taiwan; [Lin, Tseng-Hsi] Taichung Vet Gen Hosp, Dept Internal Med, Div Hematol, Taichung 407, Taiwan; [Chen, Cheng-Nan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 600, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Taichung Veterans General Hospital; National Chiayi University	Sung, ML (corresponding author), St Martin de Porres Hosp, Dept Cardiol, Chiayi 600, Taiwan.	sung1118@gmail.com; cnchen@mail.ncyu.edu.tw			Chang Gung Memorial Hospital; Chang Gung Institute of Technology Chiayi Campus [CZRPG880253, CMRPF680052, EZRPF390261]; St. Martin de Porres Hospital [P0919]; National Science Council, Taiwan [NSC97-2320-B-415-007-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung Institute of Technology Chiayi Campus; St. Martin de Porres Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital or Chang Gung Institute of Technology Chiayi Campus grants CZRPG880253, CMRPF680052, and EZRPF390261); St. Martin de Porres Hospital Project No. P0919); and the National Science Council, Taiwan Grant NSC97-2320-B-415-007-MY3.	Boulbou MS, 2005, INT J CARDIOL, V98, P39, DOI 10.1016/j.ijcard.2003.07.037; Chen CN, 2006, BLOOD, V107, P1933, DOI 10.1182/blood-2005-08-3137; Chiu JJ, 2007, BLOOD, V110, P519, DOI 10.1182/blood-2006-08-040097; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; Chou MT, 2010, BIOMATERIALS, V31, P4367, DOI 10.1016/j.biomaterials.2010.02.011; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Dasu MR, 2007, AM J PHYSIOL-ENDOC M, V293, pE337, DOI 10.1152/ajpendo.00718.2006; De Caterina R, 2001, AM J HYPERTENS, V14, P259, DOI 10.1016/S0895-7061(00)01276-0; Hackman A, 1996, CIRCULATION, V93, P1334, DOI 10.1161/01.CIR.93.7.1334; Hwang SJ, 1997, CIRCULATION, V96, P4219; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Krentz AJ, 2007, DIABETES OBES METAB, V9, P781, DOI 10.1111/j.1463-1326.2007.00670.x; Liang CP, 2007, CIRC RES, V100, P1546, DOI 10.1161/CIRCRESAHA.107.152165; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8; Marx N, 2004, ARTERIOSCL THROM VAS, V24, P540, DOI 10.1161/01.ATV.0000116027.81513.68; Matsumoto K, 2002, DIABETES RES CLIN PR, V55, P131, DOI 10.1016/S0168-8227(01)00296-0; Matsumoto K, 2001, DIABETIC MED, V18, P224, DOI 10.1046/j.1464-5491.2001.00457.x; Matsumoto K, 2010, METABOLISM, V59, P320, DOI 10.1016/j.metabol.2009.06.011; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Renard C, 2006, DIABETES METAB, V32, P15, DOI 10.1016/S1262-3636(07)70243-4; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sands WA, 2004, MOL PHARMACOL, V66, P1147, DOI 10.1124/mol.104.001107; Shanmugam N, 2003, DIABETES, V52, P1256, DOI 10.2337/diabetes.52.5.1256; Sung ML, 2009, CIRC RES, V105, P755, DOI 10.1161/CIRCRESAHA.109.206524; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tesfamariam B, 2007, VASC PHARMACOL, V46, P229, DOI 10.1016/j.vph.2006.11.005; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Wright RJ, 2008, DIABETES-METAB RES, V24, P353, DOI 10.1002/dmrr.865; Yeh CC, 2009, ARTHRITIS RHEUM-US, V60, P2350, DOI 10.1002/art.24680; Zhu WF, 2010, AM J PHYSIOL-CELL PH, V298, pC952, DOI 10.1152/ajpcell.00466.2009	36	17	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					25564	25573		10.1074/jbc.M111.230540	http://dx.doi.org/10.1074/jbc.M111.230540			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21659524	Green Published, hybrid			2022-12-25	WOS:000293073000019
J	Lindqvist, M; Nookaew, I; Brinkenberg, I; Samuelson, E; Thorn, K; Nielsen, J; Harandi, AM				Lindqvist, Madelene; Nookaew, Intawat; Brinkenberg, Ingrid; Samuelson, Emma; Thorn, Karolina; Nielsen, Jens; Harandi, Ali M.			Unraveling Molecular Signatures of Immunostimulatory Adjuvants in the Female Genital Tract through Systems Biology	PLOS ONE			English	Article							GENE-COEXPRESSION NETWORK; VACCINE ADJUVANTS; IMMUNITY; CELLS; COMPLEMENT; EXPRESSION; CYTOSCAPE; DISCOVERY; RESPONSES; TOPOLOGY	Sexually transmitted infections (STIs) unequivocally represent a major public health concern in both industrialized and developing countries. Previous efforts to develop vaccines for systemic immunization against a large number of STIs in humans have been unsuccessful. There is currently a drive to develop mucosal vaccines and adjuvants for delivery through the genital tract to confer protective immunity against STIs. Identification of molecular signatures that can be used as biomarkers for adjuvant potency can inform rational development of potent mucosal adjuvants. Here, we used systems biology to study global gene expression and signature molecules and pathways in the mouse vagina after treatment with two classes of experimental adjuvants. The Toll-like receptor 9 agonist CpG ODN and the invariant natural killer T cell agonist alpha-galactosylceramide, which we previously identified as equally potent vaginal adjuvants, were selected for this study. Our integrated analysis of genome-wide transcriptome data determined which signature pathways, processes and networks are shared by or otherwise exclusive to these 2 classes of experimental vaginal adjuvants in the mouse vagina. To our knowledge, this is the first integrated genome-wide transcriptome analysis of the effects of immunomodulatory adjuvants on the female genital tract of a mammal. These results could inform rational development of effective mucosal adjuvants for vaccination against STIs.	[Lindqvist, Madelene; Brinkenberg, Ingrid; Samuelson, Emma; Thorn, Karolina; Harandi, Ali M.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Nookaew, Intawat; Nielsen, Jens] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology	Lindqvist, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	ali.harandi@microbio.gu.se	Nielsen, Jens/Q-1347-2017	Nielsen, Jens/0000-0002-9955-6003	Swedish Research Council Medicine (VR); European Commission; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish federal government; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Chalmers Foundation	Swedish Research Council Medicine (VR)(Swedish Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish federal government; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Chalmers Foundation	This study was supported by the Swedish Research Council Medicine (VR), EURONANOMED program of the European Commission support to iNanoDCs project, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Swedish federal government under the LUA-ALF agreement, an exploratory grant of MUVAPRED project supported by FP6 program of the European Commission, the Swedish Foundation for Strategic Research MIVAC grant, the Knut and Alice Wallenberg Foundation and the Chalmers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benham AM, 1997, J IMMUNOL, V159, P5896; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROWN KE, CURR OPIN IMMUNOL, V22, P397; CROFT D, NUCL ACIDS RES, V39, pD691; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; Gawaz M, 2002, THROMB HAEMOSTASIS, V88, P307; Harandi AM, 2009, EXPERT REV VACCINES, V8, P293, DOI 10.1586/14760584.8.3.293; Hubbell E, 2005, PLIER WHITE PAPER; Kato Atsushi, 2003, BMC Immunol, V4, P8, DOI 10.1186/1471-2172-4-8; Klaschik S, 2007, MOL IMMUNOL, V44, P1095, DOI 10.1016/j.molimm.2006.07.283; Klaschik S, 2009, J LEUKOCYTE BIOL, V85, P788, DOI 10.1189/jlb.1008671; Krawczyk CM, BLOOD, V115, P4742; LAM FW, 2010, AM J PHYSL HEART CIR; Lindqvist M, 2009, VACCINE, V28, P270, DOI 10.1016/j.vaccine.2009.09.083; Lindqvist M, 2009, J IMMUNOL, V182, P6435, DOI 10.4049/jimmunol.0900136; LINHARES IM, AM J OBSTET GYNECOL; Mestecky J, 1999, J INFECT DIS, V179, pS470, DOI 10.1086/314806; Morgan BP, 2005, IMMUNOL LETT, V97, P171, DOI 10.1016/j.imlet.2004.11.010; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; NOOKAEW I, PLOS ONE, V5; Oliveira AP, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-17; Patil KR, 2005, P NATL ACAD SCI USA, V102, P2685, DOI 10.1073/pnas.0406811102; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Russell MW, 2002, AM J REPROD IMMUNOL, V47, P265, DOI 10.1034/j.1600-0897.2002.01099.x; Sajic D, 2005, IMMUNOLOGY, V114, P213, DOI 10.1111/j.1365-2567.2004.02081.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stanberry Lawrence R, 2004, Herpes, V11 Suppl 3, p161A; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tengvall S, 2006, J VIROL, V80, P5283, DOI 10.1128/JVI.02013-05; TRAMONT EC, 1989, CLIN MICROBIOL REV, V2, pS74, DOI 10.1128/CMR.2.Suppl.S74-S77.1989; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	36	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20448	10.1371/journal.pone.0020448	http://dx.doi.org/10.1371/journal.pone.0020448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666746	Green Published, gold			2022-12-25	WOS:000291607000007
J	Myers, CN; Berner, GB; Holthoff, JH; Martinez-Fonts, K; Harper, JA; Alford, S; Taylor, MN; Duina, AA				Myers, Catherine N.; Berner, Gary B.; Holthoff, Joseph H.; Martinez-Fonts, Kirby; Harper, Jennifer A.; Alford, Sarah; Taylor, Megan N.; Duina, Andrea A.			Mutant Versions of the S. cerevisiae Transcription Elongation Factor Spt16 Define Regions of Spt16 That Functionally Interact with Histone H3	PLOS ONE			English	Article							N-TERMINAL DOMAIN; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; DNA-POLYMERASE; NUCLEOSOME; YFACT; POB3; NHP6; CHROMATIN; COMPLEX	In eukaryotic cells, the highly conserved FACT (FAcilitates Chromatin Transcription) complex plays important roles in several chromatin-based processes including transcription initiation and elongation. During transcription elongation, the FACT complex interacts directly with nucleosomes to facilitate histone removal upon RNA polymerase II (Pol II) passage and assists in the reconstitution of nucleosomes following Pol II passage. Although the contribution of the FACT complex to the process of transcription elongation has been well established, the mechanisms that govern interactions between FACT and chromatin still remain to be fully elucidated. Using the budding yeast Saccharomyces cerevisiae as a model system, we provide evidence that the middle domain of the FACT subunit Spt16 - the Spt16-M domain - is involved in functional interactions with histone H3. Our results show that the Spt16-M domain plays a role in the prevention of cryptic intragenic transcription during transcription elongation and also suggest that the Spt16-M domain has a function in regulating dissociation of Spt16 from chromatin at the end of the transcription process. We also provide evidence for a role for the extreme carboxy terminus of Spt16 in functional interactions with histone H3. Taken together, our studies point to previously undescribed roles for the Spt16 M-domain and extreme carboxy terminus in regulating interactions between Spt16 and chromatin during the process of transcription elongation.	[Myers, Catherine N.; Berner, Gary B.; Holthoff, Joseph H.; Martinez-Fonts, Kirby; Harper, Jennifer A.; Alford, Sarah; Taylor, Megan N.; Duina, Andrea A.] Hendrix Coll, Dept Biol, Conway, AR 72032 USA		Myers, CN (corresponding author), Hendrix Coll, Dept Biol, Conway, AR 72032 USA.	duina@hendrix.edu			National Science Foundation [0543412, 0919241]; National Center for Research Resources, National Institutes of Health [P20 RR16460]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This material is based upon work supported by the National Science Foundation under grants No. 0543412 and No. 0919241 to AAD (http://www.nsf.gov/) and by National Institutes of Health grant P20 RR16460 from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources (http://www.ncrr.nih.gov/research_infrastructure/institutional_development_award/idea_networks_of_biomedical_research_excellence/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 1997, GENOME RES, V7, P843, DOI 10.1101/gr.7.8.843; Bai L, 2010, TRENDS GENET, V26, P476, DOI 10.1016/j.tig.2010.08.003; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Brewster NK, 2001, MOL CELL BIOL, V21, P3491, DOI 10.1128/MCB.21.10.3491-3502.2001; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Duina AA, 2004, MOL CELL BIOL, V24, P561, DOI 10.1128/MCB.24.2.561-572.2004; Duina AA, 2007, GENETICS, V177, P101, DOI 10.1534/genetics.106.067140; Evans DRH, 1998, GENETICS, V150, P1393; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Formosa T, 2008, MOL BIOSYST, V4, P1085, DOI 10.1039/b812136b; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Jamai A, 2009, MOL CELL, V35, P377, DOI 10.1016/j.molcel.2009.07.001; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; KOLODRUBETZ D, 1990, J BIOL CHEM, V265, P3234; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li-Sucholeiki X C, 2000, Nucleic Acids Res, V28, pE44, DOI 10.1093/nar/28.9.e44; Lloyd A, 2009, EUKARYOT CELL, V8, P257, DOI 10.1128/EC.00348-08; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; O'Donnell AF, 2009, MOL GENET GENOMICS, V282, P487, DOI 10.1007/s00438-009-0480-4; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; Rose MD., 1990, METHODS YEAST GENETI; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; WINSTON F, 1992, ANAL SPT GENES GENET, P1271; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20847	10.1371/journal.pone.0020847	http://dx.doi.org/10.1371/journal.pone.0020847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673966	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400033
J	Geissler, M; Dinse, HR; Neuhoff, S; Kreikemeier, K; Meier, C				Geissler, Maren; Dinse, Hubert R.; Neuhoff, Sandra; Kreikemeier, Klaus; Meier, Carola			Human Umbilical Cord Blood Cells Restore Brain Damage Induced Changes in Rat Somatosensory Cortex	PLOS ONE			English	Article							STEM-CELLS; CORTICAL REORGANIZATION; MULTIPLE MECHANISMS; BEHAVIORAL DEFICITS; MONONUCLEAR-CELLS; RECEPTIVE-FIELDS; AUDITORY-CORTEX; STROKE; INJURY; INHIBITION	Intraperitoneal transplantation of human umbilical cord blood (hUCB) cells has been shown to reduce sensorimotor deficits after hypoxic ischemic brain injury in neonatal rats. However, the neuronal correlate of the functional recovery and how such a treatment enforces plastic remodelling at the level of neural processing remains elusive. Here we show by in-vivo recordings that hUCB cells have the capability of ameliorating the injury-related impairment of neural processing in primary somatosensory cortex. Intact cortical processing depends on a delicate balance of inhibitory and excitatory transmission, which is disturbed after injury. We found that the dimensions of cortical maps and receptive fields, which are significantly altered after injury, were largely restored. Additionally, the lesion induced hyperexcitability was no longer observed in hUCB treated animals as indicated by a paired-pulse behaviour resembling that observed in control animals. The beneficial effects on cortical processing were reflected in an almost complete recovery of sensorimotor behaviour. Our results demonstrate that hUCB cells reinstall the way central neurons process information by normalizing inhibitory and excitatory processes. We propose that the intermediate level of cortical processing will become relevant as a new stage to investigate efficacy and mechanisms of cell therapy in the treatment of brain injury.	[Geissler, Maren; Dinse, Hubert R.; Kreikemeier, Klaus] Ruhr Univ Bochum, Inst Neuroinformat, Neural Plast Lab, Bochum, Germany; [Neuhoff, Sandra; Meier, Carola] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Geissler, M (corresponding author), Ruhr Univ Bochum, Dept Cell Morphol & Mol Neurobiol, Bochum, Germany.	hubert.dinse@rub.de		dinse, hubert/0000-0001-9024-0451	Stem cell network North Rhine Westfalia; Deutsche Forschungsgemeinschaft [Di 334/19-1]	Stem cell network North Rhine Westfalia; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the "Stem cell network North Rhine Westfalia" to CM, and from the Deutsche Forschungsgemeinschaft to HRD (Di 334/19-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Benali A, 2008, J NEUROSCI, V28, P12284, DOI 10.1523/JNEUROSCI.1952-08.2008; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Carvalho TP, 2009, NEURON, V61, P774, DOI 10.1016/j.neuron.2009.01.013; CHAPIN JK, 1986, EXP BRAIN RES, V62, P549; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; David-Jurgens M, 2010, CEREB CORTEX, V20, P1208, DOI 10.1093/cercor/bhp185; David-Jurgens M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003399; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Eichler SA, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.002.2008; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; GARDNER EP, 1989, J NEUROPHYSIOL, V62, P1410, DOI 10.1152/jn.1989.62.6.1410; Gervasi NM, 2008, REGEN MED, V3, P907, DOI 10.2217/17460751.3.6.907; Glaser T, 2008, J NEUROL SCI, V265, P47, DOI 10.1016/j.jns.2007.09.018; Hickmott PW, 2010, CEREB CORTEX, V20, P591, DOI 10.1093/cercor/bhp125; HICKS TP, 1983, BRAIN RES, V274, P160, DOI 10.1016/0006-8993(83)90533-4; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Leker RR, 2004, CURR NEUROVASC RES, V1, P421, DOI 10.2174/1567202043361938; LEVINE S, 1960, AM J PATHOL, V36, P1; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Luhmann HJ, 1996, PROG NEUROBIOL, V48, P131, DOI 10.1016/0301-0082(95)00042-9; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McClure MM, 2005, NEUROREPORT, V16, P1309, DOI 10.1097/01.wnr.0000175613.16183.6c; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Neuhoff S, 2007, EXP HEMATOL, V35, P1119, DOI 10.1016/j.exphem.2007.03.019; Newman MB, 2006, EXP NEUROL, V199, P201, DOI 10.1016/j.expneurol.2006.04.001; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P351, DOI 10.1089/scd.2009.0049; Pleger B, 2001, P NATL ACAD SCI USA, V98, P12255, DOI 10.1073/pnas.191176298; Reinecke S, 2003, EUR J NEUROSCI, V17, P623, DOI 10.1046/j.1460-9568.2003.02459.x; Robinson S, 2006, J NEUROSURG, V104, P396, DOI 10.3171/ped.2006.104.6.396; Rosenkranz K, 2010, J NEUROSCI RES, V88, P1223, DOI 10.1002/jnr.22292; Saporta S, 2003, J HEMATOTH STEM CELL, V12, P271, DOI 10.1089/152581603322023007; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Singec I, 2007, ANNU REV MED, V58, P313, DOI 10.1146/annurev.med.58.070605.115252; Strata F, 2004, NEUROSCIENCE, V129, P141, DOI 10.1016/j.neuroscience.2004.07.024; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Uchino H, 2008, J ANESTH, V22, P253, DOI 10.1007/s00540-008-0617-3; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Voller B, 2006, ANN NEUROL, V59, P385, DOI 10.1002/ana.20689; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Xerri C, 2003, NEUROSCIENCE, V118, P161, DOI 10.1016/S0306-4522(02)00911-9; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zepeda A, 2004, J NEUROSCI, V24, P1812, DOI 10.1523/JNEUROSCI.3213-03.2004; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	54	42	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20194	10.1371/journal.pone.0020194	http://dx.doi.org/10.1371/journal.pone.0020194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673795	gold, Green Published			2022-12-25	WOS:000291309900004
J	Malla, N; Berg, E; Moens, U; Uhlin-Hansen, L; Winberg, JO				Malla, Nabin; Berg, Eli; Moens, Ugo; Uhlin-Hansen, Lars; Winberg, Jan-Olof			Biosynthesis of Promatrix Metalloproteinase-9/Chondroitin Sulphate Proteoglycan Heteromer Involves a Rottlerin-Sensitive Pathway	PLOS ONE			English	Article							PROTEIN-KINASE-C; HUMAN NEUTROPHIL GELATINASE; COLLAGEN-BINDING DOMAIN; GENE-EXPRESSION PROFILE; FIBRONECTIN-LIKE DOMAIN; NF-KAPPA-B; MATRIX METALLOPROTEINASES; PHORBOL ESTER; HUMAN-MONOCYTES; IV COLLAGENASE	Background: Previously we have shown that a fraction of the matrix metalloproteinase-9 (MMP-9) synthesized by the macrophage cell line THP-1 was bound to a chondroitin sulphate proteoglycan (CSPG) core protein as a reduction sensitive heteromer. Several biochemical properties of the enzyme were changed when it was bound to the CSPG. Methodology/Principal Findings: By use of affinity chromatography, zymography, and radioactive labelling, various macrophage stimulators were tested for their effect on the synthesis of the proMMP-9/CSPG heteromer and its components by THP-1 cells. Of the stimulators, only PMA largely increased the biosynthesis of the heteromer. As PMA is an activator of PKC, we determined which PKC isoenzymes were expressed by performing RT-PCR and Western Blotting. Subsequently specific inhibitors were used to investigate their involvement in the biosynthesis of the heteromer. Of the inhibitors, only Rottlerin repressed the biosynthesis of proMMP-9/CSPG and its two components. Much lower concentrations of Rottlerin were needed to reduce the amount of CSPG than what was needed to repress the synthesis of the heteromer and MMP-9. Furthermore, Rottlerin caused a minor reduction in the activation of the PKC isoenzymes delta, epsilon, theta and upsilon (PKD3) in both control and PMA exposed cells. Conclusions/Significance: The biosynthesis of the proMMP-9/CSPG heteromer and proMMP-9 in THP-1 cells involves a Rottlerin-sensitive pathway that is different from the Rottlerin sensitive pathway involved in the CSPG biosynthesis. MMP-9 and CSPGs are known to be involved in various physiological and pathological processes. Formation of complexes may influence both the specificity and localization of the enzyme. Therefore, knowledge about biosynthetic pathways and factors involved in the formation of the MMP-9/CSPG heteromer may contribute to insight in the heteromers biological function as well as pointing to future targets for therapeutic agents.	[Malla, Nabin; Berg, Eli; Moens, Ugo; Uhlin-Hansen, Lars; Winberg, Jan-Olof] Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway	UiT The Arctic University of Tromso	Malla, N (corresponding author), Univ Tromso, Dept Med Biol, Fac Hlth Sci, Tromso, Norway.	jan.o.winberg@uit.no			Research Council of Norway; Norwegian Cancer Society; Erna and Olav Aakre Foundation for Cancer Research	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Erna and Olav Aakre Foundation for Cancer Research	This work was supported in part by grants from The Research Council of Norway, The Norwegian Cancer Society, and The Erna and Olav Aakre Foundation for Cancer Research. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bannikov GA, 2007, AM J VET RES, V68, P995, DOI 10.2460/ajvr.68.9.995; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Brose N, 2002, J CELL SCI, V115, P4399, DOI 10.1242/jcs.00122; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Cawston TE, 2003, BIOCHEM SOC SYMP, V70, P125, DOI 10.1042/bss0700125; Cawston TE, 2006, BEST PRACT RES CL RH, V20, P983, DOI 10.1016/j.berh.2006.06.007; Chevalier D, 2000, BIOCHEMISTRY-US, V39, P6145, DOI 10.1021/bi9928389; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; CONQUER JA, 1992, BIOCHIM BIOPHYS ACTA, V1134, P1, DOI 10.1016/0167-4889(92)90021-3; Cuschieri J, 2004, J SURG RES, V121, P76, DOI 10.1016/j.jss.2004.04.005; DATTA R, 1992, BLOOD, V79, P904; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dieter P, 2000, CELL SIGNAL, V12, P297, DOI 10.1016/S0898-6568(00)00069-3; Duffy MJ, 2008, J PATHOL, V214, P283, DOI 10.1002/path.2282; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Flannery CR, 2006, FRONT BIOSCI-LANDMRK, V11, P544, DOI 10.2741/1818; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; HALLEN A, 1972, J CHROMATOGR, V71, P83, DOI 10.1016/S0021-9673(01)85691-0; HASCALL VC, 1994, METHOD ENZYMOL, V230, P390; Hashimoto SI, 2003, SCAND J INFECT DIS, V35, P619, DOI 10.1080/00365540310015926; Hendriks BS, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-23; HerreraVelit P, 1997, J BIOL CHEM, V272, P16445, DOI 10.1074/jbc.272.26.16445; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Hornebeck W, 2005, PATHOL BIOL, V53, P405, DOI 10.1016/j.patbio.2004.12.015; Huang ZQ, 2011, INT J CARDIOL, V146, P153, DOI 10.1016/j.ijcard.2009.06.023; IKEDA C, 1994, BRAIN RES, V655, P147, DOI 10.1016/0006-8993(94)91608-X; Kang HC, 2004, MOL CELLS, V17, P454; Kim SJ, 1997, BIOCHEM MOL BIOL INT, V43, P1023; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kolset SO, 1999, CELL MOL LIFE SCI, V56, P857, DOI 10.1007/s000180050031; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; KOLSET SO, 1986, BIOCHEM J, V238, P209, DOI 10.1042/bj2380209; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; KOLSET SO, 1990, BIOCHIM BIOPHYS ACTA, V1032, P191, DOI 10.1016/0304-419X(90)90004-K; Kontny E, 2000, J LEUKOCYTE BIOL, V67, P249, DOI 10.1002/jlb.67.2.249; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Loennechen T, 2003, BIOCHEM PHARMACOL, V66, P2341, DOI 10.1016/j.bcp.2003.08.014; Makatsori E, 2003, ANTICANCER RES, V23, P3303; Malakooti J, 2006, BIOCHEM J, V396, P327, DOI 10.1042/BJ20051391; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Malla N, 2008, CONNECT TISSUE RES, V49, P180, DOI 10.1080/03008200802151755; Malla N, 2008, J BIOL CHEM, V283, P13652, DOI 10.1074/jbc.M709140200; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Mathisen B, 2003, CLIN EXP METASTAS, V20, P701, DOI 10.1023/B:CLIN.0000006819.21361.03; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Mietus-Snyder M, 1998, ARTERIOSCL THROM VAS, V18, P1440, DOI 10.1161/01.ATV.18.9.1440; MOSIOR M, 1995, J BIOL CHEM, V270, P25526, DOI 10.1074/jbc.270.43.25526; MURPHY G, 1994, J BIOL CHEM, V269, P6632; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; O'Sullivan AW, 2009, J SURG RES, V151, P138, DOI 10.1016/j.jss.2008.02.031; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Overall CM, 2002, BIOL CHEM, V383, P1059, DOI 10.1515/BC.2002.114; Oynebraten I, 2000, J LEUKOCYTE BIOL, V67, P183, DOI 10.1002/jlb.67.2.183; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Provatopoulou X, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-390; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sarkar K, 2005, IMMUNOLOGY, V116, P513, DOI 10.1111/j.1365-2567.2005.02253.x; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shipley JM, 1996, J BIOL CHEM, V271, P4335; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Shirai Y, 1998, JPN J PHARMACOL, V78, P411, DOI 10.1254/jjp.78.411; SILJANDER P, 1993, FEBS LETT, V315, P81, DOI 10.1016/0014-5793(93)81138-P; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; STRONGIN AY, 1993, KIDNEY INT, V43, P158, DOI 10.1038/ki.1993.26; Takizawa T, 2003, INT ARCH ALLERGY IMM, V131, P15, DOI 10.1159/000070476; Theocharis AD, 2006, J BIOL CHEM, V281, P35116, DOI 10.1074/jbc.M601061200; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Trautwein C, 1998, GASTROENTEROLOGY, V114, P1035, DOI 10.1016/S0016-5085(98)70324-5; TRIEBEL S, 1992, FEBS LETT, V314, P386, DOI 10.1016/0014-5793(92)81511-J; Turner NA, 2009, AM J PHYSIOL-HEART C, V297, pH1117, DOI 10.1152/ajpheart.00372.2009; UHLINHANSEN L, 1993, BLOOD, V82, P2880; Uttamsingh S, 2008, ONCOGENE, V27, P2626, DOI 10.1038/sj.onc.1210915; VANRANST M, 1991, CYTOKINE, V3, P231, DOI 10.1016/1043-4666(91)90021-5; Winberg JO, 2003, EUR J BIOCHEM, V270, P3996, DOI 10.1046/j.1432-1033.2003.03788.x; Winberg JO, 2000, J MOL BIOL, V304, P669, DOI 10.1006/jmbi.2000.4235; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; Xu XP, 2004, MATRIX BIOL, V23, P171, DOI 10.1016/j.matbio.2004.05.002; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zhou J, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-25; Zu YL, 1996, BLOOD, V87, P5287, DOI 10.1182/blood.V87.12.5287.bloodjournal87125287	101	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20616	10.1371/journal.pone.0020616	http://dx.doi.org/10.1371/journal.pone.0020616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673806	Green Submitted, Green Published, gold			2022-12-25	WOS:000291309900024
J	Feuillie, C; Merheb, MM; Gillet, B; Montagnac, G; Daniel, I; Hanni, C				Feuillie, Cecile; Merheb, Maxime Mohamad; Gillet, Benjamin; Montagnac, Gilles; Daniel, Isabelle; Haenni, Catherine			A Novel SERRS Sandwich-Hybridization Assay to Detect Specific DNA Target	PLOS ONE			English	Article							RESONANCE RAMAN-SCATTERING; POLYMERASE-CHAIN-REACTION; ANCIENT DNA; ENZYMATIC AMPLIFICATION; PCR; SEQUENCE; DAMAGE; VIRUS; EXTRACTION; INHIBITORS	In this study, we have applied Surface Enhanced Resonance Raman Scattering (SERRS) technology to the specific detection of DNA. We present an innovative SERRS sandwich-hybridization assay that allows specific DNA detection without any enzymatic amplification, such as is the case with Polymerase Chain Reaction (PCR). In some substrates, such as ancient or processed remains, enzymatic amplification fails due to DNA alteration (degradation, chemical modification) or to the presence of inhibitors. Consequently, the development of a non-enzymatic method, allowing specific DNA detection, could avoid long, expensive and inconclusive amplification trials. Here, we report the proof of concept of a SERRS sandwich-hybridization assay that leads to the detection of a specific chamois DNA. This SERRS assay reveals its potential as a nonenzymatic alternative technology to DNA amplification methods (particularly the PCR method) with several applications for species detection. As the amount and type of damage highly depend on the preservation conditions, the present SERRS assay would enlarge the range of samples suitable for DNA analysis and ultimately would provide exciting new opportunities for the investigation of ancient DNA in the fields of evolutionary biology and molecular ecology, and of altered DNA in food frauds detection and forensics.	[Feuillie, Cecile; Montagnac, Gilles; Daniel, Isabelle] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, ENS Lyon,Lab Geol Lyon Terre Planetes Environm, F-69365 Lyon, France; [Merheb, Maxime Mohamad; Haenni, Catherine] Univ Lyon 1, CNRS, Ecole Normale Super Lyon, INRA,Inst Genom Fonct Lyon, F-69365 Lyon, France; [Gillet, Benjamin] ENS Lyon, CNRS, Paleogenet UMS PALGENE, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Feuillie, C (corresponding author), Univ Lyon 1, CNRS, Ecole Normale Super Lyon, ENS Lyon,Lab Geol Lyon Terre Planetes Environm, F-69365 Lyon, France.	Catherine.Hanni@ens-lyon.fr	Daniel, Isabelle/D-2677-2012; Montagnac, Gilles/S-6440-2019; Gillet, Benjamin/ABD-6704-2020	Daniel, Isabelle/0000-0002-1448-7919; Montagnac, Gilles/0000-0001-9938-0282; 	Institut National des Sciences de l'Univers (INSU); CNRS; ENS de Lyon; INRA; University Lyon 1; ANR	Institut National des Sciences de l'Univers (INSU); CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS de Lyon; INRA; University Lyon 1; ANR(French National Research Agency (ANR))	The Raman spectroscopy facility in Ecole normale superieure de Lyon is supported by the Institut National des Sciences de l'Univers (INSU). This work was supported by the CNRS interdisciplinary programs (Origin of Life and Planets, Interface physics chemistry biology), ENS de Lyon, INRA and University Lyon 1. C.F. was supported by a grant from ENS de Lyon, and M. M. was supported by ANR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper A, 2004, CURR BIOL, V14, pR431, DOI 10.1016/j.cub.2004.05.037; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Faulds K, 2005, TALANTA, V67, P667, DOI 10.1016/j.talanta.2005.06.019; Faulds K, 2004, ANAL CHEM, V76, P412, DOI 10.1021/ac035060c; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gilbert MTP, 2004, CURR BIOL, V14, pR463, DOI 10.1016/j.cub.2004.06.008; GILBERT W, 1968, COLD SPRING HARB SYM, V33, P473, DOI 10.1101/SQB.1968.033.01.055; Graham D, 1997, ANAL CHEM, V69, P4703, DOI 10.1021/ac970657b; Graham D, 2008, NAT NANOTECHNOL, V3, P548, DOI 10.1038/nnano.2008.189; Haile J, 2007, MOL BIOL EVOL, V24, P982, DOI 10.1093/molbev/msm016; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Haller M, 1996, J TRACE MICROPROBE T, V14, P461; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Holmberg A, 2005, ELECTROPHORESIS, V26, P501, DOI 10.1002/elps.200410070; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Hudlow WR, 2008, FORENSIC SCI INT-GEN, V2, P108, DOI 10.1016/j.fsigen.2007.09.001; Jiang SC, 2004, J APPL MICROBIOL, V97, P17, DOI 10.1111/j.1365-2672.2004.02269.x; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Loreille O, 2001, CURR BIOL, V11, P200, DOI 10.1016/S0960-9822(01)00046-X; Maher RC, 2002, CHEM PHYS LETT, V352, P378, DOI 10.1016/S0009-2614(01)01474-9; Mitchell D, 2005, MUTAT RES-FUND MOL M, V571, P265, DOI 10.1016/j.mrfmmm.2004.06.060; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; ORLANDO L, 2000, SOC FRANCAISE GENETI, V16, pR1; PAABO S, 1989, J BIOL CHEM, V264, P9709; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Pafundo S, 2010, ANAL BIOANAL CHEM, V396, P1831, DOI 10.1007/s00216-009-3419-z; Poinar H, 2003, CURR BIOL, V13, P1150, DOI 10.1016/S0960-9822(03)00450-0; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Scheu PM, 1998, FOOD MICROBIOL, V15, P13, DOI 10.1006/fmic.1997.0134; Shutler GG, 1999, J FORENSIC SCI, V44, P623; Sikorsky JA, 2004, BIOCHEM BIOPH RES CO, V323, P823, DOI 10.1016/j.bbrc.2004.08.168; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stokstad E, 2003, SCIENCE, V300, P407; TANNER NK, 1994, CURR BIOL, V4, P488, DOI 10.1016/S0960-9822(00)00109-3; VALENTINI A, 2006, TRENDS ECOL EVOL, V24, P110; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Zhang JM, 2009, SCI CHINA SER C, V52, P568, DOI 10.1007/s11427-009-0069-5	46	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e17847	10.1371/journal.pone.0017847	http://dx.doi.org/10.1371/journal.pone.0017847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655320	gold, Green Published			2022-12-25	WOS:000291097600003
J	Soares, MPM; Silva-Torres, FA; Elias-Neto, M; Nunes, FMF; Simoes, ZLP; Bitondi, MMG				Soares, Michelle P. M.; Silva-Torres, Fernanda A.; Elias-Neto, Moyses; Nunes, Francis M. F.; Simoes, Zila L. P.; Bitondi, Marcia M. G.			Ecdysteroid-Dependent Expression of the Tweedle and Peroxidase Genes during Adult Cuticle Formation in the Honey Bee, Apis mellifera	PLOS ONE			English	Article							ARTHROPOD CUTICULAR PROTEINS; MANDUCA-SEXTA; TOBACCO HORNWORM; DEVELOPMENTAL EXPRESSION; HORMONAL-CONTROL; SCLEROTIZATION; MELANIZATION; SECRETION; MECHANISM; LACCASE-2	Cuticle renewal is a complex biological process that depends on the cross talk between hormone levels and gene expression. This study characterized the expression of two genes encoding cuticle proteins sharing the four conserved amino acid blocks of the Tweedle family, AmelTwdl1 and AmelTwdl2, and a gene encoding a cuticle peroxidase containing the Animal haem peroxidase domain, Ampxd, in the honey bee. Gene sequencing and annotation validated the formerly predicted tweedle genes, and revealed a novel gene, Ampxd, in the honey bee genome. Expression of these genes was studied in the context of the ecdysteroid-coordinated pupal-to-adult molt, and in different tissues. Higher transcript levels were detected in the integument after the ecdysteroid peak that induces apolysis, coinciding with the synthesis and deposition of the adult exoskeleton and its early differentiation. The effect of this hormone was confirmed in vivo by tying a ligature between the thorax and abdomen of early pupae to prevent the abdominal integument from coming in contact with ecdysteroids released from the prothoracic gland. This procedure impaired the natural increase in transcript levels in the abdominal integument. Both tweedle genes were expressed at higher levels in the empty gut than in the thoracic integument and trachea of pharate adults. In contrast, Ampxd transcripts were found in higher levels in the thoracic integument and trachea than in the gut. Together, the data strongly suggest that these three genes play roles in ecdysteroid-dependent exoskeleton construction and differentiation and also point to a possible role for the two tweedle genes in the formation of the cuticle (peritrophic membrane) that internally lines the gut.	[Soares, Michelle P. M.; Silva-Torres, Fernanda A.; Elias-Neto, Moyses; Nunes, Francis M. F.; Simoes, Zila L. P.; Bitondi, Marcia M. G.] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo	Soares, MPM (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Sao Paulo, Brazil.	mmgbit@usp.br	Elias-Neto, Moysés/B-6437-2012; Bitondi, Marcia MG/E-8014-2012; Simoes, Zila Luz Paulino/H-7314-2014; Soares, Michelle/E-1168-2012; Nunes, Francis M. F./F-5871-2010	Bitondi, Marcia MG/0000-0002-5619-6378; Nunes, Francis M. F./0000-0002-7769-3058; Simoes, Zila Luz Paulino/0000-0003-2363-6178	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil [05/03926-5, 07/04314-9, 03/10581-9, 07/08300-2, 07/07594-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil - Grant 05/03926-5 and fellowships: MPMS (07/04314-9), FAST (03/10581-9), MEN (07/08300-2), FMFN (07/07594-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1981, J COMP PHYSIOL, V145, P17, DOI 10.1007/BF00782588; Andersen SO, 1996, COMP BIOCHEM PHYS B, V113, P689, DOI 10.1016/0305-0491(95)02089-6; ANDERSEN SO, 2005, COMPREHENSIVE MOL IN, V4, P145; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2009, INSECT BIOCHEM MOLEC, V39, P355, DOI 10.1016/j.ibmb.2009.02.002; ASHBURNER M, 1990, CELL, V61, P1, DOI 10.1016/0092-8674(90)90205-S; ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; BINNINGTON KC, 1988, TISSUE CELL, V20, P405, DOI 10.1016/0040-8166(88)90073-0; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; CURTIS AT, 1984, J INSECT PHYSIOL, V30, P597, DOI 10.1016/0022-1910(84)90043-X; Dittmer NT, 2009, INSECT BIOCHEM MOLEC, V39, P596, DOI 10.1016/j.ibmb.2009.06.006; Dittmer NT, 2004, INSECT BIOCHEM MOLEC, V34, P29, DOI 10.1016/j.ibmb.2003.08.003; Elias-Neto M, 2010, INSECT BIOCHEM MOLEC, V40, P241, DOI 10.1016/j.ibmb.2010.02.004; Elias-Neto M, 2009, APIDOLOGIE, V40, P29, DOI 10.1051/apido:2008064; FRAENKEL G, 1963, SCIENCE, V141, P1057, DOI 10.1126/science.141.3585.1057; FRAENKEL G, 1962, SCIENCE, V138, P27, DOI 10.1126/science.138.3536.27; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gorman MJ, 2010, INSECT BIOCHEM MOLEC, V40, P267, DOI 10.1016/j.ibmb.2010.01.004; Guan X, 2006, P NATL ACAD SCI USA, V103, P16794, DOI 10.1073/pnas.0607616103; HASSON C, 1987, ARCH INSECT BIOCHEM, V5, P13, DOI 10.1002/arch.940050103; Hepburn H.R., 1985, P1; HIRUMA K, 1995, DEV BIOL, V169, P195, DOI 10.1006/dbio.1995.1137; Hiruma K, 2010, J INSECT PHYSIOL, V56, P1390, DOI 10.1016/j.jinsphys.2010.03.029; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Kucharski R, 2007, INSECT BIOCHEM MOLEC, V37, P128, DOI 10.1016/j.ibmb.2006.10.009; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafont R., 2005, COMPREHENSIVE MOL IN, V3, P125, DOI DOI 10.1016/B0-44-451924-6/00035-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOCKE M, 1969, Tissue and Cell, V1, P555, DOI 10.1016/S0040-8166(69)80021-2; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; MESSNER B, 1991, ZOOL JAHRB ALLG ZOOL, V95, P31; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Nijhout H.F., 1994, INSECT HORMONES; Pinto LZ, 2002, J INSECT PHYSIOL, V48, P783, DOI 10.1016/S0022-1910(02)00103-8; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; Revest JM, 2000, J BIOL CHEM, V275, P8083, DOI 10.1074/jbc.275.11.8083; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SCHWARTZ LM, 1983, DEV BIOL, V99, P103, DOI 10.1016/0012-1606(83)90257-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soares MPM, 2007, INSECT BIOCHEM MOLEC, V37, P1272, DOI 10.1016/j.ibmb.2007.07.014; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; Tang L, 2010, INSECT BIOCHEM MOLEC, V40, P228, DOI 10.1016/j.ibmb.2010.01.010; THOMPSON PR, 1978, J COMP PHYSIOL, V126, P257, DOI 10.1007/BF00688935; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRUMAN JW, 1983, J INSECT PHYSIOL, V29, P895, DOI 10.1016/0022-1910(83)90052-5; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Yamazaki Y, 2011, INSECT BIOCHEM MOLEC, V41, P283, DOI 10.1016/j.ibmb.2011.01.005; YAO Q, PLOS ONE, V5; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YE RD, 1988, J BIOL CHEM, V263, P4869; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005; Zitnan D., 2005, P1; Zufelato MS, 2000, ARTHROPOD STRUCT DEV, V29, P111, DOI 10.1016/S1467-8039(00)00023-2	64	27	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20513	10.1371/journal.pone.0020513	http://dx.doi.org/10.1371/journal.pone.0020513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655217	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600085
J	Baker, EL; Srivastava, J; Yu, DH; Bonnecaze, RT; Zaman, MH				Baker, Erin L.; Srivastava, Jaya; Yu, Dihua; Bonnecaze, Roger T.; Zaman, Muhammad H.			Cancer Cell Migration: Integrated Roles of Matrix Mechanics and Transforming Potential	PLOS ONE			English	Article							INVASIVE BREAST-CANCER; EPITHELIAL ACINI; STIFFNESS; ERBB2; OVEREXPRESSION; PROLIFERATION; PROTEOLYSIS; TRANSITION; STRATEGIES; MOVEMENT	Significant progress has been achieved toward elucidating the molecular mechanisms that underlie breast cancer progression; yet, much less is known about the associated cellular biophysical traits. To this end, we use time-lapsed confocal microscopy to investigate the interplay among cell motility, three-dimensional (3D) matrix stiffness, matrix architecture, and transforming potential in a mammary epithelial cell (MEC) cancer progression series. We use a well characterized breast cancer progression model where human-derived MCF10A MECs overexpress either ErbB2, 14-3-3 zeta, or both ErbB2 and 14-3-3 zeta, with empty vector as a control. Cell motility assays showed that MECs overexpressing ErbB2 alone exhibited notably high migration speeds when cultured atop two-dimensional (2D) matrices, while overexpression of 14-3-3 zeta alone most suppressed migration atop 2D matrices (as compared to non-transformed MECs). Our results also suggest that co-overexpression of the 14-3-3 zeta and ErbB2 proteins facilitates cell migratory capacity in 3D matrices, as reflected in cell migration speed. Additionally, 3D matrices of sufficient stiffness can significantly hinder the migratory ability of partially transformed cells, but increased 3D matrix stiffness has a lesser effect on the aggressive migratory behavior exhibited by fully transformed cells that co-overexpress both ErbB2 and 14-3-3 zeta. Finally, this study shows that for MECs possessing partial or full transforming potential, those overexpressing ErbB2 alone show the greatest sensitivity of cell migration speed to matrix architecture, while those overexpressing 14-3-3 zeta alone exhibit the least sensitivity to matrix architecture. Given the current knowledge of breast cancer mechanobiology, these findings overall suggest that cell motility is governed by a complex interplay between matrix mechanics and transforming potential.	[Baker, Erin L.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Srivastava, Jaya] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Canc Biol Program, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Bonnecaze, Roger T.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Boston University	Baker, EL (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.	zaman@bu.edu		Yu, Dihua/0000-0001-6231-9381	United Negro College Fund (UNCF)/Merck Graduate Science Research Dissertation Fellowship; Philanthropic Educational Organization (P.E.O.); Charles Tate Foundation; National Institutes of Health [1R01CA132633]; NATIONAL CANCER INSTITUTE [R01CA132633] Funding Source: NIH RePORTER	United Negro College Fund (UNCF)/Merck Graduate Science Research Dissertation Fellowship; Philanthropic Educational Organization (P.E.O.); Charles Tate Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was made possible by the United Negro College Fund (UNCF)/Merck Graduate Science Research Dissertation Fellowship to ELB, the Philanthropic Educational Organization (P.E.O.) Scholar Award to ELB, the Charles Tate Foundation UT Seed Grant to MHZ and DY, and National Institutes of Health funding (1R01CA132633) to MHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Baker EL, 2010, J BIOMECH, V43, P38, DOI 10.1016/j.jbiomech.2009.09.007; Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Danes CG, 2008, CANCER RES, V68, P1760, DOI 10.1158/0008-5472.CAN-07-3177; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Hondermarck H, 2001, PROTEOMICS, V1, P1216, DOI 10.1002/1615-9861(200110)1:10<1216::AID-PROT1216>3.0.CO;2-P; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Ligresti G, 2008, MOL MED REP, V1, P451; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lu J, 2010, CELL CYCLE, V9, P421, DOI 10.4161/cc.9.3.10633; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Nofech-Mozes S, 2005, ADV ANAT PATHOL, V12, P256, DOI 10.1097/01.pap.0000184177.65919.5e; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Porter GW, 2006, SEMIN CANCER BIOL, V16, P193, DOI 10.1016/j.semcancer.2006.03.003; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	31	35	35	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20355	10.1371/journal.pone.0020355	http://dx.doi.org/10.1371/journal.pone.0020355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647371	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500050
J	He, XF; Yang, ZY; Tsien, JZ				He, Xiaofu; Yang, Zhiyong; Tsien, Joe Z.			A Hierarchical Probabilistic Model for Rapid Object Categorization in Natural Scenes	PLOS ONE			English	Article							TOP-DOWN FACILITATION; RECOGNITION; REPRESENTATION; TEXTURE; IDENTIFICATION; FEATURES; MEMORY; SHAPE	Humans can categorize objects in complex natural scenes within 100-150 ms. This amazing ability of rapid categorization has motivated many computational models. Most of these models require extensive training to obtain a decision boundary in a very high dimensional (e. g., similar to 6,000 in a leading model) feature space and often categorize objects in natural scenes by categorizing the context that co-occurs with objects when objects do not occupy large portions of the scenes. It is thus unclear how humans achieve rapid scene categorization. To address this issue, we developed a hierarchical probabilistic model for rapid object categorization in natural scenes. In this model, a natural object category is represented by a coarse hierarchical probability distribution (PD), which includes PDs of object geometry and spatial configuration of object parts. Object parts are encoded by PDs of a set of natural object structures, each of which is a concatenation of local object features. Rapid categorization is performed as statistical inference. Since the model uses a very small number (similar to 100) of structures for even complex object categories such as animals and cars, it requires little training and is robust in the presence of large variations within object categories and in their occurrences in natural scenes. Remarkably, we found that the model categorized animals in natural scenes and cars in street scenes with a near human-level performance. We also found that the model located animals and cars in natural scenes, thus overcoming a flaw in many other models which is to categorize objects in natural context by categorizing contextual features. These results suggest that coarse PDs of object categories based on natural object structures and statistical operations on these PDs may underlie the human ability to rapidly categorize scenes.	[He, Xiaofu; Yang, Zhiyong; Tsien, Joe Z.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA; [He, Xiaofu] E China Normal Univ, Dept Comp Sci & Technol, Shanghai 200062, Peoples R China; [Yang, Zhiyong] Georgia Hlth Sci Univ, Dept Ophthalmol, Augusta, GA USA; [Tsien, Joe Z.] Georgia Hlth Sci Univ, Dept Neurol, Augusta, GA USA	University System of Georgia; Augusta University; East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	He, XF (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Augusta, GA USA.	zhyang@georgiahealth.edu; jtsien@georgiahealth.edu			National Institute of Mental Health (NIMH); National Institute of Aging (NIA); MCG; Georgia Research Alliance	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MCG; Georgia Research Alliance	This research was supported by funds from National Institute of Mental Health (NIMH), National Institute of Aging (NIA), MCG fund, and Georgia Research Alliance (All to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allili MS, 2007, PATTERN RECOGN LETT, V28, P1946, DOI 10.1016/j.patrec.2007.05.002; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Boshyan J, 2005, J COGNITIVE NEUROSCI, P148; Brady TF, 2008, P NATL ACAD SCI USA, V105, P14325, DOI 10.1073/pnas.0803390105; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Geisler WS, 2008, ANNU REV PSYCHOL, V59, P167, DOI 10.1146/annurev.psych.58.110405.085632; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Griffin G., 2007, ANN PHYS, P1; Hegde J, 2003, VISUAL NEUROSCI, V20, P313, DOI 10.1017/S0952523803203102; Humphreys GW, 1997, PHILOS T R SOC B, V352, P1275, DOI 10.1098/rstb.1997.0110; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Knill DC, 1996, PERCEPTION BAYESIAN; LAZEBNIK CSS, 2006, IEEE C COMP VIS PATT, P2169; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mack ML, 2010, J VISION, V10, DOI 10.1167/10.3.11; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Marr D., 1982, VISION COMPUTATIONAL; Mutch J, 2008, INT J COMPUT VISION, V80, P45, DOI 10.1007/s11263-007-0118-0; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Peelen MV, 2009, NATURE, V460, P94, DOI 10.1038/nature08103; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Rao R. P., 2002, PROBABILISTIC MODELS; Renninger LW, 2004, VISION RES, V44, P2301, DOI 10.1016/j.visres.2004.04.006; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Rousselet GA, 2002, NAT NEUROSCI, V5, P629, DOI 10.1038/nn866; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059; Zhang J, 2007, INT J COMPUT VISION, V73, P213, DOI 10.1007/s11263-006-9794-4	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20002	10.1371/journal.pone.0020002	http://dx.doi.org/10.1371/journal.pone.0020002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647443	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500017
J	Lee, CC; Lin, TW; Ko, TP; Wang, AHJ				Lee, Cheng-Chung; Lin, Ta-Wei; Ko, Tzu-Ping; Wang, Andrew H. -J.			The Hexameric Structures of Human Heat Shock Protein 90	PLOS ONE			English	Article							HSP90 FAMILY; BINDING; MEMBER; DIMERIZATION; INHIBITION; COMPLEXES; SYSTEM; SUITE	Background: The human 90-kDa heat shock protein (HSP90) functions as a dimeric molecular chaperone. HSP90 identified on the cell surface has been found to play a crucial role in cancer invasion and metastasis, and has become a validated anticancer target for drug development. It has been shown to self-assemble into oligomers upon heat shock or divalent cations treatment, but the functional role of the oligomeric states in the chaperone cycle is not fully understood. Principal Findings: Here we report the crystal structure of a truncated HSP90 that contains the middle segment and the carboxy-terminal domain, termed MC-HSP90. The structure reveals an architecture with triangular bipyramid geometry, in which the building block of the hexameric assembly is a dimer. In solution, MC-HSP90 exists in three major oligomer states, namely dimer, tetramer and hexamer, which were elucidated by size exclusion chromatography and analytical ultracentrifugation. The newly discovered HSP90 isoform HSP90N that lacks the N-terminal ATPase domain also exhibited similar oligomerization states as did MC-HSP90. Conclusions: While lacking the ATPase domain, both MC-HSP90 and HSP90N can self-assemble into a hexameric structure, spontaneously. The crystal structure of MC-HSP90 reveals that, in addition to the C-terminal dimerization domain, the residue W320 in the M domain plays a critical role in its oligomerization. This study not only demonstrates how the human MC-HSP90 forms a hexamer, but also justifies the similar formation of HSP90N by using 3D modeling analysis.	[Lee, Cheng-Chung; Lin, Ta-Wei; Ko, Tzu-Ping; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Lee, Cheng-Chung; Ko, Tzu-Ping; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Prod & Xray Struct Anal, Taipei 115, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan	Lee, CC (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw			National Science Council of Taiwan [NSC97-3112-B-001-035-B4]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan (NSC97-3112-B-001-035-B4 to A.H.-J.W.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chadli A, 1999, J BIOL CHEM, V274, P4133, DOI 10.1074/jbc.274.7.4133; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grammatikakis N, 2002, J BIOL CHEM, V277, P8312, DOI 10.1074/jbc.M109200200; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Koga F, 2009, ANTICANCER RES, V29, P797; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Milicevic Z, 2008, INT J ONCOL, V32, P1169; MINAMI Y, 1994, MOL CELL BIOL, V14, P1459, DOI 10.1128/MCB.14.2.1459; Moullintraffort L, 2010, J BIOL CHEM, V285, P15100, DOI 10.1074/jbc.M109.094698; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemoto T, 1998, BIOCHEM J, V330, P989, DOI 10.1042/bj3300989; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schweinfest CW, 1998, BBA-GENE STRUCT EXPR, V1398, P18, DOI 10.1016/S0167-4781(98)00031-1; Suzuki S, 2010, BIOCHEM BIOPH RES CO, V398, P525, DOI 10.1016/j.bbrc.2010.06.112; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641; Zurawska A, 2008, BBA-PROTEINS PROTEOM, V1784, P1844, DOI 10.1016/j.bbapap.2008.06.013	34	48	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19961	10.1371/journal.pone.0019961	http://dx.doi.org/10.1371/journal.pone.0019961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647436	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500014
J	Wang, CZ; Neugebauer, U; Burck, J; Myllykoski, M; Baumgartel, P; Popp, J; Kursula, P				Wang, Chaozhan; Neugebauer, Ute; Buerck, Jochen; Myllykoski, Matti; Baumgaertel, Peter; Popp, Juergen; Kursula, Petri			Charge Isomers of Myelin Basic Protein: Structure and Interactions with Membranes, Nucleotide Analogues, and Calmodulin	PLOS ONE			English	Article							RESONANCE RAMAN-SPECTROSCOPY; CIRCULAR-DICHROISM SPECTRA; 18.5 KDA ISOFORM; MULTIPLE-SCLEROSIS; POSTTRANSLATIONAL MODIFICATIONS; SECONDARY STRUCTURE; DODECYLPHOSPHOCHOLINE MICELLES; MOLECULAR-CONFORMATION; COMPLEX-FORMATION; ESCHERICHIA-COLI	As an essential structural protein required for tight compaction of the central nervous system myelin sheath, myelin basic protein (MBP) is one of the candidate autoantigens of the human inflammatory demyelinating disease multiple sclerosis, which is characterized by the active degradation of the myelin sheath. In this work, recombinant murine analogues of the natural C1 and C8 charge components (rmC1 and rmC8), two isoforms of the classic 18.5-kDa MBP, were used as model proteins to get insights into the structure and function of the charge isomers. Various biochemical and biophysical methods such as size exclusion chromatography, calorimetry, surface plasmon resonance, small angle X-ray and neutron scattering, Raman and fluorescence spectroscopy, and conventional as well as synchrotron radiation circular dichroism were used to investigate differences between these two isoforms, both from the structural point of view, and regarding interactions with ligands, including calmodulin (CaM), various detergents, nucleotide analogues, and lipids. Overall, our results provide further proof that rmC8 is deficient both in structure and especially in function, when compared to rmC1. While the CaM binding properties of the two forms are very similar, their interactions with membrane mimics are different. CaM can be used to remove MBP from immobilized lipid monolayers made of synthetic lipids - a phenomenon, which may be of relevance for MBP function and its regulation. Furthermore, using fluorescently labelled nucleotides, we observed binding of ATP and GTP, but not AMP, by MBP; the binding of nucleoside triphosphates was inhibited by the presence of CaM. Together, our results provide important further data on the interactions between MBP and its ligands, and on the differences in the structure and function between MBP charge isomers.	[Wang, Chaozhan; Myllykoski, Matti; Kursula, Petri] Univ Oulu, Dept Biochem, Oulu, Finland; [Neugebauer, Ute; Popp, Juergen] Inst Photon Technol, Jena, Germany; [Buerck, Jochen] Karlsruhe Inst Technol, Inst Biol Interfaces 2, Karlsruhe, Germany; [Baumgaertel, Peter] Helmholtz Zentrum Berlin, Berlin Elect Storage Ring Co Synchrotron Radiat, Berlin, Germany; [Popp, Juergen] Univ Jena, Inst Phys Chem, D-6900 Jena, Germany; [Kursula, Petri] German Elect Synchrotron, Ctr Struct Syst Biol, Hamburg, Germany	Finland National Institute for Health & Welfare; University of Oulu; Leibniz Institut fur Photonische Technologien; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Friedrich Schiller University of Jena; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Wang, CZ (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	petri.kursula@desy.de	Kursula, Petri/AAF-4563-2020; Popp, Juergen/E-6471-2012; Kursula, Petri/K-1058-2012	Kursula, Petri/0000-0001-8529-3751; Kursula, Petri/0000-0001-8529-3751; Myllykoski, Matti/0000-0001-6641-5856	Academy of Finland; Sigrid Juselius Foundation; ISA, Arhus	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); ISA, Arhus	This research was funded by the Academy of Finland and the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Prof. George Harauz, University of Guelph, Canada, for providing the expression constructs for rmC1 and rmC8. We thank Dr. Vasyl Haramus (GKSS) for help in collecting the SANS data and Prof. Inari Kursula (CSSB-HZI) for helpful discussions. The beamline staff at EMBL-Hamburg, BESSY, MAX-Lab, and ISA, Arhus, are acknowledged for their excellent support.	Bamm VV, 2010, BIOCHEMISTRY-US, V49, P6903, DOI 10.1021/bi100308d; Bates IR, 2003, J BIOL CHEM, V278, P29041, DOI 10.1074/jbc.M302766200; Bates IR, 2002, PROTEIN EXPRES PURIF, V25, P330, DOI 10.1016/S1046-5928(02)00017-7; Bates IR, 2000, PROTEIN EXPRES PURIF, V20, P285, DOI 10.1006/prep.2000.1307; BENJAMINS JA, 1978, NEUROCHEM RES, V3, P137, DOI 10.1007/BF00964057; Beswick V, 1998, EUR BIOPHYS J BIOPHY, V28, P48, DOI 10.1007/s002490050182; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Boggs JM, 2005, BIOCHEMISTRY-US, V44, P3524, DOI 10.1021/bi0473760; Boggs JM, 1997, BIOCHEMISTRY-US, V36, P5065, DOI 10.1021/bi962649f; Boggs JM, 2000, BIOCHEMISTRY-US, V39, P7799, DOI 10.1021/bi0002129; BOGGS JM, 1977, BIOCHEMISTRY-US, V16, P5420, DOI 10.1021/bi00644a003; Brokx RD, 2001, J BIOL CHEM, V276, P14083, DOI 10.1074/jbc.M011026200; Cerenius Y, 2000, J SYNCHROTRON RADIAT, V7, P203, DOI 10.1107/S0909049500005331; CHAN KC, 1988, BIOCHEM BIOPH RES CO, V152, P1468, DOI 10.1016/S0006-291X(88)80451-0; CHEN GC, 1977, ANAL LETT, V10, P1195, DOI 10.1080/00032717708067855; CHEN MC, 1974, J AM CHEM SOC, V96, P3038, DOI 10.1021/ja00817a003; Chen WQ, 2010, AMINO ACIDS, V39, P859, DOI 10.1007/s00726-010-0542-2; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; GARBAY B, 1988, NEUROCHEM PATHOL, V8, P91; Haas H, 2004, BIOPHYS J, V86, P455, DOI 10.1016/S0006-3495(04)74122-3; HARADA I, 1986, SPECTROCHIM ACTA A, V42, P307, DOI 10.1016/0584-8539(86)80193-3; Harauz G, 2004, MICRON, V35, P503, DOI 10.1016/j.micron.2004.04.005; Harauz G, 2007, NEUROCHEM RES, V32, P137, DOI 10.1007/s11064-006-9108-9; Harauz G, 2009, CURR PROTEIN PEPT SC, V10, P196, DOI 10.2174/138920309788452218; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hill CMD, 2005, BIOCHEM BIOPH RES CO, V329, P362, DOI 10.1016/j.bbrc.2005.01.151; Homchaudhuri L, 2010, BIOCHEMISTRY-US, V49, P8955, DOI 10.1021/bi100988p; Homchaudhuri L, 2009, BIOCHEMISTRY-US, V48, P2385, DOI 10.1021/bi8022587; Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; KRIGBAUM WR, 1975, BIOCHEMISTRY-US, V14, P2542, DOI 10.1021/bi00682a038; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Libich DS, 2008, BIOPHYS J, V94, P4847, DOI 10.1529/biophysj.107.125823; Libich DS, 2008, EUR BIOPHYS J BIOPHY, V37, P1015, DOI 10.1007/s00249-008-0334-8; Libich David S., 2002, Molecular and Cellular Biochemistry, V241, P45, DOI 10.1023/A:1020883409176; Libich DS, 2003, BIOCHEM BIOPH RES CO, V308, P313, DOI 10.1016/S0006-291X(03)01380-9; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LOWDEN JA, 1966, CAN J BIOCHEM CELL B, V44, P567, DOI 10.1139/o66-068; Lutton JD, 2004, EXP BIOL MED, V229, P12, DOI 10.1177/153537020422900102; Majava V, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-10; Majava V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010300; Majava V, 2010, AMINO ACIDS, V39, P59, DOI 10.1007/s00726-009-0364-2; McLaughlin S, 2005, BIOCHEM SOC SYMP, V72, P189, DOI 10.1042/bss0720189; MENDZ GL, 1984, BIOCHEMISTRY-US, V23, P6041, DOI 10.1021/bi00320a022; MIURA T, 1988, BIOCHEMISTRY-US, V27, P88, DOI 10.1021/bi00401a015; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Moscarello MA, 2007, NEUROCHEM RES, V32, P251, DOI 10.1007/s11064-006-9144-5; Musse AA, 2006, P NATL ACAD SCI USA, V103, P4422, DOI 10.1073/pnas.0509158103; Musse AA, 2008, BIOCHEMISTRY-US, V47, P10372, DOI 10.1021/bi801302b; Myllykoski M, 2009, BIOPHYS CHEM, V144, P130, DOI 10.1016/j.bpc.2009.08.001; Overman SA, 1999, BIOCHEMISTRY-US, V38, P4018, DOI 10.1021/bi982901e; Polverini E, 1999, EUR BIOPHYS J BIOPHY, V28, P351, DOI 10.1007/s002490050218; *R DEV COR TEAM, 2007, J NEUROCHEM, V17, P1121; Reichardt G, 2001, NUCL INSTRUM METH A, V467, P458, DOI 10.1016/S0168-9002(01)00357-6; RYAN CG, 1988, NUCL INSTRUM METH B, V34, P396, DOI 10.1016/0168-583X(88)90063-8; SANKARAM MB, 1989, BIOCHEMISTRY-US, V28, P9699, DOI 10.1021/bi00451a024; SMITH GS, 2010, J NEUROCHEM, V51, P718; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; SURESH S, 2010, BIOCHEMISTRY; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TUMA R, 1995, BIOCHEMISTRY-US, V34, P15150, DOI 10.1021/bi00046a022; Vohnik S, 1998, PROTEIN SCI, V7, P193, DOI 10.1002/pro.5560070120; Wen ZQ, 2007, J PHARM SCI-US, V96, P2861, DOI 10.1002/jps.20895; Wen ZQ, 2001, BIOCHEMISTRY-US, V40, P449, DOI 10.1021/bi0018887; WU Y, 1990, BIOPHYS J, V57, P797, DOI 10.1016/S0006-3495(90)82599-6	66	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19915	10.1371/journal.pone.0019915	http://dx.doi.org/10.1371/journal.pone.0019915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647440	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500012
J	Mustafi, D; Kevany, BM; Genoud, C; Okano, K; Cideciyan, AV; Sumaroka, A; Roman, AJ; Jacobson, SG; Engel, A; Adams, MD; Palczewski, K				Mustafi, Debarshi; Kevany, Brian M.; Genoud, Christel; Okano, Kiichiro; Cideciyan, Artur V.; Sumaroka, Alexander; Roman, Alejandro J.; Jacobson, Samuel G.; Engel, Andreas; Adams, Mark D.; Palczewski, Krzysztof			Defective photoreceptor phagocytosis in a mouse model of enhanced S-cone syndrome causes progressive retinal degeneration	FASEB JOURNAL			English	Article						Nrl; RNA-Seq; vision	SCANNING-ELECTRON-MICROSCOPY; EXPRESSED SEQUENCE TAGS; GENE-EXPRESSION; EYE DEVELOPMENT; TRANSCRIPTION FACTORS; LAMINAR ARCHITECTURE; SERIAL ANALYSIS; SURFACE-CHARGE; GANGLION-CELL; 6 FAMILY	Enhanced S-cone syndrome (ESCS), featuring an excess number of S cones, manifests as a progressive retinal degeneration that leads to blindness. Here, through optical imaging, we identified an abnormal interface between photoreceptors and the retinal pigment epithelium (RPE) in 9 patients with ESCS. The neural retina leucine zipper transcription factor-knockout (Nrl(-/-)) mouse model demonstrates many phenotypic features of human ESCS, including unstable S-cone-positive photoreceptors. Using massively parallel RNA sequencing, we identified 6203 differentially expressed transcripts between wild-type (Wt) and Nrl(-/-) mouse retinas, with 6 highly significant differentially expressed genes of the Pax, Notch, and Wnt canonical pathways. Changes were also obvious in expression of 30 genes involved in the visual cycle and 3 key genes in photoreceptor phagocytosis. Novel high-resolution (100 nm) imaging and reconstruction of Nrl(-/-) retinas revealed an abnormal packing of photoreceptors that contributed to buildup of photoreceptor deposits. Furthermore, lack of phagosomes in the RPE layer of Nrl(-/-) retina revealed impairment in phagocytosis. Cultured RPE cells from Wt and Nrl(-/-) mice illustrated that the phagocytotic defect was attributable to the aberrant interface between ESCS photoreceptors and the RPE. Overcoming the retinal phagocytosis defect could arrest the progressive degenerative component of this disease.-Mustafi, D., Kevany, B. M., Genoud, C., Okano, K., Cideciyan, A. V., Sumaroka, A., Roman, A. J., Jacobson, S. G. Engel, A., Adams, M. D., Palczewski, K. Defective photoreceptor phagocytosis in a mouse model of enhanced S-cone syndrome causes progressive retinal degeneration. FASEB J. 25, 3157-3176 (2011). www.fasebj.org	[Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Adams, Mark D.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Adams, Mark D.; Palczewski, Krzysztof] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Genoud, Christel] Friedrich Miescher Inst, Electron Microscopy Facil, CH-4002 Basel, Switzerland; [Cideciyan, Artur V.; Sumaroka, Alexander; Roman, Alejandro J.; Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Engel, Andreas] Univ Basel, ME Muller Inst, Ctr Cellular Imaging & Nanoanalyt, Basel, Switzerland	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Friedrich Miescher Institute for Biomedical Research; University of Pennsylvania; Pennsylvania Medicine; University of Basel	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X; Mustafi, Debarshi/0000-0002-9164-7488; genoud, christel/0000-0002-0933-9911	U.S. National Institutes of Health (NIH) [EY009339, EY019478]; Foundation Fighting Blindness; NIH [T32 GM007250, T32 EY007157]; Maurice E. Muller Foundation of Switzerland; National Institute of Diabetes and Digestive and Kidney Diseases [DK-007319]; NATIONAL EYE INSTITUTE [R01EY009339, R01EY019478, T32EY007157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maurice E. Muller Foundation of Switzerland; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Anand Swaroop (National Eye Institute) for helpful discussions and Dr. Leslie T. Webster Jr., Dr. Yoshikazu Imanishi, Dr. Michael E. Maguire and Dr. Akiko Maeda (Case Western Reserve University) for valuable comments about the manuscript. The authors thank Dr. Russell Van Gelder (University of Washington, Seatttle, WA, USA) for providing the scanning electron microscope for imaging and Dr. David Williams and Dr. Tanja Diemer (University of California, Los Angeles, CA, USA) for graciously offering to demonstrate their RPE isolation technique. The authors also thank Dr. Yan Liang, Dr. Hisashi Fujioka, Dr. Heather Holdaway, Dr. Glenn Lobo, Neil Molyneaux, Satsumi Roos, Simone Edelheit, Pamela Supelak, Sungho Lee (Case Western Reserve University), and Christopher Bleck (University of Basel, Basel, Switzerland) for sample preparation, imaging assistance, data analysis help and useful discussions. This research was supported by U.S. National Institutes of Health (NIH) grants EY009339 and EY019478, and by a grant from Foundation Fighting Blindness. D. M. was supported in part by Case Western Reserve University (CWRU) Medical Scientist Training Program grant T32 GM007250 from NIH, Visual Sciences Training grant T32 EY007157 from NIH, and the Maurice E. Muller Foundation of Switzerland. B. M. K. was supported by a CWRU Department of Nutrition Metabolic Training grant postdoctoral fellowship award from National Institute of Diabetes and Digestive and Kidney Diseases grant DK-007319. K. P. is John H. Hord Professor of Pharmacology.	ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; Alfano G, 2005, HUM MOL GENET, V14, P913, DOI 10.1093/hmg/ddi084; ANDERSON DH, 1978, INVEST OPHTH VIS SCI, V17, P117; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Bonilha VL, 2009, OPHTHALMIC GENET, V30, P172, DOI 10.3109/13816810903176765; BRAY DF, 1993, MICROSC RES TECHNIQ, V26, P489, DOI 10.1002/jemt.1070260603; Brown NL, 2001, DEVELOPMENT, V128, P2497; Caberoy NB, 2010, EMBO J, V29, P3898, DOI 10.1038/emboj.2010.265; Chen JC, 2007, INVEST OPHTH VIS SCI, V48, P2799, DOI 10.1167/iovs.06-0922; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Cideciyan AV, 2007, J OPT SOC AM A, V24, P1457, DOI 10.1364/JOSAA.24.001457; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Conte I, 2010, DEVELOPMENT, V137, P2307, DOI 10.1242/dev.045294; Corbo JC, 2005, PLOS GENET, V1, P140, DOI 10.1371/journal.pgen.0010011; Corbo JC, 2007, P NATL ACAD SCI USA, V104, P12069, DOI 10.1073/pnas.0705465104; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46; DELORI FC, 1995, INVEST OPHTH VIS SCI, V36, P718; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gehring WJ, 2002, INT J DEV BIOL, V46, P65; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Haynes T, 2007, P NATL ACAD SCI USA, V104, P20380, DOI 10.1073/pnas.0708202104; HOOD DC, 1995, VISION RES, V35, P1473, DOI 10.1016/0042-6989(95)98727-Q; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang YJ, 1998, INVEST OPHTH VIS SCI, V39, P2405; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Imanishi Y, 2004, J CELL BIOL, V166, P447, DOI 10.1083/jcb.200405110; IMMEL JH, 1985, CELL TISSUE RES, V239, P667; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P1886, DOI 10.1167/iovs.08-3122; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jacobson SG, 2004, HUM MOL GENET, V13, P1893, DOI 10.1093/hmg/ddh198; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Levine EM, 1997, J NEUROSCI, V17, P6277; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; Mollema N, 2010, EXP EYE RES, V91, P116, DOI 10.1016/j.exer.2010.04.013; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murali D, 2005, DEV BIOL, V283, P671; Mustafi D, 2011, J NEUROSCI METH, V198, P70, DOI 10.1016/j.jneumeth.2011.03.013; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; ROMAN AJ, 1991, EXP EYE RES, V53, P685, DOI 10.1016/0014-4835(91)90230-C; ROMAN AJ, 1991, INVEST OPHTH VIS SCI, V32, P1138; Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x; Sakagami K, 2009, J NEUROSCI, V29, P6932, DOI 10.1523/JNEUROSCI.0289-09.2009; Sharon D, 2002, P NATL ACAD SCI USA, V99, P315, DOI 10.1073/pnas.012582799; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Wang NK, 2009, BRIT J OPHTHALMOL, V93, P1234, DOI 10.1136/bjo.2008.153577; Wang WH, 2001, MOL VIS, V7, P89; Wang YP, 2005, DEVELOPMENT, V132, P5103, DOI 10.1242/dev.02096; Wang YP, 2002, NAT NEUROSCI, V5, P831, DOI 10.1038/nn911; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Webber AL, 2008, EXP EYE RES, V87, P35, DOI 10.1016/j.exer.2008.04.006; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Wright Alan F, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9285; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; Yetemian RM, 2010, INVEST OPHTH VIS SCI, V51, P6196, DOI 10.1167/iovs.10-5452; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Yu JD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r65	98	69	71	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3157	3176		10.1096/fj.11-186767	http://dx.doi.org/10.1096/fj.11-186767			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21659555	Green Published			2022-12-25	WOS:000294435200029
J	Fonseca, BD; Alain, T; Finestone, LK; Huang, BPH; Rolfe, M; Jiang, T; Yao, Z; Hernandez, G; Bennett, CF; Proud, CG				Fonseca, Bruno D.; Alain, Tommy; Finestone, Leona K.; Huang, Brandon P. H.; Rolfe, Mark; Jiang, Tian; Yao, Zhong; Hernandez, Greco; Bennett, Christopher F.; Proud, Christopher G.			Pharmacological and Genetic Evaluation of Proposed Roles of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase (MEK), Extracellular Signal-regulated Kinase (ERK), and p90(RSK) in the Control of mTORC1 Protein Signaling by Phorbol Esters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; TUMOR-SUPPRESSOR COMPLEX; TUBEROUS SCLEROSIS; MAMMALIAN TARGET; CARDIAC-HYPERTROPHY; ADULT CARDIOMYOCYTES; 3-KINASE/AKT PATHWAY; CELL-GROWTH; RAG GTPASES; IN-VITRO	The mammalian target of rapamycin complex 1 (mTORC1) links the control of mRNA translation, cell growth, and metabolism to diverse stimuli. Inappropriate activation of mTORC1 can lead to cancer. Phorbol esters are naturally occurring products that act as potent tumor promoters. They activate isoforms of protein kinase C (PKCs) and stimulate the oncogenic MEK/ERK signaling cascade. They also activate mTORC1 signaling. Previous work indicated that mTORC1 activation by the phorbol ester PMA (phorbol 12-myristate 13-acetate) depends upon PKCs and may involve MEK. However, the precise mechanism(s) through which they activate mTORC1 remains unclear. Recent studies have implicated both the ERKs and the ERK-activated 90-kDa ribosomal S6 kinases (p90(RSK)) in activating mTORC1 signaling via phosphorylation of TSC2 (a regulator of mTORC1) and/or the mTORC1 component raptor. However, the relative importance of each of these kinases and phosphorylation events for the activation of mTORC1 signaling is unknown. The recent availability of MEK (PD184352) and p90(RSK) (BI-D1870) inhibitors of improved specificity allowed us to address the roles of these protein kinases in controlling mTORC1in a variety of human and rodent cell types. In parallel, we used specific shRNAs against p90(RSK1) and p90(RSK2) to further test their roles in regulating mTORC1 signaling. Our data indicate that p90(RSKs) are dispensable for the activation of mTORC1 signaling by phorbol esters in all cell types tested. Our data also reveal striking diversity in the requirements for MEK/ERK in the control of mTORC1 between different cell types, pointing to additional signaling connections between phorbol esters and mTORC1, which do not involve MEK/ERK. This study provides important information for the design of efficient strategies to combat the hyperactivation of mTORC1 signaling by oncogenic pathways.	[Fonseca, Bruno D.; Rolfe, Mark; Proud, Christopher G.] Univ Dundee, Coll Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland; [Fonseca, Bruno D.; Huang, Brandon P. H.; Jiang, Tian; Yao, Zhong; Proud, Christopher G.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Fonseca, Bruno D.; Huang, Brandon P. H.; Jiang, Tian; Yao, Zhong; Proud, Christopher G.] Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada; [Proud, Christopher G.] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England; [Fonseca, Bruno D.; Alain, Tommy; Finestone, Leona K.; Hernandez, Greco; Bennett, Christopher F.] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada	University of Dundee; University of British Columbia; University of British Columbia; University of Southampton; McGill University	Proud, CG (corresponding author), Univ Southampton, Sch Biol Sci, Bldg 85, Southampton SO17 1BJ, Hants, England.	C.G.Proud@soton.ac.uk		Bennett, Christopher/0000-0003-1927-0732; Proud, Christopher/0000-0003-0704-6442	University of British Columbia; Heart and Stroke Foundation of British Columbia and the Yukon; British Heart Foundation; Canadian Institutes of Health Research; University of Dundee School of Life Sciences	University of British Columbia; Heart and Stroke Foundation of British Columbia and the Yukon; British Heart Foundation(British Heart Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Dundee School of Life Sciences	This work was supported in part by grants from the University of British Columbia, the Heart and Stroke Foundation of British Columbia and the Yukon, the British Heart Foundation, and Canadian Institutes of Health Research (all to C. G. P.).; Supported by the Morton Fellowship/University of Dundee School of Life Sciences Alumnus Fund and a Canadian Institutes of Health Research Post-doctoral Cancer Training Grant Award.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chen S, 2009, CELL SIGNAL, V21, P1984, DOI 10.1016/j.cellsig.2009.09.009; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Fonseca BD, 2008, BIOCHEM J, V411, P141, DOI 10.1042/BJ20071001; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Rolfe M, 2005, BIOCHEM J, V388, P973, DOI 10.1042/BJ20041888; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Scheper GC, 2003, MOL CELL BIOL, V23, P5692, DOI 10.1128/MCB.23.16.5692-5705.2003; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Smith JA, 2005, CANCER RES, V65, P1027; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Squires MS, 2002, BIOCHEM J, V366, P673, DOI 10.1042/BJ20020372; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; Wang LJ, 2003, BIOCHEM J, V373, P603, DOI 10.1042/BJ20030454; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Wang LJ, 2001, J BIOL CHEM, V276, P32670, DOI 10.1074/jbc.M102776200; Yu YJ, 2005, J VIROL, V79, P6882, DOI 10.1128/JVI.79.11.6882-6889.2005	54	36	36	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27111	27122		10.1074/jbc.M111.260794	http://dx.doi.org/10.1074/jbc.M111.260794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659537	Green Published, hybrid			2022-12-25	WOS:000293268700006
J	Demorest, ZL; Li, M; Harris, RS				Demorest, Zachary L.; Li, Ming; Harris, Reuben S.			Phosphorylation Directly Regulates the Intrinsic DNA Cytidine Deaminase Activity of Activation-induced Deaminase and APOBEC3G Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA EDITING ENZYME; ANTIBODY DIVERSIFICATION; SOMATIC HYPERMUTATION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; HIV-1 VIF; B-CELLS; FUNCTIONAL IMPLICATIONS; CYTOPLASMIC RETENTION; L1 RETROTRANSPOSITION	The beneficial effects of DNA cytidine deamination by activation-induced deaminase (AID; antibody gene diversification) and APOBEC3G (retrovirus restriction) are tempered by probable contributions to carcinogenesis. Multiple regulatory mechanisms serve to minimize this detrimental outcome. Here, we show that phosphorylation of a conserved threonine attenuates the intrinsic activity of activation-induced deaminase (Thr-27) and APOBEC3G (Thr-218). Phospho-null alanine mutants maintain intrinsic DNA deaminase activity, whereas phosphomimetic glutamate mutants are inactive. The phospho-mimetic variants fail to mediate isotype switching in activated mouse splenic B lymphocytes or suppress HIV-1 replication in human T cells. Our data combine to suggest a model in which this critical threonine acts as a phospho-switch that fine-tunes the adaptive and innate immune responses and helps protect mammalian genomic DNA from procarcinogenic lesions.	Univ Minnesota, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	rsh@umn.edu			National Institutes of Health [R01-AI064046, R01-GM080437, T32-AI007313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007313, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI064046 and R01-GM080437 and National Institutes of Health Grant T32-AI007313 ( to Z. L. D.).	Albin JS, 2010, J VIROL, V84, P10209, DOI 10.1128/JVI.00632-10; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Demorest ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011660; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Farrow MA, 2011, J BIOL CHEM, V286, P2567, DOI 10.1074/jbc.M110.154377; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Hache G, 2008, CURR BIOL, V18, P819, DOI 10.1016/j.cub.2008.04.073; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; MacDuff DA, 2006, MOL IMMUNOL, V43, P1099, DOI 10.1016/j.molimm.2005.07.024; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; Maeda K, 2010, J BIOL CHEM, V285, P23945, DOI 10.1074/jbc.M110.131441; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Shlyakhtenko LS, 2011, J BIOL CHEM, V286, P3387, DOI 10.1074/jbc.M110.195685; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015	51	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26568	26575		10.1074/jbc.M111.235721	http://dx.doi.org/10.1074/jbc.M111.235721			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659520	Green Published, hybrid			2022-12-25	WOS:000293078200035
J	Lu, Y; Zha, XM; Kim, EY; Schachtele, S; Dailey, ME; Hall, DD; Strack, S; Green, SH; Hoffman, DA; Hell, JW				Lu, Yuan; Zha, Xiang-ming; Kim, Eun Young; Schachtele, Scott; Dailey, Michael E.; Hall, Duane D.; Strack, Stefan; Green, Steven H.; Hoffman, Dax A.; Hell, Johannes W.			A Kinase Anchor Protein 150 (AKAP150)-associated Protein Kinase A Limits Dendritic Spine Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA RECEPTOR ACTIVATION; POSTSYNAPTIC DENSITIES; AMPA RECEPTORS; AKAP150-ANCHORED PKA; PLASTICITY; PHOSPHORYLATION; AKAP79; SCAFFOLD; GLUR1; MEMBRANE	The A kinase anchor protein AKAP150 recruits the cAMP-dependent protein kinase (PKA) to dendritic spines. Here we show that in AKAP150 (AKAP5) knock-out (KO) mice frequency of miniature excitatory post-synaptic currents (mEPSC) and inhibitory post-synaptic currents (mIPSC) are elevated at 2 weeks and, more modestly, 4 weeks of age in the hippocampal CA1 area versus litter mate WT mice. Linear spine density and ratio of AMPAR to NMDAR EPSC amplitudes were also increased. Amplitude and decay time of mEPSCs, decay time of mIPSCs, and spine size were unaltered. Mice in which the PKA anchoring C-terminal 36 residues of AKAP150 are deleted (D36) showed similar changes. Furthermore, whereas acute stimulation of PKA (2-4 h) increases spine density, prolonged PKA stimulation (48 h) reduces spine density in apical dendrites of CA1 pyramidal neurons in organotypic slice cultures. The data from the AKAP150 mutant mice show that AKAP150-anchored PKA chronically limits the number of spines with functional AMPARs at 2-4 weeks of age. However, synaptic transmission and spine density was normal at 8 weeks in KO and D36 mice. Thus AKAP150-independent mechanisms correct the aberrantly high number of active spines in juvenile AKAP150 KO and D36 mice during development.	[Lu, Yuan; Hall, Duane D.; Strack, Stefan; Hell, Johannes W.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Zha, Xiang-ming; Schachtele, Scott; Dailey, Michael E.; Green, Steven H.] Univ Iowa, Coll Liberal Arts & Sci, Dept Biol, Iowa City, IA 52242 USA; [Lu, Yuan] NIMH, Genes Cognit & Psychosis Program, Bethesda, MD 20892 USA; [Zha, Xiang-ming] Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Kim, Eun Young; Hoffman, Dax A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Neurophysiol & Biophys Unit, NIH, Bethesda, MD 20892 USA; [Hell, Johannes W.] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95615 USA	University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of South Alabama; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Davis	Lu, Y (corresponding author), Magnuson Clin Ctr, Bldg 10,7D38,10 Ctr Dr, Bethesda, MD 20892 USA.	luyuan@mail.nih.gov; jwhell@ucdavis.edu	Hall, Duane/ACD-6815-2022; Hoffman, Dax A/E-5155-2011; Hell, Johannes W./P-5085-2019	Hall, Duane/0000-0003-2228-0966; Hoffman, Dax A/0000-0001-6999-2157; Strack, Stefan/0000-0002-6175-7280; Zha, Xiangming/0000-0001-9490-2731	National Institutes of Health [DA015916, GM032875, NS043254, NS056244, NS057714, DC002961, NS035563, NS017502]; American Heart Association [0655764Z]; University of South Alabama; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008755] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035563, R01NS056244, R01NS043254, R56NS056244, R01NS057714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002961, R01DC009405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA015916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of South Alabama; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by Grants DA015916, GM032875 (to G. S. M.), NS043254, NS056244, NS057714 (to S. S.), DC002961 (to S. H. G.), and NS035563, NS017502 (to J. W. H.) from the National Institutes of Health. This work was also supported by Grant 0655764Z (to M. E. D.) from the American Heart Association, startup funds from the University of South Alabama (to X. M. Z.), and the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; BREGMAN DB, 1991, J BIOL CHEM, V266, P7207; Brooks IM, 2011, J BIOL CHEM, V286, P6697, DOI 10.1074/jbc.M110.183558; CARR DW, 1992, J BIOL CHEM, V267, P16816; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Dailey ME, 1996, J NEUROSCI, V16, P2983; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Harris Kristen M., 2008, P1, DOI 10.1007/978-0-387-77232-5_1; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Kim IH, 2009, J NEUROSCI, V29, P14039, DOI 10.1523/JNEUROSCI.2483-09.2009; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Matus A, 2005, CURR OPIN NEUROBIOL, V15, P67, DOI 10.1016/j.conb.2005.01.015; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McAvoy T, 2009, P NATL ACAD SCI USA, V106, P3531, DOI 10.1073/pnas.0813263106; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Pelkey KA, 2006, NEURON, V52, P497, DOI 10.1016/j.neuron.2006.08.032; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; Robertson HR, 2009, J NEUROSCI, V29, P7929, DOI 10.1523/JNEUROSCI.6093-08.2009; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Strack Stefan, 2008, P459, DOI 10.1007/978-0-387-77232-5_16; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Ulucan C, 2007, AM J PHYSIOL-HEART C, V293, pH1662, DOI 10.1152/ajpheart.00159.2007; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Woolley CS, 1997, J NEUROSCI, V17, P1848; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zha XM, 2005, MOL CELL NEUROSCI, V29, P494, DOI 10.1016/j.mcn.2005.04.007; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	74	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26496	26506		10.1074/jbc.M111.254912	http://dx.doi.org/10.1074/jbc.M111.254912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652711	Green Published, hybrid			2022-12-25	WOS:000293078200028
J	Chandler, KJ; Barrier, M; Jeffay, S; Nichols, HP; Kleinstreuer, NC; Singh, AV; Reif, DM; Sipes, NS; Judson, RS; Dix, DJ; Kavlock, R; Hunter, ES; Knudsen, TB				Chandler, Kelly J.; Barrier, Marianne; Jeffay, Susan; Nichols, Harriette P.; Kleinstreuer, Nicole C.; Singh, Amar V.; Reif, David M.; Sipes, Nisha S.; Judson, Richard S.; Dix, David J.; Kavlock, Robert; Hunter, Edward S., III; Knudsen, Thomas B.			Evaluation of 309 Environmental Chemicals Using a Mouse Embryonic Stem Cell Adherent Cell Differentiation and Cytotoxicity Assay	PLOS ONE			English	Article							VITRO EMBRYOTOXICITY TESTS; HYPOXIC PULMONARY-HYPERTENSION; ANTIOXIDANT RESPONSE ELEMENT; INDUCIBLE FACTOR 1-ALPHA; YA-SUBUNIT GENE; OXIDATIVE STRESS; TRANSCRIPTIONAL REGULATION; PHENOLIC ANTIOXIDANTS; PREDICTION MODELS; SELF-RENEWAL	The vast landscape of environmental chemicals has motivated the need for alternative methods to traditional whole-animal bioassays in toxicity testing. Embryonic stem (ES) cells provide an in vitro model of embryonic development and an alternative method for assessing developmental toxicity. Here, we evaluated 309 environmental chemicals, mostly food-use pesticides, from the ToxCast (TM) chemical library using a mouse ES cell platform. ES cells were cultured in the absence of pluripotency factors to promote spontaneous differentiation and in the presence of DMSO-solubilized chemicals at different concentrations to test the effects of exposure on differentiation and cytotoxicity. Cardiomyocyte differentiation (alpha, beta myosin heavy chain; MYH6/MYH7) and cytotoxicity (DRAQ5 (TM)/Sapphire700 (TM)) were measured by In-Cell Western (TM) analysis. Half-maximal activity concentration (AC(50)) values for differentiation and cytotoxicity endpoints were determined, with 18% of the chemical library showing significant activity on either endpoint. Mining these effects against the ToxCast Phase I assays (similar to 500) revealed significant associations for a subset of chemicals (26) that perturbed transcription-based activities and impaired ES cell differentiation. Increased transcriptional activity of several critical developmental genes including BMPR2, PAX6 and OCT1 were strongly associated with decreased ES cell differentiation. Multiple genes involved in reactive oxygen species signaling pathways (NRF2, ABCG2, GSTA2, HIF1A) were strongly associated with decreased ES cell differentiation as well. A multivariate model built from these data revealed alterations in ABCG2 transporter was a strong predictor of impaired ES cell differentiation. Taken together, these results provide an initial characterization of metabolic and regulatory pathways by which some environmental chemicals may act to disrupt ES cell growth and differentiation.	[Chandler, Kelly J.; Barrier, Marianne; Jeffay, Susan; Nichols, Harriette P.; Hunter, Edward S., III] US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Chandler, Kelly J.; Kleinstreuer, Nicole C.; Reif, David M.; Sipes, Nisha S.; Judson, Richard S.; Dix, David J.; Kavlock, Robert; Knudsen, Thomas B.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA; [Singh, Amar V.] Lockheed Martin, Res Triangle Pk, NC USA	United States Environmental Protection Agency; United States Environmental Protection Agency; Lockheed Martin	Chandler, KJ (corresponding author), US EPA, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	chandler.kelly@epa.gov	Kleinstreuer, Nicole/F-7203-2019; Singh, Amar/K-4400-2013	Kleinstreuer, Nicole/0000-0002-7914-3682; Singh, Amar/0000-0003-3780-8233; Judson, Richard/0000-0002-2348-9633; Reif, David/0000-0001-7815-6767	US EPA through Information Technology (IT-ESE) [68-W-04-005]; U.S. EPA, through its Office of Research and Development, Human Health, Cross-ORD, and CompTox	US EPA through Information Technology (IT-ESE); U.S. EPA, through its Office of Research and Development, Human Health, Cross-ORD, and CompTox(United States Environmental Protection Agency)	The U.S. EPA, through its Office of Research and Development, Human Health, Cross-ORD, and CompTox funded and managed the research described here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lockheed Martin is a contractor to the EPA. The work performed by Lockheed Martin on this study is funded by the US EPA through Information Technology (IT-ESE) contract No.: 68-W-04-005, Task Order No. 058: Technical Support for Development of Developmental Systems Toxicity Network (DevToxNet). This work statement includes contributing activities to the present study for text-mining and data visualization.	[Anonymous], TOX TEST 21 CENT VIS; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Bhattacharya S, 2007, J CELL SCI, V120, P2652, DOI 10.1242/jcs.008417; Chanas SA, 2002, BIOCHEM J, V365, P405, DOI 10.1042/BJ20020320; Chapin RE, 2009, TOXICOL SCI, V112, P17, DOI 10.1093/toxsci/kfp202; Collins FS, 2008, SCIENCE, V319, P906, DOI 10.1126/science.1154619; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Frank DB, 2008, AM J PHYSIOL-LUNG C, V294, pL98, DOI 10.1152/ajplung.00034.2007; FRILING RS, 1990, P NATL ACAD SCI USA, V87, P6258, DOI 10.1073/pnas.87.16.6258; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Genschow E, 2000, IN VITRO MOL TOXICOL, V13, P51; Genschow E, 2004, ATLA-ALTERN LAB ANIM, V32, P209, DOI 10.1177/026119290403200305; Genschow E, 2002, ATLA-ALTERN LAB ANIM, V30, P151, DOI 10.1177/026119290203000204; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jonker JW, 2007, AM J PHYSIOL-CELL PH, V292, pC2204, DOI 10.1152/ajpcell.00359.2006; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; Kang BY, 2008, EXP MOL MED, V40, P208, DOI 10.3858/emm.2008.40.2.208; Kang JS, 2009, GENE DEV, V23, P208, DOI 10.1101/gad.1750709; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Knight AW, 2009, REGUL TOXICOL PHARM, V55, P188, DOI 10.1016/j.yrtph.2009.07.004; Knudsen TB, 2009, REPROD TOXICOL, V28, P209, DOI 10.1016/j.reprotox.2009.03.016; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; LI Y, 1992, J BIOL CHEM, V267, P15097; Martin MT, 2010, CHEM RES TOXICOL, V23, P578, DOI 10.1021/tx900325g; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074; Marx-Stoelting P, 2009, ATLA-ALTERN LAB ANIM, V37, P313, DOI 10.1177/026119290903700314; Nishi H, 2002, CANCER RES, V62, P827; Rotroff DM, 2010, J TOXICOL ENV HEAL B, V13, P329, DOI 10.1080/10937404.2010.483949; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Sebastiano V, 2010, DEVELOPMENT, V137, P3551, DOI 10.1242/dev.047027; Shiraki N, 2009, BIOCHEM BIOPH RES CO, V381, P694, DOI 10.1016/j.bbrc.2009.02.120; Spielmann Horst, 1997, In Vitro Toxicology, V10, P119; Susanto J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004023; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; Tantin D, 2005, CANCER RES, V65, P10750, DOI 10.1158/0008-5472.CAN-05-2399; Thimmulappa RK, 2002, CANCER RES, V62, P5196; van Dartel DAM, 2010, TOXICOL APPL PHARM, V243, P420, DOI 10.1016/j.taap.2009.12.021; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	53	49	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e18540	10.1371/journal.pone.0018540	http://dx.doi.org/10.1371/journal.pone.0018540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666745	gold, Green Submitted, Green Published			2022-12-25	WOS:000291607000003
J	Castle, JC				Castle, John C.			SNPs Occur in Regions with Less Genomic Sequence Conservation	PLOS ONE			English	Article							GENETIC-VARIATION; MOUSE GENOME; DATABASE; SITES; CONSEQUENCES; EUKARYOTES; MUTATIONS; EVOLUTION; SILENCE; MAMMALS	Rates of SNPs (single nucleotide polymorphisms) and cross-species genomic sequence conservation reflect intra-and inter-species variation, respectively. Here, I report SNP rates and genomic sequence conservation adjacent to mRNA processing regions and show that, as expected, more SNPs occur in less conserved regions and that functional regions have fewer SNPs. Results are confirmed using both mouse and human data. Regions include protein start codons, 3' splice sites, 5' splice sites, protein stop codons, predicted miRNA binding sites, and polyadenylation sites. Throughout, SNP rates are lower and conservation is higher at regulatory sites. Within coding regions, SNP rates are highest and conservation is lowest at codon position three and the fewest SNPs are found at codon position two, reflecting codon degeneracy for amino acid encoding. Exon splice sites show high conservation and very low SNP rates, reflecting both splicing signals and protein coding. Relaxed constraint on the codon third position is dramatically seen when separating exonic SNP rates based on intron phase. At polyadenylation sites, a peak of conservation and low SNP rate occurs from 30 to 17 nt preceding the site. This region is highly enriched for the sequence AAUAAA, reflecting the location of the conserved polyA signal. miRNA 3' UTR target sites are predicted incorporating interspecies genomic sequence conservation; SNP rates are low in these sites, again showing fewer SNPs in conserved regions. Together, these results confirm that SNPs, reflecting recent genetic variation, occur more frequently in regions with less evolutionarily conservation.	[Castle, John C.] Rosetta Inpharmat LLC, Seattle, WA USA	Merck & Company	Castle, JC (corresponding author), Johannes Gutenberg Univ Mainz Med, TRON Translat Oncol, Mainz, Rheinland Palat, Germany.	john.castle@tron-mainz.de						Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Pennisi E, 2010, SCIENCE, V330, P574, DOI 10.1126/science.330.6004.574; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Stratton M, 2008, NAT BIOTECHNOL, V26, P65, DOI 10.1038/nbt0108-65; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055	27	38	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20660	10.1371/journal.pone.0020660	http://dx.doi.org/10.1371/journal.pone.0020660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674007	Green Published, Green Submitted, gold			2022-12-25	WOS:000291356400013
J	Marraco, SAF; Scott, CL; Bouillet, P; Ives, A; Masina, S; Vremec, D; Jansen, ES; O'Reilly, LA; Schneider, P; Fasel, N; Shortman, K; Strasser, A; Acha-Orbea, H				Marraco, Silvia A. Fuertes; Scott, Clare L.; Bouillet, Philippe; Ives, Annette; Masina, Slavica; Vremec, David; Jansen, Elisa S.; O'Reilly, Lorraine A.; Schneider, Pascal; Fasel, Nicolas; Shortman, Ken; Strasser, Andreas; Acha-Orbea, Hans			Type I Interferon Drives Dendritic Cell Apoptosis via Multiple BH3-Only Proteins following Activation by PolyIC In Vivo	PLOS ONE			English	Article							CHORIOMENINGITIS VIRUS-INFECTION; TOLL-LIKE RECEPTOR-3; CD8 T-CELLS; CUTTING EDGE; CLONAL EXPANSION; IMMUNE-RESPONSE; STEADY-STATE; IFN-BETA; VACCINE; INDUCTION	Background: DC are activated by pathogen-associated molecular patterns (PAMPs), and this is pivotal for the induction of adaptive immune responses. Thereafter, the clearance of activated DC is crucial to prevent immune pathology. While PAMPs are of major interest for vaccine science due to their adjuvant potential, it is unclear whether and how PAMPs may affect DC viability. We aimed to elucidate the possible apoptotic mechanisms that control activated DC lifespan in response to PAMPs, particularly in vivo. Methodology/Principal Findings: We report that polyinosinic: polycytidylic acid (PolyIC, synthetic analogue of dsRNA) induces dramatic apoptosis of mouse splenic conventional DC (cDC) in vivo, predominantly affecting the CD8 alpha subset, as shown by flow cytometry-based analysis of splenic DC subsets. Importantly, while Bim deficiency conferred only minor protection, cDC depletion was prevented in mice lacking Bim plus one of three other BH3-only proteins, either Puma, Noxa or Bid. Furthermore, we show that Type I Interferon (IFN) is necessary and sufficient for DC death both in vitro and in vivo, and that TLR3 and MAVS co-operate in IFN beta production in vivo to induce DC death in response to PolyIC. Conclusions/Significance: These results demonstrate for the first time in vivo that apoptosis restricts DC lifespan following activation by PolyIC, particularly affecting the CD8a cDC subset. Such DC apoptosis is mediated by the overlapping action of pro-apoptotic BH3-only proteins, including but not solely involving Bim, and is driven by Type I IFN. While Type I IFNs are important anti-viral factors, CD8 alpha cDC are major cross-presenting cells and critical inducers of CTL. We discuss such paradoxical finding on DC death with PolyIC/Type I IFN. These results could contribute to understand immunosuppression associated with chronic infection, and to the optimization of DC-based therapies and the clinical use of PAMPs and Type I IFNs.	[Marraco, Silvia A. Fuertes; Ives, Annette; Masina, Slavica; Schneider, Pascal; Fasel, Nicolas; Acha-Orbea, Hans] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Scott, Clare L.; Bouillet, Philippe; Vremec, David; Jansen, Elisa S.; O'Reilly, Lorraine A.; Shortman, Ken; Strasser, Andreas] Walter & Eliza Hall Inst Med Res WEHI, Melbourne, Vic, Australia; [Scott, Clare L.; Bouillet, Philippe; O'Reilly, Lorraine A.; Shortman, Ken; Strasser, Andreas] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	University of Lausanne; Walter & Eliza Hall Institute; University of Melbourne	Marraco, SAF (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	hans.acha-orbea@unil.ch	Bouillet, Philippe/E-1241-2013; Fasel, Nicolas/O-4253-2016; Marraco, Silvia A Fuertes/I-2481-2014; Strasser, Andreas/C-7581-2013	Bouillet, Philippe/0000-0002-9012-6058; Fasel, Nicolas/0000-0003-0136-7245; Strasser, Andreas/0000-0002-5020-4891; Ives, Annette/0000-0002-7407-960X; Fuertes Marraco, Silvia A/0000-0002-3456-3317; Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; Histiocytosis Research Trust; National Health and Medical Research Council Australia; Leukemia and Lymphoma Society; NCI/National Institutes of Health	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Histiocytosis Research Trust; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants and fellowships from the Swiss National Science Foundation (to HA-O) and an award from the Histiocytosis Research Trust (to HA-O and PS), the National Health and Medical Research Council Australia (to KS, CLS, PB and AS), the Leukemia and Lymphoma Society (to PB and AS) and the NCI/National Institutes of Health (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; ALTHAGE A, 1992, EUR J IMMUNOL, V22, P1803, DOI 10.1002/eji.1830220720; Andina N, 2009, CELL DEATH DIFFER, V16, P1248, DOI 10.1038/cdd.2009.50; Belz GT, 2005, J IMMUNOL, V175, P196, DOI 10.4049/jimmunol.175.1.196; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Caminschi I, 2008, BLOOD, V112, P3264, DOI 10.1182/blood-2008-05-155176; Caminschi I, 2007, J EXP MED, V204, P2579, DOI 10.1084/jem.20071351; Chawla-Sarkar M, 2002, J IMMUNOL, V169, P847, DOI 10.4049/jimmunol.169.2.847; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Chen Q, 2001, BLOOD, V98, P2183, DOI 10.1182/blood.V98.7.2183; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; De Trez C, 2005, J IMMUNOL, V175, P839, DOI 10.4049/jimmunol.175.2.839; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Ferrantini M, 2007, BIOCHIMIE, V89, P884, DOI 10.1016/j.biochi.2007.04.006; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Hasan UA, 2007, P NATL ACAD SCI USA, V104, P8047, DOI 10.1073/pnas.0700664104; Hauschild A, 2009, CURR ONCOL, V16, P144; Hotchkiss RS, 2002, J IMMUNOL, V168, P2493, DOI 10.4049/jimmunol.168.5.2493; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; JAKOBSON AM, 1987, LANCET, V2, P1520; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim TW, 2005, CANCER RES, V65, P309; Kumar H, 2008, J IMMUNOL, V180, P683, DOI 10.4049/jimmunol.180.2.683; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Lee LN, 2009, J IMMUNOL, V182, P7178, DOI 10.4049/jimmunol.0802526; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Lublin F, 2005, J NEUROL, V252, P3, DOI 10.1007/s00415-005-2010-6; Makkouk A, 2009, IMMUNOPHARM IMMUNOT, V31, P331, DOI 10.1080/08923970902802926; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Matsue H, 1999, J IMMUNOL, V162, P5287; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; McBride S, 2006, J IMMUNOL, V177, P6122, DOI 10.4049/jimmunol.177.9.6122; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Montoya M, 2005, J IMMUNOL, V174, P1851, DOI 10.4049/jimmunol.174.4.1851; Moser M, 2004, NAT IMMUNOL, V5, P559, DOI 10.1038/ni0604-559; Muraille E, 1997, J IMMUNOL, V158, P2638; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; Neuenhahn M, 2007, IMMUNOL LETT, V114, P66, DOI 10.1016/j.imlet.2007.09.007; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Salaun B, 2009, VACCINE, V27, P1841, DOI 10.1016/j.vaccine.2009.01.044; Scatizzi JC, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2204; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Scumpia PO, 2005, J IMMUNOL, V175, P3282, DOI 10.4049/jimmunol.175.5.3282; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Steiner OG, 2008, BLOOD, V111, P2073, DOI 10.1182/blood-2007-06-097576; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Trevejo JM, 2001, P NATL ACAD SCI USA, V98, P12162, DOI 10.1073/pnas.211423598; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Wang TH, 2009, BLOOD, V113, P2906, DOI 10.1182/blood-2008-08-176354; WILLIAMSON WA, 1978, LANCET, V1, P1328; Wilson NS, 2006, NAT IMMUNOL, V7, P165, DOI 10.1038/ni1300; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103; Yen JH, 2009, BLOOD, V114, P1344, DOI 10.1182/blood-2008-12-196592; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	65	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20189	10.1371/journal.pone.0020189	http://dx.doi.org/10.1371/journal.pone.0020189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674051	Green Published, gold			2022-12-25	WOS:000291310600005
J	Dai, M; Shi, XR				Dai, Min; Shi, Xiaorui			Fibro-Vascular Coupling in the Control of Cochlear Blood Flow	PLOS ONE			English	Article							SPIRAL-LIGAMENT FIBROCYTES; GUINEA-PIG COCHLEA; INNER-EAR; STRIA VASCULARIS; NITRIC-OXIDE; ACOUSTIC EXPOSURE; ARACHIDONIC-ACID; MICE LACKING; ATP RELEASE; IN-VITRO	Background: Transduction of sound in the cochlea is metabolically demanding. The lateral wall and hair cells are critically vulnerable to hypoxia, especially at high sound levels, and tight control over cochlear blood flow (CBF) is a physiological necessity. Yet despite the importance of CBF for hearing, consensus on what mechanisms are involved has not been obtained. Methodology/Principal Findings: We report on a local control mechanism for regulating inner ear blood flow involving fibrocyte signaling. Fibrocytes in the super-strial region are spatially distributed near pre-capillaries of the spiral ligament of the albino guinea pig cochlear lateral wall, as demonstrably shown in transmission electron microscope and confocal images. Immunohistochemical techniques reveal the inter-connected fibrocytes to be positive for Na+/K+ ATPase beta 1 and S100. The connected fibrocytes display more Ca(2+) signaling than other cells in the cochlear lateral wall as indicated by fluorescence of a Ca(2+) sensor, fluo-4. Elevation of Ca(2+) in fibrocytes, induced by photolytic uncaging of the divalent ion chelator o-nitrophenyl EGTA, results in propagation of a Ca(2+) signal to neighboring vascular cells and vasodilation in capillaries. Of more physiological significance, fibrocyte to vascular cell coupled signaling was found to mediate the sound stimulated increase in cochlear blood flow (CBF). Cyclooxygenase-1 (COX-1) was required for capillary dilation. Conclusions/Significance: The findings provide the first evidence that signaling between fibrocytes and vascular cells modulates CBF and is a key mechanism for meeting the cellular metabolic demand of increased sound activity.	[Dai, Min; Shi, Xiaorui] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Shi, Xiaorui] Chinese Acad Med Sci, Inst Microcirculat, Beijing 100730, Peoples R China; [Shi, Xiaorui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Xiaorui] Shanghai Jiao Tong Univ, Renji Hosp, Dept Otolaryngol, Shanghai 200030, Peoples R China	Oregon Health & Science University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University	Dai, M (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA.	shix@ohsu.edu	Dai, Min/B-9908-2012		National Institutes of Health [NIH NIDCD R03-DC008888, NIH NIDCD DC008888S1, NIH NIDCD R01-DC010844, NIHP30-DC005983, NIDCD R01 DC00105]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010844, R03DC008888, P30DC005983, R01DC000105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants NIH NIDCD R03-DC008888 (XS), NIH NIDCD DC008888S1 (XS), NIH NIDCD R01-DC010844 (XS), NIHP30-DC005983, NIDCD R01 DC00105. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 2009, J ASS RES OTOLARYNG; Alkayed NJ, 1996, AM J PHYSIOL-HEART C, V271, pH1541, DOI 10.1152/ajpheart.1996.271.4.H1541; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; AXELSSON A, 1968, ACTA OTO-LARYNGOL, P243; Boettger T, 2002, NATURE, V416, P874, DOI 10.1038/416874a; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Dai M, 2009, HEARING RES, V254, P100, DOI 10.1016/j.heares.2009.04.018; Doherty JK, 2004, OTOL NEUROTOL, V25, P457, DOI 10.1097/00129492-200407000-00010; FISCHER MJ, 2010, MICROVASC RES; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; HAMA K, 1977, J NEUROCYTOL, V6, P1, DOI 10.1007/BF01175410; Hirose K, 2003, JARO, V4, P339, DOI 10.1007/s10162-002-3036-4; Jakovcevic D, 2007, CURR TOP DEV BIOL, V79, P75, DOI 10.1016/S0070-2153(06)79004-4; Jiang ZG, 2007, J PHARMACOL EXP THER, V320, P544, DOI 10.1124/jpet.106.115212; Juhn S K, 2001, Int Tinnitus J, V7, P72; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; MILLER JM, 1988, AM J OTOLARYNG, V9, P302, DOI 10.1016/S0196-0709(88)80038-3; Moon SK, 2006, ACTA OTO-LARYNGOL, V126, P564, DOI 10.1080/00016480500452525; Nakashima T, 2003, BRAIN RES REV, V43, P17, DOI 10.1016/S0165-0173(03)00189-9; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; NUTTALL AL, 1987, HEARING RES, V27, P121, DOI 10.1016/0378-5955(87)90013-X; Ostrom RS, 2001, AM J PHYSIOL-CELL PH, V281, pC524, DOI 10.1152/ajpcell.2001.281.2.C524; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Qu CY, 2007, JARO-J ASSOC RES OTO, V8, P205, DOI 10.1007/s10162-007-0072-0; QUIRK WS, 1991, HEARING RES, V52, P217, DOI 10.1016/0378-5955(91)90201-J; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Ravnic DJ, 2005, MICROVASC RES, V70, P90, DOI 10.1016/j.mvr.2005.06.002; RYAN AF, 1988, ACTA OTO-LARYNGOL, V105, P232, DOI 10.3109/00016488809097003; SALT AN, 1987, LARYNGOSCOPE, V97, P984; SCHEIBE F, 1993, EUR ARCH OTO-RHINO-L, V250, P281; SCHEIBE F, 1992, HEARING RES, V63, P19, DOI 10.1016/0378-5955(92)90069-Y; SCHUBERT R, ISOLATED VESSELS, P198; Shi XR, 2008, MICROCIRCULATION, V15, P515, DOI 10.1080/10739680802047445; Shi XR, 2003, HEARING RES, V177, P43, DOI 10.1016/S0378-5955(02)00796-7; Shi XR, 2002, HEARING RES, V172, P73, DOI 10.1016/S0378-5955(02)00513-0; Shi XR, 2001, HEARING RES, V153, P23, DOI 10.1016/S0378-5955(00)00254-9; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Spicer SS, 2002, HEARING RES, V172, P172, DOI 10.1016/S0378-5955(02)00581-6; SPICER SS, 1991, HEARING RES, V56, P53, DOI 10.1016/0378-5955(91)90153-Z; Suko T, 2000, HEARING RES, V140, P137, DOI 10.1016/S0378-5955(99)00191-4; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Trowe MO, 2008, DEVELOPMENT, V135, P1725, DOI 10.1242/dev.014043; Wangemann P, 2002, ADV OTO-RHINO-LARYNG, V59, P51; Wangemann P, 1996, HEARING RES, V95, P49, DOI 10.1016/0378-5955(96)00007-X; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wu T, 2003, JARO-J ASSOC RES OTO, V4, P353, DOI 10.1007/s10162-002-3026-6; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	52	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20652	10.1371/journal.pone.0020652	http://dx.doi.org/10.1371/journal.pone.0020652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673815	Green Published, gold, Green Submitted			2022-12-25	WOS:000291309900026
J	Boinas, FS; Wilson, AJ; Hutchings, GH; Martins, C; Dixon, LJ				Boinas, Fernando S.; Wilson, Anthony J.; Hutchings, Geoff H.; Martins, Carlos; Dixon, Linda J.			The Persistence of African Swine Fever Virus in Field-Infected Ornithodoros erraticus during the ASF Endemic Period in Portugal	PLOS ONE			English	Article								African swine fever (ASF) is an important disease of pigs and outbreaks of ASF have occurred in Europe on multiple occasions. To explore the period for which the European soft tick species Ornithodoros erraticus (Acari: Argasidae) is able to act as a reservoir of African swine fever virus (ASFV) after infected hosts are removed, we collected specimens from farms in the provinces of Alentejo and Algarve in Portugal during the endemic period and tested them subsequently using cell culture and experimental infection. We show that ticks from previously infected farms may contain infectious virus for at least five years and three months after the removal of infectious hosts. Furthermore, in two cases infectious virus was successfully isolated from ticks on restocked farms that had not yet suffered a re-emergence of disease. Experimental transmission to pigs was demonstrated in batches tested up to 380 days after an outbreak. These results clarify the epidemiological role of O. erraticus ticks in the persistence of ASFV in the field, provide additional evidence to support its role in the re-emergence of a sporadic outbreak of ASF in Portugal in 1999 and suggest that the current quarantine legislation and restocking advice when these ticks are present on the pig farm premises is appropriate.	[Boinas, Fernando S.; Martins, Carlos] Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Med Vet, P-1100 Lisbon, Portugal; [Wilson, Anthony J.; Hutchings, Geoff H.; Dixon, Linda J.] Inst Anim Hlth, Vector Borne Dis Programme, Surrey, England	Universidade de Lisboa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Boinas, FS (corresponding author), Univ Tecn Lisboa, Fac Med Vet, Ctr Invest Interdisciplinar Med Vet, P-1100 Lisbon, Portugal.	fboinas@fmv.utl.pt	Boinas, Fernando/AAD-9779-2022; Dixon, Linda K/B-9063-2019	Boinas, Fernando/0000-0001-6259-4404; Dixon, Linda/0000-0003-3845-3016; Martins, Carlos/0000-0001-6600-6163; Wilson, Anthony/0000-0002-2000-2914	Commission of the Economic Communities - Directorate General [ATS/4]; Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN [PO/86/00]; Biotechnology and Biological Sciences Research Council [BBS/B/00603]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001040, BBS/E/I/00001003, BBS/E/I/00001409] Funding Source: researchfish; BBSRC [BBS/E/I/00001409] Funding Source: UKRI	Commission of the Economic Communities - Directorate General; Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Fernando Boinas was funded by Commission of the Economic Communities - Directorate General VI project ATS/4 and by a Junta Nacional de Investigacao Cientifica e Tecnologica, INVOTAN Permanent Commission scholarship (ref PO/86/00). Anthony Wilson is funded by the Biotechnology and Biological Sciences Research Council (grant number BBS/B/00603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOINAS F, 1995, THESIS U READING REA, P240; BOINAS F, 2001, EVALUATION ROLE ORNI, P97; Boinas F. S., 1995, Veterinaria Tecnica, V5, P30; BOOL PH, 1969, B OFF INT EPIZOOT, P819; BOTIJA CS, 1963, B OFF INT EPIZOOT, P895; CAIADO JM, 1988, ACTA VET SCAND, P136; *CEC, 1999, OFFICIAL J EUROPEAN, V310, P71; CEC, 1993, OFFICIAL J EUROPEA L, VL285, P38; *EFSA, 2010, SCI OP AFR SWIN FEV; Encinas-Grandes A, 1993, ANAPORC, V121, P38; ENDRIS RG, 1992, J MED ENTOMOL, V29, P652, DOI 10.1093/jmedent/29.4.652; *EUR COMM, 2002, COUNC DIR 2002 60 EC; *FAO, 2009, FAO AN PROD HLTH MAN; Fernandez Garcia J. M., 1970, AN FAC VET LEON, V16, P195; FERREIRA Tiago Miguel de Lima, 2008, THESIS U TECNICA LIS; MALMQUIST WA, 1960, AM J VET RES, V21, P104; *OFF INT EP, 2009, MAN DIAGN TESTS VACC, P1069; OIE, 2008, MAN DIAGN TESTS VACC; OLEAGAPEREZ A, 1990, VET REC, V126, P32; ORDAS A, 1983, EUR 8466 EN LUXEMBOU, P7; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sanchez Botija C., 1982, REV SCI TECH, V1, P1065, DOI [10.20506/rst.1.4.91, DOI 10.20506/RST.1.4.91]; SANCHEZVIZCAINO JM, 1983, CEC PUBLICATION, P297; Tendeiro J., 1962, Bol Pecuario Lisboa, V30, P1; *WORLD ORG AN HLTH, 2007, WEEKLY DIS INFORM, V20; Zimmerman J., 2002, TRENDS EMERGING VIRA	26	80	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20383	10.1371/journal.pone.0020383	http://dx.doi.org/10.1371/journal.pone.0020383			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655242	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600061
J	Hogsberg, T; Bjarnsholt, T; Thomsen, JS; Kirketerp-Moller, K				Hogsberg, Trine; Bjarnsholt, Thomas; Thomsen, Jens Schiersing; Kirketerp-Moller, Klaus			Success Rate of Split-Thickness Skin Grafting of Chronic Venous Leg Ulcers Depends on the Presence of Pseudomonas aeruginosa: A Retrospective Study	PLOS ONE			English	Article							CHRONIC WOUNDS; BACTERIAL-COLONIZATION; SURGICAL-TREATMENT; BIOFILMS; MULTIDISCIPLINARY; RESISTANCE; INFECTION; REMOVAL	The last years of research have proposed that bacteria might be involved in and contribute to the lack of healing of chronic wounds. Especially it seems that Pseudomonas aeruginosa play a crucial role in the healing. At Copenhagen Wound Healing Centre it was for many years clinical suspected that once chronic venous leg ulcers were colonized (weeks or months preoperatively) by P. aeruginosa, the success rate of skin grafting deteriorated despite aggressive treatment. To investigate this, a retrospective study was performed on the clinical outcome of 82 consecutive patients with chronic venous leg ulcers on 91 extremities, from the 1(st) of March 2005 until the 31(st) of August 2006. This was achieved by analysing the microbiology, demographic data, smoking and drinking habits, diabetes, renal impairment, co-morbidities, approximated size and age of the wounds, immunosuppressive treatment and complicating factors on the clinical outcome of each patient. The results were evaluated using a Student T-test for continuous parameters, chi-square test for categorical parameters and a logistic regression analysis to predict healing after 12 weeks. The analysis revealed that only 33,3% of ulcers with P. aeruginosa, isolated at least once from 12 weeks prior, to or during surgery, were healed (98% or more) by week 12 follow-up, while 73,1% of ulcers without P. aeruginosa were so by the same time (p = 0,001). Smoking also significantly suppressed the outcome at the 12-week follow-up. Subsequently, a logistic regression analysis was carried out leaving P. aeruginosa as the only predictor left in the model (p = 0,001). This study supports our hypothesis that P. aeruginosa in chronic venous leg ulcers, despite treatment, has considerable impact on partial take or rejection of split-thickness skin grafts.	[Hogsberg, Trine; Thomsen, Jens Schiersing; Kirketerp-Moller, Klaus] Bispebjerg Hosp, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen, Denmark; [Bjarnsholt, Thomas] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Bjarnsholt, Thomas] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark; [Kirketerp-Moller, Klaus] Hvidovre Univ Hosp, Dept Orthoped, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Hogsberg, T (corresponding author), Bispebjerg Hosp, Copenhagen Wound Healing Ctr, DK-2400 Copenhagen, Denmark.	kkm@dadlnet.dk	Kirketerp-Møller, Klaus/AAW-4256-2020; Bjarnsholt, Thomas/ABD-6178-2021	Kirketerp-Møller, Klaus/0000-0002-3248-8448; Bjarnsholt, Thomas/0000-0002-8003-7414				Bang RL, 1999, BURNS, V25, P242, DOI 10.1016/S0305-4179(98)00167-3; Barret JP, 2003, PLAST RECONSTR SURG, V111, P744, DOI 10.1097/01.PRS.0000041445.76730.23; Bitsch M, 2005, SCAND J PLAST RECONS, V39, P162, DOI 10.1080/02844310510006196; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Boutli-Kasapidou F, 2006, J EUR ACAD DERMATOL, V20, P743, DOI 10.1111/j.1468-3083.2006.01478.x; Bowler PG, 1999, INT J DERMATOL, V38, P573, DOI 10.1046/j.1365-4362.1999.00738.x; BROWSE NL, 1977, BRIT MED J, V1, P478, DOI 10.1136/bmj.1.6059.478; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Burns JL, 2003, CLIN PLAST SURG, V30, P47, DOI 10.1016/S0094-1298(02)00074-3; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dhar S, 2007, BURNS, V33, P872, DOI 10.1016/j.burns.2006.11.012; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; GILLILAND EL, 1988, ANN ROY COLL SURG, V70, P105; Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x; Gottrup F, 2004, AM J SURG, V187, p38S, DOI 10.1016/S0002-9610(03)00303-9; Gottrup F, 2001, ARCH SURG-CHICAGO, V136, P765, DOI 10.1001/archsurg.136.7.765; JACKSON DM, 1951, LANCET, V261, P137; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; KIRSNER RS, 1995, DERMATOL SURG, V21, P701, DOI 10.1111/j.1524-4725.1995.tb00273.x; KRIZEK T, 1967, SURG FORUM, P518; LIEDBERG NCF, 1954, SURG GYNECOL OBSTET, V98, P693; Lunt M J, 1999, J Tissue Viability, V9, P45; McGregor A., 2000, FUNDAMENTAL TECHNIQU, P35; Schmeller W, 2000, ACTA DERM-VENEREOL, V80, P267; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; TANNER J C Jr, 1964, Plast Reconstr Surg, V34, P287; TEH BT, 1979, PLAST RECONSTR SURG, V63, P323, DOI 10.1097/00006534-197903000-00005; Thomsen TR, 2010, WOUND REPAIR REGEN, V18, P38, DOI 10.1111/j.1524-475X.2009.00561.x; Unal S, 2005, ANN PLAS SURG, V55, P102, DOI 10.1097/01.sap.0000164531.23770.60; Valerie EJ, 2003, BURNS, V29, P15, DOI 10.1016/S0305-4179(02)00203-6; WILSON GR, 1988, ANN ROY COLL SURG, V70, P217	31	64	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20492	10.1371/journal.pone.0020492	http://dx.doi.org/10.1371/journal.pone.0020492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655269	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600078
J	Nakamura, Y; Hinoi, E; Takarada, T; Takahata, Y; Yamamoto, T; Fujita, H; Takada, S; Hashizume, S; Yoneda, Y				Nakamura, Yukari; Hinoi, Eiichi; Takarada, Takeshi; Takahata, Yoshifumi; Yamamoto, Tomomi; Fujita, Hiroyuki; Takada, Saya; Hashizume, Syota; Yoneda, Yukio			Positive Regulation by GABA(B)R1 Subunit of Leptin Expression through Gene Transactivation in Adipocytes	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; METABOTROPIC GLUTAMATE RECEPTORS; CULTURED CALVARIAL OSTEOBLASTS; PANCREATIC BETA-CELLS; MITOCHONDRIAL BIOGENESIS; 3T3-L1 ADIPOCYTES; COACTIVATOR PGC-1; PROGENITOR CELLS; PROTEIN; GABA	Background: The view that gamma-aminobutyric acid (GABA) plays a functional role in non-neuronal tissues, in addition to an inhibitory neurotransmitter role in the mammalian central nervous system, is prevailing, while little attention has been paid to GABAergic signaling machineries expressed by adipocytes to date. In this study, we attempted to demonstrate the possible functional expression of GABAergic signaling machineries by adipocytes. Methodology/Principal Findings: GABA(B) receptor 1 (GABA(B)R1) subunit was constitutively expressed by mouse embryonic fibroblasts differentiated into adipocytes and adipocytic 3T3-L1 cells in culture, as well as mouse white adipose tissue, with no responsiveness to GABA(B)R ligands. However, no prominent expression was seen with mRNA for GABA(B)R2 subunit required for heteromeric orchestration of the functional GABA(B)R by any adipocytic cells and tissues. Leptin mRNA expression was significantly and selectively decreased in adipose tissue and embryonic fibroblasts, along with drastically reduced plasma leptin levels, in GABA(B)R1-null mice than in wild-type mice. Knockdown by siRNA of GABA(B)R1 subunit led to significant decreases in leptin promoter activity and leptin mRNA levels in 3T3-L1 cells. Conclusions/Significance: Our results indicate that GABA(B)R1 subunit is constitutively expressed by adipocytes to primarily regulate leptin expression at the transcriptional level through a mechanism not relevant to the function as a partner of heterodimeric assembly to the functional GABA(B)R.	[Nakamura, Yukari; Hinoi, Eiichi; Takarada, Takeshi; Takahata, Yoshifumi; Yamamoto, Tomomi; Fujita, Hiroyuki; Takada, Saya; Hashizume, Syota; Yoneda, Yukio] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Nakamura, Y (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa 9201192, Japan.	yyoneda@p.kanazawa-u.ac.jp	Takahata, Yoshifumi/AAZ-6869-2021; Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X; Takarada, Takeshi/0000-0002-2363-7704	Ministry of Education, Culture, Sports, Science and Technology, Japan [22659065, 22500330]; ONO Medical Research Foundation, Japan; Grants-in-Aid for Scientific Research [09J03309] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ONO Medical Research Foundation, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aids for Scientific Research to E.H. (No. 22659065) and T.T. (No. 22500330) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and in part by a Research Grant to E. H. from the ONO Medical Research Foundation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Billinton A, 2001, TRENDS NEUROSCI, V24, P277, DOI 10.1016/S0166-2236(00)01815-4; Bjorbaek C, 2004, RECENT PROG HORM RES, V59, P305, DOI 10.1210/rp.59.1.305; Braun M, 2004, J PHYSIOL-LONDON, V559, P397, DOI 10.1113/jphysiol.2004.066563; Castelli MP, 1999, LIFE SCI, V64, P1321, DOI 10.1016/S0024-3205(99)00067-3; Friedman JM, 2010, NAT MED, V16, P1100, DOI 10.1038/nm1010-1100; Fujimori S, 2002, BIOCHEM BIOPH RES CO, V293, P1445, DOI 10.1016/S0006-291X(02)00405-9; Fuke T, 2010, INT J OBESITY, V34, P670, DOI 10.1038/ijo.2009.295; Fukui M, 2008, J CELL PHYSIOL, V216, P507, DOI 10.1002/jcp.21422; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Harris RBS, 2000, ANNU REV NUTR, V20, P45, DOI 10.1146/annurev.nutr.20.1.45; Hinoi E, 2001, BIOCHEM BIOPH RES CO, V281, P341, DOI 10.1006/bbrc.2001.4355; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kallen CB, 1996, P NATL ACAD SCI USA, V93, P5793, DOI 10.1073/pnas.93.12.5793; KANNER BI, 1994, J EXP BIOL, V196, P237; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Nakamichi N, 2008, J NEUROCHEM, V105, P1996, DOI 10.1111/j.1471-4159.2008.05289.x; Nakamura Y, 2009, J PHARMACOL SCI, V109, P413, DOI 10.1254/jphs.08315FP; Nehring RB, 2000, J BIOL CHEM, V275, P35185, DOI 10.1074/jbc.M002727200; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Sullivan R, 2000, J PHARMACOL EXP THER, V293, P460; Sze P Y, 1979, Adv Exp Med Biol, V123, P59; Takarada-Iemata M, 2011, J CELL PHYSIOL, V226, P652, DOI 10.1002/jcp.22390; TANIGUCHI H, 1979, DIABETES, V28, P629, DOI 10.2337/diabetes.28.7.629; VINCENT SR, 1983, NEUROENDOCRINOLOGY, V36, P197, DOI 10.1159/000123456; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; White JH, 2000, P NATL ACAD SCI USA, V97, P13967, DOI 10.1073/pnas.240452197; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	47	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20167	10.1371/journal.pone.0020167	http://dx.doi.org/10.1371/journal.pone.0020167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655283	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600026
J	Riihimaki, TA; Kukkurainen, S; Varjonen, S; Horha, J; Nyholm, TKM; Kulomaa, MS; Hytonen, VP				Riihimaki, Tiina A.; Kukkurainen, Sampo; Varjonen, Suvi; Horha, Jarno; Nyholm, Thomas K. M.; Kulomaa, Markku S.; Hytonen, Vesa P.			Construction of Chimeric Dual-Chain Avidin by Tandem Fusion of the Related Avidins	PLOS ONE			English	Article							CIRCULARLY PERMUTED AVIDINS; CHICKEN AVIDIN; BIOTIN-BINDING; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; HIGH-AFFINITY; STREPTAVIDIN; PROTEIN; THERMOSTABILITY; STABILITY	Background: Avidin is a chicken egg-white protein with high affinity to vitamin H, also known as D-biotin. Many applications in life science research are based on this strong interaction. Avidin is a homotetrameric protein, which promotes its modification to symmetrical entities. Dual-chain avidin, a genetically engineered avidin form, has two circularly permuted chicken avidin monomers that are tandem-fused into one polypeptide chain. This form of avidin enables independent modification of the two domains, including the two biotin-binding pockets; however, decreased yields in protein production, compared to wt avidin, and complicated genetic manipulation of two highly similar DNA sequences in the tandem gene have limited the use of dual-chain avidin in biotechnological applications. Principal Findings: To overcome challenges associated with the original dual-chain avidin, we developed chimeric dual-chain avidin, which is a tandem fusion of avidin and avidin-related protein 4 (AVR4), another member of the chicken avidin gene family. We observed an increase in protein production and better thermal stability, compared with the original dual-chain avidin. Additionally, PCR amplification of the hybrid gene was more efficient, thus enabling more convenient and straightforward modification of the dual-chain avidin. When studied closer, the generated chimeric dual-chain avidin showed biphasic biotin dissociation. Significance: The improved dual-chain avidin introduced here increases its potential for future applications. This molecule offers a valuable base for developing bi-functional avidin tools for bioseparation, carrier proteins, and nanoscale adapters. Additionally, this strategy could be helpful when generating hetero-oligomers from other oligomeric proteins with high structural similarity.	[Riihimaki, Tiina A.; Kukkurainen, Sampo; Varjonen, Suvi; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Riihimaki, Tiina A.; Kukkurainen, Sampo; Varjonen, Suvi; Kulomaa, Markku S.; Hytonen, Vesa P.] Tampere Univ Hosp, Tampere, Finland; [Horha, Jarno; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Nyholm, Thomas K. M.] Abo Akad Univ, Dept Biochem & Pharm, SF-20500 Turku, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Jyvaskyla; Abo Akademi University	Riihimaki, TA (corresponding author), Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland.	vesa.hytonen@uta.fi	Hytonen, Vesa P./E-8855-2013; Kulomaa, Markku S/C-9063-2014; Arola, Suvi A/K-8695-2015	Hytonen, Vesa P./0000-0002-9357-1480; Arola, Suvi A/0000-0003-4087-3837; Kukkurainen, Sampo/0000-0002-0635-784X	Academy of Finland [115976, 121236]; National Doctoral Programme in Informational and Structural Biology (ISB); Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB)	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology (ISB); Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB)	Funding by the Academy of Finland (http://www.aka.fi/en-GB/A/; project numbers 115976 and 121236), National Doctoral Programme in Informational and Structural Biology (ISB, http://web.abo.fi/isb/) and Tampere Graduate Program in Biomedicine and Biotechnology (TGPBB, http://www.uta.fi/tutkijakoulut/tgsbb/) is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlroth MK, 2000, ANIM GENET, V31, P367, DOI 10.1046/j.1365-2052.2000.00681.x; Airenne KJ, 1997, PROTEIN EXPRES PURIF, V9, P100, DOI 10.1006/prep.1996.0660; Aslan FM, 2005, P NATL ACAD SCI USA, V102, P8507, DOI 10.1073/pnas.0503112102; BARBARAKIS MS, 1993, ANAL CHEM, V65, P457, DOI 10.1021/ac00052a024; Bayer EA, 1996, ELECTROPHORESIS, V17, P1319, DOI 10.1002/elps.1150170808; BAYER EA, 1990, METHOD ENZYMOL, V184, P415; DeChancie J, 2007, J AM CHEM SOC, V129, P5419, DOI 10.1021/ja066950n; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gonzalez M, 1997, J BIOL CHEM, V272, P11288; GREEN N. M., 1970, Methods in Enzymology, V18A, P418, DOI 10.1016/0076-6879(71)18342-5; GREEN NM, 1972, BIOCHEM J, V130, P707, DOI 10.1042/bj1300707; GROMAN EV, 1990, METHOD ENZYMOL, V184, P208; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyre DE, 2006, PROTEIN SCI, V15, P459, DOI 10.1110/ps.051970306; Hytonen VP, 2006, J MOL BIOL, V359, P1352, DOI 10.1016/j.jmb.2006.04.044; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, PROTEINS, V61, P597, DOI 10.1002/prot.20604; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VP, 2003, BIOCHEM J, V372, P219, DOI 10.1042/BJ20021531; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; JONES ML, 1995, BIOCHEMISTRY-US, V34, P11750, DOI 10.1021/bi00037a012; KEINANEN RA, 1994, EUR J BIOCHEM, V220, P615, DOI 10.1111/j.1432-1033.1994.tb18663.x; Laitinen OH, 2002, BIOCHEM J, V363, P609, DOI 10.1042/0264-6021:3630609; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leppiniemi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016576; Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749; Lin H J, 1979, Methods Enzymol, V62, P287, DOI 10.1016/0076-6879(79)62231-0; MOCK DM, 1990, METHOD ENZYMOL, V184, P234; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SANO T, 1990, J BIOL CHEM, V265, P3369; WEBER PC, 1987, J BIOL CHEM, V262, P12728; Zacco E, 2006, BIOSENS BIOELECTRON, V21, P1291, DOI 10.1016/j.bios.2005.05.016	35	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20535	10.1371/journal.pone.0020535	http://dx.doi.org/10.1371/journal.pone.0020535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655240	Green Submitted, gold, Green Published			2022-12-25	WOS:000291097600090
J	Klumpp, S				Klumpp, Stefan			Growth-Rate Dependence Reveals Design Principles of Plasmid Copy Number Control	PLOS ONE			English	Article							ESCHERICHIA-COLI; ROM PROTEIN; MATHEMATICAL-MODEL; GENE-EXPRESSION; RNA-I; REPLICATION; PBR322; PROMOTERS; KINETICS; BACTERIA	Genetic circuits in bacteria are intimately coupled to the cellular growth rate as many parameters of gene expression are growth-rate dependent. Growth-rate dependence can be particularly pronounced for genes on plasmids; therefore the native regulatory systems of a plasmid such as its replication control system are characterized by growth-rate dependent parameters and regulator concentrations. This natural growth-rate dependent variation of regulator concentrations can be used for a quantitative analysis of the design of such regulatory systems. Here we analyze the growth-rate dependence of parameters of the copy number control system of ColE1-type plasmids in E. coli. This analysis allows us to infer the form of the control function and suggests that the Rom protein increases the sensitivity of control.	[Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany; [Klumpp, Stefan] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	Max Planck Society; University of California System; University of California San Diego	Klumpp, S (corresponding author), Max Planck Inst Colloids & Interfaces, Potsdam, Germany.	klumpp@mpikg.mpg.de	Klumpp, Stefan/AAC-3936-2019; Klumpp, Stefan/C-2966-2008	Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146	Deutsche Forschungsgemeinschaft [KL818/1-1, 1-2]; National Science Foundation (NSF) through the Center for Theoretical Biological Physics [PHY-0822283]; National Institutes of Health (NIH) [R01GM77298]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077298] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation (NSF) through the Center for Theoretical Biological Physics(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The initial phase of this work was supported by Deutsche Forschungsgemeinschaft (fellowship KL818/1-1 and 1-2), by the National Science Foundation (NSF) through the Center for Theoretical Biological Physics (grant PHY-0822283) and by the National Institutes of Health (NIH) through grant R01GM77298 (to Terence Hwa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E., 2006, MOL SYST BIOL, V2, P0028; ATAAI MM, 1986, PLASMID, V16, P204, DOI 10.1016/0147-619X(86)90058-2; Atlung T, 1999, PLASMID, V41, P110, DOI 10.1006/plas.1998.1386; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bremer H, 1996, ESCHERICHIA COLI SAL; BRENDEL V, 1993, J MOL BIOL, V229, P860, DOI 10.1006/jmbi.1993.1092; BRENNER M, 1991, P NATL ACAD SCI USA, V88, P405, DOI 10.1073/pnas.88.2.405; CHURCHWARD G, 1981, J BACTERIOL, V145, P1232, DOI 10.1128/JB.145.3.1232-1238.1981; Ehrenberg M, 1996, BIOPHYS J, V70, P135, DOI 10.1016/S0006-3495(96)79555-3; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Helinski D.R., 1996, ESCHERICHIA COLI SAL, V2, P2295; Jasiecki J, 2003, EMBO REP, V4, P172, DOI 10.1038/sj.embor.embor733; KEASLING JD, 1989, J THEOR BIOL, V136, P487, DOI 10.1016/S0022-5193(89)80161-4; KIM BG, 1990, BIOTECHNOL BIOENG, V36, P233, DOI 10.1002/bit.260360304; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Liang ST, 1998, J BACTERIOL, V180, P6090; LINCHAO S, 1991, CELL, V65, P1233, DOI 10.1016/0092-8674(91)90018-T; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; LINCHAO S, 1987, J BACTERIOL, V169, P1217, DOI 10.1128/jb.169.3.1217-1222.1987; Marguet P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011909; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Paulsson J, 1998, PLASMID, V39, P215, DOI 10.1006/plas.1998.1338; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; SOM T, 1983, P NATL ACAD SCI-BIOL, V80, P3232, DOI 10.1073/pnas.80.11.3232; Summers D.K., 1996, BIOL PLASMIDS; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; TOMIZAWA J, 1990, J MOL BIOL, V212, P695, DOI 10.1016/0022-2836(90)90231-A; TOMIZAWA J, 1984, CELL, V38, P871, DOI 10.1016/0092-8674(84)90282-4; Wrobel B, 1998, PLASMID, V39, P48, DOI 10.1006/plas.1997.1319; Zhang XY, 1996, J MOL BIOL, V259, P27, DOI 10.1006/jmbi.1996.0299	34	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20403	10.1371/journal.pone.0020403	http://dx.doi.org/10.1371/journal.pone.0020403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647376	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500058
J	Szalkowski, AM; Anisimova, M				Szalkowski, Adam M.; Anisimova, Maria			Markov Models of Amino Acid Substitution to Study Proteins with Intrinsically Disordered Regions	PLOS ONE			English	Article							UNSTRUCTURED PROTEINS; MAXIMUM-LIKELIHOOD; TANDEM REPEATS; PREDICTION; EVOLUTION; TOOL; IDENTIFICATION; DATABASE; DOMAIN	Background: Intrinsically disordered proteins (IDPs) or proteins with disordered regions (IDRs) do not have a well-defined tertiary structure, but perform a multitude of functions, often relying on their native disorder to achieve the binding flexibility through changing to alternative conformations. Intrinsic disorder is frequently found in all three kingdoms of life, and may occur in short stretches or span whole proteins. To date most studies contrasting the differences between ordered and disordered proteins focused on simple summary statistics. Here, we propose an evolutionary approach to study IDPs, and contrast patterns specific to ordered protein regions and the corresponding IDRs. Results: Two empirical Markov models of amino acid substitutions were estimated, based on a large set of multiple sequence alignments with experimentally verified annotations of disordered regions from the DisProt database of IDPs. We applied new methods to detect differences in Markovian evolution and evolutionary rates between IDRs and the corresponding ordered protein regions. Further, we investigated the distribution of IDPs among functional categories, biochemical pathways and their preponderance to contain tandem repeats. Conclusions: We find significant differences in the evolution between ordered and disordered regions of proteins. Most importantly we find that disorder promoting amino acids are more conserved in IDRs, indicating that in some cases not only amino acid composition but the specific sequence is important for function. This conjecture is also reinforced by the observation that for 27% of our data set IDRs evolve more slowly than the ordered parts of the proteins, while we still support the common view that IDRs in general evolve more quickly. The improvement in model fit indicates a possible improvement for various types of analyses e. g. de novo disorder prediction using a phylogenetic Hidden Markov Model based on our matrices showed a performance similar to other disorder predictors.	[Szalkowski, Adam M.; Anisimova, Maria] Swiss Inst Bioinformat, Lausanne, Switzerland; [Szalkowski, Adam M.; Anisimova, Maria] ETH, Dept Comp Sci, Computat Biochem Res Grp, Zurich, Switzerland	Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; ETH Zurich	Szalkowski, AM (corresponding author), Swiss Inst Bioinformat, Lausanne, Switzerland.	adam.szalkowski@inf.ethz.ch		Anisimova, Maria/0000-0001-8145-7966	Swiss National Science Foundation [31003A/127325]; Eidgenossische Technische Hochschule (ETH) Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Eidgenossische Technische Hochschule (ETH) Zurich(ETH Zurich)	This work was partially supported by the Swiss National Science Foundation grant to M.A. (ref. 31003A/127325). A.S. and M.A. are also funded by the Eidgenossische Technische Hochschule (ETH) Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babon JJ, 2005, FEBS J, V272, P6120, DOI 10.1111/j.1742-4658.2005.05010.x; BAIROCH A, 1992, NUCLEIC ACIDS RES, V20, P2019, DOI 10.1093/nar/20.suppl.2019; Brown CJ, 2010, MOL BIOL EVOL, V27, P609, DOI 10.1093/molbev/msp277; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Dimitrieva S, 2010, TRENDS EVOL BIOL, V2, pe1; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Gonnet GH, 2000, BIOINFORMATICS, V16, P101, DOI 10.1093/bioinformatics/16.2.101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hecker J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S9; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huang Y, 2000, J MOL BIOL, V298, P149, DOI 10.1006/jmbi.2000.3637; Huang YQ, 2010, PROTEINS, V78, P3251, DOI 10.1002/prot.22820; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Klosterman PS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-428; Kovacs E, 2010, P NATL ACAD SCI USA, V107, P5429, DOI 10.1073/pnas.0907841107; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LE SQ, 2008, PHILOS T R SOC LON B; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Midic U., 2009, P KDD 09 WORKSH STAT, P27; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; ROMERO P, 2001, PROTEINS NEW YORK, V42, P3848; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Sandhu KS, 2009, J MOL RECOGNIT, V22, P1, DOI 10.1002/jmr.915; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Tompa P, 2003, BIOESSAYS, V25, P847, DOI 10.1002/bies.10324; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2010, J MOL BIOL, V403, P346, DOI 10.1016/j.jmb.2010.07.044; UVERSKY VN, 2010, CHEM SOC REV; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; WHELAN S, 2006, NUCLEIC ACIDS RES, V34; XIE H, 2007, J PROTEOME RES, V6; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	52	31	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20488	10.1371/journal.pone.0020488	http://dx.doi.org/10.1371/journal.pone.0020488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647374	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052500063
J	Zhang, Z; Norris, J; Schwartz, C; Alexov, E				Zhang, Zhe; Norris, Joy; Schwartz, Charles; Alexov, Emil			In Silico and In Vitro Investigations of the Mutability of Disease-Causing Missense Mutation Sites in Spermine Synthase	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; POLYAMINE BIOSYNTHETIC-ENZYMES; SNYDER-ROBINSON SYNDROME; NON-SYNONYMOUS SNPS; PROTEIN FUNCTION; GENE; DECARBOXYLASE; DEFICIENCY; PREDICTION; BINDING	Background: Spermine synthase (SMS) is a key enzyme controlling the concentration of spermidine and spermine in the cell. The importance of SMS is manifested by the fact that single missense mutations were found to cause Snyder-Robinson Syndrome (SRS). At the same time, currently there are no non-synonymous single nucleoside polymorphisms, nsSNPs (harmless mutations), found in SMS, which may imply that the SMS does not tolerate amino acid substitutions, i.e. is not mutable. Methodology/Principal Findings: To investigate the mutability of the SMS, we carried out in silico analysis and in vitro experiments of the effects of amino acid substitutions at the missense mutation sites (G56, V132 and I150) that have been shown to cause SRS. Our investigation showed that the mutation sites have different degree of mutability depending on their structural micro-environment and involvement in the function and structural integrity of the SMS. It was found that the I150 site does not tolerate any mutation, while V132, despite its key position at the interface of SMS dimer, is quite mutable. The G56 site is in the middle of the spectra, but still quite sensitive to charge residue replacement. Conclusions/Significance: The performed analysis showed that mutability depends on the detail of the structural and functional factors and cannot be predicted based on conservation of wild type properties alone. Also, harmless nsSNPs can be expected to occur even at sites at which missense mutations were found to cause diseases.	[Zhang, Zhe; Alexov, Emil] Clemson Univ, Dept Phys, Clemson, SC 29634 USA; [Norris, Joy; Schwartz, Charles] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Schwartz, Charles] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA	Clemson University; Greenwood Genetic Center; Clemson University	Zhang, Z (corresponding author), Clemson Univ, Dept Phys, Clemson, SC 29634 USA.	ealexov@clemson.edu	Zhang, Zhe/J-9434-2014	Zhang, Zhe/0000-0002-1952-5726; Zhang, Zhe/0000-0002-0744-1314	NLM/NIH [1R03LM009748, 1R03LM009748-S1]; Clemson University CCIT group, especially Corey Ferrier; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093937] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R03LM009748] Funding Source: NIH RePORTER	NLM/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Clemson University CCIT group, especially Corey Ferrier; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	NLM/NIH, grant numbers 1R03LM009748 and 1R03LM009748-S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of Clemson University CCIT group, especially Corey Ferrier, is greatly appreciated. We thank Shawn Witham for reading the manuscript prior to publication and useful suggestions. Dedicated to the memory of Ethan Francis Schwartz (1996-1998).	Alexov EG, 1999, BIOCHEMISTRY-US, V38, P8253, DOI 10.1021/bi982700a; Becerra-Solano LE, 2009, AM J MED GENET A, V149A, P328, DOI 10.1002/ajmg.a.32641; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Capriotti E, 2005, BIOINFORMATICS, V21, P54, DOI 10.1093/bioinformatics/bti1109; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; de Alencastro G, 2008, J MED GENET, V45, P539, DOI 10.1136/jmg.2007.056713; GEERTS D, INT J CANC, V126, P2012; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Heby O, 2007, AMINO ACIDS, V33, P359, DOI 10.1007/s00726-007-0537-9; Heby O, 2003, BIOCHEM SOC T, V31, P415, DOI 10.1042/BST0310415; Hunt DM, 2008, INFECT IMMUN, V76, P2227, DOI 10.1128/IAI.01410-07; Ikeguchi Y, 2006, J BIOCHEM, V139, P1, DOI 10.1093/jb/mvj019; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; Kesler SR, 2009, NEUROGENETICS, V10, P299, DOI 10.1007/s10048-009-0184-2; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Mackintosh CA, 2000, BIOCHEM J, V351, P439, DOI 10.1042/0264-6021:3510439; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Ofiteru A, 2007, FEBS J, V274, P3363, DOI 10.1111/j.1742-4658.2007.05870.x; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; PONDER JW, 1999, TINKER SOFTWARE TOOL; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Teng S, 2008, CURR PHARM BIOTECHNO, V9, P123, DOI 10.2174/138920108783955164; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Wang XJ, 2009, J BIOL CHEM, V284, P930, DOI 10.1074/jbc.M807758200; Wang Z, 2003, PROTEINS, V53, P748, DOI 10.1002/prot.10522; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wu H, 2008, J BIOL CHEM, V283, P16135, DOI 10.1074/jbc.M710323200; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Ye Yuzhen, 2006, Pac Symp Biocomput, P439, DOI 10.1142/9789812701626_0040; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhang Z, 2010, HUM MUTAT, V31, P1043, DOI 10.1002/humu.21310	39	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20373	10.1371/journal.pone.0020373	http://dx.doi.org/10.1371/journal.pone.0020373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647366	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500054
J	Wu, J; Liu, S; Liu, G; Dombkowski, A; Abrams, J; Martin-Trevino, R; Wicha, MS; Ethier, SP; Yang, ZQ				Wu, J.; Liu, S.; Liu, G.; Dombkowski, A.; Abrams, J.; Martin-Trevino, R.; Wicha, M. S.; Ethier, S. P.; Yang, Z-Q			Identification and functional analysis of 9p24 amplified genes in human breast cancer	ONCOGENE			English	Article						chromosome 9p24; GASC1; UHRF2; gene amplification	HISTONE LYSINE METHYLATION; TUMOR-SUPPRESSOR GENE; CELL-LINES; JMJD2 FAMILY; DNA METHYLATION; AMPLICON; PROTEIN; AMPLIFICATION; PTPRD; DEMETHYLATION	Previously, our group identified a novel amplicon at chromosome 9p24 in human esophageal and breast cancers, and cloned the novel gene, GASC1 (gene amplified in squamous cell carcinoma 1, also known as JMJD2C/KDM4C), from this amplicon. GASC1 is a histone demethylase involved in the deregulation of histone methylation in cancer cells. In the current study, we aimed to comprehensively characterize the genes in the 9p24 amplicon in human breast cancer. We performed extensive genomic analyses on a panel of cancer cell lines and narrowed the shortest region of overlap to approximately 2 Mb. Based on statistical analysis of copy number increase and overexpression, the 9p24 amplicon contains six candidate oncogenes. Among these, four genes (GASC1 UHRF2, KIAA1432 and C9orf123) are overexpressed only in the context of gene amplification while two genes (ERMP1 and IL33) are overexpressed independent of the copy number increase. We then focused our studies on the UHRF2 gene, which has a potential involvement in both DNA methylation and histone modification. Knocking down UHRF2 expression inhibited the growth of breast cancer cells specifically with 9p24 amplification. Conversely, ectopic overexpression of UHRF2 in non-tumorigenic MCF10A cells promoted cell proliferation. Furthermore, we demonstrated that UHRF2 has the ability to suppress the expression of key cell-cycle inhibitors, such as p16(INK4a), p21(Waf1/Cip1) and p27(Kip1). Taken together, our studies support the notion that the 9p24 amplicon contains multiple oncogenes that may integrate genetic and epigenetic codes and have important roles in human tumorigenesis. Oncogene (2012) 31, 333-341; doi:10.1038/onc.2011.227; published online 13 June 2011	[Wu, J.; Liu, G.; Ethier, S. P.; Yang, Z-Q] Wayne State Univ, Breast Canc Program, Detroit, MI 48201 USA; [Liu, S.; Martin-Trevino, R.; Wicha, M. S.] Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Dombkowski, A.] Wayne State Univ, Dept Pediat, Detroit, MI 48201 USA; [Abrams, J.; Yang, Z-Q] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48201 USA	Wayne State University; University of Michigan System; University of Michigan; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Yang, ZQ (corresponding author), Wayne State Univ, Karmanos Canc Inst, Dept Oncol, 4100 John R St,HWCRC 815, Detroit, MI 48201 USA.	yangz@karmanos.org	Liu, Sheng/K-2815-2013; LIU, GANG/AAR-4584-2021; Liu, Suling/N-2796-2013; Wicha, Max/AAE-7268-2019	LIU, GANG/0000-0001-6620-176X; Liu, Suling/0000-0002-0475-0242; Dombkowski, Alan/0000-0002-0312-8750	Department of Defense [BC086177, BC083945]; National Institutes of Health [RO1 CA100724, P30-CA022453-29]; Taubman Institute; NATIONAL CANCER INSTITUTE [P30CA022453, R01CA100724] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taubman Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants from the Department of Defense Breast Cancer Program (BC086177 and BC083945) to Zeng-Quan Yang, a grant from the National Institutes of Health grant RO1 CA100724 to Stephen P. Ethier, and the Taubman Scholar Award from Taubman Institute to Max S. Wicha. The Biostatistics Core of the Karmanos Cancer Institute is supported by the National Institutes of Health Grant P30-CA022453-29. We thank Michele L. Dziubinski for technical assistance on the cell culture. We thank Dr Steve Guest, Dr Aliccia Bollig-Fischer and Kimberly Lyons for discussions and careful reading of a draft manuscript.	Akiyama M, 2005, BIOCHEM BIOPH RES CO, V335, P1264, DOI 10.1016/j.bbrc.2005.08.019; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Chan DW, 2009, PROTEOMICS, V9, P2343, DOI 10.1002/pmic.200800600; Chan TA, 2008, PLOS MED, V5, P823, DOI 10.1371/journal.pmed.0050114; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; Garcia MJ, 2005, ONCOGENE, V24, P5235, DOI 10.1038/sj.onc.1208741; Garcia-Rudaz C, 2007, DEVELOPMENT, V134, P945, DOI 10.1242/dev.02795; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Giefing M, 2011, GENE CHROMOSOME CANC, V50, P154, DOI 10.1002/gcc.20840; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; He XY, 2009, FEBS LETT, V583, P3501, DOI 10.1016/j.febslet.2009.10.007; Hopfner R, 2000, CANCER RES, V60, P121; Ishimura A, 2009, BIOCHEM BIOPH RES CO, V389, P366, DOI 10.1016/j.bbrc.2009.08.155; Italiano A, 2006, CANCER GENET CYTOGEN, V167, P122, DOI 10.1016/j.cancergencyto.2006.01.004; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Katoh M, 2004, INT J ONCOL, V24, P1623; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Kurowska-Stolarska M, 2011, J INTERN MED, V269, P29, DOI 10.1111/j.1365-2796.2010.02316.x; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mori T, 2002, BIOCHEM BIOPH RES CO, V296, P530, DOI 10.1016/S0006-291X(02)00890-2; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pole JCM, 2006, ONCOGENE, V25, P5693, DOI 10.1038/sj.onc.1209570; Qian CM, 2008, J BIOL CHEM, V283, P34490, DOI 10.1074/jbc.C800169200; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang JL, 2010, BIOL REPROD, V82, P105, DOI 10.1095/biolreprod.109.078055; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2010, CANCER RES, V70, P8487, DOI 10.1158/0008-5472.CAN-10-1013; Yang ZQ, 2004, CANCER GENET CYTOGEN, V155, P57, DOI 10.1016/j.cancergencyto.2004.03.013; Yang ZQ, 2000, CANCER RES, V60, P4735	56	63	65	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	3					333	341		10.1038/onc.2011.227	http://dx.doi.org/10.1038/onc.2011.227			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21666724	Green Accepted			2022-12-25	WOS:000299542100006
J	Buhrmann, C; Mobasheri, A; Busch, F; Aldinger, C; Stahlmann, R; Montaseri, A; Shakibaei, M				Buhrmann, Constanze; Mobasheri, Ali; Busch, Franziska; Aldinger, Constance; Stahlmann, Ralf; Montaseri, Azadeh; Shakibaei, Mehdi			Curcumin Modulates Nuclear Factor kappa B (NF-kappa B)-mediated Inflammation in Human Tenocytes in Vitro ROLE OF THE PHOSPHATIDYLINOSITOL 3-KINASE/Akt PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN TENDON CELLS; HUMAN ARTICULAR CHONDROCYTES; PROTEIN-KINASE KINASE; ROTATOR CUFF DISEASES; I CLINICAL-TRIAL; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; CHEMOPREVENTIVE AGENT; TRANSCRIPTION FACTOR	Inflammatory processes play essential roles in the pathogenesis of tendinitis and tendinopathy. These events are accompanied by catabolic processes initiated by pro-inflammatory cytokines such as interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha). Pharmacological treatments for tendinitis are restricted to the use of non-steroidal anti-inflammatory drugs. Recent studies in various cell models have demonstrated that curcumin targets the NF-kappa B signaling pathway. However, its potential for the treatment of tendinitis has not been explored. Herein, we used an in vitro model of human tenocytes to study the mechanism of curcumin action on IL-1 beta-mediated inflammatory signaling. Curcumin at concentrations of 5-20 mu M inhibited IL-1 beta-induced inflammation and apoptosis in cultures of human tenocytes. The anti-inflammatory effects of curcumin included down-regulation of gene products that mediate matrix degradation (matrix metalloproteinase-1, -9, and -13), prostanoid production (cyclooxygenase-2), apoptosis (Bax and activated caspase-3), and stimulation of cell survival (Bcl-2), all known to be regulated by NF-kappa B. Furthermore, curcumin suppressed IL-1 beta-induced NF-kappa B activation via inhibition of phosphorylation and degradation of inhibitor of kappa B alpha, inhibition of inhibitor of kappa B-kinase activity, and inhibition of nuclear translocation of NF-kappa B. Furthermore, the effects of IL-1 beta were abrogated by wortmannin, suggesting a role for the phosphatidylinositol 3-kinase (PI-3K) pathway in IL-1 beta signaling. Curcumin suppressed IL-1 beta-induced PI-3K p85/Akt activation and its association with IKK. These results demonstrate, for the first time, a potential role for curcumin in treating tendon inflammation through modulation of NF-kappa B signaling, which involves PI-3K/Akt and the tendon-specific transcription factor scleraxis in tenocytes.	[Shakibaei, Mehdi] Univ Munich, Inst Anat, Musculoskeletal Res Grp, D-80336 Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Fac Med & Hlth Sci, Sch Vet Med & Sci, Musculoskeletal Res Grp,Div Vet Med, Loughborough LE12 5RD, England; [Stahlmann, Ralf] Charite, Inst Clin Pharmacol & Toxicol, D-14195 Berlin, Germany; [Montaseri, Azadeh] Med Univ Tabriz, Fac Med, Dept Anat Sci, Tabriz, Iran	University of Munich; University of Nottingham; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Tabriz University of Medical Science	Shakibaei, M (corresponding author), Univ Munich, Inst Anat, Musculoskeletal Res Grp, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Mobasheri, Ali/D-5770-2011; Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; Montaseri, Azadeh/G-3871-2015	Mobasheri, Ali/0000-0001-6261-1286; Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Montaseri, Azadeh/0000-0003-4250-3629; Buhrmann, Constanze/0000-0002-0786-0463	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust, UK	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust, UK(Wellcome Trust)	Supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and The Wellcome Trust, UK.	Aggarwal BB, 2005, CANC TREAT, V126, P103, DOI 10.1007/0-387-24361-5_5; Aggarwal BB, 2003, ANTICANCER RES, V23, P363; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Almekinders L C, 1998, J Am Acad Orthop Surg, V6, P157; Archambault J, 2002, J ORTHOPAED RES, V20, P36, DOI 10.1016/S0736-0266(01)00075-4; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BernardBeaubois K, 1997, CELL BIOL TOXICOL, V13, P103, DOI 10.1023/B:CBTO.0000010395.51944.2a; Bharti AC, 2002, ANN NY ACAD SCI, V973, P392, DOI 10.1111/j.1749-6632.2002.tb04671.x; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Buhrmann C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3065; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240; Chan WH, 2006, FOOD CHEM TOXICOL, V44, P1362, DOI 10.1016/j.fct.2006.03.001; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cheng AL, 2001, ANTICANCER RES, V21, P2895; Coffer PJ, 1998, BIOCHEM J, V329, P121; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Gotoh M, 2002, J ORTHOP RES, V20, P1365, DOI 10.1016/S0736-0266(02)00063-3; Gotoh M, 2000, J RHEUMATOL, V27, P2886; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Jang MK, 2001, PLANTA MED, V67, P550, DOI 10.1055/s-2001-16482; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 1998, BIOCHEM PHARMACOL, V55, P775, DOI 10.1016/S0006-2952(97)00557-1; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; Mukhopadhyay A, 2001, ONCOGENE, V20, P7597, DOI 10.1038/sj.onc.1204997; Ozes ON, 1999, NATURE, V401, P82; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Rees SG, 2000, BIOCHEM J, V350, P181, DOI 10.1042/0264-6021:3500181; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; Sandur SK, 2009, INT J RADIAT ONCOL, V75, P534, DOI 10.1016/j.ijrobp.2009.06.034; Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sendzik J, 2005, TOXICOLOGY, V212, P24, DOI 10.1016/j.tox.2005.04.002; Sendzik J, 2010, INT J ANTIMICROB AG, V35, P366, DOI 10.1016/j.ijantimicag.2009.10.009; Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118; Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200; Shakibaei M, 2007, BIOCHEM PHARMACOL, V73, P1434, DOI 10.1016/j.bcp.2007.01.005; Shankar S, 2007, INT J ONCOL, V30, P905; Sharma RA, 2001, CLIN CANCER RES, V7, P1894; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shehzad A, 2010, ARCH PHARM, V343, P489, DOI 10.1002/ardp.200900319; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Squires MS, 2003, BIOCHEM PHARMACOL, V65, P361, DOI 10.1016/S0006-2952(02)01517-4; Stancovski I, 1997, CELL, V91, P299, DOI 10.1016/S0092-8674(00)80413-4; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Tsuzaki M, 2003, J CELL BIOCHEM, V89, P556, DOI 10.1002/jcb.10534; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang JHC, 2006, CLIN ORTHOP RELAT R, P320, DOI 10.1097/01.blo.0000195927.81845.46; WILLIAMS DH, 1992, BIOCHIM BIOPHYS ACTA, V1180, P9, DOI 10.1016/0925-4439(92)90020-N; Zhang CL, 2010, J INVEST DERMATOL, V130, P2110, DOI 10.1038/jid.2010.86	68	157	170	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28556	28566		10.1074/jbc.M111.256180	http://dx.doi.org/10.1074/jbc.M111.256180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669872	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000293557800070
J	Scortegagna, M; Subtil, T; Qi, JF; Kim, H; Zhao, WH; Gu, W; Kluger, H; Ronai, ZA				Scortegagna, Marzia; Subtil, Tony; Qi, Jianfei; Kim, Hyungsoo; Zhao, Wenhui; Gu, Wei; Kluger, Harriet; Ronai, Ze'ev A.			USP13 Enzyme Regulates Siah2 Ligase Stability and Activity via Noncatalytic Ubiquitin-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; TRANSCRIPTIONAL REPRESSOR; DEUBIQUITINATING ENZYME; PROLYL-HYDROXYLASES; SINA; HIF; TUMORIGENESIS; PROTEOLYSIS; HOMOLOGS; PROTEINS	The RING finger E3 ubiquitin ligase Siah2 is implicated in control of diverse cellular biological events, including MAPK signaling and hypoxia. Here we demonstrate that Siah2 is subject to regulation by the deubiquitinating enzyme USP13. Overexpression of USP13 increases Siah2 stability by attenuating its autodegradation. Consequently, the ability of Siah2 to target its substrates prolyl hydroxylase 3 and Spry2 (Sprouty2) for ubiquitin-mediated proteasomal degradation is attenuated. Conversely, inhibition of USP13 expression with corresponding shRNA decreases the stability of both Siah2 and its substrate Spry2. Thus, USP13 limits Siah2 autodegradation and its ubiquitin ligase activity against its target substrates. Strikingly, the effect of USP13 on Siah2 is not mediated by its isopeptidase activity: mutations in its ubiquitin-binding sequences positioned within the ubiquitin-specific processing protease and ubiquitin-binding domains, but not within putative catalytic sites, abolish USP13 binding to and effect on Siah2 autodegradation and targeted ubiquitination. Notably, USP13 expression is attenuated in melanoma cells maintained under hypoxia, thereby relieving Siah2 inhibition and increasing its activity under low oxygen levels. Significantly, on melanoma tissue microarray, high nuclear expression of USP13 coincided with high nuclear expression of Siah2. Overall, this study identifies a new layer of Siah2 regulation mediated by USP13 binding to ubiquitinated Siah2 protein with a concomitant inhibitory effect on its activity under normoxia.	[Scortegagna, Marzia; Qi, Jianfei; Kim, Hyungsoo; Ronai, Ze'ev A.] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA 92130 USA; [Subtil, Tony; Kluger, Harriet] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Zhao, Wenhui; Gu, Wei] Columbia Univ, Inst Canc Genet, Herbert Irving Canc Res Ctr, New York, NY 10032 USA	Sanford Burnham Prebys Medical Discovery Institute; Yale University; Columbia University	Ronai, ZA (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ronai@sbmri.org	qi, jianfei/O-9847-2014	RONAI, ZEEV/0000-0002-3859-0400; Kim, Hyungsoo/0000-0002-8189-5939; ZHAO, WENHUI/0000-0002-7703-7106	National Institutes of Health [CA128814]; XXXXXX; NATIONAL CANCER INSTITUTE [P01CA128814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); XXXXXX; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA128814 ( to Z. A. R.). This work was also supported by XXXXXX.	Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Boehm J, 2001, EMBO J, V20, P4153, DOI 10.1093/emboj/20.15.4153; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chen MF, 2011, P NATL ACAD SCI USA, V108, P9119, DOI 10.1073/pnas.1100028108; Davies GC, 2004, ONCOGENE, V23, P7104, DOI 10.1038/sj.onc.1207952; DELLA NG, 1993, DEVELOPMENT, V117, P1333; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Habelhah H, 2004, J BIOL CHEM, V279, P53782, DOI 10.1074/jbc.M410315200; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Hu G, 1999, MOL CELL BIOL, V19, P724; Hu G, 1997, GENOMICS, V46, P103, DOI 10.1006/geno.1997.4997; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lacombe T, 2002, FEBS LETT, V531, P469, DOI 10.1016/S0014-5793(02)03586-X; Li SH, 1997, CELL, V90, P469, DOI 10.1016/S0092-8674(00)80507-3; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; McCarthy MM, 2006, CLIN CANCER RES, V12, P3856, DOI 10.1158/1078-0432.CCR-06-0190; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Russell Nathaniel S., 2005, V301, P207; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Timms KM, 1998, GENE, V217, P101, DOI 10.1016/S0378-1119(98)00341-2	33	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27333	27341		10.1074/jbc.M111.218214	http://dx.doi.org/10.1074/jbc.M111.218214			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659512	Green Published, hybrid			2022-12-25	WOS:000293268700029
J	Yan, Y; Pieretti, J; Ju, ZL; Wei, SN; Christin, JR; Bah, F; Birshtein, BK; Eckhardt, LA				Yan, Yi; Pieretti, Joyce; Ju, Zhongliang; Wei, Shiniu; Christin, John R.; Bah, Fatmata; Birshtein, Barbara K.; Eckhardt, Laurel A.			Homologous Elements hs3a and hs3b in the 3 ' Regulatory Region of the Murine Immunoglobulin Heavy Chain (Igh) Locus Are Both Dispensable for Class-switch Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; GERMLINE TRANSCRIPTION; ENHANCER; END; DELETION; REQUIRE; ALPHA; HS4; IDENTIFICATION; DOWNSTREAM	Immunoglobulin heavy chain (IgH) genes are formed, tested, and modified to yield diverse, specific, and high affinity antibody responses to antigen. The processes involved must be regulated, however, to avoid unintended damage to chromosomes. The 3' regulatory region of the Igh locus plays a major role in regulating class-switch recombination (CSR), the process by which antibody effector functions are modified during an immune response. Loss of all known enhancer-like elements in this region dramatically impairs CSR, but individual element deletions have no effect on this process. In the present study, we explored the hypothesis that an underlying functional redundancy in the homologous elements hs3a and hs3b was masking the importance of either element to CSR. Several transgenic mouse lines were generated, each carrying a bacterial artificial chromosome transgene that mimicked Igh locus structure but in which hs3a was missing and hs3b was flanked by loxP sites. Matings to Cyclization Recombination Enzyme-expressing mice established "pairs" of lines that differed only in the presence or absence of hs3b. Remarkably, CSR remained robust in the absence of both hs3a and hs3b, suggesting that the remaining two elements of the 3' regulatory region, hs1.2 and hs4, although individually dispensable for CSR, are, together, sufficient to support CSR.	[Yan, Yi; Pieretti, Joyce; Wei, Shiniu; Christin, John R.; Bah, Fatmata; Eckhardt, Laurel A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Yan, Yi; Eckhardt, Laurel A.] CUNY, Grad Ctr, New York, NY 10065 USA; [Ju, Zhongliang; Birshtein, Barbara K.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10804 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine	Eckhardt, LA (corresponding author), 927 Hunter N,695 Pk Ave, New York, NY 10065 USA.	eckhardt@genectr.hunter.cuny.edu		Christin, John/0000-0002-0479-0308	National Institutes of Health [RR003037, AI30653, AI13509]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030653, R37AI013509, R01AI013509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We gratefully acknowledge Dr. Wesley Dunnick (University of Michigan Medical School, Ann Arbor, MI) for providing unmodified CHC BAC, Dr. Klaus Rajewsky (Harvard Medical School, Boston, MA) for the cloned B1-8V<INF>H</INF>gene, Dr. F. W. Alt(Harvard Medical School, Boston, MA) for the loxP vector used to flank hs3b with loxP sites, Dr. Karl Drlica (Public Health Research Institute, New York, NY) for human beta-globin plasmid, and Dr. Heiner Westphal (NICHD, National Institutes of Health) for EIIa-cre mice. We thank Joon Kim of the Hunter College Flow Cytometry Facility for expert help with cell sorting and Jodi-Ann Powell and Cheng Peng for expert technical support in mouse genotyping. Finally, we thank Dr. Benjamin Ortiz (Hunter College, The City University of New York) for helpful discussions and critical reading of the manuscript. The infrastructure and instrumentation at Hunter College are supported in part by a Research Centers in Minority Institutions award from the National Institutes of Health (RR003037).; This work was supported, in whole or in part, by National Institutes of Health Grants AI30653 (to L. A. E.) and AI13509 (to B. K. B.).	Bebin AG, 2010, J IMMUNOL, V184, P3710, DOI 10.4049/jimmunol.0901978; Chen CQ, 1997, J IMMUNOL, V159, P1310; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; Dunnick WA, 2005, J EXP MED, V201, P1459, DOI 10.1084/jem.20041988; Dunnick WA, 2004, J IMMUNOL, V173, P5531, DOI 10.4049/jimmunol.173.9.5531; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Li FB, 2009, J EXP MED, V206, P153, DOI 10.1084/jem.20081202; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; MCINTYRE TM, 1995, J IMMUNOL, V154, P3156; MICHAELSON JS, 1995, NUCLEIC ACIDS RES, V23, P975, DOI 10.1093/nar/23.6.975; Mills FC, 1997, J EXP MED, V186, P845, DOI 10.1084/jem.186.6.845; Misulovin Z, 2001, J IMMUNOL METHODS, V257, P99, DOI 10.1016/S0022-1759(01)00452-5; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Shi XR, 2001, INT IMMUNOL, V13, P1003, DOI 10.1093/intimm/13.8.1003; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Vincent-Fabert C, 2009, J IMMUNOL, V182, P6926, DOI 10.4049/jimmunol.0900214; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; ZALLER DM, 1985, P NATL ACAD SCI USA, V82, P5088, DOI 10.1073/pnas.82.15.5088; Zhang BY, 2007, J IMMUNOL, V178, P6297, DOI 10.4049/jimmunol.178.10.6297	33	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27123	27131		10.1074/jbc.M111.230995	http://dx.doi.org/10.1074/jbc.M111.230995			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21673112	hybrid, Green Published			2022-12-25	WOS:000293268700007
J	Compton, ELR; Karinou, E; Naismith, JH; Gabel, F; Javelle, A				Compton, Emma L. R.; Karinou, Eleni; Naismith, James H.; Gabel, Frank; Javelle, Arnaud			Low Resolution Structure of a Bacterial SLC26 Transporter Reveals Dimeric Stoichiometry and Mobile Intracellular Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR PROTEIN PRESTIN; MULTIFUNCTIONAL ANION-EXCHANGERS; NEUTRON-SCATTERING; BIOLOGICAL STRUCTURES; ION-TRANSPORT; STAS DOMAIN; MODULATION; CHANNELS; COMPLEX; FAMILY	The SLC26/SulP (solute carrier/sulfate transporter) proteins are a superfamily of anion transporters conserved from bacteria to man, of which four have been identified in human diseases. Proteins within the SLC26/SulP family exhibit a wide variety of functions, transporting anions from halides to carboxylic acids. The proteins comprise a transmembrane domain containing between 10-12 transmembrane helices followed a by C-terminal cytoplasmic sulfate transporter and anti-sigma factor antagonist (STAS) domain. These proteins are expected to undergo conformational changes during the transport cycle; however, structural information for this family remains sparse, particularly for the full-length proteins. To address this issue, we conducted an expression and detergent screen on bacterial Slc26 proteins. The screen identified a Yersinia enterocolitica Slc26A protein as the ideal candidate for further structural studies as it can be purified to homogeneity. Partial proteolysis, co-purification, and analytical size exclusion chromatography demonstrate that the protein purifies as stable oligomers. Using small angle neutron scattering combined with contrast variation, we have determined the first low resolution structure of a bacterial Slc26 protein without spectral contribution from the detergent. The structure confirms that the protein forms a dimer stabilized via its transmembrane core; the cytoplasmic STAS domain projects away from the transmembrane domain and is not involved in dimerization. Supported by additional biochemical data, the structure suggests that large movements of the STAS domain underlie the conformational changes that occur during transport.	[Compton, Emma L. R.; Karinou, Eleni; Javelle, Arnaud] Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland; [Naismith, James H.] Univ St Andrews, St Andrews KY16 9ST, Fife, Scotland; [Gabel, Frank] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct, F-38027 Grenoble, France	University of Dundee; University of St Andrews; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Javelle, A (corresponding author), Univ Dundee, Coll Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland.	ajavelle@dundee.ac.uk	Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Karinou, Eleni/0000-0002-1099-4964; Compton-Daw, Emma/0000-0002-3832-7194; Gabel, Frank/0000-0003-3446-2601	Tenovus Scotland [T08/26]; Royal Society [2008/R2]; Medical Research Council [G1000054]; College of Life Science (University of Dundee); Biotechnology and Biological Sciences Research Council [BB/F017022/1]; Scottish government/Royal Society of Edinburgh; MRC [G1000054] Funding Source: UKRI	Tenovus Scotland; Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); College of Life Science (University of Dundee); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish government/Royal Society of Edinburgh; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from Tenovus Scotland (T08/26), the Royal Society (2008/R2), and the Medical Research Council (G1000054).; Supported by the College of Life Science (University of Dundee).; Supported by a Biotechnology and Biological Sciences Research Council Doctoral Training Grant BB/F017022/1.; Supported by a Scottish government/Royal Society of Edinburgh personal research fellowship.	Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Gleitsman KR, 2009, AM J PHYSIOL-CELL PH, V297, pC290, DOI 10.1152/ajpcell.00647.2008; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heller WT, 2010, ACTA CRYSTALLOGR D, V66, P1213, DOI [10.1107/S0907444910017658, 10.1107/S090744491001]; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Mio K, 2008, J BIOL CHEM, V283, P1137, DOI 10.1074/jbc.M702681200; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Pasqualetto E, 2010, J MOL BIOL, V400, P448, DOI 10.1016/j.jmb.2010.05.013; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; Sharma AK, 2011, J BIOL CHEM, V286, P8534, DOI 10.1074/jbc.M110.165449; Shelden MC, 2010, MOL MEMBR BIOL, V27, P11, DOI 10.3109/09687680903400120; Stewart CE, 2000, P NATL ACAD SCI USA, V97, P454, DOI 10.1073/pnas.97.1.454; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	27	37	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27058	27067		10.1074/jbc.M111.244533	http://dx.doi.org/10.1074/jbc.M111.244533			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659513	Green Published, hybrid			2022-12-25	WOS:000293078200079
J	Kozjak-Pavlovic, V; Ott, C; Gotz, M; Rudel, T				Kozjak-Pavlovic, Vera; Ott, Christine; Goetz, Monika; Rudel, Thomas			Neisserial Omp85 Protein Is Selectively Recognized and Assembled into Functional Complexes in the Outer Membrane of Human Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-BARREL PROTEINS; BIOGENESIS; MACHINERY; IMPORT; BACTERIA; SAM50; VDAC	As a consequence of their bacterial origin, mitochondria contain beta-barrel proteins in their outer membrane (OMM). These proteins require the translocase of the outer membrane (TOM) complex and the conserved sorting and assembly machinery (SAM) complex for transport and integration into the OMM. The SAM complex and the beta-barrel assembly machinery (BAM) required for biogenesis of beta-barrel proteins in bacteria are evolutionarily related. Despite this homology, we show that bacterial beta-barrel proteins are not universally recognized and integrated into the OMM of human mitochondria. Selectivity exists both at the level of the TOM and the SAM complex. Of all of the proteins we tested, human mitochondria imported only beta-barrel proteins originating from Neisseria sp., and only Omp85, the central component of the neisserial BAM complex, integrated into the OMM. PorB proteins from different Neisseria, although imported by the TOM, were not recognized by the SAM complex and formed membrane complexes only when functional Omp85 was present at the same time in mitochondria. Omp85 alone was capable of integrating other bacterial beta-barrel proteins in human mitochondria, but could not substitute for the function of its mitochondrial homolog Sam50. Thus, signals and machineries for transport and assembly of beta-barrel proteins in bacteria and human mitochondria differ enough to allow only a certain type of beta-barrel proteins to be targeted and integrated in mitochondrial membranes in human cells.	[Kozjak-Pavlovic, Vera; Ott, Christine; Goetz, Monika; Rudel, Thomas] Univ Wurzburg, Biozentrum, Dept Microbiol, D-97074 Wurzburg, Germany	University of Wurzburg	Kozjak-Pavlovic, V (corresponding author), Univ Wurzburg, Biozentrum, Dept Microbiol, D-97074 Wurzburg, Germany.	Vera.Kozjak@uni-wuerzburg.de; Thomas.Rudel@biozentrum.uni-wuerzburg.de	Kozjak-Pavlovic, Vera/E-1494-2013	Kozjak-Pavlovic, Vera/0000-0001-9658-7018	Deutsche Forschungsgemeinschaft [KO3882/1-1, RU 631/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants KO3882/1-1 (to V. K.-P.) and RU 631/7-1 (to T. R.).	Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kozjak-Pavlovic V, 2010, J MOL BIOL, V397, P219, DOI 10.1016/j.jmb.2010.01.047; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Walther DM, 2010, MOL BIOL EVOL, V27, P887, DOI 10.1093/molbev/msp294; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	24	21	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27019	27026		10.1074/jbc.M111.232249	http://dx.doi.org/10.1074/jbc.M111.232249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652692	hybrid, Green Published			2022-12-25	WOS:000293078200075
J	Tserel, L; Runnel, T; Kisand, K; Pihlap, M; Bakhoff, L; Kolde, R; Peterson, H; Vilo, J; Peterson, P; Rebane, A				Tserel, Liina; Runnel, Toomas; Kisand, Kai; Pihlap, Maire; Bakhoff, Lairi; Kolde, Raivo; Peterson, Hedi; Vilo, Jaak; Peterson, Paert; Rebane, Ana			MicroRNA Expression Profiles of Human Blood Monocyte-derived Dendritic Cells and Macrophages Reveal miR-511 as Putative Positive Regulator of Toll-like Receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS; GENE-EXPRESSION; TARGET; DIFFERENTIATION; IMMUNOTHERAPY; PATHWAY	Dendritic cells (DCs) and macrophages (MFs) are important multifunctional immune cells. Like other cell types, they express hundreds of different microRNAs (miRNAs) that are recently discovered post-transcriptional regulators of gene expression. Here we present updated miRNA expression profiles of monocytes, DCs and MFs. Compared with monocytes, similar to 50 miRNAs were found to be differentially expressed in immature and mature DCs or MFs, with major expression changes occurring during the differentiation. Knockdown of DICER1, a protein needed for miRNA biosynthesis, led to lower DC-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) and enhanced CD14 protein levels, confirming the importance of miRNAs in DC differentiation in general. Inhibition of the two most highly up-regulated miRNAs, miR-511 and miR-99b, also resulted in reduced DC-SIGN level. Prediction of miRNA-511 targets revealed a number of genes with known immune functions, of which TLR4 and CD80 were validated using inhibition of miR-511 in DCs and luciferase assays in HEK293 cells. Interestingly, under the cell cycle arrest conditions, miR-511 seems to function as a positive regulator of TLR4. In conclusion, we have identified miR-511 as a novel potent modulator of human immune response. In addition, our data highlight that miRNA influence on gene expression is dependent on the cellular environment.	[Tserel, Liina; Runnel, Toomas; Kisand, Kai; Pihlap, Maire; Bakhoff, Lairi; Peterson, Paert; Rebane, Ana] Univ Tartu, Fac Med, EE-50411 Tartu, Estonia; [Kolde, Raivo; Peterson, Hedi; Vilo, Jaak] Univ Tartu, Inst Computater Sci, EE-50409 Tartu, Estonia; [Rebane, Ana] Swiss Inst Allergy & Asthma Res SIAF, CH-7270 Davos, Switzerland	University of Tartu; University of Tartu; Swiss Institute of Allergy & Asthma Research	Rebane, A (corresponding author), Univ Tartu, Fac Med, 19 Ravila St, EE-50411 Tartu, Estonia.	ana.rebane@ut.ee	Peterson, Hedi/C-7514-2012; Peterson, Hedi/ABA-3355-2020; Peterson, Hedi/F-4920-2017; Kolde, Raivo/AAB-8149-2022; Vilo, Jaak/A-7183-2008; Kisand, Kai/J-3483-2015; Rebane, Ana/D-4279-2013; Peterson, Pärt/A-5788-2009; Vilo, Jaak/AAK-2228-2020	Peterson, Hedi/0000-0001-9951-5116; Peterson, Hedi/0000-0001-9951-5116; Kolde, Raivo/0000-0003-2886-6298; Vilo, Jaak/0000-0001-5604-4107; Kisand, Kai/0000-0002-5426-4648; Rebane, Ana/0000-0001-6051-1361; Peterson, Pärt/0000-0001-6755-791X; Vilo, Jaak/0000-0001-5604-4107				Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; De Benedetto A, 2009, J INVEST DERMATOL, V129, P14, DOI 10.1038/jid.2008.259; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jin P, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-4; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurkin J, 2010, J IMMUNOL, V184, P4955, DOI 10.4049/jimmunol.0903021; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kramer JL, 2002, BRIT J HAEMATOL, V117, P727, DOI 10.1046/j.1365-2141.2002.03498.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; O'Connell MA, 2006, NAT STRUCT MOL BIOL, V13, P3, DOI 10.1038/nsmb0106-3; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tyagi RK, 2009, EXPERT REV ANTICANC, V9, P97, DOI 10.1586/14737140.9.1.97; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211	51	100	107	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26487	26495		10.1074/jbc.M110.213561	http://dx.doi.org/10.1074/jbc.M110.213561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646346	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000293078200027
J	Dutta, S; Ongarora, BG; Li, HR; Vicente, MDH; Kolli, BK; Chang, KP				Dutta, Sujoy; Ongarora, Benson G.; Li, Hairong; Vicente, Maria da Graca H.; Kolli, Bala K.; Chang, Kwang Poo			Intracellular Targeting Specificity of Novel Phthalocyanines Assessed in a Host-Parasite Model for Developing Potential Photodynamic Medicine	PLOS ONE			English	Article							MHC CLASS-I; CUTANEOUS LEISHMANIASIS; LEISH-F1+MPL-SE VACCINE; DENDRITIC CELLS; SINGLET OXYGEN; CLINICAL-TRIAL; THERAPY; EFFICACY; IMMUNOGENICITY; UROPORPHYRIA	Photodynamic therapy, unlikely to elicit drug-resistance, deserves attention as a strategy to counter this outstanding problem common to the chemotherapy of all diseases. Previously, we have broadened the applicability of this modality to photodynamic vaccination by exploiting the unusual properties of the trypanosomatid protozoa, Leishmania, i.e., their innate ability of homing to the phagolysosomes of the antigen-presenting cells and their selective photolysis therein, using transgenic mutants endogenously inducible for porphyrin accumulation. Here, we extended the utility of this host-parasite model for in vitro photodynamic therapy and vaccination by exploring exogenously supplied photosensitizers. Seventeen novel phthalocyanines (Pcs) were screened in vitro for their photolytic activity against cultured Leishmania. Pcs rendered cationic and soluble (csPcs) for cellular uptake were phototoxic to both parasite and host cells, i.e., macrophages and dendritic cells. The csPcs that targeted to mitochondria were more photolytic than those restricted to the endocytic compartments. Treatment of infected cells with endocytic csPcs resulted in their accumulation in Leishmania-containing phagolysosomes, indicative of reaching their target for photodynamic therapy, although their parasite versus host specificity is limited to a narrow range of csPc concentrations. In contrast, Leishmania pre-loaded with csPc were selectively photolyzed intracellularly, leaving host cells viable. Pre-illumination of such csPc-loaded Leishmania did not hinder their infectivity, but ensured their intracellular lysis. Ovalbumin (OVA) so delivered by photo-inactivated OVA transfectants to mouse macrophages and dendritic cells were co-presented with MHC Class I molecules by these antigen presenting cells to activate OVA epitope-specific CD8+ T cells. The in vitro evidence presented here demonstrates for the first time not only the potential of endocytic csPcs for effective photodynamic therapy against Leishmania but also their utility in photo-inactivation of Leishmania to produce a safe carrier to express and deliver a defined antigen with enhanced cell-mediated immunity.	[Dutta, Sujoy; Kolli, Bala K.; Chang, Kwang Poo] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL USA; [Ongarora, Benson G.; Li, Hairong; Vicente, Maria da Graca H.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Louisiana State University System; Louisiana State University	Dutta, S (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Microbiol Immunol, N Chicago, IL USA.	sujoy.dutta@rosalindfranklin.edu	Li, Hairong/B-5462-2011; Ongarora, Benson Getenga/L-5033-2019		NIH [AI-083951, CA139385]; NATIONAL CANCER INSTITUTE [R21CA139385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083951] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI-083951 to KPC and NIH grant CA139385 to GV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilov OE, 2006, CHEM BIOL, V13, P839, DOI 10.1016/j.chembiol.2006.06.008; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Asilian A, 2006, CLIN EXP DERMATOL, V31, P634, DOI 10.1111/j.1365-2230.2006.02182.x; Brandonisio O, 2004, MICROBES INFECT, V6, P1402, DOI 10.1016/j.micinf.2004.10.004; CANTI G, 1995, CANCER LETT, V93, P255, DOI 10.1016/0304-3835(95)03818-H; Castro R, 2006, J PARASITOL, V92, P1162, DOI 10.1645/GE-841R.1; CHANG KP, 1983, CIBA F SYMP, V99, P113; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Dutta S, 2005, ANTIMICROB AGENTS CH, V49, P4474, DOI 10.1128/AAC.49.11.4474-4484.2005; Dutta S, 2008, EUKARYOT CELL, V7, P1146, DOI 10.1128/EC.00365-07; Dutta S, 2008, EXP PARASITOL, V118, P629, DOI 10.1016/j.exppara.2007.11.013; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Enk CD, 2003, ARCH DERMATOL, V139, P432, DOI 10.1001/archderm.139.4.432; Escobar Patricia, 2006, Biomed., V26, P49; Gardlo K, 2003, J AM ACAD DERMATOL, V48, P893, DOI 10.1067/mjd.2003.218; Gardner DM, 2010, PHOTOCHEM PHOTOBIOL, V86, P645, DOI 10.1111/j.1751-1097.2010.00705.x; Gonzalez U, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005067.pub3; Kumari S, 2009, EUR J IMMUNOL, V39, P178, DOI 10.1002/eji.200838389; Li HR, 2008, J MED CHEM, V51, P502, DOI 10.1021/jm070781f; LIU X, 1994, MOL BIOCHEM PARASIT, V66, P201, DOI 10.1016/0166-6851(94)90147-3; Llanos-Cuentas A, 2010, VACCINE, V28, P7427, DOI 10.1016/j.vaccine.2010.08.092; Lonning PE, 2010, MOL ONCOL, V4, P284, DOI 10.1016/j.molonc.2010.04.005; Lovell JF, 2010, CHEM REV, V110, P2839, DOI 10.1021/cr900236h; McKeown N. B., 1998, PHTHALOCYANINE MAT S; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; Morris RL, 2002, PHOTOCHEM PHOTOBIOL, V75, P652, DOI 10.1562/0031-8655(2002)075<0652:TPBRIP>2.0.CO;2; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nascimento E, 2010, VACCINE, V28, P6581, DOI 10.1016/j.vaccine.2010.07.063; Oleinick NL, 1998, RADIAT RES, V150, pS146, DOI 10.2307/3579816; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; QUELLETE M, 2008, LEISHMANIA GENOME, P159; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shen ZH, 1997, J IMMUNOL, V158, P2723; Soong L, 2008, J IMMUNOL, V180, P4355, DOI 10.4049/jimmunol.180.7.4355; Varela RE, 2009, EXP PARASITOL, V122, P134, DOI 10.1016/j.exppara.2009.02.012; WHO, 2010, LEISHM BACKGR INF	38	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20786	10.1371/journal.pone.0020786	http://dx.doi.org/10.1371/journal.pone.0020786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673971	gold, Green Published			2022-12-25	WOS:000291356400029
J	Painsipp, E; Kofer, MJ; Sinner, F; Holzer, P				Painsipp, Evelin; Koefer, Martin J.; Sinner, Frank; Holzer, Peter			Prolonged Depression-Like Behavior Caused by Immune Challenge: Influence of Mouse Strain and Social Environment	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ESTROUS-CYCLE; FEMALE RATS; NERVE INJURY; MICE; STRESS; BRAIN; CYTOKINES; ANTIDEPRESSANTS; ACTIVATION	Immune challenge by bacterial lipopolysaccharide (LPS) causes short-term behavioral changes indicative of depression. The present study sought to explore whether LPS is able to induce long-term changes in depression-related behavior and whether such an effect depends on mouse strain and social context. LPS (0.83 mg/kg) or vehicle was administered intraperitoneally to female CD1 and C57BL/6 mice that were housed singly or in groups of 4. Depression-like behavior was assessed with the forced swim test (FST) 1 and 28 days post-treatment. Group-housed CD1 mice exhibited depression-like behavior 1 day post-LPS, an effect that leveled off during the subsequent 28 days, while the behavior of singly housed CD1 mice was little affected. In contrast, singly housed C57BL/6 mice responded to LPS with an increase in depression-like behavior that was maintained for 4 weeks post-treatment and confirmed by the sucrose preference test. Group-housed C57BL/6 mice likewise displayed an increased depression-like behavior 4 weeks post-treatment. The behavioral changes induced by LPS in C57BL/6 mice were associated with a particularly pronounced rise of interleukin-6 in blood plasma within 1 day post-treatment and with changes in the dynamics of the corticosterone response to the FST. The current data demonstrate that immune challenge with LPS is able to induce prolonged depression-like behavior, an effect that depends on genetic background (strain). The discovery of an experimental model of long-term depression-like behavior after acute immune challenge is of relevance to the analysis of the epigenetic and pathophysiologic mechanisms of immune system-related affective disorders.	[Painsipp, Evelin; Koefer, Martin J.; Holzer, Peter] Med Univ Graz, Inst Expt & Clin Pharmacol, Res Unit Translat Neurogastroenterol, Graz, Austria; [Sinner, Frank] Joanneum Res, Hlth Inst Biomed & Hlth Sci, Graz, Austria	Medical University of Graz	Painsipp, E (corresponding author), Med Univ Graz, Inst Expt & Clin Pharmacol, Res Unit Translat Neurogastroenterol, Graz, Austria.	peter.holzer@medunigraz.at	Holzer, Peter/F-7578-2011	Holzer, Peter/0000-0002-5754-395X; Sinner, Frank Michael/0000-0002-9292-4512	Zukunftsfonds Steiermark [262]; Austrian Science Funds [L25-B05]	Zukunftsfonds Steiermark; Austrian Science Funds(Austrian Science Fund (FWF))	Funding: This study was supported by the Zukunftsfonds Steiermark (grant 262) and the Austrian Science Funds (http://www.fwf.ac.at/FWF grant L25-B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Anisman H, 2005, CURR PHARM DESIGN, V11, P963, DOI 10.2174/1381612053381701; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Carneiro AMD, 2009, P NATL ACAD SCI USA, V106, P2047, DOI 10.1073/pnas.0809449106; Chen QL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004387; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Crowley JJ, 2004, PHARMACOL BIOCHEM BE, V78, P269, DOI 10.1016/j.pbb.2004.03.014; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Detke MJ, 1995, PSYCHOPHARMACOLOGY B, V21, P66; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Edelsbrunner ME, 2009, BEHAV BRAIN RES, V203, P97, DOI 10.1016/j.bbr.2009.04.025; Frenois F, 2007, PSYCHONEUROENDOCRINO, V32, P516, DOI 10.1016/j.psyneuen.2007.03.005; Gibb J, 2008, BRAIN BEHAV IMMUN, V22, P573, DOI 10.1016/j.bbi.2007.12.001; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; Gorman Jack M, 2006, Gend Med, V3, P93, DOI 10.1016/S1550-8579(06)80199-3; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Grippo AJ, 2005, PSYCHOPHARMACOLOGY, V179, P769, DOI 10.1007/s00213-004-2103-4; Hays W., 2007, STATISTICS; Jeon D, 2010, NAT NEUROSCI, V13, P482, DOI 10.1038/nn.2504; Kirk RE, 1995, EXPT DESIGN; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; MAES M, 1995, PSYCHONEUROENDOCRINO, V20, P111, DOI 10.1016/0306-4530(94)00066-J; Maes M, 1998, CYTOKINE, V10, P313, DOI 10.1006/cyto.1997.0290; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Martin AL, 2010, BEHAV BRAIN RES, V207, P196, DOI 10.1016/j.bbr.2009.10.006; Nappi RE, 1997, NEUROENDOCRINOLOGY, V65, P29, DOI 10.1159/000127162; Norman GJ, 2010, MOL PSYCHIATR, V15, P404, DOI 10.1038/mp.2009.91; Norman GJ, 2010, PSYCHOSOM MED, V72, P519, DOI 10.1097/PSY.0b013e3181de8678; Painsipp E, 2007, NEUROSCIENCE, V150, P522, DOI 10.1016/j.neuroscience.2007.09.024; PAINSIPP E, 2011, BR J PHARM IN PRESS; Painsipp E, 2010, J PSYCHOPHARMACOL, V24, P1551, DOI 10.1177/0269881109348171; Palanza P, 2001, PHYSIOL BEHAV, V73, P411, DOI 10.1016/S0031-9384(01)00494-2; Pyter LM, 2009, P NATL ACAD SCI USA, V106, P9069, DOI 10.1073/pnas.0811949106; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Sliwowska JH, 2008, PSYCHONEUROENDOCRINO, V33, P1111, DOI 10.1016/j.psyneuen.2008.05.001; Southwick SM, 2005, ANNU REV CLIN PSYCHO, V1, P255, DOI 10.1146/annurev.clinpsy.1.102803.143948; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tonelli LH, 2008, NEUROPSYCHOPHARMACOL, V33, P1038, DOI 10.1038/sj.npp.1301488; Valles A, 2002, NEUROSCIENCE, V112, P383, DOI 10.1016/S0306-4522(02)00047-7; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Walf AA, 2009, J PSYCHOPHARMACOL, V23, P442, DOI 10.1177/0269881108089598; Wann BP, 2010, PSYCHONEUROENDOCRINO, V35, P233, DOI 10.1016/j.psyneuen.2009.06.010; Winer B.J., 1991, STAT PRINCIPLES EXPT; Yirmiya R, 1996, BRAIN RES, V711, P163, DOI 10.1016/0006-8993(95)01415-2; YIRMIYA R, 2009, FRONT NEUROSCI, V3, P262; Zhu CB, 2010, NEUROPSYCHOPHARMACOL, V35, P2510, DOI 10.1038/npp.2010.116	50	58	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20719	10.1371/journal.pone.0020719	http://dx.doi.org/10.1371/journal.pone.0020719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673960	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400024
J	Hathcock, KS; Farrington, L; Ivanova, I; Livak, F; Selimyan, R; Sen, R; Williams, J; Tai, XG; Hodes, RJ				Hathcock, Karen S.; Farrington, Lila; Ivanova, Irina; Livak, Ferenc; Selimyan, Roza; Sen, Ranjan; Williams, Joy; Tai, Xuguang; Hodes, Richard J.			The Requirement for Pre-TCR during Thymic Differentiation Enforces a Developmental Pause That Is Essential for V-DJ beta Rearrangement	PLOS ONE			English	Article							T-CELL-RECEPTOR; CHAIN GENE REARRANGEMENT; ALLELIC EXCLUSION; V(D)J RECOMBINATION; THYMOCYTE DEVELOPMENT; IMMATURE THYMOCYTES; DEFICIENT MICE; HISTONE H3; CD3-EPSILON-MEDIATED SIGNALS; TRANSCRIPTIONAL REGULATION	T cell development occurs in the thymus and is critically dependent on productive TCR beta rearrangement and pre-TCR expression in DN3 cells. The requirement for pre-TCR expression results in the arrest of thymocytes at the DN3 stage (beta checkpoint), which is uniquely permissive for V-DJ beta recombination; only cells expressing pre-TCR survive and develop beyond the DN3 stage. In addition, the requirement for TCR beta rearrangement and pre-TCR expression enforces suppression of TCR beta rearrangement on a second allele, allelic exclusion, thus ensuring that each T cell expresses only a single TCR beta product. However, it is not known whether pre-TCR expression is essential for allelic exclusion or alternatively if allelic exclusion is enforced by developmental changes that can occur in the absence of pre-TCR. We asked if thymocytes that were differentiated without pre-TCR expression, and therefore without pause at the beta checkpoint, would suppress all V-DJ beta rearrangement. We previously reported that premature CD28 signaling in murine CD4(-)CD8(-) (DN) thymocytes supports differentiation of CD4(+)CD8(+) (DP) cells in the absence of pre-TCR expression. The present study uses this model to define requirements for TCR beta rearrangement and allelic exclusion. We demonstrate that if cells exit the DN3 developmental stage before TCR beta rearrangement occurs, V-DJ beta rearrangement never occurs, even in DP cells that are permissive for D-J beta and TCR alpha rearrangement. These results demonstrate that pre-TCR expression is not essential for thymic differentiation to DP cells or for V-DJ beta suppression. However, the requirement for pre-TCR signals and the exclusion of alternative stimuli such as CD28 enforce a developmental "pause" in early DN3 cells that is essential for productive TCR beta rearrangement to occur.	[Hathcock, Karen S.; Farrington, Lila; Williams, Joy; Tai, Xuguang; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ivanova, Irina; Selimyan, Roza; Sen, Ranjan; Hodes, Richard J.] NIA, Lab Cellular & Mol Biol, NIH, Baltimore, MD 21224 USA; [Livak, Ferenc] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland Baltimore	Hathcock, KS (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	hathcock@exchange.nih.gov			National Institutes of Health (NIH), National Cancer Institute; National Institute on Aging; NATIONAL CANCER INSTITUTE [ZIABC009265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000383] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All research was funded by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute and National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey JL, 2004, IMMUNOL CELL BIOL, V82, P393, DOI 10.1111/j.0818-9641.2004.01246.x; Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; ANDERSON SJ, 1992, EMBO J, V11, P4877, DOI 10.1002/j.1460-2075.1992.tb05594.x; BORN W, 1985, P NATL ACAD SCI USA, V82, P2925, DOI 10.1073/pnas.82.9.2925; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chakraborty T, 2009, J EXP MED, V206, P1019, DOI 10.1084/jem.20081621; Chen F, 2001, J IMMUNOL, V166, P1771, DOI 10.4049/jimmunol.166.3.1771; Cobb RM, 2006, ADV IMMUNOL, V91, P45, DOI 10.1016/S0065-2776(06)91002-5; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Falk I, 2001, EUR J IMMUNOL, V31, P3308, DOI 10.1002/1521-4141(200111)31:11<3308::AID-IMMU3308>3.0.CO;2-5; Fournier S, 1997, IMMUNITY, V6, P327, DOI 10.1016/S1074-7613(00)80335-0; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; GOLDMAN JP, 1993, J EXP MED, V177, P729, DOI 10.1084/jem.177.3.729; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Hager-Theodorides AL, 2007, EUR J IMMUNOL, V37, P487, DOI 10.1002/eji.200636503; Harada Y, 2001, J BIOL CHEM, V276, P9003, DOI 10.1074/jbc.M005051200; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Khor B, 2002, CURR OPIN IMMUNOL, V14, P230, DOI 10.1016/S0952-7915(02)00326-6; Krotkova A, 1997, J EXP MED, V186, P767, DOI 10.1084/jem.186.5.767; LEVELT CN, 1995, EUR J IMMUNOL, V25, P1257, DOI 10.1002/eji.1830250519; Li Z, 1996, IMMUNITY, V5, P575, DOI 10.1016/S1074-7613(00)80272-1; LIN WC, 1994, P NATL ACAD SCI USA, V91, P2733, DOI 10.1073/pnas.91.7.2733; Livak F, 2002, SEMIN IMMUNOL, V14, P297, DOI 10.1016/S1044-5323(02)00063-5; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Nagaoka H, 2000, CURR OPIN IMMUNOL, V12, P187, DOI 10.1016/S0952-7915(99)00070-9; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Senoo M, 1998, INT IMMUNOL, V10, P553, DOI 10.1093/intimm/10.5.553; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1994, INT IMMUNOL, V6, P995, DOI 10.1093/intimm/6.7.995; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; vonBoehmer H, 1995, ANN NY ACAD SCI, V766, P52, DOI 10.1111/j.1749-6632.1995.tb26648.x; Williams JA, 2005, J IMMUNOL, V175, P4199, DOI 10.4049/jimmunol.175.7.4199; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20639	10.1371/journal.pone.0020639	http://dx.doi.org/10.1371/journal.pone.0020639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673984	Green Submitted, Green Published, gold			2022-12-25	WOS:000291355500029
J	Fazakas, C; Wilhelm, I; Nagyoszi, P; Farkas, AE; Hasko, J; Molnar, J; Bauer, H; Bauer, HC; Ayaydin, F; Dung, NTK; Siklos, L; Krizbai, IA				Fazakas, Csilla; Wilhelm, Imola; Nagyoszi, Peter; Farkas, Attila E.; Hasko, Janos; Molnar, Judit; Bauer, Hannelore; Bauer, Hans-Christian; Ayaydin, Ferhan; Dung, Ngo Thi Khue; Siklos, Laszlo; Krizbai, Istvan A.			Transmigration of Melanoma Cells through the Blood-Brain Barrier: Role of Endothelial Tight Junctions and Melanoma-Released Serine Proteases	PLOS ONE			English	Article							SEPRASE; METASTASIS; ACTIVATION; DIAPEDESIS; EXPRESSION; MIGRATION; MODEL; INHIBITION; MONOCYTES; INTEGRITY	Malignant melanoma represents the third common cause of brain metastasis, having the highest propensity to metastasize to the brain of all primary neoplasms in adults. Since the central nervous system lacks a lymphatic system, the only possibility for melanoma cells to reach the brain is via the blood stream and the blood-brain barrier. Despite the great clinical importance, mechanisms of transmigration of melanoma cells through the blood-brain barrier are incompletely understood. In order to investigate this question we have used an in vitro experimental setup based on the culture of cerebral endothelial cells (CECs) and the A2058 and B16/F10 melanoma cell lines, respectively. Melanoma cells were able to adhere to confluent brain endothelial cells, a process followed by elimination of protrusions and transmigration from the luminal to the basolateral side of the endothelial monolayers. The transmigration process of certain cells was accelerated when they were able to use the routes preformed by previously transmigrated melanoma cells. After migrating through the endothelial monolayer several melanoma cells continued their movement beneath the endothelial cell layer. Melanoma cells coming in contact with brain endothelial cells disrupted the tight and adherens junctions of CECs and used (at least partially) the paracellular transmigration pathway. During this process melanoma cells produced and released large amounts of proteolytic enzymes, mainly gelatinolytic serine proteases, including seprase. The serine protease inhibitor Pefabloc (R) was able to decrease to 44-55% the number of melanoma cells migrating through CECs. Our results suggest that release of serine proteases by melanoma cells and disintegration of the interendothelial junctional complex are main steps in the formation of brain metastases in malignant melanoma.	[Fazakas, Csilla; Wilhelm, Imola; Nagyoszi, Peter; Farkas, Attila E.; Hasko, Janos; Molnar, Judit; Dung, Ngo Thi Khue; Siklos, Laszlo; Krizbai, Istvan A.] Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Bauer, Hannelore; Bauer, Hans-Christian] Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria; [Ayaydin, Ferhan] Biol Res Ctr, Lab Cellular Imaging, H-6701 Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Salzburg University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Fazakas, C (corresponding author), Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary.	krizbai@brc.hu	Sildos, Ilmo/I-2431-2018; Farkas, Attila/J-3879-2015	Sildos, Ilmo/0000-0003-4161-2612; Farkas, Attila/0000-0002-9519-5968; Ayaydin, Ferhan/0000-0002-9126-0865; Wilhelm, Imola/0000-0003-2366-7337; Krizbai, Istvan/0000-0002-0764-1527; Hasko, Janos/0000-0003-4687-9148	 [REG-DA-09-1-2009-0004];  [BBBTEER9]	; 	This work was partially supported by the project REG-DA-09-1-2009-0004, BBBTEER9 (IAK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Artym VV, 2002, CARCINOGENESIS, V23, P1593, DOI 10.1093/carcin/23.10.1593; Bauer HC, 2011, J NEURAL TRANSM, V118, P7, DOI 10.1007/s00702-010-0484-6; Bezuhly M, 2009, BLOOD, V113, P3371, DOI 10.1182/blood-2008-05-159434; Bridle BW, 2010, J IMMUNOL, V184, P4269, DOI 10.4049/jimmunol.0901447; Carl SM, 2010, MOL PHARMACEUT, V7, P1057, DOI 10.1021/mp900178j; Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522; Chen DH, 2006, CANCER RES, V66, P9977, DOI 10.1158/0008-5472.CAN-06-1499; Colone M, 2008, J INVEST DERMATOL, V128, P957, DOI 10.1038/sj.jid.5701082; Cranmer LD, 2005, MELANOMA RES, V15, P325, DOI 10.1097/00008390-200510000-00002; Cruz-Munoz W, 2008, CANCER RES, V68, P4500, DOI 10.1158/0008-5472.CAN-08-0041; Dejana E, 2006, NAT CELL BIOL, V8, P105, DOI 10.1038/ncb0206-105; Denkins Y, 2004, NEURO-ONCOLOGY, V6, P154, DOI 10.1215/S115285170300067X; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Gilmore BF, 2006, BIOCHEM BIOPH RES CO, V346, P436, DOI 10.1016/j.bbrc.2006.05.175; Hofmann UB, 1999, BRIT J CANCER, V81, P774, DOI 10.1038/sj.bjc.6690763; Hutamekalin P, 2008, CELL BIOL INT, V32, P198, DOI 10.1016/j.cellbi.2007.08.026; Jung ID, 2002, FEBS LETT, V532, P351, DOI 10.1016/S0014-5793(02)03698-0; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kugler S, 2007, CELL MICROBIOL, V9, P619, DOI 10.1111/j.1462-5822.2006.00813.x; Li B, 2006, FEBS LETT, V580, P4252, DOI 10.1016/j.febslet.2006.06.056; Lu WX, 2007, INT J CANCER, V120, P1023, DOI 10.1002/ijc.22388; Man S, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/384982; MONSKY WL, 1994, CANCER RES, V54, P5702; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; Perides G, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-56; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; RAZ A, 1980, BRIT J CANCER, V42, P331, DOI 10.1038/bjc.1980.235; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Rolland Y, 2009, PIGM CELL MELANOMA R, V22, P86, DOI 10.1111/j.1755-148X.2008.00525.x; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sloan AE, 2009, CANCER CONTROL, V16, P248, DOI 10.1177/107327480901600307; Sounni NE, 2002, INT J CANCER, V98, P23, DOI 10.1002/ijc.10134; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Tsung AJ, 2008, INT J ONCOL, V32, P557; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wesley UV, 1999, J EXP MED, V190, P311, DOI 10.1084/jem.190.3.311; Wilhelm I, 2007, PHYS MED BIOL, V52, P6261, DOI 10.1088/0031-9155/52/20/012; Wolburg H, 2005, ACTA NEUROPATHOL, V109, P181, DOI 10.1007/s00401-004-0928-x	42	89	94	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20758	10.1371/journal.pone.0020758	http://dx.doi.org/10.1371/journal.pone.0020758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674054	Green Published, gold, Green Submitted			2022-12-25	WOS:000291310600030
J	Bermudez, Y; Benavente, CA; Meyer, RG; Coyle, WR; Jacobson, MK; Jacobson, EL				Bermudez, Yira; Benavente, Claudia A.; Meyer, Ralph G.; Coyle, W. Russell; Jacobson, Myron K.; Jacobson, Elaine L.			Nicotinic Acid Receptor Abnormalities in Human Skin Cancer: Implications for a Role in Epidermal Differentiation	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; LANGERHANS CELLS; PUMA-G; PHOTODAMAGE; MECHANISMS; EXPRESSION; HM74A; MICE; PCR	Background: Chronic UV skin exposure leads to epidermal differentiation defects in humans that can be largely restored by pharmacological doses of nicotinic acid. Nicotinic acid has been identified as a ligand for the human G-protein-coupled receptors GPR109A and GPR109B that signal through G(i)-mediated inhibition of adenylyl cyclase. We have examined the expression, cellular distribution, and functionality of GPR109A/B in human skin and skin derived epidermal cells. Results: Nicotinic acid increases epidermal differentiation in photodamaged human skin as judged by the terminal differentiation markers caspase 14 and filaggrin. Both GPR109A and GPR109B genes are transcribed in human skin and in epidermal keratinocytes, but expression in dermal fibroblasts is below limits of detection. Receptor transcripts are greatly over-expressed in squamous cell cancers. Receptor protein in normal skin is prominent from the basal through granular layers of the epidermis, with cellular localization more dispersive in the basal layer but predominantly localized at the plasma membrane in more differentiated epidermal layers. In normal human primary and immortalized keratinocytes, nicotinic acid receptors show plasma membrane localization and functional G(i)-mediated signaling. In contrast, in a squamous cell carcinoma derived cell line, receptor protein shows a more diffuse cellular localization and the receptors are nearly non-functional. Conclusions: The results of these studies justify future genetic and pharmacological intervention studies to define possible specific role(s) of nicotinic acid receptors in human skin homeostasis.	[Bermudez, Yira] Univ Arizona, Coll Pharm, Arizona Canc Ctr, Tucson, AZ 85721 USA; Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	Arizona Center Cancer Care; University of Arizona; University of Arizona	Bermudez, Y (corresponding author), Univ Arizona, Coll Pharm, Arizona Canc Ctr, Tucson, AZ 85721 USA.	elaine.jacobson@pharmacy.arizona.edu		Benavente, Claudia/0000-0002-6875-3186	National Institutes of Health [CA43894, CA106677, CA78447, CA027502, ES06694, HD048837]; NiadynePharma, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048837] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA027502, T32CA078447, R25CA078447, R01CA043894, R01CA106677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NiadynePharma, Inc.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health grants CA43894, CA106677, CA78447, CA027502, ES06694, and HD048837. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MKJ and ELJ are principals in NiadynePharma, Inc., whose sponsored research is managed in accordance with the University of Arizona conflict-of-interest policies.	Benyo Z, 2005, J CLIN INVEST, V115, P3634, DOI 10.1172/JCI23626; Benyo Z, 2006, MOL PHARMACOL, V70, P1844, DOI 10.1124/mol.106.030833; BOUKAMP P, 1990, CANCER RES, V50, P2840; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Digby JE, 2009, CURR OPIN LIPIDOL, V20, P321, DOI 10.1097/MOL.0b013e32832d3b9d; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gensler HL, 1999, NUTR CANCER, V34, P36, DOI 10.1207/S15327914NC340105; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gille A, 2008, ANNU REV PHARMACOL, V48, P79, DOI 10.1146/annurev.pharmtox.48.113006.094746; Jacobson EL, 2007, EXP DERMATOL, V16, P490, DOI 10.1111/j.1600-0625.2007.00553.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maciejewski-Lenoir D, 2006, J INVEST DERMATOL, V126, P2637, DOI 10.1038/sj.jid.5700586; Mudgil AV, 2003, J INVEST DERMATOL, V121, P191, DOI 10.1046/j.1523-1747.2003.12320.x; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Richman JG, 2007, J BIOL CHEM, V282, P18028, DOI 10.1074/jbc.M701866200; Rowert-Huber J, 2007, BRIT J DERMATOL, V156, P8, DOI 10.1111/j.1365-2133.2007.07860.x; Schaumburg-Lever G., 1983, LIPPINCOTT, P422; Soga T, 2003, BIOCHEM BIOPH RES CO, V303, P364, DOI 10.1016/S0006-291X(03)00342-5; TANG H, 2008, BIOCH BIOPHYS RES CO; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Trautinger F, 2001, CLIN EXP DERMATOL, V26, P573, DOI 10.1046/j.1365-2230.2001.00893.x; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Walters RW, 2009, J CLIN INVEST, V119, P1312, DOI 10.1172/JCI36806; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zhou LB, 2007, MOL CELL BIOCHEM, V294, P243, DOI 10.1007/s11010-006-9150-6	26	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20487	10.1371/journal.pone.0020487	http://dx.doi.org/10.1371/journal.pone.0020487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655214	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600077
J	Robillard, JM; Gordon, GR; Choi, HB; Christie, BR; MacVicar, BA				Robillard, Julie M.; Gordon, Grant R.; Choi, Hyun B.; Christie, Brian R.; MacVicar, Brian A.			Glutathione Restores the Mechanism of Synaptic Plasticity in Aged Mice to That of the Adult	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL AREA CA1; NMDA-RECEPTOR; PEROXIDE MODULATION; ASSOCIATIVE MEMORY; REDOX MODULATION; N-ACETYLCYSTEINE; CALCIUM STORES; CA2+ RELEASE; NEURONS	Glutathione (GSH), the major endogenous antioxidant produced by cells, can modulate the activity of N-methyl-D-aspartate receptors (NMDARs) through its reducing functions. During aging, an increase in oxidative stress leads to decreased levels of GSH in the brain. Concurrently, aging is characterized by calcium dysregulation, thought to underlie impairments in hippocampal NMDAR-dependent long-term potentiation (LTP), a form of synaptic plasticity thought to represent a cellular model for memory. Here we show that orally supplementing aged mice with N-acetylcysteine, a precursor for the formation of glutathione, reverses the L-type calcium channel-dependent LTP seen in aged animals to NMDAR-dependent LTP. In addition, introducing glutathione in the intrapipette solution during whole-cell recordings restores LTP obtained in whole-cell conditions in the aged hippocampus. We conclude that aging leads to a reduced redox potential in hippocampal neurons, triggering impairments in LTP.	[Robillard, Julie M.; Gordon, Grant R.; Choi, Hyun B.; MacVicar, Brian A.] Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC, Canada; [Christie, Brian R.] Univ Victoria, Isl Med Program, Victoria, BC, Canada	University of British Columbia; University of Victoria	Robillard, JM (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Ctr, Vancouver, BC, Canada.	bmacvicar@brain.ubc.ca	Christie, Brian Ross/AAF-3766-2019; MacVicar, Brian/AAI-7729-2020; MacVicar, Brian/P-1553-2015	Christie, Brian Ross/0000-0002-6830-0160; MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Robillard, Julie/0000-0001-5765-4927	Canadian Institutes of Health Research; Fondation Leducq; Arthur and June Willms Fellowship; Heart and Stroke Foundation of Canada; Alberta Heritage Foundation for Medical Research; MSFHR; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation Leducq(Leducq Foundation); Arthur and June Willms Fellowship; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); MSFHR(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Supported by operating Grants from the Canadian Institutes of Health Research to B. A. M. and B. R. C. and by the Fondation Leducq to B. A. M. B. A. M. is a Canada Research Chair. H. B. C. was supported by postdoctoral fellowships from the Arthur and June Willms Fellowship and the Heart and Stroke Foundation of Canada. G.R.J.G. was supported by fellowships from the Alberta Heritage Foundation for Medical Research and MSFHR and Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaguer-Milian W, 2000, SYNAPSE, V38, P369, DOI 10.1002/1098-2396(20001215)38:4<369::AID-SYN1>3.0.CO;2-Q; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Auerbach JM, 1997, J NEUROSCI, V17, P8695; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bodhinathan K, 2010, J NEUROPHYSIOL, V104, P2586, DOI 10.1152/jn.00577.2010; Bodhinathan K, 2010, J NEUROSCI, V30, P1914, DOI 10.1523/JNEUROSCI.5485-09.2010; Burke SN, 2010, TRENDS NEUROSCI, V33, P153, DOI 10.1016/j.tins.2009.12.003; Choi YB, 2000, CELL MOL LIFE SCI, V57, P1535, DOI 10.1007/PL00000638; Ercal N, 1996, FREE RADICAL BIO MED, V21, P157, DOI 10.1016/0891-5849(96)00020-2; Foster TC, 2002, PROG BRAIN RES, V138, P283, DOI 10.1016/S0079-6123(02)38083-X; Foster TC, 2007, AGING CELL, V6, P319, DOI 10.1111/j.1474-9726.2007.00283.x; Fu AL, 2006, BRAIN RES, V1109, P201, DOI 10.1016/j.brainres.2006.06.042; Gant JC, 2006, J NEUROSCI, V26, P3482, DOI 10.1523/JNEUROSCI.4171-05.2006; Hidalgo C, 2004, BIOL RES, V37, P539, DOI 10.4067/S0716-97602004000400007; Hjelmstad GO, 1997, NEURON, V19, P1309, DOI 10.1016/S0896-6273(00)80421-3; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Janaky R, 1999, J NEUROCHEM, V73, P889, DOI 10.1046/j.1471-4159.1999.0730889.x; Kamsler A, 2003, J NEUROSCI, V23, P269; KATO K, 1993, NEUROSCIENCE, V53, P39, DOI 10.1016/0306-4522(93)90282-K; Klann E, 1998, J NEUROPHYSIOL, V80, P452, DOI 10.1152/jn.1998.80.1.452; Knapp LT, 2002, J NEUROSCI, V22, P674, DOI 10.1523/JNEUROSCI.22-03-00674.2002; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; KOLLER KJ, 1985, J NEUROSCI, V5, P2882; Kumar A, 2004, J NEUROPHYSIOL, V91, P2437, DOI 10.1152/jn.01148.2003; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Maher P, 2005, AGEING RES REV, V4, P288, DOI 10.1016/j.arr.2005.02.005; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Pessah IN, 2002, FRONT BIOSCI-LANDMRK, V7, pA72, DOI 10.2741/pessah; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Shaw CA, 1998, GLUTATHIONE NERVOUS; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; TANG LH, 1993, J PHYSIOL-LONDON, V465, P303, DOI 10.1113/jphysiol.1993.sp019678; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; Thiels E, 2000, J NEUROSCI, V20, P7631	42	67	68	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20676	10.1371/journal.pone.0020676	http://dx.doi.org/10.1371/journal.pone.0020676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655192	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600119
J	Marchesi, JR; Dutilh, BE; Hall, N; Peters, WHM; Roelofs, R; Boleij, A; Tjalsma, H				Marchesi, Julian R.; Dutilh, Bas E.; Hall, Neil; Peters, Wilbert H. M.; Roelofs, Rian; Boleij, Annemarie; Tjalsma, Harold			Towards the Human Colorectal Cancer Microbiome	PLOS ONE			English	Article							PROMOTES COLON TUMORIGENESIS; GRADIENT GEL-ELECTROPHORESIS; HUMAN GASTROINTESTINAL-TRACT; APC(MIN/+) MICE; MUCOSA; CELLS; COMMUNITIES; DIVERSITY; BACTERIA; ACTIVATION	Multiple factors drive the progression from healthy mucosa towards sporadic colorectal carcinomas and accumulating evidence associates intestinal bacteria with disease initiation and progression. Therefore, the aim of this study was to provide a first high-resolution map of colonic dysbiosis that is associated with human colorectal cancer (CRC). To this purpose, the microbiomes colonizing colon tumor tissue and adjacent non-malignant mucosa were compared by deep rRNA sequencing. The results revealed striking differences in microbial colonization patterns between these two sites. Although inter-individual colonization in CRC patients was variable, tumors consistently formed a niche for Coriobacteria and other proposed probiotic bacterial species, while potentially pathogenic Enterobacteria were underrepresented in tumor tissue. As the intestinal microbiota is generally stable during adult life, these findings suggest that CRC-associated physiological and metabolic changes recruit tumor-foraging commensal-like bacteria. These microbes thus have an apparent competitive advantage in the tumor microenvironment and thereby seem to replace pathogenic bacteria that may be implicated in CRC etiology. This first glimpse of the CRC microbiome provides an important step towards full understanding of the dynamic interplay between intestinal microbial ecology and sporadic CRC, which may provide important leads towards novel microbiome-related diagnostic tools and therapeutic interventions.	[Marchesi, Julian R.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Dutilh, Bas E.] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Dutilh, Bas E.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Hall, Neil] Univ Liverpool, Sch Biol Sci, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England; [Peters, Wilbert H. M.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands; [Peters, Wilbert H. M.; Roelofs, Rian; Boleij, Annemarie; Tjalsma, Harold] Radboud Univ Nijmegen, Med Ctr, RUCO, NL-6525 ED Nijmegen, Netherlands; [Roelofs, Rian; Boleij, Annemarie; Tjalsma, Harold] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen Inst Infect Inflammat & Immun N4i, NL-6525 ED Nijmegen, Netherlands	Cardiff University; Radboud University Nijmegen; California State University System; San Diego State University; California State University System; San Diego State University; University of Liverpool; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Marchesi, JR (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	H.Tjalsma@labgk.umcn.nl	Marchesi, Julian/AAC-9021-2020; Tjalsma, Harold/I-7146-2012; Hall, Neil/A-8717-2013; Peters, W.H.M./L-4572-2015; Boleij, Annemarie/L-3975-2013; Dutilh, Bas E./B-9719-2011; Marchesi, Julian/D-3731-2009	Hall, Neil/0000-0002-7995-3810; Boleij, Annemarie/0000-0003-4495-5880; Dutilh, Bas E./0000-0003-2329-7890; Marchesi, Julian/0000-0002-7994-5239; Hall, Neil/0000-0003-2808-0009	Dutch Cancer Society (KWF) [KUN 2006-3591]; Dutch Digestive Diseases Foundation (MDLS) [WO 10-53]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Dutch Digestive Diseases Foundation (MDLS)	AB was supported by the Dutch Cancer Society (KWF; Project KUN 2006-3591). Dutch Digestive Diseases Foundation (MDLS; project WO 10-53). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2007, APPL ENVIRON MICROB, V73, P7435, DOI 10.1128/AEM.01143-07; Boleij A, 2010, CANCER-AM CANCER SOC, V116, P4014, DOI 10.1002/cncr.25212; Boleij A, 2009, J CLIN MICROBIOL, V47, P516, DOI 10.1128/JCM.01755-08; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818; Borneman J, 1997, APPL ENVIRON MICROB, V63, P2647, DOI 10.1128/AEM.63.7.2647-2653.1997; Choi EJ, 2009, CHEM-BIOL INTERACT, V177, P7, DOI 10.1016/j.cbi.2008.09.031; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Corfield AP, 2000, GUT, V47, P589, DOI 10.1136/gut.47.4.589; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Green GL, 2006, J APPL MICROBIOL, V100, P460, DOI 10.1111/j.1365-2672.2005.02783.x; Hausen HZ, 2006, INT J CANCER, V119, pXI, DOI 10.1002/ijc.22314; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; JIN JS, 2009, INT J SYST EVOL MICR, V4, P4; Kang HY, 2006, DIGEST DIS SCI, V51, P2310, DOI 10.1007/s10620-006-9276-0; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Maggio-Price L, 2009, AM J PATHOL, V174, P317, DOI 10.2353/ajpath.2009.080485; Makivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553; Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Nubel U, 1996, J BACTERIOL, V178, P5636; Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Righi V, 2009, J PROTEOME RES, V8, P1859, DOI 10.1021/pr801094b; Rowland IR, 2009, CURR PHARM DESIGN, V15, P1524, DOI 10.2174/138161209788168191; Rudi K, 2007, INT J FOOD MICROBIOL, V120, P95, DOI 10.1016/j.ijfoodmicro.2007.06.004; Rudi K, 2007, APPL ENVIRON MICROB, V73, P2727, DOI 10.1128/AEM.01205-06; Rudi K, 2006, INT J SYST EVOL MICR, V56, P1565, DOI 10.1099/ijs.0.63936-0; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P1382, DOI 10.1111/j.1462-2920.2008.01622.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCOTTCONNER CEH, 1995, J AM COLL SURGEONS, V181, P182; Seder CW, 2009, J VASC SURG, V49, P1304, DOI 10.1016/j.jvs.2008.11.058; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tjalsma H, 2006, INT J CANCER, V119, P2127, DOI 10.1002/ijc.22116; Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; WAISBERG, 2002, ARQ GASTROENTEROL, V39, P177; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	57	367	398	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20447	10.1371/journal.pone.0020447	http://dx.doi.org/10.1371/journal.pone.0020447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647227	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000291005800052
J	Heiska, L; Melikova, M; Zhao, F; Saotome, I; McClatchey, AI; Carpen, O				Heiska, L.; Melikova, M.; Zhao, F.; Saotome, I.; McClatchey, A. I.; Carpen, O.			Ezrin is key regulator of Src-induced malignant phenotype in three-dimensional environment	ONCOGENE			English	Article						Src; ezrin; ERM proteins; invasion; 3D matrix	HUMAN COLORECTAL-CANCER; HUMAN COLON-CANCER; ELEVATED C-SRC; CELL-MIGRATION; TYROSINE PHOSPHORYLATION; KINASE-ACTIVITY; PROTEIN EZRIN; ERM PROTEINS; EXPRESSION; ACTIVATION	The oncogenic tyrosine kinase Src has a role in cancer development, especially by promoting invasive and metastatic behavior. It is, however, unclear which of the Src-regulated signaling cascades induce malignant phenotype in three-dimensional environment. One of Src substrates is ezrin, a cytoskeletal organiser and regulator of signal transduction. Ezrin expression correlates with poor outcome of diverse cancers and is essential in experimental metastatic osteosarcoma. We reconstituted genetically ezrin-deficient cells with wild-type (WT) or phosphorylation-deficient Y477F ezrin together with constitutively active Src. In two-dimensional cultures, Src induced malignant features regardless of the presence or absence of ezrin. In contrast, only WT ezrin-expressing cells grew efficiently in soft agar or in suspension. In Matrigel, only WT ezrin significantly promoted growth and invasion, and was targeted to specific regions on the plasma membrane. WT and Y477F ezrin-expressing cells showed marked differences only when growing or scattering in three-dimensional matrix. Additional experiments showed that Y477-phosphorylated ezrin is also needed for the growth of Src-transformed epithelial cells in three-dimensional matrix. Cells lacking functional ezrin had reduced cyclin D levels and fewer cells in G2+S phase, possibly as a consequence of abnormal mTOR signaling, as ezrin Y477F cells showed lower expression of phosphorylated intermediates downstream of mTOR than WT cells. We conclude that the pathways activated by Src depend on the type of environment and that ezrin is a crucial element of Src-induced malignant features in cells growing inside three-dimensional environment. Oncogene (2011) 30, 4953-4962; doi:10.1038/onc.2011.207; published online 13 June 2011	[Carpen, O.] Univ Turku, Dept Pathol, FIN-20520 Turku, Finland; [Heiska, L.; Melikova, M.; Zhao, F.; Carpen, O.] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Saotome, I.; McClatchey, A. I.] MGH Canc Ctr, Charlestown, MA USA; [Saotome, I.; McClatchey, A. I.] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA USA; [Melikova, M.] Turku Univ Hosp, FIN-20520 Turku, Finland	University of Turku; University of Helsinki; Harvard University; University of Turku	Carpen, O (corresponding author), Univ Turku, Dept Pathol, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	olli.carpen@utu.fi			Finnish Cancer Organizations, US Department of Defense [W81XWH-05-1-046]; Turku University Central Hospital District	Finnish Cancer Organizations, US Department of Defense; Turku University Central Hospital District	We thank JA Cooper for the pLXSH-SrcY527F plasmid; SL Fu for the RK3E cells, Sa Tsukita for the anti-moesin antibody; and H Ahola for technical assistance. The study was supported by Finnish Cancer Organizations, US Department of Defense grant W81XWH-05-1-046, and the Medical Research Fund of Turku University Central Hospital District to OC.	Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Autero M, 2003, FEBS LETT, V535, P82, DOI 10.1016/S0014-5793(02)03861-9; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Boyd DD, 2004, CLIN CANCER RES, V10, P1545, DOI 10.1158/1078-0432.CCR-1565-02; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Eleveld-Trancikova D, 2002, INT J ONCOL, V20, P501; Elliott BE, 2004, J CELL BIOCHEM, V92, P16, DOI 10.1002/jcb.20033; Elzagheid A, 2008, HUM PATHOL, V39, P1737, DOI 10.1016/j.humpath.2008.04.020; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Fu SL, 2005, BIOCHEM BIOPH RES CO, V338, P830, DOI 10.1016/j.bbrc.2005.10.045; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Geiger KD, 2000, AM J PATHOL, V157, P1785, DOI 10.1016/S0002-9440(10)64816-X; Heiska L, 2005, J BIOL CHEM, V280, P10244, DOI 10.1074/jbc.M411353200; Ilmonen S, 2005, MODERN PATHOL, V18, P503, DOI 10.1038/modpathol.3800300; Irby RB, 2000, ONCOGENE, V19, P5636, DOI 10.1038/sj.onc.1203912; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Jones RJ, 2002, BRIT J CANCER, V87, P1128, DOI 10.1038/sj.bjc.6600594; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kobel M, 2006, MODERN PATHOL, V19, P581, DOI 10.1038/modpathol.3800567; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; KRIEG J, 1992, J BIOL CHEM, V267, P19258; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Makitie T, 2001, INVEST OPHTH VIS SCI, V42, P2442; Malek RL, 2002, ONCOGENE, V21, P7256, DOI 10.1038/sj.onc.1205900; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Ohtani K, 2002, CANCER LETT, V179, P79, DOI 10.1016/S0304-3835(01)00857-6; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Weng WH, 2005, CLIN CANCER RES, V11, P6198, DOI 10.1158/1078-0432.CCR-05-0548; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yu YL, 2006, CANCER RES, V66, P1982, DOI 10.1158/0008-5472.CAN-05-2360	46	26	28	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	50					4953	4962		10.1038/onc.2011.207	http://dx.doi.org/10.1038/onc.2011.207			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YJ	21666723				2022-12-25	WOS:000298346500004
J	Wang, MY; Ji, SR; Bai, CJ; El Kebir, D; Li, HY; Shi, JM; Zhu, W; Costantino, S; Zhou, HH; Potempa, LA; Zhao, J; Filep, JG; Wu, Y				Wang, Ming-Yu; Ji, Shang-Rong; Bai, Cai-Juan; El Kebir, Driss; Li, Hai-Yun; Shi, Jing-Ming; Zhu, Wei; Costantino, Santiago; Zhou, Hai-Hong; Potempa, Lawrence A.; Zhao, Jing; Filep, Janos G.; Wu, Yi			A redox switch in C-reactive protein modulates activation of endothelial cells	FASEB JOURNAL			English	Article						thioredoxin; coronary artery disease; inflammation; pathology	E-DEFICIENT MICE; HUMAN NEUTROPHILS; THIOREDOXIN; ATHEROSCLEROSIS; DISSOCIATION; LESIONS	C-reactive protein (CRP) has been implicated in the regulation of inflammation underlying coronary artery disease; however, little is known about the molecular mechanisms responsible for the expression of its pro-or anti-inflammatory activities. Here, we have identified the intrasubunit disulfide bond as a conserved switch that controls the structure and functions of CRP. Conformational rearrangement in human pentameric CRP to monomeric CRP (mCRP) is the prerequisite for this switch to be activated by reducing agents, including thioredoxin. Immunohistochemical analysis revealed 36-79% colocalization of thioredoxin and mCRP in human advanced coronary atherosclerotic lesions. Nonreduced mCRP was largely inert in activating human coronary artery endothelial cells (HCAECs), whereas reduced or cysteine-mutated mCRP evoked marked release of IL-8 and monocyte chemoattractant protein-1 from HCAECs, with similar to 50% increase at a concentration of 1 mu g/ml. Reduced mCRP was similar to 4 to 40-fold more potent than mCRP in up-regulating adhesion molecule expression, promoting U937 monocyte adhesion to HCAECs, and inducing cytokine release from rabbit arteries ex vivo and in mice. These actions were primarily due to unlocking the lipid raft interaction motif. Therefore, expression of proinflammatory properties of CRP on endothelial cells requires sequential conformational changes, i.e., loss of pentameric symmetry followed by reduction of the intrasubunit disulfide bond.-Wang M-Y., Ji, S-R., Bai, C-J., El Kebir, D., Li, H-Y., Shi, J-M., Zhu, W., Costantino, S., Zhou, H-H., Potempa, L. A., Zhao, J., Filep, J. G., Wu, Y. A redox switch in C-reactive protein modulates activation of endothelial cells. FASEB J. 25, 3186-3196 (2011). www.fasebj.org	[Wang, Ming-Yu; Ji, Shang-Rong; Bai, Cai-Juan; Li, Hai-Yun; Shi, Jing-Ming; Zhu, Wei; Zhou, Hai-Hong; Zhao, Jing; Filep, Janos G.; Wu, Yi] Lanzhou Univ, Minist Educ Key Lab Arid & Grassland Ecol, Inst Biophys, Lanzhou 730000, Peoples R China; [Wang, Ming-Yu; Ji, Shang-Rong; Bai, Cai-Juan; Li, Hai-Yun; Shi, Jing-Ming; Zhu, Wei; Zhou, Hai-Hong; Zhao, Jing; Wu, Yi] Lanzhou Univ, Hosp 2, Lanzhou 730000, Peoples R China; [El Kebir, Driss; Costantino, Santiago; Filep, Janos G.] Univ Montreal, Res Ctr, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada; [Potempa, Lawrence A.] Roosevelt Univ, Coll Pharm, Schaumburg, IL USA	Lanzhou University; Lanzhou University; Universite de Montreal	Filep, JG (corresponding author), Lanzhou Univ, Minist Educ Key Lab Arid & Grassland Ecol, Inst Biophys, Tianshui Nanlu 222, Lanzhou 730000, Peoples R China.	janos.g.filep@umontreal.ca; wuy@lzu.edu.cn	Costantino, Santiago/ABD-5472-2020; Shi, Jing-Ming/ACS-3321-2022	Costantino, Santiago/0000-0002-2454-2635; Shi, Jing-Ming/0000-0002-8185-3130; Wang, Ming-Yu/0000-0002-6622-5996; Wu, Yi/0000-0003-0365-5590; Li, Haiyun/0000-0002-7458-7399; Ji, Shang-Rong/0000-0001-8595-3756	National Natural Science Foundation of China (NSFC) [30930024, 30770451, 30870495]; NSFC-Canadian Institutes of Health Research (CIHR) [30711120578, CCI-85707]; CIHR [MOP-94851]; Ministry of Science and Technology of China (MOST) [2011CB910500]; New Century Excellent Talents in University of China (NCET) [NCET-07-0392]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC-Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ministry of Science and Technology of China (MOST)(Ministry of Science and Technology, China); New Century Excellent Talents in University of China (NCET)(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants from the National Natural Science Foundation of China (NSFC; 30930024, 30770451, and 30870495), NSFC-Canadian Institutes of Health Research (CIHR; 30711120578 and CCI-85707), CIHR (MOP-94851), Ministry of Science and Technology of China (MOST; 2011CB910500), and the Program for New Century Excellent Talents in University of China (NCET; NCET-07-0392). The authors declare no conflicts of interest.	Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Ciubotaru I, 2005, EXP BIOL MED, V230, P762, DOI 10.1177/153537020523001010; Devaraj S, 2006, ATHEROSCLEROSIS, V184, P48, DOI 10.1016/j.atherosclerosis.2005.03.031; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Filep JG, 2009, CIRC RES, V105, P109, DOI 10.1161/CIRCRESAHA.109.202010; Heuertz RM, 2005, INT J BIOCHEM CELL B, V37, P320, DOI 10.1016/j.biocel.2004.07.002; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; Hoshino Y, 2007, ANTIOXID REDOX SIGN, V9, P689, DOI 10.1089/ars.2007.1575; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Kemp M, 2008, FREE RADICAL BIO MED, V44, P921, DOI 10.1016/j.freeradbiomed.2007.11.008; Khreiss T, 2005, CIRC RES, V97, P690, DOI 10.1161/01.RES.0000183881.11739.CB; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; Miyamoto S, 2003, AM HEART J, V146, P465, DOI 10.1016/S0002-8703(03)00311-9; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Mukherjee A, 2008, BRIT J RADIOL, V81, pS57, DOI 10.1259/bjr/34180435; Nishihira K, 2008, ATHEROSCLEROSIS, V201, P360, DOI 10.1016/j.atherosclerosis.2008.03.005; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pagliei S, 2002, EUR CYTOKINE NETW, V13, P261; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Schwedler SB, 2006, AM J KIDNEY DIS, V47, P212, DOI 10.1053/j.ajkd.2005.10.028; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Schwedler SB, 2009, CLIN CHEM, V55, P1728, DOI 10.1373/clinchem.2009.125732; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Taylor KE, 2007, IMMUNOLOGY, V120, P404, DOI 10.1111/j.1365-2567.2006.02516.x; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Verma S, 2006, CIRCULATION, V113, P2135; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Wu Y, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1377, DOI 10.1023/A:1021862027061; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; YING SC, 1989, J IMMUNOL, V143, P221; Yoshida S, 1999, J IMMUNOL, V163, P351; [赵晶 ZHAO Jing], 2010, [生物物理学报, Acta Biophysica Sinica], V26, P87; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505	46	63	72	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	SEP	2011	25	9					3186	3196		10.1096/fj.11-182741	http://dx.doi.org/10.1096/fj.11-182741			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21670067				2022-12-25	WOS:000294435200031
J	Wu, SC; Zhang, Y				Wu, Susan C.; Zhang, Yi			Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of Enhancer of Zeste 2 (Ezh2) Regulates Its Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; EMBRYONIC STEM-CELLS; SUPPRESSES METHYLATION; POLYCOMB; CANCER; DROSOPHILA; GENE; COMPLEX; DIFFERENTIATION	The H3K27 histone methyltransferase, Ezh2 (enhancer of zeste 2), is a Polycomb group protein that plays important roles in many biological processes including cellular differentiation, stem cell biology, and cancer development. Up-regulation of Ezh2 is observed in various human cancers consistent with its role in cell proliferation. Thus, understanding the regulation of Ezh2 may reveal how it contributes to the cellular proliferation process. Here, we demonstrate that Ezh2 can be regulated by the cyclin-dependent kinase, CDK1, which phosphorylates Ezh2 at threonines 345 and 487. Consistent with the cell cycle phase during which CDK1 exhibits peak activity, Ezh2 phosphorylation is enriched in cells arrested in mitosis when compared with S-phase. Phosphorylation of Thr-345 and Thr-487 promotes Ezh2 ubiquitination and subsequent degradation by the proteasome. Furthermore, expression of T345A/T487A confers a proliferative disadvantage when compared with cells expressing wild-type Ezh2, which suggests that phosphorylation of Ezh2 is important for cell proliferation. Collectively, these results establish a novel function for CDK1-mediated Ezh2 phosphorylation and provide a mechanism by which Ezh2 protein levels can be regulated in cells.	[Wu, Susan C.; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	National Institutes of Health [GM68804]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM68804 (to Y. Z.).	Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dimri M, 2010, CARCINOGENESIS, V31, P489, DOI 10.1093/carcin/bgp305; DUNCAN IM, 1982, GENETICS, V102, P49; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139	31	92	95	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28511	28519		10.1074/jbc.M111.240515	http://dx.doi.org/10.1074/jbc.M111.240515			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21659531	hybrid, Green Published			2022-12-25	WOS:000293557800066
J	Veit, G; Zwolanek, D; Eckes, B; Niland, S; Kapyla, J; Zweers, MC; Ishada-Yamamoto, A; Krieg, T; Heino, J; Eble, JA; Koch, M				Veit, Guido; Zwolanek, Daniela; Eckes, Beate; Niland, Stephan; Kapyla, Jarmo; Zweers, Manon C.; Ishada-Yamamoto, Akemi; Krieg, Thomas; Heino, Jyrki; Eble, Johannes A.; Koch, Manuel			Collagen XXIII, Novel Ligand for Integrin alpha(2)beta(1) in the Epidermis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; BRANCHING MORPHOGENESIS; CELL-ADHESION; A-DOMAIN; I-DOMAIN; ALPHA-2-BETA-1; EXPRESSION; MIGRATION; RECEPTOR; ALPHA(1)BETA(1)	Cellular receptors for collagens belong to the family of beta(1) integrins. In the epidermis, integrin alpha(2)beta(1) is the only collagen-binding integrin present. Its expression is restricted to basal keratinocytes with uniform distribution on the cell surface of those cells. Although alpha(2)beta(1) receptors localized at the basal surface interact with basement membrane proteins collagen IV and laminin 111 and 332, no interaction partners have been reported for these integrin molecules at the lateral and apical membranes of basal keratinocytes. Solid phase binding and surface plasmon resonance spectroscopy demonstrate that collagen XXIII, a member of the transmembrane collagens, directly interacts with integrin alpha(2)beta(1) in an ion-and conformation-dependent manner. The two proteins co-localize on the surface of basal keratinocytes. Furthermore, collagen XXIII is sufficient to induce adhesion and spreading of keratinocytes, a process that is significantly reduced in the absence of functional integrin alpha(2)beta(1).	[Koch, Manuel] Univ Cologne, Fac Med, Inst Oral & Musculoskeletal Biol, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Veit, Guido; Zwolanek, Daniela] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Eckes, Beate; Zweers, Manon C.; Krieg, Thomas] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Kapyla, Jarmo; Heino, Jyrki] Univ Turku, Dept Biochem & Food Chem, FI-20014 Turku, Finland; [Niland, Stephan; Eble, Johannes A.] Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, D-60590 Frankfurt, Germany; [Ishada-Yamamoto, Akemi] Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; [Koch, Manuel] Univ Cologne, Sch Dent, Inst Oral & Musculoskeletal Biol, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Turku; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Asahikawa Medical College; University of Cologne	Koch, M (corresponding author), Univ Cologne, Fac Med, Inst Oral & Musculoskeletal Biol, Ctr Mol Med Cologne, Kerpener Str 32, D-50931 Cologne, Germany.	manuel.koch@uni-koeln.de	Veit, Guido/C-9596-2009; Zwolanek, Daniela/AAN-8767-2020; Koch, Manuel/AAG-9914-2021; Zweers, Manon/E-5090-2016	Veit, Guido/0000-0002-6758-2696; Koch, Manuel/0000-0002-2962-7814; Kapyla, Jarmo/0000-0003-3036-713X	Deutsche Forschungsgemeinschaft [EC140/5-1, SFB/TR 23, SFB815, SFB829]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants EC140/5-1 (to B. E. and T. K.), SFB/TR 23 and SFB815 (to J. A. E.), and SFB829 (to M. K., T. K., and B. E.).	Aquilina A, 2002, EUR J BIOCHEM, V269, P1136, DOI 10.1046/j.0014-2956.2001.02740.x; Banyard J, 2003, J BIOL CHEM, V278, P20989, DOI 10.1074/jbc.M210616200; Banyard J, 2007, CLIN CANCER RES, V13, P2634, DOI 10.1158/1078-0432.CCR-06-2163; Calderwood DA, 1997, J BIOL CHEM, V272, P12311, DOI 10.1074/jbc.272.19.12311; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Decline F, 2001, J CELL SCI, V114, P811; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Eble JA, 2006, J BIOL CHEM, V281, P25745, DOI 10.1074/jbc.M509942200; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; Franzke CW, 2005, J BIOL CHEM, V280, P4005, DOI 10.1074/jbc.R400034200; Galle J, 2002, CELL COMMUN ADHES, V9, P161, DOI 10.1080/15419060214523; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Kapyla J, 2004, J BIOL CHEM, V279, P51677, DOI 10.1074/jbc.M409412200; Kapyla J, 2000, J BIOL CHEM, V275, P3348, DOI 10.1074/jbc.275.5.3348; Kapyla J, 2007, J MED CHEM, V50, P2742, DOI 10.1021/jm070063t; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Koch M, 2006, J BIOL CHEM, V281, P21546, DOI 10.1074/jbc.M604131200; Koivisto L, 1999, CELL ADHES COMMUN, V7, P245, DOI 10.3109/15419069909010806; Kuijpers MJE, 2007, THROMB HAEMOSTASIS, V98, P1072, DOI 10.1160/TH07-02-0089; Langholz O, 1995, J CELL BIOL, V131, P1903, DOI 10.1083/jcb.131.6.1903; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; PFAFF M, 1994, EUR J BIOCHEM, V225, P975, DOI 10.1111/j.1432-1033.1994.0975b.x; SAELMAN EUM, 1995, J CELL SCI, V108, P3531; SCHARFFETTERKOCHANEK K, 1992, J INVEST DERMATOL, V98, P3, DOI 10.1111/1523-1747.ep12493266; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Tulla M, 2001, J BIOL CHEM, V276, P48206, DOI 10.1074/jbc.M104058200; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Veit G, 2007, J BIOL CHEM, V282, P27424, DOI 10.1074/jbc.M703425200; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Werr J, 2000, BLOOD, V95, P1804, DOI 10.1182/blood.V95.5.1804.005k11_1804_1809; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; WU JE, 1994, DEV DYNAM, V199, P292, DOI 10.1002/aja.1001990405; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zigrino P, 2001, EUR J CELL BIOL, V80, P68, DOI 10.1078/0171-9335-00134; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	49	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27804	27813		10.1074/jbc.M111.220046	http://dx.doi.org/10.1074/jbc.M111.220046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652699	Green Published, hybrid			2022-12-25	WOS:000293268700072
J	Wall-Lacelle, S; Hossain, MI; Sauve, R; Blunck, R; Parent, L				Wall-Lacelle, Sebastien; Hossain, Md. Israil; Sauve, Remy; Blunck, Rikard; Parent, Lucie			Double Mutant Cycle Analysis Identified a Critical Leucine Residue in the IIS4S5 Linker for the Activation of the Ca(V)2.3 Calcium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNELS; CLOSED-STATE INACTIVATION; GATED CA2+ CHANNELS; I-II LINKER; VOLTAGE SENSOR; S4-S5 LINKER; BETA-SUBUNIT; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION	Mutations in distal S6 were shown to significantly alter the stability of the open state of Ca(V)2.3 (Raybaud, A., Baspinar, E. E., Dionne, F., Dodier, Y., Sauve, R., and Parent, L. (2007) J. Biol. Chem. 282, 27944-27952). By analogy with K-V channels, we tested the hypothesis that channel activation involves electro-mechanical coupling between S6 and the S4S5 linker in Ca(V)2.3. Among the 11 positions tested in the S4S5 linker of domain II, mutations of the leucine residue at position 596 were found to destabilize significantly the closed state with a -50 mV shift in the activation potential and a -20 mV shift in its charge-voltage relationship as compared with Ca(V)2.3 wt. Adouble mutant cycle analysis was performed by introducing pairs of glycine residues between S4S5 and S6 of Domain II. Strong coupling energies (Delta Delta G(interact) > 2 kcal mol(-1)) were measured for the activation gating of 12 of 39 pairs of mutants. Leu-596 (IIS4S5) was strongly coupled with distal residues in IIS6 from Leu-699 to Asp-704. In particular, the double mutant L596G/I701G showed strong cooperativity with a Delta Delta G(interact) approximate to 6 kcal mol(-1) suggesting that both positions contribute to the activation gating of the channel. Altogether, our results highlight the role of a leucine residue in S4S5 and provide the first series of evidence that the IIS4S5 and IIS6 regions are energetically coupled during the activation of a voltage-gated Ca-V channel.	[Hossain, Md. Israil; Sauve, Remy; Parent, Lucie] Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Wall-Lacelle, Sebastien; Blunck, Rikard] Univ Montreal, Membrane Prot Res Grp, Dept Phys, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Parent, L (corresponding author), Univ Montreal, Dept Physiol, POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	lucie.parent@umontreal.ca	Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Canadian Institutes of Health Research [MOP13390]; Canadian Heart and Stroke Foundation; FRSQ	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grant MOP13390 and a grant from the Canadian Heart and Stroke Foundation (to L. P.).; Members of the FRSQ-supported "Groupe d'etude des proteines membranaires."	Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Barghaan J, 2009, J GEN PHYSIOL, V133, P205, DOI 10.1085/jgp.200810073; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Berrou L, 2005, J BIOL CHEM, V280, P494, DOI 10.1074/jbc.M410859200; Berrou L, 2001, BIOPHYS J, V80, P215, DOI 10.1016/S0006-3495(01)76008-0; Birnbaumer L, 1998, J BIOENERG BIOMEMBR, V30, P357, DOI 10.1023/A:1021989622656; BIRNBAUMER L, 1994, NEURON, V13, P505, DOI 10.1016/0896-6273(94)90021-3; CASTELLANO A, 1993, J BIOL CHEM, V268, P3450; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Gagnon DG, 2010, J GEN PHYSIOL, V136, P555, DOI 10.1085/jgp.201010487; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Haddad GA, 2011, J GEN PHYSIOL, V137, P455, DOI 10.1085/jgp.201010573; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kudrnac M, 2009, J BIOL CHEM, V284, P12276, DOI 10.1074/jbc.M808402200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kusch J, 2010, BIOPHYS J, V99, P2488, DOI 10.1016/j.bpj.2010.07.041; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; Meza U, 2007, MOL PHARMACOL, V71, P284, DOI 10.1124/mol.106.028530; Olcese R, 1996, J PHYSIOL-LONDON, V497, P675, DOI 10.1113/jphysiol.1996.sp021799; Parent L, 1997, J MEMBRANE BIOL, V160, P127, DOI 10.1007/s002329900302; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Randall A, 1999, MOL CELL NEUROSCI, V14, P255, DOI 10.1006/mcne.1999.0795; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; SCHNEIDER T, 1994, RECEPTOR CHANNEL, V2, P255; Snutch T P, 1992, Curr Opin Neurobiol, V2, P247, DOI 10.1016/0959-4388(92)90111-W; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Van Slyke AC, 2010, BIOPHYS J, V99, P2841, DOI 10.1016/j.bpj.2010.08.030; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9	47	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27197	27205		10.1074/jbc.M111.237412	http://dx.doi.org/10.1074/jbc.M111.237412			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652722	Green Published, hybrid			2022-12-25	WOS:000293268700015
J	Le May, M; Mach, H; Lacroix, N; Hou, CC; Chen, JH; Li, Q				Le May, Melanie; Mach, Hymn; Lacroix, Natascha; Hou, Chenchen; Chen, Jihong; Li, Qiao			Contribution of Retinoid X Receptor Signaling to the Specification of Skeletal Muscle Lineage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONAL CARCINOMA-CELLS; TRANSCRIPTIONAL COACTIVATOR P300; AKT/PROTEIN KINASE-B; STEM-CELLS; RXR-ALPHA; VALPROIC ACID; BETA-CATENIN; P19 CELLS; DIFFERENTIATION; EXPRESSION	Pluripotent stem cells possess a tremendous potential for the treatment of many diseases because of their capacity to differentiate into a variety of cell lineages. However, they provide little promise for muscle-related diseases, mainly because of the lack of small molecule inducers to efficiently direct myogenic conversion. Retinoic acid, acting through the retinoic acid receptor (RAR) and retinoid X receptor (RXR), affects stem cell fate determination in a concentration-dependent manner, but it only has a modest efficacy on the commitment of ES cells into skeletal muscle lineage. The RXR is very important for embryonic development but is generally considered to act as a silent partner of RAR in a non-permissive mode. In this study, we have examined whether activation of the RXR by rexinoid or RXR-specific signaling play a role in the specification of stem cells into muscle lineage. Our findings demonstrate that mouse ES cells generate skeletal myocytes effectively upon treatment with rexinoid at the early stage of differentiation and that on a molecular level, rexinoid-enhanced myogenesis simulates the sequential events observed in vivo. Moreover, RXR-mediated myogenic conversion requires the function of beta-catenin but not RAR. Our studies establish the feasibility of applying the RXR agonist in cell-based therapies to treat muscle-related diseases. The aptitude of mouse ES cells to generate skeletal myocytes following rexinoid induction also provides a model system to study the convergence of different signaling pathways in myogenesis.	[Mach, Hymn; Lacroix, Natascha; Hou, Chenchen; Chen, Jihong; Li, Qiao] Univ Ottawa, Dept Pathol & Lab Med, Fac Med, Ottawa, ON K1H 8M5, Canada; [Le May, Melanie; Li, Qiao] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Li, Q (corresponding author), Univ Ottawa, Dept Pathol & Lab Med, Fac Med, 451 Smyth Rd,Room 2537, Ottawa, ON K1H 8M5, Canada.	qiaoli@uottawa.ca		Li, Qiao/0000-0002-5941-1985; Chen, Jihong/0000-0001-7336-8808	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Natural Sciences and Engineering Research Council of Canada and by a graduate scholarship award from the Canadian Institutes of Health Research (to M. L.).	Allsopp TE, 2010, MEDCHEMCOMM, V1, P16, DOI 10.1039/c0md00055h; Berbis P, 2010, ANN DERMATOL VENER, V137, pS97, DOI 10.1016/S0151-9638(10)70036-3; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9; Chen JH, 2005, MOL CELL BIOL, V25, P525, DOI 10.1128/MCB.25.2.525-532.2005; Chen JH, 2007, EPIGENETICS-US, V2, P92, DOI 10.4161/epi.2.2.4326; Chen JH, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-71; Chen JH, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12224; Costa SL, 1996, EXP CELL RES, V225, P35, DOI 10.1006/excr.1996.0154; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Francetic T, 2011, TRANSCR-AUSTIN, V2, P109, DOI 10.4161/trns.2.3.15829; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Higazi A, 2011, EPIGENETICS-US, V6, P202, DOI 10.4161/epi.6.2.13658; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; KUROKAWA R, 1994, NATURE, V371, P528, DOI 10.1038/371528a0; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Petropoulos H, 2004, J BIOL CHEM, V279, P23874, DOI 10.1074/jbc.M312612200; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; PRATT MAC, 1990, MOL CELL BIOL, V10, P6445, DOI 10.1128/MCB.10.12.6445; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; RUDNICKI MA, 1989, DEVELOPMENT, V107, P361; Sapin V, 1997, DEV BIOL, V191, P29, DOI 10.1006/dbio.1997.8687; Sato Y, 2008, DEV BIOL, V320, P185, DOI 10.1016/j.ydbio.2008.05.524; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tanaka T, 2009, CANCER RES, V69, P4945, DOI 10.1158/0008-5472.CAN-08-4407; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; WILLIAMS BA, 1994, DEVELOPMENT, V120, P785; Yokota Y, 1996, EXP CELL RES, V228, P1, DOI 10.1006/excr.1996.0291; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	45	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26806	26812		10.1074/jbc.M111.227058	http://dx.doi.org/10.1074/jbc.M111.227058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653693	hybrid, Green Published			2022-12-25	WOS:000293078200056
J	Liang, QL; Wu, QA; Jiang, JH; Duan, JA; Wang, C; Smith, MD; Lu, H; Wang, Q; Nagarkatti, P; Fan, DP				Liang, Qiaoli; Wu, Qinan; Jiang, Jihong; Duan, Jin'ao; Wang, Chao; Smith, Mark D.; Lu, Hong; Wang, Qian; Nagarkatti, Prakash; Fan, Daping			Characterization of Sparstolonin B, a Chinese Herb-derived Compound, as a Selective Toll-like Receptor Antagonist with Potent Anti-inflammatory Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE CELLS; DOUBLE-BLIND; INNATE; ACTIVATION; EXPRESSION; TOLL-LIKE-RECEPTOR-4; INFLAMMATION; TAK-242; MICE; TLR	BlockadeofexcessiveToll-likereceptor(TLR) signalingisatherapeutic approach being actively pursued for many inflammatory diseases. Here we report a Chinese herb-derived compound, sparstoloninB(SsnB), which selectively blocks TLR2-and TLR4-mediated inflammatory signaling. SsnB was isolated from a Chinese herb, Spaganium stoloniferum; its structure was determined by NMR spectroscopy and x-ray crystallography. SsnB effectively inhibited inflammatory cytokine expression in mouse macrophages induced by lipopolysaccharide (LPS, a TLR4 ligand), Pam3CSK4 (a TLR1/TLR2 ligand), and Fsl-1 (a TLR2/TLR6 ligand) but not that by poly(I: C) (a TLR3 ligand) or ODN1668 (a TLR9 ligand). It suppressed LPS-induced cytokine secretion from macrophages and diminished phosphorylation of Erk1/2, p38a, I kappa B alpha, and JNK in these cells. In THP-1 cells expressing a chimeric receptor CD4-TLR4, which triggers constitutive NF-kappa Bactivation, SsnB effectively blunted the NF-kappa B activity. Co-immunoprecipitation showed that SsnB reduced the association of MyD88 with TLR4 and TLR2, but not that with TLR9, in HEK293T cells and THP-1 cells overexpressing MyD88 and TLRs. Furthermore, administration of SsnB suppressed splenocyte inflammatory cytokine expression in mice challenged with LPS. These results demonstrate that SsnB acts as a selective TLR2 and TLR4 antagonist by blocking the early intracellular events in the TLR2 and TLR4 signaling. Thus, SssB may serve as a promising lead for the development of selective TLR antagonistic agents for inflammatory diseases.	[Liang, Qiaoli; Lu, Hong; Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29209 USA; [Nagarkatti, Prakash] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA; [Liang, Qiaoli; Wu, Qinan; Duan, Jin'ao] Nanjing Univ Chinese Med, Sch Pharm, Nanjing 210046, Peoples R China; [Jiang, Jihong] Xuzhou Normal Univ, Key Lab Biotechnol Med Plant Jiangsu Prov, Xuzhou 221116, Peoples R China; [Wang, Chao; Smith, Mark D.; Wang, Qian] Univ S Carolina, Dept Chem & Biochem, Coll Arts & Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Nanjing University of Chinese Medicine; Jiangsu Normal University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fan, DP (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, Columbia, SC 29209 USA.	daping.fan@uscmed.sc.edu	Lu, Hong S./ABH-3929-2020	Lu, Hong/0000-0002-0577-2558; Nagarkatti, Prakash/0000-0003-2663-0759; Smith, Mark/0000-0001-6977-7131; Wang, Qian/0000-0002-2149-384X; Wu, Qinan/0000-0002-7836-0941	National Institutes of Health [P01AT003961, P20 RR-016434, P20 RR-016461]; National Science Foundation/EPSCoR under Cooperative Agreement [EPS-0903795]; National Natural Science Foundation of China [81073002]; Innovation Grant of Production, Study, and Research (Jiangsu, China) [BY2009116]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016434, UL1RR029882, P20RR016461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation/EPSCoR under Cooperative Agreement(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Grant of Production, Study, and Research (Jiangsu, China); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AT003961, P20 RR-016434, and P20 RR-016461. This work was also supported by the National Science Foundation/EPSCoR under Cooperative Agreement EPS-0903795, the National Natural Science Foundation of China (81073002), and by an Innovation Grant of Production, Study, and Research (Jiangsu, China, BY2009116).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; [Anonymous], 2000, PHARMACOPOEIA COMM 1, P11; Barochia AV, 2010, CRIT CARE MED, V38, P306, DOI 10.1097/CCM.0b013e3181b77fe3; Bennett-Guerrero E, 2007, ANESTH ANALG, V104, P378, DOI 10.1213/01.ane.0000253501.07183.2a; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Caso JR, 2008, STROKE, V39, P1314, DOI 10.1161/STROKEAHA.107.498212; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; de Oliveira FJ, 2010, REV BRAS CIR CARDIOV, V25, P51, DOI 10.1590/S0102-76382010000100013; Gomariz RP, 2005, J LEUKOCYTE BIOL, V78, P491, DOI 10.1189/jlb.1004564; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Hua HM, 2007, FITOTERAPIA, V78, P274, DOI 10.1016/j.fitote.2006.11.014; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Inaba H, 2010, J PHARMACOL SCI, V113, P103, DOI 10.1254/jphs.09R23FM; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kolek MJ, 2004, AM HEART J, V148, P1034, DOI 10.1016/j.ahj.2004.05.049; Kuno M, 2009, CLIN EXP PHARMACOL P, V36, P589, DOI 10.1111/j.1440-1681.2008.05121.x; Lakhani SA, 2003, CURR OPIN PEDIATR, V15, P278, DOI 10.1097/00008480-200306000-00009; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500; Lee SY, 2010, ARCH PHARM RES, V33, P515, DOI 10.1007/s12272-010-0404-1; Li SX, 2010, J ASIAN NAT PROD RES, V12, P331, DOI 10.1080/10286021003730330; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2630, DOI 10.1161/01.ATV.0000247259.01257.b3; Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Opal SM, 2002, J ENDOTOXIN RES, V8, P473, DOI 10.1179/096805102125001109; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pinto MMM, 2005, CURR MED CHEM, V12, P2517, DOI 10.2174/092986705774370691; Pochet L, 2004, CURR PHARM DESIGN, V10, P3781, DOI 10.2174/1381612043382684; Qiu C., 2008, PHARM CLIN CHINESE M, V14, P7; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rice TW, 2010, CRIT CARE MED, V38, P1685, DOI 10.1097/CCM.0b013e3181e7c5c9; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Salomao R, 2008, SHOCK, V30, P73, DOI 10.1097/SHK.0b013e318181af2a; Sansonetti PJ, 2006, NAT IMMUNOL, V7, P1237, DOI 10.1038/ni1420; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Xiong Y, 2009, ARCH PHARM RES, V32, P717, DOI 10.1007/s12272-009-1510-9; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yethon J. A., 2001, Current Drug Targets - Infectious Disorders, V1, P91, DOI 10.2174/1568005014606143; Zipris D, 2005, J IMMUNOL, V174, P131, DOI 10.4049/jimmunol.174.1.131	58	92	101	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26470	26479		10.1074/jbc.M111.227934	http://dx.doi.org/10.1074/jbc.M111.227934			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21665946	hybrid, Green Published			2022-12-25	WOS:000293078200025
J	Nagata, E; Saiardi, A; Tsukamoto, H; Okada, Y; Itoh, Y; Satoh, T; Itoh, J; Margolis, RL; Takizawa, S; Sawa, A; Takagi, S				Nagata, Eiichiro; Saiardi, Adolfo; Tsukamoto, Hideo; Okada, Yoshinori; Itoh, Yoshiko; Satoh, Tadayuki; Itoh, Johbu; Margolis, Russell L.; Takizawa, Shunya; Sawa, Akira; Takagi, Shigeharu			Inositol Hexakisphosphate Kinases Induce Cell Death in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA; PYROPHOSPHATES; AUTOPHAGY; GROWTH; MODEL; AKT; POLYPHOSPHATES; LYMPHOBLASTS; LENGTH; MTOR	Inositol pyrophosphate diphosphoinositol pentakisphosphate is ubiquitously present in mammalian cells and contains highly energetic pyrophosphate bonds. We have previously reported that inositol hexakisphosphate kinase type 2 (InsP(6)K(2)), which converts inositol hexakisphosphate to inositol pyrophosphate diphosphoinositol pentakisphosphate, mediates apoptotic cell death via its translocation from the nucleus to the cytoplasm. Here, we report that InsP(6)K2 is localized mainly in the cytoplasm of lymphoblast cells from patients with Huntington disease (HD), whereas this enzyme is localized in the nucleus in control lymphoblast cells. The large number of autophagosomes detected in HD lymphoblast cells is consistent with the down-regulation of Akt in response to InsP(6)K2 activation. Consistent with these observations, the overexpression of InsP(6)Ks leads to the depletion of Akt phosphorylation and the induction of cell death. These results suggest that InsP(6)K2 activation is associated with the pathogenesis of HD.	[Nagata, Eiichiro; Takizawa, Shunya; Takagi, Shigeharu] Tokai Univ, Sch Med, Dept Neurol, Kanagawa 2591193, Japan; [Tsukamoto, Hideo; Okada, Yoshinori; Itoh, Yoshiko; Satoh, Tadayuki; Itoh, Johbu] Tokai Univ, Sch Med, Teaching & Res Support Ctr, Kanagawa 2591193, Japan; [Saiardi, Adolfo] UCL, Med Res Council Lab Mol Cell Biol, Cell Biol Unit, London WC1E 6BT, England; [Saiardi, Adolfo] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Margolis, Russell L.; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Neurol, Baltimore, MD 21287 USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Tokai University; Tokai University; University of London; University College London; University of London; University College London; Johns Hopkins University; Johns Hopkins University	Nagata, E (corresponding author), Tokai Univ, Sch Med, Dept Neurol, 143 Shimo Kasuya, Kanagawa 2591193, Japan.	enagata@is.icc.u-tokai.ac.jp			MRC [MC_U122680443] Funding Source: UKRI; Medical Research Council [MC_U122680443] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; GLENNON MC, 1993, BIOCHEM J, V293, P583, DOI 10.1042/bj2930583; Grewal SS, 2009, INT J BIOCHEM CELL B, V41, P1006, DOI 10.1016/j.biocel.2008.10.010; Heng MY, 2010, HUM MOL GENET, V19, P3702, DOI 10.1093/hmg/ddq285; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Itoh Y, 1996, PATHOL INT, V46, P726, DOI 10.1111/j.1440-1827.1996.tb03541.x; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Losito O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005580; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; Ma T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012845; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Mikoshiba Katsuhiko, 1994, Seminars in Cell Biology, V5, P273, DOI 10.1006/scel.1994.1033; Morrison BH, 2002, ONCOGENE, V21, P1882, DOI 10.1038/sj.onc.1205265; Nagata E, 2005, J BIOL CHEM, V280, P1634, DOI 10.1074/jbc.M409416200; Nagata E, 2004, NEUROREPORT, V15, P1325, DOI 10.1097/01.wnr.0000127073.66692.8f; Nagata E, 2010, INT J BIOCHEM CELL B, V42, P2065, DOI 10.1016/j.biocel.2010.09.013; Penno M. B., 1993, Journal of Tissue Culture Methods, V15, P43, DOI 10.1007/BF02387289; Rhodes D, 2002, EMBO REP, V3, P1139, DOI 10.1093/embo-reports/kvf246; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Saiardi A, 2001, J BIOL CHEM, V276, P39179, DOI 10.1074/jbc.M106842200; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Voglmaier SM, 1996, P NATL ACAD SCI USA, V93, P4305, DOI 10.1073/pnas.93.9.4305	33	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26680	26686		10.1074/jbc.M111.220749	http://dx.doi.org/10.1074/jbc.M111.220749			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652713	hybrid, Green Published			2022-12-25	WOS:000293078200045
J	Yang, GD; Pei, YX; Teng, HJ; Cao, QJ; Wang, R				Yang, Guangdong; Pei, Yanxi; Teng, Huajian; Cao, Qiuhui; Wang, Rui			Specificity Protein-1 as a Critical Regulator of Human Cystathionine gamma-Lyase in Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-SULFIDE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; SP1 PHOSPHORYLATION; PROMOTER ACTIVITY; INTIMAL HYPERPLASIA; NEOINTIMA FORMATION; IN-VITRO; DIFFERENTIATION; H2S	Cystathionine gamma-lyase (CSE) is the major enzyme in vascular smooth muscle cells (SMCs) that catalyzes the endogenous production of H2S. Phenotypic switching of SMCs is affected by endogenous H2S level and alterations of this switching may result in vascular disorders. To date, the mechanisms underlying the alteration of CSE expression and H2S production in vascular proliferative diseases have been unclear. In the present study, we found that serum deprivation induced SMC differentiation marker gene expressions and increased CSE expression and H2S production in cultured human aorta SMCs (HASMCs). Carotid artery ligation in mice resulted in enhanced neointima formation and down-regulation of CSE expression, suggesting an important role of CSE in SMC differentiation. Transient transfection of HASMCs with human CSE (hCSE) promoter/luciferase reporter revealed that the region between -226 to + 140 base pair contains the core promoter for the hCSE gene. Deletion and mutation analysis demonstrated that two specificity protein-1 (Sp1) consensus binding sites were present in the core promoter region of the hCSE gene. Incubation of HASMCs with Sp1 binding inhibitor mithramycin inhibited CSE mRNA expression in a dose-dependent manner. Overexpression of Sp1 alone was sufficient to increase the activity of the hCSE core promoter and CSE protein expression. Chromatin immunoprecipitation assay showed that the binding of Sp1 to the hCSE promoter was increased in differentiated HASMCs compared with that in proliferated HASMCs. Exogenously applied H2S at 100 mu M stimulated SMC differentiation, which was reversed by p38 MAPK inhibitor SB203580. These results suggest that transcript factor Sp1 is a critical regulator of the hCSE expression during SMC differentiation, and CSE/H2S system is essential for maintenance of SMC phenotype.	[Yang, Guangdong] Lakehead Univ, Sch Kinesiol, Thunder Bay, ON P7B 5E1, Canada; [Pei, Yanxi; Teng, Huajian; Cao, Qiuhui; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Pei, Yanxi] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Peoples R China	Lakehead University; Lakehead University; Shanxi University	Yang, GD (corresponding author), 955 Oliver Rd, Thunder Bay, ON P7B 5E1, Canada.	gyang@lakeheadu.ca	Wang, Rui/C-7824-2012; Yang, Guangdong/G-4129-2011; Pei, Yanxi/H-1501-2016	Wang, Rui/0000-0003-3825-3620; Pei, Yanxi/0000-0002-8428-3399	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by grants from Canadian Institutes of Health Research (to G. Y. and R. W.).; Supported by a New Investigator Award from Heart and Stroke Foundation of Canada and a Maureen Andrew New Investigator award from Heart and Stroke Foundation of Ontario. To whom correspondence should be addressed: 955 Oliver Rd., Thunder Bay, Ontario, P7B 5E1, Canada. Tel.: 807-346-7937; Fax: 807-346-7873; E-mail: gyang@lakeheadu.ca.	Andres V, 2001, ARTERIOSCL THROM VAS, V21, P342, DOI 10.1161/01.ATV.21.3.342; Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Chan J, 2010, CIRC RES, V106, P1061, DOI 10.1161/CIRCRESAHA.109.206029; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Ellenrieder V, 2008, ANTICANCER RES, V28, P1531; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Gao L, 2005, BBA-GENE STRUCT EXPR, V1681, P175, DOI 10.1016/j.bbaexp.2004.10.008; Ge YW, 2004, J NEUROCHEM, V90, P1432, DOI 10.1111/j.1471-4159.2004.02608.x; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; GLODE LM, 1981, CANCER RES, V41, P2249; Grond-Ginsbach C, 2010, CELL MOL LIFE SCI, V67, P1799, DOI 10.1007/s00018-010-0276-z; Han M, 2006, AM J PHYSIOL-CELL PH, V291, pC50, DOI 10.1152/ajpcell.00524.2005; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Hui DY, 2008, CURR DRUG TARGETS, V9, P251, DOI 10.2174/138945008783755601; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Jain MK, 1998, J BIOL CHEM, V273, P5993, DOI 10.1074/jbc.273.11.5993; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kavurma MM, 2001, J BIOL CHEM, V276, P4964, DOI 10.1074/jbc.M009251200; KLEIN CE, 1988, CANCER, V62, P291, DOI 10.1002/1097-0142(19880715)62:2<291::AID-CNCR2820620211>3.0.CO;2-Q; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; LINK D, 1983, BLUT, V47, P31, DOI 10.1007/BF00321048; Lu M, 2010, J AM SOC NEPHROL, V21, P993, DOI 10.1681/ASN.2009090949; Maruyama I, 2000, CURR EYE RES, V21, P886, DOI 10.1076/ceyr.21.5.886.5538; Matsushita T, 2007, EUR J CELL BIOL, V86, P617, DOI 10.1016/j.ejcb.2007.06.005; Meng QH, 2007, AM J PATHOL, V170, P1406, DOI 10.2353/ajpath.2007.060939; Metharom P, 2007, CURR VASC PHARMACOL, V5, P61, DOI 10.2174/157016107779317215; Okamoto Y, 2001, BIOCHEM BIOPH RES CO, V288, P940, DOI 10.1006/bbrc.2001.5860; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Ounallah-Saad H, 2009, GENE, V446, P81, DOI 10.1016/j.gene.2009.06.015; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Plath M, 2007, MOL ECOL, V16, P967, DOI 10.1111/j.1365-294X.2006.03212.x; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Reisinger K, 2003, J CELL SCI, V116, P225, DOI 10.1242/jcs.00237; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Santiago FS, 2007, CIRC RES, V101, P146, DOI 10.1161/CIRCRESAHA.106.145235; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; SASAGAWA M, 1987, PLACENTA, V8, P515, DOI 10.1016/0143-4004(87)90080-4; Schafer D, 1997, FEBS LETT, V417, P325, DOI 10.1016/S0014-5793(97)01314-8; Sellak H, 2002, CIRC RES, V90, P405, DOI 10.1161/hh0402.105898; Shi YX, 2007, AM J PHYSIOL-HEART C, V293, pH2093, DOI 10.1152/ajpheart.00088.2007; Sreejayan Nair, 2007, V139, P283; Sun XF, 2004, BIOCHEM PHARMACOL, V67, P147, DOI 10.1016/j.bcp.2003.08.041; Takeda T, 2007, PLACENTA, V28, P192, DOI 10.1016/j.placenta.2006.03.002; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xuan ZY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2002-4-1-r1; Yang G, 2006, FASEB J, V20, P553, DOI 10.1096/fj.05-4712fje; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang GD, 2010, CARDIOVASC RES, V86, P487, DOI 10.1093/cvr/cvp420; Yoshida T, 2005, CIRC RES, V96, P280, DOI 10.1161/01.RES.0000155951.62152.2e; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhu XY, 2010, CELL MOL LIFE SCI, V67, P1119, DOI 10.1007/s00018-009-0250-9; Zu Xuyu, 2009, BMC Res Notes, V2, P175, DOI 10.1186/1756-0500-2-175	60	66	66	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26450	26460		10.1074/jbc.M111.266643	http://dx.doi.org/10.1074/jbc.M111.266643			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659522	hybrid, Green Published			2022-12-25	WOS:000293078200023
J	Granot, T; Venticinque, L; Tseng, JC; Meruelo, D				Granot, Tomer; Venticinque, Lisa; Tseng, Jen-Chieh; Meruelo, Daniel			Activation of Cytotoxic and Regulatory Functions of NK Cells by Sindbis Viral Vectors	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IN-VIVO; STIMULATORY FACTOR; OVARIAN-CANCER; TUMOR-CELLS; IFN-GAMMA; VIRUS; EXPRESSION; INTERLEUKIN-12; XENOGRAFTS	Oncolytic viruses (OVs) represent a relatively novel anti-cancer modality. Like other new cancer treatments, effective OV therapy will likely require combination with conventional treatments. In order to design combinatorial treatments that work well together, a greater scrutiny of the mechanisms behind the individual treatments is needed. Sindbis virus (SV) based vectors have previously been shown to target and kill tumors in xenograft, syngeneic, and spontaneous mouse models. However, the effect of SV treatment on the immune system has not yet been studied. Here we used a variety of methods, including FACS analysis, cytotoxicity assays, cell depletion, imaging of tumor growth, cytokine blockade, and survival experiments, to study how SV therapy affects Natural Killer (NK) cell function in SCID mice bearing human ovarian carcinoma tumors. Surprisingly, we found that SV anti-cancer efficacy is largely NK cell-dependent. Furthermore, the enhanced therapeutic effect previously observed from Sin/IL12 vectors, which carry the gene for interleukin 12, is also NK cell dependent, but works through a separate IFN gamma-dependent mechanism, which also induces the activation of peritoneal macrophages. These results demonstrate the multimodular nature of SV therapy, and open up new possibilities for potential synergistic or additive combinatorial therapies with other treatments.	[Granot, Tomer; Venticinque, Lisa; Meruelo, Daniel] NYU, Sch Med, Inst Canc, Gene Therapy Ctr, New York, NY 10016 USA; [Granot, Tomer; Venticinque, Lisa; Meruelo, Daniel] NYU, Sch Med, Dept Pathol, New York, NY USA; [Tseng, Jen-Chieh] Dana Farber Canc Inst, Boston, MA 02115 USA	New York University; New York University; Harvard University; Dana-Farber Cancer Institute	Granot, T (corresponding author), NYU, Sch Med, Inst Canc, Gene Therapy Ctr, New York, NY 10016 USA.	DM01@mac.com			U. S. Public Health [CA100687]; National Cancer Institute; National Institutes of Health; Department of Health and Human Services; Litwin Foundation; NATIONAL CANCER INSTITUTE [R01CA100687] Funding Source: NIH RePORTER	U. S. Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; Litwin Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U. S. Public Health grants CA100687 from the National Cancer Institute, National Institutes of Health, and Department of Health and Human Services. Funding was also provided by a gift from the Litwin Foundation and a Research and License agreement between NYU and CynVec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomonte J, 2009, CANCER GENE THER, V16, P266, DOI 10.1038/cgt.2008.74; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bramson JL, 1996, HUM GENE THER, V7, P1995, DOI 10.1089/hum.1996.7.16-1995; BREDENBEEK PJ, 1993, J VIROL, V67, P6439, DOI 10.1128/JVI.67.11.6439-6446.1993; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Galivo F, 2010, GENE THER, V17, P158, DOI 10.1038/gt.2009.161; Grote D, 2001, BLOOD, V97, P3746, DOI 10.1182/blood.V97.12.3746; HABU S, 1981, J IMMUNOL, V127, P34; Heitmeier MR, 1998, J BIOL CHEM, V273, P15301, DOI 10.1074/jbc.273.24.15301; Hicks AM, 2006, P NATL ACAD SCI USA, V103, P7753, DOI 10.1073/pnas.0602382103; Hirasawa K, 2003, CANCER RES, V63, P348; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kayagaki N, 1999, J IMMUNOL, V163, P1906; KING DP, 1983, J IMMUNOL, V131, P315; Leonard JP, 1997, BLOOD, V90, P2541; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Prestwich RJ, 2009, HUM GENE THER, V20, P1119, DOI 10.1089/hum.2009.135; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Shafren DR, 2004, CLIN CANCER RES, V10, P53, DOI 10.1158/1078-0432.CCR-0690-3; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; Toda M, 1999, HUM GENE THER, V10, P385, DOI 10.1089/10430349950018832; Tseng JC, 2007, GENE THER, V14, P1166, DOI 10.1038/sj.gt.3302973; Tseng JC, 2002, JNCI-J NATL CANCER I, V94, P1790; Tseng JC, 2004, NAT BIOTECHNOL, V22, P70, DOI 10.1038/nbt917; Tseng JC, 2004, CANCER RES, V64, P6684, DOI 10.1158/0008-5472.CAN-04-1924; Tseng JC, 2006, J NUCL MED, V47, P1136; Unno Y, 2005, CLIN CANCER RES, V11, P4553, DOI 10.1158/1078-0432.CCR-04-2610; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Vaha-Koskela MJV, 2006, CANCER RES, V66, P7185, DOI 10.1158/0008-5472.CAN-05-2214; Venticinque L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-37; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; VOEST EE, 1995, J NATL CANCER I, V87, P581, DOI 10.1093/jnci/87.8.581; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Worschech A, 2009, CANCER IMMUNOL IMMUN, V58, P1355, DOI 10.1007/s00262-009-0686-7; Worschech A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-301; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	50	16	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20598	10.1371/journal.pone.0020598	http://dx.doi.org/10.1371/journal.pone.0020598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674047	Green Published, gold, Green Submitted			2022-12-25	WOS:000291310600018
J	Fan, RR; Kang, ZF; He, L; Chan, J; Xu, G				Fan, Rongrong; Kang, Zhanfang; He, Lan; Chan, Juliana; Xu, Gang			Exendin-4 Improves Blood Glucose Control in Both Young and Aging Normal Non-Diabetic Mice, Possible Contribution of Beta Cell Independent Effects	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PERFUSED RAT PANCREAS; RECEPTOR AGONIST; INSULIN-RELEASE; GENE-EXPRESSION; PROTEIN-KINASE; DIABETIC-RATS; GLP-1; SOMATOSTATIN; TOLERANCE	Aims: Type 2 diabetes is highly prevalent in the elderly population. Glucagon like Peptide-1 mimetic such as exendin-4 augments post-prandial insulin secretion. However, the potential influence of aging on the therapeutic effects of this peptide has not been well studied. In this study, we examined the glucose regulatory effects of exendin-4 in mice with different ages. Methods: We treated 3-month and 20 to 22-month old C57/DBA mice with 10 nM/kg exendin-4 for 10 days with measurements of blood glucose and body weight. We performed OGTT and ITT to evaluate the glucose response and insulin sensitivity. Islet morphology and beta cell mass were measured by immuno-staining and beta cell proliferation was evaluated by BrdU incorporation and PCNA staining. Real-time PCR and western blot were used to measure protein changes in the liver tissue after exendin-4 treatment. Results: Exendin-4 treatment improved glycemic control in both 3-month and 20 to 22-month old mice. In both groups of mice, the blood glucose lowering effect was independent of beta cell function as indicated by unchanged beta cell proliferation, insulin secretion or beta cell mass. Moreover, we found that exendin-4 treatment increased hepatic AKT and FOXO1 phosphorylation and inhibited glucose-6-phosphotase (G6P) and Phosphoenolpyruvate carboxykinase (PEPCK) expression in young mice, but this effect was attenuated in aging mice while the insulin sensitivity showed no change in the young group but significantly improved in aging mice. Conclusion: Based on these data, we conclude that the glucose lowering effect of exendin-4 in normal non-diabetic mice was not blunted by aging. We further showed that although there was slight difference in the glucose modulating mechanism of exendin-4 therapy in young and aged mice, the improved glucose control seemed uncorrelated with increased beta cell mass or insulin secretion.	[Fan, Rongrong; Kang, Zhanfang; He, Lan; Chan, Juliana; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Chan, Juliana; Xu, Gang] Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Chan, Juliana; Xu, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Xu, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	gangxu@cuhk.edu.hk	Messier, Claude/A-2322-2008; Chan, Juliana/B-7918-2016; Fan, Rongrong/AAG-2200-2019; Fan, Rongrong/N-3446-2017	Messier, Claude/0000-0002-4791-1763; Chan, Juliana/0000-0003-1325-1194; Fan, Rongrong/0000-0002-5707-1497; Fan, Rongrong/0000-0002-5707-1497; Kang, Zhanfang/0000-0001-7010-8701	CUHK; Liao Wun Yuk Diabetes Research Memorial Fund; Hong Kong Government Research Grant Committee [477008, 478110]; Chinese University of Hong Kong [2041569]	CUHK(Chinese University of Hong Kong); Liao Wun Yuk Diabetes Research Memorial Fund; Hong Kong Government Research Grant Committee; Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by the CUHK Focused Investment Scheme and Liao Wun Yuk Diabetes Research Memorial Fund (grant number N/A); the Hong Kong Government Research Grant Committee (Grant Number: 477008 and 478110) and Direct Grant from the Chinese University of Hong Kong (Grant Number: 2041569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahren Bo, 2007, Curr Diab Rep, V7, P340, DOI 10.1007/s11892-007-0056-9; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barrera JG, 2009, DIABETES, V58, P2820, DOI 10.2337/db09-0281; Barthel A, 2001, BIOCHEM BIOPH RES CO, V285, P897, DOI 10.1006/bbrc.2001.5261; Dardevet D, 2004, AM J PHYSIOL-ENDOC M, V287, pE75, DOI 10.1152/ajpendo.00035.2004; de Heer J, 2008, DIABETOLOGIA, V51, P2263, DOI 10.1007/s00125-008-1149-y; DeOre K, 1997, J GERONTOL A-BIOL, V52, pB245, DOI 10.1093/gerona/52A.5.B245; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Egido EM, 2004, HORM METAB RES, V36, P595, DOI 10.1055/s-2004-825921; EISSELE R, 1994, LIFE SCI, V55, P629, DOI 10.1016/0024-3205(94)00489-7; ENG J, 1992, J BIOL CHEM, V267, P7402; Fan R, 2010, DIABETES OBES METAB, V12, P815, DOI 10.1111/j.1463-1326.2010.01238.x; FERDAOUSSI M, 2008, DIABETES; Heller RS, 2001, DIABETES, V50, P1553, DOI 10.2337/diabetes.50.7.1553; Ihm SH, 2007, DIABETES RES CLIN PR, V77, pS150, DOI 10.1016/j.diabres.2007.01.049; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Lee YS, 2007, DIABETES, V56, P1671, DOI 10.2337/db06-1182; Li L, 2005, DIABETOLOGIA, V48, P1339, DOI 10.1007/s00125-005-1787-2; Marzioni M, 2009, GUT, V58, P990, DOI 10.1136/gut.2008.150870; Meneilly GS, 2003, DIABETES CARE, V26, P2835, DOI 10.2337/diacare.26.10.2835; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; MontroseRafizadeh C, 1997, J CELL PHYSIOL, V172, P275, DOI 10.1002/(SICI)1097-4652(199709)172:3<275::AID-JCP1>3.0.CO;2-L; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Samson SL, 2008, MOL THER, V16, P1805, DOI 10.1038/mt.2008.198; Sancho V, 2005, J MOL ENDOCRINOL, V35, P27, DOI 10.1677/jme.1.01747; Scrocchi LA, 1998, DIABETES, V47, P632, DOI 10.2337/diabetes.47.4.632; Silvestre RA, 2003, EUR J PHARMACOL, V469, P195, DOI 10.1016/S0014-2999(03)01692-3; Sinclair EM, 2008, GASTROENTEROLOGY, V135, P2096, DOI 10.1053/j.gastro.2008.07.075; SORENSON RL, 1983, DIABETES, V32, P561, DOI 10.2337/diabetes.32.6.561; STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; TangChristensen M, 1996, AM J PHYSIOL-REG I, V271, pR848, DOI 10.1152/ajpregu.1996.271.4.R848; Tanigawa K, 1997, PANCREAS, V15, P53, DOI 10.1097/00006676-199707000-00008; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Wang YH, 1997, J CLIN INVEST, V99, P2883, DOI 10.1172/JCI119482; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033; Xu G, 2006, DIABETES RES CLIN PR, V73, P107, DOI 10.1016/j.diabres.2005.11.007; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zheng D, 2009, DIABETES, V58, P352, DOI 10.2337/db08-0875	45	26	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20443	10.1371/journal.pone.0020443	http://dx.doi.org/10.1371/journal.pone.0020443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655268	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600070
J	Fan, SJ; Marchand, V; Ephrussi, A				Fan, Shih-Jung; Marchand, Virginie; Ephrussi, Anne			Drosophila Ge-1 Promotes P Body Formation and oskar mRNA Localization	PLOS ONE			English	Article							POSTERIOR LOCALIZATION; BINDING-PROTEIN; CELL-FORMATION; GENE; POLE; TRANSLATION; COMPLEX; PLASM; TRANSPORT; COMPONENT	mRNA localization coupled with translational control is a widespread and conserved strategy that allows the localized production of proteins within eukaryotic cells. In Drosophila, oskar (osk) mRNA localization and translation at the posterior pole of the oocyte are essential for proper patterning of the embryo. Several P body components are involved in osk mRNA localization and translational repression, suggesting a link between P bodies and osk RNPs. In cultured mammalian cells, Ge-1 protein is required for P body formation. Combining genetic, biochemical and immunohistochemical approaches, we show that, in vivo, Drosophila Ge-1 (dGe-1) is an essential gene encoding a P body component that promotes formation of these structures in the germline. dGe-1 partially colocalizes with osk mRNA and is required for osk RNP integrity. Our analysis reveals that although under normal conditions dGe-1 function is not essential for osk mRNA localization, it becomes critical when other components of the localization machinery, such as staufen, Drosophila decapping protein 1 and barentsz are limiting. Our findings suggest an important role of dGe-1 in optimization of the osk mRNA localization process required for patterning the Drosophila embryo.	[Fan, Shih-Jung; Marchand, Virginie; Ephrussi, Anne] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Fan, SJ (corresponding author), European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany.	ephrussi@embl.de	Ephrussi, Anne/AAG-4075-2020; MARCHAND, Virginie/A-6866-2012; Ephrussi, Anne/ABD-4393-2021	Ephrussi, Anne/0000-0002-5061-4620; Marchand, Virginie/0000-0002-8537-1139	EMBL; Fondation pour la Recherche Medicale	EMBL; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	The totality of the work in this manuscript was funded by the EMBL. Shih-Jung Fan was also fully funded by the European Molecular Biology Laboratory (for information about the EMBL, please see http://www.embl.de/aboutus/index.html). Virginie Marchand was supported by a fellowship from the Fondation pour la Recherche Medicale and by the European Molecular Biology Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Chou TB, 1996, GENETICS, V144, P1673; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Farkas RM, 2003, MOL BIOL CELL, V14, P190, DOI 10.1091/mbc.E02-06-0343; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; GLOOR GB, 1993, GENETICS, V135, P81; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Jinek M, 2008, RNA, V14, P1991, DOI 10.1261/rna.1222908; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Krauss J, 2009, CURR BIOL, V19, P1058, DOI 10.1016/j.cub.2009.04.062; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Lin MD, 2006, DEV CELL, V10, P601, DOI 10.1016/j.devcel.2006.02.021; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Snee MJ, 2009, DEV DYNAM, V238, P918, DOI 10.1002/dvdy.21914; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tritschler F, 2007, MOL CELL BIOL, V27, P8600, DOI 10.1128/MCB.01506-07; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Vanzo NF, 2002, DEVELOPMENT, V129, P3705; WIESCHAUS E, 1984, DEV BIOL, V104, P172, DOI 10.1016/0012-1606(84)90046-0; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	39	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20612	10.1371/journal.pone.0020612	http://dx.doi.org/10.1371/journal.pone.0020612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655181	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600109
J	Kaneko, M; Yamaguchi, K; Eiraku, M; Sato, M; Takata, N; Kiyohara, Y; Mishina, M; Hirase, H; Hashikawa, T; Kengaku, M				Kaneko, Megumi; Yamaguchi, Kazuhiko; Eiraku, Mototsugu; Sato, Motohiko; Takata, Norio; Kiyohara, Yoshimoto; Mishina, Masayoshi; Hirase, Hajime; Hashikawa, Tsutomu; Kengaku, Mineko			Remodeling of Monoplanar Purkinje Cell Dendrites during Cerebellar Circuit Formation	PLOS ONE			English	Article							GLUTAMATE-RECEPTOR DELTA-2; LONG-TERM DEPRESSION; CLIMBING FIBER INNERVATION; RAT CEREBELLUM; MUTANT MICE; MULTIPLE INNERVATION; SYNAPSE ELIMINATION; ELECTRICAL-ACTIVITY; ADULT CEREBELLUM; INFERIOR OLIVE	Dendrite arborization patterns are critical determinants of neuronal connectivity and integration. Planar and highly branched dendrites of the cerebellar Purkinje cell receive specific topographical projections from two major afferent pathways; a single climbing fiber axon from the inferior olive that extend along Purkinje dendrites, and parallel fiber axons of granule cells that contact vertically to the plane of dendrites. It has been believed that murine Purkinje cell dendrites extend in a single parasagittal plane in the molecular layer after the cell polarity is determined during the early postnatal development. By three-dimensional confocal analysis of growing Purkinje cells, we observed that mouse Purkinje cells underwent dynamic dendritic remodeling during circuit maturation in the third postnatal week. After dendrites were polarized and flattened in the early second postnatal week, dendritic arbors gradually expanded in multiple sagittal planes in the molecular layer by intensive growth and branching by the third postnatal week. Dendrites then became confined to a single plane in the fourth postnatal week. Multiplanar Purkinje cells in the third week were often associated by ectopic climbing fibers innervating nearby Purkinje cells in distinct sagittal planes. The mature monoplanar arborization was disrupted in mutant mice with abnormal Purkinje cell connectivity and motor discoordination. The dendrite remodeling was also impaired by pharmacological disruption of normal afferent activity during the second or third postnatal week. Our results suggest that the monoplanar arborization of Purkinje cells is coupled with functional development of the cerebellar circuitry.	[Kaneko, Megumi; Eiraku, Mototsugu; Kengaku, Mineko] RIKEN Brain Sci Inst, Lab Neural Cell Polar, Wako, Saitama, Japan; [Kiyohara, Yoshimoto; Hashikawa, Tsutomu] RIKEN Brain Sci Inst, Lab Neural Architecture, Wako, Saitama, Japan; [Yamaguchi, Kazuhiko] RIKEN Brain Sci Inst, Lab Memory & Learning, Wako, Saitama, Japan; [Takata, Norio; Hirase, Hajime] RIKEN Brain Sci Inst, Hirase Res Unit, Wako, Saitama, Japan; [Sato, Motohiko; Kengaku, Mineko] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto, Japan; [Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Bunkyo Ku, Tokyo, Japan	RIKEN; RIKEN; RIKEN; RIKEN; Kyoto University; University of Tokyo	Kaneko, M (corresponding author), RIKEN Brain Sci Inst, Lab Neural Cell Polar, Wako, Saitama, Japan.	kengaku@icems.kyoto-u.ac.jp	Hirase, Hajime/A-3709-2012	Hirase, Hajime/0000-0003-3806-6905; Eiraku, Mototsugu/0000-0002-9433-9085	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology, Japan [21300120]	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grant sponsors: RIKEN Brain Science Institute; the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant number: 21300120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; ALTMAN J, 1972, J COMP NEUROL, V146, P355, DOI 10.1002/cne.901460305; Andjus PR, 2003, NEUROSCIENCE, V121, P563, DOI 10.1016/S0306-4522(03)00556-6; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; BERRY M, 1976, BRAIN RES, V116, P361, DOI 10.1016/0006-8993(76)90487-X; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; CALVET MC, 1985, BRAIN RES, V331, P235, DOI 10.1016/0006-8993(85)91549-5; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; Fowler SC, 2001, J NEUROSCI METH, V107, P107, DOI 10.1016/S0165-0270(01)00359-4; Glickstein M, 2009, CORTEX; GOODLETT CR, 1990, DEV BRAIN RES, V53, P131, DOI 10.1016/0165-3806(90)90133-J; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; Hashimoto K, 2009, NEURON, V63, P106, DOI 10.1016/j.neuron.2009.06.008; Hioki H, 2003, NEUROSCIENCE, V117, P1, DOI 10.1016/S0306-4522(02)00943-0; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; Hirai H, 2008, CEREBELLUM, V7, P273, DOI 10.1007/s12311-008-0012-5; Huckfeldt RM, 2009, NAT NEUROSCI, V12, P35, DOI 10.1038/nn.2236; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Kapfhammer JP, 2004, PROG HISTOCHEM CYTO, V39, P131, DOI 10.1016/j.proghi.2004.07.002; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Kurihara H, 1997, J NEUROSCI, V17, P9613; Long MA, 2002, J NEUROSCI, V22, P10898; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; MARIANI J, 1977, PHILOS T R SOC B, V281, P1, DOI 10.1098/rstb.1977.0121; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Millard SS, 2008, CURR OPIN NEUROBIOL, V18, P84, DOI 10.1016/j.conb.2008.05.005; Miwa H, 2006, BRAIN RES, V1068, P94, DOI 10.1016/j.brainres.2005.11.036; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004; Nishiyama H, 2007, NEURON, V56, P472, DOI 10.1016/j.neuron.2007.09.010; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuki G, 2004, J NEUROSCI, V24, P10900, DOI 10.1523/JNEUROSCI.2240-04.2004; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Ramon y Cajal S, 1911, HISTOLOGY NERVOUS SY; ROSSI F, 1991, J COMP NEUROL, V308, P513, DOI 10.1002/cne.903080403; ROSSI F, 1995, J NEUROSCI, V15, P2040, DOI 10.1523/JNEUROSCI.15-03-02040.1995; Scelfo B, 2005, EUR J NEUROSCI, V21, P971, DOI 10.1111/j.1460-9568.2005.03933.x; Scelfo B, 2003, J NEUROPHYSIOL, V89, P2555, DOI 10.1152/jn.00884.2002; SCHILLING K, 1991, NEURON, V7, P891, DOI 10.1016/0896-6273(91)90335-W; Sotelo C, 2009, NEUROSCIENCE, V162, P589, DOI 10.1016/j.neuroscience.2008.12.035; Stuart G, 2007, DENDRITES; Sugihara I, 1999, J COMP NEUROL, V414, P131; Takayasu Y, 2006, J NEUROSCI, V26, P6563, DOI 10.1523/JNEUROSCI.5342-05.2006; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Uemura T, 2007, J NEUROSCI, V27, P12096, DOI 10.1523/JNEUROSCI.2680-07.2007; Voogd J, 2004, J NEUROCYTOL, V33, P5, DOI 10.1023/B:NEUR.0000029645.72074.2b; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941	58	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20108	10.1371/journal.pone.0020108	http://dx.doi.org/10.1371/journal.pone.0020108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655286	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600021
J	Schafer, JM; Peters, DE; Morley, T; Liu, SH; Molinolo, AA; Leppla, SH; Bugge, TH				Schafer, Jeffrey M.; Peters, Diane E.; Morley, Thomas; Liu, Shihui; Molinolo, Alfredo A.; Leppla, Stephen H.; Bugge, Thomas H.			Efficient Targeting of Head and Neck Squamous Cell Carcinoma by Systemic Administration of a Dual uPA and MMP-Activated Engineered Anthrax Toxin	PLOS ONE			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; THERAPY PRODUCES REGRESSIONS; INHIBITORS STEFIN-A; ATHYMIC NUDE-MICE; MATRIX-METALLOPROTEINASE; LETHAL FACTOR; PLASMINOGEN-ACTIVATOR; PROTECTIVE ANTIGEN; CATHEPSIN-B; IN-VIVO	Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Although considerable progress has been made in elucidating the etiology of the disease, the prognosis for individuals diagnosed with HNSCC remains poor, underscoring the need for development of additional treatment modalities. HNSCC is characterized by the upregulation of a large number of proteolytic enzymes, including urokinase plasminogen activator (uPA) and an assortment of matrix metalloproteinases (MMPs) that may be expressed by tumor cells, by tumor-supporting stromal cells or by both. Here we explored the use of an intercomplementing anthrax toxin that requires combined cell surface uPA and MMP activities for cellular intoxication and specifically targets the ERK/MAPK pathway for the treatment of HNSCC. We found that this toxin displayed strong systemic anti-tumor activity towards a variety of xenografted human HNSCC cell lines by inducing apoptotic and necrotic tumor cell death, and by impairing tumor cell proliferation and angiogenesis. Interestingly, the human HNSCC cell lines were insensitive to the intercomplementing toxin when cultured ex vivo, suggesting that either the toxin targets the tumor-supporting stromal cell compartment or that the tumor cell requirement for ERK/MAPK signaling differs in vivo and ex vivo. This intercomplementing toxin warrants further investigation as an anti-HNSCC agent.	[Schafer, Jeffrey M.; Peters, Diane E.; Molinolo, Alfredo A.; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Peters, Diane E.] Tufts Univ, Sch Med, Program Pharmacol & Expt Therapeut, Boston, MA 02111 USA; [Morley, Thomas; Liu, Shihui; Leppla, Stephen H.] NIAID, Bacterial Toxins & Therapeut Sect, Lab Bacterial Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tufts University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schafer, JM (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov		Peters, Diane/0000-0003-4185-6203; Liu, Shihui/0000-0003-3444-1069	NIAID; NIDCR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by NIAID and NIDCR Intramural Research Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Habib RJ, 2006, CLIN CANCER RES, V12, P7437, DOI 10.1158/1078-0432.CCR-06-2019; Abi-Habib RJ, 2006, MOL CANCER THER, V5, P2556, DOI 10.1158/1535-7163.MCT-06-0315; Alfano RW, 2008, MOL CANCER THER, V7, P1218, DOI 10.1158/1535-7163.MCT-08-0024; Alfano RW, 2008, CELL CYCLE, V7, P745, DOI 10.4161/cc.7.6.5627; Alfano RW, 2010, MOL CANCER THER, V9, P190, DOI 10.1158/1535-7163.MCT-09-0694; Alfano RW, 2009, MOL CANCER RES, V7, P452, DOI 10.1158/1541-7786.MCR-08-0451; ARORA N, 1993, J BIOL CHEM, V268, P3334; Birkedal-Hansen B, 2000, Oral Dis, V6, P376; BJORLIN G, 1987, ACTA OTO-LARYNGOL, V104, P568, DOI 10.3109/00016488709128290; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Budihna M, 1996, BIOL CHEM H-S, V377, P385, DOI 10.1515/bchm3.1996.377.6.385; Bugge TH, 1997, BLOOD, V90, P4522; BUGGE TH, 2003, HEAD NECK CANC, P137; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Curino A, 2004, ORAL ONCOL, V40, P1026, DOI 10.1016/j.oraloncology.2004.05.011; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emami N, 2008, CLIN CHEM, V54, P1600, DOI 10.1373/clinchem.2008.105189; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Franchi A, 2002, CANCER-AM CANCER SOC, V95, P1902, DOI 10.1002/cncr.10916; Frankel AE, 2002, PROTEIN PEPTIDE LETT, V9, P1, DOI 10.2174/0929866023409048; GIOANNI J, 1988, EUR J CANCER CLIN ON, V24, P1445, DOI 10.1016/0277-5379(88)90335-5; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; Imanishi Y, 2000, HUM PATHOL, V31, P895, DOI 10.1053/hupa.2000.9756; Itaya T, 1996, ACTA OTO-LARYNGOL, P113; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson N, 1997, AM J PATHOL, V151, P499; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Kawada A, 1996, BRIT J DERMATOL, V135, P905, DOI 10.1046/j.1365-2133.1996.d01-1093.x; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; KOS J, 1995, BIOL CHEM H-S, V376, P401, DOI 10.1515/bchm3.1995.376.7.401; KUSUKAWA J, 1993, AM J CLIN PATHOL, V99, P18, DOI 10.1093/ajcp/99.1.18; LEEMANS CR, 2010, NAT REV CAN IN PRESS; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; LEPPLA SH, 2000, BACTERIAL PROTEIN TO; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liu SH, 2000, CANCER RES, V60, P6061; Liu SH, 2005, NAT BIOTECHNOL, V23, P725, DOI 10.1038/nbt1091; Liu SH, 2003, EXPERT OPIN BIOL TH, V3, P843, DOI 10.1517/14712598.3.5.843; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Liu S, 2008, J BIOL CHEM, V283, P529, DOI 10.1074/jbc.M707419200; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Mao L, 2004, CANCER CELL, V5, P311, DOI 10.1016/S1535-6108(04)00090-X; MIYAJIMA Y, 1995, ANN OTO RHINOL LARYN, V104, P678, DOI 10.1177/000348949510400902; Mogridge J, 2002, P NATL ACAD SCI USA, V99, P7045, DOI 10.1073/pnas.052160199; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; MOORE AE, 1955, CANCER RES, V15, P598; MULLER D, 1993, CANCER RES, V53, P165; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Olson ES, 2009, INTEGR BIOL-UK, V1, P382, DOI 10.1039/b904890a; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pettus JR, 2009, HISTOL HISTOPATHOL, V24, P197, DOI 10.14670/HH-24.197; Romer J, 2001, J INVEST DERMATOL, V116, P353, DOI 10.1046/j.1523-1747.2001.01241.x; Rosenthal EL, 2006, HEAD NECK-J SCI SPEC, V28, P639, DOI 10.1002/hed.20365; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schmidt M, 2000, HEAD NECK-J SCI SPEC, V22, P498, DOI 10.1002/1097-0347(200008)22:5<498::AID-HED9>3.0.CO;2-W; Schmidt M, 1999, ACTA OTO-LARYNGOL, V119, P949; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Shi ZG, 2007, BIOCHEM J, V407, P153, DOI 10.1042/BJ20071037; Strojan P, 2000, ANTICANCER RES, V20, P3975; Su YP, 2007, CANCER RES, V67, P3329, DOI 10.1158/0008-5472.CAN-06-4642; SUGIURA K, 1955, CANCER RES, V15, P38; SZABO R, 2011, ONCOGENE IN PRESS; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; von Kleist S, 1975, J Natl Cancer Inst, V55, P555; Williams SA, 2007, JNCI-J NATL CANCER I, V99, P376, DOI 10.1093/jnci/djk065; Wong L, 2005, SEMIN ONCOL, V32, P591, DOI 10.1053/j.seminoncol.2005.08.002; Yasuda T, 1997, HEAD NECK-J SCI SPEC, V19, P611; Yoshizaki T, 2001, INT J CANCER, V95, P44, DOI 10.1002/1097-0215(20010120)95:1<44::AID-IJC1008>3.3.CO;2-D	79	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20532	10.1371/journal.pone.0020532	http://dx.doi.org/10.1371/journal.pone.0020532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655226	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600089
J	Szczepaniec, A; Creary, SF; Laskowski, KL; Nyrop, JP; Raupp, MJ				Szczepaniec, Adrianna; Creary, Scott F.; Laskowski, Kate L.; Nyrop, Jan P.; Raupp, Michael J.			Neonicotinoid Insecticide Imidacloprid Causes Outbreaks of Spider Mites on Elm Trees in Urban Landscapes	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GALENDROMUS-OCCIDENTALIS; AGRICULTURAL STREAMS; BEETLE COLEOPTERA; JAPANESE-BEETLE; ACARI; IMPACT; ARTHROPODS; TOXICITY; TETRANYCHIDAE	Background: Attempts to eradicate alien arthropods often require pesticide applications. An effort to remove an alien beetle from Central Park in New York City, USA, resulted in widespread treatments of trees with the neonicotinoid insecticide imidacloprid. Imidacloprid's systemic activity and mode of entry via roots or trunk injections reduce risk of environmental contamination and limit exposure of non-target organisms to pesticide residues. However, unexpected outbreaks of a formerly innocuous herbivore, Tetranychus schoenei (Acari: Tetranychidae), followed imidacloprid applications to elms in Central Park. This undesirable outcome necessitated an assessment of imidacloprid's impact on communities of arthropods, its effects on predators, and enhancement of the performance of T. schoenei. Methodology/Principal Findings: By sampling arthropods in elm canopies over three years in two locations, we document changes in the structure of communities following applications of imidacloprid. Differences in community structure were mostly attributable to increases in the abundance of T. schoenei on elms treated with imidacloprid. In laboratory experiments, predators of T. schoenei were poisoned through ingestion of prey exposed to imidacloprid. Imidacloprid's proclivity to elevate fecundity of T. schoenei also contributed to their elevated densities on treated elms. Conclusions/Significance: This is the first study to report the effects of pesticide applications on the arthropod communities in urban landscapes and demonstrate that imidacloprid increases spider mite fecundity through a plant-mediated mechanism. Laboratory experiments provide evidence that imidacloprid debilitates insect predators of spider mites suggesting that relaxation of top-down regulation combined with enhanced reproduction promoted a non-target herbivore to pest status. With global commerce accelerating the incidence of arthropod invasions, prophylactic applications of pesticides play a major role in eradication attempts. Widespread use of neonicotinoid insecticides, however, can disrupt ecosystems tipping the ecological balance in favor of herbivores and creating pest outbreaks.	[Szczepaniec, Adrianna; Creary, Scott F.; Laskowski, Kate L.; Raupp, Michael J.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Nyrop, Jan P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	University System of Maryland; University of Maryland College Park; Cornell University	Szczepaniec, A (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ada.s@tamu.edu		Laskowski, Kate/0000-0003-1523-9340; Szczepaniec, Adrianna/0000-0002-9603-4533	USDA [2005-35303-16269]; International Society of Arboriculture Tree Fund; Gahan and Bamford Fellowships	USDA(United States Department of Agriculture (USDA)); International Society of Arboriculture Tree Fund; Gahan and Bamford Fellowships	This work was funded by the National Research Initiative Competitive Grants Program of USDA 2005-35303-16269 and International Society of Arboriculture Tree Fund grants to M.J.R. and Gahan and Bamford Fellowships to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ako M, 2006, PEST MANAG SCI, V62, P419, DOI 10.1002/ps.1182; Balder H, 1999, ACTA HORTIC, P189, DOI 10.17660/ActaHortic.1999.496.24; Berenzen N, 2005, ECOTOX ENVIRON SAFE, V60, P37, DOI 10.1016/j.ecoenv.2003.10.010; BERLINER W, 2008, COMMUNICATION; Bostanian NJ, 2009, PEST MANAG SCI, V65, P635, DOI 10.1002/ps.1721; BROWN MW, 1989, ENVIRON ENTOMOL, V18, P600, DOI 10.1093/ee/18.4.600; Cappaert David, 2005, American Entomologist, V51, P152; Chazeau J., 1985, P211; CHIRIBOGA A, 2009, THESIS OHIO STATE U; Cole PG, 2006, AUST J ENTOMOL, V45, P244, DOI 10.1111/j.1440-6055.2006.00534.x; CORN ML, 2002, RL30123 C RES SERV, P1; Costamagna AC, 2007, ECOL APPL, V17, P441, DOI 10.1890/06-0284; Cowles RS, 2006, J ECON ENTOMOL, V99, P1258, DOI 10.1603/0022-0493-99.4.1258; Croft BA, 1997, ENVIRON ENTOMOL, V26, P391, DOI 10.1093/ee/26.2.391; DEBACH P, 1977, CALIF AGR, V31, P8; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; DREISTADT SH, 1986, ENVIRONMENT, V28, P18, DOI 10.1080/00139157.1986.9929921; Dutcher J.D., 2007, GEN CONCEPTS INTEGRA, P27, DOI [10.1007/978-1-4020-6061-8_2, DOI 10.1007/978-1-4020-6061-8_2]; FAIRCHILD WL, 1993, ARCH ENVIRON CON TOX, V25, P170, DOI 10.1007/BF00212128; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Frank Steven, 2007, Arboriculture & Urban Forestry, V33, P392; Gupta G, 2007, J ECON ENTOMOL, V100, P830, DOI 10.1603/0022-0493(2007)100[830:PACIFM]2.0.CO;2; HULL LA, 1976, ENVIRON ENTOMOL, V5, P337, DOI 10.1093/ee/5.2.337; James DG, 2003, EXP APPL ACAROL, V31, P275, DOI 10.1023/B:APPA.0000010383.33351.2f; James DG, 2003, BIOCONTROL SCI TECHN, V13, P253, DOI 10.1080/0958315021000073510; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Kropczynska D, 2002, ACARID PHYLOGENY AND EVOLUTION: ADAPTATION IN MITES AND TICKS, P303; KROPCZYNSKA D, 1988, EXP APPL ACAROL, V5, P65, DOI 10.1007/BF02053818; LEROY M, 1999, ENVIRON ENTOMOL, V28, P735; Letourneau DK, 2001, J APPL ECOL, V38, P557, DOI 10.1046/j.1365-2664.2001.00611.x; LUCK RF, 1975, ECOLOGY, V56, P893, DOI 10.2307/1936299; LUCKEY TD, 1968, J ECON ENTOMOL, V61, P7, DOI 10.1093/jee/61.1.7; MCMURTRY JA, 1970, HILGARDIA, V40, P331, DOI 10.3733/hilg.v40n11p331; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MULLINS JW, 1993, AM CHEM SOC, V524, P183; Papachristos DP, 2008, BIOL CONTROL, V47, P77, DOI 10.1016/j.biocontrol.2008.06.009; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poletti M, 2007, BIOL CONTROL, V40, P30, DOI 10.1016/j.biocontrol.2006.09.001; Prasifka JR, 2005, ENVIRON ENTOMOL, V34, P1181, DOI 10.1603/0046-225X(2005)034[1181:ATEOPM]2.0.CO;2; Pratt P. D., 2000, Journal of Environmental Horticulture, V18, P218; Raupp Michael J., 2004, Journal of Arboriculture, V30, P108; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Raupp Michael J., 2006, Arboriculture & Urban Forestry, V32, P297; RAUPP MJ, 2007, INT RES INV SPEC USD, P59; Rebek EJ, 2003, J ECON ENTOMOL, V96, P446, DOI 10.1603/0022-0493-96.2.446; Rogers MA, 2007, BIOL CONTROL, V42, P172, DOI 10.1016/j.biocontrol.2007.05.006; Rogers ME, 2003, J ECON ENTOMOL, V96, P1412, DOI 10.1603/0022-0493-96.5.1412; Rohr JR, 2005, ECOL APPL, V15, P1135, DOI 10.1890/03-5353; Schafer RB, 2007, SCI TOTAL ENVIRON, V382, P272, DOI 10.1016/j.scitotenv.2007.04.040; Schneider K., 2000, P INT S PLANT HLTH U, P102; Sclar DC, 1998, J ECON ENTOMOL, V91, P250, DOI 10.1093/jee/91.1.250; Shrewsbury PM, 2003, J ECON ENTOMOL, V96, P1675, DOI 10.1603/0022-0493-96.6.1675; Stavrinides MC, 2009, BIOL CONTROL, V48, P267, DOI 10.1016/j.biocontrol.2008.10.017; SUTTMAN CE, 1979, ECOLOGY, V60, P628, DOI 10.2307/1936083; Szczepaniec A, 2009, THESIS U MARYLAND; Szczepaniec Adrianna, 2007, Journal of Environmental Horticulture, V25, P43; Tenczar EG, 2006, J ECON ENTOMOL, V99, P102, DOI 10.1603/0022-0493(2006)099[0102:MOCLBC]2.0.CO;2; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; *USDA APHIS, 2007, ASIAN LONGH BEETL CO; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wang AH, 2005, J ECON ENTOMOL, V98, P1144, DOI 10.1603/0022-0493-98.4.1144; Wu JinCai, 2003, Scientia Agricultura Sinica, V36, P536; YEOMANS JC, 1991, COMMUN SOIL SCI PLAN, V22, P843, DOI 10.1080/00103629109368458; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	67	68	76	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20018	10.1371/journal.pone.0020018	http://dx.doi.org/10.1371/journal.pone.0020018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655275	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600014
J	Wu, LK; Wang, HB; Zhang, ZX; Lin, R; Zhang, ZY; Lin, WX				Wu, Linkun; Wang, Haibin; Zhang, Zhixing; Lin, Rui; Zhang, Zhongyi; Lin, Wenxiong			Comparative Metaproteomic Analysis on Consecutively Rehmannia glutinosa-Monocultured Rhizosphere Soil	PLOS ONE			English	Article							MICROBIAL BIOMASS; MASS-SPECTROMETRY; PHENOLIC-ACIDS; COMMUNITY; ROOTS; PROTEINS; EXUDATION; SEEDLINGS; NUTRIENT; PLANTS	Background: The consecutive monoculture for most of medicinal plants, such as Rehmannia glutinosa, results in a significant reduction in the yield and quality. There is an urgent need to study for the sustainable development of Chinese herbaceous medicine. Methodology/Principal Findings: Comparative metaproteomics of rhizosphere soil was developed and used to analyze the underlying mechanism of the consecutive monoculture problems of R. glutinosa. The 2D-gel patterns of protein spots for the soil samples showed a strong matrix dependency. Among the spots, 103 spots with high resolution and repeatability were randomly selected and successfully identified by MALDI TOF-TOF MS for a rhizosphere soil metaproteomic profile analysis. These proteins originating from plants and microorganisms play important roles in nutrient cycles and energy flow in rhizospheric soil ecosystem. They function in protein, nucleotide and secondary metabolisms, signal transduction and resistance. Comparative metaproteomics analysis revealed 33 differentially expressed protein spots in rhizosphere soil in response to increasing years of monoculture. Among them, plant proteins related to carbon and nitrogen metabolism and stress response, were mostly up-regulated except a down-regulated protein (glutathione S-transferase) involving detoxification. The phenylalanine ammonia-lyase was believed to participate in the phenylpropanoid metabolism as shown with a considerable increase in total phenolic acid content with increasing years of monoculture. Microbial proteins related to protein metabolism and cell wall biosynthesis, were up-regulated except a down-regulated protein (geranylgeranyl pyrophosphate synthase) functioning in diterpenoid synthesis. The results suggest that the consecutive monoculture of R. glutinosa changes the soil microbial ecology due to the exudates accumulation, as a result, the nutrient cycles are affected, leading to the retardation of plant growth and development. Conclusions/Significance: Our results demonstrated the interactions among plant, soil and microflora in the proteomic level are crucial for the productivity and quality of R. glutinosa in consecutive monoculture system.	[Wu, Linkun; Wang, Haibin; Zhang, Zhixing; Zhang, Zhongyi; Lin, Wenxiong] Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China; [Wu, Linkun; Wang, Haibin; Zhang, Zhixing; Lin, Rui; Lin, Wenxiong] Fujian Agr & Forestry Univ, Agroecol Inst, Fuzhou, Fujian, Peoples R China; [Lin, Rui] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen, Fujian, Peoples R China; [Zhang, Zhongyi] Henan Agr Univ, Inst Chinese Med Mat, Zhengzhou, Henan, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Xiamen University; Henan Agricultural University	Wu, LK (corresponding author), Fujian Agr & Forestry Univ, Sch Life Sci, Fuzhou, Fujian, Peoples R China.	lwx@fjau.edu.cn	Wu, Linkun/GLN-5951-2022	Wu, Linkun/0000-0001-6674-5900	National Natural Science Foundation of China [30772729, 30671220, 31070403]; Natural Science Foundation of Fujian province, China [2008J0051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian province, China(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China (Grant no. 30772729, 30671220, 31070403) and the Natural Science Foundation of Fujian province, China (Grant no. 2008J0051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2009, ELECTROPHORESIS, V30, P4149, DOI 10.1002/elps.200900474; Afroz A, 2009, PEPTIDES, V30, P1600, DOI 10.1016/j.peptides.2009.06.005; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Baker MD, 2006, BIOESSAYS, V28, P9, DOI 10.1002/bies.20343; Benndorf D, 2009, BIODEGRADATION, V20, P737, DOI 10.1007/s10532-009-9261-3; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Blum M, 2010, MOL PLANT PATHOL, V11, P227, DOI 10.1111/j.1364-3703.2009.00604.x; Buscot F, 2005, SOIL BIOL, V3, P3; CAKMAK I, 1988, J PLANT PHYSIOL, V132, P356, DOI 10.1016/S0176-1617(88)80120-2; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen Hui, 2007, Yingyong Shengtai Xuebao, V18, P2755; Cho HY, 2005, PESTIC BIOCHEM PHYS, V83, P29, DOI 10.1016/j.pestbp.2005.03.005; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Costa G, 1997, J PLANT NUTR, V20, P883, DOI 10.1080/01904169709365303; CRAMER MD, 1993, ANN BOT-LONDON, V72, P359, DOI 10.1006/anbo.1993.1119; Crowley D, 2001, BOOKS SOIL PLANT ENV, P223; Du Jia-fang, 2009, Shengtaixue Zazhi, V28, P445; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; FREDRICKSON JK, 1995, MOL ECOL, V4, P619, DOI 10.1111/j.1365-294X.1995.tb00262.x; Giovannetti M, 1996, NEW PHYTOL, V133, P65, DOI 10.1111/j.1469-8137.1996.tb04342.x; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; HE HQ, 2005, CHIN J APPL ECOL, V16, P890; Huang CZ, 2006, J PROTEOME RES, V5, P3268, DOI 10.1021/pr060257h; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; JU HY, 2002, CHINESE J APPL ECOLO, V13, P723; KAPOOR R, 2006, MICROBIAL ACTIVITY R, P55; KITAKAWA M, 1990, NUCLEIC ACIDS RES, V18, P1521, DOI 10.1093/nar/18.6.1521; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kumar RS, 2005, J APPL MICROBIOL, V98, P145, DOI 10.1111/j.1365-2672.2004.02435.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landi L, 2000, BIOL FERT SOILS, V32, P8, DOI 10.1007/s003740000205; Li, 2007, J AGROENVIRONMENT SC, V26, P347; [梁银丽 Liang Yinli], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P134; [刘峰 LIU Feng], 2007, [中草药, Chinese Traditional and Herbal Drugs], V38, P1871; [刘红彦 LIU Hongyan], 2006, [华北农学报, Acta Agriculturae Boreali-Sinica], V21, P131; Maguire M, 2002, CELL STRESS CHAPERON, V7, P317, DOI 10.1379/1466-1268(2002)007<0317:CUISOC>2.0.CO;2; Manoharachary C, 2006, SOIL BIOL, V7, P1; MEHARG AA, 1995, PLANT SOIL, V170, P345, DOI 10.1007/BF00010488; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Mirza MS, 2001, PLANT SOIL, V237, P47, DOI 10.1023/A:1013388619231; Neumann G, 2001, BOOKS SOIL PLANT ENV, P41; Neumann G., 2002, Plant roots: the hidden half, P617; Neumann G, 2007, NUTR CYCLING TERREST, P123, DOI DOI 10.1007/978-3-540-68027-7_5; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Phillips DA, 2004, PLANT PHYSIOL, V136, P2887, DOI 10.1104/pp.104.044222; Qi JJ, 2009, COMMUN SOIL SCI PLAN, V40, P1462, DOI 10.1080/00103620902818104; Qu XH, 2008, APPL SOIL ECOL, V39, P172, DOI 10.1016/j.apsoil.2007.12.007; RAJAN S, 1999, CELL, V97, P371; Read DJ, 2003, NEW PHYTOL, V157, P475, DOI 10.1046/j.1469-8137.2003.00704.x; REID CPP, 1974, PLANT PHYSIOL, V54, P44, DOI 10.1104/pp.54.1.44; Russo A, 2005, BIOL FERT SOILS, V41, P301, DOI 10.1007/s00374-005-0854-7; Sacchi GA, 2000, PLANT SOIL, V220, P1, DOI 10.1023/A:1004701912815; Sahin F, 2004, PLANT SOIL, V265, P123, DOI 10.1007/s11104-005-0334-8; Scharf B, 2002, J MOL MICROB BIOTECH, V4, P183; Semenov AM, 1999, MICROB ECOL, V37, P116, DOI 10.1007/s002489900136; SHAHIDINOGHABI S, 2010, TOXICITY MODE ACTION; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; [时向东 SHI Xiangdong], 2006, [安徽农业科学, Journal of anhui agricultural sciences], V34, P2043; Shiomi Y, 1999, APPL ENVIRON MICROB, V65, P3996; Siddiki AMAMZ, 2009, J VET SCI, V10, P203, DOI 10.4142/jvs.2009.10.3.203; Taylor EB, 2010, MICROB ECOL, V59, P390, DOI 10.1007/s00248-009-9593-x; Ter Steege MW, 1999, PLANT SOIL, V208, P125, DOI 10.1023/A:1004585200558; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VANCURA V, 1967, PLANT SOIL, V27, P319, DOI 10.1007/BF01376325; Wang HB, 2010, ACTA PHYSIOL PLANT, V32, P245, DOI 10.1007/s11738-009-0399-8; WANG HB, 2011, J PROTEOME IN PRESS; [王茹华 WANG RuHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P3152; Wilmes P, 2004, ENVIRON MICROBIOL, V6, P911, DOI 10.1111/j.1462-2920.2004.00687.x; Wu FZ, 2009, EUR J SOIL BIOL, V45, P356, DOI 10.1016/j.ejsobi.2009.04.001; [吴凤芝 Wu Fengzhi], 2003, [东北农业大学学报, Journal of Northeast Agricultural University], V34, P114; Wu Zong-wei, 2009, Shengtaixue Zazhi, V28, P660; Yost CK, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-1; ZHANG K, 1994, BIOCHEM PHARMACOL, V47, P2063, DOI 10.1016/0006-2952(94)90082-5; Zhang Zhong-yi, 2003, Zhongguo Zhongyao Zazhi, V28, P207; ZHAO YJ, 1991, J CHIN MED MAT, V14, P3; ZHU GJ, 2007, HENAN SCI, V14, P255	79	100	121	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20611	10.1371/journal.pone.0020611	http://dx.doi.org/10.1371/journal.pone.0020611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655235	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600108
J	Zhou, W; Chen, ZG; Hu, WQ; Shen, M; Zhang, XX; Li, CD; Wen, ZL; Wu, XL; Hu, YP; Zhang, XH; Duan, XZ; Han, XC; Tao, ZH				Zhou, Wu; Chen, Zhanguo; Hu, Wangqiang; Shen, Mo; Zhang, Xiaoxia; Li, Chengdi; Wen, Zhiliang; Wu, Xiuling; Hu, Yuanping; Zhang, Xiaohua; Duan, Xiuzhi; Han, Xiucui; Tao, Zhihua			Association of Short Tandem Repeat Polymorphism in the Promoter of Prostate Cancer Antigen 3 Gene with the Risk of Prostate Cancer	PLOS ONE			English	Article							RADICAL RETROPUBIC PROSTATECTOMY; EXPRESSION; DD3(PCA3); DD3	Background: PCA3 (prostate cancer antigen 3) gene is one of the most prostate cancer-specific genes at present. Consequently, the prostate-specific expression and the sharp up-regulation of PCA3 mRNA in prostate cancer suggest a unique transcriptional regulation, which possibly can be attributed to promoter polymorphism. In our study, we evaluated whether there is polymorphism in PCA3 promoter region and also assess the association of the polymorphism with prostate cancer. Methodology/Principal Findings: We designed a specific primer set to screen the promoter of PCA3 gene by polymerase chain reaction (PCR)-based cloning and sequencing with the DNA extracted from peripheral blood samples of prostate cancer (PCa) cases (n = 186) and healthy control cases (n = 135). Genotype-specific risks were estimated as odds ratios (ORs) with associated 95% confidence intervals (CIs) by chi-square test. Possible deviation of the genotype frequencies from controls and PCa cases expected under Hardy-Weinberg equilibrium was assessed by the chi-square test. Short tandem repeat polymorphism of TAAA was found in the promoter region of PCA3 gene, five polymorphisms and eight genotypes were identified. The eight genotypes were divided into three groups: <= 10TAAA, 11TAAA, >= 12TAAA. The group 11TAAA and >= 12TAAA were associated with higher relative risk for prostate cancer than group <= 10TAAA (OR = 1.76, 95% CI = 1.07-2.89[for group 11TAAA]; OR = 5.28, 95% CI = 1.76-15.89[for group >= 12TAAA]). Conclusions/Significance: The presence of the (TAAA) n short tandem repeat polymorphisms in the PCA3 promoter region may be a risk factor for prostate cancer in the Chinese population.	[Zhou, Wu; Chen, Zhanguo; Hu, Wangqiang; Shen, Mo; Duan, Xiuzhi; Han, Xiucui; Tao, Zhihua] Wenzhou Med Coll, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiaoxia] Ningbo Municipal Hosp Tradit Chinese Med, Dept Lab Med, Ningbo, Zhejiang, Peoples R China; [Li, Chengdi; Wen, Zhiliang] Wenzhou Med Coll, Affiliated Hosp 1, Dept Urol, Wenzhou, Zhejiang, Peoples R China; [Wu, Xiuling] Wenzhou Med Coll, Affiliated Hosp 1, Dept Pathol, Wenzhou, Zhejiang, Peoples R China; [Hu, Yuanping] Wenzhou Med Coll, Affiliated Hosp 1, Dept Ultrasound B, Wenzhou, Zhejiang, Peoples R China; [Zhang, Xiaohua] Wenzhou Med Coll, Affiliated Hosp 1, Dept Tumor Surg, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhou, W (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China.	wwwtzh@wz.zj.cn			Natural Science Foundation of China [30872421]; Wenzhou Municipal Science and Technology Bureau [Y20090292]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Municipal Science and Technology Bureau	This work was supported by grants from the Natural Science Foundation of China (NO. 30872421) and Wenzhou Municipal Science and Technology Bureau (Y20090292). The URL of the Natural Science Foundation of China: http://www.nsfc.gov.cn/Portal0/default124.htm. The URL of Wenzhou Municipal Science and Technology Bureau: http://www.wzkj.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussemakers MJG, 1999, CANCER RES, V59, P5975; Chen Feng-Ping, 2008, Zhonghua Yi Xue Za Zhi, V88, P261; de Kok JB, 2002, CANCER RES, V62, P2695; EPSTEIN JI, 1993, J UROLOGY, V150, P135, DOI 10.1016/S0022-5347(17)35415-0; Floriano-Sanchez E, 2009, CLIN INVEST MED, V32, pE258; Klecka J, 2010, ANTICANCER RES, V30, P665; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; LUYAO GL, 1993, JAMA-J AM MED ASSOC, V269, P2633, DOI 10.1001/jama.269.20.2633; PAULSON DF, 1990, J UROLOGY, V144, P1180, DOI 10.1016/S0022-5347(17)39686-6; Pound CR, 1997, UROL CLIN N AM, V24, P395, DOI 10.1016/S0094-0143(05)70386-4; Tao ZH, 2010, EXP MOL PATHOL, V89, P58, DOI 10.1016/j.yexmp.2010.01.008; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Verhaegh GW, 2000, J BIOL CHEM, V275, P37496, DOI 10.1074/jbc.M006293200; WALSH PC, 1994, J UROLOGY, V152, P1831, DOI 10.1016/S0022-5347(17)32396-0; ZINCKE H, 1994, J UROLOGY, V152, P1850, DOI 10.1016/S0022-5347(17)32399-6	15	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20378	10.1371/journal.pone.0020378	http://dx.doi.org/10.1371/journal.pone.0020378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655300	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600060
J	Fei, ZL; Bera, TK; Liu, XF; Xiang, LM; Pastan, I				Fei, Zhaoliang; Bera, Tapan K.; Liu, Xiufen; Xiang, Laiman; Pastan, Ira			Ankrd26 Gene Disruption Enhances Adipogenesis of Mouse Embryonic Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; ADIPOCYTE DIFFERENTIATION; PPAR-GAMMA; TRANSCRIPTIONAL REGULATION; 3T3-L1 PREADIPOCYTES; C/EBP-ALPHA; MAP KINASE; ACTIVATION; EXPRESSION; CELLS	We previously reported that partial disruption of the Ankrd26 gene in mice leads to hyperphagia and leptin-resistant obesity. To determine whether the Ankrd26 mutation can affect the development of adipocytes, we studied mouse embryo fibroblasts (MEFs) from the mutant mice. We found that Ankrd26(-/-) MEFs have a higher rate of spontaneous adipogenesis than normal MEFs and that adipocyte formation is greatly increased when the cells are induced with troglitazone alone or with a mixture of troglitazone, insulin, dexamethasone, and methyl-isobutylxanthine. Increased adipogenesis was detected as an increase in lipid droplet formation and in the expression of several markers of adipogenesis. There was an increase in expression of early stage adipogenesis genes such as Krox20, KLF5, C/EBP beta, C/EBP delta, and late stage adipogenesis regulators KLF15, C/EBP alpha, PPAR gamma, and aP2. There was also an increase in adipocyte stem cell markers CD34 and Sca-1 and preadipocyte markers Gata2 and Pref-1, indicating an increase in both stem cells and progenitor cells in the mutant MEFs. Furthermore, ERK was found constitutively activated in Anrd26(-/-) MEFs, and the addition of MEK inhibitors to mutant cells blocked ERK activation, decreased adipogenesis induction, and significantly reduced expression of C/EBP delta, KLF15, PPAR gamma 2, CD34, and Pref-1 genes. We conclude that Ankrd26 gene disruption promotes adipocyte differentiation at both the progenitor commitment and differentiation steps and that ERK activation plays a role in this process.	[Fei, Zhaoliang; Bera, Tapan K.; Liu, Xiufen; Xiang, Laiman; Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pastan, I (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, 37 Convent Dr,Rm 5106, Bethesda, MD 20892 USA.	pastani@mail.nih.gov	pastan, ira/P-9319-2019; fei, zhaoliang/ADK-2083-2022	pastan, ira/0000-0002-9223-0270; fei, zhaoliang/0000-0002-5400-8126	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010298] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research.	Belmonte N, 2001, MOL ENDOCRINOL, V15, P2037, DOI 10.1210/me.15.11.2037; Bera TK, 2008, P NATL ACAD SCI USA, V105, P270, DOI 10.1073/pnas.0710978105; Bera TK, 2006, CANCER RES, V66, P52, DOI 10.1158/0008-5472.CAN-05-3014; Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; deMora JF, 1997, MOL CELL BIOL, V17, P6068, DOI 10.1128/MCB.17.10.6068; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Hahn Y, 2006, GENE, V366, P238, DOI 10.1016/j.gene.2005.07.045; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hishida T, 2009, BIOCHIMIE, V91, P654, DOI 10.1016/j.biochi.2009.02.002; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Kim KA, 2007, MOL CELL BIOL, V27, P2294, DOI 10.1128/MCB.02207-06; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Kortum RL, 2005, MOL CELL BIOL, V25, P7592, DOI 10.1128/MCB.25.17.7592-7604.2005; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Liu XF, 2009, APOPTOSIS, V14, P1237, DOI 10.1007/s10495-009-0392-0; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2000, GENE DEV, V14, P1293; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; TOMIYAMA K, 1995, BIOCHEM BIOPH RES CO, V212, P263, DOI 10.1006/bbrc.1995.1965; Tong Q, 2003, DRUG NEWS PERSPECT, V16, P585, DOI 10.1358/dnp.2003.16.9.829340; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	32	36	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27761	27768		10.1074/jbc.M111.248435	http://dx.doi.org/10.1074/jbc.M111.248435			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669876	Green Published, hybrid			2022-12-25	WOS:000293268700068
J	Martin, Y; Gonzalez, YV; Cabrera, E; Rodriguez, C; Siverio, JM				Martin, Yuse; Gonzalez, Yelvis V.; Cabrera, Elisa; Rodriguez, Celia; Siverio, Jose M.			Npr1 Ser/Thr Protein Kinase Links Nitrogen Source Quality and Carbon Availability with the Yeast Nitrate Transporter (Ynt1) Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; HANSENULA-POLYMORPHA; PLASMA-MEMBRANE; INTRACELLULAR TRAFFICKING; DEUBIQUITINATING ENZYME; PHOSPHATE TRANSPORTER; ASPERGILLUS-NIDULANS; TRYPTOPHAN PERMEASE; SIGNALING PATHWAY	Ynt1, the single high affinity nitrate and nitrite transporter of the yeast Hansenula polymorpha, is regulated by the quality of nitrogen sources. Preferred nitrogen sources cause Ynt1 dephosphorylation, ubiquitinylation, endocytosis, and vacuolar degradation. In contrast, under nitrogen limitation Ynt1 is phosphorylated and sorted to the plasma membrane. We show here the involvement of the Ser/Thr kinase HpNpr1 in Ynt1 phosphorylation and regulation of Ynt1 levels in response to nitrogen source quality and the availability of carbon. In Delta npr1, Ynt1 phosphorylation does not take place, although Ynt1 ubiquitin conjugates increase. As a result, in this strain Ynt1 is sorted to the vacuole, from both plasma membrane and the later biosynthetic pathway in nitrogen-free conditions and nitrate. In contrast, overexpression of NPR1 blocks down-regulation of Ynt1, increasing Ynt1 phosphorylation at Ser-244 and -246 and reducing ubiquitinylation. Furthermore, Npr1 is phosphorylated in response to the preferred nitrogen sources, and indeed it is dephosphorylated in nitrogen-free medium. Under conditions where Npr1 is phosphorylated, Ynt1 is not and vice versa. We show for the first time that carbon starvation leads to Npr1 phosphorylation, whereas Ynt1 is dephosphorylated and degraded in the vacuole. Rapamycin prevents this, indicating a possible role of the target of rapamycin signaling pathway in this process. We concluded that Npr1 plays a key role in adapting Ynt1 levels to the nitrogen quality and availability of a source of carbon.	[Martin, Yuse; Gonzalez, Yelvis V.; Cabrera, Elisa; Rodriguez, Celia; Siverio, Jose M.] Univ La Laguna, Dpto Bioquim & Biol Mol, Inst Biomed Technol, Nitrogen Metab Grp, E-38206 Tenerife, Canarias, Spain	Universidad de la Laguna	Siverio, JM (corresponding author), Univ La Laguna, Dpto Bioquim & Biol Mol, Inst Biomed Technol, Nitrogen Metab Grp, Av Astrofis Fco Sanchez S-N, E-38206 Tenerife, Canarias, Spain.	jsiverio@ull.es	Rodríguez, Celia/HDL-7429-2022; Gonzalez, Yelvis V./E-9648-2011; Cabrera, Elisa/GPX-3455-2022; Siverio, José Manuel/K-7136-2014	Siverio, José Manuel/0000-0001-9404-2655	Ministerio de Ciencia e Innovacion [BFU2007-60172, BFU2010-16192]; Ministerio de Educacion y Ciencia (MEC); CajaCanarias-Universidad de La Laguna; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI), Gobierno de Canarias, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); CajaCanarias-Universidad de La Laguna; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI), Gobierno de Canarias, Spain	This work was supported by Grants BFU2007-60172 and BFU2010-16192 (to J. M. S.) from the "Ministerio de Ciencia e Innovacion."; Recipient of a predoctoral fellowship from the Ministerio de Educacion y Ciencia (MEC).; Recipient of a predoctoral fellowship from CajaCanarias-Universidad de La Laguna.; Recipient of a predoctoral fellowship from Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI), Gobierno de Canarias, Spain.	Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; AVILA J, 1995, FEBS LETT, V366, P137, DOI 10.1016/0014-5793(95)00511-7; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; CRAWFORD NM, 1993, ANNU REV GENET, V27, P115, DOI 10.1146/annurev.ge.27.120193.000555; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Devasahayam G, 2006, P NATL ACAD SCI USA, V103, P17840, DOI 10.1073/pnas.0604303103; Estrella LA, 2008, J BIOL CHEM, V283, P5327, DOI 10.1074/jbc.M703630200; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Gander S, 2009, J PROTEOME RES, V8, P5305, DOI 10.1021/pr9005469; Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790; Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000; GRENSON M, 1982, MOL GEN GENET, V188, P261, DOI 10.1007/BF00332685; GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Kaouass M, 1998, J BIOL CHEM, V273, P2109, DOI 10.1074/jbc.273.4.2109; Lagerstedt JO, 2002, FEBS LETT, V526, P31, DOI 10.1016/S0014-5793(02)03109-5; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Llamas A, 2002, PLANT J, V30, P261, DOI 10.1046/j.1365-313X.2002.01281.x; Machin F, 2004, YEAST, V21, P265, DOI 10.1002/yea.1075; Martinez P, 1998, J BACTERIOL, V180, P2253, DOI 10.1128/JB.180.8.2253-2256.1998; Narendja F, 2002, MOL MICROBIOL, V44, P573, DOI 10.1046/j.1365-2958.2002.02911.x; Navarro FJ, 2006, J BIOL CHEM, V281, P13268, DOI 10.1074/jbc.M601253200; Navarro FJ, 2003, FEMS YEAST RES, V4, P149, DOI 10.1016/S1567-1356(03)00163-6; Navarro FJ, 2008, J BIOL CHEM, V283, P31208, DOI 10.1074/jbc.M802170200; Neufeld TP, 2007, CELL METAB, V5, P3, DOI 10.1016/j.cmet.2006.12.008; Neuhauser B, 2011, EUKARYOT CELL, V10, P332, DOI 10.1128/EC.00293-10; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Omura F, 2004, FEMS MICROBIOL LETT, V230, P227, DOI 10.1016/S0378-1097(03)00918-2; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Perez MD, 1997, BIOCHEM J, V321, P397, DOI 10.1042/bj3210397; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rodriguez C, 2010, J BIOL CHEM, V285, P37551, DOI 10.1074/jbc.M110.146902; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Siverio JM, 2002, FEMS MICROBIOL REV, V26, P277, DOI 10.1016/S0168-6445(02)00100-6; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang Y, 2007, NEW PHYTOL, V175, P699, DOI 10.1111/j.1469-8137.2007.02135.x; Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	50	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27225	27235		10.1074/jbc.M111.265116	http://dx.doi.org/10.1074/jbc.M111.265116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652715	Green Published, hybrid			2022-12-25	WOS:000293268700018
J	Lopez-Huertas, MR; Mateos, E; Diaz-Gil, G; Gomez-Esquer, F; del Cojo, MS; Alcami, J; Coiras, M				Rosa Lopez-Huertas, Maria; Mateos, Elena; Diaz-Gil, Gema; Gomez-Esquer, Francisco; Sanchez del Cojo, Maria; Alcami, Jose; Coiras, Mayte			Protein Kinase C theta Is a Specific Target for Inhibition of the HIV Type 1 Replication in CD4(+) T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IMMUNODEFICIENCY-VIRUS TYPE-1; PKC-THETA; ANTIRETROVIRAL THERAPY; SELECTIVE INHIBITOR; ACTIVATION LOOP; CELL-CYCLE; INFECTION; ROTTLERIN; APOPTOSIS	Integration of HIV-1 genome in CD4(+) T cells produces latent reservoirs with long half-life that impedes the eradication of the infection. Control of viral replication is essential to reduce the size of latent reservoirs, mainly during primary infection when HIV-1 infects CD4(+) T cells massively. The addition of immunosuppressive agents to highly active antiretroviral therapy during primary infection would suppress HIV-1 replication by limiting T cell activation, but these agents show potential risk for causing lymphoproliferative disorders. Selective inhibition of PKC theta, crucial for T cell function, would limit T cell activation and HIV-1 replication without causing general immunosuppression due to PKC theta being mostly expressed in T cells. Accordingly, the effect of rottlerin, a dose-dependent PKC theta inhibitor, on HIV-1 replication was analyzed in T cells. Rottlerin was able to reduce HIV-1 replication more than 20-fold in MT-2 (IC50 = 5.2 mu M) and Jurkat (IC50 = 2.2 mu M) cells and more than 4-fold in peripheral blood lymphocytes (IC50 = 4.4 mu M). Selective inhibition of PKC theta, but not PKC delta or -zeta, was observed at <6.0 mu M, decreasing the phosphorylation at residue Thr(538) on the kinase catalytic domain activation loop and avoiding PKC theta translocation to the lipid rafts. Consequently, the main effector at the end of PKC theta pathway, NF-kappa B, was repressed. Rottlerin also caused a significant inhibition of HIV-1 integration. Recently, several specific PKC theta inhibitors have been designed for the treatment of autoimmune diseases. Using these inhibitors in combination with highly active antiretroviral therapy during primary infection could be helpful to avoid massive viral infection and replication from infected CD4(+) T cells, reducing the reservoir size at early stages of the infection.	[Rosa Lopez-Huertas, Maria; Mateos, Elena; Sanchez del Cojo, Maria; Alcami, Jose; Coiras, Mayte] Inst Salud Carlos III, Natl Ctr Microbiol, AIDS Immunopathol Unit, Madrid 28220, Spain; [Diaz-Gil, Gema; Gomez-Esquer, Francisco] Univ Rey Juan Carlos, Fac Hlth Sci, Madrid 28922, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad Rey Juan Carlos	Coiras, M (corresponding author), Ctra Majadahonda Pozuelo Km2, Madrid 28220, Spain.	mcoiras@isciii.es	Esquer, Francisco Gomez/K-8236-2017; Coiras, Mayte/R-9530-2019; Diaz-Gil, Gema/ABG-6454-2020; Alcami, Pepe/T-2242-2018; Lopez Huertas, Maria Rosa/J-6282-2014	Alcami, Pepe/0000-0003-0023-7377; Lopez Huertas, Maria Rosa/0000-0002-4183-2773; Coiras, Mayte/0000-0001-6464-5770; Diaz Gil, Gema/0000-0003-3480-1490; Gomez-Esquer, Francisco/0000-0002-5426-4349	Instituto de Salud Carlos III, Spanish Ministry of Health [FIS PI080752]; AIDS Network ISCIII-RETIC [RD06/0006]; Comunidad de Madrid (Spain), Network of Excellence EUROPRISE; FIPSE [36584/06, 36633/07, 360924/10]; European Union; Fondo de Investigaciones Sanitarias [FI09/00347]	Instituto de Salud Carlos III, Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AIDS Network ISCIII-RETIC; Comunidad de Madrid (Spain), Network of Excellence EUROPRISE(Comunidad de Madrid); FIPSE; European Union(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by Instituto de Salud Carlos III, Spanish Ministry of Health (FIS PI080752); AIDS Network ISCIII-RETIC (RD06/0006); VIRHORST Network from Comunidad de Madrid (Spain), Network of Excellence EUROPRISE; FIPSE (36584/06, 36633/07, and 360924/10).; Supported by a fellowship of the European Union Programme Health 2009 (CHAARM).; Supported by a fellowship of Fondo de Investigaciones Sanitarias (FI09/00347).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALCAMI J, 1995, EMBO J, V14, P1552, DOI 10.1002/j.1460-2075.1995.tb07141.x; Altman A, 2000, IMMUNOL TODAY, V21, P567, DOI 10.1016/S0167-5699(00)01749-7; ARENZANASEISDEDOS F, 1993, J VIROL, V67, P6596, DOI 10.1128/JVI.67.11.6596-6604.1993; BACHELERIE F, 1991, NATURE, V350, P709, DOI 10.1038/350709a0; Baier G, 2003, IMMUNOL REV, V192, P64, DOI 10.1034/j.1600-065X.2003.00018.x; BAIER G, 1993, J BIOL CHEM, V268, P4997; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Bedoya LM, 2009, BIOCHEM PHARMACOL, V77, P965, DOI 10.1016/j.bcp.2008.11.025; Berrey MM, 2001, J INFECT DIS, V183, P1466, DOI 10.1086/320189; Boschelli DH, 2010, BIOORG MED CHEM LETT, V20, P1965, DOI 10.1016/j.bmcl.2010.01.119; Boschelli DH, 2009, CURR TOP MED CHEM, V9, P640, DOI 10.2174/156802609789007372; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Cywin CL, 2007, BIOORG MED CHEM LETT, V17, P225, DOI 10.1016/j.bmcl.2006.09.056; de Lera TL, 1999, ONCOGENE, V18, P1581, DOI 10.1038/sj.onc.1202455; Deszo EL, 2001, J BIOL CHEM, V276, P10212, DOI 10.1074/jbc.M010589200; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Garcia-Perez J, 2007, J MED VIROL, V79, P127, DOI 10.1002/jmv.20770; Garcia-Perez J, 2011, J BIOL CHEM, V286, P4978, DOI 10.1074/jbc.M110.168955; Gekeler V, 1996, BRIT J CANCER, V74, P897, DOI 10.1038/bjc.1996.454; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hoen B, 1999, J INFECT DIS, V180, P1342, DOI 10.1086/315002; ICHIMURA H, 1995, VIROLOGY, V211, P554, DOI 10.1006/viro.1995.1437; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Manicassamy S, 2009, CURR OPIN INVEST DR, V10, P1225; Marquez N, 2008, BIOCHEM PHARMACOL, V75, P1370, DOI 10.1016/j.bcp.2007.12.004; MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8; Matteucci C, 2004, J MED VIROL, V74, P473, DOI 10.1002/jmv.20201; Matz M, 2010, NEPHROL DIAL TRANSPL, V25, P2159, DOI 10.1093/ndt/gfp775; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Meller N, 1998, STEM CELLS, V16, P178, DOI 10.1002/stem.160178; Meller N, 1999, CELL IMMUNOL, V193, P185, DOI 10.1006/cimm.1999.1478; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Okamoto K, 2006, GENES CELLS, V11, P177, DOI 10.1111/j.1365-2443.2006.00927.x; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; Pantaleo G, 1998, NAT MED, V4, P341, DOI 10.1038/nm0398-341; Pantaleo G, 1997, EUR J IMMUNOL, V27, P3166, DOI 10.1002/eji.1830271213; Parmer TG, 1997, CELL GROWTH DIFFER, V8, P327; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Ringshausen I, 2006, LEUKEMIA, V20, P514, DOI 10.1038/sj.leu.2404113; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rullas J, 2004, ANTIVIR THER, V9, P545; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Sancho R, 2004, J BIOL CHEM, V279, P37349, DOI 10.1074/jbc.M401993200; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Solomou EE, 2001, J IMMUNOL, V166, P5665, DOI 10.4049/jimmunol.166.9.5665; Springael C, 2007, BIOCHEM PHARMACOL, V73, P515, DOI 10.1016/j.bcp.2006.10.034; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Villalba M, 1998, NEUROREPORT, V9, P1713, DOI 10.1097/00001756-199806010-00008; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Williams SA, 2007, CYTOKINE, V39, P63, DOI 10.1016/j.cyto.2007.05.017; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669	78	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27363	27377		10.1074/jbc.M110.210443	http://dx.doi.org/10.1074/jbc.M110.210443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669868	Green Published, hybrid			2022-12-25	WOS:000293268700032
J	Sharma, B; Altman, JK; Goussetis, DJ; Verma, AK; Platanias, LC				Sharma, Bhumika; Altman, Jessica K.; Goussetis, Dennis J.; Verma, Amit K.; Platanias, Leonidas C.			Protein Kinase R as Mediator of the Effects of Interferon (IFN) gamma and Tumor Necrosis Factor (TNF) alpha on Normal and Dysplastic Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MYELODYSPLASTIC-SYNDROME; APLASTIC-ANEMIA; SIGNALING PATHWAYS; I INTERFERONS; CELL-GROWTH; P38 MAPK; C-DELTA; ACTIVATION; PKR	IFN gamma and TNF alpha are potent inhibitors of hematopoiesis and have been implicated in the pathophysiology of bone marrow failure and myelodysplastic syndromes (MDS). We examined the role of protein kinase R (PKR) in the generation of the inhibitory effects of these myelosuppressive cytokines on hematopoiesis. Our data demonstrate that PKR is rapidly phosphorylated/activated in response to engagement of IFN gamma or TNF alpha receptors in normal human hematopoietic progenitors. Such engagement of PKR is important for the suppressive effects of these cytokines on normal hematopoiesis. Pharmacological targeting of PKR using a specific inhibitor or siRNA-mediated PKR knockdown results in partial reversal of the suppressive effects of IFN gamma and TNF alpha on normal human CD34+-derived myeloid (colony-forming unit-granulocyte-monocytic) and erythroid (burst-forming unit-erythroid) progenitors. Importantly, inhibition of PKR activity or expression increases hematopoietic colony formation from human MDS progenitors, suggesting that drugs that target PKR may provide a novel approach for the treatment of MDS and marrow failure syndromes. Altogether, our data establish that beyond its key role in the induction of IFN-antiviral responses, PKR plays important roles in signaling for IFN gamma and other myelosuppressive cytokine receptors as a common mediator of signals for hematopoietic suppression.	[Sharma, Bhumika; Altman, Jessica K.; Goussetis, Dennis J.; Platanias, Leonidas C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, Chicago, IL 60611 USA; [Sharma, Bhumika; Altman, Jessica K.; Goussetis, Dennis J.] Northwestern Univ, Div Hematol Oncol, Sch Med, Chicago, IL 60611 USA; Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Verma, Amit K.; Platanias, Leonidas C.] Albert Einstein Coll Med, Dept Med, Div Hematol Oncol, Bronx, NY 10461 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Yeshiva University; Albert Einstein College of Medicine	Platanias, LC (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Sch Med, 303 E Super St,Lurie, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			National Institutes of Health [CA77816, CA121192, AG029138]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA121192, R01CA077816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA121192, and AG029138. This work was also supported by a merit review grant from the Department of Veterans Affairs.	Arnold R, 2007, CELL DEATH DIFFER, V14, P568, DOI 10.1038/sj.cdd.4402042; Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Bodo M, 2009, J Stem Cells, V4, P57, DOI jsc.2009.4.1.57; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bruserud O, 2010, CURR TOP MICROBIOL, V341, P3, DOI 10.1007/82_2010_18; Chamuleau MED, 2009, HAEMATOL-HEMATOL J, V94, P496, DOI 10.3324/haematol.13612; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Follo MY, 2008, LEUKEMIA, V22, P2267, DOI 10.1038/leu.2008.122; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Manero G, 2010, HEMATOL-AM SOC HEMAT, P330, DOI 10.1182/asheducation-2010.1.330; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; George CX, 2009, J INTERF CYTOK RES, V29, P477, DOI 10.1089/jir.2009.0065; Gersuk GR, 1998, BRIT J HAEMATOL, V103, P176, DOI 10.1046/j.1365-2141.1998.00933.x; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Hofmann WK, 2005, ANNU REV MED, V56, P1, DOI 10.1146/annurev.med.56.082103.104704; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kambhampati S, 2003, J BIOL CHEM, V278, P32544, DOI 10.1074/jbc.M301523200; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaushansky K, 2009, J THROMB HAEMOST, V7, P235, DOI 10.1111/j.1538-7836.2009.03419.x; Kitagawa M, 1997, LEUKEMIA, V11, P2049, DOI 10.1038/sj.leu.2400844; Kochenderfer JN, 2002, BLOOD, V100, P3639, DOI 10.1182/blood-2002-01-0155; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Li SD, 2006, P NATL ACAD SCI USA, V103, P10005, DOI 10.1073/pnas.0602317103; LOTEM J, 1991, CELL GROWTH DIFFER, V2, P421; McAllister CS, 2010, J VIROL, V84, P380, DOI 10.1128/JVI.02630-08; NAUDE PJ, 2001, FEBS J, V278, P888; Navas T, 2008, LEUKEMIA LYMPHOMA, V49, P1963, DOI 10.1080/10428190802322919; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Olnes MJ, 2011, JAMA-J AM MED ASSOC, V305, P814, DOI 10.1001/jama.2011.194; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Redig AJ, 2007, J INTERF CYTOK RES, V27, P623, DOI 10.1089/jir.2007.0007; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Samuel CE, 1997, INT J HEMATOL, V65, P227; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sloand EM, 2005, BLOOD, V106, P841, DOI 10.1182/blood-2004-05-2017; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Uddin S, 2000, J BIOL CHEM, V275, P27634; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wickrema A, 1999, J BIOL CHEM, V274, P24469, DOI 10.1074/jbc.274.35.24469; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Young NS, 1996, EUR J HAEMATOL, V57, P55; Young NS, 2002, ANN INTERN MED, V136, P534, DOI 10.7326/0003-4819-136-7-200204020-00011; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07	56	22	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27506	27514		10.1074/jbc.M111.238501	http://dx.doi.org/10.1074/jbc.M111.238501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659535	hybrid, Green Published			2022-12-25	WOS:000293268700045
J	Steckbeck, JD; Craigo, JK; Barnes, CO; Montelaro, RC				Steckbeck, Jonathan D.; Craigo, Jodi K.; Barnes, Christopher O.; Montelaro, Ronald C.			Highly Conserved Structural Properties of the C-terminal Tail of HIV-1 gp41 Protein Despite Substantial Sequence Variation among Diverse Clades IMPLICATIONS FOR FUNCTIONS IN VIRAL REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MEMBRANE-SPANNING DOMAIN; CIRCULAR-DICHROISM SPECTRA; CELL-CELL FUSION; DE-NOVO PEPTIDE; RELATE 2 SETS; ENVELOPE GLYCOPROTEIN; CYTOPLASMIC TAIL; STRUCTURE PREDICTION; NEUTRALIZING ANTIBODIES	Although the HIV-1 Env gp120 and gp41 ectodomain have been extensively characterized in terms of structure and function, similar characterizations of the C-terminal tail (CTT) of HIV gp41 remain relatively limited and contradictory. The current study was designed to examine in detail CTT sequence conservation relative to gp120 and the gp41 ectodomain and to examine the conservation of predicted physicochemical and structural properties across a number of divergent HIV clades and groups. Results demonstrate that CTT sequences display intermediate levels of sequence evolution and diversity in comparison to the more diverse gp120 and the more conserved gp41 ectodomain. Despite the relatively high level of CTT sequence variation, the physicochemical properties of the lentivirus lytic peptide domains (LLPs) within the CTT are evidently highly conserved across clades/groups. Additionally, predictions using PEP-FOLD indicate a high level of structural similarity in the LLP regions that was confirmed by circular dichroism measurements of secondary structure of LLP peptides from clades B, C, and group O. Results demonstrate that LLP peptides adopt helical structure in the presence of SDS or trifluoroethanol but are predominantly unstructured in aqueous buffer. Thus, these data for the first time demonstrate strong conservations of characteristic CTT physicochemical and structural properties despite substantial sequence diversity, apparently indicating a delicate balance between evolutionary pressures and the conservation of CTT structure and associated functional roles in virus replication.	[Steckbeck, Jonathan D.; Craigo, Jodi K.; Barnes, Christopher O.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15261 USA; [Craigo, Jodi K.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Montelaro, RC (corresponding author), 3501 5th Ave,9014 BST3, Pittsburgh, PA 15261 USA.	rmont@pitt.edu			National Institutes of Health [1R01AI087533, 1P50GM082251, 5T32GM065100, 5T32AI065380]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087533, T32AI065380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251, T32GM065100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01AI087533, 1P50GM082251, 5T32GM065100, and 5T32AI065380.	Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; CHERNOMORDIK L, 1994, J VIROL, V68, P7115, DOI 10.1128/JVI.68.11.7115-7123.1994; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Evans DT, 2001, IMMUNOL REV, V183, P141, DOI 10.1034/j.1600-065x.2001.1830112.x; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Gangupomu VK, 2010, BIOPHYS J, V99, P3438, DOI 10.1016/j.bpj.2010.09.054; Heap CJ, 2005, J GEN VIROL, V86, P1499, DOI 10.1099/vir.0.80414-0; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; HIRSCH VM, 1989, NATURE, V341, P573, DOI 10.1038/341573a0; HO DD, 1987, J VIROL, V61, P2024, DOI 10.1128/JVI.61.6.2024-2028.1987; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Jing WG, 2003, J BACTERIOL, V185, P4938, DOI 10.1128/JB.185.16.4938-4947.2003; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim JH, 2009, BBA-BIOMEMBRANES, V1788, P1804, DOI 10.1016/j.bbamem.2009.06.011; Kliger Y, 1997, BIOCHEMISTRY-US, V36, P5157, DOI 10.1021/bi962935r; KODAMA T, 1989, J VIROL, V63, P4709, DOI 10.1128/JVI.63.11.4709-4714.1989; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Lu L, 2008, J BIOL CHEM, V283, P16723, DOI 10.1074/jbc.M801083200; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; MacCallum JL, 2008, BIOPHYS J, V94, P3393, DOI 10.1529/biophysj.107.112805; MacCallum JL, 2007, J GEN PHYSIOL, V129, P371, DOI 10.1085/jgp.200709745; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Murakami T, 2008, MICROBIOL IMMUNOL, V52, P287, DOI 10.1111/j.1348-0421.2008.00008.x; Newman JT, 2007, VIROLOGY, V367, P102, DOI 10.1016/j.virol.2007.05.027; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; PIENIAZEK D, 1998, HUMAN RETROVIRUS AID, P112; Reading SA, 2003, VIROLOGY, V315, P362, DOI 10.1016/S0042-6822(03)00533-6; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; SRINIVAS SK, 1992, J BIOL CHEM, V267, P7121; Steckbeck JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015261; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tung CH, 2003, ADV DRUG DELIVER REV, V55, P281, DOI 10.1016/S0169-409X(02)00183-7; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; West JT, 2001, J VIROL, V75, P9601, DOI 10.1128/JVI.75.20.9601-9612.2001; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; Yue L, 2009, J VIROL, V83, P11588, DOI 10.1128/JVI.00914-09; [No title captured]	64	34	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27156	27166		10.1074/jbc.M111.258855	http://dx.doi.org/10.1074/jbc.M111.258855			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659530	Green Published, hybrid			2022-12-25	WOS:000293268700011
J	Chen, T; Xu, Y; Guo, H; Liu, YL; Hu, PT; Yang, XY; Li, XG; Ge, SC; Velu, SE; Nadkarni, DH; Wang, W; Zhang, RW; Wang, H				Chen, Tao; Xu, Yi; Guo, He; Liu, Yanling; Hu, Pingting; Yang, Xinying; Li, Xiaoguang; Ge, Shichao; Velu, Sadanandan E.; Nadkarni, Dwayaja H.; Wang, Wei; Zhang, Ruiwen; Wang, Hui			Experimental Therapy of Ovarian Cancer with Synthetic Makaluvamine Analog: In Vitro and In Vivo Anticancer Activity and Molecular Mechanisms of Action	PLOS ONE			English	Article							MARINE NATURAL-PRODUCTS; CELL-CYCLE ARREST; ZYZZYA-FULIGINOSA; GENUS ZYZZYA; APOPTOSIS; DEATH; PYRROLOIMINOQUINONES; MITOCHONDRIA; ACTIVATION; SURVIVAL	The present study was designed to determine the biological effects of novel marine alkaloid analog 7-(4-fluorobenzylamino)-1,3,4,8-tetrahydropyrrolo[4,3,2-de]quinolin-8(1H)-one (FBA-TPQ) on human ovarian cancer cells for its anti-tumor potential and the underlying mechanisms as a novel chemotherapeutic agent. Human ovarian cancer cells (A2780 and OVCAR-3), and Immortalized non-tumorigenic human Ovarian Surface Epithelial cells (IOSE-144), were exposed to FBA-TPQ for initial cytotoxicity evaluation (via MTS assay kit, Promega). The detailed in-vitro (cell level) and in-vivo (animal model) studies on the antitumor effects and possible underlying mechanisms of action of the compounds were then performed. FBA-TPQ exerted potent cytotoxicity against human ovarian cancer A2780 and OVCAR-3 cells as an effective inhibitor of cell growth and proliferation, while exerting lesser effects on non-tumorigenic IOSE-144 cells. Further study in the more sensitive OVCAR-3 cell line showed that it could potently induce cell apoptosis (Annexin V-FITC assay), G2/M cell cycle arrest (PI staining analysis) and also dose-dependently inhibit OVCAR-3 xenograft tumors' growth on female athymic nude mice (BALB/c, nu/nu). Mechanistic studies (both in vitro and in vivo) revealed that FBA-TPQ might exert its activity through Reactive Oxygen Species (ROS)-associated activation of the death receptor, p53-MDM2, and PI3K-Akt pathways in OVCAR-3 cells, which is in accordance with in vitro microarray (Human genome microarrays, Agilent) data analysis (GEO accession number: GSE25317). In conclusion, FBA-TPQ exhibits significant anticancer activity against ovarian cancer cells, with minimal toxicity to non-tumorigenic human IOSE-144 cells, indicating that it may be a potential therapeutic agent for ovarian cancer.	[Chen, Tao; Xu, Yi; Guo, He; Liu, Yanling; Hu, Pingting; Yang, Xinying; Li, Xiaoguang; Ge, Shichao; Wang, Hui] Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China; [Velu, Sadanandan E.; Nadkarni, Dwayaja H.] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA; [Wang, Wei; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Alabama System; University of Alabama Birmingham; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Chen, T (corresponding author), Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci, Shanghai Inst Biol Sci,Grad Sch, Shanghai, Peoples R China.	huiwang@sibs.ac.cn	liu, yan/HCI-5542-2022	Velu, Sadanandan/0000-0002-0342-2378	Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715]; Ministry of Science and Technology of China [2007CB947100]; Science and Technology Commission of Shanghai Municipality [08391910800, 10391902100]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2009ZX09102-114, 2009ZX09301-011]; Science and Technology Commission of Xuhui District of Shanghai Municipality [RCT201001, CRC2010002]; Director Foundation of INS [20090101]; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS; National Institutes of Health/National Cancer Institute [R01 CA112029, R01 CA121211]; NATIONAL CANCER INSTITUTE [R01CA112029, R01CA121211] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"; Science and Technology Commission of Xuhui District of Shanghai Municipality; Director Foundation of INS; Food Safety Research Center; Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS(Chinese Academy of Sciences); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This study was supported by grants from One Hundred Talents Program of the Chinese Academy of Sciences, the National Nature Science Foundation (30870513, 31070680 and 91029715), the Ministry of Science and Technology of China (2007CB947100), the Science and Technology Commission of Shanghai Municipality (08391910800, 10391902100), National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2009ZX09102-114, 2009ZX09301-011), the Science and Technology Commission of Xuhui District of Shanghai Municipality (RCT201001, CRC2010002), Director Foundation of INS (20090101), the Food Safety Research Center and Key Laboratory of Nutrition and Metabolism of INS, SIBS, CAS. R.Z. was supported in part by National Institutes of Health/National Cancer Institute grants R01 CA112029 and R01 CA121211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; BARROWS LR, 1993, ANTI-CANCER DRUG DES, V8, P333; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Blunt JW, 2005, NAT PROD REP, V22, P15, DOI 10.1039/b415080p; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CARNEY Jr, 1993, TETRAHEDRON, V49, P8483, DOI 10.1016/S0040-4020(01)96256-8; Casapullo A, 2001, J NAT PROD, V64, P1354, DOI 10.1021/np010053+; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; Dijoux MG, 2005, BIOORGAN MED CHEM, V13, P6035, DOI 10.1016/j.bmc.2005.06.019; Engel J, 2002, EUR J CANCER, V38, P2435, DOI 10.1016/S0959-8049(02)00495-1; Godefroy N, 2006, APOPTOSIS, V11, P659, DOI 10.1007/s10495-006-5543-y; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gupta L, 2007, CURR MED CHEM, V14, P1789; Han CT, 2009, AM J PHYSIOL-CELL PH, V297, pC1188, DOI 10.1152/ajpcell.00042.2009; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Huang M, 2008, MOL CANCER THER, V7, P1440, DOI 10.1158/1535-7163.MCT-07-2116; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; RADISKY DC, 1993, J AM CHEM SOC, V115, P1632, DOI 10.1021/ja00058a003; Sahu RP, 2009, BRIT J CANCER, V100, P1425, DOI 10.1038/sj.bjc.6605039; Schmidt EW, 1995, J NAT PROD, V58, P1861, DOI 10.1021/np50126a008; Shinkre BA, 2008, BIOORGAN MED CHEM, V16, P2541, DOI 10.1016/j.bmc.2007.11.051; Shinkre BA, 2007, BIOORG MED CHEM LETT, V17, P2890, DOI 10.1016/j.bmcl.2007.02.065; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Tse AN, 2007, CLIN CANCER RES, V13, P1955, DOI 10.1158/1078-0432.CCR-06-2793; Venables DA, 1997, J NAT PROD, V60, P408, DOI 10.1021/np9607262; Wang W, 2009, CLIN CANCER RES, V15, P3511, DOI 10.1158/1078-0432.CCR-08-2689; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661	34	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20729	10.1371/journal.pone.0020729	http://dx.doi.org/10.1371/journal.pone.0020729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673964	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400025
J	Huang, ZF; Wang, HY; Lu, MF; Sun, CC; Wu, XP; Tan, Y; Ye, CH; Zhu, GH; Wang, XJ; Cai, L; Li, XK				Huang, Zhifeng; Wang, Huiyan; Lu, Meifei; Sun, Chuanchuan; Wu, Xiaoping; Tan, Yi; Ye, Chaohui; Zhu, Guanghui; Wang, Xiaojie; Cai, Lu; Li, Xiaokun			A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol	PLOS ONE			English	Article							SITE-SPECIFIC MODIFICATION; BETA-KLOTHO; METABOLIC-ACTIVITY; FACTOR FAMILY; FGF21; PEGYLATION; ACTIVATION; INCREASES; FGF-21; TISSUE	As one of fibroblast growth factor (FGF) family members, FGF21 has been extensively investigated for its potential as a drug candidate to combat metabolic diseases. In the present study, recombinant human FGF21 (rhFGF21) was modified with polyethylene glycol (PEGylation) in order to increase its in vivo biostabilities and therapeutic potency. At N-terminal residue rhFGF21 was site-selectively PEGylated with mPEG20 kDa-butyraldehyde. The PEGylated rhFGF21 was purified to near homogeneity by Q Sepharose anion-exchange chromatography. The general structural and biochemical features as well as anti-diabetic effects of PEGylated rhFGF21 in a type 2 diabetic rat model were evaluated. By N-terminal sequencing and MALDI-TOF mass spectrometry, we confirmed that PEG molecule was conjugated only to the N-terminus of rhFGF21. The mono-PEGylated rhFGF21 retained the secondary structure, consistent with the native rhFGF21, but its biostabilities, including the resistance to physiological temperature and trypsinization, were significantly enhanced. The in vivo immunogenicity of PEGylated rhFGF21 was significantly decreased, and in vivo half-life time was significantly elongated. Compared to the native form, the PEGylated rhFGF21 had a similar capacity of stimulating glucose uptake in 3T3-L1 cells in vitro, but afforded a significantly long effect on reducing blood glucose and triglyceride levels in the type 2 diabetic animals. These results suggest that the PEGylated rhFGF21 is a better and more effective anti-diabetic drug candidate than the native rhFGF21 currently available. Therefore, the PEGylated rhFGF21 may be potentially applied in clinics to improve the metabolic syndrome for type 2 diabetic patients.	[Huang, Zhifeng; Lu, Meifei; Sun, Chuanchuan; Tan, Yi; Ye, Chaohui; Zhu, Guanghui; Wang, Xiaojie; Cai, Lu; Li, Xiaokun] Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China; [Huang, Zhifeng; Lu, Meifei; Sun, Chuanchuan; Tan, Yi; Ye, Chaohui; Zhu, Guanghui; Wang, Xiaojie; Cai, Lu; Li, Xiaokun] Wenzhou Med Coll, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China; [Huang, Zhifeng; Wang, Huiyan; Li, Xiaokun] Jilin Univ, Normal Bethune Med Coll, Changchun 130023, Jilin, Peoples R China; [Wu, Xiaoping; Li, Xiaokun] Jinan Univ, Key Lab, Minist Educ Tissue Transplantat & Immunol, Guangzhou, Guangdong, Peoples R China; [Tan, Yi; Cai, Lu] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	Wenzhou Medical University; Wenzhou Medical University; Jilin University; Jinan University; University of Louisville	Huang, ZF (corresponding author), Wenzhou Med Coll, Sch Pharm, Wenzhou, Zhejiang, Peoples R China.	L0cai001@louisville.edu; xiaokunli@163.net	Cai, Lu/AAG-9920-2019		Natural Science Foundation of Zhejiang Province of China [Y4100067]; Wenzhou Department of Science and Technology [Y20100004]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Extremely Key Subject Building Project; Wenzhou Medical College	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Wenzhou Department of Science and Technology; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Extremely Key Subject Building Project; Wenzhou Medical College	Funding: This work was supported, in part, by grants from Natural Science Foundation of Zhejiang Province of China (Y4100067) [Z. Huang], Key Grant of Wenzhou Department of Science and Technology (Y20100004) [Z. Huang], Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents [X. Li], Zhejiang Provincial Extremely Key Subject Building Project "Pharmacology and Biochemical Pharmaceutics 2009'', and Start-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical College [L. Cai and X. Li]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIRD A, 1991, CANCER CELL-MON REV, V3, P239; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fukumoto S, 2008, INTERNAL MED, V47, P337, DOI 10.2169/internalmedicine.47.0730; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029; KATRE NV, 1987, P NATL ACAD SCI USA, V84, P1487, DOI 10.1073/pnas.84.6.1487; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kinstler O, 2002, ADV DRUG DELIVER REV, V54, P477, DOI 10.1016/S0169-409X(02)00023-6; KITAMURA K, 1990, BIOCHEM BIOPH RES CO, V171, P1387, DOI 10.1016/0006-291X(90)90839-F; KUAN CT, 1994, J BIOL CHEM, V269, P7610; KURFURST MM, 1992, ANAL BIOCHEM, V200, P244, DOI 10.1016/0003-2697(92)90460-O; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lee BK, 2007, BIOCONJUGATE CHEM, V18, P1728, DOI 10.1021/bc060245m; Marsac Y, 2006, BIOCONJUGATE CHEM, V17, P1492, DOI 10.1021/bc0601931; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Niall H D, 1973, Methods Enzymol, V27, P942; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Scott MD, 2004, TRANSFUS CLIN BIOL, V11, P40, DOI 10.1016/j.tracli.2003.12.005; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Uonaga T, 2010, ISLETS, V2, P247, DOI 10.4161/isl.2.4.12402; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; Veronese FM, 2007, BIOCONJUGATE CHEM, V18, P1824, DOI 10.1021/bc070123+; Wang HY, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-14; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Xiao JP, 2008, BIOCONJUGATE CHEM, V19, P1113, DOI 10.1021/bc800063k; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	40	44	51	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20669	10.1371/journal.pone.0020669	http://dx.doi.org/10.1371/journal.pone.0020669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673953	Green Published, Green Submitted, gold			2022-12-25	WOS:000291356400015
J	Emig, D; Sander, O; Mayr, G; Albrecht, M				Emig, Dorothea; Sander, Oliver; Mayr, Gabriele; Albrecht, Mario			Structure Collisions between Interacting Proteins	PLOS ONE			English	Article							INTERACTION NETWORKS; CRYSTAL-STRUCTURE; COMPLEX; GROWTH; INFORMATION; CYCLOPHILIN; PATHWAYS; INSIGHTS; RECEPTOR; DATABASE	Protein-protein interactions take place at defined binding interfaces. One protein may bind two or more proteins at different interfaces at the same time. So far it has been commonly accepted that non-overlapping interfaces allow a given protein to bind other proteins simultaneously while no collisions occur between the binding protein structures. To test this assumption, we performed a comprehensive analysis of structural protein interactions to detect potential collisions. Our results did not indicate cases of biologically relevant collisions in the Protein Data Bank of protein structures. However, we discovered a number of collisions that originate from alternative protein conformations or quaternary structures due to different experimental conditions.	[Emig, Dorothea; Sander, Oliver; Mayr, Gabriele; Albrecht, Mario] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany	Max Planck Society	Emig, D (corresponding author), Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany.	mario.albrecht@mpi-inf.mpg.de	Albrecht, Mario/B-6694-2008	Albrecht, Mario/0000-0002-3103-9624	German National Genome Research Network (NGFN); German Research Foundation (DFG) [KFO 129/1-2]; DFG	German National Genome Research Network (NGFN); German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	Part of this study was financially supported by the German National Genome Research Network (NGFN) and by the German Research Foundation (DFG), contract number KFO 129/1-2. The work was also conducted in the context of the DFG-funded Cluster of Excellence for Multimodal Computing and Interaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Aragues R, 2007, PLOS COMPUT BIOL, V3, P1761, DOI 10.1371/journal.pcbi.0030178; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Campagna A, 2008, FEBS LETT, V582, P1231, DOI 10.1016/j.febslet.2008.02.019; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Devos D, 2007, CURR OPIN STRUC BIOL, V17, P370, DOI 10.1016/j.sbi.2007.05.011; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; KEARSLEY SK, 1989, ACTA CRYSTALLOGR A, V45, P208, DOI 10.1107/S0108767388010128; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kiel C, 2008, ANNU REV BIOCHEM, V77, P415, DOI 10.1146/annurev.biochem.77.062706.133317; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Liang J, 1998, PROTEINS, V33, P1; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Porollo A, 2007, PROTEINS, V66, P630, DOI 10.1002/prot.21248; Prehna G, 2007, ACTA CRYSTALLOGR D, V63, P628, DOI 10.1107/S0907444907010888; Ramirez F, 2010, TRENDS CELL BIOL, V20, P2, DOI 10.1016/j.tcb.2009.11.003; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsai CJ, 2009, TRENDS BIOCHEM SCI, V34, P594, DOI 10.1016/j.tibs.2009.07.007; Tuncbag N, 2009, MOL BIOSYST, V5, P1770, DOI [10.1039/b905661k, 10.1039/B905661K]	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e19581	10.1371/journal.pone.0019581	http://dx.doi.org/10.1371/journal.pone.0019581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655095	Green Submitted, Green Published, gold			2022-12-25	WOS:000291310600003
J	Wang, XH; Wiens, M; Schroder, HC; Schlossmacher, U; Pisignano, D; Jochum, KP; Muller, WEG				Wang, Xiaohong; Wiens, Matthias; Schroeder, Heinz C.; Schlossmacher, Ute; Pisignano, Dario; Jochum, Klaus Peter; Mueller, Werner E. G.			Evagination of Cells Controls Bio-Silica Formation and Maturation during Spicule Formation in Sponges	PLOS ONE			English	Article							DEMOSPONGE SUBERITES-DOMUNCULA; AXIAL FILAMENT; TISSUE EVAGINATION; WATER CHANNEL; IN-VITRO; BIOSILICA; EXPRESSION; SPICULOGENESIS; AQUAPORIN-8; MEMBRANE	The enzymatic-silicatein mediated formation of the skeletal elements, the spicules of siliceous sponges starts intracellularly and is completed extracellularly. With Suberites domuncula we show that the axial growth of the spicules proceeds in three phases: (I) formation of an axial canal; (II) evagination of a cell process into the axial canal, and (III) assembly of the axial filament composed of silicatein. During these phases the core part of the spicule is synthesized. Silicatein and its substrate silicate are stored in silicasomes, found both inside and outside of the cellular extension within the axial canal, as well as all around the spicule. The membranes of the silicasomes are interspersed by pores of approximate to 2 nm that are likely associated with aquaporin channels which are implicated in the hardening of the initial bio-silica products formed by silicatein. We can summarize the sequence of events that govern spicule formation as follows: differential GENETIC READOUT (of silicatein) -> FRACTAL ASSOCIATION of the silicateins -> EVAGINATION of cells by hydro-mechanical forces into the axial canal -> and finally PROCESSIVE BIO-SILICA POLYCONDENSATION around the axial canal. We termed this process, occurring sequentially or in parallel, BIO-INORGANIC SELF-ORGANIZATION.	[Wang, Xiaohong] Natl Res Ctr Geoanal, Beijing, Peoples R China; [Wang, Xiaohong; Wiens, Matthias; Schroeder, Heinz C.; Schlossmacher, Ute; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, European Res Council Adv Grant Res Grp, Mainz, Germany; [Pisignano, Dario] Univ Salento, Dipartimento Ingn Innovaz, Lecce, Italy; [Pisignano, Dario] CNR Ist Nanosci, Natl Nanotechnol Lab, Lecce, Italy; [Jochum, Klaus Peter] Max Planck Inst Chem, D-55128 Mainz, Germany	Johannes Gutenberg University of Mainz; University of Salento; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Max Planck Society	Wang, XH (corresponding author), Natl Res Ctr Geoanal, Beijing, Peoples R China.	wmueller@uni-mainz.de	wang, jie/GRS-0942-2022; Wang, Zhong Lin/E-2176-2011; Müller, W. E. G./AAR-8651-2020; Pisignano, Dario/M-8309-2015; Wang, Xiaohong/AAR-5526-2020	Wang, Zhong Lin/0000-0002-5530-0380; Müller, W. E. G./0000-0002-8223-3689; Pisignano, Dario/0000-0003-3758-5199; Schroder, Heinz C./0000-0003-0992-6427; Wiens, Matthias/0000-0001-9219-0478	European Research Council [268476 BIOSILICA]; German Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [Schr 277/10-1]; European Commission/EUREKA [4289 - SILIBACTS]; International Human Frontier Science Program; European Commission [244967]; Ministry of Land and Resources of the People's Republic of China [201011005-06]; International S & T Cooperation Program of China [2008DFA00980]	European Research Council(European Research Council (ERC)European Commission); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission/EUREKA(European CommissionEuropean Commission Joint Research Centre); International Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Ministry of Land and Resources of the People's Republic of China; International S & T Cooperation Program of China	W.E.G.M. is a holder of a European Research Council Advanced Investigator Grant (no 268476 BIOSILICA). This work was supported by grants from the German Bundesministerium fur Bildung und Forschung (project "Center of Excellence BIOTECmarin"), the Deutsche Forschungsgemeinschaft (Schr 277/10-1), the European Commission/EUREKA (EUROSTARS, no. 4289 - SILIBACTS), the International Human Frontier Science Program, the European Commission (project no. 244967 -Mem-S Project), the Public Welfare Project of Ministry of Land and Resources of the People's Republic of China (Grant No. 201011005-06) and the International S & T Cooperation Program of China (Grant No. 2008DFA00980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2003, FEBS LETT, V554, P363, DOI 10.1016/S0014-5793(03)01190-6; Calamita G, 2001, EUR J CELL BIOL, V80, P711, DOI 10.1078/0171-9335-00210; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; COLBY MW, 1988, J NON-CRYST SOLIDS, V99, P129, DOI 10.1016/0022-3093(88)90465-6; CREIGHTON JR, 1990, C WORKSH TUNGST OTH; DAVIES JA, 2005, MECH MORPHOGENESIS A; Eckert C, 2006, J HISTOCHEM CYTOCHEM, V54, P1031, DOI 10.1369/jhc.5A6903.2006; Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI 10.1038/NCHEM.899; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Garrone R., 1981, P495; GIERER A, 1977, Q REV BIOPHYS, V10, P529, DOI 10.1017/S0033583500003218; Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498; IMSIECKE G, 1995, IN VITRO CELL DEV-AN, V31, P528; Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lorenz B, 1996, CELL SIGNAL, V8, P517, DOI 10.1016/S0898-6568(96)00108-8; Morgan EF, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P3; Muller WEG, 2007, BIOMATERIALS, V28, P4501, DOI 10.1016/j.biomaterials.2007.06.030; Muller WEG, 2007, EUR J CELL BIOL, V86, P473, DOI 10.1016/j.ejcb.2007.06.002; Muller WEG, 2006, SEMIN CELL DEV BIOL, V17, P481, DOI 10.1016/j.semcdb.2006.05.006; Muller WEG, 2010, FEBS J, V277, P1182, DOI 10.1111/j.1742-4658.2009.07552.x; Muller WEG, 2006, MICRON, V37, P107, DOI 10.1016/j.micron.2005.09.003; Muller WEG, 2005, FEBS J, V272, P3838, DOI 10.1111/j.1742-4658.2005.04795.x; Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5; Muller WEG, 1999, MAR ECOL PROG SER, V178, P205, DOI 10.3354/meps178205; Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3; Muller WEG, 1997, TRENDS GLYCOSCI GLYC, V9, P123; Muller WEG, 2011, BIOCH BIOPH IN PRESS; Muller WEG, 2005, ENCY MOL CELL BIOL M, V13, P269; Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102; Perovic-Ottstadt S, 2005, J EXP BIOL, V208, P637, DOI 10.1242/jeb.01428; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; RIPPE B, 1991, KIDNEY INT, V40, P315, DOI 10.1038/ki.1991.216; Scala F, 2008, BIOMASS BIOENERG, V32, P252, DOI 10.1016/j.biombioe.2007.09.009; Schlossmacher U, 2011, FEBS J, V278, P1145, DOI 10.1111/j.1742-4658.2011.08040.x; Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200; Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h; Schroder HC, 2007, J STRUCT BIOL, V159, P325, DOI 10.1016/j.jsb.2007.01.007; Schroder HC, 2012, SILICON-NETH, V4, P33, DOI 10.1007/s12633-010-9057-4; SCHWAB DW, 1971, BIOL BULL, V140, P125, DOI 10.2307/1540032; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; SHORE RE, 1972, BIOL BULL, V143, P689, DOI 10.2307/1540191; Simpson T., 1984, CELL BIOL SPONGES; Simpson TL, SILICON SILICEOUS ST; Uriz MJ, 2006, CAN J ZOOL, V84, P322, DOI 10.1139/Z06-032; Uriz MJ, 2000, CELL TISSUE RES, V301, P299, DOI 10.1007/s004410000234; Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005; Weissenfels N, 1977, Zoologische Jb (Anat), V98, P355; Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002	50	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20523	10.1371/journal.pone.0020523	http://dx.doi.org/10.1371/journal.pone.0020523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655099	gold, Green Published, Green Submitted			2022-12-25	WOS:000291310600011
J	Briggs, J; Paoloni, M; Chen, QR; Wen, XY; Khan, J; Khanna, C				Briggs, Joseph; Paoloni, Melissa; Chen, Qing-Rong; Wen, Xinyu; Khan, Javed; Khanna, Chand			A Compendium of Canine Normal Tissue Gene Expression	PLOS ONE			English	Article							MICROARRAY; PROFILES; MOUSE; MODEL; DOG; TRANSCRIPTOMES; ANNOTATION; BLAST2GO; HEALTHY	Background: Our understanding of disease is increasingly informed by changes in gene expression between normal and abnormal tissues. The release of the canine genome sequence in 2005 provided an opportunity to better understand human health and disease using the dog as clinically relevant model. Accordingly, we now present the first genome-wide, canine normal tissue gene expression compendium with corresponding human cross-species analysis. Methodology/Principal Findings: The Affymetrix platform was utilized to catalogue gene expression signatures of 10 normal canine tissues including: liver, kidney, heart, lung, cerebrum, lymph node, spleen, jejunum, pancreas and skeletal muscle. The quality of the database was assessed in several ways. Organ defining gene sets were identified for each tissue and functional enrichment analysis revealed themes consistent with known physio-anatomic functions for each organ. In addition, a comparison of orthologous gene expression between matched canine and human normal tissues uncovered remarkable similarity. To demonstrate the utility of this dataset, novel canine gene annotations were established based on comparative analysis of dog and human tissue selective gene expression and manual curation of canine probeset mapping. Public access, using infrastructure identical to that currently in use for human normal tissues, has been established and allows for additional comparisons across species. Conclusions/Significance: These data advance our understanding of the canine genome through a comprehensive analysis of gene expression in a diverse set of tissues, contributing to improved functional annotation that has been lacking. Importantly, it will be used to inform future studies of disease in the dog as a model for human translational research and provides a novel resource to the community at large.	[Briggs, Joseph; Khanna, Chand] NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Paoloni, Melissa; Khanna, Chand] NCI, Comparat Oncol Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Chen, Qing-Rong; Wen, Xinyu; Khan, Javed] NCI, Oncogenom Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Briggs, J (corresponding author), NCI, Tumor & Metastasis Biol Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	khannac@mail.nih.gov	Khan, Javed/P-9157-2014		NATIONAL CANCER INSTITUTE [ZIGBC010569, ZIASC010366, ZIABC011002] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bluthgen Nils, 2005, Genome Inform, V16, P106; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fernandez-Suarez XM, 2007, CURR PROTOC BIOINFOR; Gallardo-Arrieta F, 2010, PROSTATE, V70, P1402, DOI 10.1002/pros.21175; Genini S, 2010, INVEST OPHTH VIS SCI, V51, P6038, DOI 10.1167/iovs.10-5443; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Higgins RJ, 2010, J NEURO-ONCOL, V98, P49, DOI 10.1007/s11060-009-0072-5; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Holzwarth JA, 2005, J HERED, V96, P817, DOI 10.1093/jhered/esi130; Hornshoj H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001203; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Khan Javed, 2003, Pharmacogenomics, V4, P245, DOI 10.1517/phgs.4.3.245.22696; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Klopfleisch R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-618; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; O'Donoghue LE, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-506; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Paoloni MC, 2007, VET CLIN N AM-SMALL, V37, P1023, DOI 10.1016/j.cvsm.2007.08.003; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saito-Hisaminato A, 2002, DNA RES, V9, P35, DOI 10.1093/dnares/9.2.35; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thomas R, 2005, GENOME RES, V15, P1831, DOI 10.1101/gr.3825705; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Zheng JY, 2009, CIRCULATION, V119, P2086, DOI 10.1161/CIRCULATIONAHA.108.826230	39	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e17107	10.1371/journal.pone.0017107	http://dx.doi.org/10.1371/journal.pone.0017107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655323	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600001
J	Daltrozzo, J; Signoret, C; Tillmann, B; Perrin, F				Daltrozzo, Jerome; Signoret, Carine; Tillmann, Barbara; Perrin, Fabien			Subliminal Semantic Priming in Speech	PLOS ONE			English	Article							UNCONSCIOUS PERCEPTION; SENSORY DISCRIMINATION; RESPONSE SELECTION; LEXICAL DECISION; MASKED STIMULI; VISUAL-SEARCH; WORD; POTENTIALS; ACTIVATION; PSYCHOPHYSICS	Numerous studies have reported subliminal repetition and semantic priming in the visual modality. We transferred this paradigm to the auditory modality. Prime awareness was manipulated by a reduction of sound intensity level. Uncategorized prime words (according to a post-test) were followed by semantically related, unrelated, or repeated target words (presented without intensity reduction) and participants performed a lexical decision task (LDT). Participants with slower reaction times in the LDT showed semantic priming (faster reaction times for semantically related compared to unrelated targets) and negative repetition priming (slower reaction times for repeated compared to semantically related targets). This is the first report of semantic priming in the auditory modality without conscious categorization of the prime.	[Daltrozzo, Jerome; Signoret, Carine; Tillmann, Barbara; Perrin, Fabien] CNRS, UMR5292, Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, Lyon, France; [Daltrozzo, Jerome; Signoret, Carine; Tillmann, Barbara; Perrin, Fabien] INSERM, U1028, Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, F-69008 Lyon, France; [Daltrozzo, Jerome; Signoret, Carine; Tillmann, Barbara; Perrin, Fabien] Univ Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Daltrozzo, J (corresponding author), CNRS, UMR5292, Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, Lyon, France.	jdaltrozzo@olfac.univ-lyon1.fr	Signoret, Carine/G-1794-2011	Signoret, Carine/0000-0001-8903-7931; , Fabien/0000-0002-1444-3414	French National Agency for Research [ANR-07-JCJC-0095 - CSD 8]	French National Agency for Research(French National Research Agency (ANR))	The work was supported by the French National Agency for Research (ANR-07-JCJC-0095 - CSD 8, www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RL, 2000, PSYCHOL SCI, V11, P118, DOI 10.1111/1467-9280.00226; American National Standards Institute, 2004, AM NAT STAND I S3 6; ANDERSON JE, 1995, PSYCHOPHYSIOLOGY, V32, P177, DOI 10.1111/j.1469-8986.1995.tb03310.x; BEATTIE RC, 1986, OTOL NEUROTOL, V7, P60; Bowman H, 2006, VIS COGN, V13, P401, DOI 10.1080/13506280444000823; COLES MGH, 1988, BIOL PSYCHOL, V26, P69, DOI 10.1016/0301-0511(88)90014-2; Dell'Acqua R, 1999, COGNITION, V73, pB1, DOI 10.1016/S0010-0277(99)00049-9; Draine SC, 1998, J EXP PSYCHOL GEN, V127, P286, DOI 10.1037/0096-3445.127.3.286; DUPOUX E, 1993, COGNITIVE MODELS OF SPEECH PROCESSING: THE SECOND SPERLONGA MEETING, P81; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; FERRAND L, 1992, Q J EXP PSYCHOL-A, V45, P353, DOI 10.1080/02724989208250619; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; GOODIN DS, 1987, CAN J NEUROL SCI, V14, P642; GOODIN DS, 1990, J NEUROPHYSIOL, V64, P1270, DOI 10.1152/jn.1990.64.4.1270; Green D. M., 1974, SIGNAL DETECTION THE; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; GREENWALD AG, 1995, J EXP PSYCHOL GEN, V124, P22, DOI 10.1037/0096-3445.124.1.22; GRICE GR, 1982, J EXPT PSYCHOL GEN, V11, P135; Haase SJ, 2001, AM J PSYCHOL, V114, P439, DOI 10.2307/1423690; HERDMAN CM, 1994, J EXP PSYCHOL HUMAN, V20, P575, DOI 10.1037/0096-1523.20.3.575; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOWELL D, 1998, MEETHODES STAT SCI H; HUMPHREYS GW, 1988, J EXP PSYCHOL HUMAN, V14, P203, DOI 10.1037/0096-1523.14.2.203; HUMPHREYS GW, 1983, COGNITIVE PSYCHOL, V15, P151, DOI 10.1016/0010-0285(83)90008-7; JOKEIT H, 1994, P NATL ACAD SCI USA, V91, P6339, DOI 10.1073/pnas.91.14.6339; Kahan TA, 2000, J EXP PSYCHOL LEARN, V26, P1392, DOI 10.1037/0278-7393.26.6.1392; KEWLEYPORT D, 1991, J ACOUST SOC AM, V89, P820, DOI 10.1121/1.1894642; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Klapp ST, 2002, J EXP PSYCHOL GEN, V131, P255, DOI 10.1037//0096-3445.131.2.255; Kouider S, 2005, PSYCHOL SCI, V16, P617, DOI 10.1111/j.1467-9280.2005.01584.x; Kouider S, 2004, PSYCHOL SCI, V15, P75, DOI 10.1111/j.0963-7214.2004.01502001.x; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kouider S, 2010, NEUROIMAGE, V49, P922, DOI 10.1016/j.neuroimage.2009.08.043; Kouider S, 2009, EXP PSYCHOL, V56, P418, DOI 10.1027/1618-3169.56.6.418; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P5, DOI 10.3758/APP.72.1.5; KRUGER D, 2010, CONSCIOUSNE IN PRESS; LUCE RD, 1978, PERCEPT PSYCHOPHYS, V23, P363, DOI 10.3758/BF03204138; Macmillan N. A., 1991, DETECTION THEORY USE; MACMILLAN NA, 1986, BEHAV BRAIN SCI, V9, P38, DOI 10.1017/S0140525X00021427; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P238, DOI 10.1016/0010-0285(83)90010-5; Mattler U, 2007, J EXP PSYCHOL HUMAN, V33, P83, DOI 10.1037/0096-1523.33.1.83; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; MERIKLE PM, 1990, J EXP PSYCHOL HUMAN, V16, P574, DOI 10.1037/0096-1523.16.3.574; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; MILNER J, 1982, J EXPT PSYCHOL HUMAN, V8, P273; Neri P, 2010, PSYCHON B REV, V17, P802, DOI 10.3758/PBR.17.6.802; New B, 2001, ANN PSYCHOL, V101, P447; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; ORTIZ T, 1993, J NEUROPHYSIOL, V69, P211; Reingold EM, 2004, CONSCIOUS COGN, V13, P117, DOI 10.1016/j.concog.2003.11.002; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; SCHEERER E, 1973, PSYCHOL FORSCH, V36, P71, DOI 10.1007/BF00424655; Schiller NO, 1998, J MEM LANG, V39, P484, DOI 10.1006/jmla.1998.2577; Schiller NO, 2000, J EXP PSYCHOL LEARN, V26, P512, DOI 10.1037//0278-7393.26.2.512; Snodgrass M, 2004, PERCEPT PSYCHOPHYS, V66, P888, DOI 10.3758/BF03194982; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; URBAN MJ, 1992, PERCEPT MOTOR SKILL, V74, P515, DOI 10.2466/PMS.74.2.515-541; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Wundt W. M., 1913, GRUNDRISS PSYCHOL	60	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20273	10.1371/journal.pone.0020273	http://dx.doi.org/10.1371/journal.pone.0020273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	770OP	21655277	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600034
J	Narayanan, A; Popova, T; Turell, M; Kidd, J; Chertow, J; Popov, SG; Bailey, C; Kashanchi, F; Kehn-Hall, K				Narayanan, Aarthi; Popova, Taissia; Turell, Michael; Kidd, Jessica; Chertow, Jessica; Popov, Serguei G.; Bailey, Charles; Kashanchi, Fatah; Kehn-Hall, Kylene			Alteration in Superoxide Dismutase 1 Causes Oxidative Stress and p38 MAPK Activation Following RVFV Infection	PLOS ONE			English	Article							RIFT-VALLEY FEVER; AMYOTROPHIC-LATERAL-SCLEROSIS; NONSTRUCTURAL PROTEIN NSS; SIGNALING PATHWAY; INFLUENZA-VIRUS; GREEN TEA; TRANSCRIPTION; DISEASE; CELLS; REPLICATION	Rift Valley fever (RVF) is a zoonotic disease caused by Rift Valley fever virus (RVFV). RVFV is a category A pathogen that belongs to the genus Phlebovirus, family Bunyaviridae. Understanding early host events to an infectious exposure to RVFV will be of significant use in the development of effective therapeutics that not only control pathogen multiplication, but also contribute to cell survival. In this study, we have carried out infections of human cells with a vaccine strain (MP12) and virulent strain (ZH501) of RVFV and determined host responses to viral infection. We demonstrate that the cellular antioxidant enzyme superoxide dismutase 1 (SOD1) displays altered abundances at early time points following exposure to the virus. We show that the enzyme is down regulated in cases of both a virulent (ZH501) and a vaccine strain (MP12) exposure. Our data demonstrates that the down regulation of SOD1 is likely to be due to post transcriptional processes and may be related to up regulation of TNF alpha following infection. We also provide evidence for extensive oxidative stress in the MP12 infected cells. Concomitantly, there is an increase in the activation of the p38 MAPK stress response, which our earlier published study demonstrated to be an essential cell survival strategy. Our data suggests that the viral anti-apoptotic protein NSm may play a role in the regulation of the cellular p38 MAPK response. Alterations in the host protein SOD1 following RVFV infection appears to be an early event that occurs in multiple cell types. Activation of the cellular stress response p38 MAPK pathway can be observed in all cell types tested. Our data implies that maintaining oxidative homeostasis in the infected cells may play an important role in improving survival of infected cells.	[Narayanan, Aarthi; Popova, Taissia; Chertow, Jessica; Popov, Serguei G.; Bailey, Charles; Kashanchi, Fatah; Kehn-Hall, Kylene] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Turell, Michael] USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Kidd, Jessica] MDA ALS Res Ctr, Neurol Inst, New York, NY USA	George Mason University	Narayanan, A (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA.	fkashanc@gmu.edu	Turell, Michael/ABE-1826-2020; Kehn-Hall, Kylene/I-5752-2013	Turell, Michael/0000-0003-1902-7740; Kehn-Hall, Kylene/0000-0001-8036-7213	US Department of Energy [DE-SC0001599]	US Department of Energy(United States Department of Energy (DOE))	This work was funded by US Department of Energy grant (DE-SC0001599) to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo-Salem S, 2006, ANN NY ACAD SCI, V1081, P240, DOI 10.1196/annals.1373.028; Afonso V, 2006, FREE RADICAL BIO MED, V41, P709, DOI 10.1016/j.freeradbiomed.2006.05.014; Agbottah E, 2005, J BIOL CHEM, V280, P3029, DOI 10.1074/jbc.M406435200; Agbottah Emmanuel, 2008, AIDS Res Ther, V5, P12, DOI 10.1186/1742-6405-5-12; Aliev G, 2011, CNS NEUROL DISORD-DR, V10, P147, DOI 10.2174/187152711794480492; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Chen TH, 2011, VIROLOGY, V410, P410, DOI 10.1016/j.virol.2010.12.013; Dasgupta A, 2004, MOL CELL, V13, P456, DOI 10.1016/S1097-2765(04)00092-9; Fagbo SF, 2002, ANN NY ACAD SCI, V969, P201, DOI 10.1111/j.1749-6632.2002.tb04378.x; Filone CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015483; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; Guendel I, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-7; Ha HL, 2010, WORLD J GASTROENTERO, V16, P6035, DOI 10.3748/wjg.v16.i48.6035; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2009, VACCINE, V27, pD69, DOI 10.1016/j.vaccine.2009.07.046; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Kanthasamy A, 2010, NEUROTOXICOLOGY, V31, P555, DOI 10.1016/j.neuro.2009.12.003; Kim YJ, 2010, ANTIVIR RES, V88, P227, DOI 10.1016/j.antiviral.2010.08.016; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; LaBeaud AD, 2007, AM J TROP MED HYG, V76, P795, DOI 10.4269/ajtmh.2007.76.795; LaBeaud AD, 2010, CURR OPIN INFECT DIS, V23, P403, DOI 10.1097/QCO.0b013e32833c3da6; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; Lee BC, 2011, J CELL BIOCHEM, V112, P118, DOI 10.1002/jcb.22896; Lee HP, 2010, EXPERT REV NEUROTHER, V10, P1201, DOI 10.1586/ERN.10.74; Lewinska A, 2010, REDOX REP, V15, P87, DOI 10.1179/174329210X12650506623366; Mathew SS, 2009, J VIROL, V83, P9304, DOI 10.1128/JVI.01826-08; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Muyderman H, 2009, NEUROCHEM RES, V34, P1847, DOI 10.1007/s11064-009-9974-z; Nakatsue T, 1998, BIOCHEM BIOPH RES CO, V253, P59, DOI 10.1006/bbrc.1998.9724; Onizuka S, 2011, J ANESTH, V25, P229, DOI 10.1007/s00540-010-1079-y; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Perry JJP, 2010, ADV EXP MED BIOL, V685, P9; Peviani M, 2010, CNS NEUROL DISORD-DR, V9, P491, DOI 10.2174/187152710791556096; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Sang R C, 2001, East Afr Med J, V78, P655; Seufi AM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-65; Simula MP, 2010, PROTEOM CLIN APPL, V4, P782, DOI 10.1002/prca.201000049; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Sun Y, 1996, FREE RADICAL BIO MED, V21, P335, DOI 10.1016/0891-5849(96)00109-8; Vigilanza P, 2008, CELL MOL LIFE SCI, V65, P991, DOI 10.1007/s00018-008-7526-3; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06; Zhu CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003716	54	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20354	10.1371/journal.pone.0020354	http://dx.doi.org/10.1371/journal.pone.0020354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655261	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600051
J	Wolff, JN; White, DJ; Woodhams, M; White, HE; Gemmell, NJ				Wolff, Jonci N.; White, Daniel J.; Woodhams, Michael; White, Helen E.; Gemmell, Neil J.			The Strength and Timing of the Mitochondrial Bottleneck in Salmon Suggests a Conserved Mechanism in Vertebrates	PLOS ONE			English	Article							RANDOM GENETIC DRIFT; RAPID SEGREGATION; PURIFYING SELECTION; POINT MUTATIONS; CONTROL REGION; DNA MUTATIONS; MTDNA; HETEROPLASMY; RECOMBINATION; INHERITANCE	In most species mitochondrial DNA (mtDNA) is inherited maternally in an apparently clonal fashion, although how this is achieved remains uncertain. Population genetic studies show not only that individuals can harbor more than one type of mtDNA (heteroplasmy) but that heteroplasmy is common and widespread across a diversity of taxa. Females harboring a mixture of mtDNAs may transmit varying proportions of each mtDNA type (haplotype) to their offspring. However, mtDNA variants are also observed to segregate rapidly between generations despite the high mtDNA copy number in the oocyte, which suggests a genetic bottleneck acts during mtDNA transmission. Understanding the size and timing of this bottleneck is important for interpreting population genetic relationships and for predicting the inheritance of mtDNA based disease, but despite its importance the underlying mechanisms remain unclear. Empirical studies, restricted to mice, have shown that the mtDNA bottleneck could act either at embryogenesis, oogenesis or both. To investigate whether the size and timing of the mitochondrial bottleneck is conserved between distant vertebrates, we measured the genetic variance in mtDNA heteroplasmy at three developmental stages (female, ova and fry) in chinook salmon and applied a new mathematical model to estimate the number of segregating units (N-e) of the mitochondrial bottleneck between each stage. Using these data we estimate values for mtDNA Ne of 88.3 for oogenesis, and 80.3 for embryogenesis. Our results confirm the presence of a mitochondrial bottleneck in fish, and show that segregation of mtDNA variation is effectively complete by the end of oogenesis. Considering the extensive differences in reproductive physiology between fish and mammals, our results suggest the mechanism underlying the mtDNA bottleneck is conserved in these distant vertebrates both in terms of it magnitude and timing. This finding may lead to improvements in our understanding of mitochondrial disorders and population interpretations using mtDNA data.	[Wolff, Jonci N.; White, Daniel J.; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Canterbury, New Zealand; [Wolff, Jonci N.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [White, Daniel J.; Gemmell, Neil J.] Univ Otago, Ctr Reprod & Genom, Dept Anat & Struct Biol, Dunedin, New Zealand; [Woodhams, Michael] Univ Sydney, Sch Informat Technol, Sydney, NSW 2006, Australia; [White, Helen E.] Salisbury Dist Hosp, Natl Genet Reference Lab Wessex, Salisbury, Wilts, England	University of Canterbury; University of New South Wales Sydney; University of Otago; University of Sydney; Salisbury District Hospital	Wolff, JN (corresponding author), Univ Canterbury, Sch Biol Sci, Canterbury, New Zealand.	neil.gemmell@otago.ac.nz	Gemmell, Neil J/C-6774-2009; Woodhams, Michael/J-7529-2014; Wolff, Jonci/M-4639-2017	Gemmell, Neil J/0000-0003-0671-3637; Woodhams, Michael/0000-0002-5204-4123; White, Daniel/0000-0002-8967-5201; Wolff, Jonci/0000-0002-8809-5010	Royal Society of New Zealand [UOC402]; NIWA Silverstream Hatchery team	Royal Society of New Zealand(Royal Society of New Zealand); NIWA Silverstream Hatchery team	This study was funded by a grant to NJG from the Royal Society of New Zealand, Marsden Fund, Grant UOC402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the NIWA Silverstream Hatchery team for their support, advice and use of their facilities. For valuable comments, we thank Bill Ballard, Alan Wilton, Lou Puslednik and two annonymous reviewers. We also thank Robbie McPhee for preparing Figure 1. Permissions for this work were covered by ERMA decision GMD00066, MAF permit # 2003018889, the University of Canterbury animal ethics board (permission # 2002/01), and the Fish and Game council of New Zealand.	Aranishi F, 2006, J SCI FOOD AGR, V86, P425, DOI 10.1002/jsfa.2370; ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bergstrom CT, 1998, GENETICS, V149, P2135; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Gemmell NJ, 1996, MOL BIOL EVOL, V13, P798, DOI 10.1093/oxfordjournals.molbev.a025640; Gemmell NJ, 2004, TRENDS ECOL EVOL, V19, P238, DOI 10.1016/j.tree.2004.02.002; HARRISON RG, 1985, SCIENCE, V228, P1446, DOI 10.1126/science.228.4706.1446; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hendy MD, 2009, BIOL LETTERS, V5, P397, DOI 10.1098/rsbl.2009.0104; Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251; Howell N, 2000, AM J HUM GENET, V66, P1589, DOI 10.1086/302910; HOWELL N, 1992, HUM GENET, V90, P117; HUET M, 1970, BREEDING CULTIVATION; Ivanov PL, 1996, NAT GENET, V12, P417, DOI 10.1038/ng0496-417; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; KOEHLER CM, 1991, GENETICS, V129, P247; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Lynch M, 1998, GENETICA, V102-3, P29, DOI 10.1023/A:1017022522486; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; MCINTYRE JD, 1991, PACIFIC SALMON CULTU; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Poulton J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001066; RAND DM, 1986, GENETICS, V114, P955; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Samuels DC, 2010, NAT GENET, V42, P471, DOI 10.1038/ng0610-471; Shoubridge EA, 2008, SCIENCE, V319, P914, DOI 10.1126/science.1154515; Shoubridge EA, 2007, CURR TOP DEV BIOL, V77, P87, DOI 10.1016/S0070-2153(06)77004-1; Slate J, 2004, TRENDS ECOL EVOL, V19, P561, DOI 10.1016/j.tree.2004.09.001; Smith Lawrence C, 2002, Reprod Biomed Online, V4, P248; SOLIGNAC M, 1984, MOL GEN GENET, V197, P183, DOI 10.1007/BF00330961; Stewart JB, 2008, NAT REV GENET, V9, P657, DOI 10.1038/nrg2396; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Taylor JS, 2002, J FISH BIOL, V60, P1346, DOI 10.1006/jfbi.2002.1935; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; White DJ, 2009, MOL BIOL EVOL, V26, P1435, DOI 10.1093/molbev/msp073; White DJ, 2008, MOL ECOL, V17, P4925, DOI 10.1111/j.1365-294X.2008.03982.x; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488; WILKINSON GS, 1991, GENETICS, V128, P607; Wolff JN, 2008, HEREDITY, V101, P429, DOI 10.1038/hdy.2008.74; Wonnapinij P, 2008, AM J HUM GENET, V83, P582, DOI 10.1016/j.ajhg.2008.10.007; Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023	55	27	27	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20522	10.1371/journal.pone.0020522	http://dx.doi.org/10.1371/journal.pone.0020522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655224	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000291097600087
J	Zhang, W; Cai, HC; Li, FF; Xi, YB; Ma, X; Yan, YB				Zhang, Wang; Cai, Hong-Chen; Li, Fei-Feng; Xi, Yi-Bo; Ma, Xu; Yan, Yong-Bin			The Congenital Cataract-Linked G61C Mutation Destabilizes gamma D-Crystallin and Promotes Non-Native Aggregation	PLOS ONE			English	Article							TRYPTOPHAN FLUORESCENCE-SPECTRA; LOG-NORMAL COMPONENTS; MISSENSE MUTATION; CRYGD MUTATION; CORALLIFORM CATARACT; NUCLEAR CATARACT; ALPHA-CRYSTALLIN; CHINESE FAMILY; GENE CRYGD; LENS CRYSTALLINS	gamma D-crystallin is one of the major structural proteins in human eye lens. The solubility and stability of gamma D-crystallin play a crucial role in maintaining the optical properties of the lens during the life span of an individual. Previous study has shown that the inherited mutation G61C results in autosomal dominant congenital cataract. In this research, we studied the effects of the G61C mutation on gamma D-crystallin structure, stability and aggregation via biophysical methods. CD, intrinsic and extrinsic fluorescence spectroscopy indicated that the G61C mutation did not affect the native structure of gamma D-crystallin. The stability of gamma D-crystallin against heat- or GdnHCl-induced denaturation was significantly decreased by the mutation, while no influence was observed on the acid-induced unfolding. The mutation mainly affected the transition from the native state to the intermediate but not that from the intermediate to the unfolded or aggregated states. At high temperatures, both proteins were able to form aggregates, and the aggregation of the mutant was much more serious than the wild type protein at the same temperature. At body temperature and acidic conditions, the mutant was more prone to form amyloid-like fibrils. The aggregation-prone property of the mutant was not altered by the addition of reductive reagent. These results suggested that the decrease in protein stability followed by aggregation-prone property might be the major cause in the hereditary cataract induced by the G61C mutation.	[Zhang, Wang; Cai, Hong-Chen; Xi, Yi-Bo; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Li, Fei-Feng; Ma, Xu] Natl Res Inst Family Planning, Dept Genet, Beijing, Peoples R China; [Li, Fei-Feng; Ma, Xu] Tsinghua Univ, Peking Union Med Coll, Beijing 100084, Peoples R China; [Xi, Yi-Bo] Lanzhou Univ, Inst Biophys, Lanzhou 730000, Peoples R China	Tsinghua University; National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Lanzhou University	Zhang, W (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	genetic@263.net.cn; ybyan@tsinghua.edu.cn	Yan, Yong-Bin/A-4282-2008	Yan, Yong-Bin/0000-0002-8565-3558; Cai, Hongchen/0000-0002-5921-5773; xi, yibo/0000-0002-9709-2698	National Natural Science Foundation of China [30970559]; National Basic Research Program of China [2010CB912402]; National Infrastructure Program of Chinese Genetic Resources [2006DKA21300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Infrastructure Program of Chinese Genetic Resources	This work was supported by the National Natural Science Foundation of China (30970559), National Basic Research Program of China (2010CB912402), and National Infrastructure Program of Chinese Genetic Resources (2006DKA21300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almarza J, 2009, BIOCHEMISTRY-US, V48, P7608, DOI 10.1021/bi9007116; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Banerjee PR, 2011, P NATL ACAD SCI USA, V108, P574, DOI 10.1073/pnas.1014653107; Banh A, 2006, PROG RETIN EYE RES, V25, P189, DOI 10.1016/j.preteyeres.2005.10.001; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Bassnett S, 2002, EXP EYE RES, V74, P1, DOI 10.1006/exer.2001.1111; BENEDEK GB, 1971, APPL OPTICS, V10, P459, DOI 10.1364/AO.10.000459; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAKENHOFF RH, 1990, J MOL BIOL, V216, P519, DOI 10.1016/0022-2836(90)90380-5; Bron AJ, 2000, OPHTHALMOLOGICA, V214, P86, DOI 10.1159/000027475; Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Devi RR, 2008, MOL VIS, V14, P1157; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Graw J, 1997, BIOL CHEM, V378, P1331; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gu F, 2006, MOL VIS, V12, P26; Gu JZ, 2005, MOL VIS, V11, P971; Hansen L, 2007, INVEST OPHTH VIS SCI, V48, P3937, DOI 10.1167/iovs.07-0013; He GJ, 2009, FEBS J, V276, P2849, DOI 10.1111/j.1742-4658.2009.07008.x; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Khan AO, 2009, MOL VIS, V15, P1407; Kmoch S, 2000, HUM MOL GENET, V9, P1779, DOI 10.1093/hmg/9.12.1779; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; KUSZAK JR, 1984, SCAN ELECTRON MICROS, P1369; Li FF, 2008, MOL VIS, V14, P378; Mackay DW, 2004, MOL VIS, V10, P155; McManus JJ, 2007, P NATL ACAD SCI USA, V104, P16856, DOI 10.1073/pnas.0707412104; Messina-Baas O, 2006, MOL VIS, V12, P995; Nandrot E, 2003, J MED GENET, V40, P262, DOI 10.1136/jmg.40.4.262; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Pande A, 2010, BIOCHEMISTRY-US, V49, P6122, DOI 10.1021/bi100664s; Pang M, 2010, BBA-PROTEINS PROTEOM, V1804, P948, DOI 10.1016/j.bbapap.2010.01.001; Papanikolopoulou K, 2008, MOL VIS, V14, P81; PIATIGORSKY J, 1989, FASEB J, V3, P1933, DOI 10.1096/fasebj.3.8.2656357; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Roshan M, 2010, MOL VIS, V16, P887; Santana A, 2009, MOL VIS, V15, P793; Shentu XC, 2004, MOL VIS, V10, P233; Stephan DA, 1999, P NATL ACAD SCI USA, V96, P1008, DOI 10.1073/pnas.96.3.1008; Su JT, 2007, BIOPHYS J, V92, P578, DOI 10.1529/biophysj.106.093666; Tholozan FMD, 2007, INT J BIOCHEM CELL B, V39, P1754, DOI 10.1016/j.biocel.2007.06.021; Wang BB, 2011, HUM MUTAT, V32, pE1939, DOI 10.1002/humu.21386; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; WANG KY, 1994, J BIOL CHEM, V269, P13601; Xu WZ, 2004, CHINESE MED J-PEKING, V117, P727; Zhang LY, 2007, MOL VIS, V13, P2096; Zhang LY, 2009, MOL VIS, V15, P1521; ZINN K M, 1973, International Ophthalmology Clinics, V13, P143, DOI 10.1097/00004397-197301330-00012	54	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20564	10.1371/journal.pone.0020564	http://dx.doi.org/10.1371/journal.pone.0020564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655238	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600100
J	Chen, K; Pociask, DA; McAleer, JP; Chan, YR; Alcorn, JF; Kreindler, JL; Keyser, MR; Shapiro, SD; Houghton, AM; Kolls, JK; Zheng, MQ				Chen, Kong; Pociask, Derek A.; McAleer, Jeremy P.; Chan, Yvonne R.; Alcorn, John F.; Kreindler, James L.; Keyser, Matthew R.; Shapiro, Steven D.; Houghton, A. McGarry; Kolls, Jay K.; Zheng, Mingquan			IL-17RA Is Required for CCL2 Expression, Macrophage Recruitment, and Emphysema in Response to Cigarette Smoke	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARYL-HYDROCARBON RECEPTOR; T-CELLS; BRONCHOALVEOLAR LAVAGE; CYTOKINE PRODUCTION; PERIPHERAL-BLOOD; GENE-EXPRESSION; INFLAMMATION; MICE; AUTOIMMUNITY	Chronic Obstructive Pulmonary Disease (COPD) is characterized by airspace enlargement and peribronchial lymphoid follicles; however, the immunological mechanisms leading to these pathologic changes remain undefined. Here we show that cigarette smoke is a selective adjuvant that augments in vitro and in vivo Th17, but not Th1, cell differentiation via the aryl hydrocarbon receptor. Smoke exposed IL-17RA(-/-) mice failed to induce CCL2 and MMP12 compared to WT mice. Remarkably, in contrast to WT mice, IL-17RA(-/-) mice failed to develop emphysema after 6 months of cigarette smoke exposure. Taken together, these data demonstrate that cigarette smoke is a potent Th17 adjuvant and that IL-17RA signaling is required for chemokine expression necessary for MMP12 induction and tissue emphysema.	[Chen, Kong; Pociask, Derek A.; McAleer, Jeremy P.; Kolls, Jay K.; Zheng, Mingquan] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Chan, Yvonne R.; Alcorn, John F.; Shapiro, Steven D.; Houghton, A. McGarry] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Kreindler, James L.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Keyser, Matthew R.] DNASTAR, Madison, WI USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Chen, K (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA.	jkolls@lsuhsc.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304	National Heart Lung and Blood Institute [5R37HL079142, 5R01HL082541]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082541, R21HL104601, R37HL079142] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Heart Lung and Blood Institute, grants 5R37HL079142 (JKK) and 5R01HL082541 (SDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Avril-Delplanque A, 2005, STEM CELLS, V23, P992, DOI 10.1634/stemcells.2004-0197; Barczyk A, 2006, J ALLERGY CLIN IMMUN, V117, P1484, DOI 10.1016/j.jaci.2006.02.013; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Costenbader KH, 2004, ARTHRITIS RHEUM-US, V50, P849, DOI 10.1002/art.20049; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Elias Jack A, 2006, Proc Am Thorac Soc, V3, P494, DOI 10.1513/pats.200603-068MS; Eustace A, 2010, CHEST; Gebremichael A, 1996, TOXICOL APPL PHARM, V141, P76; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Hodge G, 2007, CLIN EXP IMMUNOL, V150, P22, DOI 10.1111/j.1365-2249.2007.03451.x; Hogg J C, 2005, Exp Lung Res, V31 Suppl 1, P72; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Kallberg H, 2010, ANN RHEUM DIS; Kitamura M, 2007, CANCER LETT, V252, P184, DOI 10.1016/j.canlet.2006.11.015; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Kroening PR, 2008, J IMMUNOL, V181, P1536, DOI 10.4049/jimmunol.181.2.1536; Lee G, 2009, CURR OPIN PULM MED, V15, P303, DOI 10.1097/MCP.0b013e32832c975a; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Maeno T, 2007, J IMMUNOL, V178, P8090, DOI 10.4049/jimmunol.178.12.8090; Mahid SS, 2006, MAYO CLIN PROC, V81, P1462, DOI 10.4065/81.11.1462; Majori M, 1999, J ALLERGY CLIN IMMUN, V103, P458, DOI 10.1016/S0091-6749(99)70471-9; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Palmer MT, 2010, NAT IMMUNOL, V11, P36, DOI 10.1038/ni.1802; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PRIDGEON C, 2011, CLIN SCI LOND; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978	38	164	167	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20333	10.1371/journal.pone.0020333	http://dx.doi.org/10.1371/journal.pone.0020333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647421	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000291052500046
J	Chen, ZG; Schiffman, M; Herrero, R; DeSalle, R; Anastos, K; Segondy, M; Sahasrabuddhe, VV; Gravitt, PE; Hsing, AW; Burk, RD				Chen, Zigui; Schiffman, Mark; Herrero, Rolando; DeSalle, Rob; Anastos, Kathryn; Segondy, Michel; Sahasrabuddhe, Vikrant V.; Gravitt, Patti E.; Hsing, Ann W.; Burk, Robert D.			Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; MULTIPLE SEQUENCE ALIGNMENT; GRADE CERVICAL LESIONS; HIGH-RISK; GENETIC-HETEROGENEITY; PHYLOGENETIC ANALYSIS; GENITAL-TRACT; INFECTION; TYPE-16; WOMEN	Background: Human papillomavirus 16 (HPV16) species group (alpha-9) of the Alphapapillomavirus genus contains HPV16, HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. These HPVs account for 75% of invasive cervical cancers worldwide. Viral variants of these HPVs differ in evolutionary history and pathogenicity. Moreover, a comprehensive nomenclature system for HPV variants is lacking, limiting comparisons between studies. Methods: DNA from cervical samples previously characterized for HPV type were obtained from multiple geographic regions to screen for novel variants. The complete 8 kb genomes of 120 variants representing the major and minor lineages of the HPV16-related alpha-9 HPV types were sequenced to capture maximum viral heterogeneity. Viral evolution was characterized by constructing phylogenic trees based on complete genomes using multiple algorithms. Maximal and viral region specific divergence was calculated by global and pairwise alignments. Variant lineages were classified and named using an alphanumeric system; the prototype genome was assigned to the A lineage for all types. Results: The range of genome-genome sequence heterogeneity varied from 0.6% for HPV35 to 2.2% for HPV52 and included 1.4% for HPV31, 1.1% for HPV33, 1.7% for HPV58 and 1.1% for HPV67. Nucleotide differences of approximately 1.0% - 10.0% and 0.5%-1.0% of the complete genomes were used to define variant lineages and sublineages, respectively. Each gene/region differs in sequence diversity, from most variable to least variable: noncoding region 1 (NCR1)/noncoding region 2 (NCR2) > upstream regulatory region (URR) > E6/E7 > E2/L2 > E1/L1. Conclusions: These data define maximum viral genomic heterogeneity of HPV16-related alpha-9 HPV variants. The proposed nomenclature system facilitates the comparison of variants across epidemiological studies. Sequence diversity and phylogenies of this clinically important group of HPVs provides the basis for further studies of discrete viral evolution, epidemiology, pathogenesis and preventative/therapeutic interventions.	[Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA; [Schiffman, Mark; Sahasrabuddhe, Vikrant V.; Hsing, Ann W.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Herrero, Rolando] Fdn INCIENSA, Proyect Epidemiol Guanacaste, San Jose, Costa Rica; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Anastos, Kathryn] Montefiore Med Ctr, Dept Med, New York, NY USA; [Segondy, Michel] Montpellier Univ Hosp, Dept Biol & Pathol, Montpellier, France; [Sahasrabuddhe, Vikrant V.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN USA; [Gravitt, Patti E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, New York, NY USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, New York, NY USA; [Chen, Zigui; Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, New York, NY USA	Yeshiva University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Museum of Natural History (AMNH); Montefiore Medical Center; Universite de Montpellier; CHU de Montpellier; Vanderbilt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yeshiva University; Yeshiva University; Yeshiva University	Chen, ZG (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA.	robert.burk@einstein.yu.edu	Schiffman, Mark/B-9766-2015; Chen, Zigui/E-8490-2017	Chen, Zigui/0000-0002-8577-1298	National Cancer Institute [CA78527, AI-51519]; Einstein Cancer Research Center, NCI [P30CA013330]; American Museum of Natural History; FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA078527, P30CA013330, U01CA078527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Einstein Cancer Research Center, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Museum of Natural History; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Cancer Institute (CA78527), the Einstein-Montefiore Center for AIDS funded by the National Institutes of Health (AI-51519), and the Einstein Cancer Research Center (P30CA013330) from the NCI. RD thanks the Louis and Dorothy Cullman Program in Molecular Systematics at the American Museum of Natural History for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Alizon S, 2011, TRENDS MICROBIOL, V19, P24, DOI 10.1016/j.tim.2010.09.005; Arias-Pulido H, 2005, VIROLOGY, V338, P22, DOI 10.1016/j.virol.2005.04.022; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Calleja-Macias IE, 2005, J VIROL, V79, P13630, DOI 10.1128/JVI.79.21.13630-13640.2005; Calleja-Macias IE, 2005, J VIROL, V79, P6565, DOI 10.1128/JVI.79.10.6565-6569.2005; Calleja-Macias IE, 2004, VIROLOGY, V319, P315, DOI 10.1016/j.virol.2003.11.009; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Chan SY, 1997, VIROLOGY, V239, P296, DOI 10.1006/viro.1997.8896; Chen ZG, 2005, J VIROL, V79, P7014, DOI 10.1128/JVI.79.11.7014-7023.2005; Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08; Colwell RK, 2009, ESTIMATES STAT ESTIM; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DEAU MC, 1993, J CLIN MICROBIOL, V31, P2918, DOI 10.1128/JCM.31.11.2918-2926.1993; DEAU MC, 1991, VIROLOGY, V184, P492, DOI 10.1016/0042-6822(91)90419-C; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAUQUET CM, 2005, 8 INT COMM TAX VIR, P239; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gagnon S, 2005, J MED VIROL, V75, P213, DOI 10.1002/jmv.20259; Gagnon S, 2004, J INFECT DIS, V190, P1575, DOI 10.1086/424854; Gagnon S, 2007, JAIDS-J ACQ IMM DEF, V44, P61, DOI 10.1097/01.qai.0000247226.45375.01; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GOLDSBOROUGH MD, 1989, VIROLOGY, V171, P306, DOI 10.1016/0042-6822(89)90545-X; HEINZEL PA, 1995, J CLIN MICROBIOL, V33, P1746, DOI 10.1128/JCM.33.7.1746-1754.1995; Herbst LH, 2009, VIROLOGY, V383, P131, DOI 10.1016/j.virol.2008.09.022; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; *ICTV, 2002, INT COD VIR CLASS NO; *INV IHP, 2003, NATURE, V426, P789; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Katoh Kazutaka, 2010, Bioinformatics, V26, P1899, DOI 10.1093/bioinformatics/btq224; Khouadri S, 2006, J INFECT DIS, V194, P886, DOI 10.1086/507431; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; LIAW KL, 1995, INT J CANCER, V62, P565, DOI 10.1002/ijc.2910620513; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; MARKS M, 2011, INT J CANC; Maver PJ, 2011, J MED VIROL, V83, P461, DOI 10.1002/jmv.21994; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Narechania A, 2005, J VIROL, V79, P15503, DOI 10.1128/JVI.79.24.15503-15510.2005; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prado JC, 2005, VIROLOGY, V340, P95, DOI 10.1016/j.virol.2005.06.024; Raiol T, 2009, J MED VIROL, V81, P685, DOI 10.1002/jmv.21432; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Schiffman M, 2005, VIROLOGY, V337, P76, DOI 10.1016/j.virol.2005.04.002; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Stewart ACM, 1996, J VIROL, V70, P3127, DOI 10.1128/JVI.70.5.3127-3136.1996; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; TAMURA K, 2011, MOL BIOL EVOL UNPUB; Terai M, 2002, J VIROL, V76, P10020, DOI 10.1128/JVI.76.19.10020-10023.2002; Terai M, 2001, J GEN VIROL, V82, P2035, DOI 10.1099/0022-1317-82-9-2035; Wheeler CM, 1997, J CLIN MICROBIOL, V35, P11, DOI 10.1128/JCM.35.1.11-19.1997; Wongworapat K, 2008, SEX TRANSM DIS, V35, P172, DOI 10.1097/OLQ.0b013e318158af65; Woolford L, 2007, J VIROL, V81, P13280, DOI 10.1128/JVI.01662-07; Wu EQ, 2009, J GEN VIROL, V90, P1229, DOI 10.1099/vir.0.008227-0; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	64	102	106	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20183	10.1371/journal.pone.0020183	http://dx.doi.org/10.1371/journal.pone.0020183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21673791	Green Submitted, gold, Green Published			2022-12-25	WOS:000291052500039
J	Sasaki, K; Suzuki, M; Mieda, M; Tsujino, N; Roth, B; Sakurai, T				Sasaki, Koh; Suzuki, Mika; Mieda, Michihiro; Tsujino, Natsuko; Roth, Bryan; Sakurai, Takeshi			Pharmacogenetic Modulation of Orexin Neurons Alters Sleep/Wakefulness States in Mice	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; OREXIN/HYPOCRETIN NEURONS; RAT-BRAIN; SLEEP; HYPOCRETIN; HOMEOSTASIS; VECTORS; AROUSAL; ROLES; CYCLE	Hypothalamic neurons expressing neuropeptide orexins are critically involved in the control of sleep and wakefulness. Although the activity of orexin neurons is thought to be influenced by various neuronal input as well as humoral factors, the direct consequences of changes in the activity of these neurons in an intact animal are largely unknown. We therefore examined the effects of orexin neuron-specific pharmacogenetic modulation in vivo by a new method called the Designer Receptors Exclusively Activated by Designer Drugs approach (DREADD). Using this system, we successfully activated and suppressed orexin neurons as measured by Fos staining. EEG and EMG recordings suggested that excitation of orexin neurons significantly increased the amount of time spent in wakefulness and decreased both non-rapid eye movement (NREM) and rapid eye movement (REM) sleep times. Inhibition of orexin neurons decreased wakefulness time and increased NREM sleep time. These findings clearly show that changes in the activity of orexin neurons can alter the behavioral state of animals and also validate this novel approach for manipulating neuronal activity in awake, freely-moving animals.	[Sasaki, Koh; Suzuki, Mika; Mieda, Michihiro; Tsujino, Natsuko; Sakurai, Takeshi] Kanazawa Univ, Dept Mol Neurosci & Integrat Physiol, Fac Med, Kanazawa, Ishikawa, Japan; [Roth, Bryan] UNC Chapel Hill Med Sch, Chapel Hill, NC USA	Kanazawa University	Sasaki, K (corresponding author), Kanazawa Univ, Dept Mol Neurosci & Integrat Physiol, Fac Med, Kanazawa, Ishikawa, Japan.	tsakurai@med.kanazawa-u.ac.jp	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Mieda, Michihiro/0000-0002-2451-7034	Cabinet Office, Government of Japan; NIMH [U19MH82441]; Michael Hooker Distinguished Chair in Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441] Funding Source: NIH RePORTER	Cabinet Office, Government of Japan; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Distinguished Chair in Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported in part by Grants-in-Aid for Scientific Research (B) and the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers" as well as by NIMH grant U19MH82441 and the Michael Hooker Distinguished Chair in Pharmacology to BLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Auricchio A, 2001, HUM GENE THER, V12, P71, DOI 10.1089/104303401450988; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; KRASHES MJ, 2011, J CLIN INVEST; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lu J, 2002, J NEUROSCI, V22, P4568, DOI 10.1523/JNEUROSCI.22-11-04568.2002; Matsuki T, 2009, P NATL ACAD SCI USA, V106, P4459, DOI 10.1073/pnas.0811126106; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Sakurai Takeshi, 2006, CNS & Neurological Disorders-Drug Targets, V5, P313, DOI 10.2174/187152706777452218; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Takahashi K, 2008, NEUROSCIENCE, V153, P860, DOI 10.1016/j.neuroscience.2008.02.058; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tsujino N, 2005, J NEUROSCI, V25, P7459, DOI 10.1523/JNEUROSCI.1193-05.2005; VANNIMERCIER G, 1984, CR ACAD SCI III-VIE, V298, P195; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yoshida K, 2006, J COMP NEUROL, V494, P845, DOI 10.1002/cne.20859; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	25	176	178	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20360	10.1371/journal.pone.0020360	http://dx.doi.org/10.1371/journal.pone.0020360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647372	Green Published, gold			2022-12-25	WOS:000291052500052
J	Verrier, JD; Madorsky, I; Coggin, WE; Geesey, M; Hochman, M; Walling, E; Daroszewski, D; Eccles, KS; Ludlow, R; Semple-Rowland, SL				Verrier, Jonathan D.; Madorsky, Irina; Coggin, William E.; Geesey, Mero; Hochman, Michael; Walling, Elleanor; Daroszewski, Daniel; Eccles, Kristofer S.; Ludlow, Rachel; Semple-Rowland, Susan L.			Bicistronic Lentiviruses Containing a Viral 2A Cleavage Sequence Reliably Co-Express Two Proteins and Restore Vision to an Animal Model of LCA1	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; MOUTH-DISEASE VIRUS; GENE REPLACEMENT THERAPY; RETINAL DEGENERATION; PHOTORECEPTOR DEGENERATION; OPTOKINETIC NYSTAGMUS; MULTIPLE PROTEINS; SIGNAL SEQUENCES; MURINE MODEL; EXPRESSION	The disease processes underlying inherited retinal disease are complex and are not completely understood. Many of the corrective gene therapies designed to treat diseases linked to mutations in genes specifically expressed in photoreceptor cells restore function to these cells but fail to stop progression of the disease. There is growing consensus that effective treatments for these diseases will require delivery of multiple therapeutic proteins that will be selected to treat specific aspects of the disease process. The purpose of this study was to design a lentiviral transgene that reliably expresses all of the proteins it encodes and does so in a consistent manner among infected cells. We show, using both in vitro and in vivo analyses, that bicistronic lentiviral transgenes encoding two fluorescent proteins fused to a viral 2A-like cleavage peptide meet these expression criteria. To determine if this transgene design is suitable for therapeutic applications, we replaced one of the fluorescent protein genes with the gene encoding guanylate cyclase -1 (GC1) and delivered lentivirus carrying this transgene to the retinas of the GUCY1*B avian model of Leber congenital amaurosis -1 (LCA1). GUCY1*B chickens carry a null mutation in the GC1 gene that disrupts photoreceptor function and causes blindness at hatching, a phenotype that closely matches that observed in humans with LCA1. We found that treatment of these animals with the 2A lentivector encoding GC1 restored vision to these animals as evidenced by the presence of optokinetic reflexes. We conclude that 2A-like peptides, with proper optimization, can be successfully incorporated into therapeutic vectors designed to deliver multiple proteins to neural retinal. These results highlight the potential of this vector design to serve as a platform for the development of combination therapies designed to enhance or prolong the benefits of corrective gene therapies.	[Verrier, Jonathan D.; Madorsky, Irina; Coggin, William E.; Geesey, Mero; Hochman, Michael; Walling, Elleanor; Daroszewski, Daniel; Eccles, Kristofer S.; Ludlow, Rachel; Semple-Rowland, Susan L.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Verrier, JD (corresponding author), Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA.	rowland@mbi.ufl.edu			NIH [EY11388, EY08571]; NATIONAL EYE INSTITUTE [R01EY011388, P30EY021721, P30EY008571] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by NIH grants EY11388 (SSR) and an NIH Vision Core Grant EY08571 (http://www.nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Chinnasamy Nachimuthu, 2009, V515, P137, DOI 10.1007/978-1-59745-559-6_9; Chumakov SP, 2010, PLASMID, V63, P143, DOI 10.1016/j.plasmid.2009.12.003; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Coleman JE, 2004, INVEST OPHTH VIS SCI, V45, P3397, DOI 10.1167/iovs.04-0392; CONLEY M, 1980, BRAIN BEHAV EVOLUT, V17, P89, DOI 10.1159/000121792; de Felipe P, 1999, GENE THER, V6, P198, DOI 10.1038/sj.gt.3300811; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; GAO H, 1992, INVEST OPHTH VIS SCI, V33, P1; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Koch KW, 2002, MOL CELL BIOCHEM, V230, P97, DOI 10.1023/A:1014209711793; KOMENDA JK, 1983, BEHAV NEUROSCI, V97, P928, DOI 10.1037/0735-7044.97.6.928; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; Negroni M, 2001, NAT REV MOL CELL BIO, V2, P151, DOI 10.1038/35052098; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; Pawlyk BS, 2010, HUM GENE THER, V21, P993, DOI 10.1089/hum.2009.218; Pawlyk BS, 2005, INVEST OPHTH VIS SCI, V46, P3039, DOI 10.1167/iovs.05-0371; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rothwell DG, 2010, HUM GENE THER, V21, P1631, DOI 10.1089/hum.2009.197; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Schlichtenbrede FC, 2003, J GENE MED, V5, P757, DOI 10.1002/jgm.401; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Semple-Rowland SL, 2007, MOL VIS, V13, P2001; Semple-Rowland SL, 2010, MOL VIS, V16, P916; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Szymczak-Workman A.L., 2007, GENE TRANSFER DELIVE, P137; TAUBER ES, 1968, SCIENCE, V160, P1365, DOI 10.1126/science.160.3834.1365; Williams ML, 2006, PLOS MED, V3, P904, DOI 10.1371/journal.pmed.0030201; Wong ET, 2002, GENE THER, V9, P337, DOI 10.1038/sj.gt.3301667; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7	47	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20553	10.1371/journal.pone.0020553	http://dx.doi.org/10.1371/journal.pone.0020553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647387	Green Submitted, Green Published, gold			2022-12-25	WOS:000291052500068
J	Cardnell, RJG; Mikkelsen, RB				Cardnell, Robert J. G.; Mikkelsen, Ross B.			Nitric Oxide Synthase Inhibition Enhances the Antitumor Effect of Radiation in the Treatment of Squamous Carcinoma Xenografts	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FACTOR-KAPPA-B; IONIZING-RADIATION; L-ARGININE; S-NITROSYLATION; CHRONIC HYPOXIA; RECURRENT HEAD; PROTEIN-KINASE; CELL CARCINOMA; BLOOD-FLOW	This study tests whether the nitric oxide synthase (NOS) inhibitor, N-G-nitro-L-arginine (L-NNA), combines favorably with ionizing radiation (IR) in controlling squamous carcinoma tumor growth. Animals bearing FaDu and A431 xenografts were treated with L-NNA in the drinking water. IR exposure was 10 Gy for tumor growth and survival studies and 4 Gy for ex vivo clonogenic assays. Cryosections were examined immunohistochemically for markers of apoptosis and hypoxia. Blood flow was assayed by fluorescent microscopy of tissue cryosections after i.v. injection of fluorospheres. Orally administered L-NNA for 24 hrs reduces tumor blood flow by 80% (p<0.01). Within 24 hrs L-NNA treatment stopped tumor growth for at least 10 days before tumor growth again ensued. The growth arrest was in part due to increased cell killing since a combination of L-NNA and a single 4 Gy IR caused 82% tumor cell killing measured by an ex vivo clonogenic assay compared to 49% by L-NNA or 29% by IR alone. A Kaplan-Meyer analysis of animal survival revealed a distinct survival advantage for the combined treatment. Combining L-NNA and IR was also found to be at least as effective as a single i.p. dose of cisplatin plus IR. In contrast to the in vivo studies, exposure of cells to L-NNA in vitro was without effect on clonogenicity with or without IR. Western and immunochemical analysis of expression of a number of proteins involved in NO signaling indicated that L-NNA treatment enhanced arginase-2 expression and that this may represent vasculature remodeling and escape from NOS inhibition. For tumors such as head and neck squamous carcinomas that show only modest responses to inhibitors of specific angiogenic pathways, targeting NO-dependent pro-survival and angiogenic mechanisms in both tumor and supporting stromal cells may present a potential new strategy for tumor control.	[Cardnell, Robert J. G.; Mikkelsen, Ross B.] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23284 USA	Virginia Commonwealth University	Cardnell, RJG (corresponding author), Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA 23284 USA.	rjcardnell@vcu.edu			NIH/NCI [RO1-CA65896, RO1-CA90881, PO1 CA72955, T32-CA113277]; NATIONAL CANCER INSTITUTE [R01CA090881, R01CA065896, P01CA072955, T32CA113277] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/NCI Grants RO1-CA65896, RO1-CA90881, PO1 CA72955 (RBM) and NIH/NCI Training Grant T32-CA113277 (RJGC) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CT, 2007, HEAD NECK-J SCI SPEC, V29, P959, DOI 10.1002/hed.20615; Anselm E, 2005, FASEB J, V19, pA1230; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; Chan N, 2008, CANCER RES, V68, P605, DOI 10.1158/0008-5472.CAN-07-5472; Chen B, 2009, AM J PHYSIOL-LUNG C, V297, pL1151, DOI 10.1152/ajplung.00183.2009; Crokart N, 2005, INT J RADIAT ONCOL, V63, P901, DOI 10.1016/j.ijrobp.2005.02.038; Davis PD, 2002, INT J RADIAT ONCOL, V54, P1532, DOI 10.1016/S0360-3016(02)03925-1; DELAGE B, INT J CANC, V126, P2762; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Fury MG, 2007, INVEST NEW DRUG, V25, P165, DOI 10.1007/s10637-006-9011-x; Gewirtz DA, 2009, RADIOTHER ONCOL, V92, P323, DOI 10.1016/j.radonc.2009.05.022; Gorski DH, 1999, CANCER RES, V59, P3374; Hlushchuk R, 2008, AM J PATHOL, V173, P1173, DOI 10.2353/ajpath.2008.071131; Hua JY, 2003, ANTICANCER RES, V23, P1433; Isenberg JS, 2007, BLOOD, V109, P1945, DOI 10.1182/blood-2006-08-041368; Itasaka S, 2007, INT J RADIAT ONCOL, V67, P870, DOI 10.1016/j.ijrobp.2006.10.030; Jadeski LC, 2003, INT J CANCER, V106, P496, DOI 10.1002/ijc.11268; Jordan BF, 2002, CANCER RES, V62, P3555; Joschko MA, 1997, CANCER CHEMOTH PHARM, V40, P534, DOI 10.1007/s002800050699; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; KING I, 1989, CANCER RES, V49, P5677; Lahdenranta J, 2009, CANCER RES, V69, P2801, DOI 10.1158/0008-5472.CAN-08-4051; Lammering G, 2001, J NATL CANCER I, V93, P921, DOI 10.1093/jnci/93.12.921; Leach JK, 2002, J BIOL CHEM, V277, P15400, DOI 10.1074/jbc.M110309200; Leach JK, 2001, CANCER RES, V61, P3894; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; MADHOK BM, BR J CANC, V102, P1746; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Milas L, 2000, CLIN CANCER RES, V6, P701; Nelin LD, 2007, AM J PHYSIOL-CELL PH, V293, pC632, DOI 10.1152/ajpcell.00137.2006; Ng QS, 2007, LANCET ONCOL, V8, P111, DOI 10.1016/S1470-2045(07)70001-3; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; Satriano J, 2004, AMINO ACIDS, V26, P321, DOI 10.1007/s00726-004-0078-4; Sonveaux P, 2003, CANCER RES, V63, P1012; Sonveaux P, 2002, FASEB J, V16, P1979, DOI 10.1096/fj.02-0487fje; Sturla LM, 2005, J BIOL CHEM, V280, P14597, DOI 10.1074/jbc.M413287200; TOBY IT, AM J PHYSL LUNG CELL, V298, pL600; Tozer GM, 2009, CLIN CANCER RES, V15, P3781, DOI 10.1158/1078-0432.CCR-08-2906; Tozer GM, 1997, CANCER RES, V57, P948; Van den Berge DL, 2001, BRIT J CANCER, V84, P1122, DOI 10.1054/bjoc.2000.1719; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; Van Waes C, 2005, INT J RADIAT ONCOL, V63, P1400, DOI 10.1016/j.ijrobp.2005.05.007; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Vordermark D, 2003, INT J RADIAT ONCOL, V56, P1184, DOI 10.1016/S0360-3016(03)00289-X; WOOD PJ, 1994, CANCER RES, V54, P6458; Yakovlev VA, 2007, BIOCHEMISTRY-US, V46, P11671, DOI 10.1021/bi701107z; Yan B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r53; Zolzer F, 2002, INT J RADIAT ONCOL, V54, P910, DOI 10.1016/S0360-3016(02)02963-2	49	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20147	10.1371/journal.pone.0020147	http://dx.doi.org/10.1371/journal.pone.0020147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647438	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500028
J	Chen, YC; Aguan, K; Yang, CW; Wang, YT; Pal, NR; Chung, IF				Chen, Yi-Cheng; Aguan, Kripamoy; Yang, Chu-Wen; Wang, Yao-Tsung; Pal, Nikhil R.; Chung, I-Fang			Discovery of Protein Phosphorylation Motifs through Exploratory Data Analysis	PLOS ONE			English	Article							POSITION-WEIGHT MATRIX; PHOSPHOPROTEOME ANALYSIS; SEQUENCE MOTIFS; CLUSTER VALIDITY; KINASE-C; PREDICTION; SITES; IDENTIFICATION; GENOME; TOOL	Background: The need for efficient algorithms to uncover biologically relevant phosphorylation motifs has become very important with rapid expansion of the proteomic sequence database along with a plethora of new information on phosphorylation sites. Here we present a novel unsupervised method, called Motif Finder (in short, F-Motif) for identification of phosphorylation motifs. F-Motif uses clustering of sequence information represented by numerical features that exploit the statistical information hidden in some foreground data. Furthermore, these identified motifs are then filtered to find "actual" motifs with statistically significant motif scores. Results and Discussion: We have applied F-Motif to several new and existing data sets and compared its performance with two well known state-of-the-art methods. In almost all cases F-Motif could identify all statistically significant motifs extracted by the state-of-the-art methods. More importantly, in addition to this, F-Motif uncovers several novel motifs. We have demonstrated using clues from the literature that most of these new motifs discovered by F-Motif are indeed novel. We have also found some interesting phenomena. For example, for CK2 kinase, the conserved sites appear only on the right side of S. However, for CDK kinase, the adjacent site on the right of S is conserved with residue P. In addition, three different encoding methods, including a novel position contrast matrix (PCM) and the simplest binary coding, are used and the ability of F-motif to discover motifs remains quite robust with respect to encoding schemes. Conclusions: An iterative algorithm proposed here uses exploratory data analysis to discover motifs from phosphorylated data. The effectiveness of F-Motif has been demonstrated using several real data sets as well as using a synthetic data set. The method is quite general in nature and can be used to find other types of motifs also. We have also provided a server for F-Motif at http://f-motif.classcloud.org/, http://bio.classcloud.org/f-motif/ or http://ymu.classcloud.org/f-motif/.	[Chen, Yi-Cheng; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chung, I-Fang] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Aguan, Kripamoy] NE Hill Univ, Dept Biotechnol & Bioinformat, Shillong, Meghalaya, India; [Yang, Chu-Wen] Soochow Univ, Dept Microbiol, Taipei 11102, Taiwan; [Wang, Yao-Tsung] Natl Ctr High Performance Comp, Software Technol Div, Taichung, Taiwan; [Pal, Nikhil R.] Indian Stat Inst, Elect & Commun Sci Unit, Kolkata 700035, W Bengal, India	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; North Eastern Hill University; Soochow University; Indian Statistical Institute; Indian Statistical Institute Kolkata	Chen, YC (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	ifchung@ym.edu.tw			National Science Council (NSC) [NSC99-2221-E-010-013]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work is supported by National Science Council (NSC) (NSC99-2221-E-010-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Bezdek J. C., 1999, FUZZY MODELS ALGORIT, V4, DOI 10.1007/b106267; Bezdek JC, 1998, IEEE T SYST MAN CY B, V28, P301, DOI 10.1109/3477.678624; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Claverie JM, 1996, COMPUT APPL BIOSCI, V12, P431; CLAVERIE JM, 1994, COMPUT CHEM, V18, P287, DOI 10.1016/0097-8485(94)85024-0; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Han SJ, 2006, EMBO J, V25, P5716, DOI 10.1038/sj.emboj.7601431; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Nishida K, 2009, NUCLEIC ACIDS RES, V37, P939, DOI 10.1093/nar/gkn1019; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PAL NR, 1995, IEEE T FUZZY SYST, V3, P370, DOI 10.1109/91.413225; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Qiu P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-29; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Ritz A, 2009, BIOINFORMATICS, V25, P14, DOI 10.1093/bioinformatics/btn569; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Shi Y, 2008, J BIOL CHEM, V283, P2488, DOI 10.1074/jbc.M708769200; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; VILLE NJ, 2007, P NATL ACAD SCI USA, V104, P1488; Yoo PD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-272; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	43	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20025	10.1371/journal.pone.0020025	http://dx.doi.org/10.1371/journal.pone.0020025			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647451	Green Published, Green Submitted, gold			2022-12-25	WOS:000291006500019
J	Kondratyev, M; Kreso, A; Hallett, RM; Girgis-Gabardo, A; Barcelon, ME; Ilieva, D; Ware, C; Majumder, PK; Hassell, JA				Kondratyev, M.; Kreso, A.; Hallett, R. M.; Girgis-Gabardo, A.; Barcelon, M. E.; Ilieva, D.; Ware, C.; Majumder, P. K.; Hassell, J. A.			Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer	ONCOGENE			English	Article						breast cancer; tumor-initiating cells; cancer stem cells; gamma-secretase inhibitors; Notch signaling; transgenic mouse models	MAMMARY STEM/PROGENITOR CELLS; LYMPHOBLASTIC-LEUKEMIA CELLS; NOTCH SIGNALING PATHWAY; SUSPENSION BIOREACTORS; NEU PROTOONCOGENE; STEM-CELLS; IN-VITRO; FATE; ACTIVATION; EXPRESSION	Human breast tumors comprise a minor sub-population of tumor-initiating cells (TICs), commonly termed cancer stem cells. TICs are thought to sustain tumor growth and to confer resistance to current anticancer therapies. Hence, targeting TIC may be essential to achieving durable cancer cures. To identify molecular targets in breast TIC, we employed a transgenic mouse model of ERBB2 breast cancer; tumors arising in this model comprise a very high frequency of TIC, which is maintained in tumor cell populations propagated in vitro as non-adherent tumor-spheres. The Notch pathway is dysregulated in human breast tumors and overexpression of constitutively active Notch proteins induces mammary tumors in mice. The Notch pathway has also been implicated in stem cell processes including those of mammary epithelial stem cells. Hence, we investigated the potential that the Notch pathway is required for TIC activity. We found that an antagonist of Notch signaling, a gamma (gamma)-secretase inhibitor termed MRK-003, inhibited the survival of tumorsphere-derived cells in vitro and eliminated TIC as assessed by cell transplantation into syngeneic mice. Whereas MRK-003 also inhibited the self-renewal and/or proliferation of mammosphere-resident cells, this effect of the inhibitor was reversible thus suggesting that it did not compromise the survival of these cells. MRK-003 administration to tumor-bearing mice eliminated tumor-resident TIC and resulted in rapid and durable tumor regression. MRK-003 inhibited the proliferation of tumor cells, and induced their apoptosis and differentiation. These findings suggest that MRK-003 targets breast TIC and illustrate that eradicating these cells in breast tumors ensures long-term, recurrence-free survival. Oncogene (2012) 31, 93-103; doi: 10.1038/onc.2011.212; published online 13 June 2011	[Kondratyev, M.; Kreso, A.; Hallett, R. M.; Girgis-Gabardo, A.; Barcelon, M. E.; Ilieva, D.; Hassell, J. A.] McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, Hamilton, ON L8N 3Z5, Canada; [Ware, C.] Merck Res Labs, Dept Biomol Markers, Boston, MA USA; [Majumder, P. K.] Merck Res Labs, Dept Oncol, Boston, MA USA; [Majumder, P. K.] Merck Res Labs, Dept Pharmacol, Boston, MA USA	McMaster University; Merck & Company; Merck & Company; Merck & Company	Hassell, JA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Ctr Funct Genom, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	hassell@mcmaster.ca			Stem Cell Network; Canadian Breast Cancer Foundation (CBCF); Terry Fox Research Institute/Ontario Institute for Cancer Research	Stem Cell Network; Canadian Breast Cancer Foundation (CBCF); Terry Fox Research Institute/Ontario Institute for Cancer Research	The Stem Cell Network, Canadian Breast Cancer Foundation (CBCF) and the Terry Fox Research Institute/Ontario Institute for Cancer Research provided operating grants to JAH to support the research described herein. MK is the recipient of a CBCF fellowship.	Borowsky AD, 2004, COMPARATIVE MED, V54, P258; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cardiff RD, 2003, COMPARATIVE MED, V53, P250; Cardiff RD, 2001, VET PATHOL, V38, P357, DOI 10.1354/vp.38-4-357; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cullion K, 2009, BLOOD, V113, P6172, DOI 10.1182/blood-2008-02-136762; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Efferson CL, 2010, CANCER RES, V70, P2476, DOI 10.1158/0008-5472.CAN-09-3114; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kurpios NA, 2009, DEV BIOL, V325, P106, DOI 10.1016/j.ydbio.2008.09.033; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MATSUNO K, 1995, DEVELOPMENT, V121, P2633; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Sawey ET, 2008, CELL CYCLE, V7, P566, DOI 10.4161/cc.7.5.5531; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Siegel PM, 1996, P NATL ACAD SCI USA, V93, P8878, DOI 10.1073/pnas.93.17.8878; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; Smalley MJ, 1998, IN VITRO CELL DEV-AN, V34, P711; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Tammam J, 2009, BRIT J PHARMACOL, V158, P1183, DOI 10.1111/j.1476-5381.2009.00389.x; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; Youn BS, 2006, BIOTECHNOL PROGR, V22, P801, DOI 10.1021/bp050430z; Youn BS, 2005, BIOTECHNOL PROGR, V21, P984, DOI 10.1021/bp050059f; Zhang P, 2010, ONCOGENE, V29, P2916, DOI 10.1038/onc.2010.62	44	80	81	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	1					93	103		10.1038/onc.2011.212	http://dx.doi.org/10.1038/onc.2011.212			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21666715				2022-12-25	WOS:000299176200009
J	Wei, L; Salahura, G; Boncompagni, S; Kasischke, KA; Protasi, F; Sheu, SS; Dirksen, RT				Wei, Lan; Salahura, Gheorghe; Boncompagni, Simona; Kasischke, Karl A.; Protasi, Feliciano; Sheu, Shey-Shing; Dirksen, Robert T.			Mitochondrial superoxide flashes: metabolic biomarkers of skeletal muscle activity and disease	FASEB JOURNAL			English	Article						excitation-contraction coupling; reactive oxygen species; electron transport chain; permeability transition pore; adenine nucleotide translocase	PERMEABILITY TRANSITION; REACTIVE OXYGEN; CYCLOPHILIN-D; OXIDATIVE STRESS; CA2+ RELEASE; DYNAMICS; CALCIUM; DEATH	Mitochondrial superoxide flashes (mSOFs) are stochastic events of quantal mitochondrial superoxide generation. Here, we used flexor digitorum brevis muscle fibers from transgenic mice with muscle-specific expression of a novel mitochondrial-targeted superoxide biosensor (mt-cpYFP) to characterize mSOF activity in skeletal muscle at rest, following intense activity, and under pathological conditions. Results demonstrate that mSOF activity in muscle depended on electron transport chain and adenine nucleotide translocase functionality, but it was independent of cyclophilin-D-mediated mitochondrial permeability transition pore activity. The diverse spatial dimensions of individual mSOF events were found to reflect a complex underlying morphology of the mitochondrial network, as examined by electron microscopy. Muscle activity regulated mSOF activity in a biphasic manner. Specifically, mSOF frequency was significantly increased following brief tetanic stimulation (18.1 +/- 1.6 to 22.3 +/- 2.0 flashes/1000 mu m(2).100 s before and after 5 tetani) and markedly decreased (to 7.7 +/- 1.6 flashes/1000 mu m(2).100 s) following prolonged tetanic stimulation (40 tetani). A significant temperature-dependent increase in mSOF frequency (11.9 +/- 0.8 and 19.8 +/- 2.6 flashes/1000 mu m(2).100 s at 23 degrees C and 37 degrees C) was observed in fibers from RYR1(Y522S/WT) mice, a mouse model of malignant hyperthermia and heat-induced hypermetabolism. Together, these results demonstrate that mSOF activity is a highly sensitive biomarker of mitochondrial respiration and the cellular metabolic state of muscle during physiological activity and pathological oxidative stress.-Wei, L., Salahura, G., Boncompagni, S., Kasischke, K. A., Protasi, F., Sheu, S.-S., Dirksen, R. T. Mitochondrial superoxide flashes: metabolic biomarkers of skeletal muscle activity and disease. FASEB J. 25, 3068-3078 (2011). www.fasebj.org	[Wei, Lan; Sheu, Shey-Shing; Dirksen, Robert T.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Salahura, Gheorghe; Kasischke, Karl A.] Univ Rochester, Med Ctr, Ctr Neural Dev & Dis, Rochester, NY 14642 USA; [Boncompagni, Simona; Protasi, Feliciano] Univ Gabriele dAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Boncompagni, Simona; Protasi, Feliciano] Univ Gabriele dAnnunzio, Ctr Res Aging, Chieti, Italy	University of Rochester; University of Rochester; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Dirksen, RT (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Box 711,601 Elmwood Ave, Rochester, NY 14642 USA.	robert_dirksen@urmc.rochester.edu	Sheu, Shey-Shing/Y-4009-2019	Sheu, Shey-Shing/0000-0003-3838-3601; Kasischke, Karl/0000-0003-0582-4319	U.S. National Institutes of Health [AR44657, HL033333]; Italian Telethon ONLUS Foundation [GGP08153]; Academia Dei Lincea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR044657, R01AR044657] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon ONLUS Foundation(Fondazione Telethon); Academia Dei Lincea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Jeffery D. Molkentin (University of Cincinnati, Cincinnati, OH, USA) for providing the CypD<SUP>-/-</SUP> mice and skeletal muscle-specific vector used to generate the mt-cpYFP transgenic mice used in this study. The authors also thank Linda Groom (University of Rochester Medical Center) for generating the muscle-specific mt-cpYFP construct used to make the transgenic mice used in this study. The authors thank Dr. Susan L. Hamilton (Baylor College of Medicine, Houston, TX, USA) for constructive comments on the manuscript and for providing access to the RYR1<SUP>Y522S/WT</SUP> mice used in this work. The 2-photon imaging studies were performed in the Multiphoton Core Facility of the University of Rochester Medical Center. This research was supported by U.S. National Institutes of Health grants AR44657 (to R. T. D.) and HL033333 (to S. S. S.), Italian Telethon ONLUS Foundation grant GGP08153 (to F. P.), and the Academia Dei Lincea Fund (to L. W.).	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; Aon MA, 2004, P NATL ACAD SCI USA, V101, P4447, DOI 10.1073/pnas.0307156101; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BAKEEVA LE, 1978, BIOCHIM BIOPHYS ACTA, V501, P349, DOI 10.1016/0005-2728(78)90104-4; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Boncompagni S, 2009, MOL BIOL CELL, V20, P1058, DOI 10.1091/mbc.E08-07-0783; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Di Meo S, 2001, BIOL SIGNAL RECEPT, V10, P125; DiFranco M, 2006, PROTEIN EXPRES PURIF, V47, P281, DOI 10.1016/j.pep.2005.10.018; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; Giovannucci DR, 2002, J PHYSIOL-LONDON, V540, P469, DOI 10.1113/jphysiol.2001.013453; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Herrero A, 1997, J BIOENERG BIOMEMBR, V29, P241, DOI 10.1023/A:1022458010266; Jackson MJ, 2007, J APPL PHYSIOL, V102, P1664, DOI 10.1152/japplphysiol.01102.2006; Jackson MJ, 2002, MOL ASPECTS MED, V23, P209, DOI 10.1016/S0098-2997(02)00018-3; JACKSON MJ, 1985, BIOCHIM BIOPHYS ACTA, V847, P185, DOI 10.1016/0167-4889(85)90019-9; Moylan JS, 2007, MUSCLE NERVE, V35, P411, DOI 10.1002/mus.20743; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; REID MB, 1992, J APPL PHYSIOL, V73, P1805, DOI 10.1152/jappl.1992.73.5.1805; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Rudolf R, 2004, J CELL BIOL, V166, P527, DOI 10.1083/jcb.200403102; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Smith MA, 2006, RESP PHYSIOL NEUROBI, V151, P229, DOI 10.1016/j.resp.2005.12.011; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Won JH, 2007, AM J PHYSIOL-GASTR L, V293, pG1166, DOI 10.1152/ajpgi.00352.2007; Zhou LF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000657	37	78	82	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3068	3078		10.1096/fj.11-187252	http://dx.doi.org/10.1096/fj.11-187252			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21646399	Green Published			2022-12-25	WOS:000294435200021
J	Ma, Q; Fang, HQ; Shang, W; Liu, L; Xu, ZS; Ye, T; Wang, XH; Zheng, M; Chen, Q; Cheng, HP				Ma, Qi; Fang, Huaqiang; Shang, Wei; Liu, Lei; Xu, Zhengshuang; Ye, Tao; Wang, Xianhua; Zheng, Ming; Chen, Quan; Cheng, Heping			Superoxide Flashes EARLY MITOCHONDRIAL SIGNALS FOR OXIDATIVE STRESS-INDUCED APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; HYDROGEN-PEROXIDE; CYCLOPHILIN-D; CELL-DEATH; BAX; BCL-2; CALCIUM; CHANNEL; DYSFUNCTION	Irreversible mitochondrial permeability transition and the resultant cytochrome c release signify the commitment of a cell to apoptotic death. However, the role of transient MPT (tMPT) because of flickering opening of the mitochondrial permeability transition pore remains elusive. Here we show that tMPT and the associated superoxide flashes (i.e. tMPT/superoxide flashes) constitute early mitochondrial signals during oxidative stress-induced apoptosis. Selenite (a ROS-dependent insult) but not staurosporine (a ROS-independent insult) stimulated an early and persistent increase in tMPT/superoxide flash activity prior to mitochondrial fragmentation and a global ROS rise, independently of Bax translocation and cytochrome c release. Selectively targeting tMPT/superoxide flash activity by manipulating cyclophilin D expression or scavenging mitochondrial ROS markedly impacted the progression of selenite-induced apoptosis while exerting little effect on the global ROS response. Furthermore, the tMPT/superoxide flash served as a convergence point for pro-and anti-apoptotic regulation mediated by cyclophilin D and Bcl-2 proteins. These results indicate that tMPT/superoxide flashes act as early mitochondrial signals mediating the apoptotic response during oxidative stress, and provide the first demonstration of highly efficacious local mitochondrial ROS signaling in deciding cell fate.	[Fang, Huaqiang; Shang, Wei; Wang, Xianhua; Zheng, Ming; Cheng, Heping] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Fang, Huaqiang; Shang, Wei; Wang, Xianhua; Zheng, Ming; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Ma, Qi; Liu, Lei; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Joint Lab Apoptosis & Canc Biol, Beijing 100101, Peoples R China; [Ma, Qi; Liu, Lei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Xu, Zhengshuang; Ye, Tao] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Ye, Tao] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Chen, Quan] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; University Town of Shenzhen; Hong Kong Polytechnic University; Nankai University	Zheng, M (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	zhengm@pku.edu.cn; chenq@ioz.ac.cn	cheng, heping/A-7299-2011; Heping, Cheng/AAE-2680-2019; Ye，PhD，FRSC, Tao/ABB-8698-2020	Heping, Cheng/0000-0002-9604-6702; Ye，PhD，FRSC, Tao/0000-0002-2780-9761; Chen, Quan/0000-0001-7539-8728	National Science Foundation [90713006, 30971062, 30910103910, 30630021]; National Key Basic Research Program of China [2007CB512100, 2011CB809102, 2011CB910903, 2010CB912204]; State Key Laboratory of Biomembrane and Membrane Biotechnology	National Science Foundation(National Science Foundation (NSF)); National Key Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Biomembrane and Membrane Biotechnology(Chinese Academy of Sciences)	This work was supported by grants from the National Science Foundation (90713006, 30971062, 30910103910, 30630021) the National Key Basic Research Program of China (2007CB512100, 2011CB809102, 2011CB910903, and 2010CB912204) and a special grant from State Key Laboratory of Biomembrane and Membrane Biotechnology.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Crompton M, 2002, BIOCHIMIE, V84, P143, DOI 10.1016/S0300-9084(02)01368-8; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dikalova AE, 2010, CIRC RES, V107, P106, DOI 10.1161/CIRCRESAHA.109.214601; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Huang F, 2009, FREE RADICAL BIO MED, V46, P1186, DOI 10.1016/j.freeradbiomed.2009.01.026; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lipp P, 1998, J PHYSIOL-LONDON, V508, P801, DOI 10.1111/j.1469-7793.1998.801bp.x; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Nilsonne G, 2006, FREE RADICAL BIO MED, V41, P874, DOI 10.1016/j.freeradbiomed.2006.04.031; Pallepati P, 2011, FREE RADICAL BIO MED, V50, P667, DOI 10.1016/j.freeradbiomed.2010.11.022; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; Saotome M, 2009, AM J PHYSIOL-HEART C, V296, pH1125, DOI 10.1152/ajpheart.00436.2008; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI 10.1089/ARS.2008.2331; Tritto I, 1997, CIRC RES, V80, P743, DOI 10.1161/01.RES.80.5.743; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang XD, 2001, GENE DEV, V15, P2922; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wei H, 2010, J CELL BIOCHEM, V111, P967, DOI 10.1002/jcb.22785; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yaguchi Y, 2003, CIRC J, V67, P253; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200; Zhao R, 2006, CANCER RES, V66, P2296, DOI 10.1158/0008-5472.CAN-05-2216; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	49	101	125	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27573	27581		10.1074/jbc.M111.241794	http://dx.doi.org/10.1074/jbc.M111.241794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659534	Green Published, hybrid			2022-12-25	WOS:000293268700051
J	Pocanschi, CL; Kozlov, G; Brockmeier, U; Brockmeier, A; Williams, DB; Gehring, K				Pocanschi, Cosmin L.; Kozlov, Guennadi; Brockmeier, Ulf; Brockmeier, Achim; Williams, David B.; Gehring, Kalle			Structural and Functional Relationships between the Lectin and Arm Domains of Calreticulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I HISTOCOMPATIBILITY MOLECULES; ENDOPLASMIC-RETICULUM CHAPERONE; QUALITY-CONTROL; SUBSTRATE-BINDING; P-DOMAIN; CALNEXIN; PROTEIN; RECOGNITION; DEGRADATION; ERP57	Calreticulin and calnexin are key components in maintaining the quality control of glycoprotein folding within the endoplasmic reticulum. Although their lectin function of binding mono-glucosylated sugar moieties of glycoproteins is well documented, their chaperone activity in suppressing protein aggregation is less well understood. Here, we use a series of deletion mutants of calreticulin to demonstrate that its aggregation suppression function resides primarily within its lectin domain. Using hydrophobic peptides as substrate mimetics, we show that aggregation suppression is mediated through a single polypeptide binding site that exhibits a K-d for peptides of 0.5-1 mu M. This site is distinct from the oligosaccharide binding site and differs from previously identified sites of binding to thrombospondin and GABARAP (4-aminobutyrate type A receptor-associated protein). Although the arm domain of calreticulin was incapable of suppressing aggregation or binding hydrophobic peptides on its own, it did contribute to aggregation suppression in the context of the whole molecule. The high resolution x-ray crystal structure of calreticulin with a partially truncated arm domain reveals a marked difference in the relative orientations of the arm and lectin domains when compared with calnexin. Furthermore, a hydrophobic patch was detected on the arm domain that mediates crystal packing and may contribute to calreticulin chaperone function.	[Pocanschi, Cosmin L.; Brockmeier, Ulf; Brockmeier, Achim; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Pocanschi, Cosmin L.; Brockmeier, Ulf; Brockmeier, Achim; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Kozlov, Guennadi; Gehring, Kalle] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	University of Toronto; University of Toronto; McGill University	Williams, DB (corresponding author), Univ Toronto, Dept Biochem, Med Sci Bldg,Rm 5316, Toronto, ON M5S 1A8, Canada.	david.williams@utoronto.ca; kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	Canadian Institutes of Health Research [MOP-53310, MOP-81277]; Canadian Cancer Society; National Science Foundation [DMR 0225180]; National Institutes of Health [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Canadian Institutes of Health Research Grants MOP-53310 and MOP-81277 (to D. B. W. and K. G.) and the Canadian Cancer Society (to D. B. W.).; For providing various Crt substrates, we gratefully acknowledge Drs. Arianna Rath and Charles Deber (6KAAF and KHP) and Dr. Dieter Willbold (GABARAP). We also thank Dr. Ronnie Lum for the FITC-labeling protocol, initial RCMLA probes, and helpful discussions as well as Myrna Cohen-Doyle for excellent technical assistance. Data acquisition at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source was supported by the National Science Foundation Award DMR 0225180 and the National Institutes of Health Award RR-01646.	Arnaud N, 1997, ANALYST, V122, P143, DOI 10.1039/a605279g; Bosl B, 2005, J BIOL CHEM, V280, P38170, DOI 10.1074/jbc.M506149200; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Brockmeier A, 2009, J BIOL CHEM, V284, P3433, DOI 10.1074/jbc.M804866200; Chouquet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017886; Culina S, 2004, J BIOL CHEM, V279, P54210, DOI 10.1074/jbc.M410841200; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Duus K, 2009, PROTEIN PEPTIDE LETT, V16, P1414, DOI 10.2174/092986609789353772; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Ihara Y, 1999, MOL CELL, V4, P331, DOI 10.1016/S1097-2765(00)80335-4; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; Kapoor M, 2003, J BIOL CHEM, V278, P6194, DOI 10.1074/jbc.M209132200; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; OKAZAKI A, 1994, NAT STRUCT BIOL, V1, P439, DOI 10.1038/nsb0794-439; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patil AR, 2000, J BIOL CHEM, V275, P24348, DOI 10.1074/jbc.M003102200; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Sandhu N, 2007, BBA-PROTEINS PROTEOM, V1774, P701, DOI 10.1016/j.bbapap.2007.03.019; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Tan Y, 2006, BBA-GEN SUBJECTS, V1760, P745, DOI 10.1016/j.bbagen.2006.02.003; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Thomson SP, 2005, CELL STRESS CHAPERON, V10, P242, DOI 10.1379/CSC-126.1; Urbanova N, 2008, ANAL SCI, V24, P727, DOI 10.2116/analsci.24.727; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WARE FE, 1995, J BIOL CHEM, V270, P4697, DOI 10.1074/jbc.270.9.4697; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhang Y, 2009, J BIOL CHEM, V284, P10160, DOI 10.1074/jbc.M808356200	47	39	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27266	27277		10.1074/jbc.M111.258467	http://dx.doi.org/10.1074/jbc.M111.258467			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652723	hybrid, Green Published			2022-12-25	WOS:000293268700022
J	Ragheb, D; Dalal, S; Bompiani, KM; Ray, WK; Klemba, M				Ragheb, Daniel; Dalal, Seema; Bompiani, Kristin M.; Ray, W. Keith; Klemba, Michael			Distribution and Biochemical Properties of an M1-family Aminopeptidase in Plasmodium falciparum Indicate a Role in Vacuolar Hemoglobin Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUROMYCIN-SENSITIVE AMINOPEPTIDASE; ETCH VIRUS PROTEASE; RED-BLOOD-CELLS; MALARIA PARASITES; M1 FAMILY; NEUTRAL AMINOPEPTIDASE; LEUCYL AMINOPEPTIDASE; ERYTHROCYTIC STAGES; CYSTEINE PROTEASES; ESCHERICHIA-COLI	Aminopeptidases catalyze N-terminal peptide bond hydrolysis and occupy many diverse roles across all domains of life. Here we present evidence that an M1-family aminopeptidase, PfA-M1, has been recruited to specialized roles in the human malaria parasite Plasmodium falciparum. PfA-M1 is abundant in two subcellular compartments in asexual intraerythrocytic parasites; that is, the food vacuole, where the catabolism of host hemoglobin takes place, and the nucleus. A unique N-terminal extension contributes to the observed dual targeting by providing a signal peptide and putative alternate translation initiation sites. PfA-M1 exists as two major isoforms, a nuclear 120-kDa species and a processed species consisting of a complex of 68- and 35-kDa fragments. PfA-M1 is both stable and active at the acidic pH of the food vacuole lumen. Determination of steady-state kinetic parameters for both aminoacyl-beta-naphthylamide and unmodified dipeptide substrates over the pH range 5.0-8.5 reveals that k(cat) is relatively insensitive to pH, whereas K-m increases at pH values below 6.5. At the pH of the food vacuole lumen (5.0-5.5), the catalytic efficiency of PfA-M1 remains high. Consistent with the kinetic data, the affinity of peptidic competitive inhibitors is diminished at acidic pH. Together, these results support a catalytic role for PfA-M1 in the food vacuole and indicate the importance of evaluating the potency of peptidic inhibitors at physiologically relevant pH values. They also suggest a second, distinct function for this enzyme in the parasite nucleus.	[Ragheb, Daniel; Dalal, Seema; Bompiani, Kristin M.; Ray, W. Keith; Klemba, Michael] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Klemba, M (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, 306 Engel Hall, Blacksburg, VA 24061 USA.	klemba@vt.edu			National Institutes of Health [AI077638]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077638.	Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Albiston AL, 2004, PROTEIN PEPTIDE LETT, V11, P491, DOI 10.2174/0929866043406643; Allary M, 2002, PARASITOLOGY, V125, P1, DOI 10.1017/S0031182002001828; Azimzadeh O, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-189; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Breman JG, 2001, AM J TROP MED HYG, V64, P1; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; CORNISHBOWDEN A, 2004, FUNDAMENTALS ENZYME, P225; Cunningham E, 2008, ANTIMICROB AGENTS CH, V52, P3221, DOI 10.1128/AAC.01327-07; CURLEY GP, 1994, J EUKARYOT MICROBIOL, V41, P119, DOI 10.1111/j.1550-7408.1994.tb01483.x; Dalal S, 2007, J BIOL CHEM, V282, P35978, DOI 10.1074/jbc.M703643200; Diaz-Perales A, 2005, J BIOL CHEM, V280, P14310, DOI 10.1074/jbc.M413222200; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Florent I, 1998, MOL BIOCHEM PARASIT, V97, P149, DOI 10.1016/S0166-6851(98)00143-1; Gardiner DL, 2006, J BIOL CHEM, V281, P1741, DOI 10.1074/jbc.M508955200; Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HARLOW E, 1999, USING ANTIBODIES LAB, P311; HELLERSTEIN S, 1970, J LAB CLIN MED, V76, P10; Hwang SR, 2007, J NEUROCHEM, V100, P1340, DOI 10.1111/j.1471-4159.2006.04325.x; Ito K, 2006, J BIOL CHEM, V281, P33664, DOI 10.1074/jbc.M605203200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; Krugliak M, 2002, MOL BIOCHEM PARASIT, V119, P249, DOI 10.1016/S0166-6851(01)00427-3; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363; Lyczak R, 2006, DEVELOPMENT, V133, P4281, DOI 10.1242/dev.02615; Martin RE, 2007, BLOOD, V109, P2217, DOI 10.1182/blood-2005-11-026963; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Ragheb D, 2009, J BIOL CHEM, V284, P24806, DOI 10.1074/jbc.M109.018424; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Rosenthal PJ, 2002, CURR PHARM DESIGN, V8, P1659, DOI 10.2174/1381612023394197; Sanchez-Moran E, 2004, PLANT CELL, V16, P2895, DOI 10.1105/tpc.104.024992; Skinner-Adams TS, 2010, TRENDS BIOCHEM SCI, V35, P53, DOI 10.1016/j.tibs.2009.08.004; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; Stack CM, 2007, J BIOL CHEM, V282, P2069, DOI 10.1074/jbc.M609251200; SUDA H, 1976, J ANTIBIOT, V29, P100, DOI 10.7164/antibiotics.29.100; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; VANDERJAGT DL, 1984, MOL BIOCHEM PARASIT, V10, P45, DOI 10.1016/0166-6851(84)90017-3; Wang F, 2011, MOL BIOCHEM PARASIT, V175, P10, DOI 10.1016/j.molbiopara.2010.08.004; Whisstock JC, 2009, P NATL ACAD SCI USA, V106, pE56, DOI 10.1073/pnas.0903872106	53	34	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27255	27265		10.1074/jbc.M111.225318	http://dx.doi.org/10.1074/jbc.M111.225318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659511	hybrid, Green Published			2022-12-25	WOS:000293268700021
J	Van Bogaert, T; Vandevyver, S; Dejager, L; Van Hauwermeiren, F; Pinheiro, I; Petta, I; Engblom, D; Kleyman, A; Schutz, G; Tuckermann, J; Libert, C				Van Bogaert, Tom; Vandevyver, Sofie; Dejager, Lien; Van Hauwermeiren, Filip; Pinheiro, Iris; Petta, Ioanna; Engblom, David; Kleyman, Anna; Schuetz, Guenther; Tuckermann, Jan; Libert, Claude			Tumor Necrosis Factor Inhibits Glucocorticoid Receptor Function in Mice A STRONG SIGNAL TOWARD LETHAL SHOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; STEROID-HORMONE RECEPTORS; FACTOR-ALPHA; DOWN-REGULATION; C-JUN; MOLECULAR-MECHANISMS; ENDOTOXIC-SHOCK; TNF-ALPHA; TRANSCRIPTIONAL ACTIVATION	As glucocorticoid resistance (GCR) and the concomitant burden pose a worldwide problem, there is an urgent need for a more effective glucocorticoid therapy, for which insights into the molecular mechanisms of GCR are essential. In this study, we addressed the hypothesis that TNF alpha, a strong pro-inflammatory mediator in numerous inflammatory diseases, compromises the protective function of the glucocorticoid receptor (GR) against TNF alpha-induced lethal inflammation. Indeed, protection of mice by dexamethasone against TNF alpha lethality was completely abolished when it was administered after TNF alpha stimulation, indicating compromised GR function upon TNF alpha challenge. TNF alpha-induced GCR was further demonstrated by impaired GR-dependent gene expression in the liver. Furthermore, TNF alpha down-regulates the levels of both GR mRNA and protein. However, this down-regulation seems to occur independently of GC production, as TNF alpha also resulted in down-regulation of GR levels in adrenalectomized mice. These findings suggest that the decreased amount of GR determines the GR response and outcome of TNF alpha-induced shock, as supported by our studies with GR heterozygous mice. We propose that by inducing GCR, TNF alpha inhibits a major brake on inflammation and thereby amplifies the pro-inflammatory response. Our findings might prove helpful in understanding GCR in inflammatory diseases in which TNF alpha is intimately involved.	[Petta, Ioanna; Libert, Claude] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Van Bogaert, Tom; Vandevyver, Sofie; Dejager, Lien; Van Hauwermeiren, Filip; Pinheiro, Iris; Petta, Ioanna; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Engblom, David; Schuetz, Guenther] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Kleyman, Anna; Tuckermann, Jan] Fritz Lipmann Inst eV, Leibniz Inst Age Res, D-07745 Jena, Germany	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Helmholtz Association; German Cancer Research Center (DKFZ); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Libert, C (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, FSVM Bldg,Technologiepk 927, B-9052 Ghent, Belgium.	Claude.Libert@ugent.be	Petta, Ioanna/AAD-9612-2019	Petta, Ioanna/0000-0002-3736-7530; Pinheiro, Iris/0000-0003-3098-4445	Fund for Scientific Research, Flanders; Belgian Interuniversity Attraction Poles program (IAP) [IAP VI/18]; Belgische Vereniging tegen Kanker	Fund for Scientific Research, Flanders(FWO); Belgian Interuniversity Attraction Poles program (IAP)(Belgian Federal Science Policy Office); Belgische Vereniging tegen Kanker	The work was supported by the Fund for Scientific Research, Flanders, the Belgian Interuniversity Attraction Poles program (IAP VI/18), and the Belgische Vereniging tegen Kanker.	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bantel H, 2002, FASEB J, V16, P1832, DOI 10.1096/fj.02-0223fje; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; BERTINI R, 1988, J EXP MED, V167, P1708, DOI 10.1084/jem.167.5.1708; Bhandare R, 2010, AM J RESP CELL MOL, V42, P9, DOI 10.1165/rcmb.2009-0239RC; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; BROUCKAERT P, 1992, EUR J IMMUNOL, V22, P981, DOI 10.1002/eji.1830220416; BROUCKAERT PG, 1989, AGENTS ACTIONS, V26, P196, DOI 10.1007/BF02126607; BURNSTEIN KL, 1990, J BIOL CHEM, V265, P7284; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Cho YS, 2005, CLIN EXP ALLERGY, V35, P1625, DOI 10.1111/j.1365-2222.2005.02391.x; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Cucchiara S, 2007, J PEDIATR GASTR NUTR, V44, P171, DOI 10.1097/MPG.0b013e31802c41f3; Davies NM, 2003, INT J PHARMACEUT, V255, P175, DOI 10.1016/S0378-5173(03)00091-7; De Bosscher K, 2000, P NATL ACAD SCI USA, V97, P3919, DOI 10.1073/pnas.97.8.3919; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2005, P NATL ACAD SCI USA, V102, P15827, DOI 10.1073/pnas.0505554102; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Dejager L, 2010, J BIOL CHEM, V285, P31073, DOI 10.1074/jbc.M110.154484; Dekelbab BH, 2007, STEROIDS, V72, P705, DOI 10.1016/j.steroids.2007.05.007; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Falus A, 1995, ANN NY ACAD SCI, V762, P71; Fiers W, 1988, Dev Biol Stand, V69, P143; Franchimont D, 1999, J CLIN ENDOCR METAB, V84, P2834, DOI 10.1210/jc.84.8.2834; Hodges BL, 2003, EXPERT OPIN BIOL TH, V3, P911; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Herrero MJ, 2011, BIOL PHARM BULL, V34, P167, DOI 10.1248/bpb.34.167; KALINYAK JE, 1987, J BIOL CHEM, V262, P460; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kelley KW, 2004, BRAIN BEHAV IMMUN, V18, P95, DOI 10.1016/j.bbi.2003.10.003; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; Kino T, 2004, J STEROID BIOCHEM, V92, P357, DOI 10.1016/j.jsbmb.2004.09.003; Kino T, 2003, J BIOL CHEM, V278, P3023, DOI 10.1074/jbc.M209234200; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; Kreiner F, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3140; Leite RS, 2004, FASEB J, V18, P1418, DOI 10.1096/fj.04-1684fje; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; LIBERT C, 1991, J IMMUNOTHER, V10, P227, DOI 10.1097/00002371-199108000-00001; Liu DH, 2002, BURNS, V28, P315, DOI 10.1016/S0305-4179(02)00011-6; MALO D, 1994, GENOMICS, V23, P51, DOI 10.1006/geno.1994.1458; Matthews JG, 2004, J ALLERGY CLIN IMMUN, V113, P1100, DOI 10.1016/j.jaci.2004.03.018; Mattsson C, 2007, CURR MED CHEM, V14, P2918, DOI 10.2174/092986707782359972; Matysiak M, 2008, MULT SCLER J, V14, P919, DOI 10.1177/1352458508090666; McCann SM, 1995, ANN NY ACAD SCI, V771, P386, DOI 10.1111/j.1749-6632.1995.tb44697.x; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Mewar D., 2010, BRIT J PHARMACOL, V162, P785; Meyer AS, 1997, J STEROID BIOCHEM, V62, P97, DOI 10.1016/S0960-0760(97)00014-9; Miller AH, 1999, ADV EXP MED BIOL, V461, P107; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Nash PT, 2005, MED J AUSTRALIA, V183, P205, DOI 10.5694/j.1326-5377.2005.tb06998.x; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Noti M, 2010, FASEB J, V24, P1340, DOI 10.1096/fj.09-140913; Noti M, 2009, SEMIN IMMUNOPATHOL, V31, P237, DOI 10.1007/s00281-009-0159-2; Opherk C, 2004, MOL ENDOCRINOL, V18, P1346, DOI 10.1210/me.2003-0283; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Piper RD, 1996, CRIT CARE MED, V24, P2059, DOI 10.1097/00003246-199612000-00021; Prigent H, 2004, CRIT CARE, V8, P243, DOI 10.1186/cc2878; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Schaaf MJM, 2002, J STEROID BIOCHEM, V83, P37, DOI 10.1016/S0960-0760(02)00263-7; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHEINMAN RI, 1995, MOL CELL BIOL, V15, P943; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; Staelens J, 2004, MAMM GENOME, V15, P537, DOI 10.1007/s00335-004-3002-z; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tripathi Gaurav, 2008, Indian J Med Sci, V62, P383; Turner JD, 2010, BIOCHEM PHARMACOL, V80, P1860, DOI 10.1016/j.bcp.2010.06.037; Van Bogaert T, 2010, CYTOKINE GROWTH F R, V21, P275, DOI 10.1016/j.cytogfr.2010.04.003; van den Akker ELT, 2009, INTENS CARE MED, V35, P1247, DOI 10.1007/s00134-009-1468-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; VEDECKIS WV, 1989, CANCER RES, V49, pS2295; Vreugdenhil E, 2009, ENDOCRINOLOGY, V150, P2220, DOI 10.1210/en.2008-1335; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; Wang YW, 2005, J LIPID RES, V46, P2377, DOI 10.1194/jlr.M500134-JLR200; WEBSTER JC, 1994, ANN NY ACAD SCI, V746, P216; Webster JC, 1997, J BIOL CHEM, V272, P9287; Wei P, 1997, ENDOCRINE, V7, P303, DOI 10.1007/BF02801323; Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zhao Q, 2005, J BIOL CHEM, V280, P8101, DOI 10.1074/jbc.M411760200	108	56	56	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26555	26567		10.1074/jbc.M110.212365	http://dx.doi.org/10.1074/jbc.M110.212365			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21646349	Green Published, hybrid			2022-12-25	WOS:000293078200034
J	Adachi, S; Yasuda, I; Nakashima, M; Yamauchi, T; Kawaguchi, J; Shimizu, M; Itani, M; Nakamura, M; Nishii, Y; Yoshioka, T; Hirose, Y; Okano, Y; Moriwaki, H; Kozawa, O				Adachi, Seiji; Yasuda, Ichiro; Nakashima, Masanori; Yamauchi, Takahiro; Kawaguchi, Junji; Shimizu, Masahito; Itani, Masahiko; Nakamura, Momoko; Nishii, Yumi; Yoshioka, Takashi; Hirose, Yoshinobu; Okano, Yukio; Moriwaki, Hisataka; Kozawa, Osamu			Ultraviolet Irradiation Can Induce Evasion of Colon Cancer Cells from Stimulation of Epidermal Growth Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION PATHWAYS; FACTOR RECEPTOR; EGF RECEPTOR; (-)-EPIGALLOCATECHIN GALLATE; P38 MAPK; TYROSINE KINASES; IN-VITRO; PHOSPHORYLATION; INTERNALIZATION	Receptor down-regulation is the most prominent regulatory system of EGF receptor (EGFR) signal attenuation and a critical target for therapy against colon cancer, which is highly dependent on the function of the EGFR. In this study, we investigated the effect of ultraviolet-C (UV-C) on down-regulation of EGFR in human colon cancer cells (SW480, HT29, and DLD-1). UV-C caused inhibition of cell survival and proliferation, concurrently inducing the decrease in cell surface EGFR and subsequently its degradation. UV-C, as well as EGFR kinase inhibitors, decreased the expression level of cyclin D1 and the phosphorylated level of retinoblastoma, indicating that EGFR down-regulation is correlated to cell cycle arrest. Although UV-C caused a marked phosphorylation of EGFR at Ser-1046/1047, UV-C also induced activation of p38 MAPK, a stress-inducible kinase believed to negatively regulate tumorigenesis, and the inhibition of p38 MAPK canceled EGFR phosphorylation at Ser-1046/1047, as well as subsequent internalization and degradation, suggesting that p38 MAPK mediates EGFR down-regulation by UV-C. In addition, phosphorylation of p38 MAPK induced by UV-C was mediated through transforming growth factor-beta-activated kinase-1. Moreover, pretreatment of the cells with UV-C suppressed EGF-induced phosphorylation of EGFR at tyrosine residues in addition to cell survival signal, Akt. Together, these results suggest that UV-C irradiation induces the removal of EGFRs from the cell surface that can protect colon cancer cells from oncogenic stimulation of EGF, resulting in cell cycle arrest. Hence, UV-C might be applied for clinical strategy against human colon cancers.	[Adachi, Seiji; Itani, Masahiko; Nakamura, Momoko; Nishii, Yumi; Kozawa, Osamu] Gifu Univ Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan; [Adachi, Seiji; Yasuda, Ichiro; Nakashima, Masanori; Yamauchi, Takahiro; Kawaguchi, Junji; Shimizu, Masahito; Moriwaki, Hisataka] Gifu Univ Grad Sch Med, Dept Gastroenterol, Gifu 5011194, Japan; [Yoshioka, Takashi; Okano, Yukio] Gifu Univ Grad Sch Med, Dept Mol Pathobiochem, Gifu 5011194, Japan; [Hirose, Yoshinobu] Gifu Univ Hosp, Div Pathol, Gifu 5011194, Japan	Gifu University; Gifu University; Gifu University; Gifu University	Adachi, S (corresponding author), 1-1 Yanagido, Gifu 5011194, Japan.	seijiadachi0123@gmail.com	Hirose, Yoshinobu/AAW-9079-2020	Hirose, Yoshinobu/0000-0002-3860-0293	Ministry of Education, Science, Sports and Culture of Japan [22790639]; Yokoyama Foundation for Clinical Pharmacology	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokoyama Foundation for Clinical Pharmacology(Yokoyama Foundation for Clinical Pharmacology)	This work was supported in part by Grant-in-Aid for Scientific Research 22790639 (to S. A) from the Ministry of Education, Science, Sports and Culture of Japan and a grant by the Yokoyama Foundation for Clinical Pharmacology.	Adachi S, 2008, CARCINOGENESIS, V29, P1986, DOI 10.1093/carcin/bgn128; Adachi S, 2007, CANCER RES, V67, P6493, DOI 10.1158/0008-5472.CAN-07-0411; Adachi S, 2010, ONCOL REP, V23, P1709, DOI 10.3892/or_00000815; Adachi S, 2009, CARCINOGENESIS, V30, P1544, DOI 10.1093/carcin/bgp166; Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blumenthal RD, 2007, MOL BIOTECHNOL, V35, P185, DOI 10.1007/BF02686104; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Feng FY, 2007, ONCOGENE, V26, P3431, DOI 10.1038/sj.onc.1210129; FONG CJ, 1992, CANCER RES, V52, P5887; Habiro A, 2004, BIOCHEM BIOPH RES CO, V316, P71, DOI 10.1016/j.bbrc.2004.02.017; Hammaker DR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2215; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Koizumi K, 2005, ANTICANCER RES, V25, P3347; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Masuda M, 2001, CLIN CANCER RES, V7, P4220; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; Milano G, 2008, BRIT J CANCER, V99, P1, DOI 10.1038/sj.bjc.6604373; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Nakashima M, 2010, INT J ONCOL, V36, P585, DOI 10.3892/ijo_00000533; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Norval M, 2001, J PHOTOCH PHOTOBIO B, V63, P28, DOI 10.1016/S1011-1344(01)00200-7; Oksvold MP, 2002, J CELL SCI, V115, P793; Pianetti S, 2002, CANCER RES, V62, P652; Rice PL, 2003, CANCER RES, V63, P616; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rusch V, 1997, CLIN CANCER RES, V3, P515; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shimizu M, 2005, CLIN CANCER RES, V11, P2735, DOI 10.1158/1078-0432.CCR-04-2014; THEROUX SJ, 1992, J BIOL CHEM, V267, P16620; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Zandi R, 2007, CELL SIGNAL, V19, P2013, DOI 10.1016/j.cellsig.2007.06.023; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	56	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2011	286	29					26178	26187		10.1074/jbc.M111.240630	http://dx.doi.org/10.1074/jbc.M111.240630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796SS	21646361	Green Published, hybrid			2022-12-25	WOS:000293073000075
J	Soltani, M; Chen, P				Soltani, M.; Chen, P.			Numerical Modeling of Fluid Flow in Solid Tumors	PLOS ONE			English	Article							INTERSTITIAL PRESSURE; DRUG-DELIVERY; ANTIANGIOGENIC THERAPY; MAMMARY-TUMORS; BRAIN-TISSUE; BLOOD-FLOW; TRANSPORT; MACROMOLECULES; SIMULATION; VASCULATURE	A mathematical model of interstitial fluid flow is developed, based on the application of the governing equations for fluid flow, i.e., the conservation laws for mass and momentum, to physiological systems containing solid tumors. The discretized form of the governing equations, with appropriate boundary conditions, is developed for a predefined tumor geometry. The interstitial fluid pressure and velocity are calculated using a numerical method, element based finite volume. Simulations of interstitial fluid transport in a homogeneous solid tumor demonstrate that, in a uniformly perfused tumor, i.e., one with no necrotic region, because of the interstitial pressure distribution, the distribution of drug particles is non-uniform. Pressure distribution for different values of necrotic radii is examined and two new parameters, the critical tumor radius and critical necrotic radius, are defined. Simulation results show that: 1) tumor radii have a critical size. Below this size, the maximum interstitial fluid pressure is less than what is generally considered to be effective pressure (a parameter determined by vascular pressure, plasma osmotic pressure, and interstitial osmotic pressure). Above this size, the maximum interstitial fluid pressure is equal to effective pressure. As a consequence, drugs transport to the center of smaller tumors is much easier than transport to the center of a tumor whose radius is greater than the critical tumor radius; 2) there is a critical necrotic radius, below which the interstitial fluid pressure at the tumor center is at its maximum value. If the tumor radius is greater than the critical tumor radius, this maximum pressure is equal to effective pressure. Above this critical necrotic radius, the interstitial fluid pressure at the tumor center is below effective pressure. In specific ranges of these critical sizes, drug amount and therefore therapeutic effects are higher because the opposing force, interstitial fluid pressure, is low in these ranges.	[Soltani, M.; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Soltani, M (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@uwaterloo.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1991, MICROVASC RES, V41, P5, DOI 10.1016/0026-2862(91)90003-T; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Bear J., 1988, DYNAMICS UIDS POROUS; Blakeslee S., 1989, IMPENETRABLE TUMORS; BOUCHER Y, 1990, CANCER RES, V50, P4478; BUTLER TP, 1975, CANCER RES, V35, P3084; CAMPBELL N, 1996, BIOLOGY; Chapman SJ, 2008, B MATH BIOL, V70, P2334, DOI 10.1007/s11538-008-9349-7; Curry F, 1984, HDB PHYSL 2; De Boer R., 2000, THEORY POROUS MEDIA; Goh YMF, 2001, PHARM RES-DORDR, V18, P761, DOI 10.1023/A:1011076110317; GOLDACRE RJ, 1962, BRIT J CANCER, V16, P306, DOI 10.1038/bjc.1962.36; GROSS JF, 1979, TUMOR BLOOD CIRCULAT; Gullino PM, 1975, EXTRACELLULAR COMPAR; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; JAIN RK, 1987, CANCER METAST REV, V6, P559, DOI 10.1007/BF00047468; JAIN RK, 1988, CANCER RES, V48, P7022; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, 1988, CANCER RES, V48, P2641; JAIN RK, 1987, CANCER RES, V47, P3039; Jain RK, 1984, IEEE T SONICS ULTRAS, V31; JAIN RK, 1988, VASCULAR ENDOTHELIUM, P215; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; JONES PL, 1986, CANCER IMMUNOL IMMUN, V22, P139; Linninger AA, 2008, J BIOMECH, V41, P2176, DOI 10.1016/j.jbiomech.2008.04.025; NETTI PA, 1995, CANCER RES, V55, P5451; Netti PA, 1999, P NATL ACAD SCI USA, V96, P3137, DOI 10.1073/pnas.96.6.3137; Pozrikidis C, 2003, ANN BIOMED ENG, V31, P181, DOI 10.1114/1.1540103; SALATHE EP, 1976, MICROVASC RES, V11, P1, DOI 10.1016/0026-2862(76)90072-8; SALTZMAN WM, 1991, CHEM ENG SCI, V46, P2429, DOI 10.1016/0009-2509(91)80036-X; SANDS H, 1988, CANCER RES, V48, P188; SCHEIDEGGER AE, 1963, PHYS OW POROUS MEDIA; Soltani M, 2009, ADV SCI LETT, V2, P347, DOI 10.1166/asl.2009.1044; Starling E H, 1896, J Physiol, V19, P312; Tan WHK, 2003, BIOTECHNOL BIOENG, V82, P278, DOI 10.1002/bit.10571; Tan WHK, 2003, J PHARM SCI, V92, P773, DOI 10.1002/jps.10351; Teo CS, 2005, CHEM ENG SCI, V60, P4803, DOI 10.1016/j.ces.2005.04.008; Wang CH, 1998, CHEM ENG SCI, V53, P3579, DOI 10.1016/S0009-2509(98)00173-0; Wang CH, 1999, J CONTROL RELEASE, V61, P21, DOI 10.1016/S0168-3659(99)00098-X; WIIG H, 1982, SCAND J CLIN LAB INV, V42, P159; YOUNG JS, 1950, J PATHOL BACTERIOL, V62, P313, DOI 10.1002/path.1700620303; Zhao JB, 2007, MICROVASC RES, V73, P224, DOI 10.1016/j.mvr.2006.12.003	43	127	127	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20344	10.1371/journal.pone.0020344	http://dx.doi.org/10.1371/journal.pone.0020344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673952	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400004
J	Baiser, B; Ardeshiri, RS; Ellison, AM				Baiser, Benjamin; Ardeshiri, Roxanne S.; Ellison, Aaron M.			Species Richness and Trophic Diversity Increase Decomposition in a Co-Evolved Food Web	PLOS ONE			English	Article							PLANT SARRACENIA-PURPUREA; ECOSYSTEM FUNCTION; FUNCTIONAL DIVERSITY; TOP-DOWN; POPULATION-DYNAMICS; BIODIVERSITY; COMMUNITY; MUTUALISM; CONSEQUENCES; PRODUCTIVITY	Ecological communities show great variation in species richness, composition and food web structure across similar and diverse ecosystems. Knowledge of how this biodiversity relates to ecosystem functioning is important for understanding the maintenance of diversity and the potential effects of species losses and gains on ecosystems. While research often focuses on how variation in species richness influences ecosystem processes, assessing species richness in a food web context can provide further insight into the relationship between diversity and ecosystem functioning and elucidate potential mechanisms underpinning this relationship. Here, we assessed how species richness and trophic diversity affect decomposition rates in a complete aquatic food web: the five trophic level web that occurs within water-filled leaves of the northern pitcher plant, Sarracenia purpurea. We identified a trophic cascade in which top-predators - larvae of the pitcher-plant mosquito - indirectly increased bacterial decomposition by preying on bactivorous protozoa. Our data also revealed a facultative relationship in which larvae of the pitcher-plant midge increased bacterial decomposition by shredding detritus. These important interactions occur only in food webs with high trophic diversity, which in turn only occur in food webs with high species richness. We show that species richness and trophic diversity underlie strong linkages between food web structure and dynamics that influence ecosystem functioning. The importance of trophic diversity and species interactions in determining how biodiversity relates to ecosystem functioning suggests that simply focusing on species richness does not give a complete picture as to how ecosystems may change with the loss or gain of species.	[Baiser, Benjamin; Ellison, Aaron M.] Harvard Univ, Petersham, MA USA; [Ardeshiri, Roxanne S.] Univ Calif Berkeley, Berkeley, CA 94720 USA	Harvard University; University of California System; University of California Berkeley	Baiser, B (corresponding author), Harvard Univ, Petersham, MA USA.	bbaiser@fas.harvard.edu		Ellison, Aaron/0000-0003-4151-6081	NSF [DEB 05-41680]	NSF(National Science Foundation (NSF))	NSF grant DEB 05-41680 http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1974, ECOLOGY, V55, P475, DOI 10.2307/1935141; Baiser B, 2011, GLOBAL ECOL BIOGEOGR, V20, P134, DOI 10.1111/j.1466-8238.2010.00583.x; Baiser B, 2010, OIKOS, V119, P1970, DOI 10.1111/j.1600-0706.2010.18557.x; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bleher B, 2001, OECOLOGIA, V129, P385, DOI 10.1007/s004420100747; Buckley HL, 2010, GLOBAL ECOL BIOGEOGR, V19, P711, DOI 10.1111/j.1466-8238.2010.00554.x; Buckley HL, 2003, ECOL LETT, V6, P825, DOI 10.1046/j.1461-0248.2003.00504.x; Butler JL, 2008, ECOLOGY, V89, P898, DOI 10.1890/07-1314.1; Cochran-Stafira DL, 1998, ECOLOGY, V79, P880, DOI 10.1890/0012-9658(1998)079[0880:IBIFWS]2.0.CO;2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Ellis BK, 2011, P NATL ACAD SCI USA, V108, P1070, DOI 10.1073/pnas.1013006108; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Ellison AM, 2003, ADV ECOL RES, V33, P1, DOI 10.1016/S0065-2504(03)33009-0; Fashing NJ, 1998, EXP APPL ACAROL, V22, P435, DOI 10.1023/A:1006081622519; FASHING NJ, 2004, BIOL SARRACENIOPUS D, P299; FORSYTH AB, 1975, CAN J ZOOL, V53, P174, DOI 10.1139/z75-022; Gallie DR, 1997, PLANT PHYSIOL, V115, P1461, DOI 10.1104/pp.115.4.1461; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Gotelli NJ, 2006, PLOS BIOL, V4, P1869, DOI 10.1371/journal.pbio.0040324; HEARD SB, 1994, ECOLOGY, V75, P1647, DOI 10.2307/1939625; HEPBURN JS, 1927, T WAGNER FREE I SCI, V11, P49; Hoekman D, 2010, ECOLOGY, V91, P2819, DOI 10.1890/10-0260.1; Hoekman D, 2009, J N AM BENTHOL SOC, V28, P552, DOI 10.1899/08-131.1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Kneitel JM, 2002, ECOLOGY, V83, P680, DOI 10.1890/0012-9658(2002)083[0680:RATPRI]2.0.CO;2; LAWLER SP, 1993, J ANIM ECOL, V62, P711, DOI 10.2307/5391; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Miller TE, 2002, COMMUNITY ECOL, V3, P109, DOI 10.1556/ComEc.3.2002.1.13; MORIN PJ, 1995, ANNU REV ECOL SYST, V26, P505, DOI 10.1146/annurev.es.26.110195.002445; Mouquet N, 2008, FUNCT ECOL, V22, P728, DOI 10.1111/j.1365-2435.2008.01421.x; Naeem S, 2002, ECOLOGY, V83, P2925; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2008, AM NAT, V171, P568, DOI 10.1086/587068; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; SWAN JMA, 1970, ECOLOGY, V51, P829, DOI 10.2307/1933975; Thompson R, 2007, BIODIVERS CONSERV, V16, P1359, DOI 10.1007/s10531-005-6232-9; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Wall DH, 1999, BIOSCIENCE, V49, P109, DOI 10.2307/1313536; Wardle DA, 1999, OIKOS, V87, P403, DOI 10.2307/3546757; Yodzis P, 1999, OIKOS, V87, P327, DOI 10.2307/3546748	65	32	34	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20672	10.1371/journal.pone.0020672	http://dx.doi.org/10.1371/journal.pone.0020672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673992	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500030
J	Mantell, BS; Stefanovic-Racic, M; Yang, X; Dedousis, N; Sipula, IJ; O'Doherty, RM				Mantell, Benjamin S.; Stefanovic-Racic, Maja; Yang, Xiao; Dedousis, Nikolas; Sipula, Ian J.; O'Doherty, Robert M.			Mice Lacking NKT Cells but with a Complete Complement of CD8(+) T-Cells Are Not Protected against the Metabolic Abnormalities of Diet-Induced Obesity	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; INDUCED HEPATIC STEATOSIS; MURINE FATTY LIVERS; ADIPOSE-TISSUE; GLUCOSE-INTOLERANCE; SKELETAL-MUSCLE; OB/OB MICE; INFLAMMATION; INFILTRATION; LYMPHOCYTES	The contribution of natural killer T (NKT) cells to the pathogenesis of metabolic abnormalities of obesity is controversial. While the combined genetic deletion of NKT and CD8(+) T-cells improves glucose tolerance and reduces inflammation, interpretation of these data have been complicated by the recent observation that the deletion of CD8(+) T-cells alone reduces obesity-induced inflammation and metabolic dysregulation, leaving the issue of the metabolic effects of NKT cell depletion unresolved. To address this question, CD1d null mice (CD1d(-)/(-)), which lack NKT cells but have a full complement of CD8(+) T-cells, and littermate wild type controls (WT) on a pure C57BL/6J background were exposed to a high fat diet, and glucose intolerance, insulin resistance, dyslipidemia, inflammation, and obesity were assessed. Food intake (15.5 +/- 4.3 vs 15.3 +/- 1.8 kcal/mouse/day), weight gain (21.8 +/- 1.8 vs 22.8 +/- 1.4 g) and fat mass (18.6 +/- 1.9 vs 19.5 +/- 2.1 g) were similar in CD1d(-)/(-) and WT, respectively. As would be expected from these data, metabolic rate (3.0 +/- 0.1 vs 2.9 +/- 0.2 ml O-2/g/h) and activity (21.6 +/- 4.3 vs 18.5 +/- 2.6 beam breaks/min) were unchanged by NKT cell depletion. Furthermore, the degree of insulin resistance, glucose intolerance, liver steatosis, and adipose and liver inflammatory marker expression (TNF alpha, IL-6, IL-10, IFN-gamma, MCP-1, MIP1 alpha) induced by high fat feeding in CD1d(-)/(-) were not different from WT. We conclude that deletion of NKT cells, in the absence of alterations in the CD8(+) T-cell population, is insufficient to protect against the development of the metabolic abnormalities of diet-induced obesity.	[Mantell, Benjamin S.; Stefanovic-Racic, Maja; Yang, Xiao; Dedousis, Nikolas; Sipula, Ian J.; O'Doherty, Robert M.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA; [O'Doherty, Robert M.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O'Doherty, RM (corresponding author), Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA.	rmo1@pitt.edu	Mantell, Benjamin/ABE-2117-2020	Mantell, Benjamin/0000-0002-7700-6975	NIH [RO1 DK058855, K08 DK67272, F30 DK085865]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK067272, R01DK058855, F30DK085865] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NIH RO1 DK058855 (to ROD) NIH K08 DK67272 (to M.S.R.), and NIH F30 DK085865 (to BSM).	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chen YH, 1997, IMMUNITY, V6, P459, DOI 10.1016/S1074-7613(00)80289-7; Dube JJ, 2007, AM J PHYSIOL-REG I, V293, pR642, DOI 10.1152/ajpregu.00133.2007; Elinav E, 2006, J PATHOL, V209, P121, DOI 10.1002/path.1950; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Guebre-Xabier M, 2000, HEPATOLOGY, V31, P633, DOI 10.1002/hep.510310313; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Margalit M, 2006, J PHARMACOL EXP THER, V319, P105, DOI 10.1124/jpet.106.104950; Miyazaki Y, 2008, SCAND J IMMUNOL, V67, P230, DOI 10.1111/j.1365-3083.2007.02062.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007; Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang L, 2007, LAB INVEST, V87, P927, DOI 10.1038/labinvest.3700603	25	108	110	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e19831	10.1371/journal.pone.0019831	http://dx.doi.org/10.1371/journal.pone.0019831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674035	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500004
J	Etheridge, T; Nemoto, K; Hashizume, T; Mori, C; Sugimoto, T; Suzuki, H; Fukui, K; Yamazaki, T; Higashibata, A; Szewczyk, NJ; Higashitani, A				Etheridge, Timothy; Nemoto, Kanako; Hashizume, Toko; Mori, Chihiro; Sugimoto, Tomoko; Suzuki, Hiromi; Fukui, Keiji; Yamazaki, Takashi; Higashibata, Akira; Szewczyk, Nathaniel J.; Higashitani, Atsushi			The Effectiveness of RNAi in Caenorhabditis elegans Is Maintained during Spaceflight	PLOS ONE			English	Article							SPACE-FLIGHT; DURATION SPACEFLIGHT; GENE; INTERFERENCE; EXPRESSION	Background: Overcoming spaceflight-induced (patho)physiologic adaptations is a major challenge preventing long-term deep space exploration. RNA interference (RNAi) has emerged as a promising therapeutic for combating diseases on Earth; however the efficacy of RNAi in space is currently unknown. Methods: Caenorhabditis elegans were prepared in liquid media on Earth using standard techniques and treated acutely with RNAi or a vector control upon arrival in Low Earth Orbit. After culturing during 4 and 8 d spaceflight, experiments were stopped by freezing at -80 degrees C until analysis by mRNA and microRNA array chips, microscopy and Western blot on return to Earth. Ground controls (GC) on Earth were simultaneously grown under identical conditions. Results: After 8 d spaceflight, mRNA expression levels of components of the RNAi machinery were not different from that in GC (e.g., Dicer, Argonaute, Piwi; P>0.05). The expression of 228 microRNAs, of the 232 analysed, were also unaffected during 4 and 8 d spaceflight (P>0.05). In spaceflight, RNAi against green fluorescent protein (gfp) reduced chromosomal gfp expression in gonad tissue, which was not different from GC. RNAi against rbx-1 also induced abnormal chromosome segregation in the gonad during spaceflight as on Earth. Finally, culture in RNAi against lysosomal cathepsins prevented degradation of the muscle-specific alpha-actin protein in both spaceflight and GC conditions. Conclusions: Treatment with RNAi works as effectively in the space environment as on Earth within multiple tissues, suggesting RNAi may provide an effective tool for combating spaceflight-induced pathologies aboard future long-duration space missions. Furthermore, this is the first demonstration that RNAi can be utilised to block muscle protein degradation, both on Earth and in space.	[Etheridge, Timothy; Szewczyk, Nathaniel J.] Univ Nottingham, Div Clin Physiol, Royal Derby Hosp, Derby, England; [Nemoto, Kanako; Mori, Chihiro; Higashitani, Atsushi] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Hashizume, Toko] Adv Engn Serv Co Ltd, Tsukuba, Ibaraki, Japan; [Sugimoto, Tomoko; Yamazaki, Takashi; Higashibata, Akira] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, ISS Sci Project Off, Tsukuba, Ibaraki, Japan	University of Nottingham; Tohoku University; Advanced Engineering Services Co., Ltd. (A.E.S.); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Etheridge, T (corresponding author), Univ Nottingham, Div Clin Physiol, Royal Derby Hosp, Derby, England.	nathaniel.szewczyk@nottingham.ac.uk; ahigashi@ige.tohoku.ac.jp	Higashitani, Atsushi/G-7086-2015; Higashitani, Atsushi/AAT-9617-2021	Higashitani, Atsushi/0000-0001-6920-0594; Higashitani, Atsushi/0000-0001-6920-0594; Etheridge, Timothy/0000-0002-3588-8711; Szewczyk, Nathaniel/0000-0003-4425-9746	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Japan Space Forum; Medical Research Council UK [G0801271]; National Institutes of Health [NIH NIAMS ARO54342]; Medical Research Council [G0801271] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054342] Funding Source: NIH RePORTER; MRC [G0801271] Funding Source: UKRI	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Space Forum; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for the Promotion of Science, and "Ground-Based Research Announcement for Space Utilization" promoted by the Japan Space Forum. TE was supported by the Medical Research Council UK (G0801271). NJS was supported by the National Institutes of Health (NIH NIAMS ARO54342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Couzin-Frankel J, 2010, SCIENCE, V330, P1163, DOI 10.1126/science.330.6008.1163; Crucian BE, 2008, AVIAT SPACE ENVIR MD, V79, P835, DOI 10.3357/ASEM.2276.2008; Demling R H, 1999, Adv Wound Care, V12, P1; Durante M, 2003, CYTOGENET GENOME RES, V103, P40, DOI 10.1159/000076288; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fire A, 2005, Q REV BIOPHYS, V38, P303, DOI 10.1017/S0033583505004117; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Hartman PS, 2001, MUTAT RES-FUND MOL M, V474, P47, DOI 10.1016/S0027-5107(00)00154-8; Higashibata A, 2006, J EXP BIOL, V209, P3209, DOI 10.1242/jeb.02365; Higashitani A, 2005, APOPTOSIS, V10, P949, DOI 10.1007/s10495-005-1323-3; HIGASHITANI A, 2010, BIOL SCI SPACE, V23, P183; Kotakis C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-220; Lane HW, 1998, NUTR RES, V18, P1923, DOI 10.1016/S0271-5317(98)00162-6; LEBLANC A, 1995, AVIAT SPACE ENVIR MD, V66, P1151; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Praitis V, 2001, GENETICS, V157, P1217; Sasagawa Y, 2003, GENES CELLS, V8, P857, DOI 10.1046/j.1365-2443.2003.00682.x; Selch F, 2008, ADV SPACE RES, V41, P807, DOI 10.1016/j.asr.2007.11.015; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; STEFFEN JM, 1986, AM J PHYSIOL, V251, pR1059, DOI 10.1152/ajpregu.1986.251.6.R1059; Stein TP, 2005, J NUTR, V135, p1824S, DOI 10.1093/jn/135.7.1824S; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Szewczyk NJ, 2005, ASTROBIOLOGY, V5, P690, DOI 10.1089/ast.2005.5.690; Vaishnaw Akshay K, 2010, Silence, V1, P14, DOI 10.1186/1758-907X-1-14; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104	27	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20459	10.1371/journal.pone.0020459	http://dx.doi.org/10.1371/journal.pone.0020459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673804	Green Published, Green Submitted, gold			2022-12-25	WOS:000291309900021
J	Sihvonen, P; Mutanen, M; Kaila, L; Brehm, G; Hausmann, A; Staude, HS				Sihvonen, Pasi; Mutanen, Marko; Kaila, Lauri; Brehm, Gunnar; Hausmann, Axel; Staude, Hermann S.			Comprehensive Molecular Sampling Yields a Robust Phylogeny for Geometrid Moths (Lepidoptera: Geometridae)	PLOS ONE			English	Article							EMERALD MOTHS; GENERA LEPIDOPTERA; EVOLUTION; CLASSIFICATION; ENNOMINAE; OENOCHROMINAE; BIOGEOGRAPHY; SUBFAMILIES; LARENTIINAE; STERRHINAE	Background: The moth family Geometridae (inchworms or loopers), with approximately 23 000 described species, is the second most diverse family of the Lepidoptera. Apart from a few recent attempts based on morphology and molecular studies, the phylogeny of these moths has remained largely uninvestigated. Methodology/Principal Findings: We performed a rigorous and extensive molecular analysis of eight genes to examine the geometrid affinities in a global context, including a search for its potential sister-taxa. Our maximum likelihood analyses included 164 taxa distributed worldwide, of which 150 belong to the Geometridae. The selected taxa represent all previously recognized subfamilies and nearly 90% of recognized tribes, and originate from all over world. We found the Geometridae to be monophyletic with the Sematuridae+Epicopeiidae clade potentially being its sister-taxon. We found all previously recognized subfamilies to be monophyletic, with a few taxa misplaced, except the Oenochrominae+Desmobathrinae complex that is a polyphyletic assemblage of taxa and the Orthostixinae, which was positioned within the Ennominae. The Sterrhinae and Larentiinae were found to be sister to the remaining taxa, followed by Archiearinae, the polyphyletic assemblage of Oenochrominae+Desmobathrinae moths, Geometrinae and Ennominae. Conclusions/Significance: Our study provides the first comprehensive phylogeny of the Geometridae in a global context. Our results generally agree with the other, more restricted studies, suggesting that the general phylogenetic patterns of the Geometridae are now well-established. Generally the subfamilies, many tribes, and assemblages of tribes were well supported but their interrelationships were often weakly supported by our data. The Eumeleini were particularly difficult to place in the current system, and several tribes were found to be para-or polyphyletic.	[Sihvonen, Pasi] Univ Helsinki, Res Funding Serv, Helsinki, Finland; [Mutanen, Marko] Univ Oulu, Zool Museum, Oulu, Finland; [Kaila, Lauri] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Brehm, Gunnar] Phylet Museum, Inst Spezielle Zool & Evolut Biol, Jena, Germany; [Hausmann, Axel] Staatliche Nat Wissensch Sammlungen Bayerns, Munich, Germany	University of Helsinki; University of Oulu; University of Helsinki	Sihvonen, P (corresponding author), Univ Helsinki, Res Funding Serv, Helsinki, Finland.	pasi.sihvonen@helsinki.fi	Brehm, Gunnar/D-5831-2013	Brehm, Gunnar/0000-0002-7599-2847; Sihvonen, Pasi/0000-0003-2237-9325; Kaila, Lauri/0000-0003-0277-1872	Academy of Finland [1110906]	Academy of Finland(Academy of Finland)	Lauri Kaila was supported by the Academy of Finland (project 1110906, URL: http://www.aka.fi/fi/A/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2001, MOL PHYLOGENET EVOL, V20, P65, DOI 10.1006/mpev.2001.0949; [Anonymous], 2 S NEOTR LEP AR PER; [Anonymous], 1996, LEPIDOPTERA EUROPE D; [Anonymous], GROSS SCHMETTERLINGE; BELJAEV E, 2008, M MEM N A CHOL, V60; BELJAEV E, 2006, TENTATIVE TRIBAL SYS; Beljaev E. A., 2009, Evraziatskii entomologicheskii Zhurnal, V8, P249; BODNER F, 2007, THESIS U WIEN; Canfield MR, 2008, MOL PHYLOGENET EVOL, V49, P477, DOI 10.1016/j.ympev.2008.07.003; Choi Sei-Woong, 2003, Insecta Koreana, V20, P313; Choi SW, 1997, SYST ENTOMOL, V22, P287, DOI 10.1046/j.1365-3113.1997.d01-49.x; COOK MA, 1994, BIOCHEM SYST ECOL, V22, P43, DOI 10.1016/0305-1978(94)90113-9; COOK MA, 1992, SYST ENTOMOL, V17, P219, DOI 10.1111/j.1365-3113.1992.tb00334.x; CRAW RC, 1987, NEW ZEAL J ZOOL, V14, P269, DOI 10.1080/03014223.1987.10422997; Daniels G., 1993, Australian Entomologist, V20, P66; Ferguson D.C., 1985, P1; Ferguson Douglas C., 2008, P1; FLETCHER D. S., 1953, ACTA ZOOL LILLOANA, V13, P367; Fletcher D.S., 1979, GENERIC NAMES MOTHS, V3, P1; Han HX, 2009, J NAT HIST, V43, P885, DOI 10.1080/00222930802702472; Hausmann A., 2001, GEOMETRID MOTHS EURO, V1, P1, DOI DOI 10.1007/978-1-4757-3423-2_; Hausmann Axel, 1996, Nota Lepidopterologica, V19, P91; Hausmann Axel, 1996, Nota Lepidopterologica, V19, P3; Hausmann A, 2009, ZOOTAXA, P1; Hausmann Axel, 2004, V2, P7; Herbulot C., 1961, ALEXANOR, V2, P117; Herbulot C., 1962, ALEXANOR, V2, P147; HODGES RW, 1993, CHECKLIST LEPIDOPTER; Holloway J., 2001, FAUNA MALESIANA HDB, V3; Holloway J. D., 1997, Malayan Nature Journal, V51, P1; Holloway J. D., 1998, Malayan Nature Journal, V52, P1; Holloway J. D., 1996, Malayan Nature Journal, V49, P147; Holloway J.D., 1994, MALAYAN NATURE J, V47, P1; JANSE AJT, 1933, MOTHS S AFRICA, V2; KRUGER M, 2004, ESPERIANA MEMOIR, V1, P241; KULLBERG J, 2001, CHECKLIST FINNISH LE, V6, P45; Lemaire C., 1998, LEPIDOPTERA MOTHS BU, V1, P321, DOI DOI 10.1515/9783110804744.321; LERAUT P.J.A., 1997, ALEXANOR S; MCQUILLAN PB, 1996, MONOGRAPHS AUSTR LEP, V4, P201; Miller M. A., 2010, CIPRES PORTALS; MINET J, 1991, ENTOMOL SCAND, V22, P69; MINET J, 1999, EVOLUTION SYSTEMATIC, V1, P301; MINET J, 1999, EVOLUTION SYSTEMATIC, V1, P257; Mironov V., 2003, GEOMETRID MOTHS EURO, V4, P1; MONTGOMERY SL, 1982, ENTOMOL GEN, V8, P27; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; OUNAP E, 2010, THESIS BIOL U TARTUE; Ounap E, 2008, ZOOL SCR, V37, P405, DOI 10.1111/j.1463-6409.2008.00327.x; Ounap E, 2009, AUST J ENTOMOL, V48, P113, DOI 10.1111/j.1440-6055.2009.00695.x; PATOCKA J, 1981, BIOLOGIA, V36, P583; PATOCKA J, 1994, BIOLOGIA, V49, P739; PATOCKA J, 1995, PUPPEN SPANNER LEPID, V45, P231; Pierce F.N., 1914, GENITALIA GROUP GEOM; PINHEY E.C.G., 1975, MOTHS SO AFRICA DESC; Pitkin LM, 2007, ZOOL J LINN SOC-LOND, V150, P343, DOI 10.1111/j.1096-3642.2007.00287.x; Pitkin LM, 2002, ZOOL J LINN SOC-LOND, V135, P121, DOI 10.1046/j.1096-3642.2002.01200.x; Pitkin LM, 1996, ZOOL J LINN SOC-LOND, V118, P309, DOI 10.1006/zjls.1996.0060; Prout L.B., 1929, GROSS SCHMETTERLINGE, V16, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Scoble M.J., 1999, GEOMETRID MOTHS WORL, V1 & 2, DOI [10.1071/9780643101050, DOI 10.1071/9780643101050]; Scoble M.J., 2007, ONLINE LIST VALID AV; SCOBLE MJ, 1989, ENTOMOL SCAND, V20, P371; SCOBLE MJ, 1994, ZOOL J LINN SOC-LOND, V111, P99, DOI 10.1006/zjls.1994.1019; Scoble MJ, 2002, ZOOL J LINN SOC-LOND, V134, P257, DOI 10.1046/j.1096-3642.2002.00008.x; Sihvonen P, 2005, ZOOL J LINN SOC-LOND, V143, P473, DOI 10.1111/j.1096-3642.2005.00153.x; Sihvonen P, 2004, SYST ENTOMOL, V29, P324, DOI 10.1111/j.0307-6970.2004.00248.x; Snall N, 2007, BIOL J LINN SOC, V92, P241, DOI 10.1111/j.1095-8312.2007.00834.x; Sommerer Manfred, 1995, Heterocera Sumatrana, V9, P5; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Staude H.S., 2001, Metamorphosis, V12, P125; Staude H.S., 1999, Metamorphosis, V10, P97; Strutzenberger P, 2011, INSECT SCI, V18, P349, DOI 10.1111/j.1744-7917.2010.01366.x; Strutzenberger P, 2010, ZOOL SCR, V39, P603, DOI 10.1111/j.1463-6409.2010.00440.x; Vari L., 2002, CLASSIFICATION CHECK, Vxxii; Viidalepp J., 1996, CHECKLIST GEOMETRIDA; Viidalepp Jaan, 2006, Spixiana, V29, P202; Viidalepp Jaan, 2009, Revue de l'Association Roussillonnaise d'Entomologie, V18, P28; VIVES MORENO A, 1994, CATALOGO SISTEMATICO; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2010, MOL PHYLOGENET EVOL, V55, P929, DOI 10.1016/j.ympev.2010.01.025; Weintraub Jason D., 2004, Fauna of New Zealand, V49, P5; Xue Dayong, 2002, Bulletin of the Natural History Museum Entomology Series, V71, P77; Xue Dayong, 1995, Sinozoologia, V12, P215; Yamamoto S, 2007, MOL PHYLOGENET EVOL, V44, P711, DOI 10.1016/j.ympev.2006.12.027; Yen SH, 2007, ZOOL STUD, V46, P262; Young CJ, 2008, ZOOTAXA, P1; Young CJ, 2006, ZOOTAXA, P1; Young CJ, 2003, INSECT SYST EVOL, V34, P81, DOI 10.1163/187631203788964917; Zahiri R, 2011, ZOOL SCR, V40, P158, DOI 10.1111/j.1463-6409.2010.00459.x; ZHANG B-C., 1994, INDEX EC IMPORTANT L; 2010, WORLD LIST FAMILY GR	92	95	108	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20356	10.1371/journal.pone.0020356	http://dx.doi.org/10.1371/journal.pone.0020356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673814	Green Published, gold			2022-12-25	WOS:000291309900014
J	Aeby, GS; Williams, GJ; Franklin, EC; Kenyon, J; Cox, EF; Coles, S; Work, TM				Aeby, Greta S.; Williams, Gareth J.; Franklin, Erik C.; Kenyon, Jean; Cox, Evelyn F.; Coles, Steve; Work, Thierry M.			Patterns of Coral Disease across the Hawaiian Archipelago: Relating Disease to Environment	PLOS ONE			English	Article							WHITE-BAND DISEASE; INDO-PACIFIC; ACROPORA-PALMATA; GROWTH ANOMALIES; REEF SYSTEM; KANEOHE BAY; COMMUNITY STRUCTURE; PORITES-COMPRESSA; MODEL SELECTION; PALMYRA ATOLL	In Hawaii, coral reefs occur across a gradient of biological (host abundance), climatic (sea surface temperature anomalies) and anthropogenic conditions from the human-impacted reefs of the main Hawaiian Islands (MHI) to the pristine reefs of the northwestern Hawaiian Islands (NWHI). Coral disease surveys were conducted at 142 sites from across the Archipelago and disease patterns examined. Twelve diseases were recorded from three coral genera (Porites, Montipora, Acropora) with Porites having the highest prevalence. Porites growth anomalies (PorGAs) were significantly more prevalent within and indicative of reefs in the MHI and Porites trematodiasis (PorTrm) was significantly more prevalent within and indicative of reefs in the NWHI. Porites tissue loss syndrome (PorTLS) was also important in driving regional differences but that relationship was less clear. These results highlight the importance of understanding disease ecology when interpreting patterns of disease occurrence. PorTrm is caused by a parasitic flatworm that utilizes multiple hosts during its life cycle (fish, mollusk and coral). All three hosts must be present for the disease to occur and higher host abundance leads to higher disease prevalence. Thus, a high prevalence of PorTrm on Hawaiian reefs would be an indicator of a healthy coral reef ecosystem. In contrast, the high occurrence of PorGAs within the MHI suggests that PorGAs are related, directly or indirectly, to some environmental co-factor associated with increased human population sizes. Focusing on the three indicator diseases (PorGAs, PorTrm, PorTLS) we used statistical modeling to examine the underlying associations between disease prevalence and 14 different predictor variables (biotic and abiotic). All three diseases showed positive associations with host abundance and negative associations with thermal stress. The association with human population density differed among disease states with PorGAs showing a positive and PorTrm showing a negative association, but no significant explanatory power was offered for PorTLS.	[Aeby, Greta S.; Franklin, Erik C.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA; [Williams, Gareth J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Williams, Gareth J.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Kenyon, Jean] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Kenyon, Jean] NOAA, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Cox, Evelyn F.] Univ Hawaii W Oahu, Pearl City, HI USA; [Coles, Steve] Bernice P Bishop Museum, Honolulu, HI USA; [Work, Thierry M.] US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA	University of Hawaii System; Victoria University Wellington; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Hawaii System; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; United States Department of the Interior; United States Geological Survey	Aeby, GS (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA.	greta@hawaii.edu; gareth@ucsd.edu	Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090; Kenyon, Jean/0000-0001-7682-475X; Williams, Dr Gareth J./0000-0001-7837-1619; Franklin, Erik/0000-0002-8660-3085	Victoria University of Wellington (VUW); New Zealand International Doctoral Research Scholarship; Papahanaumokuakea Marine National Monument-Hawaii Institute of Marine Biology MOA; Hawaii Coral Reef Initiative; National Aeronautics and Space Administration [NAS5-03117]	Victoria University of Wellington (VUW); New Zealand International Doctoral Research Scholarship; Papahanaumokuakea Marine National Monument-Hawaii Institute of Marine Biology MOA; Hawaii Coral Reef Initiative; National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	GW was supported by a Victoria University of Wellington (VUW) Vice-Chancellor's Strategic Research Scholarship and a New Zealand International Doctoral Research Scholarship. GA was supported by the Papahanaumokuakea Marine National Monument-Hawaii Institute of Marine Biology MOA. Funding for this research came, in part, from the Hawaii Coral Reef Initiative and the Papahanaumokuakea Marine National Monument-Hawaii Institute of Marine Biology MOA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the officers and crew of the NOAA ships Oscar Elton Sette and Hi'ialakai, for logistic support and field assistance. The Coral Reef Temperature Anomaly Database (CoRTAD) was developed by the NOAA National Oceanographic Data Center and the University of North Carolina, Chapel Hill. It was provided by the NOAA National Oceanographic Data Center at http://www.nodc.noaa.gov/SatelliteData/Cortad/. Human population data was provided by the Center for International Earth Science Information Network (CIESIN), Columbia University; United Nations Food and Agriculture Programme (FAO); and Centro Internacional de Agricultura Tropical (CIAT) with funding from the National Aeronautics and Space Administration under Contract NAS5-03117 for the Continued Operation of the Socioeconomic Data and Applications Center (SEDAC). This manuscript was greatly improved by input from two anonymous reviewers.	Aeby G, 2009, P 11 INT COR REEF S, P197; Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; AEBY G S, 1992, Bulletin of the Ecological Society of America, V73, P95; AEBY G S, 1991, Pacific Science, V45, P263; Aeby GS, 2007, B MAR SCI, V80, P209; Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016887; Aeby Greta S., 1993, P809; Aeby Greta Smith, 2006, Atoll Research Bulletin, P471; Aeby GS, 1998, J PARASITOL, V84, P1259, DOI 10.2307/3284684; Akaike H., 1973, P 2 INT S INF THEOR, P261; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANTONIUS A, 1988, P 6 INT COR REEF S, V3, P145; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Aronson RB, 1997, PALEOBIOLOGY, V23, P326, DOI 10.1017/S0094837300019710; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; BRAY R, 1989, J NAT HIST, V23, P249; Bruckner AW, 1997, B MAR SCI, V61, P919; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burke L., 2002, REEFS RISK SE ASIA; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; BYTHELL J, 1993, MAR POLLUT BULL, V26, P296; CHENG TC, 1974, J INVERTEBR PATHOL, V23, P303, DOI 10.1016/0022-2011(74)90095-0; CIESIN, 2005, CTR INT EARTH SCI IN; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 2006, MAR ECOL PROG SER, V320, P11, DOI 10.3354/meps320011; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Coles SL, 1998, CORAL REEFS, V17, P195, DOI 10.1007/s003380050118; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; FRIEDLANDER A, 2008, STATE CORAL REEF ECO, P219; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; GLADFELTER WB, 1982, B MAR SCI, V32, P639; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; HUNTER CL, 1995, B MAR SCI, V57, P501; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Jokiel Paul L., 2007, Pacific Conservation Biology, V13, P60; Kaczmarsky L, 2007, J INVERTEBR PATHOL, V94, P218, DOI 10.1016/j.jip.2006.11.007; Kaczmarsky LT, 2006, DIS AQUAT ORGAN, V69, P9, DOI 10.3354/dao069009; Kenyon J. C., 2006, P 10 INT COR REEF S, P631; Kenyon JC, 2006, PAC SCI, V60, P153, DOI 10.1353/psc.2006.0006; Kenyon Jean C., 2010, Atoll Research Bulletin, P1; Kenyon Jean C., 2006, Atoll Research Bulletin, P505; Lafferty KD, 1997, PARASITOL TODAY, V13, P251, DOI 10.1016/S0169-4758(97)01072-7; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McPeters R.D., 1998, NASATP1998206895; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; Palmer CV, 2010, CORAL REEFS, V29, P469, DOI 10.1007/s00338-010-0597-2; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Stimson J, 2011, CORAL REEFS, V30, P133, DOI 10.1007/s00338-010-0672-8; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Vargas-Angel B., 2009, P 11 INT COR REEF S, V1, P175; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Williams GJ, 2008, CORAL REEFS, V27, P207, DOI 10.1007/s00338-007-0314-y; Williams GJ, 2011, J INVERTEBR PATHOL, V106, P165, DOI 10.1016/j.jip.2010.08.002; Williams GJ, 2011, DIS AQUAT ORGAN, V94, P89, DOI 10.3354/dao02323; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Work TM, 2005, CORAL REEFS, V24, P384, DOI 10.1007/s00338-005-0018-0; Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211; Yamashiro H, 2001, J EXP MAR BIOL ECOL, V265, P171, DOI 10.1016/S0022-0981(01)00333-1	90	54	54	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20370	10.1371/journal.pone.0020370	http://dx.doi.org/10.1371/journal.pone.0020370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655248	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600056
J	Askgaard, G; Kristoffersen, US; Mehlsen, J; Kronborg, G; Kjaer, A; Lebech, AM				Askgaard, Gro; Kristoffersen, Ulrik Sloth; Mehlsen, Jesper; Kronborg, Gitte; Kjaer, Andreas; Lebech, Anne-Mette			Decreased Heart Rate Variability in HIV Positive Patients Receiving Antiretroviral Therapy: Importance of Blood Glucose and Cholesterol	PLOS ONE			English	Article							AUTONOMIC DYSFUNCTION; RATE RECOVERY; CARDIOVASCULAR-DISEASE; NEUROPATHY; MORTALITY; RISK; PREDICTOR; IMPACT; AIDS	The presence of autonomic dysfunction in HIV patients is largely unknown. Early studies found autonomic dysfunction in patients with AIDS. Antiretroviral combination therapy (ART) has dramatically changed the course of the disease and improved prognosis and decreased morbidity. Aim: To evaluate whether autonomic dysfunction is present in an ART treated HIV population and if so to identify factors of importance. Methods: HIV patients receiving ART for at least 12 months (n = 97) and an age-matched control group of healthy volunteers (n = 52) were included. All were non-diabetic and had never received medication for hypertension. Following a 10 min resting period a 15 min ECG recording was performed. Heart-rate variability (HRV) analysis was performed in accordance with current guidelines and data reported as mean [interquartile range]. Results: Mean normal-to-normal (NN) and total HRV measured as standard deviation of normal-to-normal (SDNN) was lower in HIV patients compared to controls (905 vs. 982 ms; p<0.001 and 48 vs. 54 ms; p = 0.028, respectively). No differences were found between the groups in parasympathetic activity measured as square root of the mean squared difference of successive NN-intervals (RMSSD) or the percent of differences between adjacent NN intervals greater than 50 ms (pNN50). In the HIV positives, haemoglobin A1c correlated inversely with SDNN, RMSSD and pNN50 (p<0.05). Total cholesterol and LDLC correlated inversely with RMSSD and pNN50 (p<0.05). Neither HIV duration, HIV-RNA, CD4 cell count nor CD4 nadir correlated with time or phase domain HRV variables. Conclusions: Moderate autonomic dysfunction is present in HIV positives patients even with suppressed viral load due to ART. The dysfunction is correlated with HbA1c and hypercholesterolemia but not to duration of HIV or whether the patients were receiving protease inhibitors as part of the ART regime.	[Askgaard, Gro; Kronborg, Gitte; Lebech, Anne-Mette] Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark; [Kristoffersen, Ulrik Sloth; Kjaer, Andreas] Rigshosp, Clin Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Kristoffersen, Ulrik Sloth; Kjaer, Andreas] Univ Copenhagen, Copenhagen, Denmark; [Mehlsen, Jesper] Frederiksberg Univ Hosp, Dept Clin Physiol & Nucl Med, Frederiksberg, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Askgaard, G (corresponding author), Hvidovre Univ Hosp, Dept Infect Dis, DK-2650 Hvidovre, Denmark.	lebech@dadlnet.dk	Mehlsen, Jesper/AAA-5848-2022; Askgaard, Gro/AFQ-1824-2022; Kjaer, Andreas/E-8932-2015	Lebech, Anne-Mette/0000-0002-0943-3289; Askgaard, Gro/0000-0003-2775-8754; Kjaer, Andreas/0000-0002-2706-5547	Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond; Carl og Ketty Kajsings legat	Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond; Carl og Ketty Kajsings legat	Financial support from "Snedkermester Sophus Jacobsen og hustru Astrid Jacobsens Fond" and "Carl og Ketty Kajsings legat" are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cade WT, 2008, HIV MED, V9, P96, DOI 10.1111/j.1468-1293.2007.00524.x; Camm AJ, 1996, EUR HEART J, V17, P354; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Cheng YLJ, 2003, DIABETES CARE, V26, P2052, DOI 10.2337/diacare.26.7.2052; Compostella C, 2008, CLIN AUTON RES, V18, P6, DOI 10.1007/s10286-007-0451-y; Dalakas MC, 2001, LAB INVEST, V81, P1537, DOI 10.1038/labinvest.3780367; Dube M P, 1998, AIDS Clin Care, V10, P41; FREEMAN R, 1990, NEUROLOGY, V40, P575, DOI 10.1212/WNL.40.4.575; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gluck T, 2000, CLIN AUTON RES, V10, P17, DOI 10.1007/BF02291385; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Lebech AM, 2007, CLIN PHYSIOL FUNCT I, V27, P363, DOI 10.1111/j.1475-097X.2007.00760.x; Lipinski MJ, 2004, AM J CARDIOL, V93, P445, DOI 10.1016/j.amjcard.2003.10.039; Melli G, 2006, BRAIN, V129, P1330, DOI 10.1093/brain/awl058; Mittal CM, 2004, INT J CARDIOL, V94, P1, DOI 10.1016/j.ijcard.2003.02.002; Neild PJ, 2000, INT J CARDIOL, V74, P133, DOI 10.1016/S0167-5273(00)00232-1; Nzuobontane D, 2002, J ROY SOC MED, V95, P445, DOI 10.1258/jrsm.95.9.445; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peltier AC, 2002, CURR OPIN NEUROL, V15, P633, DOI 10.1097/00019052-200210000-00015; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; RUTTIMANN S, 1991, ARCH INTERN MED, V151, P2441, DOI 10.1001/archinte.151.12.2441; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; SoRelle R, 1998, CIRCULATION, V98, P829, DOI 10.1161/01.CIR.98.9.829; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; WELBY SB, 1991, J INFECTION, V23, P123, DOI 10.1016/0163-4453(91)91958-Z	25	19	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20196	10.1371/journal.pone.0020196	http://dx.doi.org/10.1371/journal.pone.0020196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655281	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600028
J	Cui, YH; Jin, J; Zhang, XL; Xu, H; Yang, LG; Du, D; Zeng, QW; Tsien, JZ; Yu, HT; Cao, XH				Cui, Yihui; Jin, Jing; Zhang, Xuliang; Xu, Hao; Yang, Liguo; Du, Dan; Zeng, Qingwen; Tsien, Joe Z.; Yu, Huiting; Cao, Xiaohua			Forebrain NR2B Overexpression Facilitating the Prefrontal Cortex Long-Term Potentiation and Enhancing Working Memory Function in Mice	PLOS ONE			English	Article							NR2B-CONTAINING NMDA RECEPTORS; ANTERIOR CINGULATE CORTEX; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; DOPAMINE-RECEPTORS; TEMPORAL CORTEX; ODOR SPAN; MONKEYS; HIPPOCAMPUS	Prefrontal cortex plays an important role in working memory, attention regulation and behavioral inhibition. Its functions are associated with NMDA receptors. However, there is little information regarding the roles of NMDA receptor NR2B subunit in prefrontal cortical synaptic plasticity and prefrontal cortex-related working memory. Whether the up-regulation of NR2B subunit influences prefrontal cortical synaptic plasticity and working memory is not yet clear. In the present study, we measured prefrontal cortical synaptic plasticity and working memory function in NR2B overexpressing transgenic mice. In vitro electrophysiological data showed that overexpression of NR2B specifically in the forebrain region resulted in enhancement of prefrontal cortical long-term potentiation (LTP) but did not alter long-term depression (LTD). The enhanced LTP was completely abolished by a NR2B subunit selective antagonist, Ro25-6981, indicating that overexpression of NR2B subunit is responsible for enhanced LTP. In addition, NR2B transgenic mice exhibited better performance in a set of working memory paradigms including delay no-match-to-place T-maze, working memory version of water maze and odor span task. Our study provides evidence that NR2B subunit of NMDA receptor in prefrontal cortex is critical for prefrontal cortex LTP and prefrontal cortex-related working memory.	[Cui, Yihui; Jin, Jing; Zhang, Xuliang; Xu, Hao; Yang, Liguo; Du, Dan; Zeng, Qingwen; Cao, Xiaohua] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab MOE, Shanghai 200062, Peoples R China; [Cui, Yihui; Jin, Jing; Zhang, Xuliang; Xu, Hao; Yang, Liguo; Du, Dan; Zeng, Qingwen; Cao, Xiaohua] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab STCSM, Shanghai 200062, Peoples R China; [Tsien, Joe Z.] Med Coll Georgia, Sch Med, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Tsien, Joe Z.] Med Coll Georgia, Sch Med, Dept Neurol, Augusta, GA 30912 USA; [Yu, Huiting] Shanghai Municipal Ctr Dis Control & Prevent, Dept Vital Stat, Shanghai, Peoples R China	East China Normal University; East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Shanghai Center for Disease Control & Prevention	Cui, YH (corresponding author), E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab MOE, Shanghai 200062, Peoples R China.	xhcao@brain.ecnu.edu.cn	Cui, Yihui/AAB-9328-2022	Cui, Yihui/0000-0002-7362-6237; zhang, xuliang/0000-0002-8952-8009	National Natural Science Fund of China [30670682, 31070993]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from National Natural Science Fund of China (No. 30670682 and No. 31070993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aultman JM, 2001, PSYCHOPHARMACOLOGY, V153, P353, DOI 10.1007/s002130000590; Axmacher N, 2009, J NEUROSCI, V29, P1052, DOI 10.1523/JNEUROSCI.5277-08.2009; Baddeley A., 2007, WORKING MEMORY THOUG; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Buckley MJ, 2009, SCIENCE, V325, P52, DOI 10.1126/science.1172377; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; FRENCH GM, 1959, J COMP PHYSIOL PSYCH, V52, P18, DOI 10.1037/h0042491; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; GRANON S, 1994, BEHAV NEUROSCI, V108, P883, DOI 10.1037/0735-7044.108.5.883; GRAY EG, 1962, J ANAT, V96, P79; Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kohr G, 2003, J NEUROSCI, V23, P10791; Lehohla M, 2004, METAB BRAIN DIS, V19, P35, DOI 10.1023/B:MEBR.0000027415.75432.ad; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Morita M, 2004, NEUROSCI LETT, V356, P203, DOI 10.1016/j.neulet.2003.11.066; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Piekema C, 2009, LEARN MEMORY, V16, P231, DOI 10.1101/lm.1283109; Procyk E, 2006, J NEUROSCI, V26, P11313, DOI 10.1523/JNEUROSCI.2157-06.2006; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Sakurai Y, 2006, J NEUROSCI, V26, P10141, DOI 10.1523/JNEUROSCI.2423-06.2006; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsukada H, 2005, NEUROPSYCHOPHARMACOL, V30, P1861, DOI 10.1038/sj.npp.1300732; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; Wang GW, 2006, BEHAV BRAIN RES, V175, P329, DOI 10.1016/j.bbr.2006.09.002; Wu LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-11; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Young JW, 2007, NEUROPHARMACOLOGY, V52, P634, DOI 10.1016/j.neuropharm.2006.09.006; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	47	82	86	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20312	10.1371/journal.pone.0020312	http://dx.doi.org/10.1371/journal.pone.0020312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655294	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600042
J	Kong, B; Guo, GL				Kong, Bo; Guo, Grace L.			Enhanced In Vitro Refolding of Fibroblast Growth Factor 15 with the Assistance of SUMO Fusion Partner	PLOS ONE			English	Article							INCLUSION-BODY PROTEINS; MALTOSE-BINDING PROTEIN; ESCHERICHIA-COLI; STEP PURIFICATION; TRANSGENIC MICE; METABOLIC-RATE; EXPRESSION; FIBROBLAST-GROWTH-FACTOR-19; POLYPEPTIDES; FGF-19	Fibroblast growth factor 15 (Fgf15) is the mouse orthologue of human FGF19. Fgf15 is highly expressed in the ileum and functions as an endocrine signal to regulate liver function, including bile acid synthesis, hepatocyte proliferation and insulin sensitivity. In order to fully understand the function of Fgf15, methods are needed to produce pure Fgf15 protein in the prokaryotic system. However, when expressed in Escherichia coli (E. coli), the recombinant Fgf15 protein was insoluble and found only in inclusion bodies. In the current study, we report a method to produce recombinant Fgf15 protein in E. coli through the use of small ubiquitin-related modifier (SUMO) fusion tag. Even though the SUMO has been shown to strongly improve protein solubility and expression levels, our studies suggest that the SUMO does not improve Fgf15 protein solubility. Instead, proper refolding of Fgf15 protein was achieved when Fgf15 was expressed as a partner protein of the fusion tag SUMO, followed by in vitro dialysis refolding. After refolding, the N-terminal SUMO tag was cleaved from the recombinant Fgf15 fusion protein by ScUlp1 (Ubiquitin-Like Protein-Specific Protease 1 from S. cerevisiae). With or without the SUMO tag, the refolded Fgf15 protein was biologically active, as revealed by its ability to reduce hepatic Cyp7a1 mRNA levels in mice. In addition, recombinant Fgf15 protein suppressed Cyp7a1 mRNA levels in a dose-dependent manner. In summary, we have developed a successful method to express functional Fgf15 protein in prokaryotic cells.	[Kong, Bo; Guo, Grace L.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Kong, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	lguo@kumc.edu	Kong, Bo/G-7650-2014	Kong, Bo/0000-0002-8200-7817	NCRR [P20-RR021940]; NIH [DK081343]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding from NCRR P20-RR021940 and NIH grant DK081343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; BEDOUELLE H, 1988, EUR J BIOCHEM, V171, P541, DOI 10.1111/j.1432-1033.1988.tb13823.x; Burgess RR, 2009, METHOD ENZYMOL, V463, P259, DOI 10.1016/S0076-6879(09)63017-2; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Harmer NJ, 2004, BIOCHEMISTRY-US, V43, P629, DOI 10.1021/bi035320k; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jungbauer A, 2007, J BIOTECHNOL, V128, P587, DOI 10.1016/j.jbiotec.2006.12.004; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mayer Marcus, 2004, Methods Mol Med, V94, P239; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Nishimura T, 1999, BBA-GENE STRUCT EXPR, V1444, P148, DOI 10.1016/S0167-4781(98)00255-3; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Wingfield P T, 2001, Curr Protoc Protein Sci, VChapter 6, DOI 10.1002/0471140864.ps0605s00; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485	25	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20307	10.1371/journal.pone.0020307	http://dx.doi.org/10.1371/journal.pone.0020307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655243	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600040
J	Wright, E; Mugaba, S; Grant, P; Parkes-Ratanshi, R; Van der Paal, L; Grosskurth, H; Kaleebu, P				Wright, Edward; Mugaba, Susan; Grant, Paul; Parkes-Ratanshi, Rosalind; Van der Paal, Lieve; Grosskurth, Heiner; Kaleebu, Pontiano			Coreceptor and Cytokine Concentrations May Not Explain Differences in Disease Progression Observed in HIV-1 Clade A and D Infected Ugandans	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; SYNCYTIUM-INDUCING PHENOTYPE; SUBTYPE-A; ANTIRETROVIRAL THERAPY; SURFACE CXCR4; TROPIC HIV-1; TYPE-1 HIV-1; RURAL UGANDA; CCR5	Background: The use of cellular coreceptors and modulation of cytokine concentrations by HIV to establish a productive infection is well documented. However, it is unknown whether the expression of these proteins affects the course of HIV clade A and D disease, reported to have different progression rates. Methodology/Principal Findings: We investigated whether the number of CD4(+) T-cells expressing CCR5 or CXCR4, the density of these coreceptors and concentrations of specific immune proteins linked to HIV pathogenesis vary between individuals infected with HIV clade A or D. We undertook additional analyses stratifying participants by early (CD4>500 cells/mu l) or late (CD4<200 cells/mu l) disease stage. Whole blood samples were taken from 50 HIV-1 infected individuals drawn from cohorts in rural south-west Uganda. Late stage participants had less than half the number of CD4(+)/CCR5(+) T-cells (p = 0.0113) and 5.6 times fewer CD4(+)/CXCR4(+) cells (p<0.0001) than early stage participants. There was also a statistically significant difference in the density of CXCR4 on CD4(+) cells between clade A and D infected early stage participants (142 [A] vs 84 [D]; p = 0.0146). Across all participants we observed significantly higher concentration of Th(1) cytokines compared to Th(2) (66.4 vs 23.8 pg/ml; p < 0.0001). Plasma concentrations of IFN gamma and IL-2 were 1.8 and 2.4 fold lower respectively in Late-D infected participants compared to Late-A participants. MIP-1 beta levels also decreased from 118.0 pg/ml to 47.1 pg/ml (p = 0.0396) as HIV disease progressed. Conclusions/Significance: We observed specific alterations in the abundance of CD4(+)/CCR5(+) and CD4(+)/CXCR4(+) T-cells, and concentrations of immune proteins across different HIV clades and as infection progresses. Our results suggest that these changes are unlikely to explain the observed differences in disease progression between subtype A and D infections. However, our observations further the understanding of the natural progression of non-clade B HIV infection and how the virus adapts to exploit the host environment.	[Wright, Edward; Mugaba, Susan; Parkes-Ratanshi, Rosalind; Van der Paal, Lieve; Grosskurth, Heiner; Kaleebu, Pontiano] Uganda Virus Res Inst, MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Wright, Edward] UCL, Div Infect & Immun, London, England; [Grant, Paul] Univ Coll London Hosp, Dept Virol, London, England; [Grosskurth, Heiner; Kaleebu, Pontiano] London Sch Hyg & Trop Med, London WC1, England	Uganda Virus Research Institute; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Wright, E (corresponding author), Uganda Virus Res Inst, MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda.	edward.wright@ucl.ac.uk	Parkes-Ratanshi, Rosalind/AAR-5409-2020	Parkes-Ratanshi, Rosalind/0000-0001-9297-1311; Grosskurth, Heiner/0000-0001-9960-7280; Wright, Edward/0000-0001-7041-5138	Medical Research Council U.K. - MRC/UVRI Uganda Research Unit on AIDS;  [G0801176]; Medical Research Council [G0801176, MC_U950080937] Funding Source: researchfish; MRC [MC_U950080937, G0801176] Funding Source: UKRI	Medical Research Council U.K. - MRC/UVRI Uganda Research Unit on AIDS; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council U.K. - MRC/UVRI Uganda Research Unit on AIDS and grant number G0801176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2006, J VIROL, V80, P10884, DOI 10.1128/JVI.01030-06; Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bernstein A, 2008, TRENDS MICROBIOL, V16, P553, DOI 10.1016/j.tim.2008.08.009; Buckton AJ, 2008, J ANTIMICROB CHEMOTH, V62, P1191, DOI 10.1093/jac/dkn412; Casper C, 2002, AIDS RES HUM RETROV, V18, P343, DOI 10.1089/088922202753519124; Choi B, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-6; Clapham PR, 2001, BRIT MED BULL, V58, P43, DOI 10.1093/bmb/58.1.43; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; DELWART EL, 1995, PCR METH APPL, V4, pS202; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Huang W, 2009, AIDS, V23, P1903, DOI 10.1097/QAD.0b013e32832f1802; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2000, AIDS RES HUM RETROV, V16, P393, DOI 10.1089/088922200309052; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; KIWANUKA N, 2008, J INFECT DIS; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kwa D, 2003, AIDS, V17, P981, DOI 10.1097/00002030-200305020-00006; Lelievre JD, 2004, AIDS RES HUM RETROV, V20, P1230, DOI 10.1089/aid.2004.20.1230; Lin YL, 2008, AIDS, V22, P430, DOI 10.1097/QAD.0b013e3282f46a6f; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Morgan D, 2001, INT J STD AIDS, V12, P116, DOI 10.1258/0956462011916758; Morgan D, 1997, AIDS, V11, P633, DOI 10.1097/00002030-199705000-00011; Neil SJD, 2005, J VIROL, V79, P9618, DOI 10.1128/JVI.79.15.9618-9624.2005; Oishi K, 2000, J INTERF CYTOK RES, V20, P597, DOI 10.1089/10799900050044796; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Poveda E, 2007, J MED VIROL, V79, P1040, DOI 10.1002/jmv.20900; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Rizzardini G, 1996, AIDS, V10, P1535, DOI 10.1097/00002030-199611000-00012; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Serwanga J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004188; Simmons G, 1996, J VIROL, V70, P8355, DOI 10.1128/JVI.70.12.8355-8360.1996; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; van Rensburg EJ, 2002, AIDS, V16, P2479, DOI [10.1097/00002030-200212060-00015, 10.1097/01.aids.0000042582.93174.df]; Van Rij RP, 2003, AIDS RES HUM RETROV, V19, P389, DOI 10.1089/088922203765551737; Wakeham K, 2010, J ANTIMICROB CHEMOTH, V65, P316, DOI 10.1093/jac/dkp451; White EJ, 2010, AIDS, V24, P1063, DOI 10.1097/QAD.0b013e328331f717; Willey S, 2008, TRENDS MICROBIOL, V16, P596, DOI 10.1016/j.tim.2008.08.008	44	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19902	10.1371/journal.pone.0019902	http://dx.doi.org/10.1371/journal.pone.0019902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655330	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600010
J	van Gent, M; Bart, MJ; van der Heide, HGJ; Heuvelman, KJ; Kallonen, T; He, QS; Mertsola, J; Advani, A; Hallander, HO; Janssens, K; Hermans, PW; Mooi, FR				van Gent, Marjolein; Bart, Marieke J.; van der Heide, Han G. J.; Heuvelman, Kees J.; Kallonen, Teemu; He, Qiushui; Mertsola, Jussi; Advani, Abdolreza; Hallander, Hans O.; Janssens, Koen; Hermans, Peter W.; Mooi, Frits R.			SNP-Based Typing: A Useful Tool to Study Bordetella pertussis Populations	PLOS ONE			English	Article							GEL-ELECTROPHORESIS PROFILES; SINGLE-NUCLEOTIDE POLYMORPHISMS; AGENTS AFFECTING HEALTH; TANDEM-REPEAT ANALYSIS; ANTIGENIC DIVERGENCE; GENETIC DIVERSITY; HOST ADAPTATION; UNITED-KINGDOM; RURAL AREA; VACCINATION	To monitor changes in Bordetella pertussis populations, mainly two typing methods are used; Pulsed-Field Gel Electrophoresis (PFGE) and Multiple-Locus Variable-Number Tandem Repeat Analysis (MLVA). In this study, a single nucleotide polymorphism (SNP) typing method, based on 87 SNPs, was developed and compared with PFGE and MLVA. The discriminatory indices of SNP typing, PFGE and MLVA were found to be 0.85, 0.95 and 0.83, respectively. Phylogenetic analysis, using SNP typing as Gold Standard, revealed false homoplasies in the PFGE and MLVA trees. Further, in contrast to the SNP-based tree, the PFGE- and MLVA-based trees did not reveal a positive correlation between root-to-tip distance and the isolation year of strains. Thus PFGE and MLVA do not allow an estimation of the relative age of the selected strains. In conclusion, SNP typing was found to be phylogenetically more informative than PFGE and more discriminative than MLVA. Further, in contrast to PFGE, it is readily standardized allowing interlaboratory comparisons. We applied SNP typing to study strains with a novel allele for the pertussis toxin promoter, ptxP3, which have a worldwide distribution and which have replaced the resident ptxP1 strains in the last 20 years. Previously, we showed that ptxP3 strains showed increased pertussis toxin expression and that their emergence was associated with increased notification in the Netherlands. SNP typing showed that the ptxP3 strains isolated in the Americas, Asia, Australia and Europe formed a monophyletic branch which recently diverged from ptxP1 strains. Two predominant ptxP3 SNP types were identified which spread worldwide. The widespread use of SNP typing will enhance our understanding of the evolution and global epidemiology of B. pertussis.	[van Gent, Marjolein; Bart, Marieke J.; van der Heide, Han G. J.; Heuvelman, Kees J.; Mooi, Frits R.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Kallonen, Teemu; He, Qiushui; Mertsola, Jussi] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland; [Kallonen, Teemu] Univ Turku, Turku Grad Sch Biomed Sci, Turku, Finland; [Advani, Abdolreza; Hallander, Hans O.] Swedish Inst Infect Dis Control, Dept Bacteriol, Solna, Sweden; [Janssens, Koen] Appl Maths NV, Sint Martens Latem, Belgium; [Hermans, Peter W.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands	Netherlands National Institute for Public Health & the Environment; Finland National Institute for Health & Welfare; University of Turku; Swedish Institute for Infectious Disease Control; Radboud University Nijmegen	van Gent, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands.	frits.mooi@rivm.nl	Kallonen, Teemu/B-5507-2008; Mooi, prof.F.R./L-4528-2015; Hermans, Peter W.M./H-8042-2014; Janssens, Koen Henri/B-8049-2011; Mertsola, Jussi/AAE-3460-2021	Kallonen, Teemu/0000-0003-1741-6486; Janssens, Koen Henri/0000-0002-6752-6408; 				Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Advani A, 2004, J CLIN MICROBIOL, V42, P2890, DOI 10.1128/JCM.42.7.2890-2897.2004; Advani A, 2009, J MICROBIOL METH, V78, P297, DOI 10.1016/j.mimet.2009.06.019; Advani A, 2007, APMIS, V115, P736, DOI 10.1111/j.1600-0463.2007.apm_628.x; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Elomaa A, 2007, VACCINE, V25, P918, DOI 10.1016/j.vaccine.2006.09.012; Elomaa A, 2009, VACCINE, V27, P5443, DOI 10.1016/j.vaccine.2009.07.010; Fingermann M, 2006, VACCINE, V24, P3513, DOI 10.1016/j.vaccine.2006.02.026; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Gzyl A, 2001, VACCINE, V20, P299, DOI 10.1016/S0264-410X(01)00356-5; Hallander HO, 2005, J CLIN MICROBIOL, V43, P2856, DOI 10.1128/JCM.43.6.2856-2865.2005; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Kodama A, 2004, J CLIN MICROBIOL, V42, P5453, DOI 10.1128/JCM.42.12.5453-5457.2004; Kurniawan J, 2010, EMERG INFECT DIS, V16, P297, DOI 10.3201/eid1602.081707; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2000, EUR J CLIN MICROBIOL, V19, P174, DOI 10.1007/s100960050455; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; MUSSER JM, 1986, J BACTERIOL, V166, P230, DOI 10.1128/jb.166.1.230-237.1986; OCTAVIA S, 2010, MOLBIOLEVOL; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PATEL S, 1978, TROP GEOGR MED, V30, P141; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; Preziosi MP, 2002, AM J EPIDEMIOL, V155, P891, DOI 10.1093/aje/155.10.891; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; van Boven M, 2005, P ROY SOC B-BIOL SCI, V272, P1617, DOI 10.1098/rspb.2005.3108; van Gent M, 2009, VACCINE, V27, P1898, DOI 10.1016/j.vaccine.2009.01.111; VanderZee A, 1997, J BACTERIOL, V179, P6609, DOI 10.1128/jb.179.21.6609-6617.1997; VOORHOEVE AM, 1978, TROP GEOGR MED, V30, P125; Yao SM, 2005, J CLIN MICROBIOL, V43, P5457, DOI 10.1128/JCM.43.11.5457-5461.2005	43	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20340	10.1371/journal.pone.0020340	http://dx.doi.org/10.1371/journal.pone.0020340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647370	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500048
J	Kline, RJ; Khan, IA; Holt, GJ				Kline, Richard J.; Khan, Izhar A.; Holt, G. Joan			Behavior, Color Change and Time for Sexual Inversion in the Protogynous Grouper (Epinephelus adscensionis)	PLOS ONE			English	Article							CORAL-REEF FISH; TELEOST SOCIAL SIGNAL; BLUEHEAD WRASSE; THALASSOMA-BIFASCIATUM; ANTHIAS-SQUAMIPINNIS; PISCES; FEMALE; DICHROMATISM; REPRODUCTION; SERRANIDAE	Hermaphroditism, associated with territoriality and dominance behavior, is common in the marine environment. While male sex-specific coloration patterns have been documented in groupers, particularly during the spawning season, few data regarding social structure and the context for these color displays are available. In the present study, we define the social structure and male typical behavior of rock hind (Epinephelus adscensionis) in the wild. In addition, we detail the captive conditions and time period necessary to induce the onset of the sex-specific coloration and sexual change. At six oil production platform locations in the Gulf of Mexico, rock hind social group size and typical male rock hind social behavior were documented. We observed a rapid temporary color display in rock hind that could be turned on and off within three seconds and was used for confronting territory intruders and displays of aggression towards females. The male-specific "tuxedo" pattern consists of a bright yellow tail, a body with alternating dark brown and white patches and a dark bar extending from the upper mandible to the operculum. Identification and size ranges of male, female and intersex fish collected from oil platforms were determined in conjunction with gonadal histology. Rock hind social order is haremic with one dominant male defending a territory and a linear dominance hierarchy among individuals. In five captive experiments, the largest remaining female rock hind displayed the male specific color pattern within 32d after dominant male removal from the social group. To our knowledge, this is the first evidence in a grouper species of color patterning used to display territoriality and dominance outside of spawning aggregations. The behavioral paradigm described here is a key advance that will enable mechanistic studies of this complex sex change process.	[Kline, Richard J.; Holt, G. Joan] Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA; [Khan, Izhar A.] US Fish & Wildlife Serv, Dexter Natl Fish Hatchery & Technol Ctr, Dexter, NM USA	University of Texas System; University of Texas Austin; United States Department of the Interior; US Fish & Wildlife Service	Kline, RJ (corresponding author), Univ Texas Austin, Inst Marine Sci, Port Aransas, TX USA.	rjkline@mail.utexas.edu		Kline, Richard/0000-0002-4116-2060; Khan, Izhar/0000-0002-2811-6561	Lund Fellowship in Marine Science; Sid Richardson Foundation	Lund Fellowship in Marine Science; Sid Richardson Foundation	We acknowledge funding from the Lund Fellowship in Marine Science to RJK and from the Sid Richardson Foundation to GJH and IAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berglund Anders, 1997, P237; Bhandari RK, 2006, ZOOL SCI, V23, P65, DOI 10.2108/zsj.23.65; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; Burns KJ, 1998, EVOLUTION, V52, P1219, DOI 10.1111/j.1558-5646.1998.tb01849.x; CARDWELL JR, 1991, GEN COMP ENDOCR, V81, P7, DOI 10.1016/0016-6480(91)90120-U; COLIN PL, 1987, B MAR SCI, V40, P220; DAWKINS MS, 1993, BEHAV PROCESS, V30, P245, DOI 10.1016/0376-6357(93)90136-F; GILMORE GR, 1992, B MAR SCI, V51, P83; Godwin J, 2009, SEMIN CELL DEV BIOL, V20, P264, DOI 10.1016/j.semcdb.2008.12.003; HASTINGS RW, 1976, FISH B-NOAA, V74, P387; Kline RJ, 2008, N AM J AQUACULT, V70, P266, DOI 10.1577/A07-033.1; Kodric-Brown A, 1998, AM ZOOL, V38, P70; Liu M, 2004, J ZOOL, V264, P239, DOI 10.1017/S0952836904005631; Liu M, 2009, AQUACULTURE, V287, P191, DOI 10.1016/j.aquaculture.2008.10.027; LNTNESKY MMF, 1994, BEHAV ECOLOGY, V5, P375; Lutnesky M, 1988, PAC SCI, V42, P46; Mackie MC, 2003, CORAL REEFS, V22, P133, DOI 10.1007/s00338-003-0296-3; MUSKE LE, 1987, J COMP PHYSIOL A, V160, P99, DOI 10.1007/BF00613445; MUSKE LE, 1987, J COMP PHYSIOL A, V160, P89, DOI 10.1007/BF00613444; Neidig CL, 2000, N AM J AQUACULT, V62, P103, DOI 10.1577/1548-8454(2000)062<0103:TFSCSB>2.0.CO;2; Noga E.J., 2000, FISH DIS DIAGNOSIS T; Polovina J, 1987, TROPICAL SNAPPERS GR; ROBERTSON DR, 1972, SCIENCE, V177, P1007, DOI 10.1126/science.177.4053.1007; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; ROSS RM, 1983, SCIENCE, V221, P574, DOI 10.1126/science.221.4610.574; SADOVY Y, 1994, COPEIA, P511; SADOVY Y, 1987, COPEIA, P136, DOI 10.2307/1446046; Sakai Y, 2003, ZOOL SCI, V20, P627, DOI 10.2108/zsj.20.627; Sakai Y, 2007, J ETHOL, V25, P57, DOI 10.1007/s10164-006-0207-5; Semsar K, 2004, HORM BEHAV, V45, P345, DOI 10.1016/j.yhbeh.2004.01.003; SHAPIRO DY, 1981, J ZOOL, V193, P105; SHAPIRO DY, 1988, ENVIRON BIOL FISH, V23, P283, DOI 10.1007/BF00005240; SHAPIRO DY, 1981, B MAR SCI, V31, P383; Siebeck UE, 2004, ANIM BEHAV, V68, P273, DOI 10.1016/j.anbehav.2003.11.010; THRESHER RE, 1984, REPRODUCTION REEF FI; Todd BD, 2007, CAN J ZOOL, V85, P1008, DOI 10.1139/Z07-082; WARNER RR, 1982, COPEIA, P653; WARNER RR, 1992, EVOLUTION, V46, P1421, DOI 10.1111/j.1558-5646.1992.tb01134.x; WARNER RR, 1991, BIOL BULL-US, V181, P199, DOI 10.2307/1542090; Yeh SL, 2003, AQUACULTURE, V218, P729, DOI 10.1016/S0044-8486(02)00565-3	41	27	27	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19576	10.1371/journal.pone.0019576	http://dx.doi.org/10.1371/journal.pone.0019576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647429	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500005
J	Simpson, SL; Hayasaka, S; Laurienti, PJ				Simpson, Sean L.; Hayasaka, Satoru; Laurienti, Paul J.			Exponential Random Graph Modeling for Complex Brain Networks	PLOS ONE			English	Article							P-ASTERISK MODELS; LOGISTIC REGRESSIONS; SOCIAL NETWORKS; LOGIT-MODELS; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; ORGANIZATION; MRI	Exponential random graph models (ERGMs), also known as p* models, have been utilized extensively in the social science literature to study complex networks and how their global structure depends on underlying structural components. However, the literature on their use in biological networks (especially brain networks) has remained sparse. Descriptive models based on a specific feature of the graph (clustering coefficient, degree distribution, etc.) have dominated connectivity research in neuroscience. Corresponding generative models have been developed to reproduce one of these features. However, the complexity inherent in whole-brain network data necessitates the development and use of tools that allow the systematic exploration of several features simultaneously and how they interact to form the global network architecture. ERGMs provide a statistically principled approach to the assessment of how a set of interacting local brain network features gives rise to the global structure. We illustrate the utility of ERGMs for modeling, analyzing, and simulating complex whole-brain networks with network data from normal subjects. We also provide a foundation for the selection of important local features through the implementation and assessment of three selection approaches: a traditional p-value based backward selection approach, an information criterion approach (AIC), and a graphical goodness of fit (GOF) approach. The graphical GOF approach serves as the best method given the scientific interest in being able to capture and reproduce the structure of fitted brain networks.	[Simpson, Sean L.; Hayasaka, Satoru] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA; [Hayasaka, Satoru; Laurienti, Paul J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Simpson, SL (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27109 USA.	slsimpso@wfubmc.edu			Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke [NS070917]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070917] Funding Source: NIH RePORTER	Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Translational Science Institute of Wake Forest University (Translational Scholar Award, URL: http://www.wfubmc.edu/TSI.htm) and by the National Institute of Neurological Disorders and Stroke (NS070917, URL: http://www.ninds.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Gaal ZA, 2010, NEUROSCI LETT, V479, P79, DOI 10.1016/j.neulet.2010.05.037; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; HANDCOCK MS, 2008, STATNET SOFTWARE TOO; HANDCOCK MS, 2002, STAT MODELS SOCIAL N, P229; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hunter DR, 2008, J AM STAT ASSOC, V103, P248, DOI 10.1198/016214507000000446; Hunter David R, 2008, J Stat Softw, V24, pnihpa54860; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; MORRIS M, 2008, J STAT SOFTWARE, V24; Muller K. E., 2002, REGRESSION ANOVA INT; Pattison P, 1999, BRIT J MATH STAT PSY, V52, P169, DOI 10.1348/000711099159053; Peiffer AM, 2009, HUM BRAIN MAPP, V30, P228, DOI 10.1002/hbm.20497; Rinaldo A, 2009, ELECTRON J STAT, V3, P446, DOI 10.1214/08-EJS350; Robins G, 1999, PSYCHOMETRIKA, V64, P371, DOI 10.1007/BF02294302; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Robins G, 2009, SOC NETWORKS, V31, P105, DOI 10.1016/j.socnet.2008.10.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Saul ZM, 2007, BIOINFORMATICS, V23, P2604, DOI 10.1093/bioinformatics/btm370; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van Duijn MAJ, 2009, SOC NETWORKS, V31, P52, DOI 10.1016/j.socnet.2008.10.003; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	38	63	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20039	10.1371/journal.pone.0020039	http://dx.doi.org/10.1371/journal.pone.0020039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647450	Green Published, Green Submitted, gold			2022-12-25	WOS:000291006500020
J	Vilaplana, C; Gil, O; Caceres, N; Pinto, S; Diaz, J; Cardona, PJ				Vilaplana, Cristina; Gil, Olga; Caceres, Neus; Pinto, Sergio; Diaz, Jorge; Cardona, Pere-Joan			Prophylactic Effect of a Therapeutic Vaccine against TB Based on Fragments of Mycobacterium tuberculosis	PLOS ONE			English	Article							DISEASE; IMMUNOTHERAPY; CHEMOTHERAPY; INFECTION; INFANTS; MURINE; MODEL; WORLD	The prophylactic capacity of the RUTI (R) vaccine, based on fragmented cells of Mycobacterium tuberculosis, has been evaluated in respect to aerosol challenge with virulent bacilli. Subcutaneous vaccination significantly reduced viable bacterial counts in both lungs and spleens of C57Bl mice, when challenged 4 weeks after vaccination. RUTI (R) protected the spleen less than BCG. Following a 9 month vaccination-challenge interval, protection was observed for the lungs, but not for the spleen. Survival of infected guinea pigs was prolonged by vaccination given 5 weeks before challenge. Inoculations of RUTI (R) shortly after infection significantly reduced the viable bacterial counts in the lungs, when compared with infected control mice. Thus, vaccination by RUTI (R) has potential for both the prophylaxis and immunotherapy of tuberculosis.	[Vilaplana, Cristina; Gil, Olga; Caceres, Neus; Pinto, Sergio; Diaz, Jorge; Cardona, Pere-Joan] Univ Autonoma Barcelona, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut Germans Trias, Crta Badalona, Catalonia, Spain; [Vilaplana, Cristina; Gil, Olga; Caceres, Neus; Pinto, Sergio; Diaz, Jorge; Cardona, Pere-Joan] CIBER Enfermedades Resp, Bunyola, Balears, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Vilaplana, C (corresponding author), Univ Autonoma Barcelona, Unitat TB Expt, Fundacio Inst Invest Ciencies Salut Germans Trias, Crta Badalona, Catalonia, Spain.	pjcardona.igtp.germanstrias@gencat.cat	Vilaplana, Cristina/K-7216-2012; Cardona, Pere-Joan/A-5258-2011	Vilaplana, Cristina/0000-0002-2808-7270; Cardona, Pere-Joan/0000-0001-5623-7873	Archivel Farma S.L., the Spanish Ministry of Health [FIS 03/0757, CM06/00123]; European Community [HEALTH-2007-2.3.2-2, 200999]; Archivel Farma S.L.	Archivel Farma S.L., the Spanish Ministry of Health(Spanish Government); European Community(European Commission); Archivel Farma S.L.	The research leading to these results has received funding from Archivel Farma S.L., the Spanish Ministry of Health (FIS 03/0757; National Plan I+D+I FIS CM06/00123; CIBERES CRP-TB) and the European Community's Seventh Framework Programme (HEALTH-2007-2.3.2-2) under grant agreement no 200999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. PJC is co-inventor of the patents for RUTI (R) as a therapeutic vaccine, prophylactic vaccine and as primary prophylaxis against TB. Regulatory approval and development is being undertaken by a spin-out biopharma company (Archivel Farma, S.L.) in collaboration with the Institut Germans Trias i Pujol. PJC is the scientific director of this development. Archivel Farma S.L. partly funded this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Azzopardi P, 2009, INT J TUBERC LUNG D, V13, P1331; Beresford B, 2010, CLIN INFECT DIS, V50, pS178, DOI 10.1086/651489; Cardona PJ, 2006, TUBERCULOSIS, V86, P273, DOI 10.1016/j.tube.2006.01.024; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Domingo M, 2009, SCAND J IMMUNOL, V69, P500, DOI 10.1111/j.1365-3083.2009.02251.x; Fine P, 2005, BRIT MED J, V331, P647, DOI 10.1136/bmj.331.7518.647; Gil O, 2008, CLIN VACCINE IMMUNOL, V15, P1742, DOI 10.1128/CVI.00255-08; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Guirado E, 2008, CLIN VACCINE IMMUNOL, V15, P1229, DOI 10.1128/CVI.00094-08; Hesseling AC, 2008, INT J TUBERC LUNG D, V12, P1376; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Marais B, 2010, LANCET; MARTINEZ A, 2005, ARCH BRONCONEUMOL, P27; McShane H, 2009, SWISS MED WKLY, V139, P156, DOI smw-12374; Moreira AL, 2002, INFECT IMMUN, V70, P2100, DOI 10.1128/IAI.70.4.2100-2107.2002; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; Rook GAW, 1996, CURR TOP MICROBIOL, V215, P239; *TB PARTN WORK GRO, 2009, TB VACC PIP; Vilaplana C, 2010, VACCINE, V28, P1106, DOI 10.1016/j.vaccine.2009.09.134; World Health Organization, 2009, GLOB TUB CONTR EP ST	23	35	35	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2011	6	5							e20404	10.1371/journal.pone.0020404	http://dx.doi.org/10.1371/journal.pone.0020404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IJ	21647222	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005800049
J	Furukawa, Y; Kaneko, K; Nukina, N				Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki			Tau Protein Assembles into Isoform- and Disulfide-dependent Polymorphic Fibrils with Distinct Structural Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMER-LIKE FILAMENTS; IN-VITRO; AMYLOID FIBRILS; DISEASE; AGGREGATION; PHOSPHORYLATION; POLYMERIZATION; CYSTEINE-322; TAUOPATHIES	Tauopathies are neurodegenerative diseases in which insoluble fibrillar aggregates of a microtubule-binding protein, Tau, are abnormally accumulated. Pathological Tau fibrils often exhibit structural polymorphisms that differ among phenotypically distinct tauopathies; however, a molecular mechanism to generate polymorphic Tau fibrils remains obscure. Here, we note the formation of a disulfide bond in isoforms of full-length Tau and show that the thiol-disulfide status as well as the isoform composition determines structural and morphological properties of Tau fibrils in vitro. Mainly two regions in a Tau primary sequence are found to act as structural blocks for building a protease-resistant core of Tau fibrils. Interactions among those two blocks for building a core structure depend upon the thiol-disulfide status in each isoform of Tau, which results in the formation of polymorphic fibrils with distinct structural properties. Furthermore, we have found that more diverse structures of Tau fibrils emerge through a cross-seeded fibrillation between heterologous pairs of Tau isoforms. We thus propose that isoform-and disulfide-dependent combinatorial interactions among multiple regions in a Tau sequence endow Tau fibrils with various structures, i.e. polymorphism.	[Furukawa, Yoshiaki] Keio Univ, Dept Chem, Kanagawa 2238522, Japan; [Furukawa, Yoshiaki; Kaneko, Kumi; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	Keio University; RIKEN	Furukawa, Y (corresponding author), 3-14-1 Hiyoshi, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp; nukina@brain.riken.jp	Furukawa, Yoshiaki/F-2871-2014; Nukina, Nobuyuki/GPP-6265-2022	Furukawa, Yoshiaki/0000-0002-1918-372X; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [22240037, 22110004, 22770162]; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-Aid 22240037 (to N. N.), 22110004 for Scientific Research on Innovative Areas (to N. N.), and 22770162 (to Y. F.), and the Strategic Research Program for Brain Science (to N. N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by funds from the Uehara Memorial Foundation (to Y. F.).	Abraha A, 2000, J CELL SCI, V113, P3737; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Arima K, 2006, NEUROPATHOLOGY, V26, P475, DOI 10.1111/j.1440-1789.2006.00669.x; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Berry RW, 2003, BIOCHEMISTRY-US, V42, P8325, DOI 10.1021/bi027348m; Bhattacharya K, 2001, BIOCHEM BIOPH RES CO, V285, P20, DOI 10.1006/bbrc.2001.5116; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; Ksiezak-Reding H, 2005, MICROSC RES TECHNIQ, V67, P126, DOI 10.1002/jemt.20188; KSIEZAKREDING H, 1994, AM J PATHOL, V145, P1496; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; MUNOZGARCIA D, 1984, ANN NEUROL, V16, P467, DOI 10.1002/ana.410160408; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; NUKINA N, 1985, J BIOCHEM-TOKYO, V98, P1715, DOI 10.1093/oxfordjournals.jbchem.a135443; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Westermark GT, 2009, FEBS LETT, V583, P2685, DOI 10.1016/j.febslet.2009.04.026; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Yanagawa H, 1998, BIOCHEMISTRY-US, V37, P1979, DOI 10.1021/bi9724265	37	43	43	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27236	27246		10.1074/jbc.M111.248963	http://dx.doi.org/10.1074/jbc.M111.248963			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659525	Green Published, hybrid			2022-12-25	WOS:000293268700019
J	Ilioaia, C; Johnson, MP; Liao, PN; Pascal, AA; van Grondelle, R; Walla, PJ; Ruban, AV; Robert, B				Ilioaia, Cristian; Johnson, Matthew P.; Liao, Pen-Nan; Pascal, Andrew A.; van Grondelle, Rienk; Walla, Peter J.; Ruban, Alexander V.; Robert, Bruno			Photoprotection in Plants Involves a Change in Lutein 1 Binding Domain in the Major Light-harvesting Complex of Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN-SPECTROSCOPY; ENERGY-DISSIPATION; GREEN PLANTS; LHC-II; CHLOROPHYLL FLUORESCENCE; CATION FORMATION; ZEAXANTHIN; DYNAMICS; ANTENNA; ARABIDOPSIS	Nonphotochemical quenching (NPQ) is the fundamental process by which plants exposed to high light intensities dissipate the potentially harmful excess energy as heat. Recently, it has been shown that efficient energy dissipation can be induced in the major light-harvesting complexes of photosystem II (LHCII) in the absence of protein-protein interactions. Spectroscopic measurements on these samples (LHCII gels) in the quenched state revealed specific alterations in the absorption and circular dichroism bands assigned to neoxanthin and lutein 1 molecules. In this work, we investigate the changes in conformation of the pigments involved in NPQ using resonance Raman spectroscopy. By selective excitation we show that, as well as the twisting of neoxanthin that has been reported previously, the lutein 1 pigment also undergoes a significant change in conformation when LHCII switches to the energy dissipative state. Selective two-photon excitation of carotenoid (Car) dark states (Car S-1) performed on LHCII gels shows that the extent of electronic interactions between Car S-1 and chlorophyll states correlates linearly with chlorophyll fluorescence quenching, as observed previously for isolated LHCII (aggregated versus trimeric) and whole plants (with versus without NPQ).	[Ilioaia, Cristian; van Grondelle, Rienk] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Ilioaia, Cristian; Pascal, Andrew A.; Robert, Bruno] Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; [Ilioaia, Cristian; Pascal, Andrew A.; Robert, Bruno] CNRS URA 2096, F-91191 Gif Sur Yvette, France; [Johnson, Matthew P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Liao, Pen-Nan; Walla, Peter J.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany; [Walla, Peter J.] Max Planck Inst Biophys Chem, Dept Spect & Photochem Kinet, D-37077 Gottingen, Germany	Vrije Universiteit Amsterdam; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; Queen Mary University London; Braunschweig University of Technology; Max Planck Society	Ilioaia, C (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, De Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	cristian.ilioaia@cea.fr; bruno.robert@cea.fr	Robert, Bruno/D-1264-2012; pascal, andrew a/B-6186-2014	Robert, Bruno/0000-0001-5999-4538; pascal, andrew a/0000-0002-1844-6065; ILIOAIA, Cristian/0000-0001-7505-1900; Johnson, Matthew/0000-0002-1663-0205	Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences; European Union [ERG 224796]; United Kingdom Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; German Science Foundation; Fondation of the Ecole Normale Superieure; European Research Council	Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences; European Union(European Commission); United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); German Science Foundation(German Research Foundation (DFG)); Fondation of the Ecole Normale Superieure; European Research Council(European Research Council (ERC)European Commission)	This work was supported by The Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences (to C. I. and R. v. G.), the European Union FP7 Marie Curie Reintegration Grant ERG 224796 (to C. I.), research and equipment grants from the United Kingdom Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council (to A. V. R. and M. P. J.), the German Science Foundation (to P.-N. L. and P. J. W.), Blaise Pascal Chair from the Fondation of the Ecole Normale Superieure (to R. v. G.), a European Union FP7 Marie Curie HARVEST Network grant and European Research Council Grant PhotProt (to B. R. and R. v. G.).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; Bode S, 2008, CHEM PHYS LETT, V450, P379, DOI 10.1016/j.cplett.2007.11.035; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; Dreuw A, 2006, J PHYS CHEM A, V110, P4592, DOI 10.1021/jp057385y; Frahmcke JS, 2006, CHEM PHYS LETT, V430, P397, DOI 10.1016/j.cplett.2006.09.009; Frank HA, 2000, BIOCHEMISTRY-US, V39, P2831, DOI 10.1021/bi9924664; Hilbert M, 2004, J PHYS CHEM B, V108, P13022, DOI 10.1021/jp048576o; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Ilioaia C, 2011, J BIOL CHEM, V286, P91, DOI 10.1074/jbc.M110.184887; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Johnson MP, 2009, J BIOL CHEM, V284, P23592, DOI 10.1074/jbc.M109.013557; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kruger TPJ, 2010, BIOPHYS J, V98, P3093, DOI 10.1016/j.bpj.2010.03.028; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liao PN, 2010, CHEM PHYS, V373, P50, DOI 10.1016/j.chemphys.2010.01.006; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; Lutz M., 1984, ADV INFRARED RAMAN S, V11, P211; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; ROBERT B, 1986, BIOCHEMISTRY-US, V25, P2303, DOI 10.1021/bi00357a001; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; RUBAN AV, 1995, BIOCHEMISTRY-US, V34, P2333, DOI 10.1021/bi00007a029; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; VANOORT B, 2011, PHYS CHEM C IN PRESS; Wehling A, 2005, J PHYS CHEM B, V109, P24510, DOI 10.1021/jp053890j	47	57	58	2	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27247	27254		10.1074/jbc.M111.234617	http://dx.doi.org/10.1074/jbc.M111.234617			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646360	Green Published, hybrid			2022-12-25	WOS:000293268700020
J	Wobber, V; Hare, B				Wobber, Victoria; Hare, Brian			Psychological Health of Orphan Bonobos and Chimpanzees in African Sanctuaries	PLOS ONE			English	Article							DIFFERENTIALLY REARED CHIMPANZEES; INTELLECTUAL-PERFORMANCE; ABNORMAL BEHAVIORS; WILD-BORN; PAN; DEPRIVATION; COGNITION; LOCATION; HUMANS; RANGE	Background: Facilities across Africa care for apes orphaned by the trade for "bushmeat.'' These facilities, called sanctuaries, provide housing for apes such as bonobos (Pan paniscus) and chimpanzees (Pan troglodytes) who have been illegally taken from the wild and sold as pets. Although these circumstances are undoubtedly stressful for the apes, most individuals arrive at the sanctuaries as infants and are subsequently provided with rich physical and social environments that can facilitate the expression of species-typical behaviors. Methods and Findings: We tested whether bonobo and chimpanzee orphans living in sanctuaries show any behavioral, physiological, or cognitive abnormalities relative to other individuals in captivity as a result of the early-life stress they experience. Orphans showed lower levels of aberrant behaviors, similar levels of average cortisol, and highly similar performances on a broad battery of cognitive tests in comparisons with individuals of the same species who were either living at a zoo or were reared by their mothers at the sanctuaries. Conclusion: Taken together, these results support the rehabilitation strategy used by sanctuaries in the Pan-African Sanctuary Alliance (PASA) and suggest that the orphans we examined did not show long-term signs of stress as a result of their capture. Our findings also show that sanctuary apes are as psychologically healthy as apes in other captive settings and thus represent a valuable resource for non-invasive research.	[Wobber, Victoria] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Hare, Brian] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Hare, Brian] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Harvard University; Duke University; Duke University	Wobber, V (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	wobber@fas.harvard.edu			European Research Commission [233297]; National Science Foundation [NSF-BCS-08-27552, NSF-BCS-10-25172, NSF-BCS-0851291]; L.S.B. Leakey Foundation; Wenner-Gren Foundation	European Research Commission(European CommissionEuropean Commission Joint Research Centre); National Science Foundation(National Science Foundation (NSF)); L.S.B. Leakey Foundation; Wenner-Gren Foundation	This work was supported in part by European Research Commission (http://ec.europa.eu/research/) Advanced Grant Agreement 233297 and National Science Foundation (http://www.nsf.gov) grants NSF-BCS-08-27552 and NSF-BCS-10-25172 to B. H, and an L.S.B. Leakey Foundation Grant (http://www.leakeyfoundation.org), NSF-BCS-0851291 (DDIG), and a Wenner-Gren Foundation Grant (http://www.wennergren.org) to V. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2008, DEV PRIMATOL-PROG PR, P303, DOI 10.1007/978-0-387-74787-3_16; Baker KC, 2000, AM J PRIMATOL, V51, P161, DOI 10.1002/1098-2345(200007)51:3<161::AID-AJP1>3.3.CO;2-X; Baker KC, 1996, APPL ANIM BEHAV SCI, V49, P403, DOI 10.1016/0168-1591(96)01061-1; BAKER KC, 1996, CONTEMP TOP LAB ANIM, V35, P71; Beck Benjamin B., 2010, P332; Beckett C, 2006, CHILD DEV, V77, P696, DOI 10.1111/j.1467-8624.2006.00898.x; Biro D, 2011, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P476; BLOOMSMITH M, 2005, NURSERY REARING NONH, P289; COX D, CHIMP SANCT GUID MAN; DAVENPOR.RK, 1969, AM J MENT DEF, V73, P963; DAVENPORT RK, 1973, DEV PSYCHOL, V9, P343, DOI 10.1037/h0034877; DAVENPORT RK, 1968, AM J MENT DEF, V72, P674; DAVENPORT RK, 1963, ARCH GEN PSYCHIAT, V8, P99; DAVENPORT RK, 1970, CHIMPANZEE, P337; Farmer KH, 2006, INT J PRIMATOL, V27, P747, DOI 10.1007/s10764-006-9041-4; Farmer KH, 2002, AM J PRIMATOL, V58, P117, DOI 10.1002/ajp.10054; FRITZ J, 1992, ZOO BIOL, V11, P313, DOI 10.1002/zoo.1430110503; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gruber T, 2010, ANIM BEHAV, V80, P1023, DOI 10.1016/j.anbehav.2010.09.005; Hanus D, 2008, CURR BIOL, V18, pR370, DOI 10.1016/j.cub.2008.02.039; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Herrmann E, 2010, PSYCHOL SCI, V21, P102, DOI 10.1177/0956797609356511; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Kalcher E, 2008, DEV PSYCHOBIOL, V50, P777, DOI 10.1002/dev.20330; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Law AJ, 2009, NEUROPSYCHOPHARMACOL, V34, P1381, DOI 10.1038/npp.2008.106; LIPSON S F, 1989, American Journal of Human Biology, V1, P249, DOI 10.1002/ajhb.1310010304; Lonsdorf EV, 2006, ANIM COGN, V9, P36, DOI 10.1007/s10071-005-0002-7; MAKI S, 1989, ZOO BIOL, V8, P79, DOI 10.1002/zoo.1430080110; MAKI S, 1993, INFANT BEHAV DEV, V16, P373, DOI 10.1016/0163-6383(93)80042-7; Martin P., 1986, MEASURING BEHAV; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; McIntyre MH, 2009, J HUM EVOL, V56, P361, DOI 10.1016/j.jhevol.2008.12.004; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; MENZEL EW, 1970, FOLIA PRIMATOL, V12, P273, DOI 10.1159/000155297; Mugisha L, 2010, J MED PRIMATOL, V39, P123, DOI 10.1111/j.1600-0684.2010.00400.x; Nash LT, 1999, AM J PRIMATOL, V48, P15, DOI 10.1002/(SICI)1098-2345(1999)48:1<15::AID-AJP2>3.3.CO;2-I; PAQUETTE D, 1988, ZOO BIOL, V7, P15, DOI 10.1002/zoo.1430070103; Pika S, 2008, AM J PRIMATOL, V70, P207, DOI 10.1002/ajp.20469; Pruetz JD, 2001, CARE MANAGEMENT CAPT, P17; Reimers M, 2007, HORM BEHAV, V51, P428, DOI 10.1016/j.yhbeh.2006.12.011; ROGERS CM, 1971, AM J MENT DEF, V75, P526; SAPOLSKY R, 1994, WHY ZEBRAS DONT GET, P1; SPIJKERMAN R, 1996, EFFECTS PEER ONLY RE; Spijkerman RP, 1997, INT J PRIMATOL, V18, P439, DOI 10.1023/A:1026342602018; Stevens HE, 2009, J AM ACAD CHILD PSY, V48, P114, DOI 10.1097/CHI.0b013e318193064c; Tomasello M, 2005, MONOGR SOC RES CHILD, V70, P1; TURNER CH, 1969, AM J PSYCHIAT, V125, P1531, DOI 10.1176/ajp.125.11.1531; Tutin CEG, 2001, CONSERV BIOL, V15, P1247, DOI 10.1046/j.1523-1739.2001.00046.x; van IJzendoorn MH, 2009, DEV PSYCHOBIOL, V51, P173, DOI 10.1002/dev.20356; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; WALSH S, 1982, AM J PRIMATOL, V3, P315, DOI 10.1002/ajp.1350030131; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Wobber V, 2010, P NATL ACAD SCI USA, V107, P12457, DOI 10.1073/pnas.1007411107; Wobber V, 2010, CURR BIOL, V20, P226, DOI 10.1016/j.cub.2009.11.070; Wrangham R, 2008, INT J PRIMATOL, V29, P3, DOI 10.1007/s10764-008-9237-x; Wrangham Richard, 2010, P370; Wrangham RW, 1992, CHIMPANZEE CONSERVAT, P71	60	63	63	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e17147	10.1371/journal.pone.0017147	http://dx.doi.org/10.1371/journal.pone.0017147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666743	Green Published, gold			2022-12-25	WOS:000291607000001
J	McGowan, EM; Alling, N; Jackson, EA; Yagoub, D; Haass, NK; Allen, JD; Martinello-Wilks, R				McGowan, Eileen M.; Alling, Nikki; Jackson, Elise A.; Yagoub, Daniel; Haass, Nikolas K.; Allen, John D.; Martinello-Wilks, Rosetta			Evaluation of Cell Cycle Arrest in Estrogen Responsive MCF-7 Breast Cancer Cells: Pitfalls of the MTS Assay	PLOS ONE			English	Article							RECEPTOR-ALPHA; MULTIDRUG TRANSPORTER; PROGESTERONE-RECEPTOR; MULTIPLE-SCLEROSIS; FINGOLIMOD FTY720; RESISTANCE; PROTEIN; MDM2; MECHANISM; GROWTH	Endocrine resistance is a major problem with anti-estrogen treatments and how to overcome resistance is a major concern in the clinic. Reliable measurement of cell viability, proliferation, growth inhibition and death is important in screening for drug treatment efficacy in vitro. This report describes and compares commonly used proliferation assays for induced estrogen-responsive MCF-7 breast cancer cell cycle arrest including: determination of cell number by direct counting of viable cells; or fluorescence SYBR (R) Green (SYBR) DNA labeling; determination of mitochondrial metabolic activity by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay; assessment of newly synthesized DNA using 5-ethynyl-2'-deoxyuridine (EdU) nucleoside analog binding and Alexa Fluor (R) azide visualization by fluorescence microscopy; cell-cycle phase measurement by flow cytometry. Treatment of MCF-7 cells with ICI 182780 (Faslodex), FTY720, serum deprivation or induction of the tumor suppressor p14ARF showed inhibition of cell proliferation determined by the Trypan Blue exclusion assay and SYBR DNA labeling assay. In contrast, the effects of treatment with ICI 182780 or p14ARF-induction were not confirmed using the MTS assay. Cell cycle inhibition by ICI 182780 and p14ARF-induction was further confirmed by flow cytometric analysis and EdU-DNA incorporation. To explore this discrepancy further, we showed that ICI 182780 and p14ARF-induction increased MCF-7 cell mitochondrial activity by MTS assay in individual cells compared to control cells thereby providing a misleading proliferation readout. Interrogation of p14ARF-induction on MCF-7 metabolic activity using TMRE assays and high content image analysis showed that increased mitochondrial activity was concomitant with increased mitochondrial biomass with no loss of mitochondrial membrane potential, or cell death. We conclude that, whilst p14ARF and ICI 182780 stop cell cycle progression, the cells are still viable and potential treatments utilizing these pathways may contribute to drug resistant cells. These experiments demonstrate how the combined measurement of metabolic activity and DNA labeling provides a more reliable interpretation of cancer cell response to treatment regimens.	[McGowan, Eileen M.; Yagoub, Daniel; Martinello-Wilks, Rosetta] Univ Technol Sydney, Translat Canc Res Grp, Sch Med & Mol Biosci, Fac Sci, Sydney, NSW 2007, Australia; [McGowan, Eileen M.; Jackson, Elise A.; Haass, Nikolas K.; Allen, John D.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Alling, Nikki] Garvan Inst Med Res, Flow Cytometry Unit, Sydney, NSW, Australia; [Jackson, Elise A.; Haass, Nikolas K.; Allen, John D.] Centenary Inst, Sydney, NSW, Australia	University of Technology Sydney; University of Sydney; Garvan Institute of Medical Research; University of Sydney; Centenary Institute	McGowan, EM (corresponding author), Univ Technol Sydney, Translat Canc Res Grp, Sch Med & Mol Biosci, Fac Sci, Sydney, NSW 2007, Australia.	Eileen.Mcgowan@uts.edu.au	Haass, Nikolas K/M-8507-2015	Haass, Nikolas K/0000-0002-3928-5360; Martiniello-Wilks, Rosetta/0000-0002-0038-3430; McGowan, Eileen/0000-0001-6371-3751	Cancer Institute NSW; Sydney Cancer Center; Royal Prince Alfred Hospital, Sydney; Prostate Cancer Foundation of Australia [PR37]; Rebecca L Cooper Medical Research Foundation; Australian Rotary Health Research Fund; Melanoma and Skin Cancer Research Institute, Australia; Cancer Council New South Wales [RG 09-08]; Priority-Driven Collaborative Cancer Research Scheme/Cancer Australia/Cure Cancer Australia Foundation [570778]; Cancer Institute New South Wales [08/RFG/1-27]; National Health and Medical Research Council [1003637]	Cancer Institute NSW; Sydney Cancer Center; Royal Prince Alfred Hospital, Sydney(University of Sydney); Prostate Cancer Foundation of Australia; Rebecca L Cooper Medical Research Foundation; Australian Rotary Health Research Fund; Melanoma and Skin Cancer Research Institute, Australia; Cancer Council New South Wales(Cancer Council New South Wales); Priority-Driven Collaborative Cancer Research Scheme/Cancer Australia/Cure Cancer Australia Foundation; Cancer Institute New South Wales; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	EMM and JDA are recipients of the Cancer Institute NSW Fellowships. Sydney Cancer Center Research Grants, Royal Prince Alfred Hospital, Sydney, were awarded to EMM and RM-W. Project Grants PR37 (Prostate Cancer Foundation of Australia) and Rebecca L Cooper Medical Research Foundation were awarded to RM-W. The Australian Rotary Health Research Fund Scholarship was awarded to EAJ. NKH is a recipient of the Cameron Fellowship from the Melanoma and Skin Cancer Research Institute, Australia. NKH is CIA on Project Grant RG 09-08 (Cancer Council New South Wales), Project Grant 570778 (Priority-Driven Collaborative Cancer Research Scheme/Cancer Australia/Cure Cancer Australia Foundation), Research Innovation Grant 08/RFG/1-27 (Cancer Institute New South Wales), and Project Grant 1003637 (National Health and Medical Research Council). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Allen JD, 2002, CANCER RES, V62, P2294; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Carroll JS, 2000, J BIOL CHEM, V275, P38221, DOI 10.1074/jbc.M004424200; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dilda PJ, 2005, JNCI-J NATL CANCER I, V97, P1539, DOI 10.1093/jnci/dji316; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Holland ML, 2007, BRIT J PHARMACOL, V152, P815, DOI 10.1038/sj.bjp.0707467; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; Liu WS, 2006, J BIOL CHEM, V281, P9837, DOI 10.1074/jbc.C600001200; McGowan EM, 2007, CANCER RES, V67, P8942, DOI 10.1158/0008-5472.CAN-07-1255; McGowan EM, 1999, MOL ENDOCRINOL, V13, P1657, DOI 10.1210/me.13.10.1657; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagahara Y, 2000, J IMMUNOL, V165, P3250, DOI 10.4049/jimmunol.165.6.3250; QUELLE DE, 1995, CELL, V83, P993; Saji S, 2001, BIOCHEM BIOPH RES CO, V281, P259, DOI 10.1006/bbrc.2001.4339; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Stam RW, 2004, LEUKEMIA, V18, P78, DOI 10.1038/sj.leu.2403168; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202	23	49	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20623	10.1371/journal.pone.0020623	http://dx.doi.org/10.1371/journal.pone.0020623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673993	Green Published, gold			2022-12-25	WOS:000291355500026
J	Han, WD; Pan, HM; Chen, Y; Sun, J; Wang, YS; Li, J; Ge, WT; Feng, LF; Lin, XY; Wang, XJ; Wang, X; Jin, HC				Han, Weidong; Pan, Hongming; Chen, Yan; Sun, Jie; Wang, Yanshan; Li, Jing; Ge, Weiting; Feng, Lifeng; Lin, Xiaoying; Wang, Xiaojia; Wang, Xian; Jin, Hongchuan			EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; PROTEIN EXPRESSION; RESISTANCE; DEATH; INDUCTION; APOPTOSIS; EFFICACY; TARGET	Epidermal growth factor receptor tyrosine kinase inhibitors gefitinib and erlotinib have been widely used in patients with non-small-cell lung cancer. Unfortunately, the efficacy of EGFR-TKIs is limited because of natural and acquired resistance. As a novel cytoprotective mechanism for tumor cell to survive under unfavorable conditions, autophagy has been proposed to play a role in drug resistance of tumor cells. Whether autophagy can be activated by gefitinib or erlotinib and thereby impair the sensitivity of targeted therapy to lung cancer cells remains unknown. Here, we first report that gefitinib or erlotinib can induce a high level of autophagy, which was accompanied by the inhibition of the PI3K/Akt/mTOR signaling pathway. Moreover, cytotoxicity induced by gefitinib or erlotinib was greatly enhanced after autophagy inhibition by the pharmacological inhibitor chloroquine (CQ) and siRNAs targeting ATG5 and ATG7, the most important components for the formation of autophagosome. Interestingly, EGFR-TKIs can still induce cell autophagy even after EGFR expression was reduced by EGFR specific siRNAs. In conclusion, we found that autophagy can be activated by EGFR-TKIs in lung cancer cells and inhibition of autophagy augmented the growth inhibitory effect of EGFR-TKIs. Autophagy inhibition thus represents a promising approach to improve the efficacy of EGFR-TKIs in the treatment of patients with advanced non-small-cell lung cancer.	[Han, Weidong; Pan, Hongming; Chen, Yan; Li, Jing; Wang, Xian] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Med Oncol,Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jie; Feng, Lifeng; Lin, Xiaoying; Jin, Hongchuan] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Lab Canc Epigenet,Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yanshan; Wang, Xiaojia] Zhejiang Chinese Med Univ, Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China; [Ge, Weiting] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; Zhejiang Chinese Medical University; Zhejiang University	Pan, HM (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Med Oncol,Biomed Res Ctr, Hangzhou 310003, Zhejiang, Peoples R China.	panhongming@medmail.com.cn; jinhc@srrsh.com	GE, Weiting/AAK-5197-2020; Jin, Hongchuan/C-3686-2009	GE, Weiting/0000-0002-4769-0251; Wang, Xian/0000-0003-0041-7589; Jin, Hongchuan/0000-0002-6697-3097	National Natural Science Foundation of China [30901740]; China National Ministry of Education [20090101120124]; Zhejiang Natural Sciences Foundation [Y2090166]; Zhejiang Education Department [Y200805751]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Ministry of Education; Zhejiang Natural Sciences Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Education Department; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (grant number 30901740, www.nsfc.gov.cn), China National Ministry of Education Grant (grant number 20090101120124, www.moe.edu.cn), Zhejiang Natural Sciences Foundation Grant (grant number Y2090166, www.zjnsf.net:81), and Research Projects of Zhejiang Education Department (grant number Y200805751, www.zjedu.gov.cn) to W. Han, and the Fundamental Research Funds for the Central Universities to H. Jin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Brehmer D, 2005, CANCER RES, V65, P379; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Galluzzi L, 2008, CURR MOL MED, V8, P78; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528; Nguyen KSH, 2009, CLIN LUNG CANCER, V10, P281, DOI 10.3816/CLC.2009.n.039; Ray M, 2009, ONCOLOGIST, V14, P1116, DOI 10.1634/theoncologist.2009-0054; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Spiro SG, 2010, RESPIROLOGY, V15, P44, DOI 10.1111/j.1440-1843.2009.01674.x; Sun SY, 2010, AUTOPHAGY, V6, P184, DOI 10.4161/auto.6.1.10816; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; WU PCC, 2010, GENES CANC, V1, P40; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	36	195	211	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e18691	10.1371/journal.pone.0018691	http://dx.doi.org/10.1371/journal.pone.0018691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655094	Green Published, gold, Green Submitted			2022-12-25	WOS:000291310600002
J	Heinrich, M; Oberbach, A; Schlichting, N; Stolzenburg, JU; Neuhaus, J				Heinrich, Marco; Oberbach, Andreas; Schlichting, Nadine; Stolzenburg, Jens-Uwe; Neuhaus, Jochen			Cytokine Effects on Gap Junction Communication and Connexin Expression in Human Bladder Smooth Muscle Cells and Suburothelial Myofibroblasts	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; TNF-ALPHA; PROINFLAMMATORY CYTOKINES; INTERSTITIAL CYSTITIS; INTERLEUKIN-4; PROLIFERATION; MODULATION; PROTEIN; PHOSPHORYLATION; DIFFERENTIATION	Background: The last decade identified cytokines as one group of major local cell signaling molecules related to bladder dysfunction like interstitial cystitis (IC) and overactive bladder syndrome (OAB). Gap junctional intercellular communication (GJIC) is essential for the coordination of normal bladder function and has been found to be altered in bladder dysfunction. Connexin (Cx) 43 and Cx45 are the most important gap junction proteins in bladder smooth muscle cells (hBSMC) and suburothelial myofibroblasts (hsMF). Modulation of connexin expression by cytokines has been demonstrated in various tissues. Therefore, we investigate the effect of interleukin (IL) 4, IL6, IL10, tumor necrosis factor-alpha (TNF alpha) and transforming growth factor-beta1 (TGF beta 1) on GJIC, and Cx43 and Cx45 expression in cultured human bladder smooth muscle cells (hBSMC) and human suburothelial myofibroblasts (hsMF). Methodology/Principal Findings: HBSMC and hsMF cultures were set up from bladder tissue of patients undergoing cystectomy. In cytokine stimulated cultured hBSMC and hsMF GJIC was analyzed via Fluorescence Recovery after Photobleaching (FRAP). Cx43 and Cx45 expression was assessed by quantitative PCR and confocal immunofluorescence. Membrane protein fraction of Cx43 and Cx45 was quantified by Dot Blot. Upregulation of cell-cell-communication was found after IL6 stimulation in both cell types. In hBSMC IL4 and TGF beta 1 decreased both, GJIC and Cx43 protein expression, while TNFa did not alter communication in FRAP-experiments but increased Cx43 expression. GJ plaques size correlated with coupling efficacy measured, while Cx45 expression did not correlate with modulation of GJIC. Conclusions/Significance: Our finding of specific cytokine effects on GJIC support the notion that cytokines play a pivotal role for pathophysiology of OAB and IC. Interestingly, the effects were independent from the classical definition of pro- and antiinflammatory cytokines. We conclude, that connexin regulation involves genomic and/or post-translational events, and that GJIC in hBSMC and hsMF depend of Cx43 rather than on Cx45.	[Heinrich, Marco; Stolzenburg, Jens-Uwe; Neuhaus, Jochen] Univ Leipzig, Dept Urol, Leipzig, Germany; [Oberbach, Andreas; Schlichting, Nadine] Univ Leipzig, Univ Hosp, Dept Pediat Surg, Leipzig, Germany; [Oberbach, Andreas; Schlichting, Nadine] Univ Leipzig, Med Ctr, IFB Adipos Dis, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Heinrich, M (corresponding author), Univ Leipzig, Dept Urol, Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de			Deutsche Forschungsgemeinschaft (DFG) [NE425/4-4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) (NE425/4-4). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaci Muriel, 2007, Biotechnology Journal, V2, P50, DOI 10.1002/biot.200600092; Ahirwar D, 2008, CANCER GENET CYTOGEN, V184, P1, DOI 10.1016/j.cancergencyto.2008.02.015; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Aoudjehane L, 2008, LAB INVEST, V88, P973, DOI 10.1038/labinvest.2008.61; Bouchelouche K, 2006, UROLOGY, V67, P214, DOI 10.1016/j.urology.2005.07.049; Bouchelouche K, 2006, J UROLOGY, V175, P760, DOI 10.1016/S0022-5347(05)00167-9; Crespin S, 2010, J CELL BIOCHEM, V110, P589, DOI 10.1002/jcb.22554; Drake MJ, 2006, BJU INT, V97, P29, DOI 10.1111/j.1464-410X.2006.05818.x; Duthe F, 2001, AM J PHYSIOL-CELL PH, V281, pC1648, DOI 10.1152/ajpcell.2001.281.5.C1648; Erickson DR, 2002, J UROLOGY, V167, P2461, DOI 10.1016/S0022-5347(05)65005-7; Eyden B, 2001, ULTRASTRUCT PATHOL, V25, P39, DOI 10.1080/019131201300004672; Eyden B, 2004, ULTRASTRUCT PATHOL, V28, P307, DOI 10.1080/019131290882204; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fortin ME, 2006, BIOL REPROD, V74, P2, DOI 10.1095/biolreprod.105.044313; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Haferkamp A, 2004, EUR UROL, V46, P799, DOI 10.1016/j.eururo.2004.08.020; Haghikia A, 2008, J NEURO-ONCOL, V86, P143, DOI 10.1007/s11060-007-9462-8; Kanai A, 2007, AM J PHYSIOL-RENAL, V292, pF1065, DOI 10.1152/ajprenal.00229.2006; Kuijpers KAJ, 2007, EUR UROL, V52, P1213, DOI 10.1016/j.eururo.2007.01.052; KWAK BR, 1995, MOL BIOL CELL, V6, P1707, DOI 10.1091/mbc.6.12.1707; Kwak BR, 1996, MOL CELL BIOCHEM, V157, P93; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Lim MCC, 2009, EUR J CELL BIOL, V88, P719, DOI 10.1016/j.ejcb.2009.08.003; Martin FJ, 2008, J IMMUNOL, V180, P4986, DOI 10.4049/jimmunol.180.7.4986; Mattey DL, 1997, ANN RHEUM DIS, V56, P426, DOI 10.1136/ard.56.7.426; Meilleur MA, 2007, ENDOCRINOLOGY, V148, P5913, DOI 10.1210/en.2007-0767; Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Neuhaus J, 2007, UROLOGE, V46, P1193, DOI 10.1007/s00120-007-1479-2; Neuhaus J, 2005, BJU INT, V96, P670, DOI 10.1111/j.1464-410X.2005.05703.x; Neuhaus J, 2009, EUR UROL, V55, P491, DOI 10.1016/j.eururo.2008.03.090; Oberbach A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010882; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Rackauskas M, 2010, MEDICINA-LITHUANIA, V46, P1, DOI 10.3390/medicina46010001; Rama A, 2006, EUR J CELL BIOL, V85, P375, DOI 10.1016/j.ejcb.2005.11.007; Roosen A, 2009, J UROLOGY, V182, P190, DOI 10.1016/j.juro.2009.02.148; Roosen A, 2009, EUR UROL, V55, P1440, DOI 10.1016/j.eururo.2008.11.009; Saban MR, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-4; Saban Ricardo, 2007, BMC Urol, V7, P7, DOI 10.1186/1471-2490-7-7; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Sharrow AC, 2008, EXP CELL RES, V314, P297, DOI 10.1016/j.yexcr.2007.10.010; Shim JY, 2008, J KOREAN MED SCI, V23, P857, DOI 10.3346/jkms.2008.23.5.857; Sui GP, 2002, BJU INT, V90, P118, DOI 10.1046/j.1464-410X.2002.02834.x; Tacheau C, 2008, J CELL PHYSIOL, V216, P438, DOI 10.1002/jcp.21412; TYAGI P, 2009, INT UROL NEPHROL; Ueda T, 2002, J UROLOGY, V167, P347, DOI 10.1016/S0022-5347(05)65466-3; Vandooren B, 2008, ARTHRITIS RHEUM, V58, P3051, DOI 10.1002/art.23886; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; Wang HZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1366, DOI 10.1152/ajpcell.00027.2006; Zhang HY, 2010, CELL PHYSIOL BIOCHEM, V26, P327, DOI 10.1159/000320556; Zhang Y, 2008, CELL COMMUN ADHES, V15, P289, DOI 10.1080/15419060802198736	56	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20792	10.1371/journal.pone.0020792	http://dx.doi.org/10.1371/journal.pone.0020792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674053	gold, Green Published, Green Submitted			2022-12-25	WOS:000291310600032
J	Lim, J; Kong, R; Murugan, E; Ho, CL; Liang, ZX; Yang, D				Lim, Jackwee; Kong, Rong; Murugan, Elavazhagan; Ho, Chun Loong; Liang, Zhao-Xun; Yang, Daiwen			Solution Structures of the Acyl Carrier Protein Domain from the Highly Reducing Type I Iterative Polyketide Synthase CalE8	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; CRYSTAL-STRUCTURES; MECHANISM; DYNAMICS; BINDING; ACP; RECOGNITION; REVEAL; THIOESTERASE; FORMS	Biosynthesis of the enediyne natural product calicheamicins gamma(I)(1) in Micromonospora echinospora ssp. calichensis is initiated by the iterative polyketide synthase (PKS) CalE8. Recent studies showed that CalE8 produces highly conjugated polyenes as potential biosynthetic intermediates and thus belongs to a family of highly-reducing (HR) type I iterative PKSs. We have determined the NMR structure of the ACP domain (meACP) of CalE8, which represents the first structure of a HR type I iterative PKS ACP domain. Featured by a distinct hydrophobic patch and a glutamate-residue rich acidic patch, meACP adopts a twisted three-helix bundle structure rather than the canonical four-helix bundle structure. The so-called 'recognition helix' (alpha 2) of meACP is less negatively charged than the typical type II ACPs. Although loop-2 exhibits greater conformational mobility than other regions of the protein with a missing short helix that can be observed in most ACPs, two bulky non-polar residues (Met(992), Phe(996)) from loop-2 packed against the hydrophobic protein core seem to restrict large movement of the loop and impede the opening of the hydrophobic pocket for sequestering the acyl chains. NMR studies of the hydroxybutyryl-and octanoyl-meACP confirm that meACP is unable to sequester the hydrophobic chains in a well-defined central cavity. Instead, meACP seems to interact with the octanoyl tail through a distinct hydrophobic patch without involving large conformational change of loop-2. NMR titration study of the interaction between meACP and the cognate thioesterase partner CalE7 further suggests that their interaction is likely through the binding of CalE7 to the meACP-tethered polyene moiety rather than direct specific protein-protein interaction.	[Lim, Jackwee; Yang, Daiwen] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Kong, Rong; Murugan, Elavazhagan; Ho, Chun Loong; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lim, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	zxliang@ntu.edu.sg; dbsydw@nus.edu.sg	Liang, Zhao-Xun/A-2191-2011; yang, daiwen/H-8408-2012; Ho, Loong/U-5867-2018; Loong, Ho Chun/AAF-9353-2020	yang, daiwen/0000-0002-6804-0071; Ho, Loong/0000-0003-2846-3392; Liang, Zhao-Xun/0000-0002-3128-1330; Lim, Jackwee/0000-0003-4344-6822	Singapore Ministry of Education (MOE) through an ARC [06/1/22/19/464]; Biomedical Research Coucil, Agency for Science, Technology and Research of Singapore [R154000373305]	Singapore Ministry of Education (MOE) through an ARC(Ministry of Education, Singapore); Biomedical Research Coucil, Agency for Science, Technology and Research of Singapore	This work is supported by Singapore Ministry of Education (MOE) through an ARC grant to Z-X L (Grant Number: 06/1/22/19/464) and by a grant from Biomedical Research Coucil, Agency for Science, Technology and Research of Singapore (R154000373305) to DY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Alekseyev VY, 2007, PROTEIN SCI, V16, P2093, DOI 10.1110/ps.073011407; Arthur CJ, 2009, ACS CHEM BIOL, V4, P625, DOI 10.1021/cb900099e; Belecki K, 2009, J AM CHEM SOC, V131, P12564, DOI 10.1021/ja904391r; Bingle LEH, 1999, FUNGAL GENET BIOL, V26, P209, DOI 10.1006/fgbi.1999.1115; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crump MP, 1997, BIOCHEMISTRY-US, V36, P6000, DOI 10.1021/bi970006+; Crump MP, 1996, FEBS LETT, V391, P302, DOI 10.1016/0014-5793(96)00756-9; Evans SE, 2008, CHEMBIOCHEM, V9, P2424, DOI 10.1002/cbic.200800180; Findlow SC, 2003, BIOCHEMISTRY-US, V42, P8423, DOI 10.1021/bi0342259; Hadfield AT, 2004, STRUCTURE, V12, P1865, DOI 10.1016/j.str.2004.08.002; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Horsman GP, 2010, P NATL ACAD SCI USA, V107, P11331, DOI 10.1073/pnas.1003442107; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; Kong R, 2008, J AM CHEM SOC, V130, P8142, DOI 10.1021/ja8019643; Kotaka M, 2009, J BIOL CHEM, V284, P15739, DOI 10.1074/jbc.M809669200; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leibundgut M, 2007, SCIENCE, V316, P288, DOI 10.1126/science.1138249; Li Q, 2003, BIOCHEMISTRY-US, V42, P4648, DOI 10.1021/bi0274120; Liang ZX, 2010, NAT PROD REP, V27, P499, DOI 10.1039/b908165h; Liew CW, 2010, J MOL BIOL, V404, P291, DOI 10.1016/j.jmb.2010.09.041; Liu W, 2003, P NATL ACAD SCI USA, V100, P11959, DOI 10.1073/pnas.2034291100; Mercer AC, 2007, NAT PROD REP, V24, P750, DOI 10.1039/b603921a; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; Murugan E, 2010, PROTEIN EXPRES PURIF, V71, P132, DOI 10.1016/j.pep.2010.01.007; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Ploskon E, 2010, CHEM BIOL, V17, P776, DOI 10.1016/j.chembiol.2010.05.024; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Smith S, 2007, NAT PROD REP, V24, P1041, DOI 10.1039/b603600g; Sun HH, 2009, CHEM COMMUN, P7399, DOI 10.1039/b916751j; Upadhyay SK, 2009, J BIOL CHEM, V284, P22390, DOI 10.1074/jbc.M109.014829; Wattana-Amorn P, 2010, BIOCHEMISTRY-US, V49, P2186, DOI 10.1021/bi902176v; Weber T, 2000, STRUCT FOLD DES, V8, P407, DOI 10.1016/S0969-2126(00)00120-9; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xu GY, 2001, STRUCTURE, V9, P277, DOI 10.1016/S0969-2126(01)00586-X; Xu YQ, 2007, J AM CHEM SOC, V129, P7722, DOI 10.1021/ja071442e; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Yang DW, 2004, J AM CHEM SOC, V126, P3710, DOI 10.1021/ja039102q; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784; Zhang J, 2008, P NATL ACAD SCI USA, V105, P1460, DOI 10.1073/pnas.0711625105; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d; Zornetzer GA, 2010, BIOCHEMISTRY-US, V49, P470, DOI 10.1021/bi9014659	49	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20549	10.1371/journal.pone.0020549	http://dx.doi.org/10.1371/journal.pone.0020549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674045	Green Published, gold, Green Submitted			2022-12-25	WOS:000291310600014
J	Wei, JCC; Yen, JH; Juo, SHH; Chen, WC; Wang, YS; Chiu, YC; Hsieh, TJ; Guo, YC; Huang, CH; Wong, RH; Wang, HP; Tsai, KL; Wu, YC; Chang, HW; Hsi, E; Chang, WP; Chang, WC				Wei, James Cheng-Chung; Yen, Jeng-Hsien; Juo, Suh-Hang Hank; Chen, Wei-Chiao; Wang, Yu-Shiuan; Chiu, Yi-Ching; Hsieh, Tusty-Jiuan; Guo, Yuh-Cherng; Huang, Chun-Huang; Wong, Ruey-Hong; Wang, Hui-Po; Tsai, Ke-Li; Wu, Yang-Chang; Chang, Hsueh-Wei; Hsi, Edward; Chang, Wei-Pin; Chang, Wei-Chiao			Association of ORAI1 Haplotypes with the Risk of HLA-B27 Positive Ankylosing Spondylitis	PLOS ONE			English	Article							ACTIVATED CALCIUM-CHANNELS; GENE-COMPLEX MEMBERS; CRAC; SUSCEPTIBILITY; POPULATION; CHINESE; TAIWAN; POLYMORPHISMS; RECEPTOR; TARGET	Ankylosing spondylitis (AS) is a chronic inflammation of the sacroiliac joints, spine and peripheral joints. The aetiology of ankylosing spondylitis is still unclear. Previous studies have indicated that genetics factors such as human leukocyte antigen HLA-B27 associates to AS susceptibility. We carried out a case-control study to determine whether the genetic polymorphisms of ORAI1 gene, a major component of store-operated calcium channels that involved the regulation of immune system, is a susceptibility factor to AS in a Taiwanese population. We enrolled 361 AS patients fulfilled the modified New York criteria and 379 controls from community. Five tagging single nucleotides polymorphisms (tSNPs) at ORAI1 were selected from the data of Han Chinese population in HapMap project. Clinical statuses of AS were assessed by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), and Bath Ankylosing Spondylitis Global Index (BAS-G). Our results indicated that subjects carrying the minor allele homozygote (CC) of the promoter SNP rs12313273 or TT homozygote of the SNP rs7135617 had an increased risk of HLA-B27 positive AS. The minor allele C of 3'UTR SNP rs712853 exerted a protective effect to HLA-B27 positive AS. Furthermore, the rs12313273/rs7135617 pairwise allele analysis found that C-G (OR 1.69, 95% CI 1.27, 2.25; p = 0.0003) and T-T (OR 1.75, 95% CI 1.36, 2.27; p<0.0001) haplotypes had a significantly association with the risk of HLA-B27-positive AS in comparison with the T-G carriers. This is the first study that indicate haplotypes of ORAI1 (rs12313273 and rs7135617) are associated with the risk of HLA-B27 positive AS.	[Wei, James Cheng-Chung; Huang, Chun-Huang; Wong, Ruey-Hong] China Med Univ, Div Allergy Immunol & Rheumatol, Chung Shan Med Univ Hosp, Chung Shan Med Univ,Dept Med,Inst Med,Grad Inst I, Taichung, Taiwan; [Juo, Suh-Hang Hank; Chen, Wei-Chiao; Wang, Yu-Shiuan; Chiu, Yi-Ching; Hsieh, Tusty-Jiuan; Hsi, Edward; Chang, Wei-Chiao] Kaohsiung Med Univ, Dept Med Genet, Coll Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank; Chang, Wei-Chiao] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Yen, Jeng-Hsien] Kaohsiung Med Univ Hosp, Div Rheumatol, Dept Internal Med, Kaohsiung, Taiwan; [Chang, Hsueh-Wei] Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Yen, Jeng-Hsien] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chang, Wei-Pin] Yuanpei Univ, Dept Healthcare Management, Hsinchu, Taiwan; [Guo, Yuh-Cherng] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Neurol, Kaohsiung, Taiwan; [Tsai, Ke-Li] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Wang, Hui-Po] Taipei Med Univ, Dept Pharm, Taipei, Taiwan; [Wu, Yang-Chang] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan	China Medical University Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Taipei Medical University; China Medical University Taiwan	Chang, WC (corresponding author), Kaohsiung Med Univ, Dept Med Genet, Coll Med, Kaohsiung, Taiwan.	wcc@kmu.edu.tw	Chang, Hsueh-Wei/C-9654-2009; Hsi, Edward/A-1356-2013; Wei, James Cheng-Chung/AAL-8947-2020; Yen, Jeng-Hsien/A-1335-2010; Wu, Yang-Chang/C-5682-2009; Juo, Suh-Hang/C-9545-2009	Chang, Hsueh-Wei/0000-0003-0068-2366; Hsi, Edward/0000-0002-8272-6707; Wei, James Cheng-Chung/0000-0002-1235-0679; Yen, Jeng-Hsien/0000-0002-1291-1739; Wu, Yang-Chang/0000-0001-7815-2686; Wang, Yu-Shiuan/0000-0001-7204-1256; Hsieh, Tusty-Jiuan/0000-0001-5387-6522; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council of Taiwan [NSC 98-2320-B-037 -028 -MY2]; Department of Health, Executive Yuan, Taiwan, ROC [DOH99-TD-C-111-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Executive Yuan, Taiwan, ROC	This study was supported by National Science Council of Taiwan (NSC 98-2320-B-037 -028 -MY2); excellence for cancer research center grant (NO.DOH99-TD-C-111-002), Department of Health, Executive Yuan, Taiwan, ROC to W. C. Chang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Assassi S, 2011, J RHEUMATOL, V38, P87, DOI 10.3899/jrheum.100469; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; BREWERTON DA, 1973, LANCET, V1, P904; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Chatzikyriakidou A, 2010, SCAND J IMMUNOL, V71, P382, DOI 10.1111/j.1365-3083.2010.02381.x; Chen C, 2010, CLIN IMMUNOL, V136, P442, DOI 10.1016/j.clim.2010.05.003; Chou CT, 2006, ANN RHEUM DIS, V65, P1106, DOI 10.1136/ard.2005.046847; Chou CT, 2001, J IMMUNOL METHODS, V255, P15, DOI 10.1016/S0022-1759(01)00414-8; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Furuichi T, 2008, J HUM GENET, V53, P419, DOI 10.1007/s10038-008-0265-3; Guo ZS, 2010, INT J IMMUNOGENET, V37, P33, DOI 10.1111/j.1744-313X.2009.00889.x; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Lee SK, 2010, LIFE SCI, V86, P863, DOI 10.1016/j.lfs.2010.03.022; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; LOPEZ D, 1994, J IMMUNOL, V152, P5557; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Roberts-Thomson SJ, 2010, PHARMACOL THERAPEUT, V127, P121, DOI 10.1016/j.pharmthera.2010.04.016; Rudwaleit M, 2001, ANN RHEUM DIS, V60, P36, DOI 10.1136/ard.60.1.36; Safrany E, 2009, SCAND J IMMUNOL, V70, P68, DOI 10.1111/j.1365-3083.2009.02265.x; Sanchez A, 2010, J RHEUMATOL, V37, P2345, DOI 10.3899/jrheum.100211; Schindl R, 2009, P NATL ACAD SCI USA, V106, P19623, DOI 10.1073/pnas.0907714106; Shiau MY, 2007, ANN RHEUM DIS, V66, P562, DOI 10.1136/ard.2006.065888; Trebak M, 2009, CIRC RES, V104, pE56, DOI 10.1161/CIRCRESAHA.109.196105; van der Heijde D, 1999, J RHEUMATOL, V26, P951; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wei JCC, 2007, CLIN RHEUMATOL, V26, P1685, DOI 10.1007/s10067-007-0573-6; Wei JCC, 2004, RHEUMATOLOGY, V43, P839, DOI 10.1093/rheumatology/keh193	38	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20426	10.1371/journal.pone.0020426	http://dx.doi.org/10.1371/journal.pone.0020426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21674042	Green Submitted, Green Published, gold			2022-12-25	WOS:000291309900018
J	Zitterbart, DP; Wienecke, B; Butler, JP; Fabry, B				Zitterbart, Daniel P.; Wienecke, Barbara; Butler, James P.; Fabry, Ben			Coordinated Movements Prevent Jamming in an Emperor Penguin Huddle	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; TRANSITION; PARTICLES; DYNAMICS	For Emperor penguins (Aptenodytes forsteri), huddling is the key to survival during the Antarctic winter. Penguins in a huddle are packed so tightly that individual movements become impossible, reminiscent of a jamming transition in compacted colloids. It is crucial, however, that the huddle structure is continuously reorganized to give each penguin a chance to spend sufficient time inside the huddle, compared with time spent on the periphery. Here we show that Emperor penguins move collectively in a highly coordinated manner to ensure mobility while at the same time keeping the huddle packed. Every 30-60 seconds, all penguins make small steps that travel as a wave through the entire huddle. Over time, these small movements lead to large-scale reorganization of the huddle. Our data show that the dynamics of penguin huddling is governed by intermittency and approach to kinetic arrest in striking analogy with inert non-equilibrium systems, including soft glasses and colloids.	[Zitterbart, Daniel P.; Fabry, Ben] Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany; [Zitterbart, Daniel P.] Alfred Wegener Inst Polar & Marine Res AWI, Bremerhaven, Germany; [Wienecke, Barbara] Australian Antarctic Div, Kingston, Tas, Australia; [Butler, James P.] Harvard Univ, Sch Publ Hlth, Mol Integrat Physiol Sci Program, Boston, MA 02115 USA; [Butler, James P.] Harvard Univ, Sch Med, Dept Med, Div Sleep Med, Boston, MA USA; [Butler, James P.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Erlangen Nuremberg; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Australian Antarctic Division; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Zitterbart, DP (corresponding author), Univ Erlangen Nurnberg, Dept Phys, Erlangen, Germany.	daniel.p.zitterbart@physik.uni-erlangen.de	Fabry, Ben/C-5496-2013; Zitterbart, Daniel/N-7489-2013; Fabry, Ben/AAT-5717-2020	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Zitterbart, Daniel/0000-0001-9429-4350				Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Ancel A, 2009, P ROY SOC B-BIOL SCI, V276, P2163, DOI 10.1098/rspb.2009.0140; Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Czirok A, 2000, PHYSICA A, V281, P17, DOI 10.1016/S0378-4371(00)00013-3; Gilbert C, 2008, POLAR BIOL, V31, P163, DOI 10.1007/s00300-007-0343-6; Gilbert C, 2007, AM J PHYSIOL-REG I, V292, pR176, DOI 10.1152/ajpregu.00912.2005; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Perc M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/1/003; Prevost J, 1961, ECOLOGIE MANCHOT EMP; Segre PN, 2001, PHYS REV LETT, V86, P6042, DOI 10.1103/PhysRevLett.86.6042; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; TAMBE D, 2010, COLLECTIVE CELL GUID; Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	21	33	35	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20260	10.1371/journal.pone.0020260	http://dx.doi.org/10.1371/journal.pone.0020260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673816	Green Published, gold			2022-12-25	WOS:000291309900008
J	Lin, SC; Huang, MH; Tsou, PC; Huang, LM; Chong, P; Wu, SC				Lin, Shih-Chang; Huang, Ming-Hsi; Tsou, Pei-Chun; Huang, Li-Min; Chong, Pele; Wu, Suh-Chin			Recombinant Trimeric HA Protein Immunogenicity of H5N1 Avian Influenza Viruses and Their Combined Use with Inactivated or Adenovirus Vaccines	PLOS ONE			English	Article							BACTERIOPHAGE-T4 FIBRITIN; HEMAGGLUTININ PROTEINS; CHALLENGE INFECTION; ANTIGENIC STRUCTURE; ANTIBODIES; DOMAIN; RESPONSES; CHICKENS; FERRETS	Background: The highly pathogenic avian influenza (HPAI) H5N1 virus continues to cause disease in poultry and humans. The hemagglutinin (HA) envelope protein is the primary target for subunit vaccine development. Methodology/Principal Findings: We used baculovirus-insect cell expression to obtain trimeric recombinant HA (rHA) proteins from two HPAI H5N1 viruses. We investigated trimeric rHA protein immunogenicity in mice via immunizations, and found that the highest levels of neutralizing antibodies resulted from coupling with a PELC/CpG adjuvant. We also found that the combined use of trimeric rHA proteins with (a) an inactivated H5N1 vaccine virus, or (b) a recombinant adenovirus encoding full-length HA sequences for prime-boost immunization, further improved antibody responses against homologous and heterologous H5N1 virus strains. Data from cross-clade prime-boost immunization regimens indicate that sequential immunization with different clade HA antigens increased antibody responses in terms of total IgG level and neutralizing antibody titers. Conclusion/Significance: Our findings suggest that the use of trimeric rHA in prime-boost vaccine regimens represents an alternative strategy for recombinant H5N1 vaccine development.	[Lin, Shih-Chang; Tsou, Pei-Chun; Wu, Suh-Chin] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Lin, Shih-Chang; Tsou, Pei-Chun; Wu, Suh-Chin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Huang, Ming-Hsi; Chong, Pele; Wu, Suh-Chin] Natl Hlth Res Inst, Vaccine Res & Dev Ctr, Zhunan, Miaoli County, Taiwan; [Huang, Li-Min] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10764, Taiwan	National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital	Lin, SC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	scwu@mx.nthu.edu.tw	Huang, Ming-Hsi/E-3872-2010; Chong, Pele/E-3855-2010; Wu, Suh-Chin/AAV-6233-2021	Huang, Ming-Hsi/0000-0002-9670-3821; HUANG, LI-MIN/0000-0002-9291-260X	National Science Council [NSC98-2321-B-007-003]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council (NSC98-2321-B-007-003) and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez BH, 2008, PROTEIN ENG DES SEL, V21, P11, DOI 10.1093/protein/gzm071; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Boudko SP, 2002, EUR J BIOCHEM, V269, P833, DOI 10.1046/j.1432-1033.2002.02734.x; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Ikeno D, 2009, VACCINE, V27, P3121, DOI 10.1016/j.vaccine.2009.01.007; Kalthoff D, 2010, J VIROL, V84, P12002, DOI 10.1128/JVI.00940-10; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; King JC, 2009, VACCINE, V27, P6589, DOI 10.1016/j.vaccine.2009.08.032; Li J, 2009, EUR J IMMUNOL, V39, P3498, DOI 10.1002/eji.200939532; Lin YJ, 2008, J VET MED SCI, V70, P1147, DOI 10.1292/jvms.70.1147; Loeffen WLA, 2011, VACCINE, V29, P1545, DOI 10.1016/j.vaccine.2010.12.096; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Nkolola JP, 2010, J VIROL, V84, P3270, DOI 10.1128/JVI.02252-09; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Sabarth N, 2010, VACCINE, V28, P650, DOI 10.1016/j.vaccine.2009.10.105; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466	36	48	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20052	10.1371/journal.pone.0020052	http://dx.doi.org/10.1371/journal.pone.0020052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655326	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600016
J	Roux, O; Cereghino, R; Solano, PJ; Dejean, A				Roux, Olivier; Cereghino, Regis; Solano, Pascal J.; Dejean, Alain			Caterpillars and Fungal Pathogens: Two Co-Occurring Parasites of an Ant-Plant Mutualism	PLOS ONE			English	Article							FUSARIUM-MONILIFORME; PRIORITY; COMPETITION; CECROPIA; DEFENSE; AZTECA; EUPHORBIACEAE; MYRMECOPHYTES; COMMUNITIES; SPECIFICITY	In mutualisms, each interacting species obtains resources from its partner that it would obtain less efficiently if alone, and so derives a net fitness benefit. In exchange for shelter (domatia) and food, mutualistic plant-ants protect their host myrmecophytes from herbivores, encroaching vines and fungal pathogens. Although selective filters enable myrmecophytes to host those ant species most favorable to their fitness, some insects can by-pass these filters, exploiting the rewards supplied whilst providing nothing in return. This is the case in French Guiana for Cecropia obtusa (Cecropiaceae) as Pseudocabima guianalis caterpillars (Lepidoptera, Pyralidae) can colonize saplings before the installation of their mutualistic Azteca ants. The caterpillars shelter in the domatia and feed on food bodies (FBs) whose production increases as a result. They delay colonization by ants by weaving a silk shield above the youngest trichilium, where the FBs are produced, blocking access to them. This probable temporal priority effect also allows female moths to lay new eggs on trees that already shelter caterpillars, and so to occupy the niche longer and exploit Cecropia resources before colonization by ants. However, once incipient ant colonies are able to develop, they prevent further colonization by the caterpillars. Although no higher herbivory rates were noted, these caterpillars are ineffective in protecting their host trees from a pathogenic fungus, Fusarium moniliforme (Deuteromycetes), that develops on the trichilium in the absence of mutualistic ants. Therefore, the Cecropia treelets can be parasitized by two often overlooked species: the caterpillars that shelter in the domatia and feed on FBs, delaying colonization by mutualistic ants, and the fungal pathogen that develops on old trichilia. The cost of greater FB production plus the presence of the pathogenic fungus likely affect tree growth.	[Roux, Olivier; Dejean, Alain] CNRS, Ecol Forets Guyane UMR 8172, Kourou, France; [Cereghino, Regis] CNRS, UMR 5245, EcoLab Lab Ecol Fonct, Toulouse, France; [Cereghino, Regis; Dejean, Alain] Univ Toulouse, UPS, Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Roux, O (corresponding author), CNRS, Ecol Forets Guyane UMR 8172, Campus Agron, Kourou, France.	olivier.roux@ird.fr	Roux, Olivier/A-1181-2011; CEREGHINO, Regis/G-9500-2011; Roux, Olivier/I-5675-2016	Roux, Olivier/0000-0001-5440-0219; Cereghino, Regis/0000-0003-3981-3159; Dejean, Alain/0000-0002-3561-2248	European Community	European Community(European Commission)	Financial support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane, from the European Community (project DEGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CHEM DEFENSES ARTHRO; Belin-Depoux M, 1997, ACTA BOT GALLICA, V144, P289, DOI 10.1080/12538078.1997.10515375; Berenger JM, 1997, CR ACAD SCI III-VIE, V320, P1007, DOI 10.1016/S0764-4469(97)82474-2; BERTNESS MD, 1993, AM NAT, V142, P718, DOI 10.1086/285567; Boulay R, 2009, OECOLOGIA, V161, P529, DOI 10.1007/s00442-009-1404-z; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bronstein Judith L., 2004, P305, DOI 10.1017/CBO9780511542022.022; Brouat C, 2001, P ROY SOC B-BIOL SCI, V268, P2131, DOI 10.1098/rspb.2001.1763; Clement LW, 2008, BEHAV ECOL SOCIOBIOL, V62, P953, DOI 10.1007/s00265-007-0520-1; COLE RJ, 1973, SCIENCE, V179, P1324, DOI 10.1126/science.179.4080.1324; COLEY PD, 1986, OECOLOGIA, V70, P238, DOI 10.1007/BF00379246; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Davidson Diane W., 1993, Journal of Hymenoptera Research, V2, P13; DAVIDSON DW, 1989, BIOTROPICA, V21, P64, DOI 10.2307/2388444; Davidson DW., 2005, FLORA NEOTROPICA MON, P214; Dejean A, 2008, EVOL ECOL RES, V10, P1217; Dejean A, 2009, NATURWISSENSCHAFTEN, V96, P57, DOI 10.1007/s00114-008-0448-y; Dejean A, 2010, NATURWISSENSCHAFTEN, V97, P925, DOI 10.1007/s00114-010-0710-y; Del Val E, 2003, PLANT ECOL, V169, P35, DOI 10.1023/A:1026227811685; Derridj S, 1996, ENTOMOL EXP APPL, V80, P197, DOI 10.1007/BF00194756; Djieto-Lordon C, 2004, ACTA OECOL, V26, P109, DOI 10.1016/j.actao.2004.03.007; Edwards DP, 2006, INSECT SOC, V53, P172, DOI 10.1007/s00040-006-0855-z; Faveri SB, 2004, BIOTROPICA, V36, P641, DOI 10.1111/j.1744-7429.2004.tb00359.x; FOLGARAIT PJ, 1994, FUNCT ECOL, V8, P22, DOI 10.2307/2390107; Fonseca CR, 2003, OIKOS, V102, P407, DOI 10.1034/j.1600-0579.2003.12021.x; Grangier J, 2009, BIOL J LINN SOC, V97, P90, DOI 10.1111/j.1095-8312.2008.01188.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; GUPTA S, 1991, MYCOPATHOLOGIA, V115, P185, DOI 10.1007/BF00462223; Heil M, 1997, J ECOL, V85, P847, DOI 10.2307/2960606; Heil M, 2000, NATURWISSENSCHAFTEN, V87, P555, DOI 10.1007/s001140050778; Heil M, 2001, OECOLOGIA, V126, P395, DOI 10.1007/s004420000532; Heil M, 1999, NATURWISSENSCHAFTEN, V86, P146, DOI 10.1007/s001140050589; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Hodge S, 1996, OIKOS, V76, P350, DOI 10.2307/3546207; JANZEN DH, 1975, SCIENCE, V188, P936, DOI 10.1126/science.188.4191.936; Jolivet P., 1996, ANTS PLANTS EXAMPLE; Jurgens A, 2006, BIOCHEM SYST ECOL, V34, P97, DOI 10.1016/j.bse.2005.08.005; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; KLEIN RW, 1992, NATURWISSENSCHAFTEN, V79, P422, DOI 10.1007/BF01138577; Ladd B, 2008, OECOLOGIA, V157, P687, DOI 10.1007/s00442-008-1110-2; LaPierre L, 2007, NATURWISSENSCHAFTEN, V94, P997, DOI 10.1007/s00114-007-0270-y; LAWLER SP, 1993, ECOLOGY, V74, P174, DOI 10.2307/1939512; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Letourneau DK, 1998, ECOLOGY, V79, P593, DOI 10.1890/0012-9658(1998)079[0593:ASBAFP]2.0.CO;2; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; Longino JT, 2007, ZOOTAXA, P1; LONGINO JT, 1989, BIOTROPICA, V21, P126, DOI 10.2307/2388703; LONGINO JT, 1991, ANT - PLANT INTERACTIONS, P271; MAC ARTHUR ROBERT H., 1967; Mack KML, 2008, OIKOS, V117, P310, DOI 10.1111/j.2007.0030-1299.15973.x; MASCHWITZ U, 1984, OECOLOGIA, V64, P78, DOI 10.1007/BF00377547; MASCHWITZ U, 1970, J INSECT PHYSIOL, V16, P387, DOI 10.1016/0022-1910(70)90180-0; McClure M, 2008, CR BIOL, V331, P663, DOI 10.1016/j.crvi.2008.06.008; NELSON PE, 1992, MYCOPATHOLOGIA, V117, P29, DOI 10.1007/BF00497276; Ortius-Lechner D, 2000, J CHEM ECOL, V26, P1667, DOI 10.1023/A:1005543030518; Palmer TM, 2002, OECOLOGIA, V133, P372, DOI 10.1007/s00442-002-1026-1; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Sagers CL, 2000, OECOLOGIA, V123, P582, DOI 10.1007/PL00008863; STOREY GK, 1991, J INVERTEBR PATHOL, V58, P88, DOI 10.1016/0022-2011(91)90166-N; Stow A, 2008, BRAIN BEHAV IMMUN, V22, P1009, DOI 10.1016/j.bbi.2008.03.008; TEETORBARSCH GH, 1983, MYCOPATHOLOGIA, V84, P3, DOI 10.1007/BF00436991; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; VASCONCELOS HL, 1993, OECOLOGIA, V95, P439, DOI 10.1007/BF00321000; Ward Philip S., 1993, Journal of Hymenoptera Research, V2, P117; WILBUR HM, 1985, ECOLOGY, V66, P1106, DOI 10.2307/1939162; Wilkinson DM, 2001, OIKOS, V92, P377, DOI 10.1034/j.1600-0706.2001.920222.x; Yu DW, 2001, BIOL J LINN SOC, V72, P529, DOI [10.1006/bijl.2000.0514, 10.1111/j.1095-8312.2001.tb01336.x]; Yu DW, 1997, ECOL MONOGR, V67, P273, DOI 10.1890/0012-9615(1997)067[0273:ESOSSI]2.0.CO;2; Zientz E, 2005, ARCH MICROBIOL, V184, P199, DOI 10.1007/s00203-005-0041-0	70	12	13	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20538	10.1371/journal.pone.0020538	http://dx.doi.org/10.1371/journal.pone.0020538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655182	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600091
J	Salsman, VS; Chow, KKH; Shaffer, DR; Kadikoy, H; Li, XN; Gerken, C; Perlaky, L; Metelitsa, LS; Gao, XH; Bhattacharjee, M; Hirschi, K; Heslop, HE; Gottschalk, S; Ahmed, N				Salsman, Vita S.; Chow, Kevin K. H.; Shaffer, Donald R.; Kadikoy, Huseyin; Li, Xiao-Nan; Gerken, Claudia; Perlaky, Laszlo; Metelitsa, Leonid S.; Gao, Xiuhua; Bhattacharjee, Meena; Hirschi, Karen; Heslop, Helen E.; Gottschalk, Stephen; Ahmed, Nabil			Crosstalk between Medulloblastoma Cells and Endothelium Triggers a Strong Chemotactic Signal Recruiting T Lymphocytes to the Tumor Microenvironment	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTORS; EXPRESSION; GROWTH; MOUSE; MIF; TRAFFICKING; REGRESSION; EOTAXIN; RANTES; CCR3	Cancer cells can live and grow if they succeed in creating a favorable niche that often includes elements from the immune system. While T lymphocytes play an important role in the host response to tumor growth, the mechanism of their trafficking to the tumor remains poorly understood. We show here that T lymphocytes consistently infiltrate the primary brain cancer, medulloblastoma. We demonstrate, both in vitro and in vivo, that these T lymphocytes are attracted to tumor deposits only after the tumor cells have interacted with tumor vascular endothelium. Macrophage Migration Inhibitory Factor (MIF)'' is the key chemokine molecule secreted by tumor cells which induces the tumor vascular endothelial cells to secrete the potent T lymphocyte attractant "Regulated upon Activation, Normal T-cell Expressed, and Secreted (RANTES)." This in turn creates a chemotactic gradient for RANTES-receptor bearing T lymphocytes. Manipulation of this pathway could have important therapeutic implications.	[Salsman, Vita S.; Chow, Kevin K. H.; Shaffer, Donald R.; Kadikoy, Huseyin; Gerken, Claudia; Metelitsa, Leonid S.; Gao, Xiuhua; Hirschi, Karen; Heslop, Helen E.; Gottschalk, Stephen; Ahmed, Nabil] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Salsman, Vita S.; Chow, Kevin K. H.; Shaffer, Donald R.; Kadikoy, Huseyin; Li, Xiao-Nan; Gerken, Claudia; Perlaky, Laszlo; Metelitsa, Leonid S.; Gao, Xiuhua; Heslop, Helen E.; Gottschalk, Stephen; Ahmed, Nabil] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Salsman, Vita S.; Chow, Kevin K. H.; Shaffer, Donald R.; Kadikoy, Huseyin; Li, Xiao-Nan; Gerken, Claudia; Perlaky, Laszlo; Metelitsa, Leonid S.; Gao, Xiuhua; Heslop, Helen E.; Gottschalk, Stephen; Ahmed, Nabil] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Metelitsa, Leonid S.; Gao, Xiuhua; Bhattacharjee, Meena; Hirschi, Karen; Gottschalk, Stephen] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Heslop, Helen E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Salsman, VS (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	nahmed@bcm.edu	Heslop, Helen/AAC-9500-2020; Gottschalk, Stephen/M-9343-2018	Gottschalk, Stephen/0000-0003-3991-7468	Clayton Foundation for Research [P30CA125123]; Dana Foundation; American Brain Tumor Association; Dan L. Duncan Chair; NATIONAL CANCER INSTITUTE [P30CA125123, P01CA094237] Funding Source: NIH RePORTER	Clayton Foundation for Research; Dana Foundation; American Brain Tumor Association; Dan L. Duncan Chair; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors were supported by P30CA125123, grants from the Clayton Foundation for Research, the Dana Foundation, and the American Brain Tumor Association. HEH is supported by a Dan L. Duncan Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SF, 2009, CANCER-AM CANCER SOC, V115, P2891, DOI 10.1002/cncr.24317; Ahmed N, 2007, CANCER RES, V67, P5957, DOI 10.1158/0008-5472.CAN-06-4309; Ahmed N, 2010, CLIN CANCER RES, V16, P474, DOI 10.1158/1078-0432.CCR-09-1322; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Borovski T, 2009, INT J CANCER, V125, P1222, DOI 10.1002/ijc.24408; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cayrol R, 2008, NAT IMMUNOL, V9, P137, DOI 10.1038/ni1551; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Desfrancois J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008437; DONNEM T, 2010, CANCER; Fisher DT, 2006, IMMUNOL INVEST, V35, P251, DOI 10.1080/08820130600745430; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Gerber BO, 1997, CURR BIOL, V7, P836, DOI 10.1016/S0960-9822(06)00371-X; Hansson G K, 1999, Curr Atheroscler Rep, V1, P150, DOI 10.1007/s11883-999-0011-0; HEEGER P, 1992, KIDNEY INT, V41, P220, DOI 10.1038/ki.1992.31; Javeed A, 2008, INFLAMM RES, V57, P45, DOI 10.1007/s00011-007-7110-6; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kwong BY, 2010, J INVEST DERMATOL, V130, P1726, DOI 10.1038/jid.2009.362; Laconi E, 2008, SEMIN CANCER BIOL, V18, P322, DOI 10.1016/j.semcancer.2008.03.019; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Lazovic J, 2008, CLIN CANCER RES, V14, P3832, DOI 10.1158/1078-0432.CCR-07-5067; LEFORT CT, 2010, J VIS EXP; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; McDowell KL, 2010, PROSTATE, V70, P377, DOI 10.1002/pros.21071; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Neumann H, 2002, TRENDS NEUROSCI, V25, P313, DOI 10.1016/S0166-2236(02)02154-9; Nikitenko LL, 2009, CELL TISSUE RES, V335, P223, DOI 10.1007/s00441-008-0707-4; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sager R, 1992, Cytokines, V4, P96; SAGER R, 1991, ADV EXP MED BIOL, V305, P73; SCHALL TJ, 1992, EUR J IMMUNOL, V22, P1477, DOI 10.1002/eji.1830220621; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Ubogu EE, 2006, CELL IMMUNOL, V243, P19, DOI 10.1016/j.cellimm.2006.12.001; Uguccioni M, 1997, J CLIN INVEST, V100, P1137, DOI 10.1172/JCI119624; Vaday GG, 2001, J LEUKOCYTE BIOL, V69, P885; Van Coillie E, 1999, CYTOKINE GROWTH F R, V10, P61, DOI 10.1016/S1359-6101(99)00005-2; Vishwanath RP, 2005, J IMMUNOL METHODS, V302, P78, DOI 10.1016/j.jim.2005.04.021; Waldner MJ, 2009, SEMIN IMMUNOPATHOL, V31, P249, DOI 10.1007/s00281-009-0161-8; Yaghoubi SS, 2009, NAT CLIN PRACT ONCOL, V6, P53, DOI 10.1038/ncponc1278; Zancope E, 2010, J ORAL PATHOL MED, V39, P162, DOI 10.1111/j.1600-0714.2009.00792.x	48	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20267	10.1371/journal.pone.0020267	http://dx.doi.org/10.1371/journal.pone.0020267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647415	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052500044
J	Hogg, OT; Barnes, DKA; Griffiths, HJ				Hogg, Oliver T.; Barnes, David K. A.; Griffiths, Huw J.			Highly Diverse, Poorly Studied and Uniquely Threatened by Climate Change: An Assessment of Marine Biodiversity on South Georgia's Continental Shelf	PLOS ONE			English	Article							GEOGRAPHICALLY SEPARATED POPULATIONS; SEAWATER TEMPERATURES; ECOLOGICAL RELEVANCE; SCOTIA SEA; OCEAN; LIMITS; BIOGEOGRAPHY; COMMUNITIES; INDICATORS; EVOLUTION	We attempt to quantify how significant the polar archipelago of South Georgia is as a source of regional and global marine biodiversity. We evaluate numbers of rare, endemic and range-edge species and how the faunal structure of South Georgia may respond to some of the fastest warming waters on the planet. Biodiversity data was collated from a comprehensive review of reports, papers and databases, collectively representing over 125 years of polar exploration. Classification of each specimen was recorded to species level and fully geo-referenced by depth, latitude and longitude. This information was integrated with physical data layers (e.g. temperature, salinity and flow) providing a visualisation of South Georgia's biogeography across spatial, temporal and taxonomic scales, placing it in the wider context of the Southern Hemisphere. This study marks the first attempt to map the biogeography of an archipelago south of the Polar Front. Through it we identify the South Georgian shelf as the most speciose region of the Southern Ocean recorded to date. Marine biodiversity was recorded as rich across taxonomic levels with 17,732 records yielding 1,445 species from 436 families, 51 classes and 22 phyla. Most species recorded were rare, with 35% recorded only once and 86% recorded,10 times. Its marine fauna is marked by the cumulative dominance of endemic and range-edge species, potentially at their thermal tolerance limits. Consequently, our data suggests the ecological implications of environmental change to the South Georgian marine ecosystem could be severe. If sea temperatures continue to rise, we suggest that changes will include depth profile shifts of some fauna towards cooler Antarctic Winter Water (90-150 m), the loss of some range-edge species from regional waters, and the wholesale extinction at a global scale of some of South Georgia's endemic species.	[Hogg, Oliver T.; Barnes, David K. A.; Griffiths, Huw J.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Hogg, OT (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England.	olgg@bas.ac.uk	Griffiths, Huw J/D-4234-2009	Griffiths, Huw J/0000-0003-1764-223X; Hogg, Oliver/0000-0003-1146-0590	Darwin Initiative (DEFRA); Government of South Georgia; South Georgia Heritage Trust; South Sandwich Islands; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Darwin Initiative (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Government of South Georgia; South Georgia Heritage Trust; South Sandwich Islands; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by grants from the Darwin Initiative (DEFRA), the Government of South Georgia and South Sandwich Islands, and the South Georgia Heritage Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCAMO J, 2005, MILLENNIUM ECOSYSTEM, P100; Allcock AL, 1997, MAR BIOL, V129, P97, DOI 10.1007/s002270050150; Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; ARNTZ WE, 1999, SCI MAR S1, V63, P1; Arntz Wolf E., 1997, P3; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; BARBER HN, 1959, NATURE, V184, P203, DOI 10.1038/184203a0; Barnes DKA, 2011, ANTARCT SCI, V23, P323, DOI 10.1017/S0954102011000253; Barnes DKA, 2010, GLOBAL CHANGE BIOL, V16, P3164, DOI 10.1111/j.1365-2486.2010.02176.x; Barnes DKA, 2008, CLIM RES, V37, P149, DOI 10.3354/cr00760; Barnes DKA, 2008, ANTARCT SCI, V20, P263, DOI 10.1017/S0954102008001089; Barnes DKA, 2006, DEEP-SEA RES PT II, V53, P853, DOI 10.1016/j.dsr2.2006.03.008; Barnes DKA, 2009, MAR ECOL PROG SER, V393, P13, DOI 10.3354/meps08246; Barnes DKA, 2009, J BIOGEOGR, V36, P756, DOI 10.1111/j.1365-2699.2008.02030.x; Barnes DKA, 2006, POLAR BIOL, V29, P223, DOI 10.1007/s00300-005-0042-0; Brandon MA, 2004, DEEP-SEA RES PT II, V51, P1301, DOI 10.1016/j.dsr2.2004.06.006; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011831; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Clarke A, 2005, TRENDS ECOL EVOL, V20, P1, DOI 10.1016/j.tree.2004.10.004; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; CLARKE A, 1988, BRIT ANTARCT SURV B, P65; CLARKE A, 1989, GEOLOGICAL SOC SPECI, V47, P253; Clarke A, 2007, DIVERS DISTRIB, V13, P620, DOI 10.1111/j.1472-4642.2007.00380.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Collins MA, 2006, SCCCAMLRWGFSA0651; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; COOMBS DS, 1966, NATURE, V209, P289, DOI 10.1038/209289b0; Curtis ML, 2010, J STRUCT GEOL, V32, P464, DOI 10.1016/j.jsg.2010.02.002; DAYTON PK, 1994, POLAR OCEANOGRAPY, P631; DEBROYER C, SCAR MARBIN ANTARCTI; DELL RK, 1972, ADV MAR BIOL, V10, P1, DOI 10.1016/S0065-2881(08)60416-2; Eldredge Lucius G., 1995, Bishop Museum Occasional Papers, V41, P3; Fujikura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011836; Gordon DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010905; Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008; Griffiths HJ, 2003, ORG DIVERS EVOL, V3, P207, DOI 10.1078/1439-6092-00079; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Griffiths HJ, 2009, J BIOGEOGR, V36, P162, DOI 10.1111/j.1365-2699.2008.01979.x; Gutt J, 2004, ANTARCT SCI, V16, P11, DOI 10.1017/S0954102004001750; Hofmann EE, 1998, ANTARCT SCI, V10, P406, DOI 10.1017/S0954102098000492; Holeton CL, 2005, POLAR BIOL, V29, P44, DOI 10.1007/s00300-005-0028-y; Hunt BM, 2003, ANTARCT SCI, V15, P333, DOI 10.1017/S0954102003001342; Kaiser M. J., 2005, MARINE ECOLOGY PROCE; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; Livermore R, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2005GC001224; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Mace GM, 2010, CURR OPIN ENV SUST, V2, P3, DOI 10.1016/j.cosust.2010.03.003; MILEIKOVSKY SA, 1971, MAR BIOL, V10, P193, DOI 10.1007/BF00352809; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Morley SA, 2010, ANTARCT SCI, V22, P774, DOI 10.1017/S0954102010000465; Morley SA, 2009, COMP BIOCHEM PHYS A, V152, P423, DOI 10.1016/j.cbpa.2008.11.015; Mukasa SB, 1996, J S AM EARTH SCI, V9, P349, DOI 10.1016/S0895-9811(96)00019-3; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peck L.S., 2005, R SOC SPEC ISSUE ANT, V17, P495; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2002, POLAR BIOL, V25, P31, DOI 10.1007/s003000100308; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Roux A, 2002, ARCH FISH MAR RES, V49, P231; Salisbury EJ, 1926, GEOGR J, V67, P312, DOI 10.2307/1782828; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; SIRENKO BI, 2001, EXPLORATIONS FAUNA S, V51, P1; Smith SDA, 2002, GLOBAL ECOL BIOGEOGR, V11, P67, DOI 10.1046/j.1466-822X.2001.00259.x; Tavares M, 2004, ANTARCT SCI, V16, P129, DOI 10.1017/S0954102004001877; Thatje S, 2003, POLAR BIOL, V26, P279, DOI 10.1007/s00300-002-0476-6; THORNHILL DJ, 2008, MOL ECOL, V17, P504; Ugland KI, 2003, J ANIM ECOL, V72, P888, DOI 10.1046/j.1365-2656.2003.00748.x; Whitehouse MJ, 2008, DEEP-SEA RES PT I, V55, P1218, DOI 10.1016/j.dsr.2008.06.002; YOUNG EF, HIGH RESOLUTION MODE, V2, DOI DOI 10.1016/J.DSR2.2009.11.003; ZELAYA DG, 2000, THESIS U BUENOS AIRE, P144	74	52	54	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19795	10.1371/journal.pone.0019795	http://dx.doi.org/10.1371/journal.pone.0019795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647236	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000291006500008
J	Tullai, JW; Tacheva, S; Owens, LJ; Graham, JR; Cooper, GM				Tullai, John W.; Tacheva, Silvia; Owens, Laura J.; Graham, Julie R.; Cooper, Geoffrey M.			AP-1 Is a Component of the Transcriptional Network Regulated by GSK-3 in Quiescent Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; DNA-BINDING ACTIVITY; C-JUN; SIGNALING PATHWAY; FOS GENE; PHOSPHORYLATION; PROTEIN; ACTIVATION; CREB	Background: The protein kinase GSK-3 is constitutively active in quiescent cells in the absence of growth factor signaling. Previously, we identified a set of genes that required GSK-3 to maintain their repression during quiescence. Computational analysis of the upstream sequences of these genes predicted transcription factor binding sites for CREB, NF kappa B and AP-1. In our previous work, contributions of CREB and NF kappa B were examined. In the current study, the AP-1 component of the signaling network in quiescent cells was explored. Methodology/Principal Findings: Using chromatin immunoprecipitation analysis, two AP-1 family members, c-Jun and JunD, bound to predicted upstream regulatory sequences in 8 of the 12 GSK-3-regulated genes. c-Jun was phosphorylated on threonine 239 by GSK-3 in quiescent cells, consistent with previous studies demonstrating inhibition of c-Jun by GSK-3. Inhibition of GSK-3 attenuated this phosphorylation, resulting in the stabilization of c-Jun. The association of c-Jun with its target sequences was increased by growth factor stimulation as well as by direct GSK-3 inhibition. The physiological role for c-Jun was also confirmed by siRNA inhibition of gene induction. Conclusions/Significance: These results indicate that inhibition of c-Jun by GSK-3 contributes to the repression of growth factor-inducible genes in quiescent cells. Together, AP-1, CREB and NF kappa B form an integrated transcriptional network that is largely responsible for maintaining repression of target genes downstream of GSK-3 signaling.	[Tullai, John W.; Tacheva, Silvia; Owens, Laura J.; Cooper, Geoffrey M.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Graham, Julie R.] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA	Boston University; Boston University	Tullai, JW (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gmcooper@bu.edu			National Institutes of Health [R01 CA18689]; American Cancer Society [IRG-72-001-33-IRG]; NATIONAL CANCER INSTITUTE [R01CA018689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grant R01 CA18689 (GMC) and by American Cancer Society Grant IRG-72-001-33-IRG (JWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Bournat JC, 2000, J NEUROSCI RES, V61, P21, DOI 10.1002/1097-4547(20000701)61:1<21::AID-JNR3>3.0.CO;2-7; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Graham JR, 2010, J BIOL CHEM, V285, P4472, DOI 10.1074/jbc.M109.053785; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hardt SE, 2004, CIRC RES, V94, P926, DOI 10.1161/01.RES.0000124977.59827.80; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; Pap M, 2002, MOL CELL BIOL, V22, P578, DOI 10.1128/MCB.22.2.578-586.2002; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Tullai JW, 2007, J BIOL CHEM, V282, P9482, DOI 10.1074/jbc.M700067200; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005	35	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20150	10.1371/journal.pone.0020150	http://dx.doi.org/10.1371/journal.pone.0020150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647439	Green Published, Green Submitted, gold			2022-12-25	WOS:000291006500030
J	HuangFu, WC; Qian, J; Liu, C; Liu, J; Lokshin, AE; Baker, DP; Rui, H; Fuchs, SY				HuangFu, W-C; Qian, J.; Liu, C.; Liu, J.; Lokshin, A. E.; Baker, D. P.; Rui, H.; Fuchs, S. Y.			Inflammatory signaling compromises cell responses to interferon alpha	ONCOGENE			English	Article						inflammation; cancer; interferon; receptor; ubiquitin; melanoma	HUMAN-MELANOMA CELLS; CANCER-RELATED INFLAMMATION; HUMAN-MALIGNANT MELANOMA; TUMOR-NECROSIS-FACTOR; I-INTERFERON; ADJUVANT THERAPY; MULTIPLEX ANALYSIS; INNATE IMMUNITY; RECEPTOR; EXPRESSION	Interferon alpha (IFN alpha) is widely used for treatment of melanoma and certain other malignancies. This cytokine as well as the related IFN beta exerts potent anti-tumorigenic effects; however, their efficacy in patients is often suboptimal. Here, we report that inflammatory signaling impedes the effects of IFN alpha/beta. Melanoma cells can secrete pro-inflammatory cytokines that inhibit cellular responses to IFN alpha/beta via activating the ligand-independent pathway for the phosphorylation and subsequent ubiquitination and accelerated degradation of the IFNAR1 chain of type I IFN receptor. Catalytic activity of the p38 protein kinase was required for IFNAR1 downregulation and inhibition of IFN alpha/beta signaling induced by proinflammatory cytokines such as interleukin 1 (IL-1). Activation of p38 kinase inversely correlated with protein levels of IFNAR1 in clinical melanoma specimens. Inhibition of p38 kinase augmented the inhibitory effects of IFN alpha/beta on cell viability and growth in vitro and in vivo. The roles of inflammation and p38 protein kinase in regulating cellular responses to IFN alpha/beta in normal and tumor cells are discussed. Oncogene (2012) 31, 161-172; doi:10.1038/onc.2011.221; published online 13 June 2011	[HuangFu, W-C; Qian, J.; Liu, J.; Fuchs, S. Y.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [HuangFu, W-C; Qian, J.; Liu, J.; Fuchs, S. Y.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Liu, C.; Rui, H.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Lokshin, A. E.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Lokshin, A. E.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Lokshin, A. E.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Lokshin, A. E.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Baker, D. P.] Biogen Idec Inc, Cambridge, MA USA	University of Pennsylvania; University of Pennsylvania; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Biogen	Fuchs, SY (corresponding author), Univ Penn, Dept Anim Biol, 380 S Univ Ave,Hill 316, Philadelphia, PA 19104 USA.	syfuchs@vet.upenn.edu		Liu, Jianghuai/0000-0002-2382-9140	NIH [CA092900, CA142425]; NATIONAL CANCER INSTITUTE [R01CA142425, R01CA092900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs M Gaestel, LM Duncan, RJ Davis, M Herlyn, M May, E Meggers, A Nebreda, J Ninomiya-Tsuji and Z Ronai for reagents. This work was supported by NIH grants CA092900 and CA142425 (to SYF).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Alonso-Curbelo D, 2010, AUTOPHAGY, V6, P148, DOI 10.4161/auto.6.1.10464; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; BENNICELLI JL, 1989, CANCER RES, V49, P930; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Bregman H, 2006, J AM CHEM SOC, V128, P877, DOI 10.1021/ja055523r; Coccia EM, 2006, CELL MOL BIOL, V52, P77, DOI 10.1170/T701; Fecher LA, 2009, J NATL COMPR CANC NE, V7, P295, DOI 10.6004/jnccn.2009.0022; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu Y, 2009, CYTOKINE, V45, P44, DOI 10.1016/j.cyto.2008.10.014; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HuangFu WC, 2010, PIGM CELL MELANOMA R, V23, P838, DOI 10.1111/j.1755-148X.2010.00770.x; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Kaehler KC, 2010, EUR J CANCER, V46, P41, DOI 10.1016/j.ejca.2009.10.004; KOCK A, 1989, J NATL CANCER I, V81, P36, DOI 10.1093/jnci/81.1.36; Kumar KGS, 2007, CANCER BIOL THER, V6, P1437; Kumar KGS, 2007, J CELL BIOL, V179, P935, DOI 10.1083/jcb.200706034; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Li Y, 2006, ONCOGENE, V25, P1896, DOI 10.1038/sj.onc.1209214; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Linkov F, 2008, PROTEOM CLIN APPL, V2, P1575, DOI 10.1002/prca.200780095; Liu J, 2007, ONCOGENE, V26, P1954, DOI 10.1038/sj.onc.1209994; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Liu JH, 2009, MOL CELL BIOL, V29, P6401, DOI 10.1128/MCB.00478-09; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marijanovic Z, 2006, BIOCHEM J, V397, P31, DOI 10.1042/BJ20060272; Megason SG, 2002, DEVELOPMENT, V129, P2087; Melnikova VO, 2009, PIGM CELL MELANOMA R, V22, P257, DOI 10.1111/j.1755-148X.2009.00570.x; Messina Jane L, 2008, Cancer Control, V15, P196; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; Moretti S, 1999, INT J CANCER, V84, P160, DOI 10.1002/(SICI)1097-0215(19990420)84:2<160::AID-IJC12>3.3.CO;2-I; Nazarian RM, 2010, J CUTAN PATHOL, V37, P41, DOI 10.1111/j.1600-0560.2010.01505.x; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; OXHOLM A, 1988, BRIT J DERMATOL, V118, P369, DOI 10.1111/j.1365-2133.1988.tb02430.x; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rigualt NR, 2008, EXPERT REV ANTICANC, V8, P403, DOI 10.1586/14737140.8.3.403; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sander B, 1996, INT J CANCER, V66, P42, DOI 10.1002/(SICI)1097-0215(19960328)66:1<42::AID-IJC8>3.0.CO;2-Z; Smalley KSM, 2009, CANCER RES, V69, P3241, DOI 10.1158/0008-5472.CAN-08-4305; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Spiegelman V, 2002, ONCOGENE, V21, P856, DOI 10.1038/sj.onc.1205132; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Weber A., 2010, SCI SIGNAL, V3; Yao K, 2009, SURG CLIN N AM, V89, P267, DOI 10.1016/j.suc.2008.11.002; Yurkovetsky ZR, 2007, CLIN CANCER RES, V13, P2422, DOI 10.1158/1078-0432.CCR-06-1805; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	55	54	55	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	2					161	172		10.1038/onc.2011.221	http://dx.doi.org/10.1038/onc.2011.221			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21666722	Green Published, Green Accepted			2022-12-25	WOS:000299307400003
J	Vanoevelen, J; Janssens, A; Huitema, LFA; Hammond, CL; Metz, JR; Flik, G; Voets, T; Schulte-Merker, S				Vanoevelen, Jo; Janssens, Annelies; Huitema, Leonie F. A.; Hammond, Christina L.; Metz, Juriaan R.; Flik, Gert; Voets, Thomas; Schulte-Merker, Stefan			Trpv5/6 is vital for epithelial calcium uptake and bone formation	FASEB JOURNAL			English	Article						zebrafish; osteogenesis	CA2+ CHANNEL; STANNIOCALCIN 1; ZEBRAFISH; RECEPTOR; KIDNEY; ABSORPTION; EXPRESSION; TRANSPORT; STANNIUS; MEDAKA	Calcium is an essential ion serving a multitude of physiological roles. Aside from its role as a second messenger, it is an essential component of the vertebrate bone matrix. Efficient uptake and storage of calcium are therefore indispensable for all vertebrates. Transient receptor potential family, vanilloid type (TRPV)5 and TRPV6 channels are known players in transcellular calcium uptake, but the exact contribution of this pathway is unclear. We used forward genetic screening in zebrafish (Danio rerio) to identify genes essential in bone formation and identified a lethal zebrafish mutant (matt-und-schlapp) with severe defects in bone formation, including lack of ossification of the vertebral column and craniofacial structures. Mutant embryos show a 68% reduction in calcium content, and systemic calcium homeostasis is disturbed when compared with siblings. The phenotype can be partially rescued by increasing ambient calcium levels to 25 mM. We identified the mutation as a loss-of-function mutation in the single orthologue of TRPV5 and 6, trpv5/6. Expression in HEK293 cells showed that Trpv5/6 is a calcium-selective channel capable of inward calcium transport at physiological concentrations whereas the mutant channel is not. Taken together, this study provides both genetic and functional evidence that transcellular epithelial calcium uptake is vital to sustain life and enable bone formation.-Vanoevelen, J., Janssens, A., Huitema, L. F. A., Hammond, C. L., Metz, J. R., Flik, G., Voets, T., Schulte-Merker, S. Trpv5/6 is vital for epithelial calcium uptake and bone formation. FASEB J. 25, 3197-3207 (2011). www.fasebj.org	[Vanoevelen, Jo; Huitema, Leonie F. A.; Hammond, Christina L.; Schulte-Merker, Stefan] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [Vanoevelen, Jo; Huitema, Leonie F. A.; Hammond, Christina L.; Schulte-Merker, Stefan] Univ Med Ctr, Utrecht, Netherlands; [Janssens, Annelies; Voets, Thomas] Catholic Univ Louvain, Lab Ion Channel Res, Dept Mol Cell Biol, B-3000 Louvain, Belgium; [Metz, Juriaan R.; Flik, Gert] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Physiol, NL-6525 ED Nijmegen, Netherlands; [Schulte-Merker, Stefan] Wageningen Univ, Expt Zool Grp, Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; KU Leuven; Universite Catholique Louvain; Radboud University Nijmegen; Wageningen University & Research	Vanoevelen, J (corresponding author), Catholic Univ Louvain, Lab Cellular Transport Syst, Dept Mol Cell Biol, Herestr 49, B-3000 Louvain, Belgium.	jo.vanoevelen@med.kuleuven.be	Flik, Gert/C-8229-2011; Voets, Thomas/E-2466-2012; Metz, Juriaan R./A-3290-2012; Vanoevelen, Jo M/F-2686-2013; Hammond, Chrissy/D-6568-2013; Voets, Thomas/AAD-4389-2019	Flik, Gert/0000-0001-9285-7957; Voets, Thomas/0000-0001-5526-5821; Metz, Juriaan R./0000-0002-1515-1958; Vanoevelen, Jo M/0000-0003-1830-8858; Hammond, Chrissy/0000-0002-4935-6724; Voets, Thomas/0000-0001-5526-5821; Janssens, Annelies/0000-0002-6735-8248	SmartMix	SmartMix	The authors thank F. Wuytack, L. Raeymaekers, L. Lieben, G. Carmeliet and B. Nilius for helpful discussions. The authors acknowledge the Hubrecht Imaging Center for expert advice on imaging. The authors thank the Tubingen 2000 screen consortium for identifying the mus<SUP>t25927</SUP> allele; this mutant was identified while S. S-M was working at Artemis Pharmaceuticals/Exelixis Deutschland. S. S.-M. is supported by the Koninklijke Nederlandse Academie van Wetenschap-penand funding from SmartMix. J.V. is a Postdoctoral Fellow of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. The authors declare no conflicts of interest. The data reported in this study have been deposited in the GenBank database (accession no. HQ676591; http://www.ncbi.nlm.gov).	Benham CD, 2002, NEUROPHARMACOLOGY, V42, P873, DOI 10.1016/S0028-3908(02)00047-3; Benn BS, 2008, ENDOCRINOLOGY, V149, P3196, DOI 10.1210/en.2007-1655; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; Brand Michael, 2002, P7; Bronner F, 2003, J NUTR, V133, P1426, DOI 10.1093/jn/133.5.1426; Bronner F, 2009, NUTR REV, V67, P109, DOI 10.1111/j.1753-4887.2008.00147.x; Chen YY, 2003, J EXP ZOOL PART A, V295A, P127, DOI 10.1002/jez.a.10195; Chou MY, 2002, J COMP PHYSIOL B, V172, P109, DOI 10.1007/s00360-001-0231-2; Datta HK, 2008, J CLIN PATHOL, V61, P577, DOI 10.1136/jcp.2007.048868; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Elizondo MR, 2010, ENDOCRINOLOGY, V151, P5700, DOI 10.1210/en.2010-0853; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Flik Gert, 1995, V14, P317; Greenwood MP, 2009, ENDOCRINOLOGY, V150, P3002, DOI 10.1210/en.2008-1758; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; Hoenderop JGJ, 2000, J AM SOC NEPHROL, V11, P1171, DOI 10.1681/ASN.V1171171; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Inohaya K, 2007, DEV DYNAM, V236, P3031, DOI 10.1002/dvdy.21329; ISHIHARA A, 1987, J EXP ZOOL, V242, P121, DOI 10.1002/jez.1402420202; Kawakami K, 1998, GENE, V225, P17, DOI 10.1016/S0378-1119(98)00537-X; KIKUCHI K, 1988, AM J PHYSIOL, V255, pG482, DOI 10.1152/ajpgi.1988.255.4.G482; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Kutuzova GD, 2008, P NATL ACAD SCI USA, V105, P19655, DOI 10.1073/pnas.0810761105; LAFEBER FPJG, 1988, GEN COMP ENDOCR, V69, P19, DOI 10.1016/0016-6480(88)90048-2; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Lee GS, 2007, J BONE MINER RES, V22, P1968, DOI 10.1359/JBMR.070801; Liao BK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-354; Lieben L, 2010, BONE, V47, P301, DOI 10.1016/j.bone.2010.04.595; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Nilius B, 2003, PFLUG ARCH EUR J PHY, V445, P584, DOI 10.1007/s00424-002-0923-9; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Pan TC, 2005, AM J PHYSIOL-REG I, V289, pR1202, DOI 10.1152/ajpregu.00816.2004; PANG PKT, 1974, GEN COMP ENDOCR, V23, P239, DOI 10.1016/0016-6480(74)90133-6; PANSU D, 1993, J NUTR, V123, P1396; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; Perez AV, 2008, DIGESTION, V77, P22, DOI 10.1159/000116623; Qiu AD, 2004, GENE, V342, P113, DOI 10.1016/j.gene.2004.07.041; Renn J, 2006, PROTOPLASMA, V229, P209, DOI 10.1007/s00709-006-0215-x; Renn J, 2009, DEV DYNAM, V238, P241, DOI 10.1002/dvdy.21836; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Schulte-Merker S., 2002, ZEBRAFISH PRACTICAL; Shahsavarani A, 2006, J EXP BIOL, V209, P1928, DOI 10.1242/jeb.02190; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Suzuki Y, 2008, J BONE MINER RES, V23, P1249, DOI [10.1359/jbmr.080314, 10.1359/JBMR.080314]; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; Vangheluwe P, 2009, CHEM REV, V109, P4733, DOI 10.1021/cr900013m; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100	59	45	48	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3197	3207		10.1096/fj.11-183145	http://dx.doi.org/10.1096/fj.11-183145			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21670068	Green Submitted			2022-12-25	WOS:000294435200032
J	Huang, SZ; Ma, J; Liu, XL; Zhang, YG; Luo, LF				Huang, Sizhou; Ma, Jun; Liu, Xiaolin; Zhang, Yaoguang; Luo, Lingfei			Retinoic Acid Signaling Sequentially Controls Visceral and Heart Laterality in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEFT-RIGHT ASYMMETRY; NODAL-RELATED GENE; PANCREAS DEVELOPMENT; OPPOSING FGF; BODY AXIS; EXPRESSION; EMBRYO; MORPHOGENESIS; PATHWAYS; MOUSE	During zebrafish development, the left-right (LR) asymmetric signals are first established around the Kupffer vesicle (KV), a ciliated organ generating directional fluid flow. Then, LR asymmetry is conveyed and stabilized in the lateral plate mesoderm. Although numerous molecules and signaling pathways are involved in controlling LR asymmetry, mechanistic difference and concordance between different organs during LR patterning are poorly understood. Here we show that RA signaling regulates laterality decisions at two stages in zebrafish. Before the 2-somite stage (2So), inhibition of RA signaling leads to randomized visceral laterality through bilateral expression of nodal/spaw in the lateral plate mesoderm, which is mediated by increases in cilia length and defective directional fluid flow in KV. Fgf8 is required for the regulation of cilia length by RA signaling. Blockage of RA signaling before 2So also leads to mild defects of heart laterality, which become much more severe through perturbation of cardiac bmp4 asymmetry when RA signaling is blocked after 2So. At this stage, visceral laterality and the left-sided Nodal remain unaffected. These findings suggest that RA signaling controls visceral laterality through the left-sided Nodal signal before 2So, and regulates heart laterality through cardiac bmp4 mainly after 2So, first identifying sequential control and concordance of visceral and heart laterality.	[Huang, Sizhou; Ma, Jun; Liu, Xiaolin; Zhang, Yaoguang; Luo, Lingfei] Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China; [Huang, Sizhou; Ma, Jun; Liu, Xiaolin; Luo, Lingfei] Southwest Univ, Sch Life Sci, Lab Mol Dev Biol, Chongqing 400715, Peoples R China	Southwest University - China; Southwest University - China	Luo, LF (corresponding author), Southwest Univ, Minist Educ, Key Lab Freshwater Fish Reprod & Dev, Chongqing 400715, Peoples R China.	lluo@swu.edu.cn			National Basic Research Program of China [2009CB941200]; National Natural Science Foundation of China [30925022]; Program for Changjiang Scholars and Innovative Research Team Program Grant [IRT0859]; Program for New Century Excellent Talents (NCET) Program Grant [NCET-07-0713]; CQ Chongqing Science and Technology Commission [2009BA5041]; Southwest University [Kb2009008]; Par-Eu Scholars Program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team Program Grant(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for New Century Excellent Talents (NCET) Program Grant(Program for New Century Excellent Talents in University (NCET)); CQ Chongqing Science and Technology Commission; Southwest University(Southwest University - China); Par-Eu Scholars Program	This work was supported by National Basic Research Program of China Grant 2009CB941200, National Natural Science Foundation of China Grant 30925022, Program for Changjiang Scholars and Innovative Research Team Program Grant IRT0859, Program for New Century Excellent Talents (NCET) Program Grant NCET-07-0713, CQ Chongqing Science and Technology Commission Grant 2009BA5041, Southwest University Grant Kb2009008, and the Par-Eu Scholars Program.	Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Alexa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008261; Anderson RM, 2009, DEV BIOL, V334, P213, DOI 10.1016/j.ydbio.2009.07.017; Baker K, 2008, P NATL ACAD SCI USA, V105, P13924, DOI 10.1073/pnas.0802159105; Carl M, 2007, NEURON, V55, P393, DOI 10.1016/j.neuron.2007.07.007; Chang H, 2000, DEV BIOL, V219, P71, DOI 10.1006/dbio.1999.9594; Chazaud C, 1999, DEVELOPMENT, V126, P2589; Chen JN, 1997, DEVELOPMENT, V124, P4373; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Ellertsdottir E, 2006, DEV DYNAM, V235, P1794, DOI 10.1002/dvdy.20800; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Esteban CR, 1999, NATURE, V401, P243, DOI 10.1038/45738; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Hashimoto H, 2004, DEVELOPMENT, V131, P1741, DOI 10.1242/dev.01070; Hong SK, 2009, P NATL ACAD SCI USA, V106, P2230, DOI 10.1073/pnas.0812880106; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Jiang Z, 2008, PLOS BIOL, V6, P2450, DOI 10.1371/journal.pbio.0060293; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Liu XL, 2009, J CELL BIOL, V184, P805, DOI 10.1083/jcb.200806074; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Lustig KD, 1996, DEVELOPMENT, V122, P3275; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Meno C, 1996, NATURE, V381, P151, DOI 10.1038/381151a0; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Osborne N, 2003, ANNU REV PHYSIOL, V65, P23, DOI 10.1146/annurev.physiol.65.092101.142235; Peterkin T, 2007, DEV BIOL, V311, P623, DOI 10.1016/j.ydbio.2007.08.018; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Ramsdell AF, 1999, DEVELOPMENT, V126, P5195; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Schulze GE, 2001, TOXICOL SCI, V59, P297, DOI 10.1093/toxsci/59.2.297; Smith KA, 2008, DEV CELL, V14, P287, DOI 10.1016/j.devcel.2007.11.015; Smith SM, 1997, DEV BIOL, V182, P162, DOI 10.1006/dbio.1996.8474; Tickle C, 2006, NAT REV MOL CELL BIO, V7, P45, DOI 10.1038/nrm1830; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; Wasiak S, 1999, DEV BIOL, V215, P332, DOI 10.1006/dbio.1999.9465; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Yokouchi Y, 1999, CELL, V98, P573, DOI 10.1016/S0092-8674(00)80045-8; Yost HJ, 2003, CURR BIOL, V13, pR808, DOI 10.1016/j.cub.2003.09.051	51	23	23	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28533	28543		10.1074/jbc.M111.244327	http://dx.doi.org/10.1074/jbc.M111.244327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669875	hybrid, Green Published			2022-12-25	WOS:000293557800068
J	Bielefeld, KA; Amini-Nik, S; Whetstone, H; Poon, R; Youn, A; Wang, J; Alman, BA				Bielefeld, Kirsten A.; Amini-Nik, Saeid; Whetstone, Heather; Poon, Raymond; Youn, Andrew; Wang, Jian; Alman, Benjamin A.			Fibronectin and beta-Catenin Act in a Regulatory Loop in Dermal Fibroblasts to Modulate Cutaneous Healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; DEPENDENT TRANSCRIPTIONAL ACTIVATION; GLYCOGEN-SYNTHASE KINASE-3; SIGNALING PATHWAY; SPLICE VARIANTS; CELL-ADHESION; BRANCHING MORPHOGENESIS; EXTRACELLULAR-MATRIX; EPITHELIAL CANCERS; CARCINOMA CELLS	beta-Catenin is an important regulator of dermal fibroblasts during cutaneous wound repair. However, the factors that modulate beta-Catenin activity in this process are not completely understood. We investigated the role of the extracellular matrix in regulating beta-Catenin and found an increase in beta-Catenin-mediated Tcf-dependent transcriptional activity in fibroblasts exposed to various extracellular matrix components. This occurs through an integrin-mediated GSK3 beta-dependent pathway. The physiologic role of this mechanism was demonstrated during wound repair in extra domain A-fibronectin-deficient mice, which exhibited decreased beta-Catenin-mediated signaling during the proliferative phase of healing. Extra domain A-fibronectin-deficient mice have wounds that fail at a lower tensile strength and contain fewer fibroblasts compared with wild type mice. This phenotype was rescued by genetic or pharmacologic activation of beta-Catenin signaling. Because fibronectin is a transcriptional target of beta-Catenin, this suggests the existence of a feedback loop between these two molecules that regulates dermal fibroblast cell behavior during wound repair.	[Alman, Benjamin A.] Hosp Sick Children, Res Inst, Dept Dev & Stem Cell Biol, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Bielefeld, Kirsten A.; Alman, Benjamin A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Wang, Jian] Univ Toronto, Fac Dent, Toronto, ON M5S 1A8, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Surg, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Alman, BA (corresponding author), Hosp Sick Children, Res Inst, Dept Dev & Stem Cell Biol, Program Dev & Stem Cell Biol, Toronto Med Discovery Tower,East Tower,101 Coll S, Toronto, ON M5G 1L7, Canada.	benjamin.alman@sickkids.ca	Nik, Saeid Amini/B-6640-2014	Nik, Saeid Amini/0000-0002-9185-9456	Canadian Institutes of Health Research [RFN 15136]; Natural Sciences and Engineering Research Council of Canada; Ontario Student Opportunity Trust; Hospital for Sick Children Foundation Fund	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Student Opportunity Trust; Hospital for Sick Children Foundation Fund	This work was supported by Canadian Institutes of Health Research Grant RFN 15136.; Recipient of a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada and of a studentship from the Ontario Student Opportunity Trust Fund, Hospital for Sick Children Foundation Student Scholarship Program.	Acconcia F, 2007, P NATL ACAD SCI USA, V104, P6782, DOI 10.1073/pnas.0701999104; Alman BA, 1997, AM J PATHOL, V151, P329; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; BAUER JS, 1992, J CELL BIOL, V116, P477, DOI 10.1083/jcb.116.2.477; Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026; Brault V, 2001, DEVELOPMENT, V128, P1253; BROWN LF, 1993, AM J PATHOL, V142, P793; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen Q, 2010, J MOL NEUROSCI, V40, P284, DOI 10.1007/s12031-009-9218-3; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; CLARK RAF, 1990, J INVEST DERMATOL, V94, P128; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; DARBY I, 1990, LAB INVEST, V63, P21; Defilippi P, 2005, J CELL BIOL, V168, P1099, DOI 10.1083/jcb.200405116; Dehpour AR, 2002, PHARMACOL TOXICOL, V90, P89, DOI 10.1034/j.1600-0773.2002.900206.x; Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211; Disatnik MH, 2002, J CELL SCI, V115, P2151; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; ECKES E, 1996, MOL CELLULAR BIOL BI, P493; FFRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903, DOI 10.1083/jcb.109.2.903; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Gurung A, 2009, AM J PATHOL, V174, P248, DOI 10.2353/ajpath.2009.080576; Hanai J, 2002, J CELL BIOL, V158, P529, DOI 10.1083/jcb.200203064; Hannigan GE, 1996, NATURE, V379, P91, DOI 10.1038/379091a0; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HAUTANEN A, 1989, J BIOL CHEM, V264, P1437; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hunter MP, 2010, AM J PHYSIOL-CELL PH, V299, pC21, DOI 10.1152/ajpcell.00543.2009; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kilian O, 2008, CALCIFIED TISSUE INT, V83, P101, DOI 10.1007/s00223-008-9156-z; Kilian O, 2004, BONE, V35, P1334, DOI 10.1016/j.bone.2004.08.008; Kim J, 2010, MATRIX BIOL, V29, P369, DOI 10.1016/j.matbio.2010.04.001; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Larsen MC, 2004, TOXICOL SCI, V82, P46, DOI 10.1093/toxsci/kfh242; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Li AQ, 2010, ONCOL REP, V23, P1247, DOI 10.3892/or_00000757; Liao YF, 2002, J BIOL CHEM, V277, P14467, DOI 10.1074/jbc.M201100200; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muro AF, 2003, J CELL BIOL, V162, P149, DOI 10.1083/jcb.200212079; Niedermeyer J, 1997, INT J CANCER, V71, P383, DOI 10.1002/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H; Okuse T, 2005, WOUND REPAIR REGEN, V13, P491, DOI 10.1111/j.1067-1927.2005.00069.x; Olaso E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-5; Oloumi A, 2006, ONCOGENE, V25, P7747, DOI 10.1038/sj.onc.1209752; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; PURKIS PE, 1990, J CELL SCI, V97, P39; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Rybak JN, 2007, CANCER RES, V67, P10948, DOI 10.1158/0008-5472.CAN-07-1436; Saito S, 1999, J BIOL CHEM, V274, P30756, DOI 10.1074/jbc.274.43.30756; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Singh P, 2004, J INVEST DERMATOL, V123, P1176, DOI 10.1111/j.0022-202X.2004.23485.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tvorogov D, 2005, J CELL SCI, V118, P601, DOI 10.1242/jcs.01643; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vi L, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-72; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; YAMAMOTO M, 1995, EXP CELL RES, V219, P249, DOI 10.1006/excr.1995.1225; Zhang DL, 2009, BIOCHEM BIOPH RES CO, V378, P149, DOI 10.1016/j.bbrc.2008.11.011; Zhang T, 2009, BLOOD, V114, P4081, DOI 10.1182/blood-2009-05-219881; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	77	52	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27687	27697		10.1074/jbc.M111.261677	http://dx.doi.org/10.1074/jbc.M111.261677			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652705	Green Published, hybrid			2022-12-25	WOS:000293268700061
J	Chou, CY; Streets, AJ; Watson, PF; Huang, LH; Verderio, EAM; Johnson, TS				Chou, Che-Yi; Streets, Andrew J.; Watson, Philip F.; Huang, Linghong; Verderio, Elisabetta A. M.; Johnson, Timothy S.			A Crucial Sequence for Transglutaminase Type 2 Extracellular Trafficking in Renal Tubular Epithelial Cells Lies in Its N-terminal beta-Sandwich Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; TISSUE TRANSGLUTAMINASE; CROSS-LINKING; SURFACE TRANSGLUTAMINASE; PLASMA-MEMBRANE; FIBRONECTIN; EXPRESSION; MATRIX; PURINOCEPTOR; ACTIVATION	Transglutaminase type 2 (TG2) catalyzes the formation of an is an element of-(gamma-glutamyl)-lysine isopeptide bond between adjacent peptides or proteins including those of the extracellular matrix (ECM). Elevated extracellular TG2 leads to accelerated ECM deposition and reduced clearance that underlie tissue scarring and fibrosis. The extracellular trafficking of TG2 is crucial to its role in ECM homeostasis; however, the mechanism by which TG2 escapes the cell is unknown as it has no signal leader peptide and therefore cannot be transported classically. Understanding TG2 transport may highlight novel mechanisms to interfere with the extracellular function of TG2 as isoform-specific TG2 inhibitors remain elusive. Mammalian expression vectors were constructed containing domain deletions of TG2. These were transfected into three kidney tubular epithelial cell lines, and TG2 export was assessed to identify critical domains. Point mutation was then used to highlight specific sequences within the domain required for TG2 export. The removal of beta-sandwich domain prevented all TG2 export. Mutations of Asp(94) and Asp(97) within the N-terminal beta-sandwich domain were identified as crucial for TG2 externalization. These form part of a previously identified fibronectin binding domain ((88)WTATVVDQQDCTLSLQLTT(106)). However, siRNA knockdown of fibronectin failed to affect TG2 export. The sequence (88)WTATVVDQQDCTLSLQLTT(106) within the beta-sandwich domain of TG2 is critical to its export in tubular epithelial cell lines. The extracellular trafficking of TG2 is independent of fibronectin.	[Johnson, Timothy S.] Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield Kidney Inst, Sheffield S10 2RZ, S Yorkshire, England; [Watson, Philip F.] Univ Sheffield, Dept Human Metab, Sheffield S10 2RZ, S Yorkshire, England; [Chou, Che-Yi] China Med Univ Hosp, Dept Internal Med, Inst Nephrol, Taichung 40402, Taiwan; [Chou, Che-Yi] China Med Univ Hosp, Dept Internal Med, Div Nephrol, Taichung 40402, Taiwan; [Verderio, Elisabetta A. M.] Nottingham Trent Univ, Sch Sci & Technol, Biomed Life & Hlth Res Ctr, Nottingham NG11 8NS, England	University of Sheffield; University of Sheffield; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Nottingham Trent University	Johnson, TS (corresponding author), Univ Sheffield, Sch Med, Acad Nephrol Unit, Sheffield Kidney Inst, Beech Hill Rd, Sheffield S10 2RZ, S Yorkshire, England.	T.Johnson@Sheffield.ac.uk	Verderio, Elisabetta/H-2789-2016; Chou, Che-Yi/N-8887-2015	Verderio, Elisabetta/0000-0001-9153-8997; Chou, Che-Yi/0000-0003-4029-9097				ACHYUTHAN KE, 1995, J IMMUNOL METHODS, V180, P69, DOI 10.1016/0022-1759(94)00300-L; Akimov SS, 2001, J CELL SCI, V114, P2989; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Auld GC, 2001, ARTERIOSCL THROM VAS, V21, P1689, DOI 10.1161/hq1001.097063; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; BO XN, 1992, J BIOL CHEM, V267, P17581; BOUGERET C, 1992, J IMMUNOL, V148, P318; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Fisher M, 2009, MATRIX BIOL, V28, P20, DOI 10.1016/j.matbio.2008.10.003; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; GENTILE V, 1991, J BIOL CHEM, V266, P478; Grenard P, 2001, J HEPATOL, V35, P367, DOI 10.1016/S0168-8278(01)00135-0; GRIFFIN M, 1979, BRIT J EXP PATHOL, V60, P653; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Hang J, 2005, J BIOL CHEM, V280, P23675, DOI 10.1074/jbc.M503323200; HEROLD C, 1995, INT IMMUNOL, V7, P1, DOI 10.1093/intimm/7.1.1; Huang LH, 2010, NEPHROL DIAL TRANSPL, V25, P3897, DOI 10.1093/ndt/gfq291; Huang LH, 2009, KIDNEY INT, V76, P383, DOI 10.1038/ki.2009.230; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; ICHINOSE A, 1988, P NATL ACAD SCI USA, V85, P5829, DOI 10.1073/pnas.85.16.5829; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Johnson TS, 2007, J AM SOC NEPHROL, V18, P3078, DOI 10.1681/ASN.2006070690; Johnson TS, 2003, J AM SOC NEPHROL, V14, P2052, DOI 10.1097/01.ASN.0000079614.63463.DD; Johnson TS, 1999, J AM SOC NEPHROL, V10, P2146; Jones RA, 1997, J CELL SCI, V110, P2461; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Juschke C, 2004, CURR BIOL, V14, P406, DOI 10.1016/j.cub.2004.02.034; Kuncio GS, 1998, AM J PHYSIOL-GASTR L, V274, pG240, DOI 10.1152/ajpgi.1998.274.2.G240; Lodish H., 2007, MOL CELL BIOL; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; MALSTROM K, 1987, BIOCHIM BIOPHYS ACTA, V902, P269, DOI 10.1016/0005-2736(87)90305-1; MOSHER DF, 1984, MOL CELL BIOCHEM, V58, P63, DOI 10.1007/BF00240605; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Skill NJ, 2004, J BIOL CHEM, V279, P47754, DOI 10.1074/jbc.M402698200; Skill NJ, 2001, LAB INVEST, V81, P705, DOI 10.1038/labinvest.3780279; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; SUTO N, 1993, J BIOL CHEM, V268, P7469; Trigwell SM, 2004, ANAL BIOCHEM, V330, P164, DOI 10.1016/j.ab.2004.03.068; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio E, 2010, THESCIENTIFICWORLDJO, V10, P1073, DOI 10.1100/tsw.2010.102; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103	47	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27825	27835		10.1074/jbc.M111.226340	http://dx.doi.org/10.1074/jbc.M111.226340			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652693	Green Published, hybrid			2022-12-25	WOS:000293268700074
J	Talley, JM; DeZwaan, DC; Maness, LD; Freeman, BC; Friedman, KL				Talley, Jennell M.; DeZwaan, Diane C.; Maness, Leslie D.; Freeman, Brian C.; Friedman, Katherine L.			Stimulation of Yeast Telomerase Activity by the Ever Shorter Telomere 3 (Est3) Subunit Is Dependent on Direct Interaction with the Catalytic Protein Est2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE TELOMERASE; REVERSE-TRANSCRIPTASE; SHUTTLE VECTORS; BUDDING YEAST; OB-FOLD; RNA; DNA; REPLICATION; COMPLEX; RECRUITMENT	Telomerase is a multisubunit enzyme that maintains genome stability through its role in telomere replication. Although the Est3 protein is long recognized as an essential telomerase component, how it associates with and functions in the telomerase complex has remained enigmatic. Here we provide the first evidence of a direct interaction between Saccharomyces cerevisiae Est3p and the catalytic protein subunit (Est2p) by demonstrating that recombinant Est3p binds the purified telomerase essential N-terminal (TEN) domain of Est2p in vitro. Mutations in a small cluster of amino acids predicted to lie on the surface of Est3p disrupt this interaction with Est2p, reduce assembly of Est3p with telomerase in vivo, and cause telomere shortening and senescence. We also show that recombinant Est3p stimulates telomerase activity above basal levels in vitro in a manner dependent on the Est2p TEN domain interaction. Together, these results define a direct binding interaction between Est3p and Est2p and reconcile the effect of S. cerevisiae Est3p with previous experiments showing that Est3p homologs in related yeast species influence telomerase activity. Additionally, it contributes functional support to the idea that Est3p is structurally related to the mammalian shelterin protein, TPP1, which also influences telomerase activity through interaction with the Est2p homolog, TERT.	[Talley, Jennell M.; Maness, Leslie D.; Friedman, Katherine L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [DeZwaan, Diane C.; Freeman, Brian C.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign	Friedman, KL (corresponding author), Vanderbilt Univ, Dept Biol Sci, Stn B,Box 351634, Nashville, TN 37235 USA.	katherine.friedman@vanderbilt.edu			National Institutes of Health [GM080393, T32 GM08554]; Vanderbilt Discovery Grant; Computational Molecular Biology-National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080393, T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Discovery Grant; Computational Molecular Biology-National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080393. This work was also supported by Vanderbilt Discovery Grant (to K. L. F.).; Supported in part by National Institutes of Health Grant T32 GM08554.; Supported by a Computational Molecular Biology-National Institutes of Health training grant. Present address: Dept. of Anatomy and Cell Biology, the University of Iowa, Iowa City, IA 52242.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; CHAN CSM, 1983, CELL, V33, P563, DOI 10.1016/0092-8674(83)90437-3; Chapon C, 1997, RNA, V3, P1337; Chappell AS, 2004, MOL CELL BIOL, V24, P7720, DOI 10.1128/MCB.24.17.7720-7736.2004; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DeZwaan DC, 2009, P NATL ACAD SCI USA, V106, P17337, DOI 10.1073/pnas.0905703106; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Friedman KL, 2003, MOL BIOL CELL, V14, P1, DOI 10.1091/mbc.E02-06-0327; Friedman KL, 1999, GENE DEV, V13, P2863, DOI 10.1101/gad.13.21.2863; Hsu M, 2007, EUKARYOT CELL, V6, P1330, DOI 10.1128/EC.00069-07; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P990, DOI 10.1038/nsmb.1472; Lee J, 2010, NUCLEIC ACIDS RES, V38, P2279, DOI 10.1093/nar/gkp1173; Lendvay TS, 1996, GENETICS, V144, P1399; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Livengood AJ, 2002, MOL CELL BIOL, V22, P2366, DOI 10.1128/MCB.22.7.2366-2374.2002; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Osterhage JL, 2006, NAT STRUCT MOL BIOL, V13, P720, DOI 10.1038/nsmb1125; Osterhage JL, 2009, J BIOL CHEM, V284, P16061, DOI 10.1074/jbc.R900011200; Seto AG, 2002, GENE DEV, V16, P2800, DOI 10.1101/gad.1029302; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Sharanov YS, 2006, FEBS LETT, V580, P4683, DOI 10.1016/j.febslet.2006.07.048; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Toogun OA, 2008, MOL CELL BIOL, V28, P457, DOI 10.1128/MCB.01417-07; Toogun OA, 2007, P NATL ACAD SCI USA, V104, P5765, DOI 10.1073/pnas.0701442104; Tuzon CT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002060; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Yu EY, 2008, NAT STRUCT MOL BIOL, V15, P985, DOI 10.1038/nsmb.1471; Zaug AJ, 2010, GENE DEV, V24, P613, DOI 10.1101/gad.1881810	34	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26431	26439		10.1074/jbc.M111.228635	http://dx.doi.org/10.1074/jbc.M111.228635			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21659533	Green Published, hybrid			2022-12-25	WOS:000293078200021
J	Wu, J; Wang, ZMM; Li, AZ; Benamara, M; Li, SB; Salamo, GJ				Wu, Jiang; Wang, Zhiming M.; Li, Alvason Z.; Benamara, Mourad; Li, Shibin; Salamo, Gregory J.			Nanoscale Footprints of Self-Running Gallium Droplets on GaAs Surface	PLOS ONE			English	Article							HOLED NANOSTRUCTURES	In this work, the nanoscale footprints of self-driven liquid gallium droplet movement on a GaAs (001) surface will be presented and analyzed. The nanoscale footprints of a primary droplet trail and ordered secondary droplets along primary droplet trails are observed on the GaAs surface. A well ordered nanoterrace from the trail is left behind by a running droplet. In addition, collision events between two running droplets are investigated. The exposed fresh surface after a collision demonstrates a superior evaporation property. Based on the observation of droplet evolution at different stages as well as nanoscale footprints, a schematic diagram of droplet evolution is outlined in an attempt to understand the phenomenon of stick-slip droplet motion on the GaAs surface. The present study adds another piece of work to obtain the physical picture of a stick-slip self-driven mechanism in nanoscale, bridging nano and micro systems.	[Wu, Jiang; Wang, Zhiming M.; Li, Alvason Z.; Benamara, Mourad; Li, Shibin; Salamo, Gregory J.] Univ Arkansas, Arkansas Inst Nanoscale Mat Sci & Engn, Fayetteville, AR 72701 USA; [Wang, Zhiming M.] Univ Elect Sci & Technol China, State Key Lab Elect Thin Films & Integrated Devic, Chengdu 610054, Peoples R China	University of Arkansas System; University of Arkansas Fayetteville; University of Electronic Science & Technology of China	Wu, J (corresponding author), Univ Arkansas, Arkansas Inst Nanoscale Mat Sci & Engn, Fayetteville, AR 72701 USA.	zmwang@uark.edu	Wang, Zhiming M/Q-1031-2015; Wu, Jiang/I-7436-2019; Li, Alvason Zhenhua/M-8380-2015; Li, Shibin/J-6289-2017	Wu, Jiang/0000-0003-0679-6196; Li, Alvason Zhenhua/0000-0001-6889-3288; Li, Shibin/0000-0002-0591-5491	Arkansas Biosciences Institute; National Science Foundation [DMR-0520550]	Arkansas Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Arkansas Biosciences Institute and the MRSEC Program of National Science Foundation Grant No. (DMR-0520550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHATILLON C, 1995, J CRYST GROWTH, V151, P91, DOI 10.1016/0022-0248(95)00044-5; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Garcia-Sucerquia J, 2011, 3D RES, V2, DOI 10.1007/3DRes.02(2011)2; Heyn C, 2010, NANOSCALE RES LETT, V5, P576, DOI 10.1007/s11671-009-9507-3; Heyn C, 2009, J CRYST GROWTH, V311, P1839, DOI 10.1016/j.jcrysgro.2008.11.001; Hilner E, 2009, NANO LETT, V9, P2710, DOI 10.1021/nl9011886; KOGUCHI N, 1993, JPN J APPL PHYS 1, V32, P2052, DOI 10.1143/JJAP.32.2052; Kumah DP, 2009, NAT NANOTECHNOL, V4, P835, DOI [10.1038/NNANO.2009.271, 10.1038/nnano.2009.271]; Lazar P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.136103; Lee JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285602; Lee J, 2010, IEEE T NANOTECHNOL, V9, P149, DOI 10.1109/TNANO.2009.2028735; Lee JH, 2009, CRYST GROWTH DES, V9, P715, DOI 10.1021/cg701142d; Li AZH, 2010, NANO RES, V3, P490, DOI 10.1007/s12274-010-0009-5; Li AZH, 2009, CRYST GROWTH DES, V9, P2941, DOI 10.1021/cg900189t; Li SS, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2778541; Liang BL, 2008, ACS NANO, V2, P2219, DOI 10.1021/nn800224p; Liang BL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455604; LOWES TD, 1993, J APPL PHYS, V73, P4937, DOI 10.1063/1.353812; Merola F, 2011, 3D RES, V2, DOI 10.1007/3DRes.01(2011)3; Mumm F, 2009, ACS NANO, V3, P2647, DOI 10.1021/nn900607p; Ogawa T, 2007, J PHYS D APPL PHYS, V40, P4603, DOI 10.1088/0022-3727/40/15/036; Richardson HH, 2009, NANO LETT, V9, P1139, DOI 10.1021/nl8036905; Somaschini C, 2009, NANO LETT, V9, P3419, DOI 10.1021/nl901493f; Tersoff J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.035702; Tersoff J, 2009, SCIENCE, V324, P236, DOI 10.1126/science.1169546; Wang LQ, 2010, NANOSCALE RES LETT, V5, P1241, DOI 10.1007/s11671-010-9638-6; Wang Z. M., 2005, PHYS STATUS SOLIDI A, V202, P1339; Wang ZM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713745; Wang ZM, 2006, NANOSCALE RES LETT, V1, P57, DOI 10.1007/s11671-006-9002-z; Yakes MK, 2010, ACS NANO, V4, P3877, DOI 10.1021/nn100623q	30	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20765	10.1371/journal.pone.0020765	http://dx.doi.org/10.1371/journal.pone.0020765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673965	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400027
J	Johnston-Monje, D; Raizada, MN				Johnston-Monje, David; Raizada, Manish N.			Conservation and Diversity of Seed Associated Endophytes in Zea across Boundaries of Evolution, Ethnography and Ecology	PLOS ONE			English	Article							PLANT-GROWTH; BACTERIAL ENDOPHYTES; MAYS L.; SP-NOV.; PANTOEA-AGGLOMERANS; ENTEROBACTER-ASBURIAE; ADVENTITIOUS ROOTS; MAIZE; TEOSINTE; IDENTIFICATION	Endophytes are non-pathogenic microbes living inside plants. We asked whether endophytic species were conserved in the agriculturally important plant genus Zea as it became domesticated from its wild ancestors (teosinte) to modern maize (corn) and moved from Mexico to Canada. Kernels from populations of four different teosintes and 10 different maize varieties were screened for endophytic bacteria by culturing, cloning and DNA fingerprinting using terminal restriction fragment length polymorphism (TRFLP) of 16S rDNA. Principle component analysis of TRFLP data showed that seed endophyte community composition varied in relation to plant host phylogeny. However, there was a core microbiota of endophytes that was conserved in Zea seeds across boundaries of evolution, ethnography and ecology. The majority of seed endophytes in the wild ancestor persist today in domesticated maize, though ancient selection against the hard fruitcase surrounding seeds may have altered the abundance of endophytes. Four TRFLP signals including two predicted to represent Clostridium and Paenibacillus species were conserved across all Zea genotypes, while culturing showed that Enterobacter, Methylobacteria, Pantoea and Pseudomonas species were widespread, with gamma-proteobacteria being the prevalent class. Twenty-six different genera were cultured, and these were evaluated for their ability to stimulate plant growth, grow on nitrogen-free media, solubilize phosphate, sequester iron, secrete RNAse, antagonize pathogens, catabolize the precursor of ethylene, produce auxin and acetoin/butanediol. Of these traits, phosphate solubilization and production of acetoin/butanediol were the most commonly observed. An isolate from the giant Mexican landrace Mixteco, with 100% identity to Burkholderia phytofirmans, significantly promoted shoot potato biomass. GFP tagging and maize stem injection confirmed that several seed endophytes could spread systemically through the plant. One seed isolate, Enterobacter asburiae, was able to exit the root and colonize the rhizosphere. Conservation and diversity in Zea-microbe relationships are discussed in the context of ecology, crop domestication, selection and migration.	[Johnston-Monje, David; Raizada, Manish N.] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada	University of Guelph	Johnston-Monje, D (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	Raizada@uoguelph.ca		Johnston-Monje, David Morris/0000-0002-5077-4894	Ontario Research Fund; OMAFRA; Canadian Foundation for Innovation; Gerald R. Stephenson Scholarship; Gordon Nixon Leadership Award; Taffy Davison Memorial Research Travel Grant	Ontario Research Fund; OMAFRA; Canadian Foundation for Innovation(Canada Foundation for Innovation); Gerald R. Stephenson Scholarship; Gordon Nixon Leadership Award; Taffy Davison Memorial Research Travel Grant	This work was made possible by generous funding given to MNR by the Ontario Research Fund, OMAFRA New Directions program and Canadian Foundation for Innovation. Additional funding was awarded to DJM by the Gerald R. Stephenson Scholarship, Gordon Nixon Leadership Award, and the Taffy Davison Memorial Research Travel Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Agren GI, 2003, ANN BOT-LONDON, V92, P795, DOI 10.1093/aob/mcg203; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; Asis CA, 2004, LETT APPL MICROBIOL, V38, P19, DOI 10.1046/j.1472-765X.2003.01434.x; BELLON MR, 1994, ECON BOT, V48, P196, DOI 10.1007/BF02908218; Block CC, 1998, PLANT DIS, V82, P775, DOI 10.1094/PDIS.1998.82.7.775; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Caballero-Mellado J, 2004, INT J SYST EVOL MICR, V54, P1165, DOI 10.1099/ijs.0.02951-0; Chee-Sanford JC, 2006, WEED SCI, V54, P575, DOI 10.1614/WS-05-055R.1; Chelius MK, 2002, INT J SYST EVOL MICR, V52, P2061, DOI 10.1099/ijs.0.02203-0; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Christensen MJ, 2007, 6 INT S FUNG END GRA, V13, P123; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Conn KL, 1997, CAN J MICROBIOL, V43, P801, DOI 10.1139/m97-117; Coutinho TA, 2009, MOL PLANT PATHOL, V10, P325, DOI [10.1111/j.1364-3703.2009.00542.x, 10.1111/J.1364-3703.2009.00542.X]; COX CD, 1994, METHOD ENZYMOL, V235, P315; Cruz AT, 2007, J CLIN MICROBIOL, V45, P1989, DOI 10.1128/JCM.00632-07; Dalling JW, 2011, J ECOL, V99, P89, DOI 10.1111/j.1365-2745.2010.01739.x; Dalton DA, 2006, PLANT-ASSOCIATED BACTERIA, P105; De Klerk GJ, 1999, IN VITRO CELL DEV-PL, V35, P189, DOI 10.1007/s11627-999-0076-z; Deepa CK, 2010, WORLD J MICROB BIOT, V26, P1233, DOI 10.1007/s11274-009-0293-y; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Drummond A., 2011, GENEIOUS V5 5; DUBOS RJ, 1960, J EXP MED, V111, P407, DOI 10.1084/jem.111.3.407; ELA SW, 1982, PLANT PHYSIOL, V70, P1564, DOI 10.1104/pp.70.5.1564; Puente ME, 2009, ENVIRON EXP BOT, V66, P402, DOI 10.1016/j.envexpbot.2009.04.007; Estrada P, 2002, CAN J MICROBIOL, V48, P285, DOI 10.1139/w02-023; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Feng Y, 2006, J APPL MICROBIOL, V100, P938, DOI 10.1111/j.1365-2672.2006.02843.x; Ferreira A, 2008, FEMS MICROBIOL LETT, V287, P8, DOI 10.1111/j.1574-6968.2008.01258.x; FISHER PJ, 1992, NEW PHYTOL, V122, P299, DOI 10.1111/j.1469-8137.1992.tb04234.x; Figueiredo JEF, 2009, BRAZ J MICROBIOL, V40, P522, DOI [10.1590/S1517-83822009000300014, 10.1590/S1517-838220090003000014]; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gai CS, 2009, J MICROBIOL, V47, P448, DOI 10.1007/s12275-008-0303-z; Gibson RW, 2005, ANN APPL BIOL, V147, P153, DOI 10.1111/j.1744-7348.2005.00021.x; Gich Frederic B., 2000, International Microbiology, V3, P103; Glick BR, 2005, FEMS MICROBIOL LETT, V251, P1, DOI 10.1016/j.femsle.2005.07.030; Gyaneshwar P, 1999, FEMS MICROBIOL LETT, V171, P223, DOI 10.1111/j.1574-6968.1999.tb13436.x; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HINTON DM, 1995, MYCOPATHOLOGIA, V129, P117, DOI 10.1007/BF01103471; Hole R. C., 2004, BARC NEWSL, V249, P91; Holst I, 2007, P NATL ACAD SCI USA, V104, P17608, DOI 10.1073/pnas.0708736104; ILTIS HH, 1979, SCIENCE, V203, P186, DOI 10.1126/science.203.4376.186; Iltis HH, 2000, NOVON, V10, P382, DOI 10.2307/3392992; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Johnston-Monje D, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P713; Junier P, 2008, APPL ENVIRON MICROB, V74, P6452, DOI 10.1128/AEM.01394-08; Kaga H, 2009, MICROBES ENVIRON, V24, P154, DOI 10.1264/jsme2.ME09113; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; KLOEPPER JW, 1980, CURR MICROBIOL, V4, P317, DOI 10.1007/BF02602840; Krakat N, 2010, APPL ENVIRON MICROB, V76, P1842, DOI 10.1128/AEM.02397-09; KREMER RJ, 1987, MICROBIAL ECOL, V14, P29, DOI 10.1007/BF02011568; LEVINGS CS, 1992, PLANT MOL BIOL, V19, P135, DOI 10.1007/BF00015611; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lidstrom ME, 2002, J BACTERIOL, V184, P1818, DOI 10.1128/JB.184.7.1818.2002; Long HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002702; Madmony A, 2005, FOLIA MICROBIOL, V50, P209, DOI 10.1007/BF02931568; Mano H., 2006, Microbes and Environments, V21, P86, DOI 10.1264/jsme2.21.86; Mano Y, 2006, PLANT SOIL, V281, P269, DOI 10.1007/s11104-005-4268-y; Mano Y, 2009, PLANT ROOT, V3, P3, DOI 10.3117/plantroot.3.3; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mauricio Sanchez R. A., 2004, Revista Fitotecnia Mexicana, V27, P213; MCINROY JA, 1995, CAN J MICROBIOL, V41, P895, DOI 10.1139/m95-123; MCINROY JA, 1995, PLANT SOIL, V173, P337, DOI 10.1007/BF00011472; Montanez A, 2009, BIOL FERT SOILS, V45, P253, DOI 10.1007/s00374-008-0322-2; MUNDT JO, 1976, APPL ENVIRON MICROB, V32, P694, DOI 10.1128/AEM.32.5.694-698.1976; Munkacsi AB, 2008, P ROY SOC B-BIOL SCI, V275, P1037, DOI 10.1098/rspb.2007.1636; Nabhan Gary Paul, 2008, RENEWING AM FOOD TRA; Narvaez Gonzalez E.D, 2007, REV FITOTEC MEX, V30, P321; Nassar AH, 2005, BIOL FERT SOILS, V42, P97, DOI 10.1007/s00374-005-0008-y; Nelson EB, 2004, ANNU REV PHYTOPATHOL, V42, P271, DOI 10.1146/annurev.phyto.42.121603.131041; Palus JA, 1996, PLANT SOIL, V186, P135, DOI 10.1007/BF00035067; Perez-Miranda S, 2007, J MICROBIOL METH, V70, P127, DOI 10.1016/j.mimet.2007.03.023; PHALIP V, 1994, J BASIC MICROB, V34, P277, DOI 10.1002/jobm.3620340412; Pirttila AM, 2000, APPL ENVIRON MICROB, V66, P3073, DOI 10.1128/AEM.66.7.3073-3077.2000; Preston GM, 2004, PHILOS T R SOC B, V359, P907, DOI 10.1098/rstb.2003.1384; QuadtHallmann A, 1997, CAN J MICROBIOL, V43, P577, DOI 10.1139/m97-081; QuadtHallmann A, 1996, CAN J MICROBIOL, V42, P1144, DOI 10.1139/m96-146; Rai R, 2007, WORLD J MICROB BIOT, V23, P853, DOI 10.1007/s11274-006-9309-z; Raven P. H., 1999, BIOL PLANTS, V6th; Reis VM, 2004, INT J SYST EVOL MICR, V54, P2155, DOI 10.1099/ijs.0.02879-0; Rice E, 2007, GENET RESOUR CROP EV, V54, P701, DOI 10.1007/s10722-006-0023-3; Riggs PJ, 2001, AUST J PLANT PHYSIOL, V28, P829, DOI 10.1071/PP01045; Rijavec T, 2007, CAN J MICROBIOL, V53, P802, DOI 10.1139/W07-048; Rodriguez H, 2000, J BIOTECHNOL, V84, P155, DOI 10.1016/S0168-1656(00)00347-3; Roesch LFW, 2008, PLANT SOIL, V302, P91, DOI 10.1007/s11104-007-9458-3; Roesch LFW, 2007, REV BRAS CIENC SOLO, V31, P1367, DOI 10.1590/S0100-06832007000600015; Romanovskaya VA, 2001, MICROBIOLOGY+, V70, P221, DOI 10.1023/A:1010441900060; Rosenblueth M, 2004, ARCH MICROBIOL, V181, P337, DOI 10.1007/s00203-004-0661-9; Corral JAR, 2008, CROP SCI, V48, P1502, DOI 10.2135/cropsci2007.09.0518; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Ryu J, 2006, J MICROBIOL BIOTECHN, V16, P1622; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Seghers D, 2004, APPL ENVIRON MICROB, V70, P1475, DOI 10.1128/AEM.70.3.1475-1482.2004; SEKELJA M, 2010, ISME J; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Smalla K., 2004, MICROBIAL DIVERSITY, P88, DOI DOI 10.1128/9781555817770.CH9; Soares MMCN, 1999, REV MICROBIOL, V30, P299, DOI 10.1590/S0001-37141999000400002; Torres AR, 2008, J MICROBIOL, V46, P373, DOI 10.1007/s12275-007-0165-9; Toth IK, 2003, MOL PLANT PATHOL, V4, P17, DOI 10.1046/j.1364-3703.2003.00149.x; Turrent A, 2004, MAIZE BIODIVERSITY E; Vollbrecht E, 2005, BIOCHEM SOC T, V33, P1502, DOI 10.1042/BST20051502; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang K, 2007, NEW PHYTOL, V174, P212, DOI 10.1111/j.1469-8137.2007.01999.x; Wilkes G., 2004, CORN ORIGIN HIST TEC; Yasinok AE, 2008, J AGR SCI-TARIM BILI, V14, P374, DOI 10.1501/Tarimbil_0000001054; Zinniel DK, 2002, APPL ENVIRON MICROB, V68, P2198, DOI 10.1128/AEM.68.5.2198-2208.2002	113	296	327	11	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20396	10.1371/journal.pone.0020396	http://dx.doi.org/10.1371/journal.pone.0020396			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673982	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500015
J	Okyar, A; Piccolo, E; Ahowesso, C; Filipski, E; Hossard, V; Guettier, C; La Sorda, R; Tinari, N; Iacobelli, S; Levi, F				Okyar, Alper; Piccolo, Enza; Ahowesso, Constance; Filipski, Elisabeth; Hossard, Virginie; Guettier, Catherine; La Sorda, Rosanna; Tinari, Nicola; Iacobelli, Stefano; Levi, Francis			Strain- and Sex-Dependent Circadian Changes in Abcc2 Transporter Expression: Implications for Irinotecan Chronotolerance in Mouse Ileum	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CLOCK; OXALIPLATIN; MECHANISMS; RHYTHMS; ACID	Background: ATP-binding cassette transporter abcc2 is involved in the cellular efflux of irinotecan. The drug is toxic for mouse ileum, where abcc2 is highly expressed. Here, we investigate whether circadian changes in local abcc2 expression participate in the circadian rhythm of irinotecan toxicity for ileum mucosa, and further assess whether genetic background or sex modify this relation. Methodology/Principal Findings: Ileum mucosa was obtained every 3-4 h for 24 h in male and female B6D2F(1) and B6CBAF(1) mice synchronized with light from Zeitgeber Time (ZT) 0 to ZT12 alternating with 12 h of darkness. Irinotecan (50 mg/kg i.v. daily for 4 days) was administered at the sex-and strain-specific times corresponding to least (ZT11-15) or largest drug-induced body weight loss (ZT23-03-07). Abcc2 expression was determined with qRT-PCR for mRNA and with immunohistochemistry and confocal microscopy for protein. Histopathologic lesions were graded in ileum tissues obtained 2, 4 or 6 days after treatment. Two-to six-fold circadian changes were demonstrated for mRNA and protein mean expressions of abcc2 in mouse ileum (p<0.05). ZT12 corresponded to high mRNA and protein expressions, with circadian waveforms differing according to genetic background and sex. The proportion of mice spared from ileum lesions varied three-fold according to irinotecan timing, with best tolerability at ZT11-15 (p = 0.00003). Irinotecan was also best tolerated in males (p = 0.05) and in B6CBAF(1) (p = 0.0006). Conclusions/Significance: Strain-and sex-dependent circadian patterns in abcc2 expressions displayed robust relations with the chronotolerance of ileum mucosa for irinotecan. This finding has strong potential implications for improving the intestinal tolerability of anticancer drugs through circadian delivery.	[Okyar, Alper; Ahowesso, Constance; Filipski, Elisabeth; Hossard, Virginie; Levi, Francis] Hop Paul Brousse, INSERM, Rythmes Biol & Cancers U776, Villejuif, France; [Okyar, Alper; Ahowesso, Constance; Filipski, Elisabeth; Hossard, Virginie; Levi, Francis] Univ Paris Sud, UMR S0776, Orsay, France; [Levi, Francis] Hop Paul Brousse, AP HP, Unite Chronotherapie, Dept Cancerol, Villejuif, France; [Okyar, Alper] Istanbul Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkey; [Piccolo, Enza; La Sorda, Rosanna; Tinari, Nicola; Iacobelli, Stefano] CESI Univ G Annunzio, CINBO, Chieti, Italy; [Guettier, Catherine] Hop Paul Brousse, AP HP, Lab Anat & Cytol Pathol, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Istanbul University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP	Okyar, A (corresponding author), Hop Paul Brousse, INSERM, Rythmes Biol & Cancers U776, Villejuif, France.	francis.levi@inserm.fr	Okyar, Alper/AAD-3114-2020	Tinari, Nicola/0000-0001-8449-5407	European Union through the Network of Excellence BIOSIM [LSHBCT-2004-005137]; Specific Targeted Research Project TEMPO (Temporal Genomics for Tailored Chronotherapeutics) [LSHG-ct-2006-037543]; Temporal Dimension in Functional Genomics [LSSG-CT-2006-037654]; Scientific and Technological Research Council of Turkey (TUBITAK); Istanbul University [UDP-8562/2010]	European Union through the Network of Excellence BIOSIM(European Commission); Specific Targeted Research Project TEMPO (Temporal Genomics for Tailored Chronotherapeutics); Temporal Dimension in Functional Genomics; Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Istanbul University(Istanbul University)	The study was funded by the European Union through the Network of Excellence BIOSIM (Biosimulation: a new tool for drug development; contract LSHBCT-2004-005137), the Specific Targeted Research Project TEMPO (Temporal Genomics for Tailored Chronotherapeutics; contract LSHG-ct-2006-037543), the Specific Support Action PROUST (The Temporal Dimension in Functional Genomics; contract LSSG-CT-2006-037654) and by the Scientific and Technological Research Council of Turkey (TUBITAK) and the Research Fund of Istanbul University (UDP-8562/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahowesso C, 2010, TOXICOL LETT, V192, P395, DOI 10.1016/j.toxlet.2009.11.017; AHOWESSO C, 2010, THESIS U PARIS SUD 1; Altinok A, 2009, EUR J PHARM SCI, V36, P20, DOI 10.1016/j.ejps.2008.10.024; Ando H, 2005, CHRONOBIOL INT, V22, P655, DOI 10.1080/07420520500180231; Berggren S, 2007, MOL PHARM, V4, P252, DOI 10.1021/mp0600687; BINGHAM C, 1982, CHRONOBIOLOGIA, V9, P397; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Clairambault J, 2009, MATH MODEL NAT PHENO, V4, P12, DOI 10.1051/mmnp/20094302; Claudel T, 2007, FEBS LETT, V581, P3626, DOI 10.1016/j.febslet.2007.04.009; DePrins J, 1992, BIOL RHYTHMS CLIN LA, P90; Filipski E, 2004, CHRONOBIOL INT, V21, P613, DOI 10.1081/CBI-120040183; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gotoh Y, 2000, J PHARMACOL EXP THER, V292, P433; Innocenti F, 2009, J CLIN ONCOL, V27, P2604, DOI 10.1200/JCO.2008.20.6300; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kweekel D, 2008, CANCER TREAT REV, V34, P656, DOI 10.1016/j.ctrv.2008.05.002; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; LEVI F, 2010, CANC SYSTEM IN PRESS; Levi F, 2007, ADV DRUG DELIVER REV, V59, P1015, DOI 10.1016/j.addr.2006.11.001; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Levi F, 2010, ANNU REV PHARMACOL, V50, P377, DOI 10.1146/annurev.pharmtox.48.113006.094626; Maher JM, 2005, DRUG METAB DISPOS, V33, P947, DOI 10.1124/dmd.105.003780; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mottino AD, 2000, J PHARMACOL EXP THER, V293, P717; Murakami Y, 2008, GASTROENTEROLOGY, V135, P1636, DOI 10.1053/j.gastro.2008.07.073; Ohdo S, 1997, J PHARMACOL EXP THER, V283, P1383; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Stearns AT, 2008, J PHARMACOL SCI, V108, P144, DOI 10.1254/jphs.08100SC; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang YKJ, 2009, DRUG METAB DISPOS, V37, P106, DOI 10.1124/dmd.108.024174	34	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20393	10.1371/journal.pone.0020393	http://dx.doi.org/10.1371/journal.pone.0020393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674030	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500014
J	Strack, S; Petersen, Y; Wagner, A; Roder, IV; Albrizio, M; Reischl, M; Wacker, IU; Wilhelm, C; Rudolf, R				Strack, Siegfried; Petersen, Yvonne; Wagner, Anika; Roeder, Ira V.; Albrizio, Marina; Reischl, Markus; Wacker, Irene U.; Wilhelm, Christoph; Rudolf, Ruediger			A Novel Labeling Approach Identifies Three Stability Levels of Acetylcholine Receptors in the Mouse Neuromuscular Junction In Vivo	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; MYOSIN VA; MUSCLE; DEGRADATION; MAINTENANCE; SYNAPSES; DYNAMICS; DENSITY; ALPHA	Background: The turnover of acetylcholine receptors at the neuromuscular junction is regulated in an activity-dependent manner. Upon denervation and under various other pathological conditions, receptor half-life is decreased. Methodology/Principal Findings: We demonstrate a novel approach to follow the kinetics of acetylcholine receptor lifetimes upon pulse labeling of mouse muscles with I-125-alpha-bungarotoxin in vivo. In contrast to previous assays where residual activity was measured ex vivo, in our setup the same animals are used throughout the whole measurement period, thereby permitting a dramatic reduction of animal numbers at increased data quality. We identified three stability levels of acetylcholine receptors depending on the presence or absence of innervation: one pool of receptors with a long half-life of similar to 13 days, a second with an intermediate half-life of similar to 8 days, and a third with a short half-life of similar to 1 day. Data were highly reproducible from animal to animal and followed simple exponential terms. The principal outcomes of these measurements were reproduced by an optical pulse-labeling assay introduced recently. Conclusions/Significance: A novel assay to determine kinetics of acetylcholine receptor turnover with small animal numbers is presented. Our data show that nerve activity acts on muscle acetylcholine receptor stability by at least two different means, one shifting receptor lifetime from short to intermediate and another, which further increases receptor stability to a long lifetime. We hypothesize on possible molecular mechanisms.	[Strack, Siegfried; Petersen, Yvonne; Wagner, Anika; Roeder, Ira V.; Albrizio, Marina; Rudolf, Ruediger] Karlsruhe Inst Technol, Inst Toxikol & Genet, Karlsruhe, Germany; [Reischl, Markus] Karlsruhe Inst Technol, Inst Angew Informat, Karlsruhe, Germany; [Wacker, Irene U.] Karlsruhe Inst Technol, Inst Biol Grenzflachen, Karlsruhe, Germany; [Wilhelm, Christoph] Karlsruhe Inst Technol, Sicherheitsmanagement Anal Labs, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Strack, S (corresponding author), Karlsruhe Inst Technol, Inst Toxikol & Genet, Karlsruhe, Germany.	ruediger.rudolf@kit.edu	Reischl, Markus/H-6970-2013; Rudolf, Rüdiger/A-6476-2009	Reischl, Markus/0000-0002-7780-6374; Rudolf, Rüdiger/0000-0002-0833-1053	Deutsche Forschungsgemeinschaft [RU923/3-1, RU923/4-1]; Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	RR was supported by the Deutsche Forschungsgemeinschaft (RU923/3-1, RU923/4-1). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; ANDREOSE JS, 1993, J NEUROSCI, V13, P3433; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Bruneau EG, 2006, MOL NEUROBIOL, V34, P137, DOI 10.1385/MN:34:2:137; Bruneau EG, 2006, DEVELOPMENT, V133, P4485, DOI 10.1242/dev.02619; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; Chang CC, 1999, J BIOMED SCI, V6, P368, DOI 10.1159/000025412; Engel A.G., 2004, MYOLOGY; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; LEVITT TA, 1981, NATURE, V291, P239, DOI 10.1038/291239a0; LINGLE CJ, 1988, INT ANESTHESIOL CLIN, V26, P288, DOI 10.1097/00004311-198802640-00007; LOMO T, 1971, J PHYSIOL-LONDON, V216, pP52; Lu Ju, 2007, Shengli Xuebao, V59, P683; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; Roder IV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003871; Rudolf R, 2011, J NEUROCHEM, V116, P177, DOI 10.1111/j.1471-4159.2010.07110.x; SALPETER MM, 1986, J CELL BIOL, V103, P1399, DOI 10.1083/jcb.103.4.1399; SALPETER MM, 1985, PROG NEUROBIOL, V25, P297, DOI 10.1016/0301-0082(85)90018-8; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; SHYNG SL, 1991, NEURON, V6, P469, DOI 10.1016/0896-6273(91)90254-W; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Xu RF, 1997, J NEUROSCI, V17, P8194; Xu RF, 1999, J CELL PHYSIOL, V181, P107, DOI 10.1002/(SICI)1097-4652(199910)181:1<107::AID-JCP11>3.3.CO;2-0; YAMPOLSKY P, 2010, EUR J NEUROSCI; Yampolsky P, 2008, MOL CELL NEUROSCI, V37, P634, DOI 10.1016/j.mcn.2007.12.014; Yampolsky P, 2010, J BIOL CHEM, V285, P34589, DOI 10.1074/jbc.M110.168880	28	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20524	10.1371/journal.pone.0020524	http://dx.doi.org/10.1371/journal.pone.0020524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655100	Green Published, Green Submitted, gold			2022-12-25	WOS:000291310600012
J	Tornero, D; Posadas, I; Cena, V				Tornero, Daniel; Posadas, Inmaculada; Cena, Valentin			Bcl-x(L) Blocks a Mitochondrial Inner Membrane Channel and Prevents Ca2+ Overload-Mediated Cell Death	PLOS ONE			English	Article							BCL-X-L; PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; FAMILY-MEMBERS; CALCIUM; APOPTOSIS; BAX; ACTIVATION; NEURONS; STAUROSPORINE	Apoptosis is an active process that plays a key role in many physiological and pathological conditions. One of the most important organelles involved in apoptosis regulation is the mitochondrion. An increase in intracellular Ca2+ is a general mechanism of toxicity in neurons which occurs in response to different noxious stimuli like excitotoxicity and ischemia producing apoptotic and necrotic cell death through mitochondria-dependent mechanisms. The Bcl-2 family of proteins modulate the release of pro-apoptotic factors from the mitochondrial intermembrane space during cell death induction by different stimuli. In this work, we have studied, using single-cell imaging and patch-clamp single channel recording, the mitochondrial mechanisms involved in the neuroprotective effect of Bcl-x(L) on Ca2+ overload-mediated cell death in human neuroblastoma SH-SY5Y cells. We have found that Bcl-x(L) neuroprotective actions take place at mitochondria where this antiapoptotic protein delays both mitochondrial potential collapse and opening of the permeability transition pore by preventing Ca2+-mediated mitochondrial multiple conductance channel opening. Bcl-x(L) neuroprotective actions were antagonized by the Bcl-x(L) inhibitor ABT-737 and potentiated by the Ca2+ chelator BAPTA-AM. As a consequence, this would prevent free radical production, mitochondrial membrane permeabilization, release from mitochondria of pro-apoptotic molecules, caspase activation and cellular death.	[Tornero, Daniel; Posadas, Inmaculada; Cena, Valentin] Univ Castilla La Mancha, Unidad Asociada Neurodeath, Albacete, Spain; [Tornero, Daniel] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Madrid, Spain; [Posadas, Inmaculada; Cena, Valentin] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Universidad de Castilla-La Mancha; General University Gregorio Maranon Hospital; CIBERNED; Instituto de Salud Carlos III	Tornero, D (corresponding author), Univ Castilla La Mancha, Unidad Asociada Neurodeath, Albacete, Spain.	valentin.cena@uclm.es	Cena, Valentin/L-1751-2017; Tornero, Daniel/N-2049-2014; Posadas, Inmaculada/M-1124-2014	Cena, Valentin/0000-0001-8928-3681; Tornero, Daniel/0000-0002-4812-4091; Posadas, Inmaculada/0000-0003-1854-3372	Fondo de Investigaciones Sanitarias, Ministerio de Ciencia e Innovacion [PI081434]; Consejeria de Educacion, JCCM [PII1I09-0163-4002, POII10-0274-3182]	Fondo de Investigaciones Sanitarias, Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentInstituto de Salud Carlos III); Consejeria de Educacion, JCCM	D.T. is a recipient of a postdoctoral contract "Sara Borrell" from Fondo de Investigaciones Sanitarias, Ministerio de Ciencia e Innovacion. This work has been supported, in part, by grants PI081434 from Fondo de Investigaciones Sanitarias, Ministerio de Ciencia e Innovacion (www.micinn.es) and PII1I09-0163-4002 and POII10-0274-3182 from Consejeria de Educacion, JCCM (www.jccm.es) to V. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Belzacq AS, 2003, CANCER RES, V63, P541; Berliocchi L, 2005, PHILOS T R SOC B, V360, P2255, DOI 10.1098/rstb.2005.1765; Boix J, 1997, NEUROPHARMACOLOGY, V36, P811, DOI 10.1016/S0028-3908(97)00030-0; Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Brini M, 2003, CELL CALCIUM, V34, P399, DOI 10.1016/S0143-4160(03)00145-3; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Chen M, 2002, J BIOL CHEM, V277, P29181, DOI 10.1074/jbc.M204951200; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Gil-Parrado S, 2002, J BIOL CHEM, V277, P27217, DOI 10.1074/jbc.M202945200; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Jacotot E, 1999, ANN NY ACAD SCI, V887, P18, DOI 10.1111/j.1749-6632.1999.tb07919.x; Jonas EA, 2009, EXP NEUROL, V218, P203, DOI 10.1016/j.expneurol.2009.03.025; Jordan J, 2000, BRIT J PHARMACOL, V130, P1496, DOI 10.1038/sj.bjp.0703451; Jordan J, 2004, J NEUROCHEM, V89, P124, DOI 10.1046/j.1471-4159.2003.02299.x; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Li C, 2002, P NATL ACAD SCI USA, V99, P9830, DOI 10.1073/pnas.152571899; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Murphy RC, 2001, FEBS LETT, V497, P73, DOI 10.1016/S0014-5793(01)02440-1; Niquet J, 2006, BIOCHEM SOC T, V34, P1347, DOI 10.1042/BST0341347; Ouyang YB, 2002, FREE RADICAL BIO MED, V33, P544, DOI 10.1016/S0891-5849(02)00912-7; Paradies G, 2009, CELL CALCIUM, V45, P643, DOI 10.1016/j.ceca.2009.03.012; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Peng TI, 1998, EXP NEUROL, V149, P1, DOI 10.1006/exnr.1997.6599; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Poncet D, 2003, APOPTOSIS, V8, P521, DOI 10.1023/A:1025546525894; Posadas I, 2007, BRIT J PHARMACOL, V150, P577, DOI 10.1038/sj.bjp.0706993; Posadas I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015360; Reddy PH, 2009, EXP NEUROL, V218, P286, DOI 10.1016/j.expneurol.2009.03.042; Rong Y, 2008, ANNU REV PHYSIOL, V70, P73, DOI 10.1146/annurev.physiol.70.021507.105852; Schinder AF, 1996, J NEUROSCI, V16, P6125; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; WHITE RJ, 1995, J NEUROSCI, V15, P1318; Yuste VJ, 2002, J NEUROCHEM, V80, P126, DOI 10.1046/j.0022-3042.2001.00695.x	49	32	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20423	10.1371/journal.pone.0020423	http://dx.doi.org/10.1371/journal.pone.0020423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674052	Green Published, gold, Green Submitted			2022-12-25	WOS:000291310600009
J	Dmitriev, A; Mohapatra, SS; Chong, P; Neely, M; Biswas, S; Biswas, I				Dmitriev, Alexander; Mohapatra, Saswat S.; Chong, Patrick; Neely, Melody; Biswas, Saswati; Biswas, Indranil			CovR-Controlled Global Regulation of Gene Expression in Streptococcus mutans	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; GROUP-B STREPTOCOCCUS; HYALURONIC-ACID CAPSULE; PROTEOMIC ANALYSIS; VIRULENCE FACTORS; RESPONSE REGULATOR; POSITIVE REGULATOR; STREPTOLYSIN-S; M-PROTEIN; PYOGENES	CovR/S is a two-component signal transduction system (TCS) that controls the expression of various virulence related genes in many streptococci. However, in the dental pathogen Streptococcus mutans, the response regulator CovR appears to be an orphan since the cognate sensor kinase CovS is absent. In this study, we explored the global transcriptional regulation by CovR in S. mutans. Comparison of the transcriptome profiles of the wild-type strain UA159 with its isogenic covR deleted strain IBS10 indicated that at least 128 genes (similar to 6.5% of the genome) were differentially regulated. Among these genes, 69 were down regulated, while 59 were up regulated in the IBS10 strain. The S. mutans CovR regulon included competence genes, virulence related genes, and genes encoded within two genomic islands (GI). Genes encoded by the GI TnSmu2 were found to be dramatically reduced in IBS10, while genes encoded by the GI TnSmu1 were up regulated in the mutant. The microarray data were further confirmed by real-time RT-PCR analyses. Furthermore, direct regulation of some of the differentially expressed genes was demonstrated by electrophoretic mobility shift assays using purified CovR protein. A proteomic study was also carried out that showed a general perturbation of protein expression in the mutant strain. Our results indicate that CovR truly plays a significant role in the regulation of several virulence related traits in this pathogenic streptococcus.	[Dmitriev, Alexander; Mohapatra, Saswat S.; Chong, Patrick; Biswas, Saswati; Biswas, Indranil] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA; [Dmitriev, Alexander] Russian Acad Med Sci, Inst Expt Med, Dept Mol Microbiol, St Petersburg, Russia; [Neely, Melody] Wayne State Sch Med, Dept Microbiol & Immunol, Detroit, MI USA	University of Kansas; University of Kansas Medical Center; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Wayne State University	Dmitriev, A (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA.	ibiswas@kumc.edu	Neely, Melody N/AAX-1130-2021; Dmitriev, Alexander/C-9407-2012; Mohapatra, Saswat Sourav/B-6487-2011	Neely, Melody N/0000-0003-2125-7836; Mohapatra, Saswat Sourav/0000-0003-2776-1363	National Institute of Dental and Craniofacial Research (NIDCR) [DE016686]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016686] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was made possible by a National Institute of Dental and Craniofacial Research (NIDCR) grant (DE016686) to IB. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; Biswas I, 2003, J BACTERIOL, V185, P3081, DOI 10.1128/JB.185.10.3081-3090.2003; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; Biswas I, 2007, BIOTECHNIQUES, V42, P487, DOI 10.2144/000112414; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Biswas S, 2005, INFECT IMMUN, V73, P6923, DOI 10.1128/IAI.73.10.6923-6934.2005; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; CARLSSON J, 1994, METABOLIC ACTIVITY O; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004; Chaussee MA, 2006, J ANTIMICROB CHEMOTH, V58, P752, DOI 10.1093/jac/dkl319; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Chong P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015528; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; EDGAR WM, 1996, SALIVA ORAL HLTH, P81; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Folio P, 2004, PROTEOMICS, V4, P3187, DOI 10.1002/pmic.200300841; Froehlich BJ, 2009, J BACTERIOL, V191, P673, DOI 10.1128/JB.01256-08; Gao JX, 2005, J BIOL CHEM, V280, P38948, DOI 10.1074/jbc.M506121200; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Graham MR, 2001, CURR OPIN MICROBIOL, V4, P65, DOI 10.1016/S1369-5274(00)00166-1; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Gryllos I, 2007, MOL MICROBIOL, V65, P671, DOI 10.1111/j.1365-2958.2007.05818.x; Guillot A, 2003, PROTEOMICS, V3, P337, DOI 10.1002/pmic.200390047; Gusa AA, 2005, MOL MICROBIOL, V56, P1195, DOI 10.1111/j.1365-2958.2005.04623.x; Gusa AA, 2007, J BACTERIOL, V189, P1407, DOI 10.1128/JB.01036-06; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Jungblut PR, 2000, MOL MICROBIOL, V36, P710, DOI 10.1046/j.1365-2958.2000.01896.x; KURAMITSU HK, 1993, CRIT REV ORAL BIOL M, V4, P159, DOI 10.1177/10454411930040020201; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; Mitrophanov AY, 2008, GENE DEV, V22, P2601, DOI 10.1101/gad.1700308; Miyoshi-Akiyama T, 2006, J INFECT DIS, V193, P1677, DOI 10.1086/504263; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Santi I, 2009, J BACTERIOL, V191, P5387, DOI 10.1128/JB.00370-09; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Steiner K, 2002, INFECT IMMUN, V70, P3627, DOI 10.1128/IAI.70.7.3627-3636.2002; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tadesse S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-105; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; ULLMAN RF, 1988, HEART LUNG, V17, P209; Waterhouse JC, 2007, ORAL MICROBIOL IMMUN, V22, P103, DOI 10.1111/j.1399-302X.2007.00330.x; Waterhouse JC, 2006, MICROBIOL-SGM, V152, P1777, DOI 10.1099/mic.0.28647-0	62	33	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20127	10.1371/journal.pone.0020127	http://dx.doi.org/10.1371/journal.pone.0020127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655290	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600022
J	Hauser, A; Mugenyi, K; Kabasinguzi, R; Kuecherer, C; Harms, G; Kunz, A				Hauser, Andrea; Mugenyi, Kizito; Kabasinguzi, Rose; Kuecherer, Claudia; Harms, Gundel; Kunz, Andrea			Emergence and Persistence of Minor Drug-Resistant HIV-1 Variants in Ugandan Women after Nevirapine Single-Dose Prophylaxis	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; PREVENTION; PREGNANCY; INTRAPARTUM; ZIDOVUDINE; MUTATIONS; K103N; POSTPARTUM; HIVNET-012	Background: Nevirapine (NVP) single-dose is still a widely used antiretroviral prophylaxis for the prevention of vertical HIV-1 transmission in resource-limited settings. However, the main disadvantage of the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) NVP is the rapid selection of NVP-resistant virus with negative implications for subsequent NNRTI-based long-term antiretroviral therapy (ART). Here, we analysed the emergence of drug-resistant HIV-1 including minor variants in the early phase after NVP single-dose prophylaxis and the persistence of drug-resistant virus over time. Methods and Findings: NVP-resistant HIV-1 harbouring the K103N and/or Y181C resistance mutations in the HIV-1 reverse transcriptase gene was measured from 1 week up to 18 months after NVP single-dose prophylaxis in 29 Ugandan women using allele-specific PCR assays capable of detecting drug-resistant variants representing less than 1% of the whole viral population. In total, drug-resistant HIV-1 was identified in 18/29 (62%) women; rates increased from 18% to 38% and 44% at week 1, 2, 6, respectively, and decreased to 18%, 25%, 13% and 4% at month 3, 6, 12 and 18, respectively. The proportion of NVP-resistant virus of the total viral population was significantly higher in women infected with subtype D (median 40.5%) as compared to subtype A (median 1.3%; p = 0.032, Mann-Whitney U test). 33% of resistant virus was not detectable at week 2 but was for the first time measurable 6-12 weeks after NVP single-dose prophylaxis. Three (10%) women harboured resistant virus in proportions >10% still at month 6. Conclusions: Current WHO guidelines recommend an additional postnatal intake of AZT and 3TC for one week to avoid NVP resistance formation. Our findings indicate that a 1-week medication might be too short to impede the emergence of NVP resistance in a substantial proportion of women. Furthermore, subsequent NNRTI-based ART should not be started earlier than 12 months after NVP single-dose prophylaxis.	[Hauser, Andrea; Harms, Gundel; Kunz, Andrea] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Hauser, Andrea; Kuecherer, Claudia] Robert Koch Inst, Project HIV Variabil & Mol Epidemiol, D-1000 Berlin, Germany; [Mugenyi, Kizito; Kabasinguzi, Rose] German Tech Cooperat PMTCT Project Western Ugand, Minist Hlth, Ft Portal, Uganda	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute	Hauser, A (corresponding author), Charite, Inst Trop Med & Int Hlth, Berlin, Germany.	andrea-ursula.kunz@charite.de			German Ministry for Economic Cooperation and Development [PN 01.2029.5]; H.W. & J. Hector Stiftung, Germany	German Ministry for Economic Cooperation and Development; H.W. & J. Hector Stiftung, Germany	This work was supported by the German Ministry for Economic Cooperation and Development through the Project PN 01.2029.5 (Prevention of Mother-to Child Transmission of HIV) and by a grant of the H.W. & J. Hector Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Eshleman SH, 2005, JAIDS-J ACQ IMM DEF, V40, P24, DOI 10.1097/01.qai.0000174656.71276.d6; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Farr SL, 2010, JAIDS-J ACQ IMM DEF, V54, P515, DOI 10.1097/QAI.0b013e3181e3a70e; Flys TS, 2007, J INFECT DIS, V195, P711, DOI 10.1086/511433; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hauser A, 2009, ANTIMICROB AGENTS CH, V53, P2965, DOI 10.1128/AAC.01672-08; Johnson JA, 2005, J INFECT DIS, V192, P16, DOI 10.1086/430741; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kunz A, 2009, J ANTIMICROB CHEMOTH, V63, P170, DOI 10.1093/jac/dkn441; Lallemant M, 2010, CLIN INFECT DIS, V50, P898, DOI 10.1086/650745; Lehman DA, 2009, JAIDS-J ACQ IMM DEF, V51, P522, DOI 10.1097/QAI.0b013e3181aa8a22; Lipshultz SE, 2011, J AM COLL CARDIOL, V57, P76, DOI 10.1016/j.jacc.2010.08.620; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Loubser S, 2006, AIDS, V20, P995, DOI 10.1097/01.aids.0000222071.60620.1d; MacLeod IJ, 2010, J CLIN VIROL, V48, P162, DOI 10.1016/j.jcv.2010.03.017; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Palmer S, 2006, P NATL ACAD SCI USA, V103, P7094, DOI 10.1073/pnas.0602033103; Paredes R, 2010, AIDS, V24, P45, DOI 10.1097/QAD.0b013e32832e5303; Pilger D, 2011, ANTIVIR THER, V16, P109, DOI 10.3851/IMP1698; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Townsend CL, 2010, ANTIVIR THER, V15, P775, DOI 10.3851/IMP1613; Wind-Rotolo M, 2009, J INFECT DIS, V199, P1301, DOI 10.1086/597759; World Health Organization, 2021, ANT DRUGS TREAT PREG	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20357	10.1371/journal.pone.0020357	http://dx.doi.org/10.1371/journal.pone.0020357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655245	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600052
J	Hygum, K; Lildballe, DL; Greibe, EH; Morkbak, AL; Poulsen, SS; Sorensen, BS; Petersen, TE; Nexo, E				Hygum, Katrine; Lildballe, Dorte L.; Greibe, Eva H.; Morkbak, Anne L.; Poulsen, Steen S.; Sorensen, Boe S.; Petersen, Torben E.; Nexo, Ebba			Mouse Transcobalamin Has Features Resembling both Human Transcobalamin and Haptocorrin	PLOS ONE			English	Article							COBALAMIN-BINDING-PROTEINS; INTRINSIC-FACTOR; PURIFICATION; SERUM; LOCALIZATION; PRINCIPLE; ANALOGS; PLASMA; CELLS; GENE	In humans, the cobalamin (Cbl)-binding protein transcobalamin (TC) transports Cbl from the intestine and into all the cells of the body, whereas the glycoprotein haptocorrin (HC), which is present in both blood and exocrine secretions, is able to bind also corrinoids other than Cbl. The aim of this study is to explore the expression of the Cbl-binding protein HC as well as TC in mice. BLAST analysis showed no homologous gene coding for HC in mice. Submaxillary glands and serum displayed one protein capable of binding Cbl. This Cbl-binding protein was purified from 300 submaxillary glands by affinity chromatography. Subsequent sequencing identified the protein as TC. Further characterization in terms of glycosylation status and binding specificity to the Cbl-analogue cobinamide revealed that mouse TC does not bind Concanavalin A sepharose (like human TC), but is capable of binding cobinamide (like human HC). Antibodies raised against mouse TC identified the protein in secretory cells of the submaxillary gland and in the ducts of the mammary gland, i.e. at locations where HC is also found in humans. Analysis of the TC-mRNA level showed a high TC transcript level in these glands and also in the kidney. By precipitation to insolubilised antibodies against mouse TC, we also showed that >97% of the Cbl-binding capacity and >98% of the Cbl were precipitated in serum. This indicates that TC is the only Cbl-binding protein in the mouse circulation. Our data show that TC but not HC is present in the mouse. Mouse TC is observed in tissues where humans express TC and/or HC. Mouse TC has features in common with both human TC and HC. Our results suggest that the Cbl-binding proteins present in the circulation and exocrine glands may vary amongst species.	[Hygum, Katrine; Lildballe, Dorte L.; Greibe, Eva H.; Morkbak, Anne L.; Sorensen, Boe S.; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Poulsen, Steen S.] Univ Copenhagen, Panum Inst, Inst Biomed Sci, DK-2200 Copenhagen, Denmark; [Petersen, Torben E.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark	Aarhus University; University of Copenhagen; Aarhus University	Hygum, K (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	e.nexo@dadlnet.dk	Greibe, Eva/E-3375-2018	Greibe, Eva/0000-0002-0417-1195; Poulsen, Steen Seier/0000-0003-4419-4911; Nexo, Ebba/0000-0001-9406-9081; Sorensen, Boe/0000-0002-9472-8099	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Danish Medical Research Council and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fedosov SN, 2007, BIOCHEMISTRY-US, V46, P6446, DOI 10.1021/bi062063l; Fedosov SN, 1996, BBA-PROTEIN STRUCT M, V1292, P113, DOI 10.1016/0167-4838(95)00173-5; FRATERSCHRODER M, 1985, BIOCHEM GENET, V23, P139, DOI 10.1007/BF00499119; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; HANSEN M, 1992, SCAND J CLIN LAB INV, V52, P647, DOI 10.3109/00365519209115508; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; JOHNSTON J, 1992, GENOMICS, V12, P459, DOI 10.1016/0888-7543(92)90435-U; KIDRONI G, 1969, BIOCHIM BIOPHYS ACTA, V188, P113, DOI 10.1016/0005-2795(69)90050-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Moestrup SK, 2001, ANNU REV NUTR, V21, P407, DOI 10.1146/annurev.nutr.21.1.407; Moestrup SK, 2006, CURR OPIN HEMATOL, V13, P119, DOI 10.1097/01.moh.0000219654.65538.5b; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; NEXO E, 1988, SCAND J CLIN LAB INV, V48, P269, DOI 10.3109/00365518809167494; NEXO E, 1975, BIOCHIM BIOPHYS ACTA, V379, P189, DOI 10.1016/0005-2795(75)90021-5; NEXO E, 1985, BIOCHIM BIOPHYS ACTA, V838, P264, DOI 10.1016/0304-4165(85)90088-1; NEXO E, 1975, SCAND J HAEMATOL, V14, P320; NEXO E, 1981, BIOCHIM BIOPHYS ACTA, V667, P370, DOI 10.1016/0005-2795(81)90204-X; Nielsen R, 2001, J AM SOC NEPHROL, V12, P1099, DOI 10.1681/ASN.V1261099; PETERSEN EA, 1960, PLASMA PROTEIN; RAMANUJAM KS, 1991, BIOCHEM BIOPH RES CO, V179, P543, DOI 10.1016/0006-291X(91)91405-2; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Wuerges J, 2007, BIOCHEM J, V403, P431, DOI 10.1042/BJ20061394	22	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20638	10.1371/journal.pone.0020638	http://dx.doi.org/10.1371/journal.pone.0020638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655200	gold, Green Published, Green Submitted			2022-12-25	WOS:000291097600113
J	Indic, P; Salvatore, P; Maggini, C; Ghidini, S; Ferraro, G; Baldessarini, RJ; Murray, G				Indic, Premananda; Salvatore, Paola; Maggini, Carlo; Ghidini, Stefano; Ferraro, Gabriella; Baldessarini, Ross J.; Murray, Greg			Scaling Behavior of Human Locomotor Activity Amplitude: Association with Bipolar Disorder	PLOS ONE			English	Article							TIME-SERIES; DYNAMICS; FLUCTUATIONS; INVARIANCE; UNIPOLAR; DISEASE	Scale invariance is a feature of complex biological systems, and abnormality of multi-scale behaviour may serve as an indicator of pathology. The hypothalamic suprachiasmatic nucleus (SCN) is a major node in central neural networks responsible for regulating multi-scale behaviour in measures of human locomotor activity. SCN also is implicated in the pathophysiology of bipolar disorder (BD) or manic-depressive illness, a severe, episodic disorder of mood, cognition and behaviour. Here, we investigated scaling behaviour in actigraphically recorded human motility data for potential indicators of BD, particularly its manic phase. A proposed index of scaling behaviour (Vulnerability Index [VI]) derived from such data distinguished between: [i] healthy subjects at high versus low risk of mood disorders; [ii] currently clinically stable BD patients versus matched controls; and [iii] among clinical states in BD patients.	[Indic, Premananda] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Salvatore, Paola; Baldessarini, Ross J.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Salvatore, Paola; Baldessarini, Ross J.] McLean Hosp, Int Consortium Psychot & Bipolar Disorders Res, Belmont, MA 02178 USA; [Salvatore, Paola; Maggini, Carlo; Ghidini, Stefano; Ferraro, Gabriella] Univ Parma, Dept Neurosci, Sect Psychiat, I-43100 Parma, Italy; [Ghidini, Stefano] Forens Hosp, Mental Hlth Dept Reggio Emilia, Reggio Emilia, Italy; [Murray, Greg] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Harvard University; McLean Hospital; University of Parma; Swinburne University of Technology	Indic, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	Premananda.Indic@umassmed.edu	Murray, Greg/N-8933-2017	Murray, Greg/0000-0001-7208-5603	Swinburne University of Technology; Beyond Blue: National Depression Initiative; Bruce J Anderson Foundation; McLean Private Donors Bipolar Disorder Research Fund	Swinburne University of Technology; Beyond Blue: National Depression Initiative; Bruce J Anderson Foundation; McLean Private Donors Bipolar Disorder Research Fund	This research was supported, in part, by grants from Swinburne University of Technology and Beyond Blue: National Depression Initiative (to GM), a grant from the Bruce J Anderson Foundation and by the McLean Private Donors Bipolar Disorder Research Fund (to RJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BARBASI AL, 1995, FRACTAL CONCEPTS SUR; Carmona RA, 1999, IEEE T SIGNAL PROCES, V47, P480, DOI 10.1109/78.740131; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; DEPUE RA, 1989, J ABNORM PSYCHOL, V98, P117, DOI 10.1037/0021-843X.98.2.117; Etchegaray JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010303; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hauge ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016291; Hegger R, 1999, CHAOS, V9, P413, DOI 10.1063/1.166424; Henry BL, 2010, NEUROSCI BIOBEHAV R, V34, P1296, DOI 10.1016/j.neubiorev.2010.04.002; Hu K, 2007, NEUROSCIENCE, V149, P508, DOI 10.1016/j.neuroscience.2007.03.058; Hu K, 2004, PHYSICA A, V337, P307, DOI 10.1016/j.physa.2004.01.042; Hu K, 2009, P NATL ACAD SCI USA, V106, P2490, DOI 10.1073/pnas.0806087106; Indic P, 2005, CHRONOBIOL INT, V22, P613, DOI 10.1080/07420520500180371; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Kantz H., 2004, NONLINEAR TIME SERIE; Klosterkotter J, 1997, NEUROL PSYCHIAT BR, V5, P137; Kodba S, 2005, EUR J PHYS, V26, P205, DOI 10.1088/0143-0807/26/1/021; Mansour HA, 2005, ANN MED, V37, P196, DOI 10.1080/07853890510007377; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; MURRAY G, 2010, PRACTICAL MANAGEMENT, P152; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Papoulis Athanasios, PROBABILITY RANDOM V; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perc M, 2005, EUR J PHYS, V26, P757, DOI 10.1088/0143-0807/26/5/008; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Price TS, 2008, BIOINFORMATICS, V24, P2794, DOI 10.1093/bioinformatics/btn521; PRIESTLEY MB, SPECTRAL ANAL TIME S; Reichart CG, 2005, J AFFECT DISORDERS, V89, P147, DOI 10.1016/j.jad.2005.09.007; ROYBAL K, 2007, P NAT AC SCI US; Stauffer D., 1996, NEWTON MANDELBROT PR; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; Williams J, 1988, STRUCTURED INTERVIEW; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	38	32	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20650	10.1371/journal.pone.0020650	http://dx.doi.org/10.1371/journal.pone.0020650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655197	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600116
J	Lages, E; Guttin, A; El Atifi, M; Ramus, C; Ipas, H; Dupre, I; Rolland, D; Salon, C; Godfraind, C; deFraipont, F; Dhobb, M; Pelletier, L; Wion, D; Gay, E; Berger, F; Issartel, JP				Lages, Elodie; Guttin, Audrey; El Atifi, Michele; Ramus, Claire; Ipas, Helene; Dupre, Isabelle; Rolland, Delphine; Salon, Caroline; Godfraind, Catherine; deFraipont, Florence; Dhobb, Mehdi; Pelletier, Laurent; Wion, Didier; Gay, Emmanuel; Berger, Francois; Issartel, Jean-Paul			MicroRNA and Target Protein Patterns Reveal Physiopathological Features of Glioma Subtypes	PLOS ONE			English	Article							EXPRESSION; GLIOBLASTOMA; SURVIVAL; IDENTIFICATION; MIR-124; TISSUE; DIFFERENTIATION; PROLIFERATION; TRANSCRIPTION; ANGIOGENESIS	Gliomas such as oligodendrogliomas (ODG) and glioblastomas (GBM) are brain tumours with different clinical outcomes. Histology-based classification of these tumour types is often difficult. Therefore the first aim of this study was to gain microRNA data that can be used as reliable signatures of oligodendrogliomas and glioblastomas. We investigated the levels of 282 microRNAs using membrane-array hybridisation and real-time PCR in ODG, GBM and control brain tissues. In comparison to these control tissues, 26 deregulated microRNAs were identified in tumours and the tissue levels of seven microRNAs (miR-21, miR-128, miR-132, miR-134, miR-155, miR-210 and miR-409-5p) appropriately discriminated oligodendrogliomas from glioblastomas. Genomic, epigenomic and host gene expression studies were conducted to investigate the mechanisms involved in these deregulations. Another aim of this study was to better understand glioma physiopathology looking for targets of deregulated microRNAs. We discovered that some targets of these microRNAs such as STAT3, PTBP1 or SIRT1 are differentially expressed in gliomas consistent with deregulation of microRNA expression. Moreover, MDH1, the target of several deregulated microRNAs, is repressed in glioblastomas, making an intramitochondrial-NAD reduction mediated by the mitochondrial aspartate-malate shuttle unlikely. Understanding the connections between microRNAs and bioenergetic pathways in gliomas may lead to identification of novel therapeutic targets.	[Lages, Elodie; Guttin, Audrey; El Atifi, Michele; Ramus, Claire; Ipas, Helene; Dupre, Isabelle; Rolland, Delphine; Dhobb, Mehdi; Pelletier, Laurent; Wion, Didier; Berger, Francois; Issartel, Jean-Paul] INSERM, Nanomed & Brain Team7, U836, Grenoble, France; [Lages, Elodie; Guttin, Audrey; El Atifi, Michele; Ramus, Claire; Ipas, Helene; Dupre, Isabelle; Rolland, Delphine; Dhobb, Mehdi; Pelletier, Laurent; Wion, Didier; Berger, Francois; Issartel, Jean-Paul] Univ Grenoble 1, Inst Neurosci, Grenoble, France; [Rolland, Delphine] CHU Grenoble, Dept Hematol Oncogenet & Immunol, Lab Hematol Cellulaire & Mol, F-38043 Grenoble, France; [Guttin, Audrey; El Atifi, Michele; Ramus, Claire; Dupre, Isabelle; Rolland, Delphine; Berger, Francois; Issartel, Jean-Paul] Grenoble Inst Neurosci, Grenoble, France; [Salon, Caroline] CHU Grenoble, Dept Pathol, F-38043 Grenoble, France; [Godfraind, Catherine] Catholic Univ Louvain, Pathol Lab, Clin Univ St Luc, B-1200 Brussels, Belgium; [deFraipont, Florence] Univ Grenoble 1, Unite Med Biochim Canc & Biotherapies, Dept Biochim Toxicol & Pharmacol, Ctr Hos Univ,INSERM U823, Grenoble, France; [Gay, Emmanuel] CHU Grenoble, Dept Neurosurg, F-38043 Grenoble, France; [Issartel, Jean-Paul] CNRS, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Lages, E (corresponding author), INSERM, Nanomed & Brain Team7, U836, Grenoble, France.	jean-paul.issartel@ujf-grenoble.fr	Guttin, Audrey/K-8577-2015; de Fraipont, Florence/P-4936-2014; ISSARTEL, Jean-Paul/B-8727-2014; Wion, Didier/M-7045-2018; Rolland, Delphine/C-3101-2011; Rolland, Delphine/ABG-2497-2021	de Fraipont, Florence/0000-0001-9594-6584; Wion, Didier/0000-0001-7144-6470; Rolland, Delphine/0000-0002-7801-6534	Ligue contre le Cancer (comite Isere and Ligue Nationale); Region Rhone-Alpes; Lyon; Auvergne; Rhone-Alpes Canceropole; Institut National du Cancer	Ligue contre le Cancer (comite Isere and Ligue Nationale); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Lyon(Region Auvergne-Rhone-Alpes); Auvergne; Rhone-Alpes Canceropole; Institut National du Cancer(Institut National du Cancer (INCA) France)	This study was supported by grants from the Ligue contre le Cancer (comite Isere and Ligue Nationale) (http://www.ligue-cancer.net/); the Region Rhone-Alpes (http://www.rhonealpes.fr/); the Lyon, Auvergne, Rhone-Alpes Canceropole (http://www.canceropole-clara.com/) and the Institut National du Cancer (http://www.e-cancer.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BELFIORE F, 1995, BIOCHEM MOL MED, V54, P19, DOI 10.1006/bmme.1995.1003; Birner P, 2010, J NEURO-ONCOL, V100, P339, DOI 10.1007/s11060-010-0195-8; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Chan SF, 2009, HEALTH ISS CHIN CONT, V2, P1; Chen FX, 2010, J MOL NEUROSCI, V40, P353, DOI 10.1007/s12031-009-9323-3; Cheung HC, 2009, BRAIN, V132, P2277, DOI 10.1093/brain/awp153; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Le QT, 2007, INT J RADIAT ONCOL, V69, P167, DOI 10.1016/j.ijrobp.2007.01.071; Lee JL, 2009, J CELL BIOL, V185, P949, DOI 10.1083/jcb.200812060; Lee SM, 2009, CELL DEATH DIFFER, V16, P738, DOI 10.1038/cdd.2009.5; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Moser JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013445; Natte R, 2005, BRAIN PATHOL, V15, P192; Nilsson CL, 2010, J PROTEOME RES, V9, P430, DOI 10.1021/pr9007927; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Pang JCS, 2009, ACTA NEUROPATHOL, V117, P599, DOI 10.1007/s00401-009-0525-0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2009, NEUROMOL MED, V11, P208, DOI 10.1007/s12017-009-8087-9; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Turner JD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09207; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2009, STEM CELLS, V27, P2393, DOI 10.1002/stem.188; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yokota Takanori, 2009, Brain and Nerve (Tokyo), V61, P167; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	67	96	103	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20600	10.1371/journal.pone.0020600	http://dx.doi.org/10.1371/journal.pone.0020600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655185	Green Published, gold			2022-12-25	WOS:000291097600107
J	Yang, H; Zhao, X; Xu, YF; Wang, LL; He, QY; Lundberg, YW				Yang, Hua; Zhao, Xing; Xu, Yinfang; Wang, Lili; He, Quanyuan; Lundberg, Yunxia Wang			Matrix Recruitment and Calcium Sequestration for Spatial Specific Otoconia Development	PLOS ONE			English	Article							X COLLAGEN; INNER-EAR; CARTILAGE MATRIX; SULFATE PROTEOGLYCAN; BINDING-PROPERTIES; PROTEIN SPARC; OSTEOPONTIN; OTOLITH; BONE; PARTICIPATION	Otoconia are bio-crystals anchored to the macular sensory epithelium of the utricle and saccule in the inner ear for motion sensing and bodily balance. Otoconia dislocation, degeneration and ectopic calcification can have detrimental effects on balance and vertigo/dizziness, yet the mechanism underlying otoconia formation is not fully understood. In this study, we show that selected matrix components are recruited to form the crystal matrix and sequester Ca2+ for spatial specific formation of otoconia. Specifically, otoconin-90 (Oc90) binds otolin through both domains (TH and C1q) of otolin, but full-length otolin shows the strongest interaction. These proteins have much higher expression levels in the utricle and saccule than other inner ear epithelial tissues in mice. In vivo, the presence of Oc90 in wildtype (wt) mice leads to an enrichment of Ca2+ in the luminal matrices of the utricle and saccule, whereas absence of Oc90 in the null mice leads to drastically reduced matrix-Ca2+. In vitro, either Oc90 or otolin can increase the propensity of extracellular matrix to calcify in cell culture, and coexpression has a synergistic effect on calcification. Molecular modeling and sequence analysis predict structural features that may underlie the interaction and Ca2+-sequestering ability of these proteins. Together, the data provide a mechanism for the otoconial matrix assembly and the role of this matrix in accumulating micro-environmental Ca2+ for efficient CaCO3 crystallization, thus uncover a critical process governing spatial specific otoconia formation.	[Yang, Hua; Zhao, Xing; Xu, Yinfang; Wang, Lili; Lundberg, Yunxia Wang] Boys Town Natl Res Hosp, Vestibular Neurogenet Lab, Omaha, NE 68131 USA; [He, Quanyuan] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Boys Town National Research Hospital; Baylor College of Medicine	Yang, H (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.	yesha.lundberg@boystown.org			National Institute on Deafness and Other Communication Disorders [RO1 DC008603, DC008603-S1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008603] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by grants from the National Institute on Deafness and Other Communication Disorders (RO1 DC008603 and DC008603-S1 to Y.W.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919; BORDIN S, 1990, J IMMUNOL, V145, P2520; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; CARLSTROM DD, 1963, BIOL BULL, V125, P441, DOI 10.2307/1539358; CHEN Q, 1992, J CELL BIOL, V117, P687, DOI 10.1083/jcb.117.3.687; CHEN Y, 1992, J BIOL CHEM, V267, P24871; Deans MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012765; ENDO S, 1991, ACTA OTO-LARYNGOL, P116; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Frischholz S, 1998, J BIOL CHEM, V273, P4547, DOI 10.1074/jbc.273.8.4547; Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5; GEBB C, 1986, J BIOL CHEM, V261, P6698; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Groeneveld TWL, 2005, J IMMUNOL, V175, P4715, DOI 10.4049/jimmunol.175.7.4715; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hambrock HO, 2003, J BIOL CHEM, V278, P11351, DOI 10.1074/jbc.M212291200; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; ITO M, 1994, HISTOCHEM J, V26, P437, DOI 10.1007/BF00160057; KIRSCH T, 1991, FEBS LETT, V294, P149, DOI 10.1016/0014-5793(91)81363-D; Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Kishore W, 2004, IMMUNOL LETT, V95, P113, DOI 10.1016/j.imlet.2004.06.015; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; Kwan KM, 1997, J CELL BIOL, V136, P459, DOI 10.1083/jcb.136.2.459; Laboux O, 2003, J HISTOCHEM CYTOCHEM, V51, P61, DOI 10.1177/002215540305100108; Lu WF, 2010, HEARING RES, V268, P172, DOI 10.1016/j.heares.2010.05.019; MURAKAMI M, 1993, J BIOL CHEM, V268, P839; Murayama E, 2005, MECH DEVELOP, V122, P791, DOI 10.1016/j.mod.2005.03.002; Murayama E, 2004, HISTOCHEM CELL BIOL, V121, P155, DOI 10.1007/s00418-003-0605-5; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; OBRINK B, 1971, BIOCHEM J, V121, P227; Petko JA, 2008, DEV NEUROBIOL, V68, P209, DOI 10.1002/dneu.20587; Pisam M, 2002, CELL TISSUE RES, V310, P163, DOI 10.1007/s00441-002-0622-z; Pote K G, 1993, Physiologist, V36, pS38; POTE KG, 1991, COMP BIOCHEM PHYS B, V98, P287, DOI 10.1016/0305-0491(91)90181-C; RANACHAVEZ VE, 2001, J HISTOCHEM CYTOCHEM, V49, P1099; REICHENBERGER E, 1991, DEV BIOL, V148, P562, DOI 10.1016/0012-1606(91)90274-7; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakagami Masafumi, 2000, Medical Electron Microscopy, V33, P3, DOI 10.1007/s007950000001; SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x; SCHMID TM, 1989, CONNECT TISSUE RES, V20, P215, DOI 10.3109/03008208909023890; SCHMID TM, 1984, BIOCHEMISTRY-US, V23, P553, DOI 10.1021/bi00298a024; SCHMID TM, 1983, J BIOL CHEM, V258, P9504; Shapses SA, 2003, CALCIFIED TISSUE INT, V73, P86, DOI 10.1007/s00223-002-1090-x; Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x; SUGA H, 1993, EUR J BIOCHEM, V218, P807, DOI 10.1111/j.1432-1033.1993.tb18435.x; Sweetwyne MT, 2004, J HISTOCHEM CYTOCHEM, V52, P723, DOI 10.1369/jhc.3A6153.2004; TAKEMURA T, 1994, HEARING RES, V79, P99, DOI 10.1016/0378-5955(94)90131-7; Thalmann I, 2006, ELECTROPHORESIS, V27, P1598, DOI 10.1002/elps.200500768; Thalmann R, 2011, ACTA OTO-LARYNGOL, V131, P382, DOI 10.3109/00016489.2010.548401; Uma L, 1996, BBA-PROTEIN STRUCT M, V1294, P8, DOI 10.1016/0167-4838(95)00255-3; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verpy E, 1999, P NATL ACAD SCI USA, V96, P529, DOI 10.1073/pnas.96.2.529; Wang YX, 1998, P NATL ACAD SCI USA, V95, P15345, DOI 10.1073/pnas.95.26.15345; Xu YF, 2010, DEV DYNAM, V239, P2659, DOI 10.1002/dvdy.22405; Zhao X, 2008, JARO-J ASSOC RES OTO, V9, P191, DOI 10.1007/s10162-008-0117-z; Zhao X, 2007, DEV BIOL, V304, P508, DOI 10.1016/j.ydbio.2007.01.013	59	38	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20498	10.1371/journal.pone.0020498	http://dx.doi.org/10.1371/journal.pone.0020498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655225	Green Submitted, gold, Green Published			2022-12-25	WOS:000291097600081
J	Miyamoto, K; Togiya, K				Miyamoto, Kazuhide; Togiya, Kayo			Solution Structure of LC4 Transmembrane Segment of CCR5	PLOS ONE			English	Article							PROTEIN STRUCTURES; HIV-1; INHIBITION; NMR; RECEPTORS; PEPTIDE; CHANNEL; ENTRY	CC-chemokine receptor 5 (CCR5) is a specific co-receptor allowing the entry of human immunodeficiency virus type 1 (HIV-1). The LC4 region in CCR5 is required for HIV-1 entry into the cells. In this study, the solution structure of LC4 in SDS micelles was elucidated by using standard 1H two-dimensional NMR spectroscopy, circular dichroism, and fluorescdence quenching. The LC4 structure adopts two helical structures, whereas the C-terminal part remains unstructured. The positions in which LC4 binds to the HIV-1 inhibitory peptide LC5 were determined by docking calculations in addition to NMR data. The poses showed the importance of the hydrophobic interface of the assembled structures. The solution structure of LC4 elucidated in the present work provides a structural basis for further studies on the HIV-1 inhibitory function of the LC4 region.	[Miyamoto, Kazuhide] Himeji Dokkyo Univ, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo, Japan	Himeji Dokkyo University	Miyamoto, K (corresponding author), Himeji Dokkyo Univ, Dept Pharmaceut Hlth Care, Fac Pharmaceut Sci, Himeji, Hyogo, Japan.	miyamoto@himeji-du.ac.jp	Miyamoto, Kazuhide/T-4933-2019					Agrawal L, 2004, BLOOD, V103, P1211, DOI 10.1182/blood-2003-08-2669; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bhattacharyya R, 2003, J MOL BIOL, V331, P925, DOI 10.1016/S0022-2836(03)00759-9; BODENHAUSEN G, 1984, J MAGN RESON, V58, P370, DOI 10.1016/0022-2364(84)90142-2; Chill JH, 2007, BBA-BIOMEMBRANES, V1768, P3260, DOI 10.1016/j.bbamem.2007.08.006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Imai M, 2007, BIOCHEM BIOPH RES CO, V353, P851, DOI 10.1016/j.bbrc.2006.12.084; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li M, 1998, BIOCHEMISTRY-US, V37, P7869, DOI 10.1021/bi9801053; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Miyamoto K, 2001, BIOPOLYMERS, V59, P380, DOI 10.1002/1097-0282(20011015)59:5<380::AID-BIP1035>3.3.CO;2-K; Miyamoto K, 2010, J PEPT SCI, V16, P165, DOI 10.1002/psc.1215; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Schlecht Hans P, 2008, Ther Clin Risk Manag, V4, P473; Tsibris AMN, 2007, ANNU REV MED, V58, P445, DOI 10.1146/annurev.med.58.080105.102908; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xue R, 2009, J STRUCT BIOL, V165, P27, DOI 10.1016/j.jsb.2008.09.008; YANG JT, 1986, METHOD ENZYMOL, V130, P208	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20452	10.1371/journal.pone.0020452	http://dx.doi.org/10.1371/journal.pone.0020452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647380	gold, Green Published, Green Submitted			2022-12-25	WOS:000291052500060
J	Pritzkow, S; Wagenfuhr, K; Daus, ML; Boerner, S; Lemmer, K; Thomzig, A; Mielke, M; Beekes, M				Pritzkow, Sandra; Wagenfuehr, Katja; Daus, Martin L.; Boerner, Susann; Lemmer, Karin; Thomzig, Achim; Mielke, Martin; Beekes, Michael			Quantitative Detection and Biological Propagation of Scrapie Seeding Activity In Vitro Facilitate Use of Prions as Model Pathogens for Disinfection	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; STAINLESS-STEEL WIRES; SURGICAL-INSTRUMENTS; INFECTIVITY ASSAY; PROTEIN; INACTIVATION; DECONTAMINATION; PRPSC; TRANSMISSION	Prions are pathogens with an unusually high tolerance to inactivation and constitute a complex challenge to the reprocessing of surgical instruments. On the other hand, however, they provide an informative paradigm which has been exploited successfully for the development of novel broad-range disinfectants simultaneously active also against bacteria, viruses and fungi. Here we report on the development of a methodological platform that further facilitates the use of scrapie prions as model pathogens for disinfection. We used specifically adapted serial protein misfolding cyclic amplification (PMCA) for the quantitative detection, on steel wires providing model carriers for decontamination, of 263K scrapie seeding activity converting normal protease-sensitive into abnormal protease-resistant prion protein. Reference steel wires carrying defined amounts of scrapie infectivity were used for assay calibration, while scrapie-contaminated test steel wires were subjected to fifteen different procedures for disinfection that yielded scrapie titre reductions of <= 10(1)- to >= 10(5.5)-fold. As confirmed by titration in hamsters the residual scrapie infectivity on test wires could be reliably deduced for all examined disinfection procedures, from our quantitative seeding activity assay. Furthermore, we found that scrapie seeding activity present in 263K hamster brain homogenate or multiplied by PMCA of scrapie-contaminated steel wires both triggered accumulation of protease-resistant prion protein and was further propagated in a novel cell assay for 263K scrapie prions, i.e., cerebral glial cell cultures from hamsters. The findings from our PMCA- and glial cell culture assays revealed scrapie seeding activity as a biochemically and biologically replicative principle in vitro, with the former being quantitatively linked to prion infectivity detected on steel wires in vivo. When combined, our in vitro assays provide an alternative to titrations of biological scrapie infectivity in animals that substantially facilitates the use of prions as potentially highly indicative test agents in the search for novel broad-range disinfectants.	[Pritzkow, Sandra; Wagenfuehr, Katja; Daus, Martin L.; Boerner, Susann; Lemmer, Karin; Thomzig, Achim; Beekes, Michael] Robert Koch Inst, Project Grp Immune Def & Pathogenesis, D-1000 Berlin, Germany; [Lemmer, Karin] Robert Koch Inst, Ctr Biol Secur, D-1000 Berlin, Germany; [Mielke, Martin] Robert Koch Inst, Dept Infect Dis, D-1000 Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute	Pritzkow, S (corresponding author), Robert Koch Inst, Project Grp Immune Def & Pathogenesis, P24, D-1000 Berlin, Germany.	BeekesM@rki.de	Beekes, Michael/S-1975-2018	Beekes, Michael/0000-0002-6454-6657	German Federal Ministry for Education and Research [PTJ-BIO/0312877]; German Federal Ministry for Economics and Technology [PTJ-FKZ 03VWP0054]; European Commission [SP5A-CT-2007-044438]; European Network of Excellence "NeuroPrion" [FOOD-CT-2004-506579]; Alliance BioSecure Research Foundation (France); Alberta Prion Research Institute (Canada)	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for Economics and Technology; European Commission(European CommissionEuropean Commission Joint Research Centre); European Network of Excellence "NeuroPrion"; Alliance BioSecure Research Foundation (France); Alberta Prion Research Institute (Canada)	This work was supported in part by the German Federal Ministry for Education and Research (PTJ-BIO/0312877), the German Federal Ministry for Economics and Technology (PTJ-FKZ 03VWP0054), the European Commission (SP5A-CT-2007-044438), the European Network of Excellence "NeuroPrion" (FOOD-CT-2004-506579), the Alliance BioSecure Research Foundation (France, Project "PrioGrasp"), and the Alberta Prion Research Institute (Canada, Project "Comprehensive risk assessment of CWD transmission to humans using non-human primates"). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier M, 2004, J HOSP INFECT, V57, P80, DOI 10.1016/j.jhin.2004.01.013; BEEKES M, 1995, J GEN VIROL, V76, P2567, DOI 10.1099/0022-1317-76-10-2567; Beekes Michael, 2004, V11, P117; Beekes M, 2010, J GEN VIROL, V91, P580, DOI 10.1099/vir.0.016337-0; Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; Brown P, 2005, LANCET, V365, P122, DOI 10.1016/S0140-6736(05)17700-9; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; EU Directive, 2010, OFFICIAL J EUROPEAN, V276, P33; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Fichet G, 2007, J MICROBIOL METH, V70, P511, DOI 10.1016/j.mimet.2007.06.005; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lehmann S, 2009, J HOSP INFECT, V72, P342, DOI 10.1016/j.jhin.2009.03.024; Lemmer K, 2004, J GEN VIROL, V85, P3805, DOI 10.1099/vir.0.80346-0; Lemmer K, 2008, J GEN VIROL, V89, P348, DOI 10.1099/vir.0.83396-0; Lima FRS, 2007, J NEUROCHEM, V103, P2164, DOI 10.1111/j.1471-4159.2007.04904.x; Lipscomb IP, 2006, J HOSP INFECT, V64, P339, DOI 10.1016/j.jhin.2006.08.007; Mahal Sukhvir P., 2008, V459, P49, DOI 10.1007/978-1-59745-234-2_4; McDonnell GE, 2007, ANTISEPSIS DISINFECT; Murayama Y, 2006, BIOCHEM BIOPH RES CO, V348, P758, DOI 10.1016/j.bbrc.2006.07.130; Peretz D, 2006, J VIROL, V80, P322, DOI 10.1128/JVI.80.1.322-331.2006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P2793, DOI 10.1073/pnas.90.7.2793; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Suyama K, 2007, BIOCHEM BIOPH RES CO, V356, P245, DOI 10.1016/j.bbrc.2007.02.113; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Taylor D M, 2004, Contrib Microbiol, V11, P136; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weber P, 2006, P NATL ACAD SCI USA, V103, P15818, DOI 10.1073/pnas.0605608103; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Yan ZX, 2004, INFECT CONT HOSP EP, V25, P280, DOI 10.1086/502392; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	47	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20384	10.1371/journal.pone.0020384	http://dx.doi.org/10.1371/journal.pone.0020384			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647368	Green Published, gold, Green Submitted			2022-12-25	WOS:000291052500055
J	Shui, B; Wang, Q; Lee, F; Byrnes, LJ; Chudakov, DM; Lukyanov, SA; Sondermann, H; Kotlikoff, MI				Shui, Bo; Wang, Qi; Lee, Frank; Byrnes, Laura J.; Chudakov, Dmitry M.; Lukyanov, Sergey A.; Sondermann, Holger; Kotlikoff, Michael I.			Circular Permutation of Red Fluorescent Proteins	PLOS ONE			English	Article							MONOMERIC RED; INSERTION	Circular permutation of fluorescent proteins provides a substrate for the design of molecular sensors. Here we describe a systematic exploration of permutation sites for mCherry and mKate using a tandem fusion template approach. Circular permutants retaining more than 60% (mCherry) and 90% (mKate) brightness of the parent molecules are reported, as well as a quantitative evaluation of the fluorescence from neighboring mutations. Truncations of circular permutants indicated essential N- and C-terminal segments and substantial flexibility in the use of these molecules. Structural evaluation of two cp-mKate variants indicated no major conformational changes from the previously reported wild-type structure, and cis conformation of the chromophores. Four cp-mKates were identified with over 80% of native fluorescence, providing important new building blocks for sensor and complementation experiments.	[Shui, Bo; Lee, Frank; Kotlikoff, Michael I.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Wang, Qi; Byrnes, Laura J.; Sondermann, Holger] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Chudakov, Dmitry M.; Lukyanov, Sergey A.] Russian Acad Sci, Inst Bioorgan Chem, Moscow, Russia	Cornell University; Cornell University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Shui, B (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	mik7@cornell.edu	Wang, Qi/H-9399-2012; Chudakov, Dmitriy M/G-7741-2014; Lukyanov, Sergey/F-9140-2014	Wang, Qi/0000-0002-9703-1676; Chudakov, Dmitriy M/0000-0003-0430-790X; 	National Institutes of Health [R01GM086736]; Russian Academy of Sciences; Russian Foundation for Basic Research [08-04-01702-a]; PEW; National Science Foundation [DMR-0225180]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); PEW; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R01GM086736 from the National Institutes of Health (MIK and HS), grants from the Molecular and Cell Biology Program of the Russian Academy of Sciences and the Russian Foundation for Basic Research (08-04-01702-a)(to DMC), and a PEW Scholar award in Biomedical Sciences (to HS). Structural studies were conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by award DMR-0225180 from the National Science Foundation and RR-01646 from the National Institutes of Health (to CHESS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], GUID REC FLUOR QUANT; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Carlson HJ, 2010, PROTEIN SCI, V19, P1490, DOI 10.1002/pro.428; Chiang JJH, 2006, BIOTECHNOL LETT, V28, P471, DOI 10.1007/s10529-006-0007-6; Chu J, 2009, BIOSENS BIOELECTRON, V25, P234, DOI 10.1016/j.bios.2009.06.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gautam Sunita Ghimire, 2009, Front Neuroeng, V2, P14, DOI 10.3389/neuro.16.014.2009; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Li YK, 2008, PHOTOCHEM PHOTOBIOL, V84, P111, DOI 10.1111/j.1751-1097.2007.00206.x; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	25	28	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20505	10.1371/journal.pone.0020505	http://dx.doi.org/10.1371/journal.pone.0020505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647365	Green Published, Green Submitted, gold			2022-12-25	WOS:000291052500066
J	Nair, S; Kukreja, N; Singh, BP; Arora, N				Nair, Smitha; Kukreja, Neetu; Singh, Bhanu Pratap; Arora, Naveen			Identification of B Cell Epitopes of Alcohol Dehydrogenase Allergen of Curvularia lunata	PLOS ONE			English	Article							MAJOR ALLERGEN; CROSS-REACTIVITY; BINDING-SITES; BIRCH POLLEN; PREDICTION; RESIDUES; ANTIGENICITY; CLONING; ASTHMA	Background/Objective: Epitope identification assists in developing molecules for clinical applications and is useful in defining molecular features of allergens for understanding structure/function relationship. The present study was aimed to identify the B cell epitopes of alcohol dehydrogenase (ADH) allergen from Curvularia lunata using in-silico methods and immunoassay. Method: B cell epitopes of ADH were predicted by sequence and structure based methods and protein-protein interaction tools while T cell epitopes by inhibitory concentration and binding score methods. The epitopes were superimposed on a three dimensional model of ADH generated by homology modeling and analyzed for antigenic characteristics. Peptides corresponding to predicted epitopes were synthesized and immunoreactivity assessed by ELISA using individual and pooled patients' sera. Result: The homology model showed GroES like catalytic domain joined to Rossmann superfamily domain by an alpha helix. Stereochemical quality was confirmed by Procheck which showed 90% residues in most favorable region of Ramachandran plot while Errat gave a quality score of 92.733%. Six B cell (P1-P6) and four T cell (P7-P10) epitopes were predicted by a combination of methods. Peptide P2 (epitope P2) showed E(X)(2)GGP(X)(3)KKI conserved pattern among allergens of pathogenesis related family. It was predicted as high affinity binder based on electronegativity and low hydrophobicity. The computational methods employed were validated using Bet v 1 and Der p 2 allergens where 67% and 60% of the epitope residues were predicted correctly. Among B cell epitopes, Peptide P2 showed maximum IgE binding with individual and pooled patients' sera (mean OD 0.604 +/- 0.059 and 0.506 +/- 0.0035, respectively) followed by P1, P4 and P3 epitopes. All T cell epitopes showed lower IgE binding. Conclusion: Four B cell epitopes of C. lunata ADH were identified. Peptide P2 can serve as a potential candidate for diagnosis of allergic diseases.	[Nair, Smitha; Singh, Bhanu Pratap; Arora, Naveen] CSIR, Inst Genom & Integrat Biol, Allergy & Immunol Lab, Delhi, India; [Kukreja, Neetu] Univ Delhi, Dept Zool, Hindu Coll, Delhi 110007, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); University of Delhi	Nair, S (corresponding author), CSIR, Inst Genom & Integrat Biol, Allergy & Immunol Lab, Delhi, India.	naveen@igib.res.in			Council of Scientific and Industrial Research, New Delhi (CSIR Network), India [05]	Council of Scientific and Industrial Research, New Delhi (CSIR Network), India(Council of Scientific & Industrial Research (CSIR) - India)	This study was financed by Council of Scientific and Industrial Research, New Delhi (CSIR Network project 05), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Blythe MJ, 2005, PROTEIN SCI, V14, P246, DOI 10.1110/ps.041059505; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Brinda KV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-296; Chen HL, 2005, PROTEINS, V61, P21, DOI 10.1002/prot.20514; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; de Lalla C, 1999, J IMMUNOL, V163, P1725; Donnes P, 2006, NUCLEIC ACIDS RES, V34, pW194, DOI 10.1093/nar/gkl284; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Guan Pingping, 2003, Appl Bioinformatics, V2, P63; Gupta R, 1999, J ALLERGY CLIN IMMUN, V104, P857, DOI 10.1016/S0091-6749(99)70299-X; Gupta R, 2004, ALLERGY, V59, P421, DOI 10.1046/j.1398-9995.2003.00378.x; Gupta R, 2002, ALLERGY, V57, P636, DOI 10.1034/j.1398-9995.2002.03331.x; GUPTA R, 1999, INDIAN J ALLERGY APP, V13, P45; Hakkaart GAJ, 1998, ALLERGY, V53, P165, DOI 10.1111/j.1398-9995.1998.tb03865.x; HSIEH KH, 1988, J ASTHMA, V25, P73, DOI 10.3109/02770908809071357; Jahn-Schmid B, 2005, J ALLERGY CLIN IMMUN, V116, P213, DOI 10.1016/j.jaci.2005.04.019; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Mine Y, 2003, PROTEIN ENG, V16, P747, DOI 10.1093/protein/gzg095; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Oezguen N, 2008, MOL IMMUNOL, V45, P3740, DOI 10.1016/j.molimm.2008.05.026; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Reese G, 2001, J CHROMATOGR B, V756, P157, DOI 10.1016/S0378-4347(01)00104-9; Saha S, 2004, LECT NOTES COMPUT SC, V3239, P197; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Sanchez R, 2000, METH MOL B, V143, P97; Sharma V, 2008, ALLERGY, V63, P189, DOI 10.1111/j.1398-9995.2007.01528.x; Sharma V, 2006, J CLIN IMMUNOL, V26, P360, DOI 10.1007/s10875-006-9032-4; Sharma V, 2009, J PROTEOME RES, V8, P2650, DOI 10.1021/pr800784q; SHEN HD, 1991, CLIN EXP ALLERGY, V21, P675, DOI 10.1111/j.1365-2222.1991.tb03195.x; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Sinha N, 2002, BIOPHYS J, V83, P2946, DOI 10.1016/S0006-3495(02)75302-2; Soman KV, 2000, BIOPHYS J, V79, P1601, DOI 10.1016/S0006-3495(00)76410-1; Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084; VANNEERVEN RJJ, 1993, J IMMUNOL, V151, P2326; Wan J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-463; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Williams SC, 1998, J IMMUNOL METHODS, V213, P1, DOI 10.1016/S0022-1759(98)00022-2; Wolff N, 2004, J ALLERGY CLIN IMMUN, V114, P1151, DOI 10.1016/j.jaci.2004.07.038; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452; [No title captured]	50	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20020	10.1371/journal.pone.0020020	http://dx.doi.org/10.1371/journal.pone.0020020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647452	Green Submitted, Green Published, gold			2022-12-25	WOS:000291006500018
J	Lu, Y; Muller, M; Smith, D; Dutta, B; Komurov, K; Iadevaia, S; Ruths, D; Tseng, JT; Yu, S; Yu, Q; Nakhleh, L; Balazsi, G; Donnelly, J; Schurdak, M; Morgan-Lappe, S; Fesik, S; Ram, PT; Mills, GB				Lu, Y.; Muller, M.; Smith, D.; Dutta, B.; Komurov, K.; Iadevaia, S.; Ruths, D.; Tseng, J-T; Yu, S.; Yu, Q.; Nakhleh, L.; Balazsi, G.; Donnelly, J.; Schurdak, M.; Morgan-Lappe, S.; Fesik, S.; Ram, P. T.; Mills, G. B.			Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling	ONCOGENE			English	Article						AKT; MAPK; proteomics; signaling networks; siRNA	RIBOSOMAL S6 KINASE; CANCER CELL-LINES; TUBEROUS-SCLEROSIS; BREAST-CANCER; PI3K PATHWAY; GROWTH; PHOSPHORYLATION; INHIBITION; PROTEIN; TSC2	To identify regulators of intracellular signaling, we targeted 541 kinases and kinase-related molecules with small interfering RNAs (siRNAs), and determined their effects on signaling with a functional proteomics reverse-phase protein array (RPPA) platform assessing 42 phospho and total proteins. The kinome-wide screen demonstrated a strong inverse correlation between phosphorylation of AKT and mitogen-activated protein kinase (MAPK) with 115 genes that, when targeted by siRNAs, demonstrated opposite effects on MAPK and AKT phosphorylation. Network-based analysis identified the MAPK subnetwork of genes along with p70S6K and FRAP1 as the most prominent targets that increased phosphorylation of AKT, a key regulator of cell survival. The regulatory loops induced by the MAPK pathway are dependent on tuberous sclerosis complex 2 but demonstrate a lesser dependence on p70S6K than the previously identified FRAP1 feedback loop. The siRNA screen also revealed novel bi-directionality in the AKT and GSK3 (Glycogen synthase kinase 3) interaction, whereby genetic ablation of GSK3 significantly blocks AKT phosphorylation, an unexpected observation as GSK3 has only been predicted to be downstream of AKT. This method uncovered novel modulators of AKT phosphorylation and facilitated the mapping of regulatory loops. Oncogene (2011) 30, 4567-4577; doi: 10.1038/onc.2011.164; published online 13 June 2011	[Lu, Y.; Muller, M.; Smith, D.; Dutta, B.; Komurov, K.; Iadevaia, S.; Tseng, J-T; Yu, S.; Yu, Q.; Balazsi, G.; Ram, P. T.; Mills, G. B.] UT MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77054 USA; [Ruths, D.; Nakhleh, L.] Rice Univ, Dept Comp Sci, Houston, TX USA; [Donnelly, J.; Schurdak, M.; Morgan-Lappe, S.; Fesik, S.] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA	University of Texas System; UTMD Anderson Cancer Center; Rice University; Abbott Laboratories	Ram, PT (corresponding author), UT MD Anderson Canc Ctr, Dept Syst Biol, 7435 Fannin St, Houston, TX 77054 USA.	pram@mdanderson.org		Balazsi, Gabor/0000-0002-6865-5818; Ram, Prahlad/0000-0003-4739-3166; Schurdak, Mark/0000-0002-1146-3268	Kleberg Center for Molecular Markers; Komen Foundation [SU2C-AACR- DT0209]; NIH [CCSG P30CA16672, T90DK070109, R01CA125109, P01CA099031, P50CA083639, U54 CA112970]; NIH Foundation [DPA86424-444938]; GBM; NIH CCTS; Komen fellowship [KG101547]; PTR; DOD [BC044268]; Seed Funding Program Collaborative Advances in Biomedical Computing (CAMC); John and Ann Doerr Fund; NATIONAL CANCER INSTITUTE [P50CA098258, R01CA125109, U54CA112970, P01CA099031, P30CA016672, P50CA083639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T90DK070109] Funding Source: NIH RePORTER	Kleberg Center for Molecular Markers; Komen Foundation(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Foundation; GBM; NIH CCTS; Komen fellowship; PTR; DOD(United States Department of Defense); Seed Funding Program Collaborative Advances in Biomedical Computing (CAMC); John and Ann Doerr Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs Kwiatkowski and J Woodgett for the knock out TSC2 and GSK3 cells, respectively. This study was funded in part by the Kleberg Center for Molecular Markers, the Komen Foundation, StandUp to Cancer/AmericanAssociation for Cancer Research Dream Team Translational Cancer Research Grant, Grant No. SU2C-AACR- DT0209, NIH CCSG P30CA16672, NIH Foundation DPA86424-444938 to BD and GBM, NIH CCTS support to DS, NIH T90DK070109 fellowship to J-TT and SI, Komen fellowship KG101547 to KK and PTR, DOD BC044268 and NIH R01CA125109 to PTR, NIH P01CA099031 and P50CA083639 to GBM, and U54 CA112970 to PTR and GBM. LN was supported by the Seed Funding Program Collaborative Advances in Biomedical Computing (CAMC), funded by the John and Ann Doerr Fund for Computational Biomedicine.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iadevaia S, 2010, CANCER RES, V70, P6704, DOI 10.1158/0008-5472.CAN-10-0460; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Komurov K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000889; Komurov K, 2010, J BIOL CHEM, V285, P21134, DOI 10.1074/jbc.M110.137828; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Li WQ, 1999, ONCOGENE, V18, P6564, DOI 10.1038/sj.onc.1203065; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Morgan-Lappe S, 2006, ONCOGENE, V25, P1340, DOI 10.1038/sj.onc.1209169; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Muller M, 2008, FASEB J, V22, P1393, DOI 10.1096/fj.07-9100com; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ruths D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000005; Ruths D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-76; Sarthy AV, 2007, MOL CANCER THER, V6, P269, DOI 10.1158/1535-7163.MCT-06-0560; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	37	48	51	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV 10	2011	30	45					4567	4577		10.1038/onc.2011.164	http://dx.doi.org/10.1038/onc.2011.164			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	846IO	21666717	Green Accepted			2022-12-25	WOS:000296890700004
J	Patra, D; DeLassus, E; Hayashi, S; Sandell, LJ				Patra, Debabrata; DeLassus, Elizabeth; Hayashi, Shinya; Sandell, Linda J.			Site-1 Protease Is Essential to Growth Plate Maintenance and Is a Critical Regulator of Chondrocyte Hypertrophic Differentiation in Postnatal Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BONE-FORMATION; ENDOCHONDRAL SKELETON; CARTILAGE; CLEAVAGE; IHH; PROLIFERATION; REVEALS; RANGE; FEMUR	Site-1 protease (S1P) is a proprotein convertase with essential functions in lipid homeostasis and unfolded protein response pathways. We previously studied a mouse model of cartilage-specific knock-out of S1P in chondroprogenitor cells. These mice exhibited a defective cartilage matrix devoid of type II collagen protein (Col II) and displayed chondrodysplasia with no endochondral bone formation even though the molecular program for endochondral bone development appeared intact. To gain insights into S1P function, we generated and studied a mouse model in which S1P is ablated in postnatal chondrocytes. Postnatal ablation of S1P results in chondrodysplasia. However, unlike early embryonic ablations, the growth plates of these mice exhibit a lack of Ihh, PTHrP-R, and Col10 expression indicating a loss of chondrocyte hypertrophic differentiation and thus disruption of the molecular program required for endochondral bone development. S1P ablation results in rapid growth plate disruption due to intracellular Col II entrapment concomitant with loss of chondrocyte hypertrophy suggesting that these two processes are related. Entrapment of Col II in the chondrocytes of the prospective secondary ossification center precludes its development. Trabecular bone formation is dramatically diminished in the primary spongiosa and is eventually lost. The primary growth plate is eradicated by apoptosis but is gradually replaced by a fully functional new growth plate from progenitor stem cells capable of supporting new bone growth. Our study thus demonstrates that S1P has fundamental roles in the preservation of postnatal growth plate through chondrocyte differentiation and Col II deposition and functions to couple growth plate maturation to trabecular bone development in growing mice.	[Patra, Debabrata; DeLassus, Elizabeth; Hayashi, Shinya; Sandell, Linda J.] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Sandell, Linda J.] Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)	Patra, D (corresponding author), Washington Univ, Sch Med, Barnes Jewish Hosp, Dept Orthopaed Surg, 660 S Euclid Ave,Box 8233, St Louis, MO 63110 USA.	patrad@wudosis.wustl.edu; sandelll@wustl.edu			National Institutes of Health [RO1 AR050847, RO1 AR045550, P30 AR057235]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR045550, R01AR050847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR050847 and RO1 AR045550 (to L. J. S.) and by Grant P30 AR057235 to the Washington University Center for Musculoskeletal Research.	Baron R.A., 1983, BONE HISTOMORPHOMETR, P13; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Farnum CE, 2006, ANAT REC PART A, V288A, P91, DOI 10.1002/ar.a.20272; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hilton MJ, 2007, DEV BIOL, V308, P93, DOI 10.1016/j.ydbio.2007.05.011; Hirai T, 2011, P NATL ACAD SCI USA, V108, P191, DOI 10.1073/pnas.1005011108; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lerner AL, 1997, J ORTHOP RES, V15, P353, DOI 10.1002/jor.1100150307; Liu X, 2010, BIOMATERIALS, V31, P9406, DOI 10.1016/j.biomaterials.2010.08.052; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Long FX, 2001, DEVELOPMENT, V128, P5099; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Murakami T, 2006, J NEUROCHEM, V96, P1090, DOI 10.1111/j.1471-4159.2005.03596.x; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Patra D, 2007, J CELL BIOL, V179, P687, DOI 10.1083/jcb.200708092; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Schlombs K, 2003, P NATL ACAD SCI USA, V100, P14024, DOI 10.1073/pnas.2331794100; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409; Xie C, 2008, BONE, V43, P1075, DOI 10.1016/j.bone.2008.08.109; Yang J, 2001, P NATL ACAD SCI USA, V98, P13607, DOI 10.1073/pnas.201524598; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069	29	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29227	29240		10.1074/jbc.M110.208686	http://dx.doi.org/10.1074/jbc.M110.208686			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21652717	Green Published, hybrid			2022-12-25	WOS:000293837000058
J	Breunig, E; Kludt, E; Czesnik, D; Schild, D				Breunig, Esther; Kludt, Eugen; Czesnik, Dirk; Schild, Detlev			The Styryl Dye FM1-43 Suppresses Odorant Responses in a Subset of Olfactory Neurons by Blocking Cyclic Nucleotide-gated (CNG) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS TADPOLES; MECHANOSENSITIVE ION CHANNELS; RECEPTOR NEURONS; HAIR-CELLS; PERMEANT BLOCKER; BULB NEURONS; AMINO-ACIDS; IN-VIVO; AMILORIDE; SELECTIVITY	Many olfactory receptor neurons use a cAMP-dependent transduction mechanism to transduce odorants into depolarizations. This signaling cascade is characterized by a sequence of two currents: a cation current through cyclic nucleotide-gated channels followed by a chloride current through calcium-activated chloride channels. To date, it is not possible to interfere with these generator channels under physiological conditions with potent and specific blockers. In this study we identified the styryl dye FM1-43 as a potent blocker of native olfactory cyclic nucleotide-gated channels. Furthermore, we characterized this substance to stain olfactory receptor neurons that are endowed with cAMP-dependent transduction. This allows optical differentiation and pharmacological interference with olfactory receptor neurons at the level of the signal transduction.	[Breunig, Esther; Kludt, Eugen; Czesnik, Dirk; Schild, Detlev] Univ Gottingen, Dept Neurophys & Cellular Biophys, D-37073 Gottingen, Germany; [Schild, Detlev] Univ Gottingen, Deutsch Forsch Gemeinschaft Cluster Excellence 17, D-37073 Gottingen, Germany; [Schild, Detlev] Univ Gottingen, Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Schild, D (corresponding author), Univ Gottingen, Dept Neurophys & Cellular Biophys, Humboldtallee 23, D-37073 Gottingen, Germany.	dschild@gwdg.de			Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain; Excellence Cluster 171; Gottingen Neuroscience Graduate School	Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); Excellence Cluster 171; Gottingen Neuroscience Graduate School	This work was supported by the Deutsche Forschungsgemeinschaft Center for Molecular Physiology of the Brain, the Excellence Cluster 171, and the Gottingen Neuroscience Graduate School.	ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; BOUVET JF, 1988, NEUROSCI RES, V5, P214, DOI 10.1016/0168-0102(88)90050-8; Brown RL, 2006, CURR PHARM DESIGN, V12, P3597; Brown RL, 1999, P NATL ACAD SCI USA, V96, P754, DOI 10.1073/pnas.96.2.754; CAPRIO J, 1984, J GEN PHYSIOL, V84, P403, DOI 10.1085/jgp.84.3.403; CARR WES, 1990, CHEM SENSES, V15, P181, DOI 10.1093/chemse/15.2.181; CARR WES, 1986, J CHEM ECOL, V12, P989, DOI 10.1007/BF01638992; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Czesnik D, 2006, EUR J NEUROSCI, V23, P119, DOI 10.1111/j.1460-9568.2005.04533.x; Czesnik D, 2007, P NATL ACAD SCI USA, V104, P2967, DOI 10.1073/pnas.0609067104; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-1; FRINGS S, 1993, J GEN PHYSIOL, V101, P183, DOI 10.1085/jgp.101.2.183; FRINGS S, 1995, NEURON, V15, P169, DOI 10.1016/0896-6273(95)90074-8; FRINGS S, 1992, J GEN PHYSIOL, V100, P45, DOI 10.1085/jgp.100.1.45; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Ghatpande AS, 2003, BIOCHEMISTRY-US, V42, P265, DOI 10.1021/bi027031m; Gliem S, 2009, EUR J NEUROSCI, V29, P2315, DOI 10.1111/j.1460-9568.2009.06778.x; Griesinger CB, 2002, J NEUROSCI, V22, P3939, DOI 10.1523/JNEUROSCI.22-10-03939.2002; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; Hille B., 2001, IONIC CHANNELS EXCIT, P539; Iida A, 1999, J GEN PHYSIOL, V114, P85, DOI 10.1085/jgp.114.1.85; KANG JS, 1995, J NEUROPHYSIOL, V73, P172, DOI 10.1152/jn.1995.73.1.172; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kawai F, 1999, NAT NEUROSCI, V2, P133, DOI 10.1038/5686; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kidokoro Y, 2004, BRAIN RES REV, V47, P18, DOI 10.1016/j.brainresrev.2004.05.004; Kleene SJ, 2000, J MEMBRANE BIOL, V178, P49, DOI 10.1007/s002320010014; KOCH KW, 1985, J BIOL CHEM, V260, P6788; Lapierre LA, 2000, ADV DRUG DELIVER REV, V41, P255, DOI 10.1016/S0169-409X(00)00045-4; LeindersZufall T, 1995, J NEUROPHYSIOL, V74, P2759, DOI 10.1152/jn.1995.74.6.2759; Manzini I, 2004, J GEN PHYSIOL, V123, P99, DOI 10.1085/jgp.200308970; Manzini I, 2003, J PHYSIOL-LONDON, V551, P115, DOI 10.1113/jphysiol.2003.043059; Manzini I, 2002, J PHYSIOL-LONDON, V545, P475, DOI 10.1113/jphysiol.2002.031914; Manzini I, 2008, J NEUROSCI METH, V167, P140, DOI 10.1016/j.jneumeth.2007.07.018; Meyer J, 2001, HEARING RES, V161, P10, DOI 10.1016/S0378-5955(01)00338-0; Meyers JR, 2003, J NEUROSCI, V23, P4054; Neher RA, 2009, BIOPHYS J, V96, P3791, DOI 10.1016/j.bpj.2008.10.068; NICOL GD, 1987, J GEN PHYSIOL, V90, P651, DOI 10.1085/jgp.90.5.651; Nieuwkoop P.D., 1994, NORMAL TABLE XENOPUS, P252; Nishikawa S, 1996, J HISTOCHEM CYTOCHEM, V44, P733, DOI 10.1177/44.7.8675994; Oka Y, 2004, CHEM SENSES, V29, P815, DOI 10.1093/chemse/bjh247; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Rankin ML, 1999, J NEUROCHEM, V72, P541, DOI 10.1046/j.1471-4159.1999.0720541.x; Rolen SH, 2007, J NEUROPHYSIOL, V97, P4058, DOI 10.1152/jn.00247.2007; Rolen SH, 2003, J EXP BIOL, V206, P1683, DOI 10.1242/jeb.00338; Rospars JP, 2003, EUR J NEUROSCI, V18, P1135, DOI 10.1046/j.1460-9568.2003.02766.x; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sato K, 2001, CHEM SENSES, V26, P1145, DOI 10.1093/chemse/26.9.1145; Schild D, 2004, EUR J NEUROSCI, V20, P2111, DOI 10.1111/j.1460-9568.2004.03672.x; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Strassmaier T, 2005, J MED CHEM, V48, P5805, DOI 10.1021/jm0502485; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; ZHUANG YX, 1984, BIOCHEMISTRY-US, V23, P4481, DOI 10.1021/bi00314a038	60	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28041	28048		10.1074/jbc.M111.233890	http://dx.doi.org/10.1074/jbc.M111.233890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21646359	Green Published, hybrid			2022-12-25	WOS:000293557800022
J	Charlot-Rabiega, P; Bardel, E; Dietrich, C; Kastelein, R; Devergne, O				Charlot-Rabiega, Pascaline; Bardel, Emilie; Dietrich, Celine; Kastelein, Robert; Devergne, Odile			Signaling Events Involved in Interleukin 27 (IL-27)-induced Proliferation of Human Naive CD4(+) T Cells and B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE PROGRESSION; TH1 DIFFERENTIATION; IL-27; EXPRESSION; INDUCTION; STAT1; BET; MYC; ACTIVATION; RECEPTOR	IL-27 induces stronger proliferation of naive than memory human B cells and CD4(+) T cells. In B cells, this differential response is associated with similar levels of IL-27 receptor chains, IL-27R alpha and gp130, in both subsets and stronger STAT1 and STAT3 activation by IL-27 in naive B cells. Here, we show that the stronger proliferative response of CD3-stimulated naive CD4(+) T cells to IL-27 is associated with lower levels of IL-27R alpha but higher levels of gp130 compared with memory CD4(+) T cells. IL-27 signaling differs between naive and memory CD4(+) T cells, as shown by more sustained STAT1, -3, and -5 activation and weaker activation of SHP-2 in naive CD4(+) T cells. In the latter, IL-27 increases G0/G1 to S phase transition, cell division and, in some cases, cell survival. IL-27 proliferative effect on naive CD4(+) T cells is independent of MAPK, but is dependent on c-Myc and Pim-1 induction by IL-27 and is associated with induction of cyclin D2, cyclin D3, and CDK4 by IL-27 in a c-Myc and Pim-1-dependent manner. In BCR-stimulated naive B cells, IL-27 only increases entry in the S phase and induces the expression of Pim-1 and of cyclins A, D2, and D3. In these cells, inhibition of Pim-1 inhibits IL-27 effect on proliferation and cyclin induction. Altogether, these data indicate that IL-27 mediates proliferation of naive CD4(+) T cells and B cells through induction of both common and distinct sets of cell cycle regulators.	[Charlot-Rabiega, Pascaline; Bardel, Emilie; Dietrich, Celine; Devergne, Odile] Univ Paris 05, CNRS, UMR 8147, F-75015 Paris, France; [Kastelein, Robert] Schering Plough Biopharma, Palo Alto, CA 94304 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Merck & Company	Devergne, O (corresponding author), Hop Necker Enfants Malad, CNRS, UMR 8147, Batiment Sevres,161 Rue Sevres, F-75015 Paris, France.	odile.devergne@inserm.fr	Devergne, Odile/M-6633-2017	Devergne, Odile/0000-0002-2838-7564	Association de Recherche contre le Cancer [3733]	Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Grant 3733 from the Association de Recherche contre le Cancer.	Alexander WS, 2002, NAT REV IMMUNOL, V2, P410, DOI 10.1038/nri818; Appleman LJ, 2002, J IMMUNOL, V168, P2729, DOI 10.4049/jimmunol.168.6.2729; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Brender C, 2007, BLOOD, V110, P2528, DOI 10.1182/blood-2006-08-041541; Coulomb-L'Hermine A, 2007, PLACENTA, V28, P1133, DOI 10.1016/j.placenta.2007.06.004; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Diveu C, 2008, CURR OPIN IMMUNOL, V20, P663, DOI 10.1016/j.coi.2008.09.003; El-behi M, 2009, J IMMUNOL, V183, P4957, DOI 10.4049/jimmunol.0900735; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hibbert L, 2003, J INTERF CYTOK RES, V23, P513, DOI 10.1089/10799900360708632; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Kanda N, 2008, EUR J IMMUNOL, V38, P1287, DOI 10.1002/eji.200738051; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Naud JF, 2007, NAT CELL BIOL, V9, P873, DOI 10.1038/ncb0807-873; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Owaki T, 2008, J IMMUNOL, V180, P2903, DOI 10.4049/jimmunol.180.5.2903; Owaki T, 2006, J IMMUNOL, V177, P7579, DOI 10.4049/jimmunol.177.11.7579; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Seita J, 2008, BLOOD, V111, P1903, DOI 10.1182/blood-2007-06-093328; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Wang S, 2007, J IMMUNOL, V179, P6421, DOI 10.4049/jimmunol.179.10.6421; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x; Yoshimoto T, 2004, J IMMUNOL, V173, P2479, DOI 10.4049/jimmunol.173.4.2479; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377	41	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27350	27362		10.1074/jbc.M111.221010	http://dx.doi.org/10.1074/jbc.M111.221010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21669870	Green Published, hybrid			2022-12-25	WOS:000293268700031
J	Poomvanicha, M; Wegener, JW; Blaich, A; Fischer, S; Domes, K; Moosmang, S; Hofmann, F				Poomvanicha, Montatip; Wegener, Joerg W.; Blaich, Anne; Fischer, Stefanie; Domes, Katrin; Moosmang, Sven; Hofmann, Franz			Facilitation and Ca2+-dependent Inactivation Are Modified by Mutation of the Ca(v)1.2 Channel IQ Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN KINASE-II; RAT VENTRICULAR MYOCYTES; GATED CA2+ CHANNELS; CALCIUM-CHANNEL; PROTEIN-KINASE; DEPENDENT FACILITATION; ION CHANNELS; VOLTAGE; PHOSPHORYLATION; IDENTIFICATION	The heart muscle responds to physiological needs with a short-term modulation of cardiac contractility. This process is determined mainly by properties of the cardiac L-type Ca2+ channel (Ca(v)1.2), including facilitation and Ca2+-dependent inactivation (CDI). Both facilitation and CDI involve the interaction of calmodulin with the IQ motif of the Ca(v)1.2 channel, especially with Ile-1624. To verify this hypothesis, we created a mouse line in which Ile-1624 was mutated to Glu (Ca(v)1.2(I1624E) mice). Homozygous Ca(v)1.2(I1624E) mice were not viable. Therefore, we inactivated the floxed Ca(v)1.2 gene of heterozygous Ca(v)1.2(I1624E) mice by the alpha-myosin heavy chain-MerCreMer system. The resulting I/E mice were studied at day 10 after treatment with tamoxifen. Electrophysiological recordings in ventricular cardiomyocytes revealed a reduced Ca(v)1.2 current (I-Ca) density in I/E mice. Steady-state inactivation and recovery from inactivation were modified in I/E versus control mice. In addition, voltage-dependent facilitation was almost abolished in I/E mice. The time course of I-Ca inactivation in I/E mice was not influenced by the use of Ba2+ as a charge carrier. Using 1,2-bis(o-aminophenoxy)ethane-N,N,N ',N '-tetraacetic acid as a chelating agent for intracellular Ca2+, inactivation of ICa was slowed down in control but not I/E mice. The results show that the I/E mutation abolishes Ca2+/calmodulin-dependent regulation of Ca(v)1.2. The Ca(v)1.2(I1624E) mutation transforms the channel to a phenotype mimicking CDI.	[Hofmann, Franz] Tech Univ Munich, Inst Pharmakol & Toxikol, FOR923, Forschergrp 923, D-80802 Munich, Germany	Technical University of Munich	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, FOR923, Forschergrp 923, Biedersteiner Str 29, D-80802 Munich, Germany.	franz.hofmann@mytum.de		Wegener, Jorg/0000-0002-8129-1537	Deutsche Forschungsgemeinschaft; Fond der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fond der Chemischen Industrie(Fonds der Chemischen Industrie)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Fond der Chemischen Industrie.	ANDERSON ME, 1994, CIRC RES, V75, P854, DOI 10.1161/01.RES.75.5.854; Anderson ME, 2001, J MOL CELL CARDIOL, V33, P639, DOI 10.1006/jmcc.2000.1354; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; Blaich A, 2010, P NATL ACAD SCI USA, V107, P10285, DOI 10.1073/pnas.0914287107; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Guo JQ, 2006, J PHYSIOL-LONDON, V574, P509, DOI 10.1113/jphysiol.2006.109199; HALLING DB, 2006, SCI STKE, pER1, DOI DOI 10.1126/STKE.3152005RE15; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; KLOCKNER U, 1987, AM J PHYSIOL, V253, pH1601, DOI 10.1152/ajpheart.1987.253.6.H1601; Lee TS, 2006, J BIOL CHEM, V281, P25560, DOI 10.1074/jbc.M508661200; Li L, 1997, J PHYSIOL-LONDON, V501, P17, DOI 10.1111/j.1469-7793.1997.017bo.x; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; ROSS J, 1995, CIRCULATION, V92, P2327, DOI 10.1161/01.CIR.92.8.2327; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Sham JSK, 1997, J PHYSIOL-LONDON, V500, P285, DOI 10.1113/jphysiol.1997.sp022020; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; YUAN WL, 1994, AM J PHYSIOL, V267, pH982, DOI 10.1152/ajpheart.1994.267.3.H982; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	34	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26702	26707		10.1074/jbc.M111.247841	http://dx.doi.org/10.1074/jbc.M111.247841			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21665954	Green Published, hybrid			2022-12-25	WOS:000293078200047
J	Xiao, XJ; Mukherjee, A; Ross, LE; Lowe, ME				Xiao, Xunjun; Mukherjee, Amitava; Ross, Leah E.; Lowe, Mark E.			Pancreatic Lipase-related Protein-2 (PLRP2) Can Contribute to Dietary Fat Digestion in Human Newborns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-STIMULATED LIPASE; COLIPASE INTERACTIONS; YEAST-CELLS; HUMAN-MILK; ACTIVATION; MICELLES; EXPRESSION; ENZYMES; ABSORPTION; SECRETION	In newborn mice, PLRP2 is essential for fat digestion. In human infants, the role of PLRP2 in fat digestion is unclear, as it has poor activity against long-chain triglycerides in vitro. Also, many infants carry a genetic polymorphism resulting in a truncated protein, PLRP2 W340X, which may impact function significantly. We re-examined the properties of recombinant human PLRP2 and studied the impact of W340X mutation on its function. In the presence of bile salt micelles and colipase, human PLRP2 hydrolyzed long-chain tri-, di-, and monoglycerides. It hydrolyzed triolein at a level much lower than that of pancreatic triglyceride lipase, but close to that of carboxyl ester lipase, after a long lag phase, which could be eliminated by the addition of oleic acids. Human PLRP2 W340X was poorly secreted and largely retained inside the cell. The retention of the mutant protein triggered endoplasmic reticulum stress and unfolded protein responses. Our results show that earlier studies underestimated human PLRP2 activity against triolein by employing suboptimal assay conditions. In vivo, dietary fat emulsions contain fatty acids as a result of the action of gastric lipase. Consequently, PLRP2 can contribute to fat digestion during early infancy. Furthermore, infants with homozygous W340X alleles will not secrete functional PLRP2 and may have inefficient dietary fat digestion, particularly when breastfeeding is unavailable. Additionally, the aberrant folding of W340X mutant may cause chronic cellular stress and increase susceptibility of pancreatic exocrine cells to other metabolic stressors.	[Xiao, Xunjun; Mukherjee, Amitava; Ross, Leah E.; Lowe, Mark E.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lowe, ME (corresponding author), 1 Childrens Hosp Dr,4401 Penn Ave, Pittsburgh, PA 15224 USA.	Mark.lowe@chp.edu	Mukherjee, Amitava/AAK-4002-2020	Mukherjee, Amitava/0000-0001-5603-5147; Xiao, Xunjun/0000-0001-5930-4664	National Institutes of Health [DK080820]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK080820.	Amara S, 2009, BBA-MOL CELL BIOL L, V1791, P983, DOI 10.1016/j.bbalip.2009.05.002; Andersson L, 1996, BBA-LIPID LIPID MET, V1302, P236, DOI 10.1016/0005-2760(96)00068-9; Andersson Y, 2007, ACTA PAEDIATR, V96, P1445, DOI 10.1111/j.1651-2227.2007.00450.x; BORGSTROM B, 1980, GASTROENTEROLOGY, V78, P954; BROCKMAN HL, 1973, J BIOL CHEM, V248, P4965; Cao HN, 2003, J HUM GENET, V48, P443, DOI 10.1007/s10038-003-0051-1; CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U; Chahinian H, 2002, BIOCHEMISTRY-US, V41, P13725, DOI 10.1021/bi0257944; Cordle RA, 1998, J LIPID RES, V39, P1759; Crandall WV, 2001, J BIOL CHEM, V276, P12505, DOI 10.1074/jbc.M009986200; CYGLER M, 1993, PROTEIN SCI, V2, P366; D'Agostino D, 2004, J NUTR, V134, P132, DOI 10.1093/jn/134.1.132; D'Agostino D, 2002, J BIOL CHEM, V277, P7170, DOI 10.1074/jbc.M108328200; Eydoux C, 2008, BIOCHEMISTRY-US, V47, P9553, DOI 10.1021/bi8005576; Eydoux C, 2007, J LIPID RES, V48, P1539, DOI 10.1194/jlr.M600486-JLR200; FOMON SJ, 1970, AM J CLIN NUTR, V23, P1299; FREDRIKZON B, 1978, PEDIATR RES, V12, P1048, DOI 10.1203/00006450-197811000-00004; Freie AB, 2006, J BIOL CHEM, V281, P7793, DOI 10.1074/jbc.M512984200; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; HANSSON L, 1993, J BIOL CHEM, V268, P26692; Hermoso J, 1997, EMBO J, V16, P5531, DOI 10.1093/emboj/16.18.5531; JENNENS ML, 1995, J LIPID RES, V36, P1029; LARSSON A, 1986, BIOCHIM BIOPHYS ACTA, V876, P543, DOI 10.1016/0005-2760(86)90042-1; Lowe ME, 1997, METHOD ENZYMOL, V284, P285; Lowe ME, 1998, J BIOL CHEM, V273, P31215, DOI 10.1074/jbc.273.47.31215; PATTON JS, 1978, BIOCHIM BIOPHYS ACTA, V529, P67, DOI 10.1016/0005-2760(78)90104-2; PAYNE RM, 1994, AM J PHYSIOL, V266, pG914, DOI 10.1152/ajpgi.1994.266.5.G914; Pignol D, 2000, J BIOL CHEM, V275, P4220, DOI 10.1074/jbc.275.6.4220; Reboul E, 2006, BBA-MOL CELL BIOL L, V1761, P4, DOI 10.1016/j.bbalip.2005.12.013; Sahasrabudhe AV, 1998, PROTEIN EXPRES PURIF, V14, P425, DOI 10.1006/prep.1998.0974; Sias B, 2004, BIOCHEMISTRY-US, V43, P10138, DOI 10.1021/bi049818d; van Tilbeurgh H, 1999, BBA-MOL CELL BIOL L, V1441, P173, DOI 10.1016/S1388-1981(99)00149-3; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; Verger R, 1980, Methods Enzymol, V64, P340; Verger R., 1984, LIPASES, P84; WANG CS, 1989, AM J CLIN NUTR, V49, P457, DOI 10.1093/ajcn/49.3.457; WIELOCH T, 1982, J BIOL CHEM, V257, P1523; Yang YQ, 2000, J LIPID RES, V41, P48; Yang YQ, 1998, PROTEIN EXPRES PURIF, V13, P36, DOI 10.1006/prep.1998.0874; Yang YQ, 2000, PEDIATR RES, V47, P184, DOI 10.1203/00006450-200002000-00006	40	29	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26353	26363		10.1074/jbc.M111.249813	http://dx.doi.org/10.1074/jbc.M111.249813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652702	hybrid, Green Published			2022-12-25	WOS:000293078200012
J	Leo, CH; Hart, JL; Woodman, OL				Leo, Chen-Huei; Hart, Joanne L.; Woodman, Owen L.			3 ',4 '-Dihydroxyflavonol Reduces Superoxide and Improves Nitric Oxide Function in Diabetic Rat Mesenteric Arteries	PLOS ONE			English	Article							FACTOR-TYPE RELAXATION; EDHF-TYPE RELAXATION; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; HIGH-RISK; ANTIOXIDANT; QUERCETIN; FLAVONOLS; REPERFUSION	Background: 3',4'-Dihydroxyflavonol (DiOHF) is an effective antioxidant that acutely preserves nitric oxide (NO) activity in the presence of elevated reactive oxygen species (ROS). We hypothesized that DiOHF treatment (7 days, 1 mg/kg per day s.c.) would improve relaxation in mesenteric arteries from diabetic rats where endothelial dysfunction is associated with elevated oxidant stress. Methodology/Principal Findings: In mesenteric arteries from diabetic rats there was an increase in ROS, measured by L-012 and 2',7'-dichlorodihydrofluorescein diacetate fluorescence. NADPH oxidase-derived superoxide levels, assayed by lucigenin chemiluminescence, were also significantly increased in diabetic mesenteric arteries (diabetes, 4892 +/- 946 counts/mg versus normal 2486 +/- 344 counts/mg, n = 7-10, p<0.01) associated with an increase in Nox2 expression but DiOHF (2094 +/- 300 counts/mg, n = 10, p<0.001) reversed that effect. Acetylcholine (ACh)-induced relaxation of mesenteric arteries was assessed using wire myography (pEC(50) = 7.94 +/- 0.13 n = 12). Diabetes significantly reduced the sensitivity to ACh and treatment with DiOHF prevented endothelial dysfunction (pEC(50), diabetic 6.86 +/- 0.12 versus diabetic+DiOHF, 7.49 +/- 0.13, n = 11, p<0.01). The contribution of NO versus endothelium-derived hyperpolarizing factor (EDHF) to ACh-induced relaxation was assessed by evaluating responses in the presence of TRAM-34+apamin+iberiotoxin or N-nitro-L-arginine+ODQ respectively. Diabetes impaired the contribution of both NO (maximum relaxation, R-max diabetic 24 +/- 7 versus normal, 68 +/- 10, n = 9-10, p<0.01) and EDHF (pEC(50), diabetic 6.63 +/- 0.15 versus normal, 7.14 +/- 0.12, n = 10-11, p<0.01) to endothelium-dependent relaxation. DiOHF treatment did not significantly affect the EDHF contribution but enhanced NO-mediated relaxation (R-max 69 +/- 66, n = 11, p<0.01). Western blotting demonstrated that diabetes also decreased expression and increased uncoupling of endothelial NO synthase (eNOS). Treatment of the diabetic rats with DiOHF significantly reduced vascular ROS and restored NO-mediated endothelium-dependent relaxation. Treatment of the diabetic rats with DiOHF also increased eNOS expression, both in total and as a dimer. Conclusions/Significance: DiOHF improves NO activity in diabetes by reducing Nox2-dependent superoxide production and preventing eNOS uncoupling to improve endothelial function.	[Leo, Chen-Huei; Hart, Joanne L.; Woodman, Owen L.] Royal Melbourne Inst Technol RMIT Univ, Hlth Innovat Res Inst, Sch Med Sci, Bundoora, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Leo, CH (corresponding author), Royal Melbourne Inst Technol RMIT Univ, Hlth Innovat Res Inst, Sch Med Sci, Bundoora, Vic, Australia.	owen.woodman@rmit.edu.au	Woodman, Owen L/H-7297-2019; leo, Chen huei/ABD-2155-2020	Woodman, Owen L/0000-0003-3759-1396; leo, Chen huei/0000-0003-1424-9694; Hart, Joanne/0000-0002-9473-0383	RMIT University	RMIT University	C. H. Leo is a recipient of RMIT University International Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjaneyulu M, 2004, CLIN EXP PHARMACOL P, V31, P244, DOI 10.1111/j.1440-1681.2004.03982.x; Brown A, 2010, NAT REV CARDIOL, V7, P369, DOI 10.1038/nrcardio.2010.35; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Burnham MP, 2006, BRIT J PHARMACOL, V148, P434, DOI 10.1038/sj.bjp.0706748; Chan ECH, 2003, J CARDIOVASC PHARM, V42, P727, DOI 10.1097/00005344-200312000-00006; Chan ECH, 2000, J CARDIOVASC PHARM, V35, P326, DOI 10.1097/00005344-200002000-00023; Coskun O, 2005, PHARMACOL RES, V51, P117, DOI 10.1016/j.phrs.2004.06.002; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Ding H, 2005, BRIT J PHARMACOL, V146, P1110, DOI 10.1038/sj.bjp.0706417; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Engler MB, 2006, NUTR REV, V64, P109, DOI [10.1301/nr.2006.mar.109-118, 10.1111/j.1753-4887.2006.tb00194.x]; Erlund I, 2000, EUR J CLIN PHARMACOL, V56, P545, DOI 10.1007/s002280000197; Fatehi-Hassanabad Z, 2010, EUR J PHARMACOL, V636, P8, DOI 10.1016/j.ejphar.2010.03.048; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Fukao M, 1997, BRIT J PHARMACOL, V121, P1383, DOI 10.1038/sj.bjp.0701258; Geleijnse JM, 2002, AM J CLIN NUTR, V75, P880, DOI 10.1093/ajcn/75.5.880; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hink U, 2001, CIRC RES, V88, pE14; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jiang F, 2008, J PHARMACOL EXP THER, V324, P261, DOI 10.1124/jpet.107.131433; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Leo CH, 2011, BRIT J PHARMACOL, V162, P365, DOI 10.1111/j.1476-5381.2010.01023.x; Leo CH, 2010, AM J PHYSIOL-HEART C, V299, pH502, DOI 10.1152/ajpheart.01197.2009; LEO CH, 2011, EUR J PHARM IN PRESS, P1; Loke WM, 2008, AM J CLIN NUTR, V88, P1018, DOI 10.1093/ajcn/88.4.1018; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Ma X, 2008, LIFE SCI, V83, P110, DOI 10.1016/j.lfs.2008.05.010; Machha A, 2007, NITRIC OXIDE-BIOL CH, V16, P442, DOI 10.1016/j.niox.2007.04.001; Makino A, 2000, BRIT J PHARMACOL, V130, P549, DOI 10.1038/sj.bjp.0703354; Malakul W, 2008, CLIN EXP PHARMACOL P, V35, P192, DOI 10.1111/j.1440-1681.2007.04811.x; Matsumoto T, 2003, AM J PHYSIOL-HEART C, V285, pH283, DOI 10.1152/ajpheart.00954.2002; Matsumoto T, 2005, AM J PHYSIOL-HEART C, V289, pH1933, DOI 10.1152/ajpheart.00303.2005; Matsumoto T, 2006, VASC PHARMACOL, V44, P450, DOI 10.1016/j.vph.2006.02.007; MCPHERSON GA, 1992, CLIN EXP PHARMACOL P, V19, P815, DOI 10.1111/j.1440-1681.1992.tb00420.x; Mladenka P, 2010, FREE RADICAL BIO MED, V49, P963, DOI 10.1016/j.freeradbiomed.2010.06.010; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Qi W, 2009, AM J PATHOL, V175, P1858, DOI 10.2353/ajpath.2009.090263; Qin CX, 2008, J MED CHEM, V51, P1874, DOI 10.1021/jm070352h; Shi Y, 2008, BRIT J PHARMACOL, V154, P639, DOI 10.1038/bjp.2008.110; Song YQ, 2009, AM J CLIN NUTR, V90, P429, DOI 10.3945/ajcn.2009.27491; Wang S, 2004, BRIT J PHARMACOL, V142, P443, DOI 10.1038/sj.bjp.0705815; Wang S, 2009, EUR J PHARMACOL, V624, P31, DOI 10.1016/j.ejphar.2009.10.001; Weston AH, 2008, BRIT J PHARMACOL, V154, P652, DOI 10.1038/bjp.2008.108; Willcox BJ, 2008, AM J CARDIOL, V101, p75D, DOI 10.1016/j.amjcard.2008.02.012; Woodman OL, 2005, J CARDIOVASC PHARM, V46, P302, DOI 10.1097/01.fjc.0000175431.62626.07; Woodman OL, 2004, CLIN EXP PHARMACOL P, V31, P786, DOI 10.1111/j.1440-1681.2004.04072.x; Woodman OL, 2009, LIFE SCI, V85, P54, DOI 10.1016/j.lfs.2009.04.012; Yap S, 2010, BIOFACTORS, V36, P350, DOI 10.1002/biof.111	51	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20813	10.1371/journal.pone.0020813	http://dx.doi.org/10.1371/journal.pone.0020813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673968	Green Published, gold			2022-12-25	WOS:000291356400031
J	Thieme, F; Engler, C; Kandzia, R; Marillonnet, S				Thieme, Frank; Engler, Carola; Kandzia, Romy; Marillonnet, Sylvestre			Quick and Clean Cloning: A Ligation-Independent Cloning Strategy for Selective Cloning of Specific PCR Products from Non-Specific Mixes	PLOS ONE			English	Article							RECOMBINANT-DNA; IN-VITRO; AMPLIFICATION; FRAGMENTS; VECTORS	We have developed an efficient strategy for cloning of PCR products that contain an unknown region flanked by a known sequence. As with ligation-independent cloning, the strategy is based on homology between sequences present in both the vector and the insert. However, in contrast to ligation-independent cloning, the cloning vector has homology with only one of the two primers used for amplification of the insert. The other side of the linearized cloning vector has homology with a sequence present in the insert, but nested and non-overlapping with the gene-specific primer used for amplification. Since only specific products contain this sequence, but none of the non-specific products, only specific products can be cloned. Cloning is performed using a one-step reaction that only requires incubation for 10 minutes at room temperature in the presence of T4 DNA polymerase to generate single-stranded extensions at the ends of the vector and insert. The reaction mix is then directly transformed into E. coli where the annealed vector-insert complex is repaired and ligated. We have tested this method, which we call quick and clean cloning (QC cloning), for cloning of the variable regions of immunoglobulins expressed in non-Hodgkin lymphoma tumor samples. This method can also be applied to identify the flanking sequence of DNA elements such as T-DNA or transposon insertions, or be used for cloning of any PCR product with high specificity.	[Thieme, Frank; Engler, Carola; Kandzia, Romy; Marillonnet, Sylvestre] Icon Genet GmbH, Halle, Germany	ICON plc	Thieme, F (corresponding author), Icon Genet GmbH, Halle, Germany.	marillonnet@icongenetics.de		Thieme, Frank/0000-0001-5733-3859	Icon Genetics GmbH	Icon Genetics GmbH	Work was funded by Icon Genetics GmbH. Icon Genetics GmbH employs all the authors of this study, therefore, they had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; ASLANIDIS C, 1994, PCR METH APPL, V4, P172; Ausubel FM, 2010, CURRENT PROTOCOLS MO; Bardoczy V, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-32; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Dan Hanhong, 2009, J Biomol Tech, V20, P241; de las Rivas B, 2007, BIOTECHNOL PROGR, V23, P680, DOI 10.1021/bp060318g; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Lee J, 2009, PROTEIN EXPRES PURIF, V63, P58, DOI 10.1016/j.pep.2008.09.005; Li CA, 1997, NUCLEIC ACIDS RES, V25, P4165, DOI 10.1093/nar/25.20.4165; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; OCHMAN H, 1988, GENETICS, V120, P621; Osterroth F, 1999, J IMMUNOL METHODS, V229, P141, DOI 10.1016/S0022-1759(99)00111-8; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROSENTHAL A, 1990, NUCLEIC ACIDS RES, V18, P3095, DOI 10.1093/nar/18.10.3095; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; XU G, 2010, NEW PHYTOL; YANG YS, 1993, NUCLEIC ACIDS RES, V21, P1889, DOI 10.1093/nar/21.8.1889	25	29	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20556	10.1371/journal.pone.0020556	http://dx.doi.org/10.1371/journal.pone.0020556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655102	gold, Green Published, Green Submitted			2022-12-25	WOS:000291310600015
J	Sadamoto, H; Saito, K; Muto, H; Kinjo, M; Ito, E				Sadamoto, Hisayo; Saito, Kenta; Muto, Hideki; Kinjo, Masataka; Ito, Etsuro			Direct Observation of Dimerization between Different CREB1 Isoforms in a Living Cell	PLOS ONE			English	Article							CROSS-CORRELATION SPECTROSCOPY; ELEMENT-BINDING PROTEIN; LONG-TERM FACILITATION; RESPONSE ELEMENT; TRANSCRIPTION FACTORS; TARGETED MUTATION; NERVOUS-SYSTEM; MESSENGER-RNA; IN-VIVO; ACTIVATOR	Cyclic AMP-responsive element binding protein 1 (CREB1) plays multiple functions as a transcription factor in gene regulation. CREB1 proteins are also known to be expressed in several spliced isoforms that act as transcriptional activators or repressors. The activator isoforms, possessing the functional domains for kinase induction and for interaction with other transcriptional regulators, act as transcriptional activators. On the other hand, some isoforms, lacking those functional domains, are reported to be repressors that make heterodimers with activator isoforms. The complex and ingenious function for CREB1 arises in part from the variation in their spliced isoforms, which allows them to interact with each other. To date, however, the dimerization between the activator and repressor isoforms has not yet been proved directly in living cells. In this study, we applied fluorescence cross-correlation spectroscopy (FCCS) to demonstrate direct observation of dimerization between CREB1 activator and repressor. The FCCS is a well established spectroscopic method to determine the interaction between the different fluorescent molecules in the aqueous condition. Using differently labeled CREB1 isoforms, we successfully observed the interaction of CREB1 activator and repressor via dimerization in the nuclei of cultured cells. As a result, we confirmed the formation of heterodimer between CREB1 activator and repressor isoforms in living cells.	[Sadamoto, Hisayo; Ito, Etsuro] Tokushima Bunri Univ, Lab Funct Biol, Kagawa Sch Pharmaceut Sci, Sanuki, Japan; [Saito, Kenta] Hokkaido Univ, Nikon Imaging Ctr, Res Inst Elect Sci, Sapporo, Hokkaido, Japan; [Muto, Hideki; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan	Tokushima Bunri University; Hokkaido University; Hokkaido University	Sadamoto, H (corresponding author), Tokushima Bunri Univ, Lab Funct Biol, Kagawa Sch Pharmaceut Sci, Sanuki, Japan.	sadamotoh@kph.bunri-u.ac.jp	Kinjo, Masataka/F-5267-2011; Saito, Kenta/G-2443-2010	Kinjo, Masataka/0000-0001-8889-8369; Saito, Kenta/0000-0003-4147-255X	Japan Society for the Promotion of Science [10765, 19770059, 21770081, 19370039, 21657022]; Zoological Society of Japan; Grants-in-Aid for Scientific Research [19058001] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Zoological Society of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for the Promotion of Science (Nos. 10765, 19770059, and 21770081 to HS, and Nos. 19370039 and 21657022 to EI) and by an OM Award from the Zoological Society of Japan (to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Baudendistel N, 2005, CHEMPHYSCHEM, V6, P984, DOI 10.1002/cphc.200400639; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; FOULKES NS, 1992, NATURE, V355, P80, DOI 10.1038/355080a0; Hatakeyama D, 2006, J MOL BIOL, V356, P569, DOI 10.1016/j.jmb.2005.12.009; Hu YH, 2008, J BIOL CHEM, V283, P9328, DOI 10.1074/jbc.M705110200; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Lee YS, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-3; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Muto H, 2006, PLANT CELL PHYSIOL, V47, P1095, DOI 10.1093/pcp/pcj080; Nantel F, 1996, NATURE, V380, P159, DOI 10.1038/380159a0; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; Park H, 2008, MOL CELLS, V26, P87; RUPPERT S, 1992, EMBO J, V11, P1503, DOI 10.1002/j.1460-2075.1992.tb05195.x; Sadamoto H, 2004, J NEUROBIOL, V58, P455, DOI 10.1002/neu.10296; Sadamoto H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00025; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Upadhya SC, 2004, J NEUROCHEM, V91, P210, DOI 10.1111/j.1471-4159.2004.02707.x; Wu XL, 1998, J BIOL CHEM, V273, P20820, DOI 10.1074/jbc.273.33.20820; YIN JCP, 1995, MOL CELL BIOL, V15, P5123	25	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20285	10.1371/journal.pone.0020285	http://dx.doi.org/10.1371/journal.pone.0020285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673803	Green Published, Green Submitted, gold			2022-12-25	WOS:000291309900011
J	Liang, Y; Chiu, PH; Yip, KY; Chan, SY				Liang, Ying; Chiu, Peng Hang; Yip, Kit Yan; Chan, Siu Yuen			Subcellular Localization of SUN2 Is Regulated by Lamin A and Rab5	PLOS ONE			English	Article							INNER NUCLEAR-MEMBRANE; PROTEIN; ENVELOPE; MIGRATION; UNC-84; CELLS; MICE; CENTROSOME; EXPRESSION; PROTEOMICS	SUN2 is an inner nuclear membrane protein with a conserved Sad1/UNC-84 homology SUN-domain at the C-terminus. Intriguingly, SUN2 has also been reported to interact with Rab5, which localizes in early endosomes. To clarify the dual subcellular localization of SUN2, we investigated its localization in lamin A/C deficient cells rescued with lamin A or lamin C isoform, and in HeLa cells transfected with Rab5 or its mutants. We found that expression of lamin A but not lamin C partly restored the nuclear envelope localization of SUN2. SUN2 was redistributed to endosomes upon overexpression of Rab5, but remained on the nuclear envelope when the SUN domain was deleted. To explore the physiological function of SUN2 in vesicle trafficking and endocytosis, we demonstrated the colocalization of endogenous SUN2 and Rab5. Moreover, overexpression of SUN2 stimulated the uptake of transferrin while suppression of SUN2 expression attenuated the process. These findings support a role of SUN2 in endocytosis.	[Liang, Ying; Chiu, Peng Hang; Yip, Kit Yan; Chan, Siu Yuen] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Liang, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Pokfulam, Hong Kong, Peoples R China.	sychan@hku.hk		Chan, Siu Yuen/0000-0001-7262-1293	Research Grants Council of the Hong Kong Special Administrative Region, China [HKU 7176/01M]; Edward Sai-Kim Hotung Paediatric Education and Research Fund; Faculty Core Imaging Facility of the Li Ka Shing Faculty of Medicine, the University of Hong Kong	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Edward Sai-Kim Hotung Paediatric Education and Research Fund; Faculty Core Imaging Facility of the Li Ka Shing Faculty of Medicine, the University of Hong Kong(University of Hong Kong)	This work was supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. HKU 7176/01M) and Edward Sai-Kim Hotung Paediatric Education and Research Fund. This work was also supported by the Faculty Core Imaging Facility of the Li Ka Shing Faculty of Medicine, the University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dreger M, 2001, P NATL ACAD SCI USA, V98, P11943, DOI 10.1073/pnas.211201898; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; FROHNERT C, 2010, MOL HUM REPROD; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Harley CA, 2001, J VIROL, V75, P1236, DOI 10.1128/JVI.75.3.1236-1251.2001; Hasan S, 2006, FEBS LETT, V580, P1263, DOI 10.1016/j.febslet.2006.01.039; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hoffenberg S, 2000, J BIOL CHEM, V275, P24661, DOI 10.1074/jbc.M909600199; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; Malone CJ, 1999, DEVELOPMENT, V126, P3171; McGee MD, 2006, MOL BIOL CELL, V17, P1790, DOI 10.1091/mbc.E05-09-0894; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Rao DS, 2003, CANCER CELL, V3, P471, DOI 10.1016/S1535-6108(03)00107-7; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Simonsen A, 2004, J CELL SCI, V117, P4239, DOI 10.1242/jcs.01287; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sun GF, 2002, BBA-MOL BASIS DIS, V1588, P241, DOI 10.1016/S0925-4439(02)00171-0; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Wang Q, 2006, DNA CELL BIOL, V25, P554, DOI 10.1089/dna.2006.25.554; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	33	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20507	10.1371/journal.pone.0020507	http://dx.doi.org/10.1371/journal.pone.0020507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655223	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600084
J	Pandya, A; Weinstein, MC; Gaziano, TA				Pandya, Ankur; Weinstein, Milton C.; Gaziano, Thomas A.			A Comparative Assessment of Non-Laboratory-Based versus Commonly Used Laboratory-Based Cardiovascular Disease Risk Scores in the NHANES III Population	PLOS ONE			English	Article							COST-EFFECTIVENESS; ABSOLUTE RISK; FOLLOW-UP; PREVENTION; VALIDATION; WORLD	Background: National and international primary CVD risk screening guidelines focus on using total CVD risk scores. Recently, we developed a non-laboratory-based CVD risk score (inputs: age, sex, smoking, diabetes, systolic blood pressure, treatment of hypertension, body-mass index), which can assess risk faster and at lower costs compared to laboratory-based scores (inputs include cholesterol values). We aimed to assess the exchangeability of the non-laboratory-based risk score to four commonly used laboratory-based scores (Framingham CVD [2008, 1991 versions], and Systematic COronary Risk Evaluation [SCORE] for low and high risk settings) in an external validation population. Methods and Findings: Analyses were based on individual-level, score-specific rankings of risk for adults in the Third National Health and Nutrition Examination Survey (NHANES III) aged 25-74 years, without history of CVD or cancer (n = 5,999). Risk characterization agreement was based on overlap in dichotomous risk characterization (thresholds of 10-year risk > 10-20%) and Spearman rank correlation. Risk discrimination was assessed using receiver operator characteristic curve analysis (10-year CVD death outcome). Risk characterization agreement ranged from 91.9-95.7% and 94.2-95.1% with Spearman correlation ranges of 0.957-0.980 and 0.946-0.970 for men and women, respectively. In men, c-statistics for the non-laboratory-based, Framingham (2008, 1991), and SCORE (high, low) functions were 0.782, 0.776, 0.781, 0.785, and 0.785, with p-values for differences relative to the non-laboratory-based score of 0.44, 0.89, 0.68 and 0.65, respectively. In women, the corresponding c-statistics were 0.809, 0.834, 0.821, 0.792, and 0.792, with corresponding p-values of 0.04, 0.34, 0.11 and 0.09, respectively. Conclusions: Every score discriminated risk of CVD death well, and there was high agreement in risk characterization between non-laboratory-based and laboratory-based risk scores, which suggests that the non-laboratory-based score can be a useful proxy for Framingham or SCORE functions in resource-limited settings. Future external validation studies can assess whether the sex-specific risk discrimination results hold in other populations.	[Pandya, Ankur; Weinstein, Milton C.; Gaziano, Thomas A.] Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Gaziano, Thomas A.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Gaziano, TA (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Hlth Decis Sci, 665 Huntington Ave, Boston, MA 02115 USA.	tgaziano@partners.org			National Heart, Lung and Blood Institute (NHLBI) [HHSN268200900030C]	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	TG is partially funded by the National Heart, Lung and Blood Institute (NHLBI) contract HHSN268200900030C. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BAISDEN KL, 2006, ENGIMA SURVEY DATA A, P194; BANK W, 2007, WORLD DEV INDICATORS; Chamnan P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1693; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Ezzati T M, 1992, Vital Health Stat 2, P1; GADDIS ML, 1990, ANN EMERG MED, V19, P1462, DOI 10.1016/S0196-0644(05)82622-8; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; *HLTH PEOPL 2010, 2000, SERV DOHAH; Jackson R, 2006, BMJ-BRIT MED J, V332, P617, DOI 10.1136/bmj.332.7542.617; LITTLE RJA, 1995, SIMULATION STUDY EVA, P257; Mendis S, 2005, B WORLD HEALTH ORGAN, V83, P820; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Panagiotakos DB, 2006, VASC HEALTH RISK MAN, V2, P309, DOI 10.2147/vhrm.2006.2.3.309; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Raghunathan TE., 2001, SURVEY METHODOL, V27, P10; Rubin DB, 2004, MULTIPLE IMPUTATION; *VIT HLTH, 1994, VIT HLTH STAT, V1, P1; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; World Health Organization, 2007, PREV CARD DIS POCK G	29	46	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20416	10.1371/journal.pone.0020416	http://dx.doi.org/10.1371/journal.pone.0020416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655241	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600064
J	Mai, XQ; Ge, Y; Tao, L; Tang, HH; Liu, C; Luo, YJ				Mai, Xiaoqin; Ge, Yue; Tao, Lin; Tang, Honghong; Liu, Chao; Luo, Yue-Jia			Eyes Are Windows to the Chinese Soul: Evidence from the Detection of Real and Fake Smiles	PLOS ONE			English	Article							EMOTION RECOGNITION; FACIAL EXPRESSIONS; CULTURAL-DIFFERENCES; UNITED-STATES; ENJOYMENT; FACE; PERCEPTION; AMYGDALA; DAMAGE; JAPAN	How do people interpret the meaning of a smile? Previous studies with Westerners have found that both the eyes and the mouth are crucial in identifying and interpreting smiles, yet less is known about Easterners. Here we reported that when asking the Chinese to judge the Duchenne and non-Duchenne smiles as either real or fake, their accuracy and sensitivity were negatively correlated with their individualism scores but positively correlated with their collectivism scores. However, such correlations were found only for participants who stated the eyes to be the most useful references, but not for those who favored the mouth. Moreover, participants who favored the eyes were more accurate and sensitive than those who favored the mouth. Our results thus indicate that Chinese who follow the typical Eastern decoding process of using the eyes as diagnostic cues to identify and interpret others' facial expressions and social intentions, are particularly accurate and sensitive, the more they self-report greater collectivistic and lower individualistic values.	[Mai, Xiaoqin] Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA; [Ge, Yue; Tang, Honghong; Liu, Chao; Luo, Yue-Jia] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Tao, Lin] Chinese Univ Hong Kong, Dept Sociol, Hong Kong, Hong Kong, Peoples R China	University of Michigan System; University of Michigan; Beijing Normal University; Chinese University of Hong Kong	Mai, XQ (corresponding author), Univ Michigan, Ctr Human Growth & Dev, Ann Arbor, MI 48109 USA.	Liuchao@bnu.edu.cn; Luoyj@bnu.edu.cn	Tao, Lin/B-4080-2011; Liu, Chao/E-9068-2017	Tao, Lin/0000-0003-3744-2067; Liu, Chao/0000-0003-1149-2314; Tang, Honghong/0000-0001-7588-0071	NSF China [30930031]; Ministry of Education, China [IRT0710]; National Key Technologies RD Program [2009BAI77B01]; NIH, USA [1R01TW007897]; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	NSF China(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); National Key Technologies RD Program(National Key Technology R&D Program); NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the NSF China (30930031), the Ministry of Education, China (PCSIRT, IRT0710), National Key Technologies R&D Program (2009BAI77B01), and Global Research Initiative Program, NIH, USA (1R01TW007897) to Yue-Jia Luo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; ADOLPHS R, AMYGDALA FUNCTIONAL, P587; *BBC, SPOT FAK SMIL; Beaupre MG, 2005, J CROSS CULT PSYCHOL, V36, P355, DOI 10.1177/0022022104273656; Bellah R.N., 1996, HABITS HEART INDIVID; Bernstein MJ, 2008, PSYCHOL SCI, V19, P981, DOI 10.1111/j.1467-9280.2008.02187.x; Bernstein MJ, 2010, J EXP SOC PSYCHOL, V46, P196, DOI 10.1016/j.jesp.2009.08.010; Duchenne de Boulogne C.B., 1862, MECH HUMAN FACIAL EX; EKMAN P, 1992, PHILOS T ROY SOC B, V335, P63, DOI 10.1098/rstb.1992.0008; EKMAN P, 1980, J PERS SOC PSYCHOL, V39, P1125, DOI 10.1037/h0077722; EKMAN P, 1969, SCIENCE, V164, P86, DOI 10.1126/science.164.3875.86; EKMAN P, 1988, J PERS SOC PSYCHOL, V54, P414, DOI 10.1037/0022-3514.54.3.414; EKMAN P, 1974, J PERS SOC PSYCHOL, V29, P288, DOI 10.1037/h0036006; Ekman P, 1978, FACIAL ACTION CODING; Elfenbein HA, 2002, PSYCHOL BULL, V128, P243, DOI 10.1037//0033-2909.128.2.243; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Elfenbein HA, 2007, EMOTION, V7, P131, DOI 10.1037/1528-3542.7.1.131; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; FRANK MG, 1993, HUMOR, V6, P9, DOI 10.1515/humr.1993.6.1.9; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; KIM MS, 1994, INT J INTERCULT REL, V18, P117, DOI 10.1016/0147-1767(94)90008-6; Kitayama S, 2000, COGNITION EMOTION, V14, P93, DOI 10.1080/026999300379003; Kontsevich LL, 2004, VISION RES, V44, P1493, DOI 10.1016/j.visres.2003.11.027; Leppanen JM, 2007, VIS COGN, V15, P468, DOI 10.1080/13506280600765333; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Marshall J., 2003, CANONICAL SMILEY 1 L; Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Matsumoto D, 2009, J NONVERBAL BEHAV, V33, P181, DOI 10.1007/s10919-009-0068-z; MCSHANE S, 2006, INDIVIDUALISM COLLEC; Miles L, 2007, J NONVERBAL BEHAV, V31, P259, DOI 10.1007/s10919-007-0036-4; Niedenthal P. M., BEHAV BRAIN IN PRESS; Nugier A, 2009, EUR J SOC PSYCHOL, V39, P1126, DOI 10.1002/ejsp.602; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Pollack A., 1996, NY TIMES, pD5; Schyns PG, 2002, PSYCHOL SCI, V13, P402, DOI 10.1111/1467-9280.00472; SHWEDER RA, DOES CONCEPT PERSON, P97; Singelis T.M., 1995, CROSS-CULT RES, V29, P240, DOI [10.1177/106939719502900302, DOI 10.1177/106939719502900302]; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; THIBAULT P, WRINKLES EY IN PRESS; Uchida Y, 2008, PERS SOC PSYCHOL B, V34, P741, DOI 10.1177/0146167208315157; Uchida Y, 2009, PERS SOC PSYCHOL B, V35, P1427, DOI 10.1177/0146167209347322; Williams LM, 2001, J PSYCHOPHYSIOL, V15, P122, DOI 10.1027//0269-8803.15.2.122; Yabar Y, 2007, NEW ZEAL J PSYCHOL, V36, P42; Yuki M, 2007, J EXP SOC PSYCHOL, V43, P303, DOI 10.1016/j.jesp.2006.02.004	47	14	15	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19903	10.1371/journal.pone.0019903	http://dx.doi.org/10.1371/journal.pone.0019903			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	769IQ	21647430	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500011
J	Yap, TL; Gruschus, JM; Velayati, A; Westbroek, W; Goldin, E; Moaven, N; Sidransky, E; Lee, JC				Yap, Thai Leong; Gruschus, James M.; Velayati, Arash; Westbroek, Wendy; Goldin, Ehud; Moaven, Nima; Sidransky, Ellen; Lee, Jennifer C.			alpha-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BETA-GLUCOSIDASE; HUMAN SAPOSIN-C; X-RAY-STRUCTURE; MUTATIONS; GENE; PROTEIN; AGGREGATION; BINDING; NEURODEGENERATION; FIBRILLATION	The presynaptic protein alpha-synuclein (alpha-syn), particularly in its amyloid form, is widely recognized for its involvement in Parkinson disease (PD). Recent genetic studies reveal that mutations in the gene GBA are the most widespread genetic risk factor for parkinsonism identified to date. GBA encodes for glucocerebrosidase (GCase), the enzyme deficient in the lysosomal storage disorder, Gaucher disease (GD). In this work, we investigated the possibility of a physical linkage between alpha-syn and GCase, examining both wild type and the GD-related N370S mutant enzyme. Using fluorescence and nuclear magnetic resonance spectroscopy, we determined that alpha-syn and GCase interact selectively under lysosomal solution conditions (pH 5.5) and mapped the interaction site to the alpha-syn C-terminal residues, 118-137. This alpha-syn-GCase complex does not form at pH 7.4 and is stabilized by electrostatics, with dissociation constants ranging from 1.2 to 22 mu M in the presence of 25 to 100mM NaCl. Intriguingly, the N370S mutant form of GCase has a reduced affinity for alpha-syn, as does the inhibitor conduritol-beta-epoxidebound enzyme. Immunoprecipitation and immunofluorescence studies verified this interaction in human tissue and neuronal cell culture, respectively. Although our data do not preclude protein-protein interactions in other cellular milieux, we suggest that the alpha-syn-GCase association is favored in the lysosome, and that this noncovalent interaction provides the groundwork to explore molecular mechanisms linking PD with mutant GBA alleles.	[Yap, Thai Leong; Gruschus, James M.; Lee, Jennifer C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Velayati, Arash; Westbroek, Wendy; Goldin, Ehud; Moaven, Nima; Sidransky, Ellen] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Sidransky, E (corresponding author), 35 Convent Dr,Room 1A213, Bethesda, MD 20892 USA.	sidranse@mail.nih.gov; leej4@mail.nih.gov	Lee, Jennifer/E-9658-2015	Lee, Jennifer/0000-0003-0506-8349	National Institutes of Health; NHLBI; NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001055, ZIAHL006144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program at the National Institutes of Health, NHLBI and NHGRI.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butters TD, 2007, CURR OPIN CHEM BIOL, V11, P412, DOI 10.1016/j.cbpa.2007.05.035; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Croke RL, 2011, PROTEIN SCI, V20, P256, DOI 10.1002/pro.556; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; de Alba E, 2003, BIOCHEMISTRY-US, V42, P14729, DOI 10.1021/bi0301338; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Goker-Alpan O, 2006, NEUROLOGY, V67, P908, DOI 10.1212/01.wnl.0000230215.41296.18; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Goldin E, 2010, MOL GENET METAB, V101, P307, DOI 10.1016/j.ymgme.2010.08.004; Grabowski GA, 1997, GENET TEST, V1, P5, DOI 10.1089/gte.1997.1.5; GRACE ME, 1994, J BIOL CHEM, V269, P2283; Gruschus JM, 2008, AMYLOID, V15, P160, DOI 10.1080/13506120802193746; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hruska KS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/78549; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kacher Y, 2008, BIOL CHEM, V389, P1361, DOI 10.1515/BC.2008.163; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; Lee JC, 2004, P NATL ACAD SCI USA, V101, P16466, DOI 10.1073/pnas.0407307101; Lee JC, 2008, J AM CHEM SOC, V130, P6898, DOI 10.1021/ja711415b; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; MEIVARLEVY I, 1994, BIOCHEM J, V303, P377, DOI 10.1042/bj3030377; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; Nath S, 2010, BIOPHYS J, V98, P1302, DOI 10.1016/j.bpj.2009.12.4290; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; van Raaij ME, 2008, BIOPHYS J, V95, P4871, DOI 10.1529/biophysj.107.127464; Velayati A, 2010, CURR NEUROL NEUROSCI, V10, P190, DOI 10.1007/s11910-010-0102-x; Wei RR, 2011, J BIOL CHEM, V286, P299, DOI 10.1074/jbc.M110.150433; Yap TL, 2011, BIOCHEMISTRY-US, V50, P1963, DOI 10.1021/bi2000824; Zabrocki P, 2008, BBA-MOL CELL RES, V1783, P1767, DOI 10.1016/j.bbamcr.2008.06.010; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	77	126	135	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28080	28088		10.1074/jbc.M111.237859	http://dx.doi.org/10.1074/jbc.M111.237859			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21653695	hybrid, Green Published			2022-12-25	WOS:000293557800026
J	Cheng, CJ; Lin, SH; Lo, YF; Yang, SS; Hsu, YJ; Cannon, SC; Huang, CL				Cheng, Chih-Jen; Lin, Shih-Hua; Lo, Yi-Fen; Yang, Sung-Sen; Hsu, Yu-Juei; Cannon, Stephen C.; Huang, Chou-Long			Identification and Functional Characterization of Kir2.6 Mutations Associated with Non-familial Hypokalemic Periodic Paralysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHINESE PATIENTS; MOLECULAR ANALYSIS; EXTRACELLULAR K+; CHANNEL MUTATION; GATING PORE; MUSCLE; NA+; DEPOLARIZATION; GENES	Hypokalemic periodic paralysis (hypoKPP) is characterized by episodic flaccid paralysis of muscle and acute hypokalemia during attacks. Familial forms of hypoKPP are predominantly caused by mutations of either voltage-gated Ca2(+) or Na+ channels. The pathogenic gene mutation in non-familial hypoKPP, consisting mainly of thyrotoxic periodic paralysis (TPP) and sporadic periodic paralysis (SPP), is largely unknown. Recently, mutations in KCNJ18, which encodes a skeletal muscle-specific inwardly rectifying K+ channel Kir2.6, were reported in some TPP patients. Whether mutations of Kir2.6 occur in other patients with non-familial hypoKPP and how mutations of the channel predispose patients to paralysis are unknown. Here, we report one conserved heterozygous mutation in KCNJ18 in two TPP patients and two separate heterozygous mutations in two SPP patients. These mutations result in V168M, R43C, and A200P amino acid substitution of Kir2.6, respectively. Compared with the wild type channel, whole-cell currents of R43C and V168M mutants were reduced by similar to 78 and 43%, respectively. No current was detected for the A200P mutant. Single channel conductance and open probability were reduced for R43C and V168M, respectively. Biotinylation assays showed reduced cell surface abundance for R43C and A200P. All three mutants exerted dominant negative inhibition on wild type Kir2.6 as well as wild type Kir2.1, another Kir channel expressed in the skeletal muscle. Thus, mutations of Kir2.6 are associated with SPP as well as TPP. We suggest that decreased outward K+ current from hypofunction of Kir2.6 predisposes the sarcolemma to hypokalemia-induced paradoxical depolarization during attacks, which in turn leads to Na+ channel inactivation and inexcitability of muscles.	[Cheng, Chih-Jen; Lin, Shih-Hua; Lo, Yi-Fen; Yang, Sung-Sen; Hsu, Yu-Juei] Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, Taipei 114, Taiwan; [Cheng, Chih-Jen; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Div Nephrol, Dept Med, Dallas, TX 75390 USA; [Cannon, Stephen C.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Cannon, Stephen C.] Univ Texas SW Med Ctr Dallas, Program Neurosci, Dallas, TX 75390 USA	National Defense Medical Center; Tri-Service General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lin, SH (corresponding author), Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan.	l521116@ndmctsgh.edu.tw; chou-long.huang@utsouthwestern.edu	Cheng, Chih-Jen/AAM-3305-2021; Cannon, Stephen/V-5343-2019	Cannon, Stephen/0000-0001-8428-3690	National Institutes of Health [DK59530, P30DK079328]; National Science Council, Taiwan [NSC 93-2314-B-016-031]; Tri-Service General Hospital [SGH-C-93-51]; Ministry of Defense, Taiwan; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR042703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, R01DK059530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Ministry of Defense, Taiwan; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK59530 (to C.-L. H.) and P30DK079328 (UT Southwestern Medical Center O'Brien Center). This study was also supported by the National Science Council, Taiwan (NSC 93-2314-B-016-031 (to S.-H. L.)) and the Research Fund of Tri-Service General Hospital (SGH-C-93-51 (to S.-H. L.)). Functional experiments were performed by C.-J. Cheng in partial fulfillment of the requirements of the Ph.D. degree at the University of Texas Southwestern Medical Center at Dallas.; Supported by a scholarship grant from the Ministry of Defense, Taiwan.	Bowen LN, 2010, NEUROLOGY, V74, P1546, DOI 10.1212/WNL.0b013e3181e222ee; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Chang HK, 2010, J BIOL CHEM, V285, P23113, DOI 10.1074/jbc.M110.121186; Chen L, 2003, EUR NEUROL, V49, P227, DOI 10.1159/000070191; Dassau L, 2011, J BIOL CHEM, V286, P9526, DOI 10.1074/jbc.M110.170597; GRUENER R, 1975, J NEUROL SCI, V24, P339, DOI 10.1016/0022-510X(75)90254-3; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; HOFMANN WW, 1972, AM J PHYSIOL, V223, P283, DOI 10.1152/ajplegacy.1972.223.2.283; Jurkat-Rott K, 2009, P NATL ACAD SCI USA, V106, P4036, DOI 10.1073/pnas.0811277106; KELLEY DE, 1989, ARCH INTERN MED, V149, P2597, DOI 10.1001/archinte.149.11.2597; Kung AWC, 2006, J CLIN ENDOCR METAB, V91, P2490, DOI 10.1210/jc.2006-0356; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lin SH, 2005, MAYO CLIN PROC, V80, P99, DOI 10.1016/S0025-6196(11)62965-0; Lin SH, 2001, QJM-MON J ASSOC PHYS, V94, P133, DOI 10.1093/qjmed/94.3.133; Lin SHH, 2005, AM J MED SCI, V329, P66, DOI 10.1097/00000441-200502000-00003; Liu TA, 2011, BBA-BIOMEMBRANES, V1808, P1772, DOI 10.1016/j.bbamem.2011.02.016; Matthews E, 2009, NEUROLOGY, V72, P1544, DOI 10.1212/01.wnl.0000342387.65477.46; Ng WY, 2004, THYROID, V14, P187, DOI 10.1089/105072504773297858; OBER KP, 1992, MEDICINE, V71, P109, DOI 10.1097/00005792-199205000-00001; OKINAKA S, 1957, J CLIN ENDOCR METAB, V17, P1454, DOI 10.1210/jcem-17-12-1454; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; PTACEK LJ, 1994, CELL, V77, P863; Puwanant A, 2010, MUSCLE NERVE, V42, P315, DOI 10.1002/mus.21693; Ruff RL, 1999, NEUROLOGY, V53, P1556, DOI 10.1212/WNL.53.7.1556; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Schalin-Jantti C, 2005, HORM RES, V63, P139, DOI 10.1159/000084689; Shiang JC, 2009, EUR J ENDOCRINOL, V161, P911, DOI 10.1530/EJE-09-0553; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; STEDWELL RE, 1992, AM J EMERG MED, V10, P143, DOI 10.1016/0735-6757(92)90048-3; Struyk AF, 2008, MUSCLE NERVE, V37, P326, DOI 10.1002/mus.20928; Struyk AF, 2007, J GEN PHYSIOL, V130, P11, DOI 10.1085/jgp.200709755; Wang WQ, 2006, MOL GENET METAB, V87, P359, DOI 10.1016/j.ymgme.2005.10.020; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160	33	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27425	27435		10.1074/jbc.M111.249656	http://dx.doi.org/10.1074/jbc.M111.249656			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21665951	Green Published, hybrid			2022-12-25	WOS:000293268700038
J	Liu, J; Liu, MY; Nguyen, JB; Bhagat, A; Mooney, V; Yan, ECY				Liu, Jian; Liu, Monica Yun; Nguyen, Jennifer B.; Bhagat, Aditi; Mooney, Victoria; Yan, Elsa C. Y.			Thermal Properties of Rhodopsin INSIGHT INTO THE MOLECULAR MECHANISM OF DIM-LIGHT VISION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HYDROGEN-BOND NETWORK; VISUAL PIGMENTS; SCHIFF-BASE; CRYSTAL-STRUCTURE; BOVINE RHODOPSIN; 1ST STEP; ACTIVATION; ISOMERIZATION; INTERMEDIATE	Rhodopsin has developed mechanisms to optimize its sensitivity to light by suppressing dark noise and enhancing quantum yield. We propose that an intramolecular hydrogen-bonding network formed by similar to 20 water molecules, the hydrophilic residues, and peptide backbones in the transmembrane region is essential to restrain thermal isomerization, the source of dark noise. We studied the thermal stability of rhodopsin at 55 degrees C with single point mutations (E181Q and S186A) that perturb the hydrogen-bonding network at the active site. We found that the rate of thermal isomerization increased by 1-2 orders of magnitude in the mutants. Our results illustrate the importance of the intact hydrogen-bonding network for dim-light detection, revealing the functional roles of water molecules in rhodopsin. We also show that thermal isomerization of 11-cis-retinal in solution can be catalyzed by wild-type opsin and that this catalytic property is not affected by the mutations. We characterize the catalytic effect and propose that it is due to steric interactions in the retinal-binding site and increases quantum yield by predetermining the trajectory of photoisomerization. Thus, our studies reveal a balancing act between dark noise and quantum yield, which have opposite effects on the thermal isomerization rate. The acquisition of the hydrogen-bonding network and the tuning of the steric interactions at the retinal-binding site are two important factors in the development of dim-light vision.	[Liu, Jian; Liu, Monica Yun; Nguyen, Jennifer B.; Bhagat, Aditi; Mooney, Victoria; Yan, Elsa C. Y.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Yan, ECY (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	elsa.yan@yale.edu	Nguyen, Jennifer/GVS-4347-2022; Liu, Jian/A-9302-2013	Liu, Monica Yun/0000-0003-3936-9377; Yan, Elsa/0000-0002-3583-1627	National Science Foundation [MCB-0955407]; Anderson postdoctoral fellowship; Yale College; National Institutes of Health	National Science Foundation(National Science Foundation (NSF)); Anderson postdoctoral fellowship; Yale College; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Science Foundation Career Grant MCB-0955407.; Recipient of an Anderson postdoctoral fellowship.; Recipient of a Yale College Dean's research fellowship.; Supported by the National Institutes of Health Predoctoral Training Program in Biophysics.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343; Crozier PS, 2003, J MOL BIOL, V333, P493, DOI 10.1016/j.jmb.2003.08.045; Del Valle LJ, 2003, CELL MOL LIFE SCI, V60, P2532, DOI 10.1007/s00018-003-3113-9; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; HUG SJ, 1990, BIOCHEMISTRY-US, V29, P1475, DOI 10.1021/bi00458a019; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; KANDORI H, 1995, J AM CHEM SOC, V117, P2669, DOI 10.1021/ja00114a040; KHORANA HG, 1992, J BIOL CHEM, V267, P1; KITO Y, 1968, NATURE, V218, P955, DOI 10.1038/218955a0; Kochendoerfer GG, 1996, BIOCHEMISTRY-US, V35, P16230, DOI 10.1021/bi961951l; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu J, 2009, J AM CHEM SOC, V131, P8750, DOI 10.1021/ja903154u; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; MIN KC, 1993, J BIOL CHEM, V268, P9400; Nakagawa M, 1999, P NATL ACAD SCI USA, V96, P6189, DOI 10.1073/pnas.96.11.6189; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Orban T, 2010, BIOCHEMISTRY-US, V49, P827, DOI 10.1021/bi901889t; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PETEANU LA, 1993, P NATL ACAD SCI USA, V90, P11762, DOI 10.1073/pnas.90.24.11762; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; RANDALL CE, 1991, J AM CHEM SOC, V113, P3473, DOI 10.1021/ja00009a037; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; Yan ECY, 2007, J PHYS CHEM C, V111, P8843, DOI 10.1021/jp067172o	39	24	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27622	27629		10.1074/jbc.M111.233312	http://dx.doi.org/10.1074/jbc.M111.233312			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659526	Green Published, hybrid			2022-12-25	WOS:000293268700055
J	Nakamura, M; Uehara, Y; Asada, M; Honda, E; Nagai, N; Kimata, K; Suzuki, M; Imamura, T				Nakamura, Masao; Uehara, Yuriko; Asada, Masahiro; Honda, Emi; Nagai, Naoko; Kimata, Koji; Suzuki, Masashi; Imamura, Toru			Sulfated Glycosaminoglycans Are Required for Specific and Sensitive Fibroblast Growth Factor (FGF) 19 Signaling via FGF Receptor 4 and betaKlotho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; HEPATOCELLULAR-CARCINOMA; SUBFAMILY MEMBERS; TRANSGENIC MICE; METABOLIC-RATE; FACTOR FAMILY; FIBROBLAST-GROWTH-FACTOR-19; KLOTHO; LIVER; EXPRESSION	Secreted from intestine, human fibroblast growth factor 19 (hFGF19) is an endocrine metabolic regulator that controls bile acid synthesis in the liver. Earlier studies have suggested that hFGF19 at 10-100 nM levels signals through FGF receptor 4 (FGFR4) in the presence of a co-receptor, betaKlotho, but its activity and receptor specificity at physiological concentrations (picomolar levels) remain unclear. Here we report that hFGF19 at picomolar levels require sulfated glycosaminoglycans (sGAGs), such as heparan sulfate, heparin, and chondroitin sulfates, for its signaling via human FGFR4 in the presence of human betaKlotho. Importantly, sGAGs isolated from liver are highly active in enhancing the picomolar hFGF19 signaling. At nanomolar levels, in contrast, hFGF19 activates all types of human FGFRs, i.e. FGFR1c, FGFR2c, FGFR3c, and FGFR4 in the co-presence of betaKlotho and heparin and activates FGFR4 even in the absence of betaKlotho. These results show that sGAGs play crucial roles in specific and sensitive hFGF19 signaling via FGF receptors and suggest that hepatic sGAGs are involved in the highly potent and specific signaling of picomolar hFGF19 through FGFR4 and betaKlotho. The results further suggest that hFGF19 at pathological concentrations may evoke aberrant signaling through various FGF receptors.	[Nakamura, Masao; Uehara, Yuriko; Asada, Masahiro; Honda, Emi; Suzuki, Masashi; Imamura, Toru] Natl Inst Adv Ind Sci & Technol, Signaling Mol Res Grp, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Nakamura, Masao; Suzuki, Masashi] Ibaraki Univ, Grad Sch Sci & Engn, Mito, Ibaraki 3108512, Japan; [Nagai, Naoko; Kimata, Koji] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Ibaraki University; Aichi Medical University	Suzuki, M (corresponding author), Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	suzuki-m@aist.go.jp; imamura-toru@aist.go.jp	Suzuki, Masashi/M-1696-2018; ASADA, MASAHIRO/M-4086-2018	Suzuki, Masashi/0000-0002-7218-0923; ASADA, MASAHIRO/0000-0001-6092-2080	National Institute of Advanced Industrial Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [22590296] Funding Source: KAKEN	National Institute of Advanced Industrial Science and Technology; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the National Institute of Advanced Industrial Science and Technology and by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Dostalova I, 2008, J CLIN ENDOCR METAB, V93, P3627, DOI 10.1210/jc.2008-0746; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fukumoto S, 2008, ENDOCR J, V55, P23, DOI 10.1507/endocrj.KR07E-002; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jones S, 2008, MOL PHARMACEUT, V5, P42, DOI 10.1021/mp700105z; Kan M, 1999, J BIOL CHEM, V274, P15947, DOI 10.1074/jbc.274.22.15947; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kimura A, 2008, J HEPATO-BILIARY-PAN, V15, P608, DOI 10.1007/s00534-007-1321-7; Kuro-o M, 2008, TRENDS ENDOCRIN MET, V19, P239, DOI 10.1016/j.tem.2008.06.002; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Smith SML, 2007, MATRIX BIOL, V26, P175, DOI 10.1016/j.matbio.2006.10.012; Strack AM, 2004, ENDOCRINOLOGY, V145, P2591, DOI 10.1210/en.2004-0367; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007; Wright TJ, 2004, DEV BIOL, V269, P264, DOI 10.1016/j.ydbio.2004.02.003; Wu XL, 2010, P NATL ACAD SCI USA, V107, P14158, DOI 10.1073/pnas.1009427107; Wu XL, 2009, AGING-US, V1, P1023, DOI 10.18632/aging.100108; Wu XL, 2009, P NATL ACAD SCI USA, V106, P14379, DOI 10.1073/pnas.0907812106; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200; Yoneda A, 2000, NAT BIOTECHNOL, V18, P641, DOI 10.1038/76487	32	17	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26418	26423		10.1074/jbc.M111.251140	http://dx.doi.org/10.1074/jbc.M111.251140			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653700	hybrid, Green Published			2022-12-25	WOS:000293078200019
J	Vinot, N; Jouin, M; Lhomme-Duchadeuil, A; Guesnet, P; Alessandri, JM; Aujard, F; Pifferi, F				Vinot, Nina; Jouin, Melanie; Lhomme-Duchadeuil, Adrien; Guesnet, Philippe; Alessandri, Jean-Marc; Aujard, Fabienne; Pifferi, Fabien			Omega-3 Fatty Acids from Fish Oil Lower Anxiety, Improve Cognitive Functions and Reduce Spontaneous Locomotor Activity in a Non-Human Primate	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; GLUCOSE-TRANSPORT; BRAIN; NEUROTRANSMISSION; DEFICIENT; MEMORY; SENESCENCE; MECHANISM; BEHAVIOR; RATS	Omega-3 (omega 3) polyunsaturated fatty acids (PUFA) are major components of brain cells membranes. omega 3 PUFA-deficient rodents exhibit severe cognitive impairments (learning, memory) that have been linked to alteration of brain glucose utilization or to changes in neurotransmission processes. omega 3 PUFA supplementation has been shown to lower anxiety and to improve several cognitive parameters in rodents, while very few data are available in primates. In humans, little is known about the association between anxiety and omega 3 fatty acids supplementation and data are divergent about their impact on cognitive functions. Therefore, the development of nutritional studies in non-human primates is needed to disclose whether a long-term supplementation with long-chain omega 3 PUFA has an impact on behavioural and cognitive parameters, differently or not from rodents. We address the hypothesis that omega 3 PUFA supplementation could lower anxiety and improve cognitive performances of the Grey Mouse Lemur (Microcebus murinus), a nocturnal Malagasy prosimian primate. Adult male mouse lemurs were fed for 5 months on a control diet or on a diet supplemented with long-chain omega 3 PUFA (n = 6 per group). Behavioural, cognitive and motor performances were measured using an open field test to evaluate anxiety, a circular platform test to evaluate reference spatial memory, a spontaneous locomotor activity monitoring and a sensory-motor test. omega 3-supplemented animals exhibited lower anxiety level compared to control animals, what was accompanied by better performances in a reference spatial memory task (80% of successful trials vs 35% in controls, p < 0.05), while the spontaneous locomotor activity was reduced by 31% in omega 3-supplemented animals (p < 0.001), a parameter that can be linked with lowered anxiety. The long-term dietary omega 3 PUFA supplementation positively impacts on anxiety and cognitive performances in the adult mouse lemur. The supplementation of human food with omega 3 fatty acids may represent a valuable dietary strategy to improve behavioural and cognitive functions.	[Vinot, Nina; Lhomme-Duchadeuil, Adrien; Aujard, Fabienne; Pifferi, Fabien] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Jouin, Melanie; Guesnet, Philippe; Alessandri, Jean-Marc] INRA, Lab Nutr & Regulat Lipid Fonct Cerebrales, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Vinot, N (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France.	pifferi@mnhn.fr		Pifferi, Fabien/0000-0001-9316-1935	Groupe Lipides et Nutrition; Centre National de la Recherche Scientifique/Museum National d'Histoire Naturelle; Institut National de la Recherche Agronomique	Groupe Lipides et Nutrition; Centre National de la Recherche Scientifique/Museum National d'Histoire Naturelle(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique	This work was financially supported by the Groupe Lipides et Nutrition, the Centre National de la Recherche Scientifique/Museum National d'Histoire Naturelle, and the Institut National de la Recherche Agronomique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri JM, 2004, REPROD NUTR DEV, V44, P509, DOI 10.1051/rnd:2004063; [Anonymous], APPORTS NUTR CONSEIL; Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEGIN ME, 2010, RECENT ADV NUTR PREV; Bemrah N, 2009, PUBLIC HEALTH NUTR, V12, P599, DOI 10.1017/S1368980008002681; Carrie I, 2000, J LIPID RES, V41, P473; Chalon S, 1998, J NUTR, V128, P2512, DOI 10.1093/jn/128.12.2512; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chalon S, 2009, NEUROPHARMACOLOGY, V57, P636, DOI 10.1016/j.neuropharm.2009.08.012; da Silva AX, 2002, J NEUROCHEM, V81, P1328; Dal-Pan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016581; DELION S, 1994, J NUTR, V124, P2466, DOI 10.1093/jn/124.12.2466; ENSLEN M, 1991, LIPIDS, V26, P203, DOI 10.1007/BF02543972; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fedorova I, 2009, BEHAV NEUROSCI, V123, P196, DOI 10.1037/a0013801; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; GUESNET P, 1993, EUR J CLIN NUTR, V47, P700; HARAUMA A, 2011, LIPIDS          0207; INNIS SM, 1991, PROG LIPID RES, V30, P39, DOI 10.1016/0163-7827(91)90006-Q; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kodas E, 2002, J LIPID RES, V43, P1209, DOI 10.1194/jlr.M200132-JLR200; Kuratko CN, 2009, PROSTAG LEUKOTR ESS, V81, P111, DOI 10.1016/j.plefa.2009.05.007; Lavialle M, 2008, J NUTR, V138, P1719, DOI 10.1093/jn/138.9.1719; Lavialle M, 2010, J NUTR BIOCHEM, V21, P899, DOI 10.1016/j.jnutbio.2009.12.005; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; MORRISON WR, 1964, J LIPID RES, V5, P600; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; PICQ JL, 2010, NEUROBIOL AGING 1021; Pifferi F, 2007, PROSTAG LEUKOTR ESS, V77, P279, DOI 10.1016/j.plefa.2007.10.011; Pifferi F, 2005, J NUTR, V135, P2241, DOI 10.1093/jn/135.9.2241; Pifferi F, 2010, NEUROCHEM INT, V56, P703, DOI 10.1016/j.neuint.2010.02.006; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ross BM, 2009, PROSTAG LEUKOTR ESS, V81, P309, DOI 10.1016/j.plefa.2009.10.004; Simopoulos AP, 2009, WORLD REV NUTR DIET, V100, P1, DOI 10.1159/000235706; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Transler C, 2010, J ATTEN DISORD, V14, P232, DOI 10.1177/1087054709347250; Tsukada H, 2000, BRAIN RES, V862, P180, DOI 10.1016/S0006-8993(00)02115-6; UMEZAWA M, 1995, BRAIN RES, V669, P225, DOI 10.1016/0006-8993(94)01250-L; Weatherall D., USE NONHUMAN PRIMATE	41	55	55	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20491	10.1371/journal.pone.0020491	http://dx.doi.org/10.1371/journal.pone.0020491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666750	Green Published, gold, Green Submitted			2022-12-25	WOS:000291607000009
J	Campino, S; Auburn, S; Kivinen, K; Zongo, I; Ouedraogo, JB; Mangano, V; Djimde, A; Doumbo, OK; Kiara, SM; Nzila, A; Borrmann, S; Marsh, K; Michon, P; Mueller, I; Siba, P; Jiang, HY; Su, XZ; Amaratunga, C; Socheat, D; Fairhurst, RM; Imwong, M; Anderson, T; Nosten, F; White, NJ; Gwilliam, R; Deloukas, P; MacInnis, B; Newbold, CI; Rockett, K; Clark, TG; Kwiatkowski, DP				Campino, Susana; Auburn, Sarah; Kivinen, Katja; Zongo, Issaka; Ouedraogo, Jean-Bosco; Mangano, Valentina; Djimde, Abdoulaye; Doumbo, Ogobara K.; Kiara, Steven M.; Nzila, Alexis; Borrmann, Steffen; Marsh, Kevin; Michon, Pascal; Mueller, Ivo; Siba, Peter; Jiang, Hongying; Su, Xin-Zhuan; Amaratunga, Chanaki; Socheat, Duong; Fairhurst, Rick M.; Imwong, Mallika; Anderson, Timothy; Nosten, Francois; White, Nicholas J.; Gwilliam, Rhian; Deloukas, Panos; MacInnis, Bronwyn; Newbold, Christopher I.; Rockett, Kirk; Clark, Taane G.; Kwiatkowski, Dominic P.			Population Genetic Analysis of Plasmodium falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; ANTIMALARIAL-DRUG RESISTANCE; MALARIA; GENOME; DIVERSITY; MICROSATELLITE; IDENTIFICATION; SEQUENCE; PCR	The diversity in the Plasmodium falciparum genome can be used to explore parasite population dynamics, with practical applications to malaria control. The ability to identify the geographic origin and trace the migratory patterns of parasites with clinically important phenotypes such as drug resistance is particularly relevant. With increasing single-nucleotide polymorphism (SNP) discovery from ongoing Plasmodium genome sequencing projects, a demand for high SNP and sample throughput genotyping platforms for large-scale population genetic studies is required. Low parasitaemias and multiple clone infections present a number of challenges to genotyping P. falciparum. We addressed some of these issues using a custom 384-SNP Illumina GoldenGate assay on P. falciparum DNA from laboratory clones (long-term cultured adapted parasite clones), short-term cultured parasite isolates and clinical (non-cultured isolates) samples from East and West Africa, Southeast Asia and Oceania. Eighty percent of the SNPs (n = 306) produced reliable genotype calls on samples containing as little as 2 ng of total genomic DNA and on whole genome amplified DNA. Analysis of artificial mixtures of laboratory clones demonstrated high genotype calling specificity and moderate sensitivity to call minor frequency alleles. Clear resolution of geographically distinct populations was demonstrated using Principal Components Analysis (PCA), and global patterns of population genetic diversity were consistent with previous reports. These results validate the utility of the platform in performing population genetic studies of P. falciparum.	[Campino, Susana; Auburn, Sarah; Kivinen, Katja; Gwilliam, Rhian; Deloukas, Panos; MacInnis, Bronwyn; Newbold, Christopher I.; Rockett, Kirk; Clark, Taane G.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton, England; [Auburn, Sarah] Charles Darwin Univ, Menzies Sch Hlth Res, Global Hlth Div, Darwin, NT 0909, Australia; [Zongo, Issaka; Ouedraogo, Jean-Bosco] Inst Rech Sci Sante, Direct Reg Ouest, Bobo Dioulasso, Burkina Faso; [Mangano, Valentina] Univ Roma La Sapienza, Dept Publ Hlth Sci, Sect Parasitol, Rome, Italy; [Djimde, Abdoulaye; Doumbo, Ogobara K.] Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Kiara, Steven M.; Nzila, Alexis; Borrmann, Steffen; Marsh, Kevin] KEMRI Wellcome Trust Res Program, Kilifi, Kenya; [Michon, Pascal; Siba, Peter] Papua New Guinea Inst Med Res, Goroka, Papua N Guinea; [Michon, Pascal; Mueller, Ivo] Divine Word Univ, Fac Hlth Sci, Madang, Papua N Guinea; [Jiang, Hongying; Su, Xin-Zhuan; Amaratunga, Chanaki; Fairhurst, Rick M.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; [Socheat, Duong] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Anderson, Timothy] SW Fdn Biomed Res, San Antonio, TX 78284 USA; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [White, Nicholas J.] Mahidol Oxford Univ, Res Unit, Fac Trop Med, Bangkok, Thailand; [White, Nicholas J.; Newbold, Christopher I.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Rockett, Kirk; Kwiatkowski, Dominic P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Wellcome Trust Sanger Institute; Charles Darwin University; Menzies School of Health Research; Sapienza University Rome; University of Bamako; PNG Institute Of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Center Parasitology, Entomology & Malaria Control; Mahidol University; Mahidol University; Texas Biomedical Research Institute; Mahidol University; Mahidol University; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine	Campino, S (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	sc11@sanger.ac.uk	Mueller, Ivo/C-7251-2013; White, Nicholas J/I-4629-2012; mangano, valentina/I-2456-2012; Nosten, Francois/AAC-5509-2019; Deloukas, Panos/B-2922-2013; Campino, Susana/AAM-2577-2020; Borrmann, Steffen/G-1838-2013; Clark, Taane G./AAM-2570-2020; White, Nick/AAC-6527-2019; Imwong, Mallika/ABE-6493-2020; Auburn, Sarah/N-2266-2013	Mueller, Ivo/0000-0001-6554-6889; Nosten, Francois/0000-0002-7951-0745; Deloukas, Panos/0000-0001-9251-070X; Campino, Susana/0000-0003-1403-6138; Borrmann, Steffen/0000-0001-9189-4393; Clark, Taane G./0000-0001-8985-9265; White, Nick/0000-0002-1897-1978; Newbold, Chris/0000-0002-9274-3789; Kwiatkowski, Dominic/0000-0002-5023-0176; Su, Xinzhuan/0000-0003-3246-3248; Mangano, Valentina D/0000-0002-2021-6162; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Kivinen, Katja/0000-0002-1135-7625; Auburn, Sarah/0000-0002-4638-536X	Bill and Melinda Gates Foundation; Wellcome Trust; Medical Research Council-UK; European Developing Countries Clinical Trials Partnership; Division of Intramural Research of the National Institutes of Health and National Institute of Allergy and Infectious Diseases-USA; National Health and Medical Research Council-Australia; National Malaria Control Program; National Budget of the Institut de Recherche en Sciences de le Sante-Burkina Faso; Howard Hughes Medical Institution International Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001066, ZIAAI001000, R37AI048071] Funding Source: NIH RePORTER; Medical Research Council [G0600718, G19/9] Funding Source: researchfish; MRC [G0600718, G19/9] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council-UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Developing Countries Clinical Trials Partnership; Division of Intramural Research of the National Institutes of Health and National Institute of Allergy and Infectious Diseases-USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Health and Medical Research Council-Australia(National Health and Medical Research Council (NHMRC) of Australia); National Malaria Control Program; National Budget of the Institut de Recherche en Sciences de le Sante-Burkina Faso; Howard Hughes Medical Institution International Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This work was in part funded by the Bill and Melinda Gates Foundation, Wellcome Trust, Medical Research Council-UK, European Developing Countries Clinical Trials Partnership, Division of Intramural Research of the National Institutes of Health and National Institute of Allergy and Infectious Diseases-USA, the National Health and Medical Research Council-Australia, The National Malaria Control Program and the National Budget of the Institut de Recherche en Sciences de le Sante-Burkina Faso. A. A. D. is supported by European and Developing Countries Clinical Trial Partnership Senior Fellowship and Howard Hughes Medical Institution International Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2005, ACTA TROP, V94, P269, DOI 10.1016/j.actatropica.2005.04.010; Bahl A, 2002, NUCLEIC ACIDS RES, V30, P87, DOI 10.1093/nar/30.1.87; Bonizzoni M, 2009, INFECT GENET EVOL, V9, P806, DOI 10.1016/j.meegid.2009.04.015; COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gonzalez JM, 2005, ENVIRON MICROBIOL, V7, P1024, DOI 10.1111/j.1462-2920.2005.00779.x; Iwagami M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-96; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Leclerc MC, 2002, MICROBES INFECT, V4, P685, DOI 10.1016/S1286-4579(02)01587-3; MU J, NAT GENET, V42, P268; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Pumpaibool T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-155; ROSARIO V, 1981, SCIENCE, V212, P1037, DOI 10.1126/science.7015505; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wang Y, 2009, J PARASITOL, V95, P253, DOI 10.1645/GE-1706.1; White NJ, 1998, BRIT MED BULL, V54, P703, DOI 10.1093/oxfordjournals.bmb.a011721; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0	26	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20251	10.1371/journal.pone.0020251	http://dx.doi.org/10.1371/journal.pone.0020251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673999	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000291356400003
J	Ng, TFF; Willner, DL; Lim, YW; Schmieder, R; Chau, B; Nilsson, C; Anthony, S; Ruan, YJ; Rohwer, F; Breitbart, M				Ng, Terry Fei Fan; Willner, Dana L.; Lim, Yan Wei; Schmieder, Robert; Chau, Betty; Nilsson, Christina; Anthony, Simon; Ruan, Yijun; Rohwer, Forest; Breitbart, Mya			Broad Surveys of DNA Viral Diversity Obtained through Viral Metagenomics of Mosquitoes	PLOS ONE			English	Article							CULEX-ERYTHROTHORAX; STOOL SAMPLES; VIRUSES; TRANSMISSION; AMPLIFICATION; BLOOD; DENSOVIRUSES; PARVOVIRUS; COMMUNITY; SELECTION	Viruses are the most abundant and diverse genetic entities on Earth; however, broad surveys of viral diversity are hindered by the lack of a universal assay for viruses and the inability to sample a sufficient number of individual hosts. This study utilized vector-enabled metagenomics (VEM) to provide a snapshot of the diversity of DNA viruses present in three mosquito samples from San Diego, California. The majority of the sequences were novel, suggesting that the viral community in mosquitoes, as well as the animal and plant hosts they feed on, is highly diverse and largely uncharacterized. Each mosquito sample contained a distinct viral community. The mosquito viromes contained sequences related to a broad range of animal, plant, insect and bacterial viruses. Animal viruses identified included anelloviruses, circoviruses, herpesviruses, poxviruses, and papillomaviruses, which mosquitoes may have obtained from vertebrate hosts during blood feeding. Notably, sequences related to human papillomaviruses were identified in one of the mosquito samples. Sequences similar to plant viruses were identified in all mosquito viromes, which were potentially acquired through feeding on plant nectar. Numerous bacteriophages and insect viruses were also detected, including a novel densovirus likely infecting Culex erythrothorax. Through sampling insect vectors, VEM enables broad survey of viral diversity and has significantly increased our knowledge of the DNA viruses present in mosquitoes.	[Ng, Terry Fei Fan; Breitbart, Mya] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Willner, Dana L.; Lim, Yan Wei; Chau, Betty; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Schmieder, Robert] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Lim, Yan Wei; Nilsson, Christina; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Anthony, Simon] San Diego Zoos Inst Conservat Res, Wildlife Dis Labs, San Diego, CA USA	State University System of Florida; University of South Florida; California State University System; San Diego State University; California State University System; San Diego State University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Zoological Society of San Diego	Ng, TFF (corresponding author), Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.	mya@marine.usf.edu	Ng, Terry Fei Fan/H-5305-2019; Breitbart, Mya/B-1366-2009; Rohwer, Forest/AAC-5315-2019	Ng, Terry Fei Fan/0000-0002-4815-8697; Breitbart, Mya/0000-0003-3210-2899; Rohwer, Forest/0000-0003-1548-5429	Canadian Institute for Advanced Research (CIFAR); National Science Foundation [DEB-1025915]; William and Elsie Knight Oceanographic Fellowship	Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); National Science Foundation(National Science Foundation (NSF)); William and Elsie Knight Oceanographic Fellowship	Funding: This work was funded through a grant to FR from the Canadian Institute for Advanced Research (CIFAR) and National Science Foundation grant DEB-1025915 to MB. TFFN was funded by the William and Elsie Knight Oceanographic Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Barreau C, 1997, AM J TROP MED HYG, V57, P126, DOI 10.4269/ajtmh.1997.57.126; Biagini P, 2006, J MED VIROL, V78, P298, DOI 10.1002/jmv.20539; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Blinkova O, 2010, J GEN VIROL, V91, P74, DOI 10.1099/vir.0.015446-0; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; Cheng LP, 2007, SCI CHINA SER C, V50, P70, DOI 10.1007/s11427-007-2036-3; DALMAT HT, 1958, J EXP MED, V108, P9, DOI 10.1084/jem.108.1.9; Davidson I, 2008, VIRUS RES, V137, P1, DOI 10.1016/j.virusres.2008.06.014; Degnan PH, 2008, APPL ENVIRON MICROB, V74, P6782, DOI 10.1128/AEM.01285-08; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107; Hino S, 2007, REV MED VIROL, V17, P45, DOI 10.1002/rmv.524; Huang C, 2001, J VIROL METHODS, V94, P121, DOI 10.1016/S0166-0934(01)00279-8; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2; Leary TP, 1999, J GEN VIROL, V80, P2115, DOI 10.1099/0022-1317-80-8-2115; Li L, 2010, J VIROL, V91, P74; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Lood R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-139; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Ng TFF, 2009, J GEN VIROL, V90, P1256, DOI 10.1099/vir.0.008987-0; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; NG TFF, 2011, PLOS ONE IN PRESS; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; ONEILL SL, 1995, J GEN VIROL, V76, P2067, DOI 10.1099/0022-1317-76-8-2067; Patel A, 2007, NAT PROTOC, V2, P269, DOI 10.1038/nprot.2007.6; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Rosario K, 2009, J GEN VIROL, V90, P2418, DOI 10.1099/vir.0.012955-0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Rwegoshora R. Theophil, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P630; Sambrook J., 2001, MOL CLONING LAB MANU; Schmieder R, 2011, BIOINFORMATICS; Shibata I, 2003, J VET MED SCI, V65, P405, DOI 10.1292/jvms.65.405; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Tietze NS, 2003, J AM MOSQUITO CONTR, V19, P134; Todd D, 2000, AVIAN PATHOL, V29, P373, DOI 10.1080/030794500750047126; van der Wilk F, 1999, VIROLOGY, V262, P104, DOI 10.1006/viro.1999.9902; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Walton WE, 1999, J MED ENTOMOL, V36, P30, DOI 10.1093/jmedent/36.1.30; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107; Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	65	164	166	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20579	10.1371/journal.pone.0020579	http://dx.doi.org/10.1371/journal.pone.0020579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21674005	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400009
J	Terao, C; Ohmura, K; Katayama, M; Takahashi, M; Kokubo, M; Diop, G; Toda, Y; Yamamoto, N; Shinkura, R; Shimizu, M; Gut, I; Heath, S; Melchers, I; Manabe, T; Lathrop, M; Mimori, T; Yamada, R; Matsuda, F				Terao, Chikashi; Ohmura, Koichiro; Katayama, Masaki; Takahashi, Meiko; Kokubo, Miki; Diop, Gora; Toda, Yoshinobu; Yamamoto, Natsuki; Shinkura, Reiko; Shimizu, Masakazu; Gut, Ivo; Heath, Simon; Melchers, Inga; Manabe, Toshiaki; Lathrop, Mark; Mimori, Tsuneyo; Yamada, Ryo; Matsuda, Fumihiko		Human Dis; Rheumatoid Arthritis RA Clinical	Myelin Basic Protein as a Novel Genetic Risk Factor in Rheumatoid Arthritis-A Genome-Wide Study Combined with Immunological Analyses	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; CYCLIC CITRULLINATED PEPTIDE; PADI4 GENE; FUNCTIONAL HAPLOTYPE; MULTIPLE-SCLEROSIS; ASSOCIATION; ANTIBODIES; SUSCEPTIBILITY; PHOSPHATASE; POPULATION	Rheumatoid arthritis (RA) is a major cause of adult chronic inflammatory arthritis and a typical complex trait. Although several genetic determinants have been identified, they account for only a part of the genetic susceptibility. We conducted a genome-wide association study of RA in Japanese using 225,079 SNPs genotyped in 990 cases and 1,236 controls from two independent collections (658 cases and 934 controls in collection1; 332 cases and 302 controls in collection2), followed by replication studies in two additional collections (874 cases and 855 controls in collection3; 1,264 cases and 948 controls in collection4). SNPs showing p<0.005 in the first two collections and p<10(-4) by meta-analysis were further genotyped in the latter two collections. A novel risk variant, rs2000811, in intron2 of the myelin basic protein (MBP) at chromosome 18q23 showed strong association with RA (p = 2.7x10(-8), OR 1.23, 95% CI: 1.14-1.32). The transcription of MBP was significantly elevated with the risk allele compared to the alternative allele (p<0.001). We also established by immunohistochemistry that MBP was expressed in the synovial lining layer of RA patients, the main target of inflammation in the disease. Circulating autoantibody against MBP derived from human brain was quantified by ELISA between patients with RA, other connective tissue diseases and healthy controls. As a result, the titer of anti-MBP antibody was markedly higher in plasma of RA patients compared to healthy controls (p<0.001) and patients with other connective tissue disorders (p<0.001). ELISA experiment using citrullinated recombinant MBP revealed that a large fraction of anti-MBP antibody in RA patients recognized citrullinated MBP. This is the first report of a genetic study in RA implicating MBP as a potential autoantigen and its involvement in pathogenesis of the disease.	[Terao, Chikashi; Takahashi, Meiko; Kokubo, Miki; Diop, Gora; Yamada, Ryo; Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Terao, Chikashi; Ohmura, Koichiro; Katayama, Masaki; Yamamoto, Natsuki; Shimizu, Masakazu; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Global Ctr Excellence COE Program, Kyoto, Japan; [Kokubo, Miki; Matsuda, Fumihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST Program, Kawaguchi, Saitama, Japan; [Toda, Yoshinobu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Kyoto, Japan; [Shinkura, Reiko] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan; [Gut, Ivo; Heath, Simon; Lathrop, Mark] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Melchers, Inga] Univ Med Ctr, Clin Res Unit Rheumatol, Freiburg, Germany; [Manabe, Toshiaki] Kyoto Univ, Grad Sch Med, Lab Diagnost Pathol, Kyoto, Japan; [Lathrop, Mark] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France; [Yamada, Ryo] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Unit Stat Genet, Kyoto, Japan; [Matsuda, Fumihiko] Kyoto Univ, Grad Sch Med, INSERM, Unite U852, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; Kyoto University; Foundation Jean Dausset-CEPH; Kyoto University; Institut National de la Sante et de la Recherche Medicale (Inserm); Kyoto University	Terao, C (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	fumi@genome.med.kyoto-u.ac.jp	Heath, Simon C/J-4138-2012; Matsuda, Fumihiko/B-9893-2009; Gut, Ivo/ABF-3188-2020	Heath, Simon C/0000-0002-9550-0897; Gut, Ivo/0000-0001-7219-632X; Yamada, Ryo/0000-0002-1587-630X; Takahashi, Meiko/0000-0002-8344-5472	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; JSPS; Core Research of Evolutional Science Technology; Solution-Oriented Research for Science and Technology; Japan Science and Technology Agency; MEXT; Ministry of Health, Labour and Welfare in Japan; Institut National de la Sante et de la Recherche Medicale in France; Okawa Foundation for Information and Telecommunications	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research of Evolutional Science Technology; Solution-Oriented Research for Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Institut National de la Sante et de la Recherche Medicale in France; Okawa Foundation for Information and Telecommunications	C.T. is an associate fellow of Global Centers of Excellence program supported by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan (http://www.mext.go.jp/english/). G.D. is a postdoctoral fellow of Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/) and M.A. is a research member of Core University Program supported by JSPS (http://www.jsps.go.jp/english/). The study was supported in part by Core Research of Evolutional Science & Technology (http://www.jst.go.jp/kisoken/crest/en/index.html), Solution-Oriented Research for Science and Technology (http://www.jst.go.jp/kisoken/sorst/en/index.html), Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html), and by grants-in-aid for scientific research from MEXT (http://www.mext.go.jp/english/) and from the Ministry of Health, Labour and Welfare in Japan (http://www.mhlw.go.jp/english/index.html), by the Institut National de la Sante et de la Recherche Medicale in France (http://english.inserm.fr/), and by Okawa Foundation for Information and Telecommunications (http://www.okawa-foundation.or.jp/e/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Boire G, 2005, ARTHRITIS RES THER, V7, pR592, DOI 10.1186/ar1719; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Caponi L, 2005, ANN RHEUM DIS, V64, P587, DOI 10.1136/ard.2004.026831; DEIGHTON CM, 1989, CLIN GENET, V36, P178; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Ikari K, 2005, ARTHRITIS RHEUM, V52, P3054, DOI 10.1002/art.21309; Ioan-Facsinay A, 2011, ANN RHEUM DIS, V70, P188, DOI 10.1136/ard.2010.131102; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kobayashi S, 2008, ARTHRITIS RHEUM, V58, P1940, DOI 10.1002/art.23494; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Lundberg K, 2008, ARTHRITIS RHEUM-US, V58, P3009, DOI 10.1002/art.23936; Lutton JD, 2004, EXP BIOL MED, V229, P12, DOI 10.1177/153537020422900102; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Orozco G, 2005, ARTHRITIS RHEUM-US, V52, P219, DOI 10.1002/art.20771; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Reindl M, 1999, BRAIN, V122, P2047, DOI 10.1093/brain/122.11.2047; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Shimane K, 2009, ANN RHEUM DIS, V68, P377, DOI 10.1136/ard.2007.085704; SIMON M, 1993, J CLIN INVEST, V92, P1387, DOI 10.1172/JCI116713; Skriner K, 2006, ARTHRITIS RHEUM, V54, P3809, DOI 10.1002/art.22276; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2008, NAT GENET, V40, P1224, DOI 10.1038/ng.205; Suzuki T, 2008, CANCER EPIDEM BIOMAR, V17, P2742, DOI 10.1158/1055-9965.EPI-08-0470; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Wheeler DL, 2001, NUCLEIC ACIDS RES, V29, P11, DOI 10.1093/nar/29.1.11	47	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20457	10.1371/journal.pone.0020457	http://dx.doi.org/10.1371/journal.pone.0020457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673997	gold, Green Submitted, Green Published			2022-12-25	WOS:000291355500019
J	Ciaranello, AL; Perez, F; Maruva, M; Chu, J; Engelsmann, B; Keatinge, J; Walensky, RP; Mushavi, A; Mugwagwa, R; Dabis, F; Freedberg, KA				Ciaranello, Andrea L.; Perez, Freddy; Maruva, Matthews; Chu, Jennifer; Engelsmann, Barbara; Keatinge, Jo; Walensky, Rochelle P.; Mushavi, Angela; Mugwagwa, Rumbidzai; Dabis, Francois; Freedberg, Kenneth A.		CEPAC Int Investigators	WHO 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe: Modeling Clinical Outcomes in Infants and Mothers	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; ANTIRETROVIRAL THERAPY PROGRAMS; TREATMENT INTERRUPTION STRATEGY; DAR-ES-SALAAM; COST-EFFECTIVENESS; SOUTH-AFRICA; PREGNANT-WOMEN; FOLLOW-UP; RANDOMIZED-TRIAL; ZIDOVUDINE	Background: The Zimbabwean national prevention of mother-to-child HIV transmission (PMTCT) program provided primarily single-dose nevirapine (sdNVP) from 2002-2009 and is currently replacing sdNVP with more effective antiretroviral (ARV) regimens. Methods: Published HIV and PMTCT models, with local trial and programmatic data, were used to simulate a cohort of HIV-infected, pregnant/breastfeeding women in Zimbabwe (mean age 24.0 years, mean CD4 451 cells/mu L). We compared five PMTCT regimens at a fixed level of PMTCT medication uptake: 1) no antenatal ARVs (comparator); 2) sdNVP; 3) WHO 2010 guidelines using "Option A" (zidovudine during pregnancy/infant NVP during breastfeeding for women without advanced HIV disease; lifelong 3-drug antiretroviral therapy (ART) for women with advanced disease); 4) WHO "Option B" (ART during pregnancy/breastfeeding without advanced disease; lifelong ART with advanced disease); and 5) "Option B+:" lifelong ART for all pregnant/breastfeeding, HIV-infected women. Pediatric (4-6 week and 18-month infection risk, 2-year survival) and maternal (2-and 5-year survival, life expectancy from delivery) outcomes were projected. Results: Eighteen-month pediatric infection risks ranged from 25.8% (no antenatal ARVs) to 10.9% (Options B/B+). Although maternal short-term outcomes (2-and 5-year survival) varied only slightly by regimen, maternal life expectancy was reduced after receipt of sdNVP (13.8 years) or Option B (13.9 years) compared to no antenatal ARVs (14.0 years), Option A (14.0 years), or Option B+ (14.5 years). Conclusions: Replacement of sdNVP with currently recommended regimens for PMTCT (WHO Options A, B, or B+) is necessary to reduce infant HIV infection risk in Zimbabwe. The planned transition to Option A may also improve both pediatric and maternal outcomes.	[Ciaranello, Andrea L.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Perez, Freddy; Dabis, Francois] Univ Bordeaux 2, INSERM, U897, Africa Team,ISPED, F-33076 Bordeaux, France; [Perez, Freddy] Pan Amer Hlth Org, HIV AIDS Unit, Washington, DC USA; [Maruva, Matthews; Keatinge, Jo] Elizabeth Glaser Pediat AIDS Fdn Zimbabwe Cty Off, Harare, Zimbabwe; [Chu, Jennifer; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Engelsmann, Barbara] Org Publ Hlth Intervent & Dev OPHID Trust, Harare, Zimbabwe; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Mushavi, Angela; Mugwagwa, Rumbidzai] Minist Hlth & Child Welf, Harare, Zimbabwe	Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Pan American Health Organization; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ciaranello, AL (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	aciaranello@partners.org	Perez, Freddy/AAN-3893-2020; Anglaret, Xavier/F-7333-2013; , Andrea/ABB-3330-2021; DABIS, FRANCOIS/S-9298-2019	, Andrea/0000-0002-4268-3263; DABIS, FRANCOIS/0000-0002-1614-8857; Lipsitch, Marc/0000-0003-1504-9213; , International Journal of Business and Applied Social Science/0000-0001-7850-0193; Perez, Freddy/0000-0003-2001-0057; Anglaret, Xavier/0000-0003-3319-8423; Walensky, Rochelle P./0000-0002-8795-379X	Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Disease [K01 AI078754, K24 AI062476, R01 AI058736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI078754, UM1AI068632, K24AI062476, U01AI068632, R01AI058736] Funding Source: NIH RePORTER	Elizabeth Glaser Pediatric AIDS Foundation; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the Elizabeth Glaser Pediatric AIDS Foundation (all authors) and the National Institute of Allergy and Infectious Disease (K01 AI078754 (ALC), K24 AI062476 (KAF), and R01 AI058736 (KAF, RPW, RW, JC)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Arrive E, 2008, JAIDS-J ACQ IMM DEF, V49, P523, DOI 10.1097/QAI.0b013e31818aadce; Barker PM, 2010, J ACQ IMMUN DEF SYND, V56, pe45; Beigi RH, 2009, CLIN INFECT DIS, V49, P1784, DOI 10.1086/649013; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Carter RJ, 2010, JAIDS-J ACQ IMM DEF, V55, P404, DOI 10.1097/QAI.0b013e3181e73f4b; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Chigwedere P, 2008, AIDS RES HUM RETROV, V24, P827, DOI 10.1089/aid.2007.0291; Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe; Ciaranello AL, 2008, AIDS, V22, P2359, DOI 10.1097/QAD.0b013e3283189bd7; Cleary S, 2005, HLTH SYSTEMS TRUST S; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Dabis F, 2005, AIDS, V19, P309; Danel C, 2006, LANCET, V367, P1981, DOI 10.1016/S0140-6736(06)68887-9; de Vincenzi I, 2010, JAIDS-J ACQ IMM DEF, V54, P533, DOI 10.1097/QAI.0b013e3181e36634; DEVINCENZI I, 2009, KENY 5 IAS C HIV PAT; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; ENGELSMANN B, 2008, MOPE0521 ENHANCING U, P174; Fassinou P, 2004, AIDS, V18, P1905, DOI 10.1097/00002030-200409240-00006; Fawzi W, 2002, JAIDS-J ACQ IMM DEF, V31, P331, DOI 10.1097/00126334-200211010-00010; Fawzi WW, 2002, AIDS, V16, P1935, DOI 10.1097/00002030-200209270-00011; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Johri Mira, 2011, Cost Eff Resour Alloc, V9, P3, DOI 10.1186/1478-7547-9-3; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; *KESH BOR STUD GRO, 2011, LANCET INFECT DIS; *KESH BOR STUD GRO, 2010, THLBB105 IMP TRIPL A; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kuhn L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001363; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Kuhn L, 2010, AIDS, V24, P1374, DOI 10.1097/QAD.0b013e3283394f5b; Kuhn L, 2009, JAIDS-J ACQ IMM DEF, V52, P132, DOI 10.1097/QAI.0b013e3181ab6d5e; KUMWENDA J, 2009, WEPDD106 COVERAGE HI; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 1998, LANCET, V352, P597, DOI 10.1016/S0140-6736(98)01419-6; Leroy V, 2002, AIDS, V16, P631, DOI 10.1097/00002030-200203080-00016; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; MARAZZI MC, 2009, 5 IAS C HIV PATH TRE; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; MARSTON M, 2011, INT J EPIDEMIOL; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MEYERRATH G, 2010, THLBB103 COST EARLY; MOFENSON L, 2009, TUPEC053 INFANT EXTE; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; *NAT I HLTH IMPAAC, 2010, P1077 PROMISE STUD P; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Palombi L, 2007, AIDS, V21, pS65, DOI 10.1097/01.aids.0000279708.09180.f5; Peltier CA, 2009, AIDS, V23, P2415, DOI 10.1097/QAD.0b013e32832ec20d; Perez F, 2004, BRIT MED J, V329, P1147, DOI 10.1136/bmj.329.7475.1147; Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3; Saba J, 2002, LANCET, V359, P1178; SCHOUTEN E, 2010, MAKING IT HAPPEN REV; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Soorapanth S, 2006, JAIDS-J ACQ IMM DEF, V42, P213, DOI 10.1097/01.qai.0000214812.72916.bc; Stinson K, 2010, TROP MED INT HEALTH, V15, P825, DOI 10.1111/j.1365-3156.2010.02538.x; Stringer JSA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000233; Sutcliffe CG, 2008, LANCET INFECT DIS, V8, P477, DOI 10.1016/S1473-3099(08)70180-4; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thistle P, 2004, Cent Afr J Med, V50, P79; Thistle P, 2007, CLIN INFECT DIS, V44, P111, DOI 10.1086/508869; THOMAS T, 2008, 45ALB PREVENTION MOT; Toro PL, 2010, AIDS, V24, P515, DOI 10.1097/QAD.0b013e3283350ecd; *UNAIDS UNICEF WHO, 2009, CHILDR AIDS 4 STOCKT; United Nations, 2009, WORLD POP PROSP 2008; VYANKANDONDERA J, 2003, N LB7 REDUCING RISK; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; WHO, 2006, ANT DRUGS TREAT PREG; World Bank, 2009, DAT STAT COUNTR CLAS; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43; *ZIMB MIN HLTH, 2009, NAT HIV EST 2009; *ZIMB MIN HLTH CHI, 2008, MAT PER MORT STUD 20; *ZIMB MIN HLTH CHI, 2009, NATL DRUG THER POL A	89	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20224	10.1371/journal.pone.0020224	http://dx.doi.org/10.1371/journal.pone.0020224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655097	Green Submitted, gold, Green Published			2022-12-25	WOS:000291310600006
J	Lo, KA; Bauchmann, MK; Baumann, AP; Donahue, CJ; Thiede, MA; Hayes, LS; des Etages, SAG; Fraenkel, E				Lo, Kinyui Alice; Bauchmann, Mary K.; Baumann, Amy P.; Donahue, Christopher J.; Thiede, Mark A.; Hayes, Lisa S.; des Etages, Shelley Ann G.; Fraenkel, Ernest			Genome-Wide Profiling of H3K56 Acetylation and Transcription Factor Binding Sites in Human Adipocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; LARGE GENE LISTS; HEPATIC GLUCONEOGENESIS; HUMAN ADIPOGENESIS; PPAR-GAMMA; HISTONE H3; LYSINE 56; EXPRESSION; SIRT1; METFORMIN	The growing epidemic of obesity and metabolic diseases calls for a better understanding of adipocyte biology. The regulation of transcription in adipocytes is particularly important, as it is a target for several therapeutic approaches. Transcriptional outcomes are influenced by both histone modifications and transcription factor binding. Although the epigenetic states and binding sites of several important transcription factors have been profiled in the mouse 3T3-L1 cell line, such data are lacking in human adipocytes. In this study, we identified H3K56 acetylation sites in human adipocytes derived from mesenchymal stem cells. H3K56 is acetylated by CBP and p300, and deacetylated by SIRT1, all are proteins with important roles in diabetes and insulin signaling. We found that while almost half of the genome shows signs of H3K56 acetylation, the highest level of H3K56 acetylation is associated with transcription factors and proteins in the adipokine signaling and Type II Diabetes pathways. In order to discover the transcription factors that recruit acetyltransferases and deacetylases to sites of H3K56 acetylation, we analyzed DNA sequences near H3K56 acetylated regions and found that the E2F recognition sequence was enriched. Using chromatin immunoprecipitation followed by high-throughput sequencing, we confirmed that genes bound by E2F4, as well as those by HSF-1 and C/EBP alpha, have higher than expected levels of H3K56 acetylation, and that the transcription factor binding sites and acetylation sites are often adjacent but rarely overlap. We also discovered a significant difference between bound targets of C/EBP alpha in 3T3-L1 and human adipocytes, highlighting the need to construct species-specific epigenetic and transcription factor binding site maps. This is the first genome-wide profile of H3K56 acetylation, E2F4, C/EBP alpha and HSF-1 binding in human adipocytes, and will serve as an important resource for better understanding adipocyte transcriptional regulation.	[Lo, Kinyui Alice; Fraenkel, Ernest] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Fraenkel, Ernest] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Bauchmann, Mary K.; Baumann, Amy P.; Donahue, Christopher J.; Thiede, Mark A.] Pfizer Global Res & Dev, Genetically Modified Models Res Ctr Emphasis, Groton, CT USA; [Hayes, Lisa S.; des Etages, Shelley Ann G.] Pfizer Global Res & Dev, Cardiovasc, Metab & Endocrine Dis, Groton, CT USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Pfizer; Pfizer	Lo, KA (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	fraenkel-admin@mit.edu		Fraenkel, Ernest/0000-0001-9249-8181	Agency of Science, Technology and Research, Singapore; Eugene Bell Career Development Chair; National Science Foundation [DBI-0821391]; Pfizer Inc.	Agency of Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Eugene Bell Career Development Chair; National Science Foundation(National Science Foundation (NSF)); Pfizer Inc.(Pfizer)	K.A.L is supported by the National Science Scholarship from Agency of Science, Technology and Research, Singapore. E. F. is the recipient of the Eugene Bell Career Development Chair. This work used computing resources funded by the National Science Foundation under Award No. DBI-0821391. This research was funded by Pfizer Inc., and the co-authors who are Pfizer employees were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Butcher NJ, 2010, CARCINOGENESIS, V31, P820, DOI 10.1093/carcin/bgq042; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Conboy CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001061; Cowherd RM, 1997, BIOCHEM BIOPH RES CO, V237, P470, DOI 10.1006/bbrc.1997.7160; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Dutta D, 2010, J BIOL CHEM, V285, P41567, DOI 10.1074/jbc.M110.190025; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; MacIsaac KD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000773; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swart GWM, 1997, BIOL CHEM, V378, P373, DOI 10.1515/bchm.1997.378.5.373; Thomas PD, 2007, CURR OPIN CHEM BIOL, V11, P4, DOI 10.1016/j.cbpa.2006.11.039; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829	31	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e19778	10.1371/journal.pone.0019778	http://dx.doi.org/10.1371/journal.pone.0019778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655096	Green Submitted, Green Published, gold			2022-12-25	WOS:000291310600004
J	Lin, MJ; Cheng, CW; Shen, CKJ				Lin, Meng-Jau; Cheng, Ching-Wei; Shen, C. -K. James			Neuronal Function and Dysfunction of Drosophila dTDP	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; BINDING-PROPERTIES; ACID BINDING; PROTEIN; MICE; FTLD; ALS; INCLUSIONS	Background: TDP-43 is an RNA-and DNA-binding protein well conserved in animals including the mammals, Drosophila, and C. elegans. In mammals, the multi-function TDP-43 encoded by the TARDBP gene is a signature protein of the ubiquitin-positive inclusions (UBIs) in the diseased neuronal/glial cells of a range of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-U). Methodology/Principal Findings: We have studied the function and dysfunction of the Drosophila ortholog of the mammalian TARDBP gene, dTDP, by genetic, behavioral, molecular, and cytological analyses. It was found that depletion of dTDP expression caused locomotion defect accompanied with an increase of the number of boutons at the neuromuscular junctions (NMJ). These phenotypes could be rescued by overexpression of Drosophila dTDP in the motor neurons. In contrast, overexpression of dTDP in the motor neurons also resulted in reduced larval and adult locomotor activities, but this was accompanied by a decrease of the number of boutons and axon branches at NMJ. Significantly, constitutive overexpression of dTDP in the mushroom bodies caused smaller axonal lobes as well as severe learning deficiency. On the other hand, constitutive mushroom body-specific knockdown of dTDP expression did not affect the structure of the mushroom bodies, but it impaired the learning ability of the flies, albeit moderately. Overexpression of dTDP also led to the formation of cytosolic dTDP (+) aggregates. Conclusion/Significance: These data together demonstrate the neuronal functions of dTDP, and by implication the mammalian TDP-43, in learning and locomotion. The effects of mis-expression of dTDP on Drosophila NMJ suggest that eukaryotic TDP-43 guards against over development of the synapses. The conservation of the regulatory pathways of functions and dysfunctions of Drosophila dTDP and mammalian TDP-43 also shows the feasibility of using the flies as a model system for studying the normal TDP-43 function and TDP-43 proteinopathies in the vertebrates including human.	[Lin, Meng-Jau; Cheng, Ching-Wei; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Cheng, Ching-Wei; Shen, C. -K. James] Natl Taiwan Univ, Inst Mol Med, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Lin, MJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	ckshen@imb.sinica.edu.tw	shen, Che-Kun James/L-1343-2015		Academia Sinica (AS); National Science Council, Taipei, ROC	Academia Sinica (AS)(Academia Sinica - Taiwan); National Science Council, Taipei, ROC(Ministry of Science and Technology, Taiwan)	This research was supported by the Academia Sinica (AS) and National Science Council, Taipei, ROC. M. -J. Lin was a NSC postdoctoral fellow and C. -K. J. Shen is an AS Investigator Awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kasai T, 2009, ACTA NEUROPATHOL, V117, P55, DOI 10.1007/s00401-008-0456-1; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lee T, 1999, DEVELOPMENT, V126, P4065; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	39	53	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20371	10.1371/journal.pone.0020371	http://dx.doi.org/10.1371/journal.pone.0020371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673800	Green Published, Green Submitted, gold			2022-12-25	WOS:000291309900015
J	Kusters, I; Mukherjee, N; de Jong, MR; Tans, S; Kocer, A; Driessen, AJM				Kusters, Ilja; Mukherjee, Nobina; de Jong, Menno R.; Tans, Sander; Kocer, Armagan; Driessen, Arnold J. M.			Taming Membranes: Functional Immobilization of Biological Membranes in Hydrogels	PLOS ONE			English	Article							FLUORESCENCE-BURST ANALYSIS; MECHANOSENSITIVE CHANNEL MSCL; PREPROTEIN TRANSLOCATION; PROTEIN TRANSLOCATION; SUPPORTED MEMBRANES; CATALYTIC CYCLE; LIPID-BILAYERS; RECONSTITUTION; PORE; EVENTS	Single molecule studies on membrane proteins embedded in their native environment are hampered by the intrinsic difficulty of immobilizing elastic and sensitive biological membranes without interfering with protein activity. Here, we present hydrogels composed of nano-scaled fibers as a generally applicable tool to immobilize biological membrane vesicles of various size and lipid composition. Importantly, membrane proteins immobilized in the hydrogel as well as soluble proteins are fully active. The triggered opening of the mechanosensitive channel of large conductance (MscL) reconstituted in giant unilamellar vesicles (GUVs) was followed in time on single GUVs. Thus, kinetic studies of vectorial transport processes across biological membranes can be assessed on single, hydrogel immobilized, GUVs. Furthermore, protein translocation activity by the membrane embedded protein conducting channel of bacteria, SecYEG, in association with the soluble motor protein SecA was quantitatively assessed in bulk and at the single vesicle level in the hydrogel. This technique provides a new way to investigate membrane proteins in their native environment at the single molecule level by means of fluorescence microscopy.	[Kusters, Ilja; Driessen, Arnold J. M.] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Ag Groningen, Netherlands; [Kusters, Ilja; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Ag Groningen, Netherlands; [Mukherjee, Nobina; Kocer, Armagan] Univ Groningen, Dept Membrane Enzymol, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [de Jong, Menno R.] BiOMaDe Technol Fdn, Groningen, Netherlands; [Tans, Sander] AMOLF Inst, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; AMOLF	Driessen, AJM (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Ag Groningen, Netherlands.	a.j.m.driessen@rug.nl	Tans, Sander/AAS-2901-2020; Kusters, Ilja/A-3256-2012; Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012; Kusters, Ilja/J-3492-2019; Kocer, A/M-6371-2013	Kusters, Ilja/0000-0003-3739-8764; Mukherjee, Nobina/0000-0003-4655-2188; kocer, Armagan/0000-0001-7343-3139; Driessen, Arnold J.M./0000-0001-9258-9104	NanoNed; MEDITRANS; NWO VIDI; ERC	NanoNed; MEDITRANS; NWO VIDI(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission)	This work was funded by NanoNed (IK, MDJ, AJMD), a national nanotechnology program coordinated by the Dutch Ministry of Economical Affairs and the Zernike Institute for Advanced Materials (IK, AJMD), and by the Chemical Sciences division of The Netherlands Organization for Scientific Research (NWO-CW; IK, AJMD). Further, this project was supported by MEDITRANS Sixth Framework Programme (AK,NM), NWO VIDI (AK), ERC-Starting grant (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; Brizard A, 2008, ANGEW CHEM INT EDIT, V47, P2063, DOI 10.1002/anie.200704609; DEVILLE K, 2010, J BIOL CHEM; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dudia A, 2008, NANO LETT, V8, P1105, DOI 10.1021/nl073211b; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; Hamai C, 2007, BIOPHYS J, V92, P1988, DOI 10.1529/biophysj.106.093831; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Kocer A, 2007, NAT PROTOC, V2, P1426, DOI 10.1038/nprot.2007.196; Kusters I, 2010, METHODS MOL BIOL, V619, P131, DOI 10.1007/978-1-60327-412-8_8; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Meleard P, 2009, METHOD ENZYMOL, V465, P161, DOI 10.1016/S0076-6879(09)65009-6; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Sackmann E, 2000, TRENDS BIOTECHNOL, V18, P58, DOI 10.1016/S0167-7799(99)01412-2; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; TAMM LK, 1985, BIOPHYS J, V47, P105, DOI 10.1016/S0006-3495(85)83882-0; Toprak E, 2007, ANNU REV BIOPH BIOM, V36, P349, DOI 10.1146/annurev.biophys.36.040306.132700; van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; van den Bogaart G, 2008, METHODS, V46, P123, DOI 10.1016/j.ymeth.2008.06.016; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9	29	16	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20435	10.1371/journal.pone.0020435	http://dx.doi.org/10.1371/journal.pone.0020435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655266	Green Published, gold			2022-12-25	WOS:000291097600068
J	Stindt, J; Ellinger, P; Stross, C; Keitel, V; Haussinger, D; Smits, SHJ; Kubitz, R; Schmitt, L				Stindt, Jan; Ellinger, Philipp; Stross, Claudia; Keitel, Verena; Haeussinger, Dieter; Smits, Sander H. J.; Kubitz, Ralf; Schmitt, Lutz			Heterologous Overexpression and Mutagenesis of the Human Bile Salt Export Pump (ABCB11) Using DREAM (Directed REcombination-Assisted Mutagenesis)	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; YEAST SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; PLASMID CONSTRUCTION; PICHIA-PASTORIS; P-GLYCOPROTEIN; TRANSPORTER; PURIFICATION; DNA; TRANSFORMATION	Homologous recombination in Saccharomyces cerevisiae is a well-studied process. Here, we describe a yeast-recombination-based approach to construct and mutate plasmids containing the cDNA of the human bile salt export pump (BSEP) that has been shown to be unstable in E. coli. Using this approach, we constructed the necessary plasmids for a heterologous overexpression of BSEP in the yeast Pichia pastoris. We then applied a new site-directed mutagenesis method, DREAM (Directed REcombination-Assisted Mutagenesis) that completely bypasses E. coli by using S. cerevisiae as the plasmid host with high mutagenesis efficiency. Finally, we show how to apply this strategy to unstable non-yeast plasmids by rapidly turning an existing mammalian BSEP expression construct into a S. cerevisiae-compatible plasmid and analyzing the impact of a BSEP mutation in several mammalian cell lines.	[Stindt, Jan; Ellinger, Philipp; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-4000 Dusseldorf, Germany; [Stross, Claudia; Keitel, Verena; Haeussinger, Dieter; Kubitz, Ralf] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Stindt, J (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-4000 Dusseldorf, Germany.	lutz.schmitt@hhu.de	Keitel, Verena/AAH-9016-2021; Keitel, Verena/AAF-3471-2019	Keitel, Verena/0000-0003-1383-7662; Stindt, Jan/0000-0002-8760-1989	 [SFB 575];  [A9];  [KFO 217]	; ; 	This work was supported by the SFB 575 "Experimental hepatology" (project A9 to L. S.) and the KFO 217 "Hepatobiliary transport and liver diseases" (project TP1 to R. K. and TP3 to L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG TECHN INC, QUIKCHANGE 2 40 SIT; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Braman J, 1996, Methods Mol Biol, V57, P31; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Byrne JA, 2009, HEPATOLOGY, V49, P553, DOI 10.1002/hep.22683; Chloupkova M, 2007, BIOCHEMISTRY-US, V46, P7992, DOI 10.1021/bi700020m; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; EVANS GL, 1995, J BIOENERG BIOMEMBR, V27, P43, DOI 10.1007/BF02110330; FEHER Z, 1983, NATURE, V302, P266, DOI 10.1038/302266a0; Figler RA, 2000, ARCH BIOCHEM BIOPHYS, V376, P34, DOI 10.1006/abbi.2000.1712; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; HATTMAN S, 1978, J BACTERIOL, V135, P1156, DOI 10.1128/JB.135.3.1156-1157.1978; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaiser C., 1994, METHODS YEAST GENETI; Keitel V, 2005, HEPATOLOGY, V41, P1160, DOI 10.1002/hep.20682; Keitel V, 2009, HEPATOLOGY, V50, P510, DOI 10.1002/hep.23083; KUCHLER K, 1992, P NATL ACAD SCI USA, V89, P2302, DOI 10.1073/pnas.89.6.2302; Lee SH, 2003, BIOCHEM BIOPH RES CO, V306, P644, DOI 10.1016/S0006-291X(03)01029-5; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Mamnun YM, 2004, FEBS LETT, V559, P111, DOI 10.1016/S0014-5793(04)00046-8; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; PROFFITT JH, 1984, MOL CELL BIOL, V4, P985, DOI 10.1128/MCB.4.5.985; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Singh MV, 2002, ANAL BIOCHEM, V307, P13, DOI 10.1016/S0003-2697(02)00018-0; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; Tate CG, 2001, FEBS LETT, V504, P94, DOI 10.1016/S0014-5793(01)02711-9; Urbatsch IL, 2001, ARCH BIOCHEM BIOPHYS, V388, P171, DOI 10.1006/abbi.2001.2299; Vu K, 2009, ANAL BIOCHEM, V393, P234, DOI 10.1016/j.ab.2009.06.039; Wang ZL, 2006, BIOCHEMISTRY-US, V45, P9929, DOI 10.1021/bi0608055	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20562	10.1371/journal.pone.0020562	http://dx.doi.org/10.1371/journal.pone.0020562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655228	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600098
J	Carnevali, O; Gioacchini, G; Maradonna, F; Olivotto, I; Migliarini, B				Carnevali, Oliana; Gioacchini, Giorgia; Maradonna, Francesca; Olivotto, Ike; Migliarini, Beatrice			Melatonin Induces Follicle Maturation in Danio rerio	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-15; OOCYTE MATURATION; FOLLISTATIN EXPRESSION; LUTEINIZING-HORMONE; ZEBRAFISH OVARY; POTENTIAL ROLE; PHOTOPERIOD; SYSTEM; IDENTIFICATION; MECHANISMS	Most organisms modulate their reproductive activity responding to day length by the nocturnal release of melatonin by the pineal gland. This hormone is also responsible for synchronizing reproduction with specific external environment stimuli in order to optimize reproductive success. The aim of this study was to establish the effect of melatonin on zebrafish reproduction. Adult females were daily exposed, via water, to two different doses (100 nM and 1 mu M) of melatonin. Melatonin led to an increase of the Gonado Somatic Index (GSI) associated with the increase of eggs production, and the raise of gene and protein levels of vitellogenin (VTG) and estradiol receptor alpha (ER alpha) in the liver. The ability of melatonin to increase fecundity was consistent with a significant increase of gene transcription of kiss 1, kiss 2, gnrh3, in the brain, and lh in the pituitary, while in the ovary (in class IIIB follicles), with a significant decrease of two genes codifying for intra-ovarian regulators of premature oocyte maturation, the tgf beta 1 and the bmp15. The reduction in the expression of these two genes was concomitant with the increase of lhr and a modulation of mpr alpha and mpr beta gene transcription, whose proteins are involved in oocyte maturation. Melatonin also exerted a direct action on follicles as shown by the increase of the oocytes undergoing to germinal vesicle break down (GVBD) and modulated mpr alpha and beta gene expression in the in vitro exposure. These data highlight the effects of melatonin in promoting zebrafish reproduction exerting its effects either in the brain-pituitary and in the gonads.	[Carnevali, Oliana; Gioacchini, Giorgia; Maradonna, Francesca; Olivotto, Ike; Migliarini, Beatrice] Univ Politecn Marche, Dipartimento Sci Mare, Ancona, Italy; [Carnevali, Oliana] Ist Nazl Biostrutture & Biosistemi, Rome, Italy	Marche Polytechnic University	Carnevali, O (corresponding author), Univ Politecn Marche, Dipartimento Sci Mare, Ancona, Italy.	o.carnevali@univpm.it	Maradonna, Francesca/AAU-3017-2021; Carnevali, Oliana/P-2751-2015; Gioacchini, Giorgia/AAU-3581-2021; Maradonna, Francesca/AAU-5167-2021; Olivotto, Ike/K-9397-2014	Carnevali, Oliana/0000-0001-5994-0572; Maradonna, Francesca/0000-0001-6677-1017; Olivotto, Ike/0000-0002-0906-4225; Gioacchini, Giorgia/0000-0003-1187-7302	Fondi di Ateneo	Fondi di Ateneo	This work was financially supported by Fondi di Ateneo 2009 to Oliana Carnevali. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens I, 2006, TOXICOLOGY, V228, P333, DOI 10.1016/j.tox.2006.09.018; Ansel L, 2010, J BIOL RHYTHM, V25, P81, DOI 10.1177/0748730410361918; Barrett P, 2003, J PINEAL RES, V35, P221, DOI 10.1034/j.1600-079X.2003.00090.x; BARTNESS TJ, 1993, J PINEAL RES, V15, P161; Bayarri MJ, 2004, GEN COMP ENDOCR, V136, P72, DOI 10.1016/j.ygcen.2003.12.004; Biran J, 2008, BIOL REPROD, V79, P776, DOI 10.1095/biolreprod.107.066266; Blanco-Vives B, 2009, PHYSIOL BEHAV, V98, P268, DOI 10.1016/j.physbeh.2009.05.015; Bromage N, 2001, AQUACULTURE, V197, P63, DOI 10.1016/S0044-8486(01)00583-X; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Carnevali O, 2010, J APPL ICHTHYOL, V26, P826, DOI 10.1111/j.1439-0426.2010.01549.x; Carnevali O, 2009, J MOL STRUCT, V938, P207, DOI 10.1016/j.molstruc.2009.09.029; CARTER DS, 1983, ENDOCRINOLOGY, V113, P1261, DOI 10.1210/endo-113-4-1261; Chalivoix S, 2010, J NEUROENDOCRINOL, V22, P110, DOI 10.1111/j.1365-2826.2009.01939.x; Chattoraj A, 2005, GEN COMP ENDOCR, V140, P145, DOI 10.1016/j.ygcen.2004.10.013; Chattoraj A, 2008, COMP BIOCHEM PHYS A, V150, P301, DOI 10.1016/j.cbpa.2008.03.014; Chattoraj A, 2009, COMP BIOCHEM PHYS A, V152, P327, DOI 10.1016/j.cbpa.2008.11.010; Chen YJ, 2008, ENDOCRINOLOGY, V149, P4658, DOI 10.1210/en.2008-0063; Clelland E, 2006, ENDOCRINOLOGY, V147, P201, DOI 10.1210/en.2005-1017; Clelland ES, 2007, ENDOCRINOLOGY, V148, P5451, DOI 10.1210/en.2007-0674; Coon SL, 1998, BIOL CELL, V90, P399, DOI 10.1016/S0248-4900(98)80089-0; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; FALCO NJ, 2006, TRENDS ENDOCRIN MET, V181, P81; Falcon J, 2010, GEN COMP ENDOCR, V165, P469, DOI 10.1016/j.ygcen.2009.04.026; Falcon Jack, 2007, Journal de la Societe de Biologie, V201, P21, DOI 10.1051/jbio:2007003; Filby AL, 2008, BIOL REPROD, V78, P278, DOI 10.1095/biolreprod.107.063420; Giorgini E, 2010, ANAL BIOANAL CHEM, V398, P3063, DOI 10.1007/s00216-010-4234-2; Goldman BD, 2001, J BIOL RHYTHM, V16, P283, DOI 10.1177/074873001129001980; Goodman RL, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2389; Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001; Keen KL, 2008, ENDOCRINOLOGY, V149, P4151, DOI 10.1210/en.2008-0231; Khan IA, 1996, GEN COMP ENDOCR, V104, P231, DOI 10.1006/gcen.1996.0166; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Kohli G, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-53; Kulczykowska E, 1998, EXP PHYSIOL, V83, P809, DOI 10.1113/expphysiol.1998.sp004161; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lopez LC, 2006, INT J BIOCHEM CELL B, V38, P267, DOI 10.1016/j.biocel.2005.09.008; Maradonna F, 2007, BIOMARKERS, V12, P240, DOI 10.1080/13547500601070859; Mazurais D, 2000, GEN COMP ENDOCR, V118, P344, DOI 10.1006/gcen.2000.7472; Moschos S, 2002, FERTIL STERIL, V77, P433, DOI 10.1016/S0015-0282(01)03010-2; Nakamura Y, 2003, FERTIL STERIL, V80, P1012, DOI 10.1016/S0015-0282(03)01008-2; Palter SF, 2001, ENDOCR REV, V22, P389, DOI 10.1210/er.22.3.389; Pang YF, 2002, ENDOCRINOLOGY, V143, P47, DOI 10.1210/en.143.1.47; Parhar IS, 2004, ENDOCRINOLOGY, V145, P3613, DOI 10.1210/en.2004-0395; Patino R, 2001, COMP BIOCHEM PHYS B, V129, P427, DOI 10.1016/S1096-4959(01)00344-X; Peng C, 2009, COMP BIOCHEM PHYS A, V153, P83, DOI 10.1016/j.cbpa.2008.09.034; Piccinetti CC, 2010, HORM BEHAV, V58, P780, DOI 10.1016/j.yhbeh.2010.07.013; POPEK W, 2005, ICHTHYOL PISCATOR, V35, P65; Prendergast BJ, 2005, HORM BEHAV, V48, P503, DOI 10.1016/j.yhbeh.2005.05.013; Renuka K, 2010, GEN COMP ENDOCR, V165, P42, DOI 10.1016/j.ygcen.2009.05.020; Sebert ME, 2008, J NEUROENDOCRINOL, V20, P917, DOI 10.1111/j.1365-2826.2008.01744.x; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Takasaki Akihisa, 2003, Reprod Med Biol, V2, P139, DOI 10.1111/j.1447-0578.2003.00035.x; Tamura H, 2009, FERTIL STERIL, V92, P328, DOI 10.1016/j.fertnstert.2008.05.016; Tena-Sempere M, 2006, CURR OPIN PEDIATR, V18, P442, DOI 10.1097/01.mop.0000236396.79580.cc; Thomas P, 2004, STEROIDS, V69, P567, DOI 10.1016/j.steroids.2004.05.004; van Aerle R, 2008, PEPTIDES, V29, P57, DOI 10.1016/j.peptides.2007.10.018; WALLACE RA, 1985, DEV BIOL, V110, P492, DOI 10.1016/0012-1606(85)90106-X; Wang Y, 2004, BIOL REPROD, V71, P2056, DOI 10.1095/biolreprod.104.032649; Wang YJ, 2003, GEN COMP ENDOCR, V134, P308, DOI 10.1016/S0016-6480(03)00275-2; Woo MMM, 2001, J CLIN ENDOCR METAB, V86, P4789, DOI 10.1210/jc.86.10.4789; Wu J, 2000, BIOL REPROD, V63, P320, DOI 10.1095/biolreprod63.1.320; YIE SM, 1995, J CLIN ENDOCR METAB, V80, P1747, DOI 10.1210/jc.80.5.1747; Zhdanova IV, 2008, BRAIN RES BULL, V75, P433, DOI 10.1016/j.brainresbull.2007.10.053; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	65	62	66	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19978	10.1371/journal.pone.0019978	http://dx.doi.org/10.1371/journal.pone.0019978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647435	gold, Green Published, Green Submitted			2022-12-25	WOS:000291006500016
J	Tanaka, RJ; Ono, M; Harrington, HA				Tanaka, Reiko J.; Ono, Masahiro; Harrington, Heather A.			Skin Barrier Homeostasis in Atopic Dermatitis: Feedback Regulation of Kallikrein Activity	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTORS; SENSITIVITY-ANALYSIS; POSITIVE FEEDBACK; EPIDERMAL BARRIER; STRATUM-CORNEUM; PROTEOLYTIC CASCADE; HUMAN KERATINOCYTES; SIGNALING PATHWAYS; NETHERTON-SYNDROME; NEGATIVE FEEDBACK	Atopic dermatitis (AD) is a widely spread cutaneous chronic disease characterised by sensitive reactions (eg. eczema) to normally innocuous elements. Although relatively little is understood about its underlying mechanisms due to its complexity, skin barrier dysfunction has been recognised as a key factor in the development of AD. Skin barrier homeostasis requires tight control of the activity of proteases, called kallikreins (KLKs), whose activity is regulated by a complex network of protein interactions that remains poorly understood despite its pathological importance. Characteristic symptoms of AD include the outbreak of inflammation triggered by external (eg. mechanical and chemical) stimulus and the persistence and aggravation of inflammation even if the initial stimulus disappears. These characteristic symptoms, together with some experimental data, suggest the presence of positive feedback regulation for KLK activity by inflammatory signals. We developed simple mathematical models for the KLK activation system to study the effects of feedback loops and carried out bifurcation analysis to investigate the model behaviours corresponding to inflammation caused by external stimulus. The model analysis confirmed that the hypothesised core model mechanisms capture the essence of inflammation outbreak by a defective skin barrier. Our models predicted the outbreaks of inflammation at weaker stimulus and its longer persistence in AD patients compared to healthy control. We also proposed a novel quantitative indicator for inflammation level by applying principal component analysis to microarray data. The model analysis reproduced qualitative AD characteristics revealed by this indicator. Our results strongly implicate the presence and importance of feedback mechanisms in KLK activity regulation. We further proposed future experiments that may provide informative data to enhance the system-level understanding on the regulatory mechanisms of skin barrier in AD and healthy individuals.	[Tanaka, Reiko J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Ono, Masahiro] UCL, Inst Child Hlth, Immunobiol Unit, London, England; [Ono, Masahiro] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan; [Harrington, Heather A.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London, England	Imperial College London; University of London; University College London; Kyoto University; Imperial College London	Tanaka, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	r.tanaka@imperial.ac.uk	Ono, Masahiro/H-2378-2011	Ono, Masahiro/0000-0002-9284-7326	EPSRC; Human Frontier Science Program; Leverfulme Trust; EPSRC [EP/G007446/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G007446/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Human Frontier Science Program(Human Frontier Science Program); Leverfulme Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	RJT is supported by EPSRC (www.epsrc.ac.uk) Career Acceleration Fellowship; MO is supported by Human Frontier Science Program (www.hfsp.org) Long-Term Fellowship; HAH is supported by Leverfulme Trust (www.leverhulme.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNETT S, 1977, SIAM REV, V19, P472, DOI 10.1137/1019070; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Buddenkotte J, 2005, J INVEST DERMATOL, V124, P38, DOI 10.1111/j.0022-202X.2004.23539.x; Callard RE, 2007, TRENDS IMMUNOL, V28, P294, DOI 10.1016/j.it.2007.05.003; Choi SJ, 2003, J KOREAN MED SCI, V18, P93, DOI 10.3346/jkms.2003.18.1.93; Chu Y, 2007, IET SYST BIOL, V1, P342, DOI 10.1049/iet-syb:20060053; CONRAD E, 2005, OSCILL8 DOCUMENTATIO; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Demerjian M, 2008, AM J PATHOL, V172, P86, DOI 10.2353/ajpath.2008.070161; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Eichenfield Lawrence F, 2003, J Am Acad Dermatol, V49, P1088, DOI 10.1016/S0190-9622(03)02539-8; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Emami N, 2008, J BIOL CHEM, V283, P3031, DOI 10.1074/jbc.M707253200; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GROVES RW, 1995, J IMMUNOL, V154, P4065; Gualandri, 1999, SKIN RES TECHNOL, V5, P221, DOI [10.1111/j.1600-0846.1999.tb00134.x, DOI 10.1111/J.1600-0846.1999.TB00134.X]; Hachem JP, 2006, J INVEST DERMATOL, V126, P2074, DOI 10.1038/sj.jid.5700351; Kim D, 2007, BIOESSAYS, V29, P85, DOI 10.1002/bies.20511; Komatsu N, 2008, J INVEST DERMATOL, V128, P1148, DOI 10.1038/sj.jid.5701153; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Mancini AJ, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2007.00572.x; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Milstone LM, 2004, J DERMATOL SCI, V36, P131, DOI 10.1016/j.jdermsci.2004.05.004; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Morizane S, 2010, J INVEST DERMATOL, V130, P1297, DOI 10.1038/jid.2009.435; O'Shaughnessy RFL, 2010, HUM MOL GENET, V19, P2594, DOI 10.1093/hmg/ddq145; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Proksch E, 1996, BRIT J DERMATOL, V134, P630, DOI 10.1046/j.1365-2133.1996.66828.x; Proksch E, 2009, J DTSCH DERMATOL GES, V7, P899, DOI 10.1111/j.1610-0387.2009.07157.x; Rattenholl A, 2003, DRUG DEVELOP RES, V59, P408, DOI 10.1002/ddr.10311; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; ROEDL D, 2009, J EURO ACAD DERMATOL; Roosterman D, 2003, AM J PHYSIOL-CELL PH, V284, pC1319, DOI 10.1152/ajpcell.00540.2002; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; SCHMIDT H, 2006, BIOINFORMATICS, V22; SCHULZ BS, 1993, J IMMUNOL, V151, P4399; Sotiropoulou G, 2009, J BIOL CHEM, V284, P32989, DOI 10.1074/jbc.R109.027946; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; Yoo J, 2005, J EXP MED, V202, P541, DOI 10.1084/jem.20041503; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200	50	25	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19895	10.1371/journal.pone.0019895	http://dx.doi.org/10.1371/journal.pone.0019895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647431	Green Published, gold, Green Submitted			2022-12-25	WOS:000291006500010
J	Zakharova, A; Kurths, J; Vadivasova, T; Koseska, A				Zakharova, Anna; Kurths, Juergen; Vadivasova, Tatyana; Koseska, Aneta			Analysing Dynamical Behavior of Cellular Networks via Stochastic Bifurcations	PLOS ONE			English	Article							ESCHERICHIA-COLI; TOGGLE SWITCH; DIFFERENTIATION; OSCILLATOR; NOISE; CELLS	The dynamical structure of genetic networks determines the occurrence of various biological mechanisms, such as cellular differentiation. However, the question of how cellular diversity evolves in relation to the inherent stochasticity and intercellular communication remains still to be understood. Here, we define a concept of stochastic bifurcations suitable to investigate the dynamical structure of genetic networks, and show that under stochastic influence, the expression of given proteins of interest is defined via the probability distribution of the phase variable, representing one of the genes constituting the system. Moreover, we show that under changing stochastic conditions, the probabilities of expressing certain concentration values are different, leading to different functionality of the cells, and thus to differentiation of the cells in the various types.	[Zakharova, Anna; Koseska, Aneta] Univ Potsdam, Ctr Dynam Complex Syst, Potsdam, Germany; [Zakharova, Anna; Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Kurths, Juergen] Humboldt Univ, Inst Phys, Berlin, Germany; [Vadivasova, Tatyana] Saratov NG Chernyshevskii State Univ, Saratov, Russia	University of Potsdam; Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin; Saratov State University	Zakharova, A (corresponding author), Univ Potsdam, Ctr Dynam Complex Syst, Potsdam, Germany.	zakharova-as@mail.ru	Vadivasova, Tatiana/D-2275-2013; Zakharova, Anna/O-1884-2018	Vadivasova, Tatiana/0000-0002-8081-2820	Federal Ministry of Education and Research [0313924]; Federal Ministry of Education and Science of the Russian Federation [14.740.11.0074]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Education and Science of the Russian Federation	A.Z., A. K. and J.K. acknowledge the GoFORSYS project funded by the Federal Ministry of Education and Research, Grant Nr. 0313924. A.Z. and T. V. acknowledge the Federal Ministry of Education and Science of the Russian Federation (state contract Nr 14.740.11.0074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L., 2003, RANDOM DYNAMICAL SYS; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; EBELING W, 1986, Z ANGEW MATH MECH, V66, P141, DOI 10.1002/zamm.19860660303; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; GARDINER CW, 1985, HDB STOCHASTICMETHOD; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hirata Y, 2010, CHAOS, V20, DOI 10.1063/1.3329369; HORSTHEMKE W, 1983, SPRINGER SERIES SYNE, V15; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; KANEKO K, 1994, PHYSICA D, V75, P89, DOI 10.1016/0167-2789(94)90277-1; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KHOVANOV IA, 2000, FLUCTUATIONAL ESCAPE, P378; Kloeden PE, 1991, INT J BIFURCAT CHAOS, V1, P277, DOI 10.1142/S021812749100021X; Koseska A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.031916; Koseska A, 2010, J THEOR BIOL, V263, P189, DOI 10.1016/j.jtbi.2009.11.007; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kuznetsov A, 2005, SIAM J APPL MATH, V65, P392, DOI 10.1137/S0036139903436029; LEFEVER R, 1986, PHYS REV LETT, V56, P1631, DOI 10.1103/PhysRevLett.56.1631; LLOYD D, 2006, BIO SYSTEMS, V23, P305; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; NAMACHCHIVAYA N, 1990, APPL MATH COMPUT, V38, P101; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; SCHIMANSKYGEIER L, 1993, J STAT PHYS, V70, P141, DOI 10.1007/BF01053959; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Ushakov OV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.123903; WANG Z, 2005, CHEM PHYS LETT, V401; Zakharova A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011106	31	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19696	10.1371/journal.pone.0019696	http://dx.doi.org/10.1371/journal.pone.0019696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647432	Green Published, Green Submitted, gold			2022-12-25	WOS:000291006500007
J	Lee, MH; Lahusen, T; Wang, RH; Xiao, C; Xu, X; Hwang, YS; He, WW; Shi, Y; Deng, CX				Lee, M-H; Lahusen, T.; Wang, R-H; Xiao, C.; Xu, X.; Hwang, Y-S; He, W-W; Shi, Y.; Deng, C-X			Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation	ONCOGENE			English	Article						BRCA1; breast cancer; promoter; nude mice; YY1	SPORADIC BREAST-CANCER; TUMOR-SUPPRESSOR; ADENOVIRUS E1A; TRANSCRIPTIONAL REPRESSION; GENE-EXPRESSION; FACTOR YY1; C-MYC; PROMOTER; BINDING; YIN-YANG-1	Expression of the breast cancer-associated gene 1 (BRCA1) in sporadic breast cancers is usually reduced, yet the underlying mechanisms remains elusive. To identify factors that are responsible for reduced BRCA1 expression, we screened 92 known transcription factors for their ability to regulate expression of BRCA1. Among several potential regulators, the Gli-Krueppel-related transcription factor Yin Yang 1 (YY1) showed the most dramatic transactivation of the BRCA1 promoter. YY1 binds to the promoter of BRCA1, and its overexpression resulted in increased expression of BRCA1 and a number of BRCA1 downstream genes. We further showed that overexpression of YY1 in cancer cells inhibited cell proliferation, foci formation and tumor growth in nude mice. To assess the clinical relevance between YY1 and BRCA1, we studied expression of YY1 and BRCA1 from human breast cancer samples and tissue arrays, and detected a significant positive correlation between the level of YY1 and BRCA1 expression in these cancers. Taken together, these findings suggest that YY1 is a key regulator of BRCA1 expression and may be causally linked to the molecular etiology of human breast cancer. Oncogene (2012) 31, 116-127; doi: 10.1038/onc.2011.217; published online 13 June 2011	[Lee, M-H; Lahusen, T.; Wang, R-H; Xiao, C.; Xu, X.; Deng, C-X] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Hwang, Y-S] NCI, Lab Cell & Dev Signaling, NIH, Frederick, MD 21701 USA; [He, W-W] Origene Technol Inc, Rockville, MD USA; [Shi, Y.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School	Deng, CX (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, 9000 Rockville Pike,Bldg 10,Rm 9N105, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016	Lee, Mi-Hye/0000-0002-5484-3383	National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056011, ZIADK056001, ZIADK056004, ZIADK056010, ZIADK056009] Funding Source: NIH RePORTER	National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of Dr Deng laboratory for their critical discussion of this work and technical assistance. This research was supported by the Intramural Research Program of the National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Alberg Anthony J., 1999, Current Opinion in Oncology, V11, P435, DOI 10.1097/00001622-199911000-00003; Atlas E, 2000, ONCOGENE, V19, P1933, DOI 10.1038/sj.onc.1203516; Atlas E, 2001, ONCOGENE, V20, P7110, DOI 10.1038/sj.onc.1204890; Austen M, 1998, ONCOGENE, V17, P511, DOI 10.1038/sj.onc.1201968; Baldassarre G, 2003, MOL CELL BIOL, V23, P2225, DOI 10.1128/MCB.23.7.2225-2238.2003; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Birgisdottir V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1522; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; Castellano G, 2009, CELL CYCLE, V8, P1367, DOI 10.4161/cc.8.9.8314; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Drost RM, 2009, BRIT J CANCER, V101, P1651, DOI 10.1038/sj.bjc.6605350; Eccles DM, 2005, LANCET ONCOL, V6, P705, DOI 10.1016/S1470-2045(05)70318-1; Furlong EEM, 1996, MOL CELL BIOL, V16, P5933; Ghosh Sagar, 2008, Int J Biomed Sci, V4, P260; Giacinti L, 2008, CLIN TER, V159, P347; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Glait C, 2006, FEBS LETT, V580, P5268, DOI 10.1016/j.febslet.2006.08.071; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Kluk BJ, 2010, INT J BIOL SCI, V6, P513; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE JS, 1995, GENE DEV, V9, P1188, DOI 10.1101/gad.9.10.1188; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; MacDonald G, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1753; Man YG, 2005, BREAST CANCER RES TR, V90, P241, DOI 10.1007/s10549-004-4492-9; Okada S, 2003, J BIOL CHEM, V278, P2015, DOI 10.1074/jbc.M208685200; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; Rauch T, 2005, CELL CYCLE, V4, P1078; RIGGS KJ, 1993, MOL CELL BIOL, V13, P7487, DOI 10.1128/MCB.13.12.7487; Rivenbark AG, 2009, FRONT BIOSCI-LANDMRK, V14, P453, DOI 10.2741/3254; Ruffner H, 1997, P NATL ACAD SCI USA, V94, P7138, DOI 10.1073/pnas.94.14.7138; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Suen TC, 2001, ONCOGENE, V20, P440, DOI 10.1038/sj.onc.1204078; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tan SH, 2003, VIROLOGY, V305, P486, DOI 10.1006/viro.2002.1779; Thakur S, 1999, J BIOL CHEM, V274, P8837, DOI 10.1074/jbc.274.13.8837; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Wang A, 2000, J BIOL CHEM, V275, P4532, DOI 10.1074/jbc.275.6.4532; Wang CC, 2005, ONCOGENE, V24, P4081, DOI 10.1038/sj.onc.1208573; Wang CC, 2007, CANCER RES, V67, P4816, DOI 10.1158/0008-5472.CAN-07-0504; Wang RH, 2004, P NATL ACAD SCI USA, V101, P17108, DOI 10.1073/pnas.0407585101; Wu S, 2007, NUCL ACIDS S SER OXF, V51, P347; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu S, 2009, MOL CELL BIOL, V29, P6245, DOI 10.1128/MCB.00679-09; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Xu CF, 1997, HUM MOL GENET, V6, P1057, DOI 10.1093/hmg/6.7.1057; Xu CF, 1997, J BIOL CHEM, V272, P20994, DOI 10.1074/jbc.272.34.20994; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Zhang JR, 2005, MOL CANCER RES, V3, P531, DOI 10.1158/1541-7786.MCR-05-0192	54	46	52	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	1					116	127		10.1038/onc.2011.217	http://dx.doi.org/10.1038/onc.2011.217			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21666725	Green Accepted			2022-12-25	WOS:000299176200011
J	Henderson, WR; Oslund, RC; Bollinger, JG; Ye, X; Tien, YT; Xue, J; Gelb, MH				Henderson, William R., Jr.; Oslund, Rob C.; Bollinger, James G.; Ye, Xin; Tien, Ying-tzang; Xue, Jun; Gelb, Michael H.			Blockade of Human Group X Secreted Phospholipase A(2) (GX-sPLA(2))-induced Airway Inflammation and Hyperresponsiveness in a Mouse Asthma Model by a Selective GX-sPLA(2) Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE SET; BINDING; LAVAGE	Group X (GX) phospholipase A(2), a member of a large group of secreted phospholipases A(2) (sPLA(2)s), has recently been demonstrated to play an important in vivo role in the release of arachidonic acid and subsequent formation of eicosanoids. In a Th2 cytokine-driven mouse asthma model, deficiency of mouse GX (mGX)-sPLA(2) significantly impairs development of the asthma phenotype. In this study, we generated mGX-sPLA(2)(-/-) mice with knock-in of human GX (hGX)-sPLA(2) (i.e. hGX-sPLA(2)(+/+) knock-in mice) to understand more fully the role of GX-sPLA(2) in these allergic pulmonary responses and to assess the effect of pharmacological blockade of the GX-sPLA(2)-mediated responses. Knock-in of hGX-sPLA(2) in mGX-sPLA(2)(-/-) mice restored the allergen-induced airway infiltration by inflammatory cells, including eosinophils, goblet cell metaplasia, and hyperresponsiveness to methacholine in the mGX-sPLA(2)-deficient mice. This knock-in mouse model enabled the use of a highly potent indole-based inhibitor of hGX-sPLA(2), RO061606 (which is ineffective against mGX-sPLA(2)), to assess the potential utility of GX-sPLA(2) blockade as a therapeutic intervention in asthma. Delivery of RO061606 via mini-osmotic pumps enabled the maintenance in vivo in the mouse asthma model of plasma inhibitor concentrations near 10 mu M, markedly higher than the IC50 for inhibition of hGX-sPLA(2) in vitro. RO061606 significantly decreased allergen-induced airway inflammation, mucus hypersecretion, and hyperresponsiveness in the hGX-sPLA(2)(+/+) knock-in mouse. Thus, development of specific hGX-sPLA(2) inhibitors may provide a new pharmacological opportunity for the treatment of patients with asthma.	[Henderson, William R., Jr.; Ye, Xin; Tien, Ying-tzang; Xue, Jun] Univ Washington, Ctr Allergy & Inflammat, Dept Med, Seattle, WA 98195 USA; [Oslund, Rob C.; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Henderson, WR (corresponding author), Univ Washington, Ctr Allergy & Inflammat, UW Med S Lake Union, 815 Mercer St, Seattle, WA 98109 USA.	wrhchem@u.washington.edu; gelb@chem.washington.edu		gelb, michael/0000-0001-7000-5219	National Institutes of Health [R01 AI42989, R37 HL036235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI42989 (to W. R. H.) and R37 HL036235 (to M. H. G.).	Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Chilton FH, 1996, J EXP MED, V183, P2235, DOI 10.1084/jem.183.5.2235; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Hallstrand T. S., 2011, CLIN EXP AL IN PRESS; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hallstrand TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008583; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2005, J ALLERGY CLIN IMMUN, V116, P332, DOI 10.1016/j.jaci.2005.04.013; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Kraus JM, 2009, J MED CHEM, V52, P1639, DOI 10.1021/jm801313t; Lai Y, 2010, J BIOL CHEM, V285, P41491, DOI 10.1074/jbc.M110.153338; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Smart BP, 2004, BIOORGAN MED CHEM, V12, P1737, DOI 10.1016/j.bmc.2004.01.022; Smart BP, 2006, J MED CHEM, V49, P2858, DOI 10.1021/jm060136t; STADEL JM, 1994, AM J RESP CELL MOL, V11, P108, DOI 10.1165/ajrcmb.11.1.8018333; Triggiani M, 2009, J ALLERGY CLIN IMMUN, V124, P558, DOI 10.1016/j.jaci.2009.04.035; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4	18	29	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28049	28055		10.1074/jbc.M111.235812	http://dx.doi.org/10.1074/jbc.M111.235812			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21652694	Green Published, hybrid			2022-12-25	WOS:000293557800023
J	Yan, JP; Diaz, J; Jiao, J; Wang, RR; You, JX				Yan, Junpeng; Diaz, Jason; Jiao, Jing; Wang, Ranran; You, Jianxin			Perturbation of BRD4 Protein Function by BRD4-NUT Protein Abrogates Cellular Differentiation in NUT Midline Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROMODOMAIN-CONTAINING PROTEIN; HOST MITOTIC CHROMOSOMES; S-PHASE; P-TEFB; AGGRESSIVE CARCINOMA; ACETYLATED CHROMATIN; GENE-TRANSCRIPTION; FUSION ONCOGENE; EXPRESSION; INTERACTS	NUT midline carcinoma (NMC) belongs to a class of highly lethal and poorly differentiated epithelial cancers arising mainly in human midline organs. NMC is caused by the chromosome translocation-mediated fusion of the NUT (nuclear protein in testis) gene on chromosome 15 to a few other genes, most frequently the BRD4 gene on chromosome 19. The mechanism by which the BRD4-NUT fusion product blocks NMC cellular differentiation and contributes to oncogenesis remains elusive. In this study, we show that BRD4-NUT and BRD4 colocalize in discrete nuclear foci that are hyperacetylated but transcriptionally inactive. BRD4-NUT recruits histone acetyltransferases to induce histone hyperacetylation in these chromatin foci, which provide docking sites for accumulation of additional BRD4 and associated P-TEFB (positive transcription elongation factor b) complexes in the transcriptionally inactive BRD4-NUT foci. These molecular events lead to repression of a BRD4.P-TEFB downstream target gene c-fos, a component of activator protein 1 (AP-1), that directly regulates epithelial differentiation. Knockdown of BRD4-NUT in NMC cells disperses the transcriptionally inactive chromatin foci and releases the transcriptional activators to stimulate c-fos expression, leading to restoration of cellular differentiation. Our study provides a novel mechanism by which the BRD4-NUT oncogene perturbs BRD4 functions to block cellular differentiation and to contribute to the oncogenic progression in the highly aggressive NMC.	[Yan, Junpeng; Diaz, Jason; Jiao, Jing; Wang, Ranran; You, Jianxin] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	You, JX (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, 3610 Hamilton Walk, Philadelphia, PA 19104 USA.	jianyou@mail.med.upenn.edu		Wang, Ranran/0000-0002-7920-0704	NCI;  [R01CA148768];  [R01CA142723]; NATIONAL CANCER INSTITUTE [R01CA142723, R01CA148768] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health HIV-associated Malignancies Pilot Project Award from NCI and Grants R01CA148768 and R01CA142723.	*AM JOINT COMM CAN, 2002, AJCC CANC STAG MAN; BIREK C, 1993, AM J PATHOL, V142, P917; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Brenner JC, 2009, BBA-REV CANCER, V1796, P201, DOI 10.1016/j.bbcan.2009.04.005; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Cho WK, 2007, J VIROL, V81, P11179, DOI 10.1128/JVI.00408-07; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; den Bakker MA, 2009, AM J SURG PATHOL, V33, P1253, DOI 10.1097/PAS.0b013e3181abe120; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Edwards PAW, 2010, J PATHOL, V220, P244, DOI 10.1002/path.2632; Engleson J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-69; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; French CA, 2003, CANCER RES, V63, P304; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; Haruki N, 2005, J MED GENET, V42, P558, DOI 10.1136/jmg.2004.029686; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; KLIMPFINGER M, 1990, VIRCHOWS ARCH B, V59, P165, DOI 10.1007/BF02899401; Lee HY, 1998, ONCOGENE, V16, P3039, DOI 10.1038/sj.onc.1201843; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Lin A, 2008, J VIROL, V82, P12009, DOI 10.1128/JVI.01680-08; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mertens F, 2007, PEDIATR BLOOD CANCER, V49, P1015, DOI 10.1002/pbc.20755; Milde-Langosch K, 2003, BREAST CANCER RES TR, V77, P265, DOI 10.1023/A:1021887100216; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Okada Y, 2008, JPN J OPHTHALMOL, V52, P1, DOI 10.1007/s10384-007-0499-1; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Rorke EA, 2010, ONCOGENE, V29, P5873, DOI 10.1038/onc.2010.315; Schweiger MR, 2007, J VIROL, V81, P9612, DOI 10.1128/JVI.00447-07; Schweiger MR, 2006, J VIROL, V80, P4276, DOI 10.1128/JVI.80.9.4276-4285.2006; Smith JA, 2010, P NATL ACAD SCI USA, V107, P3752, DOI 10.1073/pnas.0914818107; Stelow EB, 2008, AM J SURG PATHOL, V32A, P828, DOI 10.1097/PAS.0b013e31815a3900; Teixeira Manuel R., 2006, Critical Reviews in Oncogenesis, V12, P257; Wu SY, 2006, GENE DEV, V20, P2383, DOI 10.1101/gad.1448206; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; You JX, 2009, MOL CELL BIOL, V29, P5094, DOI 10.1128/MCB.00299-09; Ziai J, 2010, HEAD NECK PATHOL, V4, P163, DOI 10.1007/s12105-010-0174-6	54	35	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27663	27675		10.1074/jbc.M111.246975	http://dx.doi.org/10.1074/jbc.M111.246975			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21652721	Green Published, hybrid			2022-12-25	WOS:000293268700059
J	Hudson, K; Luo, S; Hagemann, N; Preuss, D				Hudson, Karen; Luo, Song; Hagemann, Nicole; Preuss, Daphne			Changes in Global Gene Expression in Response to Chemical and Genetic Perturbation of Chromatin Structure	PLOS ONE			English	Article							DNA METHYLATION; ARABIDOPSIS-THALIANA; NUCLEOLAR DOMINANCE; METHYLTRANSFERASE; TRANSCRIPTION; SEQUENCE; MUTANTS; DRM; HETEROCHROMATIN; MAINTENANCE	DNA methylation is important for controlling gene expression in all eukaryotes. Microarray analysis of mutant and chemically-treated Arabidopsis thaliana seedlings with reduced DNA methylation revealed an altered gene expression profile after treatment with the DNA methylation inhibitor 5-aza-2' deoxycytidine (5-AC), which included the upregulation of expression of many transposable elements. DNA damage-response genes were also coordinately upregulated by 5-AC treatment. In the ddm1 mutant, more specific changes in gene expression were observed, in particular for genes predicted to encode transposable elements in centromeric and pericentromeric locations. These results confirm that DDM1 has a very specific role in maintaining transcriptional silence of transposable elements, while chemical inhibitors of DNA methylation can affect gene expression at a global level.	[Hudson, Karen; Luo, Song; Hagemann, Nicole; Preuss, Daphne] Univ Chicago, Dept Mol Genet & Cell Biol, Howard Hughes Med Inst, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Hudson, K (corresponding author), ARS, Crop Prod & Pest Control Res Unit, USDA, W Lafayette, IN USA.	dpreuss@chromatininc.com		Hudson, Karen/0000-0002-7402-2275	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The research described herein was supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS F, 2006, P NATL ACAD SCI US; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chang S, 2005, J BIOL CHEM, V280, P796, DOI 10.1074/jbc.M409053200; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Habu Y, 2006, EMBO REP, V7, P1279, DOI 10.1038/sj.embor.7400835; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jordan ND, 2007, PLANT MOL BIOL, V65, P571, DOI 10.1007/s11103-007-9221-4; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Luo S, 2003, P NATL ACAD SCI USA, V100, P11133, DOI 10.1073/pnas.1831011100; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Rocha PSCF, 2005, PLANT CELL, V17, P404, DOI 10.1105/tpc.104.028332; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; ZHANG X, 2006, CELL; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	36	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20587	10.1371/journal.pone.0020587	http://dx.doi.org/10.1371/journal.pone.0020587			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673996	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500025
J	Valenti, MT; Garbin, U; Pasini, A; Zanatta, M; Stranieri, C; Manfro, S; Zucal, C; Carbonare, LD				Valenti, Maria Teresa; Garbin, Ulisse; Pasini, Andrea; Zanatta, Mirko; Stranieri, Chiara; Manfro, Stefania; Zucal, Chiara; Carbonare, Luca Dalle			Role of Ox-PAPCs in the Differentiation of Mesenchymal Stem Cells (MSCs) and Runx2 and PPAR gamma 2 Expression in MSCs-Like of Osteoporotic Patients	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TIME QUANTITATIVE PCR; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; PPAR-GAMMA; ADIPOGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; BONE; MARROW; ADIPOCYTE	Background: Mesenchymal stem cells (MSCs) can differentiate into osteoblasts and adipocytes and conditions causing bone loss may induce a switch from the osteoblast to adipocyte lineage. In addition, the expression of Runx2 and the PPAR gamma 2 transcription factor genes is essential for cellular commitment to an osteogenic and adipogenic differentiation, respectively. Modified lipoproteins derived from the oxidation of arachidonate-containing phospholipids (ox-PAPCs: POVPC, PGPC and PEIPC) are considered important factors in atherogenesis. Methodology: We investigated the effect of ox-PAPCs on osteogenesis and adipogenesis in human mesenchymal stem cells (hMSCs). In particular, we analyzed the transcription factor Runx2 and the PPAR gamma 2 gene expression during osteogenic and adipogenic differentiation in absence and in presence of ox-PAPCs. We also analyzed gene expression level in a panel of osteoblastic and adipogenic differentiation markers. In addition, as circulating blood cells can be used as a "sentinel" that responds to changes in the macro-or micro-environment, we analyzed the Runx2 and the PPAR gamma 2 gene expression in MSCs-like and ox-PAPC levels in serum of osteoporotic patients (OPs). Finally, we examined the effects of sera obtained from OPs in hMSCs comparing the results with age-matched normal donors (NDs). Principal findings: Quantitative RT-PCR demonstrated that ox-PAPCs enhanced PPAR gamma 2 and adipogenic gene expression and reduced Runx2 and osteoblast differentiation marker gene expression in differentiating hMSCs. In OPs, ox-PAPC levels and PPAR gamma 2 expression were higher than in NDs, whereas Runx2 was lower than in ND circulant MSCs-like. Conclusions: Ox-PAPCs affect the osteogenic differentiation by promoting adipogenic differentiation and this effect may appear involved in bone loss in OPs.	[Valenti, Maria Teresa; Garbin, Ulisse; Pasini, Andrea; Zanatta, Mirko; Stranieri, Chiara; Manfro, Stefania; Zucal, Chiara; Carbonare, Luca Dalle] Univ Verona, Sez D, Dept Med, Clin Med Interna, I-37100 Verona, Italy	University of Verona	Valenti, MT (corresponding author), Univ Verona, Sez D, Dept Med, Clin Med Interna, I-37100 Verona, Italy.	luca.dallecarbonare@univr.it	Valenti, Maria Teresa/F-4712-2011; Carbonare, Luca Dalle/E-5720-2011; Stranieri, Chiara/GWV-1749-2022	Zucal, Chiara/0000-0001-8428-2495; Valenti, Maria Teresa/0000-0003-1166-8033				Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; AUBIN JE, 2002, PRINCIPLES BONE BIOL, V1, P59; Bear M, 2008, J CELL BIOCHEM, V105, P185, DOI 10.1002/jcb.21812; BERESFORD JN, 1989, CLIN ORTHOP RELAT R, P270; Carbonare LD, 2009, ARTHRITIS RHEUM-US, V60, P3356, DOI 10.1002/art.24884; Diascro DD, 1998, J BONE MINER RES, V13, P96, DOI 10.1359/jbmr.1998.13.1.96; DIVERS J, 2011, J BONE MINER RE 0324; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Karrman A, 2006, ENVIRON SCI TECHNOL, V40, P3742, DOI 10.1021/es060301u; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200; Kim SW, 2009, J CELL BIOCHEM, V106, P626, DOI 10.1002/jcb.22042; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lee H, 2000, CIRC RES, V87, P516; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEUNIER P, 1971, CLIN ORTHOP RELAT R, V80, P147, DOI DOI 10.1097/00003086-197110000-00021; Mitry RR, 2009, J PEDIATR GASTR NUTR, V48, P604, DOI 10.1097/MPG.0b013e31819114da; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Orozco P, 2004, EUR J EPIDEMIOL, V19, P1105, DOI 10.1007/s10654-004-1706-8; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parhami F, 1999, J BONE MINER RES, V14, P2067, DOI 10.1359/jbmr.1999.14.12.2067; Parhami F, 1997, ARTERIOSCL THROM VAS, V17, P680, DOI 10.1161/01.ATV.17.4.680; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prentice L, 1997, J CLIN ENDOCR METAB, V82, P1288, DOI 10.1210/jc.82.4.1288; Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H; Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; TAN A, 2011, METABOLISM      0223; THOMA SJ, 1994, BLOOD, V83, P2103; Tintut Y, 2004, ARTERIOSCL THROM VAS, V24, pE6, DOI 10.1161/01.ATV.0000112023.62695.7f; Toms LML, 2009, ENVIRON SCI TECHNOL, V43, P4194, DOI 10.1021/es900272u; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Valenti MT, 2008, BONE, V43, P1084, DOI 10.1016/j.bone.2008.07.252; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; WANG GJ, 1977, J BONE JOINT SURG AM, V59, P729, DOI 10.2106/00004623-197759060-00003; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; WRONSKI TJ, 1986, BONE, V7, P119, DOI 10.1016/8756-3282(86)90683-6	49	37	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20363	10.1371/journal.pone.0020363	http://dx.doi.org/10.1371/journal.pone.0020363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674037	Green Submitted, Green Published, gold			2022-12-25	WOS:000291355500012
J	Cebrian, E; Uriz, MJ; Garrabou, J; Ballesteros, E				Cebrian, Emma; Jesus Uriz, Maria; Garrabou, Joaquim; Ballesteros, Enric			Sponge Mass Mortalities in a Warming Mediterranean Sea: Are Cyanobacteria-Harboring Species Worse Off?	PLOS ONE			English	Article							CLIMATE-CHANGE; EUNICELLA-SINGULARIS; BENTHIC COMMUNITIES; OCULINA-PATAGONICA; VIBRIO-SHILOI; CORAL; TEMPERATURE; DISEASE; POPULATIONS; SYMBIOSIS	Mass mortality events are increasing dramatically in all coastal marine environments. Determining the underlying causes of mass mortality events has proven difficult in the past because of the lack of prior quantitative data on populations and environmental variables. Four-year surveys of two shallow-water sponge species, Ircinia fasciculata and Sarcotragus spinosulum, were carried out in the western Mediterranean Sea. These surveys provided evidence of two severe sponge die-offs (total mortality ranging from 80 to 95% of specimens) occurring in the summers of 2008 and 2009. These events primarily affected I. fasciculata, which hosts both phototrophic and heterotrophic microsymbionts, while they did not affect S. spinosulum, which harbors only heterotrophic bacteria. We observed a significant positive correlation between the percentage of injured I. fasciculata specimens and exposure time to elevated temperature conditions in all populations, suggesting a key role of temperature in triggering mortality events. A comparative ultrastructural study of injured and healthy I. fasciculata specimens showed that cyanobacteria disappeared from injured specimens, which suggests that cyanobacterial decay could be involved in I. fasciculata mortality. A laboratory experiment confirmed that the cyanobacteria harbored by I. fasciculata displayed a significant reduction in photosynthetic efficiency in the highest temperature treatment. The sponge disease reported here led to a severe decrease in the abundance of the surveyed populations. It represents one of the most dramatic mass mortality events to date in the Mediterranean Sea.	[Cebrian, Emma] Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Girona, Spain; [Jesus Uriz, Maria; Ballesteros, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Girona, Spain; [Garrabou, Joaquim] CSIC, Inst Ciencies Mar, Barcelona, Spain	Universitat de Girona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Cebrian, E (corresponding author), Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Girona, Spain.	emma.cebrian@udg.edu	Cebrian, Emma/J-9640-2012; Ballesteros, Enric/K-6497-2012; Uriz, Maria/J-9001-2012; Uriz, Maria J./AGP-4595-2022	Cebrian, Emma/0000-0001-7588-0135; Uriz, Maria J./0000-0002-8169-3173	Fundacion Biodiversidad, EU [ERG-2009-248252]; Ministry of Science and Innovation [CTM2009-08045]; Spanish Ministry of Science and Innovation [C5D2007-00067]; Juan de la Cierva Postdoctoral Fellowship	Fundacion Biodiversidad, EU; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Juan de la Cierva Postdoctoral Fellowship(Instituto de Salud Carlos III)	Financial support was provided by the Fundacion Biodiversidad, an EU Reintegration grant (ERG-2009-248252), the BioRocK project from the Spanish Ministry of Science and Innovation (CTM2009-08045), and the GRACCIE project C5D2007-00067 from the Spanish Ministry of Science and Innovation. EC was funded by a Juan de la Cierva Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEMANDEMARTIN A, 1996, THESIS U LYON LYON; [Anonymous], 1941, ECOLOGY, V22, P415, DOI 10.2307/1930719; ANTONOV J, 1998, TEMPERATURE ATLANTIC, V27; ARILLO A, 1993, MAR BIOL, V117, P159, DOI 10.1007/BF00346438; Ballesteros E, 1992, ARXIUS SECCIO CIENCI, V101, P1; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Banin E, 2001, FEMS MICROBIOL LETT, V199, P33; Bavestrello Giorgio, 1995, Marine Life, V4, P15; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Brandt ME, 2009, CORAL REEFS, V28, P911, DOI 10.1007/s00338-009-0548-y; Cebrian E, 2006, ENVIRON POLLUT, V141, P452, DOI 10.1016/j.envpol.2005.08.070; Cebrian E, 2003, MAR POLLUT BULL, V46, P1273, DOI 10.1016/S0025-326X(03)00190-5; Cebrian E, 2007, ENVIRON TOXICOL CHEM, V26, P2430, DOI 10.1897/07-292.1; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2001, ITAL J ZOOL, V68, P131, DOI 10.1080/11250000109356397; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Coma R, 2002, LIMNOL OCEANOGR, V47, P324, DOI 10.4319/lo.2002.47.1.0324; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Cook S., 2002, SYSTEMA PORIFERA GUI, P1021; Cossins A. R., 1987, TEMPERATURE BIOL ANI; De Caralt S, 2008, MAR ECOL PROG SER, V360, P97, DOI 10.3354/meps07365; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; Fischer EM, 2009, CLIM DYNAM, V33, P917, DOI 10.1007/s00382-008-0473-8; GAINO E, 1989, DIS AQUAT ORGAN, V6, P67, DOI 10.3354/dao006067; GAINO E, 1992, B ZOOL, V59, P79, DOI 10.1080/11250009209386652; Galstoff P. S., 1942, P 8 AM SCI C, V3, P411; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Lemloh Marie-Louise, 2009, BMC Ecology, V9, P4, DOI 10.1186/1472-6785-9-4; Leys SP, 1998, BIOL BULL-US, V195, P30, DOI 10.2307/1542773; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Maldonado M, 2010, MAR BIOL, V157, P1577, DOI 10.1007/s00227-010-1431-7; Metalpa RR, 2000, CORAL REEFS, V19, P24, DOI 10.1007/s003380050221; Pansini M., 1990, NEW PERSPECTIVES SPO, P404; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Perez T., 2004, B MUS I BIOL U GEN, V68, P517; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Pronzato R, 1999, AQUAT CONSERV, V9, P485, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<485::AID-AQC362>3.3.CO;2-E; PRONZATO R, 1991, B MUSEO I BIOL U GEN, V55, P17; Regoli F, 2004, MAR ECOL PROG SER, V275, P129, DOI 10.3354/meps275129; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; RUTZLER K, 1988, DIS AQUAT ORGAN, V5, P143, DOI 10.3354/dao005143; SALOMON S, 2007, INTERGOVERNMENTAL PA; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Simpson T., 1984, CELL BIOL SPONGES; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Toren A, 1998, APPL ENVIRON MICROB, V64, P1379; Torrents O, 2008, J EXP MAR BIOL ECOL, V357, P7, DOI 10.1016/j.jembe.2007.12.006; URIZ MJ, 1992, PSZNI MAR ECOL, V13, P101; Vacelet J., 1994, SPONGES TIME SPACE, P355; VACELET J, 1994, FITCPRAB8853 FAO; Vezzulli L, 2010, ENV MICROBIOL REP, V2, P27, DOI 10.1111/j.1758-2229.2009.00128.x; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WILKINSON CR, 1987, CORAL REEFS, V5, P183, DOI 10.1007/BF00300961; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Wulff JL, 2006, BIOL CONSERV, V127, P167, DOI 10.1016/j.biocon.2005.08.007; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	67	116	117	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20211	10.1371/journal.pone.0020211	http://dx.doi.org/10.1371/journal.pone.0020211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673798	Green Published, Green Submitted, gold			2022-12-25	WOS:000291309900006
J	Bonnet, M; Gagnidze, L; Guerin, PJ; Bonte, L; Ramsay, A; Githui, W; Varaine, F				Bonnet, Maryline; Gagnidze, Laramie; Guerin, Philippe J.; Bonte, Laurence; Ramsay, Andrew; Githui, Willie; Varaine, Francis			Evaluation of Combined LED-Fluorescence Microscopy and Bleach Sedimentation for Diagnosis of Tuberculosis at Peripheral Health Service Level	PLOS ONE			English	Article							SPUTUM SMEAR MICROSCOPY; SENSITIVITY; OPPORTUNITY	Background: Sputum microscopy is the only diagnostic for tuberculosis (TB) available at peripheral levels of health service in resource-poor countries. Its sensitivity is reduced in high HIV-prevalence settings. Sodium hypochlorite (NaOCl) specimen sedimentation prior microscopy and light-emitting diode (LED)-fluorescence microscopy (FM) can individually improve performance of microscopy. This study aimed to evaluate the performance of combined LED-FM and NaOCl sputum sedimentation for TB detection at peripheral level of health services. Methods: A prospective study was conducted in an urban health clinic in Nairobi, Kenya. Three sputum specimens were collected over 2 days from consecutive TB suspects. Smears were prepared and stained with auramine O and Ziehl-Neelsen (ZN) methods. Bleach (3.5%) was added to the remaining specimen before overnight sedimentation at room temperature. Auramine O staining was performed on smears of sediment. A 4(th) specimen was collected for TB culture. Auramine smears were read under the same microscope as used for ZN smears, but equipped with the LED FluoLED (TM) fluorescence illuminator. Results: 497 patients were included, and 1394 specimens collected. The yield of positive specimen was significantly increased after NaOCl sedimentation (24.9%) compared to direct LED-FM (20.6%) and direct ZN (20.3%). In detecting smear-positive patients, sensitivity was 78.5% for LED-FM after NaOCl sedimentation compared to 73.2% and 72.0% for direct LED-FM (P = 0.06) and direct ZN (P = 0.06), respectively. Specificity was 87.8% for LED-FM after NaOCl sedimentation compared to 96.7% and 95.9% for direct LED-FM (P<0.01) and direct ZN (P<0.01), respectively. Inter-reading agreement (kappa = 0.7) and technicians' acceptability were good. Conclusion: NaOCl sedimentation did not improve the performance of LED-FM in the diagnosis of pulmonary TB at peripheral health service level.	[Bonnet, Maryline; Gagnidze, Laramie; Guerin, Philippe J.] Epictr, Paris, France; [Bonte, Laurence; Varaine, Francis] Med Sans Frontieres, Paris, France; [Ramsay, Andrew] WHO Special Programme Res & Training Trop Dis TDR, UNICEF, UNDP, World Bank, Geneva, Switzerland; [Githui, Willie] Kenya Govt Med Res Ctr, Ctr Resp Dis Res, Nairobi, Kenya	Doctors Without Borders; The World Bank; World Health Organization; Kenya Medical Research Institute	Bonnet, M (corresponding author), Epictr, Paris, France.	maryline.bonnet@geneva.msf.org	Guerin, Philippe/AAH-8873-2021	Guerin, Philippe/0000-0002-6008-2963	Medecins Sans Frontieres	Medecins Sans Frontieres	The study was funded by Medecins Sans Frontieres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Bonnet M, 2008, CLIN INFECT DIS, V46, P1710, DOI 10.1086/587891; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017214; Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10; Cruciani M, 2004, J CLIN MICROBIOL, V42, P2321, DOI 10.1128/JCM.42.5.2321-2325.2004; DAVID HL, 1996, BACTERIOLOGY MYCOBAC; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; Gilpin C, 2007, INT J TUBERC LUNG D, V11, P946; KUHN, 2010, OPEN MICROBIOLOGY J, V4, P30; Mabaera B, 2007, INT J TUBERC LUNG D, V11, P959; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Merid Y, 2009, INT J TUBERC LUNG D, V13, P136; Minion J, 2009, EXPERT REV MED DEVIC, V6, P596; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2009, INT J TUBERC LUNG D, V13, P613; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; *STOP TB PARTN RET, 2008, NEW LAB DIAGN TOOLS; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Trusov A, 2009, INT J TUBERC LUNG D, V13, P836; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P1009; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P816; Van Deun A, 2000, INT J TUBERC LUNG D, V4, P371; Van Deun A, 2007, PRIORITIES TUBERCULO, P11	26	13	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20175	10.1371/journal.pone.0020175	http://dx.doi.org/10.1371/journal.pone.0020175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655284	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600027
J	Lin, HX; Li, Z; Chen, C; Luo, XB; Xiao, JN; Dong, DL; Lu, YJ; Yang, BF; Wang, ZG				Lin, Huixian; Li, Zhe; Chen, Chang; Luo, Xiaobin; Xiao, Jiening; Dong, Deli; Lu, Yanjie; Yang, Baofeng; Wang, Zhiguo			Transcriptional and Post-Transcriptional Mechanisms for Oncogenic Overexpression of Ether A Go-Go K+ Channel	PLOS ONE			English	Article							MUSCLE-SPECIFIC MICRORNAS; SEE VOL. 227; POTASSIUM CHANNELS; TUMOR-SUPPRESSOR; CELL-CYCLE; DECOY OLIGODEOXYNUCLEOTIDES; ABERRANT EXPRESSION; CANCER PATIENTS; GENES HCN2; PG. 877	The human ether-a-go-go-1 (h-eag1) K+ channel is expressed in a variety of cell lines derived from human malignant tumors and in clinical samples of several different cancers, but is otherwise absent in normal tissues. It was found to be necessary for cell cycle progression and tumorigenesis. Specific inhibition of h-eag1 expression leads to inhibition of tumor cell proliferation. We report here that h-eag1 expression is controlled by the p53-miR-34-E2F1 pathway through a negative feed-forward mechanism. We first established E2F1 as a transactivator of h-eag1 gene through characterizing its promoter region. We then revealed that miR-34, a known transcriptional target of p53, is an important negative regulator of h-eag1 through dual mechanisms by directly repressing h-eag1 at the post-transcriptional level and indirectly silencing h-eag1 at the transcriptional level via repressing E2F1. There is a strong inverse relationship between the expression levels of miR-34 and h-eag1 protein. H-eag1antisense antagonized the growth-stimulating effects and the upregulation of h-eag1 expression in SHSY5Y cells, induced by knockdown of miR-34, E2F1 overexpression, or inhibition of p53 activity. Therefore, p53 negatively regulates h-eag1 expression by a negative feed-forward mechanism through the p53-miR-34-E2F1 pathway. Inactivation of p53 activity, as is the case in many cancers, can thus cause oncogenic overexpression of h-eag1 by relieving the negative feed-forward regulation. These findings not only help us understand the molecular mechanisms for oncogenic overexpression of h-eag1 in tumorigenesis but also uncover the cell-cycle regulation through the p53-miR-34-E2F1-h-eag1 pathway. Moreover, these findings place h-eag1 in the p53-miR-34-E2F1-h-eag1 pathway with h-eag as a terminal effecter component and with miR-34 (and E2F1) as a linker between p53 and h-eag1. Our study therefore fills the gap between p53 pathway and its cellular function mediated by h-eag1.	[Lin, Huixian; Luo, Xiaobin; Xiao, Jiening; Wang, Zhiguo] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Luo, Xiaobin; Wang, Zhiguo] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Li, Zhe; Chen, Chang; Dong, Deli; Lu, Yanjie; Yang, Baofeng] Harbin Med Univ, Dept Pharmacol, State Prov Key Labs Biomed Pharmaceut China, Harbin, Heilongjiang, Peoples R China; [Luo, Xiaobin; Lu, Yanjie; Yang, Baofeng; Wang, Zhiguo] Harbin Med Univ, Cardiovasc Res Inst, Key Lab Cardiovasc Res, Minist Educ China, Harbin, Heilongjiang, Peoples R China	Universite de Montreal; Universite de Montreal; Harbin Medical University; Harbin Medical University; Ministry of Education, China	Lin, HX (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.	yangbf@ems.hrbmu.edu.cn; wangz@mirna-tech.com	Wang, Zhiguo/GRS-4339-2022; wang, zhiguo/AAN-4182-2021	Wang, Zhiguo/0000-0002-0811-2045; 	Canadian Institute of Health Research; Fonds de la Recherche de l'Institut de Cardiologie de Montreal	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche de l'Institut de Cardiologie de Montreal	This work was supported by the Canadian Institute of Health Research to Z. Wang and Fonds de la Recherche de l'Institut de Cardiologie de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bauer CK, 2001, J MEMBRANE BIOL, V182, P1; Crosby ME, 2004, CANCER BIOL THER, V3, P1208, DOI 10.4161/cbt.3.12.1494; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; DeGregori J, 2006, CURR MOL MED, V6, P739; Ding XW, 2008, DIGEST DIS SCI, V53, P2039, DOI 10.1007/s10620-007-0116-7; Ding XW, 2007, MED ONCOL, V24, P345, DOI 10.1007/s12032-007-0015-y; Ding XW, 2007, WORLD J GASTROENTERO, V13, P1257, DOI 10.3748/wjg.v13.i8.1257; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Gao HH, 2006, MOL PHARMACOL, V70, P1621, DOI 10.1124/mol.106.024273; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Kapsimali M, 2010, RES PER NEUROSCI, P9, DOI 10.1007/978-3-642-04298-0_2; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lin HX, 2007, J CELL PHYSIOL, V212, P137, DOI 10.1002/jcp.21015; Lin HX, 2009, CELL PHYSIOL BIOCHEM, V23, P317, DOI 10.1159/000218178; Lu YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1053; LUO X, 2007, AM J PHYSIOL, V294, pH1371; Luo XB, 2008, J BIOL CHEM, V283, P20045, DOI 10.1074/jbc.M801035200; Luo XB, 2007, J CELL PHYSIOL, V212, P358, DOI 10.1002/jcp.21030; Meyer R, 1998, J PHYSIOL-LONDON, V508, P49, DOI 10.1111/j.1469-7793.1998.049br.x; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Morishita R, 2001, ANN NY ACAD SCI, V947, P294; Napp J, 2005, J BIOL CHEM, V280, P29506, DOI 10.1074/jbc.M504228200; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Pardo LA, 2008, CANCER RES, V68, P1611, DOI 10.1158/0008-5472.CAN-07-5710; Patt S, 2004, NEUROSCI LETT, V368, P249, DOI 10.1016/j.neulet.2004.07.001; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rogoff HA, 2004, CELL CYCLE, V3, P845; Spitzner M, 2008, J BIOL CHEM, V283, P7421, DOI 10.1074/jbc.M703758200; Stuhmer W, 2006, FEBS LETT, V580, P2850, DOI 10.1016/j.febslet.2006.03.062; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Wadhwa S, 2009, INT UROL NEPHROL, V41, P251, DOI 10.1007/s11255-008-9459-z; Wang HZ, 2002, CANCER RES, V62, P4843; Wang L, 2007, J NEUROSCI, V27, P12555, DOI 10.1523/JNEUROSCI.3681-07.2007; Wang ZG, 2004, PFLUG ARCH EUR J PHY, V448, P274, DOI 10.1007/s00424-004-1258-5; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569	48	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20362	10.1371/journal.pone.0020362	http://dx.doi.org/10.1371/journal.pone.0020362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655246	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600053
J	Nagarkatti-Gude, DR; Jaimez, R; Henderson, SC; Teves, ME; Zhang, ZB; Strauss, JF				Nagarkatti-Gude, David R.; Jaimez, Ruth; Henderson, Scott C.; Teves, Maria E.; Zhang, Zhibing; Strauss, Jerome F., III			Spag16, an Axonemal Central Apparatus Gene, Encodes a Male Germ Cell Nuclear Speckle Protein that Regulates SPAG16 mRNA Expression	PLOS ONE			English	Article							WD-REPEAT; CHLAMYDOMONAS FLAGELLA; SPERM AXONEME; TRANSCRIPTION; MOTILITY; DOMAINS; SPERMATOGENESIS; ASSOCIATION; ARCHITECTURE; DEFICIENCY	Spag16 is the murine orthologue of Chlamydomonas reinhardtii PF20, a protein known to be essential to the structure and function of the "9+2'' axoneme. In Chlamydomonas, the PF20 gene encodes a single protein present in the central pair of the axoneme. Loss of PF20 prevents central pair assembly/integrity and results in flagellar paralysis. Here we demonstrate that the murine Spag16 gene encodes two proteins: 71 kDa SPAG16L, which is found in all murine cells with motile cilia or flagella, and 35 kDa SPAG16S, representing the C terminus of SPAG16L, which is expressed only in male germ cells, and is predominantly found in specific regions within the nucleus that also contain SC35, a known marker of nuclear speckles enriched in pre-mRNA splicing factors. SPAG16S expression precedes expression of SPAG16L. Mice homozygous for a knockout of SPAG16L alone are infertile, but show no abnormalities in spermatogenesis. Mice chimeric for a mutation deleting the transcripts for both SPAG16L and SPAG16S have a profound defect in spermatogenesis. We show here that transduction of SPAG16S into cultured dispersed mouse male germ cells and BEAS-2B human bronchial epithelial cells increases SPAG16L expression, but has no effect on the expression of several other axoneme components. We also demonstrate that the Spag16L promoter shows increased activity in the presence of SPAG16S. The distinct nuclear localization of SPAG16S and its ability to modulate Spag16L mRNA expression suggest that SPAG16S plays an important role in the gene expression machinery of male germ cells. This is a unique example of a highly conserved axonemal protein gene that encodes two protein products with different functions.	[Nagarkatti-Gude, David R.; Zhang, Zhibing; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA; [Nagarkatti-Gude, David R.; Teves, Maria E.; Zhang, Zhibing; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA; [Jaimez, Ruth] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; [Henderson, Scott C.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Pennsylvania; Pennsylvania Medicine; Virginia Commonwealth University	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA.	jfstrauss@vcu.edu	Teves, Maria/AAJ-9523-2020; Henderson, Scott/AAP-2785-2021; Nagarkatti-Gude, David/AAF-6996-2020	Teves, Maria/0000-0001-7035-2202; Henderson, Scott/0000-0002-1076-3867; 	National Institutes of Health-NICHD [5R01HD037416, 5F31HD062314, 5D43TW007692]; Virginia Commonwealth University (VCU); NIH-NINDS Center [5P30NS047463]; NIH-NCI Cancer Center [5P30CA016059]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD062314, R01HD037416] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW007692] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	National Institutes of Health-NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Virginia Commonwealth University (VCU); NIH-NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health-NICHD grants 5R01HD037416 (to JFS), 5F31HD062314 (to DRN-G), 5D43TW007692 (to MET) and a Virginia Commonwealth University (VCU) Presidential Research Incentive Program Award (to ZZ). Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant (5P30NS047463). Viruses were amplified and titered at the VCU Macromolecule Core Facility, supported, in part, with funding from NIH-NCI Cancer Center Support Grant (5P30CA016059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ADAMS GMW, 1981, J CELL BIOL, V91, P69, DOI 10.1083/jcb.91.1.69; Bastin P, 2000, MICROBES INFECT, V2, P1865, DOI 10.1016/S1286-4579(00)01344-7; Beissbarth T, 2003, MOL CELL ENDOCRINOL, V212, P29, DOI 10.1016/j.mce.2003.09.023; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; DUTCHER SK, 1984, J CELL BIOL, V98, P229, DOI 10.1083/jcb.98.1.229; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1998, CURR TOP DEV BIOL, V37, P141; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; Fajardo MA, 1997, DEV BIOL, V191, P42, DOI 10.1006/dbio.1997.8705; Gallenberger M, 2011, HUM MOL GENET, V20, P422, DOI 10.1093/hmg/ddq478; Horowitz E, 2005, MOL HUM REPROD, V11, P307, DOI 10.1093/molehr/gah163; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hu Y, 2010, J CELL BIOL, V191, P711, DOI 10.1083/jcb.201004041; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; Inaba K, 2007, ANN NY ACAD SCI, V1101, P506, DOI 10.1196/annals.1389.017; Kleene KC, 1996, MOL REPROD DEV, V43, P268, DOI 10.1002/(SICI)1098-2795(199602)43:2&lt;268::AID-MRD17&gt;3.0.CO;2-#; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; Lallena MJ, 1997, J CELL SCI, V110, P239; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lesich KA, 2010, BIOL REPROD, V82, P736, DOI 10.1095/biolreprod.109.080143; LUCK DJL, 1984, J CELL BIOL, V98, P789, DOI 10.1083/jcb.98.3.789; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V39, pD225; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Porter ME, 2000, J CELL BIOL, V151, pF37, DOI 10.1083/jcb.151.5.F37; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Reddi PP, 2002, J REPROD IMMUNOL, V53, P25, DOI 10.1016/S0165-0378(01)00104-8; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Smith EF, 1997, CELL MOTIL CYTOSKEL, V38, P1; Smith EF, 1997, MOL BIOL CELL, V8, P455, DOI 10.1091/mbc.8.3.455; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SPECTOR DL, 1993, COLD SPRING HARB SYM, V58, P799, DOI 10.1101/SQB.1993.058.01.087; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takizawa T, 2008, GENE DEV, V22, P489, DOI 10.1101/gad.1634608; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Zhang ZB, 2006, BIOL REPROD, V74, P751, DOI 10.1095/biolreprod.105.049254; Zhang ZB, 2004, P NATL ACAD SCI USA, V101, P12946, DOI 10.1073/pnas.0404280101; Zhang ZB, 2002, MOL CELL BIOL, V22, P7993, DOI 10.1128/MCB.22.22.7993-8004.2002; Zhang ZB, 2008, BIOL REPROD, V79, P75, DOI 10.1095/biolreprod.107.066308; Zhang ZB, 2007, BIOL REPROD, V77, P864, DOI 10.1095/biolreprod.107.063206; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007	46	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20625	10.1371/journal.pone.0020625	http://dx.doi.org/10.1371/journal.pone.0020625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655194	Green Published, Green Submitted, gold			2022-12-25	WOS:000291097600110
J	Martel, P; Leo, D; Fulton, S; Berard, M; Trudeau, LE				Martel, Philippe; Leo, Damiana; Fulton, Stephanie; Berard, Maxime; Trudeau, Louis-Eric			Role of Kv1 Potassium Channels in Regulating Dopamine Release and Presynaptic D2 Receptor Function	PLOS ONE			English	Article							GLUTAMATE-DEPENDENT INHIBITION; SUBSTANTIA-NIGRA NEURONS; GATED K+ CHANNELS; IN-VIVO; MEDIATED INHIBITION; CALCIUM-CHANNELS; NERVE-TERMINALS; DEFICIENT MICE; ION CHANNELS; RAT STRIATUM	Dopamine (DA) release in the CNS is critical for motor control and motivated behaviors. Dysfunction of its regulation is thought to be implicated in drug abuse and in diseases such as schizophrenia and Parkinson's. Although various potassium channels located in the somatodendritic compartment of DA neurons such as G-protein-gated inward rectifying potassium channels (GIRK) have been shown to regulate cell firing and DA release, little is presently known about the role of potassium channels localized in the axon terminals of these neurons. Here we used fast-scan cyclic voltammetry to study electrically-evoked DA release in rat dorsal striatal brain slices. We find that although G-protein-gated inward rectifying (GIRK) and ATP-gated (K(ATP)) potassium channels play only a minor role, voltage-gated potassium channels of the Kv1 family play a major role in regulating DA release. The use of Kv subtype-selective blockers confirmed a role for Kv1.2, 1.3 and 1.6, but not Kv1.1, 3.1, 3.2, 3.4 and 4.2. Interestingly, Kv1 blockers also reduced the ability of quinpirole, a D2 receptor agonist, to inhibit evoked DA overflow, thus suggesting that Kv1 channels also regulate presynaptic D2 receptor function. Our work identifies Kv1 potassium channels as key regulators of DA release in the striatum.	[Martel, Philippe; Leo, Damiana; Fulton, Stephanie; Berard, Maxime; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Martel, P (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Trudeau, Louis-Eric/AAE-4782-2020	Trudeau, Louis-Eric/0000-0003-4684-1377; Leo, Damiana/0000-0001-9219-5498	Canadian Institutes of Health research (CIHR) [MOP-49591]; Fonds de la Recherche en Sante du Quebec (FRSQ); Universite de Montre al; National Science and Engineering Research Council (NSERC); Department of Foreign Affairs and International Trade of Canada	Canadian Institutes of Health research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Universite de Montre al; National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Foreign Affairs and International Trade of Canada	This work was supported by grant MOP-49591 from the Canadian Institutes of Health research (CIHR) to LET. LET was supported by a senior scholar award from the Fonds de la Recherche en Sante du Quebec (FRSQ) and also receives support through an infrastructure grant provided by the FRSQ to the Groupe de Recherche sur le Systeme Nerveux Central. PM was supported in part by a COPSE fellowship of the Universite de Montre al. MB was supported by a fellowship from the FRSQ. SF was supported by a National Science and Engineering Research Council (NSERC) postdoctoral fellowship. DL was supported by a postdoctoral fellowship (PDRF) from the Department of Foreign Affairs and International Trade of Canada and by a postdoctoral fellowship from the Fonds de la Recherche en Sante du Quebec (FRSQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1977, N-S ARCH PHARMACOL, V297, P1, DOI 10.1007/BF00508803; Avshalumov MV, 2003, P NATL ACAD SCI USA, V100, P11729, DOI 10.1073/pnas.1834314100; Avshalumov MV, 2003, J NEUROSCI, V23, P2744; Bath BD, 2000, ANAL CHEM, V72, P5994, DOI 10.1021/ac000849y; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Blanchet C, 2002, P NATL ACAD SCI USA, V99, P4674, DOI 10.1073/pnas.072075399; BOOTH RG, 1990, MOL PHARMACOL, V38, P92; CASS WA, 1991, J NEUROCHEM, V57, P147, DOI 10.1111/j.1471-4159.1991.tb02109.x; CHIODO LA, 1992, SYNAPSE, V11, P294, DOI 10.1002/syn.890110405; Chung YH, 2000, BRAIN RES, V875, P164, DOI 10.1016/S0006-8993(00)02586-5; Congar P, 2002, J NEUROPHYSIOL, V87, P1046, DOI 10.1152/jn.00459.2001; Cragg SJ, 1997, J NEUROSCI, V17, P5738; Davila V, 2003, J NEUROSCI, V23, P5693; DelleDonne KT, 1996, J COMP NEUROL, V371, P552; Dickinson SD, 1999, J NEUROCHEM, V72, P148, DOI 10.1046/j.1471-4159.1999.0720148.x; FARNEBO LO, 1971, ACTA PHYSIOL SCAND, P35; Fergus DJ, 2003, PFLUG ARCH EUR J PHY, V445, P697, DOI 10.1007/s00424-002-0994-7; Fulton S, 2011, J BIOL CHEM, V286, P9360, DOI 10.1074/jbc.M110.153262; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Gay EA, 2004, MOL PHARMACOL, V66, P97, DOI 10.1124/mol.66.1.97; Godino MD, 2005, NEUROPHARMACOLOGY, V48, P547, DOI 10.1016/j.neuropharm.2004.11.012; GRACE AA, 1985, BRAIN RES, V333, P285, DOI 10.1016/0006-8993(85)91582-3; Greffrath W, 1998, J PHYSIOL-LONDON, V513, P493, DOI 10.1111/j.1469-7793.1998.493bb.x; Guatteo E, 2004, J NEUROPHYSIOL, V92, P3368, DOI 10.1152/jn.00602.2004; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Harvey AL, 2004, CURR MED CHEM, V11, P3065, DOI 10.2174/0929867043363820; Harvey AL, 1997, GEN PHARMACOL-VASC S, V28, P7, DOI 10.1016/S0306-3623(96)00173-5; Inanobe A, 1999, J NEUROSCI, V19, P1006; Joseph JD, 2002, NEUROSCIENCE, V112, P39, DOI 10.1016/S0306-4522(02)00067-2; KALIVAS PW, 1991, J NEUROCHEM, V56, P961, DOI 10.1111/j.1471-4159.1991.tb02015.x; Kanjhan R, 2005, J PHARMACOL EXP THER, V314, P1353, DOI 10.1124/jpet.105.085928; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KEHR W, 1972, J PHARM PHARMACOL, V24, P744, DOI 10.1111/j.2042-7158.1972.tb09104.x; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Kloppenburg P, 1999, J NEUROPHYSIOL, V81, P29, DOI 10.1152/jn.1999.81.1.29; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Kuzhikandathil EV, 1998, MOL CELL NEUROSCI, V12, P390, DOI 10.1006/mcne.1998.0722; L'hirondel M, 1998, BRAIN RES, V792, P253, DOI 10.1016/S0006-8993(98)00146-2; LACEY MG, 1988, J PHYSIOL-LONDON, V401, P437, DOI 10.1113/jphysiol.1988.sp017171; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Langer SZ, 1997, TRENDS PHARMACOL SCI, V18, P95, DOI 10.1016/S0165-6147(96)01034-6; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; LIU LX, 1994, SYNAPSE, V17, P230, DOI 10.1002/syn.890170404; LLEDO PM, 1990, NEUROENDOCRINOLOGY, V52, P545, DOI 10.1159/000125650; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Marker CL, 2005, J NEUROSCI, V25, P3551, DOI 10.1523/JNEUROSCI.4899-04.2005; Mayfield RD, 2001, MOL PHARMACOL, V59, P113, DOI 10.1124/mol.59.1.113; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Nashmi R, 2000, EUR J NEUROSCI, V12, P491, DOI 10.1046/j.1460-9568.2000.00926.x; OHara CM, 1996, J PHARMACOL EXP THER, V277, P186; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Phillips PEM, 2002, SYNAPSE, V44, P15, DOI 10.1002/syn.10049; Pothos EN, 1998, J NEUROSCI, V18, P5575; Ralevic V, 2003, EUR J PHARMACOL, V472, P1, DOI 10.1016/S0014-2999(03)01813-2; Rouge-Pont F, 2002, J NEUROSCI, V22, P3293, DOI 10.1523/JNEUROSCI.22-08-03293.2002; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Scuvee-Moreau J, 2002, J PHARMACOL EXP THER, V302, P1176, DOI 10.1124/jpet.302.3.1176; Seutin V, 1998, J NEUROPHYSIOL, V80, P3361, DOI 10.1152/jn.1998.80.6.3361; Shen WX, 2004, J NEUROPHYSIOL, V91, P1337, DOI 10.1152/jn.00414.2003; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Southan AP, 2000, J NEUROSCI, V20, P114, DOI 10.1523/JNEUROSCI.20-01-00114.2000; STAMFORD JA, 1991, BRIT J PHARMACOL, V102, P45, DOI 10.1111/j.1476-5381.1991.tb12130.x; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Uchida S, 2000, NEUROPHARMACOLOGY, V39, P191, DOI 10.1016/S0028-3908(99)00111-2; Walker QD, 2006, NEUROPSYCHOPHARMACOL, V31, P1193, DOI 10.1038/sj.npp.1300915; Walker QD, 2000, NEUROSCIENCE, V95, P1061; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; WERKMAN TR, 1993, MOL PHARMACOL, V44, P430; Wetherington JP, 2002, J NEUROSCI, V22, P1248, DOI 10.1523/JNEUROSCI.22-04-01248.2002; WHITE FJ, 1984, LIFE SCI, V34, P1161, DOI 10.1016/0024-3205(84)90088-2; Yeung SYM, 2005, J NEUROSCI, V25, P8735, DOI 10.1523/JNEUROSCI.2119-05.2005	73	49	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20402	10.1371/journal.pone.0020402	http://dx.doi.org/10.1371/journal.pone.0020402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647367	gold, Green Published			2022-12-25	WOS:000291052500057
J	Zavalaga, CB; Dell'Omo, G; Becciu, P; Yoda, K				Zavalaga, Carlos B.; Dell'Omo, Giacomo; Becciu, Paolo; Yoda, Ken			Patterns of GPS Tracks Suggest Nocturnal Foraging by Incubating Peruvian Pelicans (Pelecanus thagus)	PLOS ONE			English	Article							BROWN-PELICAN; WANDERING ALBATROSS; DIVING BEHAVIOR; MARINE PREDATOR; NORTHERN PERU; PREY CAPTURE; SEABIRDS; SEA; ECOLOGY; DEPTH	Most seabirds are diurnal foragers, but some species may also feed at night. In Peruvian pelicans (Pelecanus thagus), the evidence for nocturnal foraging is sparse and anecdotal. We used GPS-dataloggers on five incubating Peruvian pelicans from Isla Lobos de Tierra, Peru, to examine their nocturnality, foraging movements and activities patterns at sea. All instrumented pelicans undertook nocturnal trips during a 5-7 day tracking period. Eighty-seven percent of these trips (n = 13) were strictly nocturnal, whereas the remaining occurred during the day and night. Most birds departed from the island after sunset and returned a few hours after sunrise. Birds traveled south of the island for single-day trips at a maximum range of 82.8 km. Overall, 22% of the tracking period was spent at sea, whereas the remaining time was spent on the island. In the intermediate section of the trip (between inbound and outbound commutes), birds spent 77% of the trip time in floating bouts interspersed by short flying bouts, the former being on average three times longer than the latter. Taken together, the high sinuosity of the bird's tracks during floating bouts, the exclusively nocturnal trips of most individuals, and the fact that all birds returned to the island within a few hours after sunrise suggest that pelicans were actively feeding at night. The nocturnal foraging strategy of Peruvian pelicans may reduce food competition with the sympatric and strictly diurnal Guanay cormorants (Phalacrocorax bougainvillii), Peruvian boobies (Sula variegata) and Blue-footed boobies (S. nebouxii), which were present on the island in large numbers. Likewise, plankton bioluminescence might be used by pelicans as indirect cues to locate anchovies during their upward migration at night. The foraging success of pelicans at night may be enhanced by seizing prey close to the sea surface using a sit-and-wait strategy.	[Zavalaga, Carlos B.; Yoda, Ken] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan; [Dell'Omo, Giacomo; Becciu, Paolo] Ornis ital, Rome, Italy	Nagoya University	Zavalaga, CB (corresponding author), Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan.	cbz3724@alum.uncw.edu	Becciu, Paolo/AAK-6790-2020	Becciu, Paolo/0000-0003-2145-6667; Dell'Omo, Giacomo/0000-0002-9601-9675	Japan Society for the Promotion of Science [71009317, 20519002]; Ornis italica	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ornis italica	The work was funded by Japan Society for the Promotion of Science (for CBZ), Grant No. 71009317; Japan Society for the Promotion of Science (for KY), Grant No. 20519002; and Ornis italica (for GD and PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCOS JM, 2002, MAR BIOL, V141, P177; ARNQVIST G, 1992, CONDOR, V94, P521, DOI 10.2307/1369223; Bertrand A, 2008, PROG OCEANOGR, V79, P264, DOI 10.1016/j.pocean.2008.10.018; Bertrand S, 2008, PROG OCEANOGR, V79, P379, DOI 10.1016/j.pocean.2008.10.009; Dellinger T, 1999, CAN J ZOOL, V77, P1204, DOI 10.1139/cjz-77-8-1204; DUFFY DC, 1980, IBIS, V122, P521, DOI 10.1111/j.1474-919X.1980.tb00910.x; DUFFY DC, 1983, AUK, V100, P800, DOI 10.1093/auk/100.4.800; FORBES HO, 1914, IBIS, V2, P403; GALARZA N, 1968, INFORME ESPECIAL I M, V31, P1; GARTHE S, 1996, WATERBIRDS, V19, P232; GUILLEN V, 1990, B LIMA, V67, P85; HAILMAN JACK P., 1964, WILSON BULL, V76, P347; HARPER P C, 1987, Notornis, V34, P169; HARRIS MP, 1970, AUK, V87, P215, DOI 10.2307/4083917; Jahncke J, 2000, WATERBIRDS, V23, P102; Jahncke J., 1998, B I MAR PERU, V17, P15; Joo R, 2011, ECOL MODEL, V222, P1048, DOI 10.1016/j.ecolmodel.2010.08.039; JORDA NR, 1967, CALIFORNIA COOPERATI, V1, P105; Ludynia K, 2010, J ORNITHOL, V151, P103, DOI 10.1007/s10336-009-0431-1; MATHISEN OA, 1989, ICLARM C P, P220; MCMAHON BF, 1992, CONDOR, V94, P101, DOI 10.2307/1368800; McNeil Raymond, 1993, Current Ornithology, V10, P187; Murphy RC, 1936, OCEANIC BIRDS S AM, VII; NELSON JB, 1985, PELICANS CORMORANTS; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; RICHARDSON FRANK, 1939, CONDOR, V41, P13, DOI 10.2307/1364267; ROBERT M, 1989, COLON WATERBIRD, V12, P118, DOI 10.2307/1521322; SCHREIBER RW, 1975, AUK, V92, P649, DOI 10.2307/4084778; Shamoun-Baranes J, 2011, IBIS, V153, P411, DOI 10.1111/j.1474-919X.2010.01096.x; Shealer David A., 2002, P137; Simeone A, 2003, REV CHIL HIST NAT, V76, P323, DOI 10.4067/S0716-078X2003000200016; SQUIRE JL, 1978, FISH B-NOAA, V76, P443; Vogt W., 1942, B COMPANIA ADM GUANO, V18, P3; VOTIERSC, 2004, NATURE, V427, P727; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019; Zavalaga CB, 2007, MAR ECOL PROG SER, V336, P291, DOI 10.3354/meps336291; Zavalaga CB, 2010, MAR ECOL PROG SER, V404, P259, DOI 10.3354/meps08490; Zavalaga CB, 1999, S AFR J MARINE SCI, V21, P251	42	25	25	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e19966	10.1371/journal.pone.0019966	http://dx.doi.org/10.1371/journal.pone.0019966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647444	Green Published, Green Submitted, gold			2022-12-25	WOS:000291006500015
J	Lo, SS; Hung, PS; Chen, JH; Tu, HF; Fang, WL; Chen, CY; Chen, WT; Gong, NR; Wu, CW				Lo, S-S; Hung, P-S; Chen, J-H; Tu, H-F; Fang, W-L; Chen, C-Y; Chen, W-T; Gong, N-R; Wu, C-W			Overexpression of miR-370 and downregulation of its novel target TGF beta-RII contribute to the progression of gastric carcinoma	ONCOGENE			English	Article						carcinoma; microRNA; miR-370; plasma; stomach; TGF beta-RII	MICRORNA EXPRESSION; CANCER; SIGNATURE; GROWTH; RNA; SUPPRESSION; DIAGNOSIS; PATTERNS; PATHWAY; TUMORS	MicroRNAs (miRNAs) are endogenous non-coding RNAs that are known to be involved in the pathogenesis of tumors. Gastric carcinoma (GC) is a common malignancy worldwide. The aim of this study was the identification of the expression signature and functional roles of aberrant miRNAs in GC. Initial screening established a profile of aberrantly expressed miRNAs in tumors. miR-370 was confirmed to be overexpressed in GC tissues. Higher expression of miR-370 in GC tissues was associated with more advanced nodal metastasis and a higher clinical stage compared with controls. In addition, significantly higher level of miR-370 was noted in the plasma of GC patients compared with controls. Patients having more invasive or advanced tumors also exhibited a higher plasma level of miR-370. In vitro assays indicated that exogenous miR-370 expression enhanced the oncogenic potential of GC cells. The AGS-GFPM2 cells with exogenous miR-370 expression also exhibited enhanced abdominal metastatic dissemination in nude mice. Reporter assays confirmed that miR-370 targeted predicted sites in 3'UTR of transforming growth factor-beta receptor II (TGF beta-RII) gene. The exogenous miR-370 expression decreased TGF beta-RII expression and the phosphorylation of Smad3 elicited by TGF beta 1. The TGF beta 1-mediated repression in cell migration was reverted by exogenous miR-370 expression. A reverse correlation between miR-370 and TGF beta-RII expression was noted in GC tissues. This study concludes that miR-370 is a miRNA that is associated with GC progression by downregulating TGF beta-RII. The miRNA expression profile described in this study should contribute to future studies on the role of miRNAs in GC. Oncogene (2012) 31, 226-237; doi:10.1038/onc.2011.226; published online 13 June 2011	[Lo, S-S; Chen, C-Y; Chen, W-T] Natl Yang Ming Univ Hosp, Dept Surg, Yi Lan 26042, Taiwan; [Lo, S-S; Fang, W-L; Chen, C-Y; Chen, W-T; Wu, C-W] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei 112, Taiwan; [Hung, P-S; Tu, H-F; Gong, N-R] Natl Yang Ming Univ Hosp, Dept Dent, Yi Lan 26042, Taiwan; [Chen, J-H; Fang, W-L; Wu, C-W] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Lo, SS (corresponding author), Natl Yang Ming Univ Hosp, Dept Surg, 152 Shin Min Rd, Yi Lan 26042, Taiwan.	sslo@ymuh.ym.edu.tw	Xie, Huangming/B-2260-2012		National Science Council [96-2314-B-010-055-MY3]; National Yang-Ming University Hospital [RD 2008-001]	National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University Hospital	We acknowledge helps from Dr Shu-Chun Lin, Dr Kuo-Wei Chang, Ms Yu-Pin Chen, Mr Shi-Wen Chen and Mr Chung-Sheng Chou. This study was supported by grant 96-2314-B-010-055-MY3 from National Science Council, and National Yang-Ming University Hospital Grant RD 2008-001.	Ando T, 2009, INT J CANCER, V124, P2367, DOI 10.1002/ijc.24219; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Lin HL, 2007, INT J CANCER, V121, P2547, DOI 10.1002/ijc.22963; Hsu KW, 2009, MOL BIOL CELL, V20, P5127, DOI 10.1091/mbc.E09-05-0386; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ju HR, 2003, CANCER LETT, V196, P197, DOI 10.1016/S0304-3835(03)00237-4; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Komuro A, 2009, JNCI-J NATL CANCER I, V101, P592, DOI 10.1093/jnci/djp058; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lo SS, 2009, SURGERY, V145, P280, DOI 10.1016/j.surg.2008.11.001; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Motoyama K, 2008, CLIN CANCER RES, V14, P2334, DOI 10.1158/1078-0432.CCR-07-4667; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wu CW, 2006, LANCET ONCOL, V7, P309, DOI 10.1016/S1470-2045(06)70623-4; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yoshino H, 2011, BRIT J CANCER, V104, P808, DOI 10.1038/bjc.2011.23; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	43	88	93	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	2					226	237		10.1038/onc.2011.226	http://dx.doi.org/10.1038/onc.2011.226			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21666718				2022-12-25	WOS:000299307400008
J	Min, Y; Ghose, S; Boelte, K; Li, J; Yang, L; Lin, PC				Min, Y.; Ghose, S.; Boelte, K.; Li, J.; Yang, L.; Lin, P. C.			C/EBP-delta regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1 alpha	ONCOGENE			English	Article						C/EBP-delta; VEGF-C; HIF-1 alpha; lymphangiogenesis; metastasis	BINDING-PROTEIN-DELTA; GROWTH-FACTOR-C; LYMPHATIC ENDOTHELIAL-CELLS; FACTOR-ALPHA-RECEPTOR; SMOOTH-MUSCLE-CELLS; NODE METASTASIS; GENE-EXPRESSION; BREAST-CANCER; TUMOR LYMPHANGIOGENESIS; MICE LACKING	CCAAT/enhancer-binding protein-delta (C/EBP-delta), a transcription factor, is elevated in carcinoma compared with that in normal tissue. This study reports a novel function of C/EBP-delta in lymphangiogenesis and tumor metastasis. Genetic deletion of C/EBP-delta in mice resulted in a significant reduction of lymphangiogenesis and pulmonary metastases, with a dramatic reduction of vascular endothelial growth factor-C (VEGF-C) and its cognate receptor VEGF receptor-3 (VEGFR3) in lymphatic endothelial cells (LECs). By contrast, no difference of VEGF-C in tumor tissues and bone marrow was observed between null and wild-type mice. Consistently, forced expression of C/EBP-delta increased VEGF-C and VEGFR3 expression in cultured LECs. These findings suggest a specific and important role of C/EBP-delta in the regulation of VEGFR3 signaling in LECs. Furthermore, expression of C/EBP-delta in cultured LECs significantly increased cell motility, and knockdown of C/EBP-delta inhibited cell motility and lymphatic vascular network formation in vitro. Forced expression of VEGF-C, but not recombinant VEGF-C, rescued the knockdown of C/EBP-delta-induced cell apoptosis, indicative of autonomous VEGF-C autocrine signaling essential for LEC survival. Moreover, hypoxia induces C/EBP-delta expression and C/EBP-delta regulates HIF-1 alpha expression. Blocking HIF-1 alpha activity totally blocked CEBP-delta-induced VEGF-C and VEGFR3 expression in LECs. Together, these findings uncover a new function of CEBP-delta in lymphangiogenesis through regulation of VEGFR3 signaling in LECs. Oncogene (2011) 30, 4901-4909; doi:10.1038/onc.2011.187; published online 13 June 2011	[Min, Y.; Yang, L.; Lin, P. C.] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA; [Ghose, S.; Li, J.] Vanderbilt Univ, Med Ctr, Dept Radiat Oncol, Nashville, TN USA; [Boelte, K.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University	Lin, PC (corresponding author), NCI, Mouse Canc Genet Program, Ctr Canc Res, 1050 Boyles St,Bldg 560,Room 12-89, Frederick, MD 21702 USA.	p.lin@nih.edu			NIH [CA108856, NS45888, AR053718]; NATIONAL CANCER INSTITUTE [R01CA108856, ZIABC011390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from NIH (CA108856, NS45888 and AR053718).	Akagi K, 2000, BRIT J CANCER, V83, P887, DOI 10.1054/bjoc.2000.1396; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Helotera H, 2007, CELL, V130, P591, DOI 10.1016/j.cell.2007.08.012; Irigoyen M, 2007, BBA-MOL CELL RES, V1773, P880, DOI 10.1016/j.bbamcr.2007.03.001; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Katsuta M, 2005, EXP MOL PATHOL, V78, P123, DOI 10.1016/j.yexmp.2004.11.002; Kim YS, 1998, J BIOL CHEM, V273, P27686, DOI 10.1074/jbc.273.42.27686; Kitami Y, 1999, CIRC RES, V84, P64; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Kuwai T, 2003, INT J CANCER, V105, P176, DOI 10.1002/ijc.11068; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Ota H, 2007, FEBS LETT, V581, P5220, DOI 10.1016/j.febslet.2007.10.009; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Rabek JP, 1998, BBA-GENE STRUCT EXPR, V1398, P137, DOI 10.1016/S0167-4781(98)00038-4; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Schoppmann SF, 2006, BREAST CANCER RES TR, V99, P135, DOI 10.1007/s10549-006-9190-3; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Simiantonaki N, 2008, INT J ONCOL, V32, P585; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Takata Y, 2002, CIRC RES, V91, P427, DOI 10.1161/01.RES.0000031271.20771.4F; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Yang ZH, 2001, CIRC RES, V89, P503, DOI 10.1161/hh1801.096265; Yonemura Y, 1999, CLIN CANCER RES, V5, P1823	35	53	56	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2011	30	49					4901	4909		10.1038/onc.2011.187	http://dx.doi.org/10.1038/onc.2011.187			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YI	21666710	Green Accepted			2022-12-25	WOS:000298346400006
J	Mitsutake, S; Zama, K; Yokota, H; Yoshida, T; Tanaka, M; Mitsui, M; Ikawa, M; Okabe, M; Tanaka, Y; Yamashita, T; Takemoto, H; Okazaki, T; Watanabe, K; Igarashi, Y				Mitsutake, Susumu; Zama, Kota; Yokota, Hazuki; Yoshida, Tetsuya; Tanaka, Miki; Mitsui, Masaru; Ikawa, Masahito; Okabe, Masaru; Tanaka, Yoshikazu; Yamashita, Tadashi; Takemoto, Hiroshi; Okazaki, Toshiro; Watanabe, Ken; Igarashi, Yasuyuki			Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ACID SPHINGOMYELINASE; CELL-GROWTH; SYNTHASE 2; MICE; CERAMIDE; ENDOCYTOSIS; CAVEOLIN-1; RAFTS; ATHEROSCLEROSIS	Lipid microdomains or caveolae, small invaginations of plasma membrane, have emerged as important elements for lipid uptake and glucose homeostasis. Sphingomyelin (SM) is one of the major phospholipids of the lipid microdomains. In this study, we investigated the physiological function of sphingomyelin synthase 2 (SMS2) using SMS2 knock-out mice, and we found that SMS2 deficiency prevents high fat diet-induced obesity and insulin resistance. Interestingly, in the liver of SMS2 knock-out mice, large and mature lipid droplets were scarcely observed. Treatment with siRNA for SMS2 also decreased the large lipid droplets in HepG2 cells. Additionally, the siRNA of SMS2 decreased the accumulation of triglyceride in liver of leptin-deficient (ob/ob) mice, strongly suggesting that SMS2 is involved in lipid droplet formation. Furthermore, we found that SMS2 exists in lipid microdomains and partially associates with the fatty acid transporter CD36/FAT and with caveolin 1, a scaffolding protein of caveolae. Because CD36/FAT and caveolin 1 exist in lipid microdomains and are coordinately involved in lipid droplet formation, SMS2 is implicated in the modulation of the SM in lipid microdomains, resulting in the regulation of CD36/FAT and caveolae. Here, we established new cell lines, in which we can completely distinguish SMS2 activity from SMS1 activity, and we demonstrated that SMS2 could convert ceramide produced in the outer leaflet of the plasma membrane into SM. Our findings demonstrate the novel and dynamic regulation of lipid microdomains via conformational changes in lipids on the plasma membrane by SMS2, which is responsible for obesity and type 2 diabetes.	[Mitsutake, Susumu; Zama, Kota; Yokota, Hazuki; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido 0010021, Japan; [Yamashita, Tadashi] Hokkaido Univ, Fac Adv Life Sci, Dept Dev Biotechnol, Sapporo, Hokkaido 0010021, Japan; [Yoshida, Tetsuya; Tanaka, Miki; Mitsui, Masaru; Tanaka, Yoshikazu; Takemoto, Hiroshi] Shionogi & Co Ltd, Shionogi Innovat Ctr Drug Discovery, Sapporo, Hokkaido 0010021, Japan; [Ikawa, Masahito; Okabe, Masaru] Osaka Univ, Res Inst Microbial Dis & Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Okazaki, Toshiro] Tottori Univ, Fac Med, Dept Clin Lab, Tottori 6838503, Japan; [Watanabe, Ken] Natl Ctr Geriatr & Geriatr & Gerontol, Dept Bone & Joint Dis, Aichi 4748511, Japan	Hokkaido University; Hokkaido University; Shionogi & Company Limited; Osaka University; Tottori University; National Center for Geriatrics & Gerontology	Mitsutake, S (corresponding author), Kita 21,Nishi 11,Kita Ku, Sapporo, Hokkaido 0010021, Japan.	susumu-m@pharm.hokudai.ac.jp	Mitsutake, Susumu/A-4082-2012; ikawa, masahito/A-5315-2009; Watanabe, Ken/I-3960-2013; Okabe, Masaru/B-6917-2015	ikawa, masahito/0000-0001-9859-6217; Watanabe, Ken/0000-0003-0664-3915; Takemoto, Hiroshi/0000-0001-9893-0609; Okabe, Masaru/0000-0002-0803-9044	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [20670006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Future Drug Discovery and Medical Care Innovation Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Ehehalt R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-45; Fan YF, 2010, ARTERIOSCL THROM VAS, V30, P2114, DOI 10.1161/ATVBAHA.110.213363; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fujimoto T, 2000, J CELL SCI, V113, P3509; Fukasawa M, 2000, J BIOL CHEM, V275, P34028, DOI 10.1074/jbc.M005151200; Hailemariam TK, 2008, ARTERIOSCL THROM VAS, V28, P1519, DOI 10.1161/ATVBAHA.108.168682; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; Hakomori S, 2010, FEBS LETT, V584, P1901, DOI 10.1016/j.febslet.2009.10.065; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Houjou T, 2004, RAPID COMMUN MASS SP, V18, P3123, DOI 10.1002/rcm.1737; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu J, 2009, CIRC RES, V105, P295, DOI 10.1161/CIRCRESAHA.109.194613; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V363, P519, DOI 10.1016/j.bbrc.2007.09.010; Mitsutake S, 2007, BIOCHEM BIOPH RES CO, V359, P622, DOI 10.1016/j.bbrc.2007.05.160; Mitsutake S, 2010, J DERMATOL SCI, V60, P128, DOI 10.1016/j.jdermsci.2010.08.012; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Ortegren U, 2007, TRENDS ENDOCRIN MET, V18, P344, DOI 10.1016/j.tem.2007.08.007; OTTERBACH B, 1995, CELL, V81, P1053, DOI 10.1016/S0092-8674(05)80010-8; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Takagi S, 2003, J CLIN INVEST, V112, P1372, DOI 10.1172/JCI200318513; Tam C, 2010, J CELL BIOL, V189, P1027, DOI 10.1083/jcb.201003053; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Yamaoka S, 2004, J BIOL CHEM, V279, P18688, DOI 10.1074/jbc.M401205200; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	43	132	138	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28544	28555		10.1074/jbc.M111.255646	http://dx.doi.org/10.1074/jbc.M111.255646			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21669879	Green Published, hybrid			2022-12-25	WOS:000293557800069
J	Zhaorigetu, S; Yang, ZQ; Toma, I; McCaffrey, TA; Hu, CAA				Zhaorigetu, Siqin; Yang, Zhaoqing; Toma, Ian; McCaffrey, Timothy A.; Hu, Chien-An A.			Apolipoprotein L6, Induced in Atherosclerotic Lesions, Promotes Apoptosis and Blocks Beclin 1-dependent Autophagy in Atherosclerotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; BCL-2 PROTEIN FAMILY; MAMMALIAN AUTOPHAGY; MEDIATED APOPTOSIS; CANCER-CELLS; X-L; DEATH; DEGRADATION; PROGRESSION; EXPRESSION	Inflammatory cytokine-regulated apoptosis and autophagy play pivotal roles in plaque rupture and thrombosis of atherosclerotic lesions. However, the molecular interplay between apoptosis and autophagy in vascular cells has not been investigated. Our prior study showed that human apolipoprotein L6 (ApoL6), a pro-apoptotic BH3-only member of the Bcl-2 family, was one of the downstream targets of interferon-gamma (INF gamma), which sensitizes atherosclerotic lesion-derived cells (LDCs) to Fas-induced apoptosis. To investigate whether ApoL6 plays a causal role in atherosclerotic apoptosis and autophagy, in this study, we demonstrate that IFN gamma treatment itself strongly induces ApoL6, and ApoL6 is highly expressed and partially co-localized with activated caspase 3 in activated smooth muscle cells in atherosclerotic lesions. In addition, overexpression of ApoL6 promotes reactive oxygen species (ROS) generation, caspase activation, and subsequent apoptosis, which can be blocked by pan caspase inhibitor and ROS scavenger. Knockdown of ApoL6 expression by siApoL6 suppresses INF gamma- and Fas-mediated apoptosis. Further, ApoL6 binds Bcl-X-L, one of the most abundant anti-death proteins in LDCs. Interestingly, forced ApoL6 expression in LDCs induces degradation of Beclin 1, accumulation of p62, and subsequent attenuation of LC3-II formation and translocation and thus autophagy, whereas siApoL6 treatment reverts the phenotype. Taken together, our results suggest that ApoL6 regulates both apoptosis and autophagy in SMCs. IFN gamma-initiated, ApoL6-induced apoptosis in vascular cells may be an important factor causing plaque instability and a potential therapeutic target for treating atherosclerosis and cardiovascular disease.	[Zhaorigetu, Siqin; Hu, Chien-An A.] Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, Albuquerque, NM 87131 USA; [Yang, Zhaoqing; Toma, Ian; McCaffrey, Timothy A.] George Washington Univ, Dept Med, Div Genom Med, Washington, DC 20037 USA; [Yang, Zhaoqing; Toma, Ian; McCaffrey, Timothy A.] George Washington Univ, Richard B & Lynne V Cheney Cardiovasc Inst, Washington, DC 20037 USA	University of New Mexico; George Washington University; George Washington University	Hu, CAA (corresponding author), Univ New Mexico, Dept Biochem & Mol Biol, Sch Med, MSC08 4670,1 Univ New Mexico, Albuquerque, NM 87131 USA.	AHu@salud.unm.edu	Toma, Ian/D-8833-2014	Toma, Ian/0000-0002-9637-5899	National Institutes of Health [3P20RR016480-04, AG12712]; NATIONAL CANCER INSTITUTE [R01CA106644] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012712, R01AG012712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 3P20RR016480-04 (to C. A. A. H.) and AG12712 (to T. A. M.).	Bauriedel G, 1999, CARDIOVASC RES, V41, P480, DOI 10.1016/S0008-6363(98)00318-6; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; Chan SW, 2000, CIRC RES, V86, P1038, DOI 10.1161/01.RES.86.10.1038; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Clarke M, 2006, AM J NEPHROL, V26, P531, DOI 10.1159/000097815; Clarke M, 2006, CELL CYCLE, V5, P2329, DOI 10.4161/cc.5.20.3383; Donald SP, 2001, CANCER RES, V61, P1810; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Du BH, 2000, J BIOL CHEM, V275, P39039, DOI 10.1074/jbc.M005159200; Gagarin D, 2005, J MOL CELL CARDIOL, V39, P453, DOI 10.1016/j.yjmcc.2005.01.015; Geng YH, 2002, ARTERIOSCL THROM VAS, V22, P1370, DOI 10.1161/01.ATV.0000031341.84618.A4; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hayakawa Y, 1999, ARTERIOSCL THROM VAS, V19, P2066, DOI 10.1161/01.ATV.19.9.2066; Hou W, 2010, AUTOPHAGY, V6, P891, DOI 10.4161/auto.6.7.13038; Imanishi T, 2002, ATHEROSCLEROSIS, V161, P143, DOI 10.1016/S0021-9150(01)00631-1; Jia GH, 2007, AUTOPHAGY, V3, P63, DOI 10.4161/auto.3427; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kavurma MM, 2008, ARTERIOSCL THROM VAS, V28, P1694, DOI 10.1161/ATVBAHA.107.155143; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; KOLODGIE FD, 2001, CARDIOL CLIN, V19, P9; Kolodgie Frank D., 2001, Cardiology Clinics, V19, P127, DOI 10.1016/S0733-8651(05)70199-5; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kutuk O, 2006, APOPTOSIS, V11, P1661, DOI 10.1007/s10495-006-9402-7; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Liu ZH, 2005, MOL CANCER RES, V3, P21; Lomonosova E, 2008, ONCOGENE, V27, pS2, DOI 10.1038/onc.2009.39; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Martinet W, 2009, CIRC RES, V104, P304, DOI 10.1161/CIRCRESAHA.108.188318; McCaffrey TA, 2000, J CLIN INVEST, V105, P653, DOI 10.1172/JCI8592; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Niemann A, 2001, J HISTOCHEM CYTOCHEM, V49, P177, DOI 10.1177/002215540104900205; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pollman MJ, 1998, NAT MED, V4, P222, DOI 10.1038/nm0298-222; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rosner D, 2006, AM J PATHOL, V168, P2054, DOI 10.2353/ajpath.2006.050473; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Saxena A, 2002, J PATHOL, V196, P335, DOI 10.1002/path.1040; Schrijvers DM, 2005, ARTERIOSCL THROM VAS, V25, P1256, DOI 10.1161/01.ATV.0000166517.18801.a7; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Wan GH, 2008, J BIOL CHEM, V283, P21540, DOI 10.1074/jbc.M800214200; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yang ZQ, 2007, J VASC RES, V44, P483, DOI 10.1159/000106466; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	56	48	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27389	27398		10.1074/jbc.M110.210245	http://dx.doi.org/10.1074/jbc.M110.210245			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21646352	Green Published, hybrid			2022-12-25	WOS:000293268700034
J	Mushrush, DJ; Koteiche, HA; Sammons, MA; Link, AJ; Mchaourab, HS; Lacy, DB				Mushrush, Darren J.; Koteiche, Hanane A.; Sammons, Morgan A.; Link, Andrew J.; Mchaourab, Hassane S.; Lacy, D. Borden			Studies of the Mechanistic Details of the pH-dependent Association of Botulinum Neurotoxin with Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN T-DOMAIN; DIPHTHERIA-TOXIN; HEAVY-CHAIN; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; LIPID-BILAYERS; FORMS CHANNELS; ION CHANNELS; SIDE-CHAINS; LIGHT-CHAIN	Botulinum neurotoxin (BoNT) belongs to a large class of toxic proteins that act by enzymatically modifying cytosolic substrates within eukaryotic cells. The process by which a catalytic moiety is transferred across a membrane to enter the cytosol is not understood for any such toxin. BoNT is known to form pH-dependent pores important for the translocation of the catalytic domain into the cytosol. As a first step toward understanding this process, we investigated the mechanism by which the translocation domain of BoNT associates with a model liposome membrane. We report conditions that allow pH-dependent proteoliposome formation and identify a sequence at the translocation domain C terminus that is protected from proteolytic degradation in the context of the proteoliposome. Fluorescence quenching experiments suggest that residues within this sequence move to a hydrophobic environment upon association with liposomes. EPR analyses of spin-labeled mutants reveal major conformational changes in a distinct region of the structure upon association and indicate the formation of an oligomeric membrane-associated intermediate. Together, these data support a model of how BoNT orients with membranes in response to low pH.	[Mushrush, Darren J.; Link, Andrew J.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Koteiche, Hanane A.; Mchaourab, Hassane S.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Sammons, Morgan A.] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37232 USA; [Sammons, Morgan A.] Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37232 USA; [Link, Andrew J.; Lacy, D. Borden] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Lacy, DB (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, A-5301 Med Ctr N,1161 21st Ave S, Nashville, TN 37232 USA.	borden.lacy@vanderbilt.edu	Lacy, D. Borden/AFQ-2203-2022	Lacy, Borden/0000-0003-2273-8121	National Institutes of Health [AI075259, R21 AR055231, R01 GM64779]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064779, T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI075259.; Supported by National Institutes of Health Grants R21 AR055231 and R01 GM64779.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; BLAUSTEIN RO, 1987, FEBS LETT, V226, P115, DOI 10.1016/0014-5793(87)80562-8; Borjesson SI, 2008, CELL BIOCHEM BIOPHYS, V52, P149, DOI 10.1007/s12013-008-9032-5; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; DONOVAN JJ, 1986, BIOCHEMISTRY-US, V25, P2872, DOI 10.1021/bi00358a020; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fischer A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000245; Fu FN, 2002, BIOPHYS CHEM, V99, P17, DOI 10.1016/S0301-4622(02)00135-7; Galloux M, 2008, J BIOL CHEM, V283, P27668, DOI 10.1074/jbc.M802557200; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; GIMENEZ DF, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P421; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kumaran D, 2009, J MOL BIOL, V386, P233, DOI 10.1016/j.jmb.2008.12.027; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lai B, 2010, J MEMBRANE BIOL, V236, P191, DOI 10.1007/s00232-010-9292-z; Link AJ, 2005, METHODS, V35, P274, DOI 10.1016/j.ymeth.2004.08.019; Masuyer G, 2009, BIOCHEM BIOPH RES CO, V381, P50, DOI 10.1016/j.bbrc.2009.02.003; McAfee KJ, 2006, MOL CELL PROTEOMICS, V5, P1497, DOI 10.1074/mcp.T500027-MCP200; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; MONTECUCCO C, 1994, FEBS LETT, V346, P92, DOI 10.1016/0014-5793(94)00449-8; OBLATTMONTAL M, 1995, PROTEIN SCI, V4, P1490, DOI 10.1002/pro.5560040806; Oh KJ, 1996, SCIENCE, V273, P810, DOI 10.1126/science.273.5276.810; Oh KJ, 2000, METH MOL B, V145, P147; Rosconi MP, 2002, J BIOL CHEM, V277, P16517, DOI 10.1074/jbc.M200442200; SCHIAVO G, 1994, ANN NY ACAD SCI, V710, P65, DOI 10.1111/j.1749-6632.1994.tb26614.x; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SHIN YK, 1993, SCIENCE, V259, P960, DOI 10.1126/science.8382373; SHONE CC, 1987, EUR J BIOCHEM, V167, P175, DOI 10.1111/j.1432-1033.1987.tb13320.x; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Wang Y, 1997, J BIOL CHEM, V272, P25091, DOI 10.1074/jbc.272.40.25091	37	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27011	27018		10.1074/jbc.M111.256982	http://dx.doi.org/10.1074/jbc.M111.256982			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21652698	Green Published, hybrid			2022-12-25	WOS:000293078200074
J	Fernandez-Velasco, M; Ruiz-Hurtado, G; Rueda, A; Neco, P; Mercado-Morales, M; Delgado, C; Napolitano, C; Priori, SG; Richard, S; MariaGomez, A; Benitah, JP				Fernandez-Velasco, Maria; Ruiz-Hurtado, Gema; Rueda, Angelica; Neco, Patricia; Mercado-Morales, Martha; Delgado, Carmen; Napolitano, Carlo; Priori, Silvia G.; Richard, Sylvain; MariaGomez, Ana; Benitah, Jean-Pierre			RyRCa(2+) Leak Limits Cardiac Ca2+ Window Current Overcoming the Tonic Effect of Calmodulinin Mice	PLOS ONE			English	Article							PIG VENTRICULAR MYOCYTES; CHANNEL INACTIVATION; CALCIUM-CHANNELS; RYANODINE RECEPTORS; SARCOPLASMIC-RETICULUM; DEPENDENT INACTIVATION; INTRACELLULAR CA2+; ALPHA(1C) SUBUNIT; HEART-FAILURE; RELEASE	Ca2+ mediates the functional coupling between L-type Ca2+ channel (LTCC) and sarcoplasmic reticulum (SR) Ca2+ release channel (ryanodine receptor, RyR), participating in key pathophysiological processes. This crosstalk manifests as the orthograde Ca2+-induced Ca2+-release (CICR) mechanism triggered by Ca2+ influx, but also as the retrograde Ca2+-dependent inactivation (CDI) of LTCC, which depends on both Ca2+ permeating through the LTCC itself and on SR Ca2+ release through the RyR. This latter effect has been suggested to rely on local rather than global Ca2+ signaling, which might parallel the nanodomain control of CDI carried out through calmodulin (CaM). Analyzing the CICR in catecholaminergic polymorphic ventricular tachycardia (CPVT) mice as a model of RyR-generated Ca2+ leak, we evidence here that increased occurrence of the discrete local SR Ca2+ releases through the RyRs (Ca2+ sparks) causea depolarizing shift in activation and a hyperpolarizing shift inisochronic inactivation of cardiac LTCC current resulting in the reduction of window current. Both increasing fast [Ca2+](i) buffer capacity or depleting SR Ca2+ store blunted these changes, which could be reproduced in WT cells by RyRCa(2+) leak induced with Ryanodol and CaM inhibition. Our results unveiled a new paradigm for CaM-dependent effect on LTCC gating and further the nanodomain Ca2+ control of LTCC, emphasizing the importance of spatio-temporal relationships between Ca2+ signals and CaM function.	[Fernandez-Velasco, Maria; Ruiz-Hurtado, Gema; Rueda, Angelica; Neco, Patricia; Richard, Sylvain; MariaGomez, Ana; Benitah, Jean-Pierre] Univ Montpellier 2, Univ Montpellier 1, INSERM, U637, Montpellier, France; [Fernandez-Velasco, Maria] UAM, Inst Invest Biomed Alberto Sols, CSIC, Madrid, Spain; [Ruiz-Hurtado, Gema; Neco, Patricia; MariaGomez, Ana; Benitah, Jean-Pierre] Univ Paris 11, Fac Pharm, INSERM, U769,IFR141, F-92290 Chatenay Malabry, France; [Rueda, Angelica; Mercado-Morales, Martha] CINVESTAV, Dept Biochem, Mexico City 14000, DF, Mexico; [Delgado, Carmen] Univ Complutense, Dept Farmacol, Fac Med, E-28040 Madrid, Spain; [Napolitano, Carlo; Priori, Silvia G.] Fdn Salvatore Maugeri, Pavia, Italy; [Napolitano, Carlo; Priori, Silvia G.] NYU, Sch Med, Langone Med Ctr, Leon Charney Div Cardiol, New York, NY USA; [Priori, Silvia G.] Univ Pavia, Dept Cardiol, I-27100 Pavia, Italy; [Richard, Sylvain] Univ Montpellier 2, Univ Montpellier 1, INSERM, U1046, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Complutense University of Madrid; Istituti Clinici Scientifici Maugeri IRCCS; New York University; NYU Langone Medical Center; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Fernandez-Velasco, M (corresponding author), Univ Montpellier 2, Univ Montpellier 1, INSERM, U637, Montpellier, France.	pierre.benitah@inserm.fr	Ruiz-Hurtado, Gema/C-8254-2011; Delgado, Carmen/H-2251-2016; Napolitano, Carlo/K-4760-2016; Priori, Silvia G G/A-6116-2014; velasco, maria fernandez/AAO-5062-2021; Gomez, Ana M./B-5376-2013; Benitah, Jean-Pierre/L-6060-2018; Richard, Sylvain/C-9695-2016; napolitano, carlo/ABI-4608-2020; Priori, Silvia G/ABH-6894-2020; Rueda, Angelica/G-4055-2012; Rueda, Angelica/AAW-4621-2020	Ruiz-Hurtado, Gema/0000-0003-3482-0915; Delgado, Carmen/0000-0002-0047-4674; Napolitano, Carlo/0000-0002-7643-4628; Priori, Silvia G G/0000-0001-6877-0288; Gomez, Ana M./0000-0003-0009-2884; Benitah, Jean-Pierre/0000-0002-9866-9081; napolitano, carlo/0000-0002-7643-4628; Priori, Silvia G/0000-0001-6877-0288; Rueda, Angelica/0000-0001-8749-8494; Rueda, Angelica/0000-0001-8749-8494; Richard, Sylvain/0000-0001-9460-6705	Inserm; Agence National de la Recherche [ANR-09-GENO-034]; European Union [CT 2005 No018802]; Ministerio de Educacion y Ciencia of Spain; Conacyt [No80960]; Fondation de la Recherche Medicale; Telethon [NoGGP04066, GGP06007]; Ministero dell' Universita e della Ricerca Scientifica e Tecnologica [FIRB RBNE01XMP4_006, RBLA035A4X_002]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National de la Recherche(French National Research Agency (ANR)); European Union(European Commission); Ministerio de Educacion y Ciencia of Spain(Spanish Government); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Telethon(Fondazione Telethon); Ministero dell' Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR))	This research program was funded by Inserm, a grant from the Agence National de la Recherche (ANR-09-GENO-034) and a grant from the European Union (FPG, Life Science Genomics and Biotechnology for Health, contract CT 2005 No018802, CONTICA). MF-V was funded by Ministerio de Educacion y Ciencia of Spain, AR by Conacyt (Project No80960), PN by Fondation de la Recherche Medicale, and Telethon grants NoGGP04066 and GGP06007 and FIRB RBNE01XMP4_006, RBLA035A4X_002 from the Ministero dell' Universita e della Ricerca Scientifica e Tecnologica (to SGP and CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdachiAkahane S, 1996, J GEN PHYSIOL, V108, P435, DOI 10.1085/jgp.108.5.435; Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Altamirano J, 2007, AM J PHYSIOL-HEART C, V293, pH563, DOI 10.1152/ajpheart.00469.2006; Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; Benitah JP, 1999, CIRC RES, V85, P1139; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Cerrone M, 2005, CIRC RES, V96, pE77, DOI 10.1161/01.RES.0000169067.51055.72; Cheng HP, 2008, PHYSIOL REV, V88, P1491, DOI 10.1152/physrev.00030.2007; COHEN NM, 1988, J PHYSIOL-LONDON, V406, P115, DOI 10.1113/jphysiol.1988.sp017372; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dirksen RT, 2002, FRONT BIOSCI-LANDMRK, V7, pD659, DOI 10.2741/dirksen; FABIATO A, 1985, J GEN PHYSIOL, V85, P291, DOI 10.1085/jgp.85.2.291; Fernandez-Velasco M, 2009, CIRC RES, V104, P201, DOI 10.1161/CIRCRESAHA.108.177493; Findeisen F, 2009, J GEN PHYSIOL, V133, P327, DOI 10.1085/jgp.200810143; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gomez AM, 2009, CIRCULATION, V119, P2179, DOI 10.1161/CIRCULATIONAHA.108.805804; Grantham CJ, 1996, CIRC RES, V79, P194, DOI 10.1161/01.RES.79.2.194; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; HIRANO Y, 1992, CIRC RES, V70, P445, DOI 10.1161/01.RES.70.3.445; Isaev D, 2004, J GEN PHYSIOL, V123, P555, DOI 10.1085/jgp.200308876; KLOCKNER U, 1987, AM J PHYSIOL, V253, pH1601, DOI 10.1152/ajpheart.1987.253.6.H1601; Kubota Y, 2008, J NEUROPHYSIOL, V99, P264, DOI 10.1152/jn.00876.2007; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mazur A, 1999, CIRCULATION, V100, P2437, DOI 10.1161/01.CIR.100.24.2437; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Puglisi JL, 1999, CIRC RES, V85, pE7, DOI 10.1161/01.RES.85.6.e7; Qi X, 2009, CIRC-ARRHYTHMIA ELEC, V2, P295, DOI 10.1161/CIRCEP.108.815654; Ramos-Franco J, 2010, PFLUG ARCH EUR J PHY, V460, P767, DOI 10.1007/s00424-010-0839-8; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; Sham JSK, 1997, J PHYSIOL-LONDON, V500, P285, DOI 10.1113/jphysiol.1997.sp022020; SHAM JSK, 1995, P NATL ACAD SCI USA, V92, P121, DOI 10.1073/pnas.92.1.121; SIPIDO KR, 1995, CIRC RES, V76, P102, DOI 10.1161/01.RES.76.1.102; Soldatov NM, 1998, J BIOL CHEM, V273, P957, DOI 10.1074/jbc.273.2.957; Sun H, 1997, AM J PHYSIOL-HEART C, V272, pH1625, DOI 10.1152/ajpheart.1997.272.4.H1625; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tadross MR, 2010, J GEN PHYSIOL, V135, P197, DOI 10.1085/jgp.200910308; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Villain M, 2000, J BIOL CHEM, V275, P2676, DOI 10.1074/jbc.275.4.2676; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; YUE DT, 1990, SCIENCE, V250, P1735, DOI 10.1126/science.2176745; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287	45	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20863	10.1371/journal.pone.0020863	http://dx.doi.org/10.1371/journal.pone.0020863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673970	Green Published, Green Submitted, gold			2022-12-25	WOS:000291356400035
J	Concheri, G; Bertoldi, D; Polone, E; Otto, S; Larcher, R; Squartini, A				Concheri, Giuseppe; Bertoldi, Daniela; Polone, Elisa; Otto, Stefan; Larcher, Roberto; Squartini, Andrea			Chemical Elemental Distribution and Soil DNA Fingerprints Provide the Critical Evidence in Murder Case Investigation	PLOS ONE			English	Article							COMMUNITY STRUCTURE; BACTERIAL; PH	Background: The scientific contribution to the solution of crime cases, or throughout the consequent forensic trials, is a crucial aspect of the justice system. The possibility to extract meaningful information from trace amounts of samples, and to match and validate evidences with robust and unambiguous statistical tests, are the key points of such process. The present report is the authorized disclosure of an investigation, carried out by Attorney General appointment, on a murder case in northern Italy, which yielded the critical supporting evidence for the judicial trial. Methodology/Principal Findings: The proportional distribution of 54 chemical elements and the bacterial community DNA fingerprints were used as signature markers to prove the similarity of two soil samples. The first soil was collected on the crime scene, along a corn field, while the second was found in trace amounts on the carpet of a car impounded from the main suspect in a distant location. The matching similarity of the two soils was proven by crossing the results of two independent techniques: a) elemental analysis via inductively coupled plasma mass spectrometry (ICP-MS) and optical emission spectrometry (ICP-OES) approaches, and b) amplified ribosomal DNA restriction analysis by gel electrophoresis (ARDRA). Conclusions: Besides introducing the novel application of these methods to forensic disciplines, the highly accurate level of resolution observed, opens new possibilities also in the fields of soil typing and tracking, historical analyses, geochemical surveys and global land mapping.	[Concheri, Giuseppe; Polone, Elisa; Squartini, Andrea] Univ Padua, Dipartimento Biotecnol Agr, Padua, Italy; [Otto, Stefan] Natl Res Council CNR, Inst Agroenvironm & Forest Biol, Padua, Italy; [Bertoldi, Daniela; Larcher, Roberto] IASMA Edmund Mach Fdn, San Michele All Adige, Trento, Italy	University of Padua; Fondazione Edmund Mach	Concheri, G (corresponding author), Univ Padua, Dipartimento Biotecnol Agr, Padua, Italy.	squart@unipd.it	Bertoldi, Daniela/E-5566-2014; Concheri, Giuseppe/L-4151-2015; Larcher, Roberto/B-5946-2013; Squartini, Andrea/AAX-9942-2020	Bertoldi, Daniela/0000-0001-7512-1286; Concheri, Giuseppe/0000-0002-5812-8504; Larcher, Roberto/0000-0002-4784-8389; Squartini, Andrea/0000-0002-1961-1165; Otto, Stefan/0000-0002-4341-8517	Prosecutor's Office at the Court of Padova	Prosecutor's Office at the Court of Padova	This work was supported in part by the Prosecutor's Office at the Court of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Carletti P, 2009, PLANT SOIL, V315, P47, DOI 10.1007/s11104-008-9732-z; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Gilbert R. O., 1987, STAT METHODS ENV POL; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; MURRAY R, FORENSIC GEOLOGY EAR; Murray R.C., 2004, EVIDENCE EARTH; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Pye K., 2007, GEOLOGICAL SOIL EVID; PYE K., 2004, SPECIAL PUBLICATIONS, V232; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Ruffell A, 2008, GEOFORENSICS, P332; Ruffell A, 2010, FORENSIC SCI INT, V202, P9, DOI 10.1016/j.forsciint.2010.03.044; VANEECHOUTTE M, 1993, J CLIN MICROBIOL, V31, P2061, DOI 10.1128/JCM.31.8.2061-2065.1993	15	35	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20222	10.1371/journal.pone.0020222	http://dx.doi.org/10.1371/journal.pone.0020222			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21674041	Green Submitted, gold, Green Published			2022-12-25	WOS:000291355500008
J	Morgan, K; Dennis, NA; Ruffman, T; Bilkey, DK; McLennan, IS				Morgan, Kirstie; Dennis, Nicola A.; Ruffman, Ted; Bilkey, David K.; McLennan, Ian S.			The Stature of Boys Is Inversely Correlated to the Levels of Their Sertoli Cell Hormones: Do the Testes Restrain the Maturation of Boys?	PLOS ONE			English	Article							MULLERIAN-INHIBITING SUBSTANCE; CHROMATOGRAPHY-MASS-SPECTROMETRY; HEIGHT; STANDARDS; CHILDREN; AGE	The testes of preadolescent boys appear to be dormant, as they produce only trace levels of testosterone [1]. However, they release supra-adult levels of Mullerian Inhibiting Substance (MIS, anti-Mullerian hormone) and lesser levels of inhibin B (InhB), for unknown reasons [2,3]. Boys have a variable rate of maturation, which on average is slower than girls. The height of children relative to their parents is an index of their maturity [4,5]. We report here that a boy's level of MIS and InhB is stable over time and negatively correlates with his height and his height relative to his parent's height. This suggests that boy's with high levels of MIS and InhB are short because they are immature, rather than because they are destined to be short men. The levels of MIS and InhB in the boys did not correlate with known hormonal modulators of growth, and were additive with age and the growth hormone/IGF1 axis as predictors of a boy's height. If MIS and InhB were causal regulators of maturity, then the inter-boy differences in the levels of these hormone produces variation in maturation equivalent to 18-months of development. MIS and InhB may thus account for most of the variation in the rate of male development. If boys lacked these hormones, then an average 5-year-old boy would be over 5 cm taller than age-matched girls, making boys almost as dimorphic as men, for height. This indicates that boys have a high growth potential that is initially suppressed by their testes. The concept of the childhood testes suppressing an adult male feature appears paradoxical. However, the growth of children requires intergenerational transfer of nutrients. Consequently, the MIS/InhB slowing of male growth may have been historically advantageous, as it would minimizes any sex bias in the maternal cost of early child rearing.	[Morgan, Kirstie; Dennis, Nicola A.; McLennan, Ian S.] Univ Otago, Dept Anat & Struct Biol, Brain Hlth Res Ctr, Dunedin, New Zealand; [Morgan, Kirstie; Ruffman, Ted; Bilkey, David K.] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago; University of Otago	Morgan, K (corresponding author), Univ Otago, Dept Anat & Struct Biol, Brain Hlth Res Ctr, Dunedin, New Zealand.	ian.mclennan@anatomy.otago.ac.nz		Dennis, Nicola/0000-0002-0658-6140	Royal Society of New Zealand	Royal Society of New Zealand(Royal Society of New Zealand)	The Marsden Fund of the Royal Society of New Zealand supported this work (http://www.royalsociety.org.nz/programmes/funds/marsden/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksglaede L, 2010, J CLIN ENDOCR METAB, V95, P5357, DOI 10.1210/jc.2010-1207; Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Andersson AM, 2001, MOL CELL ENDOCRINOL, V180, P103, DOI 10.1016/S0303-7207(01)00520-2; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; EATON SB, 1994, Q REV BIOL, V69, P353, DOI 10.1086/418650; HAWKES K, 1995, CURR ANTHROPOL, V36, P688, DOI 10.1086/204420; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Lee MM, 1996, J CLIN ENDOCR METAB, V81, P571, DOI 10.1210/jc.81.2.571; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; Marlowe F.W., 2005, HUNTER GATHERER CHIL, P19; MCLENNAN IS, 1994, PROG NEUROBIOL, V44, P119, DOI 10.1016/0301-0082(94)90035-3; Mircea CN, 2007, J OBSTET GYNAECOL CA, V29, P887, DOI 10.1016/S1701-2163(16)32661-5; Monteilh C, 2011, PAEDIATR PERINAT EP, V25, P75, DOI 10.1111/j.1365-3016.2010.01168.x; Morgan K, 2011, BEHAV BRAIN RES, V221, P304, DOI 10.1016/j.bbr.2011.02.048; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; TANNER JM, 1975, ARCH DIS CHILD, V50, P14, DOI 10.1136/adc.50.1.14; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; Wang PY, 2009, P NATL ACAD SCI USA, V106, P7203, DOI 10.1073/pnas.0902253106; Wang PY, 2005, P NATL ACAD SCI USA, V102, P16421, DOI 10.1073/pnas.0508304102; WUDY SA, 1995, PEDIATR RES, V38, P76, DOI 10.1203/00006450-199507000-00013; Wudy SA, 1999, J CLIN ENDOCR METAB, V84, P2724, DOI 10.1210/jc.84.8.2724; Yan W, 2003, APMIS, V111, P174, DOI 10.1034/j.1600-0463.2003.1110121.x	25	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20533	10.1371/journal.pone.0020533	http://dx.doi.org/10.1371/journal.pone.0020533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21655101	gold, Green Published, Green Submitted			2022-12-25	WOS:000291310600013
J	Bacon, C; Endris, V; Andermatt, I; Niederkofler, V; Waltereit, R; Bartsch, D; Stoeckli, ET; Rappold, G				Bacon, Claire; Endris, Volker; Andermatt, Irwin; Niederkofler, Vera; Waltereit, Robert; Bartsch, Dusan; Stoeckli, Esther T.; Rappold, Gudrun			Evidence for a Role of srGAP3 in the Positioning of Commissural Axons within the Ventrolateral Funiculus of the Mouse Spinal Cord	PLOS ONE			English	Article							ROUNDABOUT RECEPTOR; ROBO RECEPTORS; GUIDANCE; MIDLINE; SLIT; EXPRESSION; REPULSION; RAC; PROTEINS; WAVE-1	Slit-Robo signaling guides commissural axons away from the floor-plate of the spinal cord and into the longitudinal axis after crossing the midline. In this study we have evaluated the role of the Slit-Robo GTPase activating protein 3 (srGAP3) in commissural axon guidance using a knockout (KO) mouse model. Co-immunoprecipitation experiments confirmed that srGAP3 interacts with the Slit receptors Robo1 and Robo2 and immunohistochemistry studies showed that srGAP3 co-localises with Robo1 in the ventral and lateral funiculus and with Robo2 in the lateral funiculus. Stalling axons have been reported in the floor-plate of Slit and Robo mutant spinal cords but our axon tracing experiments revealed no dorsal commissural axon stalling in the floor plate of the srGAP3 KO mouse. Interestingly we observed a significant thickening of the ventral funiculus and a thinning of the lateral funiculus in the srGAP3 KO spinal cord, which has also recently been reported in the Robo2 KO. However, axons in the enlarged ventral funiculus of the srGAP3 KO are Robo1 positive but do not express Robo2, indicating that the thickening of the ventral funiculus in the srGAP3 KO is not a Robo2 mediated effect. We suggest a role for srGAP3 in the lateral positioning of post crossing axons within the ventrolateral funiculus.	[Bacon, Claire; Endris, Volker; Rappold, Gudrun] Heidelberg Univ, Dept Human Mol Genet, Heidelberg, Germany; [Andermatt, Irwin; Niederkofler, Vera; Stoeckli, Esther T.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Waltereit, Robert; Bartsch, Dusan] Heidelberg Univ, Cent Inst Mental Hlth, Dept Mol Biol, D-6800 Mannheim, Germany	Ruprecht Karls University Heidelberg; University of Zurich; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Bacon, C (corresponding author), Heidelberg Univ, Dept Human Mol Genet, Heidelberg, Germany.	Claire.bacon@med.uni-heidelberg.de		Stoeckli, Esther/0000-0002-8485-0648	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 488, D. 10040689]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported exclusively by a Sonderforschungsbereich (SFB) 488 grant entitled 'Molecular and cellular bases of neural development' from the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de, grant number D. 10040689) to Dr. G. Rappold. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chen Z, 2008, NEURON, V58, P325, DOI 10.1016/j.neuron.2008.02.016; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; Jaworski A, 2010, J NEUROSCI, V30, P9445, DOI 10.1523/JNEUROSCI.6290-09.2010; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Reeber SL, 2008, J NEUROSCI, V28, P8698, DOI 10.1523/JNEUROSCI.1479-08.2008; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Spitzweck B, 2010, CELL, V140, P409, DOI 10.1016/j.cell.2010.01.002; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yuasa-Kawada J, 2009, NAT NEUROSCI, V12, P1087, DOI 10.1038/nn.2382; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19887	10.1371/journal.pone.0019887	http://dx.doi.org/10.1371/journal.pone.0019887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655271	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000291097600009
J	Diner, P; Vilg, JV; Kjellen, J; Migdal, I; Andersson, T; Gebbia, M; Giaever, G; Nislow, C; Hohmann, S; Wysocki, R; Tamas, MJ; Grotli, M				Diner, Peter; Vilg, Jenny Veide; Kjellen, Jimmy; Migdal, Iwona; Andersson, Terese; Gebbia, Marinella; Giaever, Guri; Nislow, Corey; Hohmann, Stefan; Wysocki, Robert; Tamas, Markus J.; Grotli, Morten			Design, Synthesis, and Characterization of a Highly Effective Hog1 Inhibitor: A Powerful Tool for Analyzing MAP Kinase Signaling in Yeast	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; STRESS; ARREST; PHOSPHORYLATION; SPECIFICITY; RESISTANCE; ARSENITE; SYSTEM; PHASE	The Saccharomyces cerevisiae High-Osmolarity Glycerol (HOG) pathway is a conserved mitogen-activated protein kinase (MAPK) signal transduction system that often serves as a model to analyze systems level properties of MAPK signaling. Hog1, the MAPK of the HOG-pathway, can be activated by various environmental cues and it controls transcription, translation, transport, and cell cycle adaptations in response to stress conditions. A powerful means to study signaling in living cells is to use kinase inhibitors; however, no inhibitor targeting wild-type Hog1 exists to date. Herein, we describe the design, synthesis, and biological application of small molecule inhibitors that are cell-permeable, fast-acting, and highly efficient against wild-type Hog1. These compounds are potent inhibitors of Hog1 kinase activity both in vitro and in vivo. Next, we use these novel inhibitors to pinpoint the time of Hog1 action during recovery from G1 checkpoint arrest, providing further evidence for a specific role of Hog1 in regulating cell cycle resumption during arsenite stress. Hence, we describe a novel tool for chemical genetic analysis of MAPK signaling and provide novel insights into Hog1 action.	[Diner, Peter; Andersson, Terese; Grotli, Morten] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Vilg, Jenny Veide; Kjellen, Jimmy; Hohmann, Stefan; Tamas, Markus J.] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden; [Migdal, Iwona; Wysocki, Robert] Univ Wroclaw, Dept Genet & Cell Physiol, Inst Plant Biol, PL-50138 Wroclaw, Poland; [Gebbia, Marinella; Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Nislow, Corey] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Gothenburg; University of Gothenburg; University of Wroclaw; University of Toronto; University of Toronto	Diner, P (corresponding author), Univ Gothenburg, Dept Chem, Gothenburg, Sweden.	grotli@chem.gu.se	Hohmann, Stefan/K-9895-2013; Dinér, Peter/A-3867-2009; Tamas, Markus J/E-8183-2010; Dinér, Peter/HDM-9110-2022; Grötli, Morten/A-8735-2010; Giaever, Guri/D-3930-2009	Hohmann, Stefan/0000-0002-0809-1985; Dinér, Peter/0000-0001-6782-6622; Tamas, Markus J/0000-0002-0762-7848; Dinér, Peter/0000-0001-6782-6622; Grötli, Morten/0000-0003-3621-4222; Nislow, Corey/0000-0002-4016-8874; Migdal, Iwona/0000-0002-5585-1991; Wysocki, Robert/0000-0002-3274-2629	European Commission [043310]; Chemical Biology Platform at the University of Gothenburg; Olle Engkvist Byggmastare Foundation; Signhild Engkvist Foundation; Polish Ministry of Science and Higher Education [N303027137]; CIHR [81340, 84305]	European Commission(European CommissionEuropean Commission Joint Research Centre); Chemical Biology Platform at the University of Gothenburg; Olle Engkvist Byggmastare Foundation; Signhild Engkvist Foundation; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); CIHR(Canadian Institutes of Health Research (CIHR))	This work was financed by the European Commission (the CELLCOMPUT project, Contract No. 043310 to MG and SH), the Chemical Biology Platform at the University of Gothenburg (MG, SH, MJT), the Olle Engkvist Byggmastare Foundation (MJT), the Signhild Engkvist Foundation (JVV), the Polish Ministry of Science and Higher Education (Grant No. N303027137 to IM and RW), and the CIHR (to GG (81340) and CN (84305)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg DC., 2005, METHODS YEAST GENETI; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Diner P, 2009, NEW J CHEM, V33, P1010, DOI 10.1039/b818909a; Ericson E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000151; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Goldstein DM, 2010, J MED CHEM, V53, P2345, DOI [10.1021/jm9012906, 10.1021/acs.jmedchem.8b00124]; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2009, FEBS LETT, V583, P4025, DOI 10.1016/j.febslet.2009.10.069; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jackson JR, 1998, J PHARMACOL EXP THER, V284, P687; Kim JY, 2002, J CELL PHYSIOL, V190, P29, DOI 10.1002/jcp.10049; Kim S, 2007, FEBS LETT, V581, P1209, DOI 10.1016/j.febslet.2007.02.032; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Krantz M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.36; Li JP, 2007, J CELL PHYSIOL, V212, P481, DOI 10.1002/jcp.21042; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Migdal I, 2008, EUKARYOT CELL, V7, P1309, DOI 10.1128/EC.00038-08; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; RUDOLF F, 2008, REGULATION MAPK SIGN, P187; SCHRODINGER, 2008, MACROMODEL 9 0; SCHRODINGER, 2008, GLIDE 5 0; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; Thorsen M, 2006, MOL BIOL CELL, V17, P4400, DOI 10.1091/mbc.E06-04-0315; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Westfall PJ, 2006, EUKARYOT CELL, V5, P1215, DOI 10.1128/EC.00037-06; Wolfe JP, 2000, J ORG CHEM, V65, P1158, DOI 10.1021/jo991699y; WurglerMurphy SM, 1997, MOL CELL BIOL, V17, P1289, DOI 10.1128/MCB.17.3.1289; Yaakov G, 2009, MOL BIOL CELL, V20, P3572, DOI 10.1091/mbc.E09-02-0129; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	47	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20012	10.1371/journal.pone.0020012	http://dx.doi.org/10.1371/journal.pone.0020012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655328	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600013
J	Slyker, JA; John-Stewart, GC; Dong, T; Lohman-Payne, B; Reilly, M; Atzberger, A; Taylor, S; Maleche-Obimbo, E; Mbori-Ngacha, D; Rowland-Jones, SL				Slyker, Jennifer A.; John-Stewart, Grace C.; Dong, Tao; Lohman-Payne, Barbara; Reilly, Marie; Atzberger, Ann; Taylor, Stephen; Maleche-Obimbo, Elizabeth; Mbori-Ngacha, Dorothy; Rowland-Jones, Sarah L.			Phenotypic Characterization of HIV-Specific CD8(+) T Cells during Early and Chronic Infant HIV-1 Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AFRICAN INFANTS; BREAST-MILK; CYTOMEGALOVIRUS-INFECTION; DISEASE PROGRESSION; TETRAMER BINDING; TYPE-1 INFECTION; FAS LIGAND; VIRAL LOAD; LYMPHOCYTES	Although CD8(+) T cells play an important role in the containment of adult HIV-1 replication, their role in infant HIV-1 infection is not as well understood. Impaired HIV-specific CD8(+) T cell responses may underlie the persistently high viral loads observed in infants. We examined the frequency and phenotype of infant HIV-specific CD8(+) T cells in 7 HIV-infected antiretroviral therapy-naive infants during the first 2 years of life, using class I HLA tetramers and IFN-gamma-ELISPOT. The frequency (0.088-3.9% of CD3(+) CD8(+) cells) and phenotype (CD27(+) CD28(-) 2, CD45RA(+/-), CD57(+/-), HLA-DR+, CD95(+)) of infant HIV-specific CD8(+) T cells were similar to reports in adults undergoing early infection. Unlike adults, at 23-24 months post-infection a high frequency of HIV-specific CD8(+) T cells expressed HLA-DR (mean 80%, range 68-85%) and CD95 (mean 88%, range 79-96%), suggesting sustained activation and vulnerability to apoptosis. Despite comparable expansion of HIV-specific CD8(+) T cells of a similar phenotype to adults during early infection, infant T cells failed to contain HIV-1 replication, and remained persistently activated and vulnerable to apoptosis during chronic infection.	[Slyker, Jennifer A.; Dong, Tao; Rowland-Jones, Sarah L.] Univ Oxford, MRC Human Immunol Unit, Oxford, England; [Slyker, Jennifer A.; John-Stewart, Grace C.; Lohman-Payne, Barbara] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Slyker, Jennifer A.; John-Stewart, Grace C.; Lohman-Payne, Barbara] Univ Washington, Dept Med, Seattle, WA USA; [John-Stewart, Grace C.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lohman-Payne, Barbara; Maleche-Obimbo, Elizabeth; Mbori-Ngacha, Dorothy] Univ Nairobi, Dept Paediat, Nairobi, Kenya; [Reilly, Marie] Karolinska Inst, Stockholm, Sweden; [Atzberger, Ann] Univ Oxford, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford, England; [Taylor, Stephen] Univ Oxford, Weatherall Inst Mol Med, Computat Biol Res Grp, Oxford, England	University of Oxford; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Karolinska Institutet; University of Oxford; University of Oxford	Slyker, JA (corresponding author), Univ Oxford, MRC Human Immunol Unit, Oxford, England.	jslyker@uw.edu	John-Stewart, Grace/L-3650-2019; John-Stewart, Grace/U-3351-2019; Slyker, Jennifer/J-5439-2018	Dong, Tao/0000-0003-3545-3758	U.S. National Institutes of Child Health and Disease (NICHD) [RO1 HD-23412, K24]; MRC; University of Washington from the National Institutes of Health, USPHS [T32 AI007140]; Fogarty International Center [D43 TW000007]; Office of Research on Women's Health; University of Washington Center for AIDS Research (CFAR), NIH [P30 AI027757]; NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NCCAM); Elizabeth Glaser Pediatric AIDS Foundation; MRC [G0801751, G0600520, G1001046] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD023412] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, T32AI007140, K01AI087369] Funding Source: NIH RePORTER; Medical Research Council [G0801751, G1001046, G1000800f, G0600520] Funding Source: researchfish	U.S. National Institutes of Child Health and Disease (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Washington from the National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); University of Washington Center for AIDS Research (CFAR), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Elizabeth Glaser Pediatric AIDS Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by the U.S. National Institutes of Child Health and Disease (NICHD) through grant # RO1 HD-23412 (PI John-Stewart), K24 (PI John-Stewart) and MRC grant to the Human Immunology Unit of the Weatherall Institute of Molecular Medicine (PI Rowland-Jones). JS was supported by the University of Washington STD and AIDS Research Training Program, T32 AI007140 from the National Institutes of Health, USPHS. JS, BL-P, and EO were scholars in the AIDS International Training and Research Program, NIH Research Grant D43 TW000007, funded by the Fogarty International Center and the Office of Research on Women's Health. SR-J and GJ-S received Elizabeth Glaser Pediatric AIDS Foundation Scientist Awards. This research was supported by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757), which is supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NCCAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EJ, 1998, J INFECT DIS, V178, P101, DOI 10.1086/515596; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Appay V, 2002, J IMMUNOL, V168, P3660, DOI 10.4049/jimmunol.168.7.3660; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Biggar RJ, 1999, J INFECT DIS, V180, P1838, DOI 10.1086/315122; Biggar RJ, 2001, AIDS, V15, P1311, DOI 10.1097/00002030-200107060-00015; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BUNCE M, 1995, TISSUE ANTIGENS, V46; Chakraborty R, 2005, J IMMUNOL, V174, P8191, DOI 10.4049/jimmunol.174.12.8191; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; DEVANGE P, 1999, J CLIN MICROBIOL, V37, P350; Emery S, 2000, J CLIN MICROBIOL, V38, P2688, DOI 10.1128/JCM.38.7.2688-2695.2000; Farquhar C, 2004, AIDS RES HUM RETROV, V20, P692, DOI 10.1089/0889222041524616; Farquhar C, 2002, J INFECT DIS, V186, P1173, DOI 10.1086/343805; Feeney ME, 2005, J IMMUNOL, V174, P7524, DOI 10.4049/jimmunol.174.12.7524; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goepfert PA, 2000, J VIROL, V74, P10249, DOI 10.1128/JVI.74.21.10249-10255.2000; HOLM S, 1979, SCAND J STAT, V6, P65; Huang SH, 2008, J IMMUNOL, V181, P8103, DOI 10.4049/jimmunol.181.11.8103; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; John-Stewart GC, 2009, J INFECT DIS, V199, P889, DOI 10.1086/597120; Kaul R, 2001, J CLIN INVEST, V107, P1303, DOI 10.1172/JCI12433; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LIDINJANSSON G, 1994, PEDIATRICS, V94, P815; Lohman BL, 2005, J VIROL, V79, P8121, DOI 10.1128/JVI.79.13.8121-8130.2005; Lohman BL, 2003, J INFECT DIS, V188, P1666, DOI 10.1086/379374; Lohman-Payne B, 2009, CLIN EXP IMMUNOL, V156, P511, DOI 10.1111/j.1365-2249.2009.03937.x; McCloskey TW, 2001, CYTOMETRY, V46, P265, DOI 10.1002/cyto.1167; Miles DJC, 2008, IMMUNOLOGY, V124, P388, DOI 10.1111/j.1365-2567.2007.02787.x; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; Mueller YM, 2001, IMMUNITY, V15, P871, DOI 10.1016/S1074-7613(01)00246-1; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Obimbo EM, 2009, JAIDS-J ACQ IMM DEF, V51, P209, DOI 10.1097/QAI.0b013e31819c16d8; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Ogg GS, 1999, J VIROL, V73, P9153, DOI 10.1128/JVI.73.11.9153-9160.1999; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PANTALEO G, 1995, ANNU REV IMMUNOL, V13, P487, DOI 10.1146/annurev.immunol.13.1.487; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pillay T, 2005, J VIROL, V79, P12100, DOI 10.1128/JVI.79.18.12100-12105.2005; Richardson BA, 2003, J VIROL, V77, P7120, DOI 10.1128/JVI.77.12.7120-7123.2003; Scott-Algara D, 2005, J CLIN IMMUNOL, V25, P57, DOI 10.1007/s10875-005-0358-3; Scott-Algara D, 2001, J INFECT DIS, V183, P1565, DOI 10.1086/320708; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Shalekoff S, 2009, AIDS, V23, P789, DOI 10.1097/QAD.0b013e328329c784; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Tateyama M, 2000, BLOOD, V96, P195, DOI 10.1182/blood.V96.1.195.013k51_195_202; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Wilson JDK, 2000, AIDS, V14, P225, DOI 10.1097/00002030-200002180-00003; World Health Organisation, 2007, WHO CAS DEF HIV SURV	51	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20375	10.1371/journal.pone.0020375	http://dx.doi.org/10.1371/journal.pone.0020375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655252	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600057
J	Smajs, D; Zobanikova, M; Strouhal, M; Cejkova, D; Dugan-Rocha, S; Pospisilova, P; Norris, SJ; Albert, T; Qin, X; Hallsworth-Pepin, K; Buhay, C; Muzny, DM; Chen, L; Gibbs, RA; Weinstock, GM				Smajs, David; Zobanikova, Marie; Strouhal, Michal; Cejkova, Darina; Dugan-Rocha, Shannon; Pospisilova, Petra; Norris, Steven J.; Albert, Tom; Qin, Xiang; Hallsworth-Pepin, Kym; Buhay, Christian; Muzny, Donna M.; Chen, Lei; Gibbs, Richard A.; Weinstock, George M.			Complete Genome Sequence of Treponema paraluiscuniculi, Strain Cuniculi A: The Loss of Infectivity to Humans Is Associated with Genome Decay	PLOS ONE			English	Article							REPEAT PROTEIN ARP; GENE CONVERSION; TPRK GENE; PALLIDUM; RABBIT; SYPHILIS; IDENTIFICATION; EXPRESSION; EVOLUTION; VENEREAL	Treponema paraluiscuniculi is the causative agent of rabbit venereal spirochetosis. It is not infectious to humans, although its genome structure is very closely related to other pathogenic Treponema species including Treponema pallidum subspecies pallidum, the etiological agent of syphilis. In this study, the genome sequence of Treponema paraluiscuniculi, strain Cuniculi A, was determined by a combination of several high-throughput sequencing strategies. Whereas the overall size (1,133,390 bp), arrangement, and gene content of the Cuniculi A genome closely resembled those of the T. pallidum genome, the T. paraluiscuniculi genome contained a markedly higher number of pseudogenes and gene fragments (51). In addition to pseudogenes, 33 divergent genes were also found in the T. paraluiscuniculi genome. A set of 32 (out of 84) affected genes encoded proteins of known or predicted function in the Nichols genome. These proteins included virulence factors, gene regulators and components of DNA repair and recombination. The majority (52 or 61.9%) of the Cuniculi A pseudogenes and divergent genes were of unknown function. Our results indicate that T. paraluiscuniculi has evolved from a T. pallidum-like ancestor and adapted to a specialized host-associated niche (rabbits) during loss of infectivity to humans. The genes that are inactivated or altered in T. paraluiscuniculi are candidates for virulence factors important in the infectivity and pathogenesis of T. pallidum subspecies.	[Smajs, David; Zobanikova, Marie; Strouhal, Michal; Cejkova, Darina; Pospisilova, Petra] Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic; [Dugan-Rocha, Shannon; Qin, Xiang; Buhay, Christian; Muzny, Donna M.; Chen, Lei; Gibbs, Richard A.; Weinstock, George M.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Norris, Steven J.] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX USA; [Albert, Tom] NimbleGen Syst Inc, Madison, WI USA; [Hallsworth-Pepin, Kym; Chen, Lei; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Sequencing Ctr, St Louis, MO 63110 USA	Masaryk University Brno; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Roche Holding; Roche NimbleGen; Washington University (WUSTL)	Smajs, D (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Brno, Czech Republic.	dsmajs@med.muni.cz	Smajs, David/I-3479-2016; Norris, Steven James/K-6586-2019; Pospisilova, Petra/L-8212-2018; Weinstock, George M/C-6314-2013; Cejkova, Darina/AAA-5820-2022	Norris, Steven James/0000-0002-2501-8034; Weinstock, George M/0000-0002-2997-4592; Cejkova, Darina/0000-0002-6989-6330	U.S. Public Health Service [R01 DE12488, R01 DE13759, R01 AI49252, R03 AI69107]; Grant Agency of the Czech Republic [310/07/0321]; Ministry of Education of the Czech Republic [VZ SM0021622415]; NATIONAL EYE INSTITUTE [R01EY013759] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI069107, R01AI049252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012488, R01DE013759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013759] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the U.S. Public Health Service to G. M. W. (R01 DE12488 and R01 DE13759), and S.J.N. (R01 AI49252 and R03 AI69107) and by the grants of the Grant Agency of the Czech Republic (310/07/0321), and the Ministry of Education of the Czech Republic (VZ SM0021622415) to D. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NimbleGen Systems, Inc., provided oligonucleotide arrays and initial analysis of microarray data.	BAKERZANDER SA, 1984, INFECT IMMUN, V46, P116, DOI 10.1128/IAI.46.1.116-121.1984; BASEMAN JB, 1974, INFECT IMMUN, V10, P1062, DOI 10.1128/IAI.10.5.1062-1067.1974; Bernstein DA, 2003, NUCLEIC ACIDS RES, V31, P2778, DOI 10.1093/nar/gkg376; Brinkman MB, 2008, INFECT IMMUN, V76, P1848, DOI 10.1128/IAI.01424-07; Cameron CE, 2000, J INFECT DIS, V181, P1401, DOI 10.1086/315399; Centurion-Lara A, 2004, MOL MICROBIOL, V52, P1579, DOI 10.1111/j.1365-2958.2004.04086.x; Centurion-Lara A, 1999, J EXP MED, V189, P647, DOI 10.1084/jem.189.4.647; Centurion-Lara A, 2000, INFECT IMMUN, V68, P824, DOI 10.1128/IAI.68.2.824-831.2000; Centurion-Lara A, 2000, J BACTERIOL, V182, P2332, DOI 10.1128/JB.182.8.2332-2335.2000; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DIGIACOMO RF, 1985, GENITOURIN MED, V61, P156; DIGIACOMO RF, 1984, BRIT J VENER DIS, V60, P214; DIGIACOMO RF, 1983, LAB ANIM SCI, V33, P562; Fenno JC, 1996, J BACTERIOL, V178, P2489, DOI 10.1128/jb.178.9.2489-2497.1996; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Giacani L, 2004, INFECT IMMUN, V72, P6561, DOI 10.1128/IAI.72.11.6561-6576.2004; Giacani L, 2007, FEMS IMMUNOL MED MIC, V51, P289, DOI 10.1111/j.1574-695X.2007.00303.x; Giacani L, 2010, J BACTERIOL, V192, P2645, DOI 10.1128/JB.00159-10; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRAVES S, 1981, BRIT J VENER DIS, V57, P7; Gray RR, 2006, MOL BIOL EVOL, V23, P2220, DOI 10.1093/molbev/msl092; Harper KN, 2008, FEMS IMMUNOL MED MIC, V53, P322, DOI 10.1111/j.1574-695X.2008.00427.x; HOUGEN KH, 1973, ACTA PATH MICRO IM B, VB 81, P15; Jacobsthal E, 1920, DERMATOL WOCHENSCHR, V71, P569; KHAN AS, 1951, AM J HYG, V53, P296, DOI 10.1093/oxfordjournals.aje.a119455; Levaditi C, 1921, CR HEBD ACAD SCI, V172, P1542; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; Morozov V, 1997, TRENDS BIOCHEM SCI, V22, P417, DOI 10.1016/S0968-0004(97)01128-6; Nei M, 2000, MOL EVOLUTION PHYLOG; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Norris SJ, 2003, MANUAL CLIN MICROBIO, P955; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Peeling RW, 2006, J PATHOL, V208, P224, DOI 10.1002/path.1903; SCHELL RF, 1982, INFECT IMMUN, V37, P617, DOI 10.1128/IAI.37.2.617-621.1982; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Smajs D, 2005, J BACTERIOL, V187, P1866, DOI 10.1128/JB.187.5.1866-1874.2005; Smajs D, 2002, GENOME RES, V12, P515, DOI 10.1101/gr.207302; SMITH JL, 1967, BRIT J VENER DIS, V43, P117; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; Stohl EA, 2001, MOL MICROBIOL, V40, P1301, DOI 10.1046/j.1365-2958.2001.02463.x; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Titz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002292; Turner TB, 1957, BIOL TREPONEMATOSES; Weinstock G.M., 2000, VIRULENCE MECH BACTE, V3rd, P251; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	52	47	47	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20415	10.1371/journal.pone.0020415	http://dx.doi.org/10.1371/journal.pone.0020415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655244	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600063
J	Udayakumar, D; Zhang, G; Ji, Z; Njauw, CN; Mroz, P; Tsao, H				Udayakumar, D.; Zhang, G.; Ji, Z.; Njauw, C-N; Mroz, P.; Tsao, H.			Epha2 is a critical oncogene in melanoma	ONCOGENE			English	Article						melanoma; EphA2; survival	RECEPTOR TYROSINE KINASE; VASCULOGENIC MIMICRY; PROSTATE-CANCER; CELL-MIGRATION; OVARIAN-CANCER; TUMOR-CELLS; OVEREXPRESSION; EXPRESSION; INVASION; GROWTH	EphA2 is a member of the Eph family of receptor tyrosine kinases and is highly expressed in many aggressive cancer types, including melanoma. We recently showed that EphA2 is also upregulated by ultraviolet radiation and is able to induce apoptosis. These findings suggest that EphA2 may have different, even paradoxical, effects on viability depending on the cellular context and that EphA2 mediates a delicate balance between life and death of the cell. To functionally clarify EphA2's role in melanoma, we analyzed a panel of melanoma cell lines and found that EphA2 levels are elevated in a significant fraction of the samples. Specific depletion of EphA2 in high-expressing melanoma cells using short hairpin RNA led to profound reductions in cellular viability, colony formation and migration in vitro and a dramatic loss of tumorigenic potential in vivo. Stable introduction of EphA2 into low-expressing cell lines enhanced proliferation, colony formation and migration, further supporting its pro-malignant phenotype. Interestingly, transient expression of EphA2 and/or Braf(V600E) in non-transformed melanocytes led to significant and additive apoptosis. These results verify that EphA2 is an important oncogene and potentially a common source of 'addiction' for many melanoma cells. Moreover, acute induction of EphA2 may purge genetically susceptible cells, thereby uncovering a more aggressive population that is in fact dependent on the oncogene. Oncogene (2011) 30, 4921-4929; doi:10.1038/onc.2011.210; published online 13 June 2011	[Udayakumar, D.; Ji, Z.; Mroz, P.; Tsao, H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Dermatol, Boston, MA 02114 USA; [Udayakumar, D.; Ji, Z.; Njauw, C-N; Mroz, P.; Tsao, H.] Massachusetts Gen Hosp, Dept Dermatol, Wellman Ctr Photomed, Boston, MA 02114 USA; [Zhang, G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg,Ctr Vasc Biol Res, Boston, MA 02114 USA; [Tsao, H.] Massachusetts Gen Hosp, Melanoma & Pigmented Les Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital	Tsao, H (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Dermatol, Bartlett 622,48 Blossom St, Boston, MA 02114 USA.	htsao@partners.org	Mroz, Pawel/P-1258-2019	Mroz, Pawel/0000-0003-3838-4743	National Institutes of Health [1R21ES013964]; Dermatology Foundation; American Skin Association; Melanoma Research Alliance; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013964] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dermatology Foundation; American Skin Association; Melanoma Research Alliance; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (1R21ES013964; HT), the Dermatology Foundation (DU), the American Skin Association (HT and DU), the Melanoma Research Alliance (to HT) and the generous philanthropic donors at MGH. We thank Dr Jie Zhao and other members of the Wellman Center Pathology core facility for their help with the tissue sections and confocal analysis. We also thank Dr Michael Hamblin for his support in mice tumor studies.	ALBINI A, 1987, CANCER RES, V47, P3239; ANDRES AC, 1994, ONCOGENE, V9, P1461; Bogan C, 2009, INT J CANCER, V124, P1366, DOI 10.1002/ijc.24083; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Cui XD, 2010, INT J CANCER, V126, P940, DOI 10.1002/ijc.24798; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Easty DJ, 1999, INT J CANCER, V84, P494, DOI 10.1002/(SICI)1097-0215(19991022)84:5<494::AID-IJC8>3.3.CO;2-F; GANJU P, 1994, ONCOGENE, V9, P1613; Han LQ, 2005, GYNECOL ONCOL, V99, P278, DOI 10.1016/j.ygyno.2005.06.036; Hendrix MJC, 2003, ONCOGENE, V22, P3070, DOI 10.1038/sj.onc.1206447; Herath NI, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-144; Hess AR, 2006, CANCER BIOL THER, V5, P228, DOI 10.4161/cbt.5.2.2510; Hingorani SR, 2003, CANCER RES, V63, P5198; Kamat AA, 2009, CANCER-AM CANCER SOC, V115, P2684, DOI 10.1002/cncr.24335; Kataoka H, 2004, CANCER SCI, V95, P136, DOI 10.1111/j.1349-7006.2004.tb03194.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu Y, 2011, J CANCER RES CLIN, V137, P761, DOI 10.1007/s00432-010-0936-2; Lu C, 2008, CANCER BIOL THER, V7, P1098, DOI 10.4161/cbt.7.7.6168; Margaryan NV, 2009, CANCER BIOL THER, V8, P275, DOI 10.4161/cbt.8.3.7485; Menges CW, 2008, ONCOGENE, V27, P2934, DOI 10.1038/sj.onc.1210957; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Miyazaki T, 2003, INT J CANCER, V103, P657, DOI 10.1002/ijc.10860; Moore-Scott BA, 2007, DEV DYNAM, V236, P1997, DOI 10.1002/dvdy.21204; Nemoto T, 1997, PATHOBIOLOGY, V65, P195, DOI 10.1159/000164123; Parri M, 2009, CANCER RES, V69, P2072, DOI 10.1158/0008-5472.CAN-08-1845; RUIZ JC, 1994, MECH DEVELOP, V46, P87; Seftor EA, 2002, CRIT REV ONCOL HEMAT, V44, P17, DOI 10.1016/S1040-8428(01)00199-8; Straume O, 2002, AM J PATHOL, V160, P1009, DOI 10.1016/S0002-9440(10)64922-X; Sulman EP, 1997, GENOMICS, V40, P371, DOI 10.1006/geno.1996.4569; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Vaught D, 2009, MOL BIOL CELL, V20, P2572, DOI 10.1091/mbc.E08-04-0378; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Walker-Daniels J, 2003, AM J PATHOL, V162, P1037, DOI 10.1016/S0002-9440(10)63899-0; Walker-Daniels J, 1999, PROSTATE, V41, P275, DOI 10.1002/(SICI)1097-0045(19991201)41:4<275::AID-PROS8>3.0.CO;2-T; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; Zelinski DP, 2001, CANCER RES, V61, P2301; Zhang GQ, 2008, CANCER RES, V68, P1691, DOI 10.1158/0008-5472.CAN-07-2372	41	54	63	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	2011	30	50					4921	4929		10.1038/onc.2011.210	http://dx.doi.org/10.1038/onc.2011.210			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YJ	21666714	Green Accepted			2022-12-25	WOS:000298346500001
J	Gehi, R; Shao, Q; Laird, DW				Gehi, Ruchi; Shao, Qing; Laird, Dale W.			Pathways Regulating the Trafficking and Turnover of Pannexin1 Protein and the Role of the C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP RELEASE; 1 CHANNELS; GAP; ACTIVATION; CLATHRIN; RECEPTOR; INTERNALIZATION; INFLAMMASOME; EXPRESSION; JUNCTIONS	Pannexin1 (Panx1) is an integral membrane protein comprised of three species as follows: an unglycosylated core-Gly0, a high mannose-Gly1, and a complex glycosylated Gly2 species. Although Panx1 channels mediate several cellular responses, the domain regulating its oligomerization and cell surface trafficking and the mechanisms governing its internalization and degradation have not been identified. This study characterizes the role of the Panx1 C-tail domain by truncating the polypeptide at residue 307 and expressing the mutant in BICR-M1R(k) and HEK-293T cells. Enzymatic digestion and immunolabeling assays revealed that the Panx1(T307)-RFP was glycosylated primarily to the high mannose species consistent with its retention in the endoplasmic reticulum. Co-expression of Panx1(T307)-RFP with Panx1 followed by co-immunoprecipitation assays revealed that the mutant and Panx1 could interact, whereas biotinylation assays showed that this interaction inhibited Panx1 from maturing into the Gly2 species and reaching the cell surface. Additional inhibitor studies indicated that the degradation of the mutant was via proteasomes, whereas Panx1 was degraded by lysosomes. Analysis of the pathways important in Panx1 internalization revealed partial co-distribution of Panx1 with many molecular constituents of the endocytic machinery that include clathrin, AP2, dynamin II, caveolin-1, and caveolin-2. However, co-immunoprecipitation assays together with the disruption of lipid rafts by methyl-beta-cyclodextrin suggest that Panx1 does not engage this endocytic machinery. Furthermore, dominant-negative and pharmacological studies revealed that Panx1 internalization was dynamin II-independent. Collectively, these results indicate that the oligomerization and trafficking of Panx1 are regulated by the C-terminal domain, whereas internalization of long lived Panx1 channels occurs in a manner that is distinct from classical endocytic pathways.	[Gehi, Ruchi; Shao, Qing; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg, London, ON N6A 5C1, Canada.	Dale.Laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; 	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by a Canadian Institutes of Health Research operating grant (to D. W. L.) and an Natural Sciences and Engineering Research Council of Canada Studentship (to R. B.).	Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Baker SM, 2008, FEBS LETT, V582, P4039, DOI 10.1016/j.febslet.2008.10.043; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Bunse S, 2010, J BIOL CHEM, V285, P38444, DOI 10.1074/jbc.M110.101014; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Darby PJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1226, DOI 10.1152/ajplung.2000.279.6.L1226; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gumpert AM, 2008, FEBS LETT, V582, P2887, DOI 10.1016/j.febslet.2008.07.024; HRESKO RC, 1994, J BIOL CHEM, V269, P32110; Jordan K, 2001, J CELL SCI, V114, P763; Langlois S, 2008, MOL BIOL CELL, V19, P912, DOI 10.1091/mbc.E07-06-0596; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Nickel BM, 2008, BIOCHEM BIOPH RES CO, V374, P679, DOI 10.1016/j.bbrc.2008.07.108; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2009, PURINERG SIGNAL, V5, P129, DOI 10.1007/s11302-009-9141-7; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Simek J, 2009, J CELL SCI, V122, P554, DOI 10.1242/jcs.036970; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Trouet D, 1999, J PHYSIOL-LONDON, V520, P113, DOI 10.1111/j.1469-7793.1999.t01-1-00113.x; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Yanez RA, 2010, CELL BIOCHEM FUNCT, V28, P66, DOI 10.1002/cbf.1622	40	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27639	27653		10.1074/jbc.M111.260711	http://dx.doi.org/10.1074/jbc.M111.260711			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659516	Green Published, hybrid			2022-12-25	WOS:000293268700057
J	Syed, S; Saez, L; Young, MW				Syed, Sheyum; Saez, Lino; Young, Michael W.			Kinetics of Doubletime Kinase-dependent Degradation of the Drosophila Period Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-TIME; NUCLEAR ENTRY; CLOCK GENE; SLIMB; PHOSPHORYLATION; MUTATIONS; ROLES	Robust circadian oscillations of the proteins PERIOD (PER) and TIMELESS (TIM) are hallmarks of a functional clock in the fruit fly Drosophila melanogaster. Early morning phosphorylation of PER by the kinase Doubletime (DBT) and subsequent PER turnover is an essential step in the functioning of the Drosophila circadian clock. Here using time-lapse fluorescence microscopy we study PER stability in the presence of DBT and its short, long, arrhythmic, and inactive mutants in S2 cells. We observe robust PER degradation in a DBT allele-specific manner. With the exception of doubletime-short (DBTS), all mutants produce differential PER degradation profiles that show direct correspondence with their respective Drosophila behavioral phenotypes. The kinetics of PER degradation with DBTS in cell culture resembles that with wild-type DBT and posits that, in flies DBTS likely does not modulate the clock by simply affecting PER degradation kinetics. For all the other tested DBT alleles, the study provides a simple model in which the changes in Drosophila behavioral rhythms can be explained solely by changes in the rate of PER degradation.	[Syed, Sheyum; Saez, Lino; Young, Michael W.] Rockefeller Univ, Genet Lab, New York, NY 10065 USA	Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, New York, NY 10065 USA.	young@mail.rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020		National Institutes of Health [GM054339, NS053087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054339, R01GM054339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM054339 and NS053087 (to M. W. Y.).	Bao S, 2001, J NEUROSCI, V21, P7117, DOI 10.1523/JNEUROSCI.21-18-07117.2001; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Cyran SA, 2005, J NEUROSCI, V25, P5430, DOI 10.1523/JNEUROSCI.0263-05.2005; Gallego M, 2006, P NATL ACAD SCI USA, V103, P10618, DOI 10.1073/pnas.0604511103; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Landskron J, 2009, PLOS BIOL, V7, P820, DOI 10.1371/journal.pbio.1000003; Meyer P, 2006, SCIENCE, V311, P226, DOI 10.1126/science.1118126; Muskus MJ, 2007, MOL CELL BIOL, V27, P8049, DOI 10.1128/MCB.00680-07; Nawathean P, 2004, MOL CELL, V13, P213, DOI 10.1016/S1097-2765(03)00503-3; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Saez L, 2007, COLD SPRING HARB SYM, V72, P69, DOI 10.1101/sqb.2007.72.034; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Sekine T, 2008, J BIOL RHYTHM, V23, P3, DOI 10.1177/0748730407311652; Suri V, 1999, EMBO J, V18, P675, DOI 10.1093/emboj/18.3.675; Suri V, 2000, J NEUROSCI, V20, P7547; THUMMEL CS, 1991, DROSOPHILA INFORM NE, P71; Tyson JJ, 1999, BIOPHYS J, V77, P2411, DOI 10.1016/S0006-3495(99)77078-5; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08	27	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27654	27662		10.1074/jbc.M111.243618	http://dx.doi.org/10.1074/jbc.M111.243618			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21659538	Green Published, hybrid			2022-12-25	WOS:000293268700058
J	Hausmann, M; Leucht, K; Ploner, C; Kiessling, S; Villunger, A; Becker, H; Hofmann, C; Falk, W; Krebs, M; Kellermeier, S; Fried, M; Scholmerich, J; Obermeier, F; Rogler, G				Hausmann, Martin; Leucht, Katharina; Ploner, Christian; Kiessling, Stephan; Villunger, Andreas; Becker, Helen; Hofmann, Claudia; Falk, Werner; Krebs, Michaela; Kellermeier, Silvia; Fried, Michael; Schoelmerich, Juergen; Obermeier, Florian; Rogler, Gerhard			BCL-2 Modifying Factor (BMF) Is a Central Regulator of Anoikis in Human Intestinal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED APOPTOSIS; DIFFERENTIAL EXPRESSION; IN-SITU; CASPASES; ACTIVATION; BIM; HOMEOSTASIS; CADHERINS; COLITIS; MUCOSA	BCL-2 modifying factor (BMF) is a sentinel considered to register damage at the cytoskeleton and to convey a death signal to B-cell lymphoma 2. B-cell lymphoma 2 is neutralized by BMF and thereby facilitates cytochrome C release from mitochondria. We investigated the role of BMF for intestinal epithelial cell (IEC) homeostasis. Acute colitis was induced in Bmf-deficient mice (Bmf(-/-)) with dextran sulfate sodium. Colonic crypt length in Bmf(-/-) mice was significantly increased as compared with WT mice. Dextran sulfate sodium induced less signs of colitis in Bmf(-/-) mice, as weight loss was reduced compared with the WT. Primary human IEC exhibited increased BMF in the extrusion zone. Quantitative PCR showed a significant up-regulation of BMF expression after initiation of anoikis in primary human IEC. BMF was found on mitochondria during anoikis, as demonstrated by Western blot analysis. RNAi mediated knockdown of BMF reduced the number of apoptotic cells and led to reduced caspase 3 activity. A significant increase in phospho-AKT was determined after RNAi treatment. BMF knockdown supports survival of IEC. BMF is induced in human IEC by the loss of cell attachment and is likely to play an important role in the regulation of IEC survival.	[Hausmann, Martin; Leucht, Katharina; Krebs, Michaela; Kellermeier, Silvia; Fried, Michael; Rogler, Gerhard] Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Ploner, Christian] Med Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria; [Kiessling, Stephan; Villunger, Andreas; Becker, Helen] Med Univ Innsbruck, Bioctr, Div Dev Immunol, A-6020 Innsbruck, Austria; [Hofmann, Claudia; Falk, Werner; Schoelmerich, Juergen; Obermeier, Florian] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany	University of Zurich; University Zurich Hospital; Medical University of Innsbruck; Medical University of Innsbruck; University of Regensburg	Hausmann, M (corresponding author), Univ Zurich Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Raemistr 100, CH-8091 Zurich, Switzerland.	martin.hausmann@usz.ch	Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Hausmann, Martin/0000-0002-0696-0251; Ploner, Christian/0000-0002-0313-2960	Swiss National Science Foundation (SNF) [SNF 31003A_ 127247, SNF 310030 120312]; Deutsche Forschungsgemeinschaft [RO 1236/13-1]; Bundesministerium fur Bildung und Forschung Kompetenznetz Chronisch Entzundliche Darmerkrankungen; Zurich Center for Integrative Human Physiology (ZIHP); Swiss Inflammatory Bowel Disease Cohort Study (SIBDC); Austrian Research Foundation [SFB-F021]; German Research Foundation [OB135/10-1]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung Kompetenznetz Chronisch Entzundliche Darmerkrankungen(Federal Ministry of Education & Research (BMBF)); Zurich Center for Integrative Human Physiology (ZIHP); Swiss Inflammatory Bowel Disease Cohort Study (SIBDC); Austrian Research Foundation(Austrian Science Fund (FWF)); German Research Foundation(German Research Foundation (DFG))	This study was supported by grants from the Swiss National Science Foundation (SNF 31003A_ 127247 (to M. H.) and SNF 310030 120312 (to G. R.)), by the Deutsche Forschungsgemeinschaft (RO 1236/13-1), and the Bundesministerium fur Bildung und Forschung Kompetenznetz Chronisch Entzundliche Darmerkrankungen. Support also received from the Zurich Center for Integrative Human Physiology (ZIHP, to M. H. and G. R.) and from the Swiss Inflammatory Bowel Disease Cohort Study (SIBDC, to G. R.).; Supported by grant SFB-F021 from the Austrian Research Foundation.; Supported by grant OB135/10-1 from the German Research Foundation.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; BEAULIEU JF, 1992, J CELL SCI, V102, P427; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Grespi F, 2010, CELL DEATH DIFFER, V17, P1672, DOI 10.1038/cdd.2010.97; Grossmann J, 2003, EUR J CELL BIOL, V82, P262, DOI 10.1078/0171-9335-00312; Grossmann J, 2002, AM J GASTROENTEROL, V97, P1421, DOI 10.1016/S0002-9270(02)04143-6; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; KORETZ K, 1991, AM J PATHOL, V138, P741; Kutuk O, 2010, CELL DEATH DIFFER, V17, P1624, DOI 10.1038/cdd.2010.41; Labi V, 2008, J EXP MED, V205, P641, DOI 10.1084/jem.20071658; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; MERRITT AJ, 1995, J CELL SCI, V108, P2261; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pinon JD, 2008, ONCOGENE, V27, pS41, DOI 10.1038/onc.2009.42; Ploner C, 2008, LEUKEMIA, V22, P370, DOI 10.1038/sj.leu.2405039; POTTEN CS, 1977, J ULTRA MOL STRUCT R, V60, P272, DOI 10.1016/S0022-5320(77)80071-3; PROBSTMEIER R, 1990, DEVELOPMENT, V109, P313; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Ramjaun AR, 2007, ONCOGENE, V26, P970, DOI 10.1038/sj.onc.1209852; Riedl S, 1992, EXS, V61, P277; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; STRATER J, 1995, GUT, V37, P819, DOI 10.1136/gut.37.6.819; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Suzuki H. I., 2010, AUTOPHAGY IN PRESS; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Wick W, 1996, ONCOGENE, V12, P973; ZUTTER MM, 1990, AM J PATHOL, V137, P113	40	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					26533	26540		10.1074/jbc.M111.265322	http://dx.doi.org/10.1074/jbc.M111.265322			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21673109	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000293078200032
J	Bess, E; Fisslthaler, B; Fromel, T; Fleming, I				Bess, Elke; Fisslthaler, Beate; Froemel, Timo; Fleming, Ingrid			Nitric Oxide-Induced Activation of the AMP-Activated Protein Kinase alpha 2 Subunit Attenuates I kappa B Kinase Activity and Inflammatory Responses in Endothelial Cells	PLOS ONE			English	Article							STRESS-INDUCED ACTIVATION; SHEAR-STRESS; GENE-EXPRESSION; ADIPONECTIN; PHOSPHORYLATION; BRADYKININ; INDUCTION; ISOFORM; ENOS	Background: In endothelial cells, activation of the AMP-activated protein kinase (AMPK) has been linked with anti-inflammatory actions but the events downstream of kinase activation are not well understood. Here, we addressed the effects of AMPK activation/deletion on the activation of NF kappa B and determined whether the AMPK could contribute to the anti-inflammatory actions of nitric oxide (NO). Methodology/Principal Findings: Overexpression of a dominant negative AMPK alpha 2 mutant in tumor necrosis factor-alpha-stimulated human endothelial cells resulted in increased NF kappa B activity, E-selectin expression and monocyte adhesion. In endothelial cells from AMPK alpha 2(-/-) mice the interleukin (IL)-1 beta induced expression of E-selectin was significantly increased. DETA-NO activated the AMPK and attenuated NF kappa B activation/E-selectin expression, effects not observed in human endothelial cells in the presence of the dominant negative AMPK, or in endothelial cells from AMPK alpha 2(-/-) mice. Mechanistically, overexpression of constitutively active AMPK decreased the phosphorylation of I kappa B and p65, indicating a link between AMPK and the I kappa B kinase (IKK). Indeed, IKK (more specifically residues Ser177 and Ser181) was found to be a direct substrate of AMPK alpha 2 in vitro. The hyper-phosphorylation of the IKK, which is known to result in its inhibition, was also apparent in endothelial cells from AMPK alpha 2(+/+) versus AMPK alpha 2(-/-) mice. Conclusions: These results demonstrate that the IKK is a direct substrate of AMPK alpha 2 and that its phosphorylation on Ser177 and Ser181 results in the inhibition of the kinase and decreased NF kappa B activation. Moreover, as NO potently activates AMPK in endothelial cells, a portion of the anti-inflammatory effects of NO are mediated by AMPK.	[Bess, Elke; Fisslthaler, Beate; Froemel, Timo; Fleming, Ingrid] Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany	Goethe University Frankfurt	Fisslthaler, B (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signalling, Frankfurt, Germany.	fisslthaler@em.uni-frankfurt.de	Fleming, Ingrid/AAB-6123-2022; Fleming, Ingrid/L-1225-2014	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635	European Community [LSHM-CT-2004-005033]; Deutsche Forschungsgemeinschaft [SFB 834/A5, Exzellenzcluster 147]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by EICOSANOX, an integrated project supported by the European Community's sixth Framework Program (Contract No LSHM-CT-2004-005033), by the Deutsche Forschungsgemeinschaft (SFB 834/A5 and Exzellenzcluster 147 "Cardio-Pulmonary Systems"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Cardiovasc Res, V35, P2; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; BUSSE R, 1991, N-S ARCH PHARMACOL, V344, P126; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Chandrasekar B, 2008, J BIOL CHEM, V283, P24889, DOI 10.1074/jbc.M804236200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Devaraj S, 2008, ARTERIOSCL THROM VAS, V28, P1368, DOI 10.1161/ATVBAHA.108.163303; Dixit M, 2008, CARDIOVASC RES, V77, P160, DOI 10.1093/cvr/cvm017; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hattori Y, 2008, FEBS LETT, V582, P1719, DOI 10.1016/j.febslet.2008.04.037; Hattori Y, 2009, CARDIOVASC RES, V81, P133, DOI 10.1093/cvr/cvn226; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Li J, 2006, AM J PHYSIOL-HEART C, V291, pH1927, DOI 10.1152/ajpheart.00251.2006; Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491; Mount PF, 2008, ATHEROSCLEROSIS, V200, P28, DOI 10.1016/j.atherosclerosis.2007.12.003; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; SchiniKerth VB, 1997, ARTERIOSCL THROM VAS, V17, P672, DOI 10.1161/01.ATV.17.4.672; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Suzuki K, 2008, AM J HYPERTENS, V21, P451, DOI 10.1038/ajh.2008.6; Tomizawa A, 2009, LIFE SCI, V85, P457, DOI 10.1016/j.lfs.2009.07.012; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wang C, 2010, J CELL PHYSIOL, V222, P149, DOI 10.1002/jcp.21931; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; ZEIHER AM, 1995, CIRC RES, V76, P980, DOI 10.1161/01.RES.76.6.980; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200	38	62	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20848	10.1371/journal.pone.0020848	http://dx.doi.org/10.1371/journal.pone.0020848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673972	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400034
J	Codina, C; Pascalis, O; Mody, C; Toomey, P; Rose, J; Gummer, L; Buckley, D				Codina, Charlotte; Pascalis, Olivier; Mody, Chris; Toomey, Peter; Rose, Jill; Gummer, Laura; Buckley, David			Visual Advantage in Deaf Adults Linked to Retinal Changes	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; SIGNAL-DETECTION ANALYSIS; CONGENITALLY DEAF; GANGLION-CELL; AUDITORY-CORTEX; HEARING; FIELD; ATTENTION; SENSITIVITY	The altered sensory experience of profound early onset deafness provokes sometimes large scale neural reorganisations. In particular, auditory-visual cross-modal plasticity occurs, wherein redundant auditory cortex becomes recruited to vision. However, the effect of human deafness on neural structures involved in visual processing prior to the visual cortex has never been investigated, either in humans or animals. We investigated neural changes at the retina and optic nerve head in profoundly deaf (N = 14) and hearing (N = 15) adults using Optical Coherence Tomography (OCT), an in-vivo light interference method of quantifying retinal micro-structure. We compared retinal changes with behavioural results from the same deaf and hearing adults, measuring sensitivity in the peripheral visual field using Goldmann perimetry. Deaf adults had significantly larger neural rim areas, within the optic nerve head in comparison to hearing controls suggesting greater retinal ganglion cell number. Deaf adults also demonstrated significantly larger visual field areas (indicating greater peripheral sensitivity) than controls. Furthermore, neural rim area was significantly correlated with visual field area in both deaf and hearing adults. Deaf adults also showed a significantly different pattern of retinal nerve fibre layer (RNFL) distribution compared to controls. Significant correlations between the depth of the RNFL at the inferior-nasal peripapillary retina and the corresponding far temporal and superior temporal visual field areas (sensitivity) were found. Our results show that cross-modal plasticity after early onset deafness may not be limited to the sensory cortices, noting specific retinal adaptations in early onset deaf adults which are significantly correlated with peripheral vision sensitivity.	[Codina, Charlotte; Buckley, David] Univ Sheffield, Acad Unit Ophthalmol & Orthopt, Sheffield, S Yorkshire, England; [Pascalis, Olivier] Univ Pierre Mendes France, Lab Psychol & NeuroCognit, Grenoble, France; [Mody, Chris; Toomey, Peter; Rose, Jill; Gummer, Laura] Sheffield Teaching Hosp Trust, Dept Ophthalm Imaging, Sheffield, S Yorkshire, England	University of Sheffield; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Sheffield	Codina, C (corresponding author), Univ Sheffield, Acad Unit Ophthalmol & Orthopt, Sheffield, S Yorkshire, England.	C.Codina@Sheffield.ac.uk		Buckley, David/0000-0001-9140-8543; pascalis, olivier/0000-0003-4609-3233; Codina, Charlotte/0000-0003-0094-3052	Royal National Institute for the Deaf (RNID)	Royal National Institute for the Deaf (RNID)	The Royal National Institute for the Deaf (RNID) funded this work as part of a PhD scholarship given to the first author, Charlotte Codina (nee Westerman). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOV I, 1982, SCIENCE, V217, P265, DOI 10.1126/science.6178160; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Bavelier D, 2001, J NEUROSCI, V21, P8931, DOI 10.1523/JNEUROSCI.21-22-08931.2001; Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Bavelier D, 2006, TRENDS COGN SCI, V10, P512, DOI 10.1016/j.tics.2006.09.006; Bosworth RG, 2002, BRAIN COGNITION, V49, P170, DOI 10.1006/brcg.2001.1498; Bosworth RG, 2002, BRAIN COGNITION, V49, P152, DOI 10.1006/brcg.2001.1497; Bowd C, 2006, INVEST OPHTH VIS SCI, V47, P2889, DOI 10.1167/iovs.05-1489; BROSS M, 1980, PERCEPT MOTOR SKILL, V51, P839, DOI 10.2466/pms.1980.51.3.839; BROSS M, 1979, PERCEPT MOTOR SKILL, V48, P187, DOI 10.2466/pms.1979.48.1.187; Brown NL, 2001, DEVELOPMENT, V128, P2497; Buckley D, 2010, VISION RES, V50, P548, DOI 10.1016/j.visres.2009.11.018; Chen TC, 2006, AM J OPHTHALMOL, V141, P1165, DOI 10.1016/j.ajo.2006.01.086; CODINA CJ, 2010, DEVELOPMENTAL SCI, DOI DOI 10.1111/J.1467-7687.2010.01017; Colmenero JM, 2004, EUR J COGN PSYCHOL, V16, P791, DOI 10.1080/09541440340000312; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; DeLeon-Ortega J, 2007, AM J OPHTHALMOL, V143, P288, DOI 10.1016/j.ajo.2006.09.045; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Dye MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005640; Falchier A, 2002, J NEUROSCI, V22, P5749; Fine I, 2005, J COGNITIVE NEUROSCI, V17, P1621, DOI 10.1162/089892905774597173; Finney EM, 2001, NAT NEUROSCI, V4, P1171, DOI 10.1038/nn763; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; GARWAYHEATH DF, 2002, IOVS, V13, P2213; Ghadiali Q, 2008, J GLAUCOMA, V17, P333, DOI 10.1097/IJG.0b013e3181650f8b; Halpern SD, 1999, J COGNITIVE NEUROSCI, V11, P521, DOI 10.1162/089892999563580; HENDRICKSON AE, 1994, INVEST OPHTH VIS SCI, V35, P3129; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; HOLLYFIELD JG, 1983, INVEST OPHTH VIS SCI, V24, P893; Hood DC, 2007, PROG RETIN EYE RES, V26, P688, DOI 10.1016/j.preteyeres.2007.08.001; HUBEL DH, 1972, J COMP NEUROL, V146, P421, DOI 10.1002/cne.901460402; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Hunt DL, 2006, NEUROSCIENCE, V139, P1507, DOI 10.1016/j.neuroscience.2006.01.023; Huynh SC, 2009, OPHTHALMOLOGY, V116, P1604, DOI 10.1016/j.ophtha.2009.03.013; IKEDA H, 1976, EXP BRAIN RES, V25, P63; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lempert P, 2008, OPHTHALMOLOGY, V115, P2259, DOI 10.1016/j.ophtha.2008.07.016; LOKE WH, 1991, B PSYCHONOMIC SOC, V29, P437; LOMBER SG, 2010, NAT NEUROSCI, V13, P1241; LOVIEKITCHIN JE, 1998, OPHTHALMIC PHYSL, V8, P363; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Miglior S, 2007, AM J OPHTHALMOL, V144, P733, DOI 10.1016/j.ajo.2007.06.035; NEVILLE HJ, 1987, BRAIN RES, V405, P268, DOI 10.1016/0006-8993(87)90296-4; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; PALLAS SL, 1990, J COMP NEUROL, V298, P50, DOI 10.1002/cne.902980105; Parasnis I, 2003, J SPEECH LANG HEAR R, V46, P1166, DOI 10.1044/1092-4388(2003/091); PARASNIS I, 1985, BRAIN COGNITION, V4, P313, DOI 10.1016/0278-2626(85)90024-7; POIZNER H, 1987, BRAIN LANG, V30, P52, DOI 10.1016/0093-934X(87)90027-7; Proksch J, 2002, J COGNITIVE NEUROSCI, V14, P687, DOI 10.1162/08989290260138591; Reus NJ, 2004, INVEST OPHTH VIS SCI, V45, P840, DOI 10.1167/iovs.03-0646; SACHS GM, 1984, J COMP NEUROL, V230, P155, DOI 10.1002/cne.902300202; Schlottmann PG, 2004, INVEST OPHTH VIS SCI, V45, P1823, DOI 10.1167/iovs.03-0692; Stevens C, 2006, J COGNITIVE NEUROSCI, V18, P701, DOI 10.1162/jocn.2006.18.5.701; Stivalet P, 1998, COGNITIVE BRAIN RES, V6, P227, DOI 10.1016/S0926-6410(97)00026-8; Strouthidis NG, 2006, INVEST OPHTH VIS SCI, V47, P5356, DOI 10.1167/iovs.05-1660; VARMA R, 1998, AM J OPHTHALMOL, V114, P554; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029; WIRTSCHAFTER JD, 1982, OPHTHALMOLOGY, V89, P255; Yonehara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001533; YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4	62	38	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20417	10.1371/journal.pone.0020417	http://dx.doi.org/10.1371/journal.pone.0020417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673805	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000291309900017
J	Wittkowski, KM; Leonardi, C; Gottlieb, A; Menter, A; Krueger, GG; Tebbey, PW; Belasco, J; Soltani-Arabshahi, R; Gray, J; Horn, L; Krueger, JG				Wittkowski, Knut M.; Leonardi, Craig; Gottlieb, Alice; Menter, Alan; Krueger, Gerald G.; Tebbey, Paul W.; Belasco, Jennifer; Soltani-Arabshahi, Razieh; Gray, John; Horn, Liz; Krueger, James G.		Int Psoriasis Council	Clinical Symptoms of Skin, Nails, and Joints Manifest Independently in Patients with Concomitant Psoriasis and Psoriatic Arthritis	PLOS ONE			English	Article							DISEASE; ASSOCIATION; EPIDEMIOLOGY; PATHOGENESIS; AUTOIMMUNE; EXTENSION; GENETICS; INSIGHTS; FEATURES	This study correlated assessment tools for evaluating the severity of skin, nail, and joint symptoms in patients with psoriasis (Pso) and psoriatic arthritis (PsA). Adults with plaque Pso (with or without PsA) were enrolled from four U. S. institutions. Patients were evaluated using a novel 10-area Linear Psoriasis Area and Severity Index (XL-PASI), Psoriatic Arthritis Assessment (PsAA), Psoriatic Arthritis Screening and Evaluation Questionnaire (PASE), Nail Assessment (NA) and Joint Assessment (JA) tools, Psoriasis Weighted Extent and Severity Index (PWESI), and Lattice Physician Global Assessment (LS-PGA). Correlations between assessment tools and individual items in the assessment tools were performed. Data from 180 patients (55 with PsA) were analyzed. Highest correlations between tools (r = 0.77-0.88) were between the XL-PASI, PWESI and LS-PGA. Individual items in the XL-PASI correlated with items in the PWESI for extent skin symptoms, but not for all body areas. Overall, correlations were seen between hands and feet, between face and scalp, and between buttocks, chest, and back. Only low correlation was seen between items assessing joint symptoms with items assessing skin symptoms. These data support the notion that the complex phenotype of psoriatic disease requires instruments that assess the severity of skin, nails, and joints separately.	[Wittkowski, Knut M.; Belasco, Jennifer; Gray, John; Krueger, James G.] Rockefeller Univ, New York, NY 10021 USA; [Leonardi, Craig] St Louis Univ, Sch Med, St Louis, MO USA; [Gottlieb, Alice] Tufts Univ, Tufts Med Ctr, Boston, MA 02111 USA; [Menter, Alan] Baylor Univ, Med Ctr, Baylor Inst Res, Dermatol Res Ctr, Dallas, TX USA; [Krueger, Gerald G.; Soltani-Arabshahi, Razieh] Univ Utah, Salt Lake City, UT USA; [Tebbey, Paul W.; Horn, Liz; Int Psoriasis Council] Int Psoriasis Council, Dallas, TX USA	Rockefeller University; Saint Louis University; Tufts Medical Center; Tufts University; Baylor University; Baylor University Medical Center; Utah System of Higher Education; University of Utah	Wittkowski, KM (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	jgk@rockefeller.edu	Arabshahi, Razieh Soltani/B-5331-2008; Naldi, Luigi/K-6343-2016	Naldi, Luigi/0000-0002-3160-2835; , International Journal of Business and Applied Social Science/0000-0001-7850-0193	National Institutes of Health [UL1 RR024143]; International Psoriasis Council (IPC); Abbott; Amgen/Pfizer; Astellas; Centocor; Galderma; Janssen-Cilag; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Psoriasis Council (IPC); Abbott(Abbott Laboratories); Amgen/Pfizer(AmgenPfizer); Astellas(Astellas Pharmaceuticals); Centocor; Galderma; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported in part by a National Institutes of Health/Clinical and Translational Science Award (CTSA) grant UL1 RR024143 and an unrestricted educational grant from the International Psoriasis Council (IPC) to KMW and JGK. The project was also supported by unrestricted educational grants to the International Psoriasis Council from Abbott, Amgen/Pfizer, Astellas, Centocor, Galderma and Janssen-Cilag. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Castelino M, 2010, CURR OPIN RHEUMATOL, V22, P152, DOI 10.1097/BOR.0b013e32833669d2; Cohen MR, 1999, J RHEUMATOL, V26, P1752; Dominguez PL, 2009, ARCH DERMATOL RES, V301, P573, DOI 10.1007/s00403-009-0981-3; Duffin KC, 2008, J RHEUMATOL, V35, P1449; Elkayam O, 2000, CLIN RHEUMATOL, V19, P301, DOI 10.1007/PL00011173; Feldman SR, 2005, ANN RHEUM DIS, V64, P65, DOI 10.1136/ard.2004.031237; Gladman DD, 2009, DERMATOL THER, V22, P40, DOI 10.1111/j.1529-8019.2008.01215.x; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Goldstein I, 2008, CLIN IMMUNOL, V128, P75, DOI 10.1016/j.clim.2008.02.014; Gottlieb AB, 2006, J DERMATOL TREAT, V17, P279, DOI 10.1080/09546630600823369; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jones SM, 1998, ARTHRITIS RHEUM, V41, pS334; JONES SM, 1994, BRIT J RHEUMATOL, V33, P834; Langley RG, 2004, J AM ACAD DERMATOL, V51, P563, DOI 10.1016/j.jaad.2004.04.012; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Makredes M, 2009, J AM ACAD DERMATOL, V61, P405, DOI 10.1016/j.jaad.2009.02.015; McGonagle D, 2009, CURR OPIN RHEUMATOL, V21, P340, DOI 10.1097/BOR.0b013e32832c6ab9; McGonagle D, 2009, DERMATOLOGY, V218, P97, DOI 10.1159/000182250; Morales JF, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1372; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nograles KE, 2009, NAT CLIN PRACT RHEUM, V5, P83, DOI 10.1038/ncprheum0987; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; Ramagopalan SV, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-10; Ritchlin C, 2006, RHEUM DIS CLIN N AM, V32, P75, DOI 10.1016/j.rdc.2005.12.003; Ritchlin C, 2007, NAT CLIN PRACT RHEUM, V3, P698, DOI 10.1038/ncprheum0670; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Tan AL, 2007, RHEUMATOLOGY, V46, P253, DOI 10.1093/rheumatology/kel214; Tan AL, 2006, ARTHRITIS RHEUM-US, V54, P1328, DOI 10.1002/art.21736; Wilson FC, 2009, ARTHRIT RHEUM-ARTHR, V61, P233, DOI 10.1002/art.24172; Wittkowski K. M., 2006, C P IEEE ENG MED BIO, V1, P3464	33	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20279	10.1371/journal.pone.0020279	http://dx.doi.org/10.1371/journal.pone.0020279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673809	Green Submitted, gold, Green Published			2022-12-25	WOS:000291309900010
J	Brown, RM; Jordan, WC; Faulkes, CG; Jones, CG; Bugoni, L; Tatayah, V; Palma, RL; Nichols, RA				Brown, Ruth M.; Jordan, William C.; Faulkes, Chris G.; Jones, Carl G.; Bugoni, Leandro; Tatayah, Vikash; Palma, Ricardo L.; Nichols, Richard A.			Phylogenetic Relationships in Pterodroma Petrels Are Obscured by Recent Secondary Contact and Hybridization	PLOS ONE			English	Article							ISLAND; MODEL	The classification of petrels (Pterodroma spp.) from Round Island, near Mauritius in the Indian Ocean, has confounded researchers since their discovery in 1948. In this study we investigate the relationships between Round Island petrels and their closest relatives using evidence from mitochondrial DNA sequence data and ectoparasites. Far from providing clear delimitation of species boundaries, our results reveal that hybridization among species on Round Island has led to genetic leakage between populations from different ocean basins. The most common species on the island, Pterodroma arminjoniana, appears to be hybridizing with two rarer species (P. heraldica and P. neglecta), subverting the reproductive isolation of all three and allowing gene flow. P. heraldica and P. neglecta breed sympatrically in the Pacific Ocean, where P. arminjoniana is absent, but no record of hybridization between these two exists and they remain phenotypically distinct. The breakdown of species boundaries in Round Island petrels followed environmental change (deforestation and changes in species composition due to hunting) within their overlapping ranges. Such multi-species interactions have implications not only for conservation, but also for our understanding of the processes of evolutionary diversification and speciation.	[Brown, Ruth M.; Jordan, William C.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Brown, Ruth M.; Faulkes, Chris G.; Nichols, Richard A.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Brown, Ruth M.; Jones, Carl G.; Tatayah, Vikash] Mauritian Wildlife Fdn, Vacoas, Mauritius; [Jones, Carl G.] Durrell Wildlife Conservat Trust, Trinity, Jersey, England; [Bugoni, Leandro] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland; [Bugoni, Leandro] Fundacao Univ Fed Rio Grande, Inst Ciencias Biol, Rio Grande, Brazil; [Palma, Ricardo L.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand	Zoological Society of London; University of London; Queen Mary University London; University of Glasgow; Universidade Federal do Rio Grande	Brown, RM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	rthbwn@bas.ac.uk	Nichols, Richard Alan/T-4773-2019; Bugoni, Leandro/F-9539-2012; Faulkes, Chris/O-8101-2019	Bugoni, Leandro/0000-0003-0689-7026; Nichols, Richard Alan/0000-0002-4801-9312; Faulkes, Christopher/0000-0002-5228-9075	Natural Environment Research Council; Zoological Society of London; University of London; CAPES Foundation	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Zoological Society of London; University of London; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by the Natural Environment Research Council, The Zoological Society of London and a grant from the University of London Central Research Fund. Leandro Bugoni received funding from the CAPES Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooke M, 2004, ALBATROSSES PETRELS; Brooke MD, 1996, IBIS, V138, P420, DOI 10.1111/j.1474-919X.1996.tb08060.x; BROOKE MD, 1999, IBIS, V142, P139; Brown RM, 2010, MOL ECOL, V19, P3157, DOI 10.1111/j.1365-294X.2010.04719.x; Bullock D., 1977, Oryx, V14, P51; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Gompert Z, 2006, SCIENCE, V314, P1923, DOI 10.1126/science.1135875; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammer S, 2010, MOL PHYLOGENET EVOL, V55, P1111, DOI 10.1016/j.ympev.2010.01.013; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hume J., 2008, LOST LAND DODO; Imber M. J., 2004, Notornis, V51, P33; IMBER MJ, 1985, IBIS, V127, P197, DOI 10.1111/j.1474-919X.1985.tb05055.x; KING BR, 1991, EMU, V91, P122, DOI 10.1071/MU9910122; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; LLOYD JA, 1846, P VERBEAUX SOC NAT H, V1842, P154; MARSHALL AG, 1981, ECOLOGY ECTOPARASITI; McDonald DB, 2008, P NATL ACAD SCI USA, V105, P10837, DOI 10.1073/pnas.0712002105; Murphy R. C., 1952, American Museum Novitates, VNo. 1580, P1; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nunn GB, 1996, AUK, V113, P784; ONLEY D., 2007, FIELD GUIDE ALBATROS; Palma RL, 2000, NEW ZEAL J ZOOL, V27, P229, DOI 10.1080/03014223.2000.9518230; Paterson AM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P287; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price R. D., 2003, CHEWING LICE WORLD C, V24; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F., 2005, MRBAYES 3 1 MANUAL; ROUNTREE FRG, 1952, B MAURIT I, V3, P155; SCHNEIDER S, 2000, ARLEQUIN VER 2 0 SOF; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Timmermann G., 1965, Abhandlungen und Verhandlungen des Naturwissenschaftlichen Vereins in Hamburg NF, V8, P1; Timmermann G., 1960, Zeitschrift fuer Parasitenkunde, V20, P317; Tove Michael H., 2005, Notornis, V52, P56; VINSON J, 1949, P R SOC ARTS SCI MAU, V1, P32; Zino F, 2008, IBIS, V150, P326, DOI 10.1111/j.1474-919X.2007.00794.x	38	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20350	10.1371/journal.pone.0020350	http://dx.doi.org/10.1371/journal.pone.0020350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655247	Green Published, gold			2022-12-25	WOS:000291097600049
J	Cain, DW; Snowden, PB; Sempowski, GD; Kelsoe, G				Cain, Derek W.; Snowden, Pilar B.; Sempowski, Gregory D.; Kelsoe, Garnett			Inflammation Triggers Emergency Granulopoiesis through a Density-Dependent Feedback Mechanism	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TOLL-LIKE RECEPTORS; G-CSF; DEFICIENT MICE; C/EBP-BETA; IN-VIVO; NEUTROPHIL MOBILIZATION; CYCLIC NEUTROPENIA; BONE-MARROW; GM-CSF	Normally, neutrophil pools are maintained by homeostatic mechanisms that require the transcription factor C/EBP alpha. Inflammation, however, induces neutrophilia through a distinct pathway of "emergency" granulopoiesis that is dependent on C/EBPb. Here, we show in mice that alum triggers emergency granulopoiesis through the IL-1RI-dependent induction of G-CSF. G-CSF/G-CSF-R neutralization impairs proliferative responses of hematopoietic stem and progenitor cells (HSPC) to alum, but also abrogates the acute mobilization of BM neutrophils, raising the possibility that HSPC responses to inflammation are an indirect result of the exhaustion of BM neutrophil stores. The induction of neutropenia, via depletion with Gr-1 mAb or myeloid-specific ablation of Mcl-1, elicits G-CSF via an IL-1RI-independent pathway, stimulating granulopoietic responses indistinguishable from those induced by adjuvant. Notably, C/EBPb, thought to be necessary for enhanced generative capacity of BM, is dispensable for increased proliferation of HSPC to alum or neutropenia, but plays a role in terminal neutrophil differentiation during granulopoietic recovery. We conclude that alum elicits a transient increase in G-CSF production via IL-1RI for the mobilization of BM neutrophils, but density-dependent feedback sustains G-CSF for accelerated granulopoiesis.	[Cain, Derek W.; Snowden, Pilar B.; Kelsoe, Garnett] Duke Univ, Dept Immunol, Durham, NC 27708 USA; [Sempowski, Gregory D.] Duke Univ Med Ctr, Duke Univ Human Vaccine Inst, Durham, NC USA	Duke University; Duke University	Cain, DW (corresponding author), Duke Univ, Dept Immunol, Durham, NC 27708 USA.	ghkelsoe@duke.edu		Sempowski, Gregory/0000-0003-0391-6594; Kelsoe, Garnett/0000-0002-8770-040X	NIH [AI24335, AI56363, P30-AI051445, UC6-AI058607]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UC6AI058607, P30AI051445, U19AI056363, R01AI024335] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI24335 and AI56363 (to G. K.) (http://www.nih.gov/). The Duke Human Vaccine Institute Immune Reconstitution & Biomarker Shared Resource Facility is supported in part by NIH grants P30-AI051445 and UC6-AI058607; residual financial support is generated through user fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akagi T, 2008, BLOOD, V111, P2999, DOI 10.1182/blood-2007-04-087213; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; Basu S, 2000, BLOOD, V95, P3725; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bliss SK, 2001, INFECT IMMUN, V69, P4898, DOI 10.1128/IAI.69.8.4898-4905.2001; BOGGS DR, 1966, ANNU REV PHYSIOL, V28, P39, DOI 10.1146/annurev.ph.28.030166.000351; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; CRADDOCK CG, 1955, J LAB CLIN MED, V45, P881; CZUPRYNSKI CJ, 1994, J IMMUNOL, V152, P1836; DALE DC, 1988, BLOOD REV, V2, P178, DOI 10.1016/0268-960X(88)90023-9; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dzhagalov I, 2007, BLOOD, V109, P1620, DOI 10.1182/blood-2006-03-013771; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; KINGSMITH EA, 1970, BLOOD-J HEMATOL, V36, P254, DOI 10.1182/blood.V36.2.254.254; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; METCALF D, 1986, BLOOD, V68, P46; METCALF D, 1987, EXP HEMATOL, V15, P1; Metcalf D, 1998, IMMUNOL CELL BIOL, V76, P441, DOI 10.1046/j.1440-1711.1998.00761.x; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MORLEY A, 1970, BLOOD-J HEMATOL, V35, P312, DOI 10.1182/blood.V35.3.312.312; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Ostby I, 2004, J MATH BIOL, V49, P501, DOI 10.1007/s00285-004-0274-6; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; PATT HM, 1957, AM J PHYSIOL, V188, P585, DOI 10.1152/ajplegacy.1957.188.3.585; RUBINOW SI, 1975, J MATH BIOL, V1, P187, DOI 10.1007/BF01273744; SCUMPIA PO, 2010, J IMMUNOL; SHIRAFUJI N, 1989, EXP HEMATOL, V17, P116; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; Smith E, 2009, J IMMUNOL, V183, P5685, DOI 10.4049/jimmunol.0900887; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Ueda Y, 2004, J EXP MED, V199, P47, DOI 10.1084/jem.20031104; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; ULICH TR, 1989, BLOOD, V73, P108; von Vietinghoff S, 2008, J IMMUNOL, V181, P5183, DOI 10.4049/jimmunol.181.8.5183; VONSCHULTHESS GK, 1982, BLOOD, V59, P27; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	50	69	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e19957	10.1371/journal.pone.0019957	http://dx.doi.org/10.1371/journal.pone.0019957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655273	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600012
J	Chakravarty, MM; Aleong, R; Leonard, G; Perron, M; Pike, GB; Richer, L; Veillette, S; Pausova, Z; Paus, T				Chakravarty, M. Mallar; Aleong, Rosanne; Leonard, Gabriel; perron, Michel; Pike, G. Bruce; Richer, Louis; Veillette, Suzanne; Pausova, Zdenka; Paus, Tomas			Automated Analysis of Craniofacial Morphology Using Magnetic Resonance Images	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GEOMETRIC MORPHOMETRICS; SEXUAL-DIMORPHISM; WHITE-MATTER; MOUSE-BRAIN; DIGIT RATIO; ATLAS; GROWTH; SHAPE; BODY	Quantitative analysis of craniofacial morphology is of interest to scholars working in a wide variety of disciplines, such as anthropology, developmental biology, and medicine. T1-weighted (anatomical) magnetic resonance images (MRI) provide excellent contrast between soft tissues. Given its three-dimensional nature, MRI represents an ideal imaging modality for the analysis of craniofacial structure in living individuals. Here we describe how T1-weighted MR images, acquired to examine brain anatomy, can also be used to analyze facial features. Using a sample of typically developing adolescents from the Saguenay Youth Study (N = 597; 292 male, 305 female, ages: 12 to 18 years), we quantified inter-individual variations in craniofacial structure in two ways. First, we adapted existing nonlinear registration-based morphological techniques to generate iteratively a group-wise population average of craniofacial features. The nonlinear transformations were used to map the craniofacial structure of each individual to the population average. Using voxel-wise measures of expansion and contraction, we then examined the effects of sex and age on inter-individual variations in facial features. Second, we employed a landmark-based approach to quantify variations in face surfaces. This approach involves: (a) placing 56 landmarks (forehead, nose, lips, jaw-line, cheekbones, and eyes) on a surface representation of the MRI-based group average; (b) warping the landmarks to the individual faces using the inverse nonlinear transformation estimated for each person; and (3) using a principal components analysis (PCA) of the warped landmarks to identify facial features (i. e. clusters of landmarks) that vary in our sample in a correlated fashion. As with the voxel-wise analysis of the deformation fields, we examined the effects of sex and age on the PCA-derived spatial relationships between facial features. Both methods demonstrated significant sexual dimorphism in craniofacial structure in areas such as the chin, mandible, lips, and nose.	[Chakravarty, M. Mallar; Aleong, Rosanne; Paus, Tomas] Rotman Res Inst, Toronto, ON, Canada; [Chakravarty, M. Mallar] Hosp Sick Children, Mouse Imaging Ctr MICe, Toronto, ON M5G 1X8, Canada; [Leonard, Gabriel; Pike, G. Bruce; Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [perron, Michel; Veillette, Suzanne] ECOBES, Jonquiere, PQ, Canada; [perron, Michel; Veillette, Suzanne] Univ Quebec Chicoutimi, Saguenay, PQ, Canada; [Richer, Louis] Univ Quebec Chicoutimi, Dept Sci Educ & Psychol, Chicoutimi, PQ, Canada; [Pausova, Zdenka; Paus, Tomas] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England; [Pausova, Zdenka] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; University of Nottingham; Universite de Montreal	Chakravarty, MM (corresponding author), Rotman Res Inst, Toronto, ON, Canada.	mchakravarty@rotman-baycrest.on.ca	Pike, Bruce/K-5562-2014	Pike, Bruce/0000-0001-8924-683X	Canadian Institutes of Health Research; Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation; Canada Foundation for Innovation under Compute Canada; Government of Ontario, Ontario Research Fund - Research Excellence; University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Quebec; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Foundation for Innovation under Compute Canada; Government of Ontario, Ontario Research Fund - Research Excellence; University of Toronto(University of Toronto)	This work was supported by the Canadian Institutes of Health Research (TP, ZP), Heart and Stroke Foundation of Quebec (ZP), and the Canadian Foundation for Innovation (ZP). Computations were performed on the SciNet supercomputer at the SciNet HPC Consortium. SciNet is funded by the Canada Foundation for Innovation under the auspices of Compute Canada, the Government of Ontario, Ontario Research Fund - Research Excellence and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleong R, 2007, BEHAV RES METHODS, V39, P651, DOI 10.3758/BF03193037; Aleong R, 2010, J COGNITIVE NEUROSCI, V22, P482, DOI 10.1162/jocn.2009.21211; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; BOOKSTEIN FL, 1991, PROG CLIN BIOL RES, V363, P227; BOOKSTEIN FL, 1984, J THEOR BIOL, V107, P475, DOI 10.1016/S0022-5193(84)80104-6; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Borghammer P, 2010, EUR J NEUROL, V17, P314, DOI 10.1111/j.1468-1331.2009.02807.x; Chakravarty MM, 2006, LECT NOTES COMPUT SC, V4191, P389; Chakravarty MM, 2009, HUM BRAIN MAPP, V30, P3574, DOI 10.1002/hbm.20780; Chakravarty MM, 2008, MED IMAGE ANAL, V12, P713, DOI 10.1016/j.media.2008.04.003; Chan E, 2007, NEUROSCIENCE, V144, P604, DOI 10.1016/j.neuroscience.2006.08.080; Chen XJ, 2006, NEUROIMAGE, V29, P99, DOI 10.1016/j.neuroimage.2005.07.008; Chung MK, 2001, NEUROIMAGE, V14, P595, DOI 10.1006/nimg.2001.0862; CLARREN SK, 1987, AM J MED GENET, V26, P651, DOI 10.1002/ajmg.1320260321; COHEN SR, 1995, J CRANIOFAC SURG, V6, P184, DOI 10.1097/00001665-199505000-00002; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cootes T. F., 1998, ACTIVE APPEARANCE MO, P484; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Duchesne S, 2008, IEEE T MED IMAGING, V27, P509, DOI 10.1109/TMI.2007.908685; Duchesne S, 2010, NEUROBIOL AGING, V31, P1606, DOI 10.1016/j.neurobiolaging.2008.09.003; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; FREY S, 2011, NEUROIMAGE; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Harvati K, 2010, J HUM EVOL, V59, P445, DOI 10.1016/j.jhevol.2010.06.005; Hellier P, 2003, IEEE T MED IMAGING, V22, P1120, DOI 10.1109/TMI.2003.816961; Hennessy RJ, 2005, J ANAT, V207, P283, DOI 10.1111/j.1469-7580.2005.00444.x; Hennessy RJ, 2004, SCHIZOPHR RES, V67, P261, DOI 10.1016/j.schres.2003.08.003; Hennessy RJ, 2002, BIOL PSYCHIAT, V51, P507, DOI 10.1016/S0006-3223(01)01327-0; Hennessy RJ, 2010, SCHIZOPHR RES, V122, P63, DOI 10.1016/j.schres.2010.05.001; Henriksson KM, 2006, PSYCHIAT RES-NEUROIM, V147, P173, DOI 10.1016/j.pscychresns.2005.02.013; Henriksson KM, 2006, PSYCHIAT RES-NEUROIM, V147, P187, DOI 10.1016/j.pscychresns.2006.03.004; Hubbe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011105; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Joshi S, 2003, MED IMAGE ANAL, V7, P155, DOI 10.1016/S1361-8415(03)00002-1; Kelly BD, 2005, SCHIZOPHR RES, V80, P349, DOI 10.1016/j.schres.2005.07.036; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lerch JP, 2008, NEUROIMAGE, V39, P32, DOI 10.1016/j.neuroimage.2007.08.033; MacDonald D, 1998, METHOD IDENTIFYING G; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Miller MI, 2001, INT J COMPUT VISION, V41, P61, DOI 10.1023/A:1011161132514; Mitteroecker P, 2005, EVOL DEV, V7, P244, DOI 10.1111/j.1525-142X.2005.05027.x; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Nieman BJ, 2006, PHYSIOL GENOMICS, V24, P154, DOI 10.1152/physiolgenomics.00217.2005; Pausova Z, 2007, HUM BRAIN MAPP, V28, P502, DOI 10.1002/hbm.20402; Perrin JS, 2009, NEUROIMAGE, V45, P1055, DOI 10.1016/j.neuroimage.2009.01.023; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Powell JF, 1999, YEARB PHYS ANTHROPOL, V42, P153; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Schaefer K, 2005, COLLEGIUM ANTROPOL, V29, P415; SCHUMANN G, MOL PSYCHIA IN PRESS; Sforza C, 2010, FORENSIC SCI INT, V200, DOI 10.1016/j.forsciint.2010.04.050; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Suri M, 2005, SEMIN FETAL NEONAT M, V10, P243, DOI 10.1016/j.siny.2004.12.002; Suri S, 2010, ANGLE ORTHOD, V80, P861, DOI 10.2319/111709-650.1; Suri S, 2010, AM J ORTHOD DENTOFAC, V137, P763, DOI 10.1016/j.ajodo.2008.07.020; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933	66	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20241	10.1371/journal.pone.0020241	http://dx.doi.org/10.1371/journal.pone.0020241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655288	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000291097600033
J	Peterson, MW; Fairchild, SZ; Otto, TC; Mohtashemi, M; Cerasoli, DM; Chang, WE				Peterson, Matthew W.; Fairchild, Steven Z.; Otto, Tamara C.; Mohtashemi, Mojdeh; Cerasoli, Douglas M.; Chang, Wenling E.			VX Hydrolysis by Human Serum Paraoxonase 1: A Comparison of Experimental and Computational Results	PLOS ONE			English	Article							TRANSITION-STATE DOCKING; ACTIVE-SITE; PREDICTION; STABILITY; PON1	Human Serum paraoxonase 1 (HuPON1) is an enzyme that has been shown to hydrolyze a variety of chemicals including the nerve agent VX. While wildtype HuPON1 does not exhibit sufficient activity against VX to be used as an in vivo countermeasure, it has been suggested that increasing HuPON1's organophosphorous hydrolase activity by one or two orders of magnitude would make the enzyme suitable for this purpose. The binding interaction between HuPON1 and VX has recently been modeled, but the mechanism for VX hydrolysis is still unknown. In this study, we created a transition state model for VX hydrolysis (VXts) in water using quantum mechanical/molecular mechanical simulations, and docked the transition state model to 22 experimentally characterized HuPON1 variants using AutoDock Vina. The HuPON1-VXts complexes were grouped by reaction mechanism using a novel clustering procedure. The average Vina interaction energies for different clusters were compared to the experimentally determined activities of HuPON1 variants to determine which computational procedures best predict how well HuPON1 variants will hydrolyze VX. The analysis showed that only conformations which have the attacking hydroxyl group of VXts coordinated by the sidechain oxygen of D269 have a significant correlation with experimental results. The results from this study can be used for further characterization of how HuPON1 hydrolyzes VX and design of HuPON1 variants with increased activity against VX.	[Peterson, Matthew W.; Fairchild, Steven Z.; Mohtashemi, Mojdeh; Chang, Wenling E.] Mitre Corp, Bedford, MA 01730 USA; [Peterson, Matthew W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Otto, Tamara C.; Cerasoli, Douglas M.] USA, Physiol & Immunol Branch, Div Res, Med Res Inst Chem Def, Aberdeen Proving Ground, MD USA; [Mohtashemi, Mojdeh] MIT Comp Sci & Lab, Cambridge, MA USA; [Chang, Wenling E.] George Mason Univ, Sch Syst Biol, Manassas, VA USA	MITRE Corporation; Boston University; Research Institute of Chemical Defense - China; George Mason University	Peterson, MW (corresponding author), Mitre Corp, Burlington Rd, Bedford, MA 01730 USA.	wchang@mitre.org			Defense Threat Reduction Agency-Joint Science and Technology Office Medical ST Division	Defense Threat Reduction Agency-Joint Science and Technology Office Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency)	The research was supported by the Defense Threat Reduction Agency-Joint Science and Technology Office Medical S&T Division. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army or the Department of Defense.	Cannard K, 2006, J NEUROL SCI, V249, P86, DOI 10.1016/j.jns.2006.06.008; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fairchild SZ, 2011, J MOL MODEL, V17, P97, DOI 10.1007/s00894-010-0693-9; Fersht A., 1985, ENZYME STRUCTURE MEC; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Harel Michal, 2007, Arhiv za Higijenu Rada i Toksikologiju, V58, P347, DOI 10.2478/v10004-007-0028-0; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hu X, 2009, PROTEINS, V75, P486, DOI 10.1002/prot.22264; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Josse D, 2001, J APPL TOXICOL, V21, pS7, DOI 10.1002/jat.789; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kuo CL, 1998, DRUG METAB DISPOS, V26, P653; MACKNESS B, 2008, PARAOXONASES THEIR R, P151; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Newmark J, 2007, NEUROLOGIST, V13, P20, DOI 10.1097/01.nrl.0000252923.04894.53; Otto TC, 2010, CHEM-BIOL INTERACT, V187, P388, DOI 10.1016/j.cbi.2010.02.022; Otto TC, 2009, BIOCHEMISTRY-US, V48, P10416, DOI 10.1021/bi901161b; Rochu D, 2007, TOXICOLOGY, V233, P47, DOI 10.1016/j.tox.2006.08.037; Rydberg P, 2008, J CHEM THEORY COMPUT, V4, P673, DOI 10.1021/ct700313j; SANAN TT, J PHYS ORGANIC CHEM, V23, P357; Tantillo DJ, 2002, J COMPUT CHEM, V23, P84, DOI 10.1002/jcc.10019; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Yeung DT, 2005, FEBS J, V272, P2225, DOI 10.1111/j.1742-4658.2005.04646.x; Yeung DT, 2004, BBA-PROTEINS PROTEOM, V1702, P67, DOI 10.1016/j.bbapap.2004.08.002; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; AUTODOCKTOOLS 4 2; JAGUAR 7 7	32	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20335	10.1371/journal.pone.0020335	http://dx.doi.org/10.1371/journal.pone.0020335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655255	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600046
J	Bonner, MK; Poole, DS; Xu, T; Sarkeshik, A; Yates, JR; Skop, AR				Bonner, Mary Kate; Poole, Daniel S.; Xu, Tao; Sarkeshik, Ali; Yates, John R., III; Skop, Ahna R.			Mitotic Spindle Proteomics in Chinese Hamster Ovary Cells	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; GENOME DATABASE; CYTOKINESIS; PROTEINS; TAXOL; KINASE; CYCLE; MICROTUBULES; MECHANISMS; RESOURCE	Mitosis is a fundamental process in the development of all organisms. The mitotic spindle guides the cell through mitosis as it mediates the segregation of chromosomes, the orientation of the cleavage furrow, and the progression of cell division. Birth defects and tissue-specific cancers often result from abnormalities in mitotic events. Here, we report a proteomic study of the mitotic spindle from Chinese Hamster Ovary (CHO) cells. Four different isolations of metaphase spindles were subjected to Multi-dimensional Protein Identification Technology (MudPIT) analysis and tandem mass spectrometry. We identified 1155 proteins and used Gene Ontology (GO) analysis to categorize proteins into cellular component groups. We then compared our data to the previously published CHO midbody proteome and identified proteins that are unique to the CHO spindle. Our data represent the first mitotic spindle proteome in CHO cells, which augments the list of mitotic spindle components from mammalian cells.	[Bonner, Mary Kate; Poole, Daniel S.; Skop, Ahna R.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Xu, Tao; Sarkeshik, Ali; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute	Bonner, MK (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	skop@wisc.edu	Skop, Ahna Renee/X-3305-2019; Xu, Tao/A-9353-2009; chudobova, ivana/F-8477-2011	Skop, Ahna Renee/0000-0003-3522-4939; 	NSF [0546398]; NHGRI [T32HG002760]; NIH [P41RR0118232]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL092583] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	ARS and MKB are supported by a NSF CAREER Award (0546398). MKB is also supported by an NHGRI training grant to the Genomic Sciences Training Program T32HG002760. JRY is supported by a NIH grant (P41RR0118232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Austin GE, 1998, AM J CLIN PATHOL, V110, P575, DOI 10.1093/ajcp/110.5.575; Bader JR, 2010, SEMIN CELL DEV BIOL, V21, P269, DOI 10.1016/j.semcdb.2009.12.015; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bloom K, 2010, NATURE, V463, P446, DOI 10.1038/nature08912; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; COCIORVA D, 2006, CURRENT PROTOCOLS BI; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; DECASTRO IP, 2008, CURR OPIN PHARMACOL, V8, P375; Degenhardt Y, 2010, CLIN CANCER RES, V16, P384, DOI 10.1158/1078-0432.CCR-09-1380; Diop SB, 2008, EMBO REP, V9, P260, DOI 10.1038/embor.2008.8; Doye V, 2011, DEV CELL, V20, P281, DOI 10.1016/j.devcel.2011.02.013; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Foss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001476; Gache V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009248; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Han ZM, 2010, J PROTEOME RES, V9, P6025, DOI 10.1021/pr100827j; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; HO MY, 2010, CANC SCI; Inaki M, 2011, GENES CELLS, V16, P166, DOI 10.1111/j.1365-2443.2010.01479.x; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kingston DGI, 2007, PHYTOCHEMISTRY, V68, P1844, DOI 10.1016/j.phytochem.2006.11.009; KURIYAMA R, 1984, J CELL SCI, V66, P265; LEVINE DS, 1991, P NATL ACAD SCI USA, V88, P6427, DOI 10.1073/pnas.88.15.6427; Li J, 2010, J GENET GENOMICS, V37, P159, DOI 10.1016/S1673-8527(09)60034-5; Li R, 2007, CELL MOL LIFE SCI, V64, P3044, DOI 10.1007/s00018-007-7285-6; Liska AJ, 2004, PROTEOMICS, V4, P2707, DOI 10.1002/PMIC.200300813; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Malik R, 2009, J PROTEOME RES, V8, P4553, DOI 10.1021/pr9003773; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Marshall JC, 2010, EUR J CANCER, V46, P1278, DOI 10.1016/j.ejca.2010.02.042; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mishra RK, 2010, NAT CELL BIOL, V12, P164, DOI 10.1038/ncb2016; Moniaux N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007077; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; MULLINS JM, 1982, J CELL BIOL, V94, P654, DOI 10.1083/jcb.94.3.654; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; RAPPAPORT R, 1961, J EXP ZOOL, V148, P81, DOI 10.1002/jez.1401480107; RAPPAPORT R, 1985, J EXP ZOOL, V234, P167, DOI 10.1002/jez.1402340120; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schenk PW, 2004, NEOPLASIA, V6, P297, DOI 10.1593/neo.03406; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431; SEWALD N, 2009, PEPTIDES CHEM BIOL, pR16; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; STARGER JM, 1977, P NATL ACAD SCI USA, V74, P2422, DOI 10.1073/pnas.74.6.2422; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tanenbaum ME, 2010, DEV CELL, V19, P797, DOI 10.1016/j.devcel.2010.11.011; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; Walczak CE, 2000, GENOME BIOL, V1; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018; Wozniak R, 2010, CELL MOL LIFE SCI, V67, P2215, DOI 10.1007/s00018-010-0325-7; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	82	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20489	10.1371/journal.pone.0020489	http://dx.doi.org/10.1371/journal.pone.0020489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647379	gold, Green Published			2022-12-25	WOS:000291052500064
J	Peng, XS; Guo, W; Liu, TJ; Wang, X; Tu, XA; Xiong, DF; Chen, S; Lai, YR; Du, H; Chen, GF; Liu, GL; Tang, YB; Huang, SA; Zou, XN				Peng, Xinsheng; Guo, Wei; Liu, Tiejian; Wang, Xi; Tu, Xiang'an; Xiong, Dafu; Chen, Song; Lai, Yingrong; Du, Hong; Chen, Guangfu; Liu, Guanglin; Tang, Yubo; Huang, Shuai; Zou, Xuenong			Identification of miRs-143 and-145 that Is Associated with Bone Metastasis of Prostate Cancer and Involved in the Regulation of EMT	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA GENE-EXPRESSION; BREAST-CANCER; CELL INVASION; IN-VITRO; COLORECTAL-CANCER; PROGRESSION; CARCINOMA; TARGETS; GROWTH	The principal problem arising from prostate cancer (PCa) is its propensity to metastasize to bone. MicroRNAs (miRNAs) play a crucial role in many tumor metastases. The importance of miRNAs in bone metastasis of PCa has not been elucidated to date. We investigated whether the expression of certain miRNAs was associated with bone metastasis of PCa. We examined the miRNA expression profiles of 6 primary and 7 bone metastatic PCa samples by miRNA microarray analysis. The expression of 5 miRNAs significantly decreased in bone metastasis compared with primary PCa, including miRs-508-5p, -145, -143, -33a and -100. We further examined other samples of 16 primary PCa and 13 bone metastases using real-time PCR analysis. The expressions of miRs-143 and -145 were verified to down-regulate significantly in metastasis samples. By investigating relationship of the levels of miRs-143 and -145 with clinicopathological features of PCa patients, we found down-regulations of miRs-143 and -145 were negatively correlated to bone metastasis, the Gleason score and level of free PSA in primary PCa. Over-expression miR-143 and -145 by retrovirus transfection reduced the ability of migration and invasion in vitro, and tumor development and bone invasion in vivo of PC-3 cells, a human PCa cell line originated from a bone metastatic PCa specimen. Their upregulation also increased E-cadherin expression and reduced fibronectin expression of PC-3 cells which revealed a less invasive morphologic phenotype. These findings indicate that miRs-143 and -145 are associated with bone metastasis of PCa and suggest that they may play important roles in the bone metastasis and be involved in the regulation of EMT Both of them may also be clinically used as novel biomarkers in discriminating different stages of human PCa and predicting bone metastasis.	[Peng, Xinsheng; Guo, Wei; Chen, Guangfu; Tang, Yubo; Huang, Shuai; Zou, Xuenong] Sun Yat Sen Univ, Affiliated Hosp 1, Orthopaed Res Inst, Dept Orthopaed Surg, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Tiejian] Laura Biotech Co Ltd, Guangzhou, Guangdong, Peoples R China; [Wang, Xi; Liu, Guanglin] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Tu, Xiang'an] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Dafu; Chen, Song] Second Peoples Hosp Zhuhai City, Dept Surg, Zhuhai, Guangdong, Peoples R China; [Lai, Yingrong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Du, Hong] First Peoples Hosp Guangzhou City, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; South China University of Technology	Peng, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Orthopaed Res Inst, Dept Orthopaed Surg, Guangzhou 510275, Guangdong, Peoples R China.	pengxs66@yahoo.com; zxnong@hotmail.com	peng, Xinsheng/Q-9115-2019		NSFC-Guangdong, China [u0732001]; Natural Science Foundation of Guangdong Province, China [06021290]; Science and Technology planning project of Guangdong Province, China [2008B030301037]; Science and Technology Planning Project of Zhuhai, China	NSFC-Guangdong, China(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology planning project of Guangdong Province, China; Science and Technology Planning Project of Zhuhai, China	NSFC-Guangdong Joint funding, China (No. u0732001); the Natural Science Foundation of Guangdong Province, China (No. 06021290); Science and Technology planning project of Guangdong Province, China (No. 2008B030301037) and Science and Technology Planning Project of Zhuhai, China (2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berney DM, 2007, BJU INT, V100, P1240, DOI 10.1111/j.1464-410X.2007.07199.x; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Cai Z, 2010, CANCER LETT, V296, P88, DOI 10.1016/j.canlet.2010.03.020; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chan CM, 2010, MOL VIS, V16, P586; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Friedman JM, 2009, CELL CYCLE, V8, P2313, DOI 10.4161/cc.8.15.9168; Fu XP, 2010, MOL BIOSYST, V6, P2561, DOI 10.1039/c0mb00100g; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jin H, 2010, BIOMED RES-TOKYO, V31, P105, DOI 10.2220/biomedres.31.105; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kano M, 2010, INT J CANC; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Kitade Y, 2010, J PHARMACOL SCI, V114, P276, DOI 10.1254/jphs.10R12FM; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Larsson E, 2009, GENOME MED, V1, DOI 10.1186/gm108; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mo YY, 1999, EXP CELL RES, V252, P50, DOI 10.1006/excr.1999.4616; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Ng EKO, 2009, BRIT J CANCER, V101, P699, DOI 10.1038/sj.bjc.6605195; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Ohshima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013247; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; PARTIN AW, 1993, J UROLOGY, V150, P110, DOI 10.1016/S0022-5347(17)35410-1; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x; Rieger-Christ KM, 2004, ONCOGENE, V23, P4745, DOI 10.1038/sj.onc.1207629; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sachdeva M, 2010, AM J TRANSL RES, V2, P170; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Stephenson AJ, 2009, J CLIN ONCOL, V27, P4300, DOI 10.1200/JCO.2008.18.2501; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang GH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S22; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang M, 2006, CLIN CANCER RES, V12, P2602, DOI 10.1158/1078-0432.CCR-05-2050; Ye L, 2007, INT J MOL MED, V20, P103; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhou CH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2210	81	154	169	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20341	10.1371/journal.pone.0020341	http://dx.doi.org/10.1371/journal.pone.0020341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647377	Green Published, gold			2022-12-25	WOS:000291052500049
J	Niessner, C; Denzau, S; Gross, JC; Peichl, L; Bischof, HJ; Fleissner, G; Wiltschko, W; Wiltschko, R				Niessner, Christine; Denzau, Susanne; Gross, Julia Christina; Peichl, Leo; Bischof, Hans-Joachim; Fleissner, Gerta; Wiltschko, Wolfgang; Wiltschko, Roswitha			Avian Ultraviolet/Violet Cones Identified as Probable Magnetoreceptors	PLOS ONE			English	Article							MAGNETIC COMPASS ORIENTATION; BLUE-LIGHT; MIGRATORY BIRDS; VISUAL ECOLOGY; CRYPTOCHROME; RETINA; CHICKEN; EXPRESSION; INTENSITY; FIELD	Background: The Radical-Pair-Model postulates that the reception of magnetic compass directions in birds is based on spin-chemical reactions in specialized photopigments in the eye, with cryptochromes discussed as candidate molecules. But so far, the exact subcellular characterization of these molecules in the retina remained unknown. Methodology/Principal Findings: We here describe the localization of cryptochrome 1a (Cry1a) in the retina of European robins, Erithacus rubecula, and domestic chickens, Gallus gallus, two species that have been shown to use the magnetic field for compass orientation. In both species, Cry1a is present exclusively in the ultraviolet/violet (UV/V) cones that are distributed across the entire retina. Electron microscopy shows Cry1a in ordered bands along the membrane discs of the outer segment, and cell fractionation reveals Cry1a in the membrane fraction, suggesting the possibility that Cry1a is anchored along membranes. Conclusions/Significance: We provide first structural evidence that Cry1a occurs within a sensory structure arranged in a way that fulfils essential requirements of the Radical-Pair-Model. Our findings, identifying the UV/V-cones as probable magnetoreceptors, support the assumption that Cry1a is indeed the receptor molecule mediating information on magnetic directions, and thus provide the Radical-Pair-Model with a profound histological background.	[Niessner, Christine; Denzau, Susanne; Gross, Julia Christina; Fleissner, Gerta; Wiltschko, Wolfgang; Wiltschko, Roswitha] JW Goethe Univ Frankfurt, Fachbereich Biowissensch, Frankfurt, Germany; [Peichl, Leo] Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany; [Bischof, Hans-Joachim] Univ Bielefeld, Fak Biol, D-4800 Bielefeld, Germany	Goethe University Frankfurt; Max Planck Society; University of Bielefeld	Niessner, C (corresponding author), JW Goethe Univ Frankfurt, Fachbereich Biowissensch, Frankfurt, Germany.	wiltschko@bio.uni-frankfurt.de	Gross, Julia Christina/AAN-5730-2020	Gross, Julia Christina/0000-0002-8939-5664; Peichl, Leo/0000-0002-8141-0911	Deutsche Forschungsgemeinschaft [Wi 988/8-1, Wi 988/8-2]; Alfons und Gertrud Kassel-Foundation through the Frankfurt International Graduate School of Science	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alfons und Gertrud Kassel-Foundation through the Frankfurt International Graduate School of Science	Supported by the Deutsche Forschungsgemeinschaft (grant Wi 988/8-1 and 2 to RW). C.N. was supported by the Alfons und Gertrud Kassel-Foundation through the Frankfurt International Graduate School of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; Ahmad M, 2007, PLANTA, V225, P615, DOI 10.1007/s00425-006-0383-0; Eckmeier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003956; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FROST BJ, 1981, EXP BRAIN RES, V43, P173; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Haque R, 2002, NEUROREPORT, V13, P2247, DOI 10.1097/00001756-200212030-00016; Hart NS, 2007, AM NAT, V169, pS7, DOI 10.1086/510141; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Hill E, 2010, J R SOC INTERFACE, V7, pS265, DOI 10.1098/rsif.2009.0378.focus; Keary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011912; Keary N, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-25; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Lin CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-220; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schiviz AN, 2008, J COMP NEUROL, V507, P1336, DOI 10.1002/cne.21626; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; Seydewitz V, 2004, INVEST OPHTH VIS SCI, V45, P655, DOI 10.1167/iovs.03-0182; Smith EL, 2002, J EXP BIOL, V205, P3299; Stapput K, 2010, CURR BIOL, V20, P1259, DOI 10.1016/j.cub.2010.05.070; Thalau P, 2005, NATURWISSENSCHAFTEN, V92, P86, DOI 10.1007/s00114-004-0595-8; WANG SZ, 1992, BIOCHEMISTRY-US, V31, P3309, DOI 10.1021/bi00128a002; Wiltscbko W., 1968, Zeitschrift fuer Tierpsychologie, V25, P537; Wiltschko R, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-5; Wiltschko R, 2010, J R SOC INTERFACE, V7, pS163, DOI 10.1098/rsif.2009.0367.focus; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; Wiltschko W, 2007, J ORNITHOL, V148, pS61, DOI 10.1007/s10336-007-0233-2; Wiltschko W, 2007, J EXP BIOL, V210, P2300, DOI 10.1242/jeb.004853; Yamamoto K, 2001, NEUROSCI LETT, V313, P13, DOI 10.1016/S0304-3940(01)02227-3; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105; Zapka M, 2010, EUR J NEUROSCI, V32, P619, DOI 10.1111/j.1460-9568.2010.07311.x	41	121	124	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20091	10.1371/journal.pone.0020091	http://dx.doi.org/10.1371/journal.pone.0020091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647441	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500025
J	Yin, M; Liao, ZX; Huang, YJ; Liu, ZS; Yuan, XL; Gomez, D; Wang, LE; Wei, QY				Yin, Ming; Liao, Zhongxing; Huang, Yu-Jing; Liu, Zhensheng; Yuan, Xianglin; Gomez, Daniel; Wang, Li-E; Wei, Qingyi			Polymorphisms of Homologous Recombination Genes and Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated with Definitive Radiotherapy	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; VOLUME HISTOGRAM ANALYSIS; DNA-REPAIR GENES; RADIATION PNEUMONITIS; CONFORMAL RADIOTHERAPY; SURVIVAL; RAD51; XRCC3; NBS1; PROGNOSIS	The repair of DNA double-strand breaks (DSBs) is the major mechanism to maintain genomic stability in response to irradiation. We hypothesized that genetic polymorphisms in DSB repair genes may affect clinical outcomes among non-small cell lung cancer (NSCLC) patients treated with definitive radio(chemo) therapy. We genotyped six potentially functional single nucleotide polymorphisms (SNPs) (i.e., RAD51 - 135G>C/rs1801320 and -172G>T/rs1801321, XRCC2 4234G>C/rs3218384 and R188H/rs3218536 G>A, XRCC3 T241M/rs861539 and NBN E185Q/rs1805794) and estimated their associations with overall survival (OS) and radiation pneumonitis (RP) in 228 NSCLC patients. We found a predictive role of RAD51 -135G>C SNP in RP development (adjusted hazard ratio [HR] = 0.52, 95% confidence interval [CI], 0.31-0.86, P = 0.010 for CG/CC vs. GG). We also found that RAD51 -135G>C and XRCC2 R188H SNPs were independent prognostic factors for overall survival (adjusted HR = 1.70, 95% CI, 1.14-2.62, P = 0.009 for CG/CC vs. GG; and adjusted HR = 1.70; 95% CI, 1.02-2.85, P = 0.043 for AG vs. GG, respectively) and that the SNP-survival association was most pronounced in the presence of RP. Our study suggests that HR genetic polymorphisms, particularly RAD51 -135G>C, may influence overall survival and radiation pneumonitis in NSCLC patients treated with definitive radio(chemo) therapy. Large studies are needed to confirm our findings.	[Yin, Ming; Huang, Yu-Jing; Liu, Zhensheng; Wang, Li-E; Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Liao, Zhongxing; Gomez, Daniel] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Yuan, Xianglin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan 430074, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Huazhong University of Science & Technology	Yin, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	zliao@mdanderson.org; qwei@mdanderson.org	Wang, Weili/D-1546-2011		National Institutes of Health [R01 ES011740, CA0131274, CA 16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was in part supported by National Institutes of Health grants R01 ES011740 and CA0131274 (to Q. W.) and CA 16672 (to M. D. Anderson Cancer Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka P, 2004, MUTAT RES-FUND MOL M, V556, P169, DOI 10.1016/j.mrfmmm.2004.08.002; Araujo FD, 2002, ONCOGENE, V21, P4176, DOI 10.1038/sj.onc.1205539; Armstrong J, 1997, RADIOTHER ONCOL, V44, P17, DOI 10.1016/S0167-8140(97)01907-5; Brown ET, 2009, MOL CARCINOGEN, V48, P105, DOI 10.1002/mc.20463; Cancer Therapy Evaluation Program, 2003, COMM TERM CRIT ADV E; Chistiakov DA, 2008, ACTA ONCOL, V47, P809, DOI 10.1080/02841860801885969; Costa S, 2008, BREAST CANCER RES TR, V109, P183, DOI 10.1007/s10549-007-9637-1; Cullen MH, 1999, J CLIN ONCOL, V17, P3188, DOI 10.1200/JCO.1999.17.10.3188; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Du LQ, 2010, MED ONCOL; Fu XL, 2001, INT J RADIAT ONCOL, V50, P899, DOI 10.1016/S0360-3016(01)01524-3; Graham MV, 1999, INT J RADIAT ONCOL, V45, P323, DOI 10.1016/S0360-3016(99)00183-2; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; Hernando ML, 2001, INT J RADIAT ONCOL, V51, P650, DOI 10.1016/S0360-3016(01)01685-6; Inoue A, 2001, INT J RADIAT ONCOL, V49, P649, DOI 10.1016/S0360-3016(00)00783-5; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kobayashi J, 2004, DNA REPAIR, V3, P855, DOI 10.1016/j.dnarep.2004.03.023; Kwa SLS, 1998, INT J RADIAT ONCOL, V42, P1, DOI 10.1016/S0360-3016(98)00196-5; Legue F, 2001, CYTOKINE, V16, P232, DOI 10.1006/cyto.2001.0970; Li DH, 2006, CANCER RES, V66, P3323, DOI 10.1158/0008-5472.CAN-05-3032; Liu Liang, 2008, Zhonghua Yi Xue Za Zhi, V88, P378; Maeda T, 2000, JPN J CLIN ONCOL, V30, P534, DOI 10.1093/jjco/hyd139; Meirovitz A, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-16; Movsas B, 1997, CHEST, V111, P1061, DOI 10.1378/chest.111.4.1061; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Ohnishi K, 2006, RADIAT RES, V166, P454, DOI 10.1667/RR3606.1; Popanda O, 2006, CANCER EPIDEM BIOMAR, V15, P1048, DOI 10.1158/1055-9965.EPI-06-0046; Qiao GB, 2005, BRIT J CANCER, V93, P137, DOI 10.1038/sj.bjc.6602665; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Tambini CE, 2010, DNA REPAIR, V9, P517, DOI 10.1016/j.dnarep.2010.01.016; Tauchi H, 2002, ONCOGENE, V21, P8967, DOI 10.1038/sj.onc.1206136; Wang SL, 2006, INT J RADIAT ONCOL, V66, P1399, DOI 10.1016/j.ijrobp.2006.07.1337; Wang Y, 2000, GENE DEV, V14, P927; WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251; Williams GJ, 2010, DNA REPAIR, V9, P1299, DOI 10.1016/j.dnarep.2010.10.001; Xia DH, 2010, MED ONCOL, V27, P697, DOI 10.1007/s12032-009-9271-3; Yamano Mototsugu, 2007, Kurume Medical Journal, V54, P57, DOI 10.2739/kurumemedj.54.57; Yanagisawa T, 1998, ORAL ONCOL, V34, P524, DOI 10.1016/S1368-8375(98)00045-1; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763	40	48	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2011	6	5							e20055	10.1371/journal.pone.0020055	http://dx.doi.org/10.1371/journal.pone.0020055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769IQ	21647442	gold, Green Submitted, Green Published			2022-12-25	WOS:000291006500021
J	Calvo, E; Mizurini, DM; Sa-Nunes, A; Ribeiro, JMC; Andersen, JF; Mans, BJ; Monteiro, RQ; Kotsyfakis, M; Francischetti, IMB				Calvo, Eric; Mizurini, Daniella M.; Sa-Nunes, Anderson; Ribeiro, Jose M. C.; Andersen, John F.; Mans, Ben J.; Monteiro, Robson Q.; Kotsyfakis, Michail; Francischetti, Ivo M. B.			Alboserpin, a Factor Xa Inhibitor from the Mosquito Vector of Yellow Fever, Binds Heparin and Membrane Phospholipids and Exhibits Antithrombotic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C; OXIDIZED PHOSPHOLIPIDS; ARTHROPOD SALIVA; HIGH-AFFINITY; TICK; PHOSPHATIDYLETHANOLAMINE; ANTICOAGULANT; MECHANISM; THROMBIN; EXOSITE	The molecular mechanism of factor Xa (FXa) inhibition by Alboserpin, the major salivary gland anticoagulant from the mosquito and yellow fever vector Aedes albopictus, has been characterized. cDNA of Alboserpin predicts a 45-kDa protein that belongs to the serpin family of protease inhibitors. Recombinant Alboserpin displays stoichiometric, competitive, reversible and tight binding to FXa (picomolar range). Binding is highly specific and is not detectable for FX, catalytic site-blocked FXa, thrombin, and 12 other enzymes. Alboserpin displays high affinity binding to heparin (K-D similar to 20 nM), but no change in FXa inhibition was observed in the presence of the cofactor, implying that bridging mechanisms did not take place. Notably, Alboserpin was also found to interact with phosphatidylcholine and phosphatidylethanolamine but not with phosphatidylserine. Further, annexin V (in the absence of Ca2+) or heparin outcompetes Alboserpin for binding to phospholipid vesicles, suggesting a common binding site. Consistent with its activity, Alboserpin blocks prothrombinase activity and increases both prothrombin time and activated partial thromboplastin time in vitro or ex vivo. Furthermore, Alboserpin prevents thrombus formation provoked by ferric chloride injury of the carotid artery and increases bleeding in a dose-dependent manner. Alboserpin emerges as an atypical serpin that targets FXa and displays unique phospholipid specificity. It conceivably uses heparin and phosphatidylcholine/phosphatidylethanolamine as anchors to increase protein localization and effective concentration at sites of injury, cell activation, or inflammation.	[Calvo, Eric; Sa-Nunes, Anderson; Ribeiro, Jose M. C.; Andersen, John F.; Mans, Ben J.; Kotsyfakis, Michail; Francischetti, Ivo M. B.] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, Bethesda, MD 20852 USA; [Mizurini, Daniella M.; Monteiro, Robson Q.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil; [Sa-Nunes, Anderson] Univ Sao Paulo, Expt Immunol Lab, Dept Immunol, Inst Biomed Sci, BR-05508 Sao Paulo, Brazil; [Mans, Ben J.] Onderstepoort Vet Inst, Agr Res Council, ZA-0110 Onderstepoort, South Africa; [Kotsyfakis, Michail] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Lab Genom & Prote Dis Vectors, Ceske Budejovice 37009, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Francischetti, IMB (corresponding author), NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, 12735 Twinbrook Pkwy,Rm 2E-28, Bethesda, MD 20852 USA.	ifrancischetti@niaid.nih.gov	Monteiro, Robson/GRX-0672-2022; Sa-Nunes, Anderson/D-8667-2012; Calvo, Eric/ABB-4935-2021; de Queiroz Monteiro, Robson/M-7097-2019; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Sa-Nunes, Anderson/M-5654-2019; Kotsyfakis, Michail/G-9525-2014; Mans, Ben J./M-2427-2017	Monteiro, Robson/0000-0002-5260-2332; Sa-Nunes, Anderson/0000-0002-1859-4973; Calvo, Eric/0000-0001-7880-2730; Sa-Nunes, Anderson/0000-0002-1859-4973; Kotsyfakis, Michail/0000-0002-7526-1876; Mans, Ben J./0000-0002-0177-0029; Ribeiro, Jose/0000-0002-9107-0818	Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000810] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Intramural Research Program of the Division of Intramural Research, NIAID, National Institutes of Health.	Andersen JF, 2004, BIOCHEMISTRY-US, V43, P6987, DOI 10.1021/bi049655t; Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Bouton MC, 2007, CIRC RES, V100, P1174, DOI 10.1161/01.RES.0000265066.92923.ee; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Calvo E, 2010, FEBS J, V277, P413, DOI 10.1111/j.1742-4658.2009.07494.x; CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138; Dai JF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001205; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; GEBBINK RK, 1993, BIOCHEMISTRY-US, V32, P1675, DOI 10.1021/bi00057a035; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILBERT GE, 1995, J BIOL CHEM, V270, P18500, DOI 10.1074/jbc.270.31.18500; Guo XY, 2009, INFECT IMMUN, V77, P2320, DOI 10.1128/IAI.01507-08; Huang X, 2011, J BIOL CHEM, V286, P8740, DOI 10.1074/jbc.M110.188375; Huntington J, 2009, CELL MOL LIFE SCI, V66, P113, DOI 10.1007/s00018-008-8371-0; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kenneth KR, 1998, J BIOL CHEM, V273, P20802, DOI 10.1074/jbc.273.33.20802; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Kotsyfakis M, 2007, J BIOL CHEM, V282, P29256, DOI 10.1074/jbc.M703143200; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; LAVOIPIERRE M. M. J., 1959, ANN TROP MED AND PARASITOL, V53, P235; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Levy JH, 2010, ANESTHESIOLOGY, V113, P726, DOI 10.1097/ALN.0b013e3181ebdb15; Maffey KG, 2001, ANN CLIN LAB SCI, V31, P85; Malleier JM, 2007, BLOOD, V109, P4769, DOI 10.1182/blood-2006-09-046953; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Medcalf RL, 2005, FEBS J, V272, P4841, DOI 10.1111/j.1742-4658.2005.04904.x; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738; NEUENSCHWANDER PF, 1995, BIOCHEMISTRY-US, V34, P13988, DOI 10.1021/bi00043a004; Nishioka J, 1998, J BIOL CHEM, V273, P11281, DOI 10.1074/jbc.273.18.11281; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Rezaie AR, 2010, CURR MED CHEM, V17, P2059, DOI 10.2174/092986710791233706; Rezaie AR, 2000, TRENDS CARDIOVAS MED, V10, P333, DOI 10.1016/S1050-1738(01)00070-6; RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rubin H, 1996, NAT MED, V2, P632, DOI 10.1038/nm0696-632; Ruf W, 2004, CRIT CARE MED, V32, pS287, DOI 10.1097/01.CCM.0000126364.46191.12; Sa-Nunes A, 2007, J IMMUNOL, V179, P1497, DOI 10.4049/jimmunol.179.3.1497; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Stassen JM, 2004, CURR MED CHEM, V11, P2245, DOI 10.2174/0929867043364603; Thorpe PE, 2010, THROMB RES, V125, pS134, DOI 10.1016/S0049-3848(10)70031-1; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Tollefsen DM, 2010, PROG MOL BIOL TRANSL, V93, P351, DOI 10.1016/S1877-1173(10)93015-9; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; WESSELSCHMIDT R, 1993, BLOOD COAGUL FIBRIN, V4, P661, DOI 10.1097/00001721-199304050-00001; Wikel SK, 1999, INT J PARASITOL, V29, P851, DOI 10.1016/S0020-7519(99)00042-9; Williams J W, 1979, Methods Enzymol, V63, P437	60	37	43	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27998	28010		10.1074/jbc.M111.247924	http://dx.doi.org/10.1074/jbc.M111.247924			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21673107	Green Published, hybrid			2022-12-25	WOS:000293557800018
J	Kotake, T; Hirata, N; Degi, Y; Ishiguro, M; Kitazawa, K; Takata, R; Ichinose, H; Kaneko, S; Igarashi, K; Samejima, M; Tsumuraya, Y				Kotake, Toshihisa; Hirata, Naohiro; Degi, Yuta; Ishiguro, Maki; Kitazawa, Kiminari; Takata, Ryohei; Ichinose, Hitomi; Kaneko, Satoshi; Igarashi, Kiyohiko; Samejima, Masahiro; Tsumuraya, Yoichi			Endo-beta-1,3-galactanase from Winter Mushroom Flammulina velutipes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSIDE HYDROLASE FAMILY-16; ACID-SEQUENCE SIMILARITIES; ARABINOGALACTAN-PROTEINS; PHANEROCHAETE-CHRYSOSPORIUM; CELL EXPANSION; TRICHODERMA-VIRIDE; KAPPA-CARRAGEENASE; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; YARIV REAGENT	Arabinogalactan proteins are proteoglycans found on the cell surface and in the cell walls of higher plants. The carbohydrate moieties of most arabinogalactan proteins are composed of beta-1,3-galactan main chains and beta-1,6-galactan side chains, to which other auxiliary sugars are attached. For the present study, an endo-beta-1,3-galactanase, designated FvEn3GAL, was first purified and cloned from winter mushroom Flammulina velutipes. The enzyme specifically hydrolyzed beta-1,3-galactan, but didnot act on beta-1,3-glucan, beta-1,3: 1,4-glucan, xyloglucan, and agarose. It released various beta-1,3-galactooligosaccharides together with Gal from beta-1,3-galactohexaose in the early phase of the reaction, demonstrating that it acts on beta-1,3-galactan in an endo-fashion. Phylogenetic analysis revealed that FvEn3GAL is member of a novel subgroup distinct from known glycoside hydrolases such as endo-beta-1,3-glucanase and endo-beta-1,3: 1,4-glucanase in glycoside hydrolase family 16. Point mutations replacing the putative catalytic Glu residues conserved for enzymes in this family with Asp abolished activity. These results indicate that FvEn3GAL is a highly specific glycoside hydrolase 16 endo-beta-1,3-galactanase.	[Kotake, Toshihisa; Hirata, Naohiro; Kitazawa, Kiminari; Takata, Ryohei; Tsumuraya, Yoichi] Saitama Univ, Fac Sci, Div Life Sci, Grad Sch Sci & Engn,Sakura Ku, Saitama 3388570, Japan; [Kotake, Toshihisa] Saitama Univ, Fac Sci, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Degi, Yuta] Saitama Univ, Fac Sci, Dept Biochem & Mol Biol, Sakura Ku, Saitama 3388570, Japan; [Ishiguro, Maki; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Ichinose, Hitomi; Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan	Saitama University; Saitama University; Saitama University; University of Tokyo; National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan	Kotake, T (corresponding author), Saitama Univ, Fac Sci, Div Life Sci, Grad Sch Sci & Engn,Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	kotake@molbiol.saitama-u.ac.jp	ISHIGURO, Maki/GRJ-6273-2022; Igarashi, Kiyohiko/E-6799-2016; KOTAKE, TOSHIHISA/F-1117-2011; Tsumuraya, Yoichi/C-7903-2012	Igarashi, Kiyohiko/0000-0001-5152-7177; KOTAKE, TOSHIHISA/0000-0002-1110-5006; 	Ministry of Agriculture, Forestry, and Fisheries of Japan	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported in part by a grant-in-aid (Development of Biomass Utilization Technologies for Revitalizing Rural Areas) from the Ministry of Agriculture, Forestry, and Fisheries of Japan.	Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Dekker R F, 1976, Adv Carbohydr Chem Biochem, V32, P277; Ding L, 1997, PLANTA, V203, P289, DOI 10.1007/s004250050194; Fibriansah G, 2007, PROTEINS, V69, P683, DOI 10.1002/prot.21589; FINCHER GB, 1983, ANNU REV PLANT PHYS, V34, P47, DOI 10.1146/annurev.pp.34.060183.000403; Gao MG, 1999, PLANT J, V19, P321, DOI 10.1046/j.1365-313X.1999.00544.x; HAHN M, 1995, J BIOL CHEM, V270, P3081, DOI 10.1074/jbc.270.7.3081; HASHIMOTO Y, 1971, Nippon Nogeikagaku Kaishi, V45, P147; HASHIMOTO Y, 1969, Nippon Nogeikagaku Kaishi, V43, P831; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Ichinose H, 2005, J BIOL CHEM, V280, P25820, DOI 10.1074/jbc.M501024200; Kawai R, 2006, APPL MICROBIOL BIOT, V71, P898, DOI 10.1007/s00253-005-0214-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kiyohara H, 2002, PHYTOMEDICINE, V9, P614, DOI 10.1078/094471102321616427; KOMALAVILAS P, 1991, J BIOL CHEM, V266, P15956; KOOIMAN P, 1961, RECL TRAV CHIM PAY B, V80, P849; Kotake T, 2004, BIOCHEM J, V377, P749, DOI 10.1042/bj20031145; Kotake T, 2009, BIOSCI BIOTECH BIOCH, V73, P2303, DOI 10.1271/bbb.90433; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Majewska-Sawka A, 2000, PLANT PHYSIOL, V122, P3, DOI 10.1104/pp.122.1.3; Masuda S, 2006, EXTREMOPHILES, V10, P251, DOI 10.1007/s00792-006-0514-3; MATSUURA F, 1988, GLYCOCONJUGATE J, V5, P13, DOI 10.1007/BF01048328; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Motose H, 2004, NATURE, V429, P873, DOI 10.1038/nature02613; Nelson N, 1944, J BIOL CHEM, V153, P375; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Nothnagel EA, 1997, INT REV CYTOL, V174, P195, DOI 10.1016/S0074-7696(08)62118-X; Okemoto K, 2003, CARBOHYD RES, V338, P219, DOI 10.1016/S0008-6215(02)00405-6; Park MH, 2003, PLANT PHYSIOL, V131, P1450, DOI 10.1104/pp.015628; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Shi HZ, 2003, PLANT CELL, V15, P19, DOI 10.1105/tpc.007872; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUMURAYA Y, 1984, CARBOHYD RES, V134, P215, DOI 10.1016/0008-6215(84)85039-9; TSUMURAYA Y, 1990, J BIOL CHEM, V265, P7207; TSUMURAYA Y, 1988, PLANT PHYSIOL, V86, P155, DOI 10.1104/pp.86.1.155; Vasur J, 2009, FEBS J, V276, P4282, DOI 10.1111/j.1742-4658.2009.07099.x; Willats WGT, 1996, PLANT J, V9, P919, DOI 10.1046/j.1365-313X.1996.9060919.x; WU HM, 1995, CELL, V82, P395, DOI 10.1016/0092-8674(95)90428-X; YARIV J, 1962, BIOCHEM J, V85, P383, DOI 10.1042/bj0850383	47	31	35	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27848	27854		10.1074/jbc.M111.251736	http://dx.doi.org/10.1074/jbc.M111.251736			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21653698	hybrid, Green Published			2022-12-25	WOS:000293268700076
J	Zhu, F; Erlandsen, H; Ding, L; Li, JZ; Huang, Y; Zhou, MX; Liang, XB; Ma, JB; Wu, H				Zhu, Fan; Erlandsen, Heidi; Ding, Lei; Li, Jingzhi; Huang, Ying; Zhou, Meixian; Liang, Xiaobo; Ma, Jinbiao; Wu, Hui			Structural and Functional Analysis of a New Subfamily of Glycosyltransferases Required for Glycosylation of Serine-rich Streptococcal Adhesins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN-GSPB; ACCESSORY SEC LOCUS; CRYSTAL-STRUCTURE; SURFACE PROTEIN; HUMAN PLATELETS; GLUCOSYLTRANSFERASE; GORDONII; IDENTIFICATION; PARASANGUINIS; BIOSYNTHESIS	Serine-rich repeat glycoproteins (SRRPs) are a growing family of bacterial adhesins found in many streptococci and staphylococci; they play important roles in bacterial biofilm formation and pathogenesis. Glycosylation of this family of adhesins is essential for their biogenesis. A glucosyltransferase (Gtf3) catalyzes the second step of glycosylation of a SRRP (Fap1) from an oral streptococcus, Streptococcus parasanguinis. Although Gtf3 homologs are highly conserved in SRRP-containing streptococci, they share minimal homology with functionally known glycosyltransferases. We report here the 2.3 angstrom crystal structure of Gtf3. The structural analysis indicates that Gtf3 forms a tetramer and shares significant structural homology with glycosyltransferases from GT4, GT5, and GT20 subfamilies. Combining crystal structural analysis with site-directed mutagenesis and in vitro glycosyltransferase assays, we identified residues that are required for UDP-or UDP-glucose binding and for oligomerization of Gtf3 and determined their contribution to the enzymatic activity of Gtf3. Further in vivo studies revealed that the critical amino acid residues identified by the structural analysis are crucial for Fap1 glycosylation in S. parasanguinis in vivo. Moreover, Gtf3 homologs from other streptococci were able to rescue the gtf3 knock-out mutant of S. parasanguinis in vivo and catalyze the sugar transfer to the modified SRRP substrate in vitro, demonstrating the importance and conservation of the Gtf3 homologs in glycosylation of SRRPs. As the Gtf3 homologs only exist in SRRP-containing streptococci, we conclude that the Gtf3 homologs represent a unique subfamily of glycosyltransferases.	[Zhu, Fan; Zhou, Meixian; Liang, Xiaobo; Wu, Hui] Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent & Microbiol, Birmingham, AL 35294 USA; [Zhu, Fan; Zhou, Meixian; Liang, Xiaobo; Wu, Hui] Univ Alabama Birmingham, Sch Med, Dept Pediat Dent & Microbiol, Birmingham, AL 35294 USA; [Erlandsen, Heidi] Univ Alabama Birmingham, Sch Dent, Dept Periodontol, Birmingham, AL 35294 USA; [Erlandsen, Heidi] Univ Alabama Birmingham, Sch Med, Dept Periodontol, Birmingham, AL 35294 USA; [Ding, Lei; Huang, Ying; Ma, Jinbiao] Univ Alabama Birmingham, Sch Dent, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Ding, Lei; Huang, Ying; Ma, Jinbiao] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Li, Jingzhi] Univ Alabama Birmingham, Sch Dent, Dept Cell Biol, Birmingham, AL 35294 USA; [Li, Jingzhi] Univ Alabama Birmingham, Sch Med, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wu, H (corresponding author), Univ Alabama Birmingham, Sch Dent, Dept Pediat Dent, 802 SDB, Birmingham, AL 35294 USA.	hwu@uab.edu			National Institutes of Health [R01DE011000, R01DE017954]; National Natural Science Foundation of China [30900034]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE011000 and R01DE017954 (to H. W.). This work was also supported by National Natural Science Foundation of China Grant 30900034 (to M. Z.).	Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bu S, 2008, J BACTERIOL, V190, P1256, DOI 10.1128/JB.01078-07; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Doro F, 2009, MOL CELL PROTEOMICS, V8, P1728, DOI 10.1074/mcp.M800486-MCP200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Goedl C, 2008, FEBS J, V275, P903, DOI [10.1111/j.1742-4658.2008.06254.x, 10.1111/j.1742-4658.2007.06254.x]; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Hashimoto K, 2010, J MOL BIOL, V399, P196, DOI 10.1016/j.jmb.2010.03.059; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lairson LL, 2004, CHEM COMMUN, P2243, DOI 10.1039/b406490a; Leipold MD, 2007, J BIOL CHEM, V282, P1257, DOI 10.1074/jbc.M608164200; Li YR, 2008, MOL MICROBIOL, V70, P1094, DOI 10.1111/j.1365-2958.2008.06456.x; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Morera S, 1999, J MOL BIOL, V292, P717, DOI 10.1006/jmbi.1999.3094; Mulichak AM, 2001, STRUCTURE, V9, P547, DOI 10.1016/S0969-2126(01)00616-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seifert KN, 2006, MICROBIOL-SGM, V152, P1029, DOI 10.1099/mic.0.28516-0; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Takahashi Y, 2002, INFECT IMMUN, V70, P1209, DOI 10.1128/IAI.70.3.1209-1218.2002; Takamatsu D, 2004, J BACTERIOL, V186, P7100, DOI 10.1128/JB.186.21.7100-7111.2004; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; van Sorge NM, 2009, J INFECT DIS, V199, P1479, DOI 10.1086/598217; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 2007, INFECT IMMUN, V75, P2181, DOI 10.1128/IAI.01544-06; Yuan YQ, 2007, P NATL ACAD SCI USA, V104, P5348, DOI 10.1073/pnas.0701160104; Zhang ZD, 2003, J MOL BIOL, V332, P127, DOI 10.1016/S0022-2836(03)00858-1; Zhou MX, 2010, J BIOL CHEM, V285, P12140, DOI 10.1074/jbc.M109.066928; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	39	23	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2011	286	30					27048	27057		10.1074/jbc.M110.208629	http://dx.doi.org/10.1074/jbc.M110.208629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	796UK	21653318	hybrid, Green Published			2022-12-25	WOS:000293078200078
J	Moretti, P; Cerruti, B; Miguel, MC				Moretti, Paolo; Cerruti, Benedetta; Miguel, M. -Carmen			Yielding and Irreversible Deformation below the Microscale: Surface Effects and Non-Mean-Field Plastic Avalanches	PLOS ONE			English	Article							COLLOIDAL CRYSTALS; DISLOCATION AVALANCHES; SINGLE-CRYSTALS; STRAIN BURSTS; SCALE; FILMS; MODEL; FLOW	Nanoindentation techniques recently developed to measure the mechanical response of crystals under external loading conditions reveal new phenomena upon decreasing sample size below the microscale. At small length scales, material resistance to irreversible deformation depends on sample morphology. Here we study the mechanisms of yield and plastic flow in inherently small crystals under uniaxial compression. Discrete structural rearrangements emerge as a series of abrupt discontinuities in stress-strain curves. We obtain the theoretical dependence of the yield stress on system size and geometry and elucidate the statistical properties of plastic deformation at such scales. Our results show that the absence of dislocation storage leads to crucial effects on the statistics of plastic events, ultimately affecting the universal scaling behavior observed at larger scales.	[Moretti, Paolo; Cerruti, Benedetta; Miguel, M. -Carmen] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; [Moretti, Paolo] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain; [Cerruti, Benedetta] Inst Canc Res & Treatment, Turin, Italy	University of Barcelona; Universitat Politecnica de Catalunya	Moretti, P (corresponding author), Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain.	paolo.moretti@upc.edu	Moretti, Paolo/A-2760-2010; Miguel, M. Carmen/I-3087-2014	Moretti, Paolo/0000-0002-2936-1403; Miguel, M. Carmen/0000-0001-9050-1412	Ministerio de Ciencia e InnovaciA3n (Spain) [FIS2007-66485-C02-02, FIS2010-2178-C02-01, FIS2010-2178-C02-02]; Spanish-Hungarian Integrated Action [HH2008-0002]; Generalitat de Catalunya; Ministerio de Ciencia e InnovaciA3n	Ministerio de Ciencia e InnovaciA3n (Spain); Spanish-Hungarian Integrated Action; Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Ciencia e InnovaciA3n	Financial support by the Ministerio de Ciencia e InnovaciA3n (Spain), under Grants No. FIS2007-66485-C02-02, FIS2010-2178-C02-01 and FIS2010-2178-C02-02 and by a Spanish-Hungarian Integrated Action, under Grant No. HH2008-0002 is acknowledged. M. C. M. also acknowledges the Generalitat de Catalunya and the Ministerio de Ciencia e InnovaciA3n (Programa I3) for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cook RF, 2010, SCIENCE, V328, P183, DOI 10.1126/science.1186023; Csikor FF, 2007, SCIENCE, V318, P251, DOI 10.1126/science.1143719; Dimiduk DM, 2010, PHILOS MAG, V90, P3621, DOI 10.1080/14786431003662572; Dimiduk DM, 2006, SCIENCE, V312, P1188, DOI 10.1126/science.1123889; Greer JR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245410; Hirth J. P., 1972, THEORY DISLOCATIONS; Laurson L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.015501; Love AEH, 1944, TREATISE MATH THEORY, V4; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; MORETTI P, 2011, UNPUB; Nicola L, 2003, J APPL PHYS, V93, P5920, DOI 10.1063/1.1566471; Nix WD, 1998, SCRIPTA MATER, V39, P545, DOI 10.1016/S1359-6462(98)00195-X; Pertsinidis A, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/033; Picallo CB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.155502; Richeton T, 2005, NAT MATER, V4, P465, DOI 10.1038/nmat1393; Richeton T, 2006, MAT SCI ENG A-STRUCT, V424, P190, DOI 10.1016/j.msea.2006.03.072; Schall P, 2006, NATURE, V440, P319, DOI 10.1038/nature04557; Schall P, 2004, SCIENCE, V305, P1944, DOI 10.1126/science.1102186; Schwerdtfeger J, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/04/L04001; Shan ZW, 2008, NAT MATER, V7, P115, DOI 10.1038/nmat2085; Suresh S, 2006, NAT MATER, V5, P253, DOI 10.1038/nmat1621; TEDONE O, 1903, ANN MAT PUR APPL, V8, P129; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; Weiss J, 2003, SCIENCE, V299, P89, DOI 10.1126/science.1079312; Weiss J, 1997, J PHYS CHEM B, V101, P6113, DOI 10.1021/jp963157f; Zaiser M, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/08/P08004; Zaiser M, 2008, PHILOS MAG, V88, P3861, DOI 10.1080/14786430802132522	27	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20418	10.1371/journal.pone.0020418	http://dx.doi.org/10.1371/journal.pone.0020418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21666747	Green Published, Green Submitted, gold			2022-12-25	WOS:000291607000006
J	Chakraborty, R; Vepuri, V; Mhatre, SD; Paddock, BE; Miller, S; Michelson, SJ; Delvadia, R; Desai, A; Vinokur, M; Melicharek, DJ; Utreja, S; Khandelwal, P; Ansaloni, S; Goldstein, LE; Moir, RD; Lee, JC; Tabb, LP; Saunders, AJ; Marenda, DR				Chakraborty, Ranjita; Vepuri, Vidya; Mhatre, Siddhita D.; Paddock, Brie E.; Miller, Sean; Michelson, Sarah J.; Delvadia, Radha; Desai, Arkit; Vinokur, Marianna; Melicharek, David J.; Utreja, Suruchi; Khandelwal, Preeti; Ansaloni, Sara; Goldstein, Lee E.; Moir, Robert D.; Lee, Jeremy C.; Tabb, Loni P.; Saunders, Aleister J.; Marenda, Daniel R.			Characterization of a Drosophila Alzheimer's Disease Model: Pharmacological Rescue of Cognitive Defects	PLOS ONE			English	Article							SHORT-TERM-MEMORY; PRECURSOR PROTEIN; AMYLOID HYPOTHESIS; DIMETHYL-SULFOXIDE; COURTSHIP BEHAVIOR; OXIDATIVE STRESS; CALCIUM STORES; BETA-APP; A-BETA; NEURODEGENERATION	Transgenic models of Alzheimer's disease (AD) have made significant contributions to our understanding of AD pathogenesis, and are useful tools in the development of potential therapeutics. The fruit fly, Drosophila melanogaster, provides a genetically tractable, powerful system to study the biochemical, genetic, environmental, and behavioral aspects of complex human diseases, including AD. In an effort to model AD, we over-expressed human APP and BACE genes in the Drosophila central nervous system. Biochemical, neuroanatomical, and behavioral analyses indicate that these flies exhibit aspects of clinical AD neuropathology and symptomology. These include the generation of A beta(40) and A beta(42), the presence of amyloid aggregates, dramatic neuroanatomical changes, defects in motor reflex behavior, and defects in memory. In addition, these flies exhibit external morphological abnormalities. Treatment with a gamma-secretase inhibitor suppressed these phenotypes. Further, all of these phenotypes are present within the first few days of adult fly life. Taken together these data demonstrate that this transgenic AD model can serve as a powerful tool for the identification of AD therapeutic interventions.	[Chakraborty, Ranjita; Vepuri, Vidya; Mhatre, Siddhita D.; Paddock, Brie E.; Miller, Sean; Michelson, Sarah J.; Delvadia, Radha; Desai, Arkit; Vinokur, Marianna; Melicharek, David J.; Utreja, Suruchi; Khandelwal, Preeti; Ansaloni, Sara; Saunders, Aleister J.; Marenda, Daniel R.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Vepuri, Vidya] Univ Sci Philadelphia, Dept Biol Sci, Philadelphia, PA USA; [Goldstein, Lee E.] Boston Univ, Dept Psychiat, Boston, MA 02215 USA; [Moir, Robert D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Genet & Aging Res Unit,MIND, Boston, MA USA; [Lee, Jeremy C.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Tabb, Loni P.] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Saunders, Aleister J.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Saunders, Aleister J.; Marenda, Daniel R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA	Drexel University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California Santa Cruz; Drexel University; Drexel University; Drexel University	Chakraborty, R (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	Aleister.Saunders@drexel.edu; dm562@drexel.edu	Moir, Robert D./M-7612-2017; Mhatre, Siddhita/AAH-8051-2020	Moir, Robert D./0000-0001-5431-3553; Mhatre, Siddhita/0000-0001-9939-780X; Saunders, Aleister/0000-0002-7298-7823; Goldstein, Lee/0000-0001-8419-9800	Drexel University; Cure Alzheimer's Fund Investigator Award; National Institutes of Health (NIH) [1R01AI081990-01A1, R21RR026074, R01NS057295]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057295] Funding Source: NIH RePORTER	Drexel University; Cure Alzheimer's Fund Investigator Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from Drexel University's Human Cognition Enhancement Program (to DRM), Cure Alzheimer's Fund Investigator Award and National Institutes of Health (NIH) grant 1R01AI081990-01A1 (to RDM), NIH R21RR026074 (to DRM), and NIH R01NS057295 (to AJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; Berger C, 2007, DEV DYNAM, V236, P3562, DOI 10.1002/dvdy.21372; BONNER JM, 2010, DROSOPHILA MODEL STU; Boulianne GL, 1997, NEUROREPORT, V8, P1025, DOI 10.1097/00001756-199703030-00041; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton SJ, 2003, J NEUROGENET, V17, P91, DOI 10.1080/01677060390228342; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Carmine-Simmen K, 2009, NEUROBIOL DIS, V33, P274, DOI 10.1016/j.nbd.2008.10.014; Chiang HC, 2009, FASEB J, V23, P1969, DOI 10.1096/fj.08-121152; Chung HM, 2001, NAT CELL BIOL, V3, P1129, DOI 10.1038/ncb1201-1129; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; CRYSTAL HA, 1993, ANN NEUROL, V34, P566, DOI 10.1002/ana.410340410; De Strooper B, 2000, J CELL SCI, V113, P1857; Dubnau J, 2001, CURR BIOL, V11, pR240, DOI 10.1016/S0960-9822(01)00115-4; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Folwell J, 2010, EXP NEUROL, V223, P401, DOI 10.1016/j.expneurol.2009.09.014; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gibson GE, 2004, J BIOENERG BIOMEMBR, V36, P335, DOI 10.1023/B:JOBB.0000041764.45552.f3; Gibson GE, 2002, BBA-MOL BASIS DIS, V1586, P177, DOI 10.1016/S0925-4439(01)00091-6; Green MS, 2000, NEUROLOGY, V54, P105, DOI 10.1212/WNL.54.1.105; GREENSPAN RJ, 1995, NEURON, V15, P747, DOI 10.1016/0896-6273(95)90165-5; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Hanslick JL, 2009, NEUROBIOL DIS, V34, P1, DOI 10.1016/j.nbd.2008.11.006; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heidary G, 2001, MECH DEVELOP, V108, P171, DOI 10.1016/S0925-4773(01)00487-7; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hong CS, 1997, NEUROREPORT, V8, P665, DOI 10.1097/00001756-199702100-00017; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Iijima K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001703; Iijima K, 2010, HUM MOL GENET, V19, P2947, DOI 10.1093/hmg/ddq200; Iijima-Ando K, 2008, J BIOL CHEM, V283, P19066, DOI 10.1074/jbc.M710509200; Iijima-Ando K, 2010, BRAIN STRUCT FUNCT, V214, P245, DOI 10.1007/s00429-009-0234-4; Iijima-Ando K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008310; Ikonomovic MD, 2006, METHOD ENZYMOL, V412, P123, DOI 10.1016/S0076-6879(06)12009-1; Jeibmann A, 2009, INT J MOL SCI, V10, P407, DOI 10.3390/ijms10020407; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; LEBOURG E, 1992, GERONTOLOGY, V38, P71; Lee T, 1999, DEVELOPMENT, V126, P4065; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; LITTLETON JT, 1994, GENETICS, V138, P111; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McGeer EG, 1998, EXP GERONTOL, V33, P371, DOI 10.1016/S0531-5565(98)00013-8; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Morris JC, 1996, NEUROLOGY, V46, P707, DOI 10.1212/WNL.46.3.707; Nazir A, 2003, TOXICOL MECH METHOD, V13, P147, DOI 10.1080/15376510309846; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; PODLISNY MB, 1987, SCIENCE, V238, P669, DOI 10.1126/science.2960019; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; Sarantseva S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008191; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Siwicki KK, 2005, LEARN MEMORY, V12, P636, DOI 10.1101/lm.85605; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stokin GB, 2008, HUM MOL GENET, V17, P3474, DOI 10.1093/hmg/ddn240; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tio M, 1997, DEVELOPMENT, V124, P343; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; YAO KM, 1994, J NEUROCHEM, V63, P41; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	74	76	80	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20799	10.1371/journal.pone.0020799	http://dx.doi.org/10.1371/journal.pone.0020799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21673973	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400030
J	Sarker, P; Ahmed, S; Tiash, S; Rekha, RS; Stromberg, R; Andersson, J; Bergman, P; Gudmundsson, GH; Agerberth, B; Raqib, R				Sarker, Protim; Ahmed, Sultan; Tiash, Snigdha; Rekha, Rokeya Sultana; Stromberg, Roger; Andersson, Jan; Bergman, Peter; Gudmundsson, Gudmundur H.; Agerberth, Birgitta; Raqib, Rubhana			Phenylbutyrate Counteracts Shigella Mediated Downregulation of Cathelicidin in Rabbit Lung and Intestinal Epithelia: A Potential Therapeutic Strategy	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; CHAIN FATTY-ACIDS; PROTEIN-SYNTHESIS; IMMUNE-RESPONSES; SODIUM-BUTYRATE; GENE-EXPRESSION; CELLS; TRIBUTYRIN; RECEPTORS	Background: Cathelicidins and defensins are endogenous antimicrobial peptides (AMPs) that are downregulated in the mucosal epithelia of the large intestine in shigellosis. Oral treatment of Shigella infected rabbits with sodium butyrate (NaB) reduces clinical severity and counteracts the downregulation of cathelicidin (CAP-18) in the large intestinal epithelia. Aims: To develop novel regimen for treating infectious diseases by inducing innate immunity, we selected sodium 4-phenylbutyrate (PB), a registered drug for a metabolic disorder as a potential therapeutic candidate in a rabbit model of shigellosis. Since acute respiratory infections often cause secondary complications during shigellosis, the systemic effect of PB and NaB on CAP-18 expression in respiratory epithelia was also evaluated. Methods: The readouts were clinical outcomes, CAP-18 expression in mucosa of colon, rectum, lung and trachea (immunohistochemistry and real-time PCR) and release of the CAP-18 peptide/protein in stool (Western blot). Principal findings: Significant downregulation of CAP-18 expression in the epithelia of rectum and colon, the site of Shigella infection was confirmed. Interestingly, reduced expression of CAP-18 was also noticed in the epithelia of lung and trachea, indicating a systemic effect of the infection. This suggests a causative link to acute respiratory infections during shigellosis. Oral treatment with PB resulted in reduced clinical illness and upregulation of CAP-18 in the epithelium of rectum. Both PB and NaB counteracted the downregulation of CAP-18 in lung epithelium. The drug effect is suggested to be systemic as intravenous administration of NaB could also upregulate CAP-18 in the epithelia of lung, rectum and colon. Conclusion: Our results suggest that PB has treatment potential in human shigellosis. Enhancement of CAP-18 in the mucosal epithelia of the respiratory tract by PB or NaB is a novel discovery. This could mediate protection from secondary respiratory infections that frequently are the lethal causes in dysentery.	[Sarker, Protim; Ahmed, Sultan; Tiash, Snigdha; Rekha, Rokeya Sultana; Raqib, Rubhana] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Sarker, Protim; Rekha, Rokeya Sultana; Agerberth, Birgitta] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Stromberg, Roger] Karolinska Inst, Dept Biosci & Nutr, Ctr Infect Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Andersson, Jan; Bergman, Peter] Karolinska Inst, Dept Med, Ctr Infect Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Bergman, Peter] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Gudmundsson, Gudmundur H.] Univ Iceland, Inst Biol, Reykjavik, Iceland	International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Iceland	Sarker, P (corresponding author), Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh.	rubhana@icddrb.org	Stromberg, Roger/C-2960-2013; Gudmundsson, Gudmundur H/K-9178-2015	Gudmundsson, Gudmundur H/0000-0001-5793-0565; Bergman, Peter/0000-0003-3306-3713; Raqib, Rubhana/0000-0002-8116-4511	Swedish Agency for Research Cooperation with Developing Countries (Sida/SAREC); Swedish Research Council; Cancerfonden; Swedish Strategic Foundation (SSF); Thorsten Foundation; Ragnar Soderberg's Foundation; Swedish Institute; Karolinska Institutet; International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B); Icelandic Centre for Research (RANNIS); University of Iceland	Swedish Agency for Research Cooperation with Developing Countries (Sida/SAREC); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Swedish Strategic Foundation (SSF)(Swedish Foundation for Strategic Research); Thorsten Foundation; Ragnar Soderberg's Foundation; Swedish Institute; Karolinska Institutet(Karolinska Institutet); International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B); Icelandic Centre for Research (RANNIS); University of Iceland	The study was supported by the Swedish Agency for Research Cooperation with Developing Countries (Sida/SAREC Agreement support; grant 2005-2007), The Swedish Research Council, Cancerfonden, The Swedish Strategic Foundation (SSF), Thorsten and Ragnar Soderberg's Foundations, The Swedish Institute, Karolinska Institutet, International Centre for Diarrheal Disease Research, Bangladesh (ICDDR,B), The Icelandic Centre for Research (RANNIS) and University of Iceland research fund. ICDDR, B acknowledges with gratitude the commitment of Sida/SAREC to the Centre's research efforts. ICDDR, B also gratefully acknowledges the following donors which provide unrestricted support to the Centre's research efforts: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Cooperation (SDC), and Department for International Development, United Kingdom (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; BENNISH ML, 1991, REV INFECT DIS, V13, pS319; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BUTLER T, 1989, PEDIATR INFECT DIS J, V8, P767, DOI 10.1097/00006454-198911000-00008; Carol M, 1998, GUT, V42, P643, DOI 10.1136/gut.42.5.643; Chakraborty K, 2008, CELL MICROBIOL, V10, P2520, DOI 10.1111/j.1462-5822.2008.01227.x; Cunnane G, 1999, ANN RHEUM DIS, V58, P493, DOI 10.1136/ard.58.8.493; Dutta P, 1995, Indian Pediatr, V32, P313; Egorin MJ, 1999, CANCER CHEMOTH PHARM, V43, P445, DOI 10.1007/s002800050922; HALE TL, 1981, INFECT IMMUN, V32, P137, DOI 10.1128/IAI.32.1.137-144.1981; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Heyman SN, 1997, J CLIN GASTROENTEROL, V25, P595, DOI 10.1097/00004836-199712000-00009; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Kida Y, 2006, MOL IMMUNOL, V43, P1972, DOI 10.1016/j.molimm.2005.11.014; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MITRA A K, 1990, Journal of Diarrhoeal Diseases Research, V8, P12; OBRIG TG, 1987, BIOCHEM J, V244, P287, DOI 10.1042/bj2440287; Otte JM, 2009, REGUL PEPTIDES, V156, P104, DOI 10.1016/j.regpep.2009.03.009; Palffy R, 2009, MOL MED, V15, P51, DOI 10.2119/molmed.2008.00087; Patwari A K, 1995, Indian Pediatr, V32, P277; Raqib R, 1996, EUR J IMMUNOL, V26, P1130, DOI 10.1002/eji.1830260526; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schwab M, 2007, MOL IMMUNOL, V44, P2107, DOI 10.1016/j.molimm.2006.09.016; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Su J, 2004, RAPID COMMUN MASS SP, V18, P2217, DOI 10.1002/rcm.1607; Termen S, 2008, MOL IMMUNOL, V45, P3947, DOI 10.1016/j.molimm.2008.06.020; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	35	64	66	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20637	10.1371/journal.pone.0020637	http://dx.doi.org/10.1371/journal.pone.0020637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21673991	gold, Green Published			2022-12-25	WOS:000291355500028
J	Morita, T; Kang, H; Wolfe, J; Jadhav, SP; Feldman, DE				Morita, Takeshi; Kang, Heejae; Wolfe, Jason; Jadhav, Shantanu P.; Feldman, Daniel E.			Psychometric Curve and Behavioral Strategies for Whisker-Based Texture Discrimination in Rats	PLOS ONE			English	Article							NEURAL CODING MECHANISMS; ROUGHNESS DISCRIMINATION; PERCEIVED ROUGHNESS; OBJECT LOCALIZATION; SENSORIMOTOR SYSTEM; VIBRISSAL SYSTEM; ACTIVE TOUCH; BARREL; PERFORMANCE; MOVEMENTS	The rodent whisker system is a major model for understanding neural mechanisms for tactile sensation of surface texture (roughness). Rats discriminate surface texture using the whiskers, and several theories exist for how texture information is physically sensed by the long, moveable macrovibrissae and encoded in spiking of neurons in somatosensory cortex. However, evaluating these theories requires a psychometric curve for texture discrimination, which is lacking. Here we trained rats to discriminate rough vs. fine sandpapers and grooved vs. smooth surfaces. Rats intermixed trials at macrovibrissa contact distance (nose >2 mm from surface) with trials at shorter distance (nose <2 mm from surface). Macrovibrissae were required for distant contact trials, while microvibrissae and non-whisker tactile cues were used for short distance trials. A psychometric curve was measured for macrovibrissa-based sandpaper texture discrimination. Rats discriminated rough P150 from smoother P180, P280, and P400 sandpaper (100, 82, 52, and 35 mm mean grit size, respectively). Use of olfactory, visual, and auditory cues was ruled out. This is the highest reported resolution for rodent texture discrimination, and constrains models of neural coding of texture information.	[Morita, Takeshi] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Morita, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA.	dfeldman@berkeley.edu	Jadhav, Shantanu/H-6654-2013	Jadhav, Shantanu/0000-0001-5821-0551; Morita, Takeshi/0000-0002-8570-6744	NSF [IOB-0546098]; NINDS [R01 NS072416]; UCSD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072416] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UCSD; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this study was provided by NSF CAREER Award IOB-0546098 (www.nsf.gov), NINDS R01 NS072416 (www.nih.gov), and by Heiligenberg Chair Research Funds (UCSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; Aggestam F, 2007, PHYSIOL BEHAV, V91, P335, DOI 10.1016/j.physbeh.2007.03.015; Anjum F, 2006, P NATL ACAD SCI USA, V103, P16544, DOI 10.1073/pnas.0605573103; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Blake DT, 1997, J NEUROSCI, V17, P7480; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Catania KC, 2005, ANAT REC PART A, V287A, P1038, DOI 10.1002/ar.a.20265; Cybulska-Klosowicz A, 2001, ACTA NEUROBIOL EXP, V61, P73; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; Diamond ME, 2010, CURR OPIN NEUROBIOL, V20, P319, DOI 10.1016/j.conb.2010.03.004; GERDJIKOV TV, NEURON, V65, P530; Grant RA, 2009, J NEUROPHYSIOL, V101, P862, DOI 10.1152/jn.90783.2008; Greenspan JD, 1996, PAIN AND TOUCH, P25; GUICROBLES E, 1989, BEHAV BRAIN RES, V31, P285, DOI 10.1016/0166-4328(89)90011-9; Haidarliu S, 1997, J COMP NEUROL, V385, P515, DOI 10.1002/(SICI)1096-9861(19970908)385:4<515::AID-CNE3>3.0.CO;2-6; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; Hollins M, 2007, CAN J EXP PSYCHOL, V61, P184, DOI 10.1037/cjep2007020; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Jadhav SP, 2010, CURR OPIN NEUROBIOL, V20, P313, DOI 10.1016/j.conb.2010.02.014; JADHAV SP, 2009, NAT NEUROSCI; Jenkinson EW, 2000, J NEUROPHYSIOL, V84, P1781, DOI 10.1152/jn.2000.84.4.1781; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Lottem E, 2008, J NEUROPHYSIOL, V100, P2852, DOI 10.1152/jn.90302.2008; Mehta SB, 2007, PLOS BIOL, V5, P309, DOI 10.1371/journal.pbio.0050015; Moore CI, 2004, J NEUROPHYSIOL, V91, P2390, DOI 10.1152/jn.00925.2003; Neimark MA, 2003, J NEUROSCI, V23, P6499; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Polley DB, 2005, NEUROBIOL LEARN MEM, V83, P134, DOI 10.1016/j.nlm.2004.10.005; Prigg T, 2002, PHYSIOL BEHAV, V77, P671, DOI 10.1016/S0031-9384(02)00917-4; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Towal RB, 2006, J NEUROSCI, V26, P8838, DOI 10.1523/JNEUROSCI.0581-06.2006; Vincent S. B., 1912, BEHAV MONOGR, V1, P7; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Yoshioka T, 2001, J NEUROSCI, V21, P6905, DOI 10.1523/JNEUROSCI.21-17-06905.2001	43	49	48	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20437	10.1371/journal.pone.0020437	http://dx.doi.org/10.1371/journal.pone.0020437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673811	gold, Green Submitted, Green Published			2022-12-25	WOS:000291309900019
J	Zhou, YS; Chen, WN				Zhou, Yusi; Chen, Wei Ning			iTRAQ-Coupled 2-D LC-MS/MS Analysis of Membrane Protein Profile in Escherichia coli Incubated with Apidaecin IB	PLOS ONE			English	Article							UDP-N-ACETYLGLUCOSAMINE; ANTIMICROBIAL PEPTIDES; R-ENANTIOMERS; TACHYPLESIN-I; S-ENANTIOMERS; LIPID-A; BIOSYNTHESIS; CELLS; INDOLICIDIN; FTSH	Apidaecins are a series of proline-rich, 18- to 20-residue antimicrobial peptides produced by insects. They are predominantly active against the Gram-negative bacteria. Previous studies mainly focused on the identification of their internal macromolecular targets, few addressed on the action of apidaecins on the molecules, especially proteins, of bacterial cell membrane. In this study, iTRAQ-coupled 2-D LC-MS/MS technique was utilized to identify altered membrane proteins of Escherichia coli cells incubated with one isoform of apidaecins-apidaecin IB. Cell division protease ftsH, an essential regulator in maintenance of membrane lipid homeostasis, was found to be overproduced in cells incubated with apidaecin IB. Its over-expression intensified the degradation of cytoplasmic protein UDP-3-O-acyl-N-acetylglucosamine deacetylase, which catalyzes the first committed step in the biosynthesis of the lipid A moiety of LPS, and thus leaded to the further unbalanced biosynthesis of LPS and phospholipids. Our findings suggested a new antibacterial mechanism of apidaecins and perhaps, by extension, for other proline-rich antimicrobial peptides.	[Zhou, Yusi; Chen, Wei Ning] Nanyang Technol Univ, Sch Chem & Biomed Engn, Coll Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhou, YS (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Coll Engn, Singapore, Singapore.	WNChen@ntu.edu.sg		, Yang/0000-0002-6620-8897	Nanyang Technological University, Singapore	Nanyang Technological University, Singapore(Nanyang Technological University)	This work was supported by Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1995, BBA-BIOMEMBRANES, V1237, P109, DOI 10.1016/0005-2736(95)00087-J; ALEY SB, 1994, INFECT IMMUN, V62, P5397, DOI 10.1128/IAI.62.12.5397-5403.1994; ANDERSON MS, 1985, J BIOL CHEM, V260, P5536; ANDERSON MS, 1988, BIOCHEMISTRY-US, V27, P1908, DOI 10.1021/bi00406a017; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Arnold T., 2008, CURR PROTOC PROTEIN, DOI [10.1002/0471140864.ps0408s53, DOI 10.1002/0471140864.PS0408S53]; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; Castle M, 1999, J BIOL CHEM, V274, P32555, DOI 10.1074/jbc.274.46.32555; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Fuhrer F, 2007, J MOL BIOL, V372, P485, DOI 10.1016/j.jmb.2007.06.083; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; IWANAGA S, 1994, CIBA F SYMP, V186, P160; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; Kloser A, 1998, MOL MICROBIOL, V27, P1003, DOI 10.1046/j.1365-2958.1998.00746.x; Li WF, 2006, PEPTIDES, V27, P2350, DOI 10.1016/j.peptides.2006.03.016; Markossian KA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1082, DOI 10.1023/B:BIRY.0000046881.29486.51; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Morvan A, 1997, J INVERTEBR PATHOL, V69, P177, DOI 10.1006/jipa.1996.4642; MURAKAMI T, 1991, CHEMOTHERAPY, V37, P327, DOI 10.1159/000238875; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; Niu DD, 2009, PROTEOMICS, V9, P3856, DOI 10.1002/pmic.200900071; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Otvos L, 2000, BIOCHEMISTRY-US, V39, P14150, DOI 10.1021/bi0012843; Robinson WE, 1998, J LEUKOCYTE BIOL, V63, P94, DOI 10.1002/jlb.63.1.94; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200; Sui JJ, 2007, J PROTEOME RES, V6, P1643, DOI 10.1021/pr0605926; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Tossi A, 2000, BIOPOLYMERS, V55, P4; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zhang JH, 2008, PROTEOMICS, V8, P1595, DOI 10.1002/pmic.200700556; Zhang JH, 2009, PROTEOMICS, V9, P2836, DOI 10.1002/pmic.200800911; Zhou YS, 2010, RAPID COMMUN MASS SP, V24, P2787, DOI 10.1002/rcm.4712	36	14	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20442	10.1371/journal.pone.0020442	http://dx.doi.org/10.1371/journal.pone.0020442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21673808	gold, Green Submitted, Green Published			2022-12-25	WOS:000291309900020
J	Gabbe, BJ; Lyons, RA; Lecky, FE; Bouamra, O; Woodford, M; Coats, TJ; Cameron, PA				Gabbe, Belinda J.; Lyons, Ronan A.; Lecky, Fiona E.; Bouamra, Omar; Woodford, Maralyn; Coats, Timothy J.; Cameron, Peter A.			Comparison of Mortality Following Hospitalisation for Isolated Head Injury in England and Wales, and Victoria, Australia	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MAJOR TRAUMA; SYSTEM; CARE; REGISTRY; QUALITY; MANAGEMENT; SURVIVAL; OUTCOMES; TRENDS	Background: Traumatic brain injury (TBI) remains a leading cause of death and disability. The National Institute for Health and Clinical Excellence (NICE) guidelines recommend transfer of severe TBI cases to neurosurgical centres, irrespective of the need for neurosurgery. This observational study investigated the risk-adjusted mortality of isolated TBI admissions in England/Wales, and Victoria, Australia, and the impact of neurosurgical centre management on outcomes. Methods: Isolated TBI admissions (> 15 years, July 2005-June 2006) were extracted from the hospital discharge datasets for both jurisdictions. Severe isolated TBI (AIS severity >3) admissions were provided by the Trauma Audit and Research Network (TARN) and Victorian State Trauma Registry (VSTR) for England/Wales, and Victoria, respectively. Multivariable logistic regression was used to compare risk-adjusted mortality between jurisdictions. Findings: Mortality was 12% (749/6256) in England/Wales and 9% (91/1048) in Victoria for isolated TBI admissions. Adjusted odds of death in England/Wales were higher compared to Victoria overall (OR 2.0, 95% CI: 1.6, 2.5), and for cases <65 years (OR 2.36, 95% CI: 1.51, 3.69). For severe TBI, mortality was 23% (133/575) for TARN and 20% (68/346) for VSTR, with 72% of TARN and 86% of VSTR cases managed at a neurosurgical centre. The adjusted mortality odds for severe TBI cases in TARN were higher compared to the VSTR (OR 1.45, 95% CI: 0.96, 2.19), but particularly for cases <65 years (OR 2.04, 95% CI: 1.07, 3.90). Neurosurgical centre management modified the effect overall (OR 1.12, 95% CI: 0.73, 1.74) and for cases <65 years (OR 1.53, 95% CI: 0.77, 3.03). Conclusion: The risk-adjusted odds of mortality for all isolated TBI admissions, and severe TBI cases, were higher in England/Wales when compared to Victoria. The lower percentage of cases managed at neurosurgical centres in England and Wales was an explanatory factor, supporting the changes made to the NICE guidelines.	[Gabbe, Belinda J.; Cameron, Peter A.] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia; [Gabbe, Belinda J.; Cameron, Peter A.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Lyons, Ronan A.] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Lecky, Fiona E.; Bouamra, Omar; Woodford, Maralyn; Coats, Timothy J.] Univ Manchester, Salford Royal Hosp, Manchester Acad Hlth Sci Ctr,Sch Community Based, Trauma Audit & Res Network,Hlth Sci Res Grp, Salford, Lancs, England; [Lecky, Fiona E.] Salford Royal Hosp, Dept Emergency Med, Salford, Lancs, England; [Coats, Timothy J.] Leicester Royal Infirm, Dept Accid & Emergency, Leicester, Leics, England; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Swansea University; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Leicester; Florey Institute of Neuroscience & Mental Health	Gabbe, BJ (corresponding author), Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3181, Australia.	belinda.gabbe@monash.edu	Coats, Timothy/AAW-1254-2021; Lyons, Ronan/G-7741-2012	Coats, Timothy/0000-0003-2736-2784; Lyons, Ronan/0000-0001-5225-000X; Gabbe, Belinda/0000-0001-7096-7688; Cameron, Peter/0000-0002-1443-557X	Department of Human Services (Victoria); Transport Accident Commission (TAC) Health Research; National Health and Medical Research Council of Australia	Department of Human Services (Victoria); Transport Accident Commission (TAC) Health Research; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The VSTR is a Department of Human Services (Victoria) and Transport Accident Commission (TAC) Health Research funded and approved initiative. Dr. Belinda Gabbe and Prof. Peter Cameron were supported by a Career Development Award and a Practitioner Fellowship, respectively, from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cameron PA, 2006, INJURY, V37, P1178, DOI 10.1016/j.injury.2006.07.015; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Coats TJ, 1999, J ACCID EMERG MED, V16, P182; Esposito Thomas J, 2006, Adv Surg, V40, P213, DOI 10.1016/j.yasu.2006.06.002; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Gabbe BJ, 2011, ANN SURG, V253, P138, DOI 10.1097/SLA.0b013e3181f6685b; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; HUNT J, 1995, AUST NZ J SURG, V65, P83, DOI 10.1111/j.1445-2197.1995.tb07266.x; Lecky F, 2000, LANCET, V355, P1771, DOI 10.1016/S0140-6736(00)02264-9; Lee A, 2003, INJURY, V34, P815, DOI 10.1016/S0020-1383(02)00395-9; MacLeod JBA, 2004, AM SURGEON, V70, P805; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; Moore L, 2005, J TRAUMA, V59, P698, DOI 10.1097/01.ta.0000177700.54943.ee; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; O'Reilly GM, 2010, ACAD EMERG MED, V17, P1122, DOI 10.1111/j.1553-2712.2010.00887.x; Papa L, 2006, J TRAUMA, V61, P261, DOI 10.1097/01.ta.0000221789.53864.ba; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Yeung JHH, 2008, INJURY, V39, P1034, DOI 10.1016/j.injury.2008.03.017	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20545	10.1371/journal.pone.0020545	http://dx.doi.org/10.1371/journal.pone.0020545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655237	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000291097600093
J	Kuchenreuther, JM; George, SJ; Grady-Smith, CS; Cramer, SP; Swartz, JR				Kuchenreuther, Jon M.; George, Simon J.; Grady-Smith, Celestine S.; Cramer, Stephen P.; Swartz, James R.			Cell-free H-cluster Synthesis and [FeFe] Hydrogenase Activation: All Five CO and CN- Ligands Derive from Tyrosine	PLOS ONE			English	Article							IRON-MOLYBDENUM COFACTOR; IN-VITRO SYNTHESIS; ESCHERICHIA-COLI; THIAMINE BIOSYNTHESIS; LIGHT SENSITIVITY; ONLY HYDROGENASE; ACTIVE-SITE; MATURATION; HYDF; PROTEIN	[FeFe] hydrogenases are promising catalysts for producing hydrogen as a sustainable fuel and chemical feedstock, and they also serve as paradigms for biomimetic hydrogen-evolving compounds. Hydrogen formation is catalyzed by the H-cluster, a unique iron-based cofactor requiring three carbon monoxide (CO) and two cyanide (CN-) ligands as well as a dithiolate bridge. Three accessory proteins (HydE, HydF, and HydG) are presumably responsible for assembling and installing the Hcluster, yet their precise roles and the biosynthetic pathway have yet to be fully defined. In this report, we describe effective cell-free methods for investigating H-cluster synthesis and [FeFe] hydrogenase activation. Combining isotopic labeling with FTIR spectroscopy, we conclusively show that each of the CO and CN- ligands derive respectively from the carboxylate and amino substituents of tyrosine. Such in vitro systems with reconstituted pathways comprise a versatile approach for studying biosynthetic mechanisms, and this work marks a significant step towards an understanding of both the proteinprotein interactions and complex reactions required for H-cluster assembly and hydrogenase maturation.	[Kuchenreuther, Jon M.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [George, Simon J.; Cramer, Stephen P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [George, Simon J.; Grady-Smith, Celestine S.; Cramer, Stephen P.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Davis; Stanford University	Kuchenreuther, JM (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		George, Simon/0000-0002-4864-5479	DOE; DOE Office of Biological and Environmental Research; National Health Institute [NIH-GM-65440]; National Science Foundation [NSF-CHE-0745353, SPC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065440] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Health Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the DOE BioEnergy Science Program (JRS & SPC), the DOE Office of Biological and Environmental Research (SPC), the National Health Institute (NIH-GM-65440, SPC), and the National Science Foundation (NSF-CHE-0745353, SPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MK, 2008, APPL MICROBIOL BIOT, V78, P853, DOI 10.1007/s00253-008-1377-6; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; CHEN JS, HYDROGENASES THEIR C, P57; Chen ZJ, 2002, BIOCHEMISTRY-US, V41, P2036, DOI 10.1021/bi011510o; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Flint DH, 1996, J BIOL CHEM, V271, P16068; Fontecilla-Camps JC, 2009, NATURE, V460, P814, DOI 10.1038/nature08299; Iwuchukwu IJ, 2010, NAT NANOTECHNOL, V5, P73, DOI [10.1038/NNANO.2009.315, 10.1038/nnano.2009.315]; Jones AK, 2002, CHEM COMMUN, P866, DOI 10.1039/b201337a; Kriek M, 2007, ANGEW CHEM INT EDIT, V46, P9223, DOI 10.1002/anie.200702554; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Le Goff A, 2009, SCIENCE, V326, P1384, DOI 10.1126/science.1179773; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Nicolet Y, 2010, FEBS LETT, V584, P4197, DOI 10.1016/j.febslet.2010.09.008; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 2006, FEBS LETT, V580, P363, DOI 10.1016/j.febslet.2005.12.040; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Ryde U, 2010, J AM CHEM SOC, V132, P4512, DOI 10.1021/ja909194f; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Tard C, 2009, CHEM REV, V109, P2245, DOI 10.1021/cr800542q; THORNELEY RNF, PROKARYOTIC NITROGEN; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456; Zhao DH, 2007, J BIOL CHEM, V282, P37016, DOI 10.1074/jbc.M708097200	39	68	69	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20346	10.1371/journal.pone.0020346	http://dx.doi.org/10.1371/journal.pone.0020346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21673792	gold, Green Submitted, Green Published			2022-12-25	WOS:000291097600048
J	Liu, Y; Dong, J; Wu, N; Gao, YP; Zhang, X; Mu, CH; Shao, NS; Fan, M; Yang, G				Liu, Yu; Dong, Jie; Wu, Na; Gao, Yaping; Zhang, Xin; Mu, Chunhua; Shao, Ningsheng; Fan, Ming; Yang, Guang			The Production of Extracellular Proteins Is Regulated by Ribonuclease III via Two Different Pathways in Staphylococcus aureus	PLOS ONE			English	Article							VIRULENCE FACTORS; RNASE-III; RNAIII; GENE; AGR; BINDING; IDENTIFICATION; PURIFICATION; INHIBITION; BIOGENESIS	Staphylococcus aureus ribonuclease III belongs to the enzyme family known to degrade double-stranded RNAs. It has previously been reported that RNase III cannot influence cell growth but regulates virulence gene expression in S. aureus. Here we constructed an RNase III inactivation mutant (Delta rnc) from S. aureus 8325-4. It was found that the extracellular proteins of Drnc were decreased. Furthermore, we explored how RNase III regulated the production of the extracellular proteins in S. aureus. We found during the lag phase of the bacterial growth cycle RNase III could influence the extracellular protein secretion via regulating the expression of secY2, one component of accessory secretory (sec) pathway. After S. aureus cells grew to exponential phase, RNase III can regulate the expression of extracellular proteins by affecting the level of RNAIII. Further investigation showed that the mRNA stability of secY2 and RNAIII was affected by RNase III. Our results suggest that RNase III could regulate the pathogenicity of S. aureus by influencing the level of extracellular proteins via two different ways respectively at different growth phases.	[Liu, Yu; Dong, Jie; Wu, Na; Gao, Yaping; Zhang, Xin; Mu, Chunhua; Shao, Ningsheng; Fan, Ming; Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Liu, Y (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	yanggg@hotmail.com			China National Key Programs on Basic Research [2005CB724600]; National Natural Science Foundation of China [30700007, 30870093]; National High-Tech Research and Development Program [2006AA02Z132, 2006AA02Z323]	China National Key Programs on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by grants from China National Key Programs on Basic Research (2005CB724600, http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (30700007, 30870093, http://www.nsfc.gov.cn/) and the National High-Tech Research and Development Program (2006AA02Z132, 2006AA02Z323, http://www.most.gov.cn/eng/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chevalier C, 2008, METHOD ENZYMOL, V447, P309, DOI 10.1016/S0076-6879(08)02216-7; Darfeuille F, 2007, MOL CELL, V26, P381, DOI 10.1016/j.molcel.2007.04.003; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Harraghy N, 2005, MICROBIOL-SGM, V151, P1789, DOI 10.1099/mic.0.27902-0; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lee LYL, 2004, J INFECT DIS, V190, P571, DOI 10.1086/422259; Lee LYL, 2004, J BIOL CHEM, V279, P50710, DOI 10.1074/jbc.M408570200; Liu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013069; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Meng WZ, 2008, METHOD ENZYMOL, V447, P119, DOI 10.1016/S0076-6879(08)02207-6; Miller J. H., 1972, ASSAY BETA GALACTOSI, V1972, P352; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Okan Nihal A., 2006, PLoS Pathogens, V2, P50; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; SCHWESINGER MD, 1975, J BACTERIOL, V123, P724, DOI 10.1128/JB.123.2.724-738.1975; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; Tegmark K, 1998, J BACTERIOL, V180, P3181, DOI 10.1128/JB.180.12.3181-3186.1998; Wagner EGH, 2002, ADV GENET, V46, P361; Wu H, 2007, J BACTERIOL, V189, P1390, DOI 10.1128/JB.00836-06; Xiong YQ, 2002, J INFECT DIS, V186, P668, DOI 10.1086/342046	37	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20554	10.1371/journal.pone.0020554	http://dx.doi.org/10.1371/journal.pone.0020554			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655230	Green Submitted, gold, Green Published			2022-12-25	WOS:000291097600096
J	Yuan, Z; Wang, F; Zhao, ZW; Zhao, XY; Qiu, J; Nie, CL; Wei, YQ				Yuan, Zhu; Wang, Fang; Zhao, Zhiwei; Zhao, Xinyu; Qiu, Ji; Nie, Chunlai; Wei, Yuquan			BIM-Mediated AKT Phosphorylation Is a Key Modulator of Arsenic Trioxide-Induced Apoptosis in Cisplatin-Sensitive and -Resistant Ovarian Cancer Cells	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBER; FORKHEAD TRANSCRIPTION FACTOR; BAX-DEPENDENT APOPTOSIS; RICTOR-MTOR COMPLEX; PROAPOPTOTIC ACTIVITY; NEURONAL APOPTOSIS; CARCINOMA CELLS; DOWN-REGULATION; LEUKEMIA-CELLS; ACTIVATION	Background: Chemo-resistance to cisplatin-centered cancer therapy is a major obstacle to the effective treatment of human ovarian cancer. Previous reports indicated that arsenic trioxide (ATO) induces cell apoptosis in both drug-sensitive and resistant ovarian cancer cells. Principal Findings: In this study, we determined the molecular mechanism of ATO-induced apoptosis in ovarian cancer cells. Our data demonstrated that ATO induced cell apoptosis by decreasing levels of phosphorylated AKT (p-AKT) and activating caspase-3 and caspase-9. Importantly, BIM played a critical role in ATO-induced apoptosis. The inhibition of BIM expression prevented AKT dephosphorylation and inhibited caspase-3 activation during cell apoptosis. However, surprisingly, gene silencing of AKT or FOXO3A had little effect on BIM expression and phosphorylation. Moreover, the activation of caspase-3 by ATO treatment improved AKT dephosphorylation, not only by cleaving the regulatory A subunit of protein phosphatase 2A (PP2A), but also by increasing its activation. Furthermore, our data indicated that the c-Jun N-terminal kinases (JNK) pathway is involved in the regulation of BIM expression. Conclusions: We demonstrated the roles of BIM in ATO-induced apoptosis and the molecular mechanisms of BIM expression regulated by ATO during ovarian cancer cell apoptosis. Our findings suggest that BIM plays an important role in regulating p-AKT by activating caspase-3 and that BIM mediates the level of AKT phosphorylation to determine the threshold for overcoming cisplatin resistance in ovarian cancer cells.	[Yuan, Zhu] Sichuan Univ, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Peoples R China; Sichuan Univ, Ctr Canc, W China Hosp, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University	Yuan, Z (corresponding author), Sichuan Univ, State Key Lab Biotherapy, W China Hosp, Chengdu 610064, Peoples R China.	niecl1022@scu.du.cn			Natural Science Foundation of China [(NSFC)-81071817/H1609, (NSFC)-30800581, (NSFC)-30900744]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China (NSFC)-81071817/H1609, (NSFC)-30800581 and (NSFC)-30900744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin E, 2001, CANCER RES, V61, P1862; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Bornstein J, 2005, GYNECOL ONCOL, V99, P726, DOI 10.1016/j.ygyno.2005.07.125; Brancolini Claudio, 2008, Curr Mol Pharmacol, V1, P24; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen KF, 2008, CANCER RES, V68, P6698, DOI 10.1158/0008-5472.CAN-08-0257; Cohen MH, 2001, ONCOLOGIST, V6, P4, DOI 10.1634/theoncologist.6-1-4; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; DEL PL, 1997, SCIENCE, V278, P687; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Du YH, 2001, CANCER CHEMOTH PHARM, V47, P481, DOI 10.1007/s002800100278; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fraser M, 2003, CANCER RES, V63, P7081; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Helm CW, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-2; Hennigan RF, 2001, MOL BIOL CELL, V12, P2352, DOI 10.1091/mbc.12.8.2352; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mann KK, 2008, MOL CANCER THER, V7, P1680, DOI 10.1158/1535-7163.MCT-07-2164; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; OZOLS RF, 1985, SEMIN ONCOL, V12, P21; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Ramos AM, 2005, BLOOD, V105, P4013, DOI 10.1182/blood-2004-07-2802; Redondo-Munoz J, 2010, CLIN CANCER RES, V16, P4382, DOI 10.1158/1078-0432.CCR-10-0072; Rudin CM, 2003, CANCER RES, V63, P312; Salzberg M, 2005, ONCOLOGY-BASEL, V68, P293, DOI 10.1159/000086967; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Simonin K, 2009, MOL CANCER THER, V8, P3162, DOI 10.1158/1535-7163.MCT-09-0493; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tacka KA, 2004, CHEM RES TOXICOL, V17, P1434, DOI 10.1021/tx0498760; Uslu R, 2000, CLIN CANCER RES, V6, P4957; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; ZHANG N, 2009, CANC SCI	55	67	74	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20586	10.1371/journal.pone.0020586	http://dx.doi.org/10.1371/journal.pone.0020586			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655183	Green Submitted, Green Published, gold			2022-12-25	WOS:000291097600103
J	Huynh, AS; Abrahams, DF; Torres, MS; Baldwin, MK; Gillies, RJ; Morse, DL				Huynh, Amanda Shanks; Abrahams, Dominique F.; Torres, Monica S.; Baldwin, Margaret K.; Gillies, Robert J.; Morse, David L.			Development of an Orthotopic Human Pancreatic Cancer Xenograft Model Using Ultrasound Guided Injection of Cells	PLOS ONE			English	Article							DELTA-OPIOID RECEPTOR; NUDE-MICE; MOUSE MODEL; GROWTH; TUMORS; LINES	Mice have been employed as models of cancer for over a century, providing significant advances in our understanding of this multifaceted family of diseases. In particular, orthotopic tumor xenograft mouse models are emerging as the preference for cancer research due to increased clinical relevance over subcutaneous mouse models. In the current study, we developed orthotopic pancreatic cancer xenograft models in mice by a minimally invasive method, ultrasound guided injection (USGI) comparable to highly invasive surgical orthotopic injection (SOI) methods. This optimized method prevented injection complications such as recoil of cells through the injection canal or leakage of cells out of the pancreas into the peritoneal cavity. Tumor growth was monitored in vivo and quantified by ultrasound imaging weekly, tumors were also detected by in vivo fluorescence imaging using a tumor targeted molecular probe. The mean tumor volumes for the USGI and SOI models after 2 weeks of tumor growth were 205 mm 3 and 178 mm 3 respectively. By USGI of human pancreatic cancer cell lines, human orthotopic pancreatic cancer xenografts were established. Based on ultrasound imaging, the orthotopic human pancreatic cancer xenograft take rate was 100% for both human pancreatic cancer cell lines used, MiaPaCa-2 and Su86.86, with mean tumor volumes of 28 mm(3) and 30 mm(3). We demonstrated that this USGI method is feasible, reproducible, facile, minimally invasive and improved compared to the highly-invasive SOI method for establishing orthotopic pancreatic tumor xenograft models suitable for molecular imaging.	[Huynh, Amanda Shanks; Gillies, Robert J.; Morse, David L.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Funct & Mol Imaging, Tampa, FL 33612 USA; [Abrahams, Dominique F.; Torres, Monica S.; Baldwin, Margaret K.] Univ S Florida, Div Comparat Med, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Huynh, AS (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Funct & Mol Imaging, Tampa, FL 33612 USA.	David.Morse@Moffitt.org	Morse, David/L-7277-2018	Huynh, Amanda/0000-0001-8133-1984; Gillies, Robert/0000-0002-8888-7747	NIH/NCI [R01-CA123547]; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA123547, R01CA077575, R01CA125627] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: NIH/NCI R01-CA123547 (http://www.nih.gov/, http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEKRUSE SF, 1975, SEER CANC STAT REV; Black KC, 2008, MOL IMAGING, V7, P50, DOI 10.2310/7290.2008.0007; Bouvet M, 2002, CANCER RES, V62, P1534; CHEON DJ, ANN REV PATHOL; Ding L, 2007, HEPATOB PANCREAT DIS, V6, P393; Ding Y., PANCREAS, V39, P283; Flatmark K, 2004, EUR J CANCER, V40, P1593, DOI 10.1016/j.ejca.2004.02.023; Hausner SH, 2009, CANCER RES, V69, P5843, DOI 10.1158/0008-5472.CAN-08-4410; Josan JS, 2009, ORG LETT, V11, P2479, DOI 10.1021/ol900200k; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Killion JJ, 1998, CANCER METAST REV, V17, P279, DOI 10.1023/A:1006140513233; Loukopoulos P, 2004, PANCREAS, V29, P193, DOI 10.1097/00006676-200410000-00004; MACHADO NO, JOP, V11, P377; MARINCOLA FM, 1989, J SURG RES, V47, P520, DOI 10.1016/0022-4804(89)90130-3; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; *REYN, 2005, METHODS MOL MED, V111; Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976; Schneider C, 2004, GUT, V53, P355, DOI 10.1136/gut.2003.026005; Snyder CS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-106; TAFRESHI NK, CANC RES; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; Vulfovich M, 2008, EXPERT REV ANTICANC, V8, P993, DOI 10.1586/14737140.8.6.993	23	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2011	6	5							e20330	10.1371/journal.pone.0020330	http://dx.doi.org/10.1371/journal.pone.0020330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769XV	21647423	gold, Green Submitted, Green Published			2022-12-25	WOS:000291052500045
J	Zhang, YJ; Ma, PF; Li, DZ				Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu			High-Throughput Sequencing of Six Bamboo Chloroplast Genomes: Phylogenetic Implications for Temperate Woody Bamboos (Poaceae: Bambusoideae)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GRASS FAMILY POACEAE; NATURAL HYBRIDIZATION; EVOLUTIONARY ANALYSIS; PLASTID GENOMES; GBSSI GENE; DNA; REGIONS; BAMBUSA; NUCLEAR	Background: Bambusoideae is the only subfamily that contains woody members in the grass family, Poaceae. In phylogenetic analyses, Bambusoideae, Pooideae and Ehrhartoideae formed the BEP clade, yet the internal relationships of this clade are controversial. The distinctive life history (infrequent flowering and predominance of asexual reproduction) of woody bamboos makes them an interesting but taxonomically difficult group. Phylogenetic analyses based on large DNA fragments could only provide a moderate resolution of woody bamboo relationships, although a robust phylogenetic tree is needed to elucidate their evolutionary history. Phylogenomics is an alternative choice for resolving difficult phylogenies. Methodology/Principal Findings: Here we present the complete nucleotide sequences of six woody bamboo chloroplast (cp) genomes using Illumina sequencing. These genomes are similar to those of other grasses and rather conservative in evolution. We constructed a phylogeny of Poaceae from 24 complete cp genomes including 21 grass species. Within the BEP clade, we found strong support for a sister relationship between Bambusoideae and Pooideae. In a substantial improvement over prior studies, all six nodes within Bambusoideae were supported with >= 0.95 posterior probability from Bayesian inference and 5/6 nodes resolved with 100% bootstrap support in maximum parsimony and maximum likelihood analyses. We found that repeats in the cp genome could provide phylogenetic information, while caution is needed when using indels in phylogenetic analyses based on few selected genes. We also identified relatively rapidly evolving cp genome regions that have the potential to be used for further phylogenetic study in Bambusoideae. Conclusions/Significance: The cp genome of Bambusoideae evolved slowly, and phylogenomics based on whole cp genome could be used to resolve major relationships within the subfamily. The difficulty in resolving the diversification among three clades of temperate woody bamboos, even with complete cp genome sequences, suggests that these lineages may have diverged very rapidly.	[Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China; [Zhang, Yun-Jie; Ma, Peng-Fei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Plant Germplasm & Genom Ctr, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Zhang, Yun-Jie; Ma, Peng-Fei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, YJ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Yunnan, Peoples R China.	dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Chen, Wei/0000-0002-6383-7540; Chen, Guoxun/0000-0001-6226-4050	Chinese Academy of Sciences [KSCX-YW-N-029]; National Natural Science Foundation of China [30990244]; Innovation Teams of Yunnan Province, China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Teams of Yunnan Province, China	This project is supported by the Chinese Academy of Sciences through a project under the knowledge innovation program (KSCX-YW-N-029), National Natural Science Foundation of China (no. 30990244) and a program of Innovation Teams of Yunnan Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2004, DNA RES, V11, P93, DOI 10.1093/dnares/11.2.93; Bapteste E, 2002, MOL BIOL EVOL, V19, P972, DOI 10.1093/oxfordjournals.molbev.a004156; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bystriakova N., 2003, BAMBOO BIODIVERSITY; Bystriakova N., 2004, BAMBOO BIODIVERSITY; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; CLARK LG, 1989, NATL GEOGR RES, V5, P459; CLARK LG, 1995, SYST BOT, V20, P436, DOI 10.2307/2419803; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; CUMMINGS MP, 1994, MOL BIOL EVOL, V11, P1; Davis JI, 2010, AM J BOT, V97, P874, DOI 10.3732/ajb.0900228; Diekmann K, 2009, DNA RES, V16, P165, DOI 10.1093/dnares/dsp008; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; DOYLE JJ, 1992, P NATL ACAD SCI USA, V89, P7722, DOI 10.1073/pnas.89.16.7722; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Egan AN, 2008, MOL PHYLOGENET EVOL, V46, P532, DOI 10.1016/j.ympev.2007.10.006; Gaut BS, 1997, MOL BIOL EVOL, V14, P769, DOI 10.1093/oxfordjournals.molbev.a025817; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Gong X. S., 1994, J WUHAN BOT RES, V12, P277; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Guisinger MM, 2010, J MOL EVOL, V70, P149, DOI 10.1007/s00239-009-9317-3; Hansen DR, 2007, MOL PHYLOGENET EVOL, V45, P547, DOI 10.1016/j.ympev.2007.06.004; HIRATSUKA J, 1989, MOL GEN GENET, V217, P185, DOI 10.1007/BF02464880; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INBAR, 1999, SOC ISS CONSTR BAMB; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Judziewicz EJ, 1999, AM BAMBOOS; Junior TC, 2004, CURR GENET, V46, P366, DOI 10.1007/s00294-004-0542-4; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Li D.-Z., 2006, FLORA CHINA, V22, P7; LI DZ, 1998, BAMBOO CONSERVATION; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; Masood MS, 2004, GENE, V340, P133, DOI 10.1016/j.gene.2004.06.008; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Moore MJ, 2010, P NATL ACAD SCI USA, V107, P4623, DOI 10.1073/pnas.0907801107; Morris LM, 2010, AM J BOT, V97, P620, DOI 10.3732/ajb.0900226; Ogihara Y, 2002, MOL GENET GENOMICS, V266, P740, DOI 10.1007/s00438-001-0606-9; Ohrnberger D, 1999, BAMBOOS WORLD ANNOTA; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Peng ZH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-116; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RENVOIZE SA, 1992, GRASS EVOLUTION DOME; Sanchez-Ken JG, 2007, SYST BOT, V32, P71, DOI 10.1600/036364407780360102; Saski C, 2007, THEOR APPL GENET, V115, P571, DOI [10.1007/s00122-007-0567-4, 10.1007/s00122-007-0595-0]; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Soltis DE, 2004, TRENDS PLANT SCI, V9, P477, DOI 10.1016/j.tplants.2004.08.008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun Y, 2005, BIOCHEM GENET, V43, P603, DOI 10.1007/s10528-005-9117-4; Sungkaew S, 2009, J PLANT RES, V122, P95, DOI 10.1007/s10265-008-0192-6; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Triplett JK, 2010, AM J BOT, V97, P471, DOI 10.3732/ajb.0900244; Triplett JK, 2010, SYST BOT, V35, P102, DOI 10.1600/036364410790862678; Wu FH, 2009, TREE PHYSIOL, V29, P847, DOI 10.1093/treephys/tpp015; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang HQ, 2008, MOL PHYLOGENET EVOL, V48, P809, DOI 10.1016/j.ympev.2008.06.001; Yang JB, 2010, TAXON, V59, P1102, DOI 10.1002/tax.594010; Zeng CX, 2010, MOL PHYLOGENET EVOL, V56, P821, DOI 10.1016/j.ympev.2010.03.041; Zhang WP, 2000, MOL PHYLOGENET EVOL, V15, P135, DOI 10.1006/mpev.1999.0729; Zhong BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005297	78	293	320	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20596	10.1371/journal.pone.0020596	http://dx.doi.org/10.1371/journal.pone.0020596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21655229	Green Published, gold, Green Submitted			2022-12-25	WOS:000291097600106
J	Zhang, Y; Chen, W; Li, R; Li, Y; Ge, YB; Chen, GX				Zhang, Yan; Chen, Wei; Li, Rui; Li, Yang; Ge, Yuebin; Chen, Guoxun			Insulin-Regulated Srebp-1c and Pck1 mRNA Expression in Primary Hepatocytes from Zucker Fatty but Not Lean Rats Is Affected by Feeding Conditions	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; GENE-EXPRESSION; CALORIC RESTRICTION; SIGNALING PATHWAY; MISSENSE MUTATION; ACID SYNTHESIS; X-RECEPTOR; LIVER; OBESITY; RESISTANCE	Insulin regulates the transcription of genes for hepatic glucose and lipid metabolism. We hypothesized that this action may be impaired in hepatocytes from insulin resistant animals. Primary hepatocytes from insulin sensitive Zucker lean (ZL) and insulin resistant Zucker fatty (ZF) rats in ad libitum or after an overnight fasting were isolated, cultured and treated with insulin and other compounds for analysis of gene expression using real-time PCR. The mRNA levels of one insulin-induced (Srebp-1c) and one insulin-suppressed (Pck1) genes in response to insulin, glucagon, and compactin treatments in hepatocytes from ad libitum ZL and ZF rats were analyzed. Additionally, the effects of insulin and T1317 on their levels in hepatocytes from ad libitum or fasted ZL or ZF rats were compared. The mRNA levels of Srebp-1c, Fas, and Scd1, but not that of Insr, Gck and Pck1, were higher in freshly isolated hepatocytes from ad libitum ZF than that from ZL rats. These patterns of Srebp-1c and Pck1 mRNA levels remained in primary hepatocyte cultured in vitro. Insulin's ability to regulate Srebp-1c and Pck1 expression was diminished in hepatocytes from ad libitum ZF, but not ZL rats. Glucagon or compactin suppressed Srebp-1c mRNA expression in lean, but not fatty hepatocytes. However, glucagon induced Pck1 mRNA expression similarly in hepatocytes from ad libitum ZL and ZF rats. Insulin caused the same dose-dependent increase of Akt phosphorylation in hepatocytes from ad libitum ZL and ZF rats. It synergized with T1317 to induce Srebp-1c, and suppressed Pck1 mRNA levels in hepatocytes from fasted, but not that from ad libitum ZF rats. We demonstrated that insulin was unable to regulate its downstream genes' mRNA expression in hepatocytes from ad libitum ZF rats. This impairment can be partially restored in hepatocytes from ZF rats after an overnight fasting, a phenomenon that deserves further investigation.	[Zhang, Yan; Chen, Wei; Li, Rui; Li, Yang; Ge, Yuebin; Chen, Guoxun] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [Ge, Yuebin] S Cent Univ Nationalities, Coll Pharm, Wuhan, Hubei, Peoples R China	University of Tennessee System; University of Tennessee Knoxville; South Central Minzu University	Zhang, Y (corresponding author), Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA.	gchen6@utk.edu	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Chen, Wei/0000-0002-6383-7540; Chen, Guoxun/0000-0001-6226-4050	American Heart Association [09SDG2140003]; University of Tennessee at Knoxville; Allen Foundation Inc.	American Heart Association(American Heart Association); University of Tennessee at Knoxville; Allen Foundation Inc.	This work was supported by the Scientist Development Grant from American Heart Association (09SDG2140003, to G.C.), a start-up fund from the University of Tennessee at Knoxville (to G.C.), and a research grant from Allen Foundation Inc. (to G.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1990, BIOCHEM J, V266, P91, DOI 10.1042/bj2660091; de Artinano AA, 2009, BRIT J NUTR, V102, P1246, DOI 10.1017/S0007114509990729; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Chen GX, 2007, BIOCHEM BIOPH RES CO, V361, P805, DOI 10.1016/j.bbrc.2007.07.108; Chen GX, 2009, BIOCHEM J, V419, P645, DOI 10.1042/BJ20082368; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chirieac DV, 2004, AM J PHYSIOL-ENDOC M, V287, pE42, DOI 10.1152/ajpendo.00297.2003; CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68; CLARK JB, 1982, ENDOCRINOLOGY, V111, P964, DOI 10.1210/endo-111-3-964; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Garnett KE, 2005, J MOL ENDOCRINOL, V35, P13, DOI 10.1677/jme.1.01792; Griffen SC, 2001, DIABETES, V50, P63, DOI 10.2337/diabetes.50.1.63; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; Horton JD, 2008, SCIENCE, V320, P1433, DOI 10.1126/science.1159651; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iida M, 1996, BIOCHEM BIOPH RES CO, V224, P597, DOI 10.1006/bbrc.1996.1070; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kabir M, 2005, AM J PHYSIOL-ENDOC M, V288, pE454, DOI 10.1152/ajpendo.00203.2004; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109; OKAUCHI N, 1995, DIABETES RES CLIN PR, V27, P97, DOI 10.1016/0168-8227(95)01029-D; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; STARKE A, 1987, J CLIN INVEST, V79, P20, DOI 10.1172/JCI112784; STEVENS J, 1981, MOL CELL BIOCHEM, V37, P177, DOI 10.1007/BF02354886; Takaya K, 1996, BIOCHEM BIOPH RES CO, V225, P75, DOI 10.1006/bbrc.1996.1133; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Unger RH, 1997, TRENDS ENDOCRIN MET, V8, P276, DOI 10.1016/S1043-2760(97)00094-5; Zhou YP, 1999, METABOLISM, V48, P857, DOI 10.1016/S0026-0495(99)90219-6; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320; ZUCKER LM, 1972, J LIPID RES, V13, P234; ZUCKER LM, 1961, J HERED, V52, P275, DOI 10.1093/oxfordjournals.jhered.a107093	55	293	320	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2011	6	6							e21342	10.1371/journal.pone.0021342	http://dx.doi.org/10.1371/journal.pone.0021342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782TF	21655229	Green Published, Green Submitted, gold			2022-12-25	WOS:000292033700064
